Citrus Sinensis ID: 007478

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600--
Protein Sequence
MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHSSRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTPLTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFSELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLSPLSPLPARTSGI
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEccccccEEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHcccccccEEEEEEEEEccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEcccccHHccccccccccccccccccccEEEcccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEccccccEEEEEEEcccccEEEEEEEcHHHHcccHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEHccccEcccccccccccccHHHHcccccccccEEHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHHcccccccccHHHHHccHHHHcccccHccccccccccccccccHHHHHccccccHHHcccccHHcEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHcccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mggdmsgqLFWQQLqsrgspeyspipsprmtspgpssriqsgavtpihpraggapiesqtswpddgkqqshrlplppitisnsspfshsnsaatspsvprspgrmenpvspeshwkkgkmlgrgtfghvyvgfnsdsgemcamKEVTLFDDAKSKESAKQLMQEIVLLSRlrhpnivqyygsktvEDKLYIYLEYVSGGSIYKLLQDygqfgepaiRNYTQQILSGLAFlhskhtvhrdikganilvdpngrvkladfgmakhiagqscplsfkgspywmapeviknssgcnlAVDIWSLGCTvlemattkppwsqyeGVAAMFKignskelptipddlsdEGKDFIRLClqrnplnrptaaelldhpfvkgaaplertilapepsdvppgvtngikalgigqlrnvstfdterlavhssrvsqtslnasdinismnrscpvspigspllhprspqhlngkmspspissprttsgastpltggsgaipfnhlkqpvylqegfgnlakptsnfygngpsyqdtnpdifrgmqpggshifselvpsendvlgkqlgrpvhgepydgqsvlADRVSRQFLKDqvkmnpsldlsplsplpartsgi
Flexible Loop (DISEMBL)
MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSaatspsvprspgrMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLlsrlrhpniVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHrdikganilvdpnGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILapepsdvppgVTNGIKALGIGQLRNVSTFDTERlavhssrvsqtslnasdinisMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTPLTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFSELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVkmnpsldlsplsplpartsgi
Low Complexity Region (SEG)
MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQTSWPDDGKQQSHRLPLPPitisnsspfshsnsaatsPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHSSRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMspspisspRTTSGASTPLTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFSELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNpsldlsplsplpARTSGI
Disordered region (IsUnstruct)
**********************************************************************************************************************KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD**********LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL**********GKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTIL**********VTNGIKALGIGQLRNVSTFDTERL***********************************************************************IPFNHLKQPVYLQEGFGNLAKPTSNFYG****************************************************************************************
Disordered Region (DISOPRED)
******************************************************************************************************************WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT***************QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK***************************************************************************************************************************************************************************************************************************************
Disordered Region (DISEMBL)
MGGDMSGQLFWQQL**************************SGAVTPIHPRAGGAPIE*************HRLPLPPITISNSS*****************************HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHSSRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQ**********************PLTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFSELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLSPLS*********
Disordered Region (DISPRO)
**************************************************************************************************************PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHSSR**************************************************************************************PTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFSELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLS************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHSSRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTPLTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFSELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLSPLSPLPARTSGI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	602	2.2.26 [Sep-21-2011]
Q9FZ36	651	Mitogen-activated protein	no	no	0.501	0.463	0.464	4e-76
O22040	666	Mitogen-activated protein	no	no	0.509	0.460	0.471	2e-74
O22042	651	Mitogen-activated protein	no	no	0.435	0.402	0.509	5e-72
Q54R82	942	Mitogen-activated protein	no	no	0.423	0.270	0.486	2e-68
Q39008	608	Mitogen-activated protein	no	no	0.440	0.435	0.512	2e-68
Q01389	1478	Serine/threonine-protein	yes	no	0.428	0.174	0.447	5e-64
Q9SZ67	1895	Probable WRKY transcripti	no	no	0.438	0.139	0.473	6e-63
Q10407	1116	MAP kinase kinase kinase	yes	no	0.426	0.230	0.439	2e-62
P28829	659	Protein kinase byr2 OS=Sc	no	no	0.421	0.385	0.453	3e-61
Q99759	626	Mitogen-activated protein	yes	no	0.418	0.402	0.457	4e-61

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  286 bits (731), Expect = 4e-76,   Method: Compositional matrix adjust.
 Identities = 152/327 (46%), Positives = 204/327 (62%), Gaps = 25/327 (7%)

Query: 61  SWPDDGKQQSHRLPLPPI-------TISNSSPFSHSNSAATSPSVPRSPGRMENPVSPES 113
           S  DD  Q++H  P P +        I  S  F+ S S   + +V          + P  
Sbjct: 16  STTDDENQENHPPPFPSLLADKITSCIRKSMVFAKSQSPPNNSTVQ---------IKPPI 66

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK----QLMQEIVLLS 169
            W+KG+++GRG FG VY+G N DSGE+ A+K+V +  +  SKE  +    +L +E+ LL 
Sbjct: 67  RWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLK 126

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            L HPNIV+Y G+   ++ L I LE+V GGSI  LL+ +G F E  +R YT Q+L GL +
Sbjct: 127 NLSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEY 186

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ---SCPLSFKGSPYWMAPEVIK 286
           LH+   +HRDIKGANILVD  G +KLADFG +K +A     S   S KG+PYWMAPEVI 
Sbjct: 187 LHNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVIL 246

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWS-QYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
             +G + + DIWS+GCTV+EM T K PWS QY+ +AA+F IG +K  P IPD++S +  D
Sbjct: 247 Q-TGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDAND 305

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKG 372
           F+  CLQ+ P  RPTA+ELL HPFV G
Sbjct: 306 FLLKCLQQEPNLRPTASELLKHPFVTG 332

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  280 bits (717), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 149/316 (47%), Positives = 198/316 (62%), Gaps = 9/316 (2%)

Query: 65  DGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRG 124
           D   Q ++ P P +     +     +     PS    P      ++P   W+KG+++GRG
Sbjct: 19  DDDNQENQPPFPGVLADKITSCIRKSKIFIKPSFSPPPPANTVDMAPPISWRKGQLIGRG 78

Query: 125 TFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK----QLMQEIVLLSRLRHPNIVQYY 180
            FG VY+G N DSGE+ A+K+V +  +  SKE  +    +L +E+ LL  L HPNIV+Y 
Sbjct: 79  AFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKNLSHPNIVRYL 138

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
           G+   +D L I LE+V GGSI  LL+ +G F E  +R YT+Q+L GL +LH+   +HRDI
Sbjct: 139 GTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYLHNHAIMHRDI 198

Query: 241 KGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           KGANILVD  G +KLADFG +K +   A  +   S KG+PYWMAPEVI   +G + + DI
Sbjct: 199 KGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVILQ-TGHSFSADI 257

Query: 298 WSLGCTVLEMATTKPPWS-QYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           WS+GCTV+EM T K PWS QY+ VAA+F IG +K  P IPD LS + KDF+  CLQ  P 
Sbjct: 258 WSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKDFLLKCLQEVPN 317

Query: 357 NRPTAAELLDHPFVKG 372
            RPTA+ELL HPFV G
Sbjct: 318 LRPTASELLKHPFVMG 333

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  272 bits (696), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 138/271 (50%), Positives = 182/271 (67%), Gaps = 9/271 (3%)

Query: 110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESA----KQLMQEI 165
           +P   W+KG+++G G FG VY+G N DSGE+ A+K+V +   + SKE      ++L +E+
Sbjct: 63  APSIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEV 122

Query: 166 VLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILS 225
            LL  L HPNIV+Y G+    D L I +E+V GGSI  LL+ +G F EP I  YT+Q+L 
Sbjct: 123 QLLKNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLL 182

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAP 282
           GL +LH+   +HRDIKGANILVD  G ++LADFG +K +   A  +   S KG+PYWMAP
Sbjct: 183 GLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAP 242

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWS-QYEGVAAMFKIGNSKELPTIPDDLSD 341
           EVI   +G + + DIWS+GCTV+EMAT KPPWS QY+  AA+  IG +K  P IP+DLS 
Sbjct: 243 EVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSP 301

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
           E KDF+  CL + P  R +A ELL HPFV G
Sbjct: 302 EAKDFLMKCLHKEPSLRLSATELLQHPFVTG 332

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  260 bits (664), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 127/261 (48%), Positives = 174/261 (66%), Gaps = 6/261 (2%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD---DAKSKESAKQLMQEIVLLSRL 171
           W+KG++LGRG +G VY+G N D+GE+ A+K++ + D   D K K       +EI ++  L
Sbjct: 170 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 229

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
           RH NIV+Y G+   +  L ++LEY+ GGSI  LL  +G F E  I+ YT+QIL GL+FLH
Sbjct: 230 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 289

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKNSSG 290
           +   +HRDIKGANIL+D  G VKL+DFG +K  +G      S +G+PYWMAPEVIK  +G
Sbjct: 290 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIKQ-TG 348

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA-MFKIGNSKELPTIPDDLSDEGKDFIRL 349
              + DIWSLGC ++EMAT +PPWS    +AA M+ I +S  +P IP  +S E  DF+ L
Sbjct: 349 HGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLNL 408

Query: 350 CLQRNPLNRPTAAELLDHPFV 370
           C +R+P  RP A +LL HPF+
Sbjct: 409 CFKRDPKERPDANQLLKHPFI 429

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  260 bits (664), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 142/277 (51%), Positives = 188/277 (67%), Gaps = 12/277 (4%)

Query: 107 NPVSPE-----SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD-AKSKESAKQ 160
           +P+ P+     + W+KG++LGRG+FG VY G + D G+  A+KEV+L D  ++++E  +Q
Sbjct: 320 SPIYPDGGAIITSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQ 378

Query: 161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
           L  EI LLS+L+H NIV+Y G+      LYI+LE V+ GS+ KL Q Y Q  +  +  YT
Sbjct: 379 LEGEIKLLSQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRY-QLRDSVVSLYT 437

Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           +QIL GL +LH K  +HRDIK ANILVD NG VKLADFG+AK ++  +   S KG+P+WM
Sbjct: 438 RQILDGLKYLHDKGFIHRDIKCANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWM 496

Query: 281 APEVI--KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           APEVI  K+S G     DIWSLGCTVLEM T + P+S  E V A+F+IG    LP +PD 
Sbjct: 497 APEVINRKDSDGYGSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGT-LPEVPDT 555

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
           LS + + FI  CL+ NP  RPTAAELL+HPFV+   P
Sbjct: 556 LSLDARLFILKCLKVNPEERPTAAELLNHPFVRRPLP 592

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q01389|BCK1_YEAST Serine/threonine-protein kinase BCK1/SLK1/SSP31 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=BCK1 PE=1 SV=1

 Score =  246 bits (627), Expect = 5e-64,   Method: Compositional matrix adjust.
 Identities = 120/268 (44%), Positives = 171/268 (63%), Gaps = 10/268 (3%)

Query: 112  ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE----SAKQLMQEIVL 167
            E  W KG+M+G+G+FG VY+  N  +GEM A+K+V +   +   E    + + L  E+  
Sbjct: 1172 EFAWMKGEMIGKGSFGAVYLCLNVTTGEMMAVKQVEVPKYSSQNEAILSTVEALRSEVST 1231

Query: 168  LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
            L  L H NIVQY G +   +   ++LEYV+GGS+  L++ YG+F EP I++ T Q+L GL
Sbjct: 1232 LKDLDHLNIVQYLGFENKNNIYSLFLEYVAGGSVGSLIRMYGRFDEPLIKHLTTQVLKGL 1291

Query: 228  AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG--QSCPLSFKGSPYWMAPEVI 285
            A+LHSK  +HRD+K  N+L+D +G  K++DFG+++       +  ++ +G+ +WMAPE++
Sbjct: 1292 AYLHSKGILHRDMKADNLLLDQDGICKISDFGISRKSKDIYSNSDMTMRGTVFWMAPEMV 1351

Query: 286  KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD----LSD 341
                G +  VDIWSLGC VLEM   K PWS  E VAAMFKIG SK  P IP+D    +S 
Sbjct: 1352 DTKQGYSAKVDIWSLGCIVLEMFAGKRPWSNLEVVAAMFKIGKSKSAPPIPEDTLPLISQ 1411

Query: 342  EGKDFIRLCLQRNPLNRPTAAELLDHPF 369
             G++F+  C + NP  RPTA ELL HPF
Sbjct: 1412 IGRNFLDACFEINPEKRPTANELLSHPF 1439

Serine/threonine protein kinase involved in a signal transduction pathway that play a role in yeast cell morphogenesis and cell growth. This pathway seems to starts by SMP3; then involve the kinase PKC1 that may act on this kinase. BCK1 probably phosphorylates MKK1 and MKK2 which themselves phosphorylate the MPK1 kinase.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1

 Score =  242 bits (617), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 141/298 (47%), Positives = 183/298 (61%), Gaps = 34/298 (11%)

Query: 79   TISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSG 138
            TISN+SP   S  +  +                   W+KG++LGRG+ G VY G ++D G
Sbjct: 1608 TISNTSPIYASEGSFITC------------------WQKGQLLGRGSLGSVYEGISAD-G 1648

Query: 139  EMCAMKEVTLFDD-AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVS 197
            +  A KEV+L D  +++ E  +Q+   I LLS+L+H NIV+Y G+   E  LYI+LE V+
Sbjct: 1649 DFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLELVT 1708

Query: 198  GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLAD 257
             GS+ KL Q   Q G+  +  YT+QIL GL +LH K  +HR+IK AN+LVD NG VKLAD
Sbjct: 1709 QGSLRKLYQ-RNQLGDSVVSLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKLAD 1767

Query: 258  FGMAKHIAGQSCPLSFKGSPY--WMAPEVI---KNSSGCNLAVDIWSLGCTVLEMATTKP 312
            FG+AK        +S   +PY  WMAPEVI   K+  G     DIWSLGCTVLEM T + 
Sbjct: 1768 FGLAK-------VMSLWRTPYWNWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTGQI 1820

Query: 313  PWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
            P+S  E   A++ IG  K LP IPD LS + +DFI  CL+ NP  RPTAAELL+HPFV
Sbjct: 1821 PYSDLEIGTALYNIGTGK-LPKIPDILSLDARDFILTCLKVNPEERPTAAELLNHPFV 1877

Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1

 Score =  240 bits (613), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 119/271 (43%), Positives = 170/271 (62%), Gaps = 14/271 (5%)

Query: 115  WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL------FDDAKSKESAKQLMQEIVLL 168
            W KG+++G GT+G V++  N ++GE+ A+K+V +        D   K+    +  EI ++
Sbjct: 825  WMKGELIGNGTYGKVFLAMNINTGELIAVKQVEIPQTINGRHDQLRKDIVDSINAEISMI 884

Query: 169  SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
            + L H NIVQY G +  E  + I+LEYVSGGSI + L++YG F E  +R  ++Q+L GL+
Sbjct: 885  ADLDHLNIVQYLGFEKTETDISIFLEYVSGGSIGRCLRNYGPFEEQLVRFVSRQVLYGLS 944

Query: 229  FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH---IAGQSCPLSFKGSPYWMAPEVI 285
            +LHSK  +HRD+K  N+L+D +G  K++DFG++KH   +      LS +GS +WMAPEVI
Sbjct: 945  YLHSKGIIHRDLKADNLLIDFDGVCKISDFGISKHSDNVYDNDANLSMQGSIFWMAPEVI 1004

Query: 286  KNS-SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL----S 340
             N   G +  VD+WSLGC VLEM   + PWS  E + AMFK+G  K+ P IP +L    S
Sbjct: 1005 HNDHQGYSAKVDVWSLGCVVLEMLAGRRPWSTDEAIQAMFKLGTEKKAPPIPSELVSQVS 1064

Query: 341  DEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             E   F+  C   N   RPTA ELL+HPF+K
Sbjct: 1065 PEAIQFLNACFTVNADVRPTAEELLNHPFMK 1095

May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  236 bits (603), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 121/267 (45%), Positives = 168/267 (62%), Gaps = 13/267 (4%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ----EIVLLSR 170
           W +G ++G G+FG VY+G N+ SGE+ A+K+V L   ++SK+   +L+     EI LL  
Sbjct: 394 WIRGALIGSGSFGQVYLGMNASSGELMAVKQVILDSVSESKDRHAKLLDALAGEIALLQE 453

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           L H +IVQY GS    D L I+LEYV GGS+  LL  YG F E  ++N+ +Q L GL +L
Sbjct: 454 LSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLEYL 513

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-------SFKGSPYWMAPE 283
           HS+  VHRDIKGANILVD  G++K++DFG++K +   S          SF+GS +WMAPE
Sbjct: 514 HSRGIVHRDIKGANILVDNKGKIKISDFGISKKLELNSTSTKTGGARPSFQGSSFWMAPE 573

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
           V+K +       DIWSLGC V+EM T+K P+   + + A+F+IG +  LP  P ++S   
Sbjct: 574 VVKQTMHTE-KTDIWSLGCLVIEMLTSKHPYPNCDQMQAIFRIGENI-LPEFPSNISSSA 631

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPFV 370
            DF+      +   RPTA+ELL HPFV
Sbjct: 632 IDFLEKTFAIDCNLRPTASELLSHPFV 658

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2

 Score =  236 bits (602), Expect = 4e-61,   Method: Compositional matrix adjust.
 Identities = 123/269 (45%), Positives = 166/269 (61%), Gaps = 17/269 (6%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ---LMQEIVLLSR 170
           +W++GK+LG+G FG VY+ ++ D+G   A K+V    D  S E++K+   L  EI LL  
Sbjct: 361 NWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQF--DPDSPETSKEVSALECEIQLLKN 418

Query: 171 LRHPNIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           L+H  IVQYYG      E  L I++EY+ GGS+   L+ YG   E   R YT+QIL G++
Sbjct: 419 LQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS 478

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL------SFKGSPYWMAP 282
           +LHS   VHRDIKGANIL D  G VKL DFG +K +  Q+  +      S  G+PYWM+P
Sbjct: 479 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICMSGTGMRSVTGTPYWMSP 536

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
           EVI +  G     D+WSLGCTV+EM T KPPW++YE +AA+FKI      P +P  +S+ 
Sbjct: 537 EVI-SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 595

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           G+DF+R         RP+A ELL H F +
Sbjct: 596 GRDFLRRIFV-EARQRPSAEELLTHHFAQ 623

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	602
224137054	902	predicted protein [Populus trichocarpa]	0.993	0.662	0.819	0.0
224119968	901	predicted protein [Populus trichocarpa]	0.995	0.664	0.829	0.0
255545234	911	ATP binding protein, putative [Ricinus c	0.988	0.653	0.834	0.0
359490486	892	PREDICTED: uncharacterized protein LOC10	0.986	0.665	0.819	0.0
449446021	896	PREDICTED: uncharacterized protein LOC10	0.990	0.665	0.789	0.0
356559774	898	PREDICTED: uncharacterized protein LOC10	0.988	0.662	0.787	0.0
147792548	919	hypothetical protein VITISV_040851 [Viti	0.950	0.622	0.815	0.0
356530846	897	PREDICTED: uncharacterized protein LOC10	0.988	0.663	0.784	0.0
449488637	889	PREDICTED: uncharacterized LOC101222716	0.953	0.645	0.786	0.0
307136490	889	ATP binding protein [Cucumis melo subsp.	0.953	0.645	0.786	0.0

>gi|224137054|ref|XP_002322482.1| predicted protein [Populus trichocarpa] gi|222869478|gb|EEF06609.1| predicted protein [Populus trichocarpa]

 Score = 1009 bits (2610), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 494/603 (81%), Positives = 541/603 (89%), Gaps = 5/603 (0%)

Query: 1   MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
           MGGDMSGQLFWQQ  SRGSPE SPIPSPRMTSPGPSSR+QSGAVTPIHPRAGG  IESQT
Sbjct: 304 MGGDMSGQLFWQQ--SRGSPECSPIPSPRMTSPGPSSRVQSGAVTPIHPRAGGT-IESQT 360

Query: 61  SWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKM 120
           SWPDDGKQQSHRLPLPP+T+S+ SPFSHSNSAA SPSVPRSPGR ENP SP S WKKGK+
Sbjct: 361 SWPDDGKQQSHRLPLPPVTVSSPSPFSHSNSAAASPSVPRSPGRAENPTSPGSRWKKGKL 420

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LGRGTFGHVY+GFNS+SGEMCAMKEVTLF DDAKSKESAKQLMQEI LLSR +HPNIVQY
Sbjct: 421 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAKQLMQEISLLSRFQHPNIVQY 480

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           YGS+TV D+LYIYLEYVSGGSIYKLLQ+YGQ GE  IR+YTQQILSGLAFLHSK TVHRD
Sbjct: 481 YGSETVGDRLYIYLEYVSGGSIYKLLQEYGQLGELVIRSYTQQILSGLAFLHSKSTVHRD 540

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           IKGANILVDPNGRVKLADFGMAKHI GQSCPLSFKGSPYWMAPEVIKNS+GCNLAVDIWS
Sbjct: 541 IKGANILVDPNGRVKLADFGMAKHITGQSCPLSFKGSPYWMAPEVIKNSNGCNLAVDIWS 600

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
           LGCTVLEMATTKPPWSQ+EGVAAMFKIGNSK+LP IP+DLSDEGKDF+R CLQRNP++RP
Sbjct: 601 LGCTVLEMATTKPPWSQFEGVAAMFKIGNSKDLPEIPEDLSDEGKDFVRQCLQRNPVHRP 660

Query: 360 TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHS 419
           TA++LL+HPFVK AAPLER IL  +P+D PPGV+NG+K LGI   RN  T D+ERLAVHS
Sbjct: 661 TASQLLEHPFVKLAAPLERPILCLDPTDPPPGVSNGVKILGINHARNFPTLDSERLAVHS 720

Query: 420 SRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTP 479
           SRVS+T L+ SD++I  N SCPVSPIGSPLLH RSPQHLNG+MSPSPI+SPRTTSG+STP
Sbjct: 721 SRVSKTGLHTSDLHIPRNISCPVSPIGSPLLHSRSPQHLNGRMSPSPIASPRTTSGSSTP 780

Query: 480 LTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFS 539
           LTG +GAIPFNHLK  V+ QEGFGN+   ++  Y NG +Y D++PD+FRGMQP GS IFS
Sbjct: 781 LTGCTGAIPFNHLKHSVHFQEGFGNMQNHSNGIYVNGLAYHDSSPDLFRGMQP-GSPIFS 839

Query: 540 ELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLSPLSPLPART 599
           ELVP END++GKQLGRP  GEPYDGQSVLADRVSRQ L+D VKM PSLDLSP SPLP+RT
Sbjct: 840 ELVPCENDLIGKQLGRPTQGEPYDGQSVLADRVSRQLLRDHVKMKPSLDLSPNSPLPSRT 899

Query: 600 SGI 602
            GI
Sbjct: 900 GGI 902

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119968|ref|XP_002318210.1| predicted protein [Populus trichocarpa] gi|222858883|gb|EEE96430.1| predicted protein [Populus trichocarpa]

 Score = 1002 bits (2590), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 500/603 (82%), Positives = 541/603 (89%), Gaps = 4/603 (0%)

Query: 1   MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
           MGGDMSGQLFWQQ  SRGSPE SPIPSPRMTSPGPSSR+QSGAVTPIHPRAGG  IESQT
Sbjct: 302 MGGDMSGQLFWQQ--SRGSPECSPIPSPRMTSPGPSSRVQSGAVTPIHPRAGGTIIESQT 359

Query: 61  SWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKM 120
           SW DDGKQQSHRLPLPP+ IS+ SPFSHSNSAA SPSVPRSPGR ENP SP S WKKGK+
Sbjct: 360 SWTDDGKQQSHRLPLPPVIISSPSPFSHSNSAAASPSVPRSPGRAENPTSPGSRWKKGKL 419

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LGRGTFGHVYVGFNS+ GE+CAMKEVTLF DDAKSKESAKQLMQEI LLSRL+HPNIVQY
Sbjct: 420 LGRGTFGHVYVGFNSERGELCAMKEVTLFSDDAKSKESAKQLMQEISLLSRLQHPNIVQY 479

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           +GS+TV D+LYIYLEYVSGGSIYKLLQ+YGQ GE  IR+YTQQILSGLAFLHSK TVHRD
Sbjct: 480 HGSETVGDRLYIYLEYVSGGSIYKLLQEYGQLGELVIRSYTQQILSGLAFLHSKSTVHRD 539

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           IKGANILVDPNGRVKLADFGMAKHI GQSCPLSFKGSPYWMAPEVIKNS+GCNLAVDIWS
Sbjct: 540 IKGANILVDPNGRVKLADFGMAKHITGQSCPLSFKGSPYWMAPEVIKNSNGCNLAVDIWS 599

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
           LGCTVLEMATTKPPWSQ+EGVAAMFKIGNSK+LPTIPD LSDEGKDF+R CLQRNPL+RP
Sbjct: 600 LGCTVLEMATTKPPWSQFEGVAAMFKIGNSKDLPTIPDHLSDEGKDFVRQCLQRNPLHRP 659

Query: 360 TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHS 419
           TAA+LL+HPFVK AAPLER I +PEP+D PPGVTNG+KA+GI Q RN  T D+ERLAVHS
Sbjct: 660 TAAQLLEHPFVKSAAPLERPIPSPEPTDPPPGVTNGVKAMGINQARNFPTLDSERLAVHS 719

Query: 420 SRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTP 479
           SRVS+T L ASD++I  N SCPVSPIGSPL H RSPQHLNG+MSPSPI+SPRTTSG+STP
Sbjct: 720 SRVSKTGLLASDLHIPRNISCPVSPIGSPLFHSRSPQHLNGRMSPSPIASPRTTSGSSTP 779

Query: 480 LTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFS 539
           LTGG+GAIPFNHLKQ VYLQEGFGN+   T+  Y NG +Y D+ PD+F+GMQP GS IFS
Sbjct: 780 LTGGTGAIPFNHLKQSVYLQEGFGNMPYHTNGIYANGLAYHDSIPDLFQGMQP-GSPIFS 838

Query: 540 ELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLSPLSPLPART 599
           ELVP END++GKQ GRP  GEPYDGQSVLA RVSRQ L+D VKM PSLDLSP SPLP+RT
Sbjct: 839 ELVPCENDLMGKQFGRPTQGEPYDGQSVLAVRVSRQLLRDHVKMKPSLDLSPNSPLPSRT 898

Query: 600 SGI 602
            GI
Sbjct: 899 GGI 901

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545234|ref|XP_002513678.1| ATP binding protein, putative [Ricinus communis] gi|223547586|gb|EEF49081.1| ATP binding protein, putative [Ricinus communis]

 Score =  978 bits (2528), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 503/603 (83%), Positives = 543/603 (90%), Gaps = 8/603 (1%)

Query: 1   MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
           MGGDMSGQL WQQ  SRGSPE SPIPSPRMTSPGPSSR+QSGAVTPIHPRAGGA IESQ 
Sbjct: 316 MGGDMSGQLLWQQ--SRGSPECSPIPSPRMTSPGPSSRVQSGAVTPIHPRAGGATIESQA 373

Query: 61  SWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKM 120
           SWPDDGKQQSHRLPLPP+++S+SSPFSHSNSAA SPSVPRSPGR ENP+SP S WKKGK+
Sbjct: 374 SWPDDGKQQSHRLPLPPVSVSSSSPFSHSNSAAASPSVPRSPGRAENPISPGSRWKKGKL 433

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LGRGTFGHVYVGFNS+SGEMCAMKEVTLF DDAKSKESAKQLMQEI LLSRLRHPNIVQY
Sbjct: 434 LGRGTFGHVYVGFNSESGEMCAMKEVTLFSDDAKSKESAKQLMQEIALLSRLRHPNIVQY 493

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           YGS+TV D+LYIYLEYVSGGSIYKLLQ+YG+ GE AIR+YTQQILSGLAFLHSK TVHRD
Sbjct: 494 YGSETVGDRLYIYLEYVSGGSIYKLLQEYGELGELAIRSYTQQILSGLAFLHSKSTVHRD 553

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           IKGANILVDPNGRVKLADFGMAKHI GQSCPLSFKGSPYWMAPEVIKNS+GCNLAVDIWS
Sbjct: 554 IKGANILVDPNGRVKLADFGMAKHITGQSCPLSFKGSPYWMAPEVIKNSNGCNLAVDIWS 613

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
           LGCTVLEMATTKPPWSQ+EGVAAMFKIGNSK+LP IPD LSDEGKDF+R CLQRNPL+RP
Sbjct: 614 LGCTVLEMATTKPPWSQFEGVAAMFKIGNSKDLPAIPDHLSDEGKDFVRQCLQRNPLHRP 673

Query: 360 TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHS 419
           TAA+LL+HPFVK AAPLER I   EP +  P VTNG+KALGI Q RN ++ D+ERLAVHS
Sbjct: 674 TAAQLLEHPFVKSAAPLERPISGIEPMEQAPVVTNGVKALGISQARNFTSSDSERLAVHS 733

Query: 420 SRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTP 479
           SRV +TS +AS+I+I  N SCPVSPIGSPLLH RSPQ    +MSPSPISSPRT SG+STP
Sbjct: 734 SRVLKTSPHASEIHIPRNISCPVSPIGSPLLHSRSPQ----RMSPSPISSPRTMSGSSTP 789

Query: 480 LTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFS 539
           LTGGSGAIPFNHLKQ VYLQEGFG+L KP++  Y NG SY D+NPD+FRGMQP GSHIFS
Sbjct: 790 LTGGSGAIPFNHLKQSVYLQEGFGSLPKPSNGIYINGLSYHDSNPDLFRGMQP-GSHIFS 848

Query: 540 ELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLSPLSPLPART 599
           ELVP ENDVLGKQLGRP +GE YDGQSVLADRVSRQ L+D VKMNPSLDLSP S LP RT
Sbjct: 849 ELVPCENDVLGKQLGRPAYGELYDGQSVLADRVSRQLLRDHVKMNPSLDLSPRSSLPNRT 908

Query: 600 SGI 602
           +G+
Sbjct: 909 TGL 911

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359490486|ref|XP_003634098.1| PREDICTED: uncharacterized protein LOC100242348 [Vitis vinifera] gi|302143826|emb|CBI22687.3| unnamed protein product [Vitis vinifera]

 Score =  970 bits (2508), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 494/603 (81%), Positives = 536/603 (88%), Gaps = 9/603 (1%)

Query: 1   MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
           MGGDMSGQLFWQ   SRGSPEYSPIPSPRMTSPGPSSRI SGAVTP+HPRAGGA  ESQT
Sbjct: 298 MGGDMSGQLFWQP--SRGSPEYSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGAASESQT 355

Query: 61  SWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKM 120
           SWPD+GKQQSHRLPLPP+ +S+SSPFSHSNS A SPSVPRSPGR E P SP S WKKGK+
Sbjct: 356 SWPDEGKQQSHRLPLPPVAVSSSSPFSHSNSPAASPSVPRSPGRAEAPTSPGSRWKKGKL 415

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LGRGTFGHVYVGFNS+SGEMCAMKEVTLF DDAKSKESAKQL QEIVLLSRL HPNIVQY
Sbjct: 416 LGRGTFGHVYVGFNSESGEMCAMKEVTLFSDDAKSKESAKQLGQEIVLLSRLCHPNIVQY 475

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           YGS+TV DKLYIYLEYVSGGSIYKLLQ+YGQ GE AIR+YTQQILSGLA+LH+K+TVHRD
Sbjct: 476 YGSETVGDKLYIYLEYVSGGSIYKLLQEYGQLGELAIRSYTQQILSGLAYLHAKNTVHRD 535

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           IKGANILVDP+GRVKLADFGMAKHI GQSCPLSFKGSPYWMAPEVI+NS+GCNLAVDIWS
Sbjct: 536 IKGANILVDPSGRVKLADFGMAKHITGQSCPLSFKGSPYWMAPEVIRNSNGCNLAVDIWS 595

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
           LGCTVLEMATTKPPWSQ+EGVAAMFKIGNSK+LP IPD LSDEGKDF+R CLQRNPL+RP
Sbjct: 596 LGCTVLEMATTKPPWSQFEGVAAMFKIGNSKDLPAIPDHLSDEGKDFVRQCLQRNPLHRP 655

Query: 360 TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHS 419
           TAA+LL+HPFVK AAPLER IL+PE SD PPGVTNG+K+LGIG  +N+S+ D+ERLAVHS
Sbjct: 656 TAAQLLEHPFVKNAAPLERPILSPETSDPPPGVTNGVKSLGIGHAKNLSSLDSERLAVHS 715

Query: 420 SRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTP 479
            RV +T  ++SD +I+ N SCPVSPIGSPLLH RSPQHLNG+MSPSPISSPRTTSG STP
Sbjct: 716 FRVLKTGSHSSDPHIARNISCPVSPIGSPLLHSRSPQHLNGRMSPSPISSPRTTSGPSTP 775

Query: 480 LTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFS 539
           LTGGSGAIPF HLK  VYLQEGFGN++KP +N Y NGPSY D N DIFRGMQ  GSHIF 
Sbjct: 776 LTGGSGAIPFPHLKPSVYLQEGFGNVSKPLNNPYSNGPSYHDPNADIFRGMQL-GSHIF- 833

Query: 540 ELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLSPLSPLPART 599
                E+D LGKQ GR  H E YDGQSVLADRVSRQ L+DQVKMNPSLDLSP S LP+R 
Sbjct: 834 ----PESDALGKQFGRTAHVELYDGQSVLADRVSRQLLRDQVKMNPSLDLSPSSMLPSRN 889

Query: 600 SGI 602
           +GI
Sbjct: 890 TGI 892

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446021|ref|XP_004140770.1| PREDICTED: uncharacterized protein LOC101214961 [Cucumis sativus] gi|449526154|ref|XP_004170079.1| PREDICTED: uncharacterized LOC101214961 [Cucumis sativus]

 Score =  964 bits (2492), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 477/604 (78%), Positives = 525/604 (86%), Gaps = 8/604 (1%)

Query: 1   MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
           MGGDM+G  FWQQ  SRGSPEYSP+PS RMTSPGPSSRIQSGAVTPIHPRAG  P ESQT
Sbjct: 299 MGGDMAGHFFWQQ--SRGSPEYSPVPSSRMTSPGPSSRIQSGAVTPIHPRAGAPPAESQT 356

Query: 61  SWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKM 120
            WPD+  +Q+HRLPLPPI IS  SPFSHSNSA TSPSVPRSPGR E P SP   WKKGK+
Sbjct: 357 CWPDE--KQTHRLPLPPIAISICSPFSHSNSAVTSPSVPRSPGRTETPASPGPRWKKGKL 414

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LGRGTFGHVYVGFNS+SGEMCAMKEVTLF DDAKS+ESAKQLMQEI LLSRLRHPNIVQY
Sbjct: 415 LGRGTFGHVYVGFNSESGEMCAMKEVTLFSDDAKSRESAKQLMQEIALLSRLRHPNIVQY 474

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           YGS+TV DK YIYLEYVSGGSIYKLLQ+YGQFGE AIR+YTQQILSGLA+LH+K TVHRD
Sbjct: 475 YGSETVGDKFYIYLEYVSGGSIYKLLQEYGQFGELAIRSYTQQILSGLAYLHAKATVHRD 534

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           IKGANILVDPNGRVKLADFGMAKHI GQSCPLSFKGSPYWMAPEVIKNS+GCNLAVD+WS
Sbjct: 535 IKGANILVDPNGRVKLADFGMAKHITGQSCPLSFKGSPYWMAPEVIKNSNGCNLAVDVWS 594

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
           LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP IP+ LSD+GKDF+RLCLQRNP +RP
Sbjct: 595 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPVIPEHLSDDGKDFVRLCLQRNPHHRP 654

Query: 360 TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHS 419
           TAA+LL+HPFVK AAP+ER IL  EPSD  PGVTNG+K LGIGQ R  S     RLAVHS
Sbjct: 655 TAAQLLEHPFVKHAAPVERPILISEPSDTTPGVTNGVKILGIGQSRTTSMDSDGRLAVHS 714

Query: 420 SRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTP 479
           SRVS+  L+AS+INIS N SCPVSPIGSPLLH RSPQH +G+MSPSPISSPRT SG+STP
Sbjct: 715 SRVSKAVLHASEINISRNISCPVSPIGSPLLHSRSPQHPSGRMSPSPISSPRTMSGSSTP 774

Query: 480 LTGGSGAIPFNHLKQPVYLQEGFGNLAKP-TSNFYGNGPSYQDTNPDIFRGMQPGGSHIF 538
           LTG  GAIP+NHLKQ +YLQEGF ++ K   S+ Y +G S+ D+NPDIFRG+QP G+HIF
Sbjct: 775 LTGCGGAIPYNHLKQTIYLQEGFVSMPKSLNSSPYSSGISFHDSNPDIFRGLQP-GAHIF 833

Query: 539 SELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLSPLSPLPAR 598
           SE++P EN+VLGKQ+GRP + E YDGQ +LADRVSRQ L+D VK NPSLDLSP + L  R
Sbjct: 834 SEMIP-ENEVLGKQIGRPAYSEVYDGQHILADRVSRQLLRDHVKANPSLDLSPSATLSGR 892

Query: 599 TSGI 602
            +GI
Sbjct: 893 MNGI 896

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356559774|ref|XP_003548172.1| PREDICTED: uncharacterized protein LOC100792783 [Glycine max]

 Score =  941 bits (2431), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 479/608 (78%), Positives = 523/608 (86%), Gaps = 13/608 (2%)

Query: 1   MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
           MGGDMSGQLFWQ   SRGSPEYSP+PSPRMTSPGPSSRIQSGAVTPIHPRAGG P ESQT
Sbjct: 298 MGGDMSGQLFWQP--SRGSPEYSPVPSPRMTSPGPSSRIQSGAVTPIHPRAGGTPNESQT 355

Query: 61  SWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKM 120
              DD K QSHRLPLPP+ ++N+ PFSHSNSAATSPS+PRSPGR +NP+SP S WKKGK+
Sbjct: 356 GRIDDVKPQSHRLPLPPLAVTNTLPFSHSNSAATSPSMPRSPGRADNPISPGSRWKKGKL 415

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LGRGTFGHVYVGFN +SGEMCAMKEVTLF DDAKSKESAKQLMQEI LLSRLRHPNIVQY
Sbjct: 416 LGRGTFGHVYVGFNKESGEMCAMKEVTLFSDDAKSKESAKQLMQEITLLSRLRHPNIVQY 475

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           YGS+TV DKLYIYLEYV+GGSIYKLLQ+YGQFGE AIR+YTQQILSGLA+LH+K+TVHRD
Sbjct: 476 YGSETVGDKLYIYLEYVAGGSIYKLLQEYGQFGELAIRSYTQQILSGLAYLHAKNTVHRD 535

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           IKGANILVD NGRVKLADFGMAKHI GQSCPLSFKGSPYWMAPEVIKNS+GCNLAVDIWS
Sbjct: 536 IKGANILVDTNGRVKLADFGMAKHITGQSCPLSFKGSPYWMAPEVIKNSNGCNLAVDIWS 595

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
           LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD LS EGKDF+R CLQRNP NRP
Sbjct: 596 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDHLSSEGKDFVRKCLQRNPHNRP 655

Query: 360 TAAELLDHPFVKGAAPLERTILAPE-PSDVPP---GVTNGIKALGIGQLRNVSTFDTERL 415
           +A+ELLDHPFVK AAPLER IL PE PSD  P   G+T G  A GIGQ RN S  D++RL
Sbjct: 656 SASELLDHPFVKCAAPLERPILGPESPSDPAPAVSGITQGATASGIGQGRNPSKLDSDRL 715

Query: 416 AVHSSRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSG 475
           ++HSSR  +T+ +AS+I+I  N SCPVSPIGSPLL PRSPQH+NG+MSPSPISSPRT SG
Sbjct: 716 SLHSSRFLKTNPHASEIHIPRNISCPVSPIGSPLLRPRSPQHMNGRMSPSPISSPRTASG 775

Query: 476 ASTPLTGGSGAIPF-NHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGG 534
           ASTPL GGSGAIPF NHL   VY+QEG GNL K ++  Y +GP++ D N DIFRGMQ   
Sbjct: 776 ASTPLNGGSGAIPFSNHL---VYIQEGLGNLPKSSNGVYVSGPAHHDLNVDIFRGMQ-QT 831

Query: 535 SHIFSELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLSPLSP 594
           SHI SELVPSE+DVLGKQ  R  H EPYD QSVLADRV RQ L D VK+N  LDLSP S 
Sbjct: 832 SHITSELVPSESDVLGKQFARTPHNEPYDVQSVLADRVCRQLLGDNVKINQCLDLSPNS- 890

Query: 595 LPARTSGI 602
           L +R +G+
Sbjct: 891 LLSRANGL 898

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147792548|emb|CAN65619.1| hypothetical protein VITISV_040851 [Vitis vinifera]

 Score =  931 bits (2405), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 477/585 (81%), Positives = 517/585 (88%), Gaps = 13/585 (2%)

Query: 1   MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
           MGGDMSGQLFWQ   SRGSPEYSPIPSPRMTSPGPSSRI SGAVTP+HPRAGGA  ESQT
Sbjct: 298 MGGDMSGQLFWQP--SRGSPEYSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGAASESQT 355

Query: 61  SWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKM 120
           SWPD+GKQQSHRLPLPP+ +S+SSPFSHSNS A SPSVPRSPGR E P SP S WKKGK+
Sbjct: 356 SWPDEGKQQSHRLPLPPVAVSSSSPFSHSNSPAASPSVPRSPGRAEAPTSPGSRWKKGKL 415

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LGRGTFGHVYVGFNS+SGEMCAMKEVTLF DDAKSKESAKQL QEIVLLSRL HPNIVQY
Sbjct: 416 LGRGTFGHVYVGFNSESGEMCAMKEVTLFSDDAKSKESAKQLGQEIVLLSRLCHPNIVQY 475

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           YGS+TV DKLYIYLEYVSGGSIYKLLQ+YGQ GE AIR+YTQQILSGLA+LH+K+TVHRD
Sbjct: 476 YGSETVGDKLYIYLEYVSGGSIYKLLQEYGQLGELAIRSYTQQILSGLAYLHAKNTVHRD 535

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE----VIKNSSGCNLAV 295
           IKGANILVDP+GRVKLADFGMAKHI GQSCPLSFKGSPYWMAPE    VI+NS+GCNLAV
Sbjct: 536 IKGANILVDPSGRVKLADFGMAKHITGQSCPLSFKGSPYWMAPELFAQVIRNSNGCNLAV 595

Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           DIWSLGCTVLEMATTKPPWSQ+EGVAAMFKIGNSK+LP IPD LSDEGKDF+R CLQRNP
Sbjct: 596 DIWSLGCTVLEMATTKPPWSQFEGVAAMFKIGNSKDLPAIPDHLSDEGKDFVRQCLQRNP 655

Query: 356 LNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERL 415
           L+RPTAA+LL+HPFVK AAPLER IL+PE SD PPGVTNG+K+LGIG  +N+S+ D+ERL
Sbjct: 656 LHRPTAAQLLEHPFVKNAAPLERPILSPETSDPPPGVTNGVKSLGIGHAKNLSSLDSERL 715

Query: 416 AVHSSRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSG 475
           AVHS RV +T  ++SD +I+ N SCPVSPIGSPLLH RSPQHLNG+MSPSPISSPRTTSG
Sbjct: 716 AVHSFRVLKTGSHSSDPHIARNISCPVSPIGSPLLHSRSPQHLNGRMSPSPISSPRTTSG 775

Query: 476 ASTPLTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGS 535
            STPLTGGSGAIPF HLK  VYLQEGFGN++KP +N Y NGPSY D N DIFRGMQ  GS
Sbjct: 776 PSTPLTGGSGAIPFPHLKPSVYLQEGFGNVSKPLNNPYSNGPSYHDPNADIFRGMQL-GS 834

Query: 536 HIFSELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQ 580
           HIF      E+D LGKQ GR  H E YDGQSVLADRVSRQ L+DQ
Sbjct: 835 HIF-----PESDALGKQFGRTAHVELYDGQSVLADRVSRQLLRDQ 874

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356530846|ref|XP_003533990.1| PREDICTED: uncharacterized protein LOC100819762 [Glycine max]

 Score =  929 bits (2400), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 476/607 (78%), Positives = 522/607 (85%), Gaps = 12/607 (1%)

Query: 1   MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
           MGGDMSGQLFWQ   SRGSPEYSP+PSPRMTSPGPSSRIQSGAVTPIHPRAGG P ESQT
Sbjct: 298 MGGDMSGQLFWQP--SRGSPEYSPVPSPRMTSPGPSSRIQSGAVTPIHPRAGGTPNESQT 355

Query: 61  SWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKM 120
              DD K QSHRLPLPP+ ++N+ PFSHSNSAATSPS+PRSPGR +NP+SP S WKKGK+
Sbjct: 356 GRVDDVKPQSHRLPLPPLAVTNTLPFSHSNSAATSPSMPRSPGRADNPISPGSRWKKGKL 415

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LGRGTFGHVYVGFN +SGEMCAMKEVTLF DDAKSKESAKQLMQEI LLSRLRHPNIVQY
Sbjct: 416 LGRGTFGHVYVGFNKESGEMCAMKEVTLFSDDAKSKESAKQLMQEITLLSRLRHPNIVQY 475

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           YGS+TV DKLYIYLEYV+GGSIYKLLQ+YGQFGE AIR++TQQILSGLA+LH+K+TVHRD
Sbjct: 476 YGSETVGDKLYIYLEYVAGGSIYKLLQEYGQFGELAIRSFTQQILSGLAYLHAKNTVHRD 535

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           IKGANILVD NGRVKLADFGMAKHI GQSCPLSFKGSPYWMAPEVIKNS+GCNLAVDIWS
Sbjct: 536 IKGANILVDTNGRVKLADFGMAKHITGQSCPLSFKGSPYWMAPEVIKNSNGCNLAVDIWS 595

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
           LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD LS EGKDF+R CLQRNP NRP
Sbjct: 596 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDHLSCEGKDFVRKCLQRNPHNRP 655

Query: 360 TAAELLDHPFVKGAAPLERTILAPE-PSD-VPPGVTNGIKALGIGQLRNVSTFDTERLAV 417
           +A+ELLDHPFVK AAPLER IL PE PSD    G+T G    GIGQ RN S  D++RL++
Sbjct: 656 SASELLDHPFVKYAAPLERPILGPESPSDPAVSGITQGATTSGIGQGRNPSKLDSDRLSL 715

Query: 418 HSSRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGAS 477
           HSSR  +T+ +AS+I+I  N SCPVSPIGSPLL PRSPQH+NG+MSPSPISSPRT SGAS
Sbjct: 716 HSSRFLKTNPHASEIHIPRNISCPVSPIGSPLLRPRSPQHMNGRMSPSPISSPRTASGAS 775

Query: 478 TPLTGGSGAIPF-NHLKQPVYLQEGFGNLAKPTSNFYGNGP-SYQDTNPDIFRGMQPGGS 535
           TPL GGSGAIPF NHL   VY+QEG G+L K ++  Y + P ++ D N DIFRGMQ   S
Sbjct: 776 TPLNGGSGAIPFSNHL---VYIQEGLGSLPKSSNGVYVSVPAAHHDLNIDIFRGMQ-QTS 831

Query: 536 HIFSELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKMNPSLDLSPLSPL 595
           HI SELVPSE+DVLGKQ  R  H EPYD QSVLADRV RQ L D VK+NPSLDLSP S L
Sbjct: 832 HITSELVPSESDVLGKQFARSPHNEPYDVQSVLADRVCRQLLGDNVKINPSLDLSPNS-L 890

Query: 596 PARTSGI 602
            +R +G+
Sbjct: 891 LSRANGL 897

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449488637|ref|XP_004158123.1| PREDICTED: uncharacterized LOC101222716 [Cucumis sativus]

 Score =  925 bits (2390), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 458/582 (78%), Positives = 506/582 (86%), Gaps = 8/582 (1%)

Query: 1   MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
           MGGD+SGQLF QQ  SRGSPEYSP+PSPRMTSPGPSSR+ SGAVTPIHPRAGG P +SQT
Sbjct: 298 MGGDLSGQLFLQQ--SRGSPEYSPVPSPRMTSPGPSSRVHSGAVTPIHPRAGGIPTDSQT 355

Query: 61  SWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKM 120
           SWPD+  +Q+HRLPLPP+ ISN+ PFSHSNSAATSPSVPRSPGR +NP SP S WKKGK+
Sbjct: 356 SWPDE--KQTHRLPLPPVAISNA-PFSHSNSAATSPSVPRSPGRADNPASPGSRWKKGKL 412

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LGRGTFGHVYVGFNS+SGEMCAMKEVTLF DDAKSKESAKQLMQEI LLSRLRHPNIVQY
Sbjct: 413 LGRGTFGHVYVGFNSESGEMCAMKEVTLFSDDAKSKESAKQLMQEITLLSRLRHPNIVQY 472

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           YGS+TV D+ YIYLEYVSGGSIYKLLQ+YGQ G+ A+R+YTQQILSGLA+LH+K TVHRD
Sbjct: 473 YGSETVGDRFYIYLEYVSGGSIYKLLQEYGQLGDSALRSYTQQILSGLAYLHAKSTVHRD 532

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           IKGANILVDP GRVKLADFGMAKHI GQSCPLSFKGSPYWMAPEVIKNS+GCNLAVDIWS
Sbjct: 533 IKGANILVDPTGRVKLADFGMAKHITGQSCPLSFKGSPYWMAPEVIKNSNGCNLAVDIWS 592

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
           LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP IPD LS +GKDF+R CLQRNP +RP
Sbjct: 593 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPEIPDYLSHDGKDFVRQCLQRNPAHRP 652

Query: 360 TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHS 419
           TAA+LL+HPFVK AAPLER IL  E SD  PG+TNG++ LGI Q RN S  D++R A HS
Sbjct: 653 TAAQLLEHPFVKHAAPLERPILGSEHSDPTPGITNGVRTLGIEQGRNPSFLDSDRSAAHS 712

Query: 420 SRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTP 479
           SR+   + ++S+I+I  N SCPVSPIGSPL+H RSPQH +G+MSPSPISSPR  SGASTP
Sbjct: 713 SRLPTAAFHSSEIHIPRNLSCPVSPIGSPLVHSRSPQHPSGRMSPSPISSPRNMSGASTP 772

Query: 480 LTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFS 539
           LTGGSGAIP  HLKQ +YLQEGFGNL KP+   Y NGPS+ DTNPDIF+G+QP GSHIFS
Sbjct: 773 LTGGSGAIPHQHLKQSLYLQEGFGNLPKPSMAPYSNGPSFHDTNPDIFQGIQP-GSHIFS 831

Query: 540 ELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQV 581
           ELV  E D LGKQ G+P   E YDGQ+VLADRVSRQ L D +
Sbjct: 832 ELVHHETDFLGKQFGKPA-WELYDGQAVLADRVSRQLLSDHI 872

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|307136490|gb|ADN34290.1| ATP binding protein [Cucumis melo subsp. melo]

 Score =  925 bits (2390), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 458/582 (78%), Positives = 505/582 (86%), Gaps = 8/582 (1%)

Query: 1   MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
           MGGD+SGQLF QQ  SRGSPEYSP+PSPRMTSPGPSSR+ SGAVTPIHPRAGG P ESQT
Sbjct: 298 MGGDLSGQLFLQQ--SRGSPEYSPVPSPRMTSPGPSSRVHSGAVTPIHPRAGGIPTESQT 355

Query: 61  SWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKM 120
           SWPD+  +Q+HRLPLPP+ ISN+ PFSHSNSAATSPSVPRSPGR +NP SP S WKKGK+
Sbjct: 356 SWPDE--KQTHRLPLPPVAISNA-PFSHSNSAATSPSVPRSPGRADNPASPGSRWKKGKL 412

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LGRGTFGHVYVGFNS+SGEMCAMKEVTLF DDAKSKESAKQLMQEI LLSRLRHPNIVQY
Sbjct: 413 LGRGTFGHVYVGFNSESGEMCAMKEVTLFSDDAKSKESAKQLMQEITLLSRLRHPNIVQY 472

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           YGS+TV D+ YIYLEYVSGGSIYKLLQ+YGQ G+ A+R+YTQQILSGLA+LH+K TVHRD
Sbjct: 473 YGSETVGDRFYIYLEYVSGGSIYKLLQEYGQLGDSALRSYTQQILSGLAYLHAKSTVHRD 532

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           IKGANILVDP GRVKLADFGMAKHI GQSCPLSFKGSPYWMAPEVIKNS+GCNLAVDIWS
Sbjct: 533 IKGANILVDPTGRVKLADFGMAKHITGQSCPLSFKGSPYWMAPEVIKNSNGCNLAVDIWS 592

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
           LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP IPD LS +GKDF+R CLQRNP +RP
Sbjct: 593 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPEIPDHLSHDGKDFVRQCLQRNPAHRP 652

Query: 360 TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHS 419
           TAA+LL+HPFVK AAPLER IL  E SD  PG+TNG++ LGI Q RN S  D++R A HS
Sbjct: 653 TAAQLLEHPFVKHAAPLERPILGSEHSDPTPGITNGVRTLGIEQGRNPSFLDSDRSAAHS 712

Query: 420 SRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTP 479
           SR+   + ++S+I+I  N SCPVSPIGSPL+H RSPQH +G+MSPSPISSPR  SGASTP
Sbjct: 713 SRLPTAAFHSSEIHIPRNLSCPVSPIGSPLVHSRSPQHPSGRMSPSPISSPRNMSGASTP 772

Query: 480 LTGGSGAIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQPGGSHIFS 539
           LTGGSGAIP  HLKQ +YLQEGFGNL KP+   Y NGPS+ D NPDIF+G+QP GSHIFS
Sbjct: 773 LTGGSGAIPHQHLKQSLYLQEGFGNLPKPSMAPYSNGPSFHDINPDIFQGIQP-GSHIFS 831

Query: 540 ELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQV 581
           ELV  E D LGKQ G+P   E YDGQ+VLADRVSRQ L D +
Sbjct: 832 ELVHHETDFLGKQFGKPA-WELYDGQAVLADRVSRQLLSDHI 872

Source: Cucumis melo subsp. melo

Species: Cucumis melo

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	602
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.940	0.640	0.609	5.4e-182
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.676	0.668	0.538	1.6e-109
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.624	0.525	0.508	1.3e-96
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.509	0.460	0.471	1.8e-72
TAIR|locus:2080394	651	NP3 "NPK1-related protein kina	0.451	0.417	0.498	2.6e-71
UNIPROTKB|Q40541	690	Q40541 "Protein kinase" [Nicot	0.485	0.423	0.478	1e-68
DICTYBASE|DDB_G0283265	1267	mkkA "octicosapeptide/Phox/Bem	0.423	0.201	0.486	3.2e-65
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.440	0.435	0.512	6e-64
TAIR|locus:2133529	560	MEKK3 "MAPK/ERK kinase kinase	0.435	0.467	0.505	3.9e-60
SGD|S000003631	1478	BCK1 "MAPKKK acting in the pro	0.426	0.173	0.457	2.1e-58

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1766 (626.7 bits), Expect = 5.4e-182, P = 5.4e-182
 Identities = 362/594 (60%), Positives = 430/594 (72%)

Query:     1 MGGDMSGQLFWQQLQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQT 60
             +GGDM+ QLFW Q  SR SPE SP+PSPRMTSPGPSSRIQSGAVTP+HPRAGG+   S T
Sbjct:   288 IGGDMATQLFWPQ--SRCSPECSPVPSPRMTSPGPSSRIQSGAVTPLHPRAGGSTTGSPT 345

Query:    61 SWPDDGKQQSHRLPLPPXXXXXXXXXXXXXXXXXXPSVPRSPGRMENPVSPESHWKKGKM 120
                DD +QQSHRLPLPP                  PSVPRSP R E  VSP S WKKG++
Sbjct:   346 RRLDDNRQQSHRLPLPPLLISNTCPFSPTYSAATSPSVPRSPARAEATVSPGSRWKKGRL 405

Query:   121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
             LG G+FGHVY+GFNS+SGEMCAMKEVTL  DD KS+ESA+QL QEI +LSRLRH NIVQY
Sbjct:   406 LGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRHQNIVQY 465

Query:   180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
             YGS+TV+DKLYIYLEYVSGGSIYKLLQ+YGQFGE AIRNYTQQILSGLA+LH+K+TVHRD
Sbjct:   466 YGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAKNTVHRD 525

Query:   240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
             IKGANILVDP+GRVK+ADFGMAKHI  QS PLSFKGSPYWMAPEVIKNS+G NLAVDIWS
Sbjct:   526 IKGANILVDPHGRVKVADFGMAKHITAQSGPLSFKGSPYWMAPEVIKNSNGSNLAVDIWS 585

Query:   300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
             LGCTVLEMATTKPPWSQYEGV AMFKIGNSKELP IPD LS+EGKDF+R CLQRNP NRP
Sbjct:   586 LGCTVLEMATTKPPWSQYEGVPAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQRNPANRP 645

Query:   360 TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHS 419
             TAA+LLDH FV+   P+ER I++ EP++     ++ +++L IG  R++   D+E     +
Sbjct:   646 TAAQLLDHAFVRNVMPMERPIVSGEPAEAMNVASSTMRSLDIGHARSLPCLDSE----DA 701

Query:   420 SRVSQTSL-NASDINISM---NRSCPVSPIGSPLLHPRSPQHLNGKMXXXXXXXXRTTSG 475
             +   Q  L + S  +IS    N SCP+SP+GSP+ H  SP H++G+            SG
Sbjct:   702 TNYQQKGLKHGSGFSISQSPRNMSCPISPVGSPIFHSHSP-HISGRRSPSPISSPHALSG 760

Query:   476 ASTPLTGGSGAIPFNHLKQPV--YLQEGFGNLAKPTS--NFYGNGPSYQDTN--PDIFRG 529
             +STPLTG  GAIPF+H +Q    +L EG G+   P S  NFY N   +Q+ +   D  R 
Sbjct:   761 SSTPLTGCGGAIPFHHQRQTTVNFLHEGIGSSRSPGSGGNFYTNS-FFQEPSRQQDRSRS 819

Query:   530 MQPGGSHIFSELVPSENDVLGKQLGRPVHGEPYDGQSVLADRVSRQFLKDQVKM 583
                   H+F +     N  +     +P +    D Q VL+D VS+Q L + +K+
Sbjct:   820 SPRTPPHVFWD----NNGSI-----QPGYNWNKDNQPVLSDHVSQQLLSEHLKL 864

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1082 (385.9 bits), Expect = 1.6e-109, P = 1.6e-109
 Identities = 230/427 (53%), Positives = 281/427 (65%)

Query:    27 SPRMTSPGPSSRIQSGAVTPIHPRAGGA-PIESQTSWPDDGKQQS--HRLPLPPXXXXXX 83
             SP   SP  ++ I +   +P H R  G   +ES T   DDG+  S  H LP PP      
Sbjct:   134 SPERVSP-KAATITTRPTSPRHQRLSGVVSLESSTGRNDDGRSSSECHPLPRPPTSPTSP 192

Query:    84 XXXXXXXXXXXXPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAM 143
                             R  G  E   S  S WKKGK LG GTFG VY+GFNS+ G+MCA+
Sbjct:   193 SAVHGS----------RIGGGYETSPSGFSTWKKGKFLGSGTFGQVYLGFNSEKGKMCAI 242

Query:   144 KEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIY 202
             KEV +  DD  SKE  KQL QEI LL++L HPNIVQYYGS+  E+ L +YLEYVSGGSI+
Sbjct:   243 KEVKVISDDQTSKECLKQLNQEINLLNQLCHPNIVQYYGSELSEETLSVYLEYVSGGSIH 302

Query:   203 KLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK 262
             KLL+DYG F EP I+NYT+QIL+GLA+LH ++TVHRDIKGANILVDPNG +KLADFGMAK
Sbjct:   303 KLLKDYGSFTEPVIQNYTRQILAGLAYLHGRNTVHRDIKGANILVDPNGEIKLADFGMAK 362

Query:   263 HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA 322
             H+   S  LSFKGSPYWMAPEV+ + +G   AVDIWSLGCT+LEMAT+KPPWSQ+EGVAA
Sbjct:   363 HVTAFSTMLSFKGSPYWMAPEVVMSQNGYTHAVDIWSLGCTILEMATSKPPWSQFEGVAA 422

Query:   323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILA 382
             +FKIGNSK+ P IPD LS++ K+FIRLCLQRNP  RPTA++LL+HPF++    +  T L 
Sbjct:   423 IFKIGNSKDTPEIPDHLSNDAKNFIRLCLQRNPTVRPTASQLLEHPFLRNTTRVASTSL- 481

Query:   383 PEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHSSRVSQTSLNASDINISMNRSCPV 442
               P D PP   +G  +L   +         +  A     +S+T  + S  N+    S PV
Sbjct:   482 --PKDFPPRSYDGNFSLQPTREPYPGRLSHDNYA--KQPLSRTIKSPSRENVRAITSLPV 537

Query:   443 SPIGSPL 449
             SP  SPL
Sbjct:   538 SPCSSPL 544

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 932 (333.1 bits), Expect = 1.3e-96, Sum P(2) = 1.3e-96
 Identities = 214/421 (50%), Positives = 273/421 (64%)

Query:    19 SPEYSPIP-SPR--MTSPGPSSRIQSGAVTPIHPRAGGAPIESQTSWP-------D--DG 66
             SP +SP P SPR  + SP PS R  S    P+H     AP     S P       D  +G
Sbjct:   248 SPIHSPQPRSPRKQIRSPQPS-RPSS----PLHSVDSSAPPRDSVSSPLHPRLSTDVTNG 302

Query:    67 KQQS---HRLPLPPXXXXXXXXXXXXXXXXXXPSVPRSPGRMEN-PVSPESHWKKGKMLG 122
             ++     H LPLPP                  PS P++P ++++ P++  S WKKGK++G
Sbjct:   303 RRDCCNVHPLPLPPGATCSSSSAASV------PS-PQAPLKLDSFPMN--SQWKKGKLIG 353

Query:   123 RGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNIVQYYG 181
             RGTFG VYV  NS++G +CAMKEV LF DD KS E  KQL QEI LLS L+HPNIVQY+G
Sbjct:   354 RGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQHPNIVQYFG 413

Query:   182 SKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
             S+TVED+ +IYLEYV  GSI K ++D+ G   E  +RN+T+ ILSGLA+LH+K TVHRDI
Sbjct:   414 SETVEDRFFIYLEYVHPGSINKYIRDHCGTMTESVVRNFTRHILSGLAYLHNKKTVHRDI 473

Query:   241 KGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE----VIKNSSGCNLA-- 294
             KGAN+LVD +G VKLADFGMAKH+ GQ   LS KGSPYWMAPE    V++  S  +LA  
Sbjct:   474 KGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPELMQAVMQKDSNPDLAFA 533

Query:   295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRN 354
             VDIWSLGCT++EM T KPPWS++EG AAMFK+   ++ P IP+ +S EGKDF+RLC QRN
Sbjct:   534 VDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKV--MRDSPPIPESMSPEGKDFLRLCFQRN 591

Query:   355 PLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTER 414
             P  RPTA+ LL+H F+K +  L+ T  +P  SDV   + NG+        R    F  ++
Sbjct:   592 PAERPTASMLLEHRFLKNS--LQPT--SPSNSDVSQ-LFNGMNITEPSSRREKPNFKLDQ 646

Query:   415 L 415
             +
Sbjct:   647 V 647

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 710 (255.0 bits), Expect = 1.8e-72, Sum P(2) = 1.8e-72
 Identities = 149/316 (47%), Positives = 195/316 (61%)

Query:    65 DGKQQSHRLPLPPXXXXXXXXXXXXXXXXXXPSVPRSPGRMENPVSPESHWKKGKMLGRG 124
             D   Q ++ P P                   PS    P      ++P   W+KG+++GRG
Sbjct:    19 DDDNQENQPPFPGVLADKITSCIRKSKIFIKPSFSPPPPANTVDMAPPISWRKGQLIGRG 78

Query:   125 TFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK----QLMQEIVLLSRLRHPNIVQYY 180
              FG VY+G N DSGE+ A+K+V +  +  SKE  +    +L +E+ LL  L HPNIV+Y 
Sbjct:    79 AFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKNLSHPNIVRYL 138

Query:   181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
             G+   +D L I LE+V GGSI  LL+ +G F E  +R YT+Q+L GL +LH+   +HRDI
Sbjct:   139 GTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYLHNHAIMHRDI 198

Query:   241 KGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCNLAVDI 297
             KGANILVD  G +KLADFG +K +A  +      S KG+PYWMAPEVI  + G + + DI
Sbjct:   199 KGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVILQT-GHSFSADI 257

Query:   298 WSLGCTVLEMATTKPPWSQ-YEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
             WS+GCTV+EM T K PWSQ Y+ VAA+F IG +K  P IPD LS + KDF+  CLQ  P 
Sbjct:   258 WSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKDFLLKCLQEVPN 317

Query:   357 NRPTAAELLDHPFVKG 372
              RPTA+ELL HPFV G
Sbjct:   318 LRPTASELLKHPFVMG 333

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 693 (249.0 bits), Expect = 2.6e-71, Sum P(2) = 2.6e-71
 Identities = 142/285 (49%), Positives = 189/285 (66%)

Query:    96 PSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK 155
             P +P +P + E   +P   W+KG+++G G FG VY+G N DSGE+ A+K+V +   + SK
Sbjct:    53 PGLP-APRKEE---APSIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASK 108

Query:   156 ESA----KQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQF 211
             E      ++L +E+ LL  L HPNIV+Y G+    D L I +E+V GGSI  LL+ +G F
Sbjct:   109 EKTQGHIRELEEEVQLLKNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSF 168

Query:   212 GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQS 268
              EP I  YT+Q+L GL +LH+   +HRDIKGANILVD  G ++LADFG +K +   A  +
Sbjct:   169 PEPVIIMYTKQLLLGLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVN 228

Query:   269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWS-QYEGVAAMFKIG 327
                S KG+PYWMAPEVI  + G + + DIWS+GCTV+EMAT KPPWS QY+  AA+  IG
Sbjct:   229 GAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIG 287

Query:   328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
              +K  P IP+DLS E KDF+  CL + P  R +A ELL HPFV G
Sbjct:   288 RTKAHPPIPEDLSPEAKDFLMKCLHKEPSLRLSATELLQHPFVTG 332

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048046 "apoplast" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006270 "DNA replication initiation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0016572 "histone phosphorylation" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

GO:0051726 "regulation of cell cycle" evidence=RCA

UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)]

 Score = 697 (250.4 bits), Expect = 1.0e-68, P = 1.0e-68
 Identities = 147/307 (47%), Positives = 196/307 (63%)

Query:    96 PSVPRS--PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAK 153
             PS+ ++  P +     +P   W+KG+M+G G FG VY+G N DSGE+ A+KEV++  +  
Sbjct:    59 PSISKAELPAKARKDDTPPIRWRKGEMIGCGAFGRVYMGMNVDSGELLAIKEVSIAMNGA 118

Query:   154 SKESA----KQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG 209
             S+E A    ++L +E+ LL  L HPNIV+Y G+      L I LE+V GGSI  LL  +G
Sbjct:   119 SRERAQAHVRELEEEVNLLKNLSHPNIVRYLGTAREAGSLNILLEFVPGGSISSLLGKFG 178

Query:   210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI---AG 266
              F E  IR YT+Q+L GL +LH    +HRDIKGANILVD  G +KLADFG +K +   A 
Sbjct:   179 SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 238

Query:   267 QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQ-YEGVAAMFK 325
              +   S KG+PYWMAPEVI  + G + + DIWS+GCT++EMAT KPPWSQ Y+ VAA+F 
Sbjct:   239 MTGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTIIEMATGKPPWSQQYQEVAALFH 297

Query:   326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG----AAPLERTIL 381
             IG +K  P IP+ LS E KDF+  CLQ+ P  R +A+ LL HPFV      A P  R+  
Sbjct:   298 IGTTKSHPPIPEHLSAESKDFLLKCLQKEPHLRHSASNLLQHPFVTAEHQEARPFLRSSF 357

Query:   382 APEPSDV 388
                P ++
Sbjct:   358 MGNPENM 364

GO:0005515 "protein binding" evidence=IPI

DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)]

 Score = 656 (236.0 bits), Expect = 3.2e-65, Sum P(2) = 3.2e-65
 Identities = 127/261 (48%), Positives = 174/261 (66%)

Query:   115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD---DAKSKESAKQLMQEIVLLSRL 171
             W+KG++LGRG +G VY+G N D+GE+ A+K++ + D   D K K       +EI ++  L
Sbjct:   495 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 554

Query:   172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
             RH NIV+Y G+   +  L ++LEY+ GGSI  LL  +G F E  I+ YT+QIL GL+FLH
Sbjct:   555 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 614

Query:   232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKNSSG 290
             +   +HRDIKGANIL+D  G VKL+DFG +K  +G      S +G+PYWMAPEVIK + G
Sbjct:   615 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIKQT-G 673

Query:   291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA-MFKIGNSKELPTIPDDLSDEGKDFIRL 349
                + DIWSLGC ++EMAT +PPWS    +AA M+ I +S  +P IP  +S E  DF+ L
Sbjct:   674 HGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLNL 733

Query:   350 CLQRNPLNRPTAAELLDHPFV 370
             C +R+P  RP A +LL HPF+
Sbjct:   734 CFKRDPKERPDANQLLKHPFI 754

GO:0030587 "sorocarp development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA;ISS

GO:0000186 "activation of MAPKK activity" evidence=IEA;ISS

GO:0000165 "MAPK cascade" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 652 (234.6 bits), Expect = 6.0e-64, P = 6.0e-64
 Identities = 142/277 (51%), Positives = 188/277 (67%)

Query:   107 NPVSPE-----SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD-AKSKESAKQ 160
             +P+ P+     + W+KG++LGRG+FG VY G + D G+  A+KEV+L D  ++++E  +Q
Sbjct:   320 SPIYPDGGAIITSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQ 378

Query:   161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
             L  EI LLS+L+H NIV+Y G+      LYI+LE V+ GS+ KL Q Y Q  +  +  YT
Sbjct:   379 LEGEIKLLSQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRY-QLRDSVVSLYT 437

Query:   221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
             +QIL GL +LH K  +HRDIK ANILVD NG VKLADFG+AK ++  +   S KG+P+WM
Sbjct:   438 RQILDGLKYLHDKGFIHRDIKCANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWM 496

Query:   281 APEVI--KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD 338
             APEVI  K+S G     DIWSLGCTVLEM T + P+S  E V A+F+IG    LP +PD 
Sbjct:   497 APEVINRKDSDGYGSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGT-LPEVPDT 555

Query:   339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             LS + + FI  CL+ NP  RPTAAELL+HPFV+   P
Sbjct:   556 LSLDARLFILKCLKVNPEERPTAAELLNHPFVRRPLP 592

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 616 (221.9 bits), Expect = 3.9e-60, P = 3.9e-60
 Identities = 137/271 (50%), Positives = 178/271 (65%)

Query:   105 MENPVSPE--SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA-KSKESAKQL 161
             +EN   PE  + W KG++LGRG++  VY   + D G+  A+KEV+L D   +++E  +QL
Sbjct:   291 IENFRKPEDITSWLKGQLLGRGSYASVYEAISED-GDFFAVKEVSLLDKGIQAQECIQQL 349

Query:   162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
               EI LLS+L+H NIV+Y G+     KLYI+LE V+ GS+ KL + Y Q     +  YT+
Sbjct:   350 EGEIALLSQLQHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERY-QLSYTVVSLYTR 408

Query:   222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMA 281
             QIL+GL +LH K  VHRDIK AN+LVD NG VKLADFG+A+        +S KG+ +WMA
Sbjct:   409 QILAGLNYLHDKGFVHRDIKCANMLVDANGTVKLADFGLAEASKFNDI-MSCKGTLFWMA 467

Query:   282 PEVI--KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL 339
             PEVI  K+S G     DIWSLGCTVLEM T + P+S  + + A FKIG    LP +PD L
Sbjct:   468 PEVINRKDSDGNGSPADIWSLGCTVLEMCTGQIPYSDLKPIQAAFKIGRGT-LPDVPDTL 526

Query:   340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
             S + + FI  CL+ NP  RPTAAELL HPFV
Sbjct:   527 SLDARHFILTCLKVNPEERPTAAELLHHPFV 557

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

SGD|S000003631 BCK1 "MAPKKK acting in the protein kinase C signaling pathway" [Saccharomyces cerevisiae (taxid:4932)]

 Score = 598 (215.6 bits), Expect = 2.1e-58, Sum P(2) = 2.1e-58
 Identities = 123/269 (45%), Positives = 172/269 (63%)

Query:   112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES----AKQLMQEIVL 167
             E  W KG+M+G+G+FG VY+  N  +GEM A+K+V +   +   E+     + L  E+  
Sbjct:  1172 EFAWMKGEMIGKGSFGAVYLCLNVTTGEMMAVKQVEVPKYSSQNEAILSTVEALRSEVST 1231

Query:   168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
             L  L H NIVQY G +   +   ++LEYV+GGS+  L++ YG+F EP I++ T Q+L GL
Sbjct:  1232 LKDLDHLNIVQYLGFENKNNIYSLFLEYVAGGSVGSLIRMYGRFDEPLIKHLTTQVLKGL 1291

Query:   228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA---KHIAGQSCPLSFKGSPYWMAPEV 284
             A+LHSK  +HRD+K  N+L+D +G  K++DFG++   K I   S  ++ +G+ +WMAPE+
Sbjct:  1292 AYLHSKGILHRDMKADNLLLDQDGICKISDFGISRKSKDIYSNS-DMTMRGTVFWMAPEM 1350

Query:   285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD----LS 340
             +    G +  VDIWSLGC VLEM   K PWS  E VAAMFKIG SK  P IP+D    +S
Sbjct:  1351 VDTKQGYSAKVDIWSLGCIVLEMFAGKRPWSNLEVVAAMFKIGKSKSAPPIPEDTLPLIS 1410

Query:   341 DEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
               G++F+  C + NP  RPTA ELL HPF
Sbjct:  1411 QIGRNFLDACFEINPEKRPTANELLSHPF 1439

GO:0001101 "response to acid" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IEA;IDA;TAS

GO:0016301 "kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA;IDA

GO:0030010 "establishment of cell polarity" evidence=IMP

GO:0030242 "peroxisome degradation" evidence=IMP

GO:0004709 "MAP kinase kinase kinase activity" evidence=IGI;TAS

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=IMP

GO:0007243 "intracellular protein kinase cascade" evidence=IMP

GO:0007584 "response to nutrient" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0043332 "mating projection tip" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00121082 hypothetical protein (901 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	602
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-158
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-133
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-103
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-100
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-96
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-95
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-94
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-90
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-87
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-84
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-84
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-82
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-75
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-73
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-73
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-71
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-71
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-71
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-70
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-70
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-70
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-69
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-69
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-64
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-64
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-63
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-62
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-58
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-57
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-56
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-56
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-56
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-56
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-55
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-55
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-54
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-54
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-53
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-52
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-52
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-52
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-51
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-51
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-51
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-51
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-51
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-50
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-50
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-49
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-49
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-48
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-48
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-48
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-47
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-47
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-47
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-46
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-45
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-45
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-44
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-44
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-44
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-44
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-43
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-42
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-42
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-42
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-42
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-42
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-41
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-41
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-41
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-40
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-40
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-40
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-40
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-40
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-39
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-39
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-39
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-39
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-39
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-39
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-39
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-39
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-38
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-38
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-38
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-38
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-38
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-37
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-37
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-37
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-37
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-37
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-36
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-36
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-36
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-36
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-36
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-36
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-36
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-35
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-35
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-35
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-34
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-34
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-33
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-33
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-33
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-33
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-33
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-33
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-32
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-32
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-32
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-32
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-32
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-32
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-32
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-31
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-31
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-31
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-31
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-31
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-31
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-30
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-30
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-30
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-30
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-30
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-30
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-30
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-30
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-29
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-29
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-29
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-29
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-29
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-29
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-28
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-28
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-28
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-28
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-28
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-28
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-28
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-28
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-28
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-27
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-27
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-27
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-27
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-27
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-26
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-26
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-26
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-26
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-26
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-26
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-26
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-26
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-25
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-25
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-25
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-24
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-24
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-24
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-24
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-24
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-23
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-23
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-23
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-23
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-23
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-23
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-23
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-22
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-22
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-22
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-22
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-22
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-22
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-22
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-22
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-22
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-22
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	9e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-21
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-21
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-21
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-21
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-21
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-21
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-20
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-20
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-20
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-20
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-19
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-19
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-19
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-19
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-18
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-18
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-18
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-17
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-16
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	6e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-15
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	7e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-14
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-14
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-12
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-11
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-04

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  453 bits (1167), Expect = e-158
 Identities = 176/257 (68%), Positives = 200/257 (77%), Gaps = 1/257 (0%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD-AKSKESAKQLMQEIVLLSRLRH 173
           W+KG++LG G+FG VY G N D G+  A+KEV+L DD    +E+ KQL QEI LLS+L+H
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           PNIVQY G++  ED LYI+LE V GGS+ KLL+ YG F EP IR YT+QIL GL +LH +
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
           +TVHRDIKGANILVD NG VKLADFGMAK +   S   SFKGSPYWMAPEVI    G  L
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           A DIWSLGCTVLEMAT KPPWSQ EGVAA+FKIG SKELP IPD LSDE KDFI  CLQR
Sbjct: 182 AADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQR 241

Query: 354 NPLNRPTAAELLDHPFV 370
           +P  RPTAAELL+HPFV
Sbjct: 242 DPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  388 bits (1000), Expect = e-133
 Identities = 149/262 (56%), Positives = 190/262 (72%), Gaps = 9/262 (3%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W +G++LGRG+FG VY+  + D+GE+ A+K V L  D  S+E  + L +EI +LS L+HP
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHP 59

Query: 175 NIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           NIV+YYGS+  E+K  L I+LEYVSGGS+  LL+ +G+  EP IR YT+QIL GLA+LHS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSS 289
              VHRDIKGANILVD +G VKLADFG AK +          S +G+PYWMAPEVI+   
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEG-VAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
               A DIWSLGCTV+EMAT KPPWS+    +AA++KIG+S E P IP+ LS+E KDF+R
Sbjct: 180 YG-RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238

Query: 349 LCLQRNPLNRPTAAELLDHPFV 370
            CL+R+P  RPTA ELL HPF+
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  312 bits (802), Expect = e-103
 Identities = 106/258 (41%), Positives = 154/258 (59%), Gaps = 6/258 (2%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  + LG G+FG VY+  +  +G++ A+K +      K K+  +++++EI +L +L+HP
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVI---KKKKIKKDRERILREIKILKKLKHP 57

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NIV+ Y     EDKLY+ +EY  GG ++ LL+  G+  E   R Y +QILS L +LHSK 
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
            VHRD+K  NIL+D +G VKLADFG+A+ +       +F G+P +MAPEV+    G   A
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-GKGYGKA 176

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI--GNSKELPTIPDDLSDEGKDFIRLCLQ 352
           VDIWSLG  + E+ T KPP+   + +  +FK         P    D+S E KD IR  L 
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236

Query: 353 RNPLNRPTAAELLDHPFV 370
           ++P  R TA E L HPF 
Sbjct: 237 KDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  305 bits (783), Expect = e-100
 Identities = 119/258 (46%), Positives = 167/258 (64%), Gaps = 5/258 (1%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           +++ G ++GRG FG VY G N ++G+  A+K+++L      +E+ K +MQEI LL  L+H
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKH 58

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           PNIV+Y GS    D LYI LEY   GS+ ++++ +G F E  +  Y  Q+L GLA+LH +
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPLSFKGSPYWMAPEVIKNSSGCN 292
             +HRDIK ANIL   +G VKLADFG+A  +   S    S  G+PYWMAPEVI   SG +
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-EMSGAS 177

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            A DIWSLGCTV+E+ T  PP+     +AA+F+I      P +P+ +S E KDF+  C Q
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP-LPEGISPELKDFLMQCFQ 236

Query: 353 RNPLNRPTAAELLDHPFV 370
           ++P  RPTA +LL HP++
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  295 bits (756), Expect = 3e-96
 Identities = 132/269 (49%), Positives = 172/269 (63%), Gaps = 14/269 (5%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL------FDDAKSKESAKQLMQEIVLL 168
           W KG+++G+GT+G VY+  N  +GEM A+K+V L        D++ K+  K L  EI  L
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
             L H NIVQY G +T E+ L I+LEYV GGSI   L+ YG+F E  +R +T+Q+L GLA
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH---IAGQSCPLSFKGSPYWMAPEVI 285
           +LHSK  +HRD+K  N+LVD +G  K++DFG++K    I      +S +GS +WMAPEVI
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 286 KNSS-GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD----LS 340
            + S G +  VDIWSLGC VLEM   + PWS  E +AAMFK+GN +  P IP D    LS
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242

Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
               DF+  C   NP NRPTA ELL HPF
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  291 bits (748), Expect = 4e-95
 Identities = 125/266 (46%), Positives = 168/266 (63%), Gaps = 13/266 (4%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W++G  +G GTFG VY   N D+GE+ A+KE+ + D+     + K++  E+ +L  L+HP
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK--TIKEIADEMKVLELLKHP 59

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V+YYG +   +K+YI++EY SGG++ +LL+      E  IR YT Q+L GLA+LHS  
Sbjct: 60  NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-----SFKGSPYWMAPEVIKN-- 287
            VHRDIK ANI +D NG +KL DFG A  +   +  +     S  G+P +MAPEVI    
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPD--DLSDEGK 344
             G   A DIWSLGC VLEMAT K PWS+ +     MF +G +   P IPD   LS EGK
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPEGK 238

Query: 345 DFIRLCLQRNPLNRPTAAELLDHPFV 370
           DF+  CL+ +P  RPTA+ELL HPFV
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  290 bits (744), Expect = 2e-94
 Identities = 117/261 (44%), Positives = 163/261 (62%), Gaps = 6/261 (2%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV-TLFDDAKSKESAKQLMQEIVLLSRLRH 173
           W++GK+LG+G FG VY+ ++ D+G   A+K+V    D  ++K+    L  EI LL  L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
             IVQYYG    ++ L I++EY+ GGS+   L+ YG   E   R YT+QIL G+ +LHS 
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHI----AGQSCPLSFKGSPYWMAPEVIKNSS 289
             VHRDIKGANIL D  G VKL DFG +K +    +  +   S  G+PYWM+PEVI +  
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI-SGE 182

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
           G     D+WS+GCTV+EM T KPPW+++E +AA+FKI      P +P  +S + ++F+R 
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242

Query: 350 CLQRNPLNRPTAAELLDHPFV 370
               N   RP+A ELL H FV
Sbjct: 243 TFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  278 bits (714), Expect = 3e-90
 Identities = 108/259 (41%), Positives = 160/259 (61%), Gaps = 9/259 (3%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            ++  + +G+G FG VY   +  +G+  A+K + L    +SKE  ++++ EI +L + +H
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL----ESKEKKEKIINEIQILKKCKH 56

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHS 232
           PNIV+YYGS   +D+L+I +E+ SGGS+  LL+   Q   E  I    +++L GL +LHS
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
              +HRDIK ANIL+  +G VKL DFG++  ++      +  G+PYWMAPEVI      +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD--LSDEGKDFIRLC 350
              DIWSLG T +E+A  KPP+S+   + A+FKI      P + +    SDE KDF++ C
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234

Query: 351 LQRNPLNRPTAAELLDHPF 369
           LQ+NP  RPTA +LL HPF
Sbjct: 235 LQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  270 bits (693), Expect = 8e-87
 Identities = 102/259 (39%), Positives = 152/259 (58%), Gaps = 8/259 (3%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           + +G+G+FG VY   +  + ++ A+K + L    ++++  + + QEI  LS+ R P I +
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDL---EEAEDEIEDIQQEIQFLSQCRSPYITK 63

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           YYGS     KL+I +EY  GGS   LL+  G+  E  I    +++L GL +LH +  +HR
Sbjct: 64  YYGSFLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIAFILREVLLGLEYLHEEGKIHR 122

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKNSSGCNLAVDI 297
           DIK ANIL+   G VKLADFG++  +        +F G+P+WMAPEVIK  SG +   DI
Sbjct: 123 DIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGYDEKADI 181

Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL-SDEGKDFIRLCLQRNPL 356
           WSLG T +E+A  +PP S    +  +F I  +   P++  +  S   KDF+ LCL ++P 
Sbjct: 182 WSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSLCLNKDPK 240

Query: 357 NRPTAAELLDHPFVKGAAP 375
            RP+A ELL H F+K A  
Sbjct: 241 ERPSAKELLKHKFIKKAKK 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  264 bits (676), Expect = 2e-84
 Identities = 126/268 (47%), Positives = 170/268 (63%), Gaps = 14/268 (5%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD-DAKSKESAKQLM----QEIVLLS 169
           W KG ++G G+FG VY+G N+ SGE+ A+K+V L    A SK+  + ++    +EI LL 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            L+H NIVQY GS    D L I+LEYV GGS+  LL +YG F E  +RN+ +QIL GL +
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-------SFKGSPYWMAP 282
           LH++  +HRDIKGANILVD  G +K++DFG++K +   S          S +GS +WMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
           EV+K +S    A DIWSLGC V+EM T K P+     + A+FKIG     P IP ++S E
Sbjct: 182 EVVKQTSYTRKA-DIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSE 239

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
             DF+    + +   RPTAAELL HPF+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  262 bits (672), Expect = 8e-84
 Identities = 98/262 (37%), Positives = 146/262 (55%), Gaps = 8/262 (3%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  + LG G+FG VY   +  +G++ A+K +    +   K+  +   +EI +L RL HP
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKD--QTARREIRILRRLSHP 58

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NIV+   +   +D LY+ +EY  GG ++  L   G   E   +    QIL GL +LHS  
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            +HRD+K  NIL+D NG VK+ADFG+AK  +   S   +F G+P++MAPEV+   +G   
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD-----DLSDEGKDFIR 348
            VD+WSLG  + E+ T KPP+S    +  +  I      P   D       S+E KD I+
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK 238

Query: 349 LCLQRNPLNRPTAAELLDHPFV 370
            CL ++P  RPTA E+L HP+ 
Sbjct: 239 KCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  258 bits (660), Expect = 5e-82
 Identities = 121/267 (45%), Positives = 164/267 (61%), Gaps = 14/267 (5%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD---DAKSKESAKQLMQEIVLLSRL 171
           W KG++LG+G +G VY G  +  G++ A+K+V L      A  KE  K L +E+ LL  L
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEK-LQEEVDLLKSL 59

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
           +H NIVQY G+   ++ + I++E+V GGSI  +L  +G   EP    YT+QIL G+A+LH
Sbjct: 60  KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-------SFKGSPYWMAPEV 284
           +   VHRDIKG N+++ PNG +KL DFG A+ +A             S  G+PYWMAPEV
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL-PTIPDDLSDEG 343
           I N SG     DIWS+GCTV EMAT KPP +  + +AAMF IG  + L P +PD  S   
Sbjct: 180 I-NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPFV 370
            DF+  CL R+   RP+A +LL H F+
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  239 bits (612), Expect = 5e-75
 Identities = 128/267 (47%), Positives = 167/267 (62%), Gaps = 15/267 (5%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ---LMQEIVLLSR 170
           +W+ GK+LGRG FG VY+ +++D+G   A+K+V    D  S+E++K+   L  EI LL  
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPF--DPDSQETSKEVNALECEIQLLKN 60

Query: 171 LRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           LRH  IVQYYG      E KL I++EY+ GGSI   L+ YG   E   R YT+QIL G++
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----AGQSCPLSFKGSPYWMAPE 283
           +LHS   VHRDIKGANIL D  G VKL DFG +K I     +G     S  G+PYWM+PE
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK-SVTGTPYWMSPE 179

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
           VI +  G     D+WS+ CTV+EM T KPPW++YE +AA+FKI      P +PD +SD  
Sbjct: 180 VI-SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPFV 370
           +DF++         RPTA  LL HPFV
Sbjct: 239 RDFLKQIFVEEKR-RPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  235 bits (603), Expect = 3e-73
 Identities = 110/275 (40%), Positives = 163/275 (59%), Gaps = 13/275 (4%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P   +K  + +G G  G VY   +  +G+  A+K++ L    K       ++ EI+++  
Sbjct: 17  PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL-----IINEILIMKD 71

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAF 229
            +HPNIV YY S  V D+L++ +EY+ GGS+  ++ Q++ +  EP I    +++L GL +
Sbjct: 72  CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEY 131

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIKNS 288
           LHS++ +HRDIK  NIL+  +G VKLADFG A  +   +S   S  G+PYWMAPEVIK  
Sbjct: 132 LHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191

Query: 289 S-GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLSDEGKD 345
             G    VDIWSLG   +EMA  +PP+ +   + A+F I  +K +P +  P+  S E KD
Sbjct: 192 DYGPK--VDIWSLGIMCIEMAEGEPPYLREPPLRALFLI-TTKGIPPLKNPEKWSPEFKD 248

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTI 380
           F+  CL ++P  RP+A ELL HPF+K A P E   
Sbjct: 249 FLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFA 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  234 bits (597), Expect = 8e-73
 Identities = 122/266 (45%), Positives = 166/266 (62%), Gaps = 13/266 (4%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ---LMQEIVLLSRL 171
           W++GK+LG+G FG VY+ ++ D+G   A K+V    D +S E++K+   L  EI LL  L
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQF--DPESPETSKEVSALECEIQLLKNL 61

Query: 172 RHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
           +H  IVQYYG      E  L I++EY+ GGS+   L+ YG   E   R YT+QIL G+++
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA----GQSCPLSFKGSPYWMAPEVI 285
           LHS   VHRDIKGANIL D  G VKL DFG +K +       +   S  G+PYWM+PEVI
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
            +  G     D+WSLGCTV+EM T KPPW++YE +AA+FKI      P +P  +S+  +D
Sbjct: 182 -SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVK 371
           F+  C+     +RP+A ELL HPF +
Sbjct: 241 FLG-CIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  229 bits (586), Expect = 1e-71
 Identities = 92/251 (36%), Positives = 132/251 (52%), Gaps = 39/251 (15%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G FG VY+  +  +G+  A+K +   D +   E   +L++EI +L +L HPNIV+ Y
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE---ELLREIEILKKLNHPNIVKLY 57

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           G    E+ LY+ +EY  GGS+  LL++  G+  E  I     QIL GL +LHS   +HRD
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 240 IKGANILVD-PNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKNSSGCNLAVDI 297
           +K  NIL+D  NG+VKLADFG++K +      L +  G+P +MAPEV+      +   DI
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177

Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           WSLG  + E+                                  E KD IR  LQ++P  
Sbjct: 178 WSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204

Query: 358 RPTAAELLDHP 368
           RP+A E+L+H 
Sbjct: 205 RPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  229 bits (587), Expect = 3e-71
 Identities = 109/271 (40%), Positives = 153/271 (56%), Gaps = 21/271 (7%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+  ++  + +G GT+G VY   +  +GE+ A+K + L       +  + + QEI +L  
Sbjct: 1   PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFEIIQQEISMLKE 56

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGS---IYKLLQDYGQFGEPAIRNYTQQILSGL 227
            RHPNIV Y+GS    DKL+I +EY  GGS   IY++ +  G   E  I    ++ L GL
Sbjct: 57  CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGL 114

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIK 286
           A+LH    +HRDIKGANIL+  +G VKLADFG++  + A  +   SF G+PYWMAPEV  
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174

Query: 287 NSS--GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGK 344
                G +   DIW+LG T +E+A  +PP      + A+F I  S      P  L D+ K
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN---FPPPKLKDKEK 231

Query: 345 ------DFIRLCLQRNPLNRPTAAELLDHPF 369
                 DFI+ CL ++P  RPTA +LL HPF
Sbjct: 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  228 bits (584), Expect = 7e-71
 Identities = 99/254 (38%), Positives = 147/254 (57%), Gaps = 12/254 (4%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G++G VY   + ++G++ A+K V + +D +       +++EI +L +   P IV+YY
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIKEISILKQCDSPYIVKYY 64

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           GS      L+I +EY   GS+  +++       E  I     Q L GL +LHS   +HRD
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124

Query: 240 IKGANILVDPNGRVKLADFGMA-KHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           IK  NIL++  G+ KLADFG++ +     +   +  G+P+WMAPEVI+   G N   DIW
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIW 183

Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--IPDDLSDEGKDFIRLCLQRNPL 356
           SLG T +EMA  KPP+S    + A+F I N K  PT   P+  S E  DF++ CL ++P 
Sbjct: 184 SLGITAIEMAEGKPPYSDIHPMRAIFMIPN-KPPPTLSDPEKWSPEFNDFVKKCLVKDPE 242

Query: 357 NRPTAAELLDHPFV 370
            RP+A +LL HPF+
Sbjct: 243 ERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  228 bits (582), Expect = 2e-70
 Identities = 115/258 (44%), Positives = 156/258 (60%), Gaps = 11/258 (4%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +LG+GT+G VY   +  +    A+KE+   D        + L +EI L S L+H NIVQY
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQY 70

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQD-YG--QFGEPAIRNYTQQILSGLAFLHSKHTV 236
            GS +      I++E V GGS+  LL+  +G  +  E  I  YT+QIL GL +LH    V
Sbjct: 71  LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130

Query: 237 HRDIKGANILVDP-NGRVKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVI-KNSSGCNL 293
           HRDIKG N+LV+  +G VK++DFG +K +AG   C  +F G+  +MAPEVI K   G   
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 294 AVDIWSLGCTVLEMATTKPPWSQY-EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             DIWSLGCT++EMAT KPP+ +  E  AAMFK+G  K  P IP+ LS E K+FI  C +
Sbjct: 191 PADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFE 250

Query: 353 RNPLNRPTAAELLDHPFV 370
            +P  R +A +LL  PF+
Sbjct: 251 PDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  227 bits (581), Expect = 2e-70
 Identities = 91/262 (34%), Positives = 145/262 (55%), Gaps = 19/262 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD-DAKSKESAKQLMQEIVLLSRLRHPNIV 177
           K +G+G+FG VY+      G++  +KE+ L +   K +E A   + E+ +L +L HPNI+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA---LNEVKILKKLNHPNII 62

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ----FGEPAIRNYTQQILSGLAFLHSK 233
           +YY S   + KL I +EY  GG + + ++   +    F E  I ++  Q+   L +LHS+
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEVIKNSSGC 291
             +HRDIK  NI +  NG VKL DFG++K +   +  L  +  G+PY+++PE+ +N    
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYYLSPELCQNKP-Y 180

Query: 292 NLAVDIWSLGCTVLEMATTKPP---WSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
           N   DIWSLGC + E+ T K P    +  E      KI    + P IP   S E ++ + 
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKI-LKGQYPPIPSQYSSELRNLVS 236

Query: 349 LCLQRNPLNRPTAAELLDHPFV 370
             LQ++P  RP+ A++L  PF+
Sbjct: 237 SLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  226 bits (578), Expect = 5e-70
 Identities = 122/267 (45%), Positives = 167/267 (62%), Gaps = 13/267 (4%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ---LMQEIVLLS 169
           ++W+ GK+LG+G FG VY+ +++D+G   A+K+V    D +S E++K+   L  EI LL 
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQF--DPESPETSKEVNALECEIQLLK 59

Query: 170 RLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
            L H  IVQYYG     +E  L I++E++ GGSI   L+ YG   E   R YT+QIL G+
Sbjct: 60  NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV 119

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA----GQSCPLSFKGSPYWMAPE 283
           ++LHS   VHRDIKGANIL D  G VKL DFG +K +       +   S  G+PYWM+PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
           VI +  G     DIWS+GCTV+EM T KPPW+++E +AA+FKI      P +P  +SD  
Sbjct: 180 VI-SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPFV 370
           +DF++       L RP+A ELL H FV
Sbjct: 239 RDFLKRIFVEAKL-RPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  225 bits (576), Expect = 1e-69
 Identities = 101/267 (37%), Positives = 158/267 (59%), Gaps = 9/267 (3%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S  ++ K+LG+G+ G VY   +  +G++ A+K++ +  D + +   KQL++E+  L    
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR---KQLLRELKTLRSCE 57

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
            P +V+ YG+   E ++ I LEY+ GGS+  LL+  G+  EP +    +QIL GL +LH+
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 233 K-HTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSG 290
           K H +HRDIK +N+L++  G VK+ADFG++K +        +F G+  +M+PE I+  S 
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYE--GVAAMFKIGNSKELPTIPDDL-SDEGKDFI 347
              A DIWSLG T+LE A  K P+          + +       P++P +  S E +DFI
Sbjct: 178 SYAA-DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236

Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAA 374
             CLQ++P  RP+AAELL HPF+K A 
Sbjct: 237 SACLQKDPKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  223 bits (571), Expect = 6e-69
 Identities = 103/267 (38%), Positives = 162/267 (60%), Gaps = 14/267 (5%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKS--KESAKQLMQEIVLLSRL 171
            W KG+ LG G F   Y   +  +G + A+K+VT   +  S  +E  + L +EI L++RL
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 172 RHPNIVQYYGSKTVEDKLY-IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            HP+I++  G+ T ED  + +++E+++GGS+  LL  YG F E  I NYT+Q+L GL++L
Sbjct: 61  NHPHIIRMLGA-TCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119

Query: 231 HSKHTVHRDIKGANILVDPNGR-VKLADFGMAKHIAGQSCPL-----SFKGSPYWMAPEV 284
           H    +HRD+KGAN+L+D  G+ +++ADFG A  +A +            G+  +MAPEV
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE---GVAAMFKIGNSKELPTIPDDLSD 341
           ++       + D+WS+GC ++EMAT KPPW+  +    +A +FKI ++   P+IP+ LS 
Sbjct: 180 LRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHP 368
             +D    CL+  P +RP + ELL HP
Sbjct: 239 GLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  211 bits (540), Expect = 4e-64
 Identities = 107/270 (39%), Positives = 156/270 (57%), Gaps = 13/270 (4%)

Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           V+P   W+    LG G FG VY   + ++G   A K +      +S+E  +  M EI +L
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII----QIESEEELEDFMVEIDIL 56

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGL 227
           S  +HPNIV  Y +   E+KL+I +E+  GG++  ++ +  +   EP IR   +Q+L  L
Sbjct: 57  SECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEAL 116

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGM-AKHIAGQSCPLSFKGSPYWMAPEVIK 286
            FLHS   +HRD+K  NIL+  +G VKLADFG+ AK+ +      +F G+PYWMAPEV+ 
Sbjct: 117 NFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176

Query: 287 ----NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
                 +  +   DIWSLG T++E+A  +PP  +   +  + KI  S E PT+  P   S
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-EPPTLDQPSKWS 235

Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
               DF++ CL ++P +RPTAAELL HPFV
Sbjct: 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  211 bits (538), Expect = 7e-64
 Identities = 105/274 (38%), Positives = 153/274 (55%), Gaps = 10/274 (3%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S +++ +++GRG +G VY G +  +G + A+K + L  D    + +  + +E+ LLS+LR
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL--DTPDDDVS-DIQREVALLSQLR 57

Query: 173 H---PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
               PNI +YYGS     +L+I +EY  GGS+  L++  G   E  I    +++L  L +
Sbjct: 58  QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKY 116

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNS 288
           +H    +HRDIK ANILV   G VKL DFG+A  +   S   S F G+PYWMAPEVI   
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD-LSDEGKDFI 347
              +   DIWSLG T+ EMAT  PP+S  +   AM  I  SK  P + D+  S   ++F+
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-PRLEDNGYSKLLREFV 235

Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPLERTIL 381
             CL   P  R +A ELL   ++K  +    +IL
Sbjct: 236 AACLDEEPKERLSAEELLKSKWIKAHSKTPVSIL 269

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  210 bits (536), Expect = 1e-63
 Identities = 95/269 (35%), Positives = 145/269 (53%), Gaps = 15/269 (5%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
             ++  +++G G    VY      + E  A+K + L    K + S  +L +E+  +S+  
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL---EKCQTSVDELRKEVQAMSQCN 57

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ---DYGQFGEPAIRNYTQQILSGLAF 229
           HPN+V+YY S  V D+L++ + Y+SGGS+  +++     G   E  I    +++L GL +
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSCPLS---FKGSPYWMAPEV 284
           LHS   +HRDIK  NIL+  +G VK+ADFG++  +A  G         F G+P WMAPEV
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI--GNSKELPTIPDD--LS 340
           ++   G +   DIWS G T +E+AT   P+S+Y  +  +      +   L T  D    S
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237

Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
              +  I LCLQ++P  RPTA ELL H F
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  204 bits (522), Expect = 9e-62
 Identities = 97/261 (37%), Positives = 141/261 (54%), Gaps = 24/261 (9%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK------QLMQEIVLLSRLRHP 174
           LG+G+FG V +    D+G++ AMK +        K+           + E  +LSR+ HP
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVL-------KKKKIIKRKEVEHTLTERNILSRINHP 53

Query: 175 NIVQ-YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
            IV+ +Y  +T E+KLY+ LEY  GG ++  L   G+F E   R Y  +I+  L +LHS 
Sbjct: 54  FIVKLHYAFQT-EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
             ++RD+K  NIL+D +G +KL DFG+AK   +  S   +F G+P ++APEV+    G  
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYG 171

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCL 351
            AVD WSLG  + EM T KPP+   E    ++ KI         P+ LS E +D I   L
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDP--LRFPEFLSPEARDLISGLL 228

Query: 352 QRNPLNRPT---AAELLDHPF 369
           Q++P  R     A E+  HPF
Sbjct: 229 QKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  197 bits (502), Expect = 1e-58
 Identities = 98/282 (34%), Positives = 150/282 (53%), Gaps = 32/282 (11%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P   ++  +++G GT+G VY   +  +G++ A+K + + +D   +E  K+   E  +L +
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKE---EYNILRK 58

Query: 171 L-RHPNIVQYYG------SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG----EPAIRNY 219
              HPNI  +YG          +D+L++ +E   GGS+  L++   + G    E  I   
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGSPY 278
            ++ L GLA+LH    +HRDIKG NIL+  N  VKL DFG++  +        +F G+PY
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 279 WMAPEVIKNSSGCNLA--------VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
           WMAPEVI     C+           D+WSLG T +E+A  KPP      + A+FKI  + 
Sbjct: 179 WMAPEVI----ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234

Query: 331 ELPTI--PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
             PT+  P++ S +  DFI  CL +N   RP   ELL+HPF+
Sbjct: 235 P-PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  192 bits (491), Expect = 3e-57
 Identities = 81/263 (30%), Positives = 127/263 (48%), Gaps = 22/263 (8%)

Query: 116 KKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           + GK LG G FG VY     G    +    A+K  TL + A  +E  +  ++E  ++ +L
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK--TLKEGASEEEREE-FLEEASIMKKL 58

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFL 230
            HPNIV+  G  T  + LYI  EY+ GG +   L+ +G+      +     QI  G+ +L
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKGSPYWMAPE 283
            SK+ VHRD+   N LV  N  VK++DFG+++ I             L  K    WMAPE
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPE 174

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
            +K+        D+WS G  + E+ T  + P+        +  + +   LP  P++  DE
Sbjct: 175 SLKDGK-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLP-RPENCPDE 232

Query: 343 GKDFIRLCLQRNPLNRPTAAELL 365
             + +  C   +P +RPT +EL+
Sbjct: 233 LYELMLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  191 bits (487), Expect = 1e-56
 Identities = 105/261 (40%), Positives = 155/261 (59%), Gaps = 7/261 (2%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           PE  + K + +G+G+FG VY G ++ + E+ A+K   + D  ++++  + + QEI +LS+
Sbjct: 2   PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIK---IIDLEEAEDEIEDIQQEITVLSQ 58

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P I +YYGS     KL+I +EY+ GGS   LL+  G   E  I    ++IL GL +L
Sbjct: 59  CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYL 117

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKNSS 289
           HS+  +HRDIK AN+L+   G VKLADFG+A  +        +F G+P+WMAPEVIK S+
Sbjct: 118 HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
             +   DIWSLG T +E+A  +PP S    +  +F I  +   PT+    S   K+F+  
Sbjct: 178 -YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-PTLEGQYSKPFKEFVEA 235

Query: 350 CLQRNPLNRPTAAELLDHPFV 370
           CL ++P  RPTA ELL H F+
Sbjct: 236 CLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  190 bits (484), Expect = 3e-56
 Identities = 103/266 (38%), Positives = 155/266 (58%), Gaps = 10/266 (3%)

Query: 110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           +P+  ++  + +G GT+G VY   N ++GE+ A+K + L    +  E    + QEI+++ 
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL----EPGEDFAVVQQEIIMMK 61

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +H NIV Y+GS    DKL+I +E+  GGS+  +    G   E  I   +++ L GL +
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEV--IK 286
           LHSK  +HRDIKGANIL+  NG VKLADFG++  I        SF G+PYWMAPEV  ++
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-ELPTIPDDL--SDEG 343
              G N   DIW++G T +E+A  +PP      + A+F +  S  + P + D +  S+  
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPF 369
             F+++ L +NP  RPTA +LL HPF
Sbjct: 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  191 bits (486), Expect = 6e-56
 Identities = 103/283 (36%), Positives = 154/283 (54%), Gaps = 27/283 (9%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           PE  +   + +G G+FG VY   +  + E+ A+K++  +   +S E  + +++E+  L +
Sbjct: 13  PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQQ 71

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAF 229
           LRHPN ++Y G    E   ++ +EY  G S   +L+ + +   E  I       L GLA+
Sbjct: 72  LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAY 130

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKNS 288
           LHS   +HRDIK  NIL+   G VKLADFG A  +     P  SF G+PYWMAPEVI   
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV----SPANSFVGTPYWMAPEVI--- 183

Query: 289 SGCNLA---------VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI-PDD 338
               LA         VD+WSLG T +E+A  KPP      ++A++ I  + + PT+  +D
Sbjct: 184 ----LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLSSND 238

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTIL 381
            SD  ++F+  CLQ+ P +RP++ ELL H FV    P    I+
Sbjct: 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP-PTVII 280

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  189 bits (481), Expect = 9e-56
 Identities = 105/261 (40%), Positives = 159/261 (60%), Gaps = 7/261 (2%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           PE  + K + +G+G+FG V+ G ++ + ++ A+K + L    ++++  + + QEI +LS+
Sbjct: 2   PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL---EEAEDEIEDIQQEITVLSQ 58

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P + +YYGS     KL+I +EY+ GGS   LL+  G F E  I    ++IL GL +L
Sbjct: 59  CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYL 117

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVIKNSS 289
           HS+  +HRDIK AN+L+   G VKLADFG+A  +   Q    +F G+P+WMAPEVI+ S+
Sbjct: 118 HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
             + A DIWSLG T +E+A  +PP S    +  +F I  +   PT+  + S   K+FI  
Sbjct: 178 YDSKA-DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-PTLTGEFSKPFKEFIDA 235

Query: 350 CLQRNPLNRPTAAELLDHPFV 370
           CL ++P  RPTA ELL H F+
Sbjct: 236 CLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  189 bits (482), Expect = 1e-55
 Identities = 101/271 (37%), Positives = 156/271 (57%), Gaps = 13/271 (4%)

Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           + P   W+    LG G FG VY   N ++G + A K +    + KS+E  +  M EI +L
Sbjct: 8   LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI----ETKSEEELEDYMVEIEIL 63

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGL 227
           +   HP IV+  G+   + KL+I +E+  GG++  ++ +  +   EP I+   +Q+L  L
Sbjct: 64  ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEAL 123

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGM-AKHIAGQSCPLSFKGSPYWMAPEVI- 285
            +LHS   +HRD+K  N+L+  +G +KLADFG+ AK++       SF G+PYWMAPEV+ 
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM 183

Query: 286 ---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
                 +  +   DIWSLG T++EMA  +PP  +   +  + KI  S E PT+  P   S
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLSQPSKWS 242

Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            E +DF++  L ++P  RP+AA+LL+HPFV 
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  187 bits (475), Expect = 7e-55
 Identities = 103/261 (39%), Positives = 159/261 (60%), Gaps = 7/261 (2%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           PE  + K + +G+G+FG V+ G ++ + ++ A+K   + D  ++++  + + QEI +LS+
Sbjct: 2   PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVLSQ 58

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P + +YYGS   + KL+I +EY+ GGS   LL+  G   E  I    ++IL GL +L
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYL 117

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSS 289
           HS+  +HRDIK AN+L+  +G VKLADFG+A  +       + F G+P+WMAPEVIK S+
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
             + A DIWSLG T +E+A  +PP S+   +  +F I  +   PT+  + S   K+F+  
Sbjct: 178 YDSKA-DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEA 235

Query: 350 CLQRNPLNRPTAAELLDHPFV 370
           CL + P  RPTA ELL H F+
Sbjct: 236 CLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  185 bits (473), Expect = 2e-54
 Identities = 93/265 (35%), Positives = 136/265 (51%), Gaps = 22/265 (8%)

Query: 121 LGRGTFGHVY-VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +G+G+FG V  V   SD G++   KE+  + +   KE  +QL+ E+ +L  L+HPNIV+Y
Sbjct: 8   IGKGSFGTVRKVRRKSD-GKILVWKEID-YGNMTEKEK-QQLVSEVNILRELKHPNIVRY 64

Query: 180 YGSKTVEDK--LYIYLEYVSGGSIYKLLQDY----GQFGEPAIRNYTQQILSGLAFLH-- 231
           Y          LYI +EY  GG + +L+Q          E  I     Q+L  L   H  
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 232 --SKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKN 287
               +TV HRD+K ANI +D N  VKL DFG+AK +    S   ++ G+PY+M+PE + +
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH 184

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPW--SQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
            S  +   DIWSLGC + E+    PP+       +A+  K G   +   IP   S E  +
Sbjct: 185 MS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG---KFRRIPYRYSSELNE 240

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFV 370
            I+  L  +P  RP+  ELL  P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  185 bits (471), Expect = 2e-54
 Identities = 78/263 (29%), Positives = 128/263 (48%), Gaps = 21/263 (7%)

Query: 116 KKGKMLGRGTFGHVYVGF----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
             GK LG G FG VY G             A+K  TL +DA  ++  ++ ++E  ++ +L
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK--TLKEDASEQQI-EEFLREARIMRKL 58

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFL 230
            HPN+V+  G  T E+ LYI +EY+ GG +   L+    +     + ++  QI  G+ +L
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG------QSCPLSFKGSPYWMAPEV 284
            SK+ +HRD+   N LV  N  VK++DFG+++ +        +   L  +    WMAPE 
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPES 174

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
           +K         D+WS G  + E+ T  + P+        +  + N   LP  P +   E 
Sbjct: 175 LKEGK-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLP-QPPNCPPEL 232

Query: 344 KDFIRLCLQRNPLNRPTAAELLD 366
            D +  C   +P +RPT +EL++
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  183 bits (466), Expect = 1e-53
 Identities = 104/266 (39%), Positives = 153/266 (57%), Gaps = 10/266 (3%)

Query: 110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           +P+  ++  + +G GT+G VY   N  +GE+ A+K + L    +  +    + QEI ++ 
Sbjct: 6   NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL----EPGDDFSLIQQEIFMVK 61

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +H NIV Y+GS    +KL+I +EY  GGS+  +    G   E  I    ++ L GLA+
Sbjct: 62  ECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEV--IK 286
           LHSK  +HRDIKGANIL+  NG VKLADFG+A  I A  +   SF G+PYWMAPEV  ++
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-ELPTIPDDL--SDEG 343
            + G N   DIW++G T +E+A  +PP      + A+F +  S  + P + D    S   
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPF 369
            +F+++ L +NP  RPTA  LL H F
Sbjct: 242 HNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  181 bits (462), Expect = 1e-52
 Identities = 96/274 (35%), Positives = 147/274 (53%), Gaps = 16/274 (5%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G+FG V +  +  SG+  A+K ++     K K+  + ++ E  +L  +RHP +V 
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVN 65

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            YGS   +  LY+ +EYV GG ++  L+  G+F EP  R Y  Q++  L +LHS   V+R
Sbjct: 66  LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYR 125

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           D+K  N+L+D +G +K+ DFG AK + G++  L   G+P ++APE+I  S G   AVD W
Sbjct: 126 DLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--GTPEYLAPEIIL-SKGYGKAVDWW 182

Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           +LG  + EM    PP+   +    ++ KI   K     P   S + KD IR  LQ +   
Sbjct: 183 ALGILIYEMLAGYPPFFD-DNPIQIYEKILEGK--VRFPSFFSPDAKDLIRNLLQVDLTK 239

Query: 358 R-----PTAAELLDHPFVKGA---APLERTILAP 383
           R         ++ +HP+  G    A L+R I AP
Sbjct: 240 RLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAP 273

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  180 bits (460), Expect = 2e-52
 Identities = 84/287 (29%), Positives = 132/287 (45%), Gaps = 48/287 (16%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE------SAKQLMQEIVLLSRL 171
           GK++G G+F  V +    ++ +  A+K +        K         K +  E  +L+RL
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKEVLTRL 58

Query: 172 -RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
             HP I++ Y +   E+ LY  LEY   G + + ++ YG   E   R Y  +IL  L +L
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL------------------- 271
           HSK  +HRD+K  NIL+D +  +K+ DFG AK +   S P                    
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 272 --SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKI 326
             SF G+  +++PE++        + D+W+LGC + +M T KPP+   ++Y       KI
Sbjct: 179 FASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQKI 234

Query: 327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTA----AELLDHPF 369
              K   + P +   + KD I   L  +P +R        EL  HPF
Sbjct: 235 --LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  180 bits (459), Expect = 3e-52
 Identities = 96/294 (32%), Positives = 139/294 (47%), Gaps = 54/294 (18%)

Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE----SAKQLMQEIVLLSRL 171
           +K + LG GT+G VY   +  +GE+ A+K++ L      +E    +A   ++EI LL  L
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL---DNEEEGIPSTA---LREISLLKEL 55

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFL 230
           +HPNIV+       E KLY+  EY     + K L    G      I++   Q+L GLA+ 
Sbjct: 56  KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-------WM-AP 282
           HS   +HRD+K  NIL++ +G +KLADFG+A+               Y       W  AP
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLAR-------AFGIPLRTYTHEVVTLWYRAP 167

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKI-G--------NSK 330
           E++  S   + AVDIWS+GC   EM T KP +   S+ + +  +F+I G           
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227

Query: 331 ELPTIPDD---------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
           +LP                    L  EG D +   LQ NP  R +A E L HP+
Sbjct: 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  178 bits (455), Expect = 5e-52
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 22/264 (8%)

Query: 116 KKGKMLGRGTFGHVYVGF----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
             GK LG G FG VY G             A+K  TL +DA  ++  ++ ++E  ++ +L
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK--TLKEDASEQQI-EEFLREARIMRKL 58

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAF 229
            HPNIV+  G  T E+ L I +EY+ GG +   L+     +     + ++  QI  G+ +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG------QSCPLSFKGSPYWMAPE 283
           L SK+ +HRD+   N LV  N  VK++DFG+++ +        +   L  +    WMAPE
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPE 174

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
            +K         D+WS G  + E+ T  + P+        +  +     LP  P +   E
Sbjct: 175 SLKEGK-FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLP-KPPNCPPE 232

Query: 343 GKDFIRLCLQRNPLNRPTAAELLD 366
               +  C   +P +RPT +EL++
Sbjct: 233 LYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  177 bits (452), Expect = 2e-51
 Identities = 91/266 (34%), Positives = 137/266 (51%), Gaps = 18/266 (6%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           + +G +G V++     +G++ A+K V    D   K    Q++ E  +LS+ + P +V+ Y
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIK-VIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S   +  LY+ +EY+ GG +  LL++ G   E   R Y  +I+  L +LHS   +HRD+
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119

Query: 241 KGANILVDPNGRVKLADFGMAKHIA-GQSCPLS--------FKGSPYWMAPEVIKNSSGC 291
           K  NIL+D NG +KL DFG++K     +   L+          G+P ++APEVI    G 
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QGH 178

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSK-ELPTIPDDLSDEGKDFIRL 349
           +  VD WSLGC + E     PP+   E    +F  I N K E P    ++SDE  D I  
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPF-HGETPEEIFQNILNGKIEWPEDV-EVSDEAIDLISK 236

Query: 350 CLQRNPLNRPTAA---ELLDHPFVKG 372
            L  +P  R  A    E+ +HPF KG
Sbjct: 237 LLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  178 bits (453), Expect = 2e-51
 Identities = 95/280 (33%), Positives = 154/280 (55%), Gaps = 14/280 (5%)

Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           P  P S+      +G G+ G V +  +  +G   A+K++    D + ++  + L  E+V+
Sbjct: 14  PGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM----DLRKQQRRELLFNEVVI 69

Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
           +   +HPNIV+ Y S  V D+L++ +E++ GG++  ++  + +  E  I      +L  L
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLAVLKAL 128

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEVI 285
           +FLH++  +HRDIK  +IL+  +GRVKL+DFG    ++ +  P   S  G+PYWMAPEVI
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEVI 187

Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLSDEG 343
                    VDIWSLG  V+EM   +PP+     + AM +I ++   P +     +S   
Sbjct: 188 SRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-PKLKNLHKVSPRL 245

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAP 383
           + F+   L R+P  R TAAELL+HPF+  A P   + + P
Sbjct: 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGP--PSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  177 bits (450), Expect = 4e-51
 Identities = 103/269 (38%), Positives = 151/269 (56%), Gaps = 13/269 (4%)

Query: 110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           +PE  W+    LG G FG VY   N ++G + A K +    D KS+E  +  M EI +L+
Sbjct: 2   NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI----DTKSEEELEDYMVEIDILA 57

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLA 228
              HPNIV+   +   E+ L+I +E+ +GG++  ++ +  +   EP IR   +Q L  L 
Sbjct: 58  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALN 117

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGM-AKHIAGQSCPLSFKGSPYWMAPEVIKN 287
           +LH    +HRD+K  NIL   +G +KLADFG+ AK+        SF G+PYWMAPEV+  
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 288 SSG----CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLSD 341
            +      +   D+WSLG T++EMA  +PP  +   +  + KI  S E PT+  P   S 
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSS 236

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
           E KDF++ CL++N   R T  +LL HPFV
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  177 bits (451), Expect = 4e-51
 Identities = 97/292 (33%), Positives = 141/292 (48%), Gaps = 55/292 (18%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIV 177
           K LG GTFG VY+  N ++GE+ A+K   +     S E    L +E+  L +L  HPNIV
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNL-REVKSLRKLNEHPNIV 61

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLL--QDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +        D+LY   EY+ G ++Y+L+  +    F E  IR+   QIL GLA +H    
Sbjct: 62  KLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-------WM-APEVIKN 287
            HRD+K  N+LV     VK+ADFG+A+ I  +S P      PY       W  APE++  
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREI--RSRP------PYTDYVSTRWYRAPEILLR 172

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKP------------------------PWSQ-YEGVAA 322
           S+  +  VDIW+LGC + E+ T +P                         W + Y+  + 
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232

Query: 323 M-FKIGNSKELPTIPDDL----SDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
           + F+       PT    L    S E  D I+  L+ +P  RPTA++ L HP+
Sbjct: 233 LGFRFPQFA--PTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  175 bits (447), Expect = 8e-51
 Identities = 81/246 (32%), Positives = 123/246 (50%), Gaps = 16/246 (6%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESA----KQLMQEIVLLSRLRHPNI 176
           LG G FG V +          A+K V      K         + +  E  +L    HP I
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVK-----KRHIVETGQQEHIFSEKEILEECNHPFI 55

Query: 177 VQYYGSKTVEDKLYIY--LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           V+ Y  +T +DK YIY  +EY  GG ++ +L+D G F E   R Y   ++    +LH++ 
Sbjct: 56  VKLY--RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG 113

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
            ++RD+K  N+L+D NG VKL DFG AK +       +F G+P ++APE+I N  G + +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFS 172

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           VD WSLG  + E+ T +PP+ + +   +     I         P+ +    KD I+  L+
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232

Query: 353 RNPLNR 358
           RNP  R
Sbjct: 233 RNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  175 bits (444), Expect = 7e-50
 Identities = 97/263 (36%), Positives = 149/263 (56%), Gaps = 8/263 (3%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G+FG VY   NS + E+ A+K+++ +   ++ E  + +++E+  L +L+HPN ++Y 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
           G    E   ++ +EY  G +   L        E  I   T   L GLA+LHS + +HRDI
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 241 KGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI--KNSSGCNLAVDIW 298
           K  NIL+   G+VKLADFG A   +  +   SF G+PYWMAPEVI   +    +  VD+W
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVW 204

Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI-PDDLSDEGKDFIRLCLQRNPLN 357
           SLG T +E+A  KPP      ++A++ I  + + PT+  ++ +D  + F+  CLQ+ P  
Sbjct: 205 SLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWTDSFRGFVDYCLQKIPQE 263

Query: 358 RPTAAELLDHPFVKGAAPLERTI 380
           RP +AELL H FV+   P    I
Sbjct: 264 RPASAELLRHDFVRRDRPARVLI 286

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  174 bits (442), Expect = 8e-50
 Identities = 98/270 (36%), Positives = 151/270 (55%), Gaps = 12/270 (4%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM-QEIVLLS 169
           P+  + + + +G+G  G VY   +  +G+  A+K++ L      ++  K+L+  EI+++ 
Sbjct: 17  PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-----QQQPKKELIINEILVMR 71

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +HPNIV Y  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L F
Sbjct: 72  ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEF 130

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNS 288
           LHS   +HRDIK  NIL+  +G VKL DFG    I   QS   +  G+PYWMAPEV+   
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190

Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDF 346
           +     VDIWSLG   +EM   +PP+     + A++ I    + EL   P+ LS   +DF
Sbjct: 191 A-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSAIFRDF 248

Query: 347 IRLCLQRNPLNRPTAAELLDHPFVKGAAPL 376
           +  CL+ +   R +A ELL HPF+K A PL
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  172 bits (438), Expect = 1e-49
 Identities = 88/262 (33%), Positives = 148/262 (56%), Gaps = 18/262 (6%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G  G V    +  +G++ A+K + L  +       KQ+++E+ +L +   P IV +Y
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL--EINEAIQ-KQILRELDILHKCNSPYIVGFY 65

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKHTV-HR 238
           G+      + I +EY+ GGS+ K+L +  G+  E  +      +L GL +LH KH + HR
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQ---SCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           D+K +NILV+  G++KL DFG    ++GQ   S   +F G+  +MAPE I   +  ++  
Sbjct: 126 DVKPSNILVNSRGQIKLCDFG----VSGQLVNSLAKTFVGTSSYMAPERI-QGNDYSVKS 180

Query: 296 DIWSLGCTVLEMATTKPPWSQ----YEGVAAMFKIGNSKELPTIPDD-LSDEGKDFIRLC 350
           DIWSLG +++E+AT + P+       +G+  + +   ++  P +P    S + +DF+ LC
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC 240

Query: 351 LQRNPLNRPTAAELLDHPFVKG 372
           L ++P  RP+  ELL+HPF+K 
Sbjct: 241 LIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  171 bits (436), Expect = 3e-49
 Identities = 84/257 (32%), Positives = 139/257 (54%), Gaps = 13/257 (5%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD--DAKSKESAKQLMQEIVLLSRLRHPNI 176
           K +G+G F  VY       G + A+K+V +F+  DAK+++     ++EI LL +L HPN+
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDC---LKEIDLLKQLDHPNV 64

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ----FGEPAIRNYTQQILSGLAFLHS 232
           ++Y  S    ++L I LE    G + ++++ + +      E  I  Y  Q+ S L  +HS
Sbjct: 65  IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-PLSFKGSPYWMAPEVIKNSSGC 291
           K  +HRDIK AN+ +   G VKL D G+ +  + ++    S  G+PY+M+PE I   +G 
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-ENGY 183

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYE-GVAAMFKIGNSKELPTIPDD-LSDEGKDFIRL 349
           N   DIWSLGC + EMA  + P+   +  + ++ K     + P +P D  S+E +D +  
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243

Query: 350 CLQRNPLNRPTAAELLD 366
           C+  +P  RP  + +L 
Sbjct: 244 CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  170 bits (433), Expect = 1e-48
 Identities = 91/263 (34%), Positives = 143/263 (54%), Gaps = 17/263 (6%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTL-FDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           LG+G +G VY   +  +G   AMKE+ L  D++K      Q++ E+ +L +   P IV +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK----FNQIIMELDILHKAVSPYIVDF 64

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG---EPAIRNYTQQILSGLAFLHSKHTV 236
           YG+  +E  +Y+ +EY+  GS+ KL           E  +R  T  ++ GL FL  +H +
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 237 -HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
            HRD+K  N+LV+ NG+VKL DFG++ ++   S   +  G   +MAPE IK+        
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLV-ASLAKTNIGCQSYMAPERIKSGGPNQNPT 183

Query: 296 -----DIWSLGCTVLEMATTKPPW--SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
                D+WSLG ++LEMA  + P+    Y  + A        + PT+P   SD+ +DF+ 
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVA 243

Query: 349 LCLQRNPLNRPTAAELLDHPFVK 371
            CL + P  RPT A+LL+HP++ 
Sbjct: 244 KCLNKIPNRRPTYAQLLEHPWLV 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  171 bits (434), Expect = 2e-48
 Identities = 104/291 (35%), Positives = 161/291 (55%), Gaps = 17/291 (5%)

Query: 96  PSVPRSPGRMENPV--------SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT 147
           PS  R+ G +++P          PE  +   + +G G+FG VY   +  + E+ A+K+++
Sbjct: 1   PSTSRA-GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS 59

Query: 148 LFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD 207
            +   +S E  + +++E+  L R++HPN ++Y G    E   ++ +EY  G +   L   
Sbjct: 60  -YSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH 118

Query: 208 YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ 267
                E  I   T   L GLA+LHS + +HRDIK  NIL+   G+VKLADFG A   +  
Sbjct: 119 KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178

Query: 268 SCPLSFKGSPYWMAPEVI--KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK 325
           +   SF G+PYWMAPEVI   +    +  VD+WSLG T +E+A  KPP      ++A++ 
Sbjct: 179 N---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 235

Query: 326 IGNSKELPTI-PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
           I  + E PT+  ++ SD  ++F+  CLQ+ P +RPT+ ELL H FV    P
Sbjct: 236 IAQN-ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  173 bits (438), Expect = 2e-48
 Identities = 103/388 (26%), Positives = 167/388 (43%), Gaps = 31/388 (7%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            ++  + LG G+FG VY+  +    ++ A+K +         +  ++ ++EI +L+ L H
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVL-AKKLESKSKEVERFLREIQILASLNH 56

Query: 174 P-NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG---EPAIRNYTQQILSGLAF 229
           P NIV+ Y     E  LY+ +EYV GGS+  LL+  G+ G   E        QILS L +
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 230 LHSKHTVHRDIKGANILVDPNG-RVKLADFGMAK-------HIAGQSCPLSFKGSPYWMA 281
           LHSK  +HRDIK  NIL+D +G  VKL DFG+AK         +  + P +  G+P +MA
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 282 PEVIKNSSGCNL--AVDIWSLGCTVLEMATTKPPW------SQYEGVAAMFKIGNSKELP 333
           PEV+   S      + DIWSLG T+ E+ T  PP+      S       +     +  L 
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 334 -----TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDV 388
                + P+ +S    D ++  L ++P NR +++  L H  +      E  +      D 
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296

Query: 389 PPGVTNGIKALGIGQLRNVSTFDTER--LAVHSSRVSQTSLNASDINISMNRSCPVSPIG 446
              +   +       + ++++       L +  S  S+        +   N S  +    
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTA 356

Query: 447 SPLLHPRSPQHLNGKMSPSPISSPRTTS 474
           S               S    SS +  S
Sbjct: 357 SSKRSSLPKISARSSPSSLSSSSRQQAS 384

Length = 384

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  169 bits (430), Expect = 2e-48
 Identities = 80/277 (28%), Positives = 123/277 (44%), Gaps = 45/277 (16%)

Query: 119 KMLGRGTFGHVYVGF---NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           K LG G FG VY G            A+K +      + +   K  ++E  ++ +L HPN
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER---KDFLKEARVMKKLGHPN 57

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-----GQFGEPAIRN--------YTQQ 222
           +V+  G  T E+ LY+ LEY+ GG     L DY       F  P            +  Q
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGD----LLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKG 275
           I  G+ +L SK  VHRD+   N LV  +  VK++DFG+++ +             L  + 
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR- 172

Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA---MFKIGNSK 330
              WMAPE +K+        D+WS G  + E+ T    P    Y G++    +  +    
Sbjct: 173 ---WMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATP----YPGLSNEEVLEYLRKGY 224

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
            LP  P+   DE  + +  C Q +P +RPT +EL++ 
Sbjct: 225 RLP-KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  167 bits (423), Expect = 6e-47
 Identities = 96/269 (35%), Positives = 148/269 (55%), Gaps = 8/269 (2%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           PE  +   + +G G+FG VY   +  + E+ A+K+++ +   +S E  + +++E+  L +
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQK 71

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAF 229
           LRHPN +QY G    E   ++ +EY  G S   LL+ + +   E  I   T   L GLA+
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI--KN 287
           LHS + +HRD+K  NIL+   G VKL DFG A  +A  +    F G+PYWMAPEVI   +
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMD 187

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
               +  VD+WSLG T +E+A  KPP      ++A++ I  ++         S+  ++F+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247

Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPL 376
             CLQ+ P +RPT+  LL H FV    P 
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  164 bits (418), Expect = 7e-47
 Identities = 87/260 (33%), Positives = 139/260 (53%), Gaps = 9/260 (3%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD-DAKSKESAKQLMQEIVLLSRLR 172
           H+   ++LG+G FG   +   ++   +   KEV L     K +  A   + EIV+LS L+
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA---LNEIVILSLLQ 57

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIY-KLLQDYGQ-FGEPAIRNYTQQILSGLAFL 230
           HPNI+ YY     ++ L I +EY +GG++Y K+++  GQ F E  +  Y  QI+S ++++
Sbjct: 58  HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPYWMAPEVIKNSS 289
           H    +HRDIK  NI +   G +KL DFG++K +  + S   +  G+PY+M+PE+ +   
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
             N   DIW+LGC + E+ T K  +     +  + KI        +    S E    +  
Sbjct: 178 -YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHS 235

Query: 350 CLQRNPLNRPTAAELLDHPF 369
            LQ++P  RPTA E+LD P 
Sbjct: 236 LLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  164 bits (418), Expect = 9e-47
 Identities = 80/263 (30%), Positives = 131/263 (49%), Gaps = 13/263 (4%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           H++  +++G+G FG V +    D+ +M AMK +        K S + ++ E  +L  L H
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK-QKCVEKGSVRNVLNERRILQELNH 59

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P +V  + S   E+ +Y+ ++ + GG +   L    +F E  ++ +  +I+  L +LHSK
Sbjct: 60  PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
             +HRDIK  NIL+D  G V + DF +A  +   +   S  G+P +MAPEV+    G ++
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC-RQGYSV 178

Query: 294 AVDIWSLGCTVLEMATTKPPW-----SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
           AVD WSLG T  E    K P+     +  + + A  +          P   S E  D I 
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE----TADVLYPATWSTEAIDAIN 234

Query: 349 LCLQRNPLNR--PTAAELLDHPF 369
             L+R+P  R      +L +HP+
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  162 bits (413), Expect = 8e-46
 Identities = 85/285 (29%), Positives = 138/285 (48%), Gaps = 33/285 (11%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K   +G GT+G VY   +  +GE+ A+K++ L  +  S+   K  ++EI LL  L HP
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHP 58

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSK 233
           NI++       +  LY+  E++    +YKL++D  +   E  I++Y  Q+L GLAF HS 
Sbjct: 59  NIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCN 292
             +HRD+K  N+L++  G +KLADFG+A+       P +      W  APE++    G +
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI----GNSKE-------------LPTI 335
             VDIWS+GC   E+ + +P +     +  +FKI    G                   + 
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237

Query: 336 PD-----------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
           P            + S +  D +   L  +P  R TA + L HP+
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  162 bits (413), Expect = 1e-45
 Identities = 92/270 (34%), Positives = 150/270 (55%), Gaps = 25/270 (9%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G  G V      ++G + A+K +T      + +  KQ+++E+ +    + P IV+YY
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITT---DPNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 181 GSKTVE--DKLYIYLEYVSGGS---IYK-LLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           G+   E    + I +EY  GGS   IYK + +  G+ GE  +    + +L GL++LHS+ 
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
            +HRDIK +NIL+   G+VKL DFG++      S   +F G+ ++MAPE I+     ++ 
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGE-LVNSLAGTFTGTSFYMAPERIQGKP-YSIT 183

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEG------VAAMFKIGNSKELPTIPDDL------SDE 342
            D+WSLG T+LE+A  + P+   EG      +  +  I N    P + D+       S+E
Sbjct: 184 SDVWSLGLTLLEVAQNRFPFPP-EGEPPLGPIELLSYIVNM-PNPELKDEPGNGIKWSEE 241

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
            KDFI+ CL+++P  RPT  ++L+HP++K 
Sbjct: 242 FKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  160 bits (407), Expect = 3e-45
 Identities = 94/261 (36%), Positives = 135/261 (51%), Gaps = 19/261 (7%)

Query: 119 KMLGRGTFGHVY-VGFNSDSGEMCAMKEVTLFD-DAKSKESAKQLMQEIVLLSRLRHPNI 176
           K LG+G++G VY V   SD+    A+KEV L     K +E A   + EI +L+ + HPNI
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFY-ALKEVDLGSMSQKEREDA---VNEIRILASVNHPNI 61

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ----FGEPAIRNYTQQILSGLAFLHS 232
           + Y  +    +KL I +EY   G + K +    +      E  I     Q+L GL  LH 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN---SS 289
           +  +HRD+K ANIL+  N  VK+ D G++K +  ++   +  G+P++MAPEV K    S 
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISK-VLKKNMAKTQIGTPHYMAPEVWKGRPYSY 180

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
                 DIWSLGC + EMAT  PP+         +K+   K  P IP   S + ++FIR 
Sbjct: 181 KS----DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPIYSQDLQNFIRS 235

Query: 350 CLQRNPLNRPTAAELLDHPFV 370
            LQ  P  RP   ++L  P V
Sbjct: 236 MLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  160 bits (406), Expect = 1e-44
 Identities = 86/294 (29%), Positives = 138/294 (46%), Gaps = 59/294 (20%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE-SAKQLMQEIVLLSRLRHPNIVQY 179
           +G GT+G VY   N  +GE+ A+K++ + ++   KE      ++EI LL +LRHPNIV+ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 180 YGSKTVEDK--LYIYLEYV----SGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHS 232
               T + K  +Y+  EY+    +G     LL     +F E  I+ Y +Q+L GL +LHS
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-------WM-APEV 284
              +HRDIKG+NIL++ +G +KLADFG+A+    ++         Y       W   PE+
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA------DYTNRVITLWYRPPEL 172

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPW---------------------SQYEGVAAM 323
           +  ++     VD+WS+GC + E+   KP +                       + GV+ +
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232

Query: 324 FKIGNSKELPTIPDDLSDEGK--------DFIRLCLQRNPLNRPTAAELLDHPF 369
               N K        L +  K        D +   L  +P  R +A + L H +
Sbjct: 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  159 bits (403), Expect = 1e-44
 Identities = 79/252 (31%), Positives = 130/252 (51%), Gaps = 9/252 (3%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFD-DAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +G+G+FG V+         + AMK++ L   + + +E A   + E  +L++L    I++Y
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEA---IDEARVLAKLDSSYIIRY 64

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQ-FGEPAIRNYTQQILSGLAFLHSKHTVH 237
           Y S   + KL I +EY   G ++KLL+   G+   E  +  +  QIL GLA LHSK  +H
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILH 124

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSC-PLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           RDIK  N+ +D    VK+ D G+AK ++  +    +  G+PY+++PE+ ++    N   D
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP-YNEKSD 183

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +W+LG  + E  T K P+      A + KI      P +    S +    I  CL ++  
Sbjct: 184 VWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPPVSQMYSQQLAQLIDQCLTKDYR 242

Query: 357 NRPTAAELLDHP 368
            RP   +LL +P
Sbjct: 243 QRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  159 bits (403), Expect = 3e-44
 Identities = 95/269 (35%), Positives = 150/269 (55%), Gaps = 10/269 (3%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+  + + + +G+G  G VY   +  +G+  A+K++ L    + +   + ++ EI+++  
Sbjct: 17  PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL----QQQPKKELIINEILVMRE 72

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            ++PNIV Y  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L FL
Sbjct: 73  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFL 131

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSS 289
           HS   +HRDIK  NIL+  +G VKL DFG    I   QS   +  G+PYWMAPEV+   +
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDFI 347
                VDIWSLG   +EM   +PP+     + A++ I    + EL   P+ LS   +DF+
Sbjct: 192 -YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN-PERLSAVFRDFL 249

Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPL 376
             CL+ +   R +A ELL HPF+K A PL
Sbjct: 250 NRCLEMDVDRRGSAKELLQHPFLKLAKPL 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  158 bits (401), Expect = 5e-44
 Identities = 95/270 (35%), Positives = 152/270 (56%), Gaps = 12/270 (4%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM-QEIVLLS 169
           P+  + + + +G+G  G V+   +  +G+  A+K++ L      K+  K+L+  EI+++ 
Sbjct: 17  PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-----QKQPKKELIINEILVMK 71

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            L++PNIV +  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L F
Sbjct: 72  ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEF 130

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNS 288
           LH+   +HRDIK  N+L+  +G VKL DFG    I   QS   +  G+PYWMAPEV+   
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190

Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDF 346
           +     VDIWSLG   +EM   +PP+     + A++ I    + EL   P+ LS   +DF
Sbjct: 191 A-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSPIFRDF 248

Query: 347 IRLCLQRNPLNRPTAAELLDHPFVKGAAPL 376
           +  CL+ +   R +A ELL HPF+K A PL
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  156 bits (396), Expect = 2e-43
 Identities = 92/268 (34%), Positives = 146/268 (54%), Gaps = 12/268 (4%)

Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           +   P S  +    +G G+ G V +     SG   A+K +    D + ++  + L  E+V
Sbjct: 15  DQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMM----DLRKQQRRELLFNEVV 70

Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++   +H N+V+ Y S  V ++L++ +E++ GG++  ++    +  E  I    + +L  
Sbjct: 71  IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQA 129

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP--LSFKGSPYWMAPEV 284
           L +LHS+  +HRDIK  +IL+  +GRVKL+DFG    I+ +  P   S  G+PYWMAPEV
Sbjct: 130 LCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEV 188

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDE 342
           I  +      VDIWSLG  V+EM   +PP+     V AM ++ +S   P + +   +S  
Sbjct: 189 ISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNAHKISPV 246

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
            +DF+   L R P  R TA ELLDHPF+
Sbjct: 247 LRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  154 bits (390), Expect = 2e-42
 Identities = 92/269 (34%), Positives = 147/269 (54%), Gaps = 10/269 (3%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+  + + + +G+G  G VY   +  +G+  A++++ L    + +   + ++ EI+++  
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRE 73

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            ++PNIV Y  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L FL
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFL 132

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSS 289
           HS   +HRDIK  NIL+  +G VKL DFG    I  +    S   G+PYWMAPEV+   +
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDFI 347
                VDIWSLG   +EM   +PP+     + A++ I    + EL   P+ LS   +DF+
Sbjct: 193 -YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSAIFRDFL 250

Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPL 376
             CL  +   R +A ELL H F+K A PL
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIAKPL 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  153 bits (387), Expect = 2e-42
 Identities = 87/261 (33%), Positives = 138/261 (52%), Gaps = 18/261 (6%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD-DAKSKESAKQLMQEIVLLSRLRHPNIV 177
           K +G G+FG +Y+       E C +KE+ L     K KE++K+   E++LL++++HPNIV
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYG-QFGEPAIRNYTQQILSGLAFLHSKHT 235
            ++ S     +L+I +EY  GG + K +    G  F E  I ++  QI  GL  +H +  
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122

Query: 236 VHRDIKGANILVDPNGRV-KLADFGMAKHIA-----GQSCPLSFKGSPYWMAPEVIKNSS 289
           +HRDIK  NI +  NG V KL DFG+A+ +        +C     G+PY+++PE+ +N  
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC----VGTPYYLSPEICQNRP 178

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
             N   DIWSLGC + E+ T K P+        + KI      P  P + S + +  I  
Sbjct: 179 YNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISP-NFSRDLRSLISQ 236

Query: 350 CLQRNPLNRPTAAELLDHPFV 370
             + +P +RP+   +L  PF+
Sbjct: 237 LFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  154 bits (389), Expect = 2e-42
 Identities = 92/268 (34%), Positives = 145/268 (54%), Gaps = 23/268 (8%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIV 177
           +++G GT+G VY G +  +G++ A+K + + +D +     +++  EI +L +   H NI 
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-----EEIKLEINMLKKYSHHRNIA 76

Query: 178 QYYGS------KTVEDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAF 229
            YYG+         +D+L++ +E+   GS+  L+++       E  I    ++IL GLA 
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVI- 285
           LH+   +HRDIKG N+L+  N  VKL DFG++  +    G+    +F G+PYWMAPEVI 
Sbjct: 137 LHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--TFIGTPYWMAPEVIA 194

Query: 286 ---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
                 +  +   DIWSLG T +EMA   PP      + A+F I  +          S +
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKK 254

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
             DFI  CL +N L+RP+  +LL HPF+
Sbjct: 255 FIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  154 bits (390), Expect = 2e-42
 Identities = 79/286 (27%), Positives = 140/286 (48%), Gaps = 42/286 (14%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL-MQEIVLLSRLRHPNIVQ 178
           ++G G +G V    N  +GE+ A+K+   F +++  E  K+  ++E+ +L +LRH NIV 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKK---FKESEDDEDVKKTALREVKVLRQLRHENIVN 64

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
              +   + +LY+  EYV   ++ +LL+   G     A+R+Y  Q+L  +A+ HS + +H
Sbjct: 65  LKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCP--LSFKGSPYWMAPEVIKNSSGCNLAV 295
           RDIK  NILV  +G +KL DFG A+ +  +       +  + ++ APE++   +     V
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV 183

Query: 296 DIWSLGCTVLEMATTKPPW------------------------------SQYEGVA--AM 323
           D+W++GC + E+   +P +                               ++ GVA    
Sbjct: 184 DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP 243

Query: 324 FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
            +  + +     P  +S    DF++ CL+ +P  R T  ELL HP+
Sbjct: 244 SQPESLERRY--PGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  154 bits (392), Expect = 3e-42
 Identities = 88/312 (28%), Positives = 141/312 (45%), Gaps = 45/312 (14%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           K +G G +G V    +  +G   A+K+++ +FDD      AK++++EI LL  LRH NI+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD---LIDAKRILREIKLLRHLRHENII 62

Query: 178 Q-----YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
                    S    + +YI  E +    ++K+++      +  I+ +  QIL GL +LHS
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY----WM-APEVIKN 287
            + +HRD+K +NILV+ N  +K+ DFG+A+ +        F  + Y    W  APE++ +
Sbjct: 122 ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-TEYVVTRWYRAPELLLS 180

Query: 288 SSGCNLAVDIWSLGCTVLEMATTK---------------------PPWSQYEGVA---AM 323
           SS    A+DIWS+GC   E+ T K                     P     + +    A 
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240

Query: 324 FKIGNSKELPTIP-----DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLER 378
             + +  + P  P        S E  D +   L  +P  R TA E L HP++      E 
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300

Query: 379 TILAPEPSDVPP 390
             +A  P D   
Sbjct: 301 EPVAKPPFDFDF 312

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  153 bits (388), Expect = 2e-41
 Identities = 101/317 (31%), Positives = 159/317 (50%), Gaps = 31/317 (9%)

Query: 73  LPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVG 132
           LPLPP + S+SS  S S S +   +               S  ++   +G G  G VY  
Sbjct: 45  LPLPPPSSSSSSSSSSSASGSAPSAAK-----------SLSELERVNRIGSGAGGTVYKV 93

Query: 133 FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY 192
            +  +G + A+K +    +   +   +Q+ +EI +L  + HPN+V+ +       ++ + 
Sbjct: 94  IHRPTGRLYALKVIYGNHEDTVR---RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150

Query: 193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR 252
           LE++ GGS    L+      E  + +  +QILSG+A+LH +H VHRDIK +N+L++    
Sbjct: 151 LEFMDGGS----LEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN 206

Query: 253 VKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKNS------SGCNLAVDIWSLGCTVL 305
           VK+ADFG+++ +A    P  S  G+  +M+PE I          G   A DIWSLG ++L
Sbjct: 207 VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY--AGDIWSLGVSIL 264

Query: 306 EMATTKPPWS---QYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAA 362
           E    + P+    Q +  + M  I  S+  P  P   S E + FI  CLQR P  R +A 
Sbjct: 265 EFYLGRFPFGVGRQGDWASLMCAICMSQP-PEAPATASREFRHFISCCLQREPAKRWSAM 323

Query: 363 ELLDHPFVKGAAPLERT 379
           +LL HPF+  A P +  
Sbjct: 324 QLLQHPFILRAQPGQGQ 340

Length = 353

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  150 bits (379), Expect = 3e-41
 Identities = 86/253 (33%), Positives = 137/253 (54%), Gaps = 14/253 (5%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +++G G+FG   +  + +S +  AMKE+ L    KS  + +   +E VLL++++HPNIV 
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRL---PKSSSAVEDSRKEAVLLAKMKHPNIVA 62

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIY-KLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  S   +  LYI +EY  GG +  K+    G+ F E  I  +  Q+  G+  +H K  +
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL 122

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK----GSPYWMAPEVIKNSSGCN 292
           HRDIK  NI +  NG+VKL DFG A+ +     P ++     G+PY++ PE+ +N    N
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTS---PGAYACTYVGTPYYVPPEIWENMPYNN 179

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            + DIWSLGC + E+ T K P+        + K+      P +P   S E +  I+   +
Sbjct: 180 KS-DIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFK 237

Query: 353 RNPLNRPTAAELL 365
           RNP +RP+A  +L
Sbjct: 238 RNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  149 bits (378), Expect = 6e-41
 Identities = 96/277 (34%), Positives = 146/277 (52%), Gaps = 23/277 (8%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P   W+  + +G+GT+G V+   N  +G   A+K +    D   +  A     E  +L  
Sbjct: 16  PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA-----EYNILKA 70

Query: 171 LR-HPNIVQYYG-----SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG----EPAIRNYT 220
           L  HPN+V++YG          D+L++ LE  +GGS+  L++ + + G    EP I    
Sbjct: 71  LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130

Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK-GSPYW 279
            + L GL  LH   T+HRD+KG NIL+   G VKL DFG++  +       +   G+P+W
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190

Query: 280 MAPEVI----KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI 335
           MAPEVI    +  S  +   D+WSLG T +E+    PP +    + A+FKI  +   PT+
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP-PTL 249

Query: 336 --PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
             P+  S+E  DFIR CL ++   RPT ++LL H F+
Sbjct: 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  149 bits (377), Expect = 1e-40
 Identities = 93/283 (32%), Positives = 141/283 (49%), Gaps = 21/283 (7%)

Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           +E+   P   W+  + +G+GT+G VY   N   G + A+K +    D   +  A    + 
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA----EY 69

Query: 165 IVLLSRLRHPNIVQYYG-----SKTVEDKLYIYLEYVSGGSIYKLLQDY---GQ-FGEPA 215
            +L S   HPN+V++YG      K V  +L++ LE  +GGS+ +L++     GQ   E  
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129

Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK- 274
           I       L GL  LH+   +HRD+KG NIL+   G VKL DFG++  +       +   
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 275 GSPYWMAPEVI----KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
           G+P+WMAPEVI    +     +   D+WSLG T +E+    PP      V  +FKI  + 
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249

Query: 331 ELPTI--PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             PT+  P+        FI  CL ++   RP+   LL+HPF+K
Sbjct: 250 P-PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  149 bits (379), Expect = 1e-40
 Identities = 87/297 (29%), Positives = 137/297 (46%), Gaps = 47/297 (15%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           GK        H+    +  +  + A+K++ L  D+ SKE  K L QEI+   +L+HPNI+
Sbjct: 7   GKCFEDLMIVHLAK--HKPTNTLVAVKKINL--DSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG--EPAIRNYTQQILSGLAFLHSKHT 235
            Y  S  V+ +LY+    ++ GS   LL+ +   G  E AI    + +L+ L ++HSK  
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122

Query: 236 VHRDIKGANILVDPNGRVKLADF----GMAKHIAGQSCPLSFKGSP----YWMAPEVI-K 286
           +HR +K ++IL+  +G+V L+       M KH   Q     F  S      W++PEV+ +
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWS--------------------------QYEGV 320
           N  G N   DI+S+G T  E+A    P+                            YE  
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242

Query: 321 AAMFKIGNSKELPTIPDD------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            +  +  N         D       S+    F+ LCLQR+P +RP+A++LL+H F K
Sbjct: 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  148 bits (375), Expect = 2e-40
 Identities = 92/274 (33%), Positives = 147/274 (53%), Gaps = 14/274 (5%)

Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           +P  P  +      +G G+ G V +     +G+  A+K++    D + ++  + L  E+V
Sbjct: 16  SPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVV 71

Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++    H N+V  Y S  V D+L++ +E++ GG++  ++  + +  E  I      +L  
Sbjct: 72  IMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRA 130

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP--LSFKGSPYWMAPEV 284
           L++LH++  +HRDIK  +IL+  +GR+KL+DFG    ++ +  P   S  G+PYWMAPEV
Sbjct: 131 LSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEV 189

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SD 341
           I         VDIWSLG  V+EM   +PP+     + AM +I ++  LP    D    S 
Sbjct: 190 ISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN--LPPRVKDSHKVSS 246

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             + F+ L L R P  R TA ELL HPF+K A P
Sbjct: 247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  149 bits (377), Expect = 2e-40
 Identities = 92/302 (30%), Positives = 154/302 (50%), Gaps = 25/302 (8%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+G+FG V +     + E  A+K    +V L DD    +    +++  VL     HP
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD----DVECTMVERRVLALAWEHP 56

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +   + +   ++ L+  +EY++GG +   +Q  G+F E   R Y  +I+ GL FLH K 
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            ++RD+K  N+L+D +G +K+ADFGM K ++ G+    +F G+P ++APE++K     N 
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNE 175

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           +VD WS G  + EM   + P+   E    +F  I N  + P  P  +S E KD +    +
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFE 232

Query: 353 RNPLNR-PTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFD 411
           R+P  R     ++  HPF +    ++   L  E  ++PP     +K+       + S FD
Sbjct: 233 RDPTKRLGVDGDIRQHPFFR---GIDWERL--EKREIPPPFKPKVKSPS-----DASNFD 282

Query: 412 TE 413
            E
Sbjct: 283 RE 284

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  145 bits (368), Expect = 9e-40
 Identities = 77/259 (29%), Positives = 136/259 (52%), Gaps = 7/259 (2%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K +++GRG FG V++       ++  +K++ +    K +  A Q   E  +L  L HP
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ--NECQVLKLLSHP 59

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHS 232
           NI++YY +   +  L I +EY  GG++ + +Q        E  I ++  QIL  L  +H+
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 233 KHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           K  +HRD+K  NIL+D +  V K+ DFG++K ++ +S   +  G+P +++PE+ +     
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE-GKPY 178

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL 351
           N   DIW+LGC + E+A+ K  +      A + KI +    P I D  S + +  I   L
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-ISDRYSPDLRQLILSML 237

Query: 352 QRNPLNRPTAAELLDHPFV 370
             +P  RP  ++++  P  
Sbjct: 238 NLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  148 bits (375), Expect = 1e-39
 Identities = 90/290 (31%), Positives = 131/290 (45%), Gaps = 38/290 (13%)

Query: 117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
             K++GRG FG V++  + D+G++ AMK +   D  K  + A  +  E  +L+    P I
Sbjct: 5   VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIA-HVRAERDILADADSPWI 63

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           V+ Y S   E+ LY+ +EY+ GG +  LL     F E   R Y  +++  L  +H    +
Sbjct: 64  VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFI 123

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---------------------- 274
           HRDIK  NIL+D +G +KLADFG+ K +        +                       
Sbjct: 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183

Query: 275 --------GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI 326
                   G+P ++APEV++  +   L  D WSLG  + EM    PP+          KI
Sbjct: 184 RVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKI 242

Query: 327 GNSKELPTIPDD--LSDEGKDFIR--LCLQRNPLNRPTAAELLDHPFVKG 372
            N KE    P D  +S E  D I   LC   + L      E+  HPF KG
Sbjct: 243 INWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGS--FEEIKSHPFFKG 290

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  146 bits (368), Expect = 1e-39
 Identities = 89/268 (33%), Positives = 143/268 (53%), Gaps = 23/268 (8%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIV 177
           +++G GT+G VY G +  +G++ A+K + +  D +     +++ QEI +L +   H NI 
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-----EEIKQEINMLKKYSHHRNIA 66

Query: 178 QYYGS------KTVEDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAF 229
            YYG+        ++D+L++ +E+   GS+  L+++       E  I    ++IL GL+ 
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVI- 285
           LH    +HRDIKG N+L+  N  VKL DFG++  +    G+    +F G+PYWMAPEVI 
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--TFIGTPYWMAPEVIA 184

Query: 286 ---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
                 +  +   D+WSLG T +EMA   PP      + A+F I  +          S +
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
            + FI  CL +N   RPT  +L+ HPF+
Sbjct: 245 FQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  145 bits (367), Expect = 2e-39
 Identities = 83/250 (33%), Positives = 136/250 (54%), Gaps = 13/250 (5%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD--DAKSKESAKQLMQEIVLLSRLRHPNI 176
           K +GRG F  VY       G   A+K+V +FD  DAK++      ++EI LL +L HPN+
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADC---IKEIDLLKQLNHPNV 64

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ----FGEPAIRNYTQQILSGLAFLHS 232
           ++YY S   +++L I LE    G + ++++ + +      E  +  Y  Q+ S L  +HS
Sbjct: 65  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKNSSGC 291
           +  +HRDIK AN+ +   G VKL D G+ +  + ++    S  G+PY+M+PE I + +G 
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-HENGY 183

Query: 292 NLAVDIWSLGCTVLEMATTKPP-WSQYEGVAAMFKIGNSKELPTIPDD-LSDEGKDFIRL 349
           N   DIWSLGC + EMA  + P +     + ++ K     + P +P D  S+E +  + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243

Query: 350 CLQRNPLNRP 359
           C+  +P  RP
Sbjct: 244 CINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  146 bits (370), Expect = 2e-39
 Identities = 88/273 (32%), Positives = 138/273 (50%), Gaps = 37/273 (13%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQE--IVLLSRLR 172
           K+LG+G+FG V +     + E+ A+K    +V L DD       +  M E  ++ L+  +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD-----DVECTMTEKRVLALAG-K 54

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HP + Q +     +D+L+  +EYV+GG +   +Q  G+F EP  R Y  +I+ GL FLH 
Sbjct: 55  HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           +  ++RD+K  N+L+D  G +K+ADFGM K  I G     +F G+P ++APE++      
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP-Y 173

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--------PTIPDDLSDEG 343
             AVD W+LG  + EM   + P          F+  +  EL           P  LS E 
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSP----------FEGDDEDELFQSILEDEVRYPRWLSKEA 223

Query: 344 KDFIRLCLQRNPLNR----PTA-AELLDHPFVK 371
           K  ++  L +NP  R    PT   ++  HPF +
Sbjct: 224 KSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  144 bits (365), Expect = 5e-39
 Identities = 94/284 (33%), Positives = 144/284 (50%), Gaps = 23/284 (8%)

Query: 119 KMLGRGTFGHVY----VGFNSDSGEMCAMK---EVTLFDDAKSKESAKQLMQEIVLLSRL 171
           ++LG G +G V+    VG   D+G++ AMK   + T+   AK+ E       E  +L  +
Sbjct: 6   RVLGTGAYGKVFLVRKVG-GHDAGKLYAMKVLKKATIVQKAKTAE---HTRTERQVLEAV 61

Query: 172 RH-PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           R  P +V  + +   + KL++ L+YV+GG ++  L     F E  +R Y  +I+  L  L
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC--PLSFKGSPYWMAPEVIKN- 287
           H    ++RDIK  NIL+D  G V L DFG++K    +      SF G+  +MAPEVI+  
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--KELPTIPDDLSDEGKD 345
           S G + AVD WSLG    E+ T   P++      +  +I     K  P  P  +S E +D
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARD 241

Query: 346 FIRLCLQRNPLNR---PTAAELLDHPFVKG---AAPLERTILAP 383
           FI+  L+++P  R     A E+ +HPF +G        + I AP
Sbjct: 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  143 bits (362), Expect = 5e-39
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 29/270 (10%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD-DAKSKESAKQLMQEIVLLSRLRH 173
           + K K +G G+FG   +  + + G+   +KE+ +     K +E +++   E+ +LS ++H
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKH 58

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLL--QDYGQFGEPAIRNYTQQILSGLAFLH 231
           PNIVQY  S      LYI ++Y  GG +YK +  Q    F E  I ++  QI   L  +H
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK--GSPYWMAPEVIKNSS 289
            +  +HRDIK  NI +  +G +KL DFG+A+ +   +  L+    G+PY+++PE+ +N  
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICENRP 177

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL---------PTIPDDLS 340
             N + DIW+LGC + EM T K            F+ GN K L         P +    S
Sbjct: 178 YNNKS-DIWALGCVLYEMCTLK----------HAFEAGNMKNLVLKIIRGSYPPVSSHYS 226

Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
            + ++ +    +RNP +RP+   +L+  F+
Sbjct: 227 YDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  144 bits (364), Expect = 6e-39
 Identities = 93/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)

Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           +P  P ++      +G G+ G V +     SG++ A+K++    D + ++  + L  E+V
Sbjct: 14  DPGDPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM----DLRKQQRRELLFNEVV 69

Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++   +H N+V+ Y S  V D+L++ +E++ GG++  ++  + +  E  I      +L  
Sbjct: 70  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKA 128

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEV 284
           L+ LH++  +HRDIK  +IL+  +GRVKL+DFG    ++ +  P   S  G+PYWMAPE+
Sbjct: 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEL 187

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SD 341
           I         VDIWSLG  V+EM   +PP+     + AM  I ++  LP    +L   S 
Sbjct: 188 ISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPKLKNLHKVSP 244

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             K F+   L R+P  R TAAELL HPF+  A P
Sbjct: 245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  143 bits (361), Expect = 7e-39
 Identities = 85/257 (33%), Positives = 143/257 (55%), Gaps = 10/257 (3%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +++G+G++G V +  +   G+   +K++ L + ++ +  A +  QE  LLS+L+HPNIV 
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIVA 63

Query: 179 YYGSKTVED-KLYIYLEYVSGGSIY-KLLQDYGQF-GEPAIRNYTQQILSGLAFLHSKHT 235
           Y  S   ED  LYI + +  GG +Y KL +  G+   E  +  +  QI   L +LH KH 
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEVIKNSSGCNL 293
           +HRD+K  N+ +     +K+ D G+A+ +  Q C +  +  G+PY+M+PE+  N    N 
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-CDMASTLIGTPYYMSPELFSNKP-YNY 181

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
             D+W+LGC V EMAT K  ++  +  + +++I   K LP +P D S E  + I   L +
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPKDYSPELGELIATMLSK 240

Query: 354 NPLNRPTAAELLDHPFV 370
            P  RP+   +L  P++
Sbjct: 241 RPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  143 bits (362), Expect = 1e-38
 Identities = 88/292 (30%), Positives = 139/292 (47%), Gaps = 47/292 (16%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L HP
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELNHP 59

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQILS 225
           NIV+       E+KLY+  E++         QD  +F +         P I++Y  Q+L 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEV 284
           GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE+
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 171

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTK---------------------PPWSQYEGVAAM 323
           +      + AVDIWSLGC   EM T +                     P    + GV ++
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231

Query: 324 ------FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                 F     ++   +   L ++G+D +   L  +P  R +A   L HPF
Sbjct: 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  142 bits (361), Expect = 2e-38
 Identities = 91/294 (30%), Positives = 141/294 (47%), Gaps = 62/294 (21%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G GT+G VY G N  +G++ AMK++ L  + +   S    ++EI LL  L+HPNIV   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDY------GQFGEPA-IRNYTQQILSGLAFLHSK 233
                E +LY+  E++S       L+ Y      GQ+ +   +++Y  QIL G+ F HS+
Sbjct: 66  DVLMQESRLYLIFEFLSMD-----LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----------YWMAP 282
             +HRD+K  N+L+D  G +KLADFG+A+            G P           ++ AP
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAF----------GIPVRVYTHEVVTLWYRAP 170

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT-------- 334
           EV+  S   +  VDIWS+G    EMAT KP +     +  +F+I      PT        
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230

Query: 335 -IPD------------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
            +PD                  +L ++G D +   L  +P  R +A + L+HP+
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  142 bits (360), Expect = 3e-38
 Identities = 70/196 (35%), Positives = 114/196 (58%), Gaps = 4/196 (2%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K +G GTFG V++  +  S    A+K + + +  + K+  + +  E  +L  + HP I++
Sbjct: 7   KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEVSHPFIIR 65

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + ++  +  LY+ +EYV GG ++  L++ G+F       Y  +I+  L +LHSK  V+R
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           D+K  NIL+D  G +KL DFG AK +  ++  L   G+P ++APEVI+ S G N AVD W
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC--GTPEYLAPEVIQ-SKGHNKAVDWW 182

Query: 299 SLGCTVLEMATTKPPW 314
           +LG  + EM    PP+
Sbjct: 183 ALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  142 bits (359), Expect = 8e-38
 Identities = 104/329 (31%), Positives = 159/329 (48%), Gaps = 31/329 (9%)

Query: 119 KMLGRGTFGHVYV---GFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           K+LG+G +G V+       +D+G++ AMK +      ++++       E  +L  ++HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           IV    +     KLY+ LEY+SGG ++  L+  G F E     Y  +I   L  LH +  
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           ++RD+K  NIL+D  G VKL DFG+ K  I   +   +F G+  +MAPE++   SG   A
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR-SGHGKA 180

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRN 354
           VD WSLG  + +M T  PP++       + KI   K    +P  L+ E +D ++  L+RN
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--NLPPYLTPEARDLLKKLLKRN 238

Query: 355 PLNR-----PTAAELLDHPF---VKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRN 406
           P +R       AAE+  HPF   V     L R +  P      P + +           +
Sbjct: 239 PSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPP----FKPLLQSE---------ED 285

Query: 407 VSTFD---TERLAVHSSRVSQTSLNASDI 432
           VS FD   T +  V S   S  S +A+ I
Sbjct: 286 VSQFDSKFTRQTPVDSPDDSTLSESANQI 314

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  141 bits (357), Expect = 8e-38
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 34/281 (12%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           ++G G++G V    + ++G++ A+K+    +    K   K  M+EI +L +LRH N+V  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKK--FLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
                 + +LY+  E+V    +  L +      E  +R Y  QIL G+ F HS + +HRD
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125

Query: 240 IKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           IK  NILV  +G VKL DFG A+ +A  G+     +  + ++ APE++   +    AVDI
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYT-DYVATRWYRAPELLVGDTKYGRAVDI 184

Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKI----GNSKE----------------LPTIPD 337
           W++GC V EM T +P +     +  ++ I    GN                   LP + +
Sbjct: 185 WAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKE 244

Query: 338 ---------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                     LS    D  + CL+ +P +RP++++LL H F
Sbjct: 245 IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 1e-37
 Identities = 77/262 (29%), Positives = 123/262 (46%), Gaps = 17/262 (6%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K + +G FG VY+     +G+  A+K +   D     +      +  +++ +   P + +
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            Y S   +D LY+ +EY++GG    L++  G   E   + Y  +++ G+  LH +  +HR
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           DIK  N+L+D  G +KL DFG+++   G      F G+P ++APE I    G +   D W
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSR--NGLENK-KFVGTPDYLAPETI-LGVGDDKMSDWW 177

Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFK------IGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           SLGC + E     PP+   E   A+F       I   +E+       S E  D I   L 
Sbjct: 178 SLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEF---CSPEAVDLINRLLC 233

Query: 353 RNPLNRPTA---AELLDHPFVK 371
            +P  R  A    E+  HPF K
Sbjct: 234 MDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  139 bits (352), Expect = 2e-37
 Identities = 81/259 (31%), Positives = 141/259 (54%), Gaps = 15/259 (5%)

Query: 121 LGRGTFGHVYVGFN--SDSGE-MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           LG+G+FG VY+  +  + + E +  +KE+ +  +    E+  Q  QE  LLS+L HP IV
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV-GELNPNETV-QANQEAQLLSKLDHPAIV 65

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ----FGEPAIRNYTQQILSGLAFLHSK 233
           +++ S    D   I  EY  G  +   L++         E  +  +  Q+L G+ ++H +
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEVIKNSSGC 291
             +HRD+K  NI +  N  +K+ DFG+++ + G SC L  +F G+PY+M+PE +K+  G 
Sbjct: 126 RILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMG-SCDLATTFTGTPYYMSPEALKH-QGY 182

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL 351
           +   DIWSLGC + EM      +     ++ + +I      P++P+  S +    ++  L
Sbjct: 183 DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-PTPSLPETYSRQLNSIMQSML 241

Query: 352 QRNPLNRPTAAELLDHPFV 370
            ++P  RP+AAE+L +PF+
Sbjct: 242 NKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  139 bits (351), Expect = 3e-37
 Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 11/260 (4%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V       +G+M A K++      K ++  +  + E  +L ++    IV   
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDK-KRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            +   +D L + +  ++GG +   + + G+  F E     Y  QI+ GL  LH +  V+R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           D+K  N+L+D +G V+++D G+A  + G        G+P +MAPEV++     + +VD +
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWF 178

Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFKIGN-SKELP-TIPDDLSDEGKDFIRLCLQRNPL 356
           +LGCT+ EM   + P+ Q +      ++   + E+    PD  S E KD     LQ++P 
Sbjct: 179 ALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238

Query: 357 NR-----PTAAELLDHPFVK 371
            R      +A E+ +HP  K
Sbjct: 239 KRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  140 bits (354), Expect = 5e-37
 Identities = 86/260 (33%), Positives = 133/260 (51%), Gaps = 12/260 (4%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNIVQ 178
           +G+GTFG VY     D+  + AMK ++  +    KE A  + +  +L+  L    P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
              S   +  LY+  +Y+SGG ++  LQ  G+F E   + Y  +++  L  LH    V+R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 239 DIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           D+K  NIL+D  G + L DFG++K ++       +F G+  ++APEV+ +  G    VD 
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 298 WSLGCTVLEMATTKPPWSQY--EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           WSLG  V EM      WS +  E    M++     ++    + LSDEG+ F++  L RNP
Sbjct: 181 WSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237

Query: 356 LNR----PTAAELLDHPFVK 371
            +R      A EL +HPF  
Sbjct: 238 QHRLGAHRDAVELKEHPFFA 257

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 7e-37
 Identities = 83/293 (28%), Positives = 134/293 (45%), Gaps = 61/293 (20%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G GT+G VY   +  +GE+ A+K++ L  + +   S    ++EI LL  L HPNIV+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IREISLLKELNHPNIVRLL 64

Query: 181 GSKTVEDKLYIYLEYVSGG------SIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
                E+KLY+  E++         S             P I++Y  Q+L G+A+ HS  
Sbjct: 65  DVVHSENKLYLVFEFLDLDLKKYMDSSPLT-----GLDPPLIKSYLYQLLQGIAYCHSHR 119

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----------YWMAPE 283
            +HRD+K  N+L+D  G +KLADFG+A+         +F G P           ++ APE
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLAR---------AF-GVPVRTYTHEVVTLWYRAPE 169

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI----GN----------- 328
           ++  S   +  VDIWS+GC   EM   +P +     +  +F+I    G            
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229

Query: 329 ------------SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                        ++L  +  +L ++G D +   L  +P  R +A   L HP+
Sbjct: 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  137 bits (346), Expect = 1e-36
 Identities = 79/258 (30%), Positives = 141/258 (54%), Gaps = 17/258 (6%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD--DAKSKESAKQLMQEIVLLSR 170
           ++++  K +GRG F  VY        +  A+K+V +F+  DAK+++     ++EI LL +
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDC---VKEIDLLKQ 58

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ----FGEPAIRNYTQQILSG 226
           L HPN+++Y  S   +++L I LE    G + ++++ + +      E  +  Y  Q+ S 
Sbjct: 59  LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVI 285
           +  +HS+  +HRDIK AN+ +   G VKL D G+ +  + ++    S  G+PY+M+PE I
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE---LPTIPDD-LSD 341
            + +G N   DIWSLGC + EMA  + P+  Y     +F +    E    P +P +  S+
Sbjct: 179 -HENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235

Query: 342 EGKDFIRLCLQRNPLNRP 359
           + ++ + +C+  +P  RP
Sbjct: 236 KLRELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  137 bits (348), Expect = 1e-36
 Identities = 88/286 (30%), Positives = 142/286 (49%), Gaps = 35/286 (12%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K+ + LG GT+  VY G N  +GE+ A+KE+ L  +  +  +A   ++EI L+  L+H 
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKHE 58

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG--EPA-IRNYTQQILSGLAFLH 231
           NIV+ +     E+KL +  EY+    + K +  +G  G  +P  ++++T Q+L G+AF H
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSG 290
               +HRD+K  N+L++  G +KLADFG+A+         S +    W  AP+V+  S  
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN------------SKELPTI--- 335
            + ++DIWS+GC + EM T +P +        + KI                +LP     
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237

Query: 336 -----PDDLSD-------EGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                P DL          G D +   LQ NP  R +A + L HP+
Sbjct: 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  137 bits (346), Expect = 2e-36
 Identities = 85/296 (28%), Positives = 137/296 (46%), Gaps = 63/296 (21%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM-QEIVLLSRLR---HPNI 176
           +G G +G VY   + ++G   A+K+V +     S+E       +EI LL +L    HPNI
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRV---PLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 177 VQYY----GSKTV-EDKLYIYLEYVSGGSIYKLLQDYGQF---------GEPAIRNYTQQ 222
           V+      G +T  E KL +  E+V         QD   +             I++  +Q
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVD--------QDLATYLSKCPKPGLPPETIKDLMRQ 115

Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK----HIAGQSCPLSFKGSPY 278
           +L G+ FLHS   VHRD+K  NILV  +G+VK+ADFG+A+     +A  S  ++     +
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTL----W 171

Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKI--------- 326
           + APEV+  SS     VD+WS+GC   E+   +P +   S+ + +  +F +         
Sbjct: 172 YRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230

Query: 327 -------------GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                           +   +   ++ +EG D ++  L  NP  R +A E L HP+
Sbjct: 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  137 bits (347), Expect = 3e-36
 Identities = 86/319 (26%), Positives = 136/319 (42%), Gaps = 70/319 (21%)

Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVL 167
            S    ++    LG GTFG VY      +G + A+K++ + +    K+      ++EI +
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKI 60

Query: 168 LSRLRHPNIVQY------YGSKTVEDKLYIY--LEY----VSGGSIYKLLQDYG-QFGEP 214
           L +L+HPN+V           K+   +  +Y    Y    +SG     LL++   +  E 
Sbjct: 61  LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG-----LLENPSVKLTES 115

Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            I+ Y  Q+L G+ +LH  H +HRDIK ANIL+D  G +K+ADFG+A+   G   P + K
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDG--PPPNPK 173

Query: 275 GSP--------------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP-------- 312
           G                ++  PE++        AVDIW +GC   EM T +P        
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233

Query: 313 ------------P-------WSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC--- 350
                       P       W    G   +    N     T+ +     G + + L    
Sbjct: 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP--RTLEERFGKLGPEGLDLLSKL 291

Query: 351 LQRNPLNRPTAAELLDHPF 369
           L  +P  R TA++ L+HP+
Sbjct: 292 LSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  137 bits (346), Expect = 5e-36
 Identities = 87/257 (33%), Positives = 134/257 (52%), Gaps = 10/257 (3%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE-IVLLSRLRHPNIV 177
           K++G+G+FG V +  +   G+  A+K +      K KE  K +M E  VLL  ++HP +V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLV 59

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             + S    DKLY  L+YV+GG ++  LQ    F EP  R Y  +I S L +LHS + ++
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY 119

Query: 238 RDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           RD+K  NIL+D  G V L DFG+ K  I       +F G+P ++APEV++     +  VD
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVD 178

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
            W LG  + EM    PP+   +  A M+    +K L  +  ++S   +  +   LQ++  
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRD-TAEMYDNILNKPL-RLKPNISVSARHLLEGLLQKDRT 236

Query: 357 NRPTAA----ELLDHPF 369
            R  A     E+ +H F
Sbjct: 237 KRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  136 bits (345), Expect = 6e-36
 Identities = 88/300 (29%), Positives = 145/300 (48%), Gaps = 62/300 (20%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE----SAKQLMQEIVLLSR 170
           ++KGK LG GT+  VY   + ++G + A+K++ L +  ++K+    +A   ++EI LL  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA---LREIKLLQE 58

Query: 171 LRHPNI---VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA-IRNYTQQILSG 226
           L+HPNI   +  +G K     + +  E++    + K+++D      PA I++Y    L G
Sbjct: 59  LKHPNIIGLLDVFGHK---SNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRG 114

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP--------- 277
           L +LHS   +HRD+K  N+L+  +G +KLADFG+A+         SF GSP         
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR---------SF-GSPNRKMTHQVV 164

Query: 278 --YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--------------------PW- 314
             ++ APE++  +    + VD+WS+GC   E+    P                    P  
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224

Query: 315 SQYEGVAAM-----FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
             + GV ++     FK      L  I    SD+  D ++  L  NP  R TA + L+HP+
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  137 bits (346), Expect = 6e-36
 Identities = 88/286 (30%), Positives = 140/286 (48%), Gaps = 19/286 (6%)

Query: 113 SHWK-----KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           S WK      G+ LG G+FG V +  +  +GE  A+K +   +  K K+  + + QE  +
Sbjct: 13  SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSI 71

Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
           L  L HP IV    S   E+++Y  LE+V GG ++  L+  G+F     + Y  +++   
Sbjct: 72  LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAF 131

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
            +LHSK  ++RD+K  N+L+D  G VK+ DFG AK +  ++  L   G+P ++APEVI+ 
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC--GTPEYLAPEVIQ- 188

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           S G   AVD W++G  + E     PP+          KI   +     P+      +D +
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK--FPNWFDGRARDLV 246

Query: 348 RLCLQRNPLNR-----PTAAELLDHPFVKGA---APLERTILAPEP 385
           +  LQ +   R        A++ +HP+  GA       R   AP P
Sbjct: 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIP 292

Length = 329

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  135 bits (340), Expect = 1e-35
 Identities = 79/260 (30%), Positives = 137/260 (52%), Gaps = 20/260 (7%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +LG G  G VY  ++  +  + A+K + L     + E  KQ+M E+ +L +   P I+ +
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPL---DITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           YG+  VE+++ I  E++ GGS    L  Y +  E  +      ++ GL +L S   +HRD
Sbjct: 65  YGAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV--DI 297
           +K +N+LV+  G+VKL DFG++  +   S   ++ G+  +MAPE I   SG    +  D+
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERI---SGEQYGIHSDV 176

Query: 298 WSLGCTVLEMATTKPPWSQYEGVAA------MFKIGNSKELPTIPD-DLSDEGKDFIRLC 350
           WSLG + +E+A  + P+ Q +          + +    ++ P +P    S++   FI  C
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQC 236

Query: 351 LQRNPLNRPTAAELLDHPFV 370
           +++ P  RP    L+DHPF+
Sbjct: 237 MRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  134 bits (340), Expect = 1e-35
 Identities = 85/292 (29%), Positives = 139/292 (47%), Gaps = 47/292 (16%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K + +G GT+G V+   N ++ E+ A+K V L DD +   S+   ++EI LL  L+H 
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHK 59

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-----GQFGEPAIRNYTQQILSGLAF 229
           NIV+ Y     + KL +  EY       + L+ Y     G      ++++  Q+L GLAF
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNS 288
            HS + +HRD+K  N+L++ NG +KLADFG+A+         S +    W   P+V+  +
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 174

Query: 289 SGCNLAVDIWSLGCTVLEMATT----------------------KPPWSQYEGVAAMFKI 326
              + ++D+WS GC   E+A                         P    + GV+   K+
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS---KL 231

Query: 327 GNSKELPTIP---------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
            + K  P  P           L+  G+D ++  L  NP+ R +A E L HP+
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  134 bits (340), Expect = 1e-35
 Identities = 82/262 (31%), Positives = 133/262 (50%), Gaps = 10/262 (3%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LGRG +G V    +  +G + A+K +       S+E  + LM   + +  +  P  V +Y
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRA--TVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 181 GSKTVEDKLYIYLEYV--SGGSIYKLLQDYGQF-GEPAIRNYTQQILSGLAFLHSK-HTV 236
           G+   E  ++I +E +  S    YK + D G    E  +      I+  L +LHSK   +
Sbjct: 67  GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVI 126

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI---KNSSGCNL 293
           HRD+K +N+L++ NG+VKL DFG++ ++          G   +MAPE I    N  G ++
Sbjct: 127 HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDV 186

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD-LSDEGKDFIRLCLQ 352
             D+WSLG T++E+AT + P+  ++      K    +  P +P +  S E +DF+  CL+
Sbjct: 187 KSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLK 246

Query: 353 RNPLNRPTAAELLDHPFVKGAA 374
           +N   RP   ELL HPF +   
Sbjct: 247 KNYKERPNYPELLQHPFFELHL 268

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  132 bits (334), Expect = 6e-35
 Identities = 78/253 (30%), Positives = 134/253 (52%), Gaps = 16/253 (6%)

Query: 121 LGRGTFGHVY-VGFNSDSGEMCAMKEVTLFD-----DAKSK-ESAKQLMQEIVLL-SRLR 172
           LG G FG VY V   ++   + A+KE+ + +     D + + +S   ++ E+ ++  +LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKL---LQDYGQ-FGEPAIRNYTQQILSGLA 228
           HPNIV+YY +    D+LYI ++ + G  + +    L++  Q F E  I N   Q++  L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 229 FLH-SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
           +LH  K  VHRD+   NI++  + +V + DFG+AK    +S   S  G+  +  PE++KN
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN 187

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL-SDEGKDF 346
                 A D+W+ GC + +M T +PP+     ++   KI  +   P +P+ + S++  D 
Sbjct: 188 EPYGEKA-DVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-LPEGMYSEDVTDV 245

Query: 347 IRLCLQRNPLNRP 359
           I  CL  +   RP
Sbjct: 246 ITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  130 bits (330), Expect = 3e-34
 Identities = 87/289 (30%), Positives = 136/289 (47%), Gaps = 43/289 (14%)

Query: 110 SPESHWKKGKMLGRGTFGHVYVG---FNSD-SGEMCAMKEVTLFDDAKSKESAKQ--LMQ 163
             + H K  K LG G FG V +       D +GE  A+K +       S E   +    +
Sbjct: 1   FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-----HSGEEQHRSDFER 55

Query: 164 EIVLLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN--- 218
           EI +L  L H NIV+Y G   K     L + +EY+  GS    L+DY Q     I     
Sbjct: 56  EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS----LRDYLQRHRDQINLKRL 111

Query: 219 --YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKG- 275
             ++ QI  G+ +L S+  +HRD+   NILV+    VK++DFG+AK +         K  
Sbjct: 112 LLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP 171

Query: 276 --SP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY-------EGVA 321
             SP +W APE ++ S   + A D+WS G T+ E+ T    ++ P +++       +G  
Sbjct: 172 GESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230

Query: 322 AMFKIGN----SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            + ++       + LP  P    DE  D ++LC +  P +RP+ A+L+ 
Sbjct: 231 IVTRLLELLKEGERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 7e-34
 Identities = 78/261 (29%), Positives = 123/261 (47%), Gaps = 16/261 (6%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCA---MKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           +G+G +G V++    D+GE+ A   MK+  LF         + ++ E  +L+  +   +V
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDILTTTKSEWLV 64

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
           +   +   ++ LY+ +EYV GG    LL + G   E   R Y  ++   +  LH    +H
Sbjct: 65  KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH 124

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           RD+K  N L+D +G +KL DFG++K     +   S  GSP +MAPEV+    G +  VD 
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVL-RGKGYDFTVDY 181

Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD------DLSDEGKDFIRLCL 351
           WSLGC + E     PP+S          +   KE    P       +LSDE  D I   +
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241

Query: 352 QRNPLNRPTAAELLDHPFVKG 372
                   +  ++ +HPF K 
Sbjct: 242 NDPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  129 bits (326), Expect = 1e-33
 Identities = 75/287 (26%), Positives = 140/287 (48%), Gaps = 41/287 (14%)

Query: 119 KMLGR---GTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES--AKQLMQEIVLLSRLRH 173
           K+LGR   G  G V+   + ++GE  A+K+V L    +  E     Q ++EI  L   +H
Sbjct: 3   KILGRIGEGAHGIVFKAKDRETGETVALKKVAL----RRLEGGIPNQALREIKALQACQH 58

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHS 232
           P +V+            + +EY+    + ++L+D  +   E  +++Y + +L G+A++H+
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK--GSPYWMAPEVIKNSSG 290
              +HRD+K AN+L+  +G +K+ADFG+A+  + +   L      + ++ APE++  +  
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 291 CNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSK------ELPTIPD---- 337
            +  VD+W++GC   E+    P +   +  E +A +F+   +        L ++PD    
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237

Query: 338 ---------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                          D S E  D ++  L  +P  R +AAE L HP+
Sbjct: 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  130 bits (328), Expect = 1e-33
 Identities = 88/263 (33%), Positives = 137/263 (52%), Gaps = 20/263 (7%)

Query: 119 KMLGRGTFGHVYVG---FNSDSGEMCAMK---EVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           K+LG+G+FG V++       D+G++ AMK   + TL    K ++  +  M E  +L+ + 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL----KVRDRVRTKM-ERDILAEVN 56

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HP IV+ + +   E KLY+ L+++ GG ++  L     F E  ++ Y  ++   L  LHS
Sbjct: 57  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
              ++RD+K  NIL+D  G +KL DFG++K  I  +    SF G+  +MAPEV+ N  G 
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGH 175

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL 351
             + D WS G  + EM T   P+   +    M  I  +K    +P  LS E +  +R   
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRALF 233

Query: 352 QRNPLNRPTAA-----ELLDHPF 369
           +RNP NR  A      E+  HPF
Sbjct: 234 KRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 3e-33
 Identities = 89/297 (29%), Positives = 127/297 (42%), Gaps = 45/297 (15%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +    D+G + AMK      +   KE    +  E  +L+   +P +V+
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMK-KLRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            Y S   E+ LY+ +EY+ GG +  LL     F E   R Y  + +  +  +H    +HR
Sbjct: 66  LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125

Query: 239 DIKGANILVDPNGRVKLADFGMAK-----------HIAGQSCPLSFK------------- 274
           DIK  N+L+D  G +KL+DFG+              I   + P +F              
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKA 185

Query: 275 ---------------GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG 319
                          G+P ++APEV    +G N   D WSLG  + EM    PP+     
Sbjct: 186 ETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244

Query: 320 VAAMFKIGNSKELPTIPDD--LSDEGKDFIR--LCLQRNPLNRPTAAELLDHPFVKG 372
                KI N KE    PD+  LS E KD I+   C     L      E+  HPF KG
Sbjct: 245 QETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKG 301

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  129 bits (325), Expect = 3e-33
 Identities = 82/263 (31%), Positives = 135/263 (51%), Gaps = 17/263 (6%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
            +LG+G+FG V +     + E+ A+K    +V + DD    E    ++++ VL    + P
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDD--DVECT--MVEKRVLALPGKPP 61

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            + Q +      D+LY  +EYV+GG +   +Q  G+F EP    Y  +I  GL FLHSK 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            ++RD+K  N+++D  G +K+ADFGM K +I G     +F G+P ++APE+I        
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGK 180

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           +VD W+ G  + EM   +PP+   E    +F+    +   + P  LS E     +  L +
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQ-SIMEHNVSYPKSLSKEAVSICKGLLTK 238

Query: 354 NPLNR----PTAA-ELLDHPFVK 371
           +P  R    PT   ++ +H F +
Sbjct: 239 HPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  128 bits (324), Expect = 4e-33
 Identities = 94/327 (28%), Positives = 162/327 (49%), Gaps = 27/327 (8%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+G+FG V +      GE  A+K    +V L DD    +    ++++ VL     +P
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDD----DVECTMVEKRVLALAWENP 56

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +   Y +   ++ L+  +E+++GG +   +QD G+F       Y  +I+ GL FLHSK 
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            ++RD+K  N+++D +G +K+ADFGM K ++ G +   +F G+P ++APE+++       
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YTF 175

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           +VD WS G  + EM   + P+   +       I    + P  P  ++ E KD +    +R
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--RVDTPHYPRWITKESKDILEKLFER 233

Query: 354 NPLNR-PTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDT 412
           +P  R      +  HPF K    +  T L  E  ++ P     +K+       + S FD 
Sbjct: 234 DPTRRLGVVGNIRGHPFFK---TINWTAL--EKRELDPPFKPKVKS-----PSDYSNFDR 283

Query: 413 ERLAVHSSRVSQTSLNASDINISMNRS 439
           E L+    R+S +  N  D   SM++S
Sbjct: 284 EFLS-EKPRLSYSDKNLID---SMDQS 306

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  128 bits (323), Expect = 9e-33
 Identities = 83/260 (31%), Positives = 122/260 (46%), Gaps = 14/260 (5%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE---IVLLSRLRHPNIV 177
           LGRG FG V +     +GE+ A+K      D  +++  + LM E       +  RHP +V
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIK-ALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             +     ED +   +EY +GG +   +     F EP    Y   ++ GL +LH    V+
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVY 124

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSSGCNLAVD 296
           RD+K  N+L+D  G VK+ADFG+ K   G     S F G+P ++APEV+  +S    AVD
Sbjct: 125 RDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVD 183

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
            W LG  + EM   + P+   +       I N +     P  LS E    +R  L+RNP 
Sbjct: 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSREAISIMRRLLRRNPE 241

Query: 357 NR----PTAAE-LLDHPFVK 371
            R       AE +   PF +
Sbjct: 242 RRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  128 bits (322), Expect = 1e-32
 Identities = 93/317 (29%), Positives = 144/317 (45%), Gaps = 49/317 (15%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQE--IVLLSRLR 172
           K+LG+G+FG V +     + E+ A+K    +V L DD          M E  I+ L+  +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDD-----DVDCTMTEKRILALAA-K 54

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HP +   +     +D+L+  +EYV+GG +   +Q   +F EP  R Y  ++   L FLH 
Sbjct: 55  HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
              ++RD+K  NIL+D  G  KLADFGM K  I       +F G+P ++APE+++     
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-Y 173

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--PTIPDD------LSDEG 343
             +VD W+LG  + EM   +PP          F+  N  +L    + DD      LS E 
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP----------FEADNEDDLFESILHDDVLYPVWLSKEA 223

Query: 344 KDFIRLCLQRNPLNR-------PTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGI 396
              ++  + +NP  R            +  HPF K     E   +  E   + P     I
Sbjct: 224 VSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK-----EIDWVLLEQRKIKPPFKPKI 278

Query: 397 KALGIGQLRNVSTFDTE 413
           K       R+V+ FD +
Sbjct: 279 KT-----KRDVNNFDQD 290

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  127 bits (321), Expect = 1e-32
 Identities = 82/262 (31%), Positives = 136/262 (51%), Gaps = 20/262 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G+  AMK    EV +     +K+     + E  +L   RHP
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHP 55

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +     S    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS  
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RD+K  N+++D +G +K+ DFG+ K  I+  +   +F G+P ++APEV++++     
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGR 174

Query: 294 AVDIWSLGCTVLEMATTKPP-WSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           AVD W LG  + EM   + P ++Q      +F++   +E+   P  LS E K  +   L+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI-RFPRTLSPEAKSLLAGLLK 231

Query: 353 RNPLNR-----PTAAELLDHPF 369
           ++P  R       A E+++H F
Sbjct: 232 KDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  127 bits (320), Expect = 1e-32
 Identities = 81/259 (31%), Positives = 134/259 (51%), Gaps = 13/259 (5%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           KMLG+G+FG V++     + +  A+K    +V L DD    +    ++++ VL     HP
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDD----DVECTMVEKRVLSLAWEHP 56

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +   Y +   ++ L+  +EY++GG +   +Q   +F  P    Y  +I+ GL FLHSK 
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RD+K  NIL+D +G +K+ADFGM K ++ G +   +F G+P ++APE++      N 
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNT 175

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           +VD WS G  + EM   + P+  ++       I    + P  P  L+ E KD +     R
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--RMDNPCYPRWLTREAKDILVKLFVR 233

Query: 354 NPLNR-PTAAELLDHPFVK 371
            P  R     ++  HPF +
Sbjct: 234 EPERRLGVKGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  124 bits (314), Expect = 6e-32
 Identities = 79/289 (27%), Positives = 141/289 (48%), Gaps = 35/289 (12%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKE-VTLFDDAKSKESAKQLMQEIVLLSR 170
           E + K  K +G G++G V+   N ++G++ A+K+ V   DD   K+ A   ++EI +L +
Sbjct: 1   EKYEKLSK-IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA---LREIRMLKQ 56

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           L+HPN+V        + KL++  EY     + +L ++     E  I+    Q L  + F 
Sbjct: 57  LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSS 289
           H  + +HRD+K  NIL+   G++KL DFG A+ + G     + +  + ++ APE++   +
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--KELP-------------- 333
                VD+W++GC   E+ T +P W     V  ++ I  +    +P              
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236

Query: 334 -TIPD------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
            +IP+            ++S     F++ CLQ +P  R +  ELL+HP+
Sbjct: 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  124 bits (314), Expect = 8e-32
 Identities = 70/206 (33%), Positives = 112/206 (54%), Gaps = 18/206 (8%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G GT+G VY   + D+GE+ A+K+V L  D + +      ++EI +L +L H NIV   
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 181 GSKTVEDK------------LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
             + V DK             Y+  EY+    +  L      F E  I+++ +Q+L GL 
Sbjct: 73  --EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWM-APEVIK 286
           + H K+ +HRDIK +NIL++  G++KLADFG+A+ + + +S P + K    W   PE++ 
Sbjct: 131 YCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKP 312
                  A+D+WS GC + E+ T KP
Sbjct: 191 GEERYGPAIDVWSCGCILGELFTKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  124 bits (312), Expect = 8e-32
 Identities = 76/271 (28%), Positives = 136/271 (50%), Gaps = 17/271 (6%)

Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +    LG G  G V    +  +G + A K   +   AKS    KQ+++E+ ++   R P 
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKK--VVHIGAKSSVR-KQILRELQIMHECRSPY 64

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH- 234
           IV +YG+   E+ + + +E++  GS+ ++ +  G      +      ++ GL +L++ H 
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
            +HRDIK +NILV+  G++KL DFG++  +   S   +F G+  +M+PE I+      + 
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELI-NSIADTFVGTSTYMSPERIQ-GGKYTVK 182

Query: 295 VDIWSLGCTVLEMATTKPPWSQYE----GVAAMFKIGN------SKELPTIP-DDLSDEG 343
            D+WSLG +++E+A  K P++       G      I +       +  P +P  D  ++ 
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
           +DF+  CL ++P  RPT  +L   P    A 
Sbjct: 243 RDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  125 bits (314), Expect = 9e-32
 Identities = 81/256 (31%), Positives = 129/256 (50%), Gaps = 8/256 (3%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++G+G+FG V +      G   A+K +      K KE    + +  VLL  L+HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + S    +KLY  L+YV+GG ++  LQ    F EP  R Y  ++ S + +LHS + ++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 239 DIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           D+K  NIL+D  G V L DFG+ K  +  +    +F G+P ++APEV++     +  VD 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTVDW 179

Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           W LG  + EM    PP+   + V+ M+     K L  +P   +    D +   L ++   
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPL-QLPGGKTVAACDLLVGLLHKDQRR 237

Query: 358 RPTAA----ELLDHPF 369
           R  A     E+ +H F
Sbjct: 238 RLGAKADFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  125 bits (315), Expect = 1e-31
 Identities = 93/289 (32%), Positives = 141/289 (48%), Gaps = 32/289 (11%)

Query: 119 KMLGRGTFGHVYV---GFNSDSGEMCAMK---EVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           K+LG G +G V++       D+G++ AMK   +  L   AK+ E  +    E  +L  +R
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRT---ERNVLEHVR 62

Query: 173 H-PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
             P +V  + +   E KL++ L+YVSGG ++  L     F E  +R Y+ +I+  L  LH
Sbjct: 63  QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH 122

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC--PLSFKGSPYWMAPEVIKNSS 289
               V+RDIK  NIL+D  G V L DFG++K    +      SF G+  +MAPE+I+   
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW-------SQYEGVAAMFKIGNSKELPTIPDDLSDE 342
           G   AVD WSLG  + E+ T   P+       +Q E    + K       P  P  +  E
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD-----PPFPSFIGPE 237

Query: 343 GKDFIRLCLQRNPLNR-----PTAAELLDHPFVKG---AAPLERTILAP 383
            +D +   L+++P  R       A+E+ +HPF KG    A   R +  P
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPP 286

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 1e-31
 Identities = 74/263 (28%), Positives = 122/263 (46%), Gaps = 36/263 (13%)

Query: 121 LGRGTFGHVYVG-FNSDSGEM--CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           LG G FG V  G +   SG+    A+K  TL  +       K+ ++E  ++++L HP IV
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVK--TLKQE-HIAAGKKEFLREASVMAQLDHPCIV 59

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
           +  G     + L + +E    G + K L+   +     ++    Q+  G+A+L SKH VH
Sbjct: 60  RLIGV-CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVH 118

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY------------WMAPEVI 285
           RD+   N+L+    + K++DFGM++ +          GS Y            W APE I
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGA--------GSDYYRATTAGRWPLKWYAPECI 170

Query: 286 ---KNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSD 341
              K SS      D+WS G T+ E  +    P+ + +G   +  + + + LP  P++   
Sbjct: 171 NYGKFSS----KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR-PEECPQ 225

Query: 342 EGKDFIRLCLQRNPLNRPTAAEL 364
           E    +  C +  P +RPT +EL
Sbjct: 226 EIYSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 2e-31
 Identities = 89/308 (28%), Positives = 137/308 (44%), Gaps = 62/308 (20%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            H+KK K+LG+G  G V++     +G++ A+K +   +  K  +  K+++ E  +L+ L 
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLD 59

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLL--QDYGQFGEPAIRNYTQQILSGLAFL 230
           HP +   Y S   E  L + ++Y  GG +++LL  Q      E   R Y  ++L  L +L
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKH----------IAGQ------------- 267
           H    V+RD+K  NIL+  +G + L+DF ++K              +             
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179

Query: 268 --SCPLSFK-----GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEM--ATTKPPWSQYE 318
             S   SF+     G+  ++APEVI    G   AVD W+LG  + EM   TT P      
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTT-P------ 231

Query: 319 GVAAMFKIGNSKEL--------PTIP--DDLSDEGKDFIRLCLQRNPLNR----PTAAEL 364
                FK  N  E          T P    +S   +D IR  L ++P  R      AAE+
Sbjct: 232 -----FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286

Query: 365 LDHPFVKG 372
             HPF +G
Sbjct: 287 KQHPFFRG 294

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  124 bits (313), Expect = 3e-31
 Identities = 86/293 (29%), Positives = 139/293 (47%), Gaps = 50/293 (17%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQY 179
           LG+G +G V+   +  + E+ A+K++  FD  ++   A++  +EI+ L  L  HPNIV+ 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKI--FDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72

Query: 180 YGS-KTVEDK-LYIYLEYVSG---GSIYK-LLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
               K   DK +Y+  EY+       I   +L+D         R    Q+L  L ++HS 
Sbjct: 73  LNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV------HKRYIMYQLLKALKYIHSG 126

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK------GSPYWMAPEVIKN 287
           + +HRD+K +NIL++ + RVKLADFG+A+ ++                + ++ APE++  
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG 186

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKP--PWS----QYEGV--------------------A 321
           S+     VD+WS+GC + EM   KP  P +    Q E +                    A
Sbjct: 187 STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAA 246

Query: 322 AMFKIGNSKE---LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            M     S+    L  +    SD+  D ++  L  NP  R TA E L+HP+V 
Sbjct: 247 TMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  123 bits (310), Expect = 4e-31
 Identities = 86/266 (32%), Positives = 134/266 (50%), Gaps = 20/266 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLR-H 173
           ++LG+G+FG V +    +SG + A+K    +V L DD       +  M E  +LS  R H
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDD-----DVECTMTEKRILSLARNH 55

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P + Q Y      D+L+  +E+V+GG +   +Q   +F E   R Y  +I S L FLH K
Sbjct: 56  PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSSGCN 292
             ++RD+K  N+L+D  G  KLADFGM K         S F G+P ++APE+++      
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YG 174

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            +VD W++G  + EM     P+ + E    +F+   + E+   P  LS +  D ++  + 
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMT 232

Query: 353 RNPLNRPTAAEL------LDHPFVKG 372
           +NP  R  +  L      L HPF K 
Sbjct: 233 KNPTMRLGSLTLGGEEAILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  123 bits (309), Expect = 5e-31
 Identities = 87/256 (33%), Positives = 129/256 (50%), Gaps = 8/256 (3%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++G+G+FG V +      G+  A+K +        KE    + +  VLL  ++HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + S    +KLY  L++V+GG ++  LQ    F EP  R Y  +I S L +LHS + V+R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 239 DIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           D+K  NIL+D  G V L DFG+ K  IA      +F G+P ++APEVI+     N  VD 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TVDW 179

Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           W LG  + EM    PP+   + VA M+     K L   P   S      +   L+++   
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRD-VAEMYDNILHKPLVLRP-GASLTAWSILEELLEKDRQR 237

Query: 358 RPTAA----ELLDHPF 369
           R  A     E+ +HPF
Sbjct: 238 RLGAKEDFLEIQEHPF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  122 bits (308), Expect = 6e-31
 Identities = 94/298 (31%), Positives = 146/298 (48%), Gaps = 58/298 (19%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNIVQY 179
           LG G  G V    +  SG + A K + L    + K + + Q+++E+ +L     P IV +
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHL----EIKPAIRNQIIRELKVLHECNSPYIVGF 64

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV-HR 238
           YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  +L GL +L  KH + HR
Sbjct: 65  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHR 124

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQ---SCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           D+K +NILV+  G +KL DFG    ++GQ   S   SF G+  +M+PE ++   G +  V
Sbjct: 125 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQ---GTHYTV 177

Query: 296 --DIWSLGCTVLEMATTK---PPWSQYEGVAAMFK------------------------- 325
             DIWSLG +++EMA  +   PP    E + AMF                          
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236

Query: 326 ---------IGNSKELPTIPDD-LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA 373
                    I N    P +P    SDE +DF+  CL++NP  R    EL  HPF+K A
Sbjct: 237 MAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  121 bits (305), Expect = 1e-30
 Identities = 86/265 (32%), Positives = 134/265 (50%), Gaps = 24/265 (9%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ-EIVLLSRLRH--PNIV 177
           +G GT G VY      +G + A+K   +      +E+ + LM  ++VL S   H  P IV
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVK--QMRRTGNKEENKRILMDLDVVLKS---HDCPYIV 77

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           + YG    +  ++I +E +S   + KLL+   G   E  +   T  I+  L +L  KH V
Sbjct: 78  KCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV 136

Query: 237 -HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI---KNSSGCN 292
            HRD+K +NIL+D +G VKL DFG++  +          G   +MAPE I     +   +
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYD 196

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF----KIGNSKELPTIPDD--LSDEGKDF 346
           +  D+WSLG +++E+AT + P   Y+     F    KI    E P++P +   S +   F
Sbjct: 197 IRADVWSLGISLVELATGQFP---YKNCKTEFEVLTKILQE-EPPSLPPNEGFSPDFCSF 252

Query: 347 IRLCLQRNPLNRPTAAELLDHPFVK 371
           + LCL ++   RP   ELL HPF++
Sbjct: 253 VDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  121 bits (304), Expect = 2e-30
 Identities = 80/253 (31%), Positives = 129/253 (50%), Gaps = 8/253 (3%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G+G+FG V      D+  + A+K +       S+      + E  +L+++  P IV   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRK-AHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S    +KLY+ L +++GG ++  LQ  G+F     R YT ++L  L  LH  + ++RD+
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 241 KGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           K  NIL+D  G + L DFG+ K ++       +F G+P ++APE++    G   AVD W+
Sbjct: 120 KPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL-LGHGYTKAVDWWT 178

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR- 358
           LG  + EM T  PP+   E V  M++    + L   PD    + KD +   L R+P  R 
Sbjct: 179 LGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPL-RFPDGFDRDAKDLLIGLLSRDPTRRL 236

Query: 359 --PTAAELLDHPF 369
               A E+ +HPF
Sbjct: 237 GYNGAQEIKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  121 bits (306), Expect = 3e-30
 Identities = 84/262 (32%), Positives = 131/262 (50%), Gaps = 11/262 (4%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +  +  S ++ AMK ++ F+  K  +SA    +E  +++      IVQ
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF-FWEERDIMAHANSEWIVQ 107

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + +   +  LY+ +EY+ GG +  L+ +Y    E   R YT +++  L  +HS   +HR
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHR 166

Query: 239 DIKGANILVDPNGRVKLADFG--MAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL--- 293
           D+K  N+L+D +G +KLADFG  M     G     +  G+P +++PEV+K+  G      
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD--LSDEGKDFIRLCL 351
             D WS+G  + EM     P+     V    KI + K   T PDD  +S + KD I   L
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL 286

Query: 352 QRNP--LNRPTAAELLDHPFVK 371
                 L R    E+  HPF K
Sbjct: 287 TDREVRLGRNGVDEIKSHPFFK 308

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  119 bits (301), Expect = 4e-30
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 33/272 (12%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI-VLLSRLRHPNIVQY 179
           +GRG FG V    +  SG + A+K +    D K +   K+L+ ++ V++     P IV++
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ---KRLLMDLDVVMRSSDCPYIVKF 68

Query: 180 YGSKTVEDKLYIYLEY--VSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSK-H 234
           YG+   E   +I +E   +S    YK + +  +    E  +       +  L +L  +  
Sbjct: 69  YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---------AGQSCPLSFKGSPYWMAPEVI 285
            +HRD+K +NIL+D NG +KL DFG++  +         AG  C       PY MAPE I
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG--C------RPY-MAPERI 179

Query: 286 KNSS--GCNLAVDIWSLGCTVLEMATTKPPWSQYEGV---AAMFKIGNSKEL-PTIPDDL 339
             S+  G ++  D+WSLG T+ E+AT K P+ ++  V         G+   L  +   + 
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239

Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           S    +FI LCL ++   RP   ELL+HPF+K
Sbjct: 240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  119 bits (299), Expect = 5e-30
 Identities = 85/270 (31%), Positives = 141/270 (52%), Gaps = 20/270 (7%)

Query: 119 KMLGRGTFGHVYVG---FNSDSGEMCAMK---EVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           K+LG G +G V++       DSG++ AMK   + T+   AK+ E  +   Q   +L  +R
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQ---VLEHIR 62

Query: 173 H-PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
             P +V  + +   + KL++ L+Y++GG ++  L    +F E  ++ Y+ +I+  L  LH
Sbjct: 63  QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH 122

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAK--HIAGQSCPLSFKGSPYWMAPEVIK-NS 288
               ++RDIK  NIL+D NG V L DFG++K  H        SF G+  +MAP++++   
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182

Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--KELPTIPDDLSDEGKDF 346
            G + AVD WS+G  + E+ T   P++      +  +I     K  P  P ++S   KD 
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDI 242

Query: 347 IRLCLQRNPLNR----PTAA-ELLDHPFVK 371
           I+  L ++P  R    P+ A E+  HPF +
Sbjct: 243 IQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  119 bits (300), Expect = 8e-30
 Identities = 83/278 (29%), Positives = 141/278 (50%), Gaps = 21/278 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHP 55

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +     +    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+ 
Sbjct: 56  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RDIK  N+++D +G +K+ DFG+ K  I+  +   +F G+P ++APEV++++     
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGR 174

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L++
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKK 232

Query: 354 NPLNR-----PTAAELLDHPFVKGAA---PLERTILAP 383
           +P  R       A E+++H F         +++ +L P
Sbjct: 233 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  119 bits (300), Expect = 8e-30
 Identities = 83/266 (31%), Positives = 134/266 (50%), Gaps = 22/266 (8%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     SG+  AMK    EV +     +K+     + E  +L   RHP
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-----AKDEVAHTLTESRVLKNTRHP 55

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +     S   +D+L   +EYV+GG ++  L     F E   R Y  +I+S L +LHS  
Sbjct: 56  FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RD+K  N+++D +G +K+ DFG+ K  I   +   +F G+P ++APEV++++     
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGR 174

Query: 294 AVDIWSLGCTVLEMATTKPPW--SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL 351
           AVD W LG  + EM   + P+    +E +  +  + + K     P  LS + K  +   L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK----FPRTLSADAKSLLSGLL 230

Query: 352 QRNPLNR-----PTAAELLDHPFVKG 372
            ++P  R       A E++ H F  G
Sbjct: 231 IKDPNKRLGGGPDDAKEIMRHSFFTG 256

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  118 bits (298), Expect = 9e-30
 Identities = 83/287 (28%), Positives = 134/287 (46%), Gaps = 51/287 (17%)

Query: 124 GTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE-----SAKQLMQEIVLLSRLRHPNIVQ 178
           GT+G VY   +  +GE+ A+K++ +    K KE     S    ++EI +L +L+HPNIV 
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKME---KEKEGFPITS----LREINILLKLQHPNIVT 68

Query: 179 Y----YGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
                 GS    DK+Y+ +EYV    +  L++     F +  ++    Q+LSG+A LH  
Sbjct: 69  VKEVVVGSNL--DKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCN 292
             +HRD+K +N+L++  G +K+ DFG+A+       P +      W  APE++  +   +
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYS 185

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS------------KELPTI----- 335
            A+D+WS+GC   E+ T KP +     +  + KI                ELP       
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTF 245

Query: 336 -------------PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                           LSD G D +   L  +P  R +A + L HP+
Sbjct: 246 TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  119 bits (299), Expect = 1e-29
 Identities = 78/241 (32%), Positives = 125/241 (51%), Gaps = 4/241 (1%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++G+G+FG V +  +    +  A+K +      K KE    + +  VLL  ++HP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + S    DKLY  L+Y++GG ++  LQ    F EP  R Y  +I S L +LHS + V+R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 239 DIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           D+K  NIL+D  G + L DFG+ K +I       +F G+P ++APEV+      +  VD 
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP-YDRTVDW 179

Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           W LG  + EM    PP+      A M+    +K L   P ++++  +  +   LQ++   
Sbjct: 180 WCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQLKP-NITNSARHLLEGLLQKDRTK 237

Query: 358 R 358
           R
Sbjct: 238 R 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 2e-29
 Identities = 84/318 (26%), Positives = 131/318 (41%), Gaps = 81/318 (25%)

Query: 122 GRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSK-----ESAKQLMQEIVLLSRLRHP 174
           GRGT+G VY     N   G+  A+K+   F   K +     +SA    +EI LL  L+H 
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSA---CREIALLRELKHE 62

Query: 175 NIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQ--------DYGQFGEPAIRNYTQQIL 224
           N+V       +  +  +Y+  +Y      + L Q                 +++   QIL
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 225 SGLAFLHSKHTVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLSFKGSP--- 277
           +G+ +LHS   +HRD+K ANILV       G VK+ D G+A+       PL     P   
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL-ADLDPVVV 177

Query: 278 -YWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWS------------QYEGVAAM 323
             W  APE++  +     A+DIW++GC   E+ T +P +             Q + +  +
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237

Query: 324 FKI-GNSKE--LPTI---PD--------------------------DLSDEGKDFIRLCL 351
           F++ G   E   P I   P+                              +G D +R  L
Sbjct: 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297

Query: 352 QRNPLNRPTAAELLDHPF 369
           + +P  R TA E L+HP+
Sbjct: 298 EYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  117 bits (293), Expect = 3e-29
 Identities = 85/287 (29%), Positives = 143/287 (49%), Gaps = 25/287 (8%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH---PNI 176
           ++GRG FG VY    +D+G+M AMK +      K K+     + E ++LS +     P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           V    +    DKL   L+ ++GG ++  L  +G F E  +R Y  +I+ GL  +H++  V
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           +RD+K ANIL+D +G V+++D G+A   + +  P +  G+  +MAPEV++  +  + + D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSAD 178

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIPDDLSDEGKDFIR 348
            +SLGC + ++     P+ Q+       K  +  E+          +PD  S E K  + 
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQH-------KTKDKHEIDRMTLTVNVELPDSFSPELKSLLE 231

Query: 349 LCLQRNPLNR-----PTAAELLDHPFVKGAAPLERTILAPEPSDVPP 390
             LQR+   R       A E+ +H F KG    +  +    P  +PP
Sbjct: 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIPP 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  116 bits (292), Expect = 5e-29
 Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 30/270 (11%)

Query: 121 LGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G FG V++G  ++ +      +  V    +  S ++ K   +E  LL+  +H NIV+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL--------------QDYGQFGEPAIRNYTQQIL 224
           +YG  T  D   +  EY+  G + K L                 G+     +     QI 
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKGSP 277
           SG+ +L S+H VHRD+   N LV  +  VK+ DFGM++ +        G    L  +   
Sbjct: 133 SGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR--- 189

Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIP 336
            WM PE I          D+WS G  + E+ T  K PW        +  I   + L   P
Sbjct: 190 -WMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR-P 246

Query: 337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
                E  D +  C +R+P  R    ++ +
Sbjct: 247 RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  119 bits (299), Expect = 7e-29
 Identities = 87/326 (26%), Positives = 149/326 (45%), Gaps = 54/326 (16%)

Query: 86  FSHSNSAATSPSVPRSPGRMENPV--SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAM 143
            SH+N+A       +    ++N +  SP   +K G ++G G+FG VY     D+ E  A+
Sbjct: 40  RSHNNNAGEDEDEEKM---IDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAI 96

Query: 144 KEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV---QYYGSKTVEDK-----LYIYLEY 195
           K+V    D + K       +E++++  L H NI+    YY ++  +       L + +E+
Sbjct: 97  KKV--LQDPQYKN------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEF 148

Query: 196 VSGGSIYKLLQDYGQFGEPA----IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG 251
           +   +++K ++ Y +         ++ Y+ Q+   LA++HSK   HRD+K  N+L+DPN 
Sbjct: 149 IPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT 207

Query: 252 R-VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT 310
             +KL DFG AK++      +S+  S ++ APE++  ++     +D+WSLGC + EM   
Sbjct: 208 HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Query: 311 KPPWSQYEGVAAMFKIGNSKELPT---------------------------IPDDLSDEG 343
            P +S    V  + +I      PT                            P    D+ 
Sbjct: 268 YPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDA 327

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPF 369
            +FI   L+  PL R    E L  PF
Sbjct: 328 INFISQFLKYEPLKRLNPIEALADPF 353

Length = 440

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  117 bits (293), Expect = 7e-29
 Identities = 65/200 (32%), Positives = 110/200 (55%), Gaps = 10/200 (5%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +LG+G+FG V +     + E+ A+K    +V + DD    +    ++++ VL  + + P 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD----DVECTMVEKRVLALQDKPPF 62

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           + Q +      D+LY  +EYV+GG +   +Q  G+F EP    Y  +I  GL FLH +  
Sbjct: 63  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           ++RD+K  N+++D  G +K+ADFGM K H+       +F G+P ++APE+I        +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKS 181

Query: 295 VDIWSLGCTVLEMATTKPPW 314
           VD W+ G  + EM   +PP+
Sbjct: 182 VDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  117 bits (294), Expect = 7e-29
 Identities = 81/266 (30%), Positives = 117/266 (43%), Gaps = 24/266 (9%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           ++GRG FG V V     +G++ AMK     V L     ++E+     +E  +LS    P 
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPW 62

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKH 234
           I Q   +   +D LY+ +EY  GG +  LL  Y  QF E   + Y  +++  +  +H   
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEV---IKNSS 289
            VHRDIK  N+L+D  G +KLADFG A  +            G+P ++APEV   +    
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 290 GCNLAV--DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL--SDEGKD 345
                V  D WSLG    EM   + P+ +         I N +     P+D   S +  D
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLD 242

Query: 346 FIR--LCLQRNPLNRPTAAELLDHPF 369
            I+  LC       R     L  HPF
Sbjct: 243 LIQSLLC---GQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  116 bits (292), Expect = 1e-28
 Identities = 91/314 (28%), Positives = 147/314 (46%), Gaps = 47/314 (14%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
             + ++K   +G GT+G VY   ++ SGE+ A+K+V   D+ +       L +EI LL  
Sbjct: 5   SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSL-REITLLLN 62

Query: 171 LRHPNIVQYYGSKTVE-----DKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQIL 224
           LRHPNIV+    K V      D +++ +EY     +  LL +    F E  ++    Q+L
Sbjct: 63  LRHPNIVEL---KEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APE 283
            GL +LH    +HRD+K +N+L+   G +K+ADFG+A+     + P++ K    W  APE
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPE 178

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKP--PWS----QYEGVAAMFKIGNS------KE 331
           ++   +    A+D+W++GC + E+   KP  P      Q + +  +    N        +
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238

Query: 332 LP-----TIPDD-----------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
           LP     T+P             LS+ G   +   L  +P  R TA E L+  + K   P
Sbjct: 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK-EKP 297

Query: 376 LERTILAPEPSDVP 389
                L  EP  +P
Sbjct: 298 -----LPCEPEMMP 306

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  115 bits (288), Expect = 1e-28
 Identities = 82/282 (29%), Positives = 138/282 (48%), Gaps = 15/282 (5%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA--KSKESAKQLMQEIVLLSRLRH---P 174
           ++GRG FG VY    +D+G+M AMK     D    K K+     + E ++LS +     P
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            IV    +    DKL   L+ ++GG ++  L  +G F E  +R Y  +I+ GL  +H++ 
Sbjct: 58  FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF 117

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
            V+RD+K ANIL+D +G V+++D G+A   + +  P +  G+  +MAPEV++     + +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSS 176

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAM-FKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            D +SLGC + ++     P+ Q++                 +PD  S E +  +   LQR
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236

Query: 354 NPLNR-----PTAAELLDHPFVKGAAPLERTILAPEPSDVPP 390
           +   R       A E+ +HPF +        +    P  +PP
Sbjct: 237 DVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIPP 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  115 bits (290), Expect = 2e-28
 Identities = 78/306 (25%), Positives = 131/306 (42%), Gaps = 57/306 (18%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S ++K   +G+GTFG V+   +  + ++ A+K+V L ++ K       L +EI +L  L+
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITAL-REIKILQLLK 69

Query: 173 HPNIVQYY------GSKTVEDKLYIYL-----EYVSGGSIYKLLQD-YGQFGEPAIRNYT 220
           H N+V          +     K   YL     E+   G    LL +   +F    I+   
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG----LLSNKNVKFTLSEIKKVM 125

Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK--HIAGQSCPLSFKG--- 275
           + +L+GL ++H    +HRD+K ANIL+  +G +KLADFG+A+   ++  S P  +     
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP----------------------P 313
           + ++  PE++         +D+W  GC + EM T  P                      P
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245

Query: 314 WSQYEGVAAMFKIGNSKELPT-----IPDDL-----SDEGKDFIRLCLQRNPLNRPTAAE 363
              + GV  + ++    ELP      + + L          D I   L  +P  R  A  
Sbjct: 246 -EVWPGVDKL-ELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303

Query: 364 LLDHPF 369
            L+H F
Sbjct: 304 ALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  114 bits (287), Expect = 2e-28
 Identities = 83/275 (30%), Positives = 131/275 (47%), Gaps = 31/275 (11%)

Query: 116 KKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           KK ++LG G FG V    Y   N  +GEM A+K +      ++    K+   EI +L  L
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINILKTL 63

Query: 172 RHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            H NIV+Y G  S+     L + +EYV  GS+   L  + +     +  + QQI  G+A+
Sbjct: 64  YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAY 122

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--AGQSCPLSFKG-SP-YWMAPEVI 285
           LHS+H +HRD+   N+L+D +  VK+ DFG+AK +    +   +   G SP +W A E +
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 286 KNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQYEGVAAMFKIGNSKELPTI------ 335
           K +   + A D+WS G T+ E+ T     + P  ++E +    K G    +  I      
Sbjct: 183 KENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP-KQGQMTVVRLIELLERG 240

Query: 336 -----PDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
                P +   E    ++ C +     RPT   L+
Sbjct: 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  114 bits (286), Expect = 4e-28
 Identities = 84/288 (29%), Positives = 134/288 (46%), Gaps = 34/288 (11%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K + +G GT+G VY   +  + E  A+K++ L  + +   S    ++EI LL  ++H 
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHG 61

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--IRNYTQQILSGLAFLHS 232
           NIV+       E +LY+  EY+    + K +     F +    I+ Y  QIL G+A+ HS
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120

Query: 233 KHTVHRDIKGANILVD-PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSG 290
              +HRD+K  N+L+D     +KLADFG+A+         + +    W  APE++  S  
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRH 180

Query: 291 CNLAVDIWSLGCTVLEMATTKP--------------------PWSQ-YEGVAAM------ 323
            +  VDIWS+GC   EM   KP                    P  + + GV ++      
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240

Query: 324 FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           F     K+L T+   L   G D +   L+ +P  R TA   L+H + K
Sbjct: 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288

Length = 294

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  114 bits (288), Expect = 5e-28
 Identities = 76/303 (25%), Positives = 142/303 (46%), Gaps = 54/303 (17%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDS--GEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSR 170
            ++  K LG+G +G V    N+++   E  A+K++T +F     K  AK+ ++E+ LL  
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRH 57

Query: 171 LR-HPNIVQYYGSKTVE----DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILS 225
            R H NI   Y    V     ++LY+Y E +    ++++++      +   +++  QIL 
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILC 116

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY------- 278
           GL ++HS + +HRD+K  N+LV+ +  +K+ DFG+A+  +        + + +       
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS----ENPGENAGFMTEYVAT 172

Query: 279 -WM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF------------ 324
            W  APE++ +      A+D+WS+GC + E+   KP +   + V  +             
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232

Query: 325 ---KIGNSK------ELPTIPD--------DLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
              +IG+ K       LP IP         + +    D +   L  +P  R +  E L+H
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292

Query: 368 PFV 370
           P++
Sbjct: 293 PYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 5e-28
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 33/265 (12%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  + LG G FG V++G  + + ++    +K  T+        S +  +QE  ++
Sbjct: 4   PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--------SPEAFLQEAQIM 55

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE------PAIRNYTQQ 222
            +LRH  +VQ Y   + E+ +YI  EY+S GS    L D+ + GE      P + +   Q
Sbjct: 56  KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS----LLDFLKSGEGKKLRLPQLVDMAAQ 111

Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI------AGQSCPLSFKGS 276
           I  G+A+L S++ +HRD+   NILV  N   K+ADFG+A+ I      A +      K  
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK-- 169

Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTI 335
             W APE   N     +  D+WS G  + E+ T  + P+        + ++     +P  
Sbjct: 170 --WTAPEAA-NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-R 225

Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPT 360
           P +  +E  D +  C  ++P  RPT
Sbjct: 226 PPNCPEELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  112 bits (283), Expect = 5e-28
 Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 11/256 (4%)

Query: 119 KMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           K LG G+FG V  G +++  G++  +    L  D K  +     ++E  ++  L H N++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD-KLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           + YG   +   L +  E    GS+   L+    G F    + +Y  QI +G+ +L SK  
Sbjct: 60  RLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118

Query: 236 VHRDIKGANILVDPNGRVKLADFGM--AKHIAGQSCPLSF-KGSPY-WMAPEVIKNSSGC 291
           +HRD+   NIL+  + +VK+ DFG+  A         +      P+ W APE ++  +  
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178

Query: 292 NLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC 350
           + A D+W  G T+ EM T  + PW+   G   + KI    E    P+    +  + +  C
Sbjct: 179 H-ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237

Query: 351 LQRNPLNRPTAAELLD 366
              NP +RPT A L +
Sbjct: 238 WAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  113 bits (285), Expect = 7e-28
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 19/265 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHP 55

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-K 233
            +     S    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS K
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           + V+RD+K  N+++D +G +K+ DFG+ K  I   +   +F G+P ++APEV++++    
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YG 174

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L+
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI-RFPRTLSPEAKSLLSGLLK 232

Query: 353 RNPLNR-----PTAAELLDHPFVKG 372
           ++P  R       A E++ H F  G
Sbjct: 233 KDPKQRLGGGPDDAKEIMQHKFFAG 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  112 bits (281), Expect = 8e-28
 Identities = 74/256 (28%), Positives = 129/256 (50%), Gaps = 15/256 (5%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P    K  K LG G FG V++G+ ++S ++ A+K +          S +  ++E  L+  
Sbjct: 4   PRESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLK-----PGTMSVQAFLEEANLMKT 57

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLL--QDYGQFGEPAIRNYTQQILSGLA 228
           L+H  +V+ Y   T E+ +YI  EY++ GS+   L   + G+   P + +++ QI  G+A
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVI 285
           ++  K+ +HRD++ AN+LV  +   K+ADFG+A+ I       + +G+ +   W APE I
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI 176

Query: 286 KNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGK 344
            N     +  D+WS G  + E+ T  K P+        M  +     +P   ++  DE  
Sbjct: 177 -NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR-MENCPDELY 234

Query: 345 DFIRLCLQRNPLNRPT 360
           D ++ C +     RPT
Sbjct: 235 DIMKTCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  114 bits (286), Expect = 1e-27
 Identities = 83/262 (31%), Positives = 133/262 (50%), Gaps = 11/262 (4%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +  +  + ++ AMK ++ F+  K  +SA    +E  +++    P +VQ
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQ 107

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + +   +  LY+ +EY+ GG +  L+ +Y    + A R YT +++  L  +HS   +HR
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVVLALDAIHSMGFIHR 166

Query: 239 DIKGANILVDPNGRVKLADFG--MAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL--- 293
           D+K  N+L+D +G +KLADFG  M  +  G     +  G+P +++PEV+K+  G      
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLCL 351
             D WS+G  + EM     P+     V    KI N K   T PD  D+S E K+ I   L
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 286

Query: 352 QRNP--LNRPTAAELLDHPFVK 371
                 L R    E+  H F K
Sbjct: 287 TDREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  110 bits (278), Expect = 3e-27
 Identities = 76/252 (30%), Positives = 119/252 (47%), Gaps = 9/252 (3%)

Query: 118 GKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           G+ +G G FG VY G + S   E  A+   T  +   S    ++ +QE  ++ +  HP+I
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHI 69

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR-NYTQQILSGLAFLHSKHT 235
           V+  G    E+ ++I +E    G +   LQ      + A    Y+ Q+ + LA+L SK  
Sbjct: 70  VKLIGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF 128

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS-PY-WMAPEVIKNSSGCNL 293
           VHRDI   N+LV     VKL DFG+++++  +S   + KG  P  WMAPE I N      
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI-NFRRFTS 187

Query: 294 AVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A D+W  G  + E +     P+   +    + +I N + LP +P +        +  C  
Sbjct: 188 ASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWA 246

Query: 353 RNPLNRPTAAEL 364
            +P  RP   EL
Sbjct: 247 YDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  111 bits (278), Expect = 4e-27
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 25/282 (8%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           ++LG+G FG V       +G+M A K++      K K  A  L  E  +L ++    +V 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEKQILEKVNSRFVVS 64

Query: 179 YYGSKTVEDKLYIYLEYVSGGS----IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
              +   +D L + L  ++GG     IY +      F E     Y  +I  GL  LH + 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRER 122

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
            V+RD+K  NIL+D  G ++++D G+A  I          G+  +MAPEV+KN      +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER-YTFS 181

Query: 295 VDIWSLGCTVLEMATTKPPWSQY------EGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
            D W LGC + EM   K P+ Q       E V    K    +E     +  S+  +   R
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK--EDQE--EYSEKFSEAARSICR 237

Query: 349 LCLQRNPLNR-----PTAAELLDHPFVKGA--APLERTILAP 383
             L ++P  R       A E+  HPF + A    LE  +L P
Sbjct: 238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEP 279

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  111 bits (280), Expect = 5e-27
 Identities = 82/324 (25%), Positives = 149/324 (45%), Gaps = 58/324 (17%)

Query: 117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL----------MQEIV 166
           KG  LG GT+G V   +++ +G++ A+K+V + + +      +QL          ++E+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           +++ ++H NI+         D + + ++ ++   + K++    +  E  ++    QIL+G
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNG 131

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-----------QSCP---LS 272
           L  LH  + +HRD+  ANI ++  G  K+ADFG+A+                      ++
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191

Query: 273 FKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--- 328
            K    W  APE++  +   + AVD+WS+GC   E+ T KP +     +  + +I     
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251

Query: 329 ---------SKELP-------TIPDDL-------SDEGKDFIRLCLQRNPLNRPTAAELL 365
                    +K+LP         P DL       SD+  D ++  L+ NPL R +A E L
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311

Query: 366 DHPFVKGAAPLERTILAPEPSDVP 389
            H + K + PL       +PS +P
Sbjct: 312 KHEYFK-SDPLP-----CDPSQLP 329

Length = 335

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  110 bits (276), Expect = 7e-27
 Identities = 79/287 (27%), Positives = 124/287 (43%), Gaps = 50/287 (17%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQY 179
           +G GTF  V    +  +G+  A+K   +    KS E    L +EI  L RL  HPNI++ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63

Query: 180 ----YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKH 234
               +  KT   +L +  E +   ++Y+L++   +   E  +++Y  Q+L  L  +H   
Sbjct: 64  IEVLFDRKT--GRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCNL 293
             HRDIK  NIL+  +  +KLADFG  + I  +  P +   S  W  APE +        
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCRGIYSKP-PYTEYISTRWYRAPECLLTDGYYGP 178

Query: 294 AVDIWSLGCTVLEMATTKPPW-----------------SQYEGVAAMFK----------- 325
            +DIW++GC   E+ +  P +                 +    V   F+           
Sbjct: 179 KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238

Query: 326 ---IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
               G  K LP    + S EG D ++  L  +P  R TA + L HP+
Sbjct: 239 KKGTGLRKLLP----NASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  111 bits (279), Expect = 1e-26
 Identities = 104/374 (27%), Positives = 146/374 (39%), Gaps = 68/374 (18%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S + K K +G G FG V +    D+  + AMK +   D    +  A  +  E  +L+   
Sbjct: 1   SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM-RNQAAHVKAERDILAEAD 59

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           +  +V+ Y S   +D LY  ++Y+ GG +  LL   G F E   R Y  ++   +  +H 
Sbjct: 60  NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK 119

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGM---------------AKHIAGQS--------- 268
              +HRDIK  NIL+D +G +KL DFG+                 H    S         
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179

Query: 269 ---CPL-----------------SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMA 308
              C L                 S  G+P ++APEV+   +G     D WS+G  + EM 
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEML 238

Query: 309 TTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFI-RLCLQRNP---LNRPTAA 362
             +PP+          K+ N +    IP    LS E  D I RLC        L +  A 
Sbjct: 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC--CGAEDRLGKNGAD 296

Query: 363 ELLDHPFVKGA--APLERTILAPE-PSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHS 419
           E+  HPF KG   A L R   AP  P    P  T+           N    D E+L    
Sbjct: 297 EIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTS-----------NFDPVDPEKLRSDD 345

Query: 420 SRVSQTSLNASDIN 433
           S  S    N    N
Sbjct: 346 SGESSPDRNVKPNN 359

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  110 bits (275), Expect = 2e-26
 Identities = 65/201 (32%), Positives = 109/201 (54%), Gaps = 10/201 (4%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
            +LG+G+FG V +     + E+ A+K    +V + DD    +    ++++ VL    + P
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD----DVECTMVEKRVLALSGKPP 61

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            + Q +      D+LY  +EYV+GG +   +Q  G+F EP    Y  +I  GL FLHSK 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            ++RD+K  N+++D  G +K+ADFGM K ++       +F G+P ++APE+I        
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK- 180

Query: 294 AVDIWSLGCTVLEMATTKPPW 314
           +VD W+ G  + EM   + P+
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 3e-26
 Identities = 77/261 (29%), Positives = 122/261 (46%), Gaps = 31/261 (11%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMK--EVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +G+G FG VY G    + E+ A+K    TL  D K K      +QE  +L +  HPNIV+
Sbjct: 3   IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQIL---SGLAFLHSKHT 235
             G    +  +YI +E V GGS+   L+   +     ++   Q  L   +G+ +L SK+ 
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFLR--KKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPY-WMAPEVI---KNSS 289
           +HRD+   N LV  N  +K++DFGM++   G    +S   K  P  W APE +   + +S
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 290 GCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
                 D+WS G  + E      T  P  S  +      +I +   +P  P    +E   
Sbjct: 175 ES----DVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIESGYRMPA-PQLCPEEIYR 226

Query: 346 FIRLCLQRNPLNRPTAAELLD 366
            +  C   +P NRP+ +E+ +
Sbjct: 227 LMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 3e-26
 Identities = 85/270 (31%), Positives = 131/270 (48%), Gaps = 21/270 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V V    ++G++ AMK +  ++  K  E+A    +  VL++  R   I  
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW-ITN 65

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            + +   E+ LY+ ++Y  GG +  LL  +  +  E   R Y  +++  +  +H    VH
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVI------KNSS 289
           RDIK  N+L+D NG ++LADFG    +   G        G+P +++PE++      K   
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRY 185

Query: 290 G--CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE---LPTIPDDLSDEGK 344
           G  C    D WSLG  + EM   + P+     V    KI N KE    P    D+S+E K
Sbjct: 186 GPEC----DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK 241

Query: 345 DFIR--LCLQRNPLNRPTAAELLDHPFVKG 372
           D IR  +C     L R    +  DHPF +G
Sbjct: 242 DLIRRLICSPETRLGRNGLQDFKDHPFFEG 271

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  108 bits (271), Expect = 4e-26
 Identities = 83/297 (27%), Positives = 139/297 (46%), Gaps = 48/297 (16%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH- 173
           ++K + +G GT+G VY   + ++G++ A+K+  L  D +        ++EI LL  L   
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSES 60

Query: 174 PNIVQYYGSKTVEDK-----LYIYLEYVSGGSIYKLLQDYGQ-----FGEPAIRNYTQQI 223
             IV+    + VE+K     LY+  EY+    + K +   G+          I+++  Q+
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKG----SPY 278
           L G+A  H    +HRD+K  N+LVD   G +K+AD G+ +     S P+        + +
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF---SIPVKSYTHEIVTLW 176

Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--------------------PWSQ-Y 317
           + APEV+  S+  +  VDIWS+GC   EM+  +P                    P  Q +
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236

Query: 318 EGVAAM-----FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
            GV+ +     F     ++L     DLS EG D ++  L+ +P  R +A   L HP+
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  108 bits (270), Expect = 4e-26
 Identities = 90/287 (31%), Positives = 134/287 (46%), Gaps = 44/287 (15%)

Query: 121 LGRGTFGHVYVGFN-SDSGEMCAMKEVTLFDDAKSKESAKQL--MQEIVLLSRLR---HP 174
           +G G +G V+   +  + G   A+K V +    ++ E    L  ++E+ +L  L    HP
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 175 NIVQYYGSKTV-----EDKLYIYLEYVSGGSIYKLLQDYGQFGEP--AIRNYTQQILSGL 227
           N+V+ +   TV     E KL +  E+V    +   L    + G P   I++   Q+L GL
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
            FLHS   VHRD+K  NILV  +G++KLADFG+A+  + Q    S   + ++ APEV+  
Sbjct: 124 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD---------- 337
           SS     VD+WS+GC   EM   KP +     V  + KI +   LP   D          
Sbjct: 184 SSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 242

Query: 338 ---------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                          D+ + GKD +  CL  NP  R +A   L HP+
Sbjct: 243 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  109 bits (273), Expect = 5e-26
 Identities = 83/301 (27%), Positives = 137/301 (45%), Gaps = 59/301 (19%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G+ G V+   +SD  +  A+K++ L D     +S K  ++EI ++ RL H NIV+ Y
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVY 68

Query: 181 --------------GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
                         GS T  + +YI  EY+    +  +L+  G   E   R +  Q+L G
Sbjct: 69  EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRG 126

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKG-------SPY 278
           L ++HS + +HRD+K AN+ ++    V K+ DFG+A+ I       S KG       + +
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPH--YSHKGYLSEGLVTKW 183

Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM--------------- 323
           + +P ++ + +    A+D+W+ GC   EM T KP ++    +  M               
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 324 --------FKIGNSKELPTIP-----DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
                     + N    P  P       ++ E  DF+   L  NP++R TA E L HP++
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303

Query: 371 K 371
            
Sbjct: 304 S 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  107 bits (268), Expect = 6e-26
 Identities = 85/284 (29%), Positives = 137/284 (48%), Gaps = 30/284 (10%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY- 179
           LG+G FG V       +G++ A K++      K ++  +  M E  +L+++    IV   
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNK-KRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 180 YGSKTVEDKLYIYLEYVSGGS----IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           Y  +T  D L + +  ++GG     IY + ++   F EP    YT QI+SGL  LH +  
Sbjct: 60  YAFQTKTD-LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           ++RD+K  N+L+D +G V+++D G+A  +  GQS    + G+P +MAPE+++     + +
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE-YDFS 177

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIPDDLSDEGKDF 346
           VD ++LG T+ EM   + P+      A   K+ N KEL         T PD  S   K F
Sbjct: 178 VDYFALGVTLYEMIAARGPFR-----ARGEKVEN-KELKQRILNDSVTYPDKFSPASKSF 231

Query: 347 IRLCLQRNPLNR-----PTAAELLDHPFVKGAA--PLERTILAP 383
               L ++P  R          L  HP  +      LE  +L P
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPP 275

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  109 bits (273), Expect = 7e-26
 Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 11/262 (4%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +  +  S ++ AMK ++ F+  K  +SA    +E  +++    P +VQ
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQ 107

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + +   +  LY+ +EY+ GG +  L+ +Y    E   + YT +++  L  +HS   +HR
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHR 166

Query: 239 DIKGANILVDPNGRVKLADFG--MAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL--- 293
           D+K  N+L+D +G +KLADFG  M     G     +  G+P +++PEV+K+  G      
Sbjct: 167 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD--LSDEGKDFIRLCL 351
             D WS+G  + EM     P+     V    KI + K     P+D  +S   K+ I   L
Sbjct: 227 ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL 286

Query: 352 QRNP--LNRPTAAELLDHPFVK 371
                 L R    E+  HPF K
Sbjct: 287 TDREVRLGRNGVEEIKQHPFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 8e-26
 Identities = 70/253 (27%), Positives = 120/253 (47%), Gaps = 25/253 (9%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           + LG G FG V+ G  +++  + A+K  TL          K  + E  ++ +LRHP ++Q
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPV-AVK--TLKPGTMD---PKDFLAEAQIMKKLRHPKLIQ 65

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
            Y   T+E+ +YI  E +  GS+ + LQ         P + +   Q+ SG+A+L +++ +
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHI--------AGQSCPLSFKGSPYWMAPEVIKNS 288
           HRD+   N+LV  N   K+ADFG+A+ I         G   P+       W APE     
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK------WTAPEAA-LY 178

Query: 289 SGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           +  ++  D+WS G  + E+ T  + P+        + ++     +P  P     E  D +
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-PPGCPKELYDIM 237

Query: 348 RLCLQRNPLNRPT 360
             C + +P +RPT
Sbjct: 238 LDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 8e-26
 Identities = 75/264 (28%), Positives = 123/264 (46%), Gaps = 26/264 (9%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
                K G  +G+G FG V +G     G+  A+K   L DD+ +   A+  + E  +++ 
Sbjct: 4   NSKELKLGATIGKGEFGDVMLG--DYRGQKVAVK--CLKDDSTA---AQAFLAEASVMTT 56

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQIL------ 224
           LRHPN+VQ  G     + LYI  EY++ GS+   L+  G+    A+    QQ+       
Sbjct: 57  LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVC 112

Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEV 284
            G+ +L  K+ VHRD+   N+LV  +   K++DFG+AK         S K    W APE 
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWTAPEA 170

Query: 285 IKNSSGCNLAVDIWSLGCTVLEM-ATTKPPWSQ--YEGVAAMFKIGNSKELPTIPDDLSD 341
           ++       + D+WS G  + E+ +  + P+ +   + V    + G   E    P+    
Sbjct: 171 LREKKFSTKS-DVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME---APEGCPP 226

Query: 342 EGKDFIRLCLQRNPLNRPTAAELL 365
           E    ++ C + +P  RPT  +L 
Sbjct: 227 EVYKVMKDCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  107 bits (268), Expect = 9e-26
 Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 55/291 (18%)

Query: 112 ESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           E H K  + LG+G FG V    Y     ++GE+ A+K++       + E  +   +EI +
Sbjct: 3   ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL----QHSTAEHLRDFEREIEI 58

Query: 168 LSRLRHPNIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQIL 224
           L  L+H NIV+Y G         L + +EY+  GS+   LQ +  +     +  Y  QI 
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118

Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSF 273
            G+ +L SK  VHRD+   NILV+   RVK+ DFG+ K +            G+S P+  
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES-PI-- 175

Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQYEGVAAMFKIGNS 329
               +W APE +   S  ++A D+WS G  + E+ T    +  P +++     M  +GN 
Sbjct: 176 ----FWYAPESL-TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-----MRMMGND 225

Query: 330 KELPTI----------------PDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
           K+   I                P     E    ++ C   +P  RP+ +EL
Sbjct: 226 KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  106 bits (267), Expect = 1e-25
 Identities = 90/286 (31%), Positives = 131/286 (45%), Gaps = 43/286 (15%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL--MQEIVLLSRLR---HPN 175
           +G G +G VY   +  SG   A+K V +    ++ E    L  ++E+ LL RL    HPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRV----QTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 176 IVQYY----GSKT-VEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--IRNYTQQILSGLA 228
           IV+       S+T  E K+ +  E+V    +   L      G PA  I++  +Q L GL 
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
           FLH+   VHRD+K  NILV   G+VKLADFG+A+  + Q        + ++ APEV+  S
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182

Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP---------TIPD-- 337
           +     VD+WS+GC   EM   KP +        + KI +   LP         T+P   
Sbjct: 183 TYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA 241

Query: 338 --------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                         ++ + G   +   L  NP  R +A   L HPF
Sbjct: 242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 72/279 (25%), Positives = 125/279 (44%), Gaps = 54/279 (19%)

Query: 121 LGRGTFGHVYVG----FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G          E   A+K  T+ ++A  +E   + + E  ++      +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIK--TVNENASMRER-IEFLNEASVMKEFNCHH 70

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLL-------QDYGQFGEPA---IRNYTQQILS 225
           +V+  G  +      + +E ++ G +   L       ++    G P          +I  
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--------AGQS-CPLSFKGS 276
           G+A+L +K  VHRD+   N +V  +  VK+ DFGM + I         G+   P+     
Sbjct: 131 GMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186

Query: 277 PYWMAPEVIKN-----SSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVA---AMFKI 326
             WMAPE +K+      S      D+WS G  + EMAT   +P    Y+G++    +  +
Sbjct: 187 --WMAPESLKDGVFTTKS------DVWSFGVVLWEMATLAEQP----YQGLSNEEVLKFV 234

Query: 327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
            +   L  +P++  D+  + +R+C Q NP  RPT  E++
Sbjct: 235 IDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  105 bits (264), Expect = 2e-25
 Identities = 74/256 (28%), Positives = 126/256 (49%), Gaps = 13/256 (5%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY- 179
           LG+G FG V      ++G+M A K++      K K   K  + E  +L ++  P IV   
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDK-KRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 180 --YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR--NYTQQILSGLAFLHSKHT 235
             + SKT    L + +  ++GG +   + + G+ G    R  +Y+ QI  G+  LHS   
Sbjct: 60  YAFESKT---HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           V+RD+K  N+L+D  G  +L+D G+A  +          G+  +MAPE++K     +  V
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPV 175

Query: 296 DIWSLGCTVLEMATTKPPWSQY-EGVAA--MFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           D +++GC++ EM   + P+  + E VA   + +     E+     + ++E KD  RL L 
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235

Query: 353 RNPLNRPTAAELLDHP 368
           + P +R  + E  D P
Sbjct: 236 KKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 2e-25
 Identities = 78/307 (25%), Positives = 136/307 (44%), Gaps = 65/307 (21%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL-----MQEIVL 167
             ++    +G G +G V    +  +G   A+K+++ F+         Q      ++EI +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--------HQTFCQRTLREIKI 56

Query: 168 LSRLRHPNIVQYYG---SKTVED--KLYIYLEYVSGGSIYKLLQ------DYGQFGEPAI 216
           L R +H NI+         + E    +YI  E +    +YKL++      D+ Q+     
Sbjct: 57  LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQY----- 110

Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK-- 274
             +  QIL GL ++HS + +HRD+K +N+L++ N  +K+ DFG+A+    +     F   
Sbjct: 111 --FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168

Query: 275 --GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--PWSQYE----------GV 320
              + ++ APE++ NS G   A+DIWS+GC + EM + +P  P   Y           G 
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228

Query: 321 AAM---FKIGNSKEL---------PTIP-DDL----SDEGKDFIRLCLQRNPLNRPTAAE 363
            +      I + +           P +P + L      +  D +   L  NP  R T  E
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288

Query: 364 LLDHPFV 370
            L HP++
Sbjct: 289 ALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  104 bits (261), Expect = 1e-24
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 24/275 (8%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++  G +G VY+  + ++ +  AMK++    +   +   +Q+  E  +L+   +P +V 
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINK-QNLILRNQIQQVFVERDILTFAENPFVVS 65

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + S   +  L + +EYV GG    LL++ G       R Y  + +  L +LH+   VHR
Sbjct: 66  MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125

Query: 239 DIKGANILVDPNGRVKLADFGMAK-------------HIAGQSCPLSFK---GSPYWMAP 282
           D+K  N+L+   G +KL DFG++K             HI   +     K   G+P ++AP
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK--IGNSKELPTIPDDLS 340
           EVI    G    VD W++G  + E      P+   +    +F   I +  E P   + L 
Sbjct: 186 EVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEGDEALP 243

Query: 341 DEGKDFIRLCLQRNPLNR---PTAAELLDHPFVKG 372
            + +D I   L++NPL R     A E+  H F  G
Sbjct: 244 ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 36/265 (13%)

Query: 118 GKMLGRGTFGHVYVGF--NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
            K LG G FG V++G         +  ++E  + +D    E AK +M+       L HPN
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMK-------LSHPN 60

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKH 234
           +VQ YG  T +  ++I  EY++ G +   L++  G+ G   + +    +   + +L S  
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVI---KNS 288
            +HRD+   N LV  +  VK++DFG+A+++       S  G+ +   W  PEV    + S
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-GTKFPVKWAPPEVFDYSRFS 179

Query: 289 SGCNLAVDIWSLGCTVLEMATT-KPPWSQY------EGVAAMFKIGNSKELPTIPDDLSD 341
           S      D+WS G  + E+ +  K P+ ++      E V+A +++   K  PT       
Sbjct: 180 S----KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPT------- 228

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLD 366
           E    +  C    P +RP   +LL 
Sbjct: 229 EVYTIMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  103 bits (257), Expect = 2e-24
 Identities = 74/255 (29%), Positives = 120/255 (47%), Gaps = 24/255 (9%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D       ++ ++E  ++  ++HPN+VQ  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME---VEEFLKEAAVMKEIKHPNLVQLL 68

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR--NYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++  +    A+       QI S + +L  K+ +HR
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQ--SCPLSFKGSPYWMAPEVI---KNSSGCNL 293
           D+   N LV  N  VK+ADFG+++ + G   +     K    W APE +   K S     
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI---- 184

Query: 294 AVDIWSLGCTVLEMAT---TKPPWSQYEGVAAMFKIGNSKELPT-IPDDLSDEGKDFIRL 349
             D+W+ G  + E+AT   +  P      V  + + G   E P   P  +     + +R 
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVY----ELMRA 240

Query: 350 CLQRNPLNRPTAAEL 364
           C Q NP +RP+ AE+
Sbjct: 241 CWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  103 bits (259), Expect = 2e-24
 Identities = 80/312 (25%), Positives = 137/312 (43%), Gaps = 70/312 (22%)

Query: 111 PESHWKKGKMLGRGTFGHVYV----------------GFNSDSGEMCAMKEVTLFDDAKS 154
           P       + LG G FG V++                  N+D+  + A+K   L  DA S
Sbjct: 3   PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVK--VLRPDA-S 59

Query: 155 KESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP 214
             + +  ++E+ +LSRL  PNI +  G  TV+  L + +EY+  G + + LQ +      
Sbjct: 60  DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH-VAETS 118

Query: 215 AIRNYTQ------------QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK 262
            +   ++            QI SG+ +L S + VHRD+   N LV  N  +K+ADFGM++
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 263 H--------IAGQSCPLSFKGSPYWMAPEVI---KNSSGCNLAVDIWSLGCTVLEMAT-- 309
           +        + G++ PL  +    WMA E +   K ++      D+W+ G T+ E+ T  
Sbjct: 179 NLYSSDYYRVQGRA-PLPIR----WMAWESVLLGKFTT----KSDVWAFGVTLWEILTLC 229

Query: 310 TKPPWSQY------EGVAAMFKIGNSKEL----PTIPDDLSDEGKDFIRLCLQRNPLNRP 359
            + P+         E     F+    +      P  P D+     + +  C +R+  +RP
Sbjct: 230 REQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIY----ELMLECWRRDEEDRP 285

Query: 360 TAAELLDHPFVK 371
           T  E+  H F++
Sbjct: 286 TFREI--HLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  103 bits (257), Expect = 2e-24
 Identities = 82/270 (30%), Positives = 115/270 (42%), Gaps = 46/270 (17%)

Query: 121 LGRGTFGHVYVG----FNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQ-EIVLLSRL 171
           LG G FG V++        +  +M     A+KE +        ESA+Q  Q E  LL+ L
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------ESARQDFQREAELLTVL 64

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG---------------QFGEPAI 216
           +H +IV++YG  T    L +  EY+  G + + L+ +G               Q     +
Sbjct: 65  QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSC 269
                QI SG+ +L S H VHRD+   N LV     VK+ DFGM++ I        G   
Sbjct: 125 LAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Query: 270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGN 328
            L  +    WM PE I        + DIWS G  + E+ T  K PW Q     A+  I  
Sbjct: 185 MLPIR----WMPPESILYRKFTTES-DIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239

Query: 329 SKELPTIPDDLSDEGKDFIRLCLQRNPLNR 358
            +EL   P     E    ++ C QR P  R
Sbjct: 240 GRELER-PRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 69/244 (28%), Positives = 115/244 (47%), Gaps = 44/244 (18%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEM----CAMKEVTLFDDAKSKESAKQLMQEIV 166
            E+  +K K+LG G FG VY G     GE      A+K +    +  S ++ K+++ E  
Sbjct: 5   KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL---REETSPKANKEILDEAY 61

Query: 167 LLSRLRHPNIVQYYG---SKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQ 222
           +++ + HP++V+  G   S  V+    +  + +  G +   ++++    G   + N+  Q
Sbjct: 62  VMASVDHPHVVRLLGICLSSQVQ----LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ 117

Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---------HIAGQSCPLSF 273
           I  G+++L  K  VHRD+   N+LV     VK+ DFG+AK         H  G   P+  
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK- 176

Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAAMFKIGNSKE 331
                WMA E I +    + + D+WS G TV E+ T   KP    YEG+        + E
Sbjct: 177 -----WMALESILHRIYTHKS-DVWSYGVTVWELMTFGAKP----YEGI-------PAVE 219

Query: 332 LPTI 335
           +P +
Sbjct: 220 IPDL 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  102 bits (255), Expect = 2e-24
 Identities = 74/258 (28%), Positives = 125/258 (48%), Gaps = 20/258 (7%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGF--NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  K LG G FG V++G+        + ++K+ ++  +A         + E  L+
Sbjct: 4   PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA--------FLAEANLM 55

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ--DYGQFGEPAIRNYTQQILSG 226
            +L+HP +V+ Y   T E  +YI  EY+  GS+   L+  +  +     + +   QI  G
Sbjct: 56  KQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEG 114

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           +AF+  K+ +HRD++ ANILV      K+ADFG+A+ I       + +G+ +   W APE
Sbjct: 115 MAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPE 173

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
            I N     +  D+WS G  + E+ T  + P+        +  +     +P  PD+  +E
Sbjct: 174 AI-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR-PDNCPEE 231

Query: 343 GKDFIRLCLQRNPLNRPT 360
             + +RLC +  P  RPT
Sbjct: 232 LYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  103 bits (260), Expect = 3e-24
 Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 39/289 (13%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G +G V    ++ SG+  A+K++    D  +   AK+ ++E+ +L   +H NI+   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT--LAKRTLRELKILRHFKHDNIIAIR 70

Query: 181 GSKTVEDKLYIYLEYV---SGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
                    +  +  V       ++ ++       E  IR +  Q+L GL ++HS + +H
Sbjct: 71  DILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIH 130

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-----WMAPEVIKNSSGCN 292
           RD+K +N+LV+ +  +++ DFGMA+ ++       +  + Y     + APE++ +     
Sbjct: 131 RDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYT 190

Query: 293 LAVDIWSLGCTVLEMATTKP--PWSQYEGVAAMF-------------KIGNSK------E 331
            A+D+WS+GC   EM   +   P   Y     +              +IG+ +       
Sbjct: 191 TAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN 250

Query: 332 LPTIPD--------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
           LP              S E  D +   LQ +P  R T  + L HPF+  
Sbjct: 251 LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  105 bits (264), Expect = 4e-24
 Identities = 91/291 (31%), Positives = 136/291 (46%), Gaps = 22/291 (7%)

Query: 106 ENPVSPESHWKKGKM------LGRGTFGHVYVGFN-SDSGEMCAMKEVTLFDDAKSKESA 158
           E    PES+  +  M      +GR      +V    SD  E    K V L D+      A
Sbjct: 54  EGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE----RQA 109

Query: 159 KQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKL----LQDYGQFGEP 214
                E+  L+   H  IV+++     +DKL + +EY SGG + K     L+++  F E 
Sbjct: 110 AYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY 169

Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--- 271
            +     QI+  L  +HS+  +HRD+K ANI + P G +KL DFG +K  +  S  L   
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVA 228

Query: 272 -SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
            SF G+PY++APE+ +       A D+WSLG  + E+ T   P+        M ++   K
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKA-DMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK 287

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTIL 381
             P  P  +S   K  +   L +NP  RPT  +LL   F+K  A L + I+
Sbjct: 288 YDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIV 337

Length = 478

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  102 bits (255), Expect = 4e-24
 Identities = 80/276 (28%), Positives = 129/276 (46%), Gaps = 31/276 (11%)

Query: 116 KKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           K+ + LG G FG V    Y     ++GE  A+K  +L  ++     A  L +EI +L  L
Sbjct: 7   KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIA-DLKKEIEILRNL 63

Query: 172 RHPNIVQYYGSKTVE--DKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLA 228
            H NIV+Y G  T +  + + + +E++  GS+ + L ++  +        Y  QI  G+ 
Sbjct: 64  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSP-YWMAPEV 284
           +L S+  VHRD+   N+LV+   +VK+ DFG+ K I       + K    SP +W APE 
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY-------EG---VAAMFKI-GNS 329
           +  S    +A D+WS G T+ E+ T       P + +        G   V  + ++    
Sbjct: 184 LIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242

Query: 330 KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
           K LP  P +  +E    +R C +  P  R T   L+
Sbjct: 243 KRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  102 bits (255), Expect = 5e-24
 Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 40/282 (14%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG GT+  VY G +  +  + A+KE+ L  +  +  +A   ++E+ LL  L+H NIV  +
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA---IREVSLLKDLKHANIVTLH 70

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
                E  L +  EY+    + + L D G       ++ +  Q+L GL + H +  +HRD
Sbjct: 71  DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP----YWMAPEVIKNSSGCNLAV 295
           +K  N+L++  G +KLADFG+A+    +S P     +     ++  P+++  S+  +  +
Sbjct: 130 LKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186

Query: 296 DIWSLGCTVLEMATTKP--PWSQY-EGVAAMFKIGNSKELPTIPDDLSDE---------- 342
           D+W +GC   EM+T +P  P S   E +  +F+I  +    T P  LS+E          
Sbjct: 187 DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKY 246

Query: 343 ---------------GKDFIRLCLQRNPLNRPTAAELLDHPF 369
                          G + +   LQ     R +A E + HP+
Sbjct: 247 RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  101 bits (252), Expect = 6e-24
 Identities = 75/252 (29%), Positives = 117/252 (46%), Gaps = 14/252 (5%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V++G    +    A+K +   + A S+E     ++E  ++ +L HP +VQ
Sbjct: 10  KELGSGQFGVVHLG-KWRAQIKVAIKAIN--EGAMSEED---FIEEAKVMMKLSHPKLVQ 63

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG  T +  LYI  E++  G +   L Q  G+  +  + +  Q +  G+ +L     +H
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLA 294
           RD+   N LV   G VK++DFGM +++       S  G+ +   W  PEV  N S  +  
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS-GAKFPVKWSPPEVF-NFSKYSSK 181

Query: 295 VDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            D+WS G  + E+ T  K P+ +      +  I     L   P   S    + +  C   
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR-PKLASMTVYEVMYSCWHE 240

Query: 354 NPLNRPTAAELL 365
            P  RPT AELL
Sbjct: 241 KPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  102 bits (257), Expect = 8e-24
 Identities = 81/298 (27%), Positives = 135/298 (45%), Gaps = 65/298 (21%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ-- 178
           +G G +G V   F++ +G   A+K+  L    +S   AK+  +E+ LL  + H N++   
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKK--LSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 179 --YYGSKTVEDKLYIYLEYVS---GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
             +  + ++ED   +YL  V+   G  +  +++   +  +  I+    QIL GL ++HS 
Sbjct: 81  DVFTPASSLEDFQDVYL--VTHLMGADLNNIVK-CQKLSDDHIQFLVYQILRGLKYIHSA 137

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY----W-MAPEVIKNS 288
             +HRD+K +NI V+ +  +K+ DFG+A+H          + + Y    W  APE++ N 
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLARH-------TDDEMTGYVATRWYRAPEIMLNW 190

Query: 289 SGCNLAVDIWSLGCTVLEMATTKP------PWSQYEGVAA---------MFKIGNS---- 329
              N  VDIWS+GC + E+ T K          Q + +           + KI +     
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN 250

Query: 330 --KELPTIPDDLSDEGKDFIRLCLQRNPL--------------NRPTAAELLDHPFVK 371
             + LP +P       KDF  +    NPL               R TAAE L HP++ 
Sbjct: 251 YIQSLPQMPK------KDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  100 bits (252), Expect = 1e-23
 Identities = 82/278 (29%), Positives = 124/278 (44%), Gaps = 37/278 (13%)

Query: 118 GKMLGRGTFGHV----YVGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRL- 171
           GK LG G FG V     VG ++ +     A+K   L DDA  K+    L+ E+ ++  + 
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK--MLKDDATEKD-LSDLVSEMEMMKMIG 73

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE--------PAIRNYTQ-- 221
           +H NI+   G  T E  LY+ +EY + G++   L+     GE        P     TQ  
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 222 ------QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKG 275
                 Q+  G+ FL SK  +HRD+   N+LV  +  +K+ADFG+A+ I         K 
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI--HHIDYYRKT 191

Query: 276 S----PY-WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA--MFKIGN 328
           +    P  WMAPE +          D+WS G  + E+ T     S Y G+    +FK+  
Sbjct: 192 TNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGG--SPYPGIPVEELFKLLK 248

Query: 329 SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
                  P + + E    +R C    P  RPT  +L++
Sbjct: 249 EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  105 bits (263), Expect = 2e-23
 Identities = 83/306 (27%), Positives = 149/306 (48%), Gaps = 36/306 (11%)

Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           PG+ ++  S  + ++  K +G G FG V++  +  + E    K ++ +   K +E + QL
Sbjct: 2   PGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAIS-YRGLKEREKS-QL 59

Query: 162 MQEIVLLSRLRHPNIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQD----YGQFGEPA 215
           + E+ ++  L+H NIV+Y          KLYI +E+   G + + +Q     +G+  E A
Sbjct: 60  VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119

Query: 216 IRNYTQQILSGLAFLHS-------KHTVHRDIKGANILVDP---------------NGR- 252
           I + T+Q+L  LA+ H+       +  +HRD+K  NI +                 NGR 
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179

Query: 253 -VKLADFGMAKHIAGQSCPLSFKGSPYWMAPE-VIKNSSGCNLAVDIWSLGCTVLEMATT 310
             K+ DFG++K+I  +S   S  G+PY+ +PE ++  +   +   D+W+LGC + E+ + 
Sbjct: 180 IAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 311 KPPWSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
           K P+ +    + +  I   K  P +P    S E    I+  L  +   RP+A + L +  
Sbjct: 240 KTPFHKANNFSQL--ISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297

Query: 370 VKGAAP 375
           +K   P
Sbjct: 298 IKNVGP 303

Length = 1021

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 99.4 bits (247), Expect = 2e-23
 Identities = 77/251 (30%), Positives = 124/251 (49%), Gaps = 26/251 (10%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 67

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 68  AVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHI------AGQSCPLSFKGSPYWMAPEVIKNSSG 290
           HRD++ ANILV  N   K+ADFG+A+ I      A Q      K    W APE       
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGR- 179

Query: 291 CNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
             +  D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQ 238

Query: 350 CLQRNPLNRPT 360
           C ++ P  RPT
Sbjct: 239 CWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 3e-23
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 44/294 (14%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E++ K  K LG G++  VY G +  +G++ A+KE+ L  +  +  +A   ++E  LL  L
Sbjct: 5   ETYKKLDK-LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA---IREASLLKDL 60

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA-IRNYTQQILSGLAFL 230
           +H NIV  +     +  L +  EY+    + + + D G       +R +  Q+L GLA+ 
Sbjct: 61  KHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP----YWMAPEVIK 286
           H +  +HRD+K  N+L+   G +KLADFG+A+    +S P     +     ++  P+V+ 
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVLL 176

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKP--PWSQ--YEGVAAMFKI-GNSKE--LPTIPD-- 337
            S+  + ++D+W +GC   EMAT +P  P S    + +  +F++ G   E   P +    
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236

Query: 338 ----------------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                                 D    G++     LQ  P  R +AAE + HP+
Sbjct: 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  100 bits (250), Expect = 4e-23
 Identities = 79/266 (29%), Positives = 128/266 (48%), Gaps = 13/266 (4%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V V    ++ ++ AMK +  ++  K  E+A    +  VL++         
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
           +Y  +  E+ LY+ ++Y  GG +  LL  +  +  E   R Y  +++  +  +H  H VH
Sbjct: 67  HYAFQD-ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPYWMAPEVIK----NSSGC 291
           RDIK  NIL+D NG ++LADFG    +       S    G+P +++PE+++         
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE---LPTIPDDLSDEGKDFIR 348
               D WSLG  + EM   + P+     V    KI N KE    P    D+S++ KD IR
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIR 245

Query: 349 --LCLQRNPLNRPTAAELLDHPFVKG 372
             +C + + L +    +   HPF  G
Sbjct: 246 RLICSREHRLGQNGIEDFKQHPFFTG 271

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  100 bits (250), Expect = 4e-23
 Identities = 85/318 (26%), Positives = 150/318 (47%), Gaps = 63/318 (19%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           +++G+G++G V    ++ +GE  A+K++  +F+       A ++++EI LL  LRHP+IV
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIV 62

Query: 178 QYYG-----SKTVEDKLYIYLEYVSG------GSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           +        S+     +Y+  E +         +   L  ++ QF       +  Q+L  
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF-------FLYQLLRA 115

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-----FKGSPYWMA 281
           L ++H+ +  HRD+K  NIL + + ++K+ DFG+A+ +A    P +     +  + ++ A
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRA 174

Query: 282 PEVIKN-SSGCNLAVDIWSLGCTVLEMATTKPPW------SQYEGVAAMF---------K 325
           PE+  +  S    A+DIWS+GC   E+ T KP +       Q + +  +          +
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 326 IGNSKEL-------PTIPDDLSDE--GKDFIRLC-LQR----NPLNRPTAAELLDHPFVK 371
           + N K            P   S +    D + L  L+R    +P +RPTA E L  P+ K
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294

Query: 372 GAAPLERTILAPEPSDVP 389
           G A +ER     EPS  P
Sbjct: 295 GLAKVER-----EPSAQP 307

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 98.0 bits (244), Expect = 6e-23
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 24/257 (9%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           K LG G FG V  G      ++    +KE ++ +D        + ++E  ++ +L H  +
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED--------EFIEEAKVMMKLSHEKL 61

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA-IRNYTQQILSGLAFLHSKHT 235
           VQ YG  T +  +YI  EY+S G +   L+++G+  +P+ +    + +  G+A+L SK  
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVI---KNSS 289
           +HRD+   N LVD  G VK++DFG+++++       S  GS +   W  PEV+   K SS
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLLYSKFSS 180

Query: 290 GCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
                 D+W+ G  + E+ +  K P+ ++     + K+     L   P   S++    + 
Sbjct: 181 ----KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR-PHLASEKVYAIMY 235

Query: 349 LCLQRNPLNRPTAAELL 365
            C       RPT  +LL
Sbjct: 236 SCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  100 bits (249), Expect = 7e-23
 Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 9/211 (4%)

Query: 119 KMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAK--SKESAKQLMQEIVLLSRLRHPN 175
           + LG G+FG V +  + ++     A+K    F+ +K   ++    +  E  +L+ + HP 
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKR---FEKSKIIKQKQVDHVFSERKILNYINHPF 92

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
            V  YGS   E  LY+ LE+V GG  +  L+   +F       Y  QI+    +L S + 
Sbjct: 93  CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI 152

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           V+RD+K  N+L+D +G +K+ DFG AK +  ++  L   G+P ++APE++ N  G   A 
Sbjct: 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC--GTPEYIAPEILLN-VGHGKAA 209

Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKI 326
           D W+LG  + E+    PP+   E +    KI
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240

Length = 340

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 99.5 bits (248), Expect = 8e-23
 Identities = 86/308 (27%), Positives = 134/308 (43%), Gaps = 63/308 (20%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G FG V    +  +G+  A+K+  +     +   AK+  +E+ LL  LRH NI+   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKK--IMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75

Query: 181 GS--KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
                 +ED +Y   E + G  +++LL       +  I+ +  QIL GL ++HS   VHR
Sbjct: 76  DIFISPLED-IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHR 132

Query: 239 DIKGANILVDPNGRVKLADFGMAK----HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           D+K +NIL++ N  +K+ DFG+A+     + G      +  + Y+ APE++      ++ 
Sbjct: 133 DLKPSNILINENCDLKICDFGLARIQDPQMTG------YVSTRYYRAPEIMLTWQKYDVE 186

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD---------------- 338
           VDIWS GC   EM   KP +   + V     I  +  L T PDD                
Sbjct: 187 VDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII--TDLLGTPPDDVINTICSENTLRFVQS 244

Query: 339 ---------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAP 383
                                D +   L  +P  R +AAE L HP+           LAP
Sbjct: 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY-----------LAP 293

Query: 384 --EPSDVP 389
             +P+D P
Sbjct: 294 YHDPTDEP 301

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 98.2 bits (244), Expect = 1e-22
 Identities = 61/206 (29%), Positives = 111/206 (53%), Gaps = 13/206 (6%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E++ K  K LG GT+  V+ G +  +  + A+KE+ L  +  +  +A   ++E+ LL  L
Sbjct: 5   ETYVKLDK-LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA---IREVSLLKNL 60

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQF-GEPAIRNYTQQILSGLAFL 230
           +H NIV  +     E  L +  EY+    + + L + G       ++ +  Q+L GL++ 
Sbjct: 61  KHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP----YWMAPEVIK 286
           H +  +HRD+K  N+L++  G +KLADFG+A+    +S P     +     ++  P+V+ 
Sbjct: 120 HKRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKP 312
            S+  +  +D+W +GC + EMAT +P
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 99.3 bits (247), Expect = 1e-22
 Identities = 81/294 (27%), Positives = 124/294 (42%), Gaps = 42/294 (14%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +    D+G + AMK +    D   KE    +  E  +L       +V+
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKEQVAHIRAERDILVEADGAWVVK 65

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + S   +  LY+ +E++ GG +  LL       E A + Y  + +  +  +H    +HR
Sbjct: 66  MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAG-----------QSCPLSFK------------- 274
           DIK  N+L+D  G VKL+DFG+   +              + P  F              
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW 185

Query: 275 ------------GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA 322
                       G+P ++APEV    +G N   D WSLG  + EM    PP+        
Sbjct: 186 KKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 323 MFKIGNSKELPTIPDD--LSDEGKDFI-RLCL-QRNPLNRPTAAELLDHPFVKG 372
             K+ N KE    P +  +S++ KD I R C    N +      E+  HPF +G
Sbjct: 245 YRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEG 298

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 97.1 bits (242), Expect = 1e-22
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 17/261 (6%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P   +   + LG G FG V+ G   +   + A+K +     +      +   +E+  L R
Sbjct: 4   PREEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILK----SDDLLKQQDFQKEVQALKR 58

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQ-FGEPAIRNYTQQILSGLA 228
           LRH +++  +   +V + +YI  E +  GS+   L+   GQ     ++ +   Q+  G+A
Sbjct: 59  LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-WMAPEVIKN 287
           +L  ++++HRD+   NILV  +   K+ADFG+A+ I       S K  PY W APE   +
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA-S 177

Query: 288 SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEG 343
               +   D+WS G  + EM T  + P   Y G+       +I     +P  P     E 
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVP---YPGMNNHEVYDQITAGYRMPC-PAKCPQEI 233

Query: 344 KDFIRLCLQRNPLNRPTAAEL 364
              +  C    P +RP+   L
Sbjct: 234 YKIMLECWAAEPEDRPSFKAL 254

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 97.8 bits (243), Expect = 2e-22
 Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 19/215 (8%)

Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G+ME  +  E        LG GT+  V+ G +  +  + A+KE+ L  +  +  +A   +
Sbjct: 3   GKMETYIKLEK-------LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA---I 52

Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQ 221
           +E+ LL  L+H NIV  +     +  L +  EY+    + + + D G       ++ +  
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111

Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP---- 277
           QIL GLA+ H +  +HRD+K  N+L++  G +KLADFG+A+    +S P     +     
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTL 168

Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
           ++  P+V+  SS  +  +D+W +GC   EMA+ +P
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 97.0 bits (241), Expect = 3e-22
 Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 19/270 (7%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +++ ++LG+G FG V       +G+M A K++      K K  +  L  E  +L ++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL-NEKQILEKVNSR 60

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHS 232
            +V    +   +D L + L  ++GG +   +   G+  F E     Y  +I  GL  LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           +  V+RD+K  NIL+D +G ++++D G+A H+          G+  +MAPEV+KN     
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YT 179

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQ------YEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
            + D W+LGC + EM   + P+ Q       E V  + K    +      +  S + +  
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE----YSEKFSPDARSL 235

Query: 347 IRLCLQRNPLNR-----PTAAELLDHPFVK 371
            ++ L ++P  R       A E+ +HP  K
Sbjct: 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 98.1 bits (244), Expect = 3e-22
 Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 41/290 (14%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G +G V    +  +G   A+K+  L+   +S+  AK+  +E+ LL  ++H 
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 175 NIVQYYGSKTVEDKL------YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           N++      T +  L      Y+ + ++ G  + KL++ + +  E  I+    Q+L GL 
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLK 132

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
           ++H+   +HRD+K  N+ V+ +  +K+ DFG+A+    +     +  + ++ APEVI N 
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT--GYVVTRWYRAPEVILNW 190

Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI-------PDDLSD 341
                 VDIWS+GC + EM T KP +  ++ +  + +I      P+         +D  +
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250

Query: 342 --------EGKDFIRLCLQRNPL--------------NRPTAAELLDHPF 369
                     KDF  L    NPL              +R TAAE L HP+
Sbjct: 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 97.8 bits (243), Expect = 3e-22
 Identities = 80/272 (29%), Positives = 129/272 (47%), Gaps = 25/272 (9%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V V     +  + AMK +  ++  K  E+A    +  VL++         
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
           +Y  +  E+ LY+ ++Y  GG +  LL  +  +  E   R Y  +++  +  +H  H VH
Sbjct: 67  HYAFQD-ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125

Query: 238 RDIKGANILVDPNGRVKLADFG----MAKHIAGQSCPLSFKGSPYWMAPEVI-------- 285
           RDIK  N+L+D NG ++LADFG    M +    QS      G+P +++PE++        
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV--GTPDYISPEILQAMEDGMG 183

Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE---LPTIPDDLSDE 342
           K    C    D WSLG  + EM   + P+     V    KI N +E    P+   D+S+E
Sbjct: 184 KYGPEC----DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239

Query: 343 GKDFIR--LCLQRNPLNRPTAAELLDHPFVKG 372
            KD I+  +C +   L +    +   H F +G
Sbjct: 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 97.0 bits (241), Expect = 3e-22
 Identities = 62/208 (29%), Positives = 111/208 (53%), Gaps = 7/208 (3%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           + LG G++  VY G +  +G++ A+K +++  +     +A   ++E  LL  L+H NIV 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA---IREASLLKGLKHANIVL 67

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            +     ++ L    EY+       ++Q  G      +R +  Q+L GLA++H +H +HR
Sbjct: 68  LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCNLAVDI 297
           D+K  N+L+   G +KLADFG+A+  +  S   S +    W   P+V+  ++  + A+DI
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187

Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFK 325
           W  GC  +EM   +P    + GV+ +F+
Sbjct: 188 WGAGCIFIEMLQGQP---AFPGVSDVFE 212

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 98.1 bits (244), Expect = 3e-22
 Identities = 81/288 (28%), Positives = 129/288 (44%), Gaps = 46/288 (15%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV- 177
           K +G G +G V    +  +GE  A+K+  L    +S+  AK+  +E+ LL  ++H N++ 
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKK--LSRPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 178 --QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSK 233
               + S    D+   +  Y+    +   LQ        E  ++    Q+L GL ++HS 
Sbjct: 79  LLDVFTSAVSGDEFQDF--YLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
             +HRD+K  N+ V+ +  +K+ DFG+A+H   +     +  + ++ APEVI N    N 
Sbjct: 137 GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT--GYVVTRWYRAPEVILNWMHYNQ 194

Query: 294 AVDIWSLGCTVLEMATTK-----------------------PPWSQ-YEGVAAMFKIGNS 329
            VDIWS+GC + EM T K                       P + Q  E  AA   I   
Sbjct: 195 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI--- 251

Query: 330 KELPTIP-DDLS-------DEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
           K LP  P  D S        +  D +   L+ +   R TA E L+HP+
Sbjct: 252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 99.6 bits (248), Expect = 4e-22
 Identities = 55/153 (35%), Positives = 84/153 (54%), Gaps = 5/153 (3%)

Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG---QSCPLSFKGSPY 278
           Q+L  +  +HSKH +HRDIK ANIL+  NG VKL DFG +K  A         +F G+PY
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           ++APE+ +       A D++SLG  + E+ T K P+        M K    +  P +P  
Sbjct: 211 YVAPEIWRRKPYSKKA-DMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP-LPPS 268

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           +S E ++ +   L  +P  RP++++LL+ P  K
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301

Length = 496

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 95.8 bits (238), Expect = 7e-22
 Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 13/276 (4%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           ++LG+G FG V       +G+M A K++      K K  A  L  E  +L ++    +V 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEKRILEKVNSRFVVS 64

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTV 236
              +   +D L + L  ++GG +   + + G   F E     Y  ++  GL  L  +  V
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           +RD+K  NIL+D  G ++++D G+A  I          G+  +MAPEVI N      + D
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK-YTFSPD 183

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDFIRLCLQRN 354
            W LGC + EM   + P+ + +      ++     ++     +  S++ K   R+ L +N
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKN 243

Query: 355 PLNR-----PTAAELLDHPFVKGA--APLERTILAP 383
           P  R       AA +  HP  K      LE  +L P
Sbjct: 244 PKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEP 279

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 97.4 bits (242), Expect = 9e-22
 Identities = 89/313 (28%), Positives = 131/313 (41%), Gaps = 58/313 (18%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S + K K LG G FG V +    D+  + AMK +    D   +     +  E  +L+   
Sbjct: 1   SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRK-KDVLLRNQVAHVKAERDILAEAD 59

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           +  +V+ Y S   +D LY  ++Y+ GG +  LL   G F E   R Y  ++   +  +H 
Sbjct: 60  NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK 119

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGM---------------AKHIAGQS--------- 268
              +HRDIK  NIL+D +G +KL DFG+                 H+   S         
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179

Query: 269 ---C-------PL--------------SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTV 304
              C       PL              S  G+P ++APEV+  +    L  D WS+G  +
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC-DWWSVGVIL 238

Query: 305 LEMATTKPPWSQYEGVAAMFKIGNSKELPTIP--DDLSDEGKDFI-RLCLQRNP---LNR 358
            EM   +PP+     +    K+ N +    IP    LS E  D I +LC  R P   L +
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC--RGPEDRLGK 296

Query: 359 PTAAELLDHPFVK 371
             A E+  HPF K
Sbjct: 297 NGADEIKAHPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 78/266 (29%), Positives = 119/266 (44%), Gaps = 36/266 (13%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKE-----VTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           + LG G FG V++   ++   +C  ++     V    DA S  + K   +E  LL+ L+H
Sbjct: 11  RELGEGAFGKVFL---AECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQH 66

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-------------QFGEPAIRNYT 220
            +IV++YG     D L +  EY+  G + K L+ +G             +  +  + +  
Sbjct: 67  EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSF 273
           QQI +G+ +L S+H VHRD+   N LV  N  VK+ DFGM++ +        G    L  
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKEL 332
           +    WM PE I        + D+WSLG  + E+ T  K PW Q      +  I   + L
Sbjct: 187 R----WMPPESIMYRKFTTES-DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241

Query: 333 PTIPDDLSDEGKDFIRLCLQRNPLNR 358
              P     E  D +  C QR P  R
Sbjct: 242 QR-PRTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 74/293 (25%), Positives = 134/293 (45%), Gaps = 35/293 (11%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K + LG G++  VY G +  +G++ A+K + L ++  +  +A   ++E  LL  L+H 
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA---IREASLLKGLKHA 63

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NIV  +     ++ L +  EYV       + +  G      ++ +  Q+L GL+++H ++
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCNL 293
            +HRD+K  N+L+   G +KLADFG+A+  +  S   S +    W   P+V+  S+  + 
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 294 AVDIWSLGCTVLEM----------------------ATTKPPWSQYEGVAAM-------F 324
            +D+W +GC  +EM                          P    + GV ++       F
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243

Query: 325 KIGNSKELPTIPDDLS--DEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
            + + K L    + LS  +  +D     LQ  P NR +A   L H +     P
Sbjct: 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 96.3 bits (239), Expect = 1e-21
 Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 42/294 (14%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +    D+G + AMK +    D   KE    +  E  +L       +V+
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMK-ILRKADMLEKEQVGHIRAERDILVEADSLWVVK 65

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + S   +  LY+ +E++ GG +  LL       E   + Y  + +  +  +H    +HR
Sbjct: 66  MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIA-----------GQSCPLSFK------------- 274
           DIK  N+L+D  G VKL+DFG+   +              S P  F              
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185

Query: 275 ------------GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA 322
                       G+P ++APEV    +G N   D WSLG  + EM    PP+        
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 323 MFKIGNSKELPTIPDD--LSDEGKDFI-RLCLQ-RNPLNRPTAAELLDHPFVKG 372
             K+ N KE    P +  +S++ KD I R C +  + +  P   E+  +PF +G
Sbjct: 245 YKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG 298

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 17/282 (6%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +++ ++LG+G FG V       +G+M A K +      K ++     + E  +L ++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEK-KRIKKRKGESMALNEKQILEKVNSQ 60

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHS 232
            +V    +   +D L + L  ++GG +   + + G   F E     Y  +IL GL  LH 
Sbjct: 61  FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           ++TV+RD+K  NIL+D  G ++++D G+A  I          G+  +MAPEV+ N     
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR-YT 179

Query: 293 LAVDIWSLGCTVLEMATTKPPW-SQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIR 348
           L+ D W LGC + EM   + P+  + E V       ++  ++E        S+E K   +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE--VYSAKFSEEAKSICK 237

Query: 349 LCLQRNPLNR-----PTAAELLDHPFVKGA--APLERTILAP 383
           + L ++P  R       A E+  HPF +      LE  +L P
Sbjct: 238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDP 279

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 39/215 (18%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           K +GRG +G V    NS++ E  A+K++   FD+   +  AK+ ++EI LL  L H N++
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN---RIDAKRTLREIKLLRHLDHENVI 67

Query: 178 QYY------GSKTVEDKLYIYLEYVSGG------SIYKLLQDYGQFGEPAIRNYTQQILS 225
                      +   D +YI  E +         S   L  D+ Q+       +  Q+L 
Sbjct: 68  AIKDIMPPPHREAFND-VYIVYELMDTDLHQIIRSSQTLSDDHCQY-------FLYQLLR 119

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKG--------SP 277
           GL ++HS + +HRD+K +N+L++ N  +K+ DFG+A+         S KG        + 
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-------TTSEKGDFMTEYVVTR 172

Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
           ++ APE++ N S    A+D+WS+GC   E+   KP
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 92.8 bits (230), Expect = 5e-21
 Identities = 75/255 (29%), Positives = 123/255 (48%), Gaps = 30/255 (11%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V++G  + + ++ A+K  TL     S ES    ++E  ++ +LRH  +VQ
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKV-AVK--TLKPGTMSPES---FLEEAQIMKKLRHDKLVQ 65

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE------PAIRNYTQQILSGLAFLHS 232
            Y   + E+ +YI  EY+S GS+   L+D    GE      P + +   Q+ +G+A++  
Sbjct: 66  LYAVVS-EEPIYIVTEYMSKGSLLDFLKD----GEGRALKLPNLVDMAAQVAAGMAYIER 120

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHI------AGQSCPLSFKGSPYWMAPEVIK 286
            + +HRD++ ANILV      K+ADFG+A+ I      A Q      K    W APE   
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK----WTAPEAAL 176

Query: 287 NSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
                 +  D+WS G  + E+ T  + P+        + ++     +P  P D      +
Sbjct: 177 YGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC-PQDCPISLHE 234

Query: 346 FIRLCLQRNPLNRPT 360
            +  C +++P  RPT
Sbjct: 235 LMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 94.0 bits (233), Expect = 5e-21
 Identities = 70/270 (25%), Positives = 130/270 (48%), Gaps = 21/270 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           +++GRG++  V +     +  + AMK V   L +D +  +  +   ++ V      HP +
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQ--TEKHVFEQASNHPFL 58

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           V  +     E +L+  +EYV+GG +   +Q   +  E   R Y+ +I   L +LH +  +
Sbjct: 59  VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 118

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           +RD+K  N+L+D  G +KL D+GM K  +       +F G+P ++APE+++       +V
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSV 177

Query: 296 DIWSLGCTVLEMATTKPPWS--------QYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           D W+LG  + EM   + P+                +F++   K++  IP  LS +    +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVL 236

Query: 348 RLCLQRNPLNR----PTA--AELLDHPFVK 371
           +  L ++P  R    P    A++  HPF +
Sbjct: 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 92.4 bits (229), Expect = 5e-21
 Identities = 70/249 (28%), Positives = 120/249 (48%), Gaps = 22/249 (8%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + + ++ A+K  TL       E+    +QE  ++ +LRH  +V  Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTKV-AIK--TLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLY 67

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQ--DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
              + E+ +YI  E++  GS+   L+  D      P + +   QI  G+A++   + +HR
Sbjct: 68  AVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126

Query: 239 DIKGANILVDPNGRVKLADFGMAKHI------AGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           D++ ANILV  N   K+ADFG+A+ I      A Q      K    W APE         
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGR-FT 181

Query: 293 LAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL 351
           +  D+WS G  + E+ T  + P+        + ++     +P  P    +   + ++LC 
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC-PQGCPESLHELMKLCW 240

Query: 352 QRNPLNRPT 360
           +++P  RPT
Sbjct: 241 KKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 69/270 (25%), Positives = 129/270 (47%), Gaps = 21/270 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           +++GRG++  V +     +  + AMK +   L +D +  +  +   ++ V  +   HP +
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQ--TEKHVFETASNHPFL 58

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           V  +     E +L+  +E+VSGG +   +Q   +  E   R Y+ +I   L FLH +  +
Sbjct: 59  VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           +RD+K  N+L+D  G +KL D+GM K  I       +F G+P ++APE+++       +V
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED-YGFSV 177

Query: 296 DIWSLGCTVLEMATTKPPW--------SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           D W+LG  + EM   + P+                +F++   K++  IP  LS +    +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKASSVL 236

Query: 348 RLCLQRNPLNR------PTAAELLDHPFVK 371
           +  L ++P  R          ++  HPF +
Sbjct: 237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 18/199 (9%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
                G+++G G FG V  G    +G+  A+K +      K   +A+  ++E  ++++L 
Sbjct: 6   QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNI------KCDVTAQAFLEETAVMTKLH 57

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR--NYTQQILSGLAFL 230
           H N+V+  G   + + LYI +E +S G++   L+  G+     I+   ++  +  G+ +L
Sbjct: 58  HKNLVRLLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAK--HIAGQSCPLSFKGSPYWMAPEVIKNS 288
            SK  VHRD+   NILV  +G  K++DFG+A+   +   +  L  K    W APE +K+ 
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHK 172

Query: 289 SGCNLAVDIWSLGCTVLEM 307
              + + D+WS G  + E+
Sbjct: 173 KFSSKS-DVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 92.8 bits (230), Expect = 1e-20
 Identities = 80/303 (26%), Positives = 140/303 (46%), Gaps = 52/303 (17%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRH 173
           ++K   LG G  G V+   +  SG + A K + L    + K + + Q+++E+ +L     
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL----EIKPAIRNQIIRELQVLHECNS 62

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L  K
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 234 HTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           H + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  +M+PE ++ +   +
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-YS 180

Query: 293 LAVDIWSLGCTVLEMATTKPP-------------WSQYEGVAAMFKIGNSKELPTIPDD- 338
           +  DIWS+G +++EMA  + P                 EG  A  +       P  P   
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS 240

Query: 339 ------------------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHP 368
                                            E +DF+  CL +NP  R    +L+ H 
Sbjct: 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300

Query: 369 FVK 371
           F+K
Sbjct: 301 FIK 303

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 93.5 bits (232), Expect = 2e-20
 Identities = 83/309 (26%), Positives = 122/309 (39%), Gaps = 54/309 (17%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S + K K LG G FG V +    D+  + AMK +    D  ++     +  E  +L+   
Sbjct: 1   SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRK-KDVLNRNQVAHVKAERDILAEAD 59

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           +  +V+ Y S   +D LY  ++Y+ GG +  LL     F E   R Y  ++   +  +H 
Sbjct: 60  NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK 119

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGM---------------AKHI------------- 264
              +HRDIK  NIL+D +G +KL DFG+                 HI             
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 265 -------------------AGQSC-PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTV 304
                                Q C   S  G+P ++APEV+       L  D WS+G  +
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC-DWWSVGVIL 238

Query: 305 LEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD--LSDEGKDFIR--LCLQRNPLNRPT 360
            EM   +PP+          K+ N +    IP    LS E  D I    C     L R  
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG 298

Query: 361 AAELLDHPF 369
           A ++  HPF
Sbjct: 299 ADDIKAHPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 81/289 (28%), Positives = 121/289 (41%), Gaps = 51/289 (17%)

Query: 121 LGRGTFGHVYVG--FN-SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           LG G FG V++   +N S + +   +    L D   +  + K   +E  LL+ L+H +IV
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREAELLTNLQHEHIV 70

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLL----------------QDYGQFGEPAIRNYTQ 221
           ++YG     D L +  EY+  G + K L                Q  G+ G   + +   
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFK 274
           QI SG+ +L S+H VHRD+   N LV  N  VK+ DFGM++ +        G    L  +
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190

Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELP 333
               WM PE I        + D+WS G  + E+ T  K PW         F++ N++ + 
Sbjct: 191 ----WMPPESIMYRKFTTES-DVWSFGVILWEIFTYGKQPW---------FQLSNTEVIE 236

Query: 334 TI--------PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
            I        P     E  D +  C QR P  R    E+       G A
Sbjct: 237 CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 40/277 (14%)

Query: 121 LGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +G+G FG V+          E   M  V +  +  S +      +E  L++   HPNIV+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL----------------------QDYGQFGEPAI 216
             G   V   + +  EY++ G + + L                       +         
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS 276
               +Q+ +G+A+L  +  VHRD+   N LV  N  VK+ADFG++++I        +K S
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---YYKAS 189

Query: 277 P------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWS-QYEGVAAMFKIG 327
                   WM PE I  +       D+W+ G  + E+ +   +P +   +E V    + G
Sbjct: 190 ENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248

Query: 328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
           N   + + PD+   E  + +RLC  + P +RP+ A +
Sbjct: 249 N---VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 92.0 bits (228), Expect = 3e-20
 Identities = 55/202 (27%), Positives = 104/202 (51%), Gaps = 12/202 (5%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT---LFDDAKSK--ESAKQLMQEIVLLSRLRH 173
           +++GRG++  V +     + ++ AMK V    + DD      ++ K + ++        +
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-----SN 55

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P +V  +       +L++ +EYV+GG +   +Q   +  E   R Y  +I   L FLH +
Sbjct: 56  PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
             ++RD+K  N+L+D +G +KL D+GM K  +       +F G+P ++APE+++      
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YG 174

Query: 293 LAVDIWSLGCTVLEMATTKPPW 314
            +VD W+LG  + EM   + P+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 92.0 bits (228), Expect = 3e-20
 Identities = 68/272 (25%), Positives = 134/272 (49%), Gaps = 33/272 (12%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ-- 178
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82

Query: 179 --YYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 83  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 135

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 193

Query: 290 GCNLAVDIWSLGCTVLEMATTK---PPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
             N  VDIWS+GC + E+ T +   P     + +  + ++  +     +    S+  +++
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253

Query: 347 IRLCLQRNPLN--------RPTAAELLDHPFV 370
           I+   Q   +N         P A +LL+   V
Sbjct: 254 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 285

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 27/264 (10%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMC---AMKEVTLFDDAKSKESAKQ---LMQEIVLLSRLR 172
           K++G G FG V  G     G+     A+K  TL    K+  S KQ    + E  ++ +  
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIK--TL----KAGSSDKQRLDFLTEASIMGQFD 63

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLH 231
           HPNI++  G  T    + I  EY+  GS+ K L++  G+F    +    + I SG+ +L 
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKG--SPY-WMAPEVI--- 285
             + VHRD+   NILV+ N   K++DFG+++ +       + KG   P  W APE I   
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 286 KNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
           K +S    A D+WS G  + E+ +   +P W        +  + +   LP  P D     
Sbjct: 184 KFTS----ASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVEDGYRLPP-PMDCPSAL 237

Query: 344 KDFIRLCLQRNPLNRPTAAELLDH 367
              +  C Q++   RPT ++++  
Sbjct: 238 YQLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 76/275 (27%), Positives = 116/275 (42%), Gaps = 49/275 (17%)

Query: 119 KMLGRGTFGHVYVGFNSD-----SGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
             LG G FG VY G  +D     SG +  A+K  TL   A  +E  +  ++E  L+S   
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKE-FLKEAHLMSNFN 57

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD--YGQFGEPAIR-----NYTQQILS 225
           HPNIV+  G   + +  YI +E + GG +   L+D    +FG P +      +    +  
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGR-----VKLADFGMAKHIAGQSCPLSFKGSPY-- 278
           G  +L   H +HRD+   N LV   G      VK+ DFG+A+ I        +K   Y  
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI--------YKSDYYRK 169

Query: 279 ---------WMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQYEGVAAMFK 325
                    WMAPE + +        D+WS G  + E+ T      P  +  E +  +  
Sbjct: 170 EGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228

Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPT 360
            G  ++    PD +       +  C  ++P  RPT
Sbjct: 229 GGRLQKPENCPDKI----YQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 90.1 bits (223), Expect = 1e-19
 Identities = 51/155 (32%), Positives = 96/155 (61%), Gaps = 3/155 (1%)

Query: 160 QLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNY 219
           Q+++E+ +L     P IV +YG+   + ++ I +E++ GGS+ ++L++  +  E  +   
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 108

Query: 220 TQQILSGLAFLHSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
           +  +L GLA+L  KH + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  
Sbjct: 109 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRS 167

Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           +M+PE ++ +   ++  DIWS+G +++E+A  + P
Sbjct: 168 YMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 70/234 (29%), Positives = 113/234 (48%), Gaps = 45/234 (19%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEM----CAMKEVTLFDDAKSKESAKQLMQEIVL 167
           E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E  +
Sbjct: 6   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYV 62

Query: 168 LSRLRHPNIVQYYG---SKTVE--DKLYIY---LEYVSGGSIYKLLQDYGQFGEPAIRNY 219
           ++ + +P++ +  G   + TV+   +L  +   L+YV         +     G   + N+
Sbjct: 63  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--------EHKDNIGSQYLLNW 114

Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---------HIAGQSCP 270
             QI  G+ +L  +  VHRD+   N+LV     VK+ DFG+AK         H  G   P
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           +       WMA E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 175 IK------WMALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 217

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 59/211 (27%), Positives = 116/211 (54%), Gaps = 9/211 (4%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL-MQEIVLLSRLRHPNIVQ 178
           ++G G +G V    + ++ E+ A+K+   F D++  E  K+  ++E+ +L  L+  NIV+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKK---FKDSEENEEVKETTLRELKMLRTLKQENIVE 64

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP-AIRNYTQQILSGLAFLHSKHTVH 237
              +     KLY+  EYV   ++ +LL++      P  +R+Y  Q++  + + H    VH
Sbjct: 65  LKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLS-FKGSPYWMAPEVIKNSSGCNLAV 295
           RDIK  N+L+  N  +KL DFG A++++ G +   + +  + ++ +PE++  +     AV
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAV 182

Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKI 326
           D+WS+GC + E++  +P +     +  +F I
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTI 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 70/247 (28%), Positives = 108/247 (43%), Gaps = 14/247 (5%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +GRG FG V+ G         A+K    TL  D K+K      +QE  +L +  HPNIV+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             G  T +  +YI +E V GG     L+  G +     +    +   +G+ +L SKH +H
Sbjct: 58  LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAG--QSCPLSFKGSPY-WMAPEVIKNSSGCNLA 294
           RD+   N LV     +K++DFGM++       +     K  P  W APE + N    +  
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRYSSE 176

Query: 295 VDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            D+WS G  + E  +    P++          I     LP  P+   D     +  C + 
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP-CPELCPDAVYRLMERCWEY 235

Query: 354 NPLNRPT 360
           +P  RP+
Sbjct: 236 DPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 37/279 (13%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + D  +      V +  D  +++    L+ E+ ++  + +
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-----------DYGQFGEPAIR---- 217
           H NI+   G+ T +  LY+ +EY S G++ + L+           D  +  +  +     
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 218 -NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-------QSC 269
            + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ +          + 
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIG 327
            L  K    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+ 
Sbjct: 200 RLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLL 252

Query: 328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
                   P + ++E    +R C    P +RPT  +L++
Sbjct: 253 KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 64/253 (25%), Positives = 121/253 (47%), Gaps = 22/253 (8%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           + +G+G FG V +G     G   A+K +      K+  +A+  + E  ++++LRH N+VQ
Sbjct: 12  QTIGKGEFGDVMLG--DYRGNKVAVKCI------KNDATAQAFLAEASVMTQLRHSNLVQ 63

Query: 179 YYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKH 234
             G   VE+K  LYI  EY++ GS+   L+  G+   G   +  ++  +   + +L + +
Sbjct: 64  LLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAG--QSCPLSFKGSPYWMAPEVIKNSSGCN 292
            VHRD+   N+LV  +   K++DFG+ K  +    +  L  K    W APE ++      
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFST 178

Query: 293 LAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL 351
            + D+WS G  + E+ +  + P+ +      + ++    ++   PD       D ++ C 
Sbjct: 179 KS-DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-PDGCPPVVYDVMKQCW 236

Query: 352 QRNPLNRPTAAEL 364
             +   RP+  +L
Sbjct: 237 HLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 88.9 bits (220), Expect = 3e-19
 Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 29/275 (10%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V      G +    +      V +  D  + +    L+ E+ L+  + +
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DY---------GQFGEPAI 216
           H NI+   G  T E  LY+ +EY + G++ + L+       DY          Q     +
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSF 273
            +   Q+  G+ +L S+  +HRD+   N+LV  +  +K+ADFG+A+    I       + 
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKE 331
           +    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+     
Sbjct: 197 RLPVKWMAPEALFDRVYTHQS-DVWSFGILMWEIFTLGG--SPYPGIPVEELFKLLREGH 253

Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
               P + + E    +R C    P  RPT  +L++
Sbjct: 254 RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 60/291 (20%)

Query: 121 LGRGTFGHVYV------------GFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           LG G FG V++             F+ D         A+K   L +DA +K +    ++E
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK--MLREDA-NKNARNDFLKE 69

Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--------- 215
           I ++SRL+ PNI++        D L +  EY+  G + + L  + +  E A         
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQEAAEKADVVTIS 128

Query: 216 ---IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +     QI SG+ +L S + VHRD+   N LV  N  +K+ADFGM++++        
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-------- 180

Query: 273 FKGSPY-----------WMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQY-- 317
           + G  Y           WM+ E I        A D+W+ G T+ E+ T   + P+SQ   
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239

Query: 318 ----EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
               E     F+    +     P    D     +  C +RN   RP+  E+
Sbjct: 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 87.7 bits (217), Expect = 4e-19
 Identities = 69/281 (24%), Positives = 120/281 (42%), Gaps = 40/281 (14%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           GK LG G FG V                V   +  +  S    + L+ E  LL ++ HP+
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-----GQFGEPAIRN------------ 218
           +++ YG+ + +  L + +EY   GS+   L++         G    RN            
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 219 -------YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
                  +  QI  G+ +L     VHRD+   N+LV    ++K++DFG+++ +  +   +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 272 --SFKGSPY-WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA-----AM 323
             S    P  WMA E + +      + D+WS G  + E+ T     + Y G+A      +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQS-DVWSFGVLLWEIVTLGG--NPYPGIAPERLFNL 241

Query: 324 FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            K G   E    P++ S+E  + +  C ++ P  RPT A++
Sbjct: 242 LKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 10/250 (4%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           ++LG+G FG V+ G   D   + A+K  T  +D   +   K  + E  +L +  HPNIV+
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVK--TCKEDLPQELKIK-FLSEARILKQYDHPNIVK 56

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             G  T    +YI +E V GG     L +   +     +  +     +G+A+L SK+ +H
Sbjct: 57  LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116

Query: 238 RDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPY-WMAPEVIKNSSGCNLAV 295
           RD+   N LV  N  +K++DFGM++    G       K  P  W APE + N    +   
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL-NYGRYSSES 175

Query: 296 DIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRN 354
           D+WS G  + E  +    P+       A  ++     + + P    D+    ++ C    
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-SCPQKCPDDVYKVMQRCWDYK 234

Query: 355 PLNRPTAAEL 364
           P NRP  +EL
Sbjct: 235 PENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 88.3 bits (219), Expect = 7e-19
 Identities = 69/290 (23%), Positives = 123/290 (42%), Gaps = 42/290 (14%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKE-VTLFDDAKSKESAKQLMQEIVLLSRLRHPNI--- 176
           +G G FG V+   +   G+  A+K+   +F +  S    K++ +E+ +L   +H N+   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS---CKRVFRELKMLCFFKHDNVLSA 64

Query: 177 --VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             +         +++Y+  E +    ++K++          ++ +  QIL GL +LHS  
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA-KHIAGQSCPLSFK-GSPYWMAPEVIKNSSGCN 292
            +HRDIK  N+LV+ N  +K+ DFG+A      +S  ++ +  + Y+ APE++  S    
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183

Query: 293 LAVDIWSLGCTVLEMATTK---------------------PPWSQ--YEGVAAMFKIGNS 329
            AVDIWS+GC   E+   +                     P           A   I   
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243

Query: 330 KELP-------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
              P       T+    + E    +   L  +P  R +AA+ L HP++  
Sbjct: 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 86.2 bits (213), Expect = 8e-19
 Identities = 68/258 (26%), Positives = 124/258 (48%), Gaps = 20/258 (7%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  K LG G FG V++   +   ++    MK  ++        S +  + E  ++
Sbjct: 4   PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--------SVEAFLAEANVM 55

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGE-PAIRNYTQQILSG 226
             L+H  +V+ +   T E  +YI  E+++ GS+   L+ D G     P + +++ QI  G
Sbjct: 56  KTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 114

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           +AF+  ++ +HRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPE 173

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
            I N     +  D+WS G  ++E+ T  + P+        +  +     +P   ++  +E
Sbjct: 174 AI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP-ENCPEE 231

Query: 343 GKDFIRLCLQRNPLNRPT 360
             + +  C +  P  RPT
Sbjct: 232 LYNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.2 bits (213), Expect = 8e-19
 Identities = 67/256 (26%), Positives = 124/256 (48%), Gaps = 26/256 (10%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G FG V++G+  +  ++ A+K  T+ + A S+E     ++E  ++ +L HP +VQ Y
Sbjct: 12  IGSGQFGLVWLGYWLEKRKV-AIK--TIREGAMSEE---DFIEEAQVMMKLSHPKLVQLY 65

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           G  T    + +  E++  G +   L+   G+F +  +      +  G+A+L S + +HRD
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRD 125

Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAVD 296
           +   N LV  N  VK++DFGM + +       S  G+ +   W +PEV   S   + + D
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKS-D 183

Query: 297 IWSLGCTVLEM-ATTKPPWSQ------YEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
           +WS G  + E+ +  K P+         E + A F++   +       +L       ++ 
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYEL-------MQH 236

Query: 350 CLQRNPLNRPTAAELL 365
           C +  P +RP+ + LL
Sbjct: 237 CWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 86.1 bits (214), Expect = 9e-19
 Identities = 62/218 (28%), Positives = 111/218 (50%), Gaps = 20/218 (9%)

Query: 160 QLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNY 219
           QLM++        +PN ++ Y S T      + ++Y+  G ++ LL+  G+  E  ++  
Sbjct: 63  QLMKD--------NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKI 114

Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVD-PNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
            +Q++  L  LH  + +H DIK  N+L D    R+ L D+G+ K I   SC   + G+  
Sbjct: 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC---YDGTLD 171

Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMFKIGNSKELPT 334
           + +PE IK  +  +++ D W++G    E+ T K P+ + E     + ++ K    K+LP 
Sbjct: 172 YFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-QQKKLPF 229

Query: 335 IPDDLSDEGKDFIRLCLQRNPLNR-PTAAELLDHPFVK 371
           I  ++S    DF++  L+ N   R     E++ HPF+K
Sbjct: 230 IK-NVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 87.3 bits (216), Expect = 1e-18
 Identities = 80/311 (25%), Positives = 136/311 (43%), Gaps = 64/311 (20%)

Query: 121 LGRG--TFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +GRG      VY+  ++ +G +  ++   L  +  ++E  K L  E+VL    RHPNI+ 
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDL--ENCTEEHLKALQNEVVLSHFFRHPNIMT 63

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG--EPAIRNYTQQILSGLAFLHSKHTV 236
            +   T    L++   +++ GS   LL+ Y   G  E  I N     L GL +LH    +
Sbjct: 64  SWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI 123

Query: 237 HRDIKGANILVDPNGRVKLAD----FGMAKHIAGQSCPLSFKGSPY------WMAPEVIK 286
           HR+IK ++IL+  +G V L+     + + ++  GQ   + +    +      W++PE+++
Sbjct: 124 HRNIKASHILISGDGLVSLSGLSHLYSLVRN--GQKAKVVYDFPQFSTSVLPWLSPELLR 181

Query: 287 NS-SGCNLAVDIWSLGCTVLEMATTK------------------PPWSQYEG-------- 319
               G N+  DI+S+G T  E+AT +                  PP+S  +         
Sbjct: 182 QDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241

Query: 320 ------------------VAAMFKIGNSKELPT-IPDDLSDEGKDFIRLCLQRNPLNRPT 360
                              A M +   S+ L T      S   ++ + LCLQ++P  RP+
Sbjct: 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS 301

Query: 361 AAELLDHPFVK 371
           A+ LL H F K
Sbjct: 302 ASSLLSHAFFK 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 22/271 (8%)

Query: 111 PESHWKKGKMLGRGTFGHV-----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           P ++   GK LG G FG V     Y    SD+    A+K +     +  +E+   LM E+
Sbjct: 33  PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA---LMSEL 89

Query: 166 VLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQ 222
            ++S L  H NIV   G+ T+   + +  EY   G +   L+   +       + +++ Q
Sbjct: 90  KIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149

Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---- 278
           +  G+AFL SK+ +HRD+   N+L+     VK+ DFG+A+ I   S  +  KG+      
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV-KGNARLPVK 208

Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV---AAMFKIGNSKELPTI 335
           WMAPE I N      + D+WS G  + E+ +     + Y G+   +  +K+         
Sbjct: 209 WMAPESIFNCVYTFES-DVWSYGILLWEIFSLGS--NPYPGMPVDSKFYKLIKEGYRMAQ 265

Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           P+    E  D ++ C   +PL RPT  +++ 
Sbjct: 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 29/275 (10%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + +         V +     +++    L+ E+ ++  + +
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ----------- 221
           H NI+   G+ T +  LY+ +EY S G++ + L+     G     N TQ           
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 222 -----QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSF 273
                Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+   HI       + 
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA--MFKIGNSKE 331
           +    WMAPE + +    + + D+WS G  + E+ T     S Y GV    +FK+     
Sbjct: 203 RLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGH 259

Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
               P + ++E    +R C    P  RPT  +L++
Sbjct: 260 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 74/261 (28%), Positives = 106/261 (40%), Gaps = 24/261 (9%)

Query: 121 LGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG   FG VY G  F +  GE      +    D       ++   E ++ SRL+HPNIV 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL------QDYGQFG---------EPA-IRNYTQQ 222
             G  T E  L +   Y S   +++ L       D G            EPA   +   Q
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---W 279
           I +G+ FL S H VH+D+   N+LV     VK++D G+ + +           S     W
Sbjct: 133 IAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRW 192

Query: 280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMATTK-PPWSQYEGVAAMFKIGNSKELPTIPDD 338
           M+PE I      ++  DIWS G  + E+ +    P+  Y     +  I N + LP  PDD
Sbjct: 193 MSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC-PDD 250

Query: 339 LSDEGKDFIRLCLQRNPLNRP 359
                   +  C    P  RP
Sbjct: 251 CPAWVYTLMLECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 24/215 (11%)

Query: 117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           +G  +GRGT+GHVY     D  +    KE  L    +    +    +EI LL  L+HPN+
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDE---KEYAL-KQIEGTGISMSACREIALLRELKHPNV 60

Query: 177 V--QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG---------QFGEPAIRNYTQQILS 225
           +  Q       + K+++  +Y     ++ +++ +          Q     +++   QIL 
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119

Query: 226 GLAFLHSKHTVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLS----FKGSP 277
           G+ +LH+   +HRD+K ANILV       GRVK+AD G A+       PL+       + 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
           ++ APE++  +     A+DIW++GC   E+ T++P
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 85.5 bits (211), Expect = 4e-18
 Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 28/217 (12%)

Query: 117 KGKMLGRGTFGHVYVGFNSDSGEM--CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +G  +GRGT+GHVY     D  +    A+K++      +    +    +EI LL  L+HP
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI------EGTGISMSACREIALLRELKHP 58

Query: 175 NIV--QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG---------QFGEPAIRNYTQQI 223
           N++  Q       + K+++  +Y     ++ +++ +          Q     +++   QI
Sbjct: 59  NVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117

Query: 224 LSGLAFLHSKHTVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLS----FKG 275
           L G+ +LH+   +HRD+K ANILV       GRVK+AD G A+       PL+       
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
           + ++ APE++  +     A+DIW++GC   E+ T++P
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 61/220 (27%), Positives = 89/220 (40%), Gaps = 42/220 (19%)

Query: 119 KMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           + LG G FG VY G     +         +    +    +  ++  QE  L+S L+HPNI
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLL---------------------QDYGQFGEPA 215
           V   G  T E    +  EY++ G +++ L                      D   F   A
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--------AGQ 267
           I     QI +G+ +L S H VHRD+   N LV     VK++DFG+++ I          +
Sbjct: 131 I-----QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEM 307
           S  L  +    WM PE I          DIWS G  + E+
Sbjct: 186 S-LLPVR----WMPPEAIL-YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 87.6 bits (217), Expect = 4e-18
 Identities = 49/144 (34%), Positives = 76/144 (52%), Gaps = 1/144 (0%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K + RG FG VY+G   ++ ++ A+K V    D  +K    Q+  E   L+  + P IV 
Sbjct: 10  KPISRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALALSKSPFIVH 68

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            Y S    + +Y+ +EY+ GG +  LL  YG F E     Y  ++   L +LH    +HR
Sbjct: 69  LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHR 128

Query: 239 DIKGANILVDPNGRVKLADFGMAK 262
           D+K  N+L+   G +KL DFG++K
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 62/240 (25%), Positives = 115/240 (47%), Gaps = 24/240 (10%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMK-EVTLFDDAKSKESAKQLMQEIVLLSR 170
           E+  K+ K+LG G FG VY G     GE   +   + + ++    ++  + M E ++++ 
Sbjct: 6   ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAF 229
           + HP++V+  G   +   + +  + +  G +   + ++    G   + N+  QI  G+ +
Sbjct: 66  MDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIK 286
           L  +  VHRD+   N+LV     VK+ DFG+A+ + G     +  G      WMA E I 
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 287 NSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGK 344
                + + D+WS G T+ E+ T   KP    Y+G+        ++E+P    DL ++G+
Sbjct: 185 YRKFTHQS-DVWSYGVTIWELMTFGGKP----YDGIP-------TREIP----DLLEKGE 228

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 21/270 (7%)

Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           + P SH  K K++G G FG V+ G     G       +       +++  +  + E  ++
Sbjct: 2   IHP-SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGL 227
            +  H NI++  G  T      I  EY+  G++ K L+D+ G+F    +    + I +G+
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGM 120

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI----------AGQSCPLSFKGSP 277
            +L   + VHRD+   NILV+ N   K++DFG+++ +          +G   P+      
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR----- 175

Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIP 336
            W APE I      + A D+WS G  + E M+  + P+        M  I +   LP  P
Sbjct: 176 -WTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-P 232

Query: 337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            D        +  C Q++   RP   ++++
Sbjct: 233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 73/279 (26%), Positives = 124/279 (44%), Gaps = 37/279 (13%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + D         V +  D  + +    L+ E+ ++  + +
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG---------QFGEPAI 216
           H NI+   G+ T +  LY+ +EY S G++ + L+       DY          Q     +
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-------QSC 269
            +   Q+  G+ +L S+  +HRD+   N+LV  +  +K+ADFG+A+ +          + 
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIG 327
            L  K    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+ 
Sbjct: 197 RLPVK----WMAPEALFDRVYTHQS-DVWSFGVLLWEIFTLGG--SPYPGIPVEELFKLL 249

Query: 328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
                   P + + E    +R C    P  RPT  +L++
Sbjct: 250 KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 75/280 (26%), Positives = 115/280 (41%), Gaps = 46/280 (16%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            + LG G FG VY     G + D+ E+  A+K  TL +   S++     + E +++S+  
Sbjct: 11  LRALGHGAFGEVYEGLYRGRDGDAVELQVAVK--TLPESC-SEQDESDFLMEALIMSKFN 67

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPA------IRNYTQQILS 225
           H NIV+  G        +I LE ++GG +   L ++  +   P+      +    + +  
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNG--RV-KLADFGMAKHIAGQS-------CPLSFKG 275
           G  +L   H +HRDI   N L+   G  RV K+ADFGMA+ I   S         L  K 
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK- 186

Query: 276 SPYWMAPEV----IKNSSGCNLAVDIWSLGCTVLE---MATTKPPWSQYEGVAAMFKIGN 328
              WM PE     I  S       D+WS G  + E   +     P    + V      G 
Sbjct: 187 ---WMPPEAFLDGIFTSK-----TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238

Query: 329 SKELPT-IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             + P   P  +       +  C Q  P +RP  A +L+ 
Sbjct: 239 RLDPPKGCPGPVY----RIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.8 bits (199), Expect = 8e-17
 Identities = 81/300 (27%), Positives = 133/300 (44%), Gaps = 57/300 (19%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMK-EVTLFDDAKSKESAKQLMQEIVLLSR 170
           E+  KK K+LG G FG VY G     GE   +   + +  +  S ++ K+++ E  +++ 
Sbjct: 6   ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG 65

Query: 171 LRHPNIVQYYG---SKTVE--DKLYIY---LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQ 222
           +  P + +  G   + TV+   +L  Y   L+YV         ++  + G   + N+  Q
Sbjct: 66  VGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVR--------ENKDRIGSQDLLNWCVQ 117

Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---------HIAGQSCPLSF 273
           I  G+++L     VHRD+   N+LV     VK+ DFG+A+         H  G   P+  
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK- 176

Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA-----MFKI 326
                WMA E I +    + + D+WS G TV E+ T   KP    Y+G+ A     + + 
Sbjct: 177 -----WMALESILHRRFTHQS-DVWSYGVTVWELMTFGAKP----YDGIPAREIPDLLEK 226

Query: 327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPS 386
           G  + LP  P    D     ++ C   +   RP   EL+D          E + +A +PS
Sbjct: 227 G--ERLPQPPICTIDVYMIMVK-CWMIDSECRPRFRELVD----------EFSRMARDPS 273

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 81.1 bits (200), Expect = 2e-16
 Identities = 48/145 (33%), Positives = 78/145 (53%), Gaps = 5/145 (3%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++G+G FG V +    D+G++ AMK + L  +   K+    +  E  +L+    P +V 
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65

Query: 179 YYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
            Y S   +D  Y+YL  E++ GG +  +L  Y  F E   R Y  + +  +  +H    +
Sbjct: 66  LYYS--FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123

Query: 237 HRDIKGANILVDPNGRVKLADFGMA 261
           HRDIK  NIL+D  G +KL+DFG++
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 40/268 (14%)

Query: 124 GTFGHVYVGF--NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYG 181
           GTFG ++ G   +   G+   +   T+ D A S+     L+QE  LL  L H NI+    
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 182 SKTVE-DKLYIYLEYVSGGSIYKLLQD--YGQFGEP-AIRNYTQ-------QILSGLAFL 230
               + +  ++   Y++ G++   LQ    G+   P A+   TQ       QI  G+++L
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS--TQQLVHMAIQIACGMSYL 133

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLAD-------FGMAKHIAG--QSCPLSFKGSPYWMA 281
           H +  +H+DI   N ++D   +VK+ D       F M  H  G  ++ P+       WMA
Sbjct: 134 HKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------WMA 187

Query: 282 PEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQ---YEGVAAMFKIGNSKELPTIPD 337
            E + N    + A D+WS G  + E+ T  + P+ +   +E +AA  K G    L   P 
Sbjct: 188 LESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDG--YRLAQ-PI 242

Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELL 365
           +  DE    +  C   +P  RP+ ++L+
Sbjct: 243 NCPDELFAVMACCWALDPEERPSFSQLV 270

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 67/244 (27%), Positives = 107/244 (43%), Gaps = 51/244 (20%)

Query: 111 PESHWKKGKMLGRGTFGHVY------------VGFNSDSGE--MCAMKEVTLFDDAKSKE 156
           P    +  + LG G FG V+             G     G+  + A+K   L  D  +K 
Sbjct: 3   PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKM--LRADV-TKT 59

Query: 157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD---YGQFGE 213
           +    ++EI ++SRL++PNI++  G    +D L +  EY+  G + + L        F  
Sbjct: 60  ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 214 ----PAIR-----NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI 264
               P++          QI SG+ +L S + VHRD+   N LV  +  +K+ADFGM++++
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 265 AGQSCPLSFKGSPY-----------WMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TK 311
                   + G  Y           WMA E I        A D+W+ G T+ EM T   +
Sbjct: 180 --------YSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKE 230

Query: 312 PPWS 315
            P+S
Sbjct: 231 QPYS 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 78.2 bits (192), Expect = 5e-16
 Identities = 73/270 (27%), Positives = 120/270 (44%), Gaps = 32/270 (11%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           GK LG G FG V  G  +    +  +   T+     ++   +  + E V +    HPN++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 178 QYYGS--KTVEDKLY----IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ-------QIL 224
           +  G   +TVE + Y    + L ++  G ++  L  Y + G+      TQ        I 
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKGSP 277
           SG+ +L SK  +HRD+   N +++ N  V +ADFG++K I        G+   +  K   
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK--- 179

Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT---TKPPWSQYEGVAAMFKIGNSKELPT 334
            W+A E + +      + D+WS G T+ E+AT   T  P  +   +    + GN  + P 
Sbjct: 180 -WIAIESLADRVYTTKS-DVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP- 236

Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            PD L D     +  C   NP +RP+   L
Sbjct: 237 -PDCL-DGLYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 78.8 bits (194), Expect = 6e-16
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 63/293 (21%)

Query: 137 SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYV 196
           +GE   ++ + L  +A + E    L  E+ +     HPNIV Y  +   +++L++   ++
Sbjct: 24  TGEYVTVRRINL--EACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81

Query: 197 SGGSIYKLLQDYGQFG--EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVK 254
           + GS   L+  +   G  E AI    Q +L  L ++H    VHR +K ++IL+  +G+V 
Sbjct: 82  AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 141

Query: 255 L----ADFGMAKHIAGQSCPL-------SFKGSPYWMAPEVI-KNSSGCNLAVDIWSLGC 302
           L    ++  M  H  GQ   +       S K  P W++PEV+ +N  G +   DI+S+G 
Sbjct: 142 LSGLRSNLSMINH--GQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGI 198

Query: 303 TVLEMATTKPPWSQYEGVAAMFKIGNSK-----ELPTIPDD------------------- 338
           T  E+A    P+        + +  N       +  TIP +                   
Sbjct: 199 TACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGEST 258

Query: 339 --------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                                S     F+  CLQRNP  RP+A+ LL+H F K
Sbjct: 259 TVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 41/274 (14%)

Query: 120 MLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIV 177
           ++G G FG V       D   M A   +    +  SK+  +    E+ +L +L  HPNI+
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDA--AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQF-GEPA--IRNYT------QQILS--- 225
              G+      LY+ +EY   G++   L+       +PA  I N T      QQ+L    
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 226 ----GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPY- 278
               G+ +L  K  +HRD+   NILV  N   K+ADFG+++   GQ   +  +    P  
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 188

Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPW------SQYEGVAAMFKIGNSKE 331
           WMA E + N S      D+WS G  + E+ +    P+        YE +   +++     
Sbjct: 189 WMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK--- 244

Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
               P +  DE  D +R C +  P  RP+ A++L
Sbjct: 245 ----PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 64/241 (26%), Positives = 100/241 (41%), Gaps = 54/241 (22%)

Query: 111 PESHWKKGKMLGRGTFGHVYV--------------GFNSDSGEMCAMKEVTLFDDAKSKE 156
           P  H    + LG G FG V++               FN   G    +    L  DA +K 
Sbjct: 3   PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKN 61

Query: 157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-------- 208
           +    ++E+ +LSRL+ PNI++  G    ED L +  EY+  G + + L  +        
Sbjct: 62  ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 209 -----GQFGE------PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLAD 257
                            ++ +   QI SG+ +L S + VHRD+   N LV  N  +K+AD
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 258 FGMAKHIAGQSCPLSFKGSPY-----------WMAPEVIKNSSGCNLAVDIWSLGCTVLE 306
           FGM++++        + G  Y           WMA E I        A D+W+ G T+ E
Sbjct: 182 FGMSRNL--------YAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWE 232

Query: 307 M 307
           +
Sbjct: 233 I 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 60/275 (21%), Positives = 107/275 (38%), Gaps = 27/275 (9%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGF--NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P S+ ++   LGRG FG V++      +      +  V      K +    +  +E+ + 
Sbjct: 3   PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMF 62

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP---------AIRNY 219
            +L H N+V+  G     +  Y+ LEY   G + + L+      E               
Sbjct: 63  RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK--------HIAGQSCPL 271
             QI  G+  L +   VHRD+   N LV     VK++   ++K         +     PL
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182

Query: 272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSK 330
                  W+APE ++     +   D+WS G  + E+ T  + P+        + ++   K
Sbjct: 183 R------WLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
               +P+         +  C   NP +RP+ +EL+
Sbjct: 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 47/195 (24%), Positives = 102/195 (52%), Gaps = 8/195 (4%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ-- 178
           +G G +G V   +++   +  A+K+++     +S   A++  +E+ LL  ++H N++   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 179 --YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
             +  + ++E+   +YL     G+    +    +  +  ++    Q+L GL ++HS   +
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGII 140

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRD+K +N+ V+ +  +++ DFG+A+    +     +  + ++ APE++ N    N  VD
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLARQADDEMT--GYVATRWYRAPEIMLNWMHYNQTVD 198

Query: 297 IWSLGCTVLEMATTK 311
           IWS+GC + E+   K
Sbjct: 199 IWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 36/273 (13%)

Query: 119 KMLGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           + LG+G+FG VY G   D   GE      V   +++ S     + + E  ++      ++
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILSG 226
           V+  G  +      + +E ++ G +   L+      E       P ++   Q   +I  G
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMA 281
           +A+L++K  VHRD+   N +V  +  VK+ DFGM + I         KG        WMA
Sbjct: 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWMA 189

Query: 282 PEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI------ 335
           PE +K+      + D+WS G  + E+ +       Y+G++      N + L  +      
Sbjct: 190 PESLKDGVFTTSS-DMWSFGVVLWEITSLAE--QPYQGLS------NEQVLKFVMDGGYL 240

Query: 336 --PDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
             PD+  +   D +R+C Q NP  RPT  E+++
Sbjct: 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 64/258 (24%), Positives = 114/258 (44%), Gaps = 16/258 (6%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +++G G FG V  G     G+      +       +++  +  + E  ++ +  HPNI+ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             G  T    + I  E++  G++   L Q+ GQF    +    + I +G+ +L   + VH
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS-----PY-WMAPEVI---KNS 288
           RD+   NILV+ N   K++DFG+++ +   +   ++  S     P  W APE I   K +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT 189

Query: 289 SGCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           S    A D+WS G  + E M+  + P+        +  I     LP  P D        +
Sbjct: 190 S----ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP-PMDCPTALHQLM 244

Query: 348 RLCLQRNPLNRPTAAELL 365
             C Q++   RP   +++
Sbjct: 245 LDCWQKDRNARPKFGQIV 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 72.8 bits (179), Expect = 7e-15
 Identities = 49/166 (29%), Positives = 73/166 (43%), Gaps = 16/166 (9%)

Query: 221 QQILS-GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYW 279
           ++I +  L  L +   +HR  K  NIL+  +G +KL              P   +  PY+
Sbjct: 17  EEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGS------VAFKTPEQSRPDPYF 70

Query: 280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL 339
           MAPEVI+  S      DI+SLG T+ E    + P+++   ++A+ +I  +      P D 
Sbjct: 71  MAPEVIQGQSYTE-KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR 129

Query: 340 SDEGK--------DFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLE 377
           S+           DF+RLC  R P  R  A   L H     A  LE
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLE 175

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 71/275 (25%), Positives = 112/275 (40%), Gaps = 52/275 (18%)

Query: 121 LGRGTFGHVYVGF----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           LG   FG +Y G       D  ++ A+K +    D  + +   +  QE  L++ L HPNI
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK---DINNPQQWGEFQQEASLMAELHHPNI 69

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLL----------------------QDYGQFGEP 214
           V   G  T E  + +  EY++ G +++ L                       D+G F   
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
           AI     QI +G+ +L S   VH+D+   NIL+     VK++D G+++ I        ++
Sbjct: 130 AI-----QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD---YYR 181

Query: 275 GSP------YWMAPEVI---KNSSGCNLAVDIWSLGCTVLEMATTK-PPWSQYEGVAAMF 324
             P       WM PE I   K SS      DIWS G  + E+ +    P+  +     + 
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDS----DIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237

Query: 325 KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
            +   + LP   +D        +  C Q  P  RP
Sbjct: 238 MVRKRQLLPC-SEDCPPRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 12/199 (6%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +++ K +G G  G V   F++  G   A+K+  L    +++  AK+  +E+VLL  + H 
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKK--LSRPFQNQTHAKRAYRELVLLKCVNHK 80

Query: 175 NIVQ----YYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +Y+ +E +       +  +        +     Q+L G+ 
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQMLCGIK 137

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+          +  + Y+ APEVI   
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL-G 196

Query: 289 SGCNLAVDIWSLGCTVLEM 307
            G    VDIWS+GC + E+
Sbjct: 197 MGYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 66/277 (23%), Positives = 119/277 (42%), Gaps = 39/277 (14%)

Query: 118 GKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           GK+LG G FG V  G  + D G    +   T+  D  +    ++ + E   +    HPN+
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 177 VQYYG------SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQIL------ 224
           ++  G      S     K  + L ++  G ++  L  Y + G    +   Q +L      
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFMVDI 122

Query: 225 -SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY----- 278
             G+ +L +++ +HRD+   N ++  +  V +ADFG++K I        + G  Y     
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI--------YSGDYYRQGRI 174

Query: 279 ------WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSK 330
                 W+A E + +    + + D+W+ G T+ E+AT     + Y GV    ++      
Sbjct: 175 AKMPVKWIAIESLADRVYTSKS-DVWAFGVTMWEIATRGQ--TPYPGVENHEIYDYLRHG 231

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                P+D  DE  D +  C + +P +RPT  +L + 
Sbjct: 232 NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 70/254 (27%), Positives = 108/254 (42%), Gaps = 22/254 (8%)

Query: 121 LGRGTFGHVYVGF---NSDSGEMCAMKE--VTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+GTF ++Y G     SD   +   +E  V L         +    +   L+S+L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT-QQILSGLAFLHSKH 234
           +V+ YG   V D+  +  EYV  G +   L           +    +Q+ S L +L  K 
Sbjct: 63  LVKLYGV-CVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121

Query: 235 TVHRDIKGANILV---DPNGR----VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
            VH ++ G NILV     N      +KL+D G+   +  +   +     P W+APE I+N
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE--RIP-WIAPECIRN 178

Query: 288 -SSGCNLAVDIWSLGCTVLEMATTKP-PWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
             +   +A D WS G T+LE+ +    P S            +   LP +PD    E  +
Sbjct: 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP-MPD--CAELAN 235

Query: 346 FIRLCLQRNPLNRP 359
            I  C   +P  RP
Sbjct: 236 LINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 14/201 (6%)

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           PN+V  +     ED +++ L++  GG ++  +  +    E  ++ +  +++  L  LH +
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
             V RD+   NIL+D  G ++L  F     +       +      + APEV    S    
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEV-GGISEETE 161

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           A D WSLG  + E+ T K     +        I     L  IP+ +S+E +  ++  LQ 
Sbjct: 162 ACDWWSLGAILFELLTGKTLVECHPS-----GINTHTTL-NIPEWVSEEARSLLQQLLQF 215

Query: 354 NPLNRPTAA-----ELLDHPF 369
           NP  R  A      ++  HPF
Sbjct: 216 NPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 68/251 (27%), Positives = 104/251 (41%), Gaps = 22/251 (8%)

Query: 121 LGRGTFGHVYVGF--NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G FG V  G      S +  A+K   L +D        +L++E  ++ +L +P IV+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVK--ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
             G    E    + +E    G + K LQ      E  I     Q+  G+ +L   + VHR
Sbjct: 61  MIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS---PY-WMAPEVI---KNSSGC 291
           D+   N+L+      K++DFG++K +         K     P  W APE +   K SS  
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS-- 177

Query: 292 NLAVDIWSLGCTVLE-MATTKPPWSQYEG--VAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
               D+WS G  + E  +  + P+   +G  V  M + G   E    P     E  D ++
Sbjct: 178 --KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME---CPQRCPPEMYDLMK 232

Query: 349 LCLQRNPLNRP 359
           LC       RP
Sbjct: 233 LCWTYGVDERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 30/268 (11%)

Query: 121 LGRGTFGHVYVGFNS----DSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G       D  E   A+K V   ++A S     + + E  ++      +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 70

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLL-------QDYGQFGEPAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L       ++      P+++   Q   +I  
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG        WM
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWM 188

Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 189 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGMSNEQVLRFVMEGGLLDKPDN 245

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLD 366
             D   + +R+C Q NP  RP+  E++ 
Sbjct: 246 CPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 7/203 (3%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMK-EVTLFDDAKSKESAKQLMQEIVLLSR 170
           E+  +K K+LG G FG V+ G     G+   +   +    D   +++ +++   ++ +  
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYK-LLQDYGQFGEPAIRNYTQQILSGLAF 229
           L H  IV+  G       L +  +    GS+   + Q         + N+  QI  G+ +
Sbjct: 66  LDHAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF---KGSPYWMAPEVIK 286
           L     VHR++   NIL+  +  V++ADFG+A  +        +   K    WMA E I 
Sbjct: 125 LEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 287 NSSGCNLAVDIWSLGCTVLEMAT 309
                + + D+WS G TV EM +
Sbjct: 185 FGRYTHQS-DVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 73.6 bits (180), Expect = 4e-14
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 14/200 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H NI+ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 179 ----YYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
               +   K++E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+  LHS
Sbjct: 81  LLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS 137

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSSGC 291
              +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI    G 
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL-GMGY 195

Query: 292 NLAVDIWSLGCTVLEMATTK 311
              VDIWS+GC + EM   K
Sbjct: 196 KENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 43/274 (15%)

Query: 120 MLGRGTFGHVYVGF-NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIV 177
           ++G G FG V       D  +M A   + +  +  S+   +    E+ +L +L  HPNI+
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNA--AIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQF-GEPAIRN--------YTQQIL---- 224
              G+      LYI +EY   G++   L+       +PA            +QQ+L    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 225 ---SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK----HIAGQSCPLSFKGSP 277
              +G+ +L  K  +HRD+   N+LV  N   K+ADFG+++    ++      L  +   
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR--- 183

Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPW------SQYEGVAAMFKIGNSK 330
            WMA E + N S      D+WS G  + E+ +    P+        YE +   +++    
Sbjct: 184 -WMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK-- 239

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
                P +  DE  + +R C +  P  RP  A++
Sbjct: 240 -----PRNCDDEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 72.8 bits (179), Expect = 8e-14
 Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 26/202 (12%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K +G G  G V   +++ +G+  A+K+  L    ++   AK+  +E+VL+  + H NI+ 
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKK--LSRPFQNVTHAKRAYRELVLMKLVNHKNIIG 79

Query: 179 ----YYGSKTVED--KLYIYLEYVSGG--SIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
               +   K++E+   +Y+ +E +      + ++  D+ +     +     Q+L G+  L
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER-----MSYLLYQMLCGIKHL 134

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPEVI 285
           HS   +HRD+K +NI+V  +  +K+ DFG+A+  AG     SF  +P     Y+ APEVI
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGT----SFMMTPYVVTRYYRAPEVI 189

Query: 286 KNSSGCNLAVDIWSLGCTVLEM 307
               G    VDIWS+GC + EM
Sbjct: 190 L-GMGYKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 72.8 bits (178), Expect = 9e-14
 Identities = 58/196 (29%), Positives = 107/196 (54%), Gaps = 14/196 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIIG 87

Query: 179 ----YYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
               +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+  LHS
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS 144

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSSGC 291
              +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI    G 
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL-GMGY 202

Query: 292 NLAVDIWSLGCTVLEM 307
              VDIWS+GC + EM
Sbjct: 203 KENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 26/212 (12%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++G G FG V  G     G+      +       +++  +  + E  ++ +  HPNI+ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             G  T    + I  EY+  GS+   L+ + GQF    +    + I SG+ +L     VH
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVH 129

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI----------AGQSCPLSFKGSPYWMAPEVI-- 285
           RD+   NILV+ N   K++DFG+++ +           G   P+       W APE I  
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR------WTAPEAIAY 183

Query: 286 -KNSSGCNLAVDIWSLGCTVLEMAT--TKPPW 314
            K +S    A D+WS G  + E+ +   +P W
Sbjct: 184 RKFTS----ASDVWSYGIVMWEVMSYGERPYW 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 41/277 (14%)

Query: 118 GKMLGRGTFGHVYVGF---NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           G+MLG+G FG V          S +  A+K   L  D  S    ++ ++E   +    HP
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVAVK--MLKADIFSSSDIEEFLREAACMKEFDHP 61

Query: 175 NIVQYYG---SKTVEDKLYI---YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQIL---- 224
           N+++  G       + +L I    L ++  G ++  L    + GE        Q L    
Sbjct: 62  NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPF-TLPLQTLVRFM 119

Query: 225 ----SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSF 273
               SG+ +L SK+ +HRD+   N +++ N  V +ADFG++K I        G +  L  
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 274 KGSPYWMAPEVIKNSSGCNLAV---DIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNS 329
           K    W+A E + +    N+     D+W+ G T+ E+ T  + P++  E  + ++     
Sbjct: 180 K----WLALESLAD----NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIK 230

Query: 330 KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
                 P D  ++  + +  C    P  RP+   L D
Sbjct: 231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 74.0 bits (182), Expect = 1e-13
 Identities = 58/239 (24%), Positives = 108/239 (45%), Gaps = 36/239 (15%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           +++G+G  G VY+ ++       A+K++   L ++   K   K+ ++E  + + L HP I
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK---KRFLREAKIAADLIHPGI 64

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-------FGE----PAIRNYTQQILS 225
           V  Y   +  D +Y  + Y+ G ++  LL+   Q         E     A  +   +I +
Sbjct: 65  VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-------------SC--- 269
            + ++HSK  +HRD+K  NIL+   G V + D+G A     +              C   
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 270 ---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK 325
              P    G+P +MAPE +      + + DI++LG  + +M T   P+ + +G    ++
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242

Length = 932

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 65/268 (24%), Positives = 109/268 (40%), Gaps = 31/268 (11%)

Query: 120 MLGRGTFGHVYVGF-NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIV 177
           ++G G FG V       D   M A   +    +  SK+  +    E+ +L +L  HPNI+
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDA--AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------------DYGQFGEPAIRN---YTQ 221
              G+      LY+ +EY   G++   L+                     + +    +  
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK----HIAGQSCPLSFKGSP 277
            +  G+ +L  K  +HRD+   NILV  N   K+ADFG+++    ++      L  +   
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 176

Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIP 336
            WMA E + N S      D+WS G  + E+ +    P+          K+     L   P
Sbjct: 177 -WMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-P 233

Query: 337 DDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            +  DE  D +R C +  P  RP+ A++
Sbjct: 234 LNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 65/278 (23%), Positives = 111/278 (39%), Gaps = 38/278 (13%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
             +G G FG V +G  +  G   A   V     + + +     +QE+     L HPN++Q
Sbjct: 1   DEIGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQ-----ILSGLAFLHSK 233
             G         + LE+   G +   L+          +    Q     + SGL +LH  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMA------KHIAGQSC---PLSFKGSPYWMAPEV 284
             +H D+   N  +  +  VK+ D+G+A       +   + C   PL       W+APE+
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAPEL 173

Query: 285 IKNSSGCNLAV-------DIWSLGCTVLEMATTKP-PWSQYEGVAAMFKIGNSKEL---- 332
           +    G +L         +IWSLG T+ E+ T    P+        + ++   +++    
Sbjct: 174 V-EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232

Query: 333 PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAE---LLDH 367
           P +    SD   + ++ C   +P  RPTA E   LL +
Sbjct: 233 PQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 32/265 (12%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEM---CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++G+G FG VY G   DS      CA+K +    D    E  +Q ++E +++    HPN
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL---EEVEQFLKEGIIMKDFSHPN 57

Query: 176 IVQYYGSKTVEDKL-YIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     +    + L Y+  G +   ++       P +++   +  Q+  G+ +L 
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLA 115

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D +  VK+ADFG+A+ I            G   P+       WM
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK------WM 169

Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDL 339
           A E ++         D+WS G  + E+ T   PP+   +       +   + L   P+  
Sbjct: 170 ALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ-PEYC 227

Query: 340 SDEGKDFIRLCLQRNPLNRPTAAEL 364
            D   + +  C    P  RPT +EL
Sbjct: 228 PDPLYEVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.8 bits (176), Expect = 5e-13
 Identities = 53/190 (27%), Positives = 81/190 (42%), Gaps = 16/190 (8%)

Query: 136 DSGEMCAMKEVTLFDDAKSKESA-KQLMQEIVLLSRLRHPNIVQYYGS-KTVEDKLYIYL 193
            +G   A+K   L  DA  +E    +  +E  L +RL HPNIV    S +     L+   
Sbjct: 1   MTGHEVAIK--LLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVF 58

Query: 194 EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-- 251
           EYV G ++ ++L   G            Q+L  LA  H++  VHRD+K  NI+V   G  
Sbjct: 59  EYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118

Query: 252 -RVKLADFGMAKHIAGQSCPLSFK--------GSPYWMAPEVIKNSSGCNLAVDIWSLGC 302
              K+ DFG+   + G                G+P + APE ++         D+++ G 
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAWGL 177

Query: 303 TVLEMATTKP 312
             LE  T + 
Sbjct: 178 IFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 69.7 bits (170), Expect = 2e-12
 Identities = 60/247 (24%), Positives = 106/247 (42%), Gaps = 25/247 (10%)

Query: 87  SHSNSAATSPS----VPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYV-GFNSDSGEMC 141
           SH +     P     VP +  ++++     +H++    L  G FG +++    + + E  
Sbjct: 118 SHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAE 177

Query: 142 AMKEVTLFDDAKSK-------------ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK 188
           A + V   +  K K              +A QL  EI+ L RL H NI++       E  
Sbjct: 178 ARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEAN 237

Query: 189 LY-IYLEYVSGGSIYKLLQDYGQFGEPAI---RNYTQQILSGLAFLHSKHTVHRDIKGAN 244
            Y I  +Y      +   + +     P +   R   +Q+L  + ++H K  +HRDIK  N
Sbjct: 238 TYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN 297

Query: 245 ILVDPNGRVKLADFGMAKHIAGQSCPLSFK--GSPYWMAPEVIKNSSGCNLAVDIWSLGC 302
           I ++ +G++ L DFG A     +     +   G+    +PE++     C +  DIWS G 
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT-DIWSCGL 356

Query: 303 TVLEMAT 309
            +L+M +
Sbjct: 357 ILLDMLS 363

Length = 501

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 50/155 (32%), Positives = 76/155 (49%), Gaps = 13/155 (8%)

Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
           ++ Q+ +G+ FL SK+ VHRD+   N+L+     VK+ DFG+A+ I   S  +S KGS +
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTF 302

Query: 279 ----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAAMFKIGNSK 330
               WMAPE I N+    L+ D+WS G  + E+     T  P     E      K G   
Sbjct: 303 LPLKWMAPESIFNNLYTTLS-DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
             P      SDE  + ++ C +     RP  ++L+
Sbjct: 362 AKPA---HASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 23/225 (10%)

Query: 121 LGRGTFGHVYVG-FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G FG V  G +     ++  A+K   +  +   K    ++M+E  ++ +L +P IV+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK---VLKNENEKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ---QILSGLAFLHSKHT 235
             G    E  L + +E  SGG + K L   G+  E  + N  +   Q+  G+ +L  K+ 
Sbjct: 60  MIGVCEAEA-LMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPY-WMAPEVI---KNS 288
           VHRD+   N+L+      K++DFG++K +          S    P  W APE I   K S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 289 SGCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKEL 332
           S      D+WS G T+ E  +  + P+ + +G   M  I   K L
Sbjct: 177 S----RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 63/259 (24%), Positives = 98/259 (37%), Gaps = 67/259 (25%)

Query: 164 EIVLLSRLRHPNIVQ-----YYGSKTV------EDKLYIYLEYVSGGSIYKLLQDYGQFG 212
           E +LL  + HP++++       G+ T          LY YL   S      L  D     
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSR----PLPIDQALII 162

Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
           E       +QIL GL +LH++  +HRD+K  NI ++   +V + D G A+        L 
Sbjct: 163 E-------KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215

Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT------TKPPWSQYEGVAA---- 322
             G+    APEV+      N   DIWS G  + EM          PP +  E V +    
Sbjct: 216 LAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274

Query: 323 ------MFKIGNSKELPTIPD---------------------------DLSDEGKDFIRL 349
                   K+ + +E P  P                            +L  +G+  +  
Sbjct: 275 LLKIISTLKV-HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333

Query: 350 CLQRNPLNRPTAAELLDHP 368
            L  +   RP+A E+L++P
Sbjct: 334 MLTFDAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 49/164 (29%), Positives = 71/164 (43%), Gaps = 27/164 (16%)

Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
           Y+ Q+  G+ FL S+  +HRD+   NIL+  N  VK+ DFG+A+ I        +K   Y
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI--------YKDPDY 235

Query: 279 -----------WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAAM 323
                      WMAPE I +     +  D+WS G  + E+    A+  P     E     
Sbjct: 236 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294

Query: 324 FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
            K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 295 LKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 51/156 (32%), Positives = 75/156 (48%), Gaps = 23/156 (14%)

Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGS 276
           +++ Q+  G++FL SK+ +HRD+   NIL+  +GR+ K+ DFG+A+ I   S     KG+
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDS-NYVVKGN 275

Query: 277 PY----WMAPEVIKNSSGC--NLAVDIWSLGCTVLEMATTKPPWSQYEGVAA------MF 324
                 WMAPE I N   C      D+WS G  + E+ +     S Y G+        M 
Sbjct: 276 ARLPVKWMAPESIFN---CVYTFESDVWSYGILLWEIFSLGS--SPYPGMPVDSKFYKMI 330

Query: 325 KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPT 360
           K G     P        E  D ++ C   +PL RPT
Sbjct: 331 KEGYRMLSPECA---PSEMYDIMKSCWDADPLKRPT 363

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 49/166 (29%), Positives = 73/166 (43%), Gaps = 31/166 (18%)

Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
           Y+ Q+  G+ FL S+  +HRD+   NIL+  N  VK+ DFG+A+ I        +K   Y
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI--------YKDPDY 229

Query: 279 -----------WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV------A 321
                      WMAPE I +      + D+WS G  + E+ +     S Y GV       
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQS-DVWSFGVLLWEIFSLGA--SPYPGVQIDEEFC 286

Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
              K G        P+  + E    +  C   NP +RPT +EL++ 
Sbjct: 287 RRLKEGTRMR---APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 58/178 (32%), Positives = 87/178 (48%), Gaps = 15/178 (8%)

Query: 199 GSIYKLLQDYGQFGEPA--IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLA 256
             +  LL D G  G     + ++T Q+  G+ FL SK+ VHRD+   N+L+     VK+ 
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279

Query: 257 DFGMAKHIAGQSCPLSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
           DFG+A+ I   S  +S KGS +    WMAPE I ++    L+ D+WS G  + E+ +   
Sbjct: 280 DFGLARDIMHDSNYVS-KGSTFLPVKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGG 337

Query: 313 PWSQYEG--VAAMF--KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
             + Y G  V + F  KI +   +   PD  + E  D +  C    P  RP+   L D
Sbjct: 338 --TPYPGMIVDSTFYNKIKSGYRMAK-PDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 36/228 (15%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL------- 167
           WK  K++G G FG VY      + + C   +       ++ E+   +M+ +V        
Sbjct: 14  WKIDKLIGCGGFGCVYE--TQCASDHCINNQAVA--KIENLENETIVMETLVYNNIYDID 69

Query: 168 -------LSRLRHPNIVQYYGSKTVE-DKLY---IYLE--YVSGGSIYKLLQDYGQFGEP 214
                  +  + H  I +YYG  + +  ++Y   I LE    +   I+K ++   +    
Sbjct: 70  KIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNK---K 126

Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH--IAGQSCPLS 272
            I+N  + +L+ L ++H     H DIK  NI+VD N R  + D+G+A H  I G+    S
Sbjct: 127 LIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186

Query: 273 ------FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW 314
                  +G+ Y+   +   N +      D+ SLG  +L+ A  K PW
Sbjct: 187 KEQKDLHRGTLYYAGLDA-HNGACVTRRGDLESLGYCMLKWAGIKLPW 233

Length = 294

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 8e-11
 Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 19/159 (11%)

Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-------SCPL 271
           Y+ Q+  G+ FL S+  +HRD+   NIL+  N  VK+ DFG+A+ I          S  L
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAAMFKIG 327
             K    WMAPE I +      + D+WS G  + E+    A+  P     E      K G
Sbjct: 239 PLK----WMAPESIFDKVYTTQS-DVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293

Query: 328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
                   P++ + E    +  C Q +P  RPT + L++
Sbjct: 294 TRMR---APENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 51/156 (32%), Positives = 75/156 (48%), Gaps = 25/156 (16%)

Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSP 277
           ++ Q+  G+ FL SK+ +HRD+   N+L+  +GRV K+ DFG+A+ I   S     KG+ 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDS-NYVVKGNA 274

Query: 278 Y----WMAPEVIKNSSGCNLAV--DIWSLGCTVLEM-ATTKPPWSQYEGVAA------MF 324
                WMAPE I +   C   V  D+WS G  + E+ +  K P   Y G+        M 
Sbjct: 275 RLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGKSP---YPGILVNSKFYKMV 328

Query: 325 KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPT 360
           K G      + PD    E    +++C    P  RPT
Sbjct: 329 KRGYQM---SRPDFAPPEIYSIMKMCWNLEPTERPT 361

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 25/204 (12%)

Query: 121 LGRGTFGHVYVGFN---SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           LG+GTF  ++ G      D GE+   + +    D   +  ++   +   ++S+L H ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR-NYTQQILSGLAFLHSKHTV 236
             YG     D+  +  EYV  GS+   L+        + +    +Q+   L FL  K   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122

Query: 237 HRDIKGANILVDPNGR--------VKLADFG-----MAKHIAGQSCPLSFKGSPYWMAPE 283
           H ++   N+L+             +KL+D G     + K I  +  P        W+ PE
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP--------WVPPE 174

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEM 307
            I+N    +LA D WS G T+ E+
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 61/229 (26%), Positives = 94/229 (41%), Gaps = 36/229 (15%)

Query: 164 EIVLLSRLRHPNIVQYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQ 222
           E  +L  + HP+I+Q  G+ T      + L  Y +   +Y  L          I    + 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190

Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYW--- 279
           +L  + +LH    +HRDIK  NI ++  G V L DFG A        P+    + Y+   
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF------PVDINANKYYGWA 244

Query: 280 -----MAPEVI-KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA----------- 322
                 APE++ ++  G   AVDIWS G  + EMAT      + +G+             
Sbjct: 245 GTIATNAPELLARDPYGP--AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302

Query: 323 MFKIG-NSKELPTIPDDLSDEGKDFIRLCLQ--RNPLNRPTAAELLDHP 368
           + + G +  E P       DE   +I L  +  R P +RP    L + P
Sbjct: 303 IRRSGTHPNEFPIDAQANLDE--IYIGLAKKSSRKPGSRPLWTNLYELP 349

Length = 391

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 56/252 (22%), Positives = 106/252 (42%), Gaps = 6/252 (2%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           ++LG G FG +  G      +      +       S +  +  + E + L +  H NIV+
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             G  T  + + I  EY+S G++   L+ + GQ     +      + SG+ +L     VH
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVH 130

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKG-SP-YWMAPEVIKNSSGCNLAV 295
           + +    +LV+ +   K++ F   +    ++   +  G SP  W APE I+     + A 
Sbjct: 131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS-AS 189

Query: 296 DIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRN 354
           D+WS G  + E M+  + P+    G   +  + +   LP  P +  +     +  C Q+ 
Sbjct: 190 DVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA-PRNCPNLLHQLMLDCWQKE 248

Query: 355 PLNRPTAAELLD 366
              RP  +++  
Sbjct: 249 RGERPRFSQIHS 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 39/274 (14%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K +G G FG V +G   +SG   A   V     + S +   + ++E      L+H N++Q
Sbjct: 1   KEIGNGWFGKVILG-EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQ---QILSGLAFLHSK 233
             G  T      + +E+   G +   L+     +   P      +   +I  GL  LH  
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-----------WMAP 282
           + +H D+   N L+  +  VK+ D+G++           +K   Y           W+AP
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSH--------NKYKEDYYVTPDQLWVPLRWIAP 171

Query: 283 EVIKNSSGCNLAVD------IWSLGCTVLEM-ATTKPPWSQYEGVAAMFKIGNSKEL--- 332
           E++    G  L VD      +WSLG T+ E+      P+        +      ++L   
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP 231

Query: 333 -PTIPDDLSDEGKDFIRLC-LQRNPLNRPTAAEL 364
            P +   LSD   + ++ C LQ  P  RP+A E+
Sbjct: 232 KPRLKLPLSDRWYEVMQFCWLQ--PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 61/257 (23%), Positives = 106/257 (41%), Gaps = 25/257 (9%)

Query: 121 LGRGTFGHVYVGF-------NSDSGEMCAMKEVTL-FDDAKSKESAKQLMQEIVLLSRLR 172
           LGRGT   +Y G          D        +V L   D   ++ +    +   ++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 173 HPNIVQYYGSKTVEDKLYIYLE-YVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFL 230
           H +IV  YG   V D   I +E +V  G +   +         P      +Q+ S L++L
Sbjct: 63  HKHIVLLYGV-CVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL 121

Query: 231 HSKHTVHRDIKGANILVDPNGR-------VKLADFGMAKHI-AGQSCPLSFKGSPYWMAP 282
             K  VH ++   NIL+   G        +KL+D G+   + + Q C    +  P W+AP
Sbjct: 122 EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC---VERIP-WIAP 177

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
           E +++S   ++A D WS G T+ E+        + + +A   +    + +   P     E
Sbjct: 178 ECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPS--CKE 235

Query: 343 GKDFIRLCLQRNPLNRP 359
             D +  C+  +P  RP
Sbjct: 236 LADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 61/271 (22%), Positives = 114/271 (42%), Gaps = 38/271 (14%)

Query: 121 LGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +G G FG V +   +         +KE  L  +A SKE   + +Q+      L+HPNI+Q
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKE--LKANASSKEQ-NEFLQQGDPYRILQHPNILQ 59

Query: 179 YYGSKTVEDKLYIYL-EYVSGGSIYKLL-QDYGQFGEPAI---RNYTQQILSGLAFLHSK 233
             G + VE   Y+ + EY   G +   L Q+        +   +    +I +G+  +H  
Sbjct: 60  CLG-QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMA------KHIA---GQSCPLSFKGSPYWMAPEV 284
           + +H D+   N  +  +  VK+ D+G+        +I     +  PL       W+APE+
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR------WLAPEL 172

Query: 285 IKNSSGCNLAVD------IWSLGCTVLEM-ATTKPPWSQYEGVAAMFKIGNSKEL----P 333
           +    G  +  +      +W+LG T+ E+      P+S       +  +   +++    P
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP 232

Query: 334 TIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            +    S+   + ++ C   +P  R TA E+
Sbjct: 233 QLELPYSERWYEVLQFCWL-SPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 82/390 (21%), Positives = 136/390 (34%), Gaps = 75/390 (19%)

Query: 50  RAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPV 109
             G    +S+ +  D             +T   +   +   S +    V + P    +  
Sbjct: 26  TGGTDTSDSKDTTGDKFDDCDELGDSDDVTH-ATDYDADEESLSPQTDVCQEPCETTSSS 84

Query: 110 SPES----HWKKGKMLGRGTFGHVYV--GFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ 163
            P S     +     L  G+ G V+V      +  +   +K VT           K   +
Sbjct: 85  DPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT---------GGKTPGR 135

Query: 164 EIVLLSRLRHPNIVQ----YYGSKTV-------EDKLYIYLEYVSGGSIYKLLQDYGQFG 212
           EI +L  + H  I+     Y    TV       +  L+ Y++      + + +       
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI------- 188

Query: 213 EPAIRNYTQQ-ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA----KHIAGQ 267
                   Q+ +L  LA+LH +  +HRD+K  NI +D      L DFG A     H    
Sbjct: 189 ------TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242

Query: 268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG 327
            C   + G+    +PE++     C    DIWS G  + EM+              +F   
Sbjct: 243 QC-YGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVT---------LF--- 288

Query: 328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPT--AAELLDHPFVKGAAPLERTILAPEP 385
             K++ +    L    +  IR C+Q +PL  P   +  L  H F + A  L        P
Sbjct: 289 -GKQVKSSSSQL----RSIIR-CMQVHPLEFPQNGSTNLCKH-FKQYAIVLRP------P 335

Query: 386 SDVPPGVTNGIKALGIGQL-RNVSTFDTER 414
             +PP +      + +  L   + TFD E 
Sbjct: 336 YTIPPVIRKYGMHMDVEYLIAKMLTFDQEF 365

Length = 392

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 46/181 (25%), Positives = 66/181 (36%), Gaps = 51/181 (28%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ-------EIVLLSR 170
           GK LG G FG VY              + +L +    KE    L +       EI +  R
Sbjct: 137 GKKLGEGAFGVVY--------------KASLVNKQSKKEGKYVLKKATEYGAVEIWMNER 182

Query: 171 LRH--PNIVQYY-------GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--------QFGE 213
           +R   PN    +        S   ED+ ++   Y    ++  L+Q             G+
Sbjct: 183 VRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGK 242

Query: 214 PA------------IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLADFGM 260
                         I+   +QIL  L  LHS   VHRD+K  NI+    +G  K+ D G 
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGA 302

Query: 261 A 261
           A
Sbjct: 303 A 303

Length = 566

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 47/150 (31%), Positives = 68/150 (45%), Gaps = 6/150 (4%)

Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            E  LL RL HP ++     + V     + L +Y S    Y L       G   +    +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTY-LGARLRPLGLAQVTAVAR 267

Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSF--KGSPY 278
           Q+LS + ++H +  +HRDIK  N+LV+    + L DFG A    G  S P  +   G+  
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMA 308
             APEV+        +VDIWS G  + E A
Sbjct: 328 TNAPEVLAGDP-YTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 44/182 (24%), Positives = 83/182 (45%), Gaps = 14/182 (7%)

Query: 134 NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL 193
           N++  E+  + +V    D   ++ A    +   L+S++ H ++   +G      +  +  
Sbjct: 39  NNNGRELRVVLKVL---DPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVE 95

Query: 194 EYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR 252
           E+V  G +   L ++ G+          QQ+ S L++L  K+ VH ++   NIL+   G 
Sbjct: 96  EFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155

Query: 253 -------VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVL 305
                  +KL+D G++      S     +  P W+APE +   +  + A D WS G T+L
Sbjct: 156 AEGTSPFIKLSDPGVS--FTALSREERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLL 212

Query: 306 EM 307
           E+
Sbjct: 213 EI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 23/46 (50%), Positives = 31/46 (67%)

Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA 261
           I+   +Q+L+GL  LH    VHRDIK  N+LV  +G+VK+ DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 6/101 (5%)

Query: 275 GSPYWMAPEVI-KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK--IGNSKE 331
           G+P ++APE++     G   AVD W+LG  + E  T  PP++  E    +F+  +     
Sbjct: 542 GTPDYLAPELLLGKPHG--PAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNILNRDIP 598

Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
            P   + LS   ++ I + L  +P  R    EL  HP   G
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHG 639

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 41/220 (18%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI--- 176
           +LG GTFG V   ++    E CA+K V   +  K    AK    EI  + ++R  +    
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVR--NVPKYTRDAK---IEIQFMEKVRQADPADR 190

Query: 177 -----VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
                +Q Y          +  +Y  G  +   +  +G F    +     Q    L + H
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFH 248

Query: 232 SK-HTVHRDIKGANIL-------VDPNG---------RVKLADFGMA---KHIAGQSCPL 271
           ++ H +H D+K  NIL       VDP           RV++ D G     +H   ++  +
Sbjct: 249 TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIV 306

Query: 272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTK 311
           S +   ++ +PEV+    G   + D+WS+GC + E+ T K
Sbjct: 307 STR---HYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	602
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
PRK10345	210	hypothetical protein; Provisional	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
smart00090	237	RIO RIO-like kinase.	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.54
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.53
KOG1243	690	consensus Protein kinase [General function predict	99.5
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.4
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.39
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
KOG3087	229	consensus Serine/threonine protein kinase [General	99.13
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.11
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.03
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.99
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.85
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.77
COG4248	637	Uncharacterized protein with protein kinase and he	98.69
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.67
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.53
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.52
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.48
PRK09902	216	hypothetical protein; Provisional	98.48
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.34
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.34
PF01636	239	APH: Phosphotransferase enzyme family This family	98.29
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.27
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.22
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.18
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.05
PLN02876	822	acyl-CoA dehydrogenase	98.05
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.92
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.89
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.84
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.81
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.6
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.56
PRK10593	297	hypothetical protein; Provisional	97.54
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.46
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.38
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.33
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.31
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.24
PRK05231	319	homoserine kinase; Provisional	97.22
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.99
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.81
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.72
KOG2270	520	consensus Serine/threonine protein kinase involved	96.64
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.63
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.37
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.33
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.95
PLN02756	418	S-methyl-5-thioribose kinase	95.95
PLN02236	344	choline kinase	95.91
PRK12396	409	5-methylribose kinase; Reviewed	95.66
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.62
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.52
PTZ00384	383	choline kinase; Provisional	95.47
PRK11768	325	serine/threonine protein kinase; Provisional	95.42
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.16
PRK06148	1013	hypothetical protein; Provisional	95.1
COG2334	331	Putative homoserine kinase type II (protein kinase	94.85
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.56
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.45
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	92.62

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-58  Score=470.90  Aligned_cols=296  Identities=35%  Similarity=0.551  Sum_probs=258.5

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceE
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  189 (602)
                      ...++|++.++||+|+||+||+++.++|++.||+|++++..... ....+.+++|..||..++||+||+++..|++.+.+
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            34689999999999999999999999999999999998744333 34577889999999999999999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc-cCCC
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQS  268 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~  268 (602)
                      |||+||+.||+|+.+|++.+.|++..++.|+.+|+.||.|||++|||||||||||||||.+|+++|+||||++.. ....
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999854 4455


Q ss_pred             CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  348 (602)
                      ...++|||+.|||||++.+.. |+.++|||||||++|||++|.+||...+....+.+|...+ .+..+..++.++++||+
T Consensus       181 ~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLK  258 (357)
T ss_pred             ccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHH
Confidence            667899999999999998875 9999999999999999999999999988888888887655 34566679999999999


Q ss_pred             HHcccCCCCCC----CHHHHhcCccccCCCcccccccCCCCCCCCCCCcchhhhccCCccCCCCCCchhhhhcc
Q 007478          349 LCLQRNPLNRP----TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVH  418 (602)
Q Consensus       349 ~~L~~dP~~Rp----t~~eiL~hp~f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~s~~d~~~~~~~  418 (602)
                      ++|++||++|.    .+.+|.+||||+++.|-.... ......+.|.+         ....+++.||.++....
T Consensus       259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~-k~l~PpF~P~~---------~~~~~~~~Fd~eft~~~  322 (357)
T KOG0598|consen  259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLA-KKLSPPFKPNV---------TGLEDTSNFDNEFTSYT  322 (357)
T ss_pred             HHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHh-cCCCCCeecCC---------CCccccccccHHHHhcc
Confidence            99999999996    689999999999999844332 22222344432         45667788888876543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-59  Score=478.35  Aligned_cols=267  Identities=33%  Similarity=0.495  Sum_probs=232.6

Q ss_pred             CCCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchh-c--HHHHHHHHHHHHHHHhcCCCcEEEEeccccc
Q 007478          109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAK-S--KESAKQLMQEIVLLSRLRHPNIVQYYGSKTV  185 (602)
Q Consensus       109 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~-~--~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~  185 (602)
                      ....+.|.+.+.||+|+||.|.+|+.+.||+.||||++++..... .  ......+.+|+++|++|+|||||+++++|+.
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            345678999999999999999999999999999999997632211 1  1223446799999999999999999999999


Q ss_pred             cceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC---CceEEeccCccc
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN---GRVKLADFGMAK  262 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~vKL~DFGla~  262 (602)
                      .+..||||||++||+|++++-.++.+.+..-+.+++||+.||.|||++||+||||||+|||+..+   ..+||+|||+|+
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999776   679999999999


Q ss_pred             cccCCCCCcccCCCCCCCCcccccccC--CCCccccchhhhhHHHHHhhCCCCCCCchhHH-HHHHhhCCC--CCCCCCC
Q 007478          263 HIAGQSCPLSFKGSPYWMAPEVIKNSS--GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA-AMFKIGNSK--ELPTIPD  337 (602)
Q Consensus       263 ~~~~~~~~~~~~GT~~Y~APEvl~~~~--~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~-~~~~i~~~~--~~~~~p~  337 (602)
                      .......+.++|||+.|+|||++.+..  ++..++||||||||||.+|+|.+||.+..... ....|....  ..+..+.
T Consensus       328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~  407 (475)
T KOG0615|consen  328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD  407 (475)
T ss_pred             ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence            999888889999999999999997543  34558999999999999999999997654433 344444332  3345667


Q ss_pred             CCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       338 ~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      .+++++++||++||..||++|||++|+|+||||+.+..
T Consensus       408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            89999999999999999999999999999999997653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-57  Score=483.56  Aligned_cols=256  Identities=37%  Similarity=0.650  Sum_probs=236.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ..|+.+++||+|||++||++++..+|+.||+|+|.+... ......+.+.+||+|.++|+|||||+++++|++.+.+|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            679999999999999999999999999999999976333 2334567788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-CCCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~  271 (602)
                      +|+|+.++|..++++++.++|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||||..+... +...
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999855 6778


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      +.||||.|.|||++.. .+++..+||||+|||||.||+|++||...+-.+.+.+|.....  .+|..++.++++||.+||
T Consensus       177 TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~lL  253 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKLL  253 (592)
T ss_pred             eecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--ccccccCHHHHHHHHHHh
Confidence            9999999999999974 5699999999999999999999999999888888888866443  567899999999999999


Q ss_pred             ccCCCCCCCHHHHhcCccccC
Q 007478          352 QRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       352 ~~dP~~Rpt~~eiL~hp~f~~  372 (602)
                      +.||.+|||+++||.|+||+.
T Consensus       254 ~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  254 RPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             cCCcccCCCHHHHhcCHhhhC
Confidence            999999999999999999953

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-56  Score=454.07  Aligned_cols=259  Identities=32%  Similarity=0.619  Sum_probs=234.8

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc-eE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED-KL  189 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~  189 (602)
                      ..++.+.++.||+|+.|+||+++|+.|++.+|+|+|..   ..+.+..+++.+|+++++..+|||||++||+|..++ .+
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~---~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL---NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc---cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            35678889999999999999999999999999999953   334566789999999999999999999999999988 49


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      +|+||||.||+|.++++..++++|..+..++.+|++||.|||+ ++||||||||+||||+..|+|||||||.++.+... 
T Consensus       154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999999999998999999999999999999999995 99999999999999999999999999999988766 


Q ss_pred             CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCc-----hhHHHHHHhhCCCCCCCCCCC-CCHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY-----EGVAAMFKIGNSKELPTIPDD-LSDE  342 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~~-~s~~  342 (602)
                      ...+++||..|||||.+.+.. |+.++||||||+.|+||++|+.||...     ...+.+..|.. ...|.+|.. ++++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~e  310 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFSPE  310 (364)
T ss_pred             hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCCHH
Confidence            567899999999999998876 999999999999999999999999763     34555555554 466788887 9999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      +++||..||++||.+|+++.|+++|||++....
T Consensus       311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            999999999999999999999999999987543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-56  Score=438.72  Aligned_cols=263  Identities=32%  Similarity=0.568  Sum_probs=242.6

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|+..+.||.|+||+|.+++++.+|..||+|++++.+..+- ...+...+|..+|+.+.||+++++++.|.+.+.+|
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVkl-KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKL-KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHH-HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            46789999999999999999999999999999999987443333 34667889999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      |||||++||.|+.++++.++|++..++.++.||+.||+|||+++|++|||||||||||.+|.+||+|||+|+.+.+.  .
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998765  6


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      .+.||||.|+|||++..+. |+.++|+|||||++|||++|.+||...+......+|...+.  .+|..++.++++||+.+
T Consensus       199 ~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~L  275 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKL  275 (355)
T ss_pred             EEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCcccCHHHHHHHHHH
Confidence            7899999999999998765 99999999999999999999999999999888889987654  67889999999999999


Q ss_pred             cccCCCCCC-----CHHHHhcCccccCCCccccc
Q 007478          351 LQRNPLNRP-----TAAELLDHPFVKGAAPLERT  379 (602)
Q Consensus       351 L~~dP~~Rp-----t~~eiL~hp~f~~~~~~~~~  379 (602)
                      |+.|-.+|.     ..++|..||||+++.|....
T Consensus       276 L~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~  309 (355)
T KOG0616|consen  276 LQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAIL  309 (355)
T ss_pred             HhhhhHhhhcCcCCCccccccCcccccccHHHHh
Confidence            999999993     67899999999999885443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-55  Score=464.24  Aligned_cols=265  Identities=31%  Similarity=0.577  Sum_probs=239.3

Q ss_pred             CCCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccc
Q 007478          109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVED  187 (602)
Q Consensus       109 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~  187 (602)
                      .....+|++++.||+|+|++||+|+.+.+++.||||++.+.-. ..+...+-+.+|-.+|.+| .||.||+||..|+++.
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE  147 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-HhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence            4557899999999999999999999999999999999875222 2223355677899999999 8999999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      .+|+|+||+++|+|.++|++.+.|++..++.|+.||+.||+|||++|||||||||||||||.+|++||+|||.|+.+...
T Consensus       148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999877432


Q ss_pred             CC--------------CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC
Q 007478          268 SC--------------PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP  333 (602)
Q Consensus       268 ~~--------------~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~  333 (602)
                      ..              ..+++||..|++||+|.... .++.+|||+||||||.|+.|++||.+.+....+.+|....  .
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~--y  304 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD--Y  304 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc--c
Confidence            11              14588999999999997665 8999999999999999999999999999998888887643  4


Q ss_pred             CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCccc
Q 007478          334 TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLE  377 (602)
Q Consensus       334 ~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~~  377 (602)
                      .+|+.+++.++|||+++|..||.+|+|++||.+||||.++.|..
T Consensus       305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            78899999999999999999999999999999999999998844

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-54  Score=464.58  Aligned_cols=298  Identities=29%  Similarity=0.456  Sum_probs=258.4

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccce
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  188 (602)
                      ...++|.+.++||+|+||+|+++..+.+++.||||++++... ...+..+.++.|..|+... +||+++.++.+|++.++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I-l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI-LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce-eccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            457899999999999999999999999999999999987444 3445577889999999888 59999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc-CC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~  267 (602)
                      +|+||||+.||++. +++..+.|++..++.|+..|+.||+|||++||||||||.+|||||.+|++||+||||++..- ..
T Consensus       444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence            99999999999954 44455789999999999999999999999999999999999999999999999999998764 56


Q ss_pred             CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                      ..+.++|||+.|||||++.+.. |+.++|||||||+|||||.|+.||.+.+..+....|.+..  +.+|..++.|+.+||
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--~~yP~~ls~ea~~il  599 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSKEAIAIM  599 (694)
T ss_pred             CccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCCcccHHHHHHH
Confidence            6778999999999999998876 9999999999999999999999999988888888887644  467889999999999


Q ss_pred             HHHcccCCCCCCC-----HHHHhcCccccCCCcccccccCCCCCCCCCCCcchhhhccCCccCCCCCCchhhhhccCCcc
Q 007478          348 RLCLQRNPLNRPT-----AAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHSSRV  422 (602)
Q Consensus       348 ~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~s~~d~~~~~~~ss~~  422 (602)
                      +++|++||++|..     +++|.+||||+.+.|... .......++.|.         +...+++++||.++.+.....+
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L-~~r~i~PPf~P~---------i~~~~D~snFd~eFt~e~p~Lt  669 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL-LNRRIKPPFVPT---------IKGPEDVSNFDEEFTSEKPALT  669 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCccccCCHHHH-hhccCCCCCCcc---------cCChhhhcccchhhhcCCCccC
Confidence            9999999999985     689999999999998433 333333344444         3567788999999876554443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.2e-54  Score=457.44  Aligned_cols=277  Identities=32%  Similarity=0.521  Sum_probs=242.7

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceE
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  189 (602)
                      ...++|++++.||+|+||.||+|+.+.||+.||+|++++.. ....+..+.++.|-.+|...++++||+||..|++.+.+
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~-M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSE-MLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHH-HHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            35688999999999999999999999999999999998743 34556678899999999999999999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC---
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG---  266 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~---  266 (602)
                      ||||||++||++..+|.+.+.|++..++.++.+++.||+.||+.|+|||||||+|+|||..|++||+||||++-+..   
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999853210   


Q ss_pred             --------------------C-C------------------------CCcccCCCCCCCCcccccccCCCCccccchhhh
Q 007478          267 --------------------Q-S------------------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLG  301 (602)
Q Consensus       267 --------------------~-~------------------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLG  301 (602)
                                          . .                        ..++.+|||.|||||++.+.. |+..+||||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG  375 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLG  375 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHH
Confidence                                0 0                        012356999999999998766 99999999999


Q ss_pred             hHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCC--CCCHHHHHHHHHHcccCCCCCC---CHHHHhcCccccCCCcc
Q 007478          302 CTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLCLQRNPLNRP---TAAELLDHPFVKGAAPL  376 (602)
Q Consensus       302 viLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~Rp---t~~eiL~hp~f~~~~~~  376 (602)
                      |||||||.|.+||...+..+...+|.+......+|.  .++++++|||.+||. ||++|.   +++||.+||||+++.|-
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD  454 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence            999999999999999998888888887765555554  588999999999999 999997   59999999999999983


Q ss_pred             cccccCCCCCCCCCCC
Q 007478          377 ERTILAPEPSDVPPGV  392 (602)
Q Consensus       377 ~~~~~~~~~~~~~p~~  392 (602)
                      .   +...+..+.|.+
T Consensus       455 ~---l~~~~apfvP~v  467 (550)
T KOG0605|consen  455 H---LREMPAPFVPQV  467 (550)
T ss_pred             h---hhcCCCCCCCCC
Confidence            2   333334455544

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-53  Score=433.73  Aligned_cols=261  Identities=32%  Similarity=0.587  Sum_probs=236.7

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ...+|.+.+.||+|+||+||+|+++.++..||||.|.+..  ......+.+..||.+|+.++|||||.+++++.+.+.+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~--l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~   85 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK--LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY   85 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc--cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence            3568999999999999999999999999999999997532  14556778899999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC------CceEEeccCccccc
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN------GRVKLADFGMAKHI  264 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~------g~vKL~DFGla~~~  264 (602)
                      ||||||.||+|.+||++++.+++..++.++.||+.||++||+++||||||||.||||+..      -.+||+|||+|+.+
T Consensus        86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            999999999999999999999999999999999999999999999999999999999765      35899999999999


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC-CCCCCCCCCCHHH
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-ELPTIPDDLSDEG  343 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l  343 (602)
                      .......+.||++.|||||+++... |+.|+|+||+|+|||+|++|++||...+..+....+.... ..+.++..++...
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~  244 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL  244 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence            9888888999999999999998766 9999999999999999999999999877777776665544 3456667788899


Q ss_pred             HHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          344 KDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       344 ~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      .+|+...|+.++.+|.+..+-+.|++.....
T Consensus       245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  245 RELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            9999999999999999999999999987654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-53  Score=449.70  Aligned_cols=262  Identities=32%  Similarity=0.546  Sum_probs=236.0

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhc-HHHHHHHHHHHHHHHhcC-CCcEEEEeccccccc
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKS-KESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVED  187 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~-~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~  187 (602)
                      .....|++++.||+|+||+|++|.+..+|..||+|+++....... ....+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            346789999999999999999999999999999997765211111 134566779999999998 999999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC-CceEEeccCccccc-c
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHI-A  265 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~vKL~DFGla~~~-~  265 (602)
                      .+|+|||||.||+|++++.+.+++.|.+++.+|+||+.||+|||++||+||||||||||++.+ +++||+|||++... .
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999 99999999999988 4


Q ss_pred             CCCCCcccCCCCCCCCcccccccC-CCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCC-CHHH
Q 007478          266 GQSCPLSFKGSPYWMAPEVIKNSS-GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL-SDEG  343 (602)
Q Consensus       266 ~~~~~~~~~GT~~Y~APEvl~~~~-~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~-s~~l  343 (602)
                      ......+.|||+.|+|||++.+.. +.+.++|||||||+||.|++|+.||.+.+......+|...  ...+|..+ +.++
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~~~~p~~~~S~~~  251 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--EFKIPSYLLSPEA  251 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--CccCCCCcCCHHH
Confidence            666777899999999999998876 5678999999999999999999999998877777776554  34677788 9999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          344 KDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       344 ~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      ++||++||..||.+|+++.+|++||||+..
T Consensus       252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  252 RSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            999999999999999999999999999973

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.6e-54  Score=425.85  Aligned_cols=260  Identities=28%  Similarity=0.516  Sum_probs=227.5

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +.|+...++|+|+||+||+|++++||+.||||++..  ...+....+-.++||++|++|+|+|+|.++++|.....++||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E--sedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE--SEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeecc--CCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            578899999999999999999999999999998863  233345566678999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc-CCCCCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~  271 (602)
                      +|||+..-|.++-.....++...++.+++|++.|+.|||++++||||||||||||+.+|.+||||||+|+.+. ....+.
T Consensus        80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence            9999876666665555679999999999999999999999999999999999999999999999999999988 455556


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC--------------------C
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--------------------E  331 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~--------------------~  331 (602)
                      .++-|+||+|||.+.+...|+..+||||+||++.||++|.+.|.+..+++++..|....                    .
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            68899999999999998889999999999999999999999999998888877664311                    1


Q ss_pred             CCCCC---------CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          332 LPTIP---------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       332 ~~~~p---------~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      +|+..         +.++.-+.||++.||..||.+|++.+|+|.|+||.+..
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            11111         25677899999999999999999999999999996543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-53  Score=457.24  Aligned_cols=261  Identities=30%  Similarity=0.554  Sum_probs=242.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..-|++++.||.|+-|.|.+|+|..||+.+|||+|.+... ........+.+||.||+.|.||||+++|+++++..++|+
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccc-cccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            4569999999999999999999999999999999976322 222335668899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      |+||++||.|++++-++|++++.++..++.||+.|+.|||..+|+||||||+|+|||..+++||+|||+|..-..+....
T Consensus        90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe  169 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE  169 (786)
T ss_pred             EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999887787788


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      +.||.+.|.|||++++..|.+.++||||+|||||.||+|++||++.+....+.++..+.  .++|..++.++++||.+||
T Consensus       170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~--f~MPs~Is~eaQdLLr~ml  247 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV--FEMPSNISSEAQDLLRRML  247 (786)
T ss_pred             ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc--ccCCCcCCHHHHHHHHHHh
Confidence            99999999999999999988999999999999999999999999988888888887654  4788999999999999999


Q ss_pred             ccCCCCCCCHHHHhcCccccCCCc
Q 007478          352 QRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       352 ~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      +.||++|+|.+||++|||+.+...
T Consensus       248 ~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  248 DVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             ccCccccccHHHHhhCchhhcCCC
Confidence            999999999999999999987654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-53  Score=436.25  Aligned_cols=259  Identities=55%  Similarity=0.979  Sum_probs=231.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc--eE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED--KL  189 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~  189 (602)
                      ..+|..++.||+|+||+||++.+.++|..+|||.+...+.    ...+.+.+|+.+|++++|||||+++|.....+  .+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~----~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS----PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc----hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence            5679999999999999999999999999999999876321    12677899999999999999999999754444  69


Q ss_pred             EEEEeeecCCChhhhhhccC-CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc-CCceEEeccCccccccC-
Q 007478          190 YIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLADFGMAKHIAG-  266 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~-  266 (602)
                      +|+|||+++|+|.+++.+.+ .+++..++.+.+||+.||+|||++|||||||||+|||++. ++.+||+|||+++.... 
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999999999877 7999999999999999999999999999999999999999 79999999999987764 


Q ss_pred             ---CCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCC-chhHHHHHHhhCCCCCCCCCCCCCHH
Q 007478          267 ---QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQ-YEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       267 ---~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                         ......+.||+.|||||++.++.....++|||||||++.||+||++||.+ ......++.+......|.+|..++.+
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~  251 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE  251 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence               22234578999999999998633234599999999999999999999998 67777888888888888999999999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      +++||.+||.+||++|||++++|+|||.+...
T Consensus       252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            99999999999999999999999999997653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-54  Score=446.22  Aligned_cols=263  Identities=31%  Similarity=0.539  Sum_probs=234.9

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccc-
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVED-  187 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~-  187 (602)
                      ...++|.+++.||.|+||.||+|+.+.+|..||||.++..  ....+..-. .||++.|++|+ |||||++.+++.+.+ 
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~K--f~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKK--FYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhh--hccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            3567899999999999999999999999999999998752  222333333 48999999998 999999999998877 


Q ss_pred             eEEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      .+|+|||||+ .+|+++++.+ +.|++..++.|+.||+.||+|+|++|++||||||||||+..+..|||+|||||+.+..
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            9999999995 7999999865 5799999999999999999999999999999999999999888999999999999999


Q ss_pred             CCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCC------------
Q 007478          267 QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT------------  334 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~------------  334 (602)
                      ...+..++.|+||+|||++.....|+.++||||+|||++|+++-++.|.+.++.+++++|....+.|.            
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            88888999999999999999999999999999999999999999999999999999998875433221            


Q ss_pred             ----------------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCcc
Q 007478          335 ----------------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPL  376 (602)
Q Consensus       335 ----------------~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~  376 (602)
                                      +-..++.++.+||.+||.+||++|||+.|+|+||||+.....
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                            113588999999999999999999999999999999976543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-51  Score=430.89  Aligned_cols=257  Identities=32%  Similarity=0.546  Sum_probs=225.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc--ceE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE--DKL  189 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~  189 (602)
                      .+.|+.++.||+|+||.||+|++..||+.||+|+|....  ...+...-..+||.||++|+||||++|.+...+.  ..+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~--~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN--EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc--CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            467999999999999999999999999999999998632  2334556678999999999999999999987765  689


Q ss_pred             EEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          190 YIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      |||+|||+ -+|.-++.. .-.|++.+++.|+.||+.||+|||.+||+|||||.+|||||.+|.+||+|||||+++....
T Consensus       194 YlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  194 YLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            99999996 688888876 3479999999999999999999999999999999999999999999999999999876544


Q ss_pred             --CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC--------CCC--
Q 007478          269 --CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIP--  336 (602)
Q Consensus       269 --~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~p--  336 (602)
                        .....+-|+||+|||++++...|+.++|+||+||||.||++|++.|.+.++++++.+|.+....|        .+|  
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence              34556689999999999999999999999999999999999999999988888877765433222        111  


Q ss_pred             -----------------CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCcccc
Q 007478          337 -----------------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       337 -----------------~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~  371 (602)
                                       ..++..+.+|+..||..||.+|.|+.++|+|+||.
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence                             24788999999999999999999999999999994

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.8e-51  Score=397.49  Aligned_cols=259  Identities=28%  Similarity=0.499  Sum_probs=227.0

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      .+|...++||+|.||+||+|++..||+.||||+|+..+.  .........+||++|+.++|+||+.++++|...+.+.||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~--kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA--KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc--ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence            478899999999999999999999999999999986322  122234567999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          193 LEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      +||++ .+|...|+.. ..++..+++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.......
T Consensus        80 fEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             EEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence            99995 7999999764 578999999999999999999999999999999999999999999999999999987655444


Q ss_pred             c-cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCC----------------
Q 007478          272 S-FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT----------------  334 (602)
Q Consensus       272 ~-~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~----------------  334 (602)
                      + .+-|.||+|||++.+...|+..+||||.|||+.||+.|.+-|.+..+.+++..|......|.                
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence            3 36899999999999999999999999999999999999999999888888777654332221                


Q ss_pred             ----------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          335 ----------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       335 ----------~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                                +-..++.++.||+.+||.+||.+|+++.|+|+|+||+...
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                      1124678899999999999999999999999999999753

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-50  Score=415.18  Aligned_cols=264  Identities=31%  Similarity=0.447  Sum_probs=231.6

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceE
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  189 (602)
                      -..++|++++.||.|.-|+||+|..+.++..+|+|++.+... .......+...|-.||+.++||+++.||..|+.++..
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-hhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            346789999999999999999999999999999999986333 2344566778899999999999999999999999999


Q ss_pred             EEEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc--
Q 007478          190 YIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--  265 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~--  265 (602)
                      |+|||||.||+|+.++++.  +.|++..++.|+.+|+.||+|||..|||+||||||||||.++|+|.|+||.|+....  
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999999999764  679999999999999999999999999999999999999999999999999874220  


Q ss_pred             --------------------------------C-C----------------------CCCcccCCCCCCCCcccccccCC
Q 007478          266 --------------------------------G-Q----------------------SCPLSFKGSPYWMAPEVIKNSSG  290 (602)
Q Consensus       266 --------------------------------~-~----------------------~~~~~~~GT~~Y~APEvl~~~~~  290 (602)
                                                      . .                      ....+++||-.|+|||+|.+.. 
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-  311 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-  311 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-
Confidence                                            0 0                      1123467999999999998765 


Q ss_pred             CCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-CCCCCCCCCHHHHHHHHHHcccCCCCCCC----HHHHh
Q 007478          291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-LPTIPDDLSDEGKDFIRLCLQRNPLNRPT----AAELL  365 (602)
Q Consensus       291 ~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt----~~eiL  365 (602)
                      .+.++|||+|||+|||||.|..||.+.+..+.+..|..... .+.. ..++.+++|||+++|.+||.+|..    +.||.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC-CcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            99999999999999999999999999999888888765433 2222 368899999999999999999998    99999


Q ss_pred             cCccccCCCcc
Q 007478          366 DHPFVKGAAPL  376 (602)
Q Consensus       366 ~hp~f~~~~~~  376 (602)
                      +||||+++.|.
T Consensus       391 ~HpFF~gVnWa  401 (459)
T KOG0610|consen  391 RHPFFEGVNWA  401 (459)
T ss_pred             cCccccCCChh
Confidence            99999999995

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=411.26  Aligned_cols=265  Identities=27%  Similarity=0.453  Sum_probs=230.6

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc-----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV-----  185 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~-----  185 (602)
                      ....|...+.||+|+||.|+.|.++.||+.||||++.  +.....-..++..+|+++|+.++|+||+.+++++..     
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            3456777899999999999999999999999999875  234555667888999999999999999999998765     


Q ss_pred             cceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                      -+.+|+|+|+| +.+|...|+....+++..++.+++||++||+|+|+.||+||||||.|+|++.+..+||||||+|+...
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence            45799999999 68999999987779999999999999999999999999999999999999999999999999999886


Q ss_pred             C---CCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC---------
Q 007478          266 G---QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP---------  333 (602)
Q Consensus       266 ~---~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~---------  333 (602)
                      .   ......++-|.||+|||++.+...|+.++||||+||||.||++|++.|.+.+...++..|......|         
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            4   3444567789999999999998889999999999999999999999998877776665554322211         


Q ss_pred             ------------C--------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCcccc
Q 007478          334 ------------T--------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLER  378 (602)
Q Consensus       334 ------------~--------~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~~~  378 (602)
                                  .        +-++.++++.+|+++||..||.+|+|++|+|+||||+.....+.
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d  321 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED  321 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence                        1        12478999999999999999999999999999999998766443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-52  Score=407.62  Aligned_cols=248  Identities=33%  Similarity=0.608  Sum_probs=219.7

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEec-cccccce
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYG-SKTVEDK  188 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~-~~~~~~~  188 (602)
                      ....+|++.++||+|.||+||++.+..+|+.+|.|.|+. ... +....+.+..|+.+|++|+|||||++++ .|..++.
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f-~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF-GMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch-hhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            346789999999999999999999999999999999873 333 3445678889999999999999999999 5555555


Q ss_pred             -EEEEEeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhcc--CC--ceecCCCCCcEEEccCCceEEeccC
Q 007478          189 -LYIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHS--KH--TVHRDIKGANILVDPNGRVKLADFG  259 (602)
Q Consensus       189 -~~lVmE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~--~g--IvHrDLKp~NILl~~~g~vKL~DFG  259 (602)
                       ++||||||.+|+|..+|+.    ++.++|..++.++.|++.||.+||.  ..  |+||||||.||+|+.+|.|||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence             9999999999999999974    3579999999999999999999998  44  9999999999999999999999999


Q ss_pred             ccccccCCCC-CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC-C
Q 007478          260 MAKHIAGQSC-PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP-D  337 (602)
Q Consensus       260 la~~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~  337 (602)
                      |++.+..... ..+++|||+||+||++.... |+.++||||+||++|||+.-++||.+.+-.....+|... ..+.+| .
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~  251 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDE  251 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHH
Confidence            9999876543 44788999999999998765 999999999999999999999999999877778888776 555566 6


Q ss_pred             CCCHHHHHHHHHHcccCCCCCCCH
Q 007478          338 DLSDEGKDFIRLCLQRNPLNRPTA  361 (602)
Q Consensus       338 ~~s~~l~dLI~~~L~~dP~~Rpt~  361 (602)
                      ..|.++.+||..|+..|++.||+.
T Consensus       252 ~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HhhhHHHHHHHHHccCCcccCCCc
Confidence            799999999999999999999985

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=430.44  Aligned_cols=259  Identities=37%  Similarity=0.664  Sum_probs=232.0

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ....|...++||+|+.|.||.|....+++.||||.+.+...    ...+.+++|+.+|+.++|+|||.+++.|...+.+|
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            34568888899999999999999999999999999986332    23456889999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      +||||++||+|.|.+.+. .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+.... .
T Consensus       347 VVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             EEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            999999999999999875 59999999999999999999999999999999999999999999999999998886654 5


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-CCCCCCCCCHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-LPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~dLI~  348 (602)
                      ..+.+||++|||||++.... |++++||||||++++||+-|++||-..+....+..|..... .-..++.+++++++|+.
T Consensus       426 R~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~  504 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD  504 (550)
T ss_pred             cccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence            67889999999999998766 99999999999999999999999988777777777765432 22556789999999999


Q ss_pred             HHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          349 LCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       349 ~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      +||+.|+++|+++.|||+||||+.+..
T Consensus       505 ~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  505 RCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             HHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            999999999999999999999976544

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-50  Score=428.57  Aligned_cols=257  Identities=32%  Similarity=0.577  Sum_probs=234.0

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|.+.+.||+|+||+||+|+.+.|.+.||+|.+.+.  .+.....+.+.+|++|++.|+|||||.++++|++..++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~--gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS--GRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhc--CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            5799999999999999999999999999999998763  34455678899999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC-c
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP-L  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-~  271 (602)
                      .|||.| +|+.+|...+.++|+.++.++.|++.||.|||+++|+|||+||.|||++..|.+|+||||+|+.+..+... .
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            999976 99999999999999999999999999999999999999999999999999999999999999988765443 3


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      ...|||.|||||++.+.. |+..+|+||||||+|||++|++||...........|....  ...|...+..++.|++.+|
T Consensus       159 sikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~--v~~p~~~S~~f~nfl~gLL  235 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP--VKPPSTASSSFVNFLQGLL  235 (808)
T ss_pred             eccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC--CCCcccccHHHHHHHHHHh
Confidence            567999999999998665 9999999999999999999999998877777777776543  3556799999999999999


Q ss_pred             ccCCCCCCCHHHHhcCccccCCCc
Q 007478          352 QRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       352 ~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      .+||.+|.+-.+++.|||+++...
T Consensus       236 ~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  236 IKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             hcChhhcccHHHHhcChHHhhhhh
Confidence            999999999999999999997643

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-50  Score=391.06  Aligned_cols=258  Identities=31%  Similarity=0.543  Sum_probs=236.6

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceE
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  189 (602)
                      ...++|++++.||+|.||.||+|+.+.++-.||+|++.+.. .......+++.+|++|-..|+||||+++|++|.++.++
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-HHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            45789999999999999999999999999999999987643 33345567899999999999999999999999999999


Q ss_pred             EEEEeeecCCChhhhhh--ccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          190 YIYLEYVSGGSIYKLLQ--DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~--~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      ||++||...|+|+..|+  ..+++++..+..++.|++.||.|||.++||||||||+|+|++.+|.+||+|||.+.+.. .
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-S  176 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-C
Confidence            99999999999999998  66789999999999999999999999999999999999999999999999999998866 6


Q ss_pred             CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                      ....+.|||..|.+||+..+.. ++..+|+|++|++.||++.|.+||......+...+|.....  .+|..++.+++|||
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--~~p~~is~~a~dlI  253 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--KFPSTISGGAADLI  253 (281)
T ss_pred             CCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc--cCCcccChhHHHHH
Confidence            6678899999999999998766 99999999999999999999999998877777777765433  56789999999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccccC
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f~~  372 (602)
                      .+||.++|.+|.+..|+++|||+..
T Consensus       254 ~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHhccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999999865

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-51  Score=395.05  Aligned_cols=261  Identities=29%  Similarity=0.439  Sum_probs=231.9

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|++.+.||+|.|+.||++.++.||+.+|+|+|.......  ...+.+.+|+.|-+.|+|||||+|.+.+..+...|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence            4678999999999999999999999999999999987522222  24567889999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC---CceEEeccCccccccCC
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN---GRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~vKL~DFGla~~~~~~  267 (602)
                      ||+|+|.|++|..-|-.+-.++|..+-.+++||+.+|.|||.+||||||+||+|+|+...   .-+||+|||+|..+.+.
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            999999999998877666788999999999999999999999999999999999999543   46999999999999877


Q ss_pred             CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC--CCCCCCCCCCHHHHH
Q 007478          268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--ELPTIPDDLSDEGKD  345 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~s~~l~d  345 (602)
                      .....+.|||.|||||++...+ |+..+|||+.|||||.||.|.+||.+.+.......|+...  ..+..++.+++++++
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             cccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence            7777889999999999998776 9999999999999999999999999877666666665543  223467799999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ||++||..||.+|+|+.|+|+|||+.+..
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcchH
Confidence            99999999999999999999999998753

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-49  Score=406.71  Aligned_cols=262  Identities=32%  Similarity=0.608  Sum_probs=227.2

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|++.++||.|..++||+|+...+++.||||++.+.   +.....+.+.+|+..|+.++||||++++.+|..+..+|
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE---kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE---KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh---hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            467999999999999999999999999999999999863   33344788999999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          191 IYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      +||.||.+|++.++++..  ..+.|..|..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+-.+....
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999999874  358999999999999999999999999999999999999999999999999875543221


Q ss_pred             C----C-cccCCCCCCCCccc-ccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC-C---CCC--
Q 007478          269 C----P-LSFKGSPYWMAPEV-IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL-P---TIP--  336 (602)
Q Consensus       269 ~----~-~~~~GT~~Y~APEv-l~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~-~---~~p--  336 (602)
                      .    . .+++||++|||||+ +....+|+.|+||||||++..||++|..||..+.....+......... +   .++  
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d  260 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD  260 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence            1    1 56789999999999 666778999999999999999999999999998877665543332211 1   111  


Q ss_pred             --CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          337 --DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       337 --~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                        ..++..++++|..||++||.+|||++++|+|+||+....
T Consensus       261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence              246778999999999999999999999999999998754

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.4e-49  Score=412.80  Aligned_cols=259  Identities=30%  Similarity=0.532  Sum_probs=229.1

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|++.+.||+|+||+||+|+++.+++.||+|+++... .......+.+.+|+.+|++++||||+++++++.+++.+|
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE-ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence            4578999999999999999999999999999999987522 122234567889999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      +||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....  .
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999876443  2


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      ...+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+...  ...++..++.++++||++|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~  249 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDLVKGL  249 (329)
T ss_pred             ceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHHHHHH
Confidence            3567999999999997665 889999999999999999999999877666655555443  2356778999999999999


Q ss_pred             cccCCCCCCC-----HHHHhcCccccCCCc
Q 007478          351 LQRNPLNRPT-----AAELLDHPFVKGAAP  375 (602)
Q Consensus       351 L~~dP~~Rpt-----~~eiL~hp~f~~~~~  375 (602)
                      |+.||++|++     +++|+.||||++..+
T Consensus       250 L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~  279 (329)
T PTZ00263        250 LQTDHTKRLGTLKGGVADVKNHPYFHGANW  279 (329)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence            9999999996     799999999998655

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-50  Score=408.52  Aligned_cols=256  Identities=29%  Similarity=0.532  Sum_probs=237.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .-+|++.+.||+|.||+|.+|+....|+.||||.|++. ..++++..-.+.+||+||..|+||||+.+|++|+..+.+.|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKd-kIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKD-KIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhh-hcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            45799999999999999999999889999999999863 34556667789999999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      ||||..+|+|+||+.+++.+++.+++.|++||..|+.|||.++++|||||.+|||||.++++||+||||+..+.......
T Consensus       131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998888888


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      ++||++-|.+||++.+..+-+..+|-|||||+||.|+.|..||++.+.......|.++...   .+.-+.++.-||++||
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---EP~~PSdA~gLIRwmL  287 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---EPETPSDASGLIRWML  287 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc---CCCCCchHHHHHHHHH
Confidence            9999999999999999988889999999999999999999999998888777777665432   2356778899999999


Q ss_pred             ccCCCCCCCHHHHhcCcccc
Q 007478          352 QRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       352 ~~dP~~Rpt~~eiL~hp~f~  371 (602)
                      ..||++|.|+++|..|-|+.
T Consensus       288 mVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  288 MVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             hcCcccchhHHHHhhhheee
Confidence            99999999999999999976

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-49  Score=405.17  Aligned_cols=258  Identities=30%  Similarity=0.490  Sum_probs=227.0

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||+||+|.++.+|+.||+|++.... .......+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE-VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH-HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence            47899999999999999999999999999999987421 11223456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS  272 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  272 (602)
                      |||+.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~  157 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT  157 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence            999999999999998889999999999999999999999999999999999999999999999999999876433  235


Q ss_pred             cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcc
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ  352 (602)
Q Consensus       273 ~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  352 (602)
                      .+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+...  ...++..++.++++||++||+
T Consensus       158 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~  234 (291)
T cd05612         158 LCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIKKLLV  234 (291)
T ss_pred             ccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHHHHcC
Confidence            67999999999997655 889999999999999999999999887665555555443  235677889999999999999


Q ss_pred             cCCCCCCC-----HHHHhcCccccCCCcc
Q 007478          353 RNPLNRPT-----AAELLDHPFVKGAAPL  376 (602)
Q Consensus       353 ~dP~~Rpt-----~~eiL~hp~f~~~~~~  376 (602)
                      .||.+|++     ++++++|+||+...+.
T Consensus       235 ~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         235 VDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             CCHHHccCCccCCHHHHhcCccccCCCHH
Confidence            99999995     9999999999987663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.9e-50  Score=401.77  Aligned_cols=261  Identities=28%  Similarity=0.473  Sum_probs=224.0

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc--cce
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV--EDK  188 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~--~~~  188 (602)
                      ..++|+.++.|++|+||.||+|+++.|++.||+|+++....  .....-.-.+||.+|.+++|||||.+-++...  -+.
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            35789999999999999999999999999999999986331  11222235689999999999999999887543  457


Q ss_pred             EEEEEeeecCCChhhhhhccC-CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      +|||||||+ -+|..++...+ +|...+++.++.|++.||+|||.++|+|||||++|+|++..|.+||+|||||+.+...
T Consensus       152 iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  152 IYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            999999996 68998887754 8999999999999999999999999999999999999999999999999999998776


Q ss_pred             CC-CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCC------------
Q 007478          268 SC-PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT------------  334 (602)
Q Consensus       268 ~~-~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~------------  334 (602)
                      .. ....+-|+||+|||++.+...|+.++||||+|||+.||+++++.|.+....+++.+|......|.            
T Consensus       231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence            44 34466899999999999999999999999999999999999999998877777776654332221            


Q ss_pred             -----------------CCC-CCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          335 -----------------IPD-DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       335 -----------------~p~-~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                                       |+. .+++...+|++.+|.+||.+|.|++|.|+|.||.+..
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                             111 1568999999999999999999999999999999753

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8e-49  Score=411.70  Aligned_cols=253  Identities=30%  Similarity=0.477  Sum_probs=221.1

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecC
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSG  198 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~g  198 (602)
                      ++||+|+||.||+|.++.+|+.||||+++.... ........+.+|+.+|++++||||+++++++...+.+||||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            479999999999999999999999999875221 2233456678999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCCC
Q 007478          199 GSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGSP  277 (602)
Q Consensus       199 gsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT~  277 (602)
                      |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            99999998888999999999999999999999999999999999999999999999999999976432 22334567999


Q ss_pred             CCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCC
Q 007478          278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN  357 (602)
Q Consensus       278 ~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~  357 (602)
                      .|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+...  ...++..++.++.+||++||..||++
T Consensus       160 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~  236 (323)
T cd05571         160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQ  236 (323)
T ss_pred             cccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999997655 899999999999999999999999876655544444332  23567789999999999999999999


Q ss_pred             CC-----CHHHHhcCccccCCCc
Q 007478          358 RP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       358 Rp-----t~~eiL~hp~f~~~~~  375 (602)
                      ||     ++.+|++||||+...+
T Consensus       237 R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         237 RLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             cCCCCCCCHHHHHcCCCcCCCCH
Confidence            99     8999999999998766

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-48  Score=414.54  Aligned_cols=260  Identities=29%  Similarity=0.442  Sum_probs=222.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||+||+|.++.+++.||||++++.. .........+.+|+.++.+++|+||+++++.+.+.+.+|||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD-MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH-HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence            47999999999999999999999999999999987522 12234456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC----
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS----  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~----  268 (602)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....    
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999987543211    


Q ss_pred             --------------------------------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCC
Q 007478          269 --------------------------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQ  316 (602)
Q Consensus       269 --------------------------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~  316 (602)
                                                      .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            012457999999999997655 89999999999999999999999987


Q ss_pred             chhHHHHHHhhCCCCCCCCCC--CCCHHHHHHHHHHcccCCC---CCCCHHHHhcCccccCCCc
Q 007478          317 YEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLCLQRNPL---NRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       317 ~~~~~~~~~i~~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~---~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ........++........++.  .+++++++||.+|+. +++   .||+++||++||||++..+
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence            776666666655333333443  478999999999775 454   4589999999999999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-49  Score=411.62  Aligned_cols=264  Identities=28%  Similarity=0.451  Sum_probs=224.3

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhc----------HHHHHHHHHHHHHHHhcCCCcEEEE
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKS----------KESAKQLMQEIVLLSRLRHPNIVQY  179 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~----------~~~~~~l~~Ei~iL~~l~HpnIv~l  179 (602)
                      ...++|++++.||+|.||.|.+|++..+++.||||++.+......          ....+.+.+||.+|++|+|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            346899999999999999999999999999999999975221111          1123578999999999999999999


Q ss_pred             eccccc--cceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEec
Q 007478          180 YGSKTV--EDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLAD  257 (602)
Q Consensus       180 ~~~~~~--~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~D  257 (602)
                      +++..+  .+.+|||+|||..|.+...-.....+++.+++.|+++++.||+|||.+|||||||||+|+||+.+|.|||+|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence            999876  468999999999998876544443499999999999999999999999999999999999999999999999


Q ss_pred             cCccccccCC------CCCcccCCCCCCCCcccccc---cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhC
Q 007478          258 FGMAKHIAGQ------SCPLSFKGSPYWMAPEVIKN---SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN  328 (602)
Q Consensus       258 FGla~~~~~~------~~~~~~~GT~~Y~APEvl~~---~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~  328 (602)
                      ||.+......      .......|||.|+|||.+.+   ..+.+.+.||||+||+||.|+.|+.||.+....+...+|.+
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn  333 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN  333 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence            9998766222      11223679999999999977   33457799999999999999999999999999999999987


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          329 SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       329 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      .......-+.+.++++|||++||.+||++|.+..+|..|||+...
T Consensus       334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            544322223589999999999999999999999999999999764

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.3e-50  Score=392.76  Aligned_cols=263  Identities=28%  Similarity=0.448  Sum_probs=237.1

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccch----hcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccc
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA----KSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVED  187 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~----~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~  187 (602)
                      ..|.-.+.||+|..++|.++.++.+|+.+|+|++......    ...+..+...+|+.||+++ .||+|+++.++++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4677788999999999999999999999999999763322    2344556777899999998 7999999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      .+++|+|+|+.|.|+|+|...-.+++.+.++|++||+.|++|||.++||||||||+|||++++.++||+|||+|+++...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G  176 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG  176 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999999988


Q ss_pred             CCCcccCCCCCCCCccccc-----ccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC--CCCCCCCC
Q 007478          268 SCPLSFKGSPYWMAPEVIK-----NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--PTIPDDLS  340 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APEvl~-----~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~s  340 (602)
                      ......||||.|+|||.+.     +.++|+..+|+|++|||||.||.|.+||........+..|+.++..  ..-+.+++
T Consensus       177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis  256 (411)
T KOG0599|consen  177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADIS  256 (411)
T ss_pred             hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhcc
Confidence            8888899999999999874     5567999999999999999999999999988888777777766543  23456899


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       341 ~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      .+.+|||.+||+.||.+|.|++|+|+||||.....
T Consensus       257 ~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  257 ATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             ccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            99999999999999999999999999999976543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-48  Score=413.19  Aligned_cols=252  Identities=33%  Similarity=0.518  Sum_probs=223.8

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcE-EEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc-e
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED-K  188 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~-vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~-~  188 (602)
                      ...+..+.+.||+|+||+||+|.++  |.. ||||++......  ....+.|.+|+.+|.+++|||||+|+|++.... .
T Consensus        39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~--~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFD--DESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            3455667777999999999999987  445 999998753222  222788999999999999999999999999877 7


Q ss_pred             EEEEEeeecCCChhhhhhc--cCCCChHHHHHHHHHHHHHHhhhccCC-ceecCCCCCcEEEccCC-ceEEeccCccccc
Q 007478          189 LYIYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHSKH-TVHRDIKGANILVDPNG-RVKLADFGMAKHI  264 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~--~~~ls~~~i~~i~~qIl~aL~yLH~~g-IvHrDLKp~NILl~~~g-~vKL~DFGla~~~  264 (602)
                      ++|||||+++|+|.+++.+  .+.++...+..|+.||+.||+|||+++ |||||||++||||+.++ ++||+|||+++..
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            9999999999999999987  578999999999999999999999999 99999999999999998 9999999999887


Q ss_pred             cCC-CCCcccCCCCCCCCcccccc-cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHH
Q 007478          265 AGQ-SCPLSFKGSPYWMAPEVIKN-SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       265 ~~~-~~~~~~~GT~~Y~APEvl~~-~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                      ... .......||+.|||||++.+ ...|+.|+||||||++||||+||+.||.+.........+......+.++..+++.
T Consensus       195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~  274 (362)
T KOG0192|consen  195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPH  274 (362)
T ss_pred             ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            654 33334679999999999985 2449999999999999999999999999988878888887788888999999999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhc
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      +.+||++||..||++||++.+|+.
T Consensus       275 l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  275 LSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999999985

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-49  Score=398.36  Aligned_cols=291  Identities=29%  Similarity=0.437  Sum_probs=249.6

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|..+++||+|.||+|.+++.+.+|+.||||++++.- ...++.......|-++|+..+||++..|...|+..+++|
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev-iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV-IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh-eeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            5688999999999999999999999999999999998632 334555667778999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc-cCCCC
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSC  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~  269 (602)
                      +||||+.||.|+-+|.+.+.|++..++.+...|+.||.|||+++||+||||.+|+|+|.+|++||+||||++.- .....
T Consensus       245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999853 34555


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  349 (602)
                      ..++||||.|+|||++.... |+.++|||.+||+||||+||+.||...+.......|...  .-.+|..++++++.|+..
T Consensus       325 ~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--d~kFPr~ls~eAktLLsG  401 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--DLKFPRTLSPEAKTLLSG  401 (516)
T ss_pred             eccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--hccCCccCCHHHHHHHHH
Confidence            67899999999999997654 999999999999999999999999887665555444332  236788999999999999


Q ss_pred             HcccCCCCCC-----CHHHHhcCccccCCCcccccccCCCCCCCCCCCcchhhhccCCccCCCCCCchhhh
Q 007478          350 CLQRNPLNRP-----TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERL  415 (602)
Q Consensus       350 ~L~~dP~~Rp-----t~~eiL~hp~f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~s~~d~~~~  415 (602)
                      +|.+||.+|.     .+.||++|+||..+.| +.........++.|.+.         ..-+.+.||.++.
T Consensus       402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W-~~~~~Kki~PPfKPqVt---------SetDTryFD~EFT  462 (516)
T KOG0690|consen  402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDW-EATYRKKIEPPFKPQVT---------SETDTRYFDEEFT  462 (516)
T ss_pred             HhhcChHhhcCCCchhHHHHHhhhhhccCCH-HHHHHhccCCCCCCCcc---------cccchhhhhhhhh
Confidence            9999999996     4899999999999998 44444555555565543         2234456666654

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.8e-48  Score=397.38  Aligned_cols=259  Identities=25%  Similarity=0.422  Sum_probs=220.3

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      .|+..+.||+|+||+||+|.+..+|+.||+|++..... ........+.+|+.+++.++|+||+.+++++.+++.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh-hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence            37889999999999999999999999999999864221 12223446778999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          194 EYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       194 E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      ||+.+|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence            999999999887543  368999999999999999999999999999999999999999999999999998765444444


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH---HHHHHhhCCCCCCCCCCCCCHHHHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV---AAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~s~~l~dLI~  348 (602)
                      ...||..|+|||++.+.. ++.++|||||||++|||++|+.||......   ..+.... ......++..++.++.+||+
T Consensus       160 ~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         160 GRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-KEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             CCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-hcccccCCccCCHHHHHHHH
Confidence            567999999999998765 899999999999999999999999764332   1222211 12233566789999999999


Q ss_pred             HHcccCCCCCCC-----HHHHhcCccccCCCc
Q 007478          349 LCLQRNPLNRPT-----AAELLDHPFVKGAAP  375 (602)
Q Consensus       349 ~~L~~dP~~Rpt-----~~eiL~hp~f~~~~~  375 (602)
                      +||+.||++|++     ++++++||||++..+
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence            999999999997     899999999999866

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-48  Score=412.68  Aligned_cols=260  Identities=33%  Similarity=0.509  Sum_probs=224.1

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.... ........+.+|+.+|+.++|+||+++++++.+.+.+|||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence            479999999999999999999999999999999975221 2234456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC----
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS----  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~----  268 (602)
                      ||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....    
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987543211    


Q ss_pred             -----------------------------------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCC
Q 007478          269 -----------------------------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP  313 (602)
Q Consensus       269 -----------------------------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~P  313 (602)
                                                         ...+.+||+.|+|||++.+.. ++.++|||||||++|||++|..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCCC
Confidence                                               112356999999999997654 89999999999999999999999


Q ss_pred             CCCchhHHHHHHhhCCCCCCCCCC--CCCHHHHHHHHHHcccCCCCCCC---HHHHhcCccccCCCc
Q 007478          314 WSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLCLQRNPLNRPT---AAELLDHPFVKGAAP  375 (602)
Q Consensus       314 f~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~Rpt---~~eiL~hp~f~~~~~  375 (602)
                      |...........+........++.  .+++++++||++||. +|.+|++   ++++++||||++..+
T Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            988776666665554333333333  578999999999996 9999997   999999999998765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=412.49  Aligned_cols=259  Identities=41%  Similarity=0.732  Sum_probs=233.5

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ....|...++||+|+||.||+|++..+++.||+|++.+.   ..+.....+.+|+.+|.+++++||.++|+.+..+..++
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le---~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw   87 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE---EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW   87 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechh---hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence            345688889999999999999999999999999999863   34455778899999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  269 (602)
                      ++||||.||++.++++....+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||++.++..... 
T Consensus        88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999999999999999887789999999999999999999999999999999999999999999999999988765443 


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  349 (602)
                      ..+++||+.|||||++. ..+|+.++||||||++.|||++|.+||.+......++.|.+ ...|.+...+++.+++||..
T Consensus       168 r~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-~~PP~L~~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-SAPPRLDGDFSPPFKEFVEA  245 (467)
T ss_pred             cccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-CCCCccccccCHHHHHHHHH
Confidence            37899999999999998 45699999999999999999999999998777555555543 45567777899999999999


Q ss_pred             HcccCCCCCCCHHHHhcCccccCCC
Q 007478          350 CLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ||.+||+.||+|.++|+|.|++...
T Consensus       246 CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  246 CLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HhhcCcccCcCHHHHhhhHHHHhcC
Confidence            9999999999999999999998753

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.1e-48  Score=413.47  Aligned_cols=261  Identities=30%  Similarity=0.457  Sum_probs=220.8

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +.|++++.||+|+||+||+|+++.+++.||||++.... .........+.+|+.+|+.++|+||+++++++.+.+.+|+|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD-VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            36899999999999999999999999999999987522 12334456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-----
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-----  267 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-----  267 (602)
                      |||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...     
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            999999999999988888999999999999999999999999999999999999999999999999997543100     


Q ss_pred             -------------------------------------------CCCcccCCCCCCCCcccccccCCCCccccchhhhhHH
Q 007478          268 -------------------------------------------SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTV  304 (602)
Q Consensus       268 -------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviL  304 (602)
                                                                 ....+.+||+.|+|||++.+.. ++.++||||||||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il  238 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVIL  238 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHH
Confidence                                                       0112457999999999997655 89999999999999


Q ss_pred             HHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC--CCCCHHHHHHHHHHcc--cCCCCCCCHHHHhcCccccCCCc
Q 007478          305 LEMATTKPPWSQYEGVAAMFKIGNSKELPTIP--DDLSDEGKDFIRLCLQ--RNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       305 yELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~dLI~~~L~--~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      |||++|+.||...+......++........++  ..+++++++||.+||.  .++..|+++++|+.||||+...+
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            99999999998766655555554333222333  3589999999999654  45556999999999999998766

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.7e-47  Score=403.14  Aligned_cols=257  Identities=32%  Similarity=0.494  Sum_probs=214.1

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|+.+++||+|+||+||+|++..+++.||||++...   ........+.+|+.+|+.++|+||+++++++..++.+|
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN---HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC---CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            356789999999999999999999999999999998642   22344567889999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      +||||+++++|.+.    ....+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.... .
T Consensus       149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            99999999998754    345678889999999999999999999999999999999999999999999998765332 2


Q ss_pred             CcccCCCCCCCCcccccc----cCCCCccccchhhhhHHHHHhhCCCCCCCch--hHHHHHHhhCCCCCCCCCCCCCHHH
Q 007478          270 PLSFKGSPYWMAPEVIKN----SSGCNLAVDIWSLGCTVLEMATTKPPWSQYE--GVAAMFKIGNSKELPTIPDDLSDEG  343 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~----~~~~s~~sDVWSLGviLyELltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~s~~l  343 (602)
                      .....||..|+|||++..    ..+.+.++|||||||++|||++|+.||....  ..............+..+..++.++
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            234579999999999743    2334568999999999999999999996322  1122221112223445667899999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          344 KDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       344 ~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ++||++||..||++||++.||++||||....
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            9999999999999999999999999998764

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-48  Score=412.73  Aligned_cols=261  Identities=32%  Similarity=0.539  Sum_probs=233.5

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccce
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDK  188 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~~  188 (602)
                      .....|++++.||+|.||.||+|+++.||+.+|+|++.+.... .......+.+|+.+|+++. |||||.++++|++.+.
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~-~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR-GKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc-ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            3467899999999999999999999999999999999763332 2224567889999999998 9999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC----CceEEeccCccccc
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN----GRVKLADFGMAKHI  264 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----g~vKL~DFGla~~~  264 (602)
                      +++|||+|.||+|++.|.+. .+++..+..++.||+.+++|||+.||+||||||||+|+...    +.+|++|||++...
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            99999999999999999876 49999999999999999999999999999999999999543    47999999999998


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC--CCCCCCCCCHH
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE--LPTIPDDLSDE  342 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~s~~  342 (602)
                      .........+||+.|+|||++.... |+..+||||+||++|.|++|.+||.+........++.....  ....++.++..
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES  268 (382)
T ss_pred             cCCceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence            8866777899999999999997655 99999999999999999999999998877666666665543  34566789999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      +++||+.||..||.+|+|+.++|+|||++..
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999999999875

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-47  Score=403.09  Aligned_cols=259  Identities=29%  Similarity=0.490  Sum_probs=223.9

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      .+|++.+.||+|+||.||+|++..+++.||||+++... .........+.+|+.++..++||||+++++++...+.+|||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL-LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence            36999999999999999999999999999999987522 12223456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS  272 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  272 (602)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ....
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~  157 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS  157 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence            99999999999998888899999999999999999999999999999999999999999999999999987644  2345


Q ss_pred             cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC---CCCCC---CCCCHHHHHH
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE---LPTIP---DDLSDEGKDF  346 (602)
Q Consensus       273 ~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~---~~~~p---~~~s~~l~dL  346 (602)
                      .+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.....   .+...   ..++.++.+|
T Consensus       158 ~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l  236 (333)
T cd05600         158 VVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL  236 (333)
T ss_pred             cccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence            67999999999998764 89999999999999999999999987655444444332221   12111   2568999999


Q ss_pred             HHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          347 IRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      |.+||..+|++|++++++++||||+...+
T Consensus       237 i~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         237 ITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             HHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            99999999999999999999999998765

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2e-47  Score=401.28  Aligned_cols=254  Identities=30%  Similarity=0.475  Sum_probs=220.6

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecC
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSG  198 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~g  198 (602)
                      ++||+|+||.||++.++.+|+.||+|+++... .........+.+|+.+++.++||||+++++++...+.+||||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV-IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            47999999999999999999999999987521 12233456778899999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCCC
Q 007478          199 GSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGSP  277 (602)
Q Consensus       199 gsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT~  277 (602)
                      |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999876432 22233567999


Q ss_pred             CCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCC
Q 007478          278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN  357 (602)
Q Consensus       278 ~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~  357 (602)
                      .|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+...  ...++..+++++++||++||..||++
T Consensus       160 ~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~  236 (323)
T cd05595         160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQ  236 (323)
T ss_pred             CcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999997665 899999999999999999999999876655544444332  23567789999999999999999999


Q ss_pred             CC-----CHHHHhcCccccCCCcc
Q 007478          358 RP-----TAAELLDHPFVKGAAPL  376 (602)
Q Consensus       358 Rp-----t~~eiL~hp~f~~~~~~  376 (602)
                      |+     ++.++++|+||....+.
T Consensus       237 R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         237 RLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             hCCCCCCCHHHHHcCCCcCCCCHH
Confidence            98     89999999999987763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-47  Score=399.10  Aligned_cols=251  Identities=31%  Similarity=0.494  Sum_probs=219.3

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCC
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGS  200 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggs  200 (602)
                      ||+|+||+||+|.+..+++.||+|+++... .........+.+|+.+|++++||||+++++++...+.+|+||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH-IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            799999999999999999999999987421 1223345677899999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCCCCC
Q 007478          201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGSPYW  279 (602)
Q Consensus       201 L~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y  279 (602)
                      |.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            999998888899999999999999999999999999999999999999999999999999986432 2233456799999


Q ss_pred             CCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCC
Q 007478          280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP  359 (602)
Q Consensus       280 ~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rp  359 (602)
                      +|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+...  ...++..+++++++||.+||..||++|+
T Consensus       160 ~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~  236 (312)
T cd05585         160 LAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRL  236 (312)
T ss_pred             CCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence            9999997655 899999999999999999999999876665555555432  3456778999999999999999999997


Q ss_pred             ---CHHHHhcCccccCCCc
Q 007478          360 ---TAAELLDHPFVKGAAP  375 (602)
Q Consensus       360 ---t~~eiL~hp~f~~~~~  375 (602)
                         ++.+++.||||+...+
T Consensus       237 ~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         237 GYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             CCCCHHHHHcCCCcCCCCH
Confidence               5899999999998754

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-48  Score=412.02  Aligned_cols=260  Identities=31%  Similarity=0.506  Sum_probs=220.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++++.||+|+||+||+|.++.+++.||||++.+.. .......+.+.+|+.+++.++||||+++++++.+.+.+|||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE-MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence            47999999999999999999999999999999986422 12234456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC----
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS----  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~----  268 (602)
                      |||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....    
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999996432100    


Q ss_pred             --------------------------------------------CCcccCCCCCCCCcccccccCCCCccccchhhhhHH
Q 007478          269 --------------------------------------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTV  304 (602)
Q Consensus       269 --------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviL  304 (602)
                                                                  .....+||+.|+|||++.+.. ++.++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil  238 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIM  238 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchhh
Confidence                                                        001256999999999997655 89999999999999


Q ss_pred             HHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCC--CCCHHHHHHHHHHcccCCCCC---CCHHHHhcCccccCCCc
Q 007478          305 LEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLCLQRNPLNR---PTAAELLDHPFVKGAAP  375 (602)
Q Consensus       305 yELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~R---pt~~eiL~hp~f~~~~~  375 (602)
                      |||++|++||...........+........++.  .++.++++||.+||. +|.+|   +++.+++.||||++..+
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            999999999987666555555544332233343  578999999999997 77765   59999999999998755

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-47  Score=406.35  Aligned_cols=260  Identities=27%  Similarity=0.436  Sum_probs=227.7

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCC-cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSG-EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  189 (602)
                      ..++|++.+.||+|+||.||+|.++.++ ..||+|++..... ......+.+.+|+.+++.++||||+++++++.+++.+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~  106 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL  106 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence            4578999999999999999999876654 6899999864221 2233456788999999999999999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      |+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...  
T Consensus       107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999876432  


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  349 (602)
                      ..+.+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+......++....  ..++..++.++++||++
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~  261 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYFPKFLDNNCKHLMKK  261 (340)
T ss_pred             cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHH
Confidence            34567999999999997654 8899999999999999999999998877666666655432  35677899999999999


Q ss_pred             HcccCCCCCC-----CHHHHhcCccccCCCcc
Q 007478          350 CLQRNPLNRP-----TAAELLDHPFVKGAAPL  376 (602)
Q Consensus       350 ~L~~dP~~Rp-----t~~eiL~hp~f~~~~~~  376 (602)
                      ||+.||++|+     +++++++||||++..+.
T Consensus       262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             HcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999995     89999999999987763

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-47  Score=411.94  Aligned_cols=260  Identities=31%  Similarity=0.484  Sum_probs=222.1

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +.|+++++||+|+||+||+|+++.+++.||+|++.... .........+.+|+.++++++|+|||++++++.+++.+|+|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            36899999999999999999999999999999987522 22234466788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-----
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-----  267 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-----  267 (602)
                      ||||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+...     
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            999999999999988888999999999999999999999999999999999999999999999999997532100     


Q ss_pred             -------------------------------------------CCCcccCCCCCCCCcccccccCCCCccccchhhhhHH
Q 007478          268 -------------------------------------------SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTV  304 (602)
Q Consensus       268 -------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviL  304 (602)
                                                                 ....+.+||+.|+|||++.+.. ++.++|||||||+|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil  238 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL  238 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHH
Confidence                                                       0012357999999999997655 89999999999999


Q ss_pred             HHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC--CCCCHHHHHHHHHHcccCCCCCCC---HHHHhcCccccCCCc
Q 007478          305 LEMATTKPPWSQYEGVAAMFKIGNSKELPTIP--DDLSDEGKDFIRLCLQRNPLNRPT---AAELLDHPFVKGAAP  375 (602)
Q Consensus       305 yELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~dLI~~~L~~dP~~Rpt---~~eiL~hp~f~~~~~  375 (602)
                      |||++|++||...+......++........++  ..+++++.+||.+|+ .+|++|++   ++++++||||+...+
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            99999999998776666555555433322333  468999999999987 59999987   999999999998765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-47  Score=405.99  Aligned_cols=260  Identities=34%  Similarity=0.512  Sum_probs=226.0

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.... ........+.+|+.++..++|+||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM-IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence            479999999999999999999999999999999875221 1223456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC----
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS----  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~----  268 (602)
                      |||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....    
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999998765433    


Q ss_pred             --------------------------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHH
Q 007478          269 --------------------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA  322 (602)
Q Consensus       269 --------------------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~  322 (602)
                                                ......||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                      223456999999999998764 89999999999999999999999988776666


Q ss_pred             HHHhhCCCCCCCCCC--CCCHHHHHHHHHHcccCCCCCCC-HHHHhcCccccCCCc
Q 007478          323 MFKIGNSKELPTIPD--DLSDEGKDFIRLCLQRNPLNRPT-AAELLDHPFVKGAAP  375 (602)
Q Consensus       323 ~~~i~~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~Rpt-~~eiL~hp~f~~~~~  375 (602)
                      ..++........++.  .+++++.+||.+||. ||++|++ ++++++||||++..+
T Consensus       239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence            666555222223332  369999999999997 9999999 999999999998765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-47  Score=403.80  Aligned_cols=254  Identities=31%  Similarity=0.489  Sum_probs=220.6

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecC
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSG  198 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~g  198 (602)
                      +.||+|+||.||++.++.+|+.||+|++.... .........+.+|+.+|+.++||||+++++++..++.+||||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV-IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999987522 12234456788999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCCC
Q 007478          199 GSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGSP  277 (602)
Q Consensus       199 gsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT~  277 (602)
                      |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999876432 22234567999


Q ss_pred             CCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCC
Q 007478          278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN  357 (602)
Q Consensus       278 ~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~  357 (602)
                      .|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+..  ....++..++.++.+||++||.+||++
T Consensus       160 ~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~  236 (328)
T cd05593         160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EDIKFPRTLSADAKSLLSGLLIKDPNK  236 (328)
T ss_pred             CccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--CCccCCCCCCHHHHHHHHHHcCCCHHH
Confidence            999999997655 89999999999999999999999987655444444432  223567789999999999999999999


Q ss_pred             CC-----CHHHHhcCccccCCCcc
Q 007478          358 RP-----TAAELLDHPFVKGAAPL  376 (602)
Q Consensus       358 Rp-----t~~eiL~hp~f~~~~~~  376 (602)
                      |+     ++.+|++|+||.+..+.
T Consensus       237 R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         237 RLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             cCCCCCCCHHHHhcCCCcCCCCHH
Confidence            97     89999999999987663

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-47  Score=410.99  Aligned_cols=260  Identities=31%  Similarity=0.477  Sum_probs=220.9

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++++.||+|+||+||+|+++.+++.||||++.... .........+.+|+.+|++++|+||+++++.+.+++.+|||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD-VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH-HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence            47999999999999999999999999999999986422 12223456688999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-----
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-----  267 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-----  267 (602)
                      ||||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+...     
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999997532100     


Q ss_pred             ---------------------------------------CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHh
Q 007478          268 ---------------------------------------SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMA  308 (602)
Q Consensus       268 ---------------------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELl  308 (602)
                                                             ......+||+.|||||++.+.. ++.++|||||||++|||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell  238 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEML  238 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeehh
Confidence                                                   0012357999999999997655 899999999999999999


Q ss_pred             hCCCCCCCchhHHHHHHhhCCCCCCCCC--CCCCHHHHHHHHHHcccCCCCCC---CHHHHhcCccccCCCc
Q 007478          309 TTKPPWSQYEGVAAMFKIGNSKELPTIP--DDLSDEGKDFIRLCLQRNPLNRP---TAAELLDHPFVKGAAP  375 (602)
Q Consensus       309 tG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~dLI~~~L~~dP~~Rp---t~~eiL~hp~f~~~~~  375 (602)
                      +|+.||...+.......+........++  ..++.++.+||.+|+ .+|++|+   ++.++++||||+...+
T Consensus       239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            9999998776655555554332222222  368999999999987 5999999   9999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.8e-47  Score=400.73  Aligned_cols=260  Identities=32%  Similarity=0.519  Sum_probs=220.7

Q ss_pred             CceEeeeEeecCCeEEEEEEEC---CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNS---DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~  189 (602)
                      +|++++.||+|+||+||++++.   .+++.||+|+++...........+.+.+|+.+++.+ +|+||+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999998764   478999999987532223334456788999999999 599999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-  268 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  268 (602)
                      |+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999998654322 


Q ss_pred             -CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCch---hHHHH-HHhhCCCCCCCCCCCCCHHH
Q 007478          269 -CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE---GVAAM-FKIGNSKELPTIPDDLSDEG  343 (602)
Q Consensus       269 -~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~---~~~~~-~~i~~~~~~~~~p~~~s~~l  343 (602)
                       .....+||+.|+|||++.+...++.++|||||||++|||++|+.||....   ....+ ..+..  ..+.++..++.++
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  238 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPFPSFIGPEA  238 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHH
Confidence             23356799999999999876568889999999999999999999996422   12222 22222  2345677899999


Q ss_pred             HHHHHHHcccCCCCCC-----CHHHHhcCccccCCCc
Q 007478          344 KDFIRLCLQRNPLNRP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       344 ~dLI~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~~  375 (602)
                      ++||.+||..||++||     +++++++||||++..+
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            9999999999999999     8999999999998755

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.5e-47  Score=406.33  Aligned_cols=261  Identities=30%  Similarity=0.464  Sum_probs=224.1

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||+||+|.++.+++.||||+++... ....+....+.+|+.++..++|+||+++++.+.+++.+|||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD-MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            46999999999999999999999999999999987422 22334466788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC----
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS----  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~----  268 (602)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....    
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987543210    


Q ss_pred             --------------------------------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCC
Q 007478          269 --------------------------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQ  316 (602)
Q Consensus       269 --------------------------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~  316 (602)
                                                      ...+.+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCCC
Confidence                                            112457999999999997655 89999999999999999999999987


Q ss_pred             chhHHHHHHhhCCCCCCCCCC--CCCHHHHHHHHHHcccCCCCCC---CHHHHhcCccccCCCcc
Q 007478          317 YEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLCLQRNPLNRP---TAAELLDHPFVKGAAPL  376 (602)
Q Consensus       317 ~~~~~~~~~i~~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~Rp---t~~eiL~hp~f~~~~~~  376 (602)
                      ........++........++.  .++.++++||.+|+. ||++|+   +++++++||||++..|.
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence            776666666654333233333  478999999999874 999998   58999999999998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.5e-47  Score=395.97  Aligned_cols=255  Identities=33%  Similarity=0.525  Sum_probs=220.9

Q ss_pred             eeeEeecCCeEEEEEEEC---CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEe
Q 007478          118 GKMLGRGTFGHVYVGFNS---DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE  194 (602)
                      ++.||+|+||.||++.+.   .+++.||+|+++.............+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            367999999999999864   47899999998753222233344567899999999999999999999999999999999


Q ss_pred             eecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCccc
Q 007478          195 YVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSF  273 (602)
Q Consensus       195 ~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~  273 (602)
                      |+.+++|.+++...+.+.+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            999999999998888899999999999999999999999999999999999999999999999999875432 2223456


Q ss_pred             CCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHccc
Q 007478          274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR  353 (602)
Q Consensus       274 ~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~  353 (602)
                      +||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+.++...  ...++..+++++.+||++||++
T Consensus       161 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         161 CGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             CCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccc
Confidence            7999999999997655 889999999999999999999999887766666665543  2356778999999999999999


Q ss_pred             CCCCCC-----CHHHHhcCccccCCCc
Q 007478          354 NPLNRP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       354 dP~~Rp-----t~~eiL~hp~f~~~~~  375 (602)
                      ||++|+     +++++++||||+...+
T Consensus       238 ~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         238 NPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             CHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999     8999999999988655

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.2e-47  Score=397.09  Aligned_cols=253  Identities=31%  Similarity=0.486  Sum_probs=219.3

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++||+|+||+||+|.++.+++.||||+++.... ......+.+..|+.++..+ +||||+++++++...+.+|+||||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence            469999999999999999999999999874211 1223345677888888876 79999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      +|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            999999998888999999999999999999999999999999999999999999999999999876432 2233456799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+...  ...++..++.++.+||++||++||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~  236 (320)
T cd05590         160 PDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLSQDAVDILKAFMTKNPT  236 (320)
T ss_pred             ccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHcccCHH
Confidence            9999999997655 889999999999999999999999887766666655443  2346678999999999999999999


Q ss_pred             CCCCH------HHHhcCccccCCCc
Q 007478          357 NRPTA------AELLDHPFVKGAAP  375 (602)
Q Consensus       357 ~Rpt~------~eiL~hp~f~~~~~  375 (602)
                      +|+++      ++++.||||+...+
T Consensus       237 ~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         237 MRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             HCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            99998      99999999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.2e-47  Score=390.66  Aligned_cols=255  Identities=25%  Similarity=0.450  Sum_probs=213.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||+||+|+++.+++.||+|+++...  ......+.+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE--ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            36999999999999999999999999999999987532  1223456678899999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC--CC
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--CP  270 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~~  270 (602)
                      |||++++.|..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....  ..
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            9999988777666556679999999999999999999999999999999999999999999999999998764322  22


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC--------------------
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--------------------  330 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~--------------------  330 (602)
                      ....||+.|+|||++.+.. ++.++|||||||++|||++|++||...........+....                    
T Consensus       159 ~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            3456999999999997765 8999999999999999999999998654433322221100                    


Q ss_pred             CCC----------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          331 ELP----------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       331 ~~~----------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ..+          .....++.++.+||++||++||++|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000          0112378899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-48  Score=403.73  Aligned_cols=259  Identities=29%  Similarity=0.485  Sum_probs=237.5

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      .-|.+.+.||+|.|++|.+|++.-||..||||+|.+.+  .+.....++++|+..|+.++|||||+||++..+...+|||
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK--lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK--LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccc--cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            45888999999999999999999999999999998632  2334456899999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEE-ccCCceEEeccCccccccCCCCC
Q 007478          193 LEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV-DPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl-~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      +|+=.+|+|+|||.++ ..+.|..++.||.||+.||.|||+..+||||||||||.+ ..-|-|||+|||++..+......
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL  175 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL  175 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence            9999999999999764 579999999999999999999999999999999999887 55689999999999998888888


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      .+.||.+.|-|||++.+..+..+++||||||||||.|+||++||...++.+.+-.|+.-+.  .+|..++.++++||..|
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~eCrdLI~sM  253 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSKECRDLIQSM  253 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhHHHHHHHHHH
Confidence            8999999999999999998777899999999999999999999999999888888877554  67889999999999999


Q ss_pred             cccCCCCCCCHHHHhcCccccCCCc
Q 007478          351 LQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      |..||.+|.+.++|..|+|+++...
T Consensus       254 LvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  254 LVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HhcCchhhccHHHHhccccccCCCC
Confidence            9999999999999999999998754

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.4e-48  Score=392.37  Aligned_cols=261  Identities=31%  Similarity=0.539  Sum_probs=224.6

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCc-EEEEeccccccc---
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN-IVQYYGSKTVED---  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~---  187 (602)
                      ...|..+++||+|+||+||+|+.+.+|+.||+|++......  +.......+|+.+|+.|+|+| ||.+++++.+++   
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence            45688889999999999999999999999999999863321  223345679999999999999 999999998877   


Q ss_pred             ---eEEEEEeeecCCChhhhhhccC----CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCc
Q 007478          188 ---KLYIYLEYVSGGSIYKLLQDYG----QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       188 ---~~~lVmE~~~ggsL~~~l~~~~----~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGl  260 (602)
                         .+++|+||+ .-+|.+++....    .++...++.+++||+.||+|||+++|+||||||.||||+.+|.+||+|||+
T Consensus        88 ~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   88 GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccch
Confidence               899999999 589999998754    477788999999999999999999999999999999999999999999999


Q ss_pred             ccccc-CCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCC-----
Q 007478          261 AKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT-----  334 (602)
Q Consensus       261 a~~~~-~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~-----  334 (602)
                      |+... ........++|.||+|||++.+...|+..+||||+|||++||+++++.|.+....+++.+|......|.     
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            99776 333355677999999999999998899999999999999999999999999888888777654333221     


Q ss_pred             -----------CC------------CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          335 -----------IP------------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       335 -----------~p------------~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                 ++            +...+++.+|+.+||+++|.+|.|++.+|.||||.....
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence                       00            123458999999999999999999999999999998643

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.7e-47  Score=400.27  Aligned_cols=254  Identities=31%  Similarity=0.487  Sum_probs=219.7

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecC
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSG  198 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~g  198 (602)
                      +.||+|+||+||++.++.+|+.||+|+++... .........+.+|+++++.++||||+++++++...+.+||||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV-IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999999999999999987522 12233456677899999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          199 GSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       199 gsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      |+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            9999999888889999999999999999999997 8999999999999999999999999999876432 2223356799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+...  ...++..+++++.+||++||++||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~  236 (325)
T cd05594         160 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKKDPK  236 (325)
T ss_pred             cccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhcCHH
Confidence            9999999997655 899999999999999999999999876655444444332  2356778999999999999999999


Q ss_pred             CCC-----CHHHHhcCccccCCCcc
Q 007478          357 NRP-----TAAELLDHPFVKGAAPL  376 (602)
Q Consensus       357 ~Rp-----t~~eiL~hp~f~~~~~~  376 (602)
                      +|+     ++.++++|+||++..+.
T Consensus       237 ~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         237 QRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             HhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            997     99999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1e-46  Score=395.60  Aligned_cols=253  Identities=32%  Similarity=0.513  Sum_probs=215.5

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHH-HHHhcCCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV-LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++||+|+||+||+|+++.+|+.||||++...... .......+.+|.. +++.++||||+++++++...+.+|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            4799999999999999999999999998752221 2222344555554 5688999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      +|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            999999998888899999999999999999999999999999999999999999999999999876432 2233456799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+...  ...++..++.++.+||++||+.||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~  236 (323)
T cd05575         160 PEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLEGLLQKDRT  236 (323)
T ss_pred             hhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHH
Confidence            9999999997655 899999999999999999999999876655555555433  2345667899999999999999999


Q ss_pred             CCCCH----HHHhcCccccCCCc
Q 007478          357 NRPTA----AELLDHPFVKGAAP  375 (602)
Q Consensus       357 ~Rpt~----~eiL~hp~f~~~~~  375 (602)
                      +||++    .++++||||....+
T Consensus       237 ~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         237 KRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             hCCCCCCCHHHHHcCCCcCCCCH
Confidence            99987    69999999998765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.8e-47  Score=395.83  Aligned_cols=258  Identities=29%  Similarity=0.477  Sum_probs=223.8

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCC-cEEEEeccccccceEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP-NIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~lV  192 (602)
                      +|++.+.||+|+||.||+|.++.+++.||||++..... ......+.+..|+.++..++|+ +|+.+++++...+.+|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            58899999999999999999999999999999875221 1233456678899999999765 588899999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc-CCCCCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~  271 (602)
                      |||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ......
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987532 222334


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      ..+||+.|+|||++.+.. ++.++|||||||++|||++|+.||........+..+...  ...++..++.++.+||++||
T Consensus       160 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l  236 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICKGLL  236 (324)
T ss_pred             eecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHh
Confidence            567999999999998765 889999999999999999999999877666666665543  34567789999999999999


Q ss_pred             ccCCCCCCCH-----HHHhcCccccCCCc
Q 007478          352 QRNPLNRPTA-----AELLDHPFVKGAAP  375 (602)
Q Consensus       352 ~~dP~~Rpt~-----~eiL~hp~f~~~~~  375 (602)
                      .+||++|++.     +++++||||+...+
T Consensus       237 ~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         237 TKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             hcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999976     89999999998765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6e-47  Score=390.44  Aligned_cols=255  Identities=26%  Similarity=0.451  Sum_probs=212.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||+|+++.+++.||+|+++.....   .....+.+|+.++++++||||+++++++.+++..|+
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC---CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            56799999999999999999999999999999998753221   123456789999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccC-CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          192 YLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      ||||+. ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          81 VFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             EEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            999997 58999887644 57899999999999999999999999999999999999999999999999997654322 2


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC-------------------
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-------------------  330 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~-------------------  330 (602)
                      .....||+.|+|||++.+...++.++|||||||++|||++|++||...+....+..+....                   
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            2345689999999998776668999999999999999999999997655433332221100                   


Q ss_pred             -CCC--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          331 -ELP--------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       331 -~~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                       ..+        .....++.++++||++||++||.+|+|++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence             000        0123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.9e-47  Score=398.58  Aligned_cols=261  Identities=29%  Similarity=0.431  Sum_probs=224.6

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||+||+|.++.+|+.||+|+++... ....+..+.+.+|+.+++.++|+||+++++++.+.+.+|||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV-LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            46999999999999999999999999999999987522 12234456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC-
Q 007478          193 LEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP-  270 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-  270 (602)
                      |||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999999999876 68999999999999999999999999999999999999999999999999999876543322 


Q ss_pred             -cccCCCCCCCCcccccc-----cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC--CCCCHH
Q 007478          271 -LSFKGSPYWMAPEVIKN-----SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP--DDLSDE  342 (602)
Q Consensus       271 -~~~~GT~~Y~APEvl~~-----~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~  342 (602)
                       ....||+.|+|||++..     ...++.++|||||||++|||++|+.||........+.++........++  ..++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD  239 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence             23469999999999863     3347889999999999999999999998776666666655443333333  357999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      +.+||++||. ||++|++++++++||||+...+
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence            9999999998 9999999999999999998765

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-46  Score=393.98  Aligned_cols=259  Identities=27%  Similarity=0.442  Sum_probs=224.0

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +|++.+.||+|+||+||+|+++.+++.||||++++... ......+.+..|..++..+ +|++|+.+++++.+.+.+|+|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            58899999999999999999999999999999875221 2223345567788888777 589999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~  271 (602)
                      |||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999976432 22334


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      ..+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||.+||
T Consensus       160 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~l  236 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAICKGLM  236 (323)
T ss_pred             cCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcCCHHHHHHHHHHc
Confidence            567999999999998665 8999999999999999999999998877666666655432  3567789999999999999


Q ss_pred             ccCCCCCCC-----HHHHhcCccccCCCcc
Q 007478          352 QRNPLNRPT-----AAELLDHPFVKGAAPL  376 (602)
Q Consensus       352 ~~dP~~Rpt-----~~eiL~hp~f~~~~~~  376 (602)
                      ++||++|++     ..++++|+||+...|.
T Consensus       237 ~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         237 TKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             ccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            999999997     4899999999987763

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.9e-47  Score=391.67  Aligned_cols=260  Identities=26%  Similarity=0.475  Sum_probs=212.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||+||+|.++.+++.||||+++....   ......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            4689999999999999999999999999999999875221   1123456789999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      ||||+. ++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            999995 677777755 4578999999999999999999999999999999999999999999999999997653322 2


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHH-HHHh---hCCCC---------CCC--
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA-MFKI---GNSKE---------LPT--  334 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~-~~~i---~~~~~---------~~~--  334 (602)
                      .....||+.|+|||++.+...++.++|||||||++|||++|+.||.+...... +..+   .....         .+.  
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            23456899999999987766688999999999999999999999976533221 1111   10000         000  


Q ss_pred             -------CC---------CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          335 -------IP---------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       335 -------~p---------~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                             .+         ..++.++++||.+||++||++|+|+.|+++||||+...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence                   00         124578999999999999999999999999999987643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-46  Score=402.77  Aligned_cols=263  Identities=29%  Similarity=0.440  Sum_probs=226.0

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|++.++||+|+||+||+|.++.+++.||+|++..... ........+.+|+.+++.++||||+++++++.+++.+|
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            35789999999999999999999999999999999874221 12233455778999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC--
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--  268 (602)
                      +||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            99999999999999876 468999999999999999999999999999999999999999999999999998764332  


Q ss_pred             CCcccCCCCCCCCcccccccC---CCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCC--CCCHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSS---GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEG  343 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~---~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l  343 (602)
                      .....+||+.|+|||++.+..   .++.++|||||||++|||++|+.||........+.++........++.  .++.++
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA  278 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence            223567999999999986532   378899999999999999999999988776666666665443334444  579999


Q ss_pred             HHHHHHHcccCCCC--CCCHHHHhcCccccCCCc
Q 007478          344 KDFIRLCLQRNPLN--RPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       344 ~dLI~~~L~~dP~~--Rpt~~eiL~hp~f~~~~~  375 (602)
                      ++||++||+.+|++  |++++++++||||+...+
T Consensus       279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             HHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            99999999999987  999999999999998655

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.6e-47  Score=397.14  Aligned_cols=254  Identities=26%  Similarity=0.468  Sum_probs=215.8

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++||+|+||.||+|.++.+++.||+|+++... ....+..+.+.+|+.+++.+ +||||+++++++.+.+.+||||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL-VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            47999999999999999999999999997522 22234456788999999988 79999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc-cCCCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~GT  276 (602)
                      ||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. .........+||
T Consensus        80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            9999999988889999999999999999999999999999999999999999999999999998753 223334457899


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCc--------hhHHHHHHhhCCCCCCCCCCCCCHHHHHHHH
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY--------EGVAAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~--------~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  348 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...        .....+.+.... ....+|..++.++.+||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~  237 (329)
T cd05588         160 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKASSVLK  237 (329)
T ss_pred             ccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCCCCCCCCHHHHHHHH
Confidence            9999999997655 889999999999999999999999521        111222222222 233567789999999999


Q ss_pred             HHcccCCCCCCC------HHHHhcCccccCCCc
Q 007478          349 LCLQRNPLNRPT------AAELLDHPFVKGAAP  375 (602)
Q Consensus       349 ~~L~~dP~~Rpt------~~eiL~hp~f~~~~~  375 (602)
                      +||++||++|++      ++++++||||....+
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            999999999987      799999999988765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.5e-46  Score=391.79  Aligned_cols=253  Identities=31%  Similarity=0.547  Sum_probs=216.5

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHh-cCCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR-LRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++||+|+||+||+|.+..+++.||||+++.... ......+.+..|..++.. ++||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV-LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            479999999999999999999999999875221 122234455567777765 489999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      ||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            999999998888999999999999999999999999999999999999999999999999999986532 2333456799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+..  ..+.++..++.++.+||++||+.||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~  236 (316)
T cd05592         160 PDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFERDPT  236 (316)
T ss_pred             ccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHH
Confidence            9999999997665 89999999999999999999999987766555555543  34566778999999999999999999


Q ss_pred             CCCCH-HHHhcCccccCCCc
Q 007478          357 NRPTA-AELLDHPFVKGAAP  375 (602)
Q Consensus       357 ~Rpt~-~eiL~hp~f~~~~~  375 (602)
                      +|+++ .++++|+||+...+
T Consensus       237 ~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         237 KRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             HcCCChHHHHcCcccCCCCH
Confidence            99986 58999999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-46  Score=394.81  Aligned_cols=253  Identities=30%  Similarity=0.473  Sum_probs=219.8

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++||+|+||.||+|+++.+++.||||+++... .........+..|+.++..+ +||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDV-ILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHH-hhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence            46999999999999999999999999987521 12233445677888888866 89999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      +|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            999999998888899999999999999999999999999999999999999999999999999876432 2223456799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++.+||++||++||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~~dp~  236 (321)
T cd05591         160 PDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVSILKAFMTKNPN  236 (321)
T ss_pred             ccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHH
Confidence            9999999997655 8999999999999999999999998877666666665433  345667899999999999999999


Q ss_pred             CCC-------CHHHHhcCccccCCCc
Q 007478          357 NRP-------TAAELLDHPFVKGAAP  375 (602)
Q Consensus       357 ~Rp-------t~~eiL~hp~f~~~~~  375 (602)
                      +|+       +++++++||||....+
T Consensus       237 ~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         237 KRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             HcCCCCCCCCCHHHHhcCCccCCCCH
Confidence            999       9999999999988765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.4e-46  Score=399.94  Aligned_cols=263  Identities=27%  Similarity=0.463  Sum_probs=223.4

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|++.+.||+|+||.||++.++.+++.||+|++.+... ........+.+|+.+++.++||||+++++++.+++.+|
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            35789999999999999999999999999999999874221 12233456788999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  269 (602)
                      +|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... 
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            999999999999999764 689999999999999999999999999999999999999999999999999987643322 


Q ss_pred             -CcccCCCCCCCCcccccccC---CCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCC--CCCHHH
Q 007478          270 -PLSFKGSPYWMAPEVIKNSS---GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEG  343 (602)
Q Consensus       270 -~~~~~GT~~Y~APEvl~~~~---~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l  343 (602)
                       ..+.+||+.|+|||++.+..   .++.++|||||||+||||++|+.||........+.++........++.  .++..+
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  278 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA  278 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence             23567999999999986532   378899999999999999999999988776666666665443334444  579999


Q ss_pred             HHHHHHHcccCCCC--CCCHHHHhcCccccCCCc
Q 007478          344 KDFIRLCLQRNPLN--RPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       344 ~dLI~~~L~~dP~~--Rpt~~eiL~hp~f~~~~~  375 (602)
                      ++||.+||..++.+  |++++|+++||||+...+
T Consensus       279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             HHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            99999999865543  889999999999987644

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3e-46  Score=391.39  Aligned_cols=253  Identities=31%  Similarity=0.513  Sum_probs=219.2

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++||+|+||+||+|.++.+++.||||++++... ........+.+|+.++..+ +||||+++++++...+.+|+||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            479999999999999999999999999875221 1223455677888999888 79999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      ||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            999999998888899999999999999999999999999999999999999999999999999875322 2223456799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      ..|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++||..||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dP~  236 (318)
T cd05570         160 PDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VRYPRWLSKEAKSILKSFLTKNPE  236 (318)
T ss_pred             ccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHccCCHH
Confidence            9999999997665 8899999999999999999999998766555555554432  356678999999999999999999


Q ss_pred             CCCCH-----HHHhcCccccCCCc
Q 007478          357 NRPTA-----AELLDHPFVKGAAP  375 (602)
Q Consensus       357 ~Rpt~-----~eiL~hp~f~~~~~  375 (602)
                      +||++     .++++||||+...+
T Consensus       237 ~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         237 KRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999     99999999998765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.9e-46  Score=393.69  Aligned_cols=256  Identities=32%  Similarity=0.525  Sum_probs=218.9

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHH---HhcCCCcEEEEeccccccceEEE
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL---SRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL---~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      |++.+.||+|+||.||+|.++.+|+.||||+++.... ......+.+.+|+.++   +.++||||+++++++...+.+|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence            7889999999999999999999999999999875221 1223345566666655   56789999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCC
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~  270 (602)
                      ||||++|++|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            9999999999988865 5799999999999999999999999999999999999999999999999999875432 2233


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      ...+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~  235 (324)
T cd05589         159 STFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSREAISIMRRL  235 (324)
T ss_pred             cccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHH
Confidence            4577999999999997655 8999999999999999999999998776665555554432  346778999999999999


Q ss_pred             cccCCCCCC-----CHHHHhcCccccCCCc
Q 007478          351 LQRNPLNRP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       351 L~~dP~~Rp-----t~~eiL~hp~f~~~~~  375 (602)
                      |+.||++||     ++.++++||||++..+
T Consensus       236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         236 LRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             hhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence            999999999     7999999999998755

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-46  Score=393.99  Aligned_cols=259  Identities=26%  Similarity=0.463  Sum_probs=211.3

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc-----ce
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE-----DK  188 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~  188 (602)
                      +|++.++||+|+||.||+|+++.+|+.||||+++..  .........+.+|+.+++.++||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV--FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechh--hccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            589999999999999999999999999999988642  11223345688999999999999999999987432     35


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      +|+||||| +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          79 IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence            89999999 47899999888889999999999999999999999999999999999999999999999999998653322


Q ss_pred             C----CcccCCCCCCCCccccccc-CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhh----------------
Q 007478          269 C----PLSFKGSPYWMAPEVIKNS-SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG----------------  327 (602)
Q Consensus       269 ~----~~~~~GT~~Y~APEvl~~~-~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~----------------  327 (602)
                      .    .....||+.|+|||++.+. ..++.++|||||||++|||++|++||...+....+..+.                
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            1    1245699999999998652 348889999999999999999999997654322211100                


Q ss_pred             ----------CCCCC---CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          328 ----------NSKEL---PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       328 ----------~~~~~---~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                .....   ......+++++.+||.+||+.||++|||++|+++||||++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                      00000   0111357788999999999999999999999999999987655

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-47  Score=390.63  Aligned_cols=254  Identities=32%  Similarity=0.520  Sum_probs=221.1

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc-----c
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE-----D  187 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~-----~  187 (602)
                      -.|...+++|.|+||.||+|+...+++.||||++-.....+        .+|+.+|+.++|||||+|..+|...     -
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            35888999999999999999999999999999885422221        3699999999999999999876432     2


Q ss_pred             eEEEEEeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC-CceEEeccCccc
Q 007478          188 KLYIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAK  262 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~vKL~DFGla~  262 (602)
                      .+.+|||||+ .+|..+++.    +..++.-.++-++.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+
T Consensus        96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            4568999995 799998875    4678999999999999999999999999999999999999987 999999999999


Q ss_pred             cccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCC--------
Q 007478          263 HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--------  334 (602)
Q Consensus       263 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~--------  334 (602)
                      .+..+....++.-|++|+|||.+.+...|+.++||||.||+|.||+-|++.|.+....+++..|.+....|.        
T Consensus       175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            998888888899999999999999999999999999999999999999999999887777766544222211        


Q ss_pred             -------------------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          335 -------------------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       335 -------------------~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                         +...+++++.+|+.++|+++|.+|.++.|++.||||.....
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence                               22457999999999999999999999999999999998755

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.2e-46  Score=390.25  Aligned_cols=253  Identities=31%  Similarity=0.497  Sum_probs=214.6

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHH-HHHHhcCCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI-VLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei-~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++||+|+||+||+|+++.+|+.||+|++....... ......+.+|+ .+++.++||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            47999999999999999999999999987522212 22234455555 46788999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      |++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .......+||
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            999999998878899999999999999999999999999999999999999999999999999876422 2233456799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+...  ...++...+.++.+||.+||++||.
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~  236 (321)
T cd05603         160 PEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQR  236 (321)
T ss_pred             cccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHh
Confidence            9999999997655 899999999999999999999999876655555554432  2356678899999999999999999


Q ss_pred             CCCCH----HHHhcCccccCCCc
Q 007478          357 NRPTA----AELLDHPFVKGAAP  375 (602)
Q Consensus       357 ~Rpt~----~eiL~hp~f~~~~~  375 (602)
                      +|+++    .++++|+||....+
T Consensus       237 ~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         237 RRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             hcCCCCCCHHHHhCCCCcCCCCH
Confidence            99864    69999999988765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1e-45  Score=389.70  Aligned_cols=262  Identities=27%  Similarity=0.404  Sum_probs=221.0

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||+||+++++.+++.||+|++.+.. .........+.+|+.++..++|+||+++++++.+++.+|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            47999999999999999999999999999999987422 12233455678899999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC-
Q 007478          193 LEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP-  270 (602)
Q Consensus       193 mE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-  270 (602)
                      |||+.||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            999999999999986 467899999999999999999999999999999999999999999999999999876543322 


Q ss_pred             -cccCCCCCCCCccccccc----CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC---CCCCHH
Q 007478          271 -LSFKGSPYWMAPEVIKNS----SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP---DDLSDE  342 (602)
Q Consensus       271 -~~~~GT~~Y~APEvl~~~----~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---~~~s~~  342 (602)
                       ...+||+.|+|||++.+.    ..++.++|||||||++|||++|+.||...+......++........++   ..++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~  239 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE  239 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence             235699999999998642    247889999999999999999999998776666665555433222223   457899


Q ss_pred             HHHHHHHHcccCCCC--CCCHHHHhcCccccCCCc
Q 007478          343 GKDFIRLCLQRNPLN--RPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       343 l~dLI~~~L~~dP~~--Rpt~~eiL~hp~f~~~~~  375 (602)
                      +++||.+||..++.+  |++++++++|+||+...+
T Consensus       240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             HHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence            999999999876654  469999999999998765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.1e-46  Score=391.06  Aligned_cols=253  Identities=29%  Similarity=0.518  Sum_probs=216.4

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++||+|+||.||+|.++.+|+.||+|+++..... .......+..|..++..+ +||||+++++++.+.+.+|+||||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence            4799999999999999999999999998752111 122344566788887754 89999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc-CCCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~GT  276 (602)
                      +|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||
T Consensus        80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            99999999888889999999999999999999999999999999999999999999999999987532 22233457799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+..  ..+.++..++.++++||++||+.||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~  236 (316)
T cd05620         160 PDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFERDPT  236 (316)
T ss_pred             cCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccCCHH
Confidence            9999999997665 89999999999999999999999987665555544433  23566778999999999999999999


Q ss_pred             CCCCH-HHHhcCccccCCCc
Q 007478          357 NRPTA-AELLDHPFVKGAAP  375 (602)
Q Consensus       357 ~Rpt~-~eiL~hp~f~~~~~  375 (602)
                      +|+++ +++++||||+...+
T Consensus       237 ~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         237 RRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             HcCCChHHHHcCCCcCCCCH
Confidence            99997 58999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.4e-46  Score=390.53  Aligned_cols=258  Identities=28%  Similarity=0.510  Sum_probs=218.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||++++..+|..||+|++...   ........+.+|+++|++++||||+++++++..++.+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57899999999999999999999999999999998742   123345678999999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccC-CceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK-HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  159 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  159 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-cc
Confidence            999999999999998888899999999999999999999986 6999999999999999999999999999876433 23


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhh-----------------------
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG-----------------------  327 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~-----------------------  327 (602)
                      ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.                       
T Consensus       160 ~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            4567999999999997665 8999999999999999999999996543322111110                       


Q ss_pred             ----------------------CCCCCCCCC-CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          328 ----------------------NSKELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       328 ----------------------~~~~~~~~p-~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                                            .....+..+ ..++.++++||++||++||++|||+++|++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                  000111111 24788999999999999999999999999999998643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-46  Score=381.58  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=220.6

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      .|++.++||+|+||+||++.+..+++.||+|++..... ........+.+|+.+++.++|+||+.+++++..++.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh-hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            48899999999999999999999999999999864221 22233456778999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          194 EYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       194 E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      ||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR  159 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence            999999999888643  468999999999999999999999999999999999999999999999999998765444444


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhh--CCCCCCCCCCCCCHHHHHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG--NSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~s~~l~dLI~~  349 (602)
                      ..+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+.  .......++..++..+.+||.+
T Consensus       160 ~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (285)
T cd05605         160 GRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ  238 (285)
T ss_pred             cccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence            567999999999997655 8899999999999999999999998654422221111  1123345566799999999999


Q ss_pred             HcccCCCCCC-----CHHHHhcCccccCCCc
Q 007478          350 CLQRNPLNRP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       350 ~L~~dP~~Rp-----t~~eiL~hp~f~~~~~  375 (602)
                      ||..||++||     +++++++|+||....+
T Consensus       239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05605         239 LLTKDPGFRLGCRGEGAEEVKAHPFFRTANF  269 (285)
T ss_pred             HccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence            9999999999     8999999999998655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=394.57  Aligned_cols=296  Identities=28%  Similarity=0.426  Sum_probs=246.8

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..+.|...++||+|+||.||-++.+.||+.||+|++.+.. .+.+.....-++|-.||..++.++||.+-..|++.+.+|
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKR-iKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKR-IKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHH-HHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            3567888999999999999999999999999999886522 222333445668999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          191 IYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      +||..|.||+|.-+|.+.+  .|++..++.++.+|+.||++||+.+||+|||||+|||||+.|+|+|+|+|||..+....
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999999999998876  79999999999999999999999999999999999999999999999999999998887


Q ss_pred             CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhh--CCCCCCCCCCCCCHHHHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG--NSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~s~~l~dL  346 (602)
                      .....+||..|||||++.+.. |+...|||||||+||||+.|+.||.+........++.  ......++++.+++++++|
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL  420 (591)
T ss_pred             ccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence            777778999999999999888 9999999999999999999999997654433222221  1223446788999999999


Q ss_pred             HHHHcccCCCCCC-----CHHHHhcCccccCCCcccccccCCCCCC-CCCCCcchhhhccCCccCCCC
Q 007478          347 IRLCLQRNPLNRP-----TAAELLDHPFVKGAAPLERTILAPEPSD-VPPGVTNGIKALGIGQLRNVS  408 (602)
Q Consensus       347 I~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~s  408 (602)
                      ++.+|++||++|.     +++++.+||||+.+.|.......-.|.- .+|........+.+++...+.
T Consensus       421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~VK  488 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFSTVK  488 (591)
T ss_pred             HHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhccccc
Confidence            9999999999997     5789999999999988443332222222 234555666666776665443

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1e-45  Score=389.06  Aligned_cols=254  Identities=25%  Similarity=0.452  Sum_probs=216.5

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++||+|+||+||+|.++.+++.||+|+++... ....+..+.+.+|+.++.++ +|+||+.+++++.+.+.+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL-VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            47999999999999999999999999997522 22334456788999999888 69999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc-CCCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~GT  276 (602)
                      ||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            99999999888889999999999999999999999999999999999999999999999999997532 23334457799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCc------hhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY------EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~------~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      +.|+|||++.+.. ++.++|||||||+||||++|+.||...      +....+...... ....+|..++..+.+||++|
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~~  237 (327)
T cd05617         160 PNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPRFLSVKASHVLKGF  237 (327)
T ss_pred             cccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHH
Confidence            9999999997655 899999999999999999999999531      222223332222 23356778999999999999


Q ss_pred             cccCCCCCCC------HHHHhcCccccCCCc
Q 007478          351 LQRNPLNRPT------AAELLDHPFVKGAAP  375 (602)
Q Consensus       351 L~~dP~~Rpt------~~eiL~hp~f~~~~~  375 (602)
                      |.+||++|++      ++++++||||+...+
T Consensus       238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         238 LNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             hccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence            9999999997      579999999998876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.3e-46  Score=391.09  Aligned_cols=254  Identities=31%  Similarity=0.484  Sum_probs=215.2

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHH-HHHhcCCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV-LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++||+|+||+||+|.++.+|+.||+|++...... .......+.+|.. +++.++||||+++++++..++.+|+||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence            4699999999999999999999999998752211 2223344555554 5778999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      ||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            999999998888999999999999999999999999999999999999999999999999999875432 2333456799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++||.+||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~~p~  236 (325)
T cd05604         160 PEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--LVLRPGASLTAWSILEELLEKDRQ  236 (325)
T ss_pred             hhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhccCHH
Confidence            9999999997765 8899999999999999999999998766555555554322  234557899999999999999999


Q ss_pred             CCCCH----HHHhcCccccCCCcc
Q 007478          357 NRPTA----AELLDHPFVKGAAPL  376 (602)
Q Consensus       357 ~Rpt~----~eiL~hp~f~~~~~~  376 (602)
                      +||++    .++++||||+...+.
T Consensus       237 ~R~~~~~~~~~i~~h~~f~~~~~~  260 (325)
T cd05604         237 RRLGAKEDFLEIQEHPFFESLSWT  260 (325)
T ss_pred             hcCCCCCCHHHHhcCCCcCCCCHH
Confidence            99876    699999999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.5e-46  Score=392.25  Aligned_cols=254  Identities=26%  Similarity=0.479  Sum_probs=215.0

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      +.||+|+||+||+|.++.+++.||+|++++.. .......+.+.+|+.++.++ +||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH-hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            47999999999999999999999999997522 12334456678899888776 89999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      +|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            999999998888899999999999999999999999999999999999999999999999999976432 2233456799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCc--------hhHHHHHHhhCCCCCCCCCCCCCHHHHHHHH
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY--------EGVAAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~--------~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  348 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...        .....+.+.... ....+|..++.++.+||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~ll~  237 (329)
T cd05618         160 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASVLK  237 (329)
T ss_pred             ccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHHHHHHH
Confidence            9999999997655 889999999999999999999999521        111222222221 233577889999999999


Q ss_pred             HHcccCCCCCCC------HHHHhcCccccCCCc
Q 007478          349 LCLQRNPLNRPT------AAELLDHPFVKGAAP  375 (602)
Q Consensus       349 ~~L~~dP~~Rpt------~~eiL~hp~f~~~~~  375 (602)
                      +||+.||++|++      +.++++||||+...+
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            999999999998      589999999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.1e-46  Score=392.21  Aligned_cols=253  Identities=32%  Similarity=0.508  Sum_probs=214.4

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHH-HHHHhcCCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI-VLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei-~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      +.||+|+||+||+|+++.+++.||+|++......... ....+..|. .+++.++|+||+++++++...+.+|+||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhh-HHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            4799999999999999999999999998752221222 223344444 45788999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      +|+|.+++...+.+.+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            999999998888899999999999999999999999999999999999999999999999999976432 2233456799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      +.|+|||++.+.. ++.++|||||||++|||++|++||...+....+..+...  ...++..++.++.+||++||++||.
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~  236 (325)
T cd05602         160 PEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQKDRT  236 (325)
T ss_pred             ccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHcccCHH
Confidence            9999999997655 889999999999999999999999876665555555432  2245568999999999999999999


Q ss_pred             CCCCHH----HHhcCccccCCCc
Q 007478          357 NRPTAA----ELLDHPFVKGAAP  375 (602)
Q Consensus       357 ~Rpt~~----eiL~hp~f~~~~~  375 (602)
                      +|+++.    ++++|+||....|
T Consensus       237 ~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         237 KRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             HCCCCCCCHHHHhcCcccCCCCH
Confidence            999765    8999999988766

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-45  Score=372.75  Aligned_cols=257  Identities=45%  Similarity=0.852  Sum_probs=226.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccc-hhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD-AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      +.|+++++||+|+||.||+|.+..+++.||+|++..... .......+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            469999999999999999999999999999999875322 1223345678899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC-
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP-  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-  270 (602)
                      ||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........ 
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999999765432211 


Q ss_pred             ---cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          271 ---LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       271 ---~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                         ....|+..|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+........++..++.++.+||
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             ccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence               2356889999999998765 889999999999999999999999887766666666655556677888999999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccc
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ++||..+|++|||+.++++|+||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-45  Score=387.18  Aligned_cols=253  Identities=31%  Similarity=0.528  Sum_probs=215.9

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHh-cCCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR-LRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      +.||+|+||+||+|.+..+++.||||+++.... ........+..|..++.. ++||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            469999999999999999999999999875211 112233456677778876 499999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc-CCCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~GT  276 (602)
                      ||+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            99999999887889999999999999999999999999999999999999999999999999987542 22233456799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL  356 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~  356 (602)
                      ..|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+...  .+.++..++.++++||.+||+.||+
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~  236 (316)
T cd05619         160 PDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVREPE  236 (316)
T ss_pred             ccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhccCHh
Confidence            9999999997655 899999999999999999999999876655544444332  2346677999999999999999999


Q ss_pred             CCCCHH-HHhcCccccCCCc
Q 007478          357 NRPTAA-ELLDHPFVKGAAP  375 (602)
Q Consensus       357 ~Rpt~~-eiL~hp~f~~~~~  375 (602)
                      +|+++. ++++||||+...+
T Consensus       237 ~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         237 RRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             hcCCChHHHHcCcccCCCCH
Confidence            999996 9999999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-47  Score=387.73  Aligned_cols=325  Identities=26%  Similarity=0.386  Sum_probs=263.3

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccce
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  188 (602)
                      ....+|.++.+||+|+||+|.+|..+.+.+.||||++++.-..+ .+..+-.+.|-++|... +-|++++++.+|++-++
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ-dDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee-cCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            34678999999999999999999999999999999998632222 22334456677888776 56899999999999999


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccc-ccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~-~~~~  267 (602)
                      +|+||||+.||+|...|+..++|.+..+..++.+|+-||-|||++|||+||||.+||||+.+|++||+|||+++. +...
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999975 3445


Q ss_pred             CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                      ....++|||+.|+|||++...+ |+.++||||+||+|||||.|++||++.+..+....|.....  .+|..++.|+.+++
T Consensus       505 ~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--syPKslSkEAv~ic  581 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--SYPKSLSKEAVAIC  581 (683)
T ss_pred             cceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--cCcccccHHHHHHH
Confidence            5567899999999999998766 99999999999999999999999999888887777776543  57889999999999


Q ss_pred             HHHcccCCCCCCC-----HHHHhcCccccCCCcccccccCCCCCCCCCCCcchhhhccCCccCCCCCCchhhhhccCCcc
Q 007478          348 RLCLQRNPLNRPT-----AAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHSSRV  422 (602)
Q Consensus       348 ~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~s~~d~~~~~~~ss~~  422 (602)
                      +.+|.+.|.+|..     -.+|.+||||+.+.| +.....+...++.|.+         ...++.++||..+.+.....+
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW-ek~E~~eiqPPfkPk~---------k~~r~~eNFD~~Ft~~~~~lT  651 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW-EKLERREIQPPFKPKI---------KCGRDAENFDKFFTREPTDLT  651 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhhccH-HHHhhccCCCCCCCcc---------ccCCchhhhhHHHhcCCCCCC
Confidence            9999999999975     478999999999988 3333444444444443         345677788887765444433


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCC
Q 007478          423 SQTSLNASDINISMNRSCPVSPIGSPLLHPR  453 (602)
Q Consensus       423 ~~~s~~~s~~~~s~~~s~P~s~~~spl~~~~  453 (602)
                      ....+-...+..+-     ..+++..++.+-
T Consensus       652 PpD~~v~~nldq~e-----F~gFsfvNpefv  677 (683)
T KOG0696|consen  652 PPDKLVMMNLDQSE-----FEGFSFVNPEFV  677 (683)
T ss_pred             CchHHHHhcCchhh-----cCceeeeChhhc
Confidence            33332222222222     236666666664

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=389.35  Aligned_cols=262  Identities=29%  Similarity=0.433  Sum_probs=219.9

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||+||+++++.+++.||+|++.+... ......+.+.+|+.++..++|+||+.+++++.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence            479999999999999999999999999999999874221 2233456688999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC-
Q 007478          193 LEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP-  270 (602)
Q Consensus       193 mE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-  270 (602)
                      |||+.||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...... 
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999999976 457999999999999999999999999999999999999999999999999999766433221 


Q ss_pred             -cccCCCCCCCCcccccc----cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC---CCCCCCCCHH
Q 007478          271 -LSFKGSPYWMAPEVIKN----SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL---PTIPDDLSDE  342 (602)
Q Consensus       271 -~~~~GT~~Y~APEvl~~----~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~---~~~p~~~s~~  342 (602)
                       ...+||+.|+|||++..    ...++.++|||||||++|||++|+.||..........++......   +.....++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  239 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE  239 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence             23469999999999863    234788999999999999999999999876655555555443322   2223458999


Q ss_pred             HHHHHHHHcccCCCC--CCCHHHHhcCccccCCCc
Q 007478          343 GKDFIRLCLQRNPLN--RPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       343 l~dLI~~~L~~dP~~--Rpt~~eiL~hp~f~~~~~  375 (602)
                      +++||++||..++++  |++++++++||||.+..+
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             HHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence            999999999764443  789999999999998765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-45  Score=388.49  Aligned_cols=262  Identities=28%  Similarity=0.426  Sum_probs=221.6

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.++||+|+||+||+++++.+++.||+|++.+... ........+.+|+.++..++|+||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence            479999999999999999999999999999999864221 2223345678899999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC--
Q 007478          193 LEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC--  269 (602)
Q Consensus       193 mE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--  269 (602)
                      |||+.+|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....  
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999999999976 46789999999999999999999999999999999999999999999999999976543222  


Q ss_pred             CcccCCCCCCCCcccccc----cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC---CCCCCCCCHH
Q 007478          270 PLSFKGSPYWMAPEVIKN----SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL---PTIPDDLSDE  342 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~----~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~---~~~p~~~s~~  342 (602)
                      ....+||+.|+|||++..    ...++.++|||||||++|||++|+.||...+....+.++......   +.....++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~  239 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED  239 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence            223579999999999862    334788999999999999999999999887776666666554332   2233468999


Q ss_pred             HHHHHHHHcccCCCC--CCCHHHHhcCccccCCCc
Q 007478          343 GKDFIRLCLQRNPLN--RPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       343 l~dLI~~~L~~dP~~--Rpt~~eiL~hp~f~~~~~  375 (602)
                      +++||++||..++.+  |++++++++||||.+..+
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             HHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence            999999999765544  689999999999998765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.2e-46  Score=390.67  Aligned_cols=252  Identities=32%  Similarity=0.509  Sum_probs=218.5

Q ss_pred             eeEeecCCeEEEEEEE---CCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEee
Q 007478          119 KMLGRGTFGHVYVGFN---SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~---~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      +.||+|+||.||++.+   +.+|+.||+|+++....  .......+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            6799999999999876   45789999999875221  122334567899999999999999999999999999999999


Q ss_pred             ecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-CCCcccC
Q 007478          196 VSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFK  274 (602)
Q Consensus       196 ~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~~  274 (602)
                      +++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......+
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence            999999999988888999999999999999999999999999999999999999999999999999865443 2334567


Q ss_pred             CCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccC
Q 007478          275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRN  354 (602)
Q Consensus       275 GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~d  354 (602)
                      ||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++.+||++||+.|
T Consensus       160 g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~  236 (318)
T cd05582         160 GTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRALFKRN  236 (318)
T ss_pred             CChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcC
Confidence            999999999997654 7899999999999999999999998776666665554432  3567789999999999999999


Q ss_pred             CCCCCC-----HHHHhcCccccCCCc
Q 007478          355 PLNRPT-----AAELLDHPFVKGAAP  375 (602)
Q Consensus       355 P~~Rpt-----~~eiL~hp~f~~~~~  375 (602)
                      |++||+     +++++.|+||+...+
T Consensus       237 P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         237 PANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             HhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence            999999     788999999998754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.1e-45  Score=393.84  Aligned_cols=263  Identities=29%  Similarity=0.455  Sum_probs=222.3

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++.+... ........+.+|+.+++.++||||+++++++.+++.+|
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            35789999999999999999999999999999999874221 12233456788999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC--
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--  268 (602)
                      +||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....  
T Consensus       120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            999999999999998764 68999999999999999999999999999999999999999999999999998765332  


Q ss_pred             CCcccCCCCCCCCcccccccC---CCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC--CCCCHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSS---GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP--DDLSDEG  343 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~---~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l  343 (602)
                      .....+||+.|+|||++.+..   .++.++|||||||++|||++|+.||...+......++........++  ..++.++
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  278 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence            223567999999999986532   37889999999999999999999998877666666665544333333  3689999


Q ss_pred             HHHHHHHcccCCCC--CCCHHHHhcCccccCCCc
Q 007478          344 KDFIRLCLQRNPLN--RPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       344 ~dLI~~~L~~dP~~--Rpt~~eiL~hp~f~~~~~  375 (602)
                      ++||.+||..++.+  |+++++|++|+||++..+
T Consensus       279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             HHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            99999999844433  789999999999988644

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-46  Score=399.36  Aligned_cols=258  Identities=33%  Similarity=0.579  Sum_probs=234.6

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce-EE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK-LY  190 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~~  190 (602)
                      .++|..++.||+|+||.+++++++..++.|++|.|...... . ...+...+|+.+++++.|||||.+.+.|..++. +|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-E-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-c-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            56899999999999999999999999999999999863322 2 223366789999999999999999999999888 99


Q ss_pred             EEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          191 IYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      |||+||+||+|.+.|.+.  ..|+++.+..|+.||+.||.|||++.|+|||||+.|||++.++.|||+|||+|+.+....
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            999999999999999764  469999999999999999999999999999999999999999999999999999998776


Q ss_pred             -CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          269 -CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       269 -~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                       ...+..||+.||.||++.+.+ |+.|+|||||||++|||++-+++|...+-...+.+|.... ...+|...+.+++.||
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv  238 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLV  238 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHH
Confidence             666889999999999998877 9999999999999999999999999988888888887765 5567889999999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccccCC
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      +.||.++|+.||++.++|.+|.+...
T Consensus       239 ~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  239 KSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHhhcCCccCCCHHHHhhChhhhhH
Confidence            99999999999999999999887654

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.4e-45  Score=387.35  Aligned_cols=258  Identities=28%  Similarity=0.463  Sum_probs=222.0

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccceEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +|+..+.||+|+||+||+|.++.+|+.||+|++.+... ......+.+..|+.++..+. |++|+++++++.+.+.+|+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence            47889999999999999999999999999999875221 12334556778889998885 57788899999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-CCCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~  271 (602)
                      |||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999998764322 2233


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      ..+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||.+||
T Consensus       160 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l  236 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLM  236 (323)
T ss_pred             CccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHc
Confidence            567999999999997655 8999999999999999999999998876655555554432  3567789999999999999


Q ss_pred             ccCCCCCCC-----HHHHhcCccccCCCc
Q 007478          352 QRNPLNRPT-----AAELLDHPFVKGAAP  375 (602)
Q Consensus       352 ~~dP~~Rpt-----~~eiL~hp~f~~~~~  375 (602)
                      ++||.+|++     .+++++|+||+...+
T Consensus       237 ~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         237 TKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             ccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            999999997     589999999998765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.6e-46  Score=407.84  Aligned_cols=255  Identities=29%  Similarity=0.500  Sum_probs=210.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc------
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV------  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~------  185 (602)
                      ..+|+++++||+|+||+||+|++..+++.||||++....        ....+|+.+|+.++|+|||++++++..      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            467999999999999999999999999999999885311        123469999999999999999886532      


Q ss_pred             --cceEEEEEeeecCCChhhhhh----ccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC-ceEEecc
Q 007478          186 --EDKLYIYLEYVSGGSIYKLLQ----DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-RVKLADF  258 (602)
Q Consensus       186 --~~~~~lVmE~~~ggsL~~~l~----~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~vKL~DF  258 (602)
                        ...+++||||+. ++|.+++.    ....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence              125789999997 56776664    346789999999999999999999999999999999999998665 6999999


Q ss_pred             CccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-------
Q 007478          259 GMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-------  331 (602)
Q Consensus       259 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-------  331 (602)
                      |+|+.+..........||+.|+|||++.+...|+.++|||||||+||||++|++||.+......+.++.....       
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            9999876655555678999999999987766689999999999999999999999987655444433321100       


Q ss_pred             -----------C---------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          332 -----------L---------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       332 -----------~---------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                 .         ..++...+.++++||.+||++||.+|+|+.|+|+||||.....
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                       0         1134467899999999999999999999999999999987543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.9e-46  Score=380.87  Aligned_cols=254  Identities=33%  Similarity=0.536  Sum_probs=207.0

Q ss_pred             CCceEeeeEeecCCeEEEEEEECC-CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc---CCCcEEEEecccc----
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSD-SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL---RHPNIVQYYGSKT----  184 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l---~HpnIv~l~~~~~----  184 (602)
                      .+|++.+.||+|+||+||+|.+.. +++.||+|+++......  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            369999999999999999999854 57889999987532211  1223455677776665   6999999999874    


Q ss_pred             -ccceEEEEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcc
Q 007478          185 -VEDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA  261 (602)
Q Consensus       185 -~~~~~~lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla  261 (602)
                       ....+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence             3456999999996 6899988653  45899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC--------
Q 007478          262 KHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------  333 (602)
Q Consensus       262 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~--------  333 (602)
                      +............||+.|+|||++.+.. ++.++|||||||++|||++|++||.+......+.++......+        
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            8776554445667999999999997655 8899999999999999999999998766655554443211100        


Q ss_pred             -----------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          334 -----------------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       334 -----------------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                                       .+...++..+++||.+||+.||++|||+.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             1123578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-45  Score=377.02  Aligned_cols=251  Identities=27%  Similarity=0.453  Sum_probs=211.5

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCC
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGS  200 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggs  200 (602)
                      ||+|+||+||++.++.+|+.||+|++.... .......+.+..|+.+++.++|+||+++++++..++.+|+||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKR-LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHH-HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            799999999999999999999999986422 1222334567889999999999999999999999999999999999999


Q ss_pred             hhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CCcccCC
Q 007478          201 IYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPLSFKG  275 (602)
Q Consensus       201 L~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~~G  275 (602)
                      |.+++..    ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... ......|
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence            9887742    3568999999999999999999999999999999999999999999999999997664432 2334679


Q ss_pred             CCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH----HHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV----AAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       276 T~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||......    .....+.  .....++..++.++.+||.+||
T Consensus       160 ~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         160 TPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL--NDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             CcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc--ccCCCCcccCCHHHHHHHHHHh
Confidence            99999999998765 889999999999999999999999754321    1111221  1223556789999999999999


Q ss_pred             ccCCCCCC-----CHHHHhcCccccCCCc
Q 007478          352 QRNPLNRP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       352 ~~dP~~Rp-----t~~eiL~hp~f~~~~~  375 (602)
                      +.||++|+     +++++++||||++..+
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence            99999999     8899999999998765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-46  Score=389.55  Aligned_cols=252  Identities=34%  Similarity=0.537  Sum_probs=213.5

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc---CCCcEEEEeccccccceEEEEEeeec
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL---RHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ||+|+||+||+|+++.+|+.||||++.+.... .......+..|..++..+   +||||+++++++.+.+.+|+||||+.
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence            79999999999999999999999998642211 222334455677777665   79999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC-CCCCcccCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGS  276 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~GT  276 (602)
                      +|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            999999998888999999999999999999999999999999999999999999999999999876432 3334457799


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC-CCCCHHHHHHHHHHcccCC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCLQRNP  355 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~s~~l~dLI~~~L~~dP  355 (602)
                      +.|+|||++.+...++.++|||||||++|||++|+.||...+.......+.....  .++ ..++.++.+||++||..||
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~~L~~~P  237 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFPKNVLSDEGRQFVKGLLNRNP  237 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCCH
Confidence            9999999997766689999999999999999999999987665555555443322  223 3579999999999999999


Q ss_pred             CCCC----CHHHHhcCccccCCCc
Q 007478          356 LNRP----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       356 ~~Rp----t~~eiL~hp~f~~~~~  375 (602)
                      ++||    +++++++||||+...+
T Consensus       238 ~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         238 QHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             HHCCCCCCCHHHHhcCccccCCCH
Confidence            9998    7999999999998654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1e-45  Score=400.90  Aligned_cols=253  Identities=32%  Similarity=0.539  Sum_probs=216.7

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-C-----CcEEEEeccccccc
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-H-----PNIVQYYGSKTVED  187 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-H-----pnIv~l~~~~~~~~  187 (602)
                      +|.+.++||+|+||+|.+|.+..|++.||||+|+.     .+....+-..|+.+|..|+ |     -|||+++++|...+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            67889999999999999999999999999999974     3455677788999999997 4     48999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC--ceEEeccCcccc
Q 007478          188 KLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG--RVKLADFGMAKH  263 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g--~vKL~DFGla~~  263 (602)
                      ++|||+|++ ..+|+++|+.+  ..|+...++.|+.||+.||.+||+.||||+|||||||||.+.+  .|||+|||.|.+
T Consensus       262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999999999 68999999875  4688999999999999999999999999999999999996543  799999999998


Q ss_pred             ccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC----------
Q 007478          264 IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP----------  333 (602)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~----------  333 (602)
                      .....  .+++-++.|+|||+|.+.. |+.+.||||||||++||++|.+.|.+.+..+++..|......|          
T Consensus       341 ~~q~v--ytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  341 ESQRV--YTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             cCCcc--eeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            76543  3788999999999999887 9999999999999999999999999887777665543211100          


Q ss_pred             ----------------------------------------CCC-----------CCCCHHHHHHHHHHcccCCCCCCCHH
Q 007478          334 ----------------------------------------TIP-----------DDLSDEGKDFIRLCLQRNPLNRPTAA  362 (602)
Q Consensus       334 ----------------------------------------~~p-----------~~~s~~l~dLI~~~L~~dP~~Rpt~~  362 (602)
                                                              ..|           ..-...+.|||++||++||.+|+|..
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence                                                    011           01124578999999999999999999


Q ss_pred             HHhcCccccCCCc
Q 007478          363 ELLDHPFVKGAAP  375 (602)
Q Consensus       363 eiL~hp~f~~~~~  375 (602)
                      |+|+||||.+...
T Consensus       498 qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  498 QALNHPFLTGTSL  510 (586)
T ss_pred             HHhcCcccccccc
Confidence            9999999997654

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-45  Score=393.02  Aligned_cols=258  Identities=25%  Similarity=0.428  Sum_probs=215.9

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc-----e
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED-----K  188 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~  188 (602)
                      +|++++.||+|+||+||+|.+..+|+.||||++...  .......+.+.+|+.+|+.++|+||+++++++...+     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            478899999999999999999999999999988532  122334567889999999999999999999988766     7


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      +|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            999999996 6888888877889999999999999999999999999999999999999999999999999998654322


Q ss_pred             --CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC-----------------
Q 007478          269 --CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-----------------  329 (602)
Q Consensus       269 --~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~-----------------  329 (602)
                        ......+|+.|+|||++.+...++.++||||||||+|||++|+.||...+....+..+...                 
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence              1223468999999999987666889999999999999999999999765544333322110                 


Q ss_pred             -------CCCC------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          330 -------KELP------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       330 -------~~~~------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                             ...+      .+....++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                   0001      22345688999999999999999999999999999998854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.3e-44  Score=397.09  Aligned_cols=255  Identities=22%  Similarity=0.355  Sum_probs=202.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC------CCcEEEEeccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR------HPNIVQYYGSKTV  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~------HpnIv~l~~~~~~  185 (602)
                      ..+|++.++||+|+||+||+|.+..+++.||||+++...     .....+..|+.+++.++      |.+|+.+++++..
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            467999999999999999999999999999999986421     12233455666666665      4568888888765


Q ss_pred             c-ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCC------------
Q 007478          186 E-DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNG------------  251 (602)
Q Consensus       186 ~-~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g------------  251 (602)
                      + ..+|||||++ |++|.+++.+.+.+++..++.|+.||+.||+|||. .|||||||||+||||+.++            
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            4 5789999998 78999999888899999999999999999999997 5999999999999998765            


Q ss_pred             ----ceEEeccCccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhh
Q 007478          252 ----RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG  327 (602)
Q Consensus       252 ----~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~  327 (602)
                          .+||+|||++....  ......+||+.|+|||++.+.. |+.++|||||||+||||++|++||...+....+..+.
T Consensus       282 ~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence                49999999886432  2234578999999999998765 8999999999999999999999997655433322211


Q ss_pred             CCCC-------------------------CCCCC---------------CCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          328 NSKE-------------------------LPTIP---------------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       328 ~~~~-------------------------~~~~p---------------~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ....                         .+...               ....+.+.|||.+||++||++|||++|+|+|
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            1000                         00000               0124567899999999999999999999999


Q ss_pred             ccccCCCc
Q 007478          368 PFVKGAAP  375 (602)
Q Consensus       368 p~f~~~~~  375 (602)
                      |||.....
T Consensus       439 p~~~~~~~  446 (467)
T PTZ00284        439 PYVLKYYP  446 (467)
T ss_pred             ccccccCC
Confidence            99987543

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.2e-45  Score=375.68  Aligned_cols=253  Identities=31%  Similarity=0.506  Sum_probs=205.7

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc---CCCcEEEEeccccc-----
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL---RHPNIVQYYGSKTV-----  185 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l---~HpnIv~l~~~~~~-----  185 (602)
                      +|++.+.||+|+||+||+|.++.+++.||+|+++......  .....+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            5889999999999999999999999999999987522111  1122344566666655   79999999998754     


Q ss_pred             cceEEEEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccc
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~  263 (602)
                      ...+++||||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        79 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          79 ETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             CceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            346899999997 5888888653  3589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC------------
Q 007478          264 IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE------------  331 (602)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~------------  331 (602)
                      ...........||..|+|||++.+.. ++.++|||||||++|||++|++||........+.++.....            
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            76544444567899999999997655 89999999999999999999999976655444333321100            


Q ss_pred             -------------CCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          332 -------------LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       332 -------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                                   ...+...++.++.+||.+||++||++|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                         001223578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.6e-45  Score=387.28  Aligned_cols=257  Identities=25%  Similarity=0.412  Sum_probs=210.3

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE----  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~----  186 (602)
                      ...+|++.+.||+|+||.||+|.++.+|+.||+|++...  .........+.+|+.+++.++||||+++++++...    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP--FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccc--ccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            467899999999999999999999999999999998642  12233456778999999999999999999987543    


Q ss_pred             --ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          187 --DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       187 --~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                        ..+|+||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence              357999999964 5666664  35889999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC---------------
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS---------------  329 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~---------------  329 (602)
                      ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+...               
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             ccCccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            5544445567999999999997755 889999999999999999999999765443322111100               


Q ss_pred             --------CCCC-----------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          330 --------KELP-----------------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       330 --------~~~~-----------------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                              ...+                 ......+.++++||.+||+.||++|||+.|+|+||||...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence                    0000                 0112346789999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=422.50  Aligned_cols=263  Identities=30%  Similarity=0.444  Sum_probs=237.6

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|+++++||+|+||.|.+++++.|++.||+|++.+....+.. ...-|..|-.+|.-.+.+-|+.++..|.+++++|
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~-~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRA-ETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhch-hHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            357899999999999999999999999999999999864443332 3456888999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  269 (602)
                      +||||+.||+|..++.++.++++..++.|+..|..||.-||+.|+|||||||+|||||..|++||+|||.+-.+..+.. 
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            9999999999999999998999999999999999999999999999999999999999999999999999887764432 


Q ss_pred             -CcccCCCCCCCCcccccc---c-CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC--CCCCHH
Q 007478          270 -PLSFKGSPYWMAPEVIKN---S-SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP--DDLSDE  342 (602)
Q Consensus       270 -~~~~~GT~~Y~APEvl~~---~-~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~  342 (602)
                       ....+|||.|.+||++..   + ..|+..+||||+||++|||+.|..||+...-...+-+|.+.+..-.||  ..+|.+
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence             345679999999999852   2 458999999999999999999999999999999999999887777777  569999


Q ss_pred             HHHHHHHHcccCCCCCCC---HHHHhcCccccCCCc
Q 007478          343 GKDFIRLCLQRNPLNRPT---AAELLDHPFVKGAAP  375 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt---~~eiL~hp~f~~~~~  375 (602)
                      +++||++++. +|+.|..   ++++..||||.+..|
T Consensus       312 akdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  312 AKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             HHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence            9999999985 7899988   999999999999999

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.9e-45  Score=384.34  Aligned_cols=258  Identities=29%  Similarity=0.518  Sum_probs=216.5

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.++||+|+||.||++.++.++..+|+|++...   ........+.+|++++++++|+||+++++++.+++.+|+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            47899999999999999999999999999999988752   123345678899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccC-CceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK-HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      ||||+.+++|.+++...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~  159 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  159 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-cc
Confidence            999999999999998888899999999999999999999975 7999999999999999999999999999765432 22


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHh------------------------
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI------------------------  326 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i------------------------  326 (602)
                      ....||..|+|||++.+.. ++.++|||||||++|||++|+.||...........+                        
T Consensus       160 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             ccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            3457999999999997654 889999999999999999999999753322111100                        


Q ss_pred             -------------------hCCCCCCCCC-CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          327 -------------------GNSKELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       327 -------------------~~~~~~~~~p-~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                                         ......+.++ ..++.++++||.+||++||++|||+.|+++|+||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                               0001111111 13678999999999999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.4e-45  Score=373.80  Aligned_cols=259  Identities=25%  Similarity=0.439  Sum_probs=218.3

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      .|+..++||+|+||.||++.+..+++.||+|.+.... .........+.+|+.++++++|+||+.+++.+.+.+.+|+||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh-ccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            3788899999999999999999999999999886422 122333456778999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          194 EYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       194 E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      ||+.|++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..........
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  159 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence            999999999988643  358899999999999999999999999999999999999999999999999998765444444


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH---HHHHHhhCCCCCCCCCCCCCHHHHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV---AAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~s~~l~dLI~  348 (602)
                      ...||..|+|||++.+.. ++.++|||||||++|||++|+.||......   .....+.. .....++..+++++++||+
T Consensus       160 ~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  237 (285)
T cd05630         160 GRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSLCK  237 (285)
T ss_pred             CCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCccCCHHHHHHHH
Confidence            567999999999997765 899999999999999999999999754321   11111111 1122456678999999999


Q ss_pred             HHcccCCCCCCC-----HHHHhcCccccCCCc
Q 007478          349 LCLQRNPLNRPT-----AAELLDHPFVKGAAP  375 (602)
Q Consensus       349 ~~L~~dP~~Rpt-----~~eiL~hp~f~~~~~  375 (602)
                      +||+.||++|+|     ++|+++||||+...+
T Consensus       238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         238 MLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             HHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence            999999999999     999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=392.87  Aligned_cols=247  Identities=30%  Similarity=0.533  Sum_probs=216.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .+.+++++.||+|.||.||+|.+.. ...||+|.++...     ...+.|.+|+++|++|+|+|||+++++|..++.+||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-----MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-----cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence            4556778899999999999999875 3479999987421     223567799999999999999999999999889999


Q ss_pred             EEeeecCCChhhhhhc--cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~--~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      |||||..|+|.++|+.  ...+...+.+.++.|||+|++||+++++|||||.+.||||+++..+||+|||||+.+.++..
T Consensus       279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            9999999999999986  56799999999999999999999999999999999999999999999999999995443332


Q ss_pred             Ccc--cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          270 PLS--FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       270 ~~~--~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                      ...  ..-...|.|||.+.... ++.|+|||||||+||||+| |+.||.++...+.+..+..+..++. |..||+++.+|
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~-P~~CP~~vY~l  436 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR-PEGCPDEVYEL  436 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-CCCCCHHHHHH
Confidence            221  12235799999998766 9999999999999999999 9999999999999999888877765 78999999999


Q ss_pred             HHHHcccCCCCCCCHHHHhc
Q 007478          347 IRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~  366 (602)
                      |..||..+|++|||++.+..
T Consensus       437 M~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  437 MKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHhhCCcccCCCHHHHHH
Confidence            99999999999999997764

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=395.39  Aligned_cols=250  Identities=45%  Similarity=0.808  Sum_probs=226.2

Q ss_pred             eEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCC
Q 007478          120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGG  199 (602)
Q Consensus       120 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~gg  199 (602)
                      +||+|.||+||-|+++.|....|||.|..    +.....+-+.+||.+.++|+|.|||+++|++..++.+-|+||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccc----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            69999999999999999999999998863    33344667889999999999999999999999999999999999999


Q ss_pred             Chhhhhhc-cCCC--ChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc-CCceEEeccCccccccCCC-CCcccC
Q 007478          200 SIYKLLQD-YGQF--GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLADFGMAKHIAGQS-CPLSFK  274 (602)
Q Consensus       200 sL~~~l~~-~~~l--s~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~-~~~~~~  274 (602)
                      +|.++|+. .+++  .+..+-.+.+||++||+|||++.|||||||-+||||+. .|.+||+|||-++.+.+-+ ...++.
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            99999975 4777  78889999999999999999999999999999999965 6899999999999887643 455788


Q ss_pred             CCCCCCCcccccc-cCCCCccccchhhhhHHHHHhhCCCCCCCc-hhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcc
Q 007478          275 GSPYWMAPEVIKN-SSGCNLAVDIWSLGCTVLEMATTKPPWSQY-EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ  352 (602)
Q Consensus       275 GT~~Y~APEvl~~-~~~~s~~sDVWSLGviLyELltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  352 (602)
                      ||+.|||||+|.. -.+|+.++|||||||++.||.||++||.+. +....+++++.-+.-|.+|..++.+++.||.+|+.
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            9999999999964 457999999999999999999999999764 45677888888888899999999999999999999


Q ss_pred             cCCCCCCCHHHHhcCccccCC
Q 007478          353 RNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       353 ~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      .||.+||++.++|+.||++..
T Consensus       818 pd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  818 PDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCcccCccHHHhccCcccccC
Confidence            999999999999999999865

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.8e-45  Score=371.89  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=209.1

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCC
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGS  200 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggs  200 (602)
                      ||+|+||+||++.++.+|+.||+|++.... .........+..|++++++++||||+++++++..+..+|+||||+.|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR-LKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHH-hhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            799999999999999999999999986421 1112223455679999999999999999999999999999999999999


Q ss_pred             hhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCCCCC
Q 007478          201 IYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY  278 (602)
Q Consensus       201 L~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~  278 (602)
                      |.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............||..
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  159 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG  159 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence            99888653  3588888999999999999999999999999999999999999999999999987655444345679999


Q ss_pred             CCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh---HHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCC
Q 007478          279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG---VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP  355 (602)
Q Consensus       279 Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  355 (602)
                      |+|||++.+.. ++.++|||||||++|||++|+.||.....   ...................++.++++||++||++||
T Consensus       160 y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P  238 (277)
T cd05607         160 YMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP  238 (277)
T ss_pred             ccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence            99999998766 89999999999999999999999975322   111211111112222234689999999999999999


Q ss_pred             CCCCCH----HHHhcCccccCCCc
Q 007478          356 LNRPTA----AELLDHPFVKGAAP  375 (602)
Q Consensus       356 ~~Rpt~----~eiL~hp~f~~~~~  375 (602)
                      ++||++    ++++.|+||+...+
T Consensus       239 ~~R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         239 EDRLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             hhCCCCccchhhhhcChhhcCCCH
Confidence            999999    77889999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-45  Score=394.50  Aligned_cols=250  Identities=25%  Similarity=0.341  Sum_probs=207.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ...|++.+.||+|+||.||+|++..+++.||+|+..          ...+.+|+.+|++++|||||++++++......|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            467999999999999999999999999999999643          1345789999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC--CC
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ--SC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--~~  269 (602)
                      |||++ +++|.+++.....+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....  ..
T Consensus       161 v~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        161 ILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             EEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            99999 4789999988788999999999999999999999999999999999999999999999999999754322  22


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh-------HHHHHHhh---------------
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG-------VAAMFKIG---------------  327 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~-------~~~~~~i~---------------  327 (602)
                      ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....       ...+..+.               
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             cccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            33567999999999997655 89999999999999999999987743210       00111000               


Q ss_pred             -----------C-CCCCC-CCC-----CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          328 -----------N-SKELP-TIP-----DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       328 -----------~-~~~~~-~~p-----~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                                 . ....+ ..+     ..++.++.+||.+||++||++|||++|+|+||||+..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                       0 00000 000     1356789999999999999999999999999999874

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=399.72  Aligned_cols=260  Identities=37%  Similarity=0.673  Sum_probs=231.2

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..+.|.++..||.|+||.||+|.++.++-..|.|+|..    ++.+..+.++-||.||..++||+||+|++.|..++.+|
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            45789999999999999999999999999999998864    55677889999999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc-cCCC
Q 007478          191 IYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQS  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~  268 (602)
                      |..|||.||-...++-. ...+++.+|..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+... ....
T Consensus       106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            99999999999887654 467999999999999999999999999999999999999999999999999987543 2334


Q ss_pred             CCcccCCCCCCCCccccc----ccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC-CCCCCCCHHH
Q 007478          269 CPLSFKGSPYWMAPEVIK----NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-TIPDDLSDEG  343 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~----~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~s~~l  343 (602)
                      ...++.|||+|||||+++    ....|++++||||||++|.||..+.+|....+..-.+.+|....... --|...+..+
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            456789999999999975    23459999999999999999999999999999998999887654322 2345788999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          344 KDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       344 ~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      .||+++||.+||..||++.+||+||||..+.
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            9999999999999999999999999999764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.7e-45  Score=378.66  Aligned_cols=260  Identities=26%  Similarity=0.457  Sum_probs=214.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||+|+++.+++.||+|+++.....   .....+.+|+.++++++|+||+++++++..++.+|+
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            56899999999999999999999999999999998753221   123356789999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      ||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          82 VFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             EEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            999997 4888877654 458899999999999999999999999999999999999999999999999997654322 2


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC-------------------
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-------------------  330 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~-------------------  330 (602)
                      .....+|+.|+|||++.+...++.++|||||||++|||++|++||...+..+.+..+....                   
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            2345689999999998766668899999999999999999999997654433322221100                   


Q ss_pred             -CCC--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          331 -ELP--------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       331 -~~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                       ..+        .....++.++++||.+||..||++|+|+.|+++||||+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence             000        111357889999999999999999999999999999987543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.8e-44  Score=369.05  Aligned_cols=260  Identities=27%  Similarity=0.441  Sum_probs=219.5

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      .|+..+.||+|+||+||+|.+..+++.||+|++.... .........+.+|+.+|++++|+||+.+++++..++.+|+||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR-IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhh-hhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence            3788899999999999999999999999999986422 122233455778999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          194 EYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       194 E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      ||+.+++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR  159 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence            999999999888643  369999999999999999999999999999999999999999999999999997765444344


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhC--CCCCCCCCCCCCHHHHHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~s~~l~dLI~~  349 (602)
                      ...|+..|+|||++.+.. ++.++|||||||++|||++|+.||...........+..  ......++..++.++.+||.+
T Consensus       160 ~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM  238 (285)
T ss_pred             CCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence            567999999999997655 88999999999999999999999986544322222211  112234566789999999999


Q ss_pred             HcccCCCCCCC-----HHHHhcCccccCCCc
Q 007478          350 CLQRNPLNRPT-----AAELLDHPFVKGAAP  375 (602)
Q Consensus       350 ~L~~dP~~Rpt-----~~eiL~hp~f~~~~~  375 (602)
                      ||+.||++||+     +.++++|+||+....
T Consensus       239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             HccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence            99999999999     899999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.6e-45  Score=382.18  Aligned_cols=251  Identities=27%  Similarity=0.427  Sum_probs=205.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEEC-----CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNS-----DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTV  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~  185 (602)
                      .++|+++++||+|+||.||+|.+.     .+++.||||+++..   ......+.+.+|+.+|..+ +||||+++++++..
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            468999999999999999999752     34678999988632   2233456788999999999 89999999998765


Q ss_pred             c-ceEEEEEeeecCCChhhhhhcc--------------------------------------------------------
Q 007478          186 E-DKLYIYLEYVSGGSIYKLLQDY--------------------------------------------------------  208 (602)
Q Consensus       186 ~-~~~~lVmE~~~ggsL~~~l~~~--------------------------------------------------------  208 (602)
                      . +.+|+||||+++|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 4689999999999999998642                                                        


Q ss_pred             ------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC---CcccCCCCCC
Q 007478          209 ------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYW  279 (602)
Q Consensus       209 ------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y  279 (602)
                            ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....   .....++..|
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence                  2377788999999999999999999999999999999999999999999999986543221   1223467889


Q ss_pred             CCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCC
Q 007478          280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR  358 (602)
Q Consensus       280 ~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~R  358 (602)
                      +|||++.+.. ++.++|||||||+||||++ |..||........+............+..+++++.+||.+||..||++|
T Consensus       243 ~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         243 MAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             cCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            9999997665 8999999999999999997 9999986543333333333333445567889999999999999999999


Q ss_pred             CCHHHHhc
Q 007478          359 PTAAELLD  366 (602)
Q Consensus       359 pt~~eiL~  366 (602)
                      ||+.+|++
T Consensus       322 Ps~~el~~  329 (338)
T cd05102         322 PTFSALVE  329 (338)
T ss_pred             cCHHHHHH
Confidence            99999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-44  Score=398.03  Aligned_cols=256  Identities=30%  Similarity=0.447  Sum_probs=221.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCC-CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDS-GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ...|.+.+.||+|+||.||+|.+..+ ++.||+|.+...    .......+.+|+.+|+.++|||||++++++..++.+|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            34599999999999999999998877 788999976532    2333456778999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          191 IYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      |||||++||+|.+++..    ...+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999999988753    35689999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHH
Q 007478          267 QSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG  343 (602)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  343 (602)
                      ...   ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||........+..+.... ...++..++.++
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~s~~~  299 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-YDPFPCPVSSGM  299 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCccCCHHH
Confidence            322   34567999999999997654 8999999999999999999999998776666565554432 334567899999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          344 KDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       344 ~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      ++||.+||..||++||++++++.|+|++..
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            999999999999999999999999999754

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.2e-44  Score=368.39  Aligned_cols=259  Identities=32%  Similarity=0.566  Sum_probs=227.2

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... ......+.+.+|++++++++||||+++++++...+.+|+|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence            479999999999999999999999999999999864221 2233456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS  272 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  272 (602)
                      |||+.+++|.+++...+.+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++......  ...
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~  157 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT  157 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence            999999999999988889999999999999999999999999999999999999999999999999999876544  345


Q ss_pred             cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcc
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ  352 (602)
Q Consensus       273 ~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  352 (602)
                      .+|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+..  ....++..++..++++|++||.
T Consensus       158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~  234 (290)
T cd05580         158 LCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKVRFPSFFSPDAKDLIRNLLQ  234 (290)
T ss_pred             CCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCccCCccCCHHHHHHHHHHcc
Confidence            57999999999987654 78899999999999999999999987665444444432  2345677889999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCccccCCCccc
Q 007478          353 RNPLNRP-----TAAELLDHPFVKGAAPLE  377 (602)
Q Consensus       353 ~dP~~Rp-----t~~eiL~hp~f~~~~~~~  377 (602)
                      .||.+|+     +++++++||||+...+..
T Consensus       235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  264 (290)
T cd05580         235 VDLTKRLGNLKNGVNDIKNHPWFAGIDWIA  264 (290)
T ss_pred             CCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence            9999999     999999999999887644

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-44  Score=383.54  Aligned_cols=257  Identities=24%  Similarity=0.395  Sum_probs=210.5

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE----  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~----  186 (602)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .........+.+|+.+++.++|+||+++++++...    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc--ccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            467899999999999999999999999999999988642  12233456778999999999999999999987543    


Q ss_pred             --ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          187 --DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       187 --~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                        ..+|+||||+.+ +|.+.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              357999999964 67666653  5889999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC--------------
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--------------  330 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~--------------  330 (602)
                      ..........||..|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+....              
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            5554445667999999999997655 8999999999999999999999997654333222111000              


Q ss_pred             --------------C------------CCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          331 --------------E------------LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       331 --------------~------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                                    .            ....+...+.++++||.+||+.||++|||+.|+|+||||...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                          0            001112346788999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.5e-44  Score=383.54  Aligned_cols=257  Identities=24%  Similarity=0.379  Sum_probs=211.7

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE----  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~----  186 (602)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....  ........+.+|+.+++.++||||+++++++...    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            4678999999999999999999999999999999886421  2233456678999999999999999999877543    


Q ss_pred             --ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          187 --DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       187 --~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                        ..+|+||||+. ++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         100 EFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             ccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence              35899999996 567777753  5889999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC------------
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL------------  332 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~------------  332 (602)
                      ..........||..|+|||++.+.. ++.++|||||||++|||++|+.||...+....+.++......            
T Consensus       177 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         177 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CCCCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            5554445567999999999997755 899999999999999999999999876554443332211000            


Q ss_pred             ----------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          333 ----------------------------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       333 ----------------------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                                                  .......+.++++||.+||+.||.+|||+.|+|+||||...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                                        00111235688999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-45  Score=384.04  Aligned_cols=258  Identities=22%  Similarity=0.427  Sum_probs=212.8

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE----  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~----  186 (602)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...  .......+.+.+|+.+|++++|+||+++++++...    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP--FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch--hhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            357899999999999999999999999999999988642  12223345677899999999999999999987543    


Q ss_pred             --ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          187 --DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       187 --~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                        ..+|++||++ +++|.++++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence              4579999998 7899888764 57999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC--------------
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--------------  330 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~--------------  330 (602)
                      ...  .....||+.|+|||++.+...++.++|||||||++|||++|+.||...+....+..+....              
T Consensus       169 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             CCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            443  3456799999999999876668999999999999999999999997654433332221100              


Q ss_pred             -------CCCC--------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          331 -------ELPT--------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       331 -------~~~~--------~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                             ..+.        +....++.+.+||.+||..||++|||+.|+++||||....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                   0011        1124567889999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5e-44  Score=359.31  Aligned_cols=257  Identities=68%  Similarity=1.122  Sum_probs=227.3

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccc-hhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD-AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +|+..+.||+|+||+||+|.+..+++.|++|++..... ....+..+.+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            47888999999999999999998899999999875322 22345567889999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS  272 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  272 (602)
                      |||+++++|.+++.+.+.+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++...........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999998877899999999999999999999999999999999999999999999999999987655443445


Q ss_pred             cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcc
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ  352 (602)
Q Consensus       273 ~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  352 (602)
                      ..|+..|++||.+.....++.++|+|||||++|+|++|+.||..........++......+.++..++.++.+||++||+
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            67999999999986544478899999999999999999999987766666666655456667788899999999999999


Q ss_pred             cCCCCCCCHHHHhcCccc
Q 007478          353 RNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       353 ~dP~~Rpt~~eiL~hp~f  370 (602)
                      .+|++||++.+++.|||+
T Consensus       241 ~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         241 RDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCcccCcCHHHHhcCCCC
Confidence            999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.2e-44  Score=360.79  Aligned_cols=257  Identities=45%  Similarity=0.814  Sum_probs=221.0

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccc-hhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc--cceE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD-AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV--EDKL  189 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~  189 (602)
                      .+|+++++||+|+||.||++.+..+|+.||||++..... .......+.+.+|+.++++++|+||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999998864221 2223446788899999999999999999998765  3568


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC--
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ--  267 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  267 (602)
                      ++||||+++++|.+++.....+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            899999999999999988778999999999999999999999999999999999999999999999999998765321  


Q ss_pred             --CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          268 --SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       268 --~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                        .......|+..|+|||++.+.. ++.++|||||||++|||++|+.||........+.++......+.++..++..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             cccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence              1223456899999999997654 8899999999999999999999998776666665555444455667788999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhcCcccc
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~hp~f~  371 (602)
                      +|.+||. +|++||++++|++|+|+.
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.5e-45  Score=365.33  Aligned_cols=254  Identities=39%  Similarity=0.597  Sum_probs=212.7

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEe
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE  194 (602)
                      |++++.||+|+||+||++.+..+++.||+|++.....  .........+|+.++++++|+||+++++++...+.+++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhcccccccccccccccccccccccccccc
Confidence            7899999999999999999999999999999986322  22223344569999999999999999999999999999999


Q ss_pred             eecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc-cCCCCCccc
Q 007478          195 YVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSF  273 (602)
Q Consensus       195 ~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~  273 (602)
                      |+.+++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++... .........
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999997789999999999999999999999999999999999999999999999999999864 223333456


Q ss_pred             CCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCc---hhHHHHHHhhCCCCCCC--CCCCCCHHHHHHHH
Q 007478          274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY---EGVAAMFKIGNSKELPT--IPDDLSDEGKDFIR  348 (602)
Q Consensus       274 ~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~---~~~~~~~~i~~~~~~~~--~p~~~s~~l~dLI~  348 (602)
                      .+|..|+|||++.....++.++||||||+++|+|++|..||...   +....+.+.........  .......++.+||+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  238 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK  238 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence            78999999999873445899999999999999999999999876   22222222221111001  11123489999999


Q ss_pred             HHcccCCCCCCCHHHHhcCccc
Q 007478          349 LCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       349 ~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +||+.||++||++.++++||||
T Consensus       239 ~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  239 KMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6e-44  Score=361.84  Aligned_cols=255  Identities=48%  Similarity=0.868  Sum_probs=222.1

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchh-----cHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAK-----SKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~-----~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      +|.+++.||+|+||.||+|.+..+++.||+|.+.......     ..+..+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4888999999999999999999899999999886532211     22345678899999999999999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      .++||||+++++|.+++...+.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.+....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999998765221


Q ss_pred             -------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCH
Q 007478          269 -------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSD  341 (602)
Q Consensus       269 -------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  341 (602)
                             ......|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+.++.. ...+.++..++.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISS  238 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCcccCH
Confidence                   112345889999999997655 78899999999999999999999988766666665544 334566778999


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          342 EGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       342 ~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ++.+||++||+.||++||++.+|++|+||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.4e-44  Score=362.02  Aligned_cols=257  Identities=46%  Similarity=0.857  Sum_probs=220.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccc-hhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc--cceE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD-AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV--EDKL  189 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~  189 (602)
                      .+|+..+.||+|+||.||+|.+..+++.||+|++..... .........+.+|+.++++++|+||+++++++.+  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            468999999999999999999999999999998865321 1223445678899999999999999999998765  4678


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-  268 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  268 (602)
                      +++|||+.+++|.+++...+.+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            9999999999999999887789999999999999999999999999999999999999999999999999987653211 


Q ss_pred             ---CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          269 ---CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       269 ---~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                         ......++..|+|||++.+.. ++.++|||||||++|||++|+.||........+.++......+.++..+++.+++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence               112345889999999997654 8899999999999999999999998776666666655555556777788999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhcCcccc
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~hp~f~  371 (602)
                      || .||..+|++||+++||++||||+
T Consensus       241 li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhcCcccc
Confidence            99 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.1e-44  Score=396.51  Aligned_cols=259  Identities=29%  Similarity=0.438  Sum_probs=221.6

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc---
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED---  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~---  187 (602)
                      ...+|++.++||+|+||+||+|.+..+|+.||||++....  ........+.+|+.++..++|+||+++++.+...+   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc--CCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3579999999999999999999999999999999987532  22344567889999999999999999988764322   


Q ss_pred             -----eEEEEEeeecCCChhhhhhcc----CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEecc
Q 007478          188 -----KLYIYLEYVSGGSIYKLLQDY----GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADF  258 (602)
Q Consensus       188 -----~~~lVmE~~~ggsL~~~l~~~----~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DF  258 (602)
                           .+++||||+.+|+|.++|...    ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence                 478999999999999998642    46899999999999999999999999999999999999999999999999


Q ss_pred             CccccccCC---CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCC
Q 007478          259 GMAKHIAGQ---SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI  335 (602)
Q Consensus       259 Gla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~  335 (602)
                      |+++.+...   ......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+....+.++... ....+
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~-~~~~~  265 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG-RYDPL  265 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-CCCCC
Confidence            999876432   2234567999999999997765 899999999999999999999999876655555555443 23356


Q ss_pred             CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       336 p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      +..+++++.+||.+||..||++||++.++++|||++..
T Consensus       266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            77899999999999999999999999999999998864

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.2e-44  Score=360.45  Aligned_cols=255  Identities=45%  Similarity=0.841  Sum_probs=219.3

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccc--hhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD--AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      +|++++.||+|+||+||+|... +|+.+|+|.++....  .........+.+|+.++++++|+||+++++++.+.+.+|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5889999999999999999864 688999999875321  1223345678899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC----
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ----  267 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~----  267 (602)
                      ||||+.+++|.+++.+.+.+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++......    
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            9999999999999988788999999999999999999999999999999999999999999999999998765321    


Q ss_pred             ---CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC-CCCCCCCCCCCHHH
Q 007478          268 ---SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-KELPTIPDDLSDEG  343 (602)
Q Consensus       268 ---~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l  343 (602)
                         .......|+..|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+... ...+.++..++.++
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             cccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence               1122356899999999997654 889999999999999999999999876655554444332 33456777899999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          344 KDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       344 ~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .+||++||..+|++||++.++++||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-45  Score=361.12  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=215.2

Q ss_pred             CCCCCCceEe-eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccc-
Q 007478          109 VSPESHWKKG-KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTV-  185 (602)
Q Consensus       109 ~~~~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~-  185 (602)
                      ....++|.+- ++||-|--|.|..|.++.||+.+|+|++.  +.       ..-++|+++.-+. .|||||.++++|+. 
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs  127 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--DS-------PKARREVELHWMASGHPHIVSIIDVYENS  127 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--cC-------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence            3456777764 57999999999999999999999999864  11       1234677765554 79999999998764 


Q ss_pred             ---cceEEEEEeeecCCChhhhhhccCC--CChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC---CceEEec
Q 007478          186 ---EDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN---GRVKLAD  257 (602)
Q Consensus       186 ---~~~~~lVmE~~~ggsL~~~l~~~~~--ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~vKL~D  257 (602)
                         ...+.||||+++||+|+..|+.++.  |+|.++..|++||..|+.|||+.+|.||||||||+|...+   ..+||+|
T Consensus       128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence               4678999999999999999998765  9999999999999999999999999999999999999654   4799999


Q ss_pred             cCccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH----HHHHHhhCCC--C
Q 007478          258 FGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV----AAMFKIGNSK--E  331 (602)
Q Consensus       258 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~----~~~~~i~~~~--~  331 (602)
                      ||+|+.........+.|-|++|+|||++.... |+..+|+||+|||||.||+|.+||....+.    ..-.+|....  .
T Consensus       208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             cccccccCCCccccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            99999877667777889999999999996655 999999999999999999999999765442    1222333322  2


Q ss_pred             CCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       332 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ..+-|..+|++++|+|+.+|..+|.+|.|++++++|||+.....
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            22334579999999999999999999999999999999987643

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-45  Score=391.16  Aligned_cols=260  Identities=28%  Similarity=0.446  Sum_probs=235.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ...|.+.++||+|.|++|.+|++..|+..||||++++..  .+......+.+|+++|+.|+|||||+++.+.+.+..+|+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~--ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ--LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc--cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            457999999999999999999999999999999988632  333344558999999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      ||||+.+|++++++.+++.+.+..++.++.|+..|++|||+++|||||||.+||||+.+.++||+|||++.++.......
T Consensus       133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999888888


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      ++||++.|.|||++.+..+.++.+|+||+|++||.|++|.+||++.+-.....+....+  ..++..++-++++||+++|
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk--~rIp~~ms~dce~lLrk~l  290 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK--YRIPFYMSCDCEDLLRKFL  290 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee--ecccceeechhHHHHHHhh
Confidence            99999999999999999888899999999999999999999998765544444433332  3567789999999999999


Q ss_pred             ccCCCCCCCHHHHhcCccccCCCc
Q 007478          352 QRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       352 ~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ..+|.+|++.++|++|.|+.....
T Consensus       291 vl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  291 VLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             ccCccccCCHHHhhhhcccchhhh
Confidence            999999999999999999986544

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-43  Score=407.10  Aligned_cols=264  Identities=28%  Similarity=0.494  Sum_probs=220.2

Q ss_pred             CCCCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc--
Q 007478          108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV--  185 (602)
Q Consensus       108 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~--  185 (602)
                      ......+|++++.||+|+||+||+|.++.+++.||+|++....  ........+..|+.+|++|+|||||+++++|..  
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~--l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG--LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc--cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            3445679999999999999999999999999999999987532  223345678899999999999999999998754  


Q ss_pred             cceEEEEEeeecCCChhhhhhcc----CCCChHHHHHHHHHHHHHHhhhccC-------CceecCCCCCcEEEcc-----
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDY----GQFGEPAIRNYTQQILSGLAFLHSK-------HTVHRDIKGANILVDP-----  249 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~~----~~ls~~~i~~i~~qIl~aL~yLH~~-------gIvHrDLKp~NILl~~-----  249 (602)
                      ...+||||||+.+|+|.++|...    +.+++..++.|+.||+.||.|||..       +||||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            45799999999999999998752    5799999999999999999999984       5999999999999964     


Q ss_pred             ------------CCceEEeccCccccccCCCCCcccCCCCCCCCccccccc-CCCCccccchhhhhHHHHHhhCCCCCCC
Q 007478          250 ------------NGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS-SGCNLAVDIWSLGCTVLEMATTKPPWSQ  316 (602)
Q Consensus       250 ------------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~~sDVWSLGviLyELltG~~Pf~~  316 (602)
                                  .+.+||+|||++..+.........+||+.|+|||++.+. ..++.++||||||||||||++|+.||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                        235899999999877655444566799999999998643 3478899999999999999999999986


Q ss_pred             chhHHHHHHhhCCCCCCCCC-CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          317 YEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       317 ~~~~~~~~~i~~~~~~~~~p-~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ......+........  .++ ..++.++.+||..||..+|++||++.|+|.|+||+...+
T Consensus       246 ~~~~~qli~~lk~~p--~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        246 ANNFSQLISELKRGP--DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CCcHHHHHHHHhcCC--CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            655554444333221  222 357899999999999999999999999999999987644

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-47  Score=373.77  Aligned_cols=256  Identities=36%  Similarity=0.659  Sum_probs=227.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ++-|.++.+||+|+||.||+|+++.+|+.+|||.+...      ...+++..||.||.+++.+++|++||.+.....+||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            45688999999999999999999999999999988652      235678899999999999999999999888889999


Q ss_pred             EEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-CC
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~  269 (602)
                      |||||..|++.|+++. ++.+++.++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|.++... ..
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            9999999999999874 578999999999999999999999999999999999999999999999999999877543 34


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC--CCCCCCCHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--TIPDDLSDEGKDFI  347 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~s~~l~dLI  347 (602)
                      .+++.||+.|||||++..- +|+.++||||||++..||..|++||.+......++.|... ..|  .-|+..+.++.|||
T Consensus       186 RNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~-PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK-PPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             hCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC-CCCCCCChHhhhhHHHHHH
Confidence            5678899999999999764 4999999999999999999999999987777666666432 222  23456889999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      +.||.++|++|-|+.++++|+|++.+..
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            9999999999999999999999998754

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=388.08  Aligned_cols=280  Identities=27%  Similarity=0.433  Sum_probs=251.5

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceE
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  189 (602)
                      ...++++++..||-|+||.|=++........+|+|++++..... ....+.+..|-+||..++.|+||++|-.|.++..+
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            34677888999999999999999877665679999998744333 33456788999999999999999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      |+.||-|-||+|+..|++++.|.+..++.++..+++|++|||++|||+|||||||+||+.+|.+||.|||+|+.+.....
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  349 (602)
                      +.++|||+.|+|||++.++. .+.++|.||||+++||||+|.+||.+.+.......|.+......+|..++..+.+||++
T Consensus       576 TwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             eeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            99999999999999999865 99999999999999999999999999999988888888888889999999999999999


Q ss_pred             HcccCCCCCCC-----HHHHhcCccccCCCcccccccCCCCCCCCCCC
Q 007478          350 CLQRNPLNRPT-----AAELLDHPFVKGAAPLERTILAPEPSDVPPGV  392 (602)
Q Consensus       350 ~L~~dP~~Rpt-----~~eiL~hp~f~~~~~~~~~~~~~~~~~~~p~~  392 (602)
                      +...+|.+|..     +.+|.+|.||.+-.| +.......++++.+.+
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw-eglr~~~L~pPi~~~v  701 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDW-EGLRSRTLPPPIIPSV  701 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCCh-hhhhhccCCCCccccC
Confidence            99999999985     899999999999888 3333334444444443

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=367.82  Aligned_cols=262  Identities=30%  Similarity=0.485  Sum_probs=222.6

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+.+|+++++.++|+||+++++.+...+..|+|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence            379999999999999999999999999999999875322 2223566788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC--
Q 007478          193 LEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--  268 (602)
                      |||+.|++|.+++...  ..+++..++.++.||+.||+|||++|++|+||||+|||++.++.++|+|||++.......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            9999999999998753  568999999999999999999999999999999999999999999999999987543211  


Q ss_pred             ----------------------------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH
Q 007478          269 ----------------------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV  320 (602)
Q Consensus       269 ----------------------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~  320 (602)
                                                  ......||..|+|||++.+.. ++.++|||||||++|+|++|+.||...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence                                        111346899999999997655 889999999999999999999999877666


Q ss_pred             HHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCC----HHHHhcCccccCCCcc
Q 007478          321 AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPT----AAELLDHPFVKGAAPL  376 (602)
Q Consensus       321 ~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt----~~eiL~hp~f~~~~~~  376 (602)
                      ..+.++............++.++++||++||..||++||+    +++++.||||+...+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~  298 (316)
T cd05574         239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA  298 (316)
T ss_pred             HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence            6565554332222222237999999999999999999999    9999999999987663

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.4e-44  Score=363.84  Aligned_cols=254  Identities=33%  Similarity=0.559  Sum_probs=210.4

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||+|+++.+++.||||+++....  .....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence            58899999999999999999999999999999865321  1223456778999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhcc---CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-
Q 007478          194 EYVSGGSIYKLLQDY---GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-  269 (602)
Q Consensus       194 E~~~ggsL~~~l~~~---~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  269 (602)
                      ||+. ++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence            9997 6888887542   4689999999999999999999999999999999999999999999999999876543221 


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC--------------------
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--------------------  329 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~--------------------  329 (602)
                      .....++..|+|||++.+...++.++|||||||++|||++|++||.+.........+...                    
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            223457899999999876666788999999999999999999999765443333221100                    


Q ss_pred             -------CCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          330 -------KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       330 -------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                             .........+++++.+||++||+.||++|||+.+|++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                   00011223578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-43  Score=358.50  Aligned_cols=253  Identities=30%  Similarity=0.525  Sum_probs=222.1

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCC
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGS  200 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggs  200 (602)
                      ||.|+||.||+|++..+++.||+|++.... .......+.+.+|+.+++.++|+||+++++.+.+++.+|+||||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH-IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhc-chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            699999999999999999999999987532 2223345778999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCCCCCCC
Q 007478          201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM  280 (602)
Q Consensus       201 L~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~  280 (602)
                      |.+++.+...+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.............|+..|+
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  159 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV  159 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence            99999887789999999999999999999999999999999999999999999999999998876554444567899999


Q ss_pred             CcccccccCCCCccccchhhhhHHHHHhhCCCCCCCch--hHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCC
Q 007478          281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE--GVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR  358 (602)
Q Consensus       281 APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~R  358 (602)
                      +||++.+.. ++.++|+|||||++|+|++|+.||....  ......++........++..++.++.+||.+||..||++|
T Consensus       160 ~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  238 (262)
T cd05572         160 APEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER  238 (262)
T ss_pred             ChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence            999987654 8899999999999999999999997665  4445555554445566777789999999999999999999


Q ss_pred             CC-----HHHHhcCccccCCCc
Q 007478          359 PT-----AAELLDHPFVKGAAP  375 (602)
Q Consensus       359 pt-----~~eiL~hp~f~~~~~  375 (602)
                      ++     ++|+++||||++..|
T Consensus       239 ~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         239 LGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             cCCcccCHHHHhcChhhhCCCC
Confidence            99     999999999997654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=387.23  Aligned_cols=236  Identities=32%  Similarity=0.597  Sum_probs=216.4

Q ss_pred             eeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeec
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      ++.||.|+.|.||+|+.+  ++.||||+++.   .        -..+|+-|+.|+|+|||.|.|+|.....+|||||||.
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e---l--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE---L--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh---h--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            567999999999999876  68999998752   1        1247888999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP  277 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~  277 (602)
                      .|.|+..|+....++......|..+|+.|++|||.+.|||||||.-||||..+..|||+|||-++.+........++||.
T Consensus       196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV  275 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV  275 (904)
T ss_pred             cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence            99999999999999999999999999999999999999999999999999999999999999999988888788999999


Q ss_pred             CCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCC
Q 007478          278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN  357 (602)
Q Consensus       278 ~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~  357 (602)
                      .|||||+|.+.. .++|+|||||||+|||||||..||.+.+....++-+......-..|..|++.++-||+.||.-.|..
T Consensus       276 aWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN  354 (904)
T KOG4721|consen  276 AWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN  354 (904)
T ss_pred             hhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence            999999999877 9999999999999999999999999887777776666554445678899999999999999999999


Q ss_pred             CCCHHHHhcC
Q 007478          358 RPTAAELLDH  367 (602)
Q Consensus       358 Rpt~~eiL~h  367 (602)
                      ||++.+||.|
T Consensus       355 RPSFrqil~H  364 (904)
T KOG4721|consen  355 RPSFRQILLH  364 (904)
T ss_pred             CccHHHHHHH
Confidence            9999999988

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.8e-43  Score=352.95  Aligned_cols=253  Identities=30%  Similarity=0.531  Sum_probs=220.5

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|.+.+.||+|+||.||+|.++.+++.|++|.+....  ........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK--MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh--CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence            4888999999999999999999999999999987522  12344567889999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-C
Q 007478          194 EYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-P  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~  270 (602)
                      ||+++++|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.+..... .
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence            999999999999764  5788999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      ....|+..|+|||++.+.. ++.++|||||||++|||++|+.||...+......++... ..+.++..++.++.++|.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG-VFPPVSQMYSQQLAQLIDQC  236 (256)
T ss_pred             hccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCccccCHHHHHHHHHH
Confidence            3456899999999997765 889999999999999999999999877655555555433 34456668899999999999


Q ss_pred             cccCCCCCCCHHHHhcCccc
Q 007478          351 LQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      |+.+|++||++.++++|||+
T Consensus       237 l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         237 LTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=383.32  Aligned_cols=259  Identities=28%  Similarity=0.467  Sum_probs=227.7

Q ss_pred             CCceE--eeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          113 SHWKK--GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       113 ~~y~~--~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      .-|++  .++||+|.||+||-|+++.+|+.||||+|.+.......  ..++++|+.||..++||.||.+-..|++.++++
T Consensus       562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq--esqlR~EVaILq~l~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ--ESQLRNEVAILQNLHHPGIVNLECMFETPERVF  639 (888)
T ss_pred             HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch--HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence            34554  47899999999999999999999999999875444333  378999999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhh-hccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC---CceEEeccCccccccC
Q 007478          191 IYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN---GRVKLADFGMAKHIAG  266 (602)
Q Consensus       191 lVmE~~~ggsL~~~l-~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~vKL~DFGla~~~~~  266 (602)
                      +|||-+.|.-|.-+| .+.+++++...+.++.||+.||+|||-+||+|+||||||||+...   -++||||||+|+.+..
T Consensus       640 VVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  640 VVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             EEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            999999654444444 356899999999999999999999999999999999999999654   3799999999999999


Q ss_pred             CCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          267 QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                      .....+++||+.|+|||+++++. |+..-|+||+|||+|.-|.|..||.+.+++.....-..-...+.-+..++.++.||
T Consensus       720 ksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~Aidl  798 (888)
T KOG4236|consen  720 KSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDL  798 (888)
T ss_pred             hhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHH
Confidence            88888999999999999998765 99999999999999999999999998777665555444455566677899999999


Q ss_pred             HHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          347 IRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      |+.+|+..-++|.++++.|.|||+++..
T Consensus       799 In~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  799 INNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHhcchHhhccchhhhcch
Confidence            9999999999999999999999999864

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-43  Score=362.56  Aligned_cols=256  Identities=28%  Similarity=0.547  Sum_probs=215.1

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.....  .....+.+.+|+.++++++|+||+++++++.....+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence            469999999999999999999999999999998864221  112234577899999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  271 (602)
                      |||++++.|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..+.... ...
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence            9999999998888777789999999999999999999999999999999999999999999999999998765443 223


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC--------------------CC
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--------------------KE  331 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~--------------------~~  331 (602)
                      ...++..|+|||++.+...++.++|||||||++|||++|+.||.+....+....+...                    ..
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            4568899999999876555888999999999999999999999866554433322110                    00


Q ss_pred             CCC---------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          332 LPT---------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       332 ~~~---------~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .+.         ....++..+.+||.+||+.||++||++.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            000         013568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-43  Score=360.05  Aligned_cols=255  Identities=40%  Similarity=0.674  Sum_probs=214.4

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ...+|++++.||+|+||.||+|+++.+++.||+|++....    ......+.+|+.++++++|+||+++++++..++.+|
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            3568999999999999999999999999999999986421    122346788999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      +||||+.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..+.... .
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence            999999999999999887889999999999999999999999999999999999999999999999999998764322 2


Q ss_pred             CcccCCCCCCCCcccccc--cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC-C--CCCCCCHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-T--IPDDLSDEGK  344 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~--~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~-~--~p~~~s~~l~  344 (602)
                      .....|+..|+|||++..  ...++.++|||||||++|||++|+.||...........+......+ .  ....++.++.
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence            234568999999999842  3346789999999999999999999997654433333322221111 1  1235789999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhcCcc
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDHPF  369 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~hp~  369 (602)
                      +||++||..||++||++++|++|+|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-43  Score=360.61  Aligned_cols=254  Identities=34%  Similarity=0.659  Sum_probs=213.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccc-----
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTV-----  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~-----  185 (602)
                      ...|++.+.||+|+||.||+|.+..+++.||+|++....     .....+.+|+.+++++ +|+||+++++++..     
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            467889999999999999999999999999999986422     1234677899999998 79999999998764     


Q ss_pred             -cceEEEEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          186 -EDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       186 -~~~~~lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                       +..+|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||++.
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence             24689999999999999998763  468999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC-CCCcccCCCCCCCCcccccc----cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCC
Q 007478          263 HIAGQ-SCPLSFKGSPYWMAPEVIKN----SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD  337 (602)
Q Consensus       263 ~~~~~-~~~~~~~GT~~Y~APEvl~~----~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  337 (602)
                      ..... .......|+..|+|||++..    ...++.++|||||||++|||++|+.||...........+.........+.
T Consensus       160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd06637         160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK  239 (272)
T ss_pred             ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence            65432 22335679999999999863    22478899999999999999999999976655444444433333333345


Q ss_pred             CCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       338 ~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .++.++.+||.+||..||++|||+.++++||||
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            688999999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.3e-43  Score=367.42  Aligned_cols=256  Identities=32%  Similarity=0.551  Sum_probs=215.6

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||.||++.+..++..+|+|.++..   .......++.+|++++++++||||+++++++.+++.+|+|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE---IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            3699999999999999999999999999999988642   1233456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      |||+++++|.+++.+.+.+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++...... ...
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~  156 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN  156 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccc
Confidence            9999999999999888889999999999999999999997 69999999999999999999999999998765432 234


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhC-----------------------
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN-----------------------  328 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~-----------------------  328 (602)
                      ..+|+..|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+..                       
T Consensus       157 ~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         157 SFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             cCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            567999999999987654 88899999999999999999999965432222111110                       


Q ss_pred             ------------CCCCCCCC-CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          329 ------------SKELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       329 ------------~~~~~~~p-~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                                  ....+.++ ..++.++++||.+||..||++||++.+|++||||...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                        00111222 1367899999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.5e-44  Score=371.07  Aligned_cols=246  Identities=27%  Similarity=0.499  Sum_probs=193.4

Q ss_pred             eeeEeecCCeEEEEEEECC--CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc--cceEEEEE
Q 007478          118 GKMLGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV--EDKLYIYL  193 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lVm  193 (602)
                      +++||+|+||+||+|+++.  +++.||+|.+....      ....+.+|+.+|++++||||+++++++..  +..+|++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            5789999999999999763  67899999886421      12345689999999999999999998753  45789999


Q ss_pred             eeecCCChhhhhhcc---------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEE----ccCCceEEeccCc
Q 007478          194 EYVSGGSIYKLLQDY---------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV----DPNGRVKLADFGM  260 (602)
Q Consensus       194 E~~~ggsL~~~l~~~---------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl----~~~g~vKL~DFGl  260 (602)
                      ||+. ++|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            9985 6888877532         258899999999999999999999999999999999999    4567899999999


Q ss_pred             cccccCCC----CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh------------HHHHH
Q 007478          261 AKHIAGQS----CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG------------VAAMF  324 (602)
Q Consensus       261 a~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~------------~~~~~  324 (602)
                      ++.+....    ......||+.|+|||++.+...++.++|||||||++|||++|++||.....            ...+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            98764322    223467899999999998766689999999999999999999999953221            11111


Q ss_pred             HhhCC---------CCCC------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          325 KIGNS---------KELP------------------------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       325 ~i~~~---------~~~~------------------------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .+...         ...+                        ......+.++.+||++||++||++|+|++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            11000         0000                        0011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-43  Score=357.29  Aligned_cols=257  Identities=39%  Similarity=0.786  Sum_probs=220.1

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccch--hcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA--KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~--~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      +|+.++.||+|+||.||++.+..+++.||+|++......  ......+.+.+|++++++++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            488899999999999999999999999999998753221  122346788999999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC-ceEEeccCccccccCCC--
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-RVKLADFGMAKHIAGQS--  268 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~--  268 (602)
                      ||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++..+....  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998776 59999999987764321  


Q ss_pred             ---CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh---HHHHHHhhCCCCCCCCCCCCCHH
Q 007478          269 ---CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG---VAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       269 ---~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                         ......||..|+|||++.+.. ++.++|||||||++|+|++|+.||.....   ...+..+......+.++..++++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             CCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence               122346889999999987654 88999999999999999999999964332   23333443344556677789999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhcCcccc
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~  371 (602)
                      +.++|.+||..+|++||++.++++||||+
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-43  Score=367.44  Aligned_cols=259  Identities=25%  Similarity=0.446  Sum_probs=214.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||+|.++.+++.||+|.++.....   .....+.+|+.+++.++|+||+++++++..++.+|+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            56899999999999999999999999999999998753221   123356789999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      ||||+. ++|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus        82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            999996 688888765 3568999999999999999999999999999999999999999999999999997654322 2


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC--------------------
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--------------------  329 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~--------------------  329 (602)
                      .....+++.|+|||++.+...++.++|||||||++|||++|++||...+.......+...                    
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            223457899999999877666888999999999999999999999765543332221110                    


Q ss_pred             CCCC--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          330 KELP--------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       330 ~~~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ...+        .....+++++++||.+||+.||.+|||++|+++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            0001        11235788999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.9e-43  Score=361.92  Aligned_cols=264  Identities=36%  Similarity=0.663  Sum_probs=221.9

Q ss_pred             CCCCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       108 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      .....+.|++++.||.|+||.||+|.+..+++.||+|++..    ......+.+.+|+.+++.++|+||+++++++..++
T Consensus         7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644           7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            33445789999999999999999999999999999999864    23345677889999999999999999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          188 KLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      .+|+||||+++++|..++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999999999988754 45789999999999999999999999999999999999999999999999999876433


Q ss_pred             C-CCCcccCCCCCCCCcccccc----cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-CCCCCCCCC
Q 007478          267 Q-SCPLSFKGSPYWMAPEVIKN----SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-LPTIPDDLS  340 (602)
Q Consensus       267 ~-~~~~~~~GT~~Y~APEvl~~----~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s  340 (602)
                      . .......++..|+|||++..    ...++.++|||||||++|||++|..||...+......++..... ....+..++
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS  242 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccC
Confidence            2 12234568999999999852    23367899999999999999999999987655444444433221 123345788


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       341 ~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      .++.+||++||..||++||+++++++||||....+
T Consensus       243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            99999999999999999999999999999987654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-43  Score=360.27  Aligned_cols=254  Identities=40%  Similarity=0.702  Sum_probs=214.0

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++...    ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence            458999999999999999999999999999999987522    2234567789999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CC
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  270 (602)
                      ||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999987654322 12


Q ss_pred             cccCCCCCCCCccccc--ccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC-CCC--CCCCHHHHH
Q 007478          271 LSFKGSPYWMAPEVIK--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-TIP--DDLSDEGKD  345 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~--~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p--~~~s~~l~d  345 (602)
                      ....||..|+|||++.  ....++.++|||||||++|||++|+.||..................+ .+.  ..++..+.+
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH  243 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence            3456999999999974  23347889999999999999999999997654433333322222111 111  247789999


Q ss_pred             HHHHHcccCCCCCCCHHHHhcCcc
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPF  369 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~hp~  369 (602)
                      ||++||..||++||++++|++|||
T Consensus       244 li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         244 FVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.7e-43  Score=351.78  Aligned_cols=253  Identities=32%  Similarity=0.601  Sum_probs=216.3

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc-cceEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV-EDKLYIY  192 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV  192 (602)
                      .|++.+.||+|+||.||++.++.+++.||+|++....  ......+.+.+|+.++++++|+||+++++.+.. +..+|+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence            4899999999999999999999999999999986422  223345668899999999999999999988764 4568999


Q ss_pred             EeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          193 LEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      |||+++++|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence            9999999999999753  458999999999999999999999999999999999999999999999999998764322 2


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  349 (602)
                      .....|++.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+... ..+.++..+++++.+||.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~  236 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-KLPPMPKDYSPELGELIAT  236 (257)
T ss_pred             cccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCccccCHHHHHHHHH
Confidence            23456899999999997765 888999999999999999999999876554444444332 3345667899999999999


Q ss_pred             HcccCCCCCCCHHHHhcCccc
Q 007478          350 CLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ||+.||++||++.++++||||
T Consensus       237 ~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         237 MLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-43  Score=363.64  Aligned_cols=254  Identities=31%  Similarity=0.558  Sum_probs=208.0

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||+|+++.+|+.||+|+++....  .......+.+|+.++++++|+||+++++++.+.+.+|+|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence            48899999999999999999999999999999875321  1223355778999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CCc
Q 007478          194 EYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPL  271 (602)
Q Consensus       194 E~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  271 (602)
                      ||+. ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence            9996 578877754 5679999999999999999999999999999999999999999999999999998654322 223


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCC-CchhHHHHHHhhC------------------CCCC
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWS-QYEGVAAMFKIGN------------------SKEL  332 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~-~~~~~~~~~~i~~------------------~~~~  332 (602)
                      ...++..|+|||++.+...++.++|||||||++|||++|..||. ..+....+..+..                  ....
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence            34578999999998776667899999999999999999888863 3222222211110                  0001


Q ss_pred             C---------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          333 P---------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       333 ~---------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +         .....+++++++||.+||..||++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            1         1123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.3e-43  Score=359.51  Aligned_cols=251  Identities=29%  Similarity=0.560  Sum_probs=210.9

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.++||+|+||.||+|++..+++.||+|++....   .......+.+|+.++++++||||+++++++...+..++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            36889999999999999999999999999999886421   233456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS  272 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  272 (602)
                      |||+++++|..+    ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... ...
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-~~~  152 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKT  152 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-ccC
Confidence            999999998654    357889999999999999999999999999999999999999999999999998764332 334


Q ss_pred             cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh-------HHHHHHhhCCCCCCCC-CCCCCHHHH
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG-------VAAMFKIGNSKELPTI-PDDLSDEGK  344 (602)
Q Consensus       273 ~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~-p~~~s~~l~  344 (602)
                      .+||..|+|||++.+.. ++.++|||||||++|+|++|+.||.....       ......+... ..+.+ ....+.+++
T Consensus       153 ~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  230 (279)
T cd06619         153 YVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-DPPVLPVGQFSEKFV  230 (279)
T ss_pred             CCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-CCCCCCCCcCCHHHH
Confidence            67999999999997655 88999999999999999999999964221       1111112111 11222 235788999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      +||.+||+.||++||+++++++||||...
T Consensus       231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         231 HFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            99999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-43  Score=356.45  Aligned_cols=254  Identities=31%  Similarity=0.506  Sum_probs=222.0

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+.+|++++++++||||+++++++...+.+|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK-CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh-hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            4899999999999999999999999999999987522 222234678899999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCccc
Q 007478          194 EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF  273 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  273 (602)
                      ||+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  159 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST  159 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence            99999999999988778999999999999999999999999999999999999999999999999999876554444456


Q ss_pred             CCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh--HHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       274 ~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      .|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||.....  ...+...... ....++..++.++.++|.+||
T Consensus       160 ~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l  237 (258)
T cd05578         160 SGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKLL  237 (258)
T ss_pred             CCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHHc
Confidence            6899999999997655 88999999999999999999999986543  2333332222 445667789999999999999


Q ss_pred             ccCCCCCCCH--HHHhcCccc
Q 007478          352 QRNPLNRPTA--AELLDHPFV  370 (602)
Q Consensus       352 ~~dP~~Rpt~--~eiL~hp~f  370 (602)
                      ..||.+|+++  .|+++||||
T Consensus       238 ~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         238 ERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             cCChhHcCCccHHHHhcCCCC
Confidence            9999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.2e-43  Score=362.70  Aligned_cols=243  Identities=20%  Similarity=0.271  Sum_probs=209.4

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc----cceEEEEEe
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV----EDKLYIYLE  194 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lVmE  194 (602)
                      ..||+|++|.||+|.+  +|+.||||+++... .......+.+.+|+.+|++++||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccc-cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            6799999999999987  58899999987532 2334446778899999999999999999998866    357899999


Q ss_pred             eecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccCCCCCccc
Q 007478          195 YVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF  273 (602)
Q Consensus       195 ~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  273 (602)
                      |+.+|+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+....  ...
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~  180 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKN  180 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccc
Confidence            99999999999988889999999999999999999998 499999999999999999999999999998764332  345


Q ss_pred             CCCCCCCCccccccc-CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcc
Q 007478          274 KGSPYWMAPEVIKNS-SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ  352 (602)
Q Consensus       274 ~GT~~Y~APEvl~~~-~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  352 (602)
                      .||..|+|||++.+. ..++.++|||||||++|||++|+.||...+.......+......+.++..++.++++||.+||+
T Consensus       181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~  260 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS  260 (283)
T ss_pred             cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence            689999999998652 3489999999999999999999999988766555555544444556666899999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q 007478          353 RNPLNRPTAAELLD  366 (602)
Q Consensus       353 ~dP~~Rpt~~eiL~  366 (602)
                      .||++|||+.++++
T Consensus       261 ~dp~~Rps~~ell~  274 (283)
T PHA02988        261 HDSIKRPNIKEILY  274 (283)
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999986

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.9e-43  Score=371.17  Aligned_cols=255  Identities=26%  Similarity=0.429  Sum_probs=207.0

Q ss_pred             EeeeEeec--CCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEe
Q 007478          117 KGKMLGRG--TFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       117 ~~~~LG~G--~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE  194 (602)
                      ++++||+|  +|++||++.++.+|+.||+|+++...  ......+.+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA--CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhh--ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            56789999  78999999999999999999986422  223445678889999999999999999999999999999999


Q ss_pred             eecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC---
Q 007478          195 YVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC---  269 (602)
Q Consensus       195 ~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~---  269 (602)
                      |+++|+|.+++..+  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||+.+........   
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            99999999999653  4589999999999999999999999999999999999999999999999987544321110   


Q ss_pred             -----CcccCCCCCCCCccccccc-CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC-----------
Q 007478          270 -----PLSFKGSPYWMAPEVIKNS-SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL-----------  332 (602)
Q Consensus       270 -----~~~~~GT~~Y~APEvl~~~-~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~-----------  332 (602)
                           .....++..|+|||++.+. ..++.++|||||||++|||++|+.||..................           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE  239 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence                 1123467889999999753 35889999999999999999999999764433322221111000           


Q ss_pred             ---------------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          333 ---------------------------------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       333 ---------------------------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                                                       ......+++++.+||++||+.||++|||++|+++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                             00112357789999999999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.1e-43  Score=353.82  Aligned_cols=254  Identities=36%  Similarity=0.670  Sum_probs=218.0

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++++.||.|+||+||+|.+..++..+|+|++.....   ....+.+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence            479999999999999999999998999999998864222   22567789999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhcc---CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          193 LEYVSGGSIYKLLQDY---GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~---~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||++..+.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999999999763   4589999999999999999999999999999999999999999999999999877654332


Q ss_pred             C-----cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC-----CCC
Q 007478          270 P-----LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP-----DDL  339 (602)
Q Consensus       270 ~-----~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-----~~~  339 (602)
                      .     ....|+..|+|||++.....++.++|||||||++|||++|+.||...+......++.... .+.+.     ..+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  236 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKY  236 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccccc
Confidence            2     345689999999998776558899999999999999999999998766554444443321 11121     267


Q ss_pred             CHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       340 s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +.++.+||.+||..||++||++++|++||||
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            8999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.4e-43  Score=356.14  Aligned_cols=257  Identities=50%  Similarity=0.876  Sum_probs=218.3

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccc------hhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD------AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~------~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|.++....      .......+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68899999999999999999999999999998864211      112223457889999999999999999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      .+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999765432


Q ss_pred             C---CCcccCCCCCCCCcccccccC-CCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC----CCC
Q 007478          268 S---CPLSFKGSPYWMAPEVIKNSS-GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP----DDL  339 (602)
Q Consensus       268 ~---~~~~~~GT~~Y~APEvl~~~~-~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p----~~~  339 (602)
                      .   ......|+..|+|||++.... .++.++|||||||++|||++|..||...+....+.++........++    ..+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence            1   123456899999999987543 47889999999999999999999998766655555544333222222    356


Q ss_pred             CHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       340 s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +.++.+||.+||..||++||+++++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=383.22  Aligned_cols=259  Identities=39%  Similarity=0.690  Sum_probs=229.0

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ....|.-++.||.|+||.||.|++..|.+.||||++.. ......+...++..|+.+|.+++|||+|.+-|||.-+...|
T Consensus        24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsy-SGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW  102 (948)
T KOG0577|consen   24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW  102 (948)
T ss_pred             HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccc-cccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence            34568888999999999999999999999999999875 33455666788999999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          191 IYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||||||- |+-.|++.- ++++-+.+|..|..+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|..+..   
T Consensus       103 LVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  103 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            9999994 677777753 46899999999999999999999999999999999999999999999999999987654   


Q ss_pred             CcccCCCCCCCCccccc--ccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC-CCCCHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIK--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDF  346 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~--~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~s~~l~dL  346 (602)
                      .++++|||+|||||+|.  ....|+-++||||||++-.||...++|+..++....+..|.... .|.++ ...+..++.|
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPtLqs~eWS~~F~~F  257 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQSNEWSDYFRNF  257 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCCCCCchhHHHHHHH
Confidence            45789999999999984  33458999999999999999999999999999999998887543 34443 4588999999


Q ss_pred             HHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          347 IRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      |..||++-|.+|||.+++|.|+|+...++
T Consensus       258 vd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  258 VDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             HHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            99999999999999999999999976554

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-43  Score=357.94  Aligned_cols=256  Identities=39%  Similarity=0.713  Sum_probs=222.3

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||.|+||.||+|++..+++.||+|++....   .......+.+|+.+++.++|+||+++++++.++..+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            36889999999999999999999999999999987422   233446678999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-CCCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~  271 (602)
                      +||+.+++|.+++... .+++..++.++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++.+... ....
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence            9999999999999865 8899999999999999999999999999999999999999999999999999887644 2233


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCC-CCHHHHHHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD-LSDEGKDFIRLC  350 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~s~~l~dLI~~~  350 (602)
                      ...|+..|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+... ..+.++.. ++.++.++|.+|
T Consensus       157 ~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~  234 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSLC  234 (274)
T ss_pred             cccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccccCHHHHHHHHHH
Confidence            456899999999997766 899999999999999999999999876654444444332 33444444 899999999999


Q ss_pred             cccCCCCCCCHHHHhcCccccCCC
Q 007478          351 LQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      |..||++|||++++++|+||+...
T Consensus       235 l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         235 LNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             hhCChhhCcCHHHHhhChhhcCCC
Confidence            999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-43  Score=359.75  Aligned_cols=259  Identities=39%  Similarity=0.683  Sum_probs=221.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||.|+||.||++.+..+++.||+|+++..    .....+.+.+|+.++++++|+||+++++.+..+..+|+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            45799999999999999999999989999999998642    33345678899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      ||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... .
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            99999999999998764 569999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             CcccCCCCCCCCcccccc----cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-CCCCCCCCCHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKN----SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-LPTIPDDLSDEGK  344 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~----~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~  344 (602)
                      .....||..|+|||++..    ...++.++|||||||++|||++|+.||...+....+.++..... ....+..++.++.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN  239 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence            234568999999999853    23367799999999999999999999988766655555544322 1233557899999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      +||.+||+.||++||+++++++|+||....
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            999999999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=420.35  Aligned_cols=262  Identities=44%  Similarity=0.769  Sum_probs=231.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .-+|+.+.+||.|.||.||.|.+.+||+..|+|.+++....  ....+.+.+|..+|..|+|||||++||+....+.++|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            45788999999999999999999999999999999874433  4456778899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC--
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC--  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--  269 (602)
                      .||||+||+|.++++..+...+...+.+..|++.||.|||+.|||||||||+||||+.+|.+|++|||.|..+.....  
T Consensus      1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            999999999999999887888888999999999999999999999999999999999999999999999988765531  


Q ss_pred             ---CcccCCCCCCCCcccccccC--CCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHH
Q 007478          270 ---PLSFKGSPYWMAPEVIKNSS--GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGK  344 (602)
Q Consensus       270 ---~~~~~GT~~Y~APEvl~~~~--~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  344 (602)
                         .....||+.|||||++.+..  +..-+.|||||||++.||+||+.||.+.+..-++.-.......|.+|..++.+.+
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence               22467999999999997643  4566999999999999999999999887665444433345567899999999999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      +||..||+.||++|+++.||++|.|-+....
T Consensus      1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             HHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence            9999999999999999999999999876543

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.8e-43  Score=357.98  Aligned_cols=257  Identities=37%  Similarity=0.638  Sum_probs=218.0

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +.|++.+.||+|+||.||++.+..++..+++|.+...    .....+.+.+|+.+++.++|+||+++++++..++..|+|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            4578899999999999999999999999999988642    233456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-CCC
Q 007478          193 LEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCP  270 (602)
Q Consensus       193 mE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~  270 (602)
                      |||+.+++|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... ...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            999999999988754 467899999999999999999999999999999999999999999999999998765332 122


Q ss_pred             cccCCCCCCCCccccc----ccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-CCCCCCCCCHHHHH
Q 007478          271 LSFKGSPYWMAPEVIK----NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-LPTIPDDLSDEGKD  345 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~----~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~d  345 (602)
                      ....||..|+|||++.    ....++.++|||||||++|||++|++||...+.......+..... ....+..++.++++
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence            3456899999999984    223477899999999999999999999987665555555433221 22345578999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      ||++||..||++||+++++++||||+..
T Consensus       241 li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            9999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-43  Score=352.30  Aligned_cols=254  Identities=41%  Similarity=0.692  Sum_probs=217.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++....    .+..+.+.+|+.++++++||||+++++++...+.+|+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            468999999999999999999999999999999987522    2245778899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      +|||+.+++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... .
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            99999999999999775 789999999999999999999999999999999999999999999999999998765432 2


Q ss_pred             CcccCCCCCCCCccccccc--CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC---CCCCCCCCHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNS--SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL---PTIPDDLSDEGK  344 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~--~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~---~~~p~~~s~~l~  344 (602)
                      .....++..|+|||++.+.  ..++.++|||||||++|||++|+.||.+.........+......   .......+.++.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            2345689999999998655  24788999999999999999999999876554444433322111   122345678999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhcCcc
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDHPF  369 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~hp~  369 (602)
                      +||++||..||++|||+.+|+.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-42  Score=374.01  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=207.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEEC--CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNS--DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  189 (602)
                      ..+|++++.||+|+||.||+|...  .+++.||+|.+...         +...+|+.+|+.++|+|||++++++..++.+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            457999999999999999999764  35678999987531         1245799999999999999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      |+|||++. ++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus       162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            99999995 78999997778899999999999999999999999999999999999999999999999999977654322


Q ss_pred             ---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh---HHHHHHhh---CC-----------
Q 007478          270 ---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG---VAAMFKIG---NS-----------  329 (602)
Q Consensus       270 ---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~---~~~~~~i~---~~-----------  329 (602)
                         .....||+.|+|||++.... ++.++|||||||+||||++|+.||.+...   ...+..+.   ..           
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             cccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence               23467999999999997655 88999999999999999999999964321   11111110   00           


Q ss_pred             -----------CCCC--CCC-----CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          330 -----------KELP--TIP-----DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       330 -----------~~~~--~~p-----~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                 ...+  .++     ..++.++++||++||..||++|||+.|+|.||||+...+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence                       0000  011     235678999999999999999999999999999987544

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.9e-43  Score=356.78  Aligned_cols=255  Identities=36%  Similarity=0.663  Sum_probs=213.2

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTV----  185 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~----  185 (602)
                      ....|++.+.||.|+||.||+|.+..+++.||+|++...     ......+..|+.+++++ +|+||+++++++..    
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            346899999999999999999999999999999988642     12335677899999998 79999999998742    


Q ss_pred             --cceEEEEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcc
Q 007478          186 --EDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA  261 (602)
Q Consensus       186 --~~~~~lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla  261 (602)
                        .+.+|++|||+.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence              46789999999999999999753  45788889999999999999999999999999999999999999999999998


Q ss_pred             ccccCC-CCCcccCCCCCCCCcccccc----cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC
Q 007478          262 KHIAGQ-SCPLSFKGSPYWMAPEVIKN----SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP  336 (602)
Q Consensus       262 ~~~~~~-~~~~~~~GT~~Y~APEvl~~----~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p  336 (602)
                      ...... .......|+..|+|||++..    ...++.++|||||||++|||++|+.||........+..+..........
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  248 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS  248 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence            765432 22334669999999999853    2347889999999999999999999997765555454443333322333


Q ss_pred             CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       337 ~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ..++.++.+||++||+.||.+||++.||++||||
T Consensus       249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            4689999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-43  Score=373.06  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=202.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ...|++.+.||+|+||.||+|.+..+++.||+|+....          ....|+.++++++|+||+++++++...+..|+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            45799999999999999999999999999999975321          12468999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      ||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++........
T Consensus       135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            999995 688888764 467999999999999999999999999999999999999999999999999999865444444


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCC-CCCCchh---------HHHHHHhhCCC--CCCCCC--
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP-PWSQYEG---------VAAMFKIGNSK--ELPTIP--  336 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~-Pf~~~~~---------~~~~~~i~~~~--~~~~~p--  336 (602)
                      ....||..|+|||++.+.. ++.++|||||||++|||+++.. +|.....         ...+.++....  ....++  
T Consensus       214 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            5667999999999997765 8999999999999999998544 4432110         11111111000  000011  


Q ss_pred             ----------------------------CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccC
Q 007478          337 ----------------------------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       337 ----------------------------~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~  372 (602)
                                                  ..++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                        146778889999999999999999999999999985

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.3e-42  Score=350.32  Aligned_cols=257  Identities=39%  Similarity=0.667  Sum_probs=223.2

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||.||+|++..+++.||+|++......   .....+.+|+.++..++|+||+++++++...+.+|+|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            3689999999999999999999999999999998753221   4467788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      |||+++++|.+++.....+++..++.++.||+.||.|||+ +|++||||+|+||+++.++.++|+|||++..........
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            9999999999999887889999999999999999999999 999999999999999999999999999998765443332


Q ss_pred             -ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCch--hHHHHHHhhCCCCCCCCCCC-CCHHHHHHH
Q 007478          272 -SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE--GVAAMFKIGNSKELPTIPDD-LSDEGKDFI  347 (602)
Q Consensus       272 -~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~-~s~~l~dLI  347 (602)
                       ...++..|+|||.+.+.. ++.++||||||+++|+|++|+.||....  ......+.......+.++.. ++..+.++|
T Consensus       158 ~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (264)
T cd06623         158 NTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI  236 (264)
T ss_pred             cceeecccccCHhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence             456899999999987664 8899999999999999999999997764  32333322233344455666 899999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccccCC
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      .+||..+|++||++.++++||||+..
T Consensus       237 ~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         237 SACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHccCChhhCCCHHHHHhCHHHHhc
Confidence            99999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-42  Score=360.33  Aligned_cols=261  Identities=27%  Similarity=0.423  Sum_probs=219.9

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||.||++.++.+++.||+|.+.... .........+.+|+.+++.++|+||+++++.+..++.+|+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh-hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            36899999999999999999999999999999887532 12233456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC----
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS----  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~----  268 (602)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999986421100    


Q ss_pred             ------------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC-CCCCC
Q 007478          269 ------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-ELPTI  335 (602)
Q Consensus       269 ------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~  335 (602)
                                  ......|+..|+|||.+.+.. ++.++|||||||++|||++|..||.+.........+.... ..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG  238 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc
Confidence                        011245788999999987654 8899999999999999999999998665544444433322 22333


Q ss_pred             CCCCCHHHHHHHHHHcccCCCCCCC---HHHHhcCccccCCCc
Q 007478          336 PDDLSDEGKDFIRLCLQRNPLNRPT---AAELLDHPFVKGAAP  375 (602)
Q Consensus       336 p~~~s~~l~dLI~~~L~~dP~~Rpt---~~eiL~hp~f~~~~~  375 (602)
                      ...++.++.+||++||+.||++||+   +.++++||||....+
T Consensus       239 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            3468999999999999999999998   799999999987655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-42  Score=360.55  Aligned_cols=259  Identities=34%  Similarity=0.641  Sum_probs=219.8

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+.....    .....+.+|+.+++.++|+||+++++.+......|
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence            34689999999999999999999999999999998875222    22456789999999999999999999999899999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  269 (602)
                      +||||+++++|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999999999999865 4689999999999999999999999999999999999999999999999999886543322 


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC-CCCCCCCCCCCHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-KELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~dLI~  348 (602)
                      .....|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+... ......+..++..+.+||.
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             cCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence            22356899999999987654 789999999999999999999999876554433333222 1222345678899999999


Q ss_pred             HHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          349 LCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       349 ~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      +||.+||++||++.+|++|+||.....
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhhccCC
Confidence            999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-42  Score=357.44  Aligned_cols=253  Identities=31%  Similarity=0.479  Sum_probs=207.4

Q ss_pred             eEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHH---HHHhcCCCcEEEEeccccccceEEEEEeee
Q 007478          120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV---LLSRLRHPNIVQYYGSKTVEDKLYIYLEYV  196 (602)
Q Consensus       120 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~---iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~  196 (602)
                      +||+|+||.||++.+..+++.||+|++......... ......+|..   ++...+|+||+.+++++..++..|+||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch-HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence            489999999999999999999999988653221111 1222334433   344458999999999999899999999999


Q ss_pred             cCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCCC
Q 007478          197 SGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS  276 (602)
Q Consensus       197 ~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT  276 (602)
                      .+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....||
T Consensus        80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  158 (279)
T cd05633          80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT  158 (279)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCC
Confidence            999999999888889999999999999999999999999999999999999999999999999987654332 2345699


Q ss_pred             CCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh--HHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccC
Q 007478          277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRN  354 (602)
Q Consensus       277 ~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~d  354 (602)
                      ..|+|||++.+...++.++|||||||++|||++|..||.....  ........ ......++..++.++.+||++||..|
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~  237 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLLQRD  237 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHhcCC
Confidence            9999999987555588999999999999999999999965322  22222221 12233567789999999999999999


Q ss_pred             CCCCC-----CHHHHhcCccccCCCc
Q 007478          355 PLNRP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       355 P~~Rp-----t~~eiL~hp~f~~~~~  375 (602)
                      |++|+     ++.++++||||++..+
T Consensus       238 p~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         238 VSKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             HHHhcCCCCCCHHHHHhCccccCCCH
Confidence            99999     6999999999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=351.26  Aligned_cols=256  Identities=48%  Similarity=0.848  Sum_probs=222.3

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccc-hhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc--ceE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD-AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE--DKL  189 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~  189 (602)
                      .+|++.+.||+|+||.||+|.++.+++.||+|++..... .........+.+|+.++++++|+||+++++++.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            579999999999999999999999999999998764221 12334567888999999999999999999987653  568


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC--
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ--  267 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  267 (602)
                      ++||||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            999999999999999988778999999999999999999999999999999999999999999999999999865321  


Q ss_pred             --CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          268 --SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       268 --~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                        .......|+..|+|||++.+.. ++.++|||||||++|||++|+.||........+.++......+.++..+++++.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence              1122456899999999997654 8889999999999999999999998877777777666555556788899999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhcCccc
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +|++||+ ++.+||++.+++.|||+
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999 57999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7e-43  Score=360.37  Aligned_cols=261  Identities=28%  Similarity=0.491  Sum_probs=217.4

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccch-hcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA-KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +|++.+.||+|+||.||+|.+..+|+.||||+++..... ........+..|+.++++++|+||+++++++.+++.+|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            488999999999999999999999999999998753322 1123345677899999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccC-CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CC
Q 007478          193 LEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CP  270 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  270 (602)
                      |||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 999999998765 79999999999999999999999999999999999999999999999999998765432 22


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-------------------
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-------------------  331 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-------------------  331 (602)
                      ....++..|+|||++.+...++.++|||||||++|||++|.++|........+.++.....                   
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            2345788999999987655688999999999999999999988876554443333321100                   


Q ss_pred             -------CCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          332 -------LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       332 -------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                             .......++.++.+||.+||..||++|||+.|+++|+||++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence                   00112346789999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.7e-43  Score=356.88  Aligned_cols=255  Identities=26%  Similarity=0.472  Sum_probs=214.6

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.....  .......+.+|+.++++++|+||+++++++...+.+|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence            58999999999999999999999999999999875321  1233567889999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC--CC
Q 007478          194 EYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--CP  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~~  270 (602)
                      ||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......  ..
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence            999 9999999865 4568999999999999999999999999999999999999999999999999998765433  12


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-------------------
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-------------------  331 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-------------------  331 (602)
                      ....|+..|+|||++.+...++.++|||||||++|||++|.++|...........+.....                   
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            3456899999999987666678999999999999999999998876554433332221100                   


Q ss_pred             ---------CCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCcccc
Q 007478          332 ---------LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       332 ---------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~  371 (602)
                               ...+...++.++.+||++||..||++||++++++.||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                     0011235678999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.9e-43  Score=357.89  Aligned_cols=258  Identities=33%  Similarity=0.587  Sum_probs=217.8

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||.||++.+..+++.||+|.++..   ........+.+|+.++++++|+||+++++++...+.+|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence            4689999999999999999999999999999988642   1233346788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhcc---CCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          193 LEYVSGGSIYKLLQDY---GQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~---~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      |||+++++|..++...   ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..+....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999999988763   378999999999999999999996 699999999999999999999999999997764332


Q ss_pred             CCcccCCCCCCCCcccccccC-----CCCccccchhhhhHHHHHhhCCCCCCCchhHH---HHHHhhCCCCCCCCCCCCC
Q 007478          269 CPLSFKGSPYWMAPEVIKNSS-----GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLS  340 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~-----~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~---~~~~i~~~~~~~~~p~~~s  340 (602)
                       .....|+..|+|||++.+..     .++.++|||||||++|||++|+.||.......   .+..+. ....+.++..++
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (286)
T cd06622         158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV-DGDPPTLPSGYS  235 (286)
T ss_pred             -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh-hcCCCCCCcccC
Confidence             23456889999999985432     25789999999999999999999996543322   222222 233456677799


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       341 ~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      .++.+||.+||..+|++||++++++.||||.....
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            99999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.5e-43  Score=350.40  Aligned_cols=252  Identities=38%  Similarity=0.691  Sum_probs=217.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||+|.++.+++.||+|.+....      ..+.+.+|+.++++++|+||+++++++.+...+|+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            468999999999999999999999889999999886421      15678899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      ++||+.+++|.+++.. ...+++..++.++.||+.||.|||+++|+||||+|+||+++.++.+||+|||++....... .
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            9999999999999975 4578999999999999999999999999999999999999999999999999998765443 2


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC-CCCCCCCCCCHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-ELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~  348 (602)
                      .....|+..|+|||++.+.. ++.++||||||||+|+|++|+.||...........+.... .....+..++.++.+||.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             cccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            23445889999999987654 8899999999999999999999998765544444332211 112234567889999999


Q ss_pred             HHcccCCCCCCCHHHHhcCccc
Q 007478          349 LCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       349 ~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +||+.||++|||+.|+++||||
T Consensus       235 ~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.4e-42  Score=359.85  Aligned_cols=258  Identities=33%  Similarity=0.652  Sum_probs=221.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..+|++.+.||.|+||.||+|++..+++.||+|.+....    ....+.+.+|+.+++.++|+||+++++++...+.+|+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence            467999999999999999999999999999999886422    1234567899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-C
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-P  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~  270 (602)
                      ||||+.+++|.+++.. ..+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........ .
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence            9999999999999875 4689999999999999999999999999999999999999999999999999887644332 2


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC-CCCCCCCCCCCHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-KELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~dLI~~  349 (602)
                      ....|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+....+..+... ......+..++..+.+||++
T Consensus       173 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence            3456899999999987655 888999999999999999999999876655555444322 22223456789999999999


Q ss_pred             HcccCCCCCCCHHHHhcCccccCCCc
Q 007478          350 CLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ||..||++||++.+|++||||+....
T Consensus       252 ~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         252 CLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HhhcChhhCCCHHHHhhChHhhhccc
Confidence            99999999999999999999987554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.3e-43  Score=354.76  Aligned_cols=255  Identities=33%  Similarity=0.612  Sum_probs=217.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|+..+.||+|+||.||++.++.+++.+|+|.+....   ..+..+.+.+|++++++++||||+++++.+..++.+|++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            36888899999999999999999999999999887522   224456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          193 LEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      |||+.+++|.+++... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.+||+|||++.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            9999999999999875 789999999999999999999999 99999999999999999999999999998766433222


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCc----h-hHHHHHHhhCCCCCCCCCCC-CCHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY----E-GVAAMFKIGNSKELPTIPDD-LSDEGK  344 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~----~-~~~~~~~i~~~~~~~~~p~~-~s~~l~  344 (602)
                       ...|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...    . ....+..+.. ...+.++.. ++.+++
T Consensus       158 -~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (265)
T cd06605         158 -TFVGTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQ  234 (265)
T ss_pred             -cccCChhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCCCCCChhhcCHHHH
Confidence             266899999999997664 899999999999999999999999654    1 2222333322 223344444 899999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      +||.+||..||++|||+.+++.||||+..
T Consensus       235 ~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         235 DFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            99999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.9e-42  Score=355.19  Aligned_cols=254  Identities=30%  Similarity=0.457  Sum_probs=208.8

Q ss_pred             eEeecCCeEEEEEEECCCCcEEEEEEEecccchhcH--HHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeec
Q 007478          120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK--ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       120 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~--~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      +||+|+||.||+|.+..+++.||+|++.........  ........++.+++...||||+.+++++...+.+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998652211111  111122233445566789999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP  277 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~  277 (602)
                      |++|.+++...+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++....... .....|+.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence            99999999888889999999999999999999999999999999999999999999999999987654332 33457999


Q ss_pred             CCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh--HHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCC
Q 007478          278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP  355 (602)
Q Consensus       278 ~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  355 (602)
                      .|+|||++.+...++.++|||||||++|||++|+.||.....  .....+... .....++..++.++.+||.+||..||
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-ccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            999999997655588999999999999999999999976521  122222211 22345667789999999999999999


Q ss_pred             CCCC-----CHHHHhcCccccCCCc
Q 007478          356 LNRP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       356 ~~Rp-----t~~eiL~hp~f~~~~~  375 (602)
                      ++|+     ++.++++||||+...+
T Consensus       239 ~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         239 NRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             HhccCCCCCCHHHHHhCccccCCCc
Confidence            9999     9999999999998765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2e-42  Score=348.19  Aligned_cols=253  Identities=34%  Similarity=0.599  Sum_probs=217.8

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccc--ccceEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKT--VEDKLYI  191 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~l  191 (602)
                      +|++.+.||.|+||.||++.+..+++.||+|++....  ......+.+.+|+.+++.++|+||+++++++.  ....+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN--MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc--CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence            5889999999999999999999999999999886422  23344567889999999999999999999764  3457899


Q ss_pred             EEeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhc-----cCCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          192 YLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLH-----SKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH-----~~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                      +|||+.+++|.+++..    ...+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++.+||+|||++.
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence            9999999999999865    357899999999999999999999     9999999999999999999999999999998


Q ss_pred             cccCCCC-CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCH
Q 007478          263 HIAGQSC-PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSD  341 (602)
Q Consensus       263 ~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  341 (602)
                      ....... .....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+. ....+.++..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  236 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSS  236 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCH
Confidence            8765443 33456899999999997765 8889999999999999999999998765443333333 3344567778999


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          342 EGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       342 ~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ++.+|+.+||..+|++||++.+|++|||+
T Consensus       237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.2e-42  Score=347.04  Aligned_cols=253  Identities=32%  Similarity=0.588  Sum_probs=220.5

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|+..+.||.|+||.||.+.+..+++.+++|.+.....  .....+.+.+|+.++++++|+||+++++++.+.+.++++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence            58999999999999999999999999999999865321  2234567889999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CC
Q 007478          194 EYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CP  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  270 (602)
                      ||+.+++|.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence            999999999999764  468999999999999999999999999999999999999999999999999998764433 23


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      ....|+..|+|||++.+.. ++.++|||||||++|||++|..||...+.......+.... ....+..++.++.+||.+|
T Consensus       159 ~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHSL  236 (256)
T ss_pred             cccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHHH
Confidence            3456899999999987655 7889999999999999999999998766666555554433 3344567899999999999


Q ss_pred             cccCCCCCCCHHHHhcCccc
Q 007478          351 LQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      |..+|++||++.++++|+|+
T Consensus       237 l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         237 LQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cccCcccCCCHHHHhhCcCC
Confidence            99999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.6e-42  Score=348.48  Aligned_cols=255  Identities=48%  Similarity=0.859  Sum_probs=217.5

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++....  .....+.+.+|+.+++.++|+||+++++.+...+.+++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence            58899999999999999999998999999999875322  2445678999999999999999999999999899999999


Q ss_pred             eeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC---
Q 007478          194 EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP---  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~---  270 (602)
                      ||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.........   
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            99999999999988777999999999999999999999999999999999999999999999999999876543321   


Q ss_pred             --cccCCCCCCCCcccccccC--CCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCC--CCHHHH
Q 007478          271 --LSFKGSPYWMAPEVIKNSS--GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD--LSDEGK  344 (602)
Q Consensus       271 --~~~~GT~~Y~APEvl~~~~--~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~s~~l~  344 (602)
                        ....++..|+|||++.+..  .++.++|||||||++|||++|+.||...+..............+.++..  ++..+.
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK  238 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHH
Confidence              1346889999999986543  3778999999999999999999999765332222222222334455554  489999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +||++||+.||++||++.+++.|||+
T Consensus       239 ~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         239 DFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-43  Score=356.52  Aligned_cols=256  Identities=29%  Similarity=0.565  Sum_probs=216.1

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||.||+|.++.+++.||+|+++...  ......+.+.+|+++++.++|+||+++++++...+.+|+|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc--ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            36999999999999999999999999999999886421  1233456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC--CC
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--CP  270 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~~  270 (602)
                      |||+.++.|..++.+...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  ..
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            9999988888777766779999999999999999999999999999999999999999999999999998765543  23


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC--------------------C
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--------------------K  330 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~--------------------~  330 (602)
                      ....++..|+|||++.+...++.++|||||||++|+|++|++||...........+...                    .
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            34668999999999987745899999999999999999999999765444333222110                    0


Q ss_pred             CCC----------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          331 ELP----------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       331 ~~~----------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ..+          .++..++.++++||++||..||++||+++++++|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000          1233458999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.4e-42  Score=347.19  Aligned_cols=253  Identities=29%  Similarity=0.534  Sum_probs=219.8

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+.....  .......+.+|+.+|++++|+||+++++.+..++.+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence            58999999999999999999999999999999875321  2334577889999999999999999999999899999999


Q ss_pred             eeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC-ceEEeccCccccccCCCCC
Q 007478          194 EYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-RVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~~~  270 (602)
                      ||+++++|.+++...  ..+++..++.++.|++.||+|||++||+|+||||+||+++.++ .+||+|||++.........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA  158 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence            999999999999764  3588999999999999999999999999999999999998654 5899999999887655544


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      ....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...+......++... ....++..++.++++||.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~  236 (256)
T cd08220         159 YTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-TFAPISDRYSPDLRQLILSM  236 (256)
T ss_pred             cccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-CCCCCCCCcCHHHHHHHHHH
Confidence            5567899999999997654 788999999999999999999999876655555554433 23356678999999999999


Q ss_pred             cccCCCCCCCHHHHhcCccc
Q 007478          351 LQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      |..||++|||+.|+++||||
T Consensus       237 l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         237 LNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-42  Score=360.71  Aligned_cols=258  Identities=34%  Similarity=0.643  Sum_probs=219.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..+|.+.+.||+|+||.||++++..+++.||+|.+.....    ...+.+.+|+.+++.++|+||+++++++...+.+|+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            4789999999999999999999999999999999864221    223567889999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-C
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-P  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~  270 (602)
                      ||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........ .
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence            9999999999999865 4688999999999999999999999999999999999999999999999999987644322 2


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC-CCCCCCCCCCCHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-KELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~dLI~~  349 (602)
                      ....|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+... ......+..++..+++||.+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR  251 (297)
T ss_pred             CcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence            2356899999999997654 889999999999999999999999765543333332221 12223456788999999999


Q ss_pred             HcccCCCCCCCHHHHhcCccccCCCc
Q 007478          350 CLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ||..||++||+++++++||||+....
T Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         252 CLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             HccCChhhCcCHHHHhcCchhccccc
Confidence            99999999999999999999987765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=345.68  Aligned_cols=261  Identities=29%  Similarity=0.515  Sum_probs=221.9

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccce
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  188 (602)
                      ...++.+.+..||.|+.|+|++++.+.+|...|||.+..   ..+++..+++...+.++... ++|+||+++|+|..+..
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r---t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR---TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecc---cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            345677788899999999999999999999999999875   33455667777777776665 58999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          189 LYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      ++|.||.|. .-+.++++. +++++|..+-.+...+++||.||.+ +|||||||||+|||+|+.|++||||||++..+..
T Consensus       166 V~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  166 VFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence            999999984 344555543 5689999999999999999999997 5899999999999999999999999999988877


Q ss_pred             CCCCcccCCCCCCCCcccccc--cCCCCccccchhhhhHHHHHhhCCCCCCCch-hHHHHHHhhCCCCCCCCCC--CCCH
Q 007478          267 QSCPLSFKGSPYWMAPEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYE-GVAAMFKIGNSKELPTIPD--DLSD  341 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~--~~~~s~~sDVWSLGviLyELltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~--~~s~  341 (602)
                      ......-.|.+.|||||.+.-  ...|+.++||||||++++||+||+.||.+.+ +.+.+-++.+ ...|.++.  .+++
T Consensus       245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp  323 (391)
T KOG0983|consen  245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSP  323 (391)
T ss_pred             ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCH
Confidence            776667779999999999853  4568999999999999999999999998744 4556666666 34465554  4899


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       342 ~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ++.+|+..||++|+.+||...++|+|||+.....
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            9999999999999999999999999999987654

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.6e-43  Score=357.74  Aligned_cols=256  Identities=32%  Similarity=0.553  Sum_probs=214.6

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++.....  .....+.+.+|+++++.++|+||+++++++..++..|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence            468999999999999999999998999999998764222  223455678899999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-Cc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-PL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~  271 (602)
                      |||+.++.|..++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++..+..... ..
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence            99999999998887666799999999999999999999999999999999999999999999999999987644322 23


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhC--------------------CCC
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--------------------SKE  331 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~--------------------~~~  331 (602)
                      ...++..|+|||++.+...++.++|||||||++|||++|++||...........+..                    ...
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            456889999999987655578899999999999999999999975544333222211                    000


Q ss_pred             CC---------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          332 LP---------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       332 ~~---------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .+         .....++..+.+||.+||..||++||++.++++|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            11         1123678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.5e-43  Score=375.56  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=208.6

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCC-----CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDS-----GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKT  184 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~  184 (602)
                      ..++|++++.||+|+||.||+|++..+     ++.||+|+++...   ..+....+.+|+.+++.+ +|+|||++++++.
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            456899999999999999999986443     4579999986422   223456788999999999 8999999999999


Q ss_pred             ccceEEEEEeeecCCChhhhhhcc--------------------------------------------------------
Q 007478          185 VEDKLYIYLEYVSGGSIYKLLQDY--------------------------------------------------------  208 (602)
Q Consensus       185 ~~~~~~lVmE~~~ggsL~~~l~~~--------------------------------------------------------  208 (602)
                      ..+.+|+|||||.+|+|.+++...                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999988542                                                        


Q ss_pred             --------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC---c
Q 007478          209 --------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP---L  271 (602)
Q Consensus       209 --------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~---~  271 (602)
                                    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......   .
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                          23677889999999999999999999999999999999999999999999999865433221   1


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      ...++..|||||++.+.. ++.++|||||||++|||++ |+.||........+.+..........+..+++++++||.+|
T Consensus       273 ~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  351 (374)
T cd05106         273 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC  351 (374)
T ss_pred             CCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence            223566899999997655 8999999999999999997 99999875544444444333334445667899999999999


Q ss_pred             cccCCCCCCCHHHHhc
Q 007478          351 LQRNPLNRPTAAELLD  366 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~  366 (602)
                      |+.||++||++.+|++
T Consensus       352 l~~dp~~RPs~~~l~~  367 (374)
T cd05106         352 WNLEPTERPTFSQISQ  367 (374)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-42  Score=354.26  Aligned_cols=252  Identities=29%  Similarity=0.485  Sum_probs=213.8

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCC
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGS  200 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggs  200 (602)
                      ||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.+|+.++||||+++++++...+.+|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKR-LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhh-hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            699999999999999999999999986422 1222334566789999999999999999999999999999999999999


Q ss_pred             hhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCCCCC
Q 007478          201 IYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY  278 (602)
Q Consensus       201 L~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~  278 (602)
                      |.+++.+.+  .+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.............++..
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  159 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence            999997655  789999999999999999999999999999999999999999999999999987654444445568899


Q ss_pred             CCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh---HHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCC
Q 007478          279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG---VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP  355 (602)
Q Consensus       279 Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  355 (602)
                      |+|||++.+.. ++.++|||||||++|+|++|+.||.....   ...+.+.. ......++..+++++.+||++||+.||
T Consensus       160 y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (277)
T cd05577         160 YMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLCEALLQKDP  237 (277)
T ss_pred             cCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-ccccccCCccCCHHHHHHHHHHccCCh
Confidence            99999987766 88999999999999999999999976433   11222211 122335666789999999999999999


Q ss_pred             CCCC-----CHHHHhcCccccCCCc
Q 007478          356 LNRP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       356 ~~Rp-----t~~eiL~hp~f~~~~~  375 (602)
                      ++||     ++.+++.||||+...+
T Consensus       238 ~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         238 EKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             hHccCCCcccHHHHHhChhhhcCCh
Confidence            9999     8999999999998766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1e-42  Score=356.27  Aligned_cols=254  Identities=32%  Similarity=0.571  Sum_probs=211.1

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|+..+.||.|+||.||+|+++.+|+.||||+++....  .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence            48899999999999999999999999999998864221  2223356788999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhc--cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CC
Q 007478          194 EYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CP  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~--~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  270 (602)
                      ||+. ++|.+++..  ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++..+.... ..
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence            9995 688888754  3568999999999999999999999999999999999999999999999999987654332 22


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC------------------
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL------------------  332 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~------------------  332 (602)
                      ....++..|+|||++.+...++.++|||||||++|||++|+.||...+......++......                  
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            23457889999999876665788999999999999999999999765554443332211100                  


Q ss_pred             ---------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          333 ---------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       333 ---------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                               ..+...++.++++||.+||+.||++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                     01123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.4e-42  Score=353.12  Aligned_cols=257  Identities=30%  Similarity=0.531  Sum_probs=209.4

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHH-HHhcCCCcEEEEeccccccceEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL-LSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ++|++.+.||+|+||.||+++++.+|+.||+|+++....  ... ...+..|+.+ ++.++|+||+++++++..++.+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            478999999999999999999999999999999875221  112 2344456554 677799999999999999999999


Q ss_pred             EEeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccC-CceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          192 YLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSK-HTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      ||||++ |+|.+++..    ...+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999996 678777653    34689999999999999999999997 999999999999999999999999999987654


Q ss_pred             CCCCcccCCCCCCCCccccccc---CCCCccccchhhhhHHHHHhhCCCCCCCch-hHHHHHHhhCCCCCCCCC-CCCCH
Q 007478          267 QSCPLSFKGSPYWMAPEVIKNS---SGCNLAVDIWSLGCTVLEMATTKPPWSQYE-GVAAMFKIGNSKELPTIP-DDLSD  341 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~---~~~s~~sDVWSLGviLyELltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p-~~~s~  341 (602)
                      ........|+..|+|||++.+.   ..++.++|||||||++|||++|+.||.... ....+..+... ..+.++ ..++.
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-PSPQLPAEKFSP  235 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-CCCCCCccccCH
Confidence            4333345689999999988542   336889999999999999999999997532 23333333322 222333 35889


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       342 ~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ++.+||.+||..+|++||+++++++|+||....
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.4e-43  Score=373.81  Aligned_cols=252  Identities=28%  Similarity=0.445  Sum_probs=208.5

Q ss_pred             CCCceEeeeEeecCCeEEEEEEE-----CCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFN-----SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTV  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~  185 (602)
                      .++|++++.||+|+||+||+|.+     ..++..||||+++...   .....+.+.+|+.+|+.+ +||||+++++++..
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            45799999999999999999964     3467789999886422   223346788999999999 89999999999999


Q ss_pred             cceEEEEEeeecCCChhhhhhccC--------------------------------------------------------
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDYG--------------------------------------------------------  209 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~~~--------------------------------------------------------  209 (602)
                      .+..|+|||||++|+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999999986422                                                        


Q ss_pred             -------------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          210 -------------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       210 -------------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                                         .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                               3677889999999999999999999999999999999999999999999999876543221


Q ss_pred             ---cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          271 ---LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       271 ---~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                         ....++..|+|||++.+.. ++.++|||||||++|||++ |..||........+.+..........+...+.++++|
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  349 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI  349 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence               1223566799999997665 8999999999999999998 9999987654444444433333344556788999999


Q ss_pred             HHHHcccCCCCCCCHHHHhcC
Q 007478          347 IRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      |.+||+.||++||++.+|++.
T Consensus       350 i~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         350 MKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.2e-42  Score=342.73  Aligned_cols=254  Identities=58%  Similarity=1.030  Sum_probs=224.9

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc--ceEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE--DKLYI  191 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~l  191 (602)
                      +|++.+.||+|+||.||+|.+..+++.|++|++.....  .....+.+.+|+.++++++|+||+++++.+...  +.+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence            48899999999999999999999999999999875322  134567889999999999999999999999888  89999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC--
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC--  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--  269 (602)
                      ||||+.+++|.+++.....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||.+........  
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            999999999999998877999999999999999999999999999999999999999999999999999988765543  


Q ss_pred             -CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCch-hHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          270 -PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE-GVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       270 -~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                       .....++..|+|||.+.... ++.++|||||||++|+|++|..||.... ......++......+.++..++.++++||
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i  237 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL  237 (260)
T ss_pred             cccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence             34566899999999987665 8899999999999999999999998765 34444555444556677888999999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccc
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .+||+.||++||++.+++.||||
T Consensus       238 ~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         238 RKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4e-42  Score=346.32  Aligned_cols=253  Identities=31%  Similarity=0.585  Sum_probs=218.9

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+.....  .....+.+.+|+.+++.++|+||+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence            58999999999999999999999999999999875221  2233467889999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-C
Q 007478          194 EYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-P  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~  270 (602)
                      ||+.+++|.+++....  .+++..++.++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++........ .
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence            9999999999987542  578999999999999999999999999999999999999999999999999987644322 1


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      ....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...+......++... ..+..+..++.++.+||.+|
T Consensus       159 ~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  236 (256)
T cd08218         159 RTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-SYPPVSSHYSYDLRNLVSQL  236 (256)
T ss_pred             hhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC-CCCCCcccCCHHHHHHHHHH
Confidence            2345889999999987655 888999999999999999999999876665555555433 33456678899999999999


Q ss_pred             cccCCCCCCCHHHHhcCccc
Q 007478          351 LQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      |+.+|++||++.++++||||
T Consensus       237 l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         237 FKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             hhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2e-42  Score=358.92  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=203.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECC----------------CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD----------------SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN  175 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hpn  175 (602)
                      ..+|++.++||+|+||.||+|.+..                ++..||+|++...   ........+.+|+.+|++++|||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD---ANKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC---CCHHHHHHHHHHHHHHhhcCCCC
Confidence            4689999999999999999997543                3457999988642   22344567889999999999999


Q ss_pred             EEEEeccccccceEEEEEeeecCCChhhhhhccC-------------------CCChHHHHHHHHHHHHHHhhhccCCce
Q 007478          176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-------------------QFGEPAIRNYTQQILSGLAFLHSKHTV  236 (602)
Q Consensus       176 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~-------------------~ls~~~i~~i~~qIl~aL~yLH~~gIv  236 (602)
                      |+++++++.+.+..|+||||+.+|+|.+++....                   .+++..+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999986431                   356778899999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh--CC
Q 007478          237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TK  311 (602)
Q Consensus       237 HrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt--G~  311 (602)
                      ||||||+|||++.++.+||+|||+++.+.....   .....++..|+|||++.... ++.++|||||||++|||++  +.
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCC
Confidence            999999999999999999999999986543321   12234678899999987655 8999999999999999986  67


Q ss_pred             CCCCCchhHHHHHHhh------CCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          312 PPWSQYEGVAAMFKIG------NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       312 ~Pf~~~~~~~~~~~i~------~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .||........+..+.      ........+..++..+.+||.+||+.||++|||+++|.+
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            8887654433332211      111122345678999999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=329.84  Aligned_cols=258  Identities=29%  Similarity=0.535  Sum_probs=220.3

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      .+|...++||+|.||+||+|+++++++.||+|.++..+..  ........+||.+|+.|+|.|||+++++...+..+.+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd--egvpssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC--CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            4678889999999999999999999999999999874432  23344567999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CC
Q 007478          193 LEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CP  270 (602)
Q Consensus       193 mE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  270 (602)
                      +||| ..+|.++... ++.+..+.++.++.|+++||.|||+++++||||||.|+||+.+|++||+|||+++.++-.. ..
T Consensus        80 fe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   80 FEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            9999 4788888765 5789999999999999999999999999999999999999999999999999999876443 23


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCC-----------------
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKEL-----------------  332 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~-----------------  332 (602)
                      ...+-|.||++|.++.+..-|+...|+||.|||+.|+.. |++.|.+.+..+++.+|......                 
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            345679999999999998889999999999999999987 89999887766666555432111                 


Q ss_pred             -CCCC---------CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          333 -PTIP---------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       333 -~~~p---------~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                       |.+|         +.+....+||++++|..+|.+|++++++++||||.+.
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence             1111         2456678899999999999999999999999999864

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.8e-42  Score=352.47  Aligned_cols=256  Identities=36%  Similarity=0.659  Sum_probs=212.0

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecccc----
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKT----  184 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~----  184 (602)
                      ...++|++.+.||+|+||.||+|.++.+++.+|+|+++...     .....+.+|+.+++.+ +|+||+++++++.    
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            45689999999999999999999999999999999875321     1234577899999999 7999999999863    


Q ss_pred             -ccceEEEEEeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccC
Q 007478          185 -VEDKLYIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFG  259 (602)
Q Consensus       185 -~~~~~~lVmE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFG  259 (602)
                       .++.+|+||||++|++|.+++..    ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence             45679999999999999988752    3568889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC-CCcccCCCCCCCCccccccc----CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-CC
Q 007478          260 MAKHIAGQS-CPLSFKGSPYWMAPEVIKNS----SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-LP  333 (602)
Q Consensus       260 la~~~~~~~-~~~~~~GT~~Y~APEvl~~~----~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~  333 (602)
                      +++.+.... ......|+..|+|||++...    ..++.++|||||||++|||++|+.||........+.++..... ..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (286)
T cd06638         170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL  249 (286)
T ss_pred             ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence            998764322 22345699999999998532    3378899999999999999999999987665554444332211 11


Q ss_pred             CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          334 TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       334 ~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ..+..++.++.+||.+||+.||++||++.+|++|+||
T Consensus       250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            2344578899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-42  Score=352.57  Aligned_cols=250  Identities=22%  Similarity=0.357  Sum_probs=211.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEEC---CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNS---DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      ..+|++.+.||+|+||.||+|.++   ..+..||+|.++..   ........+.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG---CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC---CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            457999999999999999999875   34678999988642   223345678899999999999999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      +|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999999764 57899999999999999999999999999999999999999999999999987654322


Q ss_pred             CCCc--ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHH
Q 007478          268 SCPL--SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGK  344 (602)
Q Consensus       268 ~~~~--~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  344 (602)
                      ....  ...++..|+|||++.+.. ++.++|||||||++|||++ |+.||........+..+..... ...+..++..+.
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-LPAPRNCPNLLH  238 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CCCCCCCCHHHH
Confidence            2111  233567899999987655 8999999999999999775 9999987766665555544433 345778999999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhc
Q 007478          345 DFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      +|+.+||+.+|++||++++|++
T Consensus       239 ~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         239 QLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.1e-42  Score=352.02  Aligned_cols=256  Identities=33%  Similarity=0.626  Sum_probs=213.4

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecccccc---
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVE---  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~---  186 (602)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|++...     ......+.+|+.++.++ +|+||+++++++...   
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            357899999999999999999999999999999988632     12234567899999998 899999999987643   


Q ss_pred             --ceEEEEEeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCc
Q 007478          187 --DKLYIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       187 --~~~~lVmE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGl  260 (602)
                        +.+|+||||+++++|.++++.    ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~  174 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV  174 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence              468999999999999998853    35789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-CCcccCCCCCCCCcccccccC----CCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-CCC
Q 007478          261 AKHIAGQS-CPLSFKGSPYWMAPEVIKNSS----GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-LPT  334 (602)
Q Consensus       261 a~~~~~~~-~~~~~~GT~~Y~APEvl~~~~----~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~  334 (602)
                      +..+.... ......|+..|+|||++....    .++.++|||||||++|||++|+.||..........++..... ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  254 (291)
T cd06639         175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL  254 (291)
T ss_pred             chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence            88754322 223456899999999985432    257899999999999999999999987766555555433221 112


Q ss_pred             CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCcccc
Q 007478          335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       335 ~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~  371 (602)
                      .+..++.++.+||.+||+.||++||++.+|++||||+
T Consensus       255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            3446778999999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-42  Score=360.31  Aligned_cols=261  Identities=28%  Similarity=0.476  Sum_probs=213.1

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc--ce
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE--DK  188 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~--~~  188 (602)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|+++.....  ......+.+|+.++++++|+||+++++++...  +.
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            357899999999999999999999999999999998752211  11223456799999999999999999988654  56


Q ss_pred             EEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      +|+||||+. ++|.+++.. ...+++.+++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            899999996 578888765 367899999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC--------------
Q 007478          268 SC-PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--------------  332 (602)
Q Consensus       268 ~~-~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~--------------  332 (602)
                      .. .....++..|+|||++.+...++.++|||||||++|||++|++||...+....+..+......              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            22 223346889999999876666889999999999999999999999876655444433221100              


Q ss_pred             ---CCC-----------CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          333 ---PTI-----------PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       333 ---~~~-----------p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                         ..+           ...+++++.+||.+||+.||++|||+++++.||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence               000           013588999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=352.34  Aligned_cols=256  Identities=39%  Similarity=0.702  Sum_probs=218.5

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC---CCcEEEEeccccccceEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR---HPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~  190 (602)
                      .|++.+.||+|+||.||+|.+..+++.||+|.++...   .......+.+|+.++++++   |+||+++++++..+...|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~   78 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW   78 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence            5888999999999999999999999999999886421   2233456778999999996   999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  269 (602)
                      +||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            99999999999999876 4789999999999999999999999999999999999999999999999999987654332 


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCC-CCCHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD-DLSDEGKDFIR  348 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~s~~l~dLI~  348 (602)
                      .....|+..|+|||.+.+...++.++|||||||++|+|++|+.||...+.......+... ..+.++. .++.++.+||.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~  236 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFVA  236 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHHH
Confidence            234569999999999876666788999999999999999999999876654444333222 2334444 38899999999


Q ss_pred             HHcccCCCCCCCHHHHhcCccccCCC
Q 007478          349 LCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       349 ~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      +||+.||++||++.+++.|+||+...
T Consensus       237 ~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         237 ACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999997754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-42  Score=380.89  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=202.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....          ..+.+|+++|++|+|+|||++++++..++..|+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            3479999999999999999999999999999996431          234689999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  269 (602)
                      |||++. ++|.+++... +.+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..... 
T Consensus       238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            999995 7888887653 5799999999999999999999999999999999999999999999999999987643321 


Q ss_pred             --CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCch-------hHHHHHHhhCCCC--CCCCC--
Q 007478          270 --PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE-------GVAAMFKIGNSKE--LPTIP--  336 (602)
Q Consensus       270 --~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~-------~~~~~~~i~~~~~--~~~~p--  336 (602)
                        ....+||..|+|||++.+.. ++.++||||||||||||++|..++....       ....+.++.....  ...++  
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence              22467999999999998765 8999999999999999999876542211       0111111111000  00000  


Q ss_pred             -----------------------------CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccC
Q 007478          337 -----------------------------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       337 -----------------------------~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~  372 (602)
                                                   ..++.++.+||.+||+.||++|||+.|||+||||+.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                         135668999999999999999999999999999975

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.7e-42  Score=354.58  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=213.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCC-----cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSG-----EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      .++|++.+.||+|+||.||+|.+...+     ..||+|.++..   ........+.+|+.++++++||||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            457899999999999999999876554     67999987632   2234456788999999999999999999999988


Q ss_pred             ceEEEEEeeecCCChhhhhhcc----------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDY----------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN  250 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~----------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~  250 (602)
                      +..|++|||+++++|.+++...                ..+++..++.++.||+.||.|||++|++||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999999754                457888999999999999999999999999999999999999


Q ss_pred             CceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHh
Q 007478          251 GRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKI  326 (602)
Q Consensus       251 g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i  326 (602)
                      +.+||+|||+++.......   .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.........+
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999986533221   22345688999999987665 8999999999999999998 99999876665555555


Q ss_pred             hCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       327 ~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ... ..+..+..++.++.+|+.+||+.||++||++.+|+++
T Consensus       240 ~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            433 3445677899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2e-42  Score=353.16  Aligned_cols=251  Identities=27%  Similarity=0.437  Sum_probs=206.0

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEecccccc--ceEEE
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVE--DKLYI  191 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~~l  191 (602)
                      |++.+.||+|+||.||+|.++.+++.||+|+++....  .... ....+|+.++.++. |+||+++++++.+.  +.+++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            6789999999999999999999999999998864211  1111 23457888898885 99999999998877  88999


Q ss_pred             EEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      ||||+. ++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||+++. +.+||+|||+++.+......
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            999996 578887765 357899999999999999999999999999999999999999 99999999999877554444


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC----------------CCCC
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK----------------ELPT  334 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~----------------~~~~  334 (602)
                      ....++..|+|||++.....++.++|||||||++|||++|++||...+..+....+....                ....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN  235 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccccc
Confidence            455689999999987655557889999999999999999999997655433322221100                0001


Q ss_pred             -----------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          335 -----------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       335 -----------~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                                 +...++.++.+||.+||.+||++||+++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                       123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=348.26  Aligned_cols=252  Identities=29%  Similarity=0.486  Sum_probs=209.5

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHH-HHhcCCCcEEEEeccccccceEEEEEeeec
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL-LSRLRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      +.||+|+||.||+|.+..+|+.||+|++...... .......+..|..+ ...++|+||+++++++..++.+|+||||+.
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            5699999999999999999999999988642211 12223334455444 455689999999999999999999999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCCCC
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP  277 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~  277 (602)
                      +++|.+++...+.+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||+++....   .....|+.
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~  157 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP  157 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence            999999998888899999999999999999999999999999999999999999999999999876543   23456899


Q ss_pred             CCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC--CCCCCCCCCCHHHHHHHHHHcccCC
Q 007478          278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--ELPTIPDDLSDEGKDFIRLCLQRNP  355 (602)
Q Consensus       278 ~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~s~~l~dLI~~~L~~dP  355 (602)
                      .|+|||.+.+.. ++.++|||||||++|||++|..||...+.......+....  ........++.++.+||.+||+.||
T Consensus       158 ~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  236 (260)
T cd05611         158 DYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP  236 (260)
T ss_pred             CccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCH
Confidence            999999997765 8899999999999999999999998765544444433221  2223444689999999999999999


Q ss_pred             CCCC---CHHHHhcCccccCCCc
Q 007478          356 LNRP---TAAELLDHPFVKGAAP  375 (602)
Q Consensus       356 ~~Rp---t~~eiL~hp~f~~~~~  375 (602)
                      ++||   +++|++.||||+...|
T Consensus       237 ~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         237 AKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             HHccCCCcHHHHHcChHhhcCCC
Confidence            9999   5589999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.4e-42  Score=359.56  Aligned_cols=247  Identities=26%  Similarity=0.463  Sum_probs=192.6

Q ss_pred             EeeeEeecCCeEEEEEEECC--CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccc--ccceEEEE
Q 007478          117 KGKMLGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKT--VEDKLYIY  192 (602)
Q Consensus       117 ~~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~lV  192 (602)
                      .+++||+|+||+||+|+++.  ++..||+|.+....      ....+.+|+.+|+.++||||+++++++.  .+..+|+|
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            35689999999999999764  56889999886421      1234678999999999999999999874  45678999


Q ss_pred             EeeecCCChhhhhhc---------cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEE----ccCCceEEeccC
Q 007478          193 LEYVSGGSIYKLLQD---------YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV----DPNGRVKLADFG  259 (602)
Q Consensus       193 mE~~~ggsL~~~l~~---------~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl----~~~g~vKL~DFG  259 (602)
                      |||+. ++|.+++..         ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            99986 577777642         1247888999999999999999999999999999999999    556789999999


Q ss_pred             ccccccCCC----CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh------------HHHH
Q 007478          260 MAKHIAGQS----CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG------------VAAM  323 (602)
Q Consensus       260 la~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~------------~~~~  323 (602)
                      +++......    ......||..|+|||++.+...++.++|||||||++|||++|++||.....            ...+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            998764332    123456899999999997766689999999999999999999999963221            0001


Q ss_pred             HHhhCCC---------------------------------CCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          324 FKIGNSK---------------------------------ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       324 ~~i~~~~---------------------------------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .......                                 .........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1100000                                 0000111345678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=352.48  Aligned_cols=257  Identities=29%  Similarity=0.459  Sum_probs=216.5

Q ss_pred             CCceE-eeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEE
Q 007478          113 SHWKK-GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       113 ~~y~~-~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~  190 (602)
                      +-|++ .++||+|+|+.|--++...||..||||+|.+.    ......++.+|++++.+. .|+||++|+++|+++.++|
T Consensus        77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY  152 (463)
T KOG0607|consen   77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY  152 (463)
T ss_pred             HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence            33554 46899999999999999999999999999763    223456788999999999 6999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC---ceEEeccCccccccCC
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG---RVKLADFGMAKHIAGQ  267 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~vKL~DFGla~~~~~~  267 (602)
                      ||||-|.||.|..+|++++.|++.++.+++.+|+.||.|||.+||.||||||+|||.....   -||||||.|+..+...
T Consensus       153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            9999999999999999999999999999999999999999999999999999999996654   4899999987644211


Q ss_pred             --------CCCcccCCCCCCCCccccc----ccCCCCccccchhhhhHHHHHhhCCCCCCCch---------------hH
Q 007478          268 --------SCPLSFKGSPYWMAPEVIK----NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE---------------GV  320 (602)
Q Consensus       268 --------~~~~~~~GT~~Y~APEvl~----~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~---------------~~  320 (602)
                              ....+.+|+..|||||+..    ....|+.++|.||||||||.||+|.+||.+.-               ..
T Consensus       233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~  312 (463)
T KOG0607|consen  233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN  312 (463)
T ss_pred             CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence                    1234678999999999863    33458999999999999999999999995421               12


Q ss_pred             HHHHHhhCCCCCCCCC----CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          321 AAMFKIGNSKELPTIP----DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       321 ~~~~~i~~~~~~~~~p----~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ..+..|...+  .++|    ..++.+++|||..+|..|+.+|.++.+++.|||++....
T Consensus       313 ~LFesIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  313 KLFESIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             HHHHHHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            2233344332  3444    469999999999999999999999999999999998766

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.9e-42  Score=347.62  Aligned_cols=253  Identities=44%  Similarity=0.725  Sum_probs=211.4

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      .+.....||+|+||.||+|.+..++..||+|.+...    .....+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            344456899999999999999999999999987642    2334567889999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhcc-CCC--ChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc-CCceEEeccCccccccCCCC
Q 007478          194 EYVSGGSIYKLLQDY-GQF--GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       194 E~~~ggsL~~~l~~~-~~l--s~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||+.+++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            999999999999764 455  78889999999999999999999999999999999976 67999999999876543222


Q ss_pred             -CcccCCCCCCCCccccccc-CCCCccccchhhhhHHHHHhhCCCCCCCchhH-HHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          270 -PLSFKGSPYWMAPEVIKNS-SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       270 -~~~~~GT~~Y~APEvl~~~-~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                       .....|+..|+|||++.+. ..++.++|||||||++|+|++|+.||...... ............+.++..+++++++|
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence             2234589999999998653 34788999999999999999999999754322 22223322233456777899999999


Q ss_pred             HHHHcccCCCCCCCHHHHhcCccc
Q 007478          347 IRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      |++||+.+|++|||+.+++.||||
T Consensus       245 i~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-43  Score=375.66  Aligned_cols=262  Identities=31%  Similarity=0.491  Sum_probs=224.5

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +.|..++.||-|+||+|.++...+|...||+|.+++.+. ........++.|-.||...+++-||+||..|.+++.+|+|
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            457888999999999999999999999999999876443 3344567788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc-------
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-------  265 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~-------  265 (602)
                      |+|++||++..+|-+.+-|.|..++.|+.+|.+|+++.|..|+|||||||+|||||.+|+|||+||||++-+.       
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999986321       


Q ss_pred             ---CC---------------------------------CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh
Q 007478          266 ---GQ---------------------------------SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT  309 (602)
Q Consensus       266 ---~~---------------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt  309 (602)
                         ++                                 ......+||+.|+|||+|... +|+..+||||.|||||||+.
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHHhh
Confidence               00                                 001235699999999999764 59999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHhhCCCCCCCCC--CCCCHHHHHHHHHHcccCCCCCC---CHHHHhcCccccCCCccc
Q 007478          310 TKPPWSQYEGVAAMFKIGNSKELPTIP--DDLSDEGKDFIRLCLQRNPLNRP---TAAELLDHPFVKGAAPLE  377 (602)
Q Consensus       310 G~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~dLI~~~L~~dP~~Rp---t~~eiL~hp~f~~~~~~~  377 (602)
                      |++||-.........++++......++  .+++.++.+||.+++ .+++.|.   .++||..||||+++.+..
T Consensus       867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHh
Confidence            999998776666666665554444444  479999999999866 4788887   478899999999997743

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-42  Score=348.71  Aligned_cols=254  Identities=35%  Similarity=0.671  Sum_probs=212.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecccccc----
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVE----  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~----  186 (602)
                      .++|++.+.||+|+||.||+|.++.+++.+++|++....     ...+.+.+|+.+++++ .|+||+++++++...    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            478999999999999999999999899999999886422     1345688999999999 799999999988653    


Q ss_pred             --ceEEEEEeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCc
Q 007478          187 --DKLYIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       187 --~~~~lVmE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGl  260 (602)
                        ..+|+||||+++++|.+++..    ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence              358999999999999999865    35789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-CCcccCCCCCCCCccccccc----CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC-CC
Q 007478          261 AKHIAGQS-CPLSFKGSPYWMAPEVIKNS----SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL-PT  334 (602)
Q Consensus       261 a~~~~~~~-~~~~~~GT~~Y~APEvl~~~----~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~-~~  334 (602)
                      +....... ......|+..|+|||++...    ..++.++|||||||+||+|++|+.||..........++...... ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK  239 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence            87654322 22345689999999987532    34678999999999999999999999876555555554433211 12


Q ss_pred             CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       335 ~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .+..++.++++||++||..||++|||+.++++|||+
T Consensus       240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            223478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-43  Score=380.16  Aligned_cols=254  Identities=34%  Similarity=0.575  Sum_probs=225.8

Q ss_pred             eEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce--EEEEE
Q 007478          116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--LYIYL  193 (602)
Q Consensus       116 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~--~~lVm  193 (602)
                      +...+||+|+|-+||+|.+..+|..||.-.+++.+..+..+..++|..|+.+|+.|+|+|||++|++|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4567899999999999999999999998877776666777888999999999999999999999999987654  88899


Q ss_pred             eeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccC--CceecCCCCCcEEEccC-CceEEeccCccccccCCCCC
Q 007478          194 EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK--HTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~--gIvHrDLKp~NILl~~~-g~vKL~DFGla~~~~~~~~~  270 (602)
                      |++..|+|..|+++++.++...++.|++||++||.|||++  -|||||||-+||+|+.+ |.|||+|+|||+.+......
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak  202 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK  202 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc
Confidence            9999999999999999999999999999999999999987  59999999999999765 89999999999988765544


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC-CCCCCCCHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-TIPDDLSDEGKDFIRL  349 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~s~~l~dLI~~  349 (602)
                       ...|||.|||||++.  ..|+..+||||||++|+||+|+..||..-.+..++.+.......| .+..--.+++++||.+
T Consensus       203 -svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek  279 (632)
T KOG0584|consen  203 -SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK  279 (632)
T ss_pred             -eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence             378999999999986  459999999999999999999999999988888887655444433 3434457899999999


Q ss_pred             HcccCCCCCCCHHHHhcCccccCC
Q 007478          350 CLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      ||.. .++|+|+.|||+|+||...
T Consensus       280 Cl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  280 CLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HhcC-chhccCHHHHhhChhhccc
Confidence            9998 9999999999999999875

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.6e-42  Score=355.60  Aligned_cols=256  Identities=29%  Similarity=0.508  Sum_probs=212.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc--ceE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE--DKL  189 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~  189 (602)
                      .++|++.+.||+|+||.||+|.++.+++.+|+|.++.....  ......+.+|+.++++++||||+++++++...  +.+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            45799999999999999999999999999999998753221  22334567899999999999999999988776  889


Q ss_pred             EEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-
Q 007478          190 YIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-  267 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-  267 (602)
                      |+||||+. ++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++...... 
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99999997 5999888764 35899999999999999999999999999999999999999999999999999876554 


Q ss_pred             CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC-----------------
Q 007478          268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-----------------  330 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~-----------------  330 (602)
                      .......++..|+|||++.+...++.++|||||||++|||++|++||........+.++....                 
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            222345588999999998766557889999999999999999999997655443333221100                 


Q ss_pred             ------------CCCCCCCC-CCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          331 ------------ELPTIPDD-LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       331 ------------~~~~~p~~-~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                                  ....++.. +++.+.+||++||+.||++|||+.|+++|+||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                        00112223 58899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-42  Score=353.74  Aligned_cols=256  Identities=28%  Similarity=0.504  Sum_probs=216.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||+||++.+..+|+.||+|++....   .....+.+.+|+++++.++|+||+++++++...+.+|+
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            357999999999999999999999999999999886421   23345678899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      ||||+++++|.+++.+.+.+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....... .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~  159 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-A  159 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-c
Confidence            99999999999999888889999999999999999999997 699999999999999999999999999987653322 2


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH-----------HHHHHhhCCCCCCCCCC-C
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-----------AAMFKIGNSKELPTIPD-D  338 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~p~-~  338 (602)
                      ....||..|+|||++.+.. ++.++|||||||++|||++|+.||......           .....+.. ...+.++. .
T Consensus       160 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSSD  237 (284)
T ss_pred             CccccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCCCchh
Confidence            3457999999999987654 889999999999999999999999754321           12222222 12223333 3


Q ss_pred             CCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       339 ~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      ++.++.+||.+||+.||++|||+.|+++|+||...
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            88899999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.6e-42  Score=354.25  Aligned_cols=256  Identities=30%  Similarity=0.512  Sum_probs=208.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccce---
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDK---  188 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~~---  188 (602)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++....  .......+.+|+.+++.+. |+||+++++++...+.   
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            469999999999999999999999999999998765221  1223356788999999995 6999999998877665   


Q ss_pred             --EEEEEeeecCCChhhhhhcc-----CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc-CCceEEeccCc
Q 007478          189 --LYIYLEYVSGGSIYKLLQDY-----GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLADFGM  260 (602)
Q Consensus       189 --~~lVmE~~~ggsL~~~l~~~-----~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~vKL~DFGl  260 (602)
                        .|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence              8999999985 788887542     35799999999999999999999999999999999999998 88999999999


Q ss_pred             cccccCCCC-CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC--------
Q 007478          261 AKHIAGQSC-PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE--------  331 (602)
Q Consensus       261 a~~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~--------  331 (602)
                      +..+..... .....+++.|+|||++.+...++.++|||||||++|||++|..||...+......++.....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            986543221 22335788999999987655588999999999999999999999987655544433321100        


Q ss_pred             ----------CC--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCcccc
Q 007478          332 ----------LP--------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       332 ----------~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~  371 (602)
                                .+        ...+.++.++.+||.+||..||++||++.|++.||||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                      00        01135789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.4e-42  Score=351.40  Aligned_cols=256  Identities=40%  Similarity=0.725  Sum_probs=220.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ..|+..+.||.|+||.||+|.+..++..||+|++...   ........+.+|+.++++++|+||+++++++.+.+.+|+|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            4688899999999999999999999999999988742   2233456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-Cc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-PL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~  271 (602)
                      |||+.|++|.+++.. +.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence            999999999999875 5789999999999999999999999999999999999999999999999999977654332 22


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      ...++..|+|||++.+.. ++.++|||||||++|||++|+.||...........+. ....+.++..++.++.+||.+||
T Consensus       160 ~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACL  237 (277)
T ss_pred             cccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHc
Confidence            346889999999987654 8899999999999999999999998766544443332 23345566678899999999999


Q ss_pred             ccCCCCCCCHHHHhcCccccCCC
Q 007478          352 QRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       352 ~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ..+|++||++++++.|+||....
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         238 NKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             ccCcccCcCHHHHHhChHhhhcc
Confidence            99999999999999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=371.12  Aligned_cols=249  Identities=28%  Similarity=0.469  Sum_probs=211.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++..++..||+|.||+||+|++-.   .||||+++....  ..+..+.|++|+.++++-+|.||+-+.|++..... .|
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             HHHhhccceeccccccceeeccccc---ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            4556678999999999999998865   599999986433  34578899999999999999999999999987775 99


Q ss_pred             EEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc---cCC
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQ  267 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~---~~~  267 (602)
                      |..+|+|.+|+.+|+- ..+|....++.|++||+.|+.|||.++|||||||..||||.+++.|||+||||+...   ...
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence            9999999999999974 357899999999999999999999999999999999999999999999999998653   233


Q ss_pred             CCCcccCCCCCCCCccccccc--CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC---CCCCCCCCCCHH
Q 007478          268 SCPLSFKGSPYWMAPEVIKNS--SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK---ELPTIPDDLSDE  342 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APEvl~~~--~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~---~~~~~p~~~s~~  342 (602)
                      .......|...|||||+++..  ..|++.+|||||||++|||++|..||...+....++.+..+.   ....+..+++.+
T Consensus       545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~  624 (678)
T KOG0193|consen  545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKA  624 (678)
T ss_pred             cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHH
Confidence            333445688999999998633  358899999999999999999999999544445555666653   333455678999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhc
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      +++|+..||.+++++||.+.+||.
T Consensus       625 mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  625 MKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHhcCcccCccHHHHHH
Confidence            999999999999999999999986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=347.05  Aligned_cols=263  Identities=25%  Similarity=0.450  Sum_probs=230.0

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccce
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  188 (602)
                      ....+|.+.++||+|+|++|.+++++.|.+.||+|++++. ...+.+.++-+..|-.+..+. +||++|.++.+|+++.+
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkke-l~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKE-LVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHH-hcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            3468999999999999999999999999999999999862 223334455566677777766 79999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc-cCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~  267 (602)
                      +++|.||+.||+|.-++++.++++++.++.+...|+.||.|||++|||+||||..|||||..|++||+|+|+++.- ...
T Consensus       326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999863 445


Q ss_pred             CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCC-------CchhHHHHHHhhCCCCCCCCCCCCC
Q 007478          268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWS-------QYEGVAAMFKIGNSKELPTIPDDLS  340 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~-------~~~~~~~~~~i~~~~~~~~~p~~~s  340 (602)
                      ....++|||+.|.|||++.+.. |+..+|||+|||+|+||+.|+.||+       +.+..+-++.+...+. -.+|..++
T Consensus       406 d~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-iriprsls  483 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-IRIPRSLS  483 (593)
T ss_pred             cccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-ccccceee
Confidence            6677899999999999998876 9999999999999999999999995       3344555555544333 36788899


Q ss_pred             HHHHHHHHHHcccCCCCCC------CHHHHhcCccccCCCc
Q 007478          341 DEGKDFIRLCLQRNPLNRP------TAAELLDHPFVKGAAP  375 (602)
Q Consensus       341 ~~l~dLI~~~L~~dP~~Rp------t~~eiL~hp~f~~~~~  375 (602)
                      -.+..+++..|.+||.+|.      .+.++..|+||+.+.|
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence            9999999999999999995      4789999999998877

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.3e-42  Score=364.86  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=210.7

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE----  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~----  186 (602)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++...  .........+.+|+.++++++|+||+++++++...    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP--FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc--ccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            357899999999999999999999999999999988642  12233445677899999999999999999987543    


Q ss_pred             --ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          187 --DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       187 --~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                        ..+|+||||+. ++|.+.+...  +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence              35799999995 5888887653  899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC-----------
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-----------  333 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~-----------  333 (602)
                      ..........||..|+|||++.+.. ++.++|||||||++|+|++|+.||...+......++......+           
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            5544444567899999999997655 8999999999999999999999997655433322221100000           


Q ss_pred             ------------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          334 ------------------------------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       334 ------------------------------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                                                    ..+...+.++++||.+||+.||++|||+.|+|+||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence                                          0011346678999999999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.9e-42  Score=343.59  Aligned_cols=249  Identities=33%  Similarity=0.601  Sum_probs=214.8

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||++.++.+++.||+|.++...   .....+.+.+|+.+++.++|+||+++++.+.+++.+|+||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            5889999999999999999999999999999986422   2234567788999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhc--cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-C
Q 007478          194 EYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-P  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~--~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~  270 (602)
                      ||+++++|.+++..  ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........ .
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  157 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA  157 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence            99999999998864  34588999999999999999999999999999999999999999999999999987644322 2


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      ....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+... ....++..++.++++||.+|
T Consensus       158 ~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  235 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-SYKPLPSHYSYELRSLIKQM  235 (255)
T ss_pred             ccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC-CCCCCCcccCHHHHHHHHHH
Confidence            3456899999999987655 889999999999999999999999876655555444433 33446678899999999999


Q ss_pred             cccCCCCCCCHHHHhcC
Q 007478          351 LQRNPLNRPTAAELLDH  367 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~h  367 (602)
                      |+.||++||++.+|+.-
T Consensus       236 l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         236 FKRNPRSRPSATTILSR  252 (255)
T ss_pred             HhCCcccCCCHHHHhhc
Confidence            99999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-42  Score=352.05  Aligned_cols=255  Identities=29%  Similarity=0.503  Sum_probs=206.6

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||+|.++.+++.||||.+......   .....+.+|+.++++++|+||+++++++.+++..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            46899999999999999999999999999999998752211   112345689999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      ||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 v~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          81 VFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             EEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            999997 5899988653 468999999999999999999999999999999999999999999999999987643221 1


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh-HHHHHHhhCCCC-----------------
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG-VAAMFKIGNSKE-----------------  331 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~-~~~~~~i~~~~~-----------------  331 (602)
                      .....++..|+|||++.+...++.++|||||||++|||++|+.||..... ......+.....                 
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            12234788999999987655588899999999999999999999975442 121111110000                 


Q ss_pred             ---CC--------CCCCCCC--HHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          332 ---LP--------TIPDDLS--DEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       332 ---~~--------~~p~~~s--~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                         ..        .....++  .++.+||.+||+.||++||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence               00        0001234  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.1e-42  Score=352.93  Aligned_cols=257  Identities=31%  Similarity=0.525  Sum_probs=211.2

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccceEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~l  191 (602)
                      ++|+..+.||+|+||.||++.+..+++.||+|.+.....   ......+.+|+.++.++. |+||+++++++..++..++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            467788899999999999999999999999998864222   234567889999999996 9999999999988889999


Q ss_pred             EEeeecCCChhhhhh-----ccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          192 YLEYVSGGSIYKLLQ-----DYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       192 VmE~~~ggsL~~~l~-----~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                      +|||+. ++|.++..     ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            999985 45544332     23579999999999999999999997 499999999999999999999999999998765


Q ss_pred             CCCCCcccCCCCCCCCccccccc--CCCCccccchhhhhHHHHHhhCCCCCCCchhH-HHHHHhhCCCCCCC----CCCC
Q 007478          266 GQSCPLSFKGSPYWMAPEVIKNS--SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPT----IPDD  338 (602)
Q Consensus       266 ~~~~~~~~~GT~~Y~APEvl~~~--~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~~----~p~~  338 (602)
                      .........||..|+|||++.+.  ..++.++|||||||++|||++|+.||...... ..+.++... ..+.    .+..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-DPPILSNSEERE  238 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC-CCCcCCCcCCCc
Confidence            54444455689999999999765  35889999999999999999999999765432 222222221 1122    2235


Q ss_pred             CCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       339 ~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ++.++.+||.+||+.||++|||+++|++||||+...
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            889999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5e-42  Score=345.27  Aligned_cols=251  Identities=34%  Similarity=0.582  Sum_probs=215.1

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCC
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGS  200 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggs  200 (602)
                      ||.|+||.||++.+..+|+.||+|++.... .......+.+.+|+.++++++|+||+++++.+..++..|++|||+.+++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchh-hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999999999999999886422 2223456778899999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC---------CCc
Q 007478          201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS---------CPL  271 (602)
Q Consensus       201 L~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---------~~~  271 (602)
                      |.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+|||++.++.+||+|||++.......         ...
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            99999887789999999999999999999999999999999999999999999999999987654331         123


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCC--CCHHHHHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD--LSDEGKDFIRL  349 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~s~~l~dLI~~  349 (602)
                      ...++..|+|||++.... ++.++|||||||++|||++|+.||...........+....  ...+..  ++.++.+||++
T Consensus       160 ~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~  236 (265)
T cd05579         160 RIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--IEWPEDVEVSDEAIDLISK  236 (265)
T ss_pred             CcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--cCCCccccCCHHHHHHHHH
Confidence            356889999999987665 8889999999999999999999998766555554444322  223333  48999999999


Q ss_pred             HcccCCCCCCCH---HHHhcCccccCCCc
Q 007478          350 CLQRNPLNRPTA---AELLDHPFVKGAAP  375 (602)
Q Consensus       350 ~L~~dP~~Rpt~---~eiL~hp~f~~~~~  375 (602)
                      ||+.+|++|||+   .++++||||+.+.|
T Consensus       237 ~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         237 LLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            999999999999   99999999987643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.1e-42  Score=353.48  Aligned_cols=256  Identities=40%  Similarity=0.727  Sum_probs=218.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +.|+..+.||+|+||.||+|.+..+++.||+|+++...   .....+.+.+|+.++++++|+||+++++++..++.+|+|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence            45788899999999999999999999999999886421   233456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-Cc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-PL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~  271 (602)
                      |||+.+++|.+++.. +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+..... ..
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            999999999999865 5789999999999999999999999999999999999999999999999999987654321 22


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      ...|+..|+|||++.+.. ++.++|||||||++|||++|+.||...........+.. ...+.+...++.++.+||.+||
T Consensus       160 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             cccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-CCCCCCCcccCHHHHHHHHHHc
Confidence            346889999999997654 88899999999999999999999976554433333322 2334555678899999999999


Q ss_pred             ccCCCCCCCHHHHhcCccccCCC
Q 007478          352 QRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       352 ~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ..+|++||++.++++|+||....
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHHHHh
Confidence            99999999999999999997643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9e-42  Score=380.44  Aligned_cols=248  Identities=27%  Similarity=0.431  Sum_probs=204.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEecc-ccc----
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGS-KTV----  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~-~~~----  185 (602)
                      ..++++.+.|.+|||+.||+|.+...|..||+|++-.    .++...+.+.+||.+|+.|+ |+|||.|++. ...    
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec----CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            4567888999999999999999998889999998864    35667888999999999996 9999999993 211    


Q ss_pred             --cceEEEEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCC--ceecCCCCCcEEEccCCceEEeccC
Q 007478          186 --EDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKH--TVHRDIKGANILVDPNGRVKLADFG  259 (602)
Q Consensus       186 --~~~~~lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~~~g~vKL~DFG  259 (602)
                        .-+++|.||||.||.|-|++..+  ..|++.++++|+.|+++|+.+||...  |||||||-|||||+.+|+.||||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence              13588999999999999999743  56999999999999999999999987  9999999999999999999999999


Q ss_pred             ccccccCCCC-C---------cccCCCCCCCCccccc--ccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhh
Q 007478          260 MAKHIAGQSC-P---------LSFKGSPYWMAPEVIK--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG  327 (602)
Q Consensus       260 la~~~~~~~~-~---------~~~~GT~~Y~APEvl~--~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~  327 (602)
                      .|+....... .         .....|+.|+|||+|.  .+...++|+|||||||+||-|+....||++...    ..|.
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIl  267 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAIL  267 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEE
Confidence            9875432221 1         1123799999999974  233478999999999999999999999986532    2333


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       328 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      +.+....-.+.++..+++||+.||+.||++||++.|++.+
T Consensus       268 ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  268 NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            4333222224789999999999999999999999999975

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.4e-42  Score=350.64  Aligned_cols=253  Identities=31%  Similarity=0.545  Sum_probs=209.7

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||.|+||.||+|++..+|+.||||+++.....   .....+.+|+.++++++|+||+++++++.+.+.+|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence            589999999999999999999999999999998753221   22345678999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhcc---CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          194 EYVSGGSIYKLLQDY---GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       194 E~~~ggsL~~~l~~~---~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      ||+.+ +|.+++...   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            99974 888887653   358999999999999999999999999999999999999999999999999997654322 1


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC-------------------
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-------------------  330 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~-------------------  330 (602)
                      .....+|..|++||++.+...++.++|||||||++|||++|+.||.+.+......++....                   
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            2334578999999998776667889999999999999999999997655433333221100                   


Q ss_pred             CCC--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          331 ELP--------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       331 ~~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ..+        .+.+.++.+++++|.+||+.||++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            000        1113467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-41  Score=344.66  Aligned_cols=253  Identities=29%  Similarity=0.539  Sum_probs=211.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||.||+|+++.+++.||||.++.... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            579999999999999999999999999999998865322 2344556788999999999999999999999989999999


Q ss_pred             EeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          193 LEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      |||+++++|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988853    3458899999999999999999999999999999999999999999999999988764332


Q ss_pred             C-CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCch--hHHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          269 C-PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE--GVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       269 ~-~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                      . .....|+..|+|||.+.+.. ++.++|||||||++|||++|+.||....  .......+......+.....++..+.+
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE  239 (267)
T ss_pred             HHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            2 22356899999999997655 8889999999999999999999996432  223333333322223333468889999


Q ss_pred             HHHHHcccCCCCCCCHHHHhcC
Q 007478          346 FIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ||.+||..+|++||++.++++.
T Consensus       240 li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         240 LVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHCCCCcccCcCHHHHHHH
Confidence            9999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-41  Score=353.36  Aligned_cols=260  Identities=37%  Similarity=0.649  Sum_probs=218.0

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceE
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  189 (602)
                      .....|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..+.+.+|+.+++.++||||+++++++...+..
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~   90 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA   90 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence            34567999999999999999999999999999999886422 22334456788999999999999999999999999999


Q ss_pred             EEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          190 YIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      |+||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++...... 
T Consensus        91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99999996 567666643 457899999999999999999999999999999999999999999999999998765432 


Q ss_pred             CCcccCCCCCCCCcccccc--cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~--~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                        ....|+..|+|||++..  ...++.++|||||||++|||++|+.||...+.......+.........+..++.++++|
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF  246 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence              24568899999999852  33478899999999999999999999987766555555443322222234578899999


Q ss_pred             HHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          347 IRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      |.+||..||++||++.+|+.|+||....
T Consensus       247 i~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         247 VDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            9999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.6e-42  Score=361.71  Aligned_cols=261  Identities=25%  Similarity=0.458  Sum_probs=214.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc-----
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE-----  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~-----  186 (602)
                      ..+|++.+.||+|+||+||+|++..+++.||||.++...  ........+.+|+.+++.++|+||+++++++...     
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            457999999999999999999999999999999886421  1222345677899999999999999999987644     


Q ss_pred             ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      ..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            35899999995 78999998888899999999999999999999999999999999999999999999999999987644


Q ss_pred             C-CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhC-----------------
Q 007478          267 Q-SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN-----------------  328 (602)
Q Consensus       267 ~-~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~-----------------  328 (602)
                      . .......++..|+|||++.+...++.++|||||||++|+|++|++||...+.......+..                 
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            3 2233456899999999987655588999999999999999999999976443221111100                 


Q ss_pred             ----------C--CCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          329 ----------S--KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       329 ----------~--~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                .  .......+.++.++.+||++||+.||++|||++++++||||+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                      0  0001123468899999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.7e-41  Score=339.69  Aligned_cols=253  Identities=34%  Similarity=0.659  Sum_probs=221.3

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||++.+..+++.||+|++....  ........+.+|+++++.++|+|++++++.+...+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc--CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence            5889999999999999999999999999999987522  22345667889999999999999999999999889999999


Q ss_pred             eeecCCChhhhhhcc----CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-
Q 007478          194 EYVSGGSIYKLLQDY----GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-  268 (602)
Q Consensus       194 E~~~ggsL~~~l~~~----~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  268 (602)
                      ||+++++|.+++...    ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++....... 
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            999999999999763    679999999999999999999999999999999999999999999999999998765443 


Q ss_pred             CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  348 (602)
                      ......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+.. .....++..++.++.++|+
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~  236 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVS  236 (258)
T ss_pred             eecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHHH
Confidence            223456899999999987665 88899999999999999999999987665544444433 3355667789999999999


Q ss_pred             HHcccCCCCCCCHHHHhcCccc
Q 007478          349 LCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       349 ~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +||..+|++||++.++|+||||
T Consensus       237 ~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         237 SLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.6e-42  Score=347.26  Aligned_cols=254  Identities=32%  Similarity=0.567  Sum_probs=220.6

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccceEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~l  191 (602)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++..... ......+.+.+|+.++++++ |+||+++++++...+.+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence            479999999999999999999999999999998865221 22333467889999999998 9999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC--
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC--  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--  269 (602)
                      ||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........  
T Consensus        80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            999999999999999888899999999999999999999999999999999999999999999999999876643221  


Q ss_pred             -------------------CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC
Q 007478          270 -------------------PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK  330 (602)
Q Consensus       270 -------------------~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~  330 (602)
                                         .....|+..|+|||++.... ++.++|||||||++|+|++|+.||...........+..  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--  236 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK--  236 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--
Confidence                               22345889999999987655 88899999999999999999999987665444444432  


Q ss_pred             CCCCCCCCCCHHHHHHHHHHcccCCCCCCCH----HHHhcCccc
Q 007478          331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTA----AELLDHPFV  370 (602)
Q Consensus       331 ~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~----~eiL~hp~f  370 (602)
                      ....++..+++.+.+||++||+.||++||++    +++++||||
T Consensus       237 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            2335667889999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-41  Score=349.84  Aligned_cols=255  Identities=27%  Similarity=0.453  Sum_probs=205.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .+.|++.+.||+|+||.||+|.++.+|+.||+|++......   .....+.+|+.+++.++|+||+++++++..++..|+
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE---GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC---CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            46899999999999999999999999999999998652211   122356789999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-C
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  269 (602)
                      ||||+. ++|.+++.. ...+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            999995 677666643 4567888999999999999999999999999999999999999999999999987653322 2


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH-HHHHHhhCC----------------CCC
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNS----------------KEL  332 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~-~~~~~i~~~----------------~~~  332 (602)
                      .....++..|+|||++.+...++.++|||||||++|||++|+.||...... ..+.++...                ...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            233457999999999876556788999999999999999999999764432 111111000                000


Q ss_pred             C------------CCCC--CCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          333 P------------TIPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       333 ~------------~~p~--~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +            .+..  ..+.++.+||.+||..||++|||+.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0            0000  235789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.8e-42  Score=355.88  Aligned_cols=258  Identities=33%  Similarity=0.607  Sum_probs=216.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .+.|.....||+|+||.||++.+..++..||||++..    ......+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL----RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec----chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence            3456667889999999999999999999999998864    223345668899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CC
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  270 (602)
                      ||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus        97 v~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658          97 VMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             EEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            9999999999998864 568999999999999999999999999999999999999999999999999987654322 22


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC-CCCCCCCCCCHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-ELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~~  349 (602)
                      ....|+..|+|||++.+.. ++.++|||||||++|||++|+.||........+..+.... ........++..+.+||.+
T Consensus       176 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            3456899999999987655 8889999999999999999999998765544444333221 1112223578899999999


Q ss_pred             HcccCCCCCCCHHHHhcCccccCCCc
Q 007478          350 CLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ||..||++|||++++++|+||+....
T Consensus       255 ~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         255 MLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HccCChhHCcCHHHHhhChhhhccCC
Confidence            99999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-41  Score=349.28  Aligned_cols=257  Identities=35%  Similarity=0.623  Sum_probs=218.1

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      .+|...+.||+|+||.||++.+..+++.+++|+++..    .....+.+.+|+.+++.++|+||+++++++...+..|+|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence            3566678999999999999999989999999988642    223345678999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  271 (602)
                      +||+.|++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648          95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence            999999999999987 679999999999999999999999999999999999999999999999999887654322 223


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-CCCCCCCCCHHHHHHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-LPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~dLI~~~  350 (602)
                      ...|+..|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+..... ....+..++..+.+||.+|
T Consensus       174 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         174 SLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             cccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence            356899999999987655 88999999999999999999999987665555544433211 1122334889999999999


Q ss_pred             cccCCCCCCCHHHHhcCccccCCCc
Q 007478          351 LQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      |+.||++||++.++++|+||+....
T Consensus       253 l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         253 LVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             cccChhhCcCHHHHccCcccccCCC
Confidence            9999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.1e-41  Score=335.73  Aligned_cols=250  Identities=42%  Similarity=0.774  Sum_probs=217.0

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|...+.||+|+||.||++.+..+++.+++|++.....    .....+.+|+.+++.++|+||+++++++...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            48889999999999999999998999999999865221    34567889999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcc
Q 007478          194 EYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS  272 (602)
Q Consensus       194 E~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  272 (602)
                      ||+.+++|.+++... ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++...........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  156 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT  156 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence            999999999999775 6899999999999999999999999999999999999999999999999999987765443345


Q ss_pred             cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCC--CCHHHHHHHHHH
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD--LSDEGKDFIRLC  350 (602)
Q Consensus       273 ~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~s~~l~dLI~~~  350 (602)
                      ..|+..|++||++.... ++.++|||||||++|+|++|+.||...+....+..+.. ...+.++..  ++.++.+||.+|
T Consensus       157 ~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         157 MVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             eecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence            66899999999997655 88899999999999999999999987654444444333 223333333  489999999999


Q ss_pred             cccCCCCCCCHHHHhcCcc
Q 007478          351 LQRNPLNRPTAAELLDHPF  369 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~hp~  369 (602)
                      |+.||++|||+.++++|||
T Consensus       235 l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         235 LQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ccCChhhCCCHHHHhcCCC
Confidence            9999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.9e-42  Score=360.35  Aligned_cols=261  Identities=25%  Similarity=0.442  Sum_probs=214.6

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc----cc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV----ED  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~----~~  187 (602)
                      ..+|++.+.||+|+||.||+|.++.+|+.||+|++....  ......+.+.+|+.+|++++|+||+++++++..    ..
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            468999999999999999999999999999999986421  122335667789999999999999999988753    35


Q ss_pred             eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      .+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            7899999995 689999987778999999999999999999999999999999999999999999999999999765432


Q ss_pred             CC-----CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC-------------
Q 007478          268 SC-----PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-------------  329 (602)
Q Consensus       268 ~~-----~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------  329 (602)
                      ..     .....|+..|+|||++.+...++.++|||||||++|||++|+.||...+....+..+...             
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            21     123568999999999876555889999999999999999999999765433222211110             


Q ss_pred             -----------CCCC-----CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          330 -----------KELP-----TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       330 -----------~~~~-----~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                 ....     .+...++.++.+||++||+.||++||++++++.||||+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence                       0000     112457899999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=358.41  Aligned_cols=259  Identities=27%  Similarity=0.500  Sum_probs=209.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc-----
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE-----  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~-----  186 (602)
                      .++|++.++||+|+||.||+|++..+|+.||||++....   .......+.+|+.++++++|+||+++++++...     
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            468999999999999999999999999999999886421   223455677899999999999999999876543     


Q ss_pred             ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      ..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          81 NDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             ceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            35899999996 588887754 5799999999999999999999999999999999999999999999999999976543


Q ss_pred             CCC----CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhC--------------
Q 007478          267 QSC----PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--------------  328 (602)
Q Consensus       267 ~~~----~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~--------------  328 (602)
                      ...    .....||..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+..              
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            221    12356899999999986655688999999999999999999999975433222211100              


Q ss_pred             -C---------CCCC-----CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          329 -S---------KELP-----TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       329 -~---------~~~~-----~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                       .         ....     .....++.++.+||.+||+.||++|||+.++++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence             0         0000     011346788999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=337.37  Aligned_cols=253  Identities=47%  Similarity=0.858  Sum_probs=223.6

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||++++..+++.||+|.+....  ........+.+|++++++++|+||+++++++.+.+.+|++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK--IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc--cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence            5889999999999999999999999999999987532  22345678999999999999999999999999899999999


Q ss_pred             eeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-Ccc
Q 007478          194 EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-PLS  272 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~~  272 (602)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ...
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999987654332 234


Q ss_pred             cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcc
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ  352 (602)
Q Consensus       273 ~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  352 (602)
                      ..++..|+|||.+.+.. ++.++|||+||+++|+|++|+.||..........+... ...+.++..++.++.++|.+||.
T Consensus       159 ~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~  236 (254)
T cd06627         159 VVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQCFQ  236 (254)
T ss_pred             cccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCCHHHHHHHHHHHh
Confidence            56899999999987655 88899999999999999999999987666555555543 34456777899999999999999


Q ss_pred             cCCCCCCCHHHHhcCccc
Q 007478          353 RNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       353 ~dP~~Rpt~~eiL~hp~f  370 (602)
                      .+|++||++.+++.|+||
T Consensus       237 ~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         237 KDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CChhhCcCHHHHhcCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.6e-41  Score=345.66  Aligned_cols=256  Identities=39%  Similarity=0.728  Sum_probs=220.1

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +-|++.+.||+|+||.||+|.+..+++.||+|++...   ........+.+|+.++++++|+||+++++++..++.+|+|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc---cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            4588899999999999999999989999999987642   2223456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CCc
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPL  271 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  271 (602)
                      |||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+.... ...
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            999999999999875 468999999999999999999999999999999999999999999999999987654322 122


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      ...|+..|+|||.+.+.. ++.++|||||||++|+|++|..||...........+.. ...+.++..++.++.++|.+||
T Consensus       160 ~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVEACL  237 (277)
T ss_pred             cccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccCHHHHHHHHHHc
Confidence            356899999999987654 78899999999999999999999987665444444432 3344566778999999999999


Q ss_pred             ccCCCCCCCHHHHhcCccccCCC
Q 007478          352 QRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       352 ~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ..+|++||++.++++||||....
T Consensus       238 ~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         238 NKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             cCChhhCcCHHHHHhCHHHhhhh
Confidence            99999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-42  Score=357.58  Aligned_cols=259  Identities=29%  Similarity=0.469  Sum_probs=219.0

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc-----e
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED-----K  188 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~  188 (602)
                      +|++.+.||+|+||.||+|++..+++.||||++....  ......+.+.+|+.+++.++|+||+++++++...+     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence            5899999999999999999999999999999886421  22344567889999999999999999999987765     7


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      +|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence            999999997 5899999887789999999999999999999999999999999999999999999999999998765543


Q ss_pred             ----CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC------------
Q 007478          269 ----CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL------------  332 (602)
Q Consensus       269 ----~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~------------  332 (602)
                          ......+|..|+|||++.+...++.++|||||||++|+|++|++||...+....+..+......            
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence                2334568999999999987746899999999999999999999999876654444333221110            


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          333 -----------------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       333 -----------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                       ..+...++.++.+||.+||++||++||++++++.||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                             0112347889999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-42  Score=349.33  Aligned_cols=253  Identities=31%  Similarity=0.584  Sum_probs=210.4

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEe
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE  194 (602)
                      |++.+.||.|++|.||+|.++.+|..||+|++.....  .......+.+|+.+++.++|+||+++++++.+.+..|++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence            6778999999999999999999999999999875321  12233567789999999999999999999999999999999


Q ss_pred             eecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CCc
Q 007478          195 YVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPL  271 (602)
Q Consensus       195 ~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  271 (602)
                      |+. ++|.+++....  .+++..++.++.||+.||+|||+++++||||+|+|||++.++.+||+|||++....... ...
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence            994 78999987655  68999999999999999999999999999999999999999999999999997654322 122


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC----------------------
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS----------------------  329 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~----------------------  329 (602)
                      ...++..|+|||++.+...++.++|||||||++|||++|++||...+......++...                      
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            3357889999999876555788999999999999999999999766554433332110                      


Q ss_pred             -----CCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          330 -----KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       330 -----~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                           .........++.++.+||.+||+.||++|||++|+++|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                 00011234678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-41  Score=350.48  Aligned_cols=259  Identities=31%  Similarity=0.501  Sum_probs=211.3

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.....  .....+.+.+|++++++++|+||+++++++.+.+..|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            579999999999999999999999999999998864221  122345678899999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc-CCceEEeccCccccccCCCC
Q 007478          193 LEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~~  269 (602)
                      |||+. ++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++........
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            99995 58888776543  3578889999999999999999999999999999999985 45799999999976543221


Q ss_pred             -CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-----------------
Q 007478          270 -PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-----------------  331 (602)
Q Consensus       270 -~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-----------------  331 (602)
                       .....+++.|+|||++.+...++.++|||||||++|+|++|++||........+.++.....                 
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence             22345789999999987655588899999999999999999999976555444443221000                 


Q ss_pred             --CC--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          332 --LP--------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       332 --~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                        .+        .....+++++.+||.+||+.||++||++.++++||||.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence              00        01235788999999999999999999999999999998753

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-41  Score=355.89  Aligned_cols=250  Identities=26%  Similarity=0.415  Sum_probs=208.0

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcE----EEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEM----CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      ..+|++.+.||+|+||+||+|++..+++.    ||+|+++..   ......+.+.+|+.+++.++|+||+++++++... 
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            56899999999999999999998766654    899987532   2234456788999999999999999999988764 


Q ss_pred             eEEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      ..++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            578999999999999999764 4688999999999999999999999999999999999999999999999999987754


Q ss_pred             CCCCc---ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHH
Q 007478          267 QSCPL---SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       267 ~~~~~---~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                      .....   ...++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+...... ..+.........+..++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTID  239 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCCCCHH
Confidence            33322   223467899999997655 8999999999999999997 9999987544332 2333333333446678999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      +.+||.+||..||++||++.+++.+
T Consensus       240 ~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         240 VYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.7e-41  Score=348.94  Aligned_cols=261  Identities=30%  Similarity=0.501  Sum_probs=217.8

Q ss_pred             CceEeeeEeecCCeEEEEEEEC---CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNS---DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~  189 (602)
                      +|++.+.||+|+||.||+|.+.   .+|+.||+|+++...........+.+.+|+.+++++ +|+||+.+++++..+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999874   478999999987532222333456778899999999 699999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-  268 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  268 (602)
                      |+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999998764432 


Q ss_pred             -CCcccCCCCCCCCccccccc-CCCCccccchhhhhHHHHHhhCCCCCCCchh---HHHHHHhhCCCCCCCCCCCCCHHH
Q 007478          269 -CPLSFKGSPYWMAPEVIKNS-SGCNLAVDIWSLGCTVLEMATTKPPWSQYEG---VAAMFKIGNSKELPTIPDDLSDEG  343 (602)
Q Consensus       269 -~~~~~~GT~~Y~APEvl~~~-~~~s~~sDVWSLGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~s~~l  343 (602)
                       ......|+..|+|||++... ..++.++|||||||++|+|++|+.||.....   ...+.+... ...+.++..++..+
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  239 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQEMSALA  239 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh-ccCCCCCccCCHHH
Confidence             22345689999999998653 2467899999999999999999999964221   122222111 12234567789999


Q ss_pred             HHHHHHHcccCCCCCC-----CHHHHhcCccccCCCc
Q 007478          344 KDFIRLCLQRNPLNRP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       344 ~dLI~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~~  375 (602)
                      .+|+++||+.||++|+     ++++++.||||....+
T Consensus       240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            9999999999999997     8999999999998876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-41  Score=347.58  Aligned_cols=250  Identities=29%  Similarity=0.463  Sum_probs=211.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECC-----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      ..+|.+.+.||+|+||.||+|.+..     +++.||||+++..   ...+..+.+.+|+++|+.++|+||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc---CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            4568899999999999999998753     3678999988642   2233457889999999999999999999999999


Q ss_pred             ceEEEEEeeecCCChhhhhhcc--------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDY--------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR  252 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~--------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~  252 (602)
                      +..|+||||+++++|.+++...              ..+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            9999999999999999999754              24788899999999999999999999999999999999999999


Q ss_pred             eEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhC
Q 007478          253 VKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGN  328 (602)
Q Consensus       253 vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~  328 (602)
                      +||+|||+++.+.....   .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.........+..
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ  239 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            99999999976533221   12334678899999997765 8999999999999999998 9999987666555555543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          329 SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       329 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      . .....+..++.++++||.+||..||++||++.|+++
T Consensus       240 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         240 G-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             C-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3 334456689999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-41  Score=340.38  Aligned_cols=253  Identities=31%  Similarity=0.620  Sum_probs=215.8

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||++.++.+|..||+|.+.....  .....+.+.+|+.+++.++|+||+++++.+...+..|+|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence            58899999999999999999999999999999875221  1123456789999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCc-eEEeccCccccccCCCCC
Q 007478          194 EYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~-vKL~DFGla~~~~~~~~~  270 (602)
                      ||+.+++|.+++.+..  .+++..+..++.||+.||.|||+++|+|+||||+||+++.++. +||+|||.+.........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence            9999999999987643  4789999999999999999999999999999999999998864 699999999876543322


Q ss_pred             -cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHH
Q 007478          271 -LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       271 -~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  349 (602)
                       ....|++.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+... ....+...++.++.++|.+
T Consensus       159 ~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~  236 (257)
T cd08225         159 AYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG-YFAPISPNFSRDLRSLISQ  236 (257)
T ss_pred             ccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-cCCCCCCCCCHHHHHHHHH
Confidence             2345899999999987655 889999999999999999999999876555555444432 3344556789999999999


Q ss_pred             HcccCCCCCCCHHHHhcCccc
Q 007478          350 CLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ||..+|++|||+.++++||||
T Consensus       237 ~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         237 LFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=353.74  Aligned_cols=255  Identities=27%  Similarity=0.472  Sum_probs=205.0

Q ss_pred             CceEeeeEeecCCeEEEEEEECC--CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc--ceE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE--DKL  189 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~  189 (602)
                      .|++.+.||+|+||.||+|.++.  +++.||+|.+..... ........+.+|+.+++.++||||+++++++.+.  +.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence            48899999999999999999988  899999999875221 1222345677899999999999999999999887  889


Q ss_pred             EEEEeeecCCChhhhhhcc-----CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc----CCceEEeccCc
Q 007478          190 YIYLEYVSGGSIYKLLQDY-----GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP----NGRVKLADFGM  260 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~-----~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~----~g~vKL~DFGl  260 (602)
                      |+||||++ ++|.+++...     ..+++..++.++.||+.||.|||+++|+||||||+|||++.    ++.+||+|||+
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            99999996 4677666422     36889999999999999999999999999999999999999    89999999999


Q ss_pred             cccccCCCC----CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHH---------HHHHh-
Q 007478          261 AKHIAGQSC----PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---------AMFKI-  326 (602)
Q Consensus       261 a~~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~---------~~~~i-  326 (602)
                      ++.......    .....+|..|+|||++.+...++.++|||||||++|||++|++||.......         .+.++ 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            987643322    2245689999999998776668899999999999999999999996433211         00000 


Q ss_pred             --hC---------------------CCCCCCCC-----------CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          327 --GN---------------------SKELPTIP-----------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       327 --~~---------------------~~~~~~~p-----------~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                        ..                     ......++           ...+.++.+||.+||+.||++|||+.|+++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence              00                     00011111           1567789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.3e-41  Score=348.25  Aligned_cols=260  Identities=24%  Similarity=0.403  Sum_probs=213.1

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECC-----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV  185 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~  185 (602)
                      ..++|++.+.||+|+||.||+|..+.     .+..||+|.+...   ........+.+|+.+++.++|+||+++++++.+
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES---ASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            35689999999999999999997653     3557999987532   122234457889999999999999999999998


Q ss_pred             cceEEEEEeeecCCChhhhhhccC----------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEE
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDYG----------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKL  255 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~~~----------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL  255 (602)
                      .+..|+||||+.+|+|.+++.+.+          .++...+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            899999999999999999997532          2456788999999999999999999999999999999999999999


Q ss_pred             eccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCC
Q 007478          256 ADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKE  331 (602)
Q Consensus       256 ~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~  331 (602)
                      +|||+++.+.....   .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||...........+.. ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-~~  238 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD-GG  238 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CC
Confidence            99999986543221   11223567899999987655 8899999999999999998 8999987655444444433 23


Q ss_pred             CCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc------CccccCCCc
Q 007478          332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD------HPFVKGAAP  375 (602)
Q Consensus       332 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~------hp~f~~~~~  375 (602)
                      ....+..++.++++||.+||+.||++|||+.++++      ||||.++.|
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            34556678899999999999999999999999987      899988653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-41  Score=338.74  Aligned_cols=244  Identities=30%  Similarity=0.500  Sum_probs=212.0

Q ss_pred             eeEeecCCeEEEEEEECCC---CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEee
Q 007478          119 KMLGRGTFGHVYVGFNSDS---GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      +.||+|+||.||+|.+...   +..||+|++.....   ....+.+.+|+.+++.++|+||+++++++.+...+++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            4699999999999999866   88999999875222   12467888999999999999999999999999999999999


Q ss_pred             ecCCChhhhhhcc---------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          196 VSGGSIYKLLQDY---------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       196 ~~ggsL~~~l~~~---------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      +++++|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999999875         7899999999999999999999999999999999999999999999999999987754


Q ss_pred             CC---CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHH
Q 007478          267 QS---CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       267 ~~---~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                      ..   ......++..|+|||++.... ++.++|||||||++|||++ |..||...........+.. ......+..++.+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDE  235 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChH
Confidence            32   223455788999999987664 8999999999999999999 6999988766555555544 3344567788999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      +.++|.+||..||++||++.|++++
T Consensus       236 ~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         236 LYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHh
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-41  Score=353.21  Aligned_cols=257  Identities=35%  Similarity=0.609  Sum_probs=217.6

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ...|.....||+|+||.||+|.+..+++.||+|++....    ....+.+.+|+.+++.++||||+++++++..++..|+
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i   95 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV   95 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence            345666778999999999999999899999999986422    1234567899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CC
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  270 (602)
                      ||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus        96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659          96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence            9999999999998765 568999999999999999999999999999999999999999999999999987654332 22


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC-CCCCCCCCCCHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-ELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~~  349 (602)
                      ....|+..|+|||++.+.. ++.++|||||||++|||++|+.||........+..+.... .....+..++.++.++|.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             cceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence            3466999999999997655 8899999999999999999999997665555544443221 1223345688999999999


Q ss_pred             HcccCCCCCCCHHHHhcCccccCCC
Q 007478          350 CLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ||+.+|++||+++++++|+||....
T Consensus       254 ~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         254 MLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HhcCCcccCcCHHHHhhChhhccCC
Confidence            9999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.3e-41  Score=341.95  Aligned_cols=242  Identities=25%  Similarity=0.383  Sum_probs=204.9

Q ss_pred             eEeecCCeEEEEEEE--CCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeec
Q 007478          120 MLGRGTFGHVYVGFN--SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       120 ~LG~G~fG~Vy~a~~--~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      .||+|+||.||+|.+  +.+++.+|+|+++..  .......+.+.+|+.+++.++|+||+++++++. .+..++||||+.
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCC--CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence            589999999999965  456789999988642  223345677889999999999999999999876 456799999999


Q ss_pred             CCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC----ccc
Q 007478          198 GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP----LSF  273 (602)
Q Consensus       198 ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~----~~~  273 (602)
                      +++|.+++...+.+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||+++.+......    ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence            9999999988788999999999999999999999999999999999999999999999999999876543321    122


Q ss_pred             CCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcc
Q 007478          274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ  352 (602)
Q Consensus       274 ~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~  352 (602)
                      .++..|+|||++.... ++.++|||||||++|||++ |+.||...........+... ..+.++..++.++.+||.+||+
T Consensus       159 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~~~  236 (257)
T cd05116         159 KWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERMECPQRCPPEMYDLMKLCWT  236 (257)
T ss_pred             CCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHhc
Confidence            3467899999986554 8889999999999999998 99999876665555555443 3456777899999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q 007478          353 RNPLNRPTAAELLD  366 (602)
Q Consensus       353 ~dP~~Rpt~~eiL~  366 (602)
                      .||++||++++|.+
T Consensus       237 ~~p~~Rp~~~~i~~  250 (257)
T cd05116         237 YGVDERPGFAVVEL  250 (257)
T ss_pred             cCchhCcCHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.6e-41  Score=357.28  Aligned_cols=262  Identities=27%  Similarity=0.453  Sum_probs=214.5

Q ss_pred             CCCce-EeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcH----------HHHHHHHHHHHHHHhcCCCcEEEEe
Q 007478          112 ESHWK-KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK----------ESAKQLMQEIVLLSRLRHPNIVQYY  180 (602)
Q Consensus       112 ~~~y~-~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~----------~~~~~l~~Ei~iL~~l~HpnIv~l~  180 (602)
                      .++|. +.+.||+|+||+||+|.++.+++.||||+++........          .....+.+|+.+++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            45675 457899999999999999999999999998753221110          0112477899999999999999999


Q ss_pred             ccccccceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCc
Q 007478          181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       181 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGl  260 (602)
                      +++..++..|+||||+. |+|.+++.....+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence            99999999999999996 69999998878899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---------------CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHH
Q 007478          261 AKHIAGQ---------------SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK  325 (602)
Q Consensus       261 a~~~~~~---------------~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~  325 (602)
                      +......               .......++..|+|||++.+...++.++|||||||++|||++|++||...+....+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9765411               1112334788999999997766578999999999999999999999987665554433


Q ss_pred             hhCCCC--------------------------CCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          326 IGNSKE--------------------------LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       326 i~~~~~--------------------------~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      +.....                          .......++.++.+||.+||+.||++||+++|++.|+||+...
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            321100                          0011234688899999999999999999999999999998754

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.1e-41  Score=350.27  Aligned_cols=258  Identities=35%  Similarity=0.649  Sum_probs=218.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..+|++.+.||+|+||.||++.+..+++.||+|.+....    ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence            468999999999999999999999899999999886421    2234567899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CC
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  270 (602)
                      |+||+++++|.+++.+ ..+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            9999999999999876 368899999999999999999999999999999999999999999999999987654332 22


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC-CCCCCCCCCCCHHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-KELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~dLI~~  349 (602)
                      ....|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+... ......+..++..+++||++
T Consensus       173 ~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  251 (293)
T ss_pred             ccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence            3356899999999987654 888999999999999999999999865544433322211 11112344578899999999


Q ss_pred             HcccCCCCCCCHHHHhcCccccCCCc
Q 007478          350 CLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ||..+|++||++.+++.|+||+....
T Consensus       252 ~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         252 CLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             HccCChhhCcCHHHHhcCHHHhcCcc
Confidence            99999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-41  Score=366.87  Aligned_cols=252  Identities=29%  Similarity=0.422  Sum_probs=207.6

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCC-----CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEecccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDS-----GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKT  184 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~  184 (602)
                      ..++|.++++||+|+||.||+|.+...     +..||||+++..   ......+.+.+|+.+|+++. ||||+++++++.
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT---ARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            356899999999999999999987433     357999988642   22333567889999999996 999999999999


Q ss_pred             ccceEEEEEeeecCCChhhhhhcc--------------------------------------------------------
Q 007478          185 VEDKLYIYLEYVSGGSIYKLLQDY--------------------------------------------------------  208 (602)
Q Consensus       185 ~~~~~~lVmE~~~ggsL~~~l~~~--------------------------------------------------------  208 (602)
                      ..+.+|||||||++|+|.++|.+.                                                        
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999988542                                                        


Q ss_pred             ----------------------------------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEc
Q 007478          209 ----------------------------------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVD  248 (602)
Q Consensus       209 ----------------------------------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~  248 (602)
                                                              ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                    1367778899999999999999999999999999999999


Q ss_pred             cCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHH
Q 007478          249 PNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMF  324 (602)
Q Consensus       249 ~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~  324 (602)
                      .++.+||+|||+++.+.....   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||........+.
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            999999999999987643322   12344678899999997655 8999999999999999997 999997654333333


Q ss_pred             HhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          325 KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       325 ~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ...........+..++.++.+||.+||+.||++||++.+|.+
T Consensus       351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333333334556788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.4e-41  Score=351.52  Aligned_cols=252  Identities=25%  Similarity=0.423  Sum_probs=207.5

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEE--EEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVED  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~v--AvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~  187 (602)
                      ..++|++.+.||+|+||.||+|.++.++..+  |+|.++.   .........+.+|+.++.++ +|+||+++++++..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~---~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc---cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            3568999999999999999999998877654  6665542   22334456788999999999 8999999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhccC----------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYG----------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG  251 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~----------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g  251 (602)
                      .+|+||||+++++|.+++.+.+                .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            9999999999999999997542                478889999999999999999999999999999999999999


Q ss_pred             ceEEeccCccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCC
Q 007478          252 RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSK  330 (602)
Q Consensus       252 ~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~  330 (602)
                      .+||+|||++.............++..|+|||++.+.. ++.++|||||||++|||++ |..||...+.......+.. .
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~  239 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-G  239 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-C
Confidence            99999999986432222122223467899999986654 8899999999999999998 9999976655444444332 2


Q ss_pred             CCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       331 ~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .....+..++.++.+||.+||+.+|++||++++++.+
T Consensus       240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2334456788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.7e-41  Score=339.80  Aligned_cols=243  Identities=24%  Similarity=0.424  Sum_probs=203.5

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecC
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSG  198 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~g  198 (602)
                      +.||+|+||.||+|+++.+++.||+|.+...   ...+....+.+|++++++++|+||+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            4699999999999999999999999987531   2234456788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc---ccC
Q 007478          199 GSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFK  274 (602)
Q Consensus       199 gsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~---~~~  274 (602)
                      ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........   ...
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999999764 468999999999999999999999999999999999999999999999999987654321111   111


Q ss_pred             CCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHccc
Q 007478          275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR  353 (602)
Q Consensus       275 GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~  353 (602)
                      ++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+... .....+..++.++.+||++||+.
T Consensus       158 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~  235 (252)
T cd05084         158 IPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVYRLMERCWEY  235 (252)
T ss_pred             CceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCcccCCHHHHHHHHHHcCC
Confidence            245699999987665 8889999999999999998 99999765544444333332 23345677899999999999999


Q ss_pred             CCCCCCCHHHHhc
Q 007478          354 NPLNRPTAAELLD  366 (602)
Q Consensus       354 dP~~Rpt~~eiL~  366 (602)
                      ||++|||+.++++
T Consensus       236 ~p~~Rps~~~~~~  248 (252)
T cd05084         236 DPGQRPSFSTVHQ  248 (252)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.8e-41  Score=349.49  Aligned_cols=250  Identities=25%  Similarity=0.435  Sum_probs=207.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCc--EEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGE--MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~--~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~  189 (602)
                      ++|++.++||+|+||.||+|..+.++.  .+++|.++..   ......+.+.+|+.++.++ +||||+++++++...+.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL   78 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence            579999999999999999999887765  4688877531   2233456788999999999 799999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccC----------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCce
Q 007478          190 YIYLEYVSGGSIYKLLQDYG----------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRV  253 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~----------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~v  253 (602)
                      |+||||+++++|.+++.+..                .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence            99999999999999996532                47888999999999999999999999999999999999999999


Q ss_pred             EEeccCccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCC
Q 007478          254 KLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKEL  332 (602)
Q Consensus       254 KL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~  332 (602)
                      ||+|||++..............+..|+|||++.... ++.++|||||||++|||++ |..||..........++... ..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-~~  236 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YR  236 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CC
Confidence            999999986533221122223356799999987655 8899999999999999997 99999876655555555433 23


Q ss_pred             CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          333 PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       333 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ...+..++.++.+||.+||..||.+||+++++++.
T Consensus       237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            34566799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-41  Score=344.71  Aligned_cols=255  Identities=33%  Similarity=0.591  Sum_probs=209.8

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc--cceEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV--EDKLY  190 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~  190 (602)
                      ++|+..+.||.|+||.||+|.+..+++.||+|.+....   .......+.+|++++++++|+||+++++++.+  .+.+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            36889999999999999999999999999999887422   22445678899999999999999999998754  34799


Q ss_pred             EEEeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          191 IYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      +||||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999999888653    34688999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCch-----hHHHHHHhhCCCCCCCCC-----
Q 007478          267 QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE-----GVAAMFKIGNSKELPTIP-----  336 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~p-----  336 (602)
                      .. .....++..|+|||.+.+.. ++.++|||||||++|||++|+.||....     ..+....+.. ...+.++     
T Consensus       158 ~~-~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (287)
T cd06621         158 SL-AGTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGN  234 (287)
T ss_pred             cc-cccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCC
Confidence            22 12455889999999987655 8899999999999999999999997541     1222222222 1111221     


Q ss_pred             -CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          337 -DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       337 -~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                       ...++++.+||.+||..||++|||+.|+++|+||+..
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence             2346789999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.9e-41  Score=340.74  Aligned_cols=247  Identities=28%  Similarity=0.436  Sum_probs=208.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||++.++. +..+|+|.+....     .....+.+|+.+|++++||||+++++++...+.+|+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            3579999999999999999998765 5679999875321     113467889999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      ||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            9999999999999875 356899999999999999999999999999999999999999999999999999865432221


Q ss_pred             --cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          271 --LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       271 --~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                        ....++..|+|||++.+.. ++.++|||||||++|||++ |+.||...+......++.... ....+...+.++.+||
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li  234 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYEVM  234 (256)
T ss_pred             ccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHH
Confidence              1223566899999987654 8899999999999999999 999998777666666655433 2334566789999999


Q ss_pred             HHHcccCCCCCCCHHHHhc
Q 007478          348 RLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .+||..||++||+++++++
T Consensus       235 ~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.2e-41  Score=345.80  Aligned_cols=251  Identities=24%  Similarity=0.415  Sum_probs=209.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEEC----CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNS----DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~----~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      .++|++.+.||+|+||+||+|.+.    .+++.||+|.+...   ...+....+.+|+.++++++|+||+++++++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            467899999999999999999853    45678999988642   22334567889999999999999999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhcc-----------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDY-----------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN  250 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~-----------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~  250 (602)
                      ..|+||||+.+++|.+++...                 ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            999999999999999998532                 246788899999999999999999999999999999999999


Q ss_pred             CceEEeccCccccccCCC---CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHh
Q 007478          251 GRVKLADFGMAKHIAGQS---CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKI  326 (602)
Q Consensus       251 g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i  326 (602)
                      +.+||+|||+++.+....   ......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+......+..+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999998754322   122344677899999987655 8899999999999999998 99999776554444444


Q ss_pred             hCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       327 ~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .. ......+..++.++.+||.+||+.||++||++.+|+++
T Consensus       240 ~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         240 RK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             Hc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            33 33345667899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-42  Score=362.65  Aligned_cols=256  Identities=30%  Similarity=0.493  Sum_probs=212.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~  190 (602)
                      ...|++.+.||+||.+.||++.... ...||+|++..  ...+......+.+||.+|.+| .|.+||+||++...++.+|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~--~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL--LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH--hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            4679999999999999999998765 45677776543  334566788899999999999 5999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCC-ChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          191 IYLEYVSGGSIYKLLQDYGQF-GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~l-s~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      |||||= ..+|.++|+++... ....++.|..||+.|++++|+.||||.||||.|+|+- .|.+||+|||+|..+..+..
T Consensus       437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence            999975 58999999876543 3358999999999999999999999999999999995 56899999999998876554


Q ss_pred             C---cccCCCCCCCCcccccccC----------CCCccccchhhhhHHHHHhhCCCCCCCch-hHHHHHHhhCCCCCCCC
Q 007478          270 P---LSFKGSPYWMAPEVIKNSS----------GCNLAVDIWSLGCTVLEMATTKPPWSQYE-GVAAMFKIGNSKELPTI  335 (602)
Q Consensus       270 ~---~~~~GT~~Y~APEvl~~~~----------~~s~~sDVWSLGviLyELltG~~Pf~~~~-~~~~~~~i~~~~~~~~~  335 (602)
                      .   .+.+||+.||+||.+....          ..+.++||||||||||+|+.|++||.... ....+..|......-++
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief  594 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF  594 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence            3   3567999999999985322          14678999999999999999999998866 55566666654333344


Q ss_pred             CCCCCH-HHHHHHHHHcccCCCCCCCHHHHhcCccccC
Q 007478          336 PDDLSD-EGKDFIRLCLQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       336 p~~~s~-~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~  372 (602)
                      |..-+. ++.++++.||.+||.+||++.++|+|||++.
T Consensus       595 p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  595 PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            443333 3999999999999999999999999999986

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-41  Score=342.40  Aligned_cols=250  Identities=25%  Similarity=0.417  Sum_probs=210.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCC-----CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDS-----GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      .++|++.+.||+|+||.||+|.++..     +..||+|.+...   ........+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc---cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            56899999999999999999988643     478999987532   1223345688999999999999999999999999


Q ss_pred             ceEEEEEeeecCCChhhhhhcc----------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEe
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDY----------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLA  256 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~----------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~  256 (602)
                      ...|+||||+.+++|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence            9999999999999999998643          236778899999999999999999999999999999999999999999


Q ss_pred             ccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCC
Q 007478          257 DFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKEL  332 (602)
Q Consensus       257 DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~  332 (602)
                      |||+++.+.....   .....+|..|+|||++.+.. ++.++|||||||++|||++ |+.||...........+. ....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~  239 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGH  239 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCC
Confidence            9999986643321   12344678999999987655 8899999999999999998 999998766554444444 3344


Q ss_pred             CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          333 PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       333 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ..++..++.++.+||.+||+.+|++|||+.+|++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            5667788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-41  Score=359.54  Aligned_cols=252  Identities=28%  Similarity=0.418  Sum_probs=205.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECC-----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTV  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~  185 (602)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|+++..   ......+.+.+|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC---CCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            4589999999999999999997543     4578999988632   1233456678899999999 89999999998754


Q ss_pred             -cceEEEEEeeecCCChhhhhhcc--------------------------------------------------------
Q 007478          186 -EDKLYIYLEYVSGGSIYKLLQDY--------------------------------------------------------  208 (602)
Q Consensus       186 -~~~~~lVmE~~~ggsL~~~l~~~--------------------------------------------------------  208 (602)
                       +..++++|||+.+++|.++|...                                                        
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             46789999999999999988532                                                        


Q ss_pred             -----CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC---CcccCCCCCCC
Q 007478          209 -----GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWM  280 (602)
Q Consensus       209 -----~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~  280 (602)
                           ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....   .....++..|+
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence                 2578889999999999999999999999999999999999999999999999987643321   12334677899


Q ss_pred             CcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCC
Q 007478          281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP  359 (602)
Q Consensus       281 APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rp  359 (602)
                      |||++.+.. ++.++|||||||++|||++ |..||.+......+............+..+++++.+|+.+||+.+|++||
T Consensus       243 aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP  321 (337)
T cd05054         243 APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP  321 (337)
T ss_pred             CcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence            999997765 8999999999999999998 99999764332333333223233445667889999999999999999999


Q ss_pred             CHHHHhcC
Q 007478          360 TAAELLDH  367 (602)
Q Consensus       360 t~~eiL~h  367 (602)
                      +++||++|
T Consensus       322 s~~ell~~  329 (337)
T cd05054         322 TFSELVEI  329 (337)
T ss_pred             CHHHHHHH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.1e-41  Score=349.02  Aligned_cols=258  Identities=25%  Similarity=0.425  Sum_probs=205.1

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc--
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED--  187 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~--  187 (602)
                      ...++|++.+.||+|+||.||+|.++.+++.||||++.....  .......+.+|+.++++++||||+++++++...+  
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATP   86 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence            345789999999999999999999999999999998864221  1122344568999999999999999999876543  


Q ss_pred             ------eEEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCc
Q 007478          188 ------KLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       188 ------~~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGl  260 (602)
                            ..|+||||+. ++|.+++... ..+++.+++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence                  4699999996 5788777654 3789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC-----CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHH---HHhhCCCCC
Q 007478          261 AKHIAGQSC-----PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM---FKIGNSKEL  332 (602)
Q Consensus       261 a~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~---~~i~~~~~~  332 (602)
                      +..+.....     .....++..|+|||++.+...++.++|||||||++|||++|++||...+.....   ..+......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            976643221     123457889999999876655788999999999999999999999765432221   111110000


Q ss_pred             --------------CCC-------------CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          333 --------------PTI-------------PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       333 --------------~~~-------------p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                                    ..+             +...+..+.+||.+||..||++|||++++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                          000             11235778899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1e-42  Score=346.93  Aligned_cols=261  Identities=27%  Similarity=0.474  Sum_probs=209.8

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCc----EEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGE----MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV  185 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~  185 (602)
                      .....|+.++.||+|+||.||+|..++++.    .||||.++-..+  .......-.+|+.+++.|+|||||.|..+|..
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            346789999999999999999997766543    789998874322  11223345689999999999999999999877


Q ss_pred             -cceEEEEEeeecCCChhhhhhcc-----CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC----CceEE
Q 007478          186 -EDKLYIYLEYVSGGSIYKLLQDY-----GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN----GRVKL  255 (602)
Q Consensus       186 -~~~~~lVmE~~~ggsL~~~l~~~-----~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----g~vKL  255 (602)
                       +..+++++||.+ -+|+.+|+-+     +.++...++.|+.||+.|+.|||++.|+||||||.||||..+    |.|||
T Consensus        99 ~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen   99 HDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             cCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence             789999999996 6888888632     468888999999999999999999999999999999999887    89999


Q ss_pred             eccCccccccCCCC----CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh---------HHH
Q 007478          256 ADFGMAKHIAGQSC----PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG---------VAA  322 (602)
Q Consensus       256 ~DFGla~~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~---------~~~  322 (602)
                      +|||+++.+...-.    ...++-|.||+|||.+.+...|+.++||||+|||+.||++-++.|.+.+.         .++
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999998754322    23456799999999999999999999999999999999999999964321         223


Q ss_pred             HHHhhCCCCCC---------CCC--------------C------------CCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          323 MFKIGNSKELP---------TIP--------------D------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       323 ~~~i~~~~~~~---------~~p--------------~------------~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      +.+|......|         .+|              .            .-++.+.+|+.+||++||-+|.|++++|+|
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            33332211111         011              0            134558899999999999999999999999


Q ss_pred             ccccCC
Q 007478          368 PFVKGA  373 (602)
Q Consensus       368 p~f~~~  373 (602)
                      +||...
T Consensus       338 ~yF~~d  343 (438)
T KOG0666|consen  338 PYFTED  343 (438)
T ss_pred             cccccC
Confidence            999864

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4e-41  Score=344.33  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=209.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECC-----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+...   ........+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES---CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            4679999999999999999999987     7788999987532   2233345688899999999999999999999888


Q ss_pred             ceEEEEEeeecCCChhhhhhccC-------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC---ceEEe
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYG-------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG---RVKLA  256 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~-------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~vKL~  256 (602)
                      +..|+||||+.|++|.+++...+       .+++..+..++.||+.||+|||+++++||||||+|||++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            89999999999999999997643       488899999999999999999999999999999999998765   59999


Q ss_pred             ccCccccccCCCCC---cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCC
Q 007478          257 DFGMAKHIAGQSCP---LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKEL  332 (602)
Q Consensus       257 DFGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~  332 (602)
                      |||+++.+......   .....+..|+|||++.+.. ++.++|||||||++|||++ |+.||...........+.. ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~  239 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-GGR  239 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCc
Confidence            99999876332211   1222356799999997765 8999999999999999997 9999987655444443333 233


Q ss_pred             CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          333 PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       333 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ...+..++.++.+||.+||+.||++||++.++++|
T Consensus       240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            45567889999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.5e-41  Score=341.03  Aligned_cols=248  Identities=26%  Similarity=0.452  Sum_probs=211.0

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..+|.+.+.||+|+||.||+|.++.+++.||+|+++..     ......+.+|+.++++++|+||+++++++..++.+++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            45689999999999999999999999999999987631     1224568899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||||+.+++|.+++...  ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999998753  3588899999999999999999999999999999999999999999999999987654322


Q ss_pred             Cc--ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          270 PL--SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       270 ~~--~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                      ..  ...++..|+|||++.+.. ++.++|||||||++|||++ |..||...+.......+.. ......+..++.++.+|
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPEGCPPKVYEL  237 (263)
T ss_pred             eccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHH
Confidence            11  223466799999987655 8889999999999999998 9999987655444444433 23345677899999999


Q ss_pred             HHHHcccCCCCCCCHHHHhc
Q 007478          347 IRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~  366 (602)
                      |.+||..||++||++.++++
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-41  Score=340.31  Aligned_cols=249  Identities=24%  Similarity=0.401  Sum_probs=206.8

Q ss_pred             ceEeeeEeecCCeEEEEEEECCC---CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce---
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDS---GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK---  188 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~---  188 (602)
                      |++++.||+|+||.||+|.+..+   +..||+|+++..  .........+.+|+.+++.++|+||+++++++...+.   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD--IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC--cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence            67889999999999999987653   478999988742  2233445678899999999999999999998765443   


Q ss_pred             ---EEEEEeeecCCChhhhhhcc------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccC
Q 007478          189 ---LYIYLEYVSGGSIYKLLQDY------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFG  259 (602)
Q Consensus       189 ---~~lVmE~~~ggsL~~~l~~~------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFG  259 (602)
                         .+++|||+.+|+|..++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcc
Confidence               79999999999999988432      358899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCC---cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCC
Q 007478          260 MAKHIAGQSCP---LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTI  335 (602)
Q Consensus       260 la~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  335 (602)
                      +++.+......   ....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+.......+... .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~  236 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQ  236 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCC
Confidence            99876443221   1123567899999986554 8899999999999999999 99999876665555544433 34456


Q ss_pred             CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       336 p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      +..++.++.+||.+||+.||++||++.+++++
T Consensus       237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-41  Score=374.78  Aligned_cols=262  Identities=25%  Similarity=0.307  Sum_probs=198.1

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCC-CcEEEEEEEec-------------ccchhcHHHHHHHHHHHHHHHhcCCCcE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDS-GEMCAMKEVTL-------------FDDAKSKESAKQLMQEIVLLSRLRHPNI  176 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~i~~-------------~~~~~~~~~~~~l~~Ei~iL~~l~HpnI  176 (602)
                      ...+|++++.||+|+||+||+|..+.. +..+++|.+..             ............+.+|+.+|++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            357899999999999999999876543 22233331110             0001122345568899999999999999


Q ss_pred             EEEeccccccceEEEEEeeecCCChhhhhhcc-----CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC
Q 007478          177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-----GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG  251 (602)
Q Consensus       177 v~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-----~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g  251 (602)
                      |++++++...+..|+|+|++. ++|.+++...     .......++.|+.||+.||+|||++|||||||||+||||+.++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            999999999999999999984 6777776432     2344667889999999999999999999999999999999999


Q ss_pred             ceEEeccCccccccCCCC--CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCC-CCCc--hhHHHHHHh
Q 007478          252 RVKLADFGMAKHIAGQSC--PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP-WSQY--EGVAAMFKI  326 (602)
Q Consensus       252 ~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~P-f~~~--~~~~~~~~i  326 (602)
                      .+||+|||+++.+.....  ....+||..|+|||++.+.. ++.++|||||||+||||++|..+ |...  .....+.++
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            999999999987654332  23467999999999997765 89999999999999999998754 4321  112222221


Q ss_pred             hCCC---------------------CCCCC---------CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          327 GNSK---------------------ELPTI---------PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       327 ~~~~---------------------~~~~~---------p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      ....                     .....         ...++.++.++|.+||++||++|||+.|+|+||||....
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            1100                     00000         013567788999999999999999999999999998754

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-41  Score=343.14  Aligned_cols=253  Identities=31%  Similarity=0.530  Sum_probs=210.6

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc--ceEEEE
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE--DKLYIY  192 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV  192 (602)
                      |++.+.||+|+||.||+|.+..+++.+|+|++....  ........+.+|+.++++++|+||+++++++...  +..|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence            678999999999999999999999999999997532  2233345678899999999999999999999887  889999


Q ss_pred             EeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC--C
Q 007478          193 LEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--C  269 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~  269 (602)
                      |||+. ++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++.......  .
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          79 FEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            99997 5898888765 579999999999999999999999999999999999999999999999999998765443  1


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC------C----------
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL------P----------  333 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~------~----------  333 (602)
                      .....++..|+|||.+.+...++.++|||||||++|||++|+.||...+......++......      +          
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            223457889999998876555889999999999999999999999876554433332211000      0          


Q ss_pred             -------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          334 -------------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       334 -------------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                                   .+...++.++.++|++||..||++||+++++++|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                         0111238899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.9e-41  Score=343.32  Aligned_cols=251  Identities=24%  Similarity=0.408  Sum_probs=207.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECC-----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      .++|++.+.||+|+||.||+|.++.     ++..||+|+++..   ........+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            5679999999999999999998652     3567999987532   1223345688999999999999999999999998


Q ss_pred             ceEEEEEeeecCCChhhhhhccC----------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEe
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYG----------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLA  256 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~----------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~  256 (602)
                      +..++||||+.+++|.+++.+..          .++...+..++.||+.||.|||++|++||||||+|||++.++.+||+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999999986532          25677889999999999999999999999999999999999999999


Q ss_pred             ccCccccccCCCCC---cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCC
Q 007478          257 DFGMAKHIAGQSCP---LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKEL  332 (602)
Q Consensus       257 DFGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~  332 (602)
                      |||+++.+......   ....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+.. ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~-~~~  239 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME-GGL  239 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCc
Confidence            99998765332211   1234577899999997655 8999999999999999999 7899987665444443333 233


Q ss_pred             CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          333 PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       333 ~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ..++..++.++.+||.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            45667889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.5e-41  Score=348.08  Aligned_cols=256  Identities=30%  Similarity=0.499  Sum_probs=209.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc----
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED----  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~----  187 (602)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|+++....  .......+.+|+.++++++||||+++++++.+..    
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            5689999999999999999999999999999999875322  1222345678999999999999999999887654    


Q ss_pred             ------eEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCc
Q 007478          188 ------KLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       188 ------~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGl  260 (602)
                            .+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                  79999999975 67777664 35789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC--CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC------
Q 007478          261 AKHIAGQSC--PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL------  332 (602)
Q Consensus       261 a~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~------  332 (602)
                      +..+.....  .....++..|+|||++.+...++.++|||||||++|||++|++||...+....+..+......      
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            987654331  122346788999999876555788999999999999999999999865554443332211000      


Q ss_pred             C----------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          333 P----------------------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       333 ~----------------------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +                      .....++..+.+||.+||..||++||+++++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            0                      0122478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-41  Score=340.04  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=211.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCC---CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDS---GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      .++|++.+.||+|+||+||+|.++.+   ...||||+++..   ........+.+|+.++++++|+||+++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG---SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            45799999999999999999998654   457999987642   233445678899999999999999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      .|+||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999998763 57899999999999999999999999999999999999999999999999999887522


Q ss_pred             CCC-c--ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHH
Q 007478          268 SCP-L--SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG  343 (602)
Q Consensus       268 ~~~-~--~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  343 (602)
                      ... .  ...++..|+|||.+.+.. ++.++|||||||++|||++ |..||...........+..... ...+..++.++
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  237 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR-LPPPMDCPSAL  237 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHH
Confidence            211 1  223567899999987655 8899999999999999998 9999987666555555544322 23456789999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHhcC
Q 007478          344 KDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       344 ~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .+|+.+||+.+|++||++.+|+++
T Consensus       238 ~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         238 YQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.7e-41  Score=340.64  Aligned_cols=252  Identities=32%  Similarity=0.587  Sum_probs=210.2

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      .+|++.+.||+|+||.||+|.++.+++.||||.+..... ........+.+|+.+++.++|+||+++++++..++..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            478899999999999999999999999999998865322 2333456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          193 LEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      |||+.+++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999998863    3468999999999999999999999999999999999999999999999999988764332


Q ss_pred             C-CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh--HHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          269 C-PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       269 ~-~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                      . .....|+..|+|||++.+.. ++.++|||||||++|||++|..||.....  ......+......+..+..++.++++
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ  239 (267)
T ss_pred             cccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence            2 23456899999999997654 88899999999999999999999964332  22222222222222233468899999


Q ss_pred             HHHHHcccCCCCCCCHHHHhc
Q 007478          346 FIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ||.+||..||++|||+.+|++
T Consensus       240 li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         240 LVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHhcCCCcccCCCHHHHHH
Confidence            999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.9e-41  Score=343.81  Aligned_cols=259  Identities=40%  Similarity=0.732  Sum_probs=221.5

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ....|+..+.||+|+||.||++.+..+++.||+|+++....     ....+.+|+.+++.++|+||+++++++...+..|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            45678999999999999999999998899999999875222     4566789999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccC-CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-
Q 007478          191 IYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  268 (602)
                      +|+||+++++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... 
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            9999999999999998876 89999999999999999999999999999999999999999999999999987654322 


Q ss_pred             CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC-CCCCCCCHHHHHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-TIPDDLSDEGKDFI  347 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~s~~l~dLI  347 (602)
                      ......++..|++||++.+.. ++.++|||||||++|+|++|+.||...+.......+....... ..+..++.++++||
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL  250 (286)
T ss_pred             hhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence            223445889999999987655 8899999999999999999999998766555444443322111 22234889999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ++||+.+|.+||++.++++|+||+...+
T Consensus       251 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         251 NKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             HHHhccChhhCcCHHHHhhChHhhccCc
Confidence            9999999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-41  Score=354.50  Aligned_cols=259  Identities=26%  Similarity=0.458  Sum_probs=214.8

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc---
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED---  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~---  187 (602)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++...  .........+.+|+.+|++++|+||+++++++..+.   
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            457899999999999999999999999999999988542  122334456789999999999999999999886543   


Q ss_pred             ---eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          188 ---KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       188 ---~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                         .+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence               469999999 7899888865 57999999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC--------------
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--------------  330 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~--------------  330 (602)
                      ...  .....+++.|+|||++.+...++.++|||||||++|+|++|+.||...+......++....              
T Consensus       169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         169 DSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             ccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            432  2345689999999998765558889999999999999999999998655433332221100              


Q ss_pred             ---------------CCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          331 ---------------ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       331 ---------------~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                     ....+...++.++.+||.+||..||++|||+.+++.||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                           011123467889999999999999999999999999999997644

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7e-41  Score=338.57  Aligned_cols=248  Identities=29%  Similarity=0.508  Sum_probs=209.6

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|++.++||+|+||.||+|.+. ++..||+|.+...     ....+.+.+|+.++++++|+||+++++++...+..|
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG-----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC-----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            3568999999999999999999875 4677999987531     123467889999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          191 IYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      ++|||+++++|.+++...  ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999998653  568889999999999999999999999999999999999999999999999998764332


Q ss_pred             C--CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          269 C--PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       269 ~--~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                      .  .....++..|+|||++.... ++.++|||||||++|||++ |+.||...........+...... .....++.++.+
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-PRMENCPDELYD  235 (261)
T ss_pred             eeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence            1  12234567899999987655 8889999999999999998 99999876665555555443332 334578999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhc
Q 007478          346 FIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ||.+||..+|++||+++++++
T Consensus       236 li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         236 IMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.7e-40  Score=335.79  Aligned_cols=251  Identities=32%  Similarity=0.607  Sum_probs=210.7

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.++.... ......+.+.+|+.++++++|+||+++++++...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            579999999999999999999999999999999875332 2233456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          193 LEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            999999999998864    3458899999999999999999999999999999999999999999999999988664432


Q ss_pred             -CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh--HHHHHHhhCCCCCCCCCC-CCCHHHH
Q 007478          269 -CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKELPTIPD-DLSDEGK  344 (602)
Q Consensus       269 -~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~-~~s~~l~  344 (602)
                       ......|+..|+|||++.+.. ++.++|||||||++|+|++|+.||.....  ......+... ..+..+. .++.++.
T Consensus       161 ~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  238 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPPLPADHYSEELR  238 (267)
T ss_pred             cccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC-CCCCCChhhcCHHHH
Confidence             223456899999999987654 88999999999999999999999964321  1222222222 2233344 7888999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhc
Q 007478          345 DFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ++|.+||..+|++||++.+|++
T Consensus       239 ~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         239 DLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-41  Score=342.01  Aligned_cols=252  Identities=35%  Similarity=0.584  Sum_probs=210.1

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccceEEEEE
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      |++.+.||+|+||+||+|+...+++.||||++.....  .. ......+|+..+++++ |+||+++++++..++..|+||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   77 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF   77 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--ch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence            6788999999999999999999999999998764211  11 1223457899999999 999999999999999999999


Q ss_pred             eeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc
Q 007478          194 EYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  271 (602)
                      ||+ +|+|.+++....  .+++..+..++.||+.+|.|||++|++|+||||+||+++.++.++|+|||+++.........
T Consensus        78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          78 EYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             ecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence            999 889999887654  78999999999999999999999999999999999999999999999999998776544444


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC-------------------
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL-------------------  332 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~-------------------  332 (602)
                      ...|+..|+|||++.....++.++|||||||++|||++|++||..........++......                   
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR  236 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence            5668999999999876555889999999999999999999999765544443332211000                   


Q ss_pred             ---------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          333 ---------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       333 ---------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                               ..+....+.++.+||++||+.||++|||++|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                     01112346889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1e-40  Score=353.08  Aligned_cols=256  Identities=30%  Similarity=0.507  Sum_probs=208.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc-----
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE-----  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~-----  186 (602)
                      ..+|++.+.||.|+||.||+|.++.+|+.||+|++.....    ...+.+.+|+.+++.++||||+++++++...     
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            4789999999999999999999999999999999865322    3346678899999999999999999876543     


Q ss_pred             ---------ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc-CCceEEe
Q 007478          187 ---------DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLA  256 (602)
Q Consensus       187 ---------~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~vKL~  256 (602)
                               ..+|+||||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                     35899999996 589888864 47899999999999999999999999999999999999974 5578999


Q ss_pred             ccCccccccCCCC----CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC--
Q 007478          257 DFGMAKHIAGQSC----PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--  330 (602)
Q Consensus       257 DFGla~~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~--  330 (602)
                      |||+++.+.....    .....|+..|+|||++.....++.++|||||||++|||++|+.||.+.+.......+....  
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999976532211    1123578999999988665568889999999999999999999997655444333322110  


Q ss_pred             ---------------------CCC-----CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          331 ---------------------ELP-----TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       331 ---------------------~~~-----~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                                           ...     .+...++.++.+||++||+.||++|||+.+++.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                                 000     1123578899999999999999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=366.17  Aligned_cols=252  Identities=28%  Similarity=0.490  Sum_probs=217.9

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCc---E-EEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGE---M-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~-vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      ++-.+.++||+|+||.||+|..+..+.   . ||||..+. ......+....+++|+++|++++|||||++||+...+.-
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~-~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG-SSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc-cccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            445566899999999999998876432   3 89998764 223456778899999999999999999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhccC-CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      +|||||+|.||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+||||++.....
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY  315 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence            999999999999999999876 4999999999999999999999999999999999999999999999999998875422


Q ss_pred             CCCccc-CCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          268 SCPLSF-KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       268 ~~~~~~-~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                      ...... .-...|+|||.+.... |++++|||||||++||+++ |..||.+........++.........+...+.++..
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~-~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~  394 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGI-FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAK  394 (474)
T ss_pred             eeccccccCcceecChhhhccCc-cccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence            211111 2346899999998775 9999999999999999999 899999999888888885555556677889999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhc
Q 007478          346 FIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ++.+||..||++|+++.++.+
T Consensus       395 ~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  395 VMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHhccCChhhccCHHHHHH
Confidence            999999999999999999876

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.3e-41  Score=343.79  Aligned_cols=249  Identities=30%  Similarity=0.473  Sum_probs=209.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEEC-----CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNS-----DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      ..+|.+.+.||+|+||+||++...     .++..+|+|.+..    ........+.+|+.++++++|+||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            357899999999999999999752     3456799998763    2233456788999999999999999999999999


Q ss_pred             ceEEEEEeeecCCChhhhhhccC-------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCce
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYG-------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRV  253 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~-------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~v  253 (602)
                      +.+|+||||+.+++|.+++...+             .+++..++.++.||+.||+|||++|++||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999997543             48999999999999999999999999999999999999999999


Q ss_pred             EEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCC
Q 007478          254 KLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNS  329 (602)
Q Consensus       254 KL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~  329 (602)
                      ||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+...
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~  238 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  238 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999986543221   11233577899999987654 8899999999999999998 99999876665555555543


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          330 KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       330 ~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      . ....+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       239 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         239 R-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             C-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3 33456678999999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-41  Score=341.87  Aligned_cols=252  Identities=31%  Similarity=0.504  Sum_probs=207.4

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc---CCCcEEEEeccccccce---
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL---RHPNIVQYYGSKTVEDK---  188 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l---~HpnIv~l~~~~~~~~~---  188 (602)
                      |++.+.||+|+||.||+|+++.+++.||+|+++....  .......+.+|+.+++++   +|+||+++++++...+.   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            6889999999999999999998999999999875322  222234566777777666   69999999999887766   


Q ss_pred             --EEEEEeeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          189 --LYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       189 --~~lVmE~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                        ++++|||+. ++|.+++....  .+++..++.++.||+.||.|||+++++|+||||+|||++.++.+||+|||++..+
T Consensus        79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence              999999996 58988887643  5899999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC------------
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL------------  332 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~------------  332 (602)
                      ..........++..|+|||++.+.. ++.++|||||||++|||++|++||......+.+.++......            
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             cCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            5554444556889999999997765 888999999999999999999999876655444433221000            


Q ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          333 -------------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       333 -------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                                   ......++.++.+||.+||+.||++||++++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                         00112356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-40  Score=333.68  Aligned_cols=252  Identities=35%  Similarity=0.541  Sum_probs=218.7

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|++.+.||+|+||.||++.++.+++.+|+|.+.....  .......+.+|+.+++.++|+||+++++++......|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence            58899999999999999999999999999999875221  2334567788999999999999999999999999999999


Q ss_pred             eeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          194 EYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       194 E~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||+++++|.+++.+    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...... .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-C
Confidence            99999999999866    356889999999999999999999999999999999999999999999999999877654 2


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  349 (602)
                      .....|+..|++||.+.+.. ++.++|+||||+++|||++|+.||...+.......+.. ...+.++..++.+++++|.+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPIYSQDLQNFIRS  235 (256)
T ss_pred             cccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCchhhCHHHHHHHHH
Confidence            33456899999999997655 88899999999999999999999987665444444433 33445666889999999999


Q ss_pred             HcccCCCCCCCHHHHhcCccc
Q 007478          350 CLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      ||..+|++||++.++++||++
T Consensus       236 ~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         236 MLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.3e-41  Score=341.22  Aligned_cols=245  Identities=26%  Similarity=0.437  Sum_probs=201.8

Q ss_pred             CCceEeeeE--eecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHh-cCCCcEEEEeccccccceE
Q 007478          113 SHWKKGKML--GRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR-LRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       113 ~~y~~~~~L--G~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~  189 (602)
                      +.|++.+.+  |+|+||.||++.++.+++.+|+|++...... .        .|+.+... .+|+||+++++++...+.+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-A--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-h--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            455665555  9999999999999999999999998642111 0        12222222 2799999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC-ceEEeccCccccccCCC
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-RVKLADFGMAKHIAGQS  268 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~  268 (602)
                      |+||||+++++|.+++.....+++.+++.++.||+.||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  164 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS  164 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc
Confidence            99999999999999998877899999999999999999999999999999999999999998 99999999988764332


Q ss_pred             CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH----HHHHHhhCCCCCCCCCCCCCHHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV----AAMFKIGNSKELPTIPDDLSDEGK  344 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~~s~~l~  344 (602)
                         ...|+..|+|||++.+.. ++.++|||||||++|||++|+.||......    ..+....  ......+..++..++
T Consensus       165 ---~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  238 (267)
T PHA03390        165 ---CYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNAN  238 (267)
T ss_pred             ---cCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHH
Confidence               346899999999997655 889999999999999999999999743321    1222221  222344557999999


Q ss_pred             HHHHHHcccCCCCCCC-HHHHhcCccccC
Q 007478          345 DFIRLCLQRNPLNRPT-AAELLDHPFVKG  372 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt-~~eiL~hp~f~~  372 (602)
                      +||.+||+.||.+|++ ++++|+||||+.
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            9999999999999996 699999999973

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.7e-41  Score=353.94  Aligned_cols=254  Identities=28%  Similarity=0.470  Sum_probs=204.3

Q ss_pred             eeEeec--CCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeee
Q 007478          119 KMLGRG--TFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYV  196 (602)
Q Consensus       119 ~~LG~G--~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~  196 (602)
                      +.||+|  +||+||+|.+..+|+.||+|++....  ...+..+.+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN--CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            456666  99999999999999999999986522  22344578899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC----
Q 007478          197 SGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP----  270 (602)
Q Consensus       197 ~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~----  270 (602)
                      .+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++||+.+.........    
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            999999998764  35889999999999999999999999999999999999999999999999865433211110    


Q ss_pred             ----cccCCCCCCCCccccccc-CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC-------------
Q 007478          271 ----LSFKGSPYWMAPEVIKNS-SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL-------------  332 (602)
Q Consensus       271 ----~~~~GT~~Y~APEvl~~~-~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~-------------  332 (602)
                          ....++..|+|||++.+. ..++.++|||||||++|||++|+.||...........+......             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence                112356779999998754 34788999999999999999999999765443333222111100             


Q ss_pred             --------------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          333 --------------------------------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       333 --------------------------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                                                      ...+..++.++.+||++||+.||++|||++|+++|+||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                            011224677899999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.6e-41  Score=351.72  Aligned_cols=258  Identities=27%  Similarity=0.481  Sum_probs=209.4

Q ss_pred             CceEeeeEeecCCeEEEEEEECCC--CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccc----c
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDS--GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTV----E  186 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~t--g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~----~  186 (602)
                      +|++.+.||+|+||.||++.+..+  +..||+|++...  .......+.+.+|+.+++++ +|+||+++++.+..    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV--FSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccc--cccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            488999999999999999999888  899999988642  12223355678899999999 59999999986432    2


Q ss_pred             ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      ..+|++|||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          79 NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence            46889999985 78999998888899999999999999999999999999999999999999999999999999986543


Q ss_pred             CCC-----CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC------------
Q 007478          267 QSC-----PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS------------  329 (602)
Q Consensus       267 ~~~-----~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~------------  329 (602)
                      ...     .....||..|+|||++.+...++.++|||||||++|+|++|++||...+....+..+...            
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            221     223568999999999876556889999999999999999999999765432222211100            


Q ss_pred             -----------------CCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          330 -----------------KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       330 -----------------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                                       .........++.++.+||.+||+.||++|||+.+++.||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence                             001112235688999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5e-41  Score=347.61  Aligned_cols=256  Identities=30%  Similarity=0.545  Sum_probs=205.0

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc------
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV------  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~------  185 (602)
                      .++|++.++||+|+||.||+|.++.+++.||||++......  ......+.+|+++++.++|+||+++++++..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            57899999999999999999999999999999988652211  1112346789999999999999999987643      


Q ss_pred             --cceEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          186 --EDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       186 --~~~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                        ...+|+||||+. ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          85 RKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             ccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence              235799999996 467666654 4579999999999999999999999999999999999999999999999999997


Q ss_pred             cccCCCC------------CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC
Q 007478          263 HIAGQSC------------PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK  330 (602)
Q Consensus       263 ~~~~~~~------------~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~  330 (602)
                      .......            .....|++.|+|||++.+...++.++|||||||++|||++|++||.+.+.......+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            6543221            1223578899999998766568899999999999999999999998655443333221100


Q ss_pred             C------------CC---------CC-------CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          331 E------------LP---------TI-------PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       331 ~------------~~---------~~-------p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .            .+         ..       ...+..++.+||.+||..||++|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            0            00         00       12355788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1e-40  Score=343.41  Aligned_cols=252  Identities=26%  Similarity=0.441  Sum_probs=210.2

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCC-----CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDS-----GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKT  184 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~  184 (602)
                      ..++|++.+.||+|+||.||++.++..     ...+|+|.+...   ........+.+|+.+++++ +|+||+++++++.
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            356899999999999999999987643     378999988642   2223446688999999999 8999999999999


Q ss_pred             ccceEEEEEeeecCCChhhhhhc----------------cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEc
Q 007478          185 VEDKLYIYLEYVSGGSIYKLLQD----------------YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVD  248 (602)
Q Consensus       185 ~~~~~~lVmE~~~ggsL~~~l~~----------------~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~  248 (602)
                      .++.+|++|||+.+|+|.+++..                .+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            99999999999999999999854                24688899999999999999999999999999999999999


Q ss_pred             cCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHH
Q 007478          249 PNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMF  324 (602)
Q Consensus       249 ~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~  324 (602)
                      .++.+||+|||+++.+.....   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||..........
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            999999999999987654321   11223567899999987654 8899999999999999997 999998765544444


Q ss_pred             HhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          325 KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       325 ~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .+.. ......+..++.++.+|+.+||..||++|||+.+++++
T Consensus       246 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            4333 33445667889999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.6e-41  Score=343.80  Aligned_cols=251  Identities=26%  Similarity=0.398  Sum_probs=208.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCC----------------cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSG----------------EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN  175 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg----------------~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hpn  175 (602)
                      ..+|++++.||+|+||.||+|.+..++                ..||+|.+...   ......+.+.+|++++++++|+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD---ASDNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc---cCHHHHHHHHHHHHHHHhcCCCC
Confidence            468999999999999999999876544                45799987642   22345677889999999999999


Q ss_pred             EEEEeccccccceEEEEEeeecCCChhhhhhccC-----------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCc
Q 007478          176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-----------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGAN  244 (602)
Q Consensus       176 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~-----------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~N  244 (602)
                      |+++++++..++..++||||+.+++|.+++.+..           .+++..++.++.||+.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999899999999999999999997765           68999999999999999999999999999999999


Q ss_pred             EEEccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh--CCCCCCCchh
Q 007478          245 ILVDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEG  319 (602)
Q Consensus       245 ILl~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt--G~~Pf~~~~~  319 (602)
                      ||++.++.+||+|||+++.+.....   .....++..|+|||++.+.. ++.++|||||||++|||++  +..||.....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999999986543321   22344678899999987655 8899999999999999998  7889976554


Q ss_pred             HHHHHHhhCC------CCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          320 VAAMFKIGNS------KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       320 ~~~~~~i~~~------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ...+..+...      ......+..++.++.+||.+||+.||++|||+.+|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            4443333221      1112234567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.8e-40  Score=347.14  Aligned_cols=259  Identities=37%  Similarity=0.651  Sum_probs=218.8

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ....|+..+.||+|+||.||++++..++..||+|++..... ...+....+.+|+.+++.++|+||+++++++..++..|
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW  101 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence            34568899999999999999999999999999999865322 23345567889999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          191 IYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      +||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......  
T Consensus       102 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         102 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             EEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            9999996 577777643 567899999999999999999999999999999999999999999999999998765432  


Q ss_pred             CcccCCCCCCCCcccccc--cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~--~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                       ....|+..|+|||++..  ...++.++|||||||++|||++|+.||...+.......+............++..+++||
T Consensus       179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  257 (317)
T cd06635         179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  257 (317)
T ss_pred             -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence             34568999999999742  234788999999999999999999999877666666655544433334456889999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      .+||+.+|++||++.++++|+|+....
T Consensus       258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         258 DSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHHccCCcccCcCHHHHHhChhhhccC
Confidence            999999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.3e-41  Score=343.82  Aligned_cols=251  Identities=26%  Similarity=0.385  Sum_probs=210.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCC-----CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDS-----GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      ..+|++.+.||+|+||.||+|.+..+     ++.||+|+++..   ........+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK---AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            34688899999999999999987543     578999988642   2233456788999999999999999999999999


Q ss_pred             ceEEEEEeeecCCChhhhhhcc----------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDY----------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN  250 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~----------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~  250 (602)
                      +..++++||+.+++|.+++...                ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998521                347888899999999999999999999999999999999999


Q ss_pred             CceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHh
Q 007478          251 GRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKI  326 (602)
Q Consensus       251 g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i  326 (602)
                      +.+||+|||+++.+.....   .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.........+
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999886543221   12234678999999987665 8899999999999999998 89999876665555555


Q ss_pred             hCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       327 ~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .... ...++..++.++.+|+..||+.+|++||++.+|+..
T Consensus       240 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         240 RNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            4433 334577899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-40  Score=338.52  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=203.5

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCc--EEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc------c
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGE--MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV------E  186 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~--~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~------~  186 (602)
                      |.++++||+|+||.||+|.+..++.  .+|+|.++..  .......+.+.+|+.+++.++|+||+++++++..      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA--ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccC--cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            3467899999999999999887765  6899987642  2234446778899999999999999999986532      1


Q ss_pred             ceEEEEEeeecCCChhhhhhc------cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQD------YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~------~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGl  260 (602)
                      ...+++|||+.+|+|.+++..      ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCc
Confidence            257899999999999988742      23478999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCC
Q 007478          261 AKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIP  336 (602)
Q Consensus       261 a~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  336 (602)
                      ++.+.....   .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||...........+... .....+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~  236 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NRLKQP  236 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCC
Confidence            987643321   11234677899999997654 8899999999999999999 89999876554444444433 333456


Q ss_pred             CCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       337 ~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ..++..+.+||.+||+.||++|||+++|+++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-40  Score=337.42  Aligned_cols=248  Identities=27%  Similarity=0.437  Sum_probs=208.0

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||+||++.+.. +..+|+|.++....     ....+.+|+.++++++||||+++++++...+.+|+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            3579999999999999999998764 45699998763211     13467899999999999999999999998889999


Q ss_pred             EEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      ||||+.+++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||+++.+......
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999999999764 46899999999999999999999999999999999999999999999999998765433211


Q ss_pred             --cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          271 --LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       271 --~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                        ....++..|+|||++.+.. ++.++|||||||++|||++ |+.||...+.......+.... ....+...+.++++|+
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li  234 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-RLYRPHLASEKVYAIM  234 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHH
Confidence              1223567899999997655 8889999999999999998 999998766555555554432 2334556789999999


Q ss_pred             HHHcccCCCCCCCHHHHhcC
Q 007478          348 RLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .+||..||++||++.+|+++
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.4e-41  Score=343.60  Aligned_cols=246  Identities=33%  Similarity=0.557  Sum_probs=204.4

Q ss_pred             eEeeeEeecCCeEEEEEEEC----CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          116 KKGKMLGRGTFGHVYVGFNS----DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       116 ~~~~~LG~G~fG~Vy~a~~~----~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ++.+.||.|.||.||+|.+.    ..+..|+||.++.   ....+..+.+.+|++++++++||||++++|++...+.+++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP---SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST---TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc---ccccccceeeeecccccccccccccccccccccccccccc
Confidence            46789999999999999988    4567899998853   2334457788999999999999999999999998888999


Q ss_pred             EEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||||+.+|+|.++|...  ..+++..+..|+.||+.||.|||+++++|+||+++|||++.++.+||+|||++........
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999876  6799999999999999999999999999999999999999999999999999987632211


Q ss_pred             ---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          270 ---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       270 ---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                         .....+...|+|||++.... ++.++||||||+++|||++ |+.||.+........++... .....+..++..+.+
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  236 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG-QRLPIPDNCPKDIYS  236 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-EETTSBTTSBHHHHH
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc-ccceeccchhHHHHH
Confidence               12234677899999997766 8999999999999999999 78999888776666666443 334567789999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhc
Q 007478          346 FIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ||..||..||++||++.+|++
T Consensus       237 li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  237 LIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.3e-40  Score=345.84  Aligned_cols=258  Identities=37%  Similarity=0.653  Sum_probs=216.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .+.|...+.||+|+||+||+|++..+|+.||+|++..... ........+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            3457778889999999999999999999999999875322 233445678899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      ||||+. ++|.+++.. ...+++.++..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.....   .
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~  174 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---A  174 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---C
Confidence            999995 577777754 45789999999999999999999999999999999999999999999999999865332   2


Q ss_pred             cccCCCCCCCCcccccc--cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~--~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  348 (602)
                      ....|+..|+|||++..  ...++.++|||||||++|||++|..||...+.......+............++..+++||.
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  254 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD  254 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence            34568999999999842  2347889999999999999999999998776666665554433333333467889999999


Q ss_pred             HHcccCCCCCCCHHHHhcCccccCCC
Q 007478          349 LCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       349 ~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      +||+++|++||++.+++.||||+...
T Consensus       255 ~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         255 YCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHccCChhhCcCHHHHhcCcccCCCc
Confidence            99999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-40  Score=346.24  Aligned_cols=252  Identities=28%  Similarity=0.471  Sum_probs=209.3

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEE-----CCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFN-----SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKT  184 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~  184 (602)
                      ..++|++.+.||+|+||.||++.+     ..++..||+|+++...   .....+.+.+|+.+++++ +|+||+++++++.
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            346799999999999999999975     3356689999876421   233456788999999999 7999999999999


Q ss_pred             ccceEEEEEeeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          185 VEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       185 ~~~~~~lVmE~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                      ..+.+|+||||+.+|+|.+++....  .+++.++..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||+++
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999999997533  38999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCC
Q 007478          263 HIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDD  338 (602)
Q Consensus       263 ~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  338 (602)
                      .......   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||..........+..........+..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH  268 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence            6643321   11234678899999997665 8899999999999999998 99999876544444443333333344567


Q ss_pred             CCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          339 LSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       339 ~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .+.++.+||.+||..+|++||++.++++
T Consensus       269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         269 APAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            8899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=334.64  Aligned_cols=242  Identities=27%  Similarity=0.449  Sum_probs=203.3

Q ss_pred             eeEeecCCeEEEEEEECCCC---cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEee
Q 007478          119 KMLGRGTFGHVYVGFNSDSG---EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      ++||+|+||.||+|++..++   ..||+|.+.....   ....+.+.+|+.+++.++|+||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            47999999999999876655   7899998864222   134567889999999999999999999876 4568999999


Q ss_pred             ecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc----
Q 007478          196 VSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL----  271 (602)
Q Consensus       196 ~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~----  271 (602)
                      +.+++|.+++.....+++..+..++.||+.||+|||.++++||||||+|||++.++.+||+|||+++.+.......    
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            9999999999887789999999999999999999999999999999999999999999999999998764433211    


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      ...++..|+|||++.+.. ++.++|||||||++|||++ |++||...+.......+... .....+..++..+++||.+|
T Consensus       157 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~c  234 (257)
T cd05060         157 AGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ERLPRPEECPQEIYSIMLSC  234 (257)
T ss_pred             CccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHH
Confidence            112356799999997655 8999999999999999998 99999876655444444333 33355678899999999999


Q ss_pred             cccCCCCCCCHHHHhc
Q 007478          351 LQRNPLNRPTAAELLD  366 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~  366 (602)
                      |..||++||++.++++
T Consensus       235 l~~~p~~Rp~~~~l~~  250 (257)
T cd05060         235 WKYRPEDRPTFSELES  250 (257)
T ss_pred             hcCChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-41  Score=353.49  Aligned_cols=259  Identities=26%  Similarity=0.453  Sum_probs=215.7

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce--
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--  188 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~--  188 (602)
                      ..++|++.+.||+|+||.||+|++..+++.||||++...  .......+.+.+|+.+++.++|+||+++++++...+.  
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc--cchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            467899999999999999999999999999999987642  1223344667889999999999999999998766554  


Q ss_pred             ----EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          189 ----LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       189 ----~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                          +|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence                89999999 6799998876 57999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC------------
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL------------  332 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~------------  332 (602)
                      ...  .....+|..|+|||++.+...++.++|||||||++|||++|+.||...+.......+......            
T Consensus       169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             ccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            443  334568999999999876556889999999999999999999999766554443332221110            


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          333 -----------------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       333 -----------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                       ......++.++.+||++||..||++|||+.+|++||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence                             0112346899999999999999999999999999999987644

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=333.26  Aligned_cols=246  Identities=37%  Similarity=0.614  Sum_probs=215.0

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCC
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGS  200 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggs  200 (602)
                      ||+|+||.||++.+..+++.||+|++.... .........+..|+.++++++|+||+++++.+..++.+|+||||+.+++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK-IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhh-hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999999889999999987532 2233456678899999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-CCCcccCCCCCC
Q 007478          201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPYW  279 (602)
Q Consensus       201 L~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y  279 (602)
                      |.+++.....+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++...... .......|+..|
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            9999988778999999999999999999999999999999999999999999999999999876543 223445689999


Q ss_pred             CCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCC
Q 007478          280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP  359 (602)
Q Consensus       280 ~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rp  359 (602)
                      ++||.+.+.. .+.++|+||||+++|+|++|+.||...+.......+..  ....++..++.++.+||++||..||++||
T Consensus       160 ~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~  236 (250)
T cd05123         160 LAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRL  236 (250)
T ss_pred             cChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence            9999987655 78899999999999999999999977665444444433  33457778899999999999999999999


Q ss_pred             CH---HHHhcCccc
Q 007478          360 TA---AELLDHPFV  370 (602)
Q Consensus       360 t~---~eiL~hp~f  370 (602)
                      ++   +++++||||
T Consensus       237 ~~~~~~~l~~~~~f  250 (250)
T cd05123         237 GSGGAEEIKAHPFF  250 (250)
T ss_pred             CcccHHHHHhCCCC
Confidence            99   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.7e-40  Score=339.68  Aligned_cols=249  Identities=26%  Similarity=0.394  Sum_probs=207.0

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCc----EEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGE----MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      ..+|++.++||+|+||+||+|.+..+|+    .||+|+++..   ........+.+|+.+++.++|+||+++++++.. .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            5689999999999999999999877776    4899987642   223345678899999999999999999998875 4


Q ss_pred             eEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          188 KLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      ..+++|||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            57899999999999999976 45789999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCc---ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHH
Q 007478          267 QSCPL---SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       267 ~~~~~---~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                      .....   ...++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+.. ......+..++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  239 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLPQPPICTID  239 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCCCccCCHH
Confidence            33221   223567899999997655 8899999999999999998 9999976554333333333 2333456678999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhc
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      +.+||.+||..||++||++.++++
T Consensus       240 ~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-41  Score=377.69  Aligned_cols=250  Identities=26%  Similarity=0.435  Sum_probs=217.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECC-----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      ..+.+..+.||+|+||+||+|+...     ....||||.++.   ..+.+...+|++|+++|..|+|||||+|+|+|..+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd---~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD---KAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc---cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            4566778899999999999997542     356899998873   34445678999999999999999999999999999


Q ss_pred             ceEEEEEeeecCCChhhhhhccC--------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYG--------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR  252 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~--------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~  252 (602)
                      +-+|+|+|||..|||.++|..+.              +++..+.+.|+.||+.|++||-++.+|||||...|+||.++..
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence            99999999999999999997432              2778899999999999999999999999999999999999999


Q ss_pred             eEEeccCccccccCCCCCccc---CCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhC
Q 007478          253 VKLADFGMAKHIAGQSCPLSF---KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGN  328 (602)
Q Consensus       253 vKL~DFGla~~~~~~~~~~~~---~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~  328 (602)
                      |||+||||++.+-..+.+...   .-..+||+||.|+.++ |+.++||||+||+|||+++ |+.||.+..+.+.+..+..
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            999999999876443322211   1235899999998877 9999999999999999999 9999999999999998887


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          329 SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       329 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      +.. ..-|++||.++++||..||+.+|.+||++.||-.
T Consensus       721 g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  721 GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            776 4568999999999999999999999999999853

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-40  Score=342.76  Aligned_cols=260  Identities=33%  Similarity=0.544  Sum_probs=215.6

Q ss_pred             CceEeeeEeecCCeEEEEEEEC---CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNS---DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~  189 (602)
                      +|++.+.||+|+||.||++++.   .+++.||||+++...........+.+.+|+.++.++ +|+||+++++++...+.+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   467899999987533223334456788999999999 699999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      |+||||+.+++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            99999999999999998777899999999999999999999999999999999999999999999999999876543322


Q ss_pred             --CcccCCCCCCCCcccccccC-CCCccccchhhhhHHHHHhhCCCCCCCchh---HHHH-HHhhCCCCCCCCCCCCCHH
Q 007478          270 --PLSFKGSPYWMAPEVIKNSS-GCNLAVDIWSLGCTVLEMATTKPPWSQYEG---VAAM-FKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       270 --~~~~~GT~~Y~APEvl~~~~-~~s~~sDVWSLGviLyELltG~~Pf~~~~~---~~~~-~~i~~~~~~~~~p~~~s~~  342 (602)
                        .....|+..|+|||++.+.. ..+.++||||||+++|||++|..||.....   ...+ ..+..  ..+..+..++.+
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  238 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--SKPPFPKTMSAE  238 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc--cCCCCCcccCHH
Confidence              22356899999999986543 367899999999999999999999953221   1111 12222  223556778999


Q ss_pred             HHHHHHHHcccCCCCCCC---HHHHhcCccccCCCc
Q 007478          343 GKDFIRLCLQRNPLNRPT---AAELLDHPFVKGAAP  375 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt---~~eiL~hp~f~~~~~  375 (602)
                      +++||.+||+.||++|||   +.++|+||||+...|
T Consensus       239 l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             HHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            999999999999999998   578899999998766

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.4e-40  Score=379.88  Aligned_cols=150  Identities=33%  Similarity=0.566  Sum_probs=138.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.++||+|+||+||+|.+..+++.||||+++... .........+.+|+.+++.++|+||+++++++...+.+||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~-~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKAD-MINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhh-ccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            568999999999999999999999999999999987532 2234456778899999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                      ||||+.|++|.+++...+.+++..++.|+.||+.||+|||.+|||||||||+||||+.++.+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=335.31  Aligned_cols=247  Identities=27%  Similarity=0.458  Sum_probs=208.6

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|.++....     ..+.+.+|+.++++++|+||+++++++...+.+|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            4679999999999999999998754 57899998864221     23567889999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||||+.+++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999999997643  689999999999999999999999999999999999999999999999999987653221


Q ss_pred             C--cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          270 P--LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       270 ~--~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                      .  ....++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.........+..... ...+..++.++.+|
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  236 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MPCPPGCPKELYDI  236 (261)
T ss_pred             cccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCcCCHHHHHH
Confidence            1  1122345799999987654 8899999999999999999 9999987766555555544322 33456789999999


Q ss_pred             HHHHcccCCCCCCCHHHHhc
Q 007478          347 IRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~  366 (602)
                      |.+||+.||++||++.+|++
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-41  Score=340.53  Aligned_cols=253  Identities=32%  Similarity=0.584  Sum_probs=212.3

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEe
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE  194 (602)
                      |++.+.||+|++|.||+|.+..+++.+++|.++....  .......+.+|+.++++++|+||+++++++...+.+|+|||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence            5678899999999999999999999999998864221  22345677889999999999999999999999999999999


Q ss_pred             eecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CCcc
Q 007478          195 YVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPLS  272 (602)
Q Consensus       195 ~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~  272 (602)
                      |+++ +|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+....... ....
T Consensus        79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence            9975 88888766 3688999999999999999999999999999999999999999999999999998765443 2223


Q ss_pred             cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC--------------------
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--------------------  332 (602)
Q Consensus       273 ~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~--------------------  332 (602)
                      ..++..|+|||.+.+...++.++|||||||++|+|++|+.||...+..+.+.++......                    
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            458889999999987645899999999999999999999999876655544433211000                    


Q ss_pred             --------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          333 --------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       333 --------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                              ......++.++.+||.+||..||.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                    01223578899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.3e-41  Score=338.09  Aligned_cols=248  Identities=25%  Similarity=0.410  Sum_probs=211.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..+|+++++||.|+||.||+|.++. ++.+|+|++...    .......+.+|+.+++.++|+||+++++++...+..|+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            4679999999999999999999987 889999988642    22234568889999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||||+++++|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999999753  4689999999999999999999999999999999999999999999999999987643221


Q ss_pred             -CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          270 -PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       270 -~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                       .....++..|+|||++.+.. ++.++|||||||++|+|++ |+.||...........+... .....+..+++++.++|
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i  237 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIM  237 (261)
T ss_pred             cccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCCCCCCCCHHHHHHH
Confidence             11233567899999987654 8889999999999999998 89999876655555555433 23345678999999999


Q ss_pred             HHHcccCCCCCCCHHHHhc
Q 007478          348 RLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .+||+.||++|||+.+|++
T Consensus       238 ~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         238 LECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHcCCCchhCcCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=336.34  Aligned_cols=248  Identities=26%  Similarity=0.430  Sum_probs=207.5

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..+|++.+.||+|+||.||++.++ ++..+|+|++.....     ....+.+|+.++++++|+||+++++++...+..|+
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI   76 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence            356889999999999999999886 467899998753211     12457789999999999999999999999999999


Q ss_pred             EEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      ||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999999999999753 46899999999999999999999999999999999999999999999999999876432211


Q ss_pred             c--ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          271 L--SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       271 ~--~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                      .  ...++..|+|||++.+.. ++.++|||||||++|||++ |+.||...........+... .....+..++.++.+|+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  234 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             ccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHH
Confidence            1  112345799999997655 8899999999999999999 89999876655555555433 23345667899999999


Q ss_pred             HHHcccCCCCCCCHHHHhcC
Q 007478          348 RLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .+||..+|++|||+.++++.
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-40  Score=352.68  Aligned_cols=257  Identities=28%  Similarity=0.476  Sum_probs=209.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc-----
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE-----  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~-----  186 (602)
                      ..+|.+.+.||+|+||.||+|+++.+|+.||||+++...  ........+.+|+.+++.++|+||+++++++...     
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            468999999999999999999999999999999886421  1222345678999999999999999999987654     


Q ss_pred             -ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          187 -DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       187 -~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                       ..+|+||||+. .+|..++.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          92 FQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             CceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence             35799999995 47776653  368999999999999999999999999999999999999999999999999998653


Q ss_pred             CCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC--------------
Q 007478          266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE--------------  331 (602)
Q Consensus       266 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~--------------  331 (602)
                      ..  .....+|..|+|||++.+...++.++|||||||++|||++|+.||...+....+..+.....              
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         169 AE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             CC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence            32  23456889999999987655588899999999999999999999987554333332221000              


Q ss_pred             -------CC--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          332 -------LP--------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       332 -------~~--------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                             .+        .....++.++.+||++||+.||++||++++++.||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                   00        111356788999999999999999999999999999998755

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.4e-40  Score=341.26  Aligned_cols=248  Identities=29%  Similarity=0.464  Sum_probs=208.2

Q ss_pred             CCceEeeeEeecCCeEEEEEEEC-----CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNS-----DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.++.    ......+.+.+|+.++++++|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            46899999999999999999754     3456788988753    22333466889999999999999999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhcc----------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDY----------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG  251 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~----------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g  251 (602)
                      ..++||||+++++|.+++...                +.+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            999999999999999998653                3478899999999999999999999999999999999999999


Q ss_pred             ceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhh
Q 007478          252 RVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIG  327 (602)
Q Consensus       252 ~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~  327 (602)
                      .+||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||........+..+.
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            999999999976543221   12344678899999987655 8889999999999999998 999997766555444443


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       328 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      . ......+..++.++.+||.+||+.||++||++.++++
T Consensus       240 ~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         240 Q-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             C-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            3 3334456678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.6e-40  Score=344.54  Aligned_cols=260  Identities=37%  Similarity=0.648  Sum_probs=217.7

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ....|...+.||+|+||.||+|+++.+++.+|+|.+..... .......++.+|+++++.++|+||+++++++...+..|
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence            34568888999999999999999999999999998864221 23344567889999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhh-ccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          191 IYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~-~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      +||||+. |+|.+++. ....+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||++......  
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9999996 57777764 3456899999999999999999999999999999999999999999999999998765432  


Q ss_pred             CcccCCCCCCCCcccccc--cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~--~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                       ....|+..|+|||++..  ...++.++|||||||++|||++|+.||...+.......+............++.++.+||
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  247 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (308)
T ss_pred             -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence             34568999999999852  233788999999999999999999999876665555554443332233457889999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ++||..+|++||+++++++|+|+.....
T Consensus       248 ~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         248 DSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             HHHhhCCcccCCCHHHHhhCccccccCC
Confidence            9999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-40  Score=359.77  Aligned_cols=253  Identities=28%  Similarity=0.413  Sum_probs=208.7

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEEC-----CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEecccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNS-----DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKT  184 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~  184 (602)
                      ..++|.++++||+|+||.||+|++.     .+++.||+|+++...   .....+.+++|+.+|.++. |||||++++++.
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3467888999999999999999864     345789999987421   2233456889999999997 999999999999


Q ss_pred             ccceEEEEEeeecCCChhhhhhccC-------------------------------------------------------
Q 007478          185 VEDKLYIYLEYVSGGSIYKLLQDYG-------------------------------------------------------  209 (602)
Q Consensus       185 ~~~~~~lVmE~~~ggsL~~~l~~~~-------------------------------------------------------  209 (602)
                      ..+.+|+|||||.+|+|.+++.+.+                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999986432                                                       


Q ss_pred             -------------------------------------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEE
Q 007478          210 -------------------------------------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANIL  246 (602)
Q Consensus       210 -------------------------------------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL  246 (602)
                                                                 .+++..++.|+.||+.||+|||+++|+||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                       2566678889999999999999999999999999999


Q ss_pred             EccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHH
Q 007478          247 VDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAA  322 (602)
Q Consensus       247 l~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~  322 (602)
                      ++.++.+||+|||+++.+.....   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||........
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            99999999999999986533221   12345788999999997655 8899999999999999998 8999976554444


Q ss_pred             HHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       323 ~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ..........+..+..++.++.+||.+||..+|++||++.+|++.
T Consensus       351 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         351 FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            444333333445677889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.5e-40  Score=340.82  Aligned_cols=260  Identities=29%  Similarity=0.534  Sum_probs=211.3

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccce
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  188 (602)
                      ...++|++.+.||+|+||.||+|.+..+++.||||.++....   ......+.+|+.++.++ .|+||+++++++.+...
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            346789999999999999999999999999999999874221   22334556677766666 59999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          189 LYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      +|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..+..
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            999999985 577777655 4578999999999999999999997 6999999999999999999999999999987654


Q ss_pred             CCCCcccCCCCCCCCccccccc---CCCCccccchhhhhHHHHHhhCCCCCCCchh-HHHHHHhhCCCCCCCCC--CCCC
Q 007478          267 QSCPLSFKGSPYWMAPEVIKNS---SGCNLAVDIWSLGCTVLEMATTKPPWSQYEG-VAAMFKIGNSKELPTIP--DDLS  340 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~---~~~s~~sDVWSLGviLyELltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p--~~~s  340 (602)
                      ........++..|+|||++.+.   ..++.++|||||||++|||++|+.||..... ...+.++.... .+.++  ..++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  246 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPPNEGFS  246 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCCCCCCC
Confidence            4433445588899999998644   2377899999999999999999999976433 23333333222 22222  2478


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       341 ~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      .++.+||.+||..||++||++++++.|+||....
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            9999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3e-40  Score=335.77  Aligned_cols=250  Identities=24%  Similarity=0.421  Sum_probs=209.6

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCc---EEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGE---MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      ..+|++.+.||+|+||.||+|.++.+++   .||||+++..   ........+..|+.+++.++||||+++++++..++.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            3569999999999999999999887665   5999987642   233445778999999999999999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      +++||||+.+++|.+++.. .+.+++.+++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++..+...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999999999875 356899999999999999999999999999999999999999999999999998765433


Q ss_pred             CCCccc---C---CCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCC
Q 007478          268 SCPLSF---K---GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLS  340 (602)
Q Consensus       268 ~~~~~~---~---GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  340 (602)
                      ......   .   .+..|+|||++.+.. ++.++|||||||++|||++ |..||...........+..... ...+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~  237 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR-LPPPMDCP  237 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-CCCcccCC
Confidence            221111   1   245799999997655 8899999999999999886 9999987665555555543322 23456789


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          341 DEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       341 ~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .++.+++.+||..+|++||++++|+.
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         238 TALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-40  Score=339.74  Aligned_cols=249  Identities=29%  Similarity=0.438  Sum_probs=208.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEEC-----CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNS-----DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      ..+|...++||+|+||.||++...     .++..+|+|.+..    ........+.+|+++++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            357888999999999999999643     3567899998753    2234456788999999999999999999999999


Q ss_pred             ceEEEEEeeecCCChhhhhhccC---------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYG---------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG  251 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~---------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g  251 (602)
                      +..|++|||+.+++|.+++...+               .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999987542               478899999999999999999999999999999999999999


Q ss_pred             ceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhh
Q 007478          252 RVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIG  327 (602)
Q Consensus       252 ~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~  327 (602)
                      .+||+|||++..+.....   .....+++.|+|||++.+.. ++.++|||||||++|||++ |++||...........+.
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            999999999976543221   11233578899999987665 8999999999999999998 999998766655555554


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       328 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ... ....+..+++.+.+||.+||+.||++||++++|++
T Consensus       239 ~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 QGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             cCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            432 23456688999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-40  Score=350.34  Aligned_cols=260  Identities=29%  Similarity=0.506  Sum_probs=212.0

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecccccc--c
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVE--D  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~--~  187 (602)
                      ...+|++.+.||+|+||.||+|.+..+|+.+|+|++...  .........+.+|+.+++++ +|+||+++++++...  .
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc--cCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            356899999999999999999999989999999987531  11222345677899999999 999999999987643  4


Q ss_pred             eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      .+|+||||+. ++|..++... .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            6899999996 5999988765 7889999999999999999999999999999999999999999999999999866433


Q ss_pred             C------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC------------
Q 007478          268 S------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS------------  329 (602)
Q Consensus       268 ~------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~------------  329 (602)
                      .      ....+.||..|+|||++.+...++.++|||||||++|||++|+.||..........++...            
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence            2      1223568999999999876666888999999999999999999999754433322221110            


Q ss_pred             -----------------CCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          330 -----------------KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       330 -----------------~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                                       .........++.++.+||.+||+.||++|||+.++++|+||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence                             011112234789999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4e-40  Score=337.81  Aligned_cols=249  Identities=24%  Similarity=0.362  Sum_probs=204.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcE----EEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEM----CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      ..+|++.+.||+|+||+||+|.+..+++.    +++|.+..   .........+..|+.++++++||||+++++++.. .
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD---RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc---ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            46899999999999999999999877774    56665532   2223345677889999999999999999998764 5


Q ss_pred             eEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          188 KLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      ..++++||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            57899999999999999975 45789999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHH
Q 007478          267 QSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                      ...   .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+....... ++.........+..++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLAQPQICTID  239 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCCCCCHH
Confidence            322   12345778899999997665 8999999999999999998 99999775443322 222333334445678889


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhc
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      +.+++.+||..||++||++.|+++
T Consensus       240 ~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         240 VYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4e-40  Score=333.80  Aligned_cols=241  Identities=25%  Similarity=0.404  Sum_probs=201.1

Q ss_pred             eEeecCCeEEEEEEEC--CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeec
Q 007478          120 MLGRGTFGHVYVGFNS--DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       120 ~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      .||+|+||.||+|.++  .++..||+|++...   ......+.+.+|+.++++++|+||+++++++.. +..++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE---NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc---cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            4899999999999775  44567999987642   223445678899999999999999999998764 56899999999


Q ss_pred             CCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC----cc
Q 007478          198 GGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP----LS  272 (602)
Q Consensus       198 ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~----~~  272 (602)
                      +++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++.........    ..
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999999874 457899999999999999999999999999999999999999999999999999865433221    11


Q ss_pred             cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHc
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       273 ~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L  351 (602)
                      ..++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.........+... .....+..+++++.+||.+||
T Consensus       158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~c~  235 (257)
T cd05115         158 GKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-KRLDCPAECPPEMYALMKDCW  235 (257)
T ss_pred             CCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHc
Confidence            22357899999987655 8899999999999999996 99999877665555544433 334567789999999999999


Q ss_pred             ccCCCCCCCHHHHhc
Q 007478          352 QRNPLNRPTAAELLD  366 (602)
Q Consensus       352 ~~dP~~Rpt~~eiL~  366 (602)
                      ..||++||++.+|++
T Consensus       236 ~~~~~~Rp~~~~i~~  250 (257)
T cd05115         236 IYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2e-40  Score=335.05  Aligned_cols=254  Identities=29%  Similarity=0.539  Sum_probs=213.6

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccch-hcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA-KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +|.+.+.||+|+||.||++.+..++..+++|+++..... .......++.+|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            588999999999999999999888777888877642211 1222334567899999999999999999999998999999


Q ss_pred             EeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          193 LEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       193 mE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999998863    356899999999999999999999999999999999999975 579999999987764332


Q ss_pred             -CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          269 -CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       269 -~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                       ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||..........++.. ...+.++..++.++.+||
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  237 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETYSRQLNSIM  237 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcchhcHHHHHHH
Confidence             223456899999999986544 78899999999999999999999987665555555543 334556678899999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccc
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .+||..||++||++.++++||||
T Consensus       238 ~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         238 QSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=339.10  Aligned_cols=253  Identities=36%  Similarity=0.584  Sum_probs=211.7

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEe
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE  194 (602)
                      |++.+.||+|+||.||+|++..+++.||+|++....  ......+.+.+|+.+++.++|+||+++++++.+.+.+++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence            677889999999999999999999999999987532  122334567789999999999999999999999999999999


Q ss_pred             eecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CCcc
Q 007478          195 YVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPLS  272 (602)
Q Consensus       195 ~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~  272 (602)
                      |+. ++|.+++.+. ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.+||+|||+++...... ....
T Consensus        79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence            997 5899999876 579999999999999999999999999999999999999999999999999998765433 2223


Q ss_pred             cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC-------------------CCCC
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-------------------KELP  333 (602)
Q Consensus       273 ~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~  333 (602)
                      ..++..|+|||++.+...++.++|||||||++|||++|++||........+.++...                   ...+
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            456788999999977655889999999999999999999999876554443332210                   0000


Q ss_pred             --------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          334 --------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       334 --------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                              .....++.++.++|++||..||++||++++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                    1112357899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.2e-40  Score=344.33  Aligned_cols=251  Identities=25%  Similarity=0.427  Sum_probs=207.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECC-------CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD-------SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSK  183 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~  183 (602)
                      .++|.+++.||+|+||.||++.+..       ++..+|+|.++..   ........+.+|+.+++.+ +|+||+++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4689999999999999999998643       2357999988642   1233456788899999999 799999999999


Q ss_pred             cccceEEEEEeeecCCChhhhhhccC----------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEE
Q 007478          184 TVEDKLYIYLEYVSGGSIYKLLQDYG----------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV  247 (602)
Q Consensus       184 ~~~~~~~lVmE~~~ggsL~~~l~~~~----------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl  247 (602)
                      ...+.+|+||||+.+|+|.+++...+                .+++.+++.++.||+.||+|||++|++||||||+|||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  173 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  173 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence            99999999999999999999997542                47888999999999999999999999999999999999


Q ss_pred             ccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHH
Q 007478          248 DPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAM  323 (602)
Q Consensus       248 ~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~  323 (602)
                      +.++.+||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.........
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            9999999999999876543221   11122456899999997655 8899999999999999998 89999765543333


Q ss_pred             HHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          324 FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       324 ~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ..+ ........+..++.++.+||.+||..+|++||++.+++++
T Consensus       253 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         253 KLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            333 3333445677899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-40  Score=348.95  Aligned_cols=259  Identities=24%  Similarity=0.417  Sum_probs=210.9

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE----  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~----  186 (602)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|+++..  .......+.+.+|+.++++++|+||+++++++...    
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~   92 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   92 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence            457899999999999999999999999999999988642  11223345678899999999999999999987532    


Q ss_pred             --ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          187 --DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       187 --~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                        ..+|++++++ +++|.++++. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence              3478899887 7899888765 46999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC--------------
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--------------  330 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~--------------  330 (602)
                      ...  .....||..|+|||++.+...++.++|||||||++|||++|+.||...+.......+....              
T Consensus       171 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         171 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             ccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            432  2345689999999998775558889999999999999999999997544333222211100              


Q ss_pred             ----------CC-----CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          331 ----------EL-----PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       331 ----------~~-----~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                                ..     .......+.++.+||.+||+.||++|+++.+++.||||+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence                      00     0111246888999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-40  Score=331.33  Aligned_cols=244  Identities=27%  Similarity=0.461  Sum_probs=209.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..+|++.+.||+|+||.||+|...  |+.||+|.++...     ...+++.+|+.+++.++|+||+++++++.+.+..|+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            468999999999999999999865  7899999886421     145678899999999999999999999998899999


Q ss_pred             EEeeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||||+++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            999999999999997655  689999999999999999999999999999999999999999999999999987643222


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  348 (602)
                        ...++..|+|||++.... ++.++|||||||++|||++ |..||...........+.. ......+..+++++.+||+
T Consensus       158 --~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  233 (256)
T cd05039         158 --SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVMK  233 (256)
T ss_pred             --cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHHH
Confidence              334567899999987654 8889999999999999997 9999987655444443333 2334556778999999999


Q ss_pred             HHcccCCCCCCCHHHHhc
Q 007478          349 LCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       349 ~~L~~dP~~Rpt~~eiL~  366 (602)
                      +||..+|++||++.++++
T Consensus       234 ~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         234 DCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=336.53  Aligned_cols=243  Identities=26%  Similarity=0.452  Sum_probs=199.9

Q ss_pred             eeEeecCCeEEEEEEECCCCcE--EEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEEEEEee
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEM--CAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~--vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      ++||+|+||.||+|+++.++..  +|+|.++.   .........+.+|+.++.++ +||||+++++++...+.+|+||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc---cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            3699999999999999887764  57787653   12234456788999999999 899999999999999999999999


Q ss_pred             ecCCChhhhhhccC----------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccC
Q 007478          196 VSGGSIYKLLQDYG----------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFG  259 (602)
Q Consensus       196 ~~ggsL~~~l~~~~----------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFG  259 (602)
                      +.+|+|.+++....                .+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999999997542                47888999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCC
Q 007478          260 MAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDD  338 (602)
Q Consensus       260 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  338 (602)
                      ++..............+..|+|||++.... ++.++|||||||++|||++ |..||...+.......+... .....+..
T Consensus       158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~  235 (270)
T cd05047         158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLN  235 (270)
T ss_pred             CccccchhhhccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCCCc
Confidence            986432221112223466799999986554 8899999999999999997 99999766554444444332 23345567


Q ss_pred             CCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          339 LSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       339 ~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ++.++.+|+.+||..||.+||++.++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         236 CDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            8899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=382.04  Aligned_cols=251  Identities=26%  Similarity=0.496  Sum_probs=216.4

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCc-----EEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGE-----MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV  185 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~  185 (602)
                      ..+..++.+.||+|+||.||.|.......     .||||.++.   ..+.+...+|.+|..+|+.++|||||+++|++.+
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~---~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR---LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc---cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            34567788999999999999998765322     388888764   3445667889999999999999999999999999


Q ss_pred             cceEEEEEeeecCCChhhhhhcc-------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEecc
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDY-------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADF  258 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~~-------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DF  258 (602)
                      ....+|++|||+||+|..+|++.       ..++..++..|+.||++|++||+++++|||||...|+||+....|||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999875       35889999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCc-ccCC--CCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCC
Q 007478          259 GMAKHIAGQSCPL-SFKG--SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPT  334 (602)
Q Consensus       259 Gla~~~~~~~~~~-~~~G--T~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~  334 (602)
                      |||+.+-....+. ...+  -..|||||.++.+. ++.|+|||||||+|||+++ |..||.+..+.+.+....... .-.
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~  924 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD  924 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence            9999543322211 1112  25799999998765 9999999999999999999 999999988888887665555 445


Q ss_pred             CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       335 ~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .|..|++.+.+||..||+.+|++||++..|++
T Consensus       925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            68899999999999999999999999999997

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-40  Score=351.94  Aligned_cols=252  Identities=27%  Similarity=0.424  Sum_probs=203.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEE-----CCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFN-----SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTV  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~  185 (602)
                      .++|++++.||+|+||+||+|.+     ..+++.||||+++...   .......+.+|+.+|.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            56899999999999999999984     3467899999986421   223356788999999999 68999999997754


Q ss_pred             -cceEEEEEeeecCCChhhhhhcc--------------------------------------------------------
Q 007478          186 -EDKLYIYLEYVSGGSIYKLLQDY--------------------------------------------------------  208 (602)
Q Consensus       186 -~~~~~lVmE~~~ggsL~~~l~~~--------------------------------------------------------  208 (602)
                       +..+++|||||.+|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence             45689999999999999998642                                                        


Q ss_pred             -----------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC---CcccC
Q 007478          209 -----------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC---PLSFK  274 (602)
Q Consensus       209 -----------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~~  274 (602)
                                 ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....   .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                       1357778889999999999999999999999999999999999999999999986533221   11233


Q ss_pred             CCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHccc
Q 007478          275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR  353 (602)
Q Consensus       275 GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~  353 (602)
                      ++..|+|||++.+.. ++.++|||||||++|||++ |..||........+............+..+++++.+++.+||..
T Consensus       243 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~  321 (343)
T cd05103         243 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  321 (343)
T ss_pred             CCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence            567899999987655 8899999999999999997 99999765433223322222233445667889999999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 007478          354 NPLNRPTAAELLDH  367 (602)
Q Consensus       354 dP~~Rpt~~eiL~h  367 (602)
                      ||++||++.+|++|
T Consensus       322 ~p~~Rps~~eil~~  335 (343)
T cd05103         322 EPSQRPTFSELVEH  335 (343)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.9e-40  Score=332.01  Aligned_cols=243  Identities=29%  Similarity=0.490  Sum_probs=205.1

Q ss_pred             eeEeecCCeEEEEEEECC-CCc--EEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEee
Q 007478          119 KMLGRGTFGHVYVGFNSD-SGE--MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~-tg~--~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      ++||+|+||.||+|.+.. +++  .||||.+......   ...+.+.+|+.++++++|+||+++++.+.. ..+++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            468999999999998865 333  6899988642221   556788999999999999999999999887 889999999


Q ss_pred             ecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC---
Q 007478          196 VSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP---  270 (602)
Q Consensus       196 ~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~---  270 (602)
                      +++++|.+++....  .+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.+......   
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999999997653  6899999999999999999999999999999999999999999999999999876542211   


Q ss_pred             -cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHH
Q 007478          271 -LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       271 -~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  348 (602)
                       ....++..|+|||++.... ++.++|||||||++|||++ |+.||...........+.........+..++.++.+|+.
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML  235 (257)
T ss_pred             ccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence             1244778899999987655 8899999999999999998 999998766655555554333334456678999999999


Q ss_pred             HHcccCCCCCCCHHHHhc
Q 007478          349 LCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       349 ~~L~~dP~~Rpt~~eiL~  366 (602)
                      +||..+|++||++.++++
T Consensus       236 ~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         236 QCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHCCCCcccCCCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.5e-40  Score=342.52  Aligned_cols=255  Identities=34%  Similarity=0.593  Sum_probs=213.2

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEe
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE  194 (602)
                      |....+||+|+||.||++.++.+++.||||++...    .......+.+|+.+++.++|+||+++++.+...+..|+|||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence            44457899999999999999999999999987532    22345668899999999999999999999999999999999


Q ss_pred             eecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-CCccc
Q 007478          195 YVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPLSF  273 (602)
Q Consensus       195 ~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~  273 (602)
                      |+++++|.+++.. +.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..+.... .....
T Consensus        98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657          98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            9999999998754 568999999999999999999999999999999999999999999999999987654332 22345


Q ss_pred             CCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC-CCCCCCCCCCHHHHHHHHHHcc
Q 007478          274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-ELPTIPDDLSDEGKDFIRLCLQ  352 (602)
Q Consensus       274 ~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~~~L~  352 (602)
                      .|+..|+|||++.+.. ++.++|||||||++|||++|+.||...........+.... ........++.++.++|.+||+
T Consensus       177 ~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (292)
T cd06657         177 VGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV  255 (292)
T ss_pred             ccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence            6899999999986654 7889999999999999999999998655444333332211 1111234678999999999999


Q ss_pred             cCCCCCCCHHHHhcCccccCCCc
Q 007478          353 RNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       353 ~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      .||.+||++.++++|+||.....
T Consensus       256 ~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         256 RDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             CCcccCcCHHHHhcChHHhccCC
Confidence            99999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.2e-40  Score=342.93  Aligned_cols=251  Identities=25%  Similarity=0.431  Sum_probs=207.7

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECC-------CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSD-------SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGS  182 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~  182 (602)
                      ...+|.+++.||+|+||.||+|.+..       ....+|+|.++..   ........+.+|+.+++++ +||||++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            34689999999999999999997632       3457999987632   2233456788999999999 69999999999


Q ss_pred             ccccceEEEEEeeecCCChhhhhhcc----------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEE
Q 007478          183 KTVEDKLYIYLEYVSGGSIYKLLQDY----------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANIL  246 (602)
Q Consensus       183 ~~~~~~~~lVmE~~~ggsL~~~l~~~----------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL  246 (602)
                      +...+.+|+||||+.+|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence            99889999999999999999999653                24788899999999999999999999999999999999


Q ss_pred             EccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHH
Q 007478          247 VDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAA  322 (602)
Q Consensus       247 l~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~  322 (602)
                      ++.++.+||+|||+++.+.....   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||........
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999987643221   11222456799999997654 8899999999999999999 8999987655444


Q ss_pred             HHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       323 ~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ...+... .....+..++.++++||.+||..||++||++.++++
T Consensus       246 ~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         246 FKLLREG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            4444332 334556788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3e-40  Score=335.40  Aligned_cols=246  Identities=28%  Similarity=0.473  Sum_probs=204.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..+|++.++||+|+||.||+|.+..+ ..||+|+++....     ..+.+.+|+.+++.++|+||+++++.+. ++..|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence            46799999999999999999988765 4699998864221     1246788999999999999999998875 456899


Q ss_pred             EEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||||+.+|+|.+++.+.  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999999753  3578899999999999999999999999999999999999999999999999986643332


Q ss_pred             C--cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          270 P--LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       270 ~--~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                      .  ....++..|+|||++.+.. ++.++|||||||++|||++ |+.||........+..+.... ....+..++.++.+|
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  235 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPESLHDL  235 (262)
T ss_pred             ccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CCCCccccCHHHHHH
Confidence            1  1234667899999987655 8999999999999999999 899998765555555444332 223456789999999


Q ss_pred             HHHHcccCCCCCCCHHHHhc
Q 007478          347 IRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~  366 (602)
                      |.+||+.||++||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.5e-40  Score=338.78  Aligned_cols=248  Identities=24%  Similarity=0.419  Sum_probs=205.1

Q ss_pred             CceEeeeEeecCCeEEEEEEECC-----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      +|++.+.||+|+||.||+|++..     ....+|+|.+...   .......++.+|+.+++.++||||+++++.+..++.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC---CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence            47889999999999999998753     2356888877532   222335678899999999999999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhcc------------------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCc
Q 007478          189 LYIYLEYVSGGSIYKLLQDY------------------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGAN  244 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~------------------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~N  244 (602)
                      .|++|||+.+++|.+++...                        ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            99999999999999988642                        247788899999999999999999999999999999


Q ss_pred             EEEccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhH
Q 007478          245 ILVDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGV  320 (602)
Q Consensus       245 ILl~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~  320 (602)
                      ||++.++.+||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999986543221   12334677899999987655 8899999999999999998 99999876544


Q ss_pred             HHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          321 AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       321 ~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .....+.. ......+..++.++.+||.+||+.||++||++.++++
T Consensus       237 ~~~~~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         237 RLFNLLKT-GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHhC-CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            43333332 2233456788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.8e-40  Score=379.70  Aligned_cols=253  Identities=23%  Similarity=0.362  Sum_probs=205.5

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      .+|++.++||+|+||.||+|++..+|+.||||++... ........+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~-l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcc-cccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            5799999999999999999999999999999998642 122334456788999999999999999999999999999999


Q ss_pred             EeeecCCChhhhhhcc-----------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcc
Q 007478          193 LEYVSGGSIYKLLQDY-----------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA  261 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~-----------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla  261 (602)
                      |||++||+|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999998641           23456678899999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-------------------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHH
Q 007478          262 KHIAGQS-------------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA  322 (602)
Q Consensus       262 ~~~~~~~-------------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~  322 (602)
                      +......                   .....+||+.|||||++.+.. ++.++|||||||++|||++|+.||........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            8652110                   011356999999999997765 89999999999999999999999976444332


Q ss_pred             HHHhhCCCCC-CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          323 MFKIGNSKEL-PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       323 ~~~i~~~~~~-~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .......... ......+++.+.+++.+||..||++|++..+.+.+
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2221111100 01123688999999999999999999876665543

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2e-40  Score=345.00  Aligned_cols=255  Identities=30%  Similarity=0.465  Sum_probs=202.0

Q ss_pred             eEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEee
Q 007478          116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       116 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      .+++.+|.|  |.||+++...+++.||||++....  ...+..+.+.+|+.+++.++|+||+++++++...+..|++|||
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~   80 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL   80 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence            344444444  556666667789999999987531  2334567899999999999999999999999999999999999


Q ss_pred             ecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC----
Q 007478          196 VSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC----  269 (602)
Q Consensus       196 ~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~----  269 (602)
                      +.+++|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||.+..+.....    
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999999999753  4688999999999999999999999999999999999999999999999999876532211    


Q ss_pred             ----CcccCCCCCCCCccccccc-CCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCC--------CC----
Q 007478          270 ----PLSFKGSPYWMAPEVIKNS-SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--------EL----  332 (602)
Q Consensus       270 ----~~~~~GT~~Y~APEvl~~~-~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~--------~~----  332 (602)
                          .....++..|+|||++... ..++.++|||||||++|||++|+.||................        ..    
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence                1234578899999998653 348889999999999999999999998654433322111100        00    


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          333 --------------------PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       333 --------------------~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                                          ......++.++.+||.+||..||++|||++++|+||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                                001123456889999999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=362.33  Aligned_cols=244  Identities=26%  Similarity=0.408  Sum_probs=210.4

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~  189 (602)
                      ....|.+...||.|+|+.|..+.+..+++.+++|++...        ..+..+|+.++... +||||+++++++.+....
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc--------ccccccccchhhhhcCCCcceeecceecCCcee
Confidence            467888999999999999999999999999999998753        12233566555444 899999999999999999


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEE-ccCCceEEeccCccccccCCC
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV-DPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl-~~~g~vKL~DFGla~~~~~~~  268 (602)
                      |+|||++.|+.|.+.+.....+. .++..|+++|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++.+... 
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            99999999999999988766665 7888999999999999999999999999999999 58899999999999987655 


Q ss_pred             CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH-HHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                       ..+.|-|..|.|||++.. .+|+.++||||||++||+||+|+.||.....- +.+.++    ..+.+...+|.++++||
T Consensus       470 -~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKdLl  543 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKDLL  543 (612)
T ss_pred             -hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHHHH
Confidence             345567899999999984 55999999999999999999999999754433 333333    23344579999999999


Q ss_pred             HHHcccCCCCCCCHHHHhcCccc
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      +.||+.||.+|+++.+++.|+||
T Consensus       544 ~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  544 QQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.7e-40  Score=332.66  Aligned_cols=246  Identities=27%  Similarity=0.471  Sum_probs=206.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+.....     ..+.+.+|+.++++++|+||+++++++. ++..|+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence            467999999999999999999876 467799998864221     1245889999999999999999999875 456899


Q ss_pred             EEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      +|||+.+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999999999753  4589999999999999999999999999999999999999999999999999987644322


Q ss_pred             C--cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          270 P--LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       270 ~--~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                      .  ....++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+.......+... .....+..++.++.+|
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  235 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHEL  235 (260)
T ss_pred             ccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHH
Confidence            1  1233566899999987655 8899999999999999999 99999876665555555433 3334567889999999


Q ss_pred             HHHHcccCCCCCCCHHHHhc
Q 007478          347 IRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~  366 (602)
                      |.+||..||++|||++++++
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.3e-40  Score=328.25  Aligned_cols=247  Identities=28%  Similarity=0.488  Sum_probs=210.5

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCC----cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSG----EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      +.+.+.||+|+||.||++.+..++    ..||+|+++..   ...+..+.+.+|+.+++.++|+||+++++++.+.+..|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED---ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC---CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            356789999999999999998766    89999988642   22225678889999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCC--CChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          191 IYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~--ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      ++|||+.+++|.+++.....  +++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999999976544  8999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcc--cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          269 CPLS--FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       269 ~~~~--~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                      ....  ..++..|+|||.+.+. .++.++|||||||++|||++ |++||...........+.... ....+..++.++.+
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  235 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIYK  235 (258)
T ss_pred             ccccccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHH
Confidence            2221  2377899999998654 48999999999999999998 899998766655555554433 34456678999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhc
Q 007478          346 FIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ++.+||..||++|||+.++++
T Consensus       236 ~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      236 LMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=340.61  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=203.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCC--------------cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSG--------------EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV  177 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg--------------~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv  177 (602)
                      ..+|++.+.||+|+||.||+|.+..++              ..||+|.++..   ........+.+|++++++++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence            358999999999999999999875432              35899987642   2233456788999999999999999


Q ss_pred             EEeccccccceEEEEEeeecCCChhhhhhccC------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcE
Q 007478          178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANI  245 (602)
Q Consensus       178 ~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NI  245 (602)
                      ++++++...+..|+||||+.+++|.+++....            .+++..+..++.||+.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986432            367888999999999999999999999999999999


Q ss_pred             EEccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh--CCCCCCCchhH
Q 007478          246 LVDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGV  320 (602)
Q Consensus       246 Ll~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt--G~~Pf~~~~~~  320 (602)
                      |++.++.+||+|||++..+.....   .....++..|+|||++.+.. ++.++|||||||++|||++  |..||......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            999999999999999976533221   11233567899999987665 8999999999999999988  67888765443


Q ss_pred             HHHHHhh------CCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          321 AAMFKIG------NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       321 ~~~~~i~------~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ..+..+.      ........+..+++.+.+||.+||+.||++||++++|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3322221      111122345568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.6e-40  Score=333.19  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=209.0

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCc---EEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGE---MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      ..+|++.+.||+|+||.||+|.++.++.   .+|+|.++..   ......+.+.+|+.++++++||||+++++++..++.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            3579999999999999999998875543   6899987542   123345678899999999999999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      .|+||||+++++|.+++... +.+++.++..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999999764 56899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC----cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHH
Q 007478          268 SCP----LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       268 ~~~----~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                      ...    ....++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.........+..... ...+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LPAPMDCPAA  237 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CCCCCCCCHH
Confidence            211    1122356899999997655 8999999999999999886 9999987665555454444322 2345578999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhc
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      +.+|+.+||+++|++||++.++++
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         238 LHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHcccCchhCCCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.6e-40  Score=336.03  Aligned_cols=249  Identities=29%  Similarity=0.452  Sum_probs=200.1

Q ss_pred             CCc-eEeeeEeecCCeEEEEEE----ECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc--
Q 007478          113 SHW-KKGKMLGRGTFGHVYVGF----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV--  185 (602)
Q Consensus       113 ~~y-~~~~~LG~G~fG~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~--  185 (602)
                      ++| ++.+.||+|+||+||++.    ...+++.||+|.++...   .......+.+|+.+|+.++||||+++++++..  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345 899999999999998865    34568899999886421   22334567899999999999999999998654  


Q ss_pred             cceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                      ...+|+||||+.+++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            34689999999999999999764 69999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCC----cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH--------------HHHHHhh
Q 007478          266 GQSCP----LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV--------------AAMFKIG  327 (602)
Q Consensus       266 ~~~~~----~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~--------------~~~~~i~  327 (602)
                      .....    ....++..|+|||++.+.. ++.++|||||||++|||++|..||......              .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            43221    1223567799999987655 889999999999999999999998542210              0111111


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       328 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ........+..++.++.+|+.+||..||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            111222345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.8e-40  Score=333.88  Aligned_cols=251  Identities=22%  Similarity=0.390  Sum_probs=210.3

Q ss_pred             CCceEeeeEeecCCeEEEEEEECC-----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      ++|++.+.||+|+||.||+|+.+.     +.+.|++|.+..   .......+.+.+|+.++++++|+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK---TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCC---ccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            679999999999999999999754     346788997653   222334667889999999999999999999999889


Q ss_pred             eEEEEEeeecCCChhhhhhccC---------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEecc
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYG---------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADF  258 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~---------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DF  258 (602)
                      ..|+||||+++|+|.+++....         .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999997655         6899999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCC--CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCC
Q 007478          259 GMAKHIAGQS--CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTI  335 (602)
Q Consensus       259 Gla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  335 (602)
                      |++.......  ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...........+.........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV  240 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence            9987543221  122334677899999987655 7889999999999999998 88999776555555544433333344


Q ss_pred             CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       336 p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      +..++..+.++|.+||+.||++||++.+++++
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            56789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=351.63  Aligned_cols=251  Identities=28%  Similarity=0.449  Sum_probs=199.2

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc-e
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED-K  188 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~-~  188 (602)
                      ...++|....+||+|+||.||+|...+ |..||||++......   . .++|.+|+.+|.+++|||+|+|+|+|.+.+ .
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~  146 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH  146 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence            345788888999999999999998875 589999977642211   1 345999999999999999999999999888 5


Q ss_pred             EEEEEeeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCC---ceecCCCCCcEEEccCCceEEeccCcccc
Q 007478          189 LYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKH---TVHRDIKGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~g---IvHrDLKp~NILl~~~g~vKL~DFGla~~  263 (602)
                      .+||+|||++|+|.++|....  .+++....+|+.++|+||+|||+..   |||||||++|||||.+.+.||+|||+|+.
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~  226 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL  226 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence            999999999999999998654  8999999999999999999999853   99999999999999999999999999976


Q ss_pred             ccC-CCCCccc-CCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCch------hHHHHH-HhhCCC----
Q 007478          264 IAG-QSCPLSF-KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE------GVAAMF-KIGNSK----  330 (602)
Q Consensus       264 ~~~-~~~~~~~-~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~------~~~~~~-~i~~~~----  330 (602)
                      ... .....+. .||..|+|||++..+. .+.++|||||||+|.||++|+.+.+...      ...... .+....    
T Consensus       227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei  305 (361)
T KOG1187|consen  227 GPEGDTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI  305 (361)
T ss_pred             CCccccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence            554 3333333 7999999999997755 8999999999999999999998876421      111111 111110    


Q ss_pred             CCCCCC-CCCC--HH---HHHHHHHHcccCCCCCCCHHHHhc
Q 007478          331 ELPTIP-DDLS--DE---GKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       331 ~~~~~p-~~~s--~~---l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ..+.+. ....  .+   +..+..+|++.+|.+||++.|+++
T Consensus       306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            111221 2222  23   456777899999999999999854

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.4e-40  Score=330.08  Aligned_cols=243  Identities=25%  Similarity=0.453  Sum_probs=203.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccc-cccceEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSK-TVEDKLY  190 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~  190 (602)
                      ..+|++.+.||+|+||.||++...  |..||+|.++..      ...+.+.+|+.++++++|+||+++++++ ..++..|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            457999999999999999999765  778999987531      1245688999999999999999999875 4556799


Q ss_pred             EEEeeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          191 IYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      +||||+++++|.+++.+..  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999999999999997643  47889999999999999999999999999999999999999999999999988654322


Q ss_pred             CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                        ....++..|+|||++.+.. ++.++|||||||++|||++ |+.||...........+.. ...+..+..++..+.+||
T Consensus       157 --~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  232 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDVM  232 (256)
T ss_pred             --CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHH
Confidence              2334567899999987654 8899999999999999997 9999976554444444433 233456678999999999


Q ss_pred             HHHcccCCCCCCCHHHHhc
Q 007478          348 RLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .+||..||++|||+.++++
T Consensus       233 ~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         233 KQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.5e-40  Score=330.80  Aligned_cols=246  Identities=29%  Similarity=0.503  Sum_probs=206.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .+.|+++++||+|+||.||+|..+ +++.||+|.+.....     ....+.+|+.++++++|+||+++++++. .+.+|+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence            467999999999999999999865 478899998864221     2346788999999999999999998864 456899


Q ss_pred             EEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      +|||+.+++|.+++...  ..+++.++..++.||+.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999999998653  4688899999999999999999999999999999999999999999999999977653221


Q ss_pred             --CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          270 --PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       270 --~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                        .....++..|+|||++.... ++.++|||||||++|||++ |+.||...+.......+.... ....+..++.++.+|
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  235 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-RMPRPDNCPEELYEL  235 (260)
T ss_pred             ccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCHHHHHH
Confidence              12234667899999987655 8889999999999999999 999998766555554443332 234566789999999


Q ss_pred             HHHHcccCCCCCCCHHHHhc
Q 007478          347 IRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~  366 (602)
                      |.+||..+|++||+++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHccCChhhCCCHHHHHH
Confidence            99999999999999999985

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.8e-40  Score=339.54  Aligned_cols=253  Identities=25%  Similarity=0.426  Sum_probs=209.3

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEEC-------CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEec
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNS-------DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYG  181 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~  181 (602)
                      ....+|.+++.||+|+||.||+|++.       .++..||+|.++..   ........+.+|+.+++.+ +|+||+++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            34678999999999999999999753       23457999987531   2233456788999999999 8999999999


Q ss_pred             cccccceEEEEEeeecCCChhhhhhcc----------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcE
Q 007478          182 SKTVEDKLYIYLEYVSGGSIYKLLQDY----------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANI  245 (602)
Q Consensus       182 ~~~~~~~~~lVmE~~~ggsL~~~l~~~----------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NI  245 (602)
                      ++...+.+|+||||+.+|+|.+++...                ..++...+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            999999999999999999999998753                2467788999999999999999999999999999999


Q ss_pred             EEccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHH
Q 007478          246 LVDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVA  321 (602)
Q Consensus       246 Ll~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~  321 (602)
                      |++.++.+||+|||+++.+.....   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.......
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            999999999999999987643221   12234567899999997654 8899999999999999998 889997765544


Q ss_pred             HHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       322 ~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ....+... .....+..++.++++||.+||..+|++||++.++++.
T Consensus       248 ~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         248 LFKLLKEG-HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            44444333 3334567899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.5e-40  Score=336.53  Aligned_cols=251  Identities=28%  Similarity=0.457  Sum_probs=203.0

Q ss_pred             CCceEeeeEeecCCeEEEEEEE----CCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc--
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFN----SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE--  186 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~----~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~--  186 (602)
                      ..|++.+.||+|+||.||+|..    +.+++.||+|.++..   ........+.+|+.+++.++|+||+++++++...  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE---SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            3578999999999999999974    457889999987642   2233456788999999999999999999988764  


Q ss_pred             ceEEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                      ...++||||++|++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            5789999999999999999654 468999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC----CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCch--------------hHHHHHHhh
Q 007478          266 GQSC----PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE--------------GVAAMFKIG  327 (602)
Q Consensus       266 ~~~~----~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~--------------~~~~~~~i~  327 (602)
                      ....    .....|+..|+|||++.+.. ++.++|||||||++|||++++.|+....              ......+..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            4322    12345778899999987655 8899999999999999999876643210              011111111


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       328 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ........+..++.++.+||.+||+.||++||++.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1222233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.1e-40  Score=336.63  Aligned_cols=250  Identities=24%  Similarity=0.434  Sum_probs=208.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEEC-----CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNS-----DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++...   ........+.+|+.++++++||||+++++++.++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC---cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            467999999999999999999875     36789999987642   2233456788999999999999999999999998


Q ss_pred             ceEEEEEeeecCCChhhhhhccC----------------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYG----------------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGAN  244 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~----------------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~N  244 (602)
                      +.+|+||||+.+++|.+++....                      .+++..++.++.||+.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999996432                      36778889999999999999999999999999999


Q ss_pred             EEEccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhH
Q 007478          245 ILVDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGV  320 (602)
Q Consensus       245 ILl~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~  320 (602)
                      ||++.++.+||+|||++..+.....   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999876543221   11223466799999987655 8999999999999999997 88899776555


Q ss_pred             HHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          321 AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       321 ~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .....+.... ....+..++.++.+||.+||+.||++|||+.||++
T Consensus       240 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         240 EVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            5555544333 33446678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-39  Score=333.79  Aligned_cols=250  Identities=29%  Similarity=0.468  Sum_probs=201.5

Q ss_pred             CCCceEeeeEeecCCeEEEEEEE----CCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc--
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFN----SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV--  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~----~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~--  185 (602)
                      ..+|++.+.||+|+||.||++..    ..+++.||+|++...    .....+.+.+|++++++++||||+++++++..  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            35799999999999999999974    457889999987642    23345678899999999999999999987643  


Q ss_pred             cceEEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                      ...+|+||||+++++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            45689999999999999999764 46899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCc----ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH---------------HHHHH
Q 007478          265 AGQSCPL----SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV---------------AAMFK  325 (602)
Q Consensus       265 ~~~~~~~----~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~---------------~~~~~  325 (602)
                      .......    ...++..|+|||++.+.. ++.++|||||||++|||++|..++......               ..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            5433211    122345699999997655 889999999999999999987776432111               01111


Q ss_pred             hhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       326 i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      +.........+..++.++.+||.+||..+|++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            22222233345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-40  Score=335.74  Aligned_cols=239  Identities=23%  Similarity=0.389  Sum_probs=197.2

Q ss_pred             eeEeecCCeEEEEEEECCCCcE-------EEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEM-------CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~-------vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      +.||+|+||.||+|.++.++..       +|+|.+..    ......+.+.+|+.+++.++||||+++++++...+..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence            3699999999999998765543       77887642    223445678889999999999999999999998889999


Q ss_pred             EEeeecCCChhhhhhccC-CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCc--------eEEeccCccc
Q 007478          192 YLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR--------VKLADFGMAK  262 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~--------vKL~DFGla~  262 (602)
                      ||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.        +||+|||++.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999997644 5899999999999999999999999999999999999987765        6999999987


Q ss_pred             cccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhC-CCCCCCchhHHHHHHhhCCCCCCCCCCCCCH
Q 007478          263 HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSD  341 (602)
Q Consensus       263 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  341 (602)
                      .....   ....++..|+|||++.+...++.++|||||||++|||++| .+||...+..........   ...++...+.
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  230 (258)
T cd05078         157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---RHQLPAPKWT  230 (258)
T ss_pred             ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc---cccCCCCCcH
Confidence            65432   2356889999999998755688999999999999999998 567665444333322222   2345667788


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          342 EGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       342 ~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ++.+||.+||+.||++|||+++|++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-39  Score=330.20  Aligned_cols=250  Identities=26%  Similarity=0.440  Sum_probs=209.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCc---EEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGE---MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      .++|...+.||+|+||.||+|.++.++.   .+|+|.++..   ......+.+.+|+++++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG---YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            3578899999999999999999876665   6899987542   123345678899999999999999999999999999


Q ss_pred             EEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      .|+||||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999999753 67899999999999999999999999999999999999999999999999999866432


Q ss_pred             CCCc----ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHH
Q 007478          268 SCPL----SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       268 ~~~~----~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                      ....    ....+..|+|||++.+.. ++.++|||||||++|||++ |+.||...+.......+.... ....+..++.+
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~  238 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLPAPMDCPSA  238 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCCCCCCCCHH
Confidence            2111    112345799999987655 8899999999999999997 999997766655555554432 22344578999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhc
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      +.+|+.+||+.||++||++.+|++
T Consensus       239 ~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         239 VYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-39  Score=330.47  Aligned_cols=246  Identities=26%  Similarity=0.471  Sum_probs=204.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..+|++.+.||+|+||.||+|.+..+ ..+|+|.+....     ...+.+.+|+.++++++|+||+++++++. .+..|+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            35699999999999999999988764 469999875321     12356788999999999999999998875 456899


Q ss_pred             EEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||||+.+++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            99999999999999753  3478899999999999999999999999999999999999999999999999987643321


Q ss_pred             --CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          270 --PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       270 --~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                        .....++..|+|||.+.+.. ++.++|||||||++|||++ |+.||.+.........+... .....+..++..+.+|
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  235 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESLHEL  235 (260)
T ss_pred             cccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHH
Confidence              12234667899999987655 8899999999999999999 99999876655555544432 3334566789999999


Q ss_pred             HHHHcccCCCCCCCHHHHhc
Q 007478          347 IRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~  366 (602)
                      |++||.+||++||+++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-39  Score=337.43  Aligned_cols=251  Identities=26%  Similarity=0.398  Sum_probs=202.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECC----------------CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD----------------SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN  175 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hpn  175 (602)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|++...   ........+.+|+.+|+.++|+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED---ANKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCC
Confidence            4579999999999999999986432                3457899987632   22344567889999999999999


Q ss_pred             EEEEeccccccceEEEEEeeecCCChhhhhhccC-----------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCc
Q 007478          176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-----------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGAN  244 (602)
Q Consensus       176 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~-----------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~N  244 (602)
                      |+++++++...+.+|+||||+.+++|.+++....           .+++..+..++.||+.||+|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999987542           36677899999999999999999999999999999


Q ss_pred             EEEccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh--CCCCCCCchh
Q 007478          245 ILVDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEG  319 (602)
Q Consensus       245 ILl~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt--G~~Pf~~~~~  319 (602)
                      ||++.++.+||+|||+++.+.....   .....++..|++||++.+.. ++.++|||||||++|||++  |..||.....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9999999999999999986543221   11233467899999887655 8999999999999999998  7889976544


Q ss_pred             HHHHHHhh------CCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          320 VAAMFKIG------NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       320 ~~~~~~i~------~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ...+....      ........+..++..+.+||.+||+.||++||++.+|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            33322211      111112334568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=332.08  Aligned_cols=250  Identities=27%  Similarity=0.411  Sum_probs=209.2

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCc----EEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGE----MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      ...+|++.+.||+|+||+||+|.++.+|.    .+|+|.+...   ........+.+|+.++++++|+||+++++++.. 
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            35689999999999999999999877665    5888877542   224455678899999999999999999998876 


Q ss_pred             ceEEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                      ...++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999999763 568999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCcc---cCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCH
Q 007478          266 GQSCPLS---FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSD  341 (602)
Q Consensus       266 ~~~~~~~---~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  341 (602)
                      .......   ..++..|+|||.+.... ++.++|||||||++|||++ |+.||...........+.. ......+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERLPQPPICTI  238 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCCCCCCCCH
Confidence            4332221   22356899999986554 8899999999999999998 9999987655444444433 233345667889


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          342 EGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       342 ~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ++.+++.+||..||++||++.++++
T Consensus       239 ~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         239 DVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-39  Score=329.84  Aligned_cols=253  Identities=28%  Similarity=0.517  Sum_probs=212.3

Q ss_pred             CceEeeeEeecCCeEEEEEEECC-CCcEEEEEEEecccc------hhcHHHHHHHHHHHHHHHh-cCCCcEEEEeccccc
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSD-SGEMCAMKEVTLFDD------AKSKESAKQLMQEIVLLSR-LRHPNIVQYYGSKTV  185 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~~------~~~~~~~~~l~~Ei~iL~~-l~HpnIv~l~~~~~~  185 (602)
                      .|++.+.||+|+||.||++.+.. +++.+|+|.+.....      .........+.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47889999999999999999987 688999998864221      1223445667789988865 799999999999999


Q ss_pred             cceEEEEEeeecCCChhhhhhc----cCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCc
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGl  260 (602)
                      ++..|+||||+++++|.+++..    ...+++..++.++.||+.||.|||+ .||+|+||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999988743    3468999999999999999999996 7899999999999999999999999999


Q ss_pred             cccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCC
Q 007478          261 AKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLS  340 (602)
Q Consensus       261 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  340 (602)
                      +.............|+..|++||++.+.. ++.++|||||||++|||++|+.||...+.......+......+.....++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS  239 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence            98766554444567899999999998655 88999999999999999999999987665555555544433333333688


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          341 DEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       341 ~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .++.+||.+||+.||++||++.|+.++
T Consensus       240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         240 EDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=328.84  Aligned_cols=248  Identities=29%  Similarity=0.485  Sum_probs=209.5

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|.+.+.||+|+||.||+|.+.. ++.||||.+.....     ..+.+.+|+.++++++|+||+++++++......+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            35789999999999999999998764 57899998864221     2356889999999999999999999999888999


Q ss_pred             EEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          191 IYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      +||||+++++|.+++...  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++.+....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999999999764  368999999999999999999999999999999999999999999999999988764321


Q ss_pred             C--CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          269 C--PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       269 ~--~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                      .  .....++..|+|||.+.+.. ++.++|||||||++|||++ |+.||.+......+.++.... ....+..++.++.+
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  235 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-RMPRPPNCPEELYD  235 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence            1  11223567899999997654 8899999999999999998 999998766655555554432 23445677999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhc
Q 007478          346 FIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ++.+||..+|++||+++++++
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=326.40  Aligned_cols=242  Identities=26%  Similarity=0.446  Sum_probs=203.8

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecC
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSG  198 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~g  198 (602)
                      ++||+|+||.||+|.+.. ++.||+|++.....   ......+.+|++++++++|+||+++++++...+..|+||||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            469999999999999887 99999998865322   23456788999999999999999999999999999999999999


Q ss_pred             CChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC---cccC
Q 007478          199 GSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP---LSFK  274 (602)
Q Consensus       199 gsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~---~~~~  274 (602)
                      ++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++.........   ....
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            999999965 356889999999999999999999999999999999999999999999999999865422111   1122


Q ss_pred             CCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHccc
Q 007478          275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR  353 (602)
Q Consensus       275 GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~  353 (602)
                      ++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+... .....+..++.++.+||.+||..
T Consensus       157 ~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         157 IPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             ceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHhcc
Confidence            456799999987654 8899999999999999998 89999776654444444332 22345668899999999999999


Q ss_pred             CCCCCCCHHHHhc
Q 007478          354 NPLNRPTAAELLD  366 (602)
Q Consensus       354 dP~~Rpt~~eiL~  366 (602)
                      +|++||++.|+++
T Consensus       235 ~p~~Rp~~~ell~  247 (251)
T cd05041         235 DPENRPSFSEIYN  247 (251)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-39  Score=343.13  Aligned_cols=251  Identities=25%  Similarity=0.420  Sum_probs=207.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCC-------CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDS-------GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSK  183 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-------g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~  183 (602)
                      ..+|++++.||+|+||.||+|.+...       +..||+|.++..   ......+.+.+|+.+++++ +|+||+++++++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            45799999999999999999986432       236899977631   2234456788999999999 899999999999


Q ss_pred             cccceEEEEEeeecCCChhhhhhccC----------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEE
Q 007478          184 TVEDKLYIYLEYVSGGSIYKLLQDYG----------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV  247 (602)
Q Consensus       184 ~~~~~~~lVmE~~~ggsL~~~l~~~~----------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl  247 (602)
                      ..++.+|++|||+.+|+|.+++.+..                .++...+..++.||+.||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill  167 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV  167 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            99999999999999999999987532                36778889999999999999999999999999999999


Q ss_pred             ccCCceEEeccCccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHH
Q 007478          248 DPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAM  323 (602)
Q Consensus       248 ~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~  323 (602)
                      +.++.+||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.........
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            9999999999999986643221   11223456799999997655 8899999999999999998 89999876555544


Q ss_pred             HHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          324 FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       324 ~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ..+.. ......+..++.++.+||.+||..+|++||++.+++++
T Consensus       247 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         247 KLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            44433 23345567889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-39  Score=325.51  Aligned_cols=242  Identities=26%  Similarity=0.445  Sum_probs=202.7

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecC
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSG  198 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~g  198 (602)
                      ++||+|+||.||+|... ++..+|+|+++..   ........+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED---LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCc---CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence            46999999999999865 5889999987642   1233345688999999999999999999999999999999999999


Q ss_pred             CChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc--ccCC
Q 007478          199 GSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKG  275 (602)
Q Consensus       199 gsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~--~~~G  275 (602)
                      ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..........  ...+
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            999999865 3467899999999999999999999999999999999999999999999999987644322111  1234


Q ss_pred             CCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccC
Q 007478          276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRN  354 (602)
Q Consensus       276 T~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~d  354 (602)
                      +..|+|||++.... ++.++|||||||++|||++ |..||...........+... .....+..++.++.+|+.+||..+
T Consensus       157 ~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~  234 (250)
T cd05085         157 PIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRMSCPQKCPDDVYKVMQRCWDYK  234 (250)
T ss_pred             cccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccC
Confidence            66799999987655 8889999999999999998 99999876655555554433 233556678999999999999999


Q ss_pred             CCCCCCHHHHhc
Q 007478          355 PLNRPTAAELLD  366 (602)
Q Consensus       355 P~~Rpt~~eiL~  366 (602)
                      |++||++.++++
T Consensus       235 p~~Rp~~~~l~~  246 (250)
T cd05085         235 PENRPKFSELQK  246 (250)
T ss_pred             cccCCCHHHHHH
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-39  Score=331.05  Aligned_cols=244  Identities=23%  Similarity=0.401  Sum_probs=194.5

Q ss_pred             eeEeecCCeEEEEEEECC--CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeee
Q 007478          119 KMLGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYV  196 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~  196 (602)
                      +.||+|+||+||+|....  ....+|+|.+..   .........+.+|+.+++.++|+||+++++.+...+.+|+||||+
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRA---SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCc---cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            359999999999996543  345677776543   223344567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccC-----CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC--
Q 007478          197 SGGSIYKLLQDYG-----QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC--  269 (602)
Q Consensus       197 ~ggsL~~~l~~~~-----~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--  269 (602)
                      .+|+|.+++....     .+.+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999999997642     245778899999999999999999999999999999999999999999999875432211  


Q ss_pred             -CcccCCCCCCCCcccccc------cCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCC----CCCCCCC
Q 007478          270 -PLSFKGSPYWMAPEVIKN------SSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSK----ELPTIPD  337 (602)
Q Consensus       270 -~~~~~GT~~Y~APEvl~~------~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~----~~~~~p~  337 (602)
                       .....++..|+|||++..      ...++.++|||||||++|||++ |..||........+..+....    ..+.++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL  237 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence             122346778999999753      2346789999999999999999 889998766554444433222    1234455


Q ss_pred             CCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          338 DLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       338 ~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .++..+.+++..|| .||++|||+++|++
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            78899999999999 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-39  Score=329.53  Aligned_cols=250  Identities=27%  Similarity=0.436  Sum_probs=208.0

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCC---CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDS---GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      ..+|.+.++||+|+||.||+|.+..+   ...||||......   .....+.+.+|+.+++.++|+||+++++++.+ +.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            45689999999999999999987654   3468999775422   13445678899999999999999999998875 45


Q ss_pred             EEEEEeeecCCChhhhhhccC-CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  267 (602)
                      .|+||||+++++|.+++.... .+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            789999999999999997643 5899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCc--ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHH
Q 007478          268 SCPL--SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGK  344 (602)
Q Consensus       268 ~~~~--~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  344 (602)
                      ....  ...++..|+|||.+.... ++.++|||||||++|||++ |..||...........+..... ...+..++.++.
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER-LPMPPNCPPTLY  238 (270)
T ss_pred             cceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc-CCCCCCCCHHHH
Confidence            2211  222456899999986554 8899999999999999986 9999987766555555544433 345678999999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhcC
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      +||.+||..+|++|||+.++++.
T Consensus       239 ~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         239 SLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.9e-39  Score=341.71  Aligned_cols=259  Identities=28%  Similarity=0.432  Sum_probs=211.2

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc-cceE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV-EDKL  189 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~  189 (602)
                      ..++|++.+.||+|+||.||+|.++.+++.||||++.+..  ......+.+.+|+.+++.++||||+++++++.. .+..
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF--STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            4678999999999999999999999999999999876421  122334667889999999999999999998865 5678


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      |++|||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--  161 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--  161 (328)
T ss_pred             EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence            9999998 6789888865 46888899999999999999999999999999999999999999999999999865332  


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhh----------------------
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG----------------------  327 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~----------------------  327 (602)
                      .....++..|+|||++.+...++.++|||||||++|||++|+.||...+.......+.                      
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            2345688999999998765558999999999999999999999997644321111000                      


Q ss_pred             --CCCCC-----CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          328 --NSKEL-----PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       328 --~~~~~-----~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                        .....     ......++.++.++|++||+.+|++||++++++.|+||.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence              00000     0112357899999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-39  Score=329.91  Aligned_cols=244  Identities=23%  Similarity=0.376  Sum_probs=193.7

Q ss_pred             eeEeecCCeEEEEEEEC--CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeee
Q 007478          119 KMLGRGTFGHVYVGFNS--DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYV  196 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~  196 (602)
                      +.||+|+||.||+|...  .++..+|+|.++...   .......+.+|+.++++++||||+++++++.+...+++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence            46999999999999764  345679999876422   1233456888999999999999999999999888999999999


Q ss_pred             cCCChhhhhhccC-----CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC--
Q 007478          197 SGGSIYKLLQDYG-----QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC--  269 (602)
Q Consensus       197 ~ggsL~~~l~~~~-----~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--  269 (602)
                      ++|+|.+++....     ..++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.......  
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999999986532     356677889999999999999999999999999999999999999999999975433221  


Q ss_pred             -CcccCCCCCCCCcccccccC------CCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCC----CCCCCCCC
Q 007478          270 -PLSFKGSPYWMAPEVIKNSS------GCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNS----KELPTIPD  337 (602)
Q Consensus       270 -~~~~~GT~~Y~APEvl~~~~------~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~----~~~~~~p~  337 (602)
                       .....|+..|+|||++.+..      .++.++|||||||++|||++ |+.||...............    ...+.+..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL  237 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence             12345788899999986421      25789999999999999996 99999765544333222111    11223334


Q ss_pred             CCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          338 DLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       338 ~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .++..+.+||++|| .+|++|||+++|+.
T Consensus       238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            57889999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2e-39  Score=331.66  Aligned_cols=250  Identities=23%  Similarity=0.375  Sum_probs=208.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECC----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc-c
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV-E  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~-~  186 (602)
                      .++|++.++||+|+||.||+|.+..    ++..|++|.+..   .........+.+|+.+++.++|+||+++++++.. .
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC---CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            5689999999999999999999876    357899998753   2234446778899999999999999999997655 5


Q ss_pred             ceEEEEEeeecCCChhhhhhcc--------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEecc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDY--------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADF  258 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~--------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DF  258 (602)
                      ...++++||+.+++|.+++...        ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            6789999999999999998653        35889999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCC---cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCC
Q 007478          259 GMAKHIAGQSCP---LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPT  334 (602)
Q Consensus       259 Gla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~  334 (602)
                      |+++.+......   ....++..|+|||++.+.. ++.++|||||||++|||++ |+.||...+.......+... ....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~  239 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRLA  239 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCCC
Confidence            999866433211   1234677899999997655 8899999999999999999 99999876554444444333 2233


Q ss_pred             CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       335 ~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .+..+++++.++|.+||..||++|||+.++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            45578999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-39  Score=333.81  Aligned_cols=238  Identities=23%  Similarity=0.326  Sum_probs=192.7

Q ss_pred             eEeecCCeEEEEEEECCC------------------------CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCc
Q 007478          120 MLGRGTFGHVYVGFNSDS------------------------GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN  175 (602)
Q Consensus       120 ~LG~G~fG~Vy~a~~~~t------------------------g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hpn  175 (602)
                      +||+|+||.||+|....+                        ...||+|++..    ........+.+|+.+++.++|+|
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP----SHRDIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh----HHHHHHHHHHHHHHHHhcCCCCC
Confidence            699999999999975322                        23578887653    22334567888999999999999


Q ss_pred             EEEEeccccccceEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC---
Q 007478          176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG---  251 (602)
Q Consensus       176 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g---  251 (602)
                      |+++++++......|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+   
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999999865 46789999999999999999999999999999999999997654   


Q ss_pred             ----ceEEeccCccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHh-hCCCCCCCchhHHHHHHh
Q 007478          252 ----RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMA-TTKPPWSQYEGVAAMFKI  326 (602)
Q Consensus       252 ----~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELl-tG~~Pf~~~~~~~~~~~i  326 (602)
                          .+||+|||++.......   ...++..|+|||++.+...++.++|||||||++|||+ +|+.||............
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSRE---ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             CccceeeecCCcccccccccc---ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence                48999999886543222   2347888999999876556899999999999999985 699999765433222221


Q ss_pred             hCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       327 ~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ..   ...++.....++.+||.+||+.+|++||++.+|+++
T Consensus       235 ~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 EK---KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             Hh---ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            11   123344567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-39  Score=329.94  Aligned_cols=239  Identities=21%  Similarity=0.363  Sum_probs=193.0

Q ss_pred             eeEeecCCeEEEEEEECCC------------CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          119 KMLGRGTFGHVYVGFNSDS------------GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~t------------g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      +.||+|+||.||+|+....            ...+|+|++..    ........+.+|+.+++.++||||+++++++..+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4689999999999975322            23578887653    2233455788899999999999999999999988


Q ss_pred             ceEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCc-------eEEecc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-------VKLADF  258 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~-------vKL~DF  258 (602)
                      ...++||||+.+++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.       +||+||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            899999999999999998875 356899999999999999999999999999999999999987664       899999


Q ss_pred             CccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHh-hCCCCCCCchhHHHHHHhhCCCCCCCCCC
Q 007478          259 GMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMA-TTKPPWSQYEGVAAMFKIGNSKELPTIPD  337 (602)
Q Consensus       259 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELl-tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  337 (602)
                      |++......   ....|+..|+|||++.+...++.++|||||||++|||+ .|..||......... .+....  .....
T Consensus       157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~--~~~~~  230 (262)
T cd05077         157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ--CMLVT  230 (262)
T ss_pred             CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC--ccCCC
Confidence            998765332   23458889999999875566899999999999999998 588998764432221 211111  12233


Q ss_pred             CCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       338 ~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ..+.++.+||.+||+.||++||++.+|+++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1e-39  Score=327.05  Aligned_cols=229  Identities=24%  Similarity=0.368  Sum_probs=193.7

Q ss_pred             cCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCChhh
Q 007478          124 GTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYK  203 (602)
Q Consensus       124 G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~  203 (602)
                      |.||.||+++++.+++.||+|.+....         ...+|...+....||||+++++++...+.+|+||||++||+|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999999999999999986421         12234555566679999999999999999999999999999999


Q ss_pred             hhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCCCCCCCCcc
Q 007478          204 LLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE  283 (602)
Q Consensus       204 ~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE  283 (602)
                      ++.+...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..+....  ....++..|+|||
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE  152 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPE  152 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccCCc
Confidence            99887789999999999999999999999999999999999999999999999999887654432  2345678899999


Q ss_pred             cccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCH--
Q 007478          284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTA--  361 (602)
Q Consensus       284 vl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~--  361 (602)
                      ++.... ++.++||||+||++|||++|+.||......     + .......++..++.++++||++||+.||++|+++  
T Consensus       153 ~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         153 VGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             ccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence            986554 788999999999999999999887543211     0 1111224567789999999999999999999985  


Q ss_pred             ---HHHhcCccc
Q 007478          362 ---AELLDHPFV  370 (602)
Q Consensus       362 ---~eiL~hp~f  370 (602)
                         +++++||||
T Consensus       226 ~~~~~~~~h~~~  237 (237)
T cd05576         226 AGVEDIKSHPFF  237 (237)
T ss_pred             cchHHHHcCCCC
Confidence               999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.2e-39  Score=325.14  Aligned_cols=248  Identities=25%  Similarity=0.454  Sum_probs=206.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      ..+|++.+.||+|+||.||++.+.. +..+|+|++.....     ....+.+|++++++++||||+++++++......|+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL   76 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence            4579999999999999999998764 67899998764211     12457889999999999999999999999899999


Q ss_pred             EEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC-
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  269 (602)
                      ||||+.+++|.+++... +.+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||++........ 
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999999999998754 5689999999999999999999999999999999999999999999999999876543221 


Q ss_pred             -CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          270 -PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       270 -~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                       .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||...........+... .....+...+.++.+|+
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~  234 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELM  234 (256)
T ss_pred             ccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHH
Confidence             11223567899999987655 8889999999999999998 99999866554444444332 12233556789999999


Q ss_pred             HHHcccCCCCCCCHHHHhcC
Q 007478          348 RLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .+||..+|++||++.+++++
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHcccChhhCCCHHHHHHh
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.6e-39  Score=324.15  Aligned_cols=247  Identities=26%  Similarity=0.459  Sum_probs=205.9

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..++|++.+.||+|+||.||++.+.. +..+|+|++...     ....+.+.+|+.+++.++|+||+++++++.. ...|
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            35789999999999999999998654 567999987631     2234678899999999999999999998877 7789


Q ss_pred             EEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          191 IYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      ++|||+.+++|.+++.+.  ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999753  457888899999999999999999999999999999999999999999999997654322


Q ss_pred             C--CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHH
Q 007478          269 C--PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       269 ~--~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~d  345 (602)
                      .  .....++..|+|||++.... ++.++|||||||++|+|++ |+.||...+.......+.... ....+..++.++.+
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMPRPENCPEELYN  234 (260)
T ss_pred             cccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCCCcccCCHHHHH
Confidence            1  11233567799999997654 8889999999999999998 999998766555555444432 22345678999999


Q ss_pred             HHHHHcccCCCCCCCHHHHhc
Q 007478          346 FIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       346 LI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ++.+||..||++||++.++++
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.4e-39  Score=328.52  Aligned_cols=243  Identities=26%  Similarity=0.470  Sum_probs=201.9

Q ss_pred             eeEeecCCeEEEEEEECCCC------cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          119 KMLGRGTFGHVYVGFNSDSG------EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg------~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +.||+|+||.||+|.++...      +.+|+|.+...   ........+.+|+.+++.++||||+++++++...+..|+|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            46999999999999886544      68999987531   1123456788999999999999999999999988999999


Q ss_pred             EeeecCCChhhhhhcc-------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC-----ceEEeccCc
Q 007478          193 LEYVSGGSIYKLLQDY-------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-----RVKLADFGM  260 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~-------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g-----~vKL~DFGl  260 (602)
                      |||+++++|.+++...       ..+++..+..++.||+.||+|||+++++|+||||+|||++.++     .+||+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999999642       3478889999999999999999999999999999999999887     899999999


Q ss_pred             cccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCC
Q 007478          261 AKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIP  336 (602)
Q Consensus       261 a~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  336 (602)
                      +..+.....   .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||...+.......+.. ......+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~  235 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-GGRLQKP  235 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-CCccCCc
Confidence            976543221   11234578899999997765 8999999999999999998 9999987665554444433 2334556


Q ss_pred             CCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       337 ~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ..++.++.+||.+||..+|++||+++++++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            788999999999999999999999999975

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.9e-40  Score=373.97  Aligned_cols=255  Identities=30%  Similarity=0.504  Sum_probs=206.8

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE----  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~----  186 (602)
                      ..++|+..++||+||||.||+++++-+|+.||||+|....   .......+.+|+.+|.+|+|||||++|..|.+.    
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            4578899999999999999999999999999999987522   445567889999999999999999977432100    


Q ss_pred             --------------------------------------------------------------------------------
Q 007478          187 --------------------------------------------------------------------------------  186 (602)
Q Consensus       187 --------------------------------------------------------------------------------  186 (602)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------ceEEEEEeeecCCChhhhhhccCCC-ChHHHHHHHHHHHHHHhhh
Q 007478          187 -----------------------------------DKLYIYLEYVSGGSIYKLLQDYGQF-GEPAIRNYTQQILSGLAFL  230 (602)
Q Consensus       187 -----------------------------------~~~~lVmE~~~ggsL~~~l~~~~~l-s~~~i~~i~~qIl~aL~yL  230 (602)
                                                         -.+||-||||+...|.+++..+... ....++++++||++||.|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                               1268899999998888888775544 3677999999999999999


Q ss_pred             ccCCceecCCCCCcEEEccCCceEEeccCcccccc-------------------CCCCCcccCCCCCCCCcccccccC--
Q 007478          231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-------------------GQSCPLSFKGSPYWMAPEVIKNSS--  289 (602)
Q Consensus       231 H~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~-------------------~~~~~~~~~GT~~Y~APEvl~~~~--  289 (602)
                      |++|||||||||.||+|+.++.|||+|||+|+...                   ......+.+||.-|+|||++.+..  
T Consensus       714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            99999999999999999999999999999998721                   111234577999999999997766  


Q ss_pred             CCCccccchhhhhHHHHHhhCCCCCC-CchhHHHHHHhhCCCCCCCC---CCCCCHHHHHHHHHHcccCCCCCCCHHHHh
Q 007478          290 GCNLAVDIWSLGCTVLEMATTKPPWS-QYEGVAAMFKIGNSKELPTI---PDDLSDEGKDFIRLCLQRNPLNRPTAAELL  365 (602)
Q Consensus       290 ~~s~~sDVWSLGviLyELltG~~Pf~-~~~~~~~~~~i~~~~~~~~~---p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL  365 (602)
                      .|+.|+|||||||||+||+.   ||. .++....+..+.+ ...|..   ...--+.-..+|++||+.||.+|||+.|+|
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~-g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK-GSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc-CCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence            59999999999999999985   475 3555555555543 223322   333445667899999999999999999999


Q ss_pred             cCccccC
Q 007478          366 DHPFVKG  372 (602)
Q Consensus       366 ~hp~f~~  372 (602)
                      .+.||..
T Consensus       870 ~s~llpp  876 (1351)
T KOG1035|consen  870 NSELLPP  876 (1351)
T ss_pred             hccCCCc
Confidence            9999873

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.7e-39  Score=325.57  Aligned_cols=236  Identities=26%  Similarity=0.411  Sum_probs=193.5

Q ss_pred             eeEeecCCeEEEEEEECCCC----------cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          119 KMLGRGTFGHVYVGFNSDSG----------EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg----------~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      +.||+|+||.||+|.+..++          ..+++|++....    .. ...+.+|+.+++.++|+||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hh-HHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence            46999999999999998776          347777654311    11 5678899999999999999999998877 77


Q ss_pred             EEEEEeeecCCChhhhhhccC-CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC-------ceEEeccCc
Q 007478          189 LYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-------RVKLADFGM  260 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g-------~vKL~DFGl  260 (602)
                      .++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++       .+||+|||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            899999999999999998765 789999999999999999999999999999999999999887       799999999


Q ss_pred             cccccCCCCCcccCCCCCCCCccccccc-CCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCC
Q 007478          261 AKHIAGQSCPLSFKGSPYWMAPEVIKNS-SGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDD  338 (602)
Q Consensus       261 a~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  338 (602)
                      +......   ....++..|+|||++... ..++.++|||||||++|||++ |..||................   ..+..
T Consensus       155 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~---~~~~~  228 (259)
T cd05037         155 PITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH---RLPMP  228 (259)
T ss_pred             ccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC---CCCCC
Confidence            9876542   234477889999998765 358899999999999999999 688887654322222222111   12223


Q ss_pred             CCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          339 LSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       339 ~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ...++.+||.+||..+|++||++.++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         229 DCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            3489999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=320.10  Aligned_cols=252  Identities=28%  Similarity=0.413  Sum_probs=204.1

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE----  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~----  186 (602)
                      ..++|++.+.||+|||+-||++.+..+++.||+|+|...    ..+..+..++|++..++++||||++++++...+    
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            467999999999999999999999999999999998752    245567788999999999999999999976543    


Q ss_pred             -ceEEEEEeeecCCChhhhhhcc----CCCChHHHHHHHHHHHHHHhhhccCC--ceecCCCCCcEEEccCCceEEeccC
Q 007478          187 -DKLYIYLEYVSGGSIYKLLQDY----GQFGEPAIRNYTQQILSGLAFLHSKH--TVHRDIKGANILVDPNGRVKLADFG  259 (602)
Q Consensus       187 -~~~~lVmE~~~ggsL~~~l~~~----~~ls~~~i~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~~~g~vKL~DFG  259 (602)
                       ...||++.|...|+|.+.+...    ..+++.++..|+.+|++||++||+..  +.||||||.|||+.+.+.++|.|||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence             3599999999999999998653    36899999999999999999999998  9999999999999999999999999


Q ss_pred             ccccccCCCCC----------cccCCCCCCCCcccccccC--CCCccccchhhhhHHHHHhhCCCCCCCchh--HHHHHH
Q 007478          260 MAKHIAGQSCP----------LSFKGSPYWMAPEVIKNSS--GCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFK  325 (602)
Q Consensus       260 la~~~~~~~~~----------~~~~GT~~Y~APEvl~~~~--~~s~~sDVWSLGviLyELltG~~Pf~~~~~--~~~~~~  325 (602)
                      .++...-.-..          ....-|..|+|||.+.-..  -.++++|||||||+||+|+.|..||+....  ......
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            98765321110          0123688999999985332  267899999999999999999999963221  011111


Q ss_pred             hhCC-CCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          326 IGNS-KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       326 i~~~-~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      +.+. ...|.- ..+++.+.+||+.||+.||.+||++.+++.+
T Consensus       255 v~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  255 VQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1121 112221 2489999999999999999999999999874

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.5e-39  Score=334.19  Aligned_cols=250  Identities=25%  Similarity=0.415  Sum_probs=204.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCc----EEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGE----MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      .++|+..+.||+|+||.||+|.+..+|.    .+|+|.+...   ........+.+|+.+++.++|+||+++++++... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            5689999999999999999999887776    4677876532   2223344688999999999999999999988654 


Q ss_pred             eEEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      ..++++||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            478999999999999998764 3688999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCC---cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHH
Q 007478          267 QSCP---LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       267 ~~~~---~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                      ....   ....++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+....... .+.........+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERLPQPPICTID  239 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCCCCCCCCCHH
Confidence            3321   1233577899999987655 8899999999999999997 99999765432222 222223333445678899


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       343 l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      +.++|.+||..+|++||++.++++.
T Consensus       240 ~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         240 VYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.4e-39  Score=323.61  Aligned_cols=244  Identities=26%  Similarity=0.455  Sum_probs=197.7

Q ss_pred             eeEeecCCeEEEEEEECC---CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccc-ccceEEEEEe
Q 007478          119 KMLGRGTFGHVYVGFNSD---SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKT-VEDKLYIYLE  194 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~lVmE  194 (602)
                      +.||+|+||.||+|.+..   .+..||+|.+...   ......+.+.+|+.+++.++||||+++++++. .++..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            468999999999998754   3457999987531   22344567889999999999999999999764 4567899999


Q ss_pred             eecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC-----
Q 007478          195 YVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-----  268 (602)
Q Consensus       195 ~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-----  268 (602)
                      |+.+++|.+++.+. ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++.+....     
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999999764 456778889999999999999999999999999999999999999999999997654321     


Q ss_pred             CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                      ......++..|+|||++.+.. ++.++|||||||++|||++ |.+||...+.......+... ..+..+..++..+.+|+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  235 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRLLQPEYCPDPLYEVM  235 (262)
T ss_pred             ccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCcCCHHHHHHH
Confidence            111334677899999987654 8899999999999999999 56777766555444444332 23344567889999999


Q ss_pred             HHHcccCCCCCCCHHHHhcC
Q 007478          348 RLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .+||..+|++||++.+|++.
T Consensus       236 ~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         236 LSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.7e-39  Score=326.13  Aligned_cols=243  Identities=20%  Similarity=0.323  Sum_probs=192.4

Q ss_pred             eEeecCCeEEEEEEECCCC--cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeec
Q 007478          120 MLGRGTFGHVYVGFNSDSG--EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVS  197 (602)
Q Consensus       120 ~LG~G~fG~Vy~a~~~~tg--~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~  197 (602)
                      .||+|+||.||++....++  ..+++|.++.   .......+.+.+|+.+++.++||||+++++.+......|+||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKA---NASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecC---CCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            5999999999999754322  3455665543   2223345678999999999999999999999999899999999999


Q ss_pred             CCChhhhhhcc----CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC---CC
Q 007478          198 GGSIYKLLQDY----GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS---CP  270 (602)
Q Consensus       198 ggsL~~~l~~~----~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---~~  270 (602)
                      +|+|.+++.+.    ..+.+..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......   ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999999753    345667788999999999999999999999999999999999999999999986432211   12


Q ss_pred             cccCCCCCCCCccccccc------CCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCC----CCCCCCCCC
Q 007478          271 LSFKGSPYWMAPEVIKNS------SGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSK----ELPTIPDDL  339 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~------~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~~  339 (602)
                      ...+|+..|+|||++...      ..++.++|||||||++|||++ |..||...+....+.++....    ..+.++..+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            245688999999998532      125679999999999999997 678997666555544433222    223455568


Q ss_pred             CHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          340 SDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       340 s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ++.+.+|+..|| .+|++||++++|++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            899999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.2e-39  Score=323.38  Aligned_cols=242  Identities=25%  Similarity=0.444  Sum_probs=202.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||++.  .+++.||+|.++...      ....+.+|+.++++++|+||+++++++..+ ..|+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            4679999999999999999986  467899999876421      235678899999999999999999988654 4799


Q ss_pred             EEeeecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCC
Q 007478          192 YLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  269 (602)
                      ||||+.+++|.+++....  .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......  
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            999999999999997643  5788999999999999999999999999999999999999999999999998764322  


Q ss_pred             CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHH
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~  348 (602)
                      ......+..|+|||++.+.. ++.++|||||||++|||++ |+.||...........+... .....+..++.++.+||.
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~  231 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVLMT  231 (254)
T ss_pred             CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCCCCCcCCHHHHHHHH
Confidence            12233467899999987655 8899999999999999997 99999876554444444332 333445678999999999


Q ss_pred             HHcccCCCCCCCHHHHhc
Q 007478          349 LCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       349 ~~L~~dP~~Rpt~~eiL~  366 (602)
                      +||..+|++||+++++++
T Consensus       232 ~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         232 SCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.3e-39  Score=326.37  Aligned_cols=250  Identities=31%  Similarity=0.497  Sum_probs=204.5

Q ss_pred             CCceEeeeEeecCCeEEEEEEECC----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc--c
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSD----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV--E  186 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~--~  186 (602)
                      .+|++.+.||+|+||.||+|.+..    +++.||||+++.....   .....+.+|+++++.++|+||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            568888999999999999998653    4789999998752221   346778999999999999999999998876  5


Q ss_pred             ceEEEEEeeecCCChhhhhhccC-CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                      ...++||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            67999999999999999997654 68999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCc----ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh--------------HHHHHHhh
Q 007478          266 GQSCPL----SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--------------VAAMFKIG  327 (602)
Q Consensus       266 ~~~~~~----~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~--------------~~~~~~i~  327 (602)
                      ......    ...++..|++||.+.+.. ++.++|||||||++|||++|+.||.....              ...+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            332211    123556799999987655 88999999999999999999999864321              11122222


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       328 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ........+..++.++.+|+.+||..+|++||++.||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            222223345678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=330.35  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=191.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCC---CcEEEEEEEecccchhcHHH-------HHHHHHHHHHHHhcCCCcEEEEec
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDS---GEMCAMKEVTLFDDAKSKES-------AKQLMQEIVLLSRLRHPNIVQYYG  181 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~-------~~~l~~Ei~iL~~l~HpnIv~l~~  181 (602)
                      ..+|++.++||+|+||+||+|.+..+   +..+|+|+..........+.       ......++..+..++|+||+.+++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46899999999999999999998877   66777776543221111110       112233445566779999999998


Q ss_pred             cccccc----eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEec
Q 007478          182 SKTVED----KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLAD  257 (602)
Q Consensus       182 ~~~~~~----~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~D  257 (602)
                      ++....    ..+++||++ ..++.+++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             eeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence            755433    347788877 356777776655678889999999999999999999999999999999999999999999


Q ss_pred             cCccccccCCC--------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHH-------
Q 007478          258 FGMAKHIAGQS--------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA-------  322 (602)
Q Consensus       258 FGla~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~-------  322 (602)
                      ||+|+.+....        ......||+.|+|||++.+.. ++.++|||||||+||||++|+.||........       
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~  248 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC  248 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence            99998764221        122356999999999987665 89999999999999999999999976532111       


Q ss_pred             --HHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          323 --MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       323 --~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                        +..+...+.   ....++.++.++++.||..+|++||++++|++
T Consensus       249 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        249 DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              112221111   12467899999999999999999999999975

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.8e-38  Score=322.75  Aligned_cols=249  Identities=23%  Similarity=0.387  Sum_probs=201.7

Q ss_pred             ceEeeeEeecCCeEEEEEEECC---CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc----
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSD---SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED----  187 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~----  187 (602)
                      |++.++||+|+||.||+|.++.   +++.||||++...  .......+++.+|++++++++||||+++++++...+    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD--IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc--cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            6778899999999999998653   5789999988642  223334567889999999999999999999775432    


Q ss_pred             --eEEEEEeeecCCChhhhhhcc------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccC
Q 007478          188 --KLYIYLEYVSGGSIYKLLQDY------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFG  259 (602)
Q Consensus       188 --~~~lVmE~~~ggsL~~~l~~~------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFG  259 (602)
                        ..++++||+.+|+|.+++...      ..++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccc
Confidence              347889999999998887421      247888999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC---CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCC
Q 007478          260 MAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTI  335 (602)
Q Consensus       260 la~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  335 (602)
                      +++.......   .....++..|++||.+.... ++.++|||||||++|||++ |++||...+.......+..... ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~  236 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-LKQ  236 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-CCC
Confidence            9987643321   12234567899999987654 8889999999999999999 9999987665544444433322 234


Q ss_pred             CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       336 p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      +..++..+.+|+.+||..+|++||++.+++++
T Consensus       237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            45788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=333.68  Aligned_cols=256  Identities=28%  Similarity=0.403  Sum_probs=206.8

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC--CCc----EEEEeccc
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR--HPN----IVQYYGSK  183 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~--Hpn----Iv~l~~~~  183 (602)
                      ....+|++.++||+|+||.|-.+.+..++..||||+++...     ...+.-+-|+++|.++.  .|+    +|.+.++|
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            34678999999999999999999999999999999987421     12233456899999993  232    78899999


Q ss_pred             cccceEEEEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc------------
Q 007478          184 TVEDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP------------  249 (602)
Q Consensus       184 ~~~~~~~lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~------------  249 (602)
                      +..+..|||+|.+ |-+++++|+++  .+++...++.++.||+.+++|||+++++|-||||||||+..            
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            9999999999998 77999999875  46889999999999999999999999999999999999932            


Q ss_pred             --------CCceEEeccCccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh--
Q 007478          250 --------NGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--  319 (602)
Q Consensus       250 --------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~--  319 (602)
                              +-.|||+|||.|+......  .+.+.|..|+|||++++-. ++..+||||+||||+||++|...|..-++  
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    2258999999998755443  5678999999999999765 99999999999999999999999975443  


Q ss_pred             -HHHHHHhhCCCC----------------CCCCC-------------------------CCCCHHHHHHHHHHcccCCCC
Q 007478          320 -VAAMFKIGNSKE----------------LPTIP-------------------------DDLSDEGKDFIRLCLQRNPLN  357 (602)
Q Consensus       320 -~~~~~~i~~~~~----------------~~~~p-------------------------~~~s~~l~dLI~~~L~~dP~~  357 (602)
                       ...+.+|.....                .-.++                         +..-.++.|||++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence             334444322100                00000                         011235779999999999999


Q ss_pred             CCCHHHHhcCccccCCC
Q 007478          358 RPTAAELLDHPFVKGAA  374 (602)
Q Consensus       358 Rpt~~eiL~hp~f~~~~  374 (602)
                      |+|+.|+|.||||+...
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998653

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=324.47  Aligned_cols=260  Identities=28%  Similarity=0.448  Sum_probs=215.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHH-HHhcCCCcEEEEeccccccceEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL-LSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      .++.+-...||.|+||+|++-.++.+|+..|||.|+....   ....+++..|... ++.-+.||||++||.+..++..|
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence            4556667889999999999999999999999999985332   2334566667664 55568999999999999999999


Q ss_pred             EEEeeecCCChhhhhh-----ccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          191 IYLEYVSGGSIYKLLQ-----DYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~-----~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                      |.||+| ..+|..+.+     +...++|..+-.|....+.||.||-+ .+||||||||+||||+..|.+||||||++..+
T Consensus       140 iCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  140 ICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             eeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            999999 466665543     24578999888999999999999986 58999999999999999999999999999887


Q ss_pred             cCCCCCcccCCCCCCCCcccccccC-CCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC-----CC
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSS-GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP-----DD  338 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~-~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-----~~  338 (602)
                      .+.-......|...|||||.+.... +|+.++||||||++|||++||+.||.+++.......+......|.+.     -.
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~  298 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH  298 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence            7665555667999999999996543 49999999999999999999999999887755544444444444322     13


Q ss_pred             CCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       339 ~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ++..+..||..||.+|-..||...+++++||++..+.
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            7899999999999999999999999999999986543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=336.64  Aligned_cols=251  Identities=28%  Similarity=0.408  Sum_probs=209.4

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ..+...++++||+|-||.|.+|.-.. +..||||.++.   ...+...+.|.+||++|.+|+|||||.++|+|..++-++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~---~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRP---DATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCc---ccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            45667889999999999999997643 68999998874   233444688999999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCC--CChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          191 IYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~--ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      +|+||+++|+|.+++.++..  .......+|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+-...
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence            99999999999999987632  3445567799999999999999999999999999999999999999999999765443


Q ss_pred             CCc---ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh--CCCCCCCchhHHHHHHhhC------CCCCCCCCC
Q 007478          269 CPL---SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAAMFKIGN------SKELPTIPD  337 (602)
Q Consensus       269 ~~~---~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt--G~~Pf~~~~~~~~~~~i~~------~~~~~~~p~  337 (602)
                      .+.   ..+-...|||+|.|..++ ++.++|+|+||++|||+++  .+.||.+..+.........      .......|.
T Consensus       692 yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence            221   233457899999998777 9999999999999999865  8899987766554443221      222335577


Q ss_pred             CCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          338 DLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       338 ~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      -|+.++.+||.+||.+|-++||+++++-.
T Consensus       771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            89999999999999999999999999854

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-41  Score=324.89  Aligned_cols=260  Identities=25%  Similarity=0.454  Sum_probs=210.9

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE----  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~----  186 (602)
                      ..+.|+...+||+|.||.||+|+.+.+|+.||+|++-.... + ......-.+|+++|..|+|+|++.+++.|...    
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-K-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-K-EGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-c-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            35678889999999999999999999999999997643111 1 11223456899999999999999999887542    


Q ss_pred             ----ceEEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcc
Q 007478          187 ----DKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA  261 (602)
Q Consensus       187 ----~~~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla  261 (602)
                          ..+|+||.+|+ -+|+-+|... .+|+..+++.++.+++.||.|+|++.|+|||+|++|+||+.+|.+||+|||++
T Consensus        93 ~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence                35999999996 6888888765 68999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-----CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhC--CCCCCC
Q 007478          262 KHIAGQS-----CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPT  334 (602)
Q Consensus       262 ~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~--~~~~~~  334 (602)
                      +.+....     .+...+-|++|++||.+.+...|+.+.|||..||||.||.++.+.|.+.....++..|..  +...++
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            7664322     122344699999999999999999999999999999999999999987665544443321  001111


Q ss_pred             ------------------CCC-------------CCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          335 ------------------IPD-------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       335 ------------------~p~-------------~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                                        ++.             .-.+++.+|++++|..||.+|+++++++.|.||...
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence                              111             124588899999999999999999999999999753

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=353.08  Aligned_cols=258  Identities=35%  Similarity=0.662  Sum_probs=223.3

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccc----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTV----  185 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~----  185 (602)
                      ....|++.++||.|.+|.||+++++.+|+.+|+|+.....+     ..+++..|+++|+.+ .|||++.+||+|.-    
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            45679999999999999999999999999999998865322     223456788999888 79999999998743    


Q ss_pred             -cceEEEEEeeecCCChhhhhhc--cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          186 -EDKLYIYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       186 -~~~~~lVmE~~~ggsL~~~l~~--~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                       ++.+|||||||.||+..|+++.  ..++.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||++.
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA  171 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence             5789999999999999999975  3578899999999999999999999999999999999999999999999999998


Q ss_pred             cccCC-CCCcccCCCCCCCCcccccccC----CCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCC-CCC
Q 007478          263 HIAGQ-SCPLSFKGSPYWMAPEVIKNSS----GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-TIP  336 (602)
Q Consensus       263 ~~~~~-~~~~~~~GT~~Y~APEvl~~~~----~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p  336 (602)
                      ++... ...++.+||++|||||++.-..    .|+..+|+||||++..||..|.+|+-++-....+++|....... .-|
T Consensus       172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp  251 (953)
T KOG0587|consen  172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP  251 (953)
T ss_pred             eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccch
Confidence            87643 3456788999999999996332    36779999999999999999999999998888888886533221 225


Q ss_pred             CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       337 ~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      ...+.++.+||..||.+|-++||+..++|+|||++..
T Consensus       252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             hhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            6788999999999999999999999999999999854

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=335.90  Aligned_cols=262  Identities=26%  Similarity=0.422  Sum_probs=216.3

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccch---hcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc-c
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA---KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV-E  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~---~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~-~  186 (602)
                      ..++|-++.+||+|||+.||+|++....++||||+-.+....   +.....+...+|..|.+.|+||.||++|++|.- .
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            346788889999999999999999998999999976543222   222334567899999999999999999999864 5


Q ss_pred             ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccC--CceecCCCCCcEEEcc---CCceEEeccCcc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK--HTVHRDIKGANILVDP---NGRVKLADFGMA  261 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~--gIvHrDLKp~NILl~~---~g~vKL~DFGla  261 (602)
                      +.+|-|+|||+|.+|.-+|+.++-+++.+++.|+.||+.||.||.+.  .|||-||||.||||..   -|.+||+||||+
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            67899999999999999999999999999999999999999999986  5999999999999943   478999999999


Q ss_pred             ccccCCCCC--------cccCCCCCCCCccccccc---CCCCccccchhhhhHHHHHhhCCCCCCCchh---HHHHHHhh
Q 007478          262 KHIAGQSCP--------LSFKGSPYWMAPEVIKNS---SGCNLAVDIWSLGCTVLEMATTKPPWSQYEG---VAAMFKIG  327 (602)
Q Consensus       262 ~~~~~~~~~--------~~~~GT~~Y~APEvl~~~---~~~s~~sDVWSLGviLyELltG~~Pf~~~~~---~~~~~~i~  327 (602)
                      +.+.++...        ....||.||++||++.-.   +..+.++||||+|||+|.++.|+.||.....   +.....|.
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            998765432        235699999999998533   3467899999999999999999999975432   22222333


Q ss_pred             CCCCCCCCC--CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          328 NSKELPTIP--DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       328 ~~~~~~~~p--~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      +.... .||  +.++.++++||++||++.-++|..+.++..||||...
T Consensus       701 kAtEV-qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  701 KATEV-QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             cceec-cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            32222 233  4689999999999999999999999999999999763

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=352.76  Aligned_cols=244  Identities=31%  Similarity=0.515  Sum_probs=199.4

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc-----
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED-----  187 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~-----  187 (602)
                      -.|...+.||+|+||.||+++++.+|+.||||.++...   .....+...+|+++|++|+|+|||+++++-++..     
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            35788899999999999999999999999999887532   2334566789999999999999999999876543     


Q ss_pred             -eEEEEEeeecCCChhhhhhc---cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEc--cCC--ceEEeccC
Q 007478          188 -KLYIYLEYVSGGSIYKLLQD---YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVD--PNG--RVKLADFG  259 (602)
Q Consensus       188 -~~~lVmE~~~ggsL~~~l~~---~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~--~~g--~vKL~DFG  259 (602)
                       .-.+|||||.||+|+.+|.+   +..+++.+++.++.++..||.|||++|||||||||+||++-  .+|  ..||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence             46899999999999999974   46799999999999999999999999999999999999983  223  57999999


Q ss_pred             ccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH----HHHHHhhCCCC----
Q 007478          260 MAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV----AAMFKIGNSKE----  331 (602)
Q Consensus       260 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~----~~~~~i~~~~~----  331 (602)
                      .|+.+..+....++.||+.|++||++.+..+|+..+|.|||||++|+++||..||....+.    ..+..+...+.    
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            9999999988889999999999999986566999999999999999999999999533222    22322221110    


Q ss_pred             ---------------CCCCCCCCCHHH----HHHHHHHcccCCCCCC
Q 007478          332 ---------------LPTIPDDLSDEG----KDFIRLCLQRNPLNRP  359 (602)
Q Consensus       332 ---------------~~~~p~~~s~~l----~dLI~~~L~~dP~~Rp  359 (602)
                                     .-.++..++..+    ..++..+|..++++|.
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                           001233444443    3567788999999998

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-39  Score=341.07  Aligned_cols=245  Identities=28%  Similarity=0.479  Sum_probs=211.5

Q ss_pred             eEeeeEeecCCeEEEEEEECCC----CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEE
Q 007478          116 KKGKMLGRGTFGHVYVGFNSDS----GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       116 ~~~~~LG~G~fG~Vy~a~~~~t----g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .+.++||+|-||.||+|++..-    .-.||||..+...   ..+..+.|+.|..+|+.++|||||+++|+|.+ .-+||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            3457899999999999987542    3458889877532   23346789999999999999999999999985 45999


Q ss_pred             EEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      |||+++-|.|..+|+.+ ..++...+..++.||+.||.|||++.+|||||...|||+....-|||+||||++.+..+..+
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            99999999999999864 46888899999999999999999999999999999999999999999999999998877655


Q ss_pred             cccCCC--CCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHH
Q 007478          271 LSFKGS--PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       271 ~~~~GT--~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI  347 (602)
                      ....|-  ..|||||-+.-.. ++.++|||-|||+|||++. |..||.+.++.+.+..+.++..+| .|++|++.+..|+
T Consensus       548 kaS~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP-~P~nCPp~LYslm  625 (974)
T KOG4257|consen  548 KASRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP-CPPNCPPALYSLM  625 (974)
T ss_pred             hccccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC-CCCCCChHHHHHH
Confidence            544443  4799999996544 9999999999999999887 999999988888888887776654 5889999999999


Q ss_pred             HHHcccCCCCCCCHHHHhc
Q 007478          348 RLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .+||.+||.+||.+.+|..
T Consensus       626 skcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  626 SKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHhccCcccCCcHHHHHH
Confidence            9999999999999988764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=344.04  Aligned_cols=257  Identities=25%  Similarity=0.434  Sum_probs=223.2

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCC-C--cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDS-G--EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~t-g--~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      ..+++.+++++||+|.||+|++|.++.- |  ..||||+++...   .......|.+|+.+|.+|+|+|+|+|||+..+ 
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~---l~~~mddflrEas~M~~L~H~hliRLyGvVl~-  182 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS---LNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-  182 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc---cchhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence            3456788899999999999999988753 3  468999987422   22267889999999999999999999999887 


Q ss_pred             ceEEEEEeeecCCChhhhhhc--cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~--~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                      ..+.||||++++|+|.+.|.+  ...|-...+..|+.||+.|+.||..+++|||||...||||.....||||||||.+.+
T Consensus       183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence            668999999999999999986  356888899999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCcccCC----CCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCC
Q 007478          265 AGQSCPLSFKG----SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDL  339 (602)
Q Consensus       265 ~~~~~~~~~~G----T~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  339 (602)
                      ...+.++.+.+    ...|+|||.|.... ++.++|||++||+||||++ |+.||.+......+.+|... ..-.-|..|
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-erLpRPk~c  340 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-ERLPRPKYC  340 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-ccCCCCCCC
Confidence            88877775543    35799999998776 9999999999999999999 99999999998888888744 444558899


Q ss_pred             CHHHHHHHHHHcccCCCCCCCHHHHhcCccccC
Q 007478          340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       340 s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~  372 (602)
                      +++++++++.||..+|++|||+..|.+.-+...
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            999999999999999999999999976544443

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.6e-37  Score=347.61  Aligned_cols=257  Identities=24%  Similarity=0.307  Sum_probs=181.8

Q ss_pred             CCCCCCceEeeeEeecCCeEEEEEEECCC----CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecc--
Q 007478          109 VSPESHWKKGKMLGRGTFGHVYVGFNSDS----GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGS--  182 (602)
Q Consensus       109 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~t----g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~--  182 (602)
                      ....++|++.+.||+|+||.||+|++..+    +..||+|++.....   .   +....|  .+....+.+++.++..  
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~---e~~~~e--~l~~~~~~~~~~~~~~~~  199 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---V---EIWMNE--RVRRACPNSCADFVYGFL  199 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---h---HHHHHH--HHHhhchhhHHHHHHhhh
Confidence            34567999999999999999999999988    99999998753111   1   111111  1122222222222221  


Q ss_pred             ----ccccceEEEEEeeecCCChhhhhhccCC--------------------CChHHHHHHHHHHHHHHhhhccCCceec
Q 007478          183 ----KTVEDKLYIYLEYVSGGSIYKLLQDYGQ--------------------FGEPAIRNYTQQILSGLAFLHSKHTVHR  238 (602)
Q Consensus       183 ----~~~~~~~~lVmE~~~ggsL~~~l~~~~~--------------------ls~~~i~~i~~qIl~aL~yLH~~gIvHr  238 (602)
                          ...+..++|||||+.+++|.+++.....                    .....+..++.||+.||+|||++||+||
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence                2456679999999999999999875321                    1233467899999999999999999999


Q ss_pred             CCCCCcEEEcc-CCceEEeccCccccccCC--CCCcccCCCCCCCCcccccccC---------------------CCCcc
Q 007478          239 DIKGANILVDP-NGRVKLADFGMAKHIAGQ--SCPLSFKGSPYWMAPEVIKNSS---------------------GCNLA  294 (602)
Q Consensus       239 DLKp~NILl~~-~g~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APEvl~~~~---------------------~~s~~  294 (602)
                      ||||+|||++. ++.+||+|||+|+.+...  .....++||+.|||||++....                     .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999986 579999999999865432  2234567999999999764221                     23456


Q ss_pred             ccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC--------------CCCC------CCCCCCCHHHHHHHHHHcccC
Q 007478          295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--------------KELP------TIPDDLSDEGKDFIRLCLQRN  354 (602)
Q Consensus       295 sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~--------------~~~~------~~p~~~s~~l~dLI~~~L~~d  354 (602)
                      +||||||||||||+++..++...  ...+.++...              ...+      .+.+.....+.+||++||++|
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            79999999999999987765432  1111111110              0000      111123345669999999999


Q ss_pred             CCCCCCHHHHhcCccccCCCc
Q 007478          355 PLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       355 P~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      |++|||+.|+|+||||++...
T Consensus       438 P~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        438 GRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             cccCCCHHHHhCCcCcCCCCc
Confidence            999999999999999998655

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=347.49  Aligned_cols=252  Identities=27%  Similarity=0.458  Sum_probs=223.4

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCC---cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSG---EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      ..+..++.++||.|.||.|++|+.+..|   ..||||.++.   ........+|+.|+.||-+.+||||++|.|+.....
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~---GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA---GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc---CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            3456678899999999999999988765   5799998874   233445678999999999999999999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          188 KLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      -++||.|||++|+|..+|++ .++|+.-++..+++.|+.|++||-+.|.|||||...|||++.+-.+|++||||++.+.+
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            99999999999999999976 47899999999999999999999999999999999999999999999999999998865


Q ss_pred             CC-CCcccC-C--CCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCH
Q 007478          267 QS-CPLSFK-G--SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSD  341 (602)
Q Consensus       267 ~~-~~~~~~-G--T~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  341 (602)
                      +. ..++.. |  ...|.|||.|...+ ++.++||||+|++|||.++ |..||.++.+.+.+..|.....+|. |-+|+.
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-PmDCP~  861 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-PMDCPA  861 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC-CCCCcH
Confidence            54 222222 2  36899999998766 9999999999999999887 9999999999999999988877765 679999


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          342 EGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       342 ~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .+.+|+..||++|-.+||.+.||+.+
T Consensus       862 aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            99999999999999999999999873

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.2e-37  Score=303.44  Aligned_cols=242  Identities=40%  Similarity=0.713  Sum_probs=206.3

Q ss_pred             CCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCChhhh
Q 007478          125 TFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKL  204 (602)
Q Consensus       125 ~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~  204 (602)
                      +||.||+|++..+|+.+|+|++......   ...+.+.+|++.+++++|+||+++++++......+++|||+.+++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            5899999999988999999998642221   1157888999999999999999999999988999999999999999999


Q ss_pred             hhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCCCCCCCCccc
Q 007478          205 LQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEV  284 (602)
Q Consensus       205 l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEv  284 (602)
                      +.....++...+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||++.............++..|++||+
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~  157 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV  157 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHH
Confidence            98766689999999999999999999999999999999999999999999999999988766544456678999999999


Q ss_pred             ccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCC--CCHHHHHHHHHHcccCCCCCCCHH
Q 007478          285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD--LSDEGKDFIRLCLQRNPLNRPTAA  362 (602)
Q Consensus       285 l~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~s~~l~dLI~~~L~~dP~~Rpt~~  362 (602)
                      +.+.. ++.++||||||+++|+|++|..||........+...............  ++.++.+++.+||..+|++||++.
T Consensus       158 ~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~  236 (244)
T smart00220      158 LLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE  236 (244)
T ss_pred             HccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence            87554 788999999999999999999999873333333333332222222222  889999999999999999999999


Q ss_pred             HHhcCccc
Q 007478          363 ELLDHPFV  370 (602)
Q Consensus       363 eiL~hp~f  370 (602)
                      ++++||||
T Consensus       237 ~~~~~~~~  244 (244)
T smart00220      237 EALQHPFF  244 (244)
T ss_pred             HHhhCCCC
Confidence            99999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-38  Score=332.84  Aligned_cols=245  Identities=25%  Similarity=0.449  Sum_probs=209.9

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEe
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE  194 (602)
                      .....+||-|.||.||.|+++.-.-.||||.++.     +.-..++|+.|+.+|+.++|||+|+|+|+|..+.-+|||.|
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            3345689999999999999999889999998863     33457789999999999999999999999999999999999


Q ss_pred             eecCCChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc-
Q 007478          195 YVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-  271 (602)
Q Consensus       195 ~~~ggsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~-  271 (602)
                      ||..|+|.+||+++.  .++.-.++.++.||..|++||..+++|||||...|+|+.++..||++||||++.+.++.... 
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH  423 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH  423 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence            999999999998764  36666778999999999999999999999999999999999999999999999987654321 


Q ss_pred             -ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHH
Q 007478          272 -SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       272 -~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~  349 (602)
                       ...-...|.|||-+.... ++.|+|||+|||+|||+.| |..||.+.+....+..+.+ .....-|..|++...+||+.
T Consensus       424 AGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM~~PeGCPpkVYeLMra  501 (1157)
T KOG4278|consen  424 AGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRMDGPEGCPPKVYELMRA  501 (1157)
T ss_pred             cCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-cccccCCCCCCHHHHHHHHH
Confidence             223456799999997655 8899999999999999998 9999998765444443333 33345678999999999999


Q ss_pred             HcccCCCCCCCHHHHhc
Q 007478          350 CLQRNPLNRPTAAELLD  366 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~  366 (602)
                      ||+++|.+||++.||-+
T Consensus       502 CW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  502 CWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HhcCCcccCccHHHHHH
Confidence            99999999999998753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.5e-38  Score=305.68  Aligned_cols=254  Identities=26%  Similarity=0.448  Sum_probs=213.7

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEecccccc--c
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVE--D  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~--~  187 (602)
                      ..++|++.+++|+|.|+.||.|++..+++.++||+++.       -..+.+.+|++||..|. ||||++++++..+.  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            45789999999999999999999999999999999873       22466889999999996 99999999988764  4


Q ss_pred             eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC-CceEEeccCccccccC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~vKL~DFGla~~~~~  266 (602)
                      ...||+||+.+.+...+.   ..++..+++.++.||+.||.|||++||+|||+||.|++||.. ..++|+|+|||.++..
T Consensus       109 tpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  109 TPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             CchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            678999999887766654   468889999999999999999999999999999999999865 5799999999999988


Q ss_pred             CCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCC-CchhHHHHHHhhCCCC--------------
Q 007478          267 QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWS-QYEGVAAMFKIGNSKE--------------  331 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~-~~~~~~~~~~i~~~~~--------------  331 (602)
                      ....+..+.+.+|--||.+.....|+..-|+|||||+|..|+..+-||- +.++.+++.+|.....              
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            7777777788999999999988889999999999999999999988873 3334444333322100              


Q ss_pred             -CCCC--------------------CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          332 -LPTI--------------------PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       332 -~~~~--------------------p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                       .+.+                    ..-.++++.||+.++|.+|..+|+|+.|++.||||....
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence             0000                    012579999999999999999999999999999998654

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=314.65  Aligned_cols=258  Identities=27%  Similarity=0.447  Sum_probs=214.6

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc-----ce
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE-----DK  188 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~  188 (602)
                      +.+-.+-||.|+||+||.+.+..+|+.||+|++..  ...+-...+.+.+|+++|.-.+|.|++..++...-.     .+
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn--vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN--VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcch--HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            44556789999999999999999999999998753  344455678899999999999999999988865432     35


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                      +|++.|++ ..+|+++|-.-..++.+.++-+++||++||+|||+.||+||||||.|+|++.+..+||||||+++....+.
T Consensus       132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            88999998 57999999888899999999999999999999999999999999999999999999999999999876544


Q ss_pred             CCc--ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC--------------
Q 007478          269 CPL--SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--------------  332 (602)
Q Consensus       269 ~~~--~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~--------------  332 (602)
                      ...  ..+-|.+|+|||++++...|+.++||||+|||+.||+..+..|...+.+.++..|......              
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            332  3457899999999999999999999999999999999999999766555544433221111              


Q ss_pred             ----------CCC--------CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCC
Q 007478          333 ----------PTI--------PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       333 ----------~~~--------p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                                |.+        +..-..+..+++..+|..||.+|.+.++++.|++....+
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                      111        123455788999999999999999999999999987654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-36  Score=333.47  Aligned_cols=263  Identities=21%  Similarity=0.291  Sum_probs=191.6

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEEC----------------CCCcEEEEEEEecccchhcHH----------HHHHHHH
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNS----------------DSGEMCAMKEVTLFDDAKSKE----------SAKQLMQ  163 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~----------------~tg~~vAvK~i~~~~~~~~~~----------~~~~l~~  163 (602)
                      ...++|++.++||+|+||+||+|...                ..++.||||.++........+          ..+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            45779999999999999999999752                235689999986422111111          1122345


Q ss_pred             HHHHHHhcCCCcE-----EEEeccccc--------cceEEEEEeeecCCChhhhhhccC---------------------
Q 007478          164 EIVLLSRLRHPNI-----VQYYGSKTV--------EDKLYIYLEYVSGGSIYKLLQDYG---------------------  209 (602)
Q Consensus       164 Ei~iL~~l~HpnI-----v~l~~~~~~--------~~~~~lVmE~~~ggsL~~~l~~~~---------------------  209 (602)
                      |+.++.+++|.++     ++++++|..        ++..||||||+++++|.+++....                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777788876654     566666542        356899999999999999886421                     


Q ss_pred             ---CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCccc--CCCCCCCCccc
Q 007478          210 ---QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF--KGSPYWMAPEV  284 (602)
Q Consensus       210 ---~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~--~GT~~Y~APEv  284 (602)
                         .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+.........  .+|+.|+|||+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence               2345678899999999999999999999999999999999999999999999765433322222  34889999999


Q ss_pred             ccccCC---------------------CCccccchhhhhHHHHHhhCCC-CCCCchhHHHH-----------HHhhCCCC
Q 007478          285 IKNSSG---------------------CNLAVDIWSLGCTVLEMATTKP-PWSQYEGVAAM-----------FKIGNSKE  331 (602)
Q Consensus       285 l~~~~~---------------------~s~~sDVWSLGviLyELltG~~-Pf~~~~~~~~~-----------~~i~~~~~  331 (602)
                      +.....                     ...+.||||+|||+|+|++|.. ||.........           ..+.....
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            853221                     1235799999999999999886 77542211111           11111111


Q ss_pred             CCCCCCCCCHHHHHHHHHHcccCC---CCCCCHHHHhcCccccC
Q 007478          332 LPTIPDDLSDEGKDFIRLCLQRNP---LNRPTAAELLDHPFVKG  372 (602)
Q Consensus       332 ~~~~p~~~s~~l~dLI~~~L~~dP---~~Rpt~~eiL~hp~f~~  372 (602)
                      .....+.++++++|||.+||.++|   .+|+|++|+|+||||..
T Consensus       462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            223345789999999999999876   68999999999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=305.65  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=212.7

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc-----
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE-----  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~-----  186 (602)
                      ..+|.-.+.+|.|+- .|.-|.+.-+++.||+|++...  .......++-.+|..++..+.|+||++++.+|.-.     
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            567888899999998 7888889889999999987542  22233456677999999999999999999987543     


Q ss_pred             -ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          187 -DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       187 -~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                       ..+|+||||| ..+|...+.  -.+.-..+..++.|+++|++|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus        93 ~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   93 FQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence             3689999999 578888876  357788999999999999999999999999999999999999999999999999866


Q ss_pred             CCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCC-----------
Q 007478          266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT-----------  334 (602)
Q Consensus       266 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------  334 (602)
                      ..-....++.|++|+|||++.+.. |...+||||+|||+.||++|+..|.+.+..++..++....+.+.           
T Consensus       170 ~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  170 TDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             cccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            654566788999999999998876 99999999999999999999999988777776666543221111           


Q ss_pred             ------------------CC-----------CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCcccc
Q 007478          335 ------------------IP-----------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       335 ------------------~p-----------~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~  371 (602)
                                        +|           ..-...+++|+.+||..||++|.+++++|.||||+
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                              11           12245688999999999999999999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=6.3e-37  Score=321.77  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=206.6

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC------CCcEEEEecccccc
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR------HPNIVQYYGSKTVE  186 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~------HpnIv~l~~~~~~~  186 (602)
                      .+|.+....|+|-|++|.+|.+...|..||||+|..     +.-..+.=++|+.||+.|.      --|+++|+-.|...
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-----NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-----NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-----chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            567888889999999999999999999999999974     2333445568999999995      34789999999999


Q ss_pred             ceEEEEEeeecCCChhhhhhccC---CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC-ceEEeccCccc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYG---QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-RVKLADFGMAK  262 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~---~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~vKL~DFGla~  262 (602)
                      +++|||+|-+ ..+|.++|++++   .|....++.|+.||+.||..|-.+||+|.||||.||||++.. .+||||||.|.
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence            9999999988 589999999876   478889999999999999999999999999999999998764 68999999998


Q ss_pred             cccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCC----------
Q 007478          263 HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL----------  332 (602)
Q Consensus       263 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~----------  332 (602)
                      .+..+.. ..+.-+..|.|||+|.+.. |++..|+||+||+||||+||+..|.+..+..++...+..+..          
T Consensus       586 ~~~enei-tPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq  663 (752)
T KOG0670|consen  586 FASENEI-TPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ  663 (752)
T ss_pred             ccccccc-cHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence            8765543 3445677899999999887 999999999999999999999999876543333221111000          


Q ss_pred             ---------------------------------------------CCCCC---CCCHHHHHHHHHHcccCCCCCCCHHHH
Q 007478          333 ---------------------------------------------PTIPD---DLSDEGKDFIRLCLQRNPLNRPTAAEL  364 (602)
Q Consensus       333 ---------------------------------------------~~~p~---~~s~~l~dLI~~~L~~dP~~Rpt~~ei  364 (602)
                                                                   +.++.   .+-.++++|+.+||..||++|.|..|+
T Consensus       664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA  743 (752)
T KOG0670|consen  664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA  743 (752)
T ss_pred             hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence                                                         00111   122467899999999999999999999


Q ss_pred             hcCccccC
Q 007478          365 LDHPFVKG  372 (602)
Q Consensus       365 L~hp~f~~  372 (602)
                      |+||||..
T Consensus       744 L~HpFi~~  751 (752)
T KOG0670|consen  744 LKHPFITE  751 (752)
T ss_pred             hcCCcccC
Confidence            99999974

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=324.65  Aligned_cols=259  Identities=41%  Similarity=0.699  Sum_probs=223.2

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  190 (602)
                      ...+|++...+|.|+||.||+|+++.+++..|+|+|+....    +...-+.+|+-+++..+|||||.+++.+.-.+.++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC----ccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            45789999999999999999999999999999999987332    33556778999999999999999999999999999


Q ss_pred             EEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC-CC
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SC  269 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~  269 (602)
                      |+||||.||+|.+..+-.+.+++.++....+..+.||+|||++|=+|||||-.|||+++.|.+||+|||.+-.+... ..
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            99999999999999988899999999999999999999999999999999999999999999999999998766432 33


Q ss_pred             CcccCCCCCCCCcccc--cccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCC-CCCC--CCCCCHHHH
Q 007478          270 PLSFKGSPYWMAPEVI--KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-LPTI--PDDLSDEGK  344 (602)
Q Consensus       270 ~~~~~GT~~Y~APEvl--~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~-~~~~--p~~~s~~l~  344 (602)
                      ...+.||++|||||+-  ....+|...+|||++|+...|+-.-++|-.+.-....++..-+... .+.+  +...++.+.
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh  248 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH  248 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence            4578899999999985  3445699999999999999999998888655544444444333332 2222  235788999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      +|++.+|.++|.+||+++.+|.|||+...
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc
Confidence            99999999999999999999999999865

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-35  Score=329.75  Aligned_cols=250  Identities=29%  Similarity=0.491  Sum_probs=207.5

Q ss_pred             CCceEeeeEeecCCeEEEEEEECC-------CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecccc
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSD-------SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKT  184 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~  184 (602)
                      ++.++.+.||+|.||.|++|....       ....||||.++...  . ....+.++.|+++|+.+ .|+||+.++|++.
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~-~~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--S-SSEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--C-cHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            444667799999999999996431       14579999876422  2 25577899999999999 6999999999999


Q ss_pred             ccceEEEEEeeecCCChhhhhhccC----------------CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEc
Q 007478          185 VEDKLYIYLEYVSGGSIYKLLQDYG----------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVD  248 (602)
Q Consensus       185 ~~~~~~lVmE~~~ggsL~~~l~~~~----------------~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~  248 (602)
                      ..+.+++|+||++.|+|.+++++++                .++..++..++.||+.|++||+++.+|||||...|||+.
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence            9999999999999999999998765                388899999999999999999999999999999999999


Q ss_pred             cCCceEEeccCccccccCCCCCcc--cCCCC--CCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHH
Q 007478          249 PNGRVKLADFGMAKHIAGQSCPLS--FKGSP--YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAM  323 (602)
Q Consensus       249 ~~g~vKL~DFGla~~~~~~~~~~~--~~GT~--~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~  323 (602)
                      .+..+||+|||+|+..........  -.||+  .|||||.+.... |+.++||||+||+|||+++ |..||.+......+
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~-ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV-FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc-ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence            999999999999996554443321  12323  499999998744 9999999999999999999 99999885422222


Q ss_pred             HHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          324 FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       324 ~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .+..........|..|+.++.+||+.||..+|++||++.++.+
T Consensus       532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            3333444455668899999999999999999999999999986

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=346.26  Aligned_cols=238  Identities=24%  Similarity=0.358  Sum_probs=187.2

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      .|+..++||+|+||.||+|+++.+++.||||+++.....        ...|++++++++|||||++++++.+.+..|+||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            455667899999999999999989999999988632211        124688899999999999999999999999999


Q ss_pred             eeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhc---cCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          194 EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH---SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH---~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      ||+++|+|.++++.   +++..+..++.||+.||+|||   +.+|+||||||+|||++.++..++. ||........   
T Consensus       763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            99999999999963   889999999999999999999   6799999999999999999888775 6665443222   


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchh----HHHHHHhh-CCC-----CCCCC-----
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMFKIG-NSK-----ELPTI-----  335 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~----~~~~~~i~-~~~-----~~~~~-----  335 (602)
                      ....||..|||||++.+.. ++.++|||||||++|||++|+.||.....    .....+.. ...     ..+.+     
T Consensus       836 ~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (968)
T PLN00113        836 TKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS  914 (968)
T ss_pred             CCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence            2336899999999997655 89999999999999999999999853211    11111100 000     00111     


Q ss_pred             -CCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          336 -PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       336 -p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                       ......++.+|+.+||+.||++||++.|+++.
T Consensus       915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence             11122357789999999999999999999874

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-34  Score=313.13  Aligned_cols=250  Identities=28%  Similarity=0.446  Sum_probs=210.1

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCC----cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSG----EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~  186 (602)
                      .+.+.+..++||+|+||+||+|.+--.|    .+||||++...   ........+++|+.+|.+|+|||+++|++++...
T Consensus       694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s  770 (1177)
T KOG1025|consen  694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIELLDEALRMASLDHPNLLRLLGVCMLS  770 (1177)
T ss_pred             hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence            4567788899999999999999875444    46888877542   2334456788999999999999999999999865


Q ss_pred             ceEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                      . +.||++|+++|.|.|+++. +..+.....+.|..||++||.|||++.+|||||...||||..-..+||.|||+++.+.
T Consensus       771 ~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  771 T-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             h-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            5 8999999999999999976 4679999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccC---CCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCCCCCCH
Q 007478          266 GQSCPLSFK---GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSD  341 (602)
Q Consensus       266 ~~~~~~~~~---GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  341 (602)
                      .+...+...   -...|||=|.+.... |+.++|||||||++||++| |..||.+....+.-..+.....+ .-|+.++-
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL-sqPpiCti  927 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL-SQPPICTI  927 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC-CCCCCccH
Confidence            766555433   246799999998766 9999999999999999999 99999876543333333333333 44779999


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          342 EGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       342 ~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      ++.-++.+||..|+..||+++++..
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHH
Confidence            9999999999999999999998875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=301.21  Aligned_cols=129  Identities=24%  Similarity=0.477  Sum_probs=112.9

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-----C---CcEEEEecccc
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-----H---PNIVQYYGSKT  184 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-----H---pnIv~l~~~~~  184 (602)
                      .+|.+.++||-|.|++||+|.+..+.+.||+|+++-     .....+.-+.||++|++++     |   .+||+|++.|.
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            689999999999999999999999999999999873     2233455678999999983     3   46999999986


Q ss_pred             c----cceEEEEEeeecCCChhhhhhc--cCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEE
Q 007478          185 V----EDKLYIYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILV  247 (602)
Q Consensus       185 ~----~~~~~lVmE~~~ggsL~~~l~~--~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl  247 (602)
                      .    ..++|||+|++ |.+|..+|+.  ++.++...++.|++||+.||.|||+ .||||-||||+|||+
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            5    45899999998 8899999975  4679999999999999999999996 699999999999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=275.14  Aligned_cols=221  Identities=29%  Similarity=0.495  Sum_probs=182.0

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~  190 (602)
                      .+....+..||+|+||.|=+.++..+|...|+|.+..  ...+ ...+++.+|+.+..+. .+|++|.+||.+..+..++
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~--tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA--TVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehh--hcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            4556677889999999999999999999999999874  2223 3345667788776554 8999999999999999999


Q ss_pred             EEEeeecCCChhhhh----hccCCCChHHHHHHHHHHHHHHhhhccC-CceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          191 IYLEYVSGGSIYKLL----QDYGQFGEPAIRNYTQQILSGLAFLHSK-HTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       191 lVmE~~~ggsL~~~l----~~~~~ls~~~i~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                      |.||.| ..+|..+.    ++.+.++|..+-+|+.-++.||.|||++ .|||||+||+||||+.+|+|||||||++-.+.
T Consensus       122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            999999 46776664    3457799999999999999999999986 89999999999999999999999999998876


Q ss_pred             CCCCCcccCCCCCCCCcccccc---cCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCC
Q 007478          266 GQSCPLSFKGSPYWMAPEVIKN---SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP  336 (602)
Q Consensus       266 ~~~~~~~~~GT~~Y~APEvl~~---~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p  336 (602)
                      +.-......|...|||||.+..   ..+|+.++||||||+++.||.+++.||.......+..+.......|.+|
T Consensus       201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp  274 (282)
T KOG0984|consen  201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP  274 (282)
T ss_pred             hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence            6554444668899999999852   3469999999999999999999999998876665555554444444444

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=322.02  Aligned_cols=243  Identities=34%  Similarity=0.506  Sum_probs=192.9

Q ss_pred             eeeEeecCCeEE-EEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEEEEEee
Q 007478          118 GKMLGRGTFGHV-YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       118 ~~~LG~G~fG~V-y~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      .+++|.|+-|+| |+|...  |+.||||.+-       .+...-..+||.+|+.- +|||||++|+...++..+||+.|+
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            456899988764 999875  7899999764       23345567899999988 699999999999999999999999


Q ss_pred             ecCCChhhhhhccC-C---CChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc---C--CceEEeccCccccccC
Q 007478          196 VSGGSIYKLLQDYG-Q---FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP---N--GRVKLADFGMAKHIAG  266 (602)
Q Consensus       196 ~~ggsL~~~l~~~~-~---ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~---~--g~vKL~DFGla~~~~~  266 (602)
                      |. .+|.++++..+ .   ......+.++.|++.||++||+.+||||||||.||||+.   +  ..++|+|||+++.+..
T Consensus       585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            95 79999998741 1   111456889999999999999999999999999999976   3  4689999999999876


Q ss_pred             CCCC----cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCC-CCCCCCCCCCC
Q 007478          267 QSCP----LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNS-KELPTIPDDLS  340 (602)
Q Consensus       267 ~~~~----~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s  340 (602)
                      +...    .+..||-.|+|||++.... -+.++||||||||+|+.++ |..||.+.-..+.-  |... ..+..+.....
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~~~L~~L~~~~d  740 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGNYTLVHLEPLPD  740 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhhhh--hhcCccceeeeccCch
Confidence            5443    3456999999999998766 5679999999999999998 59999764332221  1111 11112222222


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       341 ~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      .+++|||.+||.+||..||++.++|.||||=..
T Consensus       741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             HHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            299999999999999999999999999999543

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=293.85  Aligned_cols=244  Identities=24%  Similarity=0.379  Sum_probs=192.4

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHh--cCCCcEEEEeccccccc--
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR--LRHPNIVQYYGSKTVED--  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~--l~HpnIv~l~~~~~~~~--  187 (602)
                      ....++.++||+|.||+||+|...  ++.||||++..       +..+.+.+|-+|.+.  +.|+||++|++..+...  
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~  279 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD  279 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence            556778899999999999999765  58999998863       334566777777665  58999999999866544  


Q ss_pred             --eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccC---------CceecCCCCCcEEEccCCceEEe
Q 007478          188 --KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK---------HTVHRDIKGANILVDPNGRVKLA  256 (602)
Q Consensus       188 --~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~---------gIvHrDLKp~NILl~~~g~vKL~  256 (602)
                        .++||+||.+.|+|.++|+.+ .+++....+++.-|++||+|||+-         .|+|||||..||||..|+.+.|+
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence              899999999999999999875 689999999999999999999962         69999999999999999999999


Q ss_pred             ccCccccccCCC---CCcccCCCCCCCCcccccccCCCC-----ccccchhhhhHHHHHhhCCC------------CCCC
Q 007478          257 DFGMAKHIAGQS---CPLSFKGSPYWMAPEVIKNSSGCN-----LAVDIWSLGCTVLEMATTKP------------PWSQ  316 (602)
Q Consensus       257 DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~s-----~~sDVWSLGviLyELltG~~------------Pf~~  316 (602)
                      |||||..+....   .....+||.+|||||++.+...+.     .+.||||+|.|||||++...            ||..
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            999998875332   223467999999999997655444     37899999999999998543            3321


Q ss_pred             ----chhHHHHH-HhhCCCCCCCCCCC-----CCHHHHHHHHHHcccCCCCCCCHHHHh
Q 007478          317 ----YEGVAAMF-KIGNSKELPTIPDD-----LSDEGKDFIRLCLQRNPLNRPTAAELL  365 (602)
Q Consensus       317 ----~~~~~~~~-~i~~~~~~~~~p~~-----~s~~l~dLI~~~L~~dP~~Rpt~~eiL  365 (602)
                          ....+.+. .....+..|.+++.     --..+++.|+.||+.|++.|.|+.=+.
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence                01122232 23344556666643     234678999999999999999986443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.3e-33  Score=292.51  Aligned_cols=256  Identities=29%  Similarity=0.449  Sum_probs=204.4

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECC---CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecccccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSD---SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVE  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~  186 (602)
                      ..+.|+.+++||+|.|++||++++..   ..+.||+|.+.....      ...+.+|+++|..+ .+.||+++.+++..+
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~------p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS------PSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC------chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            45679999999999999999998877   789999998865322      34578999999999 699999999999999


Q ss_pred             ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC-CceEEeccCcccccc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIA  265 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~vKL~DFGla~~~~  265 (602)
                      +.+.+||||++..+..+++..   ++..+++.+++.++.||.++|.+|||||||||+|+|.+.. +.-.|+|||||....
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999999888888754   6789999999999999999999999999999999999754 678999999996210


Q ss_pred             CC---------------------------------C------------CCcccCCCCCCCCcccccccCCCCccccchhh
Q 007478          266 GQ---------------------------------S------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSL  300 (602)
Q Consensus       266 ~~---------------------------------~------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSL  300 (602)
                      ..                                 .            ......||++|+|||++......+.++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            00                                 0            00113499999999999988888999999999


Q ss_pred             hhHHHHHhhCCCCCCCch-hHHHH------------HHhhC--CC-----------------------------------
Q 007478          301 GCTVLEMATTKPPWSQYE-GVAAM------------FKIGN--SK-----------------------------------  330 (602)
Q Consensus       301 GviLyELltG~~Pf~~~~-~~~~~------------~~i~~--~~-----------------------------------  330 (602)
                      |||+..+++++.||-... +...+            .+...  +.                                   
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            999999999999984211 11100            00000  00                                   


Q ss_pred             CCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       331 ~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      ......+..+..+.+|+.+||+.||.+|.|++++|+||||.....
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence            000011234568999999999999999999999999999996543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=299.96  Aligned_cols=204  Identities=26%  Similarity=0.393  Sum_probs=179.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHH----HHHHHHHHHHHHHhcC---CCcEEEEecccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE----SAKQLMQEIVLLSRLR---HPNIVQYYGSKT  184 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~----~~~~l~~Ei~iL~~l~---HpnIv~l~~~~~  184 (602)
                      .++|...+.||+|+||.|++|+++.+...|+||.|.+.....+..    ..-.+-.||+||..|+   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            356888899999999999999999999999999887532221111    1123557999999997   999999999999


Q ss_pred             ccceEEEEEeee-cCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccc
Q 007478          185 VEDKLYIYLEYV-SGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       185 ~~~~~~lVmE~~-~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~  263 (602)
                      +++.+||+||-- +|.+|+++|..+..++|.+++.|++||+.|+++||+.||||||||-|||.++.+|-+||+|||.|..
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            999999999975 5789999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCC
Q 007478          264 IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQ  316 (602)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~  316 (602)
                      .... ....++||..|.|||++.+..+.+..-|||+||++||.++...-||..
T Consensus       720 ~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            6543 356788999999999999999889999999999999999999988864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=2.2e-31  Score=255.33  Aligned_cols=212  Identities=42%  Similarity=0.728  Sum_probs=187.0

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCC
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGS  200 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggs  200 (602)
                      ||+|.+|.||++....+++.+++|++.......   ....+.+|+.+++.++|++|+++++++......+++|||+.|++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999998889999999987422111   45678899999999999999999999998899999999999999


Q ss_pred             hhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc-CCceEEeccCccccccCCC-CCcccCCCC
Q 007478          201 IYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLADFGMAKHIAGQS-CPLSFKGSP  277 (602)
Q Consensus       201 L~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~-~~~~~~GT~  277 (602)
                      |.+++... ..++...++.++.+++.+|++||++|++|+||+|.||+++. ++.++|+|||.+....... ......+..
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP  157 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence            99999875 57899999999999999999999999999999999999999 8999999999998765432 123345788


Q ss_pred             CCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCC
Q 007478          278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN  357 (602)
Q Consensus       278 ~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~  357 (602)
                      .|++||.+.....++.+.|+|+||+++|+|                                 ..+.+++..||..||++
T Consensus       158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~  204 (215)
T cd00180         158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK  204 (215)
T ss_pred             CccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCccc
Confidence            999999987653578899999999999999                                 78899999999999999


Q ss_pred             CCCHHHHhcCc
Q 007478          358 RPTAAELLDHP  368 (602)
Q Consensus       358 Rpt~~eiL~hp  368 (602)
                      ||++.++++|+
T Consensus       205 R~~~~~l~~~~  215 (215)
T cd00180         205 RPSAKEILEHL  215 (215)
T ss_pred             CcCHHHHhhCC
Confidence            99999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.4e-32  Score=284.07  Aligned_cols=246  Identities=28%  Similarity=0.454  Sum_probs=192.5

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHH--hcCCCcEEEEecccccc--
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS--RLRHPNIVQYYGSKTVE--  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~--~l~HpnIv~l~~~~~~~--  186 (602)
                      ...+..+.+.||+|.||.||+|.++  |+.||||++...+       .+.+.+|.+|..  .|+|+||+.|++.-..+  
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEecccc-------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            4567889999999999999999887  8899999986321       234456666665  56999999999875433  


Q ss_pred             --ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccC--------CceecCCCCCcEEEccCCceEEe
Q 007478          187 --DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK--------HTVHRDIKGANILVDPNGRVKLA  256 (602)
Q Consensus       187 --~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~--------gIvHrDLKp~NILl~~~g~vKL~  256 (602)
                        ..+|||.+|-+.|+|+|+|.+ ..++.....+++.-++.||++||..        .|.|||||..|||+..+|.+-|+
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence              369999999999999999988 5799999999999999999999952        59999999999999999999999


Q ss_pred             ccCccccccCCC-----CCcccCCCCCCCCcccccccCCC----C-ccccchhhhhHHHHHhhC----------CCCCCC
Q 007478          257 DFGMAKHIAGQS-----CPLSFKGSPYWMAPEVIKNSSGC----N-LAVDIWSLGCTVLEMATT----------KPPWSQ  316 (602)
Q Consensus       257 DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~----s-~~sDVWSLGviLyELltG----------~~Pf~~  316 (602)
                      |+|||.......     ..+..+||..|||||++...-..    + ..+||||||.||||++..          ++||.+
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            999997665432     23457899999999998643221    1 268999999999999752          478864


Q ss_pred             c----hhHHHHHHhh-CCCCCCCCCCCC--C---HHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          317 Y----EGVAAMFKIG-NSKELPTIPDDL--S---DEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       317 ~----~~~~~~~~i~-~~~~~~~~p~~~--s---~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .    ...+.+.++. ..+..|.+|...  .   ..+..||+.||..+|..|.|+-.|.+
T Consensus       439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            3    3355555543 334445555432  2   24567899999999999999987764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=8e-31  Score=256.90  Aligned_cols=207  Identities=39%  Similarity=0.678  Sum_probs=179.6

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEe
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE  194 (602)
                      |.+.+.||+|+||.||++.+..+++.+|+|.+......   ...+.+.+|+..++.++|+||+++++++......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence            67789999999999999999988999999998752211   246788899999999999999999999988899999999


Q ss_pred             eecCCChhhhhhccCC-CChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC--CCc
Q 007478          195 YVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--CPL  271 (602)
Q Consensus       195 ~~~ggsL~~~l~~~~~-ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~~~  271 (602)
                      |+.+++|.+++..... +++..+..++.+++.+|.|||+++++|+||++.||+++.++.++|+|||++.......  ...
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            9999999999987666 8999999999999999999999999999999999999999999999999998775543  334


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCC-chhHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQ-YEGVAAMF  324 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~-~~~~~~~~  324 (602)
                      ...++..|++||.+.....++.++|||+||+++|||++|+.||.. .+....+.
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~  211 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS  211 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence            456889999999984334477899999999999999999999977 44443333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=267.20  Aligned_cols=250  Identities=23%  Similarity=0.357  Sum_probs=204.1

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCC-----cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc-
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSG-----EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV-  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~-  185 (602)
                      ..++++..++-+|+||+||.|++++..     +.|-+|.++.   ..+.-....+..|..+|..+.|||+..+.+++.+ 
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~---~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ---HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh---cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            345777788999999999999877533     3344554431   2334456678899999999999999999997654 


Q ss_pred             cceEEEEEeeecCCChhhhhhcc--------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEec
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDY--------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLAD  257 (602)
Q Consensus       186 ~~~~~lVmE~~~ggsL~~~l~~~--------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~D  257 (602)
                      .+..++++.++.-|+|..+|..+        ..++..++..++.||++|++|||+.||||.||...|++||+.-++||+|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence            45678888999889999999733        2356677889999999999999999999999999999999999999999


Q ss_pred             cCccccccCCCCCc---ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCC
Q 007478          258 FGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELP  333 (602)
Q Consensus       258 FGla~~~~~~~~~~---~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~  333 (602)
                      =.+++.+-..+..-   ..--...||++|.+.+.. |+.++|||||||+||||+| |+.||.+.+..+...-++++..+.
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla  518 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA  518 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence            99998764332110   011245799999999877 9999999999999999999 999999988877777777766654


Q ss_pred             CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          334 TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       334 ~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      + |.+|++++..+|..||..+|++||+++|+..
T Consensus       519 Q-P~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  519 Q-PFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             C-CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            3 7799999999999999999999999999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-31  Score=258.85  Aligned_cols=256  Identities=24%  Similarity=0.347  Sum_probs=201.8

Q ss_pred             CCCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEecc-cccc
Q 007478          109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGS-KTVE  186 (602)
Q Consensus       109 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~-~~~~  186 (602)
                      ....+.|.+.+.||+|-||.+.+|.|+.+...+++|.+..     .....++|.+|...--.| .|.||+.-|++ |++.
T Consensus        20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-----p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-----PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-----chhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            3456789999999999999999999999999999998863     234467888998776666 58999998874 7778


Q ss_pred             ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc--CCceEEeccCccccc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP--NGRVKLADFGMAKHI  264 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~--~g~vKL~DFGla~~~  264 (602)
                      +.++++|||++-|+|..-+... .+.|...+.++.|+++||.|+|++++||||||.+||||-.  .-.|||||||+.+..
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            8899999999999999988764 5889999999999999999999999999999999999932  348999999999876


Q ss_pred             cCCCCCcccCCCCCCCCcccccccC----CCCccccchhhhhHHHHHhhCCCCCCCch----hHHHHHHhhC--CCCCCC
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSS----GCNLAVDIWSLGCTVLEMATTKPPWSQYE----GVAAMFKIGN--SKELPT  334 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~----~~s~~sDVWSLGviLyELltG~~Pf~~~~----~~~~~~~i~~--~~~~~~  334 (602)
                      +.....  ..-+..|.+||++....    .....+|||.||+|+|.+|+|++||....    ......+...  ....|.
T Consensus       174 g~tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  174 GTTVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             Cceehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence            433221  22456799999874322    24568999999999999999999996321    1222222222  223344


Q ss_pred             CCCCCCHHHHHHHHHHcccCCCCC---CCHHHHhcCccccC
Q 007478          335 IPDDLSDEGKDFIRLCLQRNPLNR---PTAAELLDHPFVKG  372 (602)
Q Consensus       335 ~p~~~s~~l~dLI~~~L~~dP~~R---pt~~eiL~hp~f~~  372 (602)
                      .-..+++.+..+.++-|..++++|   .++.......|...
T Consensus       252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            445689999999999999999999   67777777777654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=5e-31  Score=308.89  Aligned_cols=199  Identities=20%  Similarity=0.228  Sum_probs=148.0

Q ss_pred             hcCC-CcEEEEeccc-------cccceEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCceecCC
Q 007478          170 RLRH-PNIVQYYGSK-------TVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI  240 (602)
Q Consensus       170 ~l~H-pnIv~l~~~~-------~~~~~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDL  240 (602)
                      .++| .||+.++++|       ...+.++++|||+ +++|+++|.. ...+++.+++.|+.||+.||.|||++|||||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3344 4677777766       2234677888987 6799999975 356999999999999999999999999999999


Q ss_pred             CCCcEEEcc-------------------CCceEEeccCccccccCCC-----------------CCcccCCCCCCCCccc
Q 007478          241 KGANILVDP-------------------NGRVKLADFGMAKHIAGQS-----------------CPLSFKGSPYWMAPEV  284 (602)
Q Consensus       241 Kp~NILl~~-------------------~g~vKL~DFGla~~~~~~~-----------------~~~~~~GT~~Y~APEv  284 (602)
                      ||+||||+.                   ++.+||+|||+++......                 .....+||++|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            999999954                   4456677777765422100                 0112468999999999


Q ss_pred             ccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHH
Q 007478          285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL  364 (602)
Q Consensus       285 l~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~ei  364 (602)
                      +.+.. |+.++||||||||||||++|.+||......  +..+... ..+........+..+++.+||.+||.+||++.||
T Consensus       187 ~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei  262 (793)
T PLN00181        187 DNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLRHR-VLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL  262 (793)
T ss_pred             hccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHHHh-hcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence            98766 899999999999999999999988643221  1111111 1111111234567799999999999999999999


Q ss_pred             hcCccccCC
Q 007478          365 LDHPFVKGA  373 (602)
Q Consensus       365 L~hp~f~~~  373 (602)
                      ++||||...
T Consensus       263 l~h~~~~~~  271 (793)
T PLN00181        263 LQSEFINEP  271 (793)
T ss_pred             hhchhhhhh
Confidence            999999764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=5.2e-29  Score=237.54  Aligned_cols=161  Identities=30%  Similarity=0.389  Sum_probs=129.3

Q ss_pred             CChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCCCC
Q 007478          199 GSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP  277 (602)
Q Consensus       199 gsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~  277 (602)
                      |+|.+++..+ +.+++.+++.|+.||+.||+|||+++      ||+|||++.++.+|+  ||+++......    ..||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            7899999864 46999999999999999999999999      999999999999999  99998765432    25899


Q ss_pred             CCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHH-HhhCCC--CCC---CCCCCCCH--HHHHHHHH
Q 007478          278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSK--ELP---TIPDDLSD--EGKDFIRL  349 (602)
Q Consensus       278 ~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~-~i~~~~--~~~---~~p~~~s~--~l~dLI~~  349 (602)
                      .|||||++.+.. ++.++|||||||++|||++|+.||.......... .+....  ..+   ..+..++.  ++++||++
T Consensus        69 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       69 YFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             cccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            999999998765 8999999999999999999999997644322221 111111  100   11223344  69999999


Q ss_pred             HcccCCCCCCCHHHHhcCccccC
Q 007478          350 CLQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       350 ~L~~dP~~Rpt~~eiL~hp~f~~  372 (602)
                      ||..||++||++.++++|+|+..
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1e-29  Score=286.11  Aligned_cols=262  Identities=25%  Similarity=0.379  Sum_probs=210.6

Q ss_pred             CCc-eEeeeEeecCCeEEEEEEECCCCcEEEEEEEecc--cchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceE
Q 007478          113 SHW-KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLF--DDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       113 ~~y-~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~--~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  189 (602)
                      +.| +..+++|.|++|.|+.+......+.++.|.....  ...........+..|+.+-..+.|+||+..+..+.+....
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            334 4578899999999998888777777777765421  1222223333377888899999999999988887776666


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCC--
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ--  267 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  267 (602)
                      +-+||||++ +|+.++...+.++..++..++.||+.||+|||..||.|||||++|+|++.+|.+||+|||.+......  
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            667999999 99999998888999999999999999999999999999999999999999999999999998765322  


Q ss_pred             ---CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHH-Hh------hCCCCCCCCCC
Q 007478          268 ---SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KI------GNSKELPTIPD  337 (602)
Q Consensus       268 ---~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~-~i------~~~~~~~~~p~  337 (602)
                         .....++|+..|+|||++.+..+-...+||||.|++++.|++|+.||......+..+ ..      ........+..
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence               234467899999999999888855678999999999999999999997544332221 11      01112223445


Q ss_pred             CCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCCCc
Q 007478          338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       338 ~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~~~  375 (602)
                      .++.+.+.+|.+||+.||.+|.|+++|++.+||+.+..
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            68899999999999999999999999999999998754

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=4.4e-27  Score=237.44  Aligned_cols=255  Identities=35%  Similarity=0.578  Sum_probs=207.6

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCC-cEEEEeccccccceEEEEE
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP-NIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~lVm  193 (602)
                      |.+.+.||.|+||.||++.+.   ..+++|.+....... ......+.+|+.++..+.|+ +|+++++.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            788999999999999999887   789999887522221 13467788999999999988 7999999997777789999


Q ss_pred             eeecCCChhhhhhccC---CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC-ceEEeccCccccccCCC-
Q 007478          194 EYVSGGSIYKLLQDYG---QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-RVKLADFGMAKHIAGQS-  268 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~---~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~-  268 (602)
                      +++.+++|.+++....   .+.+..+..++.|++.+|+|+|+.+++||||||+|||++..+ .++++|||+++.+.... 
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            9999999998887664   799999999999999999999999999999999999999988 79999999998655433 


Q ss_pred             ------CCcccCCCCCCCCccccccc--CCCCccccchhhhhHHHHHhhCCCCCCCchh---HHHHHHhhCCCCCC----
Q 007478          269 ------CPLSFKGSPYWMAPEVIKNS--SGCNLAVDIWSLGCTVLEMATTKPPWSQYEG---VAAMFKIGNSKELP----  333 (602)
Q Consensus       269 ------~~~~~~GT~~Y~APEvl~~~--~~~s~~sDVWSLGviLyELltG~~Pf~~~~~---~~~~~~i~~~~~~~----  333 (602)
                            ......||..|+|||++.+.  ..+....|+|++|++++++++|..||.....   .............+    
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                  23567799999999999874  4588899999999999999999999876553   22332222222211    


Q ss_pred             CCCCCC----CHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          334 TIPDDL----SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       334 ~~p~~~----s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      ......    ...+.+++..|+..+|..|.+..+...++|....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            111122    2578999999999999999999999998666544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3e-29  Score=271.73  Aligned_cols=243  Identities=28%  Similarity=0.462  Sum_probs=208.1

Q ss_pred             eEeecCCeEEEEEE---ECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccceEEEEEee
Q 007478          120 MLGRGTFGHVYVGF---NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       120 ~LG~G~fG~Vy~a~---~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      ++|+|+||.|+++.   -.+.|+.||+|+.++.........  ....|-.++..++ ||++|+++..++.+..++++++|
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            37999999999764   245688999998876333222221  4556778888886 99999999999999999999999


Q ss_pred             ecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCCcccCC
Q 007478          196 VSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKG  275 (602)
Q Consensus       196 ~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~G  275 (602)
                      ..||+|+..+.+...+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++|+.|||+++........   ||
T Consensus        79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---cc
Confidence            999999999999999999999999999999999999999999999999999999999999999999876554433   89


Q ss_pred             CCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCC
Q 007478          276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP  355 (602)
Q Consensus       276 T~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP  355 (602)
                      |..|||||++.   +...++|+||||++++||++|..||..    +.+..|...  ...+|..++.++++++..++..+|
T Consensus       156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~~~~~~l~~r~p  226 (612)
T KOG0603|consen  156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEARSLFRQLFKRNP  226 (612)
T ss_pred             chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHHHHHHHHHhhCH
Confidence            99999999997   467899999999999999999999987    334444332  235678999999999999999999


Q ss_pred             CCCCC-----HHHHhcCccccCCCcc
Q 007478          356 LNRPT-----AAELLDHPFVKGAAPL  376 (602)
Q Consensus       356 ~~Rpt-----~~eiL~hp~f~~~~~~  376 (602)
                      .+|..     +.++++|+||..+.|.
T Consensus       227 ~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  227 ENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHHhccCcchhHHHhccchheeeeHh
Confidence            99964     5899999999998874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-26  Score=242.28  Aligned_cols=248  Identities=25%  Similarity=0.300  Sum_probs=195.6

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCC-cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCC----CcEEEEeccc-cccc
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSG-EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH----PNIVQYYGSK-TVED  187 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H----pnIv~l~~~~-~~~~  187 (602)
                      +|++.+.||+|+||.||++.+..++ ..+|+|+.........    ..+..|+.++..+..    .++..+++.. ..+.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence            8999999999999999999988764 6789997764222111    146678888888863    5888888888 5777


Q ss_pred             eEEEEEeeecCCChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC-----CceEEeccCc
Q 007478          188 KLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-----GRVKLADFGM  260 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-----g~vKL~DFGl  260 (602)
                      ..||||+++ |.+|.++....  +.|+...+..++.|++.+|++||+.|++||||||+|+++...     ..+.|.|||+
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            899999998 89999988544  589999999999999999999999999999999999999765     4699999999


Q ss_pred             cc--cccCCCC---------CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH---HHHHHh
Q 007478          261 AK--HIAGQSC---------PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV---AAMFKI  326 (602)
Q Consensus       261 a~--~~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~---~~~~~i  326 (602)
                      ++  .+.....         ...+.||..|+++++..+.. .+.+.|+||++.++.||+.|..||...+..   ....+.
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            98  4322111         12356999999999998766 899999999999999999999999765532   222222


Q ss_pred             hCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       327 ~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .............+.++.+++..+-..+..++|....+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            22222211344567888999988888999999998888764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.4e-26  Score=242.23  Aligned_cols=167  Identities=18%  Similarity=0.212  Sum_probs=131.7

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECC-CCcEEEEEEEecccc-hhcHHHHHHHHHHHHHHHhcCCCcEEE-Eeccccccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSD-SGEMCAMKEVTLFDD-AKSKESAKQLMQEIVLLSRLRHPNIVQ-YYGSKTVED  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~~-~~~~~~~~~l~~Ei~iL~~l~HpnIv~-l~~~~~~~~  187 (602)
                      ....|.+.+.||+|+||+||+|+++. +++.||||++..... .......+.+.+|+++|++++|+||+. +++.    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            45789999999999999999998876 678889998652111 012334567899999999999999984 5542    4


Q ss_pred             eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCC-CCCcEEEccCCceEEeccCccccccC
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI-KGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDL-Kp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      ..|||||||+|++|... ..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            58999999999999732 21   11   2568899999999999999999999 99999999999999999999986643


Q ss_pred             CCC---------CcccCCCCCCCCccccccc
Q 007478          267 QSC---------PLSFKGSPYWMAPEVIKNS  288 (602)
Q Consensus       267 ~~~---------~~~~~GT~~Y~APEvl~~~  288 (602)
                      ...         .....++..|+|||.+...
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            321         1245688999999998643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=8.6e-26  Score=227.92  Aligned_cols=245  Identities=23%  Similarity=0.350  Sum_probs=201.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccceEE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~  190 (602)
                      .-+|+++++||+|+||+.|+|.+.-+++.||||.-..      +...-++..|....+.| ..+.|..+|.+....-.-.
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr------kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR------KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc------cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            4589999999999999999999999999999996432      12245677888888888 5789999998888777889


Q ss_pred             EEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC-----ceEEeccCccccc
Q 007478          191 IYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-----RVKLADFGMAKHI  264 (602)
Q Consensus       191 lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g-----~vKL~DFGla~~~  264 (602)
                      ||||++ |-+|.|+..-+ +.|+...+..++.|++.-++|+|++.+|+|||||+|+||...+     .|.|+|||+|+.+
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999998 88998888765 4799999999999999999999999999999999999996543     5899999999987


Q ss_pred             cCCCC--------CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCc---hhHHHHHHhhCCCCCC
Q 007478          265 AGQSC--------PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY---EGVAAMFKIGNSKELP  333 (602)
Q Consensus       265 ~~~~~--------~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~---~~~~~~~~i~~~~~~~  333 (602)
                      .+...        ..+..||..||+=....+.. -+.+.|+-|||.+++.+|-|.+||.+.   +......+|...+...
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            54332        23567999999988888776 788999999999999999999999764   3456666776655433


Q ss_pred             ---CCCCCCCHHHHHHHHHHcccCCCCCCCHHHH
Q 007478          334 ---TIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL  364 (602)
Q Consensus       334 ---~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~ei  364 (602)
                         .+-.+++.++...++..-..+-++-|..+-+
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl  292 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL  292 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence               3345788899988888888888888876544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=5.6e-26  Score=256.64  Aligned_cols=226  Identities=27%  Similarity=0.423  Sum_probs=178.2

Q ss_pred             CCCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccce
Q 007478          109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       109 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~  188 (602)
                      ...+++|..+|+|-.|+||.||+++|+.+.+.+|+| +.+.     .    .+.+-  ++....+|++|           
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq-----~----lilRn--ilt~a~npfvv-----------  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ-----N----LILRN--ILTFAGNPFVV-----------  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhc-cccc-----c----hhhhc--cccccCCccee-----------
Confidence            345788999999999999999999999999999996 3321     1    11110  34444455554           


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  268 (602)
                                |+...+++.-+.++..-        +.+++|||..||+|||+||+|+||+.-|++|++|||+++......
T Consensus       136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                      66777777766666544        789999999999999999999999999999999999986532110


Q ss_pred             ----------------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhC-CCC
Q 007478          269 ----------------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN-SKE  331 (602)
Q Consensus       269 ----------------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~-~~~  331 (602)
                                      ....+|||+.|.|||++.... |+..+|||++|+|+||++.|+.||.+....+.+-.+.. ...
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence                            112468999999999997654 99999999999999999999999998876666555433 334


Q ss_pred             CCCCCCCCCHHHHHHHHHHcccCCCCCC---CHHHHhcCccccCCCcc
Q 007478          332 LPTIPDDLSDEGKDFIRLCLQRNPLNRP---TAAELLDHPFVKGAAPL  376 (602)
Q Consensus       332 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rp---t~~eiL~hp~f~~~~~~  376 (602)
                      +++-.+.+++|++++|.++|+.+|..|.   .+-++.+|+||+...|.
T Consensus       277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            4455567899999999999999999994   67899999999998773

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=9.1e-25  Score=212.22  Aligned_cols=244  Identities=22%  Similarity=0.329  Sum_probs=193.1

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCC-CcEEEEeccccccceE
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNIVQYYGSKTVEDKL  189 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~  189 (602)
                      ....|+++++||.|+||.+|+|.+..+|..||||+-..      ...--++..|.++.+.|++ ..|..+.-+..+.+.-
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~------~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS------KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc------cCCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            45789999999999999999999999999999997542      1123456788888888865 5666677677778888


Q ss_pred             EEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC---CceEEeccCcccccc
Q 007478          190 YIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN---GRVKLADFGMAKHIA  265 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~vKL~DFGla~~~~  265 (602)
                      .+||+++ |-+|.+++.-+ +.|+..+++.++-|++.-|+|+|.+++|||||||+|+|+.-+   ..+.|+|||||+.+.
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999998 88999988643 579999999999999999999999999999999999999644   368999999998775


Q ss_pred             CCCC--------CcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhH---HHHHHhhCCC---C
Q 007478          266 GQSC--------PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV---AAMFKIGNSK---E  331 (602)
Q Consensus       266 ~~~~--------~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~---~~~~~i~~~~---~  331 (602)
                      +...        .....||..|.+=....+.. -+...|+-|+|.+|..+.-|..||.+....   ....+|...+   .
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            4322        22456999999877665544 577899999999999999999999875432   2223333222   2


Q ss_pred             CCCCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 007478          332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAA  362 (602)
Q Consensus       332 ~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~  362 (602)
                      ...+-..+|.|+.-.+..|-..--++-|...
T Consensus       245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            2234457899999999999888888888754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=2.4e-23  Score=203.11  Aligned_cols=143  Identities=17%  Similarity=0.141  Sum_probs=110.6

Q ss_pred             eeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcH----------------------HHHHHHHHHHHHHHhcCCCc
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK----------------------ESAKQLMQEIVLLSRLRHPN  175 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~----------------------~~~~~l~~Ei~iL~~l~Hpn  175 (602)
                      ...||+|+||.||+|.+. +|+.||||+++........                      .......+|+++|.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 8999999999753111000                      01123346999999998766


Q ss_pred             EEEEeccccccceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhh-ccCCceecCCCCCcEEEccCCceE
Q 007478          176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL-HSKHTVHRDIKGANILVDPNGRVK  254 (602)
Q Consensus       176 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yL-H~~gIvHrDLKp~NILl~~~g~vK  254 (602)
                      |.......  ....+|||||++|++|...+.+.+.+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPIL--LKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEE--ecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            53322111  122489999999888776644456899999999999999999999 799999999999999998 57899


Q ss_pred             EeccCccccc
Q 007478          255 LADFGMAKHI  264 (602)
Q Consensus       255 L~DFGla~~~  264 (602)
                      |+|||+|...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=9.6e-24  Score=238.66  Aligned_cols=246  Identities=22%  Similarity=0.299  Sum_probs=187.7

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVm  193 (602)
                      +|...+.||++.|=+|.+|++.+ |. |+||++-+.+....-....+..+|++ ...+++||.+.+.-+...+...|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            78889999999999999998875 44 99999876554444444555566777 77779999999998888888899999


Q ss_pred             eeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc--cCCC-CC
Q 007478          194 EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--AGQS-CP  270 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~--~~~~-~~  270 (602)
                      +|+ .-+|+|.|..+.-+.+-+.+.|+.||+.||.-||+.||+|+|||.|||||+.=.-+.|+||...+..  ..++ ..
T Consensus       101 qyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            999 4799999998877888899999999999999999999999999999999998778999999876532  1111 11


Q ss_pred             cc-cC----CCCCCCCcccccccC----------CCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCC-CCC
Q 007478          271 LS-FK----GSPYWMAPEVIKNSS----------GCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSK-ELP  333 (602)
Q Consensus       271 ~~-~~----GT~~Y~APEvl~~~~----------~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~-~~~  333 (602)
                      .+ +-    --.+|.|||.+....          ..+.+.||||+||++.||++ |+++|.-    .++++-.... ..+
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDP  255 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCH
Confidence            11 11    224699999985421          14678999999999999988 8999952    2222211110 000


Q ss_pred             -C-CCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          334 -T-IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       334 -~-~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                       . +..--+..++.||..|++.||++|.++++.|+.
T Consensus       256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence             0 000112368999999999999999999999974

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=5.9e-23  Score=204.58  Aligned_cols=173  Identities=16%  Similarity=0.166  Sum_probs=132.2

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHH------HHHHHHHHHhcCCCcEEEEeccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ------LMQEIVLLSRLRHPNIVQYYGSKTV  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~------l~~Ei~iL~~l~HpnIv~l~~~~~~  185 (602)
                      ..+|+..++||.|+||.||++..  ++..+|||++..... ........      +.+|+..+.++.|++|..+.+++..
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~-~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK-RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcC-chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            46899999999999999999654  467899999864221 22222222      5799999999999999988877553


Q ss_pred             c--------ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEec
Q 007478          186 E--------DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLAD  257 (602)
Q Consensus       186 ~--------~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~D  257 (602)
                      .        +..+|||||++|.+|.++..    +++    ....+|+.+|..||+.|++||||||+||+++.+| ++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            2        35899999999999988732    333    3466999999999999999999999999999998 99999


Q ss_pred             cCccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHh
Q 007478          258 FGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMA  308 (602)
Q Consensus       258 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELl  308 (602)
                      ||..+..........           +++.. .|+.++|+|+|||++..+.
T Consensus       178 fg~~~~~~e~~a~d~-----------~vler-~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAKDR-----------IDLER-HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhHHH-----------HHHHh-HhcccccccceeEeehHHH
Confidence            998876533221111           23333 3678999999999887553

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=1.8e-22  Score=196.59  Aligned_cols=145  Identities=18%  Similarity=0.121  Sum_probs=113.0

Q ss_pred             eeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhc----------------------HHHHHHHHHHHHHHHhcCCCc
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKS----------------------KESAKQLMQEIVLLSRLRHPN  175 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~----------------------~~~~~~l~~Ei~iL~~l~Hpn  175 (602)
                      .+.||+|+||+||+|.+. +|+.||||+++.......                      ......+.+|+..+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 899999999875321100                      011223467999999999988


Q ss_pred             EEEEeccccccceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceE
Q 007478          176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVK  254 (602)
Q Consensus       176 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vK  254 (602)
                      |.....+...  ..||||||++|+++...+.....++..++..++.|++.+|.+||. +||+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            7433322222  248999999988665443344678889999999999999999999 9999999999999998 88999


Q ss_pred             EeccCccccccC
Q 007478          255 LADFGMAKHIAG  266 (602)
Q Consensus       255 L~DFGla~~~~~  266 (602)
                      |+|||+++.+..
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=3.8e-23  Score=211.80  Aligned_cols=235  Identities=24%  Similarity=0.313  Sum_probs=152.3

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCC----------Cc------EE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH----------PN------IV  177 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H----------pn------Iv  177 (602)
                      .+..++.||.|+|+.||.+++..||+.+|+|++.... .......+++.+|......+.+          -.      ++
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            5678899999999999999999999999999987644 2333446677777655544322          11      22


Q ss_pred             EEecc---cccc---c-----eEEEEEeeecCCChhhhhh---ccCCC----ChHHHHHHHHHHHHHHhhhccCCceecC
Q 007478          178 QYYGS---KTVE---D-----KLYIYLEYVSGGSIYKLLQ---DYGQF----GEPAIRNYTQQILSGLAFLHSKHTVHRD  239 (602)
Q Consensus       178 ~l~~~---~~~~---~-----~~~lVmE~~~ggsL~~~l~---~~~~l----s~~~i~~i~~qIl~aL~yLH~~gIvHrD  239 (602)
                      ++-+-   +...   .     ..+++|+-+ -++|.+++.   .....    .......+..|+++.+++||..||||+|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd  170 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD  170 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence            32221   1111   1     236677766 578877754   22222    1222345668999999999999999999


Q ss_pred             CCCCcEEEccCCceEEeccCccccccCCCCCcccCCCCCCCCccccccc-------CCCCccccchhhhhHHHHHhhCCC
Q 007478          240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS-------SGCNLAVDIWSLGCTVLEMATTKP  312 (602)
Q Consensus       240 LKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-------~~~s~~sDVWSLGviLyELltG~~  312 (602)
                      |||+|+|++.+|.++|+||+.....+....  ....+..|.+||.....       ..++.+.|.|+||++||.|.||..
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            999999999999999999987765443221  13356789999986432       237889999999999999999999


Q ss_pred             CCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCC
Q 007478          313 PWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR  358 (602)
Q Consensus       313 Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~R  358 (602)
                      ||...........     ....-. ++++..++||+.+|++||++|
T Consensus       249 Pf~~~~~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9975432111110     111112 788999999999999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.8e-22  Score=197.54  Aligned_cols=187  Identities=17%  Similarity=0.125  Sum_probs=140.5

Q ss_pred             EeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccceEEEEEee
Q 007478          117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       117 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      +...|++|+||+||++..  .+..++.+.+.........-....+.+|+++|++|. |++|++++++    +..|++|||
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            567899999999997754  577888776653221111112235789999999995 5788888875    347999999


Q ss_pred             ecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCC-CCCcEEEccCCceEEeccCccccccCCCCC----
Q 007478          196 VSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI-KGANILVDPNGRVKLADFGMAKHIAGQSCP----  270 (602)
Q Consensus       196 ~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDL-Kp~NILl~~~g~vKL~DFGla~~~~~~~~~----  270 (602)
                      +.|.+|.+.+..       ....++.|++.+|++||++||+|||| ||+|||++.+|.++|+|||+|.........    
T Consensus        80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence            999998765422       12357889999999999999999999 799999999999999999999865433210    


Q ss_pred             ----------cccCCCCCCCCcccccccCCCC-ccccchhhhhHHHHHhhCCCCCCC
Q 007478          271 ----------LSFKGSPYWMAPEVIKNSSGCN-LAVDIWSLGCTVLEMATTKPPWSQ  316 (602)
Q Consensus       271 ----------~~~~GT~~Y~APEvl~~~~~~s-~~sDVWSLGviLyELltG~~Pf~~  316 (602)
                                .-...++.|++|+...--...+ ...++++.|+-+|.++|+..++.+
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                      0122688899998753322233 477999999999999999988644

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-22  Score=209.22  Aligned_cols=258  Identities=23%  Similarity=0.364  Sum_probs=182.2

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCc-----------------------------------EEEEEEEecccc-hhc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGE-----------------------------------MCAMKEVTLFDD-AKS  154 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----------------------------------~vAvK~i~~~~~-~~~  154 (602)
                      ..++|+++..||+|.-..||.|..+.+|.                                   +.|||.+-.++. ..+
T Consensus       155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~  234 (598)
T KOG4158|consen  155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD  234 (598)
T ss_pred             chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence            46789999999999999999987554211                                   234554432222 222


Q ss_pred             HHHHHHHHHHHH------HH--------Hh--------cCCCcEEEEecccccc--------------------------
Q 007478          155 KESAKQLMQEIV------LL--------SR--------LRHPNIVQYYGSKTVE--------------------------  186 (602)
Q Consensus       155 ~~~~~~l~~Ei~------iL--------~~--------l~HpnIv~l~~~~~~~--------------------------  186 (602)
                      ....+.+.+|..      .+        +.        -+|||||+++++|.+.                          
T Consensus       235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~  314 (598)
T KOG4158|consen  235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE  314 (598)
T ss_pred             HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence            233344444431      11        11        2599999998876442                          


Q ss_pred             -ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEc--cCC--ceEEeccCcc
Q 007478          187 -DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVD--PNG--RVKLADFGMA  261 (602)
Q Consensus       187 -~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~--~~g--~vKL~DFGla  261 (602)
                       ..+|+||.-. ..+|..++..+ ..+....+-++.|+++|+.|||++||.|||+|.+||||.  +|+  .+.|+|||.+
T Consensus       315 ~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  315 PKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             CceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence             2488998766 47888888763 567778888999999999999999999999999999994  343  5899999976


Q ss_pred             ccccC-------CCCCcccCCCCCCCCcccccccCCCC-----ccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCC
Q 007478          262 KHIAG-------QSCPLSFKGSPYWMAPEVIKNSSGCN-----LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS  329 (602)
Q Consensus       262 ~~~~~-------~~~~~~~~GT~~Y~APEvl~~~~~~s-----~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~  329 (602)
                      -.-..       .......-|...-||||+....++..     .++|.|+.|.+.||+++..-||.+......-..-...
T Consensus       393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe  472 (598)
T KOG4158|consen  393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE  472 (598)
T ss_pred             eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence            43221       11112234788899999986444321     3899999999999999999999874332222222345


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHcccCCCCCCCH---HHHhcCccc
Q 007478          330 KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTA---AELLDHPFV  370 (602)
Q Consensus       330 ~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~---~eiL~hp~f  370 (602)
                      ..+|.+|+.+++.+++||..+|+.||.+|++.   ..+++--.|
T Consensus       473 ~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw  516 (598)
T KOG4158|consen  473 SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLW  516 (598)
T ss_pred             hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence            56788999999999999999999999999884   445543333

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=4.1e-21  Score=189.94  Aligned_cols=135  Identities=19%  Similarity=0.290  Sum_probs=107.7

Q ss_pred             EeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-----CCCcEEEEeccccccc---e
Q 007478          117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-----RHPNIVQYYGSKTVED---K  188 (602)
Q Consensus       117 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-----~HpnIv~l~~~~~~~~---~  188 (602)
                      -.++||+|+||.||.  ++.++.. +||++....    ....+.+.+|+.+++.+     +||||++++++++++.   .
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            356899999999995  7777666 689876522    12346789999999999     6799999999998863   4


Q ss_pred             EE-EEEee--ecCCChhhhhhccCCCChHHHHHHHHHHHHHH-hhhccCCceecCCCCCcEEEccC----CceEEeccCc
Q 007478          189 LY-IYLEY--VSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL-AFLHSKHTVHRDIKGANILVDPN----GRVKLADFGM  260 (602)
Q Consensus       189 ~~-lVmE~--~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL-~yLH~~gIvHrDLKp~NILl~~~----g~vKL~DFGl  260 (602)
                      ++ +||||  +.+++|.+++++. .+++.  ..++.|++.++ +|||+++||||||||+|||++.+    +.++|+||+-
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            34 78999  5579999999763 56665  46688888888 99999999999999999999743    3799999543


Q ss_pred             c
Q 007478          261 A  261 (602)
Q Consensus       261 a  261 (602)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.1e-21  Score=190.25  Aligned_cols=243  Identities=21%  Similarity=0.354  Sum_probs=194.8

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      +...+..+|.+...|..|+|++..  ..+++|+++..+  -.....+.|..|.-.|+-..||||+.+++.|.....+.++
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~--~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVRE--VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             hhhhhhhhhccCCCcccccccccC--cchhhhhhhhhh--cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            445567789999999999998874  466777765422  1223346788899899999999999999999999999999


Q ss_pred             EeeecCCChhhhhhccCC--CChHHHHHHHHHHHHHHhhhccCC--ceecCCCCCcEEEccCCceEE--eccCccccccC
Q 007478          193 LEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKH--TVHRDIKGANILVDPNGRVKL--ADFGMAKHIAG  266 (602)
Q Consensus       193 mE~~~ggsL~~~l~~~~~--ls~~~i~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~~~g~vKL--~DFGla~~~~~  266 (602)
                      ..||+-|+|+..|.+...  ....++.+++.+|++|+.|||+..  |.---|....|+||++-..+|  +|--++.+.. 
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~-  344 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV-  344 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecc-
Confidence            999999999999987543  566789999999999999999863  333467888999998876554  4433222211 


Q ss_pred             CCCCcccCCCCCCCCcccccccCCC--CccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHH
Q 007478          267 QSCPLSFKGSPYWMAPEVIKNSSGC--NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGK  344 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~~~--s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  344 (602)
                           ...-.+.||+||.++..+..  -.++|+|||.++||||.|...||.+....+--.++........+|+.++..+.
T Consensus       345 -----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~  419 (448)
T KOG0195|consen  345 -----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN  419 (448)
T ss_pred             -----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence                 11246889999999766532  24899999999999999999999998888777788777778899999999999


Q ss_pred             HHHHHHcccCCCCCCCHHHHh
Q 007478          345 DFIRLCLQRNPLNRPTAAELL  365 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL  365 (602)
                      .||+-|+..||.+||.++.|+
T Consensus       420 klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999988764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1e-21  Score=221.54  Aligned_cols=259  Identities=28%  Similarity=0.431  Sum_probs=212.9

Q ss_pred             CCCceEeeeEeecCCeEEEEEEEC-CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccceE
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNS-DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~  189 (602)
                      ...|++.+.||+|+|+.|-++... .+...+|+|.+....  .......++..|..+-+.+. |.|++.+++.....+..
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            446788888999999999988764 345567777765432  44455667777888888887 99999999999999999


Q ss_pred             EEEEeeecCCChhhhh-hccC-CCChHHHHHHHHHHHHHHhhhc-cCCceecCCCCCcEEEccCC-ceEEeccCcccccc
Q 007478          190 YIYLEYVSGGSIYKLL-QDYG-QFGEPAIRNYTQQILSGLAFLH-SKHTVHRDIKGANILVDPNG-RVKLADFGMAKHIA  265 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l-~~~~-~ls~~~i~~i~~qIl~aL~yLH-~~gIvHrDLKp~NILl~~~g-~vKL~DFGla~~~~  265 (602)
                      +++++|..|+++++.+ .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+|++|||+|+.+.
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999999999 5554 6788899999999999999999 99999999999999999999 99999999998776


Q ss_pred             C-CCC---CcccCC-CCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHH-HHhhCCC--CCCCCCC
Q 007478          266 G-QSC---PLSFKG-SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM-FKIGNSK--ELPTIPD  337 (602)
Q Consensus       266 ~-~~~---~~~~~G-T~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~-~~i~~~~--~~~~~p~  337 (602)
                      . ...   ....+| ++.|+|||...+..+.....|+||+|+++.-|++|..||......... .......  .....+.
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            5 222   224678 999999999987666788999999999999999999999653332211 1111111  1234566


Q ss_pred             CCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccC
Q 007478          338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       338 ~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~  372 (602)
                      .++..+.+++.++|..+|..|.+.+++..++|+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            89999999999999999999999999999999987

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=1.9e-21  Score=207.75  Aligned_cols=175  Identities=24%  Similarity=0.404  Sum_probs=139.5

Q ss_pred             eEEEEEeeecCCChhhhhhccC---CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYG---QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~---~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                      .+||.|++|...+|.++|....   ..+...++.++.|++.|++|   +|.+|||+||.||++..+..+||+|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            5899999999999999997543   35667889999999999999   99999999999999999999999999999887


Q ss_pred             cCCC-------CCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhh-CCCCCCCchhHHHHHHhhCCCCCCCCC
Q 007478          265 AGQS-------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIP  336 (602)
Q Consensus       265 ~~~~-------~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  336 (602)
                      ....       ......||.+||+||+|.+.. |+.++||||||+||+||+. -...|   +....+..+......+.+.
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~~~  482 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPEFL  482 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChHHh
Confidence            6655       455677999999999998766 9999999999999999998 23222   2333333333333322333


Q ss_pred             CCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccc
Q 007478          337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       337 ~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f  370 (602)
                      .+. ++-.+|+.+||...|.+||++.+.--|.|.
T Consensus       483 ~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  483 QDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            333 345689999999999999977777667664

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=2.7e-20  Score=187.76  Aligned_cols=148  Identities=20%  Similarity=0.169  Sum_probs=116.4

Q ss_pred             CCceEeeeEeecCCeEEEEEE-ECCCCcEEEEEEEecccch-hc-------------------HHHHHHHHHHHHHHHhc
Q 007478          113 SHWKKGKMLGRGTFGHVYVGF-NSDSGEMCAMKEVTLFDDA-KS-------------------KESAKQLMQEIVLLSRL  171 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~-~~~tg~~vAvK~i~~~~~~-~~-------------------~~~~~~l~~Ei~iL~~l  171 (602)
                      ..|++.+.||+|+||.||+|. +..+|+.||||+++..... ..                   ......+.+|+.+++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998 6778999999998752210 00                   01123467899999999


Q ss_pred             CCC--cEEEEeccccccceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCC-ceecCCCCCcEEEc
Q 007478          172 RHP--NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH-TVHRDIKGANILVD  248 (602)
Q Consensus       172 ~Hp--nIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~g-IvHrDLKp~NILl~  248 (602)
                      .+.  .+.++++.    ...+|||||+.|++|..++.....+....+..++.||+.+|.+||.+| |+||||||+|||++
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            753  23444432    235899999999888776644456677778899999999999999999 99999999999999


Q ss_pred             cCCceEEeccCcccccc
Q 007478          249 PNGRVKLADFGMAKHIA  265 (602)
Q Consensus       249 ~~g~vKL~DFGla~~~~  265 (602)
                       ++.++|+|||++....
T Consensus       184 -~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 -DGKVVIIDVSQSVELD  199 (237)
T ss_pred             -CCCEEEEEChhhhccC
Confidence             8899999999887543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=5.7e-20  Score=211.98  Aligned_cols=192  Identities=22%  Similarity=0.318  Sum_probs=154.3

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC---CCcEEEEeccccccce
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR---HPNIVQYYGSKTVEDK  188 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~---HpnIv~l~~~~~~~~~  188 (602)
                      ...|.+.+.||+|+||+||+|.+.+ |+.||+|+-+..   ..++    |.--.+++.+|+   -+.|..+..++.-.+.
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~---~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPP---NPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCC---Ccee----eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            3568888999999999999999887 999999975431   1111    222233444554   2344555555555677


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc-------CCceEEeccCcc
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-------NGRVKLADFGMA  261 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-------~g~vKL~DFGla  261 (602)
                      -+||+||.+.|+|.+++...+.+++..+..|..||+..|++||..+|||+||||+|+||..       .--++|+|||-+
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            8999999999999999998889999999999999999999999999999999999999942       235999999988


Q ss_pred             ccc---cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCC
Q 007478          262 KHI---AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP  312 (602)
Q Consensus       262 ~~~---~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~  312 (602)
                      ..+   .........++|-.+--+|+..++. +++.+|.|.|..+++.||.|+.
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence            654   3333445677899999999998877 9999999999999999999984

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=4.6e-19  Score=174.38  Aligned_cols=138  Identities=22%  Similarity=0.326  Sum_probs=113.0

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccc----hhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEe
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD----AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~----~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE  194 (602)
                      +.||+|++|.||+|.+  +|..+++|+......    .........+.+|+.++..+.|++|.....++...+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  577899997643111    1111223467889999999999888766555656677899999


Q ss_pred             eecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccc
Q 007478          195 YVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       195 ~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~  263 (602)
                      |++|++|.+++.....    ....++.+|+.+|.+||..|++|||++|+|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999865332    7889999999999999999999999999999999 78999999998765

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=8.4e-19  Score=171.63  Aligned_cols=142  Identities=19%  Similarity=0.241  Sum_probs=111.1

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhc------------------HHHHHHHHHHHHHHHhcCCCc
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKS------------------KESAKQLMQEIVLLSRLRHPN  175 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~------------------~~~~~~l~~Ei~iL~~l~Hpn  175 (602)
                      .|.+.+.||+|+||.||++.+. +|+.||||++........                  ........+|+.++..+.|.+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4778899999999999999875 799999998764221000                  011123667899999997774


Q ss_pred             --EEEEeccccccceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCce
Q 007478          176 --IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRV  253 (602)
Q Consensus       176 --Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~v  253 (602)
                        +...++.    ...++||||++|++|.++...      .....++.+|+.++.++|+.||+||||||+||+++.++.+
T Consensus        95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence              4444432    346999999999998776431      3567899999999999999999999999999999999999


Q ss_pred             EEeccCccccccC
Q 007478          254 KLADFGMAKHIAG  266 (602)
Q Consensus       254 KL~DFGla~~~~~  266 (602)
                      +|+|||++.....
T Consensus       165 ~liDfg~~~~~~~  177 (198)
T cd05144         165 YIIDWPQMVSTDH  177 (198)
T ss_pred             EEEECCccccCCC
Confidence            9999999966543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=1e-18  Score=170.42  Aligned_cols=134  Identities=23%  Similarity=0.328  Sum_probs=106.0

Q ss_pred             eEeecCCeEEEEEEECCCCcEEEEEEEecccch----hcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEee
Q 007478          120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA----KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       120 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~----~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      +||+|+||.||++..  +|..+++|+.......    ........+.+|++++..+.|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  5788999985432111    1122346778999999999887654333334455667999999


Q ss_pred             ecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccc
Q 007478          196 VSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       196 ~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~  263 (602)
                      ++|++|.+++.....       .++.||+.+|.+||+.|++|+|+||+|||++ ++.++|+|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998765321       8899999999999999999999999999999 78999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=2.2e-18  Score=193.68  Aligned_cols=142  Identities=20%  Similarity=0.284  Sum_probs=112.8

Q ss_pred             CCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEec--ccc--hhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccc
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL--FDD--AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~--~~~--~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~  187 (602)
                      ...|...++||+|+||+||++.+...  .+++|+...  ...  .......+.+.+|+++++.++|++|+..+.++.+.+
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            34456789999999999999987543  444443321  111  111223456889999999999999988766666667


Q ss_pred             eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                      ..++||||++|++|.+++.        ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus       410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            7899999999999999885        356799999999999999999999999999999 6779999999998763

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=2.5e-18  Score=186.78  Aligned_cols=199  Identities=24%  Similarity=0.417  Sum_probs=156.6

Q ss_pred             HHhcCCCcEEEEeccccccceEEEEEeeecCCChhhhhhc-cCCCChHHHHHHHHHHHHHHhhhccCCc-eecCCCCCcE
Q 007478          168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHT-VHRDIKGANI  245 (602)
Q Consensus       168 L~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~aL~yLH~~gI-vHrDLKp~NI  245 (602)
                      |+.+.|.|+.+++|.+.+...+++|.+||..|+|.|.+.. .-.++.-....++++|+.||.|||.-.| .|+-|+..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678999999999999999999999999999999999987 4567777888999999999999998766 9999999999


Q ss_pred             EEccCCceEEeccCccccccCC---CCCcccCCCCCCCCcccccccCC------CCccccchhhhhHHHHHhhCCCCCCC
Q 007478          246 LVDPNGRVKLADFGMAKHIAGQ---SCPLSFKGSPYWMAPEVIKNSSG------CNLAVDIWSLGCTVLEMATTKPPWSQ  316 (602)
Q Consensus       246 Ll~~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~------~s~~sDVWSLGviLyELltG~~Pf~~  316 (602)
                      ++|..+.+||+|||+.......   .......-..-|.|||.+.....      .+.+.||||+|+++||+++.+.||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998776421   11111123356999999976421      35679999999999999999999964


Q ss_pred             c----hhHHHHHHhhC---CCCCCCCCC--CCCHHHHHHHHHHcccCCCCCCCHHHHhc
Q 007478          317 Y----EGVAAMFKIGN---SKELPTIPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       317 ~----~~~~~~~~i~~---~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~  366 (602)
                      .    ...+.+..+.+   ....|.+..  .+.+++..+++.||..+|++||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            2    22233333333   112233321  45668999999999999999999998864

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=1.6e-17  Score=160.28  Aligned_cols=140  Identities=25%  Similarity=0.310  Sum_probs=100.2

Q ss_pred             eeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHH---------------------HHHHHHHHHHhcCCCc-
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK---------------------QLMQEIVLLSRLRHPN-  175 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~---------------------~l~~Ei~iL~~l~Hpn-  175 (602)
                      ++.||+|+||+||+|.+. +|+.||||+++....... ....                     ....|...+..+.+.. 
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFK-KRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchh-hhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            567999999999999886 799999998864221111 1111                     1135666666664432 


Q ss_pred             -EEEEeccccccceEEEEEeeecCCChhh-hhhccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCc
Q 007478          176 -IVQYYGSKTVEDKLYIYLEYVSGGSIYK-LLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGR  252 (602)
Q Consensus       176 -Iv~l~~~~~~~~~~~lVmE~~~ggsL~~-~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~  252 (602)
                       +.+++++    ...++||||++|+.+.. .+.... . ..+++.++.+++.++.++|. .||+||||||+||+++ ++.
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence             3444433    23689999999855432 222211 1 16788999999999999999 9999999999999999 889


Q ss_pred             eEEeccCccccccC
Q 007478          253 VKLADFGMAKHIAG  266 (602)
Q Consensus       253 vKL~DFGla~~~~~  266 (602)
                      ++|+|||.+.....
T Consensus       153 ~~liDfg~a~~~~~  166 (187)
T cd05119         153 VYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEEECcccccccC
Confidence            99999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.70  E-value=5.4e-17  Score=184.52  Aligned_cols=266  Identities=24%  Similarity=0.338  Sum_probs=213.3

Q ss_pred             CCCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceE
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  189 (602)
                      ...+.+.+.+-+-+|.|+.++.+.-..+|...++|+..+.... .....+.+.++-.++-...+|.++.....+......
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i-~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI-RTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhh-ccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            3456788888999999999999988888988888876542221 112233344444455455678888877776677889


Q ss_pred             EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc----
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA----  265 (602)
Q Consensus       190 ~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~----  265 (602)
                      +|+|+|..+++|...|+..+..+.+-++.+...+..+++|||...++|||++|.|+|+..+|..+++|||......    
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            9999999999999999998888888899999999999999999999999999999999999999999998443211    


Q ss_pred             --C------------------------C--CCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCc
Q 007478          266 --G------------------------Q--SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY  317 (602)
Q Consensus       266 --~------------------------~--~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~  317 (602)
                        .                        +  .......||+.|.+||.+.+.. ....+|+|++|++++|.++|.+||...
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence              0                        0  1122356999999999998776 778999999999999999999999887


Q ss_pred             hhHHHHHHhhCCC-CCCCCCCCCCHHHHHHHHHHcccCCCCCCCHH---HHhcCccccCCCccc
Q 007478          318 EGVAAMFKIGNSK-ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAA---ELLDHPFVKGAAPLE  377 (602)
Q Consensus       318 ~~~~~~~~i~~~~-~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~---eiL~hp~f~~~~~~~  377 (602)
                      ........+.+.. ..+.-+...+.++++++.++|..++.+|..+.   ++-.|+||++.+|..
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence            6655555554433 34456677899999999999999999998877   999999999998843

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=2.1e-16  Score=159.65  Aligned_cols=139  Identities=22%  Similarity=0.298  Sum_probs=105.6

Q ss_pred             eeeEe-ecCCeEEEEEEECCCCcEEEEEEEecccc---------hhcHHHHHHHHHHHHHHHhcCCCcE--EEEeccccc
Q 007478          118 GKMLG-RGTFGHVYVGFNSDSGEMCAMKEVTLFDD---------AKSKESAKQLMQEIVLLSRLRHPNI--VQYYGSKTV  185 (602)
Q Consensus       118 ~~~LG-~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---------~~~~~~~~~l~~Ei~iL~~l~HpnI--v~l~~~~~~  185 (602)
                      +..|| .|+.|+||++...  +..++||.+.....         .-.......+.+|+.++..|.|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45688 8999999998664  77899998753110         0011234567889999999998775  566655332


Q ss_pred             c-c---eEEEEEeeecC-CChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCc
Q 007478          186 E-D---KLYIYLEYVSG-GSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       186 ~-~---~~~lVmE~~~g-gsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGl  260 (602)
                      + .   ..+|||||++| .+|.+++.. ..+++.    .+.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            2 2   23599999997 689888865 345544    367899999999999999999999999999999999999998


Q ss_pred             ccc
Q 007478          261 AKH  263 (602)
Q Consensus       261 a~~  263 (602)
                      ++.
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            875

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=2.6e-16  Score=143.83  Aligned_cols=132  Identities=23%  Similarity=0.282  Sum_probs=110.9

Q ss_pred             EeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCC--CcEEEEeccccccceEEEEEe
Q 007478          117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       117 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lVmE  194 (602)
                      +.+.||+|.++.||++....  ..+++|.+.....      ...+.+|+.+++.++|  .++++++.++...+..+++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence            45789999999999998754  6899998754211      3567789999999976  588898888887788999999


Q ss_pred             eecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccC---CceecCCCCCcEEEccCCceEEeccCcccc
Q 007478          195 YVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK---HTVHRDIKGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       195 ~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~---gIvHrDLKp~NILl~~~g~vKL~DFGla~~  263 (602)
                      |+.|+.+..+       +......++.+++.+|++||..   +++|+||||+|||++..+.++|+|||+++.
T Consensus        74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9998887765       5566778899999999999984   799999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=5.4e-16  Score=168.93  Aligned_cols=252  Identities=23%  Similarity=0.249  Sum_probs=197.1

Q ss_pred             CCceEeeeEee--cCCeEEEEEEE--CCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccc
Q 007478          113 SHWKKGKMLGR--GTFGHVYVGFN--SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVED  187 (602)
Q Consensus       113 ~~y~~~~~LG~--G~fG~Vy~a~~--~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~  187 (602)
                      ..+.+.+.+|.  |.+|.||.+..  +.++..+|+|.-++.-.  .......-++|+...+.+ .|+|.++.+..++..+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s--~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS--PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC--CccccccccchhhcccccCccccccccCcccccCC
Confidence            34566788999  99999999988  88999999997443111  111112234566666666 5999999999999999


Q ss_pred             eEEEEEeeecCCChhhhhhccCC-CChHHHHHHHHHHHH----HHhhhccCCceecCCCCCcEEEccC-CceEEeccCcc
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILS----GLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMA  261 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~-ls~~~i~~i~~qIl~----aL~yLH~~gIvHrDLKp~NILl~~~-g~vKL~DFGla  261 (602)
                      .+|+-+|+| +.+|..+...... +++..++..+.+...    ||.++|..+++|-|+||+||++..+ ..++++|||+.
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            999999999 5888888876544 888999999999999    9999999999999999999999999 89999999999


Q ss_pred             ccccCCCCCc------ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCc--hhHHHHHHhhCCCCCC
Q 007478          262 KHIAGQSCPL------SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY--EGVAAMFKIGNSKELP  333 (602)
Q Consensus       262 ~~~~~~~~~~------~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~--~~~~~~~~i~~~~~~~  333 (602)
                      ..+.......      ...|...|++||.+.+.  ++.+.|||+||.++.+..++...+...  .....+   .......
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~---r~~~ip~  345 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL---RQGYIPL  345 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---ccccCch
Confidence            8876554222      12478889999998643  788999999999999999887665322  211111   1222233


Q ss_pred             CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccC
Q 007478          334 TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       334 ~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~  372 (602)
                      ++-...+.++...+..|++.++-.|++++.++.|.++..
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            444566777888999999999999999999999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=1.2e-14  Score=158.60  Aligned_cols=252  Identities=26%  Similarity=0.249  Sum_probs=188.1

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEEC-CCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc-CCCcEEEEeccccccce
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNS-DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  188 (602)
                      ...+|.++..||.|.|+.||.+..+ .++..|++|.+.... ....+.+..+ .|+-+...+ .|.+++.++..|...+.
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcch-hhhhHhhHhhcccccCCCCCCcccccc
Confidence            3567888999999999999988755 688999999875421 1222222222 455555555 68999999988888888


Q ss_pred             EEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccC-CceEEeccCccccccCC
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~vKL~DFGla~~~~~~  267 (602)
                      .||-.|||+++++...+.-...+.+...+++..|++.++.++|++.++|+|+||+||++..+ +..++.|||..+.+.-.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            89999999999998877555568888999999999999999999999999999999999886 78999999988753211


Q ss_pred             CCCcccCCCCCCC-CcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHH
Q 007478          268 SCPLSFKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       268 ~~~~~~~GT~~Y~-APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dL  346 (602)
                      .  ....++-+++ ..|++.....+..+.|++|||..++|.+++...-......   ..+ ....++..+ ....++..+
T Consensus       421 ~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i-~~~~~p~~~-~~~~~~q~~  493 (524)
T KOG0601|consen  421 S--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI-RSGDTPNLP-GLKLQLQVL  493 (524)
T ss_pred             c--ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eee-ecccccCCC-chHHhhhhh
Confidence            1  1222344455 3666655555788999999999999999987543222111   111 122344444 334889999


Q ss_pred             HHHHcccCCCCCCCHHHHhcCcccc
Q 007478          347 IRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       347 I~~~L~~dP~~Rpt~~eiL~hp~f~  371 (602)
                      .+.++..++..|+.+.++..|.-|.
T Consensus       494 ~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  494 LKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhcCCccccchhhhhhcccchhh
Confidence            9999999999999999998886654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.53  E-value=8.4e-15  Score=162.85  Aligned_cols=145  Identities=19%  Similarity=0.232  Sum_probs=96.9

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccch------------------------------hcHHHHHHHHH
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA------------------------------KSKESAKQLMQ  163 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~------------------------------~~~~~~~~l~~  163 (602)
                      .|+. +.||+|++|+||+|+.+.+|+.||||+++..-..                              .-.+..+.+.+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4555 7899999999999999988999999998632100                              00122233344


Q ss_pred             HHHHHH------hcC----CCcEEEEecccc-ccceEEEEEeeecCCChhhh--hhccC----CCChHHHHHHHHHHHHH
Q 007478          164 EIVLLS------RLR----HPNIVQYYGSKT-VEDKLYIYLEYVSGGSIYKL--LQDYG----QFGEPAIRNYTQQILSG  226 (602)
Q Consensus       164 Ei~iL~------~l~----HpnIv~l~~~~~-~~~~~~lVmE~~~ggsL~~~--l~~~~----~ls~~~i~~i~~qIl~a  226 (602)
                      |+.++.      ++.    +.+.+.+-.++. .....+|||||+.|+.|.++  +...+    .+.+..+..++.||+  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence            444333      331    222222222221 13456799999999999875  33333    244555556666665  


Q ss_pred             HhhhccCCceecCCCCCcEEEccCC----ceEEeccCccccccC
Q 007478          227 LAFLHSKHTVHRDIKGANILVDPNG----RVKLADFGMAKHIAG  266 (602)
Q Consensus       227 L~yLH~~gIvHrDLKp~NILl~~~g----~vKL~DFGla~~~~~  266 (602)
                           ..|++|+|+||+||+++.+|    .++++|||++..+..
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 58999999999999999988    999999999977643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.50  E-value=2.3e-13  Score=149.85  Aligned_cols=168  Identities=26%  Similarity=0.406  Sum_probs=132.5

Q ss_pred             EEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCChhhhhhccCC
Q 007478          131 VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ  210 (602)
Q Consensus       131 ~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~  210 (602)
                      .|..+.++.+|.|.+.+....    +......+-++.|+.++||||+++++.++.++.+|||+|-+  ..|..++++.  
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l--  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL--  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh--
Confidence            466677889999998875322    45566778889999999999999999999999999999998  4677777653  


Q ss_pred             CChHHHHHHHHHHHHHHhhhc-cCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC-cccCCCCCCCCccccccc
Q 007478          211 FGEPAIRNYTQQILSGLAFLH-SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP-LSFKGSPYWMAPEVIKNS  288 (602)
Q Consensus       211 ls~~~i~~i~~qIl~aL~yLH-~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-~~~~GT~~Y~APEvl~~~  288 (602)
                       +...+..-++||+.||.||| +++++|++|.-..|+|+..|+.||++|-++....+.... ....---.|..|+.+...
T Consensus       102 -~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  102 -GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence             47788889999999999997 679999999999999999999999999987655433321 111112236667765322


Q ss_pred             CCCCccccchhhhhHHHHHhhC
Q 007478          289 SGCNLAVDIWSLGCTVLEMATT  310 (602)
Q Consensus       289 ~~~s~~sDVWSLGviLyELltG  310 (602)
                         .-..|.|-|||+++|++.|
T Consensus       181 ---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 ---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ---ccchhhhhHHHHHHHHhCc
Confidence               1357999999999999999

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=1.5e-13  Score=150.51  Aligned_cols=142  Identities=18%  Similarity=0.203  Sum_probs=97.7

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhc------------------------------HHHHH------HHH
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKS------------------------------KESAK------QLM  162 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~------------------------------~~~~~------~l~  162 (602)
                      +.||.|++|+||+|+.+ +|+.||||+.+..-...-                              .+...      ++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            56999999999999876 589999998753110000                              00011      244


Q ss_pred             HHHHHHHhcC-----CCcEEEEeccc-cccceEEEEEeeecCCChhhhhhcc-CCCChHHHHHHHHHHHH-HHhhhccCC
Q 007478          163 QEIVLLSRLR-----HPNIVQYYGSK-TVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILS-GLAFLHSKH  234 (602)
Q Consensus       163 ~Ei~iL~~l~-----HpnIv~l~~~~-~~~~~~~lVmE~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~-aL~yLH~~g  234 (602)
                      +|+..+.++.     +++| .+-.++ ......+|||||++|++|.++.... ...   ....++.+++. .+..+|..|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence            4555555542     3333 222222 2234579999999999999876532 112   23456666665 478899999


Q ss_pred             ceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          235 TVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       235 IvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                      ++|+|+||+||+++.++.++|+|||++..+.
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999997764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=4.5e-13  Score=126.74  Aligned_cols=127  Identities=18%  Similarity=0.135  Sum_probs=93.9

Q ss_pred             eeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcE-EEEeccccccceEEEEEeee
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI-VQYYGSKTVEDKLYIYLEYV  196 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lVmE~~  196 (602)
                      ++.|+.|.++.||++...  ++.|++|+......     ....+.+|+.+++.+.+.++ .+++.+..  ...++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEec
Confidence            467899999999999764  77899997643111     12235678888888855443 34444432  2357999999


Q ss_pred             cCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCc-----eecCCCCCcEEEccCCceEEeccCccc
Q 007478          197 SGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT-----VHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       197 ~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gI-----vHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                      +|.++.+.        ......++.+++.+|..||..++     +|+|+|++||+++ ++.++|+|||.+.
T Consensus        74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            99887653        11123467899999999999885     9999999999999 6689999999765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.40  E-value=2.4e-12  Score=125.82  Aligned_cols=141  Identities=18%  Similarity=0.226  Sum_probs=101.0

Q ss_pred             eeEeecCCeEEEEEEECC------CCcEEEEEEEeccc-chhc-----------------HHHHHHHH----HHHHHHHh
Q 007478          119 KMLGRGTFGHVYVGFNSD------SGEMCAMKEVTLFD-DAKS-----------------KESAKQLM----QEIVLLSR  170 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~------tg~~vAvK~i~~~~-~~~~-----------------~~~~~~l~----~Ei~iL~~  170 (602)
                      ..||.|.-+.||.|....      .+..+|||+.+... ..+.                 ....+.+.    +|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997653      35799999876411 0000                 01122333    79999988


Q ss_pred             cCC--CcEEEEeccccccceEEEEEeeecCCChhh-hhhccCCCChHHHHHHHHHHHHHHhhh-ccCCceecCCCCCcEE
Q 007478          171 LRH--PNIVQYYGSKTVEDKLYIYLEYVSGGSIYK-LLQDYGQFGEPAIRNYTQQILSGLAFL-HSKHTVHRDIKGANIL  246 (602)
Q Consensus       171 l~H--pnIv~l~~~~~~~~~~~lVmE~~~ggsL~~-~l~~~~~ls~~~i~~i~~qIl~aL~yL-H~~gIvHrDLKp~NIL  246 (602)
                      +..  -++.+.+++    ...+|||||+.++.+.. .++. ..+++.++..+..|++.+|..| |+.||||+||++.|||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            843  334444443    45789999997654433 2332 3456667788899999999998 8999999999999999


Q ss_pred             EccCCceEEeccCcccccc
Q 007478          247 VDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       247 l~~~g~vKL~DFGla~~~~  265 (602)
                      ++ ++.+.|+|||.+....
T Consensus       158 ~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE-CCcEEEEECCCceeCC
Confidence            97 4689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=4.4e-14  Score=143.56  Aligned_cols=241  Identities=24%  Similarity=0.320  Sum_probs=156.6

Q ss_pred             EEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEecccccc-----ceEEEEEeeecCCChh
Q 007478          128 HVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE-----DKLYIYLEYVSGGSIY  202 (602)
Q Consensus       128 ~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~lVmE~~~ggsL~  202 (602)
                      .||++.++..|..|..-.+.......-++.......-..-|-++.|-|||+++.++.+.     .+..++.||++.|+|.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            46777777777666554433211111111111122222345566799999999987653     3578899999999999


Q ss_pred             hhhhcc----CCCChHHHHHHHHHHHHHHhhhccC--CceecCCCCCcEEEccCCceEEeccCcccc-c----cCCCCCc
Q 007478          203 KLLQDY----GQFGEPAIRNYTQQILSGLAFLHSK--HTVHRDIKGANILVDPNGRVKLADFGMAKH-I----AGQSCPL  271 (602)
Q Consensus       203 ~~l~~~----~~ls~~~i~~i~~qIl~aL~yLH~~--gIvHrDLKp~NILl~~~g~vKL~DFGla~~-~----~~~~~~~  271 (602)
                      .+|++.    ..+.....++|+.||+.||.|||+.  -|+|+.+...-|++..+|-+||+----... .    .......
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~  240 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS  240 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence            999753    4577888999999999999999986  599999999999999999888864221110 0    0011111


Q ss_pred             ccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCc-hhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHH
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY-EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       272 ~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~  350 (602)
                      ...|-++|.|||.=.... .+.++|||++|....||..+..--... ........+.+...  .   .-..--+++|.+|
T Consensus       241 ~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~--~---len~lqr~~i~kc  314 (458)
T KOG1266|consen  241 VNTSLPGFSAPESGTTTN-TTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII--G---LENGLQRGSITKC  314 (458)
T ss_pred             ccccCCccccCCcCcccc-cccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee--e---ccCccccCcCccc
Confidence            233678899999643322 566999999999999998876432111 11111111111000  0   0011124789999


Q ss_pred             cccCCCCCCCHHHHhcCccccCCC
Q 007478          351 LQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       351 L~~dP~~Rpt~~eiL~hp~f~~~~  374 (602)
                      |+-.|..||++.+++.||..=.+.
T Consensus       315 l~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  315 LEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             ccCCCCCCcchhhhhcCceeeecc
Confidence            999999999999999999865543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=4.9e-11  Score=117.35  Aligned_cols=140  Identities=20%  Similarity=0.213  Sum_probs=104.0

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCC--CcEEEEecccccc---ceEEEEE
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNIVQYYGSKTVE---DKLYIYL  193 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H--pnIv~l~~~~~~~---~~~~lVm  193 (602)
                      +.|+.|.++.||++.... |+.+++|+.......   .....+.+|+.+++.+.+  .++.+++.+....   +..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            568999999999998754 688999986532111   123467789999999865  3345566555443   3678999


Q ss_pred             eeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc-----------------------------------------
Q 007478          194 EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-----------------------------------------  232 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-----------------------------------------  232 (602)
                      ||++|.+|.+.+.. ..+++.+...++.+++.+|.+||+                                         
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99999998886642 356677777777888888777773                                         


Q ss_pred             ---------------CCceecCCCCCcEEEcc--CCceEEeccCcccc
Q 007478          233 ---------------KHTVHRDIKGANILVDP--NGRVKLADFGMAKH  263 (602)
Q Consensus       233 ---------------~gIvHrDLKp~NILl~~--~g~vKL~DFGla~~  263 (602)
                                     ..++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           23699999999999998  66789999987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=1.2e-10  Score=111.28  Aligned_cols=132  Identities=20%  Similarity=0.313  Sum_probs=96.0

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccc-----hhcHHHHHHHHHHHHHHHhcCCCcE--EEEeccccccceEEE
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD-----AKSKESAKQLMQEIVLLSRLRHPNI--VQYYGSKTVEDKLYI  191 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~~~~~~~l~~Ei~iL~~l~HpnI--v~l~~~~~~~~~~~l  191 (602)
                      ..|++|+-+.+|++...  |..+++|. .+.+.     ...+-......+|+.+|..+.--.|  ..++  +.+.+...|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~--dvD~~~~~I   76 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVY--DVDPDNGLI   76 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEE--EEcCCCCEE
Confidence            35789999999998664  44566663 22111     1222234567789999988853333  2333  334566789


Q ss_pred             EEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccc
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       192 VmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~  263 (602)
                      +|||++|-.|.+++...       ...++..+-.-+.-||..||||+||.++||++..++ +.++||||+..
T Consensus        77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999999888764       245677777778889999999999999999997764 99999999875

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.13  E-value=2.6e-10  Score=108.54  Aligned_cols=145  Identities=23%  Similarity=0.287  Sum_probs=103.7

Q ss_pred             EeeeEeecCCeEEEEEEECCCCcEEEEEEEec--c--cchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccccceEEEE
Q 007478          117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL--F--DDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       117 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~--~--~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  192 (602)
                      ...+|-+|+-+.|+++...  |+.+.||.=-.  .  .....+-..++..+|+++|.++.--.|..-.-++.+...-+|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5678999999999999764  88888885211  0  1112223346778899999887533332211124445557899


Q ss_pred             EeeecC-CChhhhhhccC--CCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC---ceEEeccCcccc
Q 007478          193 LEYVSG-GSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG---RVKLADFGMAKH  263 (602)
Q Consensus       193 mE~~~g-gsL~~~l~~~~--~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~vKL~DFGla~~  263 (602)
                      |||++| -++.+++....  .........++.+|-..|.-||.++|||+||..+||+|..++   .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999976 47788876532  233333478999999999999999999999999999997665   458999999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.11  E-value=1.3e-09  Score=117.42  Aligned_cols=212  Identities=17%  Similarity=0.210  Sum_probs=154.7

Q ss_pred             CeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc----cceEEEEEeeecC-CC
Q 007478          126 FGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV----EDKLYIYLEYVSG-GS  200 (602)
Q Consensus       126 fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lVmE~~~g-gs  200 (602)
                      -.+.|++....+|..|++|.++.......    .....-+++++++.|.|||.+.++|..    +..+++|++|.++ ++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            45679999999999999999854222111    112345678999999999999998873    4568999999865 67


Q ss_pred             hhhhhhcc---------------CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcccccc
Q 007478          201 IYKLLQDY---------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       201 L~~~l~~~---------------~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~  265 (602)
                      |.++.-..               ...+|..+|.|+.||..||.++|+.|+..+-|.+.+||++.+.+++|..-|+...+.
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            77765321               236788999999999999999999999999999999999999889998877776654


Q ss_pred             CCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCC-CCCchhHHHHHHhhCCCCCCCCCCCCCHHHH
Q 007478          266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAAMFKIGNSKELPTIPDDLSDEGK  344 (602)
Q Consensus       266 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~P-f~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  344 (602)
                      .+..             |-+...    .+-|.=.||.+++.|.||..= |.........        ...+-...+.+++
T Consensus       445 ~d~~-------------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--------~~~I~~~yS~D~r  499 (655)
T KOG3741|consen  445 EDPT-------------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSH--------LTRITTTYSTDLR  499 (655)
T ss_pred             CCCC-------------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHH--------HHHhhhhhhHHHH
Confidence            4330             112222    266888999999999999632 2111111110        1123347889999


Q ss_pred             HHHHHHcccCCCCCCCHHHHhcC
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       345 dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      ++|..+...++++ -++.+++.|
T Consensus       500 n~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  500 NVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHhcCccc-ccHHHHHHH
Confidence            9999999999886 577777754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.03  E-value=3e-10  Score=126.00  Aligned_cols=151  Identities=25%  Similarity=0.344  Sum_probs=115.3

Q ss_pred             HHHHHHhhhcc-CCceecCCCCCcEEEccCCceEEeccCccccccCCCCCc----------ccCCCCCCCCcccccccCC
Q 007478          222 QILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL----------SFKGSPYWMAPEVIKNSSG  290 (602)
Q Consensus       222 qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~----------~~~GT~~Y~APEvl~~~~~  290 (602)
                      +++.||.|+|. .++||+.|.|++|.++.+|.+||+.|+.+....+.....          ...-...|.|||++.+.. 
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~-  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT-  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-
Confidence            44489999996 599999999999999999999999999887655422211          112356799999998744 


Q ss_pred             CCccccchhhhhHHHHHh-hCCCCCCCchhHHHHHH--hhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcC
Q 007478          291 CNLAVDIWSLGCTVLEMA-TTKPPWSQYEGVAAMFK--IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       291 ~s~~sDVWSLGviLyELl-tG~~Pf~~~~~~~~~~~--i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~h  367 (602)
                      .+.++|+|||||++|.+. .|+..+...........  .........+..+++.++++=|.++|..+...||++.+++.-
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence            788999999999999999 56666654332222111  111222334557899999999999999999999999999999


Q ss_pred             ccccCC
Q 007478          368 PFVKGA  373 (602)
Q Consensus       368 p~f~~~  373 (602)
                      +||.+.
T Consensus       266 ~ff~D~  271 (700)
T KOG2137|consen  266 PFFSDP  271 (700)
T ss_pred             cccCCc
Confidence            999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=2e-09  Score=104.70  Aligned_cols=130  Identities=25%  Similarity=0.318  Sum_probs=85.6

Q ss_pred             EEEEEEECCCCcEEEEEEEeccc--------------c--------hhcHHHHHHHHHHHHHHHhcCCC--cEEEEeccc
Q 007478          128 HVYVGFNSDSGEMCAMKEVTLFD--------------D--------AKSKESAKQLMQEIVLLSRLRHP--NIVQYYGSK  183 (602)
Q Consensus       128 ~Vy~a~~~~tg~~vAvK~i~~~~--------------~--------~~~~~~~~~l~~Ei~iL~~l~Hp--nIv~l~~~~  183 (602)
                      .||.|... .|..+|||+.+...              .        ...........+|.+.|.++..-  ++.+.+++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999875 47899999875310              0        01112234567899999999755  455555432


Q ss_pred             cccceEEEEEeeec--CCChhhhhhccCCCChHHHHHHHHHHHHHHhh-hccCCceecCCCCCcEEEccCCceEEeccCc
Q 007478          184 TVEDKLYIYLEYVS--GGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF-LHSKHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       184 ~~~~~~~lVmE~~~--ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~y-LH~~gIvHrDLKp~NILl~~~g~vKL~DFGl  260 (602)
                          ..+|||||++  |..+..+...  .++......++.+++..+.. +|..||||+||.+.|||++++ .+.|+|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                3579999998  6555544332  22356678888999985555 689999999999999999887 899999998


Q ss_pred             ccccc
Q 007478          261 AKHIA  265 (602)
Q Consensus       261 a~~~~  265 (602)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            87643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.99  E-value=3.7e-09  Score=108.58  Aligned_cols=140  Identities=14%  Similarity=0.029  Sum_probs=97.5

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHH----------HHHHHHHHHHhcC-----CCcEEEEeccc
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK----------QLMQEIVLLSRLR-----HPNIVQYYGSK  183 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~----------~l~~Ei~iL~~l~-----HpnIv~l~~~~  183 (602)
                      +++-+-....|+++..  .|+.|.||......   ..+..+          ...+|...+.+|.     .|.+|-+...-
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~---~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~  102 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTG---WGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERG  102 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCc---HHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEec
Confidence            4455555555777643  47789999653211   111111          3567888777763     34444443211


Q ss_pred             c--ccceEEEEEeeecCC-Chhhhhhc--cCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEcc-------CC
Q 007478          184 T--VEDKLYIYLEYVSGG-SIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-------NG  251 (602)
Q Consensus       184 ~--~~~~~~lVmE~~~gg-sL~~~l~~--~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-------~g  251 (602)
                      .  ....-+||||++++- +|.+++..  ...........++.+|+..+.-||.+||+|+|+++.|||++.       +.
T Consensus       103 ~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        103 SNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             CCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCc
Confidence            1  134578999999875 89988864  244566778899999999999999999999999999999975       46


Q ss_pred             ceEEeccCcccc
Q 007478          252 RVKLADFGMAKH  263 (602)
Q Consensus       252 ~vKL~DFGla~~  263 (602)
                      .+.|+||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.85  E-value=7.9e-10  Score=121.43  Aligned_cols=242  Identities=25%  Similarity=0.241  Sum_probs=173.0

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCc-EEEEeccccccceEEEE
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN-IVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV  192 (602)
                      .+....-+++|+++++++.+...+...+ .+.+...         ....-++++|.+++||| .+..++.++.++..+++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence            3455667899999999998776654444 6666421         22345788999999999 78888888888999999


Q ss_pred             EeeecCC-Chhhhh-hccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCccccccCCCCC
Q 007478          193 LEYVSGG-SIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       193 mE~~~gg-sL~~~l-~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  270 (602)
                      |+++.++ +-.... ...-.+.+-+...+.+.-+++|+|||+.-=+|||    |||... +..|+.||+....+......
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccccc
Confidence            9999887 222221 1112344445566677778899999998888999    888765 68999999999888776667


Q ss_pred             cccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCchhHHHHHHhhCCCCCCCCCC---CCCHHHHHHH
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD---DLSDEGKDFI  347 (602)
Q Consensus       271 ~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~---~~s~~l~dLI  347 (602)
                      .+..+|+.|+|||+..... +..+.|+|++++--.+|.-|-+|-..  .......+......+.+-.   .-+..-.++.
T Consensus       388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~  464 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFP  464 (829)
T ss_pred             ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCc
Confidence            7888999999999987766 88899999999988888888877533  1111111222111111111   0011112577


Q ss_pred             HHHcccCCCCCCCHHHHhcCccccCC
Q 007478          348 RLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       348 ~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      ..|+...|..|+..-.++.|.+|.+.
T Consensus       465 ~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  465 APCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             ccccCCCCCCCcchhhHHHHHHhccC
Confidence            88999999999999999999999865

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.77  E-value=3.7e-08  Score=99.46  Aligned_cols=139  Identities=24%  Similarity=0.289  Sum_probs=101.6

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEeccc----------------chhc--HHHHHHHHHHHHHHHhcCCC--
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD----------------DAKS--KESAKQLMQEIVLLSRLRHP--  174 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~----------------~~~~--~~~~~~l~~Ei~iL~~l~Hp--  174 (602)
                      +.++..||-|.-+.||.|.+. .|..+|||.=+.-.                ...+  ......-.+|.++|.+|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            456788999999999999887 58999999643210                0001  01123455788999988644  


Q ss_pred             cEEEEeccccccceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceE
Q 007478          175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVK  254 (602)
Q Consensus       175 nIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vK  254 (602)
                      .|.+-++    .++..+||||++|-.|...-     ++...+..++..|+.-+.-+-..||||+|+..-|||++++|.+.
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            4555443    46789999999997776542     24555666777777777666699999999999999999999999


Q ss_pred             EeccCcccc
Q 007478          255 LADFGMAKH  263 (602)
Q Consensus       255 L~DFGla~~  263 (602)
                      ++||--+..
T Consensus       243 vIDwPQ~v~  251 (304)
T COG0478         243 VIDWPQAVP  251 (304)
T ss_pred             EEeCccccc
Confidence            999965543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.69  E-value=1.1e-07  Score=100.35  Aligned_cols=237  Identities=19%  Similarity=0.209  Sum_probs=152.6

Q ss_pred             EeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEE--------Eeccccccce
Q 007478          117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ--------YYGSKTVEDK  188 (602)
Q Consensus       117 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~--------l~~~~~~~~~  188 (602)
                      .++.||+|+-+.+|-.-.-   ...+.|+.........    .+...|  +.+.-.||-+-.        ++|--. ...
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~----aqk~a~--la~~p~~p~~~~rvaWPqa~L~G~~~-~~~   84 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQ----AQKVAE--LAATPDAPLLNYRVAWPQATLHGGRR-GKV   84 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHH----HHHHHH--hccCCCCcchhhhhcccHHHhhCCCc-cce
Confidence            4677999999999965322   2355677654222111    111111  122335654322        222211 223


Q ss_pred             EEEEEeeecCCC-hhhhhh------ccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEeccCcc
Q 007478          189 LYIYLEYVSGGS-IYKLLQ------DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA  261 (602)
Q Consensus       189 ~~lVmE~~~ggs-L~~~l~------~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DFGla  261 (602)
                      +.+.|..+.|.. +.+++.      .+..+.+..+.+.++.|+.+...||+.|.+-+|+.++|+|+.+++.|.|.|=...
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            778888887642 233332      2344678889999999999999999999999999999999999999999985543


Q ss_pred             ccccCCCCCcccCCCCCCCCcccccc----cCCCCccccchhhhhHHHHHhhC-CCCCCCchh-------HH-HHH----
Q 007478          262 KHIAGQSCPLSFKGSPYWMAPEVIKN----SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEG-------VA-AMF----  324 (602)
Q Consensus       262 ~~~~~~~~~~~~~GT~~Y~APEvl~~----~~~~s~~sDVWSLGviLyELltG-~~Pf~~~~~-------~~-~~~----  324 (602)
                      ............+|...|.+||...-    +.+-+...|.|.|||+|++||.| +.||.+...       .+ .+-    
T Consensus       165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            33344444556779999999998641    12245689999999999999885 999965321       11 110    


Q ss_pred             ----HhhCCC-CCC-CCC-CCCCHHHHHHHHHHcccC--CCCCCCHHH
Q 007478          325 ----KIGNSK-ELP-TIP-DDLSDEGKDFIRLCLQRN--PLNRPTAAE  363 (602)
Q Consensus       325 ----~i~~~~-~~~-~~p-~~~s~~l~dLI~~~L~~d--P~~Rpt~~e  363 (602)
                          +..... ..| .+| .-++++++.|..+|+...  +.-|||++.
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                000011 111 122 247899999999999753  457999754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.67  E-value=2.1e-07  Score=92.02  Aligned_cols=104  Identities=29%  Similarity=0.407  Sum_probs=80.9

Q ss_pred             HHHHHHHHHHhcC-----CCcEEEEeccccc-cceEEEEEeeecC-CChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc
Q 007478          160 QLMQEIVLLSRLR-----HPNIVQYYGSKTV-EDKLYIYLEYVSG-GSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS  232 (602)
Q Consensus       160 ~l~~Ei~iL~~l~-----HpnIv~l~~~~~~-~~~~~lVmE~~~g-gsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~  232 (602)
                      ...+|...+..|.     -|.+|.+...-.. ....+||+|++++ .+|.+++......+......++.+++..+.-||+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            4566777666663     3444444322111 1356899999987 4899999875557778889999999999999999


Q ss_pred             CCceecCCCCCcEEEccCC---ceEEeccCcccc
Q 007478          233 KHTVHRDIKGANILVDPNG---RVKLADFGMAKH  263 (602)
Q Consensus       233 ~gIvHrDLKp~NILl~~~g---~vKL~DFGla~~  263 (602)
                      +||+|+|+++.|||++.++   .+.|+||+.++.
T Consensus       137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999887   899999987765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.53  E-value=5.4e-07  Score=100.27  Aligned_cols=144  Identities=19%  Similarity=0.234  Sum_probs=90.6

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccc--------------------------hhc----HHHHHH------HH
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD--------------------------AKS----KESAKQ------LM  162 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------------------------~~~----~~~~~~------l~  162 (602)
                      +-|+.++-|+||+|+.+. |+.||||+.+..-.                          ..-    .+..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            568999999999999876 99999998652100                          000    111122      33


Q ss_pred             HHHHHHHhcC-----CCcEEEEeccccccceEEEEEeeecCCChhhhh--hccCCCChHHHHHHHHHHHHHHhhhccCCc
Q 007478          163 QEIVLLSRLR-----HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLL--QDYGQFGEPAIRNYTQQILSGLAFLHSKHT  235 (602)
Q Consensus       163 ~Ei~iL~~l~-----HpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l--~~~~~ls~~~i~~i~~qIl~aL~yLH~~gI  235 (602)
                      +|...+.+++     .++|.--.=+++-.+.-.|+|||++|-.+.+..  +. ..++...+.....++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            4444444442     233321111233345678999999999998884  44 3344333222222211  222334899


Q ss_pred             eecCCCCCcEEEccCCceEEeccCccccccC
Q 007478          236 VHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       236 vHrDLKp~NILl~~~g~vKL~DFGla~~~~~  266 (602)
                      +|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            9999999999999999999999999876643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.52  E-value=3e-07  Score=107.36  Aligned_cols=205  Identities=24%  Similarity=0.298  Sum_probs=150.8

Q ss_pred             HHHHHHHHHHHHHhcCCCcEEEEeccccccceE----EEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc
Q 007478          157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL----YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS  232 (602)
Q Consensus       157 ~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~----~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~  232 (602)
                      ......-|+..+..+.|+|++.++.+-......    .+..|+|..-++...++.-+..+...++.+..++++||.|+|+
T Consensus       225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            344455677888899999999998875443322    3345889999999999998999999999999999999999999


Q ss_pred             CCceecCCCCC---cEEEccCCceEEe--ccCccccccCCCCCcccCCCCCCCCcccccccCCCCc--cccchhhhhHHH
Q 007478          233 KHTVHRDIKGA---NILVDPNGRVKLA--DFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL--AVDIWSLGCTVL  305 (602)
Q Consensus       233 ~gIvHrDLKp~---NILl~~~g~vKL~--DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~--~sDVWSLGviLy  305 (602)
                      ....|.-|...   +..++..+.+.++  ||+....+..........-+..|.++|...... +..  ..|+|.+|.++.
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHHHHh
Confidence            96666555444   4444556667766  999888776665555555667788999876544 433  469999999999


Q ss_pred             HHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          306 EMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       306 ELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      .+..|..+-....   ....        -++..+..+..+++.+|+.-+.++|+++.+++.|+|.+..
T Consensus       384 ~~~~~~~i~~~~~---~~~~--------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  384 QLSQGEDISEKSA---VPVS--------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             hhhhcCccccccc---chhh--------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            9998875421110   0000        1111222378899999999999999999999999998754

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.48  E-value=1.9e-06  Score=85.40  Aligned_cols=139  Identities=17%  Similarity=0.195  Sum_probs=87.8

Q ss_pred             CCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHH------HHHHHHHHHHhcC---CCcEEEEec--
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK------QLMQEIVLLSRLR---HPNIVQYYG--  181 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~------~l~~Ei~iL~~l~---HpnIv~l~~--  181 (602)
                      .+|+..+++-......|.+..  -+|+.+++|..+...... +....      ...+++..+..+.   .-.++.++.  
T Consensus        31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~-er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRP-ERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhH-HHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            567777888777777777653  347889999765321111 11111      1123333333332   222222222  


Q ss_pred             ---cccccceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCceEEecc
Q 007478          182 ---SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADF  258 (602)
Q Consensus       182 ---~~~~~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~vKL~DF  258 (602)
                         .+......+|+|||++|..|.++..    +++    .+...|..+|.-||+.|++|+|+.|.|++++.+ .++++||
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~  178 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT  178 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence               1222345678999999998887642    222    245667788999999999999999999999866 4999999


Q ss_pred             Ccccc
Q 007478          259 GMAKH  263 (602)
Q Consensus       259 Gla~~  263 (602)
                      +..+.
T Consensus       179 ~~k~~  183 (229)
T PF06176_consen  179 QGKRM  183 (229)
T ss_pred             ccccc
Confidence            86554

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.48  E-value=7.4e-07  Score=87.89  Aligned_cols=141  Identities=14%  Similarity=0.201  Sum_probs=98.7

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEec--ccchhcHHHHHHHHHHHHHHHhcCCCc--EEEEe--ccccc--cceEEEE
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTL--FDDAKSKESAKQLMQEIVLLSRLRHPN--IVQYY--GSKTV--EDKLYIY  192 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~--~~~~~~~~~~~~l~~Ei~iL~~l~Hpn--Iv~l~--~~~~~--~~~~~lV  192 (602)
                      -|+||.+-|++....  |+.|-+|.-..  ........-...|.+|+..|.+|..-+  +.+..  +....  .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            477899999987543  44688886541  000000112356888999888885322  33333  11111  2357899


Q ss_pred             EeeecC-CChhhhhhcc--CCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCc--eEEeccCcccc
Q 007478          193 LEYVSG-GSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR--VKLADFGMAKH  263 (602)
Q Consensus       193 mE~~~g-gsL~~~l~~~--~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~--vKL~DFGla~~  263 (602)
                      +|-+.| .+|.+++.+.  .+.+......+..+|+..|.-||..|+.|+|+-+.|||++.+|.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997754 6888888653  34577777899999999999999999999999999999987777  99999976543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.34  E-value=2.8e-06  Score=85.23  Aligned_cols=133  Identities=14%  Similarity=0.161  Sum_probs=79.5

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCc--EEEEeccccccceEEEEEeee
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN--IVQYYGSKTVEDKLYIYLEYV  196 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~lVmE~~  196 (602)
                      ..||+|..+.||+.    .|..+++|....   ..   ....+.+|.++++.+..-.  +.+.+++....+..++|||++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~---~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNP---GF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCC---CC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence            56899999999984    245677887642   11   1234578998888875322  355666666677788999999


Q ss_pred             cCCC-hhhhh---------------------hcc--CCCChHH-HHHHHHHH----------HH-HHhhhc----cCCce
Q 007478          197 SGGS-IYKLL---------------------QDY--GQFGEPA-IRNYTQQI----------LS-GLAFLH----SKHTV  236 (602)
Q Consensus       197 ~ggs-L~~~l---------------------~~~--~~ls~~~-i~~i~~qI----------l~-aL~yLH----~~gIv  236 (602)
                      +|.+ +...+                     +..  ....... ...+..++          .. ...+|.    ...++
T Consensus        77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            9864 11111                     000  0111111 00111011          11 111221    12578


Q ss_pred             ecCCCCCcEEEccCCceEEeccCccc
Q 007478          237 HRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       237 HrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                      |+|+.|.||++++++ +.|+||+.+.
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcC
Confidence            999999999999888 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.34  E-value=6.4e-06  Score=82.66  Aligned_cols=140  Identities=17%  Similarity=0.168  Sum_probs=92.4

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcH-------------------H-HHHHHHHHHHHHHhcC--CCcE
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK-------------------E-SAKQLMQEIVLLSRLR--HPNI  176 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~-------------------~-~~~~l~~Ei~iL~~l~--HpnI  176 (602)
                      ..|..|.-+.||+|.. .++..+|+|+.+.....-..                   . ...=..+|+.-|+++.  +-.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3677888899999975 45889999998642110000                   0 0011235666676663  2223


Q ss_pred             EEEeccccccceEEEEEeeecCC-ChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc-CCceecCCCCCcEEEccCCceE
Q 007478          177 VQYYGSKTVEDKLYIYLEYVSGG-SIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVK  254 (602)
Q Consensus       177 v~l~~~~~~~~~~~lVmE~~~gg-sL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~vK  254 (602)
                      .+-+++.    .-.|||||+... .-.-.|+. -.+...++..+..+++..+.-|-. .++||+||..-|||+. ++.+.
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            3333332    257999999543 11222222 233444788899999999988776 9999999999999999 77999


Q ss_pred             EeccCcccccc
Q 007478          255 LADFGMAKHIA  265 (602)
Q Consensus       255 L~DFGla~~~~  265 (602)
                      |+|||-|....
T Consensus       207 iID~~QaV~~~  217 (268)
T COG1718         207 IIDVSQAVTID  217 (268)
T ss_pred             EEECccccccC
Confidence            99999887654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.29  E-value=1.3e-05  Score=79.05  Aligned_cols=137  Identities=24%  Similarity=0.356  Sum_probs=79.3

Q ss_pred             eeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCC--cEEEEeccc---cccceEEEE
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP--NIVQYYGSK---TVEDKLYIY  192 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hp--nIv~l~~~~---~~~~~~~lV  192 (602)
                      ++.|+.|..+.||++....  ..+++|+...    .  .....+.+|+.+++.+...  .+.+++...   ......+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~----~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP----P--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESS----H--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCC----C--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence            5679999999999998765  4899997642    1  3455667888888777422  244555422   233457999


Q ss_pred             EeeecCCChhh----------------hhh---cc-CC---CCh-H-----HHHHH---------------HHHHHH-HH
Q 007478          193 LEYVSGGSIYK----------------LLQ---DY-GQ---FGE-P-----AIRNY---------------TQQILS-GL  227 (602)
Q Consensus       193 mE~~~ggsL~~----------------~l~---~~-~~---ls~-~-----~i~~i---------------~~qIl~-aL  227 (602)
                      |++++|..+..                .+.   .. ..   +.. .     ....+               ...+.. .+
T Consensus        74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            99999988877                111   10 00   000 0     00000               011111 22


Q ss_pred             hhhc-------cCCceecCCCCCcEEEc-cCCceEEeccCccc
Q 007478          228 AFLH-------SKHTVHRDIKGANILVD-PNGRVKLADFGMAK  262 (602)
Q Consensus       228 ~yLH-------~~gIvHrDLKp~NILl~-~~g~vKL~DFGla~  262 (602)
                      ..++       ...++|+|+.+.|||++ .++.+-|+||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3332       35699999999999999 66667899998654

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=4.3e-06  Score=92.99  Aligned_cols=142  Identities=23%  Similarity=0.216  Sum_probs=89.6

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccc---------------------------hhcHHHHHHHHHHHHHHHh-
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD---------------------------AKSKESAKQLMQEIVLLSR-  170 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---------------------------~~~~~~~~~l~~Ei~iL~~-  170 (602)
                      +.||.-+.|+||+|+.+. |+.||||+-+..-.                           ..-.+..+.+..|+..++. 
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            569999999999999887 99999997542000                           0011222333334333322 


Q ss_pred             ---------cCCCc------EEEEeccccccceEEEEEeeecCCChhhhh--hccCCCChHHHHHHHHHHHHHHhhhccC
Q 007478          171 ---------LRHPN------IVQYYGSKTVEDKLYIYLEYVSGGSIYKLL--QDYGQFGEPAIRNYTQQILSGLAFLHSK  233 (602)
Q Consensus       171 ---------l~Hpn------Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l--~~~~~ls~~~i~~i~~qIl~aL~yLH~~  233 (602)
                               +.|-+      |.++|-  .-.....|+||||+|..+.|+-  .+. .++...+..-+.+...-  -|=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~--qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLE--QIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHH--HHHhc
Confidence                     22444      334432  2234678999999999887764  333 45554443333332222  22346


Q ss_pred             CceecCCCCCcEEEcc----CCceEEeccCccccccC
Q 007478          234 HTVHRDIKGANILVDP----NGRVKLADFGMAKHIAG  266 (602)
Q Consensus       234 gIvHrDLKp~NILl~~----~g~vKL~DFGla~~~~~  266 (602)
                      |++|+|-+|.|||+..    ++.+.|.|||+...+..
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            7999999999999984    67899999999876643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.22  E-value=2.3e-05  Score=76.92  Aligned_cols=129  Identities=23%  Similarity=0.271  Sum_probs=90.2

Q ss_pred             CCceEeeeEeecCC-eEEEEEEECCCCcEEEEEEEecc---cc------hhcH--------HHHHHHHHHHHHHHhc---
Q 007478          113 SHWKKGKMLGRGTF-GHVYVGFNSDSGEMCAMKEVTLF---DD------AKSK--------ESAKQLMQEIVLLSRL---  171 (602)
Q Consensus       113 ~~y~~~~~LG~G~f-G~Vy~a~~~~tg~~vAvK~i~~~---~~------~~~~--------~~~~~l~~Ei~iL~~l---  171 (602)
                      .+++.++.||.|.- |.||++...  |+.||+|+++..   ..      ....        ....-|..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 999999764  789999994321   00      0000        1233577788776666   


Q ss_pred             CCCcE--EEEecccccc------------------ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhc
Q 007478          172 RHPNI--VQYYGSKTVE------------------DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH  231 (602)
Q Consensus       172 ~HpnI--v~l~~~~~~~------------------~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH  231 (602)
                      .+.++  |+++|+..-.                  ....||.||+....         .+    ...-+.+|++-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence            45555  8999876221                  12456777765433         12    2334667788889999


Q ss_pred             cCCceecCCCCCcEEEccCCceEEeccCcc
Q 007478          232 SKHTVHRDIKGANILVDPNGRVKLADFGMA  261 (602)
Q Consensus       232 ~~gIvHrDLKp~NILl~~~g~vKL~DFGla  261 (602)
                      ..||+-+|+|+.|..     .-||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999987     4689999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.18  E-value=9.3e-06  Score=81.88  Aligned_cols=133  Identities=17%  Similarity=0.137  Sum_probs=78.7

Q ss_pred             EeecCC-eEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcEEEEeccccccceEEEEEeeecC
Q 007478          121 LGRGTF-GHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDKLYIYLEYVSG  198 (602)
Q Consensus       121 LG~G~f-G~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lVmE~~~g  198 (602)
                      |-.|.. ..||+....  +..+.+|+.....       ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            334444 889998643  4678888654211       234567888887773 33355667666666678999999998


Q ss_pred             CChhhhhh----------------ccC-------CCChH--H-HHHH----------------------HHHHHHHHhh-
Q 007478          199 GSIYKLLQ----------------DYG-------QFGEP--A-IRNY----------------------TQQILSGLAF-  229 (602)
Q Consensus       199 gsL~~~l~----------------~~~-------~ls~~--~-i~~i----------------------~~qIl~aL~y-  229 (602)
                      .+|.....                +-.       .+...  . ....                      ..++..-|.. 
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            77754310                000       01100  0 0000                      1111111111 


Q ss_pred             ---hccCCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          230 ---LHSKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       230 ---LH~~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                         .....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence               122358999999999999998778899998654

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.05  E-value=3.9e-07  Score=108.19  Aligned_cols=213  Identities=14%  Similarity=0.024  Sum_probs=148.0

Q ss_pred             HHHHHHHHHHHHhcCCCcEEEEeccccc--cceEEEEEeeecCCChhhhhhcc----CCCChHHHHHHHHHHHHHHhhhc
Q 007478          158 AKQLMQEIVLLSRLRHPNIVQYYGSKTV--EDKLYIYLEYVSGGSIYKLLQDY----GQFGEPAIRNYTQQILSGLAFLH  231 (602)
Q Consensus       158 ~~~l~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lVmE~~~ggsL~~~l~~~----~~ls~~~i~~i~~qIl~aL~yLH  231 (602)
                      .+.+..|...++...|+++...+.-...  ....|++++||.+|.+++.|-+.    ..+...-+.....+...+..-+|
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            3445566666777889999887765433  34578999999999999998642    23333344444445477777777


Q ss_pred             cC-----CceecCCCCCcEEEccCCceEEeccCccccc-cCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHH
Q 007478          232 SK-----HTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVL  305 (602)
Q Consensus       232 ~~-----gIvHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLy  305 (602)
                      ..     =.+|++||+-|.+|..+-++|++++|+.+.. ..........+++.|+++++...-. ++.++|+|..|+.+|
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLY 1431 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHH
Confidence            53     2689999999999999999999999999933 2223334566888999999875544 787899999999999


Q ss_pred             HHhhCCCCCCCchhHHHHHHhhCCCCCCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccC
Q 007478          306 EMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       306 ELltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~  372 (602)
                      ++..|..+|...-.......+ .......++.-.+.++-.+...+|-..-..||.-..++.-+.|..
T Consensus      1432 ~rs~~n~~fi~flq~~Lkgii-dn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFFLQPALKGII-DNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             HHhcccHHHHHHHHHHHcCcc-cccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence            999999887433222222222 222223444444555555555555556668999999988777754

>PLN02876 acyl-CoA dehydrogenase

Probab=98.05  E-value=2.8e-05  Score=92.34  Aligned_cols=81  Identities=17%  Similarity=0.239  Sum_probs=55.2

Q ss_pred             eeeEeecCCeEEEEEEECCCC--cEEEEEEEecccchhcHHHHHHHHHHHHHHHhcC-CCcE--EEEecccccc---ceE
Q 007478          118 GKMLGRGTFGHVYVGFNSDSG--EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNI--VQYYGSKTVE---DKL  189 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg--~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnI--v~l~~~~~~~---~~~  189 (602)
                      .+.|+.|.+..+|+......+  ..+++|+.......   .....+.+|+.+|+.+. |.+|  .+++.++.+.   +..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            577899999999998765432  46777754321111   12346778999999985 6654  6777666553   467


Q ss_pred             EEEEeeecCCCh
Q 007478          190 YIYLEYVSGGSI  201 (602)
Q Consensus       190 ~lVmE~~~ggsL  201 (602)
                      |+||||++|..+
T Consensus       120 flVME~v~G~~~  131 (822)
T PLN02876        120 FYIMEYLEGRIF  131 (822)
T ss_pred             eEEEEecCCccc
Confidence            999999988653

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.92  E-value=2.6e-05  Score=74.47  Aligned_cols=130  Identities=22%  Similarity=0.237  Sum_probs=88.6

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcE-EEEeccccccceEEEEE
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI-VQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lVm  193 (602)
                      .+..+.||+|.+|.||++.++  |..+|+|+-+.      ......+..|+++|..+.-.++ .++|.+..    .++.|
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~------ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~m   91 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR------DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRM   91 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecC------CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhh
Confidence            345678999999999999876  56899996542      1224567889999998876555 34444332    34559


Q ss_pred             eeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCC-CCcEEEccCCceEEeccCcccc
Q 007478          194 EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIK-GANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       194 E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLK-p~NILl~~~g~vKL~DFGla~~  263 (602)
                      ||+.|-.|.++-...   +    +.-...+++.---|-..||-|..|. |..++|..++.+.|+||.-|+.
T Consensus        92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            999988887765421   1    2223344444444667899999884 5555555556999999988874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.89  E-value=0.00011  Score=72.38  Aligned_cols=132  Identities=21%  Similarity=0.312  Sum_probs=92.8

Q ss_pred             eeeEeecCCeEEEEEEECCCCcEEEEEEEecccch------------hcHHHHHHHHHHHHHHHhcC------CCcEEEE
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA------------KSKESAKQLMQEIVLLSRLR------HPNIVQY  179 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~------------~~~~~~~~l~~Ei~iL~~l~------HpnIv~l  179 (602)
                      ...||+|+.-.||.  |.. .....||++......            ......++..+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35699999999996  344 456778988653300            00112355666766666555      7889999


Q ss_pred             eccccccceEEEEEeeecC------CChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCC--
Q 007478          180 YGSKTVEDKLYIYLEYVSG------GSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG--  251 (602)
Q Consensus       180 ~~~~~~~~~~~lVmE~~~g------gsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g--  251 (602)
                      +|+.+++-...+|+|.+.+      -+|.+++++ +.+++    .+...+-.-.+||-+.+|+.+||+|.||++..+.  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999998743      357777754 34555    3334444556788899999999999999996442  


Q ss_pred             --ceEEec
Q 007478          252 --RVKLAD  257 (602)
Q Consensus       252 --~vKL~D  257 (602)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              578887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.84  E-value=0.00011  Score=73.76  Aligned_cols=73  Identities=14%  Similarity=0.129  Sum_probs=43.8

Q ss_pred             eeEeecCCe-EEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCC---cEEEEecccccc---ceEEE
Q 007478          119 KMLGRGTFG-HVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP---NIVQYYGSKTVE---DKLYI  191 (602)
Q Consensus       119 ~~LG~G~fG-~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hp---nIv~l~~~~~~~---~~~~l  191 (602)
                      +.|+.|+.. .||+.     +..+++|....      ......+.+|+++|..|...   .+.++++.....   ...|+
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSA------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCc------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            457777776 48975     23567775431      11234678899888877421   233444433322   23588


Q ss_pred             EEeeecCCChh
Q 007478          192 YLEYVSGGSIY  202 (602)
Q Consensus       192 VmE~~~ggsL~  202 (602)
                      +||+++|.++.
T Consensus        72 l~~~i~G~~l~   82 (235)
T cd05155          72 VYRWLEGETAT   82 (235)
T ss_pred             EEEeecCCCCC
Confidence            99999997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.81  E-value=5.4e-05  Score=73.87  Aligned_cols=99  Identities=26%  Similarity=0.272  Sum_probs=80.3

Q ss_pred             HHHHHHHHhcCC-CcEEEEeccccccceEEEEEeeecCCChhhh---hhccCCCChHHHHHHHHHHHHHHhhhcc---CC
Q 007478          162 MQEIVLLSRLRH-PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKL---LQDYGQFGEPAIRNYTQQILSGLAFLHS---KH  234 (602)
Q Consensus       162 ~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~---l~~~~~ls~~~i~~i~~qIl~aL~yLH~---~g  234 (602)
                      ..|..+|+.+.+ +++.+++|+|-    .++|.||+..+++...   +......++....+|+.+++..+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999976 69999999984    3668899987766532   2223356789999999999999999997   35


Q ss_pred             ceecCCCCCcEEEccCCceEEeccCccccc
Q 007478          235 TVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       235 IvHrDLKp~NILl~~~g~vKL~DFGla~~~  264 (602)
                      +...|++++|+-++++|++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            777999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.60  E-value=0.00036  Score=69.78  Aligned_cols=75  Identities=11%  Similarity=0.099  Sum_probs=46.4

Q ss_pred             eeeEeecCCeEEEEEEECC-CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCC-CcEEEEeccccccceEEEEEee
Q 007478          118 GKMLGRGTFGHVYVGFNSD-SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      ++.|..|-...||++.... .++.|++|+......     ..-...+|+.+++.+.. -...++++.+.  +  .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEe
Confidence            4568888889999986543 356888996543111     11123468888887743 22344444332  1  479999


Q ss_pred             ecCCCh
Q 007478          196 VSGGSI  201 (602)
Q Consensus       196 ~~ggsL  201 (602)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.56  E-value=6.1e-05  Score=78.17  Aligned_cols=138  Identities=16%  Similarity=0.211  Sum_probs=97.0

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecc----cchhc------------HHHH--HHHHHHHHHHHhcC-CC
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLF----DDAKS------------KESA--KQLMQEIVLLSRLR-HP  174 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~----~~~~~------------~~~~--~~l~~Ei~iL~~l~-Hp  174 (602)
                      -+.+++.||-|.-+-||.+.+.. |+..++|.-++-    ...+.            +-..  -...+|...|+.|. |-
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            35678899999999999998764 888999954320    00000            1111  12346888888884 22


Q ss_pred             -cEEEEeccccccceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceecCCCCCcEEEccCCce
Q 007478          175 -NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRV  253 (602)
Q Consensus       175 -nIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~g~v  253 (602)
                       -+.+.++    .++.++|||++.|..|...-+      ...+..+...++.-|.-|-.+|+||+|..--||+|++++.+
T Consensus       172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence             2333333    456899999999988876532      12344556666667778899999999999999999999999


Q ss_pred             EEeccCccc
Q 007478          254 KLADFGMAK  262 (602)
Q Consensus       254 KL~DFGla~  262 (602)
                      +++||--..
T Consensus       242 ~vIDFPQmv  250 (465)
T KOG2268|consen  242 VVIDFPQMV  250 (465)
T ss_pred             EEeechHhh
Confidence            999997543

>PRK10593 hypothetical protein; Provisional

Probab=97.54  E-value=0.0011  Score=69.40  Aligned_cols=78  Identities=19%  Similarity=0.211  Sum_probs=52.2

Q ss_pred             eEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCC---CcEEEEecccc---ccceE
Q 007478          116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH---PNIVQYYGSKT---VEDKL  189 (602)
Q Consensus       116 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H---pnIv~l~~~~~---~~~~~  189 (602)
                      ...+.||.|..+.||+..... + .+.+|..+..      .....+.+|...|+.|.-   -.+.++++++.   ..+..
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEeccc------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            345679999999999985432 3 4677764320      012456788888887742   34566666554   34678


Q ss_pred             EEEEeeecCCCh
Q 007478          190 YIYLEYVSGGSI  201 (602)
Q Consensus       190 ~lVmE~~~ggsL  201 (602)
                      +||||+++|.++
T Consensus        89 ~LVmE~i~G~~~  100 (297)
T PRK10593         89 VLLLERLRGVSV  100 (297)
T ss_pred             EEEEeccCCEec
Confidence            999999998765

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.46  E-value=0.0014  Score=71.25  Aligned_cols=81  Identities=15%  Similarity=0.172  Sum_probs=53.0

Q ss_pred             eeeEeecCCeEEEEEEECCCCcEEEEEEEecccc--hhc-HHHHHHHHHHHHHHHhcC---CCcEEEEeccccccceEEE
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD--AKS-KESAKQLMQEIVLLSRLR---HPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~-~~~~~~l~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~l  191 (602)
                      .+.||.|.+..||++.....++.++||.-.....  ... ....++...|...|+.+.   -.++.+++.+.  .+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            4679999999999998865446899997431100  011 123445667777777752   24567777553  355789


Q ss_pred             EEeeecCCC
Q 007478          192 YLEYVSGGS  200 (602)
Q Consensus       192 VmE~~~ggs  200 (602)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998644

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.38  E-value=0.0018  Score=67.86  Aligned_cols=140  Identities=20%  Similarity=0.190  Sum_probs=79.4

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCC--cEEEEecc------cccc
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP--NIVQYYGS------KTVE  186 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hp--nIv~l~~~------~~~~  186 (602)
                      ...++.|+.|.-..||++.. .+| .+++|+....   ..   ...+..|+.++..|..-  .+.+++..      ....
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~---~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKR---VK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             ceeccccCCccccceEEEEe-CCC-cEEEEEecCC---CC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            34466788888889998854 334 5778876431   11   12334566666666321  13333332      1234


Q ss_pred             ceEEEEEeeecCCChhhh-----------h---hcc-CCCC--------hHH-----HH----------HHHHHHHHHHh
Q 007478          187 DKLYIYLEYVSGGSIYKL-----------L---QDY-GQFG--------EPA-----IR----------NYTQQILSGLA  228 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~-----------l---~~~-~~ls--------~~~-----i~----------~i~~qIl~aL~  228 (602)
                      +..+++|||++|..+...           +   +.. ..++        ...     ..          .....+...++
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            668999999988554210           0   000 0010        000     00          00112233444


Q ss_pred             hhc-------cCCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          229 FLH-------SKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       229 yLH-------~~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                      ++.       ..++||+|+++.||+++.++.+.|+||+.+.
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            443       3689999999999999998877899998654

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.33  E-value=0.00052  Score=69.79  Aligned_cols=132  Identities=19%  Similarity=0.211  Sum_probs=72.6

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcE-EEEeccccccceEEEEEeeecCC
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI-VQYYGSKTVEDKLYIYLEYVSGG  199 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lVmE~~~gg  199 (602)
                      +..|-...+|+..  .+++.+++|.......    ...-...+|..+++.+..-.+ .+++....    -++||||++|.
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            4567778899886  3467788886432111    100123567888887753222 23332222    36899999987


Q ss_pred             Chhhh--------------hh---cc----CCCCh-HHHHHHHHHH---------HHHHhhhc--------cCCceecCC
Q 007478          200 SIYKL--------------LQ---DY----GQFGE-PAIRNYTQQI---------LSGLAFLH--------SKHTVHRDI  240 (602)
Q Consensus       200 sL~~~--------------l~---~~----~~ls~-~~i~~i~~qI---------l~aL~yLH--------~~gIvHrDL  240 (602)
                      .+...              +.   ..    ..++. ..+..+..++         ...++.+-        ...++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            65421              11   10    01111 1122222121         11111111        125899999


Q ss_pred             CCCcEEEccCCceEEeccCcccc
Q 007478          241 KGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       241 Kp~NILl~~~g~vKL~DFGla~~  263 (602)
                      .+.|||+++++ +.|+||..+..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999999887 89999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.31  E-value=0.001  Score=69.35  Aligned_cols=76  Identities=17%  Similarity=0.115  Sum_probs=45.8

Q ss_pred             eeeEeecCCeEEEEEEECC------CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCc-EEEEeccccccceEE
Q 007478          118 GKMLGRGTFGHVYVGFNSD------SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN-IVQYYGSKTVEDKLY  190 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~------tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~  190 (602)
                      ++.|..|-...||++....      +++.|++|+.....     .......+|+.+++.+.... ..++++++..    .
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~   73 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIFPN----G   73 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEeCC----C
Confidence            3556677777899886543      25789999864311     11223457777777774322 2344444431    3


Q ss_pred             EEEeeecCCChh
Q 007478          191 IYLEYVSGGSIY  202 (602)
Q Consensus       191 lVmE~~~ggsL~  202 (602)
                      +|+||++|..+.
T Consensus        74 ~v~e~i~G~~l~   85 (302)
T cd05156          74 RIEEFIPSRTLT   85 (302)
T ss_pred             chhheeCCCcCC
Confidence            589999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.24  E-value=0.0026  Score=65.89  Aligned_cols=138  Identities=17%  Similarity=0.158  Sum_probs=80.6

Q ss_pred             eEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCC--cEEEEecc------ccccc
Q 007478          116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP--NIVQYYGS------KTVED  187 (602)
Q Consensus       116 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hp--nIv~l~~~------~~~~~  187 (602)
                      ..++.|..|....+|+....  +..+++|+...    ..   ...+..|+.++..|.+-  .+.+++..      ....+
T Consensus        17 ~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          17 LSFEGISAGIENTNYFVTTD--SGRYVLTLFEK----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             hheecccCccccceEEEEeC--CCcEEEEEcCC----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            34667888888899998543  44788897642    11   23455677777776432  23444332      12345


Q ss_pred             eEEEEEeeecCCChhh----hhh----------cc-CCCCh--------HHHH------------HHHHHHHHHHhhhcc
Q 007478          188 KLYIYLEYVSGGSIYK----LLQ----------DY-GQFGE--------PAIR------------NYTQQILSGLAFLHS  232 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~----~l~----------~~-~~ls~--------~~i~------------~i~~qIl~aL~yLH~  232 (602)
                      ..++|++|++|..+..    .+.          .. ..+..        ....            .....+..++.++.+
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999999876532    000          00 00000        0000            011112233444432


Q ss_pred             -------CCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          233 -------KHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       233 -------~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                             .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                   479999999999999988777899997654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.22  E-value=0.0042  Score=65.16  Aligned_cols=30  Identities=23%  Similarity=0.355  Sum_probs=25.8

Q ss_pred             CCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          233 KHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       233 ~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                      .++||+|+++.|||++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            489999999999999876556899998764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.99  E-value=0.00099  Score=72.99  Aligned_cols=162  Identities=17%  Similarity=0.244  Sum_probs=104.9

Q ss_pred             HHHHHHHHHHhcCCCcEEEEeccccc-cceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccCCceec
Q 007478          160 QLMQEIVLLSRLRHPNIVQYYGSKTV-EDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR  238 (602)
Q Consensus       160 ~l~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~gIvHr  238 (602)
                      ++.--..+++.+.|+|...++++... ..+..+|||++ +.+|.+++..+. +-.....              .+++.|-
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~~   91 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLHL   91 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cccccee
Confidence            44556788999999999999987654 34688999998 689999887643 2211111              2222221


Q ss_pred             CCCCCcEEEccCCceEEeccCccccccCCCCCcccCCCCCCCCcccccccCCCCccccchhhhhHHHHHhhCCCCCCCch
Q 007478          239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE  318 (602)
Q Consensus       239 DLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~~sDVWSLGviLyELltG~~Pf~~~~  318 (602)
                                  +.++++| -++..               |  |-.      ...|+|||++|.|+.|+..|...|....
T Consensus        92 ------------~~~~~td-~~~t~---------------~--~~~------~~pKsdVwsl~~i~~el~L~~~l~~~~~  135 (725)
T KOG1093|consen   92 ------------NIIYITD-HFLTK---------------Y--PSP------IGPKSDVWSLGFIILELYLGISLEAELT  135 (725)
T ss_pred             ------------hhhhccc-ccccc---------------C--CCC------CCcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence                        1233444 11110               0  111      1149999999999999999998887655


Q ss_pred             hHHHHHHhhCCCCCC----------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHhcCccccCC
Q 007478          319 GVAAMFKIGNSKELP----------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       319 ~~~~~~~i~~~~~~~----------~~p~~~s~~l~dLI~~~L~~dP~~Rpt~~eiL~hp~f~~~  373 (602)
                      .......+..-...+          .+-..++....++.++|+...|..||...++++++-|.+.
T Consensus       136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            444433332211111          1112456677789999999999999999999999988764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.81  E-value=0.0086  Score=61.98  Aligned_cols=30  Identities=37%  Similarity=0.522  Sum_probs=25.2

Q ss_pred             CceecCCCCCcEEEccCCc-eEEeccCcccc
Q 007478          234 HTVHRDIKGANILVDPNGR-VKLADFGMAKH  263 (602)
Q Consensus       234 gIvHrDLKp~NILl~~~g~-vKL~DFGla~~  263 (602)
                      .++|+|+++.|||++.++. +-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            5899999999999997555 56999997754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.72  E-value=0.016  Score=61.15  Aligned_cols=144  Identities=15%  Similarity=0.257  Sum_probs=80.7

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCC--CcEEEEeccccccc--eEE
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNIVQYYGSKTVED--KLY  190 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H--pnIv~l~~~~~~~~--~~~  190 (602)
                      ..+++.+-.|.--.+|.....  ++.+++. ..  .............+|+.+|+.+.-  --+...+++|.++.  ..|
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P--~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf  101 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KP--PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF  101 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-cC--CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence            334444433333344544433  7778887 21  112223345566778888887742  22344555665554  779


Q ss_pred             EEEeeecCCChhhh------------------hhcc-----------C---CCChHHHHHHHHHH--------------H
Q 007478          191 IYLEYVSGGSIYKL------------------LQDY-----------G---QFGEPAIRNYTQQI--------------L  224 (602)
Q Consensus       191 lVmE~~~ggsL~~~------------------l~~~-----------~---~ls~~~i~~i~~qI--------------l  224 (602)
                      .||+|++|..+...                  |..-           +   .+...++..+..+.              .
T Consensus       102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~  181 (321)
T COG3173         102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD  181 (321)
T ss_pred             EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence            99999998433221                  1100           0   01111222222222              1


Q ss_pred             HHHhhhcc--------CCceecCCCCCcEEEccCCceEEeccCcccc
Q 007478          225 SGLAFLHS--------KHTVHRDIKGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       225 ~aL~yLH~--------~gIvHrDLKp~NILl~~~g~vKL~DFGla~~  263 (602)
                      .-..+|+.        ..++|+|+.+.||+++.++.+=|.||+++..
T Consensus       182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            22334433        2589999999999999999999999999875

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.64  E-value=0.013  Score=62.21  Aligned_cols=142  Identities=18%  Similarity=0.174  Sum_probs=91.1

Q ss_pred             eeeEeecCCeEEEEEEECCCCcEEEEEEEecc-cchhc--------------------HHHHHH-HHHHHHHHHhcCCCc
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKS--------------------KESAKQ-LMQEIVLLSRLRHPN  175 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~-~~~~~--------------------~~~~~~-l~~Ei~iL~~l~Hpn  175 (602)
                      -..|..|.-+.||.|... +|..+|||+.+.. -..+.                    ....+. -..|+.-|++|..-.
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345778888999999765 5888999987531 00000                    011111 124677777775433


Q ss_pred             EEEEeccccccceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhh-ccCCceecCCCCCcEEEccCCceE
Q 007478          176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL-HSKHTVHRDIKGANILVDPNGRVK  254 (602)
Q Consensus       176 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yL-H~~gIvHrDLKp~NILl~~~g~vK  254 (602)
                      |.. -.-.. -....|||+|+.......-.-+...++...+..+-.|++.-+.-| |.+++||.||.--|+|+. +|.+.
T Consensus       228 IP~-PePIl-Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ly  304 (520)
T KOG2270|consen  228 IPC-PEPIL-LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLY  304 (520)
T ss_pred             CCC-CCcee-eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEE
Confidence            211 00000 123579999995333222222334678888888888888888776 467999999999999995 56899


Q ss_pred             EeccCcccc
Q 007478          255 LADFGMAKH  263 (602)
Q Consensus       255 L~DFGla~~  263 (602)
                      |+|.+-+..
T Consensus       305 iIDVSQSVE  313 (520)
T KOG2270|consen  305 IIDVSQSVE  313 (520)
T ss_pred             EEEcccccc
Confidence            999986654

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.63  E-value=0.008  Score=64.27  Aligned_cols=77  Identities=13%  Similarity=0.144  Sum_probs=47.1

Q ss_pred             eEeecCCeEEEEEEECCCCcEEEEEEEecccc---hhcHHHHHHHHHHHHHHHhcC--CC-cEEEEeccccccceEEEEE
Q 007478          120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD---AKSKESAKQLMQEIVLLSRLR--HP-NIVQYYGSKTVEDKLYIYL  193 (602)
Q Consensus       120 ~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---~~~~~~~~~l~~Ei~iL~~l~--Hp-nIv~l~~~~~~~~~~~lVm  193 (602)
                      .||.|...-||++.....++.++||.-...-.   ....-...+..-|...|+...  -| .+.++|.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57999999999999764446899996432100   011122334456777776653  23 45556533  345567999


Q ss_pred             eeecC
Q 007478          194 EYVSG  198 (602)
Q Consensus       194 E~~~g  198 (602)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.37  E-value=0.03  Score=58.32  Aligned_cols=29  Identities=28%  Similarity=0.393  Sum_probs=25.2

Q ss_pred             CCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          233 KHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       233 ~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                      .+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            58999999999999987 678999997543

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.33  E-value=0.025  Score=58.90  Aligned_cols=76  Identities=14%  Similarity=0.127  Sum_probs=44.5

Q ss_pred             ceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc---CCCcEEEEeccccccceEEE
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL---RHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~l  191 (602)
                      .+..+.|+.|....+|+..  .+++.+.||+-..       .....+..|..-|+.|   .--.+.+++++...++.-||
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL   89 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL   89 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecCh-------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence            3456779999999999976  6688899997541       1123456677777776   33446677777666666799


Q ss_pred             EEeeecCC
Q 007478          192 YLEYVSGG  199 (602)
Q Consensus       192 VmE~~~gg  199 (602)
                      ||||++.+
T Consensus        90 lle~l~~~   97 (288)
T PF03881_consen   90 LLEFLEMG   97 (288)
T ss_dssp             EEE-----
T ss_pred             EEEeecCC
Confidence            99999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.95  E-value=0.025  Score=60.02  Aligned_cols=28  Identities=21%  Similarity=0.546  Sum_probs=24.2

Q ss_pred             ceecCCCCCcEEEcc-CCceEEeccCccc
Q 007478          235 TVHRDIKGANILVDP-NGRVKLADFGMAK  262 (602)
Q Consensus       235 IvHrDLKp~NILl~~-~g~vKL~DFGla~  262 (602)
                      ++|.|+.+.|||+++ ++.++|+||..|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            799999999999975 4689999997653

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.95  E-value=0.052  Score=59.13  Aligned_cols=77  Identities=16%  Similarity=0.182  Sum_probs=48.6

Q ss_pred             eeeEeecCCeEEEEEEECCCCcEEEEEEEecccc---hhcHHHHHHHHHHHHHHHhcC---CCcEEEEeccccccceEEE
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD---AKSKESAKQLMQEIVLLSRLR---HPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~---~~~~~~~~~l~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~l  191 (602)
                      .+.||.|....||+..+.  +..++||.-.....   ....-...+...|+..|+.+.   -.++.+++.++.  +..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            677999999999998763  45688996431111   000012333345566666553   246777887766  44678


Q ss_pred             EEeeecC
Q 007478          192 YLEYVSG  198 (602)
Q Consensus       192 VmE~~~g  198 (602)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>PLN02236 choline kinase

Probab=95.91  E-value=0.037  Score=59.16  Aligned_cols=136  Identities=13%  Similarity=0.061  Sum_probs=76.1

Q ss_pred             eeeEeecCCeEEEEEEECC----CCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcE-EEEeccccccceEEEE
Q 007478          118 GKMLGRGTFGHVYVGFNSD----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI-VQYYGSKTVEDKLYIY  192 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV  192 (602)
                      .+.|-.|-.-.+|++....    +++.|++|+.....    ..... -.+|..+++.+..-++ .++++.+.. +   .|
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v  111 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RV  111 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence            4456568888999986432    24678899764311    11111 2467788877753333 244454432 2   57


Q ss_pred             EeeecCCChhhh--------------hh---ccC-C----C-ChHHHHHHHHHHH--------------------HHHh-
Q 007478          193 LEYVSGGSIYKL--------------LQ---DYG-Q----F-GEPAIRNYTQQIL--------------------SGLA-  228 (602)
Q Consensus       193 mE~~~ggsL~~~--------------l~---~~~-~----l-s~~~i~~i~~qIl--------------------~aL~-  228 (602)
                      +||+++.+|...              +.   ... .    . ....+..+..++.                    ..|+ 
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            899987666311              00   000 0    1 1122333332221                    1111 


Q ss_pred             h----hccCCceecCCCCCcEEEcc-CCceEEeccCccc
Q 007478          229 F----LHSKHTVHRDIKGANILVDP-NGRVKLADFGMAK  262 (602)
Q Consensus       229 y----LH~~gIvHrDLKp~NILl~~-~g~vKL~DFGla~  262 (602)
                      .    .+...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1    22346899999999999986 4689999997654

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.66  E-value=0.037  Score=59.97  Aligned_cols=82  Identities=16%  Similarity=0.104  Sum_probs=51.2

Q ss_pred             CceEeeeEeecCCeEEEEEEECCCCcEEEEEEEeccc--chhcHHHHHHHHHHHHHHHhcC--CC-cEEEEeccccccce
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD--DAKSKESAKQLMQEIVLLSRLR--HP-NIVQYYGSKTVEDK  188 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~--~~~~~~~~~~l~~Ei~iL~~l~--Hp-nIv~l~~~~~~~~~  188 (602)
                      .+. .+.||.|.-.-||++.+...++.++||.-...-  .....-..++..-|..+|+.+.  .| ++.++|.  .+.+.
T Consensus        31 ~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~  107 (409)
T PRK12396         31 GLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVM  107 (409)
T ss_pred             cce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHH
Confidence            344 677999999999999885445679999643211  1111223445566777777653  23 4556663  33455


Q ss_pred             EEEEEeeecC
Q 007478          189 LYIYLEYVSG  198 (602)
Q Consensus       189 ~~lVmE~~~g  198 (602)
                      ..+|||+++.
T Consensus       108 ~~~vMEdL~~  117 (409)
T PRK12396        108 NCCVMEDLSD  117 (409)
T ss_pred             hhHHHHhCcc
Confidence            6788998854

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.62  E-value=0.056  Score=56.64  Aligned_cols=29  Identities=21%  Similarity=0.212  Sum_probs=26.6

Q ss_pred             CceecCCCCCcEEEccCCceEEeccCccc
Q 007478          234 HTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       234 gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                      ++||+|+.+.|||++.++.+.|+||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999997664

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.52  E-value=0.094  Score=52.62  Aligned_cols=75  Identities=16%  Similarity=0.191  Sum_probs=48.8

Q ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhc---CCCcEEEEeccccccceEEEEEee
Q 007478          119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL---RHPNIVQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~lVmE~  195 (602)
                      +.+--|..-..|...+  ....|.||+=       ..+....+..|+.-|..+   +.-++.+++.+..+.+..|+||||
T Consensus        22 ~~v~gG~inea~~v~d--g~~~~FvK~n-------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~   92 (286)
T COG3001          22 EEVSGGDINEAWRLRD--GTDPFFVKCN-------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY   92 (286)
T ss_pred             cccCCccccceeEeec--CCcceEEEec-------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence            3444444444555432  2457888852       234455677777666655   345577888888888999999999


Q ss_pred             ecCCChh
Q 007478          196 VSGGSIY  202 (602)
Q Consensus       196 ~~ggsL~  202 (602)
                      ++-+.+.
T Consensus        93 L~~~~~d   99 (286)
T COG3001          93 LPTGPLD   99 (286)
T ss_pred             ccCCCCC
Confidence            9876654

>PTZ00384 choline kinase; Provisional

Probab=95.47  E-value=0.061  Score=58.37  Aligned_cols=81  Identities=16%  Similarity=0.151  Sum_probs=44.6

Q ss_pred             eeeEeecCCeEEEEEEECCC-CcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcE-EEEeccccccceEEEEEee
Q 007478          118 GKMLGRGTFGHVYVGFNSDS-GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI-VQYYGSKTVEDKLYIYLEY  195 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lVmE~  195 (602)
                      .+.|..|-...+|++..... +..+.+|.+-........+..-.-.+|+.+++.|...++ .++++.+.    -++|.||
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            44565688899999875432 223323321110000111111122468888988865444 55666654    2689999


Q ss_pred             ecCCChh
Q 007478          196 VSGGSIY  202 (602)
Q Consensus       196 ~~ggsL~  202 (602)
                      ++|-.|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9987763

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.42  E-value=0.16  Score=53.84  Aligned_cols=29  Identities=24%  Similarity=0.294  Sum_probs=24.0

Q ss_pred             cCCceecCCCCCcEEEccCCceEEeccCccc
Q 007478          232 SKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       232 ~~gIvHrDLKp~NILl~~~g~vKL~DFGla~  262 (602)
                      ..++||+|+.+.|||++ + .+.|+||+.+.
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            35789999999999995 4 58899998654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.16  E-value=0.073  Score=53.09  Aligned_cols=84  Identities=23%  Similarity=0.263  Sum_probs=59.0

Q ss_pred             HHHHHHHHHHHhcCCCcEEEEeccccccceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhcc--CCce
Q 007478          159 KQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS--KHTV  236 (602)
Q Consensus       159 ~~l~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~--~gIv  236 (602)
                      ..+..+..+++++.  .|+++..-  ....+.+++|+|-.-            .. .-..++..=+.+|.-.|+  .+.+
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~------------~i-~~~N~i~agi~~L~~fH~~~~~~l  165 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI------------KI-NFSNFITAGIKDLMDFHSENQHCL  165 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc------------cc-chhHHHHHhHHHHHHhhccCCCee
Confidence            34567888888775  67887733  445688999998311            00 111222222567778884  4799


Q ss_pred             ecCCCCCcEEEccCCceEEeccC
Q 007478          237 HRDIKGANILVDPNGRVKLADFG  259 (602)
Q Consensus       237 HrDLKp~NILl~~~g~vKL~DFG  259 (602)
                      |+|..|+||+-|..|.+||.|=+
T Consensus       166 HGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  166 HGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             cCCCChhheeecCCCCEEecChh
Confidence            99999999999999999999976

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=95.10  E-value=0.19  Score=61.38  Aligned_cols=31  Identities=45%  Similarity=0.736  Sum_probs=26.2

Q ss_pred             CCceecCCCCCcEEEccCC--ceE-EeccCcccc
Q 007478          233 KHTVHRDIKGANILVDPNG--RVK-LADFGMAKH  263 (602)
Q Consensus       233 ~gIvHrDLKp~NILl~~~g--~vK-L~DFGla~~  263 (602)
                      .++||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999875  555 999997753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.85  E-value=0.098  Score=55.59  Aligned_cols=133  Identities=17%  Similarity=0.218  Sum_probs=75.7

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCc------EEEEecc--ccccc--eEE
Q 007478          121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN------IVQYYGS--KTVED--KLY  190 (602)
Q Consensus       121 LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hpn------Iv~l~~~--~~~~~--~~~  190 (602)
                      |.+ .-..||+....+ |+ +++|+....      ....++..|+.+|..|.-..      |..+-|-  .....  +.+
T Consensus        34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~------~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a  104 (331)
T COG2334          34 LNS-EENSNFRVQTED-GR-YILKIYRPG------WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA  104 (331)
T ss_pred             ccc-ccCceEEEEecC-CC-eEEEEecCC------CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence            444 556689886543 44 488877532      12344566777777763211      2222221  11234  788


Q ss_pred             EEEeeecCCChhh-hhh------------------ccC--------CCChH----H---------HHHHHHHHHHHHhhh
Q 007478          191 IYLEYVSGGSIYK-LLQ------------------DYG--------QFGEP----A---------IRNYTQQILSGLAFL  230 (602)
Q Consensus       191 lVmE~~~ggsL~~-~l~------------------~~~--------~ls~~----~---------i~~i~~qIl~aL~yL  230 (602)
                      -+++|++|..+.. .-.                  ...        ...+.    .         -.....++...++.+
T Consensus       105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~  184 (331)
T COG2334         105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL  184 (331)
T ss_pred             EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence            8999999877762 110                  000        00111    0         011233344444444


Q ss_pred             cc--------CC--ceecCCCCCcEEEccCCc-eEEeccCccc
Q 007478          231 HS--------KH--TVHRDIKGANILVDPNGR-VKLADFGMAK  262 (602)
Q Consensus       231 H~--------~g--IvHrDLKp~NILl~~~g~-vKL~DFGla~  262 (602)
                      .+        .+  +||+|+.+.|||++.+.. +.++||+-+.
T Consensus       185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            43        34  999999999999999885 8999998654

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.56  E-value=0.07  Score=56.81  Aligned_cols=71  Identities=27%  Similarity=0.352  Sum_probs=54.0

Q ss_pred             ceEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHhhhccC-CceecCCCCCcEEEccCCceEEeccCcccc
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK-HTVHRDIKGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       187 ~~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~vKL~DFGla~~  263 (602)
                      ...|++|++- |+.|. .+   .....+++..|+.+.+..|.-+..+ .+-|||+.-.||||+ +|+|.|+||-+++.
T Consensus       299 ~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            3456677764 44443 22   2334678888998888887777765 688999999999999 99999999999984

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.45  E-value=0.065  Score=57.78  Aligned_cols=61  Identities=20%  Similarity=0.274  Sum_probs=43.9

Q ss_pred             eEEEEEeeecCCChhhhhhccCCCChHHHHHHHHHHHHHHh-hhccCCceecCCCCCcEEEcc
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA-FLHSKHTVHRDIKGANILVDP  249 (602)
Q Consensus       188 ~~~lVmE~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~aL~-yLH~~gIvHrDLKp~NILl~~  249 (602)
                      ...|+-+|..|.++..+++.. ..++...+.++.-...||- -|--.+++|.|+.|.||++..
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            456777899999999998764 3444455555555555553 344579999999999999954

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=92.62  E-value=0.022  Score=62.64  Aligned_cols=72  Identities=29%  Similarity=0.535  Sum_probs=59.4

Q ss_pred             CCCCceEeeeEeecCCeEEEEEEECCCCcEEEEEEEecccchhcHHHHHHHHHHHHHHHhcCCCcEEEEeccccc
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV  185 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~~~~~~  185 (602)
                      ..++|+.+..+|.|+||+|+.+.++.++..+|||.|...   ..........+|+.-+..+.|++|++++..|..
T Consensus        47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlk---n~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLK---NREESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hhccccccccccccCccccCCccccccchhhHHHHhccc---chhhhhhhhhccccchhhhcccchhhheeceec
Confidence            457789999999999999999999988889999998752   233445567789999999999999998876644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	602
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-47
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-47
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-47
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-47
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-46
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-46
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-46
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-46
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-46
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-45
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-44
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-43
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-43
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-43
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-40
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-40
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-40
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-40
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-40
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-39
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-39
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-39
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-39
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-38
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-37
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-37
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-37
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-37
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-36
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-36
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-36
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-36
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-36
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-35
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-35
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-35
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-35
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-35
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-35
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-35
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-35
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-35
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-35
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-35
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-35
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-35
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-35
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-35
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-35
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-35
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-35
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-35
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-35
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-35
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-35
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-34
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-34
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-34
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-34
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-34
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-34
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-34
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-34
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-34
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-34
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-34
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-32
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-32
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-32
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-32
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-32
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-32
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-32
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-32
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-32
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-32
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-32
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-32
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-32
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-31
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-31
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-31
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-31
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-31
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-31
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-31
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-31
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-31
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-31
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-31
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-31
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-31
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-31
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-31
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-31
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-31
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-31
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-31
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-31
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-31
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-31
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-31
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-31
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-31
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-31
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-31
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-31
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-31
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-31
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-31
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-31
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-31
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-31
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-31
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-31
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-31
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-31
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-31
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-31
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-31
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-31
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-31
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-31
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-31
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-31
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-31
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-31
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-31
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-31
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-31
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-31
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-31
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-31
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-31
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-31
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-31
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-31
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-31
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-31
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-31
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-31
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-31
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-31
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-31
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-31
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-31
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-30
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-30
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-30
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-30
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-30
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-30
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-30
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-30
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-30
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-30
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-30
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-30
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-30
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-30
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-30
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-29
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-29
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-29
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-29
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-29
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-29
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-29
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-29
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-29
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-29
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-29
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-29
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-29
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-29
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-29
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-29
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-29
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-29
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-28
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-28
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-28
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-28
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-28
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-28
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-28
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-28
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-28
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-28
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-28
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-28
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-27
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-27
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-27
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-27
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-27
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-27
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-27
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-27
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-27
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-27
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-27
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-27
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-27
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-27
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-27
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-27
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-27
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-27
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-27
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-27
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-27
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-27
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-27
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-27
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-27
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-27
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-27
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-26
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-26
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-26
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-26
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-26
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-26
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-26
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-26
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-26
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-26
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-26
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-26
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-26
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-26
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-26
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-26
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-26
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-26
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-26
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-26
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-26
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-26
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-26
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-26
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-26
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-26
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-26
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-26
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-26
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-26
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-26
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-26
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-26
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-26
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-26
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-26
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-26
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-26
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-26
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-26
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-26
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-26
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-26
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-26
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-26
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-26
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-26
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-26
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-26
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-26
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-26
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-26
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-25
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-25
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-25
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-25
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-25
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-25
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-25
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-25
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-25
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-25
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-25
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-25
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-25
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-25
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-25
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-25
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-25
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-25
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-25
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-25
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-25
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-25
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-25
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-25
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-25
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-25
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-25
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-25
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-25
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-25
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-25
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-25
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-25
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-25
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-25
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-25
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-25
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-25
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-25
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-25
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-25
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-25
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-25
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-25
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-25
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-25
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-25
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-25
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-24
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-24
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-24
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-24
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-24
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-24
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-24
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-24
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-24
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-24
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-24
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-24
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-24
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-24
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-24
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-24
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-24
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-24
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-24
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-24
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-24
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-24
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-24
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-24
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-24
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-24
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-24
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-24
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-24
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-24
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-24
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-24
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-24
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-23
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-23
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-23
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-23
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-23
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-23
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-23
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-23
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-23
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-23
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-23
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-23
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-23
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-23
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-23
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-23
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-23
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-23
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-23
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-23
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-23
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-23
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-23
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-23
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-23
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-23
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-23
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-23
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-23
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-22
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-22
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-22
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-22
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-22
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-22
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-22
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-22
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-22
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-22
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-22
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-22
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-22
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-22
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-22
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-22
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-22
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-22
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-22
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-21
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-21
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-21
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-21
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-21
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-21
3soa_A	444	Full-Length Human Camkii Length = 444		3e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-21
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-21
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-21
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-21
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-21
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-21
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-21
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-21
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-21
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-21
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-21
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-21
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-21
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-21
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-21
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-21
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-21
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-20
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-20
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-20
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-20
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-20
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-20
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-20
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-20
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-20
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-20
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-20
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-20
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-20
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-20
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-20
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-20
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-20
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-20
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-20
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-20
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-20
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-20
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-20
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-20
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-20
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-20
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-20
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-20
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-20
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-20
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-20
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-20
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-20
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-20
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-20
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-20
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-20
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-20
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-20
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-20
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-20
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-20
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-20
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-20
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-20
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-20
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-20
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-20
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-20
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-20
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-20
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-20
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-20
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-20
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-20
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-20
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-20
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-20
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-20
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-19
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-19
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-19
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-19
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-19
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-19
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-19
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-19
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-19
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-19
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-19
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-19
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-19
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-19
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-19
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-19
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-19
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-19
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-19
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-19
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-19
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-19
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-19
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-19
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-19
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-19
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-19
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-19
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-19
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-19
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-19
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-19
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-19
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-19
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-19
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-19
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-19
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-19
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-19
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-19
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-19
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-19
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-19
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-19
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-19
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-19
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-19
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-19
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-19
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-19
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-19
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-19
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-19
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-19
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-19
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-19
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-19
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-19
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-19
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-19
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-19
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-19
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-19
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-19
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-19
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-19
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-19
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-19
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-19
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-19
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-19
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-19
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-19
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-19
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-19
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-19
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-19
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-19
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-19
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-19
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-19
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-19
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-19
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-19
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-19
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-19
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-19
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-19
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-19
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-19
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-19
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-19
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-19
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-19
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-19
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-19
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-19
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-19
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-19
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-19
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-19
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-19
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-19
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-19
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-19
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-19
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-19
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-19
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-19
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-19
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-19
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-19
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-19
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-19
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-19
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		9e-19
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-18
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-18
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-18
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-18
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-18
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-18
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-18
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-18
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-18
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-18
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-18
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-18
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-18
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-18
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-18
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-18
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-18
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-18
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-18
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-18
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-18
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-18
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-18
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-18
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-18
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-18
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-18
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-18
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-18
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-18
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-18
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-18
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-18
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-18
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-18
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-18
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-18
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-18
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-17
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-17
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-17
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-17
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-17
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-17
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-17
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-17
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-17
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-17
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-17
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-17
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-17
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-17
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-17
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-17
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-17
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-17
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-17
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-17
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-17
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-17
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-17
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-17
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-17
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-17
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-17
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-17
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-17
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-17
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-17
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-17
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-16
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-16
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-16
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-16
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-15
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-15
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-15
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-15
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-15
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-15
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-15
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-15
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-15
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-15
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-15
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-15
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-15
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-14
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-14
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-14
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-14
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-14
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-14
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-14
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-14
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-14
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-14
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-14
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-14
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-14
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-14
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-13
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-13
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-13
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-13
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-13
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-13
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-13
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-13
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-13
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-13
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-13
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-13
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-13
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-13
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-13
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  187 bits (476), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 107/276 (38%), Positives = 162/276 (58%), Gaps = 7/276 (2%)
Query: 96  PSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK 155
           P   + PG   N   PE  + K + +G+G+FG V+ G ++ + ++ A+K   + D  +++
Sbjct: 6   PVAVQVPGMQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIK---IIDLEEAE 62
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA 215
           +  + + QEI +LS+     + +YYGS     KL+I +EY+ GGS   LL+  G F E  
Sbjct: 63  DEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLR-AGPFDEFQ 121
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFK 274
           I    ++IL GL +LHS+  +HRDIK AN+L+   G VKLADFG+A  +        +F 
Sbjct: 122 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 181
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           G+P+WMAPEVI+ S+  + A DIWSLG T +E+A  +PP S    +  +F I  +   PT
Sbjct: 182 GTPFWMAPEVIQQSAYDSKA-DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-PT 239
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
           +  D +   K+FI  CL ++P  RPTA ELL H F+
Sbjct: 240 LVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  186 bits (472), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 114/267 (42%), Positives = 163/267 (61%), Gaps = 11/267 (4%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +LG+GT+G VY G +  +    A+KE+   D   S+     L +EI L   L+H NIVQY
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ----PLHEEIALHKHLKHKNIVQY 84
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQD-YG--QFGEPAIRNYTQQILSGLAFLHSKHTV 236
            GS +    + I++E V GGS+  LL+  +G  +  E  I  YT+QIL GL +LH    V
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 237 HRDIKGANILVDP-NGRVKLADFGMAKHIAGQS-CPLSFKGSPYWMAPEVI-KNSSGCNL 293
           HRDIKG N+L++  +G +K++DFG +K +AG + C  +F G+  +MAPE+I K   G   
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 294 AVDIWSLGCTVLEMATTKPPWSQY-EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A DIWSLGCT++EMAT KPP+ +  E  AAMFK+G  K  P IP+ +S E K FI  C +
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264
Query: 353 RNPLNRPTAAELLDHPFVKGAAPLERT 379
            +P  R  A +LL   F+K ++  ++T
Sbjct: 265 PDPDKRACANDLLVDEFLKVSSKKKKT 291

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  186 bits (472), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 105/270 (38%), Positives = 161/270 (59%), Gaps = 7/270 (2%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           PG       PE  + K + +G+G+FG V+ G ++ + ++ A+K   + D  ++++  + +
Sbjct: 11  PGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDI 67
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            QEI +LS+   P + +YYGS   + KL+I +EY+ GGS   LL+  G   E  I    +
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILR 126
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWM 280
           +IL GL +LHS+  +HRDIK AN+L+  +G VKLADFG+A  +       + F G+P+WM
Sbjct: 127 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 186
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLS 340
           APEVIK S+  + A DIWSLG T +E+A  +PP S+   +  +F I  +   PT+  + S
Sbjct: 187 APEVIKQSAYDSKA-DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYS 244
Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
              K+F+  CL + P  RPTA ELL H F+
Sbjct: 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  184 bits (468), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 103/263 (39%), Positives = 160/263 (60%), Gaps = 7/263 (2%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           + PE  + K + +G+G+FG V+ G ++ + ++ A+K   + D  ++++  + + QEI +L
Sbjct: 23  MDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVL 79
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           S+   P + +YYGS   + KL+I +EY+ GGS   LL+  G   E  I    ++IL GL 
Sbjct: 80  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD 138
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKN 287
           +LHS+  +HRDIK AN+L+  +G VKLADFG+A  +        +F G+P+WMAPEVIK 
Sbjct: 139 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           S+  + A DIWSLG T +E+A  +PP S+   +  +F I  +   PT+  + S   K+F+
Sbjct: 199 SAYDSKA-DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFV 256
Query: 348 RLCLQRNPLNRPTAAELLDHPFV 370
             CL + P  RPTA ELL H F+
Sbjct: 257 EACLNKEPSFRPTAKELLKHKFI 279

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  184 bits (468), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 103/263 (39%), Positives = 160/263 (60%), Gaps = 7/263 (2%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           + PE  + K + +G+G+FG V+ G ++ + ++ A+K   + D  ++++  + + QEI +L
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVL 59
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           S+   P + +YYGS   + KL+I +EY+ GGS   LL+  G   E  I    ++IL GL 
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD 118
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKN 287
           +LHS+  +HRDIK AN+L+  +G VKLADFG+A  +        +F G+P+WMAPEVIK 
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           S+  + A DIWSLG T +E+A  +PP S+   +  +F I  +   PT+  + S   K+F+
Sbjct: 179 SAYDSKA-DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFV 236
Query: 348 RLCLQRNPLNRPTAAELLDHPFV 370
             CL + P  RPTA ELL H F+
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFI 259

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  184 bits (466), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 111/259 (42%), Positives = 157/259 (60%), Gaps = 11/259 (4%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +LG+GT+G VY G +  +    A+KE+      +    ++ L +EI L   L+H NIVQY
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIP----ERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQF--GEPAIRNYTQQILSGLAFLHSKHTV 236
            GS +    + I++E V GGS+  LL+  +G     E  I  YT+QIL GL +LH    V
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 237 HRDIKGANILVDP-NGRVKLADFGMAKHIAGQS-CPLSFKGSPYWMAPEVI-KNSSGCNL 293
           HRDIKG N+L++  +G +K++DFG +K +AG + C  +F G+  +MAPE+I K   G   
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 190
Query: 294 AVDIWSLGCTVLEMATTKPPWSQY-EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A DIWSLGCT++EMAT KPP+ +  E  AAMFK+G  K  P IP+ +S E K FI  C +
Sbjct: 191 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 250
Query: 353 RNPLNRPTAAELLDHPFVK 371
            +P  R  A +LL   F+K
Sbjct: 251 PDPDKRACANDLLVDEFLK 269

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  184 bits (466), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 103/263 (39%), Positives = 160/263 (60%), Gaps = 7/263 (2%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           + PE  + K + +G+G+FG V+ G ++ + ++ A+K   + D  ++++  + + QEI +L
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVL 59
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           S+   P + +YYGS   + KL+I +EY+ GGS   LL+  G   E  I    ++IL GL 
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD 118
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
           +LHS+  +HRDIK AN+L+  +G VKLADFG+A  +       + F G+P+WMAPEVIK 
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           S+  + A DIWSLG T +E+A  +PP S+   +  +F I  +   PT+  + S   K+F+
Sbjct: 179 SAYDSKA-DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFV 236
Query: 348 RLCLQRNPLNRPTAAELLDHPFV 370
             CL + P  RPTA ELL H F+
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFI 259

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  184 bits (466), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 105/263 (39%), Positives = 155/263 (58%), Gaps = 7/263 (2%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           V PE  + K   +G+G+FG VY G ++ + E+ A+K   + D  ++++  + + QEI +L
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIK---IIDLEEAEDEIEDIQQEITVL 71
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           S+   P I +Y+GS     KL+I +EY+ GGS   LL+  G   E  I    ++IL GL 
Sbjct: 72  SQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLD 130
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
           +LHS+  +HRDIK AN+L+   G VKLADFG+A  +       + F G+P+WMAPEVIK 
Sbjct: 131 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           S+  +   DIWSLG T +E+A  +PP S    +  +F I  +   PT+    S   K+F+
Sbjct: 191 SA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-PTLEGQHSKPFKEFV 248
Query: 348 RLCLQRNPLNRPTAAELLDHPFV 370
             CL ++P  RPTA ELL H F+
Sbjct: 249 EACLNKDPRFRPTAKELLKHKFI 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  181 bits (460), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 102/279 (36%), Positives = 159/279 (56%), Gaps = 13/279 (4%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK 159
           R    +   + P   W+    LG G FG VY   N ++G + A K +    + KS+E  +
Sbjct: 6   REYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI----ETKSEEELE 61
Query: 160 QLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRN 218
             + EI +L+   HP IV+  G+   + KL+I +E+  GG++  ++ +  +   EP I+ 
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121
Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM-AKHIAGQSCPLSFKGSP 277
             +Q+L  L FLHSK  +HRD+K  N+L+   G ++LADFG+ AK++       SF G+P
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP 181
Query: 278 YWMAPEVI----KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP 333
           YWMAPEV+       +  +   DIWSLG T++EMA  +PP  +   +  + KI  S + P
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPP 240
Query: 334 TI--PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
           T+  P   S E +DF+++ L +NP  RP+AA+LL+HPFV
Sbjct: 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  181 bits (459), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 101/270 (37%), Positives = 157/270 (58%), Gaps = 13/270 (4%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           + P   W+    LG G FG VY   N ++G + A K +    + KS+E  +  + EI +L
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI----ETKSEEELEDYIVEIEIL 62
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGL 227
           +   HP IV+  G+   + KL+I +E+  GG++  ++ +  +   EP I+   +Q+L  L
Sbjct: 63  ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 122
Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGM-AKHIAGQSCPLSFKGSPYWMAPEVI- 285
            FLHSK  +HRD+K  N+L+   G ++LADFG+ AK++       SF G+PYWMAPEV+ 
Sbjct: 123 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 182
Query: 286 ---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
                 +  +   DIWSLG T++EMA  +PP  +   +  + KI  S + PT+  P   S
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLTPSKWS 241
Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
            E +DF+++ L +NP  RP+AA+LL+HPFV
Sbjct: 242 VEFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  176 bits (445), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 151/267 (56%), Gaps = 12/267 (4%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           PE  +   + LG G++G VY   + ++G++ A+K+V +  D +      ++++EI ++ +
Sbjct: 27  PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ------EIIKEISIMQQ 80
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAF 229
              P++V+YYGS      L+I +EY   GS+  +++   +   E  I    Q  L GL +
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNS 288
           LH    +HRDIK  NIL++  G  KLADFG+A  +       +   G+P+WMAPEVI+  
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQE- 199
Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLSDEGKDF 346
            G N   DIWSLG T +EMA  KPP++    + A+F I  +   PT   P+  SD   DF
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-PTFRKPELWSDNFTDF 258
Query: 347 IRLCLQRNPLNRPTAAELLDHPFVKGA 373
           ++ CL ++P  R TA +LL HPFV+ A
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRSA 285

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  174 bits (442), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 105/297 (35%), Positives = 162/297 (54%), Gaps = 16/297 (5%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           ++PE  W+    LG G FG VY   N ++  + A K +    D KS+E  +  M EI +L
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDIL 88
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGL 227
           +   HPNIV+   +   E+ L+I +E+ +GG++  ++ +  +   E  I+   +Q L  L
Sbjct: 89  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGM-AKHIAGQSCPLSFKGSPYWMAPEVIK 286
            +LH    +HRD+K  NIL   +G +KLADFG+ AK+        SF G+PYWMAPEV+ 
Sbjct: 149 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 287 NSSG----CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
             +      +   D+WSLG T++EMA  +PP  +   +  + KI  S E PT+  P   S
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWS 267
Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPF--VKGAAPLERTILAPEPSDVPPGVTNG 395
              KDF++ CL++N   R T ++LL HPF  V    P+ R ++A   ++V   V +G
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI-RELIAEAKAEVTEEVEDG 323

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  174 bits (442), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 105/297 (35%), Positives = 162/297 (54%), Gaps = 16/297 (5%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           ++PE  W+    LG G FG VY   N ++  + A K +    D KS+E  +  M EI +L
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDIL 88
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGL 227
           +   HPNIV+   +   E+ L+I +E+ +GG++  ++ +  +   E  I+   +Q L  L
Sbjct: 89  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGM-AKHIAGQSCPLSFKGSPYWMAPEVIK 286
            +LH    +HRD+K  NIL   +G +KLADFG+ AK+        SF G+PYWMAPEV+ 
Sbjct: 149 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 208
Query: 287 NSSG----CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
             +      +   D+WSLG T++EMA  +PP  +   +  + KI  S E PT+  P   S
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWS 267
Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPF--VKGAAPLERTILAPEPSDVPPGVTNG 395
              KDF++ CL++N   R T ++LL HPF  V    P+ R ++A   ++V   V +G
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI-RELIAEAKAEVTEEVEDG 323

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  172 bits (437), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 104/297 (35%), Positives = 161/297 (54%), Gaps = 16/297 (5%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           ++PE  W+    LG G FG VY   N ++  + A K +    D KS+E  +  M EI +L
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDIL 88
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGL 227
           +   HPNIV+   +   E+ L+I +E+ +GG++  ++ +  +   E  I+   +Q L  L
Sbjct: 89  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGM-AKHIAGQSCPLSFKGSPYWMAPEVIK 286
            +LH    +HRD+K  NIL   +G +KLADFG+ AK+         F G+PYWMAPEV+ 
Sbjct: 149 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 287 NSSG----CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
             +      +   D+WSLG T++EMA  +PP  +   +  + KI  S E PT+  P   S
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWS 267
Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPF--VKGAAPLERTILAPEPSDVPPGVTNG 395
              KDF++ CL++N   R T ++LL HPF  V    P+ R ++A   ++V   V +G
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI-RELIAEAKAEVTEEVEDG 323

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  164 bits (416), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 148/268 (55%), Gaps = 8/268 (2%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           PE  +   + +G G+FG VY   +  + E+ A+K+++ +   +S E  + +++E+  L +
Sbjct: 52  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQK 110
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAF 229
           LRHPN +QY G    E   ++ +EY  G S   LL+ + +   E  I   T   L GLA+
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI--KN 287
           LHS + +HRD+K  NIL+   G VKL DFG A  +A  +    F G+PYWMAPEVI   +
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMD 226
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
               +  VD+WSLG T +E+A  KPP      ++A++ I  ++         S+  ++F+
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286
Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             CLQ+ P +RPT+  LL H FV    P
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLRERP 314

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 148/268 (55%), Gaps = 8/268 (2%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           PE  +   + +G G+FG VY   +  + E+ A+K+++ +   +S E  + +++E+  L +
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQK 71
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAF 229
           LRHPN +QY G    E   ++ +EY  G S   LL+ + +   E  I   T   L GLA+
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI--KN 287
           LHS + +HRD+K  NIL+   G VKL DFG A  +A  +    F G+PYWMAPEVI   +
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMD 187
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
               +  VD+WSLG T +E+A  KPP      ++A++ I  ++         S+  ++F+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             CLQ+ P +RPT+  LL H FV    P
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERP 275

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 95/279 (34%), Positives = 150/279 (53%), Gaps = 29/279 (10%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +++G G    V   + +   E  A+K + L    K + S  +L++EI  +S+  HPNIV 
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINL---EKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY--------GQFGEPAIRNYTQQILSGLAFL 230
           YY S  V+D+L++ ++ +SGGS+  +++          G   E  I    +++L GL +L
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG------QSCPLSFKGSPYWMAPEV 284
           H    +HRD+K  NIL+  +G V++ADFG++  +A            +F G+P WMAPEV
Sbjct: 138 HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA-MFKIGNSKELPTIPDDLSDE- 342
           ++   G +   DIWS G T +E+AT   P+ +Y  +   M  + N    P++   + D+ 
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP--PSLETGVQDKE 255
Query: 343 -----GKDF---IRLCLQRNPLNRPTAAELLDHPFVKGA 373
                GK F   I LCLQ++P  RPTAAELL H F + A
Sbjct: 256 MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 93/278 (33%), Positives = 150/278 (53%), Gaps = 27/278 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +++G G    V   + +   E  A+K + L    K + S  +L++EI  +S+  HPNIV 
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINL---EKCQTSMDELLKEIQAMSQCHHPNIVS 72
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY--------GQFGEPAIRNYTQQILSGLAFL 230
           YY S  V+D+L++ ++ +SGGS+  +++          G   E  I    +++L GL +L
Sbjct: 73  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 132
Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG------QSCPLSFKGSPYWMAPEV 284
           H    +HRD+K  NIL+  +G V++ADFG++  +A            +F G+P WMAPEV
Sbjct: 133 HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 192
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE-- 342
           ++   G +   DIWS G T +E+AT   P+ +Y  +  +  +    + P++   + D+  
Sbjct: 193 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LTLQNDPPSLETGVQDKEM 251
Query: 343 ----GKDF---IRLCLQRNPLNRPTAAELLDHPFVKGA 373
               GK F   I LCLQ++P  RPTAAELL H F + A
Sbjct: 252 LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 289

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  159 bits (402), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 146/269 (54%), Gaps = 10/269 (3%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+  + + + +G+G  G VY   +  +G+  A++++ L    K +     ++ EI+++  
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE----LIINEILVMRE 73
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            ++PNIV Y  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L FL
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFL 132
Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSS 289
           HS   +HRDIK  NIL+  +G VKL DFG    I   QS      G+PYWMAPEV+    
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV-TRK 191
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDFI 347
                VDIWSLG   +EM   +PP+     + A++ I    + EL   P+ LS   +DF+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSAIFRDFL 250
Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPL 376
             CL+ +   R +A ELL H F+K A PL
Sbjct: 251 NRCLEMDVEKRGSAKELLQHQFLKIAKPL 279

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  159 bits (401), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 146/269 (54%), Gaps = 10/269 (3%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+  + + + +G+G  G VY   +  +G+  A++++ L    K +     ++ EI+++  
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE----LIINEILVMRE 73
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            ++PNIV Y  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L FL
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFL 132
Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSS 289
           HS   +HRDIK  NIL+  +G VKL DFG    I   QS   +  G+PYWMAPEV+    
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRK 191
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDFI 347
                VDIWSLG   +EM   +PP+     + A++ I    + EL   P+ LS   +DF+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSAIFRDFL 250
Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPL 376
             CL  +   R +A ELL H F+K A PL
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIAKPL 279

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  158 bits (400), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 145/269 (53%), Gaps = 10/269 (3%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+  + + + +G+G  G VY   +  +G+  A++++ L    K +     ++ EI+++  
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE----LIINEILVMRE 73
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            ++PNIV Y  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L FL
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFL 132
Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSS 289
           HS   +HRDIK  NIL+  +G VKL DFG    I   QS      G+PYWMAPEV+    
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV-TRK 191
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDFI 347
                VDIWSLG   +EM   +PP+     + A++ I    + EL   P+ LS   +DF+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSAIFRDFL 250
Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPL 376
             CL  +   R +A ELL H F+K A PL
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIAKPL 279

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  158 bits (400), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 146/269 (54%), Gaps = 10/269 (3%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+  + + + +G+G  G VY   +  +G+  A++++ L    K +     ++ EI+++  
Sbjct: 19  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE----LIINEILVMRE 74
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            ++PNIV Y  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L FL
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFL 133
Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSS 289
           HS   +HRDIK  NIL+  +G VKL DFG    I   QS      G+PYWMAPEV+    
Sbjct: 134 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV-TRK 192
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDFI 347
                VDIWSLG   +EM   +PP+     + A++ I    + EL   P+ LS   +DF+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSAIFRDFL 251
Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPL 376
             CL+ +   R +A EL+ H F+K A PL
Sbjct: 252 NRCLEMDVEKRGSAKELIQHQFLKIAKPL 280

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 147/269 (54%), Gaps = 10/269 (3%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+  + + + +G+G  G VY   +  +G+  A++++ L    K +     ++ EI+++  
Sbjct: 19  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE----LIINEILVMRE 74
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            ++PNIV Y  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L FL
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFL 133
Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSS 289
           HS   +HR+IK  NIL+  +G VKL DFG    I   QS   +  G+PYWMAPEV+    
Sbjct: 134 HSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRK 192
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN--SKELPTIPDDLSDEGKDFI 347
                VDIWSLG   +EM   +PP+     + A++ I    + EL   P+ LS   +DF+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSAIFRDFL 251
Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPL 376
             CL+ +   R +A EL+ H F+K A PL
Sbjct: 252 NRCLEMDVEKRGSAKELIQHQFLKIAKPL 280

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 146/273 (53%), Gaps = 12/273 (4%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           +P  P  +      +G G+ G V +     +G+  A+K++    D + ++  + L  E+V
Sbjct: 39  SPGDPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVV 94
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++    H N+V  Y S  V D+L++ +E++ GG++  ++  + +  E  I      +L  
Sbjct: 95  IMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRA 153
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVI 285
           L++LH++  +HRDIK  +IL+  +GR+KL+DFG    ++ +        G+PYWMAPEVI
Sbjct: 154 LSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVI 213
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SDE 342
                    VDIWSLG  V+EM   +PP+     + AM +I +S  LP    DL   S  
Sbjct: 214 SRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDS--LPPRVKDLHKVSSV 270
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
            + F+ L L R P  R TA ELL HPF+K A P
Sbjct: 271 LRGFLDLMLVREPSQRATAQELLGHPFLKLAGP 303

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  153 bits (386), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           +P  P S+      +G G+ G V +     SG++ A+K++    D + ++  + L  E+V
Sbjct: 145 DPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVV 200
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++   +H N+V+ Y S  V D+L++ +E++ GG++  ++  + +  E  I      +L  
Sbjct: 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQA 259
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEV 284
           L+ LH++  +HRDIK  +IL+  +GRVKL+DFG    ++ +  P      G+PYWMAPE+
Sbjct: 260 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPEL 318
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SD 341
           I         VDIWSLG  V+EM   +PP+     + AM  I ++  LP    +L   S 
Sbjct: 319 ISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHKVSP 375
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             K F+   L R+P  R TAAELL HPF+  A P
Sbjct: 376 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  152 bits (385), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 90/254 (35%), Positives = 143/254 (56%), Gaps = 12/254 (4%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G+ G V +     SG   A+K +    D + ++  + L  E+V++   +H N+V+ Y
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S  V ++L++ +E++ GG++  ++    +  E  I    + +L  LA+LH++  +HRDI
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 241 KGANILVDPNGRVKLADFGMAKHIAGQSCP--LSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           K  +IL+  +GRVKL+DFG    I+ +  P      G+PYWMAPEVI  S      VDIW
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKXLVGTPYWMAPEVISRSLYAT-EVDIW 225
Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLCLQRNPL 356
           SLG  V+EM   +PP+     V AM ++ +S   P + +   +S   +DF+   L R+P 
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNSHKVSPVLRDFLERMLVRDPQ 284
Query: 357 NRPTAAELLDHPFV 370
            R TA ELLDHPF+
Sbjct: 285 ERATAQELLDHPFL 298

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  152 bits (383), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           +P  P S+      +G G+ G V +     SG++ A+K++    D + ++  + L  E+V
Sbjct: 68  DPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVV 123
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++   +H N+V+ Y S  V D+L++ +E++ GG++  ++  + +  E  I      +L  
Sbjct: 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQA 182
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEV 284
           L+ LH++  +HRDIK  +IL+  +GRVKL+DFG    ++ +  P      G+PYWMAPE+
Sbjct: 183 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPEL 241
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SD 341
           I         VDIWSLG  V+EM   +PP+     + AM  I ++  LP    +L   S 
Sbjct: 242 ISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHKVSP 298
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             K F+   L R+P  R TAAELL HPF+  A P
Sbjct: 299 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  151 bits (382), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           +P  P S+      +G G+ G V +     SG++ A+K++    D + ++  + L  E+V
Sbjct: 23  DPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVV 78
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++   +H N+V+ Y S  V D+L++ +E++ GG++  ++  + +  E  I      +L  
Sbjct: 79  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQA 137
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEV 284
           L+ LH++  +HRDIK  +IL+  +GRVKL+DFG    ++ +  P      G+PYWMAPE+
Sbjct: 138 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPEL 196
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SD 341
           I         VDIWSLG  V+EM   +PP+     + AM  I ++  LP    +L   S 
Sbjct: 197 ISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHKVSP 253
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             K F+   L R+P  R TAAELL HPF+  A P
Sbjct: 254 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 287

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           +P  P S+      +G G+ G V +     SG++ A+K++    D + ++  + L  E+V
Sbjct: 25  DPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVV 80
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++   +H N+V+ Y S  V D+L++ +E++ GG++  ++  + +  E  I      +L  
Sbjct: 81  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQA 139
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEV 284
           L+ LH++  +HRDIK  +IL+  +GRVKL+DFG    ++ +  P      G+PYWMAPE+
Sbjct: 140 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPEL 198
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SD 341
           I         VDIWSLG  V+EM   +PP+     + AM  I ++  LP    +L   S 
Sbjct: 199 ISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHKVSP 255
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             K F+   L R+P  R TAAELL HPF+  A P
Sbjct: 256 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 289

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/278 (32%), Positives = 146/278 (52%), Gaps = 24/278 (8%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIV 177
           +++G GT+G VY G +  +G++ A+K + +  D +     +++ QEI +L +   H NI 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-----EEIKQEINMLKKYSHHRNIA 84
Query: 178 QYYGSKT------VEDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAF 229
            YYG+        ++D+L++ +E+   GS+  L+++       E  I    ++IL GL+ 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIK 286
           LH    +HRDIKG N+L+  N  VKL DFG++  +    G+    +F G+PYWMAPEVI 
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--TFIGTPYWMAPEVIA 202
Query: 287 NSSG----CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
                    +   D+WSLG T +EMA   PP      + A+F I  +          S +
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 262
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTI 380
            + FI  CL +N   RP   +L+ HPF++   P ER +
Sbjct: 263 FQSFIESCLVKNHSQRPATEQLMKHPFIRD-QPNERQV 299

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           +P  P S+      +G G+ G V +     SG++ A+K++    D + ++  + L  E+V
Sbjct: 14  DPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVV 69
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++   +H N+V+ Y S  V D+L++ +E++ GG++  ++  + +  E  I      +L  
Sbjct: 70  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQA 128
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEV 284
           L+ LH++  +HRDIK  +IL+  +GRVKL+DFG    ++ +  P      G+PYWMAPE+
Sbjct: 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPEL 187
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SD 341
           I         VDIWSLG  V+EM   +PP+     + AM  I ++  LP    +L   S 
Sbjct: 188 ISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHKVSP 244
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             K F+   L R+P  R TAAELL HPF+  A P
Sbjct: 245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           +P  P S+      +G G+ G V +     SG++ A+K++    D + ++  + L  E+V
Sbjct: 18  DPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVV 73
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++   +H N+V+ Y S  V D+L++ +E++ GG++  ++  + +  E  I      +L  
Sbjct: 74  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQA 132
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEV 284
           L+ LH++  +HRDIK  +IL+  +GRVKL+DFG    ++ +  P      G+PYWMAPE+
Sbjct: 133 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPEL 191
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SD 341
           I         VDIWSLG  V+EM   +PP+     + AM  I ++  LP    +L   S 
Sbjct: 192 ISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHKVSP 248
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             K F+   L R+P  R TAAELL HPF+  A P
Sbjct: 249 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 282

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/256 (34%), Positives = 139/256 (54%), Gaps = 7/256 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALK--VLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVI 134
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+  NG +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 192
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E     PP+  +       +I  S+   T PD +++  +D I   L+ N  
Sbjct: 193 LWSLGVLCYEFLVGMPPFEAHTYQETYRRI--SRVEFTFPDFVTEGARDLISRLLKHNAS 250
Query: 357 NRPTAAELLDHPFVKG 372
            R T AE+L+HP++K 
Sbjct: 251 QRLTLAEVLEHPWIKA 266

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 144/274 (52%), Gaps = 12/274 (4%)
Query: 103 GRMENPVSPESHW-----KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
            + +N  S +  W     + G+ LG+G FG+VY+     S  + A+K   LF     K  
Sbjct: 19  SKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAG 76
Query: 158 AK-QLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAI 216
            + QL +E+ + S LRHPNI++ YG      ++Y+ LEY   G++Y+ LQ   +F E   
Sbjct: 77  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 136
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS 276
             Y  ++ + L++ HSK  +HRDIK  N+L+   G +K+ADFG + H A  S   +  G+
Sbjct: 137 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGT 195
Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP 336
             ++ PE+I+     +  VD+WSLG    E    KPP+          +I  S+   T P
Sbjct: 196 LDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFP 252
Query: 337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
           D +++  +D I   L+ NP  RP   E+L+HP++
Sbjct: 253 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 135/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G +YK LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 76  LRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLXGTLDYLPPEMIEGRMH-DEKVD 193
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 252 QRPMLREVLEHPWI 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  146 bits (369), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G +YK LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 76  LRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 193
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 252 QRPMLREVLEHPWI 265

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  146 bits (369), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/256 (34%), Positives = 139/256 (54%), Gaps = 7/256 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALK--VLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVI 134
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+  NG +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEMIEGRMH-DEKVD 192
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E     PP+  +       +I  S+   T PD +++  +D I   L+ N  
Sbjct: 193 LWSLGVLCYEFLVGMPPFEAHTYQETYRRI--SRVEFTFPDFVTEGARDLISRLLKHNAS 250
Query: 357 NRPTAAELLDHPFVKG 372
            R T AE+L+HP++K 
Sbjct: 251 QRLTLAEVLEHPWIKA 266

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSCH-APSSRRTTLSGTLDYLPPEMIEGRMH-DEKVD 189
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 190 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 247
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 248 QRPMLREVLEHPWI 261

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 144/274 (52%), Gaps = 12/274 (4%)
Query: 103 GRMENPVSPESHW-----KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
            + +N  S +  W     + G+ LG+G FG+VY+     S  + A+K   LF     K  
Sbjct: 10  SKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAG 67
Query: 158 AK-QLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAI 216
            + QL +E+ + S LRHPNI++ YG      ++Y+ LEY   G++Y+ LQ   +F E   
Sbjct: 68  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 127
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS 276
             Y  ++ + L++ HSK  +HRDIK  N+L+   G +K+ADFG + H A  S   +  G+
Sbjct: 128 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGT 186
Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP 336
             ++ PE+I+     +  VD+WSLG    E    KPP+          +I  S+   T P
Sbjct: 187 LDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFP 243
Query: 337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
           D +++  +D I   L+ NP  RP   E+L+HP++
Sbjct: 244 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 13/263 (4%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD--DAKSKESAKQLMQEIVLLSR 170
           ++++  K +GRG F  VY       G   A+K+V +FD  DAK++      ++EI LL +
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADC---IKEIDLLKQ 88
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ----FGEPAIRNYTQQILSG 226
           L HPN+++YY S   +++L I LE    G + ++++ + +      E  +  Y  Q+ S 
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVI 285
           L  +HS+  +HRDIK AN+ +   G VKL D G+ +  + ++    S  G+PY+M+PE I
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAAMFKIGNSKELPTIPDD-LSDEG 343
            + +G N   DIWSLGC + EMA  + P +     + ++ K     + P +P D  S+E 
Sbjct: 209 -HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 344 KDFIRLCLQRNPLNRPTAAELLD 366
           +  + +C+  +P  RP    + D
Sbjct: 268 RQLVNMCINPDPEKRPDVTYVYD 290

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 134
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 135 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 192
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 193 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 250
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 251 QRPMLREVLEHPWI 264

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 193
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 252 QRPMLREVLEHPWI 265

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 143/274 (52%), Gaps = 12/274 (4%)
Query: 103 GRMENPVSPESHW-----KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
            + +N  S +  W     + G+ LG+G FG+VY+     S  + A+K   LF     K  
Sbjct: 19  SKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAG 76
Query: 158 AK-QLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAI 216
            + QL +E+ + S LRHPNI++ YG      ++Y+ LEY   G++Y+ LQ   +F E   
Sbjct: 77  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 136
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS 276
             Y  ++ + L++ HSK  +HRDIK  N+L+   G +K+ADFG + H A  S      G+
Sbjct: 137 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDDLCGT 195
Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP 336
             ++ PE+I+     +  VD+WSLG    E    KPP+          +I  S+   T P
Sbjct: 196 LDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFP 252
Query: 337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
           D +++  +D I   L+ NP  RP   E+L+HP++
Sbjct: 253 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE I+     +  VD
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEXIEGRXH-DEKVD 193
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 252 QRPXLREVLEHPWI 265

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTELCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 69
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 70  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 129
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 130 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 187
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 188 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 245
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 246 QRPMLREVLEHPWI 259

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  145 bits (366), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  145 bits (365), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 138/254 (54%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+    +S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 71  LRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVI 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQDTYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMH-DEKVD 193
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 252 QRPMLREVLEHPWI 265

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 132
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 133 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIEGRMH-DEKVD 190
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 191 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 248
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 249 QRPMLREVLEHPWI 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMH-DEKVD 189
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 190 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 247
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 248 QRPMLREVLEHPWI 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTXLCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEMIEGRMH-DEKVD 189
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 190 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 247
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 248 QRPMLREVLEHPWI 261

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S      G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDDLCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 132
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+A+FG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 133 HRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 190
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 191 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 248
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 249 QRPMLREVLEHPWI 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+A+FG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 136/254 (53%), Gaps = 7/254 (2%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+        + A+K   LF     K   + QL +E+ + S LRHPNI
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 67
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HSK  +
Sbjct: 68  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 127
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A  S   +  G+  ++ PE+I+     +  VD
Sbjct: 128 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 185
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +WSLG    E    KPP+          +I  S+   T PD +++  +D I   L+ NP 
Sbjct: 186 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 243
Query: 357 NRPTAAELLDHPFV 370
            RP   E+L+HP++
Sbjct: 244 QRPMLREVLEHPWI 257

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 145/307 (47%), Gaps = 54/307 (17%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           PG MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      
Sbjct: 2   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA 52
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------- 213
           ++EI LL  L HPNIV+       E+KLY+  E+V         QD  +F +        
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD--------QDLKKFMDASALTGIP 104
Query: 214 -PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
            P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+          
Sbjct: 105 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 273 FKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE 331
            +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +  
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224
Query: 332 LP---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAEL 364
            P         ++PD                   L ++G+  +   L  +P  R +A   
Sbjct: 225 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 365 LDHPFVK 371
           L HPF +
Sbjct: 285 LAHPFFQ 291

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 145/307 (47%), Gaps = 54/307 (17%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           PG MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      
Sbjct: 1   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA 51
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------- 213
           ++EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +        
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIP 103
Query: 214 -PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
            P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+          
Sbjct: 104 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX 163
Query: 273 FKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE 331
            +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +  
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223
Query: 332 LP---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAEL 364
            P         ++PD                   L ++G+  +   L  +P  R +A   
Sbjct: 224 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 365 LDHPFVK 371
           L HPF +
Sbjct: 284 LAHPFFQ 290

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 145/307 (47%), Gaps = 54/307 (17%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           PG MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      
Sbjct: 2   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA 52
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------- 213
           ++EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +        
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIP 104
Query: 214 -PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
            P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+          
Sbjct: 105 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 273 FKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE 331
            +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +  
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224
Query: 332 LP---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAEL 364
            P         ++PD                   L ++G+  +   L  +P  R +A   
Sbjct: 225 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 365 LDHPFVK 371
           L HPF +
Sbjct: 285 LAHPFFQ 291

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 145/307 (47%), Gaps = 54/307 (17%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           PG MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      
Sbjct: 1   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA 51
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------- 213
           ++EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +        
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIP 103
Query: 214 -PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
            P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+          
Sbjct: 104 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 163
Query: 273 FKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE 331
            +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +  
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223
Query: 332 LP---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAEL 364
            P         ++PD                   L ++G+  +   L  +P  R +A   
Sbjct: 224 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 365 LDHPFVK 371
           L HPF +
Sbjct: 284 LAHPFFQ 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 145/307 (47%), Gaps = 54/307 (17%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           PG MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      
Sbjct: 1   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA 51
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------- 213
           ++EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +        
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIP 103
Query: 214 -PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
            P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+          
Sbjct: 104 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 163
Query: 273 FKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE 331
            +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +  
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223
Query: 332 LP---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAEL 364
            P         ++PD                   L ++G+  +   L  +P  R +A   
Sbjct: 224 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 365 LDHPFVK 371
           L HPF +
Sbjct: 284 LAHPFFQ 290

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 146/308 (47%), Gaps = 54/308 (17%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           SP  MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++     
Sbjct: 5   SPEFMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPST 55
Query: 161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE------- 213
            ++EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +       
Sbjct: 56  AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGI 107
Query: 214 --PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
             P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         
Sbjct: 108 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 167
Query: 272 SFKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
           + +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  + 
Sbjct: 168 THEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 331 ELP---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAE 363
             P         ++PD                   L ++G+  +   L  +P  R +A  
Sbjct: 228 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 287
Query: 364 LLDHPFVK 371
            L HPF +
Sbjct: 288 ALAHPFFQ 295

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 146/308 (47%), Gaps = 54/308 (17%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           SP  MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++     
Sbjct: 5   SPEFMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPST 55
Query: 161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE------- 213
            ++EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +       
Sbjct: 56  AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGI 107
Query: 214 --PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
             P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         
Sbjct: 108 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 167
Query: 272 SFKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
           + +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  + 
Sbjct: 168 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 331 ELP---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAE 363
             P         ++PD                   L ++G+  +   L  +P  R +A  
Sbjct: 228 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 287
Query: 364 LLDHPFVK 371
            L HPF +
Sbjct: 288 ALAHPFFQ 295

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  136 bits (342), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 144/307 (46%), Gaps = 54/307 (17%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           PG MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      
Sbjct: 2   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA 52
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------- 213
           ++EI LL  L HPNIV+       E+KLY+  E+        L QD   F +        
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKTFMDASALTGIP 104
Query: 214 -PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
            P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+          
Sbjct: 105 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 273 FKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE 331
            +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +  
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224
Query: 332 LP---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAEL 364
            P         ++PD                   L ++G+  +   L  +P  R +A   
Sbjct: 225 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 365 LDHPFVK 371
           L HPF +
Sbjct: 285 LAHPFFQ 291

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 138/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K +G G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +K+ADFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 144/304 (47%), Gaps = 47/304 (15%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           P+    +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI L
Sbjct: 2   PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISL 59
Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRN 218
           L  L HPNIV+       E+KLY+  E+        L QD  +F +         P I++
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKS 111
Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
           Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + +    
Sbjct: 112 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 171
Query: 279 WM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP---- 333
           W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P    
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 231
Query: 334 -----TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
                ++PD                   L ++G+  +   L  +P  R +A   L HPF 
Sbjct: 232 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291
Query: 371 KGAA 374
           +   
Sbjct: 292 QDVT 295

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 138/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  135 bits (340), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 145/306 (47%), Gaps = 54/306 (17%)
Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      +
Sbjct: 1   GSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAI 51
Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE--------- 213
           +EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +         
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPL 103
Query: 214 PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF 273
           P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + 
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 163
Query: 274 KGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL 332
           +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 223
Query: 333 P---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELL 365
           P         ++PD                   L ++G+  +   L  +P  R +A   L
Sbjct: 224 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 283
Query: 366 DHPFVK 371
            HPF +
Sbjct: 284 AHPFFQ 289

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  135 bits (339), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 144/299 (48%), Gaps = 40/299 (13%)
Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      +
Sbjct: 1   GSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAI 51
Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG--EPAIRNYT 220
           +EI LL  L HPNIV+       E+KLY+  E++S   + K +      G   P I++Y 
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYL 110
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
            Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    W 
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 281 -APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP------ 333
            APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P      
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 230
Query: 334 ---TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
              ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 144/299 (48%), Gaps = 40/299 (13%)
Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      +
Sbjct: 3   GSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAI 53
Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG--EPAIRNYT 220
           +EI LL  L HPNIV+       E+KLY+  E++S   + K +      G   P I++Y 
Sbjct: 54  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYL 112
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
            Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    W 
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 281 -APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP------ 333
            APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P      
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 232
Query: 334 ---TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
              ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 136/258 (52%), Gaps = 9/258 (3%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +      K KE  + 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEH 87
Query: 161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
            + E  +L  +  P +V+   S      LY+ +EY  GG ++  L+  G+F EP  R Y 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYA 147
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
            QI+    +LHS   ++RD+K  N+++D  G +K+ DFG+AK + G++  L   G+P ++
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC--GTPEYL 205
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLS 340
           APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P   S
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFS 262
Query: 341 DEGKDFIRLCLQRNPLNR 358
            + KD +R  LQ +   R
Sbjct: 263 SDLKDLLRNLLQVDLTKR 280

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 138/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K +G G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EY+ GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +K+ADFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 144/306 (47%), Gaps = 54/306 (17%)
Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      +
Sbjct: 1   GHMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAI 51
Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE--------- 213
           +EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +         
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPL 103
Query: 214 PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF 273
           P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 163
Query: 274 KGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL 332
           +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 223
Query: 333 P---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELL 365
           P         ++PD                   L ++G+  +   L  +P  R +A   L
Sbjct: 224 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 283
Query: 366 DHPFVK 371
            HPF +
Sbjct: 284 AHPFFQ 289

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 138/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K +G G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EY+ GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +K+ADFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 143/301 (47%), Gaps = 47/301 (15%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           P+    +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI L
Sbjct: 2   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISL 59
Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRN 218
           L  L HPNIV+       E+KLY+  E+        L QD  +F +         P I++
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKS 111
Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
           Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    
Sbjct: 112 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 171
Query: 279 WM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP---- 333
           W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P    
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 231
Query: 334 -----TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
                ++PD                   L ++G+  +   L  +P  R +A   L HPF 
Sbjct: 232 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291
Query: 371 K 371
           +
Sbjct: 292 Q 292

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 144/303 (47%), Gaps = 48/303 (15%)
Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      +
Sbjct: 2   GSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAI 52
Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE------PAI 216
           +EI LL  L HPNIV+       E+KLY+  E++S       L+D+           P I
Sbjct: 53  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMD-----LKDFMDASALTGIPLPLI 107
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS 276
           ++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +  
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 277 PYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-- 333
             W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P  
Sbjct: 168 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 227
Query: 334 -------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHP 368
                  ++PD                   L ++G+  +   L  +P  R +A   L HP
Sbjct: 228 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 287
Query: 369 FVK 371
           F +
Sbjct: 288 FFQ 290

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/298 (29%), Positives = 143/298 (47%), Gaps = 41/298 (13%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           P+    +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI L
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISL 58
Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE------PAIRNYTQ 221
           L  L HPNIV+       E+KLY+  E++S       L+D+           P I++Y  
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMD-----LKDFMDASALTGIPLPLIKSYLF 113
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM- 280
           Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    W  
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP------- 333
           APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P       
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 334 --TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 144/306 (47%), Gaps = 54/306 (17%)
Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      +
Sbjct: 1   GSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAI 51
Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE--------- 213
           +EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +         
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPL 103
Query: 214 PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF 273
           P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH 163
Query: 274 KGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL 332
           +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 223
Query: 333 P---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELL 365
           P         ++PD                   L ++G+  +   L  +P  R +A   L
Sbjct: 224 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 283
Query: 366 DHPFVK 371
            HPF +
Sbjct: 284 AHPFFQ 289

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 144/306 (47%), Gaps = 54/306 (17%)
Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      +
Sbjct: 3   GSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAI 53
Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE--------- 213
           +EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +         
Sbjct: 54  REISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPL 105
Query: 214 PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF 273
           P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 274 KGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL 332
           +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 225
Query: 333 P---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELL 365
           P         ++PD                   L ++G+  +   L  +P  R +A   L
Sbjct: 226 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 285
Query: 366 DHPFVK 371
            HPF +
Sbjct: 286 AHPFFQ 291

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 144/306 (47%), Gaps = 54/306 (17%)
Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G MEN       ++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      +
Sbjct: 1   GSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAI 51
Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE--------- 213
           +EI LL  L HPNIV+       E+KLY+  E+        L QD  +F +         
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPL 103
Query: 214 PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF 273
           P I++Y  Q+L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 163
Query: 274 KGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL 332
           +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 223
Query: 333 P---------TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELL 365
           P         ++PD                   L ++G+  +   L  +P  R +A   L
Sbjct: 224 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 283
Query: 366 DHPFVK 371
            HPF +
Sbjct: 284 AHPFFQ 289

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  134 bits (337), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 15  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 70
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 71  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 130
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 131 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC--GTP 188
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 189 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 245
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 246 HFSSDLKDLLRNLLQVDLTKR 266

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  134 bits (337), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 142/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 60
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + +    W  AP
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 142/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 60
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + +    W  AP
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 142/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 59
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + +    W  AP
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 142/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 60
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + +    W  AP
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   E +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 142/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 59
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + +    W  AP
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 59
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+V         QD   F +         P I++Y  Q+
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVH--------QDLKTFMDASALTGIPLPLIKSYLFQL 111
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + +    W  AP
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 130/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L+  G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 136/258 (52%), Gaps = 9/258 (3%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +      K KE  + 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEH 87
Query: 161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
            + E  +L  +  P +V+   S      LY+ +EY  GG ++  L+  G+F EP  R Y 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYA 147
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
            QI+    +LHS   ++RD+K  N+++D  G +++ DFG+AK + G++  L   G+P ++
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC--GTPEYL 205
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLS 340
           APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P   S
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFS 262
Query: 341 DEGKDFIRLCLQRNPLNR 358
            + KD +R  LQ +   R
Sbjct: 263 SDLKDLLRNLLQVDLTKR 280

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 136/265 (51%), Gaps = 17/265 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G+FG V+       G   A+K   L +     E   + ++E+ ++ RLRHPNIV + 
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVK--ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG---QFGEPAIRNYTQQILSGLAFLHSKH--T 235
           G+ T    L I  EY+S GS+Y+LL   G   Q  E    +    +  G+ +LH+++   
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVIKNSSGCN 292
           VHR++K  N+LVD    VK+ DFG+++  A  S  LS K   G+P WMAPEV+++    N
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPS-N 217
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
              D++S G  + E+AT + PW        +  +G   +   IP +L+ +    I  C  
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277
Query: 353 RNPLNRPTAAELLD--HPFVKGAAP 375
             P  RP+ A ++D   P +K A P
Sbjct: 278 NEPWKRPSFATIMDLLRPLIKSAVP 302

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 60
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    W  AP
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 132/263 (50%), Gaps = 13/263 (4%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G+FG V+       G   A+K   L +     E   + ++E+ ++ RLRHPNIV + 
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVK--ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG---QFGEPAIRNYTQQILSGLAFLHSKH--T 235
           G+ T    L I  EY+S GS+Y+LL   G   Q  E    +    +  G+ +LH+++   
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF-KGSPYWMAPEVIKNSSGCNLA 294
           VHRD+K  N+LVD    VK+ DFG+++  A          G+P WMAPEV+++    N  
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPS-NEK 219
Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRN 354
            D++S G  + E+AT + PW        +  +G   +   IP +L+ +    I  C    
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNE 279
Query: 355 PLNRPTAAELLD--HPFVKGAAP 375
           P  RP+ A ++D   P +K A P
Sbjct: 280 PWKRPSFATIMDLLRPLIKSAVP 302

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 60
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    W  AP
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 59
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    W  AP
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 171
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 136/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EY  GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 60
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    W  AP
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 60
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    W  AP
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 59
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    W  AP
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 171
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 89
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 90  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 149
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 150 IYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 206
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 207 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 264
Query: 356 LNR 358
             R
Sbjct: 265 TKR 267

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 136/258 (52%), Gaps = 9/258 (3%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + E+P    +H   +++ K LG G+FG V +  + ++G   AMK +      K K+  + 
Sbjct: 50  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEH 108
Query: 161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
            + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R Y 
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYA 168
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
            QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYL 226
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLS 340
           APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P   S
Sbjct: 227 APEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFS 283
Query: 341 DEGKDFIRLCLQRNPLNR 358
            + KD +R  LQ +   R
Sbjct: 284 SDLKDLLRNLLQVDLTKR 301

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 142/299 (47%), Gaps = 47/299 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 60
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GL+F HS   +HRD+K  N+L++  G +KLADFG+A+         + +    W  AP
Sbjct: 113 LQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +   
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 163
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 220
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 221 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 278
Query: 356 LNR 358
             R
Sbjct: 279 TKR 281

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 136/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EY  GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDL 183
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 240
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 241 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 298
Query: 356 LNR 358
             R
Sbjct: 299 TKR 301

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + E+P    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 22  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQ 77
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 78  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 137
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 138 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 195
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 196 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 252
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 253 HFSSDLKDLLRNLLQVDLTKR 273

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 140/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELN 60
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD   F +         P I++Y  Q+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKDFMDASALTGIPLPLIKSYLFQL 112
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+           +    W  AP
Sbjct: 113 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + E+P    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + E+P    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 128/243 (52%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 183
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G +  L   G+P ++APE+I  S G N AV
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC--GTPEYLAPEIIL-SKGYNKAV 240
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 241 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 298
Query: 356 LNR 358
             R
Sbjct: 299 TKR 301

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + E+P    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + E+P    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 22  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQ 77
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EYV GG ++  L+  G+F EP  R
Sbjct: 78  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR 137
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P
Sbjct: 138 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 195
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 196 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 252
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 253 HFSSDLKDLLRNLLQVDLTKR 273

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 142/262 (54%), Gaps = 14/262 (5%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESA---KQLMQEIVLLSRL 171
           +K G +LG+G+F  VY   +  +G   A+K +    D K+   A   +++  E+ +  +L
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI----DKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFL 230
           +HP+I++ Y      + +Y+ LE    G + + L++  + F E   R++  QI++G+ +L
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVIKNSS 289
           HS   +HRD+  +N+L+  N  +K+ADFG+A  +        +  G+P +++PE I   S
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRS 187
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-ELPTIPDDLSDEGKDFIR 348
              L  D+WSLGC    +   +PP+        + K+  +  E+P+    LS E KD I 
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF---LSIEAKDLIH 244
Query: 349 LCLQRNPLNRPTAAELLDHPFV 370
             L+RNP +R + + +LDHPF+
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFM 266

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  132 bits (331), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 83/237 (35%), Positives = 127/237 (53%), Gaps = 12/237 (5%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 97
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 98  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDL 157
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 158 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 214
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 215 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 272
Query: 356 LNR 358
             R
Sbjct: 273 TKR 275

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+ ++ L  D +++      ++EI LL  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL--DTETEGVPSTAIREISLLKELN 60
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + +    W  AP
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            +++K + +G GT+G VY   N  +GE+ A+ ++ L  D +++      ++EI LL  L 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL--DTETEGVPSTAIREISLLKELN 59
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE---------PAIRNYTQQI 223
           HPNIV+       E+KLY+  E+        L QD  +F +         P I++Y  Q+
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF--------LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-AP 282
           L GLAF HS   +HRD+K  N+L++  G +KLADFG+A+         + +    W  AP
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------- 333
           E++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 334 TIPDD------------------LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           ++PD                   L ++G+  +   L  +P  R +A   L HPF +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+++D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIII-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 136/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 84
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EY  GG ++  L+  G+F EP  R
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+++D  G +++ DFG AK + G++  L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 259
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 129/243 (53%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + +MA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P + +   S      LY+ +EY  GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 136/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + E+P    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P +V+   S      LY+ +EY  GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/253 (33%), Positives = 136/253 (53%), Gaps = 15/253 (5%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNS---DSGEMCAMK---EVTLFDDAKSKESAKQLMQEIV 166
           SH++  K+LG+G+FG V++       DSG + AMK   + TL    K ++  +  M+  +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATL----KVRDRVRTKMERDI 83
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           L + + HP +V+ + +   E KLY+ L+++ GG ++  L     F E  ++ Y  ++  G
Sbjct: 84  L-ADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALG 142
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVI 285
           L  LHS   ++RD+K  NIL+D  G +KL DFG++K  I  +    SF G+  +MAPEV+
Sbjct: 143 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV 202
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
            N  G + + D WS G  + EM T   P+   +    M  I  +K    +P  LS E + 
Sbjct: 203 -NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAK--LGMPQFLSTEAQS 259
Query: 346 FIRLCLQRNPLNR 358
            +R   +RNP NR
Sbjct: 260 LLRALFKRNPANR 272

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P + +   S      LY+ +EY  GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 136/261 (52%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + E+P    +H   +++ + LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +   +  P +V+   S      LY+ LEY  GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+L+D  G +K+ADFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 15/261 (5%)
Query: 104 RMENPVSPESH---WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
           + ENP    +H   +++ K LG G+FG V +  + ++G   AMK +    D +     KQ
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQ 85
Query: 161 L---MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           +   + E  +L  +  P + +   S      LY+ +EY  GG ++  L+  G+F EP  R
Sbjct: 86  IEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHAR 145
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Y  QI+    +LHS   ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTP 203
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            ++APE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P 
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS 260
Query: 338 DLSDEGKDFIRLCLQRNPLNR 358
             S + KD +R  LQ +   R
Sbjct: 261 HFSSDLKDLLRNLLQVDLTKR 281

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/243 (34%), Positives = 128/243 (52%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P  +APE+I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEALAPEIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 128/243 (52%), Gaps = 12/243 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL---MQEIVLLSRLRHPN 175
           K LG G+FG V +  + +SG   AMK +    D +     KQ+   + E  +L  +  P 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++AP +I  S G N AV
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPAIIL-SKGYNKAV 219
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           D W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ + 
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDL 277
Query: 356 LNR 358
             R
Sbjct: 278 TKR 280

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 144/272 (52%), Gaps = 20/272 (7%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFD-DAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +G G+FG   +  +++ G    +KE+ +    +K +E +++   E+ +L+ ++HPNIVQY
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR---EVAVLANMKHPNIVQY 88
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLL--QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             S      LYI ++Y  GG ++K +  Q    F E  I ++  QI   L  +H +  +H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI-----AGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           RDIK  NI +  +G V+L DFG+A+ +       ++C     G+PY+++PE+ +N    N
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI----GTPYYLSPEICENKPYNN 204
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            + DIW+LGC + E+ T K  +        + KI  S   P +    S + +  +    +
Sbjct: 205 KS-DIWALGCVLYELCTLKHAFEAGSMKNLVLKI-ISGSFPPVSLHYSYDLRSLVSQLFK 262
Query: 353 RNPLNRPTAAELLDHPFVKGAAPLERTILAPE 384
           RNP +RP+   +L+  F+  A  +E+  L+P+
Sbjct: 263 RNPRDRPSVNSILEKGFI--AKRIEK-FLSPQ 291

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  129 bits (323), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 133/258 (51%), Gaps = 4/258 (1%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           NP +  S +   K++G+G+FG V +  +       A+K +      K KE    + +  V
Sbjct: 32  NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV 91
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           LL  ++HP +V  + S    DKLY  L+Y++GG ++  LQ    F EP  R Y  +I S 
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 151
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVI 285
           L +LHS + V+RD+K  NIL+D  G + L DFG+ K +I   S   +F G+P ++APEV+
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
            +    +  VD W LG  + EM    PP+      A M+    +K L   P ++++  + 
Sbjct: 212 -HKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQLKP-NITNSARH 268
Query: 346 FIRLCLQRNPLNRPTAAE 363
            +   LQ++   R  A +
Sbjct: 269 LLEGLLQKDRTKRLGAKD 286

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  128 bits (322), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 143/265 (53%), Gaps = 14/265 (5%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K  ++LG+G+FG V +  +  +G+ CA+K ++     K K   + L++E+ LL +L HP
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISK-RQVKQKTDKESLLREVQLLKQLDHP 110
Query: 175 NIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           NI++ Y  +  EDK Y YL  E  +GG ++  +    +F E       +Q+LSG+ ++H 
Sbjct: 111 NIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 233 KHTVHRDIKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
              VHRD+K  N+L++   +   +++ DFG++ H           G+ Y++APEV+  + 
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 227
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
             +   D+WS G  +  + +  PP+   ++Y+ +  + K   + ELP     +S+  KD 
Sbjct: 228 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSESAKDL 285
Query: 347 IRLCLQRNPLNRPTAAELLDHPFVK 371
           IR  L   P  R +A + LDH +++
Sbjct: 286 IRKMLTYVPSMRISARDALDHEWIQ 310

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  128 bits (322), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 143/265 (53%), Gaps = 14/265 (5%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K  ++LG+G+FG V +  +  +G+ CA+K ++     K K   + L++E+ LL +L HP
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISK-RQVKQKTDKESLLREVQLLKQLDHP 109
Query: 175 NIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           NI++ Y  +  EDK Y YL  E  +GG ++  +    +F E       +Q+LSG+ ++H 
Sbjct: 110 NIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 233 KHTVHRDIKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
              VHRD+K  N+L++   +   +++ DFG++ H           G+ Y++APEV+  + 
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 226
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
             +   D+WS G  +  + +  PP+   ++Y+ +  + K   + ELP     +S+  KD 
Sbjct: 227 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSESAKDL 284
Query: 347 IRLCLQRNPLNRPTAAELLDHPFVK 371
           IR  L   P  R +A + LDH +++
Sbjct: 285 IRKMLTYVPSMRISARDALDHEWIQ 309

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/250 (32%), Positives = 133/250 (53%), Gaps = 9/250 (3%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFN---SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           S ++  K+LG+G+FG V++      SD+ ++ AMK V      K ++  +  M+  +L+ 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK-VLKKATLKVRDRVRTKMERDILVE 82
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            + HP IV+ + +   E KLY+ L+++ GG ++  L     F E  ++ Y  ++   L  
Sbjct: 83  -VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNS 288
           LHS   ++RD+K  NIL+D  G +KL DFG++K  I  +    SF G+  +MAPEV+ N 
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NR 200
Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
            G   + D WS G  + EM T   P+   +    M  I  +K    +P  LS E +  +R
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLR 258
Query: 349 LCLQRNPLNR 358
           +  +RNP NR
Sbjct: 259 MLFKRNPANR 268

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/284 (31%), Positives = 145/284 (51%), Gaps = 17/284 (5%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFN---SDSGEMCAMKEVTLFDDAK 153
           SV R P +    + PE  ++  ++LG+G +G V+       +++G++ AMK +      +
Sbjct: 6   SVNRGPEK----IRPEC-FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 154 SKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE 213
           + +       E  +L  ++HP IV    +     KLY+ LEY+SGG ++  L+  G F E
Sbjct: 61  NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 214 PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLS 272
                Y  +I   L  LH K  ++RD+K  NI+++  G VKL DFG+ K  I   +   +
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL 332
           F G+  +MAPE++   SG N AVD WSLG  + +M T  PP++       + KI   K  
Sbjct: 181 FCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-- 237
Query: 333 PTIPDDLSDEGKDFIRLCLQRNPLNRP-----TAAELLDHPFVK 371
             +P  L+ E +D ++  L+RN  +R       A E+  HPF +
Sbjct: 238 LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 147/277 (53%), Gaps = 14/277 (5%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K  ++LG+G+FG V +  +  +G+ CA+K ++     K K   + L++E+ LL +L HP
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISK-RQVKQKTDKESLLREVQLLKQLDHP 86
Query: 175 NIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           NI++ Y  +  EDK Y YL  E  +GG ++  +    +F E       +Q+LSG+ ++H 
Sbjct: 87  NIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 233 KHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
              VHRD+K  N+L++    +  +++ DFG++ H           G+ Y++APEV+  + 
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 204
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
             +   D+WS G  +  + +  PP+   ++Y+ +  + K   + ELP     +S+  KD 
Sbjct: 205 --DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSESAKDL 261
Query: 347 IRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAP 383
           IR  L   P  R +A + LDH +++     + ++  P
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 133/267 (49%), Gaps = 10/267 (3%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     +  + A+K   LF     KE  + QL +EI + S LRHPNI
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALK--VLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 77
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y       ++Y+ LE+   G +YK LQ +G+F E     + +++   L + H +  +
Sbjct: 78  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVI 137
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A         G+  ++ PE+I+  +  +  VD
Sbjct: 138 HRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEMIEGKTH-DEKVD 195
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           +W  G    E     PP+          +I N       P  LSD  KD I   L+ +P 
Sbjct: 196 LWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISKLLRYHPP 253
Query: 357 NRPTAAELLDHPFVKGAAPLERTILAP 383
            R     +++HP+VK  +   R +L P
Sbjct: 254 QRLPLKGVMEHPWVKANS---RRVLPP 277

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 134/253 (52%), Gaps = 9/253 (3%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFN---SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           S ++  K+LG+G+FG V++      SD+ ++ AMK V      K ++  +  M+  +L+ 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK-VLKKATLKVRDRVRTKMERDILVE 82
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            + HP IV+ + +   E KLY+ L+++ GG ++  L     F E  ++ Y  ++   L  
Sbjct: 83  -VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNS 288
           LHS   ++RD+K  NIL+D  G +KL DFG++K  I  +    SF G+  +MAPEV+ N 
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NR 200
Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
            G   + D WS G  + EM T   P+   +    M  I  +K    +P  LS E +  +R
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLR 258
Query: 349 LCLQRNPLNRPTA 361
           +  +RNP NR  A
Sbjct: 259 MLFKRNPANRLGA 271

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 133/271 (49%), Gaps = 6/271 (2%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           H+  G  LG GTFG V +G +  +G   A+K +      +S +   ++ +EI  L   RH
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P+I++ Y   +     ++ +EYVSGG ++  +  +G+  E   R   QQILS + + H  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
             VHRD+K  N+L+D +   K+ADFG++  ++      +  GSP + APEVI        
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            VDIWS G  +  +     P+   E V  +FK         IP+ L+      +   LQ 
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVF-YIPEYLNRSVATLLMHMLQV 248
Query: 354 NPLNRPTAAELLDHPFVKGAAPLERTILAPE 384
           +PL R T  ++ +H + K   P   + L PE
Sbjct: 249 DPLKRATIKDIREHEWFKQDLP---SYLFPE 276

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 134/253 (52%), Gaps = 9/253 (3%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFN---SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           S ++  K+LG+G+FG V++      SD+ ++ AMK V      K ++  +  M+  +L+ 
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK-VLKKATLKVRDRVRTKMERDILVE 83
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            + HP IV+ + +   E KLY+ L+++ GG ++  L     F E  ++ Y  ++   L  
Sbjct: 84  -VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 142
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNS 288
           LHS   ++RD+K  NIL+D  G +KL DFG++K  I  +    SF G+  +MAPEV+ N 
Sbjct: 143 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NR 201
Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
            G   + D WS G  + EM T   P+   +    M  I  +K    +P  LS E +  +R
Sbjct: 202 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLR 259
Query: 349 LCLQRNPLNRPTA 361
           +  +RNP NR  A
Sbjct: 260 MLFKRNPANRLGA 272

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 143/265 (53%), Gaps = 14/265 (5%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K  ++LG+G+FG V +  +  +G+ CA+K ++     K K   + L++E+ LL +L HP
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISK-RQVKQKTDKESLLREVQLLKQLDHP 92
Query: 175 NIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           NI++ Y  +  EDK Y YL  E  +GG ++  +    +F E       +Q+LSG+ ++H 
Sbjct: 93  NIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 150
Query: 233 KHTVHRDIKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
              VHRD+K  N+L++   +   +++ DFG++ H           G+ Y++APEV+  + 
Sbjct: 151 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 210
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
             +   D+WS G  +  + +  PP+   ++Y+ +  + K   + ELP     +S+  KD 
Sbjct: 211 --DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSESAKDL 267
Query: 347 IRLCLQRNPLNRPTAAELLDHPFVK 371
           IR  L   P  R +A + LDH +++
Sbjct: 268 IRKMLTYVPSMRISARDALDHEWIQ 292

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 133/257 (51%), Gaps = 4/257 (1%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G+FG V + +++ +G+  A+K +     AKS    + + +EI  L  LRHP+I++
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIK 72
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            Y     +D++ + +EY +G  ++  +    +  E   R + QQI+S + + H    VHR
Sbjct: 73  LYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHR 131
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           D+K  N+L+D +  VK+ADFG++  +   +   +  GSP + APEVI         VD+W
Sbjct: 132 DLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 191
Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR 358
           S G  +  M   + P+   E +  +FK   S  + T+P  LS      I+  L  NPLNR
Sbjct: 192 SCGVILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPLNR 249
Query: 359 PTAAELLDHPFVKGAAP 375
            +  E++   + K   P
Sbjct: 250 ISIHEIMQDDWFKVDLP 266

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 133/257 (51%), Gaps = 4/257 (1%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G+FG V + +++ +G+  A+K +     AKS    + + +EI  L  LRHP+I++
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIK 68
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            Y     +D++ + +EY +G  ++  +    +  E   R + QQI+S + + H    VHR
Sbjct: 69  LYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHR 127
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           D+K  N+L+D +  VK+ADFG++  +   +   +  GSP + APEVI         VD+W
Sbjct: 128 DLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 187
Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR 358
           S G  +  M   + P+   E +  +FK   S  + T+P  LS      I+  L  NPLNR
Sbjct: 188 SCGVILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPLNR 245
Query: 359 PTAAELLDHPFVKGAAP 375
            +  E++   + K   P
Sbjct: 246 ISIHEIMQDDWFKVDLP 262

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 133/257 (51%), Gaps = 4/257 (1%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G+FG V + +++ +G+  A+K +     AKS    + + +EI  L  LRHP+I++
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIK 77
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            Y     +D++ + +EY +G  ++  +    +  E   R + QQI+S + + H    VHR
Sbjct: 78  LYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHR 136
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           D+K  N+L+D +  VK+ADFG++  +   +   +  GSP + APEVI         VD+W
Sbjct: 137 DLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 196
Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR 358
           S G  +  M   + P+   E +  +FK   S  + T+P  LS      I+  L  NPLNR
Sbjct: 197 SCGVILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPLNR 254
Query: 359 PTAAELLDHPFVKGAAP 375
            +  E++   + K   P
Sbjct: 255 ISIHEIMQDDWFKVDLP 271

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 90/284 (31%), Positives = 144/284 (50%), Gaps = 17/284 (5%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFN---SDSGEMCAMKEVTLFDDAK 153
           SV R P +    + PE  ++  ++LG+G +G V+       +++G++ AMK +      +
Sbjct: 6   SVNRGPEK----IRPEC-FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 154 SKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE 213
           + +       E  +L  ++HP IV    +     KLY+ LEY+SGG ++  L+  G F E
Sbjct: 61  NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 214 PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLS 272
                Y  +I   L  LH K  ++RD+K  NI+++  G VKL DFG+ K  I   +    
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHX 180
Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL 332
           F G+  +MAPE++   SG N AVD WSLG  + +M T  PP++       + KI   K  
Sbjct: 181 FCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-- 237
Query: 333 PTIPDDLSDEGKDFIRLCLQRNPLNRP-----TAAELLDHPFVK 371
             +P  L+ E +D ++  L+RN  +R       A E+  HPF +
Sbjct: 238 LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 133/257 (51%), Gaps = 4/257 (1%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G+FG V + +++ +G+  A+K +     AKS    + + +EI  L  LRHP+I++
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIK 78
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            Y     +D++ + +EY +G  ++  +    +  E   R + QQI+S + + H    VHR
Sbjct: 79  LYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHR 137
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           D+K  N+L+D +  VK+ADFG++  +   +   +  GSP + APEVI         VD+W
Sbjct: 138 DLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 197
Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR 358
           S G  +  M   + P+   E +  +FK   S  + T+P  LS      I+  L  NPLNR
Sbjct: 198 SCGVILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPLNR 255
Query: 359 PTAAELLDHPFVKGAAP 375
            +  E++   + K   P
Sbjct: 256 ISIHEIMQDDWFKVDLP 272

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 132/271 (48%), Gaps = 6/271 (2%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           H+  G  LG GTFG V +G +  +G   A+K +      +S +   ++ +EI  L   RH
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P+I++ Y   +     ++ +EYVSGG ++  +  +G+  E   R   QQILS + + H  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
             VHRD+K  N+L+D +   K+ADFG++  ++         GSP + APEVI        
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            VDIWS G  +  +     P+   E V  +FK         IP+ L+      +   LQ 
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVF-YIPEYLNRSVATLLMHMLQV 248
Query: 354 NPLNRPTAAELLDHPFVKGAAPLERTILAPE 384
           +PL R T  ++ +H + K   P   + L PE
Sbjct: 249 DPLKRATIKDIREHEWFKQDLP---SYLFPE 276

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 145/277 (52%), Gaps = 14/277 (5%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K  ++LG+G+FG V +  +  +G+ CA+K ++     K K   + L++E+ LL +L HP
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISK-RQVKQKTDKESLLREVQLLKQLDHP 86
Query: 175 NIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           NI + Y  +  EDK Y YL  E  +GG ++  +    +F E       +Q+LSG+ + H 
Sbjct: 87  NIXKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 233 KHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
              VHRD+K  N+L++    +  +++ DFG++ H           G+ Y++APEV+  + 
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT- 203
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
             +   D+WS G  +  + +  PP+   ++Y+ +  + K   + ELP     +S+  KD 
Sbjct: 204 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSESAKDL 261
Query: 347 IRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAP 383
           IR  L   P  R +A + LDH +++     + ++  P
Sbjct: 262 IRKXLTYVPSXRISARDALDHEWIQTYTKEQISVDVP 298

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 131/264 (49%), Gaps = 10/264 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNIVQY 179
           LG+G FG+VY+     +  + A+K   LF     KE  + QL +EI + S LRHPNI++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALK--VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           Y       ++Y+ LE+   G +YK LQ +G+F E     + +++   L + H +  +HRD
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 139
Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
           IK  N+L+   G +K+ADFG + H A         G+  ++ PE+I+  +  +  VD+W 
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEMIEGKTH-DEKVDLWC 197
Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
            G    E     PP+          +I N       P  LSD  KD I   L+ +P  R 
Sbjct: 198 AGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRL 255
Query: 360 TAAELLDHPFVKGAAPLERTILAP 383
               +++HP+VK  +   R +L P
Sbjct: 256 PLKGVMEHPWVKANS---RRVLPP 276

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  125 bits (313), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 129/262 (49%), Gaps = 3/262 (1%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           H+  G  LG GTFG V VG +  +G   A+K +      +S +   ++ +EI  L   RH
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75
Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P+I++ Y   +    +++ +EYVSGG ++  +   G+  E   R   QQILSG+ + H  
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
             VHRD+K  N+L+D +   K+ADFG++  ++         GSP + APEVI        
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            VDIWS G  +  +     P+   + V  +FK        T P  L+      ++  LQ 
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYT-PQYLNPSVISLLKHMLQV 253
Query: 354 NPLNRPTAAELLDHPFVKGAAP 375
           +P+ R T  ++ +H + K   P
Sbjct: 254 DPMKRATIKDIREHEWFKQDLP 275

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  125 bits (313), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 137/267 (51%), Gaps = 12/267 (4%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLSRLR 172
           + +G+ LG+G F   Y   + D+ E+ A K V  ++      KE   ++  EI +   L 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE---KMSTEIAIHKSLD 100
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           +P++V ++G    +D +Y+ LE     S+ +L +      EP  R + +Q + G+ +LH+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSG 290
              +HRD+K  N+ ++ +  VK+ DFG+A  I   G+    +  G+P ++APEV+    G
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKTLCGTPNYIAPEVL-CKKG 218
Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC 350
            +  VDIWSLGC +  +   KPP+          +I  ++   ++P  ++      IR  
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHINPVASALIRRM 276
Query: 351 LQRNPLNRPTAAELL-DHPFVKGAAPL 376
           L  +P  RP+ AELL D  F  G AP+
Sbjct: 277 LHADPTLRPSVAELLTDEFFTSGYAPM 303

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 136/267 (50%), Gaps = 12/267 (4%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLSRLR 172
           + +G+ LG+G F   Y   + D+ E+ A K V  ++      KE   ++  EI +   L 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE---KMSTEIAIHKSLD 100
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           +P++V ++G    +D +Y+ LE     S+ +L +      EP  R + +Q + G+ +LH+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSG 290
              +HRD+K  N+ ++ +  VK+ DFG+A  I   G+       G+P ++APEV+    G
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAPEVL-CKKG 218
Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC 350
            +  VDIWSLGC +  +   KPP+          +I  ++   ++P  ++      IR  
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHINPVASALIRRM 276
Query: 351 LQRNPLNRPTAAELL-DHPFVKGAAPL 376
           L  +P  RP+ AELL D  F  G AP+
Sbjct: 277 LHADPTLRPSVAELLTDEFFTSGYAPM 303

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 136/267 (50%), Gaps = 12/267 (4%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLSRLR 172
           + +G+ LG+G F   Y   + D+ E+ A K V  ++      KE   ++  EI +   L 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE---KMSTEIAIHKSLD 100
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           +P++V ++G    +D +Y+ LE     S+ +L +      EP  R + +Q + G+ +LH+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSG 290
              +HRD+K  N+ ++ +  VK+ DFG+A  I   G+       G+P ++APEV+    G
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTPNYIAPEVL-CKKG 218
Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC 350
            +  VDIWSLGC +  +   KPP+          +I  ++   ++P  ++      IR  
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHINPVASALIRRM 276
Query: 351 LQRNPLNRPTAAELL-DHPFVKGAAPL 376
           L  +P  RP+ AELL D  F  G AP+
Sbjct: 277 LHADPTLRPSVAELLTDEFFTSGYAPM 303

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 136/267 (50%), Gaps = 12/267 (4%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLSRLR 172
           + +G+ LG+G F   Y   + D+ E+ A K V  ++      KE   ++  EI +   L 
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE---KMSTEIAIHKSLD 84
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           +P++V ++G    +D +Y+ LE     S+ +L +      EP  R + +Q + G+ +LH+
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSG 290
              +HRD+K  N+ ++ +  VK+ DFG+A  I   G+       G+P ++APEV+    G
Sbjct: 145 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAPEVL-CKKG 202
Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC 350
            +  VDIWSLGC +  +   KPP+          +I  ++   ++P  ++      IR  
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHINPVASALIRRM 260
Query: 351 LQRNPLNRPTAAELL-DHPFVKGAAPL 376
           L  +P  RP+ AELL D  F  G AP+
Sbjct: 261 LHADPTLRPSVAELLTDEFFTSGYAPM 287

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 135/261 (51%), Gaps = 18/261 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHP 68
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +     +    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+ 
Sbjct: 69  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 128
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RDIK  N+++D +G +K+ DFG+ K  I+  +   +F G+P ++APEV++++     
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGR 187
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L++
Sbjct: 188 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKK 245
Query: 354 NPLNR-----PTAAELLDHPF 369
           +P  R       A E+++H F
Sbjct: 246 DPKQRLGGGPSDAKEVMEHRF 266

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 135/261 (51%), Gaps = 18/261 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHP 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +     +    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+ 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RDIK  N+++D +G +K+ DFG+ K  I+  +   +F G+P ++APEV++++     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGR 184
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L++
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKK 242
Query: 354 NPLNR-----PTAAELLDHPF 369
           +P  R       A E+++H F
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRF 263

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  122 bits (307), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 135/261 (51%), Gaps = 18/261 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHP 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +     +    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+ 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RDIK  N+++D +G +K+ DFG+ K  I+  +   +F G+P ++APEV++++     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGR 184
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L++
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKK 242
Query: 354 NPLNR-----PTAAELLDHPF 369
           +P  R       A E+++H F
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRF 263

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 140/301 (46%), Gaps = 45/301 (14%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           +S  S +K+ + LG GT+  VY G N  +G   A+KEV L  +  +  +A   ++EI L+
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA---IREISLM 57
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP-------AIRNYTQ 221
             L+H NIV+ Y     E+KL +  E++      K   D    G          ++ +  
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDND--LKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM- 280
           Q+L GLAF H    +HRD+K  N+L++  G++KL DFG+A+         S +    W  
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIG---NSKELPT 334
           AP+V+  S   + ++DIWS GC + EM T KP +   +  E +  +F I    N    P+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235
Query: 335 I--------------PDDLSDEGK------------DFIRLCLQRNPLNRPTAAELLDHP 368
           +              P DL    +            DF+   LQ NP  R +A + L HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 369 F 369
           +
Sbjct: 296 W 296

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 128/263 (48%), Gaps = 18/263 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLRHPNIVQY 179
           +G G++G          G++   KE+   D     E+ KQ L+ E+ LL  L+HPNIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 180 YGS--KTVEDKLYIYLEYVSGGSIYKLL----QDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           Y          LYI +EY  GG +  ++    ++     E  +     Q+   L   H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 234 ----HTV-HRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKN 287
               HTV HRD+K AN+ +D    VKL DFG+A+ +    S   +F G+PY+M+PE + N
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM-N 189
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
               N   DIWSLGC + E+    PP++ +       KI   K    IP   SDE  + I
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDELNEII 248
Query: 348 RLCLQRNPLNRPTAAELLDHPFV 370
              L     +RP+  E+L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 128/263 (48%), Gaps = 18/263 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLRHPNIVQY 179
           +G G++G          G++   KE+   D     E+ KQ L+ E+ LL  L+HPNIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 180 YGS--KTVEDKLYIYLEYVSGGSIYKLL----QDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           Y          LYI +EY  GG +  ++    ++     E  +     Q+   L   H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 234 ----HTV-HRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKN 287
               HTV HRD+K AN+ +D    VKL DFG+A+ +    S   +F G+PY+M+PE + N
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM-N 189
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
               N   DIWSLGC + E+    PP++ +       KI   K    IP   SDE  + I
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDELNEII 248
Query: 348 RLCLQRNPLNRPTAAELLDHPFV 370
              L     +RP+  E+L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 134/261 (51%), Gaps = 18/261 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHP 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +     +    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+ 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RDIK  N+++D +G +K+ DFG+ K  I+  +    F G+P ++APEV++++     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGR- 184
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L++
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKK 242
Query: 354 NPLNR-----PTAAELLDHPF 369
           +P  R       A E+++H F
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRF 263

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 134/261 (51%), Gaps = 18/261 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHP 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +     +    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+ 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RDIK  N+++D +G +K+ DFG+ K  I+  +    F G+P ++APEV++++     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YGR 184
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L++
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKK 242
Query: 354 NPLNR-----PTAAELLDHPF 369
           +P  R       A E+++H F
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRF 263

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 134/261 (51%), Gaps = 18/261 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHP 70
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +     +    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+ 
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 130
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RDIK  N+++D +G +K+ DFG+ K  I+  +    F G+P ++APEV++++     
Sbjct: 131 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YGR 189
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L++
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKK 247
Query: 354 NPLNR-----PTAAELLDHPF 369
           +P  R       A E+++H F
Sbjct: 248 DPKQRLGGGPSDAKEVMEHRF 268

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 130/257 (50%), Gaps = 10/257 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LGRG +G V    +  SG++ A+K +       S+E  + LM   + +  +  P  V +Y
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 181 GSKTVEDKLYIYLEYV--SGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKHTV- 236
           G+   E  ++I +E +  S    YK + D GQ   E  +      I+  L  LHSK +V 
Sbjct: 117 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 176
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK---NSSGCNL 293
           HRD+K +N+L++  G+VK+ DFG++ ++          G   +MAPE I    N  G ++
Sbjct: 177 HRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSV 236
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCLQ 352
             DIWSLG T++E+A  + P+  +       K    +  P +P D  S E  DF   CL+
Sbjct: 237 KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLK 296
Query: 353 RNPLNRPTAAELLDHPF 369
           +N   RPT  EL+ HPF
Sbjct: 297 KNSKERPTYPELMQHPF 313

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 134/293 (45%), Gaps = 40/293 (13%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           ++G G++G V    N D+G + A+K+    DD   K   K  M+EI LL +LRH N+V  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD--DKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQF----GEPAIRNYTQQILSGLAFLHSKHT 235
                 + + Y+  E+V     + +L D   F        ++ Y  QI++G+ F HS + 
Sbjct: 90  LEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI 145
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCNLA 294
           +HRDIK  NILV  +G VKL DFG A+ +A        + +  W  APE++        A
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205
Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI----GN----------------SKELPT 334
           VD+W++GC V EM   +P +     +  ++ I    GN                   LP 
Sbjct: 206 VDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPE 265
Query: 335 IPD---------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLER 378
           I +          LS+   D  + CL  +P  RP  AELL H F +     ER
Sbjct: 266 IKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER 318

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 134/261 (51%), Gaps = 18/261 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHP 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +     +    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+ 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RDIK  N+++D +G +K+ DFG+ K  I+  +    F G+P ++APEV++++     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YGR 184
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L++
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKK 242
Query: 354 NPLNR-----PTAAELLDHPF 369
           +P  R       A E+++H F
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRF 263

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLRHPNIVQY 179
           +G G++G          G++   KE+   D     E+ KQ L+ E+ LL  L+HPNIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 180 YGS--KTVEDKLYIYLEYVSGGSIYKLL----QDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           Y          LYI +EY  GG +  ++    ++     E  +     Q+   L   H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 234 ----HTV-HRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKN 287
               HTV HRD+K AN+ +D    VKL DFG+A+ +   +     F G+PY+M+PE + N
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM-N 189
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
               N   DIWSLGC + E+    PP++ +       KI   K    IP   SDE  + I
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDELNEII 248
Query: 348 RLCLQRNPLNRPTAAELLDHPFV 370
              L     +RP+  E+L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 19/275 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           KMLG+G+FG V++     + +  A+K    +V L DD    +    ++++ VL     HP
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD----DVECTMVEKRVLSLAWEHP 79
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +   + +   ++ L+  +EY++GG +   +Q   +F       Y  +I+ GL FLHSK 
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 139
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RD+K  NIL+D +G +K+ADFGM K ++ G +    F G+P ++APE++      N 
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKY-NH 198
Query: 294 AVDIWSLGCTVLEMATTKPPW--SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL 351
           +VD WS G  + EM   + P+     E +    ++ N    P  P  L  E KD +    
Sbjct: 199 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN----PFYPRWLEKEAKDLLVKLF 254
Query: 352 QRNPLNRP-TAAELLDHPFVK--GAAPLERTILAP 383
            R P  R     ++  HP  +      LER  + P
Sbjct: 255 VREPEKRLGVRGDIRQHPLFREINWEELERKEIDP 289

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 132/266 (49%), Gaps = 22/266 (8%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSRLR 172
           +++  K +G+G F  V +  +  +G   A+K   + D  +    S ++L +E+ ++  L 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNIV+ +     E  LY+ +EY SGG ++  L  +G+  E   R+  +QI+S + + H 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  VHRD+K  N+L+D +  +K+ADFG +          +F GSP + APE+ +      
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--------IPDDLSDEGK 344
             VD+WSLG  +  + +   P          F   N KEL          IP  +S + +
Sbjct: 190 PEVDVWSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCE 239
Query: 345 DFIRLCLQRNPLNRPTAAELLDHPFV 370
           + ++  L  NP+ R T  +++   ++
Sbjct: 240 NLLKRFLVLNPIKRGTLEQIMKDRWI 265

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 141/279 (50%), Gaps = 26/279 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ------EIVLLSRLR 172
           + LG G+FG V++  +  +G   AMK +        KE   +L Q      E ++LS + 
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HP I++ +G+     ++++ ++Y+ GG ++ LL+   +F  P  + Y  ++   L +LHS
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  ++RD+K  NIL+D NG +K+ DFG AK++   +  L   G+P ++APEV+ ++   N
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC--GTPDYIAPEVV-STKPYN 181
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            ++D WS G  + EM     P+     +    KI N++     P   +++ KD +   + 
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLIT 239
Query: 353 RNPLNR-----PTAAELLDHPFVKGAA---PLERTILAP 383
           R+   R         ++ +HP+ K       L R I  P
Sbjct: 240 RDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 278

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 19/275 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           KMLG+G+FG V++     + +  A+K    +V L DD    +    ++++ VL     HP
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD----DVECTMVEKRVLSLAWEHP 78
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            +   + +   ++ L+  +EY++GG +   +Q   +F       Y  +I+ GL FLHSK 
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            V+RD+K  NIL+D +G +K+ADFGM K ++ G +    F G+P ++APE++      N 
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKY-NH 197
Query: 294 AVDIWSLGCTVLEMATTKPPW--SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL 351
           +VD WS G  + EM   + P+     E +    ++ N    P  P  L  E KD +    
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN----PFYPRWLEKEAKDLLVKLF 253
Query: 352 QRNPLNRP-TAAELLDHPFVK--GAAPLERTILAP 383
            R P  R     ++  HP  +      LER  + P
Sbjct: 254 VREPEKRLGVRGDIRQHPLFREINWEELERKEIDP 288

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 138/290 (47%), Gaps = 31/290 (10%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K + +G GT+G V+   N ++ E+ A+K V L DD +   S+   ++EI LL  L+H 
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHK 61
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NIV+ +     + KL +  E+             G      ++++  Q+L GL F HS++
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            +HRD+K  N+L++ NG +KLADFG+A+       C  +   + ++  P+V+  +   + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 294 AVDIWSLGCTVLEMATTKPPWS-------------------QYEGVAAMFKIGNSKELPT 334
           ++D+WS GC   E+A    P                       E   +M K+ + K  P 
Sbjct: 182 SIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 335 IPD---------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
            P           L+  G+D ++  L+ NP+ R +A E L HP+     P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 149/266 (56%), Gaps = 12/266 (4%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSR 170
           +  ++K   LG G  G V+   +  SG + A K + L    + K + + Q+++E+ +L  
Sbjct: 24  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHE 79
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L
Sbjct: 80  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 139
Query: 231 HSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             KH + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  +M+PE ++ + 
Sbjct: 140 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 198
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN---SKELPTIPDDL-SDEGKD 345
             ++  DIWS+G +++EMA  + P     G  A+F++ +   ++  P +P  + S E +D
Sbjct: 199 -YSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQD 257
Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVK 371
           F+  CL +NP  R    +L+ H F+K
Sbjct: 258 FVNKCLIKNPAERADLKQLMVHAFIK 283

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 139/286 (48%), Gaps = 16/286 (5%)
Query: 99  PRSPGRMENPVSPES-HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
           P   G M+ P+  +S  ++  K +G G FG   +  +  S E+ A+K +      + ++ 
Sbjct: 4   PAVSGPMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-----RGEKI 58
Query: 158 AKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
           A  + +EI+    LRHPNIV++         L I +EY SGG +++ + + G+F E   R
Sbjct: 59  AANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVD--PNGRVKLADFGMAKHIAGQSCPLSFKG 275
            + QQ++SG+++ H+    HRD+K  N L+D  P  R+K+ DFG +K     S P S  G
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMFKIGNSKE 331
           +P ++APEV+          D+WS G T+  M     P+   E        + +I N + 
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 332 LPTIPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
              IPD   +S E +  I      +P  R +  E+ +H +     P
Sbjct: 239 --AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 136/265 (51%), Gaps = 20/265 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLR-H 173
           ++LG+G+FG V +    ++G++ A+K    +V L DD       +  M E  +LS  R H
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD-----DVECTMTEKRILSLARNH 83
Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P + Q +      D+L+  +E+V+GG +   +Q   +F E   R Y  +I+S L FLH K
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
             ++RD+K  N+L+D  G  KLADFGM K  I       +F G+P ++APE+++      
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-G 202
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            AVD W++G  + EM     P+ + E    +F+   + E+   P  L ++    ++  + 
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEV-VYPTWLHEDATGILKSFMT 260
Query: 353 RNP------LNRPTAAELLDHPFVK 371
           +NP      L +     +L HPF K
Sbjct: 261 KNPTMRLGSLTQGGEHAILRHPFFK 285

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 146/296 (49%), Gaps = 28/296 (9%)
Query: 102 PGRMENPVSPESHWKKGK----------MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD 151
           PG +E P      WK+ +          +LG G F  V +  +  + ++ A+K +     
Sbjct: 2   PGAVEGP-----RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA---- 52
Query: 152 AKSKESAKQLMQ-EIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ 210
            K+ E  +  M+ EI +L +++HPNIV           LY+ ++ VSGG ++  + + G 
Sbjct: 53  KKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF 112
Query: 211 FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANIL---VDPNGRVKLADFGMAKHIAGQ 267
           + E        Q+L  + +LH    VHRD+K  N+L   +D + ++ ++DFG++K     
Sbjct: 113 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 172
Query: 268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK-- 325
           S   +  G+P ++APEV+        AVD WS+G     +    PP+   E  A +F+  
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQI 230
Query: 326 IGNSKELPT-IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTI 380
           +    E  +   DD+SD  KDFIR  ++++P  R T  + L HP++ G   L++ I
Sbjct: 231 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNI 286

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLR 172
           +++  K +G+G F  V +  +  +G+  A+K   + D  +   S+ Q L +E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNIV+ +     E  LY+ +EY SGG ++  L  +G+  E   R   +QI+S + + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  VHRD+K  N+L+D +  +K+ADFG +      +   +F GSP + APE+ +      
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--------IPDDLSDEGK 344
             VD+WSLG  +  + +   P          F   N KEL          IP  +S + +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCE 241
Query: 345 DFIRLCLQRNPLNRPTAAELL 365
           + ++  L  NP  R T  +++
Sbjct: 242 NLLKKFLILNPSKRGTLEQIM 262

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLR 172
           +++  K +G+G F  V +  +  +G+  A+K   + D  +   S+ Q L +E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNIV+ +     E  LY+ +EY SGG ++  L  +G+  E   R   +QI+S + + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  VHRD+K  N+L+D +  +K+ADFG +      +   +F GSP + APE+ +      
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--------IPDDLSDEGK 344
             VD+WSLG  +  + +   P          F   N KEL          IP  +S + +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCE 241
Query: 345 DFIRLCLQRNPLNRPTAAELL 365
           + ++  L  NP  R T  +++
Sbjct: 242 NLLKKFLILNPSKRGTLEQIM 262

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 132/266 (49%), Gaps = 22/266 (8%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSRLR 172
           +++  K +G+G F  V +  +  +G   A+K   + D  +    S ++L +E+ ++  L 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNIV+ +     E  LY+ +EY SGG ++  L  +G+  E   R+  +QI+S + + H 
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  VHRD+K  N+L+D +  +K+ADFG +          +F G+P + APE+ +      
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--------IPDDLSDEGK 344
             VD+WSLG  +  + +   P          F   N KEL          IP  +S + +
Sbjct: 193 PEVDVWSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCE 242
Query: 345 DFIRLCLQRNPLNRPTAAELLDHPFV 370
           + ++  L  NP+ R T  +++   ++
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMKDRWI 268

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 141/284 (49%), Gaps = 17/284 (5%)
Query: 99  PRSPGRMENPVSPES-HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
           P   G M+ P+  +S  ++  K +G G FG   +  +  + E+ A+K +      + ++ 
Sbjct: 4   PAVAGPMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE-----RGEKI 58
Query: 158 AKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
            + + +EI+    LRHPNIV++         L I +EY SGG +++ + + G+F E   R
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVD--PNGRVKLADFGMAKHIAGQSCPLSFKG 275
            + QQ++SG+++ H+    HRD+K  N L+D  P  R+K+ADFG +K     S P S  G
Sbjct: 119 FFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVG 178
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMFKIGNSKE 331
           +P ++APEV+          D+WS G T+  M     P+   E        + +I N + 
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 332 LPTIPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHP-FVKG 372
              IPD   +S E +  I      +P  R +  E+ +H  F+K 
Sbjct: 239 --AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 130/257 (50%), Gaps = 10/257 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LGRG +G V    +  SG++ A+K +       S+E  + LM   + +  +  P  V +Y
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 181 GSKTVEDKLYIYLEYV--SGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKHTV- 236
           G+   E  ++I +E +  S    YK + D GQ   E  +      I+  L  LHSK +V 
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK---NSSGCNL 293
           HRD+K +N+L++  G+VK+ DFG++ ++          G   +MAPE I    N  G ++
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV 192
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCLQ 352
             DIWSLG T++E+A  + P+  +       K    +  P +P D  S E  DF   CL+
Sbjct: 193 KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLK 252
Query: 353 RNPLNRPTAAELLDHPF 369
           +N   RPT  EL+ HPF
Sbjct: 253 KNSKERPTYPELMQHPF 269

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 129/261 (49%), Gaps = 22/261 (8%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLR 172
           +++  K +G+G F  V +  +  +G+  A   V + D  +   S+ Q L +E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVA---VRIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNIV+ +     E  LY+ +EY SGG ++  L  +G+  E   R   +QI+S + + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  VHRD+K  N+L+D +  +K+ADFG +      +   +F GSP + APE+ +      
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--------IPDDLSDEGK 344
             VD+WSLG  +  + +   P          F   N KEL          IP  +S + +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCE 241
Query: 345 DFIRLCLQRNPLNRPTAAELL 365
           + ++  L  NP  R T  +++
Sbjct: 242 NLLKKFLILNPSKRGTLEQIM 262

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 137/279 (49%), Gaps = 21/279 (7%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAK-------QLM 162
           ES++K  K LG G +G V +    +     A+K +  + FD  +  +  K       ++ 
Sbjct: 36  ESYFKVRK-LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYT 220
            EI LL  L HPNI++ +     EDK Y YL  E+  GG +++ + +  +F E    N  
Sbjct: 95  NEISLLKSLDHPNIIKLFD--VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNG---RVKLADFGMAKHIAGQSCPLSFKGSP 277
           +QILSG+ +LH  + VHRDIK  NIL++       +K+ DFG++   +         G+ 
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
           Y++APEV+K     N   D+WS G  +  +    PP+        + K+   K      D
Sbjct: 213 YYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270
Query: 338 --DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
             ++SDE K+ I+L L  +   R TA E L+  ++K  A
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  119 bits (297), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 137/280 (48%), Gaps = 31/280 (11%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQLMQEIVLLS 169
           E H++ G+ LG G F  V       +G+  A K +     + S+   S +++ +E+ +L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            +RHPNI+  +     +  + + LE VSGG ++  L +     E     + +QIL G+ +
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 230 LHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           LHSK   H D+K  NI L+D   PN R+KL DFG+A  I   +   +  G+P ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-----LPTIPDDLS 340
            N     L  D+WS+G     + +   P+           +G +K+     +  +  D  
Sbjct: 184 -NYEPLGLEADMWSIGVITYILLSGASPF-----------LGETKQETLTNISAVNYDFD 231
Query: 341 DE--------GKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
           +E         KDFIR  L ++P  R T A+ L+H ++K 
Sbjct: 232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 137/270 (50%), Gaps = 20/270 (7%)
Query: 119 KMLGRGTFGHVYVGFN---SDSGEMCAMK---EVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           K+LG G +G V++       D+G++ AMK   + T+   AK+ E  +   Q   +L  +R
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ---VLEHIR 116
Query: 173 H-PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
             P +V  + +   E KL++ L+Y++GG ++  L    +F E  ++ Y  +I+  L  LH
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC--PLSFKGSPYWMAPEVIK-NS 288
               ++RDIK  NIL+D NG V L DFG++K            F G+  +MAP++++   
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 236
Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--KELPTIPDDLSDEGKDF 346
           SG + AVD WSLG  + E+ T   P++      +  +I     K  P  P ++S   KD 
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDL 296
Query: 347 IRLCLQRNPLNR-----PTAAELLDHPFVK 371
           I+  L ++P  R       A E+ +H F +
Sbjct: 297 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 132/271 (48%), Gaps = 19/271 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 93
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+   SF G+  +++PE++   S C
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 214 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 267
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGA 373
             L  +   R    E      L  HPF +  
Sbjct: 268 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 138/290 (47%), Gaps = 31/290 (10%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K + +G GT+G V+   N ++ E+ A+K V L DD +   S+   ++EI LL  L+H 
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHK 61
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NIV+ +     + KL +  E+             G      ++++  Q+L GL F HS++
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            +HRD+K  N+L++ NG +KLA+FG+A+       C  +   + ++  P+V+  +   + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 294 AVDIWSLGCTVLEMATTKPPWS-------------------QYEGVAAMFKIGNSKELPT 334
           ++D+WS GC   E+A    P                       E   +M K+ + K  P 
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 335 IPD---------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
            P           L+  G+D ++  L+ NP+ R +A E L HP+     P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  118 bits (296), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLR 172
           +++  K +G+G F  V +  +  +G+  A+K   + D  +   S+ Q L +E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNIV+ +     E  LY+ +EY SGG ++  L  +G+  E   R   +QI+S + + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  VHRD+K  N+L+D +  +K+ADFG +      +   +F G+P + APE+ +      
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--------IPDDLSDEGK 344
             VD+WSLG  +  + +   P          F   N KEL          IP  +S + +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCE 241
Query: 345 DFIRLCLQRNPLNRPTAAELL 365
           + ++  L  NP  R T  +++
Sbjct: 242 NLLKKFLILNPSKRGTLEQIM 262

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 22/261 (8%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLR 172
           +++  K +G+G F  V +  +  +G+  A   V + D  +   S+ Q L +E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVA---VRIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNIV+ +     E  LY+ +EY SGG ++  L  +G+  E   R   +QI+S + + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  VHRD+K  N+L+D +  +K+ADFG +      +    F GSP + APE+ +      
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--------IPDDLSDEGK 344
             VD+WSLG  +  + +   P          F   N KEL          IP  +S + +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCE 241
Query: 345 DFIRLCLQRNPLNRPTAAELL 365
           + ++  L  NP  R T  +++
Sbjct: 242 NLLKKFLILNPSKRGTLEQIM 262

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 133/261 (50%), Gaps = 11/261 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K+LG+GTFG V +     +G   AMK +   +   +K+     + E  +L   RHP +  
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVH 237
              S    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS K+ V+
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 275
Query: 238 RDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           RD+K  N+++D +G +K+ DFG+ K  I   +   +F G+P ++APEV++++     AVD
Sbjct: 276 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVD 334
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
            W LG  + EM   + P+   +    +F++   +E+   P  L  E K  +   L+++P 
Sbjct: 335 WWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPK 392
Query: 357 NR-----PTAAELLDHPFVKG 372
            R       A E++ H F  G
Sbjct: 393 QRLGGGSEDAKEIMQHRFFAG 413

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 134/265 (50%), Gaps = 19/265 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHP 208
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-K 233
            +     S    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS K
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           + V+RD+K  N+++D +G +K+ DFG+ K  I   +   +F G+P ++APEV++++    
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YG 327
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            AVD W LG  + EM   + P+   +    +F++   +E+   P  L  E K  +   L+
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI-RFPRTLGPEAKSLLSGLLK 385
Query: 353 RNPLNR-----PTAAELLDHPFVKG 372
           ++P  R       A E++ H F  G
Sbjct: 386 KDPKQRLGGGSEDAKEIMQHRFFAG 410

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 136/269 (50%), Gaps = 15/269 (5%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ--LMQEIVLLSRLRHPNIV 177
           +LG G F  V +  +  + ++ A+K +     AK     K+  +  EI +L +++HPNIV
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI-----AKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
                      LY+ ++ VSGG ++  + + G + E        Q+L  + +LH    VH
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 238 RDIKGANIL---VDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           RD+K  N+L   +D + ++ ++DFG++K     S   +  G+P ++APEV+        A
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK-A 198
Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFK--IGNSKELPT-IPDDLSDEGKDFIRLCL 351
           VD WS+G     +    PP+   E  A +F+  +    E  +   DD+SD  KDFIR  +
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 257
Query: 352 QRNPLNRPTAAELLDHPFVKGAAPLERTI 380
           +++P  R T  + L HP++ G   L++ I
Sbjct: 258 EKDPEKRFTCEQALQHPWIAGDTALDKNI 286

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 136/269 (50%), Gaps = 15/269 (5%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ--LMQEIVLLSRLRHPNIV 177
           +LG G F  V +  +  + ++ A+K +     AK     K+  +  EI +L +++HPNIV
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI-----AKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
                      LY+ ++ VSGG ++  + + G + E        Q+L  + +LH    VH
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 238 RDIKGANIL---VDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           RD+K  N+L   +D + ++ ++DFG++K     S   +  G+P ++APEV+        A
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK-A 198
Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFK--IGNSKELPT-IPDDLSDEGKDFIRLCL 351
           VD WS+G     +    PP+   E  A +F+  +    E  +   DD+SD  KDFIR  +
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 257
Query: 352 QRNPLNRPTAAELLDHPFVKGAAPLERTI 380
           +++P  R T  + L HP++ G   L++ I
Sbjct: 258 EKDPEKRFTCEQALQHPWIAGDTALDKNI 286

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 136/269 (50%), Gaps = 15/269 (5%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ--LMQEIVLLSRLRHPNIV 177
           +LG G F  V +  +  + ++ A+K +     AK     K+  +  EI +L +++HPNIV
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI-----AKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
                      LY+ ++ VSGG ++  + + G + E        Q+L  + +LH    VH
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 238 RDIKGANIL---VDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           RD+K  N+L   +D + ++ ++DFG++K     S   +  G+P ++APEV+        A
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK-A 198
Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFK--IGNSKELPT-IPDDLSDEGKDFIRLCL 351
           VD WS+G     +    PP+   E  A +F+  +    E  +   DD+SD  KDFIR  +
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 257
Query: 352 QRNPLNRPTAAELLDHPFVKGAAPLERTI 380
           +++P  R T  + L HP++ G   L++ I
Sbjct: 258 EKDPEKRFTCEQALQHPWIAGDTALDKNI 286

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 128/255 (50%), Gaps = 4/255 (1%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G+FG V +  +  + +  A+K ++     K  +   ++ +EI  L  LRHP+I++ Y
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
              T    + + +EY +GG ++  + +  +  E   R + QQI+  + + H    VHRD+
Sbjct: 76  DVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDL 134
Query: 241 KGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSL 300
           K  N+L+D N  VK+ADFG++  +   +   +  GSP + APEVI         VD+WS 
Sbjct: 135 KPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194
Query: 301 GCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPT 360
           G  +  M   + P+   E +  +FK  NS  +  +PD LS   +  IR  +  +P+ R T
Sbjct: 195 GIVLYVMLVGRLPFDD-EFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRIT 252
Query: 361 AAELLDHPFVKGAAP 375
             E+   P+     P
Sbjct: 253 IQEIRRDPWFNVNLP 267

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 138/277 (49%), Gaps = 19/277 (6%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLM 162
           +P    + ++  K+LG+GTFG V +     +G   AMK    EV +     +K+     +
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTL 58
Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQ 222
            E  +L   RHP +     S    D+L   +EY +GG ++  L     F E   R Y  +
Sbjct: 59  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 118
Query: 223 ILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWM 280
           I+S L +LHS K+ V+RD+K  N+++D +G +K+ DFG+ K  I   +    F G+P ++
Sbjct: 119 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYL 178
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLS 340
           APEV++++     AVD W LG  + EM   + P+   +    +F++   +E+   P  L 
Sbjct: 179 APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI-RFPRTLG 235
Query: 341 DEGKDFIRLCLQRNPLNR-----PTAAELLDHPFVKG 372
            E K  +   L+++P  R       A E++ H F  G
Sbjct: 236 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 272

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 132/271 (48%), Gaps = 19/271 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 90
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+   +F G+  +++PE++   S C
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 211 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 264
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGA 373
             L  +   R    E      L  HPF +  
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 139/259 (53%), Gaps = 13/259 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +GRG+F  VY G ++++    A  E  L D   +K   ++  +E   L  L+HPNIV++Y
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCE--LQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 181 GS--KTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH-- 234
            S   TV+ K  I L  E  + G++   L+ +       +R++ +QIL GL FLH++   
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 235 TVHRDIKGANILVD-PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            +HRD+K  NI +  P G VK+ D G+A  +   S   +  G+P + APE  +     + 
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYEEKY--DE 208
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSD-EGKDFIRLCLQ 352
           +VD+++ G   LE AT++ P+S+ +  A +++   S   P   D ++  E K+ I  C++
Sbjct: 209 SVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 353 RNPLNRPTAAELLDHPFVK 371
           +N   R +  +LL+H F +
Sbjct: 269 QNKDERYSIKDLLNHAFFQ 287

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 4/203 (1%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSRLR 172
           +++  K +G+G F  V +  +  +G   A+K   + D  +    S ++L +E+ ++  L 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVK---IIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNIV+ +     E  LY+ +EY SGG ++  L  +G+  E   R   +QI+S + + H 
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K+ VHRD+K  N+L+D +  +K+ADFG +      +   +F GSP + APE+ +      
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 192
Query: 293 LAVDIWSLGCTVLEMATTKPPWS 315
             VD+WSLG  +  + +   P+ 
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 19/272 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 89
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+   SF G+  +++PE++   S C
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 210 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 263
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGAA 374
             L  +   R    E      L  HPF +   
Sbjct: 264 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 295

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 19/272 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 70
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 130
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 191 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 244
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGAA 374
             L  +   R    E      L  HPF +   
Sbjct: 245 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 276

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 129/261 (49%), Gaps = 22/261 (8%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLR 172
           +++  K +G+G F  V +  +  +G+  A+K   + D  +   S+ Q L +E+ ++  L 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLN 64
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNIV+ +     E  LY+ +EY SGG ++  L  +G   E   R   +QI+S + + H 
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  VHRD+K  N+L+D +  +K+ADFG +      +   +F GSP + APE+ +      
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--------IPDDLSDEGK 344
             VD+WSLG  +  + +   P          F   N KEL          IP  +S + +
Sbjct: 185 PEVDVWSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCE 234
Query: 345 DFIRLCLQRNPLNRPTAAELL 365
           + ++  L  NP  R T  +++
Sbjct: 235 NLLKKFLILNPSKRGTLEQIM 255

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 133/265 (50%), Gaps = 19/265 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHP 69
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-K 233
            +     S    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS K
Sbjct: 70  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 129
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           + V+RD+K  N+++D +G +K+ DFG+ K  I   +    F G+P ++APEV++++    
Sbjct: 130 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-YG 188
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            AVD W LG  + EM   + P+   +    +F++   +E+   P  L  E K  +   L+
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLK 246
Query: 353 RNPLNR-----PTAAELLDHPFVKG 372
           ++P  R       A E++ H F  G
Sbjct: 247 KDPKQRLGGGSEDAKEIMQHRFFAG 271

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 136/276 (49%), Gaps = 13/276 (4%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT----LFDDAKSKESAKQLMQ 163
           P +    +   K LG G  G V + F   + +  A+K ++        A+  + A  +  
Sbjct: 11  PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 70
Query: 164 EIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI 223
           EI +L +L HP I++       ED  YI LE + GG ++  +    +  E   + Y  Q+
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 224 LSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           L  + +LH    +HRD+K  N+L+   + +  +K+ DFG +K +   S   +  G+P ++
Sbjct: 130 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 189
Query: 281 APEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM---FKIGNSKELPTI 335
           APEV+ +  ++G N AVD WSLG  +    +  PP+S++    ++      G    +P +
Sbjct: 190 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 249
Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             ++S++  D ++  L  +P  R T  E L HP+++
Sbjct: 250 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 285

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 133/265 (50%), Gaps = 19/265 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           K+LG+GTFG V +     +G   AMK    EV +     +K+     + E  +L   RHP
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHP 68
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-K 233
            +     S    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS K
Sbjct: 69  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 128
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           + V+RD+K  N+++D +G +K+ DFG+ K  I   +    F G+P ++APEV++++    
Sbjct: 129 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-YG 187
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            AVD W LG  + EM   + P+   +    +F++   +E+   P  L  E K  +   L+
Sbjct: 188 RAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLK 245
Query: 353 RNPLNR-----PTAAELLDHPFVKG 372
           ++P  R       A E++ H F  G
Sbjct: 246 KDPKQRLGGGSEDAKEIMQHRFFAG 270

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 19/272 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 69
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 129
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 190 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 243
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGAA 374
             L  +   R    E      L  HPF +   
Sbjct: 244 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 275

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 19/271 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 92
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 213 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 266
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGA 373
             L  +   R    E      L  HPF +  
Sbjct: 267 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 93
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 214 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 267
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVK 371
             L  +   R    E      L  HPF +
Sbjct: 268 KLLVLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 19/271 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 90
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 211 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 264
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGA 373
             L  +   R    E      L  HPF +  
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 19/271 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 90
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 211 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 264
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGA 373
             L  +   R    E      L  HPF +  
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 19/272 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 68
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 189 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 242
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGAA 374
             L  +   R    E      L  HPF +   
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 19/271 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 92
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 213 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 266
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGA 373
             L  +   R    E      L  HPF +  
Sbjct: 267 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 92
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 213 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 266
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVK 371
             L  +   R    E      L  HPF +
Sbjct: 267 KLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 19/272 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 67
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 127
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 188 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 241
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGAA 374
             L  +   R    E      L  HPF +   
Sbjct: 242 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 273

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 5/203 (2%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 95
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 292 NLAVDIWSLGCTVLEMATTKPPW 314
             + D+W+LGC + ++    PP+
Sbjct: 216 K-SSDLWALGCIIYQLVAGLPPF 237

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 5/203 (2%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 92
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 292 NLAVDIWSLGCTVLEMATTKPPW 314
             + D+W+LGC + ++    PP+
Sbjct: 213 K-SSDLWALGCIIYQLVAGLPPF 234

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 136/276 (49%), Gaps = 13/276 (4%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT----LFDDAKSKESAKQLMQ 163
           P +    +   K LG G  G V + F   + +  A+K ++        A+  + A  +  
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 164 EIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI 223
           EI +L +L HP I++       ED  YI LE + GG ++  +    +  E   + Y  Q+
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 224 LSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           L  + +LH    +HRD+K  N+L+   + +  +K+ DFG +K +   S   +  G+P ++
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 281 APEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM---FKIGNSKELPTI 335
           APEV+ +  ++G N AVD WSLG  +    +  PP+S++    ++      G    +P +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             ++S++  D ++  L  +P  R T  E L HP+++
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 136/276 (49%), Gaps = 13/276 (4%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT----LFDDAKSKESAKQLMQ 163
           P +    +   K LG G  G V + F   + +  A+K ++        A+  + A  +  
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 164 EIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI 223
           EI +L +L HP I++       ED  YI LE + GG ++  +    +  E   + Y  Q+
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 224 LSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           L  + +LH    +HRD+K  N+L+   + +  +K+ DFG +K +   S   +  G+P ++
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 281 APEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM---FKIGNSKELPTI 335
           APEV+ +  ++G N AVD WSLG  +    +  PP+S++    ++      G    +P +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             ++S++  D ++  L  +P  R T  E L HP+++
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 134/275 (48%), Gaps = 27/275 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT---LFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           ++LG G F  V++     +G++ A+K +     F D+        L  EI +L +++H N
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS-------SLENEIAVLKKIKHEN 67
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           IV            Y+ ++ VSGG ++  + + G + E       QQ+LS + +LH    
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 236 VHRDIKGANILV---DPNGRVKLADFGMAKH----IAGQSCPLSFKGSPYWMAPEVIKNS 288
           VHRD+K  N+L    + N ++ + DFG++K     I   +C     G+P ++APEV+   
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC-----GTPGYVAPEVLAQK 182
Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF---KIGNSKELPTIPDDLSDEGKD 345
                AVD WS+G     +    PP+ + E  + +F   K G  +      DD+S+  KD
Sbjct: 183 PYSK-AVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKD 240
Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTI 380
           FI   L+++P  R T  + L HP++ G   L R I
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWIDGNTALHRDI 275

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 136/276 (49%), Gaps = 13/276 (4%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT----LFDDAKSKESAKQLMQ 163
           P +    +   K LG G  G V + F   + +  A+K ++        A+  + A  +  
Sbjct: 4   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 63
Query: 164 EIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI 223
           EI +L +L HP I++       ED  YI LE + GG ++  +    +  E   + Y  Q+
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 224 LSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           L  + +LH    +HRD+K  N+L+   + +  +K+ DFG +K +   S   +  G+P ++
Sbjct: 123 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 182
Query: 281 APEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM---FKIGNSKELPTI 335
           APEV+ +  ++G N AVD WSLG  +    +  PP+S++    ++      G    +P +
Sbjct: 183 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 242
Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             ++S++  D ++  L  +P  R T  E L HP+++
Sbjct: 243 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/297 (30%), Positives = 144/297 (48%), Gaps = 39/297 (13%)
Query: 101 SPGRMENPVSPESHW-------KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAK 153
           S G+++  +SPE HW       K    +GRG +G V    +  SG++ A+K +    D K
Sbjct: 5   SSGKLK--ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 154 SKESAKQLMQEI-VLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGG------SIYKLLQ 206
            +   KQL+ ++ V++     P IVQ+YG+   E   +I +E +S         +Y +L 
Sbjct: 63  EQ---KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLD 119
Query: 207 DYGQFGEPAIRNYTQQILSGLAFLHSK-HTVHRDIKGANILVDPNGRVKLADFGMAKHIA 265
           D     E  +   T   +  L  L      +HRDIK +NIL+D +G +KL DFG++  + 
Sbjct: 120 DV--IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
Query: 266 GQSCPLSFKGSPYWMAPEVIKNSS---GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA 322
                    G   +MAPE I  S+   G ++  D+WSLG T+ E+AT + P+ ++  V  
Sbjct: 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
Query: 323 MF---------KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
                      ++ NS+E    P  +     +F+ LCL ++   RP   ELL HPF+
Sbjct: 238 QLTQVVKGDPPQLSNSEEREFSPSFI-----NFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 57  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 108
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 167
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S+  S Y+ 
Sbjct: 168 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 227
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 281

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 137/286 (47%), Gaps = 16/286 (5%)
Query: 99  PRSPGRMENPVSPES-HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
           P + G ++ P+  +S  +   K +G G FG   +  +  + E+ A+K +      +    
Sbjct: 5   PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI-----ERGAAI 59
Query: 158 AKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
            + + +EI+    LRHPNIV++         L I +EY SGG +Y+ + + G+F E   R
Sbjct: 60  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVD--PNGRVKLADFGMAKHIAGQSCPLSFKG 275
            + QQ+LSG+++ HS    HRD+K  N L+D  P  R+K+ DFG +K     S P S  G
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMFKIGNSKE 331
           +P ++APEV+          D+WS G T+  M     P+   E        + +I + K 
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 332 LPTIPDD--LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             +IPDD  +S E    I      +P  R +  E+  H +     P
Sbjct: 240 --SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 55  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 106
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 165
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S+  S Y+ 
Sbjct: 166 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 225
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 279

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 98  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 149
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 208
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S+  S Y+ 
Sbjct: 209 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 268
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 322

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 136/276 (49%), Gaps = 13/276 (4%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT----LFDDAKSKESAKQLMQ 163
           P +    +   K LG G  G V + F   + +  A+K ++        A+  + A  +  
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 164 EIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI 223
           EI +L +L HP I++       ED  YI LE + GG ++  +    +  E   + Y  Q+
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 224 LSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           L  + +LH    +HRD+K  N+L+   + +  +K+ DFG +K +   S   +  G+P ++
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 281 APEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM---FKIGNSKELPTI 335
           APEV+ +  ++G N AVD WSLG  +    +  PP+S++    ++      G    +P +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             ++S++  D ++  L  +P  R T  E L HP+++
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 104
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S+  S Y+ 
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 31/280 (11%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQLMQEIVLLS 169
           E H++ G+ LG G F  V       +G+  A K +     + S+   S +++ +E+ +L 
Sbjct: 11  EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 70
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            +RHPNI+  +     +  + + LE VSGG ++  L +     E     + +QIL G+ +
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 130
Query: 230 LHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           LHSK   H D+K  NI L+D   PN R+KL DFG+A  I   +   +  G+P ++APE++
Sbjct: 131 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 190
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-----LPTIPDDLS 340
            N     L  D+WS+G     + +   P+           +G +K+     +  +  D  
Sbjct: 191 -NYEPLGLEADMWSIGVITYILLSGASPF-----------LGETKQETLTNISAVNYDFD 238
Query: 341 DE--------GKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
           +E         KDFIR  L ++P  R   A+ L+H ++K 
Sbjct: 239 EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKA 278

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 24  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 75
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 134
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S+  S Y+ 
Sbjct: 135 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 194
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 248

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 47  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 98
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 157
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S+  S Y+ 
Sbjct: 158 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 217
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 271

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 130/271 (47%), Gaps = 19/271 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 97
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y     ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 218 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 271
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGA 373
             L  +   R    E      L  HPF +  
Sbjct: 272 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV 302

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 135/280 (48%), Gaps = 31/280 (11%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           E H++ G+ LG G F  V       +G+  A K +       ++   S +++ +E+ +L 
Sbjct: 25  EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILR 84
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            +RHPNI+  +     +  + + LE VSGG ++  L +     E     + +QIL G+ +
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 144
Query: 230 LHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           LHSK   H D+K  NI L+D   PN R+KL DFG+A  I   +   +  G+P ++APE++
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-----LPTIPDDLS 340
            N     L  D+WS+G     + +   P+           +G +K+     +  +  D  
Sbjct: 205 -NYEPLGLEADMWSIGVITYILLSGASPF-----------LGETKQETLTNISAVNYDFD 252
Query: 341 DE--------GKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
           +E         KDFIR  L ++P  R   A+ L+H ++K 
Sbjct: 253 EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKA 292

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 138/286 (48%), Gaps = 16/286 (5%)
Query: 99  PRSPGRMENPVSPES-HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
           P   G M+ P+  +S  ++  K +G G FG   +  +  S E+ A+K +      + ++ 
Sbjct: 4   PAVSGPMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-----RGEKI 58
Query: 158 AKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
            + + +EI+    LRHPNIV++         L I +EY SGG +++ + + G+F E   R
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVD--PNGRVKLADFGMAKHIAGQSCPLSFKG 275
            + QQ++SG+++ H+    HRD+K  N L+D  P  R+K+  FG +K     S P S  G
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVG 178
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMFKIGNSKE 331
           +P ++APEV+          D+WS G T+  M     P+   E        + +I N + 
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 332 LPTIPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
              IPD   +S E +  I      +P  R +  E+ +H +     P
Sbjct: 239 --AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 32  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 83
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S+  S Y+ 
Sbjct: 143 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 202
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 256

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 19/272 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 74
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 195 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 248
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGAA 374
             L  +   R    E      L  HPF +   
Sbjct: 249 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 280

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 149/276 (53%), Gaps = 26/276 (9%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSR 170
           +  ++K   LG G  G V+   +  SG + A K + L    + K + + Q+++E+ +L  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHE 60
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 231 HSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             KH + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  +M+PE ++ + 
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 179
Query: 290 GCNLAVDIWSLGCTVLEMAT-------------TKPPWSQYEGVAAMFKIGNSKELPTIP 336
             ++  DIWS+G +++EMA              ++PP + +E +  +     ++  P +P
Sbjct: 180 -YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIV----NEPPPKLP 234
Query: 337 DDL-SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             + S E +DF+  CL +NP  R    +L+ H F+K
Sbjct: 235 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 270

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 131/269 (48%), Gaps = 15/269 (5%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G FG   +  +  S E+ A+K +      + ++  + + +EI+    LRHP
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-----RGEKIDENVKREIINHRSLRHP 74
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NIV++         L I +EY SGG +++ + + G+F E   R + QQ++SG+++ H+  
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 235 TVHRDIKGANILVD--PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
             HRD+K  N L+D  P  R+K+ DFG +K     S P S  G+P ++APEV+       
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMFKIGNSKELPTIPD--DLSDEGKDF 346
              D+WS G T+  M     P+   E        + +I N +    IPD   +S E +  
Sbjct: 195 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY--AIPDYVHISPECRHL 252
Query: 347 IRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
           I      +P  R +  E+ +H +     P
Sbjct: 253 ISRIFVADPAKRISIPEIRNHEWFLKNLP 281

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 19/272 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 89
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 210 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 263
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGAA 374
             L  +   R    E      L  HPF +   
Sbjct: 264 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 295

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 147/266 (55%), Gaps = 16/266 (6%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSR 170
           +  ++K   LG G  G V+   +  SG + A K + L    + K + + Q+++E+ +L  
Sbjct: 8   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHE 63
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L
Sbjct: 64  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 123
Query: 231 HSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             KH + HRD+K +NILV+  G +KL DFG++  +  +     F G+  +M+PE ++ + 
Sbjct: 124 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQGTH 182
Query: 290 GCNLAVDIWSLGCTVLEMATT---KPPWSQYEGVAAMFKIGNSKELPTIPDDL-SDEGKD 345
             ++  DIWS+G +++EMA     +PP + +E +  +     ++  P +P  + S E +D
Sbjct: 183 -YSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIV----NEPPPKLPSAVFSLEFQD 237
Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVK 371
           F+  CL +NP  R    +L+ H F+K
Sbjct: 238 FVNKCLIKNPAERADLKQLMVHAFIK 263

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 70
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S+  S Y+ 
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 130/271 (47%), Gaps = 19/271 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F    +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 90
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S C
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 211 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 264
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGA 373
             L  +   R    E      L  HPF +  
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 8/259 (3%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
            LG+G F   +   ++D+ E+ A K V      K  +  K  M EI +   L H ++V +
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 86
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           +G     D +++ LE     S+ +L +      EP  R Y +QI+ G  +LH    +HRD
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 146
Query: 240 IKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           +K  N+ ++ +  VK+ DFG+A  +   G+    +  G+P ++APEV+ +  G +  VD+
Sbjct: 147 LKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPEVL-SKKGHSFEVDV 204
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           WS+GC +  +   KPP+          +I  ++   +IP  ++      I+  LQ +P  
Sbjct: 205 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTA 262
Query: 358 RPTAAELL-DHPFVKGAAP 375
           RPT  ELL D  F  G  P
Sbjct: 263 RPTINELLNDEFFTSGYIP 281

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 8/259 (3%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
            LG+G F   +   ++D+ E+ A K V      K  +  K  M EI +   L H ++V +
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 82
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           +G     D +++ LE     S+ +L +      EP  R Y +QI+ G  +LH    +HRD
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 142
Query: 240 IKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           +K  N+ ++ +  VK+ DFG+A  +   G+    +  G+P ++APEV+ +  G +  VD+
Sbjct: 143 LKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPEVL-SKKGHSFEVDV 200
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           WS+GC +  +   KPP+          +I  ++   +IP  ++      I+  LQ +P  
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTA 258
Query: 358 RPTAAELL-DHPFVKGAAP 375
           RPT  ELL D  F  G  P
Sbjct: 259 RPTINELLNDEFFTSGYIP 277

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 8/259 (3%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
            LG+G F   +   ++D+ E+ A K V      K  +  K  M EI +   L H ++V +
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 82
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           +G     D +++ LE     S+ +L +      EP  R Y +QI+ G  +LH    +HRD
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 142
Query: 240 IKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           +K  N+ ++ +  VK+ DFG+A  +   G+    +  G+P ++APEV+ +  G +  VD+
Sbjct: 143 LKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPEVL-SKKGHSFEVDV 200
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           WS+GC +  +   KPP+          +I  ++   +IP  ++      I+  LQ +P  
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTA 258
Query: 358 RPTAAELL-DHPFVKGAAP 375
           RPT  ELL D  F  G  P
Sbjct: 259 RPTINELLNDEFFTSGYIP 277

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 104
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 223
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 8/259 (3%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
            LG+G F   +   ++D+ E+ A K V      K  +  K  M EI +   L H ++V +
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 106
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           +G     D +++ LE     S+ +L +      EP  R Y +QI+ G  +LH    +HRD
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 166
Query: 240 IKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           +K  N+ ++ +  VK+ DFG+A  +   G+   +   G+P ++APEV+ +  G +  VD+
Sbjct: 167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL-SKKGHSFEVDV 224
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           WS+GC +  +   KPP+          +I  ++   +IP  ++      I+  LQ +P  
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTA 282
Query: 358 RPTAAELL-DHPFVKGAAP 375
           RPT  ELL D  F  G  P
Sbjct: 283 RPTINELLNDEFFTSGYIP 301

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 136/276 (49%), Gaps = 13/276 (4%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT----LFDDAKSKESAKQLMQ 163
           P +    +   K LG G  G V + F   + +  A++ ++        A+  + A  +  
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189
Query: 164 EIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI 223
           EI +L +L HP I++       ED  YI LE + GG ++  +    +  E   + Y  Q+
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 224 LSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           L  + +LH    +HRD+K  N+L+   + +  +K+ DFG +K +   S   +  G+P ++
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 281 APEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM---FKIGNSKELPTI 335
           APEV+ +  ++G N AVD WSLG  +    +  PP+S++    ++      G    +P +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             ++S++  D ++  L  +P  R T  E L HP+++
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 137/286 (47%), Gaps = 16/286 (5%)
Query: 99  PRSPGRMENPVSPES-HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
           P   G M+ P+  +S  ++  K +G G FG   +  +  S E+ A+K +      + ++ 
Sbjct: 4   PAVSGPMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-----RGEKI 58
Query: 158 AKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
            + + +EI+    LRHPNIV++         L I +EY SGG +++ + + G+F E   R
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVD--PNGRVKLADFGMAKHIAGQSCPLSFKG 275
            + QQ++SG+++ H+    HRD+K  N L+D  P  R+K+  FG +K     S P    G
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVG 178
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMFKIGNSKE 331
           +P ++APEV+          D+WS G T+  M     P+   E        + +I N + 
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 332 LPTIPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
              IPD   +S E +  I      +P  R +  E+ +H +     P
Sbjct: 239 --AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 91/313 (29%), Positives = 152/313 (48%), Gaps = 34/313 (10%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH---PN 175
           +++GRG FG VY    +D+G+M AMK +      K K+     + E ++LS +     P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           IV    +    DKL   L+ ++GG ++  L  +G F E  +R Y  +I+ GL  +H++  
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           V+RD+K ANIL+D +G V+++D G+A   + +  P +  G+  +MAPEV++     + + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIPDDLSDEGKDFI 347
           D +SLGC + ++     P+ Q+       K  +  E+          +PD  S E +  +
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQH-------KTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 348 RLCLQRNPLNRPT------AAELLDHPFVKGAAPLERTILAPEPSDVPP-GVTNGIKALG 400
              LQR+ +NR        A E+ + PF +        +    P  +PP G  N   A  
Sbjct: 426 EGLLQRD-VNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 484
Query: 401 IGQLRNVSTFDTE 413
           IG      +FD E
Sbjct: 485 IG------SFDEE 491

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 19/271 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 92
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+   SF G+  +++PE++   S  
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 292 NLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D + 
Sbjct: 213 K-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVE 266
Query: 349 LCLQRNPLNRPTAAE------LLDHPFVKGA 373
             L  +   R    E      L  HPF +  
Sbjct: 267 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 134/259 (51%), Gaps = 21/259 (8%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCA--MKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  K LG G FG V++G+ ++S ++    +K  T+        S +  ++E  L+
Sbjct: 11  PRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--------SVQAFLEEANLM 62
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ--DYGQFGEPAIRNYTQQILSG 226
             L+H  +V+ Y   T E+ +YI  EY++ GS+   L+  + G+   P + +++ QI  G
Sbjct: 63  KTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEG 122
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           +A++  K+ +HRD++ AN+LV  +   K+ADFG+A+ I       + +G+ +   W APE
Sbjct: 123 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPE 181
Query: 284 VIKNSSGC-NLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSD 341
            I  + GC  +  D+WS G  + E+ T  K P+        M  +     +P + ++  D
Sbjct: 182 AI--NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV-ENCPD 238
Query: 342 EGKDFIRLCLQRNPLNRPT 360
           E  D +++C +     RPT
Sbjct: 239 ELYDIMKMCWKEKAEERPT 257

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 8/259 (3%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
            LG+G F   +   ++D+ E+ A K V      K  +  K  M EI +   L H ++V +
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 104
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           +G     D +++ LE     S+ +L +      EP  R Y +QI+ G  +LH    +HRD
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 164
Query: 240 IKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           +K  N+ ++ +  VK+ DFG+A  +   G+   +   G+P ++APEV+ +  G +  VD+
Sbjct: 165 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL-SKKGHSFEVDV 222
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           WS+GC +  +   KPP+          +I  ++   +IP  ++      I+  LQ +P  
Sbjct: 223 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTA 280
Query: 358 RPTAAELL-DHPFVKGAAP 375
           RPT  ELL D  F  G  P
Sbjct: 281 RPTINELLNDEFFTSGYIP 299

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/313 (29%), Positives = 152/313 (48%), Gaps = 34/313 (10%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH---PN 175
           +++GRG FG VY    +D+G+M AMK +      K K+     + E ++LS +     P 
Sbjct: 194 RIIGRGGFGEVYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGDCPF 252
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           IV    +    DKL   L+ ++GG ++  L  +G F E  +R Y  +I+ GL  +H++  
Sbjct: 253 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 312
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           V+RD+K ANIL+D +G V+++D G+A   + +  P +  G+  +MAPEV++     + + 
Sbjct: 313 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSA 371
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIPDDLSDEGKDFI 347
           D +SLGC + ++     P+ Q+       K  +  E+          +PD  S E +  +
Sbjct: 372 DWFSLGCMLFKLLRGHSPFRQH-------KTKDKHEIDRMTLTMAVELPDSFSPELRSLL 424
Query: 348 RLCLQRNPLNRPT------AAELLDHPFVKGAAPLERTILAPEPSDVPP-GVTNGIKALG 400
              LQR+ +NR        A E+ + PF +        +    P  +PP G  N   A  
Sbjct: 425 EGLLQRD-VNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 483
Query: 401 IGQLRNVSTFDTE 413
           IG      +FD E
Sbjct: 484 IG------SFDEE 490

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 82
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 201
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 255

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 132/290 (45%), Gaps = 32/290 (11%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K + +G GT+G VY   +S  G + A+K + L  DA+ +      ++EI LL  L HP
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRL--DAEDEGIPSTAIREISLLKELHHP 79
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NIV        E  L +  E++       L ++     +  I+ Y  Q+L G+A  H   
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCNL 293
            +HRD+K  N+L++ +G +KLADFG+A+         + +    W  AP+V+  S   + 
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 294 AVDIWSLGCTVLEMATTKP------------------------PWSQYEGV----AAMFK 325
           +VDIWS+GC   EM T KP                         W Q + +       F+
Sbjct: 200 SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259
Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
           +   K   +I      EG D +   L  +P  R +A + ++HP+ K   P
Sbjct: 260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 132/290 (45%), Gaps = 32/290 (11%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K + +G GT+G VY   +S  G + A+K + L  DA+ +      ++EI LL  L HP
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRL--DAEDEGIPSTAIREISLLKELHHP 79
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NIV        E  L +  E++       L ++     +  I+ Y  Q+L G+A  H   
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCNL 293
            +HRD+K  N+L++ +G +KLADFG+A+         + +    W  AP+V+  S   + 
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 294 AVDIWSLGCTVLEMATTKP------------------------PWSQYEGV----AAMFK 325
           +VDIWS+GC   EM T KP                         W Q + +       F+
Sbjct: 200 SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259
Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
           +   K   +I      EG D +   L  +P  R +A + ++HP+ K   P
Sbjct: 260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 140/275 (50%), Gaps = 14/275 (5%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           MLG+G+FG V    +  + +  A+K +     AK+K+++  +++E+ LL +L HPNI++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTS-TILREVELLKKLDHPNIMKL 86
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           +         YI  E  +GG ++  +    +F E       +Q+ SG+ ++H  + VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 240 IKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           +K  NIL++   +   +K+ DFG++      +      G+ Y++APEV++ +   +   D
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY--DEKCD 204
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLCLQRN 354
           +WS G  +  + +  PP+        + ++   K    +P    +SD+ KD IR  L  +
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH 264
Query: 355 PLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVP 389
           P  R TA + L+HP+++  +        P  SD+P
Sbjct: 265 PSLRITATQCLEHPWIQKYSS-----ETPTISDLP 294

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 136/276 (49%), Gaps = 13/276 (4%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT----LFDDAKSKESAKQLMQ 163
           P +    +   K LG G  G V + F   + +  A++ ++        A+  + A  +  
Sbjct: 144 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 203
Query: 164 EIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI 223
           EI +L +L HP I++       ED  YI LE + GG ++  +    +  E   + Y  Q+
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 224 LSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           L  + +LH    +HRD+K  N+L+   + +  +K+ DFG +K +   S   +  G+P ++
Sbjct: 263 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 322
Query: 281 APEVIKN--SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM---FKIGNSKELPTI 335
           APEV+ +  ++G N AVD WSLG  +    +  PP+S++    ++      G    +P +
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 382
Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             ++S++  D ++  L  +P  R T  E L HP+++
Sbjct: 383 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 4/203 (1%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLR 172
           +++  K +G+G F  V +  +  +G+  A+K   + D  +   S+ Q L +E+ +   L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIXKVLN 71
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNIV+ +     E  LY+  EY SGG ++  L  +G+  E   R   +QI+S + + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  VHRD+K  N+L+D +  +K+ADFG +      +   +F G+P + APE+ +      
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 293 LAVDIWSLGCTVLEMATTKPPWS 315
             VD+WSLG  +  + +   P+ 
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 82
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 201
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 255

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 38  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 89
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 90  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 149 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 208
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 262

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 27  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 78
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 138 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 197
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 251

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 134/265 (50%), Gaps = 25/265 (9%)
Query: 112 ESHWKKGKM-LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           E HW   ++ LGRG+FG V+   +  +G  CA+K+V L       E  +   +E++  + 
Sbjct: 91  EVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRL-------EVFR--AEELMACAG 141
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           L  P IV  YG+      + I++E + GGS+ +L+++ G   E     Y  Q L GL +L
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYL 201
Query: 231 HSKHTVHRDIKGANILVDPNG-RVKLADFGMAKHIA----GQSCPLS--FKGSPYWMAPE 283
           HS+  +H D+K  N+L+  +G    L DFG A  +     G+S        G+   MAPE
Sbjct: 202 HSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPE 261
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS----KELPTIPDDL 339
           V+   S C+  VD+WS  C +L M     PW+Q+       KI +     +E+P     L
Sbjct: 262 VVLGRS-CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPL 320
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAEL 364
           + +    I+  L++ P++R +AAEL
Sbjct: 321 TAQA---IQEGLRKEPIHRVSAAEL 342

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 138/296 (46%), Gaps = 47/296 (15%)
Query: 121 LGRGTFGHVYVGFN-SDSGEMCAMKEVTLFDDAKSKESAKQL--MQEIVLLSRLR---HP 174
           +G G +G V+   +  + G   A+K V +    ++ E    L  ++E+ +L  L    HP
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 175 NIVQYYGSKTV-----EDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--IRNYTQQILSGL 227
           N+V+ +   TV     E KL +  E+V    +   L    + G P   I++   Q+L GL
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
            FLHS   VHRD+K  NILV  +G++KLADFG+A+  + Q    S   + ++ APEV+  
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD---------- 337
           SS     VD+WS+GC   EM   KP +     V  + KI +   LP   D          
Sbjct: 194 SSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 338 ---------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLER 378
                          D+ + GKD +  CL  NP  R +A   L HP+ +    LER
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD---LER 305

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/313 (29%), Positives = 152/313 (48%), Gaps = 34/313 (10%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH---PN 175
           +++GRG FG VY    +D+G+M AMK +      K K+     + E ++LS +     P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           IV    +    DKL   L+ ++GG ++  L  +G F E  +R Y  +I+ GL  +H++  
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           V+RD+K ANIL+D +G V+++D G+A   + +  P +  G+  +MAPEV++     + + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIPDDLSDEGKDFI 347
           D +SLGC + ++     P+ Q+       K  +  E+          +PD  S E +  +
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQH-------KTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 348 RLCLQRNPLNRPT------AAELLDHPFVKGAAPLERTILAPEPSDVPP-GVTNGIKALG 400
              LQR+ +NR        A E+ + PF +        +    P  +PP G  N   A  
Sbjct: 426 EGLLQRD-VNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 484
Query: 401 IGQLRNVSTFDTE 413
           IG      +FD E
Sbjct: 485 IG------SFDEE 491

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/313 (29%), Positives = 152/313 (48%), Gaps = 34/313 (10%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH---PN 175
           +++GRG FG VY    +D+G+M AMK +      K K+     + E ++LS +     P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           IV    +    DKL   L+ ++GG ++  L  +G F E  +R Y  +I+ GL  +H++  
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           V+RD+K ANIL+D +G V+++D G+A   + +  P +  G+  +MAPEV++     + + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIPDDLSDEGKDFI 347
           D +SLGC + ++     P+ Q+       K  +  E+          +PD  S E +  +
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQH-------KTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 348 RLCLQRNPLNRPT------AAELLDHPFVKGAAPLERTILAPEPSDVPP-GVTNGIKALG 400
              LQR+ +NR        A E+ + PF +        +    P  +PP G  N   A  
Sbjct: 426 EGLLQRD-VNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 484
Query: 401 IGQLRNVSTFDTE 413
           IG      +FD E
Sbjct: 485 IG------SFDEE 491

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 20  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 71
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 131 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 190
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 244

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 23  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 74
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 134 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 193
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 247

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 70
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 70
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 132/266 (49%), Gaps = 11/266 (4%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G F  V +     +G++ A+K +      K KES+  +  EI +L +++H NIV   
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPK-KALKGKESS--IENEIAVLRKIKHENIVALE 86
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
                 + LY+ ++ VSGG ++  + + G + E       +Q+L  + +LH    VHRD+
Sbjct: 87  DIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDL 146
Query: 241 KGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           K  N+L    D   ++ ++DFG++K         +  G+P ++APEV+        AVD 
Sbjct: 147 KPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSK-AVDC 205
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFK--IGNSKELPT-IPDDLSDEGKDFIRLCLQRN 354
           WS+G     +    PP+   E  + +F+  +    E  +   DD+SD  KDFIR  ++++
Sbjct: 206 WSIGVIAYILLCGYPPFYD-ENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKD 264
Query: 355 PLNRPTAAELLDHPFVKGAAPLERTI 380
           P  R T  +   HP++ G   L + I
Sbjct: 265 PNKRYTCEQAARHPWIAGDTALNKNI 290

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 136/263 (51%), Gaps = 9/263 (3%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           MLG+G+FG V    +  + +  A+K +     AK+K+++  +++E+ LL +L HPNI++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTS-TILREVELLKKLDHPNIMKL 86
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           +         YI  E  +GG ++  +    +F E       +Q+ SG+ ++H  + VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 240 IKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           +K  NIL++   +   +K+ DFG++      +      G+ Y++APEV++ +   +   D
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY--DEKCD 204
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLCLQRN 354
           +WS G  +  + +  PP+        + ++   K    +P    +SD+ KD IR  L  +
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH 264
Query: 355 PLNRPTAAELLDHPFVKGAAPLE 377
           P  R TA + L+HP+++  +  E
Sbjct: 265 PSLRITATQCLEHPWIQKYSSEE 287

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 121 LGRGTFGHVYVGFN-SDSGEMCAMKEVTLFDDAKSKESAKQL--MQEIVLLSRLR---HP 174
           +G G +G V+   +  + G   A+K V +    ++ E    L  ++E+ +L  L    HP
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 175 NIVQYYGSKTV-----EDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--IRNYTQQILSGL 227
           N+V+ +   TV     E KL +  E+V    +   L    + G P   I++   Q+L GL
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
            FLHS   VHRD+K  NILV  +G++KLADFG+A+  + Q    S   + ++ APEV+  
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD---------- 337
           SS     VD+WS+GC   EM   KP +     V  + KI +   LP   D          
Sbjct: 194 SSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 338 ---------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                          D+ + GKD +  CL  NP  R +A   L HP+ +
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 133/269 (49%), Gaps = 33/269 (12%)
Query: 112 ESHWKKGKM-LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           E HW   ++ LGRG+FG V+   +  +G  CA+K+V L       E  +   +E++  + 
Sbjct: 72  EVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRL-------EVFR--AEELMACAG 122
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           L  P IV  YG+      + I++E + GGS+ +L+++ G   E     Y  Q L GL +L
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYL 182
Query: 231 HSKHTVHRDIKGANILVDPNG-RVKLADFGMA----------KHIAGQSCPLSFKGSPYW 279
           HS+  +H D+K  N+L+  +G    L DFG A            + G   P    G+   
Sbjct: 183 HSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP----GTETH 238
Query: 280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS----KELPTI 335
           MAPEV+   S C+  VD+WS  C +L M     PW+Q+       KI +     +E+P  
Sbjct: 239 MAPEVVLGRS-CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPS 297
Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
              L+ +    I+  L++ P++R +AAEL
Sbjct: 298 CAPLTAQA---IQEGLRKEPIHRVSAAEL 323

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 111/206 (53%), Gaps = 21/206 (10%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G++LG+G FG      + ++GE+  MKE+  FD+    E+ +  ++E+ ++  L HPN++
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE----ETQRTFLKEVKVMRCLEHPNVL 70
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ G    + +L    EY+ GG++  +++    Q+      ++ + I SG+A+LHS + +
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP---------------LSFKGSPYWMA 281
           HRD+   N LV  N  V +ADFG+A+ +  +                   +  G+PYWMA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 282 PEVIKNSSGCNLAVDIWSLGCTVLEM 307
           PE+I N    +  VD++S G  + E+
Sbjct: 191 PEMI-NGRSYDEKVDVFSFGIVLCEI 215

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 138/297 (46%), Gaps = 47/297 (15%)
Query: 121 LGRGTFGHVYVGFN-SDSGEMCAMKEVTLFDDAKSKESAKQL--MQEIVLLSRLR---HP 174
           +G G +G V+   +  + G   A+K V +    ++ E    L  ++E+ +L  L    HP
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 175 NIVQYYGSKTV-----EDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--IRNYTQQILSGL 227
           N+V+ +   TV     E KL +  E+V    +   L    + G P   I++   Q+L GL
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
            FLHS   VHRD+K  NILV  +G++KLADFG+A+  + Q    S   + ++ APEV+  
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD---------- 337
           SS     VD+WS+GC   EM   KP +     V  + KI +   LP   D          
Sbjct: 194 SSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 338 ---------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
                          D+ + GKD +  CL  NP  R +A   L HP+ +    LER 
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD---LERC 306

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 134/257 (52%), Gaps = 9/257 (3%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           MLG+G+FG V    +  + +  A+K +     AK+K+++  +++E+ LL +L HPNI++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTS-TILREVELLKKLDHPNIMKL 86
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           +         YI  E  +GG ++  +    +F E       +Q+ SG+ ++H  + VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 240 IKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           +K  NIL++   +   +K+ DFG++      +      G+ Y++APEV++ +   +   D
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY--DEKCD 204
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLCLQRN 354
           +WS G  +  + +  PP+        + ++   K    +P    +SD+ KD IR  L  +
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH 264
Query: 355 PLNRPTAAELLDHPFVK 371
           P  R TA + L+HP+++
Sbjct: 265 PSLRITATQCLEHPWIQ 281

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 8/259 (3%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
            LG+G F   +   ++D+ E+ A K V      K  +  K  M EI +   L H ++V +
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 80
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           +G     D +++ LE     S+ +L +      EP  R Y +QI+ G  +LH    +HRD
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 140
Query: 240 IKGANILVDPNGRVKLADFGMAKHIA--GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           +K  N+ ++ +  VK+ DFG+A  +   G+   +   G+P ++APEV+ +  G +  VD+
Sbjct: 141 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL-SKKGHSFEVDV 198
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           WS+GC +  +   KPP+          +I  ++   +IP  ++      I+  LQ +P  
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTA 256
Query: 358 RPTAAELL-DHPFVKGAAP 375
           RPT  ELL D  F  G  P
Sbjct: 257 RPTINELLNDEFFTSGYIP 275

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 136/278 (48%), Gaps = 30/278 (10%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVT---LFDDA-------------------KSKESA 158
           +G+G++G V + +N +     AMK ++   L   A                   + +   
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 159 KQLMQEIVLLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAI 216
           +Q+ QEI +L +L HPN+V+         ED LY+  E V+ G + ++        E   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSEDQA 139
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK-G 275
           R Y Q ++ G+ +LH +  +HRDIK +N+LV  +G +K+ADFG++    G    LS   G
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199
Query: 276 SPYWMAPEVIKNSSGC--NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI-GNSKEL 332
           +P +MAPE +  +       A+D+W++G T+      + P+     +    KI   + E 
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF 259
Query: 333 PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
           P  P D++++ KD I   L +NP +R    E+  HP+V
Sbjct: 260 PDQP-DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 122/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V    D + K    Q+M+      +L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQIMR------KL 70
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D +Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V      K++E        + ++ +L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE--------LQIMRKL 70
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S+  S Y+ 
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V      K++E        + ++ +L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE--------LQIMRKL 70
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S+  S Y+ 
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 144/299 (48%), Gaps = 20/299 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +  +  + ++ AMK ++ F+  K  +SA    +E  +++    P +VQ
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA-FFWEERDIMAFANSPWVVQ 138
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + +   +  LY+ +EY+ GG +  L+ +Y    E   R YT +++  L  +HS   +HR
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHR 197
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQ---SCPLSFKGSPYWMAPEVIKNSSGCNL-- 293
           D+K  N+L+D +G +KLADFG    +  +    C  +  G+P +++PEV+K+  G     
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYG 256
Query: 294 -AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLC 350
              D WS+G  + EM     P+     V    KI N K   T PD  D+S E K+ I   
Sbjct: 257 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 316
Query: 351 LQRNP--LNRPTAAELLDHPFVKG---AAPLERTILAPEPSDVPPGVTNGIKALGIGQL 404
           L      L R    E+  H F K    A    R  +AP    V P +++ I       L
Sbjct: 317 LTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP----VVPDLSSDIDTSNFDDL 371

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 144/299 (48%), Gaps = 20/299 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +  +  + ++ AMK ++ F+  K  +SA    +E  +++    P +VQ
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA-FFWEERDIMAFANSPWVVQ 133
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + +   +  LY+ +EY+ GG +  L+ +Y    E   R YT +++  L  +HS   +HR
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHR 192
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQ---SCPLSFKGSPYWMAPEVIKNSSGCNL-- 293
           D+K  N+L+D +G +KLADFG    +  +    C  +  G+P +++PEV+K+  G     
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYG 251
Query: 294 -AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLC 350
              D WS+G  + EM     P+     V    KI N K   T PD  D+S E K+ I   
Sbjct: 252 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 311
Query: 351 LQRNP--LNRPTAAELLDHPFVKG---AAPLERTILAPEPSDVPPGVTNGIKALGIGQL 404
           L      L R    E+  H F K    A    R  +AP    V P +++ I       L
Sbjct: 312 LTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP----VVPDLSSDIDTSNFDDL 366

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 109/203 (53%), Gaps = 5/203 (2%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K GK+LG G+F  V +     +    A+K +      K  +    + +E  ++SRL HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 92
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
             V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            +HRD+K  NIL++ +  +++ DFG AK +   + Q+    F G+  +++PE++   S  
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 292 NLAVDIWSLGCTVLEMATTKPPW 314
             + D+W+LGC + ++    PP+
Sbjct: 213 K-SSDLWALGCIIYQLVAGLPPF 234

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +LG+G+FG V +     + E+ A+K    +V + DD    +    ++++ VL    + P 
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDD----DVECTMVEKRVLALLDKPPF 81
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           + Q +      D+LY  +EYV+GG +   +Q  G+F EP    Y  +I  GL FLH +  
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGI 141
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           ++RD+K  N+++D  G +K+ADFGM K H+        F G+P ++APE+I        +
Sbjct: 142 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGK-S 200
Query: 295 VDIWSLGCTVLEMATTKPPWS 315
           VD W+ G  + EM   +PP+ 
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFD 221

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 179
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG VY     DSGE+ A+K+V      K++E        + ++ +L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE--------LQIMRKL 70
Query: 172 RHPNIVQ----YYGSKTVEDKLYI--YLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
            H NIV+    +Y S   +D++Y+   L+YV   ++Y++ + Y +  +      ++ Y  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK +      +S   S Y+ 
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           APE+I  ++    ++D+WS GC + E+   +P +    GV  + +I      PT
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 180
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 144/299 (48%), Gaps = 20/299 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +  +  + ++ AMK ++ F+  K  +SA    +E  +++    P +VQ
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA-FFWEERDIMAFANSPWVVQ 138
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + +   +  LY+ +EY+ GG +  L+ +Y    E   R YT +++  L  +HS   +HR
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHR 197
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQ---SCPLSFKGSPYWMAPEVIKNSSGCNL-- 293
           D+K  N+L+D +G +KLADFG    +  +    C  +  G+P +++PEV+K+  G     
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYG 256
Query: 294 -AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRLC 350
              D WS+G  + EM     P+     V    KI N K   T PD  D+S E K+ I   
Sbjct: 257 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 316
Query: 351 LQRNP--LNRPTAAELLDHPFVKG---AAPLERTILAPEPSDVPPGVTNGIKALGIGQL 404
           L      L R    E+  H F K    A    R  +AP    V P +++ I       L
Sbjct: 317 LTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP----VVPDLSSDIDTSNFDDL 371

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 6/205 (2%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA---KHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
             HRDIK  N+L+D    +K++DFG+A   ++   +       G+  ++APE++K     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQ 316
              VD+WS G  +  M   + PW Q
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 180
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 180
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 180
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 6/205 (2%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA---KHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
             HRDIK  N+L+D    +K++DFG+A   ++   +       G+  ++APE++K     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQ 316
              VD+WS G  +  M   + PW Q
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 131/263 (49%), Gaps = 12/263 (4%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +++ K LG G +G V +  +  +G   A+K +       +  ++  L+ E+ +L +L HP
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLTGAERAIK-IIKKSSVTTTSNSGALLDEVAVLKQLDHP 81
Query: 175 NIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           NI++ Y  +  EDK   Y+ +E   GG ++  +    +F E       +Q+LSG  +LH 
Sbjct: 82  NIMKLY--EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK 139
Query: 233 KHTVHRDIKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
            + VHRD+K  N+L++   R   +K+ DFG++ H           G+ Y++APEV++   
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKY 199
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFI 347
             +   D+WS G  +  +    PP+        + ++   K     PD   +SDE K  +
Sbjct: 200 --DEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 257
Query: 348 RLCLQRNPLNRPTAAELLDHPFV 370
           +L L   P  R +A E L+HP++
Sbjct: 258 KLMLTYEPSKRISAEEALNHPWI 280

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 128/262 (48%), Gaps = 17/262 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LGRG    VY      + +  A+K +      K     K +  EI +L RL HPNI++  
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVL------KKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
                  ++ + LE V+GG ++  + + G + E    +  +QIL  +A+LH    VHRD+
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDL 174
Query: 241 KGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA--V 295
           K  N+L     P+  +K+ADFG++K +  Q    +  G+P + APE+++   GC     V
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR---GCAYGPEV 231
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIP--DDLSDEGKDFIRLCLQ 352
           D+WS+G     +     P+    G   MF +I N +     P  D++S   KD +R  + 
Sbjct: 232 DMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIV 291
Query: 353 RNPLNRPTAAELLDHPFVKGAA 374
            +P  R T  + L HP+V G A
Sbjct: 292 LDPKKRLTTFQALQHPWVTGKA 313

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 6/205 (2%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA---KHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
             HRDIK  N+L+D    +K++DFG+A   ++   +       G+  ++APE++K     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQ 316
              VD+WS G  +  M   + PW Q
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI + + L H 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 180
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 178
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 179
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 6/205 (2%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA---KHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
             HRDIK  N+L+D    +K++DFG+A   ++   +       G+  ++APE++K     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQ 316
              VD+WS G  +  M   + PW Q
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 180
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 6/205 (2%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA---KHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
             HRDIK  N+L+D    +K++DFG+A   ++   +       G+  ++APE++K     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQ 316
              VD+WS G  +  M   + PW Q
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 130/270 (48%), Gaps = 16/270 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     S  + A+K   LF     KE  + QL +EI + + L HPNI
Sbjct: 28  GRPLGKGKFGNVYLAREKKSHFIVALK--VLFKSQIEKEGVEHQLRREIEIQAHLHHPNI 85
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y       ++Y+ LEY   G +YK LQ    F E       +++   L + H K  +
Sbjct: 86  LRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVI 145
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRDIK  N+L+   G +K+ADFG + H A      +  G+  ++ PE+I+     N  VD
Sbjct: 146 HRDIKPENLLLGLKGELKIADFGWSVH-APSLRRKTMCGTLDYLPPEMIEGRMH-NEKVD 203
Query: 297 IWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           +W +G    E+    PP+   S  E    + K+         P  +    +D I   L+ 
Sbjct: 204 LWCIGVLCYELLVGNPPFESASHNETYRRIVKVD-----LKFPASVPTGAQDLISKLLRH 258
Query: 354 NPLNRPTAAELLDHPFVKGAAPLERTILAP 383
           NP  R   A++  HP+V+  +   R +L P
Sbjct: 259 NPSERLPLAQVSAHPWVRANS---RRVLPP 285

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 179
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 138/281 (49%), Gaps = 35/281 (12%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G GT+G VY   N + GE  A+K++ L  + +   S    ++EI +L  L+H NIV+ Y
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLY 66
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAI--RNYTQQILSGLAFLHSKHTVHR 238
                + +L +  E++      K L D  + G  ++  +++  Q+L+G+A+ H +  +HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCNLAVDI 297
           D+K  N+L++  G +K+ADFG+A+         + +    W  AP+V+  S   +  +DI
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 298 WSLGCTVLEMATTKPPW---SQYEGVAAMFKIG---NSKELPTIPD-------------- 337
           WS+GC   EM    P +   S+ + +  +F+I    NSK  P + +              
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 338 -------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                   L + G D +   L+ +P  R TA + L+H + K
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 179
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 179
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 179
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 179
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 138/281 (49%), Gaps = 35/281 (12%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G GT+G VY   N + GE  A+K++ L  + +   S    ++EI +L  L+H NIV+ Y
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLY 66
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAI--RNYTQQILSGLAFLHSKHTVHR 238
                + +L +  E++      K L D  + G  ++  +++  Q+L+G+A+ H +  +HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCNLAVDI 297
           D+K  N+L++  G +K+ADFG+A+         + +    W  AP+V+  S   +  +DI
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 298 WSLGCTVLEMATTKPPW---SQYEGVAAMFKIG---NSKELPTIPD-------------- 337
           WS+GC   EM    P +   S+ + +  +F+I    NSK  P + +              
Sbjct: 185 WSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 338 -------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                   L + G D +   L+ +P  R TA + L+H + K
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 180
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 134/259 (51%), Gaps = 21/259 (8%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCA--MKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  K LG G FG V++G+ ++S ++    +K  T+        S +  ++E  L+
Sbjct: 10  PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--------SVQAFLEEANLM 61
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ--DYGQFGEPAIRNYTQQILSG 226
             L+H  +V+ Y   T E+ +YI  E+++ GS+   L+  + G+   P + +++ QI  G
Sbjct: 62  KTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEG 121
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           +A++  K+ +HRD++ AN+LV  +   K+ADFG+A+ I       + +G+ +   W APE
Sbjct: 122 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPE 180
Query: 284 VIKNSSGC-NLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSD 341
            I  + GC  +  ++WS G  + E+ T  K P+        M  +     +P + ++  D
Sbjct: 181 AI--NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRM-ENCPD 237
Query: 342 EGKDFIRLCLQRNPLNRPT 360
           E  D +++C +     RPT
Sbjct: 238 ELYDIMKMCWKEKAEERPT 256

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 138/281 (49%), Gaps = 35/281 (12%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G GT+G VY   N + GE  A+K++ L  + +   S    ++EI +L  L+H NIV+ Y
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLY 66
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAI--RNYTQQILSGLAFLHSKHTVHR 238
                + +L +  E++      K L D  + G  ++  +++  Q+L+G+A+ H +  +HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGCNLAVDI 297
           D+K  N+L++  G +K+ADFG+A+         + +    W  AP+V+  S   +  +DI
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 298 WSLGCTVLEMATTKPPW---SQYEGVAAMFKIG---NSKELPTIPD-------------- 337
           WS+GC   EM    P +   S+ + +  +F+I    NSK  P + +              
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 338 -------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                   L + G D +   L+ +P  R TA + L+H + K
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 131/263 (49%), Gaps = 12/263 (4%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +++ K LG G +G V +  +  +G   A+K +       +  ++  L+ E+ +L +L HP
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIK-IIKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 175 NIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           NI++ Y  +  EDK   Y+ +E   GG ++  +    +F E       +Q+LSG  +LH 
Sbjct: 65  NIMKLY--EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK 122
Query: 233 KHTVHRDIKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
            + VHRD+K  N+L++   R   +K+ DFG++ H           G+ Y++APEV++   
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKY 182
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFI 347
             +   D+WS G  +  +    PP+        + ++   K     PD   +SDE K  +
Sbjct: 183 --DEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 240
Query: 348 RLCLQRNPLNRPTAAELLDHPFV 370
           +L L   P  R +A E L+HP++
Sbjct: 241 KLMLTYEPSKRISAEEALNHPWI 263

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 132/262 (50%), Gaps = 9/262 (3%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +++ K LG G +G V +  +  +    A+K +     + S  S  +L++E+ +L  L HP
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR--KTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NI++ Y     +   Y+ +E   GG ++  +    +F E       +Q+LSG+ +LH  +
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 235 TVHRDIKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            VHRD+K  N+L++   +   +K+ DFG++     Q       G+ Y++APEV++     
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY-- 214
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD--DLSDEGKDFIRL 349
           +   D+WS+G  +  +    PP+        + K+   K     P+  ++S+  KD I+ 
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 350 CLQRNPLNRPTAAELLDHPFVK 371
            LQ +   R +A + L+HP++K
Sbjct: 275 MLQFDSQRRISAQQALEHPWIK 296

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 143/299 (47%), Gaps = 39/299 (13%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL-MQEIVLLSR 170
           E + K GK +G G++G V+   N D+G++ A+K+   F +++     K++ ++EI +L +
Sbjct: 3   EKYEKIGK-IGEGSYGVVFKCRNRDTGQIVAIKK---FLESEDDPVIKKIALREIRMLKQ 58
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--IRNYTQQILSGLA 228
           L+HPN+V        + +L++  EY     +++L  D  Q G P   +++ T Q L  + 
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVN 116
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKN 287
           F H  + +HRD+K  NIL+  +  +KL DFG A+ + G S     + +  W  +PE++  
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--KELP------------ 333
            +     VD+W++GC   E+ +  P W     V  ++ I  +    +P            
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 334 ---TIPD------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLE 377
               IPD            ++S      ++ CL  +P  R T  +LL HP+ +    +E
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W   + LG G  G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H 
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMA--------KHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRDIK  N+L+D    +K++DFG+A        + +  + C     G+  ++APE++K
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLK 179
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQ 316
                   VD+WS G  +  M   + PW Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 147/304 (48%), Gaps = 50/304 (16%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSR 170
           +  ++K   LG G  G V+   +  SG + A K + L    + K + + Q+++E+ +L  
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHE 87
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 231 HSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             KH + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  +M+PE ++ + 
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW-------------SQYEGVAA------------MF 324
             ++  DIWS+G +++EMA  + P               Q EG AA            + 
Sbjct: 207 -YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 325 KIGNSKELPTIPDDLSD-----------------EGKDFIRLCLQRNPLNRPTAAELLDH 367
           K G     P    +L D                 E +DF+  CL +NP  R    +L+ H
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325
Query: 368 PFVK 371
            F+K
Sbjct: 326 AFIK 329

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 11/262 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +  +  S ++ AMK ++ F+  K  +SA    +E  +++    P +VQ
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSA-FFWEERDIMAFANSPWVVQ 139
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + +   +  LY+ +EY+ GG +  L+ +Y    E   + YT +++  L  +HS   +HR
Sbjct: 140 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHR 198
Query: 239 DIKGANILVDPNGRVKLADFG--MAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL--- 293
           D+K  N+L+D +G +KLADFG  M     G     +  G+P +++PEV+K+  G      
Sbjct: 199 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGR 258
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD--LSDEGKDFIRLCL 351
             D WS+G  + EM     P+     V    KI + K     P+D  +S   K+ I   L
Sbjct: 259 ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFL 318
Query: 352 QRNP--LNRPTAAELLDHPFVK 371
                 L R    E+  HPF K
Sbjct: 319 TDREVRLGRNGVEEIKQHPFFK 340

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 152/304 (50%), Gaps = 50/304 (16%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSR 170
           +  ++K   LG G  G V+   +  SG + A K + L    + K + + Q+++E+ +L  
Sbjct: 67  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHE 122
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L
Sbjct: 123 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 182
Query: 231 HSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             KH + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  +M+PE ++ + 
Sbjct: 183 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 241
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW-------------SQYEGVA--------------- 321
             ++  DIWS+G +++EMA  + P               Q EG A               
Sbjct: 242 -YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 300
Query: 322 ----------AMFKIGN---SKELPTIPDDL-SDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                     A+F++ +   ++  P +P  + S E +DF+  CL +NP  R    +L+ H
Sbjct: 301 SYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVH 360
Query: 368 PFVK 371
            F+K
Sbjct: 361 AFIK 364

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 132/257 (51%), Gaps = 6/257 (2%)
Query: 106 ENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           EN      H++  + +G+G+FG V +   +D+ +M AMK +        +   + + +E+
Sbjct: 8   ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-QKCVERNEVRNVFKEL 66
Query: 166 VLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILS 225
            ++  L HP +V  + S   E+ +++ ++ + GG +   LQ    F E  ++ +  +++ 
Sbjct: 67  QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
            L +L ++  +HRD+K  NIL+D +G V + DF +A  +  ++   +  G+  +MAPE+ 
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186
Query: 286 --KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE--LPTIPDDLSD 341
             +  +G + AVD WSLG T  E+   + P+      ++  +I ++ E  + T P   S 
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-EIVHTFETTVVTYPSAWSQ 245
Query: 342 EGKDFIRLCLQRNPLNR 358
           E    ++  L+ NP  R
Sbjct: 246 EMVSLLKKLLEPNPDQR 262

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 133/267 (49%), Gaps = 15/267 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI-VLLSRLRHPNIVQY 179
           +G GT G V+      +G + A+K++     + +KE  K+++ ++ V+L     P IVQ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 180 YGSKTVEDKLYIYLEYV--SGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH-TV 236
           +G+      ++I +E +      + K +Q  G   E  +   T  I+  L +L  KH  +
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK----NSSGCN 292
           HRD+K +NIL+D  G++KL DFG++  +          G   +MAPE I          +
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG--KDFIRLC 350
           +  D+WSLG +++E+AT + P+   +    +      +E P +P  +   G  + F++ C
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDC 267
Query: 351 LQRNPLNRPTAAELLDHPFVKGAAPLE 377
           L ++   RP   +LL+H F+K    LE
Sbjct: 268 LTKDHRKRPKYNKLLEHSFIKRYETLE 294

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 126/258 (48%), Gaps = 12/258 (4%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR-LRHPNIVQY 179
           LGRG +G V    +  SG++ A+K +       + +  K+L+ ++ +  R +  P  V +
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRA---TVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 180 YGSKTVEDKLYIYLEY--VSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKHTV 236
           YG+   E  ++I  E    S    YK + D GQ   E  +      I+  L  LHSK +V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 237 -HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK---NSSGCN 292
            HRD+K +N+L++  G+VK  DFG++ ++          G   + APE I    N  G +
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYS 218
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCL 351
           +  DIWSLG T +E+A  + P+  +       K    +  P +P D  S E  DF   CL
Sbjct: 219 VKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 278
Query: 352 QRNPLNRPTAAELLDHPF 369
           ++N   RPT  EL  HPF
Sbjct: 279 KKNSKERPTYPELXQHPF 296

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 139/291 (47%), Gaps = 41/291 (14%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E++ K  K LG GT+  VY G +  +  + A+KE+ L  +  +  +A   ++E+ LL  L
Sbjct: 2   ETYIKLDK-LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA---IREVSLLKDL 57
Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQF-GEPAIRNYTQQILSGLAFL 230
           +H NIV  +     E  L +  EY+    + + L D G       ++ +  Q+L GLA+ 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP----YWMAPEVIK 286
           H +  +HRD+K  N+L++  G +KLADFG+A+    +S P     +     ++  P+++ 
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDE- 342
            S+  +  +D+W +GC   EMAT +P +   +  E +  +F+I  +    T P  LS+E 
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233
Query: 343 ------------------------GKDFIRLCLQRNPLNRPTAAELLDHPF 369
                                   G D +   LQ    NR +A + + HPF
Sbjct: 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 21/270 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V V    ++ ++ AMK +  ++  K  E+A    +  VL++         
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
           +Y  +  ++ LY+ ++Y  GG +  LL  +  +  E   R Y  +++  +  +H  H VH
Sbjct: 140 HYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPYWMAPEVIKNSSG----- 290
           RDIK  NIL+D NG ++LADFG    +       S    G+P +++PE+++   G     
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258
Query: 291 ---CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE---LPTIPDDLSDEGK 344
              C    D WSLG  + EM   + P+     V    KI N KE    PT   D+S+  K
Sbjct: 259 GPEC----DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 345 DFIR--LCLQRNPLNRPTAAELLDHPFVKG 372
           D IR  +C + + L +    +   HPF  G
Sbjct: 315 DLIRRLICSREHRLGQNGIEDFKKHPFFSG 344

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 139/296 (46%), Gaps = 48/296 (16%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E  +   K++G G+FG V+     +S E+ A+K+V    D + K    Q+M+ +      
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKV--LQDKRFKNRELQIMRIV------ 89
Query: 172 RHPNIVQ----YY--GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA----IRNYTQ 221
           +HPN+V     +Y  G K  E  L + LEYV   ++Y+  + Y +  +      I+ Y  
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           Q+L  LA++HS    HRDIK  N+L+DP +G +KL DFG AK +      +S   S Y+ 
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYR 208
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN-----SKE---- 331
           APE+I  ++     +DIWS GC + E+   +P +    G+  + +I       S+E    
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268
Query: 332 ---------LPTI-PDDLSD--------EGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                     P I P   S         +  D I   L+  P  R TA E L HPF
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 18/261 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +++G G FG VY  F    G+  A+K      D    ++ + + QE  L + L+HPNI+ 
Sbjct: 13  EIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR-NYTQQILSGLAFLHSKHTV- 236
             G    E  L + +E+  GG + ++L   G+   P I  N+  QI  G+ +LH +  V 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 237 --HRDIKGANILVD--------PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK 286
             HRD+K +NIL+          N  +K+ DFG+A+    ++  +S  G+  WMAPEVI+
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-WHRTTKMSAAGAYAWMAPEVIR 187
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
            +S  +   D+WS G  + E+ T + P+   +G+A  + +  +K    IP    +     
Sbjct: 188 -ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKL 246
Query: 347 IRLCLQRNPLNRPTAAELLDH 367
           +  C   +P +RP+   +LD 
Sbjct: 247 MEDCWNPDPHSRPSFTNILDQ 267

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 19/262 (7%)
Query: 112 ESHWKKGK-MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           E HW   +  LGRG+FG V+   +  +G  CA+K+V L       E  +  ++E+V  + 
Sbjct: 70  EVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFR--VEELVACAG 120
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           L  P IV  YG+      + I++E + GGS+ +L++  G   E     Y  Q L GL +L
Sbjct: 121 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 180
Query: 231 HSKHTVHRDIKGANILVDPNG-RVKLADFGMAKHIA----GQSCPLS--FKGSPYWMAPE 283
           H++  +H D+K  N+L+  +G R  L DFG A  +     G+S        G+   MAPE
Sbjct: 181 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 240
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN-SKELPTIPDDLSDE 342
           V+     C+  VDIWS  C +L M     PW+QY       KI +    +  IP   +  
Sbjct: 241 VVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 299
Query: 343 GKDFIRLCLQRNPLNRPTAAEL 364
               I+  L++ P++R +A EL
Sbjct: 300 TAQAIQEGLRKEPVHRASAMEL 321

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 152/304 (50%), Gaps = 50/304 (16%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSR 170
           +  ++K   LG G  G V+   +  SG + A K + L    + K + + Q+++E+ +L  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHE 60
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 231 HSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             KH + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  +M+PE ++ + 
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 179
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW-------------SQYEGVA--------------- 321
             ++  DIWS+G +++EMA  + P               Q EG A               
Sbjct: 180 -YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 322 ----------AMFKIGN---SKELPTIPDDL-SDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                     A+F++ +   ++  P +P  + S E +DF+  CL +NP  R    +L+ H
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 368 PFVK 371
            F+K
Sbjct: 299 AFIK 302

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +LG+G+FG V +     + E+ A+K    +V + DD    +    ++++ VL    + P 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD----DVECTMVEKRVLALPGKPPF 403
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           + Q +      D+LY  +EYV+GG +   +Q  G+F EP    Y  +I  GL FL SK  
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           ++RD+K  N+++D  G +K+ADFGM K +I        F G+P ++APE+I        +
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKS 522
Query: 295 VDIWSLGCTVLEMATTKPPWS 315
           VD W+ G  + EM   + P+ 
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFE 543

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 152/304 (50%), Gaps = 50/304 (16%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSR 170
           +  ++K   LG G  G V+   +  SG + A K + L    + K + + Q+++E+ +L  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHE 60
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 231 HSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             KH + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  +M+PE ++ + 
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 179
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW-------------SQYEGVA--------------- 321
             ++  DIWS+G +++EMA  + P               Q EG A               
Sbjct: 180 -YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 322 ----------AMFKIGN---SKELPTIPDDL-SDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                     A+F++ +   ++  P +P  + S E +DF+  CL +NP  R    +L+ H
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 368 PFVK 371
            F+K
Sbjct: 299 AFIK 302

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 127/264 (48%), Gaps = 12/264 (4%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ----EIVLLSRLR-HP 174
           ++GRG    V    +  +G   A+K + +  +  S E  +++ +    E  +L ++  HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           +I+    S      +++  + +  G ++  L +     E   R+  + +L  ++FLH+ +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS----- 289
            VHRD+K  NIL+D N +++L+DFG + H+          G+P ++APE++K S      
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHP 280
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP--DDLSDEGKDFI 347
           G    VD+W+ G  +  +    PP+     +  +  I   +   + P  DD S   KD I
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLI 340
Query: 348 RLCLQRNPLNRPTAAELLDHPFVK 371
              LQ +P  R TA + L HPF +
Sbjct: 341 SRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 152/304 (50%), Gaps = 50/304 (16%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSR 170
           +  ++K   LG G  G V+   +  SG + A K + L    + K + + Q+++E+ +L  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHE 60
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 231 HSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             KH + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  +M+PE ++ + 
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 179
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW-------------SQYEGVA--------------- 321
             ++  DIWS+G +++EMA  + P               Q EG A               
Sbjct: 180 -YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 322 ----------AMFKIGN---SKELPTIPDDL-SDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                     A+F++ +   ++  P +P  + S E +DF+  CL +NP  R    +L+ H
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 368 PFVK 371
            F+K
Sbjct: 299 AFIK 302

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 152/304 (50%), Gaps = 50/304 (16%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSR 170
           +  ++K   LG G  G V+   +  SG + A K + L    + K + + Q+++E+ +L  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHE 60
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 231 HSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             KH + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  +M+PE ++ + 
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 179
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW-------------SQYEGVA--------------- 321
             ++  DIWS+G +++EMA  + P               Q EG A               
Sbjct: 180 -YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 322 ----------AMFKIGN---SKELPTIPDDL-SDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                     A+F++ +   ++  P +P  + S E +DF+  CL +NP  R    +L+ H
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 368 PFVK 371
            F+K
Sbjct: 299 AFIK 302

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 129/262 (49%), Gaps = 19/262 (7%)
Query: 112 ESHWKKGK-MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           E HW   +  +GRG+FG V+   +  +G  CA+K+V L       E  +  ++E+V  + 
Sbjct: 56  EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFR--VEELVACAG 106
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           L  P IV  YG+      + I++E + GGS+ +L++  G   E     Y  Q L GL +L
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 231 HSKHTVHRDIKGANILVDPNG-RVKLADFGMAKHIA----GQSCPLS--FKGSPYWMAPE 283
           H++  +H D+K  N+L+  +G R  L DFG A  +     G+S        G+   MAPE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN-SKELPTIPDDLSDE 342
           V+     C+  VDIWS  C +L M     PW+QY       KI +    +  IP   +  
Sbjct: 227 VVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285
Query: 343 GKDFIRLCLQRNPLNRPTAAEL 364
               I+  L++ P++R +A EL
Sbjct: 286 TAQAIQEGLRKEPVHRASAMEL 307

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 129/262 (49%), Gaps = 19/262 (7%)
Query: 112 ESHWKKGK-MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           E HW   +  +GRG+FG V+   +  +G  CA+K+V L       E  +  ++E+V  + 
Sbjct: 72  EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFR--VEELVACAG 122
Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           L  P IV  YG+      + I++E + GGS+ +L++  G   E     Y  Q L GL +L
Sbjct: 123 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 182
Query: 231 HSKHTVHRDIKGANILVDPNG-RVKLADFGMAKHIA----GQSCPLS--FKGSPYWMAPE 283
           H++  +H D+K  N+L+  +G R  L DFG A  +     G+S        G+   MAPE
Sbjct: 183 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN-SKELPTIPDDLSDE 342
           V+     C+  VDIWS  C +L M     PW+QY       KI +    +  IP   +  
Sbjct: 243 VVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 301
Query: 343 GKDFIRLCLQRNPLNRPTAAEL 364
               I+  L++ P++R +A EL
Sbjct: 302 TAQAIQEGLRKEPVHRASAMEL 323

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 148/297 (49%), Gaps = 27/297 (9%)
Query: 106 ENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES----AKQL 161
           ++ V  E  ++  +++G+G F  V    N ++G+  A+K   + D AK   S     + L
Sbjct: 17  DDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVK---IVDVAKFTSSPGLSTEDL 73
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSI-YKLLQ--DYG-QFGEPAIR 217
            +E  +   L+HP+IV+   + + +  LY+  E++ G  + +++++  D G  + E    
Sbjct: 74  KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLS-- 272
           +Y +QIL  L + H  + +HRD+K  N+L+   + +  VKL DFG+A  + G+S  ++  
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGG 192
Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW-----SQYEGVAAMFKIG 327
             G+P++MAPEV+K        VD+W  G  +  + +   P+       +EG+      G
Sbjct: 193 RVGTPHFMAPEVVKREPYGK-PVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK----G 247
Query: 328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPE 384
             K  P     +S+  KD +R  L  +P  R T  E L+HP++K        I  PE
Sbjct: 248 KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPE 304

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +LG+G+FG V +     + E+ A+K    +V + DD    +    ++++ VL    + P 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD----DVECTMVEKRVLALPGKPPF 82
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           + Q +      D+LY  +EYV+GG +   +Q  G+F EP    Y  +I  GL FL SK  
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           ++RD+K  N+++D  G +K+ADFGM K +I        F G+P ++APE+I        +
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKS 201
Query: 295 VDIWSLGCTVLEMATTKPPWS 315
           VD W+ G  + EM   + P+ 
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFE 222

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 141/286 (49%), Gaps = 40/286 (13%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S +++  +LG+G FG V    N+      A+K++       ++E    ++ E++LL+ L 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASLN 60
Query: 173 HPNIVQYYGS-----------KTVEDK--LYIYLEYVSGGSIYKLL--QDYGQFGEPAIR 217
           H  +V+YY +             V+ K  L+I +EY   G++Y L+  ++  Q  +   R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA---------GQS 268
            + +QIL  L+++HS+  +HRD+K  NI +D +  VK+ DFG+AK++           Q+
Sbjct: 121 LF-RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 269 CP------LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA 322
            P       S  G+  ++A EV+  +   N  +D++SLG    EM    P  +  E V  
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNI 237
Query: 323 MFKIGN-SKEL-PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           + K+ + S E  P   D+     K  IRL +  +P  RP A  LL+
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
              + S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FS-NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 4   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 120
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 181 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 240 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 4   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 120
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 181 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 240 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 AFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 14/277 (5%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
            +E+ +L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G+P
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPT 334
            ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E   
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 241 FSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 138/295 (46%), Gaps = 38/295 (12%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDA 152
           S  R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++      
Sbjct: 2   SEDRDPTQFE-----ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----H 52
Query: 153 KSKESAKQLMQEIVLLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQ 210
            ++E  +   +EI +L  L+H NIV+Y G         L + +EY+  GS+   LQ + +
Sbjct: 53  STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 112
Query: 211 -FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
                 +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +     
Sbjct: 113 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172
Query: 270 PLSFK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY---- 317
               K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++    
Sbjct: 173 XXKVKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 231
Query: 318 ----EGVAAMFK----IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
               +G   +F     + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 232 GNDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 138/292 (47%), Gaps = 38/292 (13%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSK 155
           R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++       ++
Sbjct: 33  RDPTQFE-----ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 83
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ-FG 212
           E  +   +EI +L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + +   
Sbjct: 84  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 143
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +        
Sbjct: 144 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 203
Query: 273 FK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY------- 317
            K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++       
Sbjct: 204 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
Query: 318 -EGVAAMFK----IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            +G   +F     + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 263 KQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 133/283 (46%), Gaps = 9/283 (3%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           +S ++  + LG+G F  V       +G+  A K +       S    ++L +E  +   L
Sbjct: 21  QSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIIN--TKKLSARDHQKLEREARICRLL 78
Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
           +HPNIV+ + S + E   Y+  + V+GG +++ +     + E    +  QQIL  +   H
Sbjct: 79  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 138
Query: 232 SKHTVHRDIKGANILVDPNGR---VKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVIKN 287
               VHRD+K  N+L+    +   VKLADFG+A  + G Q     F G+P +++PEV++ 
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKD 345
                  VD+W+ G  +  +    PP W + +          + + P+   D ++ E KD
Sbjct: 199 DPYGK-PVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 257
Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDV 388
            I   L  NP  R TAAE L HP++   + +   +   E  D 
Sbjct: 258 LINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDC 300

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 138/292 (47%), Gaps = 38/292 (13%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSK 155
           R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++       ++
Sbjct: 5   RDPTQFE-----ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 55
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ-FG 212
           E  +   +EI +L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + +   
Sbjct: 56  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERID 115
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +        
Sbjct: 116 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 175
Query: 273 FK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY------- 317
            K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++       
Sbjct: 176 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234
Query: 318 -EGVAAMFK----IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            +G   +F     + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 235 KQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           + LG G FG V++     SG    +K +   +  +S+   +Q+  EI +L  L HPNI++
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTI---NKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL---QDYGQ-FGEPAIRNYTQQILSGLAFLHSKH 234
            +        +YI +E   GG + + +   Q  G+   E  +    +Q+++ LA+ HS+H
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 235 TVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
            VH+D+K  NIL     P+  +K+ DFG+A+         +  G+  +MAPEV K     
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD--V 202
Query: 292 NLAVDIWSLGCTVLEMATTKPPW--SQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFI 347
               DIWS G  +  + T   P+  +  E V   A +K  N   +   P  L+ +  D +
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-VECRP--LTPQAVDLL 259
Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGA 373
           +  L ++P  RP+AA++L H + K A
Sbjct: 260 KQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 128/255 (50%), Gaps = 25/255 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEM--CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           ++LGRG FG V+      +G++  C           K  + A   M E  +L+++    I
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSI----YKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           V    +   +  L + +  ++GG I    Y + +D   F EP    YT QI+SGL  LH 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           ++ ++RD+K  N+L+D +G V+++D G+A  + AGQ+    + G+P +MAPE++      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-Y 366
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIPDDLSDEG 343
           + +VD ++LG T+ EM   + P+      A   K+ N KEL         T PD  S   
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFR-----ARGEKVEN-KELKQRVLEQAVTYPDKFSPAS 420
Query: 344 KDFIRLCLQRNPLNR 358
           KDF    LQ++P  R
Sbjct: 421 KDFCEALLQKDPEKR 435

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 138/292 (47%), Gaps = 38/292 (13%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSK 155
           R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++       ++
Sbjct: 6   RDPTQFE-----ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 56
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ-FG 212
           E  +   +EI +L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + +   
Sbjct: 57  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 116
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +        
Sbjct: 117 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 176
Query: 273 FK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY------- 317
            K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++       
Sbjct: 177 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 235
Query: 318 -EGVAAMFK----IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            +G   +F     + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 236 KQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 286

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 138/294 (46%), Gaps = 35/294 (11%)
Query: 98  VPRSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAK 153
           VPR    M      E H K  + LG+G FG V    Y     ++GE+ A+K++       
Sbjct: 15  VPRGSHNMTQ--FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HS 68
Query: 154 SKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ- 210
           ++E  +   +EI +L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + + 
Sbjct: 69  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 128
Query: 211 FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +      
Sbjct: 129 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 188
Query: 271 LSFK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY----- 317
              K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++     
Sbjct: 189 XKVKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 247
Query: 318 ---EGVAAMFK----IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
              +G   +F     + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 248 NDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 128/255 (50%), Gaps = 25/255 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEM--CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           ++LGRG FG V+      +G++  C           K  + A   M E  +L+++    I
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSI----YKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           V    +   +  L + +  ++GG I    Y + +D   F EP    YT QI+SGL  LH 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           ++ ++RD+K  N+L+D +G V+++D G+A  + AGQ+    + G+P +MAPE++      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-Y 366
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIPDDLSDEG 343
           + +VD ++LG T+ EM   + P+      A   K+ N KEL         T PD  S   
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFR-----ARGEKVEN-KELKQRVLEQAVTYPDKFSPAS 420
Query: 344 KDFIRLCLQRNPLNR 358
           KDF    LQ++P  R
Sbjct: 421 KDFCEALLQKDPEKR 435

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 128/255 (50%), Gaps = 25/255 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEM--CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           ++LGRG FG V+      +G++  C           K  + A   M E  +L+++    I
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSI----YKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           V    +   +  L + +  ++GG I    Y + +D   F EP    YT QI+SGL  LH 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           ++ ++RD+K  N+L+D +G V+++D G+A  + AGQ+    + G+P +MAPE++      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-Y 366
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIPDDLSDEG 343
           + +VD ++LG T+ EM   + P+      A   K+ N KEL         T PD  S   
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFR-----ARGEKVEN-KELKQRVLEQAVTYPDKFSPAS 420
Query: 344 KDFIRLCLQRNPLNR 358
           KDF    LQ++P  R
Sbjct: 421 KDFCEALLQKDPEKR 435

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 138/294 (46%), Gaps = 35/294 (11%)
Query: 98  VPRSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAK 153
           VPR    M      E H K  + LG+G FG V    Y     ++GE+ A+K++       
Sbjct: 15  VPRGSHNMTQ--FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HS 68
Query: 154 SKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ- 210
           ++E  +   +EI +L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + + 
Sbjct: 69  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 128
Query: 211 FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +      
Sbjct: 129 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 188
Query: 271 LSFK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY----- 317
              K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++     
Sbjct: 189 XKVKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 247
Query: 318 ---EGVAAMFK----IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
              +G   +F     + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 248 NDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 136/296 (45%), Gaps = 46/296 (15%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSK 155
           R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++       ++
Sbjct: 8   RDPTQFE-----ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 58
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ-FG 212
           E  +   +EI +L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + +   
Sbjct: 59  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 118
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +        
Sbjct: 119 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 178
Query: 273 FK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQYEGVAAMF 324
            K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++     M 
Sbjct: 179 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MR 232
Query: 325 KIGNSKELPTI----------------PDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            IGN K+   I                PD   DE    +  C   N   RP+  +L
Sbjct: 233 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 288

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 136/296 (45%), Gaps = 46/296 (15%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSK 155
           R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++       ++
Sbjct: 9   RDPTQFE-----ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 59
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ-FG 212
           E  +   +EI +L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + +   
Sbjct: 60  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 119
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +        
Sbjct: 120 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 179
Query: 273 FK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQYEGVAAMF 324
            K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++     M 
Sbjct: 180 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MR 233
Query: 325 KIGNSKELPTI----------------PDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            IGN K+   I                PD   DE    +  C   N   RP+  +L
Sbjct: 234 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 289

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 135/296 (45%), Gaps = 46/296 (15%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSK 155
           R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++       ++
Sbjct: 7   RDPTQFE-----ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 57
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FG 212
           E  +   +EI +L  L+H NIV+Y G         L + +EY+  GS+   LQ + +   
Sbjct: 58  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 117
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +        
Sbjct: 118 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 177
Query: 273 FK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQYEGVAAMF 324
            K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++     M 
Sbjct: 178 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MR 231
Query: 325 KIGNSKELPTI----------------PDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            IGN K+   I                PD   DE    +  C   N   RP+  +L
Sbjct: 232 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 287

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 138/292 (47%), Gaps = 38/292 (13%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSK 155
           R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++       ++
Sbjct: 1   RDPTQFE-----ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 51
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ-FG 212
           E  +   +EI +L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + +   
Sbjct: 52  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 111
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +        
Sbjct: 112 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 171
Query: 273 FK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY------- 317
            K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++       
Sbjct: 172 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 230
Query: 318 -EGVAAMFK----IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            +G   +F     + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 231 KQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 281

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 138/292 (47%), Gaps = 38/292 (13%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSK 155
           R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++       ++
Sbjct: 2   RDPTQFE-----ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 52
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ-FG 212
           E  +   +EI +L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + +   
Sbjct: 53  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 112
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +        
Sbjct: 113 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 172
Query: 273 FK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY------- 317
            K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++       
Sbjct: 173 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 318 -EGVAAMFK----IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            +G   +F     + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 111/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +YL  ++ G  +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 166
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 167 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 223
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRP 246

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 128/255 (50%), Gaps = 25/255 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEM--CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           ++LGRG FG V+      +G++  C           K  + A   M E  +L+++    I
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSI----YKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           V    +   +  L + +  ++GG I    Y + +D   F EP    YT QI+SGL  LH 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           ++ ++RD+K  N+L+D +G V+++D G+A  + AGQ+    + G+P +MAPE++      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-Y 366
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--------TIPDDLSDEG 343
           + +VD ++LG T+ EM   + P+      A   K+ N KEL         T PD  S   
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFR-----ARGEKVEN-KELKQRVLEQAVTYPDKFSPAS 420
Query: 344 KDFIRLCLQRNPLNR 358
           KDF    LQ++P  R
Sbjct: 421 KDFCEALLQKDPEKR 435

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 133/280 (47%), Gaps = 33/280 (11%)
Query: 112 ESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           E H K  + LG+G FG V    Y     ++GE+ A+K++       ++E  +   +EI +
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEI 64
Query: 168 LSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQIL 224
           L  L+H NIV+Y G         L + +EY+  GS+   LQ + +      +  YT QI 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSP-YWM 280
            G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +         K    SP +W 
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY--------EGVAAMFK--- 325
           APE +   S  ++A D+WS G  + E+ T    +K P +++        +G   +F    
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 326 -IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 244 LLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 112 ESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           E H K  + LG+G FG V    Y     ++GE+ A+K++       ++E  +   +EI +
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEI 64
Query: 168 LSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQIL 224
           L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + +      +  YT QI 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSP-YWM 280
            G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +         K    SP +W 
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY--------EGVAAMFK--- 325
           APE +   S  ++A D+WS G  + E+ T    +K P +++        +G   +F    
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 326 -IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 244 LLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 112 ESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           E H K  + LG+G FG V    Y     ++GE+ A+K++       ++E  +   +EI +
Sbjct: 7   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEI 62
Query: 168 LSRLRHPNIVQYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQIL 224
           L  L+H NIV+Y G      +  L + +EY+  GS+   LQ + +      +  YT QI 
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 122
Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSP-YWM 280
            G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +         K    SP +W 
Sbjct: 123 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 182
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY--------EGVAAMFK--- 325
           APE +   S  ++A D+WS G  + E+ T    +K P +++        +G   +F    
Sbjct: 183 APESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 241
Query: 326 -IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 242 LLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 280

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/292 (29%), Positives = 138/292 (47%), Gaps = 38/292 (13%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSK 155
           R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++       ++
Sbjct: 5   RDPTQFE-----ERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 55
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FG 212
           E  +   +EI +L  L+H NIV+Y G         L + +E++  GS+ + LQ + +   
Sbjct: 56  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERID 115
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  YT QI  G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +        
Sbjct: 116 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 175
Query: 273 FK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY------- 317
            K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++       
Sbjct: 176 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234
Query: 318 -EGVAAMFK----IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            +G   +F     + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 235 KQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 142/314 (45%), Gaps = 45/314 (14%)
Query: 99  PRSPGRME----NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKS 154
           P  PG +E     P      + + + +G G +G V   ++       A+K+++ F+    
Sbjct: 25  PGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFE---H 81
Query: 155 KESAKQLMQEIVLLSRLRHPNIV---QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQ 210
           +   ++ ++EI +L R RH N++       + T+E    +Y+ + +    +YKLL+   Q
Sbjct: 82  QTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS-QQ 140
Query: 211 FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                I  +  QIL GL ++HS + +HRD+K +N+L++    +K+ DFG+A+    +   
Sbjct: 141 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDH 200
Query: 271 LSF----KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--PWSQY------- 317
             F      + ++ APE++ NS G   ++DIWS+GC + EM + +P  P   Y       
Sbjct: 201 TGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260
Query: 318 ---------EGVAAMFKIGNSKELPTIPDDL-----------SDEGKDFIRLCLQRNPLN 357
                    E +  +  +     L ++P                +  D +   L  NP  
Sbjct: 261 LGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNK 320
Query: 358 RPTAAELLDHPFVK 371
           R T  E L HP+++
Sbjct: 321 RITVEEALAHPYLE 334

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 15/268 (5%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG F  V V     +G++ AMK +  +D  K  E +    +  VL++  R   I Q
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR-WITQ 125
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKHTVH 237
            + +   E+ LY+ +EY  GG +  LL  +G+       R Y  +I+  +  +H    VH
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185
Query: 238 RDIKGANILVDPNGRVKLADFG--MAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA- 294
           RDIK  NIL+D  G ++LADFG  +     G    L   G+P +++PE+++   G     
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245
Query: 295 -----VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE---LPTIPDDLSDEGKDF 346
                 D W+LG    EM   + P+          KI + KE   LP + + + +E +DF
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDF 305
Query: 347 IR--LCLQRNPLNRPTAAELLDHPFVKG 372
           I+  LC     L R  A +   HPF  G
Sbjct: 306 IQRLLCPPETRLGRGGAGDFRTHPFFFG 333

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 123/256 (48%), Gaps = 9/256 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G F  V       +G+  A K +       S    ++L +E  +   L+HPNIV+ +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIIN--TKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S + E   Y+  + V+GG +++ +     + E    +  QQIL  +   H    VHRD+
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDL 129
Query: 241 KGANILVDPNGR---VKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           K  N+L+    +   VKLADFG+A  + G Q     F G+P +++PEV++        VD
Sbjct: 130 KPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGK-PVD 188
Query: 297 IWSLGCTVLEMATTKPP-WSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCLQRN 354
           +W+ G  +  +    PP W + +          + + P+   D ++ E KD I   L  N
Sbjct: 189 MWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTIN 248
Query: 355 PLNRPTAAELLDHPFV 370
           P  R TA+E L HP++
Sbjct: 249 PAKRITASEALKHPWI 264

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 140/286 (48%), Gaps = 40/286 (13%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S +++  +LG+G FG V    N+      A+K++       ++E    ++ E++LL+ L 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASLN 60
Query: 173 HPNIVQYYGS-----------KTVEDK--LYIYLEYVSGGSIYKLL--QDYGQFGEPAIR 217
           H  +V+YY +             V+ K  L+I +EY    ++Y L+  ++  Q  +   R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA---------GQS 268
            + +QIL  L+++HS+  +HRD+K  NI +D +  VK+ DFG+AK++           Q+
Sbjct: 121 LF-RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 269 CP------LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA 322
            P       S  G+  ++A EV+  +   N  +D++SLG    EM    P  +  E V  
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNI 237
Query: 323 MFKIGN-SKEL-PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           + K+ + S E  P   D+     K  IRL +  +P  RP A  LL+
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 123/256 (48%), Gaps = 9/256 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G F  V       +G+  A K +       S    ++L +E  +   L+HPNIV+ +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIIN--TKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S + E   Y+  + V+GG +++ +     + E    +  QQIL  +   H    VHRD+
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDL 129
Query: 241 KGANILVDPNGR---VKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           K  N+L+    +   VKLADFG+A  + G Q     F G+P +++PEV++        VD
Sbjct: 130 KPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGK-PVD 188
Query: 297 IWSLGCTVLEMATTKPP-WSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCLQRN 354
           +W+ G  +  +    PP W + +          + + P+   D ++ E KD I   L  N
Sbjct: 189 MWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTIN 248
Query: 355 PLNRPTAAELLDHPFV 370
           P  R TA+E L HP++
Sbjct: 249 PAKRITASEALKHPWI 264

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 136/279 (48%), Gaps = 18/279 (6%)
Query: 104 RMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQL 161
           R EN    + ++  G+ LG G F  V       +G   A K +       S+   S + +
Sbjct: 5   RQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNY 219
            +E+ +L  ++HPN++  +  +  E+K  + L  E V+GG ++  L +     E     +
Sbjct: 62  EREVSILKEIQHPNVITLH--EVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEF 119
Query: 220 TQQILSGLAFLHSKHTVHRDIKGANI-LVD---PNGRVKLADFGMAKHIAGQSCPLSFKG 275
            +QIL+G+ +LHS    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +  G
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKEL 332
           +P ++APE++ N     L  D+WS+G     + +   P+   ++ E +A +  +    E 
Sbjct: 180 TPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 333 PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               +  S   KDFIR  L ++P  R T  + L HP++K
Sbjct: 239 EYFSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 127/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 76
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI +E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 136
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDT-XTAHAGAKFPIKWTAPESLAYNK-FSIKS 194
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 195 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 252
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 253 NPSDRPSFAEI 263

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 127/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 73
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI +E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDT-XTAHAGAKFPIKWTAPESLAYNK-FSIKS 191
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 192 DVWAFGVLLWEIATYGM--SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 249
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 250 NPSDRPSFAEI 260

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G FG VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 73
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDT-XTAHAGAKFPIKWTAPESLAYNK-FSIKS 191
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 192 DVWAFGVLLWEIATYGM--SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 249
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 250 NPSDRPSFAEI 260

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 116/214 (54%), Gaps = 20/214 (9%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  +M G+GTFG V +G    +G   A+K+V    D + +    Q+MQ+   L+ L HP
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQDPRFRNRELQIMQD---LAVLHHP 79
Query: 175 NIVQ---YYGSKTVEDKLYIYL----EYVSGGSIYKLLQDY--GQFGEP--AIRNYTQQI 223
           NIVQ   Y+ +    D+  IYL    EYV   ++++  ++Y   Q   P   I+ +  Q+
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 224 LSGLAFLH--SKHTVHRDIKGANILV-DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           +  +  LH  S +  HRDIK  N+LV + +G +KL DFG AK ++     +++  S Y+ 
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR 198
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW 314
           APE+I  +     AVDIWS+GC   EM   +P +
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 124/250 (49%), Gaps = 14/250 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 77
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQ--SCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           D+   N LV  N  VK+ADFG+++ + G   + P   K    W APE +  +   ++  D
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNK-FSIKSD 196
Query: 297 IWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRN 354
           +W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q N
Sbjct: 197 VWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 254
Query: 355 PLNRPTAAEL 364
           P +RP+ AE+
Sbjct: 255 PSDRPSFAEI 264

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 127/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI +E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 193
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 194 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 124/250 (49%), Gaps = 14/250 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 76
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 136
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQ--SCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           D+   N LV  N  VK+ADFG+++ + G   + P   K    W APE +  +   ++  D
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNK-FSIKSD 195
Query: 297 IWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRN 354
           +W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q N
Sbjct: 196 VWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 253
Query: 355 PLNRPTAAEL 364
           P +RP+ AE+
Sbjct: 254 PSDRPSFAEI 263

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 127/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 80
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI +E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 198
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 199 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 257 NPSDRPSFAEI 267

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/292 (29%), Positives = 137/292 (46%), Gaps = 38/292 (13%)
Query: 100 RSPGRMENPVSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSK 155
           R P + E     E H K  + LG+G FG V    Y     ++GE+ A+K++       ++
Sbjct: 3   RDPTQFE-----ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 53
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FG 212
           E  +   +EI +L  L+H NIV+Y G         L + +EY+  GS+   LQ + +   
Sbjct: 54  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 113
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  YT QI  G+ +L +K  +HR++   NILV+   RVK+ DFG+ K +        
Sbjct: 114 HIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYK 173
Query: 273 FK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT----TKPPWSQY------- 317
            K    SP +W APE +   S  ++A D+WS G  + E+ T    +K P +++       
Sbjct: 174 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 232
Query: 318 -EGVAAMFK----IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            +G   +F     + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 233 KQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 283

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 127/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI +E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 193
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 194 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 121/255 (47%), Gaps = 8/255 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G F  V    +  +G   A K +       S    ++L +E  +  +L+HPNIV+ +
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINT--KKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S   E   Y+  + V+GG +++ +     + E    +  QQIL  +A+ HS   VHR++
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 154
Query: 241 KGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           K  N+L+    +   VKLADFG+A  +        F G+P +++PEV+K        VDI
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK-PVDI 213
Query: 298 WSLGCTVLEMATTKPP-WSQYEG-VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           W+ G  +  +    PP W + +  + A  K G         D ++ E K  I   L  NP
Sbjct: 214 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 273
Query: 356 LNRPTAAELLDHPFV 370
             R TA + L  P++
Sbjct: 274 KKRITADQALKVPWI 288

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 13/263 (4%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            K LGRG F  V    +  +G+  A K   L    + ++   +++ EI +L   +  P +
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAK--FLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKL-LQDYGQF-GEPAIRNYTQQILSGLAFLHSKH 234
           +  +       ++ + LEY +GG I+ L L +  +   E  +    +QIL G+ +LH  +
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 235 TVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKNSSG 290
            VH D+K  NIL+    P G +K+ DFGM++ I G +C L    G+P ++APE++ N   
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTPEYLAPEIL-NYDP 209
Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG--NSKELPTIPDDLSDEGKDFIR 348
              A D+W++G     + T   P+   +       I   N          +S    DFI+
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQ 269
Query: 349 LCLQRNPLNRPTAAELLDHPFVK 371
             L +NP  RPTA   L H +++
Sbjct: 270 SLLVKNPEKRPTAEICLSHSWLQ 292

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 128/248 (51%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 79
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI +EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 80  AVVS-EEPIYIVIEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNE-XTARQGAKFPIKWTAPEAALYGR-FTI 194
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 253
Query: 353 RNPLNRPT 360
           ++P  RPT
Sbjct: 254 KDPEERPT 261

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 13/266 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-----FDDAKSKESAKQLMQEIVLLSRLR- 172
           ++LGRG    V    +  + +  A+K + +     F   + +E  +  ++E+ +L ++  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNI+Q   +       ++  + +  G ++  L +     E   R   + +L  +  LH 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK-----N 287
            + VHRD+K  NIL+D +  +KL DFG +  +       S  G+P ++APE+I+     N
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDN 202
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAA-MFKIGNSKELPTIPDDLSDEGKD 345
             G    VD+WS G  +  +    PP W + + +   M   GN +      DD SD  KD
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVK 371
            +   L   P  R TA E L HPF +
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFFQ 288

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 80
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDT-XTAHAGAKFPIKWTAPESLAYNK-FSIKS 198
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 199 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 257 NPSDRPSFAEI 267

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 321
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 381
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           ++   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 382 NLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 439
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 440 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 497
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 498 NPSDRPSFAEI 508

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 80
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 198
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 199 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 257 NPSDRPSFAEI 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 80
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 198
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 199 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 257 NPSDRPSFAEI 267

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           ++   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 400
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 401 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 458
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 459 NPSDRPSFAEI 469

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 80
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 198
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 199 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 257 NPSDRPSFAEI 267

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 128/248 (51%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 79
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI +EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 80  AVVS-EEPIYIVIEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 194
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 253
Query: 353 RNPLNRPT 360
           ++P  RPT
Sbjct: 254 KDPEERPT 261

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 79
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 139
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 197
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 198 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 255
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 256 NPSDRPSFAEI 266

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 73
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTFT-AHAGAKFPIKWTAPESLAYNK-FSIKS 191
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 192 DVWAFGVLLWEIATYGM--SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 249
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 250 NPSDRPSFAEI 260

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 10/209 (4%)
Query: 110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESA-KQLMQEIVLL 168
           S    ++K   LG G F  VY   + ++ ++ A+K++ L   +++K+   +  ++EI LL
Sbjct: 7   SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 169 SRLRHPNIV---QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA-IRNYTQQIL 224
             L HPNI+     +G K+    ++ ++E      +  +++D      P+ I+ Y    L
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APE 283
            GL +LH    +HRD+K  N+L+D NG +KLADFG+AK     +     +    W  APE
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPE 182
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
           ++  +    + VD+W++GC + E+    P
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 193
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 194 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 9/274 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G F  V       +G+  A   + +     S    ++L +E  +   L+HPNIV+ +
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAA--MIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S + E   Y+  + V+GG +++ +     + E    +  QQIL  +   H    VHR++
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNL 136
Query: 241 KGANILVDPNGR---VKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           K  N+L+    +   VKLADFG+A  + G Q     F G+P +++PEV++        VD
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK-PVD 195
Query: 297 IWSLGCTVLEMATTKPP-WSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCLQRN 354
           +W+ G  +  +    PP W + +          + + P+   D ++ E KD I   L  N
Sbjct: 196 LWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTIN 255
Query: 355 PLNRPTAAELLDHPFVKGAAPLERTILAPEPSDV 388
           P  R TAAE L HP++   + +   +   E  D 
Sbjct: 256 PSKRITAAEALKHPWISHRSTVASCMHRQETVDC 289

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 77
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 195
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 196 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 253
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 254 NPSDRPSFAEI 264

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 124/268 (46%), Gaps = 11/268 (4%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESA--KQLMQEIVLLS 169
           E  +  G+ LG G F  V       +G   A K +       S+     +++ +E+ +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
           ++ HPNI+  +        + + LE VSGG ++  L       E    ++ +QIL G+ +
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 230 LHSKHTVHRDIKGANI-LVDPNG---RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           LH+K   H D+K  NI L+D N     +KL DFG+A  I       +  G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDE 342
            N     L  D+WS+G     + +   P+   ++ E +A +  +    +        S+ 
Sbjct: 191 -NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD-EEFFSQTSEL 248
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
            KDFIR  L +    R T  E L HP++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKF-SIKS 193
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 194 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 193
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 194 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 77
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 195
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 196 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 253
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 254 NPSDRPSFAEI 264

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 121/255 (47%), Gaps = 8/255 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G F  V    +  +G   A K +       S    ++L +E  +  +L+HPNIV+ +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINT--KKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S   E   Y+  + V+GG +++ +     + E    +  QQIL  +A+ HS   VHR++
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 131
Query: 241 KGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           K  N+L+    +   VKLADFG+A  +        F G+P +++PEV+K        VDI
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK-PVDI 190
Query: 298 WSLGCTVLEMATTKPP-WSQYEG-VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           W+ G  +  +    PP W + +  + A  K G         D ++ E K  I   L  NP
Sbjct: 191 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 250
Query: 356 LNRPTAAELLDHPFV 370
             R TA + L  P++
Sbjct: 251 KKRITADQALKVPWI 265

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKF-SIKS 193
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 194 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 127/248 (51%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 79
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 80  AVVS-EEPIYIVCEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRF-TI 194
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 253
Query: 353 RNPLNRPT 360
           ++P  RPT
Sbjct: 254 KDPEERPT 261

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 122/257 (47%), Gaps = 24/257 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCA--MKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           K LG G FG V +G      ++    +KE ++ +D        +  QE   + +L HP +
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED--------EFFQEAQTMMKLSHPKL 65
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA-IRNYTQQILSGLAFLHSKHT 235
           V++YG  + E  +YI  EY+S G +   L+ +G+  EP+ +      +  G+AFL S   
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEV---IKNSS 289
           +HRD+   N LVD +  VK++DFGM +++      +S  G+ +   W APEV    K SS
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 290 GCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
                 D+W+ G  + E+ +  K P+  Y     + K+     L   P   SD     + 
Sbjct: 185 ----KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTIYQIMY 239
Query: 349 LCLQRNPLNRPTAAELL 365
            C    P  RPT  +LL
Sbjct: 240 SCWHELPEKRPTFQQLL 256

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 134/277 (48%), Gaps = 28/277 (10%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 328
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 329 AVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNYV 385
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 443
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWR 502
Query: 353 RNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVP 389
           + P  RPT   L         A LE    + EP   P
Sbjct: 503 KEPEERPTFEYL--------QAFLEDYFTSTEPQXQP 531

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 121/255 (47%), Gaps = 8/255 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G F  V    +  +G   A K +       S    ++L +E  +  +L+HPNIV+ +
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINT--KKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S   E   Y+  + V+GG +++ +     + E    +  QQIL  +A+ HS   VHR++
Sbjct: 71  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 130
Query: 241 KGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           K  N+L+    +   VKLADFG+A  +        F G+P +++PEV+K        VDI
Sbjct: 131 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK-PVDI 189
Query: 298 WSLGCTVLEMATTKPP-WSQYEG-VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           W+ G  +  +    PP W + +  + A  K G         D ++ E K  I   L  NP
Sbjct: 190 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 249
Query: 356 LNRPTAAELLDHPFV 370
             R TA + L  P++
Sbjct: 250 KKRITADQALKVPWI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VY G         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 88
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           G  T E   YI  E+++ G++   L++    +     +     QI S + +L  K+ +HR
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 148
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  +   ++  
Sbjct: 149 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKS 206
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++++         P+   ++  + +R C Q 
Sbjct: 207 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 264
Query: 354 NPLNRPTAAEL 364
           NP +RP+ AE+
Sbjct: 265 NPSDRPSFAEI 275

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 121/255 (47%), Gaps = 8/255 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G F  V    +  +G   A K +       S    ++L +E  +  +L+HPNIV+ +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINT--KKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S   E   Y+  + V+GG +++ +     + E    +  QQIL  +A+ HS   VHR++
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 131
Query: 241 KGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           K  N+L+    +   VKLADFG+A  +        F G+P +++PEV+K        VDI
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK-PVDI 190
Query: 298 WSLGCTVLEMATTKPP-WSQYEG-VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           W+ G  +  +    PP W + +  + A  K G         D ++ E K  I   L  NP
Sbjct: 191 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 250
Query: 356 LNRPTAAELLDHPFV 370
             R TA + L  P++
Sbjct: 251 KKRITADQALKVPWI 265

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 151/306 (49%), Gaps = 30/306 (9%)
Query: 98  VPRSPGRM-ENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE 156
           VPR  G M ++ V  E  ++  +++G+G F  V    N ++G+  A+K V   D AK   
Sbjct: 12  VPR--GSMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIV---DVAKFTS 66
Query: 157 S----AKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSI-YKLLQ--DYG 209
           S     + L +E  +   L+HP+IV+   + + +  LY+  E++ G  + +++++  D G
Sbjct: 67  SPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 126
Query: 210 -QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIA 265
             + E    +Y +QIL  L + H  + +HRD+K   +L+   + +  VKL  FG+A  + 
Sbjct: 127 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL- 185
Query: 266 GQSCPLS--FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW-----SQYE 318
           G+S  ++    G+P++MAPEV+K        VD+W  G  +  + +   P+       +E
Sbjct: 186 GESGLVAGGRVGTPHFMAPEVVKREPYGK-PVDVWGCGVILFILLSGCLPFYGTKERLFE 244
Query: 319 GVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLER 378
           G+      G  K  P     +S+  KD +R  L  +P  R T  E L+HP++K       
Sbjct: 245 GIIK----GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 300
Query: 379 TILAPE 384
            I  PE
Sbjct: 301 KIHLPE 306

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 127/248 (51%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 79
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 80  AVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 194
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 253
Query: 353 RNPLNRPT 360
           ++P  RPT
Sbjct: 254 KDPEERPT 261

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 127/248 (51%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 15  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 68
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 69  AVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 125
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 183
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 184 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 242
Query: 353 RNPLNRPT 360
           ++P  RPT
Sbjct: 243 KDPEERPT 250

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 127/248 (51%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 79
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI +EY+S G +   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 80  AVVS-EEPIYIVMEYMSKGCLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRF-TI 194
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 253
Query: 353 RNPLNRPT 360
           ++P  RPT
Sbjct: 254 KDPEERPT 261

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 128/270 (47%), Gaps = 21/270 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V V    ++  + AMK +  ++  K  E+A    +  VL++         
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
           +Y  +  E+ LY+ ++Y  GG +  LL  +  +  E   R Y  +++  +  +H  H VH
Sbjct: 156 HYAFQD-ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 214
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPYWMAPEVI--------KN 287
           RDIK  N+L+D NG ++LADFG    +       S    G+P +++PE++        K 
Sbjct: 215 RDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 274
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE---LPTIPDDLSDEGK 344
              C    D WSLG  + EM   + P+     V    KI N +E    P+   D+S+E K
Sbjct: 275 GPEC----DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAK 330
Query: 345 DFIR--LCLQRNPLNRPTAAELLDHPFVKG 372
           D I+  +C +   L +    +   H F +G
Sbjct: 331 DLIQRLICSRERRLGQNGIEDFKKHAFFEG 360

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 122/266 (45%), Gaps = 13/266 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-----FDDAKSKESAKQLMQEIVLLSRLR- 172
           ++LGRG    V    +  + +  A+K + +     F   + +E  +  ++E+ +L ++  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNI+Q   +       ++  + +  G ++  L +     E   R   + +L  +  LH 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK-----N 287
            + VHRD+K  NIL+D +  +KL DFG +  +          G+P ++APE+I+     N
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 202
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAA-MFKIGNSKELPTIPDDLSDEGKD 345
             G    VD+WS G  +  +    PP W + + +   M   GN +      DD SD  KD
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVK 371
            +   L   P  R TA E L HPF +
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFFQ 288

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 127/248 (51%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 17  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 70
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 71  AVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 127
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 185
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 186 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 244
Query: 353 RNPLNRPT 360
           ++P  RPT
Sbjct: 245 KDPEERPT 252

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 128/270 (47%), Gaps = 21/270 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V V    ++  + AMK +  ++  K  E+A    +  VL++         
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
           +Y  +  E+ LY+ ++Y  GG +  LL  +  +  E   R Y  +++  +  +H  H VH
Sbjct: 140 HYAFQD-ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 198
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPYWMAPEVI--------KN 287
           RDIK  N+L+D NG ++LADFG    +       S    G+P +++PE++        K 
Sbjct: 199 RDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 258
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE---LPTIPDDLSDEGK 344
              C    D WSLG  + EM   + P+     V    KI N +E    P+   D+S+E K
Sbjct: 259 GPEC----DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAK 314
Query: 345 DFIR--LCLQRNPLNRPTAAELLDHPFVKG 372
           D I+  +C +   L +    +   H F +G
Sbjct: 315 DLIQRLICSRERRLGQNGIEDFKKHAFFEG 344

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 137/299 (45%), Gaps = 36/299 (12%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G +G V    +  SGE  A+K+++     +S+  AK+  +E++LL  ++H N++   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 181 GSKTVEDKLY-IYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVH 237
              T    L   Y  Y+    +   LQ     +F E  I+    Q+L GL ++HS   VH
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVH 167
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           RD+K  N+ V+ +  +K+ DFG+A+H   +     +  + ++ APEVI +    N  VDI
Sbjct: 168 RDLKPGNLAVNEDCELKILDFGLARHADAEMT--GYVVTRWYRAPEVILSWMHYNQTVDI 225
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--TIPDDLSDEG------------ 343
           WS+GC + EM T K  +   + +  + +I     +P       L+D+             
Sbjct: 226 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP 285
Query: 344 -KDFIRL--------------CLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSD 387
            KDF +L               L+ +   R TAA+ L HPF +     E    A +P D
Sbjct: 286 RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFD 344

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 24/272 (8%)
Query: 99  PRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKE 156
           P+ P   +    P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA    
Sbjct: 7   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---- 62
Query: 157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEP 214
                + E  L+ +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +    
Sbjct: 63  ----FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTIN 117
Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            + +   QI  G+AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +
Sbjct: 118 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-ARE 176
Query: 275 GSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSK 330
           G+ +   W APE I N     +  D+WS G  + E+ T  + P   Y G+     I N +
Sbjct: 177 GAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE 232
Query: 331 ELPTI--PDDLSDEGKDFIRLCLQRNPLNRPT 360
               +  PD+  +E    +RLC +  P +RPT
Sbjct: 233 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 264

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 122/266 (45%), Gaps = 13/266 (4%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-----FDDAKSKESAKQLMQEIVLLSRLR- 172
           ++LGRG    V    +  + +  A+K + +     F   + +E  +  ++E+ +L ++  
Sbjct: 10  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 69
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNI+Q   +       ++  + +  G ++  L +     E   R   + +L  +  LH 
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 129
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK-----N 287
            + VHRD+K  NIL+D +  +KL DFG +  +          G+P ++APE+I+     N
Sbjct: 130 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 189
Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAA-MFKIGNSKELPTIPDDLSDEGKD 345
             G    VD+WS G  +  +    PP W + + +   M   GN +      DD SD  KD
Sbjct: 190 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 249
Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVK 371
            +   L   P  R TA E L HPF +
Sbjct: 250 LVSRFLVVQPQKRYTAEEALAHPFFQ 275

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 130/256 (50%), Gaps = 23/256 (8%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +++GRG FG   V       +  A+K++      +S+   K  + E+  LSR+ HPNIV+
Sbjct: 15  EVVGRGAFG--VVCKAKWRAKDVAIKQI------ESESERKAFIVELRQLSRVNHPNIVK 66
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL---QDYGQFGEPAIRNYTQQILSGLAFLHS--- 232
            YG+    + + + +EY  GGS+Y +L   +    +      ++  Q   G+A+LHS   
Sbjct: 67  LYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 233 KHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           K  +HRD+K  N+L+   G V K+ DFG A  I  Q+   + KGS  WMAPEV + S+  
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEGSNYS 182
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
               D++S G  + E+ T + P+ +  G A   M+ + N    P I  +L    +  +  
Sbjct: 183 E-KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI-KNLPKPIESLMTR 240
Query: 350 CLQRNPLNRPTAAELL 365
           C  ++P  RP+  E++
Sbjct: 241 CWSKDPSQRPSMEEIV 256

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 24/272 (8%)
Query: 99  PRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKE 156
           P+ P   +    P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA    
Sbjct: 9   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---- 64
Query: 157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEP 214
                + E  L+ +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +    
Sbjct: 65  ----FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTIN 119
Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            + +   QI  G+AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +
Sbjct: 120 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-ARE 178
Query: 275 GSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSK 330
           G+ +   W APE I N     +  D+WS G  + E+ T  + P   Y G+     I N +
Sbjct: 179 GAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE 234
Query: 331 ELPTI--PDDLSDEGKDFIRLCLQRNPLNRPT 360
               +  PD+  +E    +RLC +  P +RPT
Sbjct: 235 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 266

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 24/272 (8%)
Query: 99  PRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKE 156
           P+ P   +    P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA    
Sbjct: 5   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---- 60
Query: 157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEP 214
                + E  L+ +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +    
Sbjct: 61  ----FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            + +   QI  G+AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-ARE 174
Query: 275 GSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSK 330
           G+ +   W APE I N     +  D+WS G  + E+ T  + P   Y G+     I N +
Sbjct: 175 GAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE 230
Query: 331 ELPTI--PDDLSDEGKDFIRLCLQRNPLNRPT 360
               +  PD+  +E    +RLC +  P +RPT
Sbjct: 231 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 262

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 146/297 (49%), Gaps = 27/297 (9%)
Query: 106 ENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES----AKQL 161
           ++ V  E  ++  +++G+G F  V    N ++G+  A+K V   D AK   S     + L
Sbjct: 17  DDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIV---DVAKFTSSPGLSTEDL 73
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSI-YKLLQ--DYG-QFGEPAIR 217
            +E  +   L+HP+IV+   + + +  LY+  E++ G  + +++++  D G  + E    
Sbjct: 74  KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLS-- 272
           +Y +QIL  L + H  + +HRD+K   +L+   + +  VKL  FG+A  + G+S  ++  
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGG 192
Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW-----SQYEGVAAMFKIG 327
             G+P++MAPEV+K        VD+W  G  +  + +   P+       +EG+      G
Sbjct: 193 RVGTPHFMAPEVVKREPYGK-PVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK----G 247
Query: 328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPE 384
             K  P     +S+  KD +R  L  +P  R T  E L+HP++K        I  PE
Sbjct: 248 KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPE 304

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 140/305 (45%), Gaps = 53/305 (17%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S +   K LG G  G V+   ++D  +  A+K++ L D     +S K  ++EI ++ RL 
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD----PQSVKHALREIKIIRRLD 66
Query: 173 HPNIVQYY--------------GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN 218
           H NIV+ +              GS T  + +YI  EY+       L Q  G   E   R 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARL 124
Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAK----HIAGQSCPLSF 273
           +  Q+L GL ++HS + +HRD+K AN+ ++    V K+ DFG+A+    H + +      
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWS----------QYEGVAAM 323
             + ++ +P ++ + +    A+D+W+ GC   EM T K  ++            E +  +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 324 FKIGNSKELPTIP----DDLSD--------------EGKDFIRLCLQRNPLNRPTAAELL 365
            +    + L  IP    +D+++              E  DF+   L  +P++R TA E L
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 366 DHPFV 370
            HP++
Sbjct: 305 SHPYM 309

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 121/258 (46%), Gaps = 15/258 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +GRG++G V +     +    A K++  +      E   +  QEI ++  L HPNI++ Y
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            +      +Y+ +E  +GG +++ +     F E       + +LS +A+ H  +  HRD+
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDL 132
Query: 241 KGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           K  N L     P+  +KL DFG+A          +  G+PY+++P+V++   G     D 
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPE--CDE 190
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD----DLSDEGKDFIRLCLQR 353
           WS G  +  +    PP+S       M KI       T P+    ++S + +  IR  L +
Sbjct: 191 WSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGT--FTFPEKDWLNVSPQAESLIRRLLTK 248
Query: 354 NPLNRPTAAELLDHPFVK 371
           +P  R T+ + L+H + +
Sbjct: 249 SPKQRITSLQALEHEWFE 266

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 121/258 (46%), Gaps = 15/258 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +GRG++G V +     +    A K++  +      E   +  QEI ++  L HPNI++ Y
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVDRFKQEIEIMKSLDHPNIIRLY 89
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            +      +Y+ +E  +GG +++ +     F E       + +LS +A+ H  +  HRD+
Sbjct: 90  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDL 149
Query: 241 KGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           K  N L     P+  +KL DFG+A          +  G+PY+++P+V++   G     D 
Sbjct: 150 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPE--CDE 207
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD----DLSDEGKDFIRLCLQR 353
           WS G  +  +    PP+S       M KI       T P+    ++S + +  IR  L +
Sbjct: 208 WSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGT--FTFPEKDWLNVSPQAESLIRRLLTK 265
Query: 354 NPLNRPTAAELLDHPFVK 371
           +P  R T+ + L+H + +
Sbjct: 266 SPKQRITSLQALEHEWFE 283

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 127/248 (51%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ ++RH  +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKIRHEKLVQLY 79
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 80  AVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 194
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 253
Query: 353 RNPLNRPT 360
           ++P  RPT
Sbjct: 254 KDPEERPT 261

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 31/278 (11%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQLMQEIVLLS 169
           E  +  G+ LG G F  V       +G   A K +       S+   S +++ +E+ +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
           ++ H N++  +        + + LE VSGG ++  L       E    ++ +QIL G+ +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 230 LHSKHTVHRDIKGANI-LVDPNG---RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           LH+K   H D+K  NI L+D N     +KL DFG+A  I       +  G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-----LPTIPDDLS 340
            N     L  D+WS+G     + +   P+           +G++K+     + ++  D  
Sbjct: 191 -NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANITSVSYDFD 238
Query: 341 DE--------GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
           +E         KDFIR  L +    R T  E L HP++
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 24/272 (8%)
Query: 99  PRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKE 156
           P+ P   +    P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA    
Sbjct: 8   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---- 63
Query: 157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEP 214
                + E  L+ +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +    
Sbjct: 64  ----FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTIN 118
Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            + +   QI  G+AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +
Sbjct: 119 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-ARE 177
Query: 275 GSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSK 330
           G+ +   W APE I N     +  D+WS G  + E+ T  + P   Y G+     I N +
Sbjct: 178 GAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE 233
Query: 331 ELPTI--PDDLSDEGKDFIRLCLQRNPLNRPT 360
               +  PD+  +E    +RLC +  P +RPT
Sbjct: 234 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 265

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 166
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 167 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 223
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRP 246

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 126/248 (50%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 79
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 80  AVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD+  ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 194
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 253
Query: 353 RNPLNRPT 360
           ++P  RPT
Sbjct: 254 KDPEERPT 261

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 146
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 203
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRP 226

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 146
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 203
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 130/256 (50%), Gaps = 23/256 (8%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +++GRG FG   V       +  A+K++      +S+   K  + E+  LSR+ HPNIV+
Sbjct: 14  EVVGRGAFG--VVCKAKWRAKDVAIKQI------ESESERKAFIVELRQLSRVNHPNIVK 65
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL---QDYGQFGEPAIRNYTQQILSGLAFLHS--- 232
            YG+    + + + +EY  GGS+Y +L   +    +      ++  Q   G+A+LHS   
Sbjct: 66  LYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 233 KHTVHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           K  +HRD+K  N+L+   G V K+ DFG A  I  Q+   + KGS  WMAPEV + S+  
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
               D++S G  + E+ T + P+ +  G A   M+ + N    P I  +L    +  +  
Sbjct: 182 E-KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI-KNLPKPIESLMTR 239
Query: 350 CLQRNPLNRPTAAELL 365
           C  ++P  RP+  E++
Sbjct: 240 CWSKDPSQRPSMEEIV 255

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 95
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 154
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 155 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 211
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 146
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 203
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 89
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 148
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 205
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRP 228

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 96/155 (61%), Gaps = 3/155 (1%)
Query: 160 QLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNY 219
           Q+++E+ +L     P IV +YG+   + ++ I +E++ GGS+ ++L++  +  E  +   
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 119
Query: 220 TQQILSGLAFLHSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
           +  +L GLA+L  KH + HRD+K +NILV+  G +KL DFG++  +   S   SF G+  
Sbjct: 120 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRS 178
Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           +MAPE ++ +   ++  DIWS+G +++E+A  + P
Sbjct: 179 YMAPERLQGTH-YSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 31/278 (11%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQLMQEIVLLS 169
           E  +  G+ LG G F  V       +G   A K +       S+   S +++ +E+ +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
           ++ H N++  +        + + LE VSGG ++  L       E    ++ +QIL G+ +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 230 LHSKHTVHRDIKGANI-LVDPNG---RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           LH+K   H D+K  NI L+D N     +KL DFG+A  I       +  G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-----LPTIPDDLS 340
            N     L  D+WS+G     + +   P+           +G++K+     + ++  D  
Sbjct: 191 -NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANITSVSYDFD 238
Query: 341 DE--------GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
           +E         KDFIR  L +    R T  E L HP++
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 146
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 203
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRP 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 151
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 208
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRP 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 152
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 153 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 209
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 210 GYTKSIDIWSVGCILAEMLSNRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 143
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 144 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 200
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 201 GYTKSIDIWSVGCILAEMLSNRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 150
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 207
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 150
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 207
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 137/299 (45%), Gaps = 36/299 (12%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G +G V    +  SGE  A+K+++     +S+  AK+  +E++LL  ++H N++   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 181 GSKTVEDKLY-IYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVH 237
              T    L   Y  Y+    +   LQ     +F E  I+    Q+L GL ++HS   VH
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVH 149
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           RD+K  N+ V+ +  +K+ DFG+A+H   +     +  + ++ APEVI +    N  VDI
Sbjct: 150 RDLKPGNLAVNEDCELKILDFGLARHADAEMT--GYVVTRWYRAPEVILSWMHYNQTVDI 207
Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--TIPDDLSDEG------------ 343
           WS+GC + EM T K  +   + +  + +I     +P       L+D+             
Sbjct: 208 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP 267
Query: 344 -KDFIRL--------------CLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSD 387
            KDF +L               L+ +   R TAA+ L HPF +     E    A +P D
Sbjct: 268 RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFD 326

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 19/272 (6%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLR 172
           H+   + LG G FG V+      +G   A K V         ES K+ + +EI  +S LR
Sbjct: 52  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKEIQTMSVLR 106
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIY-KLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
           HP +V  + +   ++++ +  E++SGG ++ K+  ++ +  E     Y +Q+  GL  +H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 232 SKHTVHRDIKGANILVDP--NGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             + VH D+K  NI+     +  +KL DFG+  H+  +       G+  + APEV +   
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 226
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD-----LSDEGK 344
                 D+WS+G     + +   P+    G      + N K      DD     +S++GK
Sbjct: 227 -VGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWNMDDSAFSGISEDGK 282
Query: 345 DFIRLCLQRNPLNRPTAAELLDHPFVK-GAAP 375
           DFIR  L  +P  R T  + L+HP++  G AP
Sbjct: 283 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 314

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 24/272 (8%)
Query: 99  PRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKE 156
           P+ P   +    P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA    
Sbjct: 5   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---- 60
Query: 157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEP 214
                + E  L+ +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +    
Sbjct: 61  ----FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            + +   QI  G+AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-ARE 174
Query: 275 GSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSK 330
           G+ +   W APE I N     +  D+WS G  + E+ T  + P   Y G+     I N +
Sbjct: 175 GAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE 230
Query: 331 ELPTI--PDDLSDEGKDFIRLCLQRNPLNRPT 360
               +  PD+  +E    +RLC +  P +RPT
Sbjct: 231 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 262

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 144
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 201
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRP 224

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 144
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 201
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRP 224

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 24/272 (8%)
Query: 99  PRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKE 156
           P+ P   +    P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA    
Sbjct: 4   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---- 59
Query: 157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEP 214
                + E  L+ +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +    
Sbjct: 60  ----FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTIN 114
Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            + +   QI  G+AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +
Sbjct: 115 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-ARE 173
Query: 275 GSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSK 330
           G+ +   W APE I N     +  D+WS G  + E+ T  + P   Y G+     I N +
Sbjct: 174 GAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE 229
Query: 331 ELPTI--PDDLSDEGKDFIRLCLQRNPLNRPT 360
               +  PD+  +E    +RLC +  P +RPT
Sbjct: 230 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 261

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 126/248 (50%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 79
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S G +   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 80  AVVS-EEPIYIVTEYMSKGCLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRF-TI 194
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 253
Query: 353 RNPLNRPT 360
           ++P  RPT
Sbjct: 254 KDPEERPT 261

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 19/272 (6%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLR 172
           H+   + LG G FG V+      +G   A K V         ES K+ + +EI  +S LR
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKEIQTMSVLR 212
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIY-KLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
           HP +V  + +   ++++ +  E++SGG ++ K+  ++ +  E     Y +Q+  GL  +H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 232 SKHTVHRDIKGANILVDP--NGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
             + VH D+K  NI+     +  +KL DFG+  H+  +       G+  + APEV +   
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD-----LSDEGK 344
                 D+WS+G     + +   P+    G      + N K      DD     +S++GK
Sbjct: 333 -VGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 345 DFIRLCLQRNPLNRPTAAELLDHPFVK-GAAP 375
           DFIR  L  +P  R T  + L+HP++  G AP
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 146
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 147 HRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 203
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 24/272 (8%)
Query: 99  PRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKE 156
           P+ P   +    P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA    
Sbjct: 1   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---- 56
Query: 157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEP 214
                + E  L+ +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +    
Sbjct: 57  ----FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTIN 111
Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            + +   QI  G+AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +
Sbjct: 112 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-ARE 170
Query: 275 GSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSK 330
           G+ +   W APE I N     +  D+WS G  + E+ T  + P   Y G+     I N +
Sbjct: 171 GAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE 226
Query: 331 ELPTI--PDDLSDEGKDFIRLCLQRNPLNRPT 360
               +  PD+  +E    +RLC +  P +RPT
Sbjct: 227 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 258

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 109/216 (50%), Gaps = 25/216 (11%)
Query: 109 VSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           V  + + KK + LG G FG V    Y   N  +GEM A+K +      + +   KQ   E
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---E 83
Query: 165 IVLLSRLRHPNIVQYYGSKTVED----KLYIYLEYVSGGSIYKLLQDY---GQFGEPAIR 217
           I +L  L H +I++Y G    ED     L + +EYV  GS    L+DY      G   + 
Sbjct: 84  IDILRTLYHEHIIKYKGC--CEDAGAASLQLVMEYVPLGS----LRDYLPRHSIGLAQLL 137
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK--- 274
            + QQI  G+A+LH++H +HRD+   N+L+D +  VK+ DFG+AK +         +   
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDG 197
Query: 275 GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT 309
            SP +W APE +K       A D+WS G T+ E+ T
Sbjct: 198 DSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLT 232

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 124/268 (46%), Gaps = 11/268 (4%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQLMQEIVLLS 169
           E  +  G+ LG G F  V       +G   A K +       S+   S +++ +E+ +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
           ++ H N++  +        + + LE VSGG ++  L       E    ++ +QIL G+ +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 230 LHSKHTVHRDIKGANI-LVDPNG---RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           LH+K   H D+K  NI L+D N     +KL DFG+A  I       +  G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDE 342
            N     L  D+WS+G     + +   P+   ++ E +A +  +    +        S+ 
Sbjct: 191 -NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD-EEFFSQTSEL 248
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
            KDFIR  L +    R T  E L HP++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 4/213 (1%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K    LG G    VY+  ++      A+K +      + +E+ K+  +E+   S+L H 
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NIV        +D  Y+ +EY+ G ++ + ++ +G        N+T QIL G+   H   
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPYWMAPEVIKNSSGCN 292
            VHRDIK  NIL+D N  +K+ DFG+AK ++  S   +    G+  + +PE  K     +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-GEATD 190
Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK 325
              DI+S+G  + EM   +PP++    V+   K
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 121/256 (47%), Gaps = 9/256 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G+G F  V       +G   A K +       S    ++L +E  +   L+H NIV+ +
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIIN--TKKLSARDHQKLEREARICRLLKHSNIVRLH 69
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S + E   Y+  + V+GG +++ +     + E    +  QQIL  +   H    VHRD+
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDL 129
Query: 241 KGANILVDPNGR---VKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           K  N+L+    +   VKLADFG+A  + G Q     F G+P +++PEV++  +     VD
Sbjct: 130 KPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY-GKPVD 188
Query: 297 IWSLGCTVLEMATTKPP-WSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCLQRN 354
           IW+ G  +  +    PP W + +          + + P+   D ++ E K+ I   L  N
Sbjct: 189 IWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTIN 248
Query: 355 PLNRPTAAELLDHPFV 370
           P  R TA E L HP+V
Sbjct: 249 PAKRITAHEALKHPWV 264

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 126/248 (50%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 19  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 72
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 73  AVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNYV 129
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 187
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 188 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 246
Query: 353 RNPLNRPT 360
           + P  RPT
Sbjct: 247 KEPEERPT 254

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 31/278 (11%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQLMQEIVLLS 169
           E  +  G+ LG G F  V       +G   A K +       S+   S +++ +E+ +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
           ++ H N++  +        + + LE VSGG ++  L       E    ++ +QIL G+ +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 230 LHSKHTVHRDIKGANI-LVDPNG---RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           LH+K   H D+K  NI L+D N     +KL DFG+A  I       +  G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-----LPTIPDDLS 340
            N     L  D+WS+G     + +   P+           +G++K+     + ++  D  
Sbjct: 191 -NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANITSVSYDFD 238
Query: 341 DE--------GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
           +E         KDFIR  L +    R T  E L HP++
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLK-CQHLSNDHICYFLYQILRGLKYIHSANVL 150
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 207
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 128/272 (47%), Gaps = 21/272 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           +++GRG++  V +     +  + AMK V   L +D +  +  +   ++ V      HP +
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT--EKHVFEQASNHPFL 72
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           V  +     E +L+  +EYV+GG +   +Q   +  E   R Y+ +I   L +LH +  +
Sbjct: 73  VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 132
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           +RD+K  N+L+D  G +KL D+GM K  +        F G+P ++APE+++       +V
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSV 191
Query: 296 DIWSLGCTVLEMATTKPPWS--------QYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           D W+LG  + EM   + P+                +F++   K++  IP  LS +    +
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVL 250
Query: 348 RLCLQRNPLNRPTA------AELLDHPFVKGA 373
           +  L ++P  R         A++  HPF +  
Sbjct: 251 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 150
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 207
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRP 230

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 127/248 (51%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 76
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY++ GS+   L+  G+ G+    P + + + QI SG+A++   + V
Sbjct: 77  AVVS-EEPIYIVTEYMNKGSLLDFLK--GETGKYLRLPQLVDMSAQIASGMAYVERMNYV 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWT-ARQGAKFPIKWTAPEAALYGR-FTI 191
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 250
Query: 353 RNPLNRPT 360
           + P  RPT
Sbjct: 251 KEPEERPT 258

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 129/272 (47%), Gaps = 21/272 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           +++GRG++  V +     +  + AM+ V   L +D +  +  +   ++ V      HP +
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT--EKHVFEQASNHPFL 115
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           V  +     E +L+  +EYV+GG +   +Q   +  E   R Y+ +I   L +LH +  +
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 175
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           +RD+K  N+L+D  G +KL D+GM K  +       +F G+P ++APE+++       +V
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSV 234
Query: 296 DIWSLGCTVLEMATTKPPWS--------QYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           D W+LG  + EM   + P+                +F++   K++  IP  LS +    +
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVL 293
Query: 348 RLCLQRNPLNRPTA------AELLDHPFVKGA 373
           +  L ++P  R         A++  HPF +  
Sbjct: 294 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 134/277 (48%), Gaps = 28/277 (10%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 245
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 246 AVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 360
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWR 419
Query: 353 RNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVP 389
           + P  RPT        F    A LE    + EP   P
Sbjct: 420 KEPEERPT--------FEYLQAFLEDYFTSTEPQXQP 448

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 126/250 (50%), Gaps = 16/250 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G +G VYVG         A+K  TL +D    E   + ++E  ++  ++HPN+VQ  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 94
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAI--RNYTQQILSGLAFLHSKHTVHR 238
           G  T+E   YI  EY+  G++   L++  +    A+       QI S + +L  K+ +HR
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHR 154
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAV 295
           D+   N LV  N  VK+ADFG+++ + G +   +  G+ +   W APE +  ++  ++  
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNT-FSIKS 212
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGV--AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           D+W+ G  + E+AT     S Y G+  + ++ +         P+    +  + +R C + 
Sbjct: 213 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKW 270
Query: 354 NPLNRPTAAE 363
           +P +RP+ AE
Sbjct: 271 SPADRPSFAE 280

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 128/272 (47%), Gaps = 21/272 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           +++GRG++  V +     +  + AMK V   L +D +  +  +   ++ V      HP +
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT--EKHVFEQASNHPFL 68
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           V  +     E +L+  +EYV+GG +   +Q   +  E   R Y+ +I   L +LH +  +
Sbjct: 69  VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 128
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           +RD+K  N+L+D  G +KL D+GM K  +        F G+P ++APE+++       +V
Sbjct: 129 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSV 187
Query: 296 DIWSLGCTVLEMATTKPPWS--------QYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           D W+LG  + EM   + P+                +F++   K++  IP  LS +    +
Sbjct: 188 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVL 246
Query: 348 RLCLQRNPLNRPTA------AELLDHPFVKGA 373
           +  L ++P  R         A++  HPF +  
Sbjct: 247 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 278

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S ++    +G G +G VY   +  SG   A+K V + +  +    +   ++E+ LL RL 
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST--VREVALLRRLE 61
Query: 173 ---HPNIVQYYG----SKT-VEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--IRNYTQQ 222
              HPN+V+       S+T  E K+ +  E+V    +   L      G PA  I++  +Q
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAP 282
            L GL FLH+   VHRD+K  NILV   G VKLADFG+A+  + Q        + ++ AP
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAP 180
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           EV+  S+     VD+WS+GC   EM   KP +        + KI +   LP  P+D
Sbjct: 181 EVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP--PED 233

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 124/268 (46%), Gaps = 11/268 (4%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE--SAKQLMQEIVLLS 169
           E  +  G+ LG G F  V       +G   A K +       S+   S +++ +E+ +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
           ++ H N++  +        + + LE VSGG ++  L       E    ++ +QIL G+ +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 230 LHSKHTVHRDIKGANI-LVDPNG---RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           LH+K   H D+K  NI L+D N     +KL DFG+A  I       +  G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDE 342
            N     L  D+WS+G     + +   P+   ++ E +A +  +    +        S+ 
Sbjct: 191 -NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD-EEFFSQTSEL 248
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
            KDFIR  L +    R T  E L HP++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 148/316 (46%), Gaps = 53/316 (16%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           P R+   +S  S ++   +LG G +G V    +  +GE+ A+K++  FD       A + 
Sbjct: 2   PKRIVYNIS--SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF---ALRT 56
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVE-----DKLYIYLEYVSGGSIYKLLQDYGQFGEPAI 216
           ++EI +L   +H NI+  +  +  +     +++YI  E +    +++++       +  I
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHI 114
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------A 265
           + +  Q L  +  LH  + +HRD+K +N+L++ N  +K+ DFG+A+ I            
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--PWSQYEG-VAA 322
            QS  + F  + ++ APEV+  S+  + A+D+WS GC + E+   +P  P   Y   +  
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 323 MFKIGNS-------------------KELPTIPD--------DLSDEGKDFIRLCLQRNP 355
           +F I  +                   K LP  P          ++ +G D ++  L  +P
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 356 LNRPTAAELLDHPFVK 371
             R TA E L+HP+++
Sbjct: 295 AKRITAKEALEHPYLQ 310

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 127/248 (51%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 76
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY++ GS+   L+  G+ G+    P + + + QI SG+A++   + V
Sbjct: 77  AVVS-EEPIYIVTEYMNKGSLLDFLK--GETGKYLRLPQLVDMSAQIASGMAYVERMNYV 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 191
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 250
Query: 353 RNPLNRPT 360
           + P  RPT
Sbjct: 251 KEPEERPT 258

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+++++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 150
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 207
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRP 230

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 126/248 (50%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 245
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 246 AVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 360
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWR 419
Query: 353 RNPLNRPT 360
           + P  RPT
Sbjct: 420 KEPEERPT 427

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 150
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF----KGSPYWMAPEVIKNSSGCN 292
           HRD+K +N+L++    +K+ DFG+A+          F      + ++ APE++ NS G  
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 210
Query: 293 LAVDIWSLGCTVLEMATTKP 312
            ++DIWS+GC + EM + +P
Sbjct: 211 KSIDIWSVGCILAEMLSNRP 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R RH NI+   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 151
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF----KGSPYWMAPEVIKNSSGCN 292
           HRD+K +N+L++    +K+ DFG+A+          F      + ++ APE++ NS G  
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 211
Query: 293 LAVDIWSLGCTVLEMATTKP 312
            ++DIWS+GC + EM + +P
Sbjct: 212 KSIDIWSVGCILAEMLSNRP 231

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     F  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 132/277 (47%), Gaps = 28/277 (10%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K +          S +  +QE  ++ +LRH  +VQ Y
Sbjct: 193 LGQGCFGEVWMGTWNGTTRV-AIKTL-----KPGNMSPEAFLQEAQVMKKLRHEKLVQLY 246
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 247 AVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 303
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+ + I       + +G+ +   W APE         +
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 361
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 362 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWR 420
Query: 353 RNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVP 389
           ++P  RPT   L         A LE    + EP   P
Sbjct: 421 KDPEERPTFEYL--------QAFLEDYFTSTEPQXQP 449

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 109/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 147
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H A +     +  + ++ APE++ N  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEIMLNWM 205
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 206 HYNQTVDIWSVGCIMAELLT 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 136
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     F  + ++ APE++ N  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIMLNWM 194
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 195 HYNQTVDIWSVGCIMAELLT 214

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     F  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 109/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 147
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H A +     +  + ++ APE++ N  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEIMLNWM 205
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 206 HYNQTVDIWSVGCIMAELLT 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 109/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 147
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H A +     +  + ++ APE++ N  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEIMLNWM 205
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 206 HYNQTVDIWSVGCIMAELLT 225

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 115/237 (48%), Gaps = 15/237 (6%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK-QLMQEIVLLSRL 171
           S ++    +G G +G VY   +  SG   A+K V + +            ++E+ LL RL
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 172 R---HPNIVQYYG----SKT-VEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--IRNYTQ 221
               HPN+V+       S+T  E K+ +  E+V    +   L      G PA  I++  +
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMA 281
           Q L GL FLH+   VHRD+K  NILV   G VKLADFG+A+  + Q        + ++ A
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRA 187
Query: 282 PEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           PEV+  S+     VD+WS+GC   EM   KP +        + KI +   LP  P+D
Sbjct: 188 PEVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP--PED 241

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 120/256 (46%), Gaps = 9/256 (3%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G F  V         +  A K +       S    ++L +E  +   L+HPNIV+ +
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIIN--TKKLSARDHQKLEREARICRLLKHPNIVRLH 96
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
            S + E   Y+  + V+GG +++ +     + E    +   QIL  +  +H    VHRD+
Sbjct: 97  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDL 156
Query: 241 KGANILVDPNGR---VKLADFGMAKHIAG-QSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           K  N+L+    +   VKLADFG+A  + G Q     F G+P +++PEV++        VD
Sbjct: 157 KPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVD 215
Query: 297 IWSLGCTVLEMATTKPP-WSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRLCLQRN 354
           IW+ G  +  +    PP W + +          + + P+   D ++ E K+ I   L  N
Sbjct: 216 IWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTIN 275
Query: 355 PLNRPTAAELLDHPFV 370
           P  R TA + L HP+V
Sbjct: 276 PAKRITADQALKHPWV 291

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 24/260 (9%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA         + E  L+
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--------FLAEANLM 62
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSG 226
            +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +     + +   QI  G
Sbjct: 63  KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           +AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +G+ +   W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPE 180
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
            I N     +  D+WS G  + E+ T  + P   Y G+     I N +    +  PD+  
Sbjct: 181 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 341 DEGKDFIRLCLQRNPLNRPT 360
           +E    +RLC +  P +RPT
Sbjct: 237 EELYQLMRLCWKERPEDRPT 256

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 109 VSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           V  + + KK + LG G FG V    Y   N  +GEM A+K +      + +   KQ   E
Sbjct: 10  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---E 66
Query: 165 IVLLSRLRHPNIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQDY---GQFGEPAIRNY 219
           I +L  L H +I++Y G      E  L + +EYV  GS    L+DY      G   +  +
Sbjct: 67  IDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS----LRDYLPRHSIGLAQLLLF 122
Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GS 276
            QQI  G+A+LHS+H +HR++   N+L+D +  VK+ DFG+AK +         +    S
Sbjct: 123 AQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 277 P-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT 309
           P +W APE +K       A D+WS G T+ E+ T
Sbjct: 183 PVFWYAPECLKEYKF-YYASDVWSFGVTLYELLT 215

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S ++    +G G +G VY   +  SG   A+K V + +  +    +   ++E+ LL RL 
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST--VREVALLRRLE 61
Query: 173 ---HPNIVQYYG----SKT-VEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--IRNYTQQ 222
              HPN+V+       S+T  E K+ +  E+V    +   L      G PA  I++  +Q
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAP 282
            L GL FLH+   VHRD+K  NILV   G VKLADFG+A+  + Q        + ++ AP
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAP 180
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           EV+  S+     VD+WS+GC   EM   KP +        + KI +   LP  P+D
Sbjct: 181 EVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP--PED 233

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 130/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 75
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 76  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQY---EGVAAMFKIGN-SKELPTIPDDL 339
           +  +S+  +   D+++ G  + E+ T + P+S     + +  M   G+ S +L  +  + 
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELL 365
               K  +  CL++    RP+   +L
Sbjct: 255 PKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 134/277 (48%), Gaps = 28/277 (10%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 245
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ +YI  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 246 AVVS-EEPIYIVGEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTI 360
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWR 419
Query: 353 RNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVP 389
           + P  RPT        F    A LE    + EP   P
Sbjct: 420 KEPEERPT--------FEYLQAFLEDYFTSTEPQXQP 448

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 122/254 (48%), Gaps = 39/254 (15%)
Query: 150 DDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG 209
           D    K        E+ +++ +++   +   G  T  D++YI  EY+   SI K    + 
Sbjct: 79  DKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK----FD 134
Query: 210 QFGEPAIRNYT------------QQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLA 256
           ++     +NYT            + +L+  +++H+ K+  HRD+K +NIL+D NGRVKL+
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLS 194
Query: 257 DFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA-VDIWSLGCTVLEMATTKPPWS 315
           DFG ++++  +    S +G+  +M PE   N S  N A VDIWSLG  +  M     P+S
Sbjct: 195 DFGESEYMVDKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
Query: 316 QYEGVAAMFKIGNSKELPTIPDD-------------------LSDEGKDFIRLCLQRNPL 356
               +  +F    +K +   P D                   LS+E  DF++L L++NP 
Sbjct: 254 LKISLVELFNNIRTKNIEY-PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312
Query: 357 NRPTAAELLDHPFV 370
            R T+ + L H ++
Sbjct: 313 ERITSEDALKHEWL 326

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 37/284 (13%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V    +  +G   A+K+  L+   +S+  AK+  +E+ LL  +RH N++   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 178 -QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
             +   +T++D    YL     G+    L  + + GE  I+    Q+L GL ++H+   +
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRD+K  N+ V+ +  +K+ DFG+A+     S       + ++ APEVI N       VD
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMXGXVVTRWYRAPEVILNWMRYTQTVD 208
Query: 297 IWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEG---------- 343
           IWS+GC + EM T K  +      + +  + K+  +     +    SDE           
Sbjct: 209 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 268
Query: 344 --KDFIRLCLQRNPL--------------NRPTAAELLDHPFVK 371
             KDF  +    +PL               R TA E L HP+ +
Sbjct: 269 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  ++E    L+ E+ 
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEME 92
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+       +Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 211
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 212 --YYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 266
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 128/272 (47%), Gaps = 21/272 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           +++GRG++  V +     +  + AMK V   L +D +  +  +   ++ V      HP +
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT--EKHVFEQASNHPFL 83
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           V  +     E +L+  +EYV+GG +   +Q   +  E   R Y+ +I   L +LH +  +
Sbjct: 84  VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 143
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKH-IAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           +RD+K  N+L+D  G +KL D+GM K  +        F G+P ++APE+++       +V
Sbjct: 144 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSV 202
Query: 296 DIWSLGCTVLEMATTKPPWS--------QYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
           D W+LG  + EM   + P+                +F++   K++  IP  +S +    +
Sbjct: 203 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSMSVKAASVL 261
Query: 348 RLCLQRNPLNRPTA------AELLDHPFVKGA 373
           +  L ++P  R         A++  HPF +  
Sbjct: 262 KSFLNKDPKERLGCLPQTGFADIQGHPFFRNV 293

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 75
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T   +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 76  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQY---EGVAAMFKIGN-SKELPTIPDDL 339
           +  +S+  +   D+++ G  + E+ T + P+S     + +  M   G+ S +L  +  + 
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELL 365
               K  +  CL++    RP+   +L
Sbjct: 255 PKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 24/260 (9%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA         + E  L+
Sbjct: 12  PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--------FLAEANLM 63
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSG 226
            +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +     + +   QI  G
Sbjct: 64  KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 122
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           +AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +G+ +   W APE
Sbjct: 123 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPE 181
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
            I N     +  D+WS G  + E+ T  + P   Y G+     I N +    +  PD+  
Sbjct: 182 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCP 237
Query: 341 DEGKDFIRLCLQRNPLNRPT 360
           +E    +RLC +  P +RPT
Sbjct: 238 EELYQLMRLCWKERPEDRPT 257

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N+ 
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNAM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 109/194 (56%), Gaps = 10/194 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
             +  ++++E+   +YL  ++ G  +  +++   +  +  ++    QIL GL ++HS   
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CAKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N    N  V
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWMHYNQTV 200
Query: 296 DIWSLGCTVLEMAT 309
           DIWS+GC + E+ T
Sbjct: 201 DIWSVGCIMAELLT 214

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 24/260 (9%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA         + E  L+
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--------FLAEANLM 62
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSG 226
            +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +     + +   QI  G
Sbjct: 63  KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           +AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +G+ +   W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPE 180
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
            I N     +  D+WS G  + E+ T  + P   Y G+     I N +    +  PD+  
Sbjct: 181 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 341 DEGKDFIRLCLQRNPLNRPT 360
           +E    +RLC +  P +RPT
Sbjct: 237 EELYQLMRLCWKERPEDRPT 256

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 117/264 (44%), Gaps = 36/264 (13%)
Query: 121 LGRGTFGHVYVGFNSDSGEMC-----AMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG G FG V++   ++   +C      +  V    DA S  + K   +E  LL+ L+H +
Sbjct: 21  LGEGAFGKVFL---AECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEH 76
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-------------QFGEPAIRNYTQQ 222
           IV++YG     D L +  EY+  G + K L+ +G             +  +  + +  QQ
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKG 275
           I +G+ +L S+H VHRD+   N LV  N  VK+ DFGM++ +        G    L  + 
Sbjct: 137 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 195
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPT 334
              WM PE I        + D+WSLG  + E+ T  K PW Q      +  I   + L  
Sbjct: 196 ---WMPPESIMYRKFTTES-DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR 251
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNR 358
            P     E  + +  C QR P  R
Sbjct: 252 -PRTCPQEVYELMLGCWQREPHMR 274

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/323 (23%), Positives = 145/323 (44%), Gaps = 76/323 (23%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIV 177
           K LG+G +G V+   +  +GE+ A+K++  FD  ++   A++  +EI++L+ L  H NIV
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 178 QYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT-QQILSGLAFLHSKH 234
                   ++   +Y+  +Y+    ++ +++      EP  + Y   Q++  + +LHS  
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMET-DLHAVIR--ANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAG-----QSCPLS----------------- 272
            +HRD+K +NIL++    VK+ADFG+++          + PLS                 
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW------SQYEGVAAMFKI 326
           +  + ++ APE++  S+     +D+WSLGC + E+   KP +      +Q E +  +   
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDF 249
Query: 327 GNSKELPTIPD---------------------------------------DLSDEGKDFI 347
            +++++ +I                                         D ++E  D +
Sbjct: 250 PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309
Query: 348 RLCLQRNPLNRPTAAELLDHPFV 370
              LQ NP  R +A + L HPFV
Sbjct: 310 DKLLQFNPNKRISANDALKHPFV 332

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 159
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 217
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 218 HYNQTVDIWSVGCIMAELLT 237

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 110/214 (51%), Gaps = 21/214 (9%)
Query: 109 VSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           V  + + KK + LG G FG V    Y   N  +GEM A+K +      + +   KQ   E
Sbjct: 10  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---E 66
Query: 165 IVLLSRLRHPNIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQDY---GQFGEPAIRNY 219
           I +L  L H +I++Y G      E  L + +EYV  GS    L+DY      G   +  +
Sbjct: 67  IDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS----LRDYLPRHSIGLAQLLLF 122
Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--AGQSCPLSFKG-S 276
            QQI  G+A+LH++H +HR++   N+L+D +  VK+ DFG+AK +    +   +   G S
Sbjct: 123 AQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 277 P-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT 309
           P +W APE +K       A D+WS G T+ E+ T
Sbjct: 183 PVFWYAPECLKEYKF-YYASDVWSFGVTLYELLT 215

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 24/260 (9%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA         + E  L+
Sbjct: 6   PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--------FLAEANLM 57
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSG 226
            +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +     + +   QI  G
Sbjct: 58  KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 116
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           +AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +G+ +   W APE
Sbjct: 117 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPE 175
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
            I N     +  D+WS G  + E+ T  + P   Y G+     I N +    +  PD+  
Sbjct: 176 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCP 231
Query: 341 DEGKDFIRLCLQRNPLNRPT 360
           +E    +RLC +  P +RPT
Sbjct: 232 EELYQLMRLCWKERPEDRPT 251

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 109/203 (53%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L   RH NI+   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 148
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 149 HRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 205
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRP 228

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 24/260 (9%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA         + E  L+
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--------FLAEANLM 62
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSG 226
            +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +     + +   QI  G
Sbjct: 63  KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           +AF+  ++ +HRD++ ANILV      K+ADFG+A+ I       + +G+ +   W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPE 180
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
            I N     +  D+WS G  + E+ T  + P   Y G+     I N +    +  PD+  
Sbjct: 181 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 341 DEGKDFIRLCLQRNPLNRPT 360
           +E    +RLC +  P +RPT
Sbjct: 237 EELYQLMRLCWKERPEDRPT 256

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 160
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 218
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 219 HYNQTVDIWSVGCIMAELLT 238

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 79  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+       +Y          
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 257
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 258 --YYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 312
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 313 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S ++    +G G +G VY   +  SG   A+K V + +  +    +   ++E+ LL RL 
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST--VREVALLRRLE 61
Query: 173 ---HPNIVQYYG----SKT-VEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA--IRNYTQQ 222
              HPN+V+       S+T  E K+ +  E+V    +   L      G PA  I++  +Q
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAP 282
            L GL FLH+   VHRD+K  NILV   G VKLADFG+A+  + Q        + ++ AP
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAP 180
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           EV+  S+     VD+WS+GC   EM   KP +        + KI +   LP  P+D
Sbjct: 181 EVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP--PED 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 12/274 (4%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
            PV+  + +++ ++LG+G FG V       +G+M A K++      K K  A  L  E  
Sbjct: 179 QPVTKNT-FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEKQ 236
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN--YTQQIL 224
           +L ++    +V    +   +D L + L  ++GG +   +   GQ G P  R   Y  +I 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEV 284
            GL  LH +  V+RD+K  NIL+D +G ++++D G+A H+          G+  +MAPEV
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN-SKELP-TIPDDLSDE 342
           +KN      + D W+LGC + EM   + P+ Q +      ++    KE+P    +  S +
Sbjct: 357 VKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415
Query: 343 GKDFIRLCLQRNPLNRP-----TAAELLDHPFVK 371
            +      L ++P  R      +A E+ +HP  K
Sbjct: 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 109/203 (53%), Gaps = 18/203 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L   RH NI+   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 178 QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
               + T+E    +Y+ + +    +YKLL+         I  +  QIL GL ++HS + +
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVL 148
Query: 237 HRDIKGANILVDPNGRVKLADFGMAK-------HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HRD+K +N+L++    +K+ DFG+A+       H    +    +  + ++ APE++ NS 
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---EYVATRWYRAPEIMLNSK 205
Query: 290 GCNLAVDIWSLGCTVLEMATTKP 312
           G   ++DIWS+GC + EM + +P
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRP 228

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 12/274 (4%)
Query: 107 NPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
            PV+  + +++ ++LG+G FG V       +G+M A K++      K K  A  L  E  
Sbjct: 179 QPVTKNT-FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEKQ 236
Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN--YTQQIL 224
           +L ++    +V    +   +D L + L  ++GG +   +   GQ G P  R   Y  +I 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEV 284
            GL  LH +  V+RD+K  NIL+D +G ++++D G+A H+          G+  +MAPEV
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN-SKELP-TIPDDLSDE 342
           +KN      + D W+LGC + EM   + P+ Q +      ++    KE+P    +  S +
Sbjct: 357 VKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415
Query: 343 GKDFIRLCLQRNPLNRP-----TAAELLDHPFVK 371
            +      L ++P  R      +A E+ +HP  K
Sbjct: 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 136/286 (47%), Gaps = 40/286 (13%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S +++  +LG+G FG V    N+      A+K++       ++E    ++ E+ LL+ L 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVXLLASLN 60
Query: 173 HPNIVQYYGS-----------KTVEDK--LYIYLEYVSGGSIYKLL--QDYGQFGEPAIR 217
           H  +V+YY +             V+ K  L+I  EY    ++Y L+  ++  Q  +   R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA---------GQS 268
            + +QIL  L+++HS+  +HR++K  NI +D +  VK+ DFG+AK++           Q+
Sbjct: 121 LF-RQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 269 CP------LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA 322
            P       S  G+  ++A EV+  +   N  +D +SLG    E     P  +  E V  
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE--XIYPFSTGXERVNI 237
Query: 323 MFKIGN-SKEL-PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           + K+ + S E  P   D+     K  IRL +  +P  RP A  LL+
Sbjct: 238 LKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 136
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 194
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 195 HYNQTVDIWSVGCIMAELLT 214

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 97
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 98  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 150
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 151 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 208
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 209 HYNQTVDIWSVGCIMAELLT 228

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 146
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 204
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 205 HYNQTVDIWSVGCIMAELLT 224

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 125/248 (50%), Gaps = 20/248 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG+G FG V++G  + +  + A+K  TL     S E+    +QE  ++ +LRH  +VQ Y
Sbjct: 16  LGQGCFGEVWMGTWNGTTRV-AIK--TLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 69
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE----PAIRNYTQQILSGLAFLHSKHTV 236
              + E+ + I  EY+S GS+   L+  G+ G+    P + +   QI SG+A++   + V
Sbjct: 70  AVVS-EEPIXIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNYV 126
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           HRD++ ANILV  N   K+ADFG+A+ I       + +G+ +   W APE         +
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNE-XTARQGAKFPIKWTAPEAALYGR-FTI 184
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G  + E+ T  + P+        + ++     +P  P +  +   D +  C +
Sbjct: 185 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWR 243
Query: 353 RNPLNRPT 360
           + P  RPT
Sbjct: 244 KEPEERPT 251

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 130/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 10  PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 63
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 64  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 122
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 123 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 182
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQY---EGVAAMFKIGN-SKELPTIPDDL 339
           +  +S+  +   D+++ G  + E+ T + P+S     + +  M   G+ S +L  +  + 
Sbjct: 183 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 242
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELL 365
               K  +  CL++    RP+   +L
Sbjct: 243 PKRMKRLMAECLKKKRDERPSFPRIL 268

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 142
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 200
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 201 HYNQTVDIWSVGCIMAELLT 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 134/261 (51%), Gaps = 14/261 (5%)
Query: 117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           K ++LG G FG V+    + +G   A K +      +  +  +++  EI ++++L H N+
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIK----TRGMKDKEEVKNEISVMNQLDHANL 148
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIY-KLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           +Q Y +   ++ + + +EYV GG ++ +++ +     E     + +QI  G+  +H  + 
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYI 208
Query: 236 VHRDIKGANIL-VDPNGR-VKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           +H D+K  NIL V+ + + +K+ DFG+A+     +   ++F G+P ++APEV+ N    +
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVV-NYDFVS 266
Query: 293 LAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
              D+WS+G     + +   P+   +  E +  +       E      D+S+E K+FI  
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ-DISEEAKEFISK 325
Query: 350 CLQRNPLNRPTAAELLDHPFV 370
            L +    R +A+E L HP++
Sbjct: 326 LLIKEKSWRISASEALKHPWL 346

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 145
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 203
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 204 HYNQTVDIWSVGCIMAELLT 223

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 29/282 (10%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     +G + D         V +     +++    L+ E+ 
Sbjct: 67  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 126
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + LQ       +Y          
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAG 266
           Q     + +   Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+   HI  
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 267 QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMF 324
                + +    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +F
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEELF 303
Query: 325 KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           K+         P + ++E    +R C    P  RPT  +L++
Sbjct: 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + D         V +     +++    L+ E+ ++  + +
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG---------QFGEPAI 216
           H NI+   G+ T +  LY+ +EY S G++ + LQ       +Y          Q     +
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSF 273
            +   Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+   HI       + 
Sbjct: 145 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKE 331
           +    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+     
Sbjct: 205 RLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGH 261
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
               P + ++E    +R C    P  RPT  +L++
Sbjct: 262 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 146
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 204
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 205 HYNQTVDIWSVGCIMAELLT 224

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 147/316 (46%), Gaps = 53/316 (16%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           P R+   +S  S ++   +LG G +G V    +  +GE+ A+K++  FD       A + 
Sbjct: 2   PKRIVYNIS--SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF---ALRT 56
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVE-----DKLYIYLEYVSGGSIYKLLQDYGQFGEPAI 216
           ++EI +L   +H NI+  +  +  +     +++YI  E +    +++++       +  I
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHI 114
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------A 265
           + +  Q L  +  LH  + +HRD+K +N+L++ N  +K+ DFG+A+ I            
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--PWSQYEG-VAA 322
            QS    +  + ++ APEV+  S+  + A+D+WS GC + E+   +P  P   Y   +  
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 323 MFKIGNS-------------------KELPTIPD--------DLSDEGKDFIRLCLQRNP 355
           +F I  +                   K LP  P          ++ +G D ++  L  +P
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 356 LNRPTAAELLDHPFVK 371
             R TA E L+HP+++
Sbjct: 295 AKRITAKEALEHPYLQ 310

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+       +Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 211
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 212 --YYKNTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 266
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + D         V +     +++    L+ E+ ++  + +
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG---------QFGEPAI 216
           H NI+   G+ T +  LY+ +EY S G++ + LQ       +Y          Q     +
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSF 273
            +   Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+   HI       + 
Sbjct: 142 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKE 331
           +    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+     
Sbjct: 202 RLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGH 258
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
               P + ++E    +R C    P  RPT  +L++
Sbjct: 259 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + D         V +     +++    L+ E+ ++  + +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG---------QFGEPAI 216
           H NI+   G+ T +  LY+ +EY S G++ + LQ       +Y          Q     +
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSF 273
            +   Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+   HI       + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKE 331
           +    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+     
Sbjct: 213 RLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGH 269
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
               P + ++E    +R C    P  RPT  +L++
Sbjct: 270 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + D         V +     +++    L+ E+ ++  + +
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG---------QFGEPAI 216
           H NI+   G+ T +  LY+ +EY S G++ + LQ       +Y          Q     +
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSF 273
            +   Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+   HI       + 
Sbjct: 146 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKE 331
           +    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+     
Sbjct: 206 RLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGH 262
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
               P + ++E    +R C    P  RPT  +L++
Sbjct: 263 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 143/307 (46%), Gaps = 42/307 (13%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           PG+ E+     S     ++LG G +  V    +  +G+  A+K +    + ++  S  ++
Sbjct: 7   PGKFEDMYKLTS-----ELLGEGAYAKVQGAVSLQNGKEYAVKII----EKQAGHSRSRV 57
Query: 162 MQEIVLLSRLR-HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
            +E+  L + + + NI++       + + Y+  E + GGSI   +Q    F E       
Sbjct: 58  FREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVV 117
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGR---VKLADFGMAKHIA-GQSC-PLSF-- 273
           + + + L FLH+K   HRD+K  NIL +   +   VK+ DF +   +    SC P++   
Sbjct: 118 RDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE 177
Query: 274 ----KGSPYWMAPEVIK----NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA--- 322
                GS  +MAPEV++     ++  +   D+WSLG  +  M +  PP+  + G      
Sbjct: 178 LTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWD 237
Query: 323 ---MFKIGNSKELPTI-------PDD----LSDEGKDFIRLCLQRNPLNRPTAAELLDHP 368
              + ++  +K   +I       PD     +S E KD I   L R+   R +AA++L HP
Sbjct: 238 RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHP 297
Query: 369 FVKGAAP 375
           +V+G AP
Sbjct: 298 WVQGQAP 304

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + D         V +     +++    L+ E+ ++  + +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG---------QFGEPAI 216
           H NI+   G+ T +  LY+ +EY S G++ + LQ       +Y          Q     +
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSF 273
            +   Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+   HI       + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKE 331
           +    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+     
Sbjct: 213 RLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGH 269
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
               P + ++E    +R C    P  RPT  +L++
Sbjct: 270 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 29/275 (10%)
Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + D         V +     +++    L+ E+ ++  + +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY----------------GQFGEPAI 216
           H NI+   G+ T +  LY+ +EY S G++ + LQ                   Q     +
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSF 273
            +   Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+   HI       + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKE 331
           +    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+     
Sbjct: 213 RLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGH 269
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
               P + ++E    +R C    P  RPT  +L++
Sbjct: 270 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 145
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 203
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 204 HYNQTVDIWSVGCIMAELLT 223

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS--KPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 152
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 210
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 211 HYNQTVDIWSVGCIMAELLT 230

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 29/282 (10%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+       +Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDX 212
Query: 270 PLSFKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMF 324
                       WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +F
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVEELF 269
Query: 325 KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           K+         P + ++E    +R C    P  RPT  +L++
Sbjct: 270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 142
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 200
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 201 HYNQTVDIWSVGCIMAELLT 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 151
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 209
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 210 HYNQTVDIWSVGCIMAELLT 229

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 159
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 217
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 218 HYNQTVDIWSVGCIMAELLT 237

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 142
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 200
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 201 HYNQTVDIWSVGCIMAELLT 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 160
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 218
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 219 HYNQTVDIWSVGCIMAELLT 238

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 142
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 200
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 201 HYNQTVDIWSVGCIMAELLT 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 163
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 221
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 222 HYNQTVDIWSVGCIMAELLT 241

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 147
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 205
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 206 HYNQTVDIWSVGCIMAELLT 225

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 145
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 203
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 204 HYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 139
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 197
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 198 HYNQTVDIWSVGCIMAELLT 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 152
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 210
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 211 HYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 152
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 210
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 211 HYNQTVDIWSVGCIMAELLT 230

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 20  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 79
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+       +Y          
Sbjct: 80  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 139
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 140 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID- 198
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 199 --YYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 253
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 254 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+       +Y          
Sbjct: 93  MMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 211
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 212 --YYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 266
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 22  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 81
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+       +Y          
Sbjct: 82  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 141
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 142 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 200
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 201 --YYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 255
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 256 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 137/309 (44%), Gaps = 47/309 (15%)
Query: 102 PGRMENPVSPES----HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
           PG M    +P +     +++   LG GT+G VY   ++ + E  A+K + L  + + +  
Sbjct: 19  PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL--EHEEEGV 76
Query: 158 AKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR 217
               ++E+ LL  L+H NI++         +L++  EY +   + K +          I+
Sbjct: 77  PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIK 135
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-----VKLADFGMAKHIAGQSCPLS 272
           ++  Q+++G+ F HS+  +HRD+K  N+L+  +       +K+ DFG+A+         +
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 273 FKGSPYWMA-PEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE 331
            +    W   PE++  S   + +VDIWS+ C   EM    P +     +  +FKI    E
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF---E 252
Query: 332 LPTIPDD--------LSD--------EGKDFIRLC---------------LQRNPLNRPT 360
           +  +PDD        L D         GK   R+                L+ +P+ R +
Sbjct: 253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312
Query: 361 AAELLDHPF 369
           A   L+HP+
Sbjct: 313 AKNALEHPY 321

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 145
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 203
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 204 HYNQTVDIWSVGCIMAELLT 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 137
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 195
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 196 HYNQTVDIWSVGCIMAELLT 215

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 137
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 195
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 196 HYNQTVDIWSVGCIMAELLT 215

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 151
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 209
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 210 HYNQTVDIWSVGCIMAELLT 229

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 75  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV  N  VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESI-NFRRFTSA 192
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 193 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 247
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 86  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 138
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 196
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 197 HYNQTVDIWSVGCIMAELLT 216

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 136
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 194
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 195 HYNQTVDIWSVGCIMAELLT 214

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + D         V +     +++    L+ E+ ++  + +
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG---------QFGEPAI 216
           H NI+   G+ T +  LY+ +EY S G++ + LQ       +Y          Q     +
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSF 273
            +   Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+   HI       + 
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKE 331
           +    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+     
Sbjct: 198 RLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGH 254
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
               P + ++E    +R C    P  RPT  +L++
Sbjct: 255 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 29/282 (10%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-----------DYGQFGEP 214
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+           D  +  E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEE 152
Query: 215 AIR-----NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
            +      + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDX 212
Query: 270 PLSFKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMF 324
                       WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +F
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVEELF 269
Query: 325 KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           K+         P + ++E    +R C    P  RPT  +L++
Sbjct: 270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 146
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 204
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 205 HYNQTVDIWSVGCIMAELLT 224

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 25  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 84
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+       +Y          
Sbjct: 85  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 144
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 145 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 203
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 204 --YYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 258
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 259 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 146
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 204
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 205 HYNQTVDIWSVGCIMAELLT 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 24/260 (9%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  + LG G FG V++G+ +   ++   ++K+ ++  DA         + E  L+
Sbjct: 7   PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--------FLAEANLM 58
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSG 226
            +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +     + +   QI  G
Sbjct: 59  KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 117
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           +AF+  ++ +HR+++ ANILV      K+ADFG+A+ I       + +G+ +   W APE
Sbjct: 118 MAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPE 176
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTI--PDDLS 340
            I N     +  D+WS G  + E+ T  + P   Y G+     I N +    +  PD+  
Sbjct: 177 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCP 232
Query: 341 DEGKDFIRLCLQRNPLNRPT 360
           +E    +RLC +  P +RPT
Sbjct: 233 EELYQLMRLCWKERPEDRPT 252

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 121 LGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +G G+FG VY G ++ D     A+K + + D   + E  +    E+ +L + RH NI+ +
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLF 97
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            G  T +D L I  ++  G S+YK L     +F    + +  +Q   G+ +LH+K+ +HR
Sbjct: 98  MGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHR 156
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVIK--NSSGCNL 293
           D+K  NI +     VK+ DFG+A   +  S     +   GS  WMAPEVI+  +++  + 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGN---SKELPTIPDDLSDEGKDFIRL 349
             D++S G  + E+ T + P+S        +F +G    S +L  +  +     K  +  
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVAD 276
Query: 350 CLQRNPLNRP------TAAELLDHPF 369
           C+++    RP      ++ ELL H  
Sbjct: 277 CVKKVKEERPLFPQILSSIELLQHSL 302

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 118 GKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-R 172
           GK LG G FG V     +G + D         V +     +++    L+ E+ ++  + +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG---------QFGEPAI 216
           H NI+   G+ T +  LY+ +EY S G++ + LQ       +Y          Q     +
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSF 273
            +   Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+   HI       + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKE 331
           +    WMAPE + +    + + D+WS G  + E+ T     S Y G  V  +FK+     
Sbjct: 213 RLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEELFKLLKEGH 269
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
               P + ++E    +R C    P  RPT  +L++
Sbjct: 270 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+       +Y          
Sbjct: 93  MMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 211
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 212 --YYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 266
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G  +G G FG VY G+ +++    A+K++    D  ++E  +Q  QEI ++++ +H N+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR-----NYTQQILSGLAFLHS 232
           +  G  +  D L +   Y+  GS+   L      G P +         Q   +G+ FLH 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
            H +HRDIK ANIL+D     K++DFG+A+     A         G+  +MAPE ++   
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE- 210
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQY 317
                 DI+S G  +LE+ T  P   ++
Sbjct: 211 -ITPKSDIYSFGVVLLEIITGLPAVDEH 237

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 132/286 (46%), Gaps = 44/286 (15%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNIV 177
           ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+IV
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHIV 88
Query: 178 Q--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGL 227
           +        Y G K     L I +E + GG ++  +QD G   F E       + I   +
Sbjct: 89  RIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 144
Query: 228 AFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEV 284
            +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APEV
Sbjct: 145 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 204
Query: 285 I---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPTI 335
           +   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P  
Sbjct: 205 LGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN- 258
Query: 336 PD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
           P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 259 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 304

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 73  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHI 123
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I +E + GG ++  +QD G   F E       + I   
Sbjct: 124 VRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 179
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APE
Sbjct: 180 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 239
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P 
Sbjct: 240 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 294
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 295 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 340

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 163
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMX--GYVATRWYRAPEIMLNWM 221
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 222 HYNQTVDIWSVGCIMAELLT 241

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 33/217 (15%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           ++GRG++G+VY+ ++ ++ +  A+K+V  +F+D       K++++EI +L+RL+   I++
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID---CKRILREITILNRLKSDYIIR 89
Query: 179 YYGSKTVED-----KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
            Y     +D     +LYI LE ++   + KL +      E  I+     +L G  F+H  
Sbjct: 90  LYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP----------------------- 270
             +HRD+K AN L++ +  VK+ DFG+A+ I  +                          
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
Query: 271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEM 307
            S   + ++ APE+I        ++DIWS GC   E+
Sbjct: 209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 108/194 (55%), Gaps = 10/194 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
             +  ++++E+   +YL  ++ G  +  +++   +  +  ++    QIL GL ++HS   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           +HRD+K +N+ V+ +  +K+ DFG+ +H   +     +  + ++ APE++ N    N  V
Sbjct: 147 IHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT--GYVATRWYRAPEIMLNWMHYNQTV 204
Query: 296 DIWSLGCTVLEMAT 309
           DIWS+GC + E+ T
Sbjct: 205 DIWSVGCIMAELLT 218

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G  +G G FG VY G+ +++    A+K++    D  ++E  +Q  QEI ++++ +H N+V
Sbjct: 30  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR-----NYTQQILSGLAFLHS 232
           +  G  +  D L +   Y+  GS+   L      G P +         Q   +G+ FLH 
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHE 145
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
            H +HRDIK ANIL+D     K++DFG+A+     A         G+  +MAPE ++   
Sbjct: 146 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE- 204
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQY 317
                 DI+S G  +LE+ T  P   ++
Sbjct: 205 -ITPKSDIYSFGVVLLEIITGLPAVDEH 231

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 34  PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 87
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 88  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 146
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 147 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDE 342
           +  + +  +   D+++ G  + E+ T + P+S        +F +G     P +    S+ 
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 266
Query: 343 GKDFIRL---CLQRNPLNRPTAAELL 365
            K   RL   CL++    RP   ++L
Sbjct: 267 PKAMKRLMAECLKKKRDERPLFPQIL 292

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHI 117
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I +E + GG ++  +QD G   F E       + I   
Sbjct: 118 VRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P 
Sbjct: 234 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 288
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 289 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 334

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 23/280 (8%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 14  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 71
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 190
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE 331
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 244
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                  +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 245 -----QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQ 279

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 28  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHI 78
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I +E + GG ++  +QD G   F E       + I   
Sbjct: 79  VRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 134
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APE
Sbjct: 135 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 194
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P 
Sbjct: 195 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 249
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 250 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 295

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 29  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHI 79
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I +E + GG ++  +QD G   F E       + I   
Sbjct: 80  VRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 135
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APE
Sbjct: 136 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 195
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P 
Sbjct: 196 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 250
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 251 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 296

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHI 73
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I +E + GG ++  +QD G   F E       + I   
Sbjct: 74  VRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APE
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P 
Sbjct: 190 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 244
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 245 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 290

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 14/277 (5%)
Query: 100 RSPGRMENPVSPESHWKKG----KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK 155
           +SPG   +P  PES +++       LG G++G V+   + + G + A+K  ++      K
Sbjct: 42  QSPGY--DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPK 98
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEP 214
           + A++L +        +HP  V+   +      LY+  E + G S+ +  + +G    E 
Sbjct: 99  DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEA 157
Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            +  Y +  L  LA LHS+  VH D+K ANI + P GR KL DFG+   +         +
Sbjct: 158 QVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE 217
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           G P +MAPE+++ S G   A D++SLG T+LE+A         EG     ++      P 
Sbjct: 218 GDPRYMAPELLQGSYGT--AADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPE 272
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               LS E +  + + L+ +P  R TA  LL  P ++
Sbjct: 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 147/316 (46%), Gaps = 53/316 (16%)
Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           P R+   +S  S ++   +LG G +G V    +  +GE+ A+K++  FD       A + 
Sbjct: 2   PKRIVYNIS--SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF---ALRT 56
Query: 162 MQEIVLLSRLRHPNIVQYYGSKTVE-----DKLYIYLEYVSGGSIYKLLQDYGQFGEPAI 216
           ++EI +L   +H NI+  +  +  +     +++YI  E +    +++++       +  I
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHI 114
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI----------AG 266
           + +  Q L  +  LH  + +HRD+K +N+L++ N  +K+ DFG+A+ I           G
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 267 QSCPLSFKGSPYWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--PWSQYEG-VAA 322
           Q   ++   +  W  APEV+  S+  + A+D+WS GC + E+   +P  P   Y   +  
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 323 MFKIGNS-------------------KELPTIPD--------DLSDEGKDFIRLCLQRNP 355
           +F I  +                   K LP  P          ++ +G D ++  L  +P
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 356 LNRPTAAELLDHPFVK 371
             R TA E L+HP+++
Sbjct: 295 AKRITAKEALEHPYLQ 310

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 103 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 161
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV  N  VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSA 220
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 221 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 275
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 276 CWAYDPSRRPRFTEL 290

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 27  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHI 77
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I +E + GG ++  +QD G   F E       + I   
Sbjct: 78  VRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 133
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APE
Sbjct: 134 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 193
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P 
Sbjct: 194 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 248
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 249 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 294

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHI 73
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I +E + GG ++  +QD G   F E       + I   
Sbjct: 74  VRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APE
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P 
Sbjct: 190 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 244
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 245 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 290

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 124/273 (45%), Gaps = 17/273 (6%)
Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           M  P      ++ G++LG G    V++  +       A+K V   D A+      +  +E
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRRE 62
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKL----YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
               + L HP IV  Y +   E       YI +EYV G ++  ++   G           
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSC--PLSFKGS 276
                 L F H    +HRD+K ANIL+     VK+ DFG+A+ IA  G S     +  G+
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP 336
             +++PE  +  S  +   D++SLGC + E+ T +PP++    V+  ++  + +E P  P
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ--HVREDPIPP 239
Query: 337 ----DDLSDEGKDFIRLCLQRNPLNR-PTAAEL 364
               + LS +    +   L +NP NR  TAAE+
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 29/301 (9%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 33  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 90
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 91  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 209
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE 331
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 263
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA------APLERTILAPEP 385
                  +S E +  IR CL   P +RPT  E+ +HP+++        A +    L+P P
Sbjct: 264 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGP 318
Query: 386 S 386
           S
Sbjct: 319 S 319

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHI 71
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I +E + GG ++  +QD G   F E       + I   
Sbjct: 72  VRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APE
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 187
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P 
Sbjct: 188 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 242
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 243 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 288

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 18/261 (6%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G FG V+      +G +   K    F +         +  EI ++++L HP ++  +
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAK----FINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLL--QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            +   + ++ + LE++SGG ++  +  +DY +  E  + NY +Q   GL  +H    VH 
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHSIVHL 173
Query: 239 DIKGANILVDPN--GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           DIK  NI+ +      VK+ DFG+A  +           +  + APE++ +        D
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTD 232
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD-----LSDEGKDFIRLCL 351
           +W++G     + +   P++   G   +  + N K      D+     +S E KDFI+  L
Sbjct: 233 MWAIGVLGYVLLSGLSPFA---GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 289
Query: 352 QRNPLNRPTAAELLDHPFVKG 372
           Q+ P  R T  + L+HP++KG
Sbjct: 290 QKEPRKRLTVHDALEHPWLKG 310

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + L+       +Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +++ADFG+A+ I     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID- 211
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 212 --YYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 266
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 78  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 136
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV  N  VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSA 195
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 196 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 250
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 251 CWAYDPSRRPRFTEL 265

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 17/277 (6%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 27  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 203
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 255
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 256 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 26  PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 79
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 80  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 138
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 139 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 198
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDE 342
           +  + +  +   D+++ G  + E+ T + P+S        +F +G     P +    S+ 
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 258
Query: 343 GKDFIRL---CLQRNPLNRPTAAELL 365
            K   RL   CL++    RP   ++L
Sbjct: 259 PKAMKRLMAECLKKKRDERPLFPQIL 284

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 22  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHI 72
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I +E + GG ++  +QD G   F E       + I   
Sbjct: 73  VRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 128
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APE
Sbjct: 129 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 188
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P 
Sbjct: 189 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 243
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 244 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 289

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 23/280 (8%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 14  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 71
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 190
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE 331
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 244
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                  +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 245 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 107/200 (53%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 160
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +        + ++ APE++ N  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMX--GXVATRWYRAPEIMLNWM 218
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 219 HYNQTVDIWSVGCIMAELLT 238

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 17/277 (6%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 27  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 203
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 255
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 256 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 23/280 (8%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 13  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 70
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 71  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 189
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE 331
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 243
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                  +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 244 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 80  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 138
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV  N  VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSA 197
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 198 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 252
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 253 CWAYDPSRRPRFTEL 267

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G  +G G FG VY G+ +++    A+K++    D  ++E  +Q  QEI ++++ +H N+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR-----NYTQQILSGLAFLHS 232
           +  G  +  D L +   Y+  GS+   L      G P +         Q   +G+ FLH 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
            H +HRDIK ANIL+D     K++DFG+A+     A         G+  +MAPE ++   
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE- 210
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQY 317
                 DI+S G  +LE+ T  P   ++
Sbjct: 211 -ITPKSDIYSFGVVLLEIITGLPAVDEH 237

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 133/297 (44%), Gaps = 38/297 (12%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQ 178
           +LG G    V    N  + +  A+K +    + +      ++ +E+ +L + + H N+++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKII----EKQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
                  ED+ Y+  E + GGSI   +     F E       Q + S L FLH+K   HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 239 DIKGANILVD-PNGR--VKLADFGMAKHIA--GQSCPLSF------KGSPYWMAPEVI-- 285
           D+K  NIL + PN    VK+ DFG+   I   G   P+S        GS  +MAPEV+  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 286 --KNSSGCNLAVDIWSLGCTVLEMATTKPP----------WSQYEGVAA---MFKIGNSK 330
             + +S  +   D+WSLG  +  + +  PP          W + E   A   M      +
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255
Query: 331 ELPTIPDD----LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAP 383
                PD     +S   KD I   L R+   R +AA++L HP+V+G AP E T+  P
Sbjct: 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP-ENTLPTP 311

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 77  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 135
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV  N  VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSA 194
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 195 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 249
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 250 CWAYDPSRRPRFTEL 264

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 17/277 (6%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 26  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 202
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 254
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 255 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 75  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV  N  VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSA 192
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 193 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 247
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 17/277 (6%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 26  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 202
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 254
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 255 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 24/269 (8%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCA--MKEVTLFDDAKS 154
           S P+ P   +    P    K  K LG G FG V++   +   ++    MK  ++      
Sbjct: 166 SKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------ 219
Query: 155 KESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFG- 212
             S +  + E  ++  L+H  +V+ +   T E  +YI  E+++ GS+   L+ D G    
Sbjct: 220 --SVEAFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQP 276
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
            P + +++ QI  G+AF+  ++ +HRD++ ANILV  +   K+ADFG+A+   G   P+ 
Sbjct: 277 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VGAKFPIK 334
Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKE 331
                 W APE I N     +  D+WS G  ++E+ T  + P+        +  +     
Sbjct: 335 ------WTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR 387
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPT 360
           +P  P++  +E  + +  C +  P  RPT
Sbjct: 388 MPR-PENCPEELYNIMMRCWKNRPEERPT 415

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 72  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV  N  VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSA 189
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 190 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 244
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 245 CWAYDPSRRPRFTEL 259

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 59
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 60  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDE 342
           +  + +  +   D+++ G  + E+ T + P+S        +F +G     P +    S+ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 343 GKDFIRL---CLQRNPLNRPTAAELL 365
            K   RL   CL++    RP   ++L
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 23/280 (8%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 46  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 103
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 104 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 163
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 164 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 222
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE 331
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 223 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 276
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                  +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 277 -----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 311

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 22/259 (8%)
Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMC--AMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K  + LG G  G V++G+ +   ++   ++K+ ++  DA         + E  L+
Sbjct: 11  PRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA--------FLAEANLM 62
Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSG 226
            +L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +     + +   QI  G
Sbjct: 63  KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--AGQSCPLSFKGSPYWMAPEV 284
           +AF+  ++ +HRD++ ANILV      K+ADFG+A+ I  A  +     K    W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEA 181
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTI--PDDLSD 341
           I N     +  D+WS G  + E+ T  + P   Y G+     I N +    +  PD+  +
Sbjct: 182 I-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPE 237
Query: 342 EGKDFIRLCLQRNPLNRPT 360
           E    +RLC +  P +RPT
Sbjct: 238 ELYQLMRLCWKERPEDRPT 256

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ-----EIVLLSRLRH 173
           ++LG G  G V   F+  +G+ CA+K   L+D  K+++      Q      IV +  + +
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALK--LLYDSPKARQEVDHHWQASGGPHIVCILDV-Y 91
Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLH 231
            N+  ++G +     L I +E + GG ++  +Q+ G   F E       + I + + FLH
Sbjct: 92  ENM--HHGKRC----LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 232 SKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI--- 285
           S +  HRD+K  N+L    + +  +KL DFG AK    Q+   +   +PY++APEV+   
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVLGPE 204
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA------MFKIGNSKELPTIPDDL 339
           K    C    D+WSLG  +  +    PP+    G A         ++G          ++
Sbjct: 205 KYDKSC----DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
           S++ K  IRL L+ +P  R T  + ++HP++  +  + +T
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT 300

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 75  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV  N  VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSA 192
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 193 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 247
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 23/280 (8%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 14  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 71
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 190
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE 331
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 244
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                  +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 245 -----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 17/277 (6%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 27  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 203
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 255
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 256 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 17/277 (6%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 26  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 202
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 254
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 255 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 108/200 (54%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ D+G+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 29/301 (9%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 41  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 98
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 99  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 217
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE 331
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 271
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA------APLERTILAPEP 385
                  +S E +  IR CL   P +RPT  E+ +HP+++        A +    L+P P
Sbjct: 272 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGP 326
Query: 386 S 386
           S
Sbjct: 327 S 327

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 17/277 (6%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 27  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 203
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 255
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 256 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 23/280 (8%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 13  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 70
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 71  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 189
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE 331
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 243
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                  +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 244 -----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 107/200 (53%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   ++  SG   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  + ++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 117 DVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 169
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +     +  + ++ APE++ N  
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 227
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N+ VDIWS+GC + E+ T
Sbjct: 228 HYNMTVDIWSVGCIMAELLT 247

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 23/280 (8%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 26  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 202
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE 331
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 256
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                  +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 257 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 131/287 (45%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHI 71
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I +E + GG ++  +QD G   F E       + I   
Sbjct: 72  VRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +       +PY++APE
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE 187
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D+WSLG  +  +    PP+    G+A         ++G   E P 
Sbjct: 188 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 242
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 243 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 288

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 114/270 (42%), Gaps = 33/270 (12%)
Query: 121 LGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G FG V++   +N    +   +  V    D  +  + K   +E  LL+ L+H +IV+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 81
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL----------------QDYGQFGEPAIRNYTQQ 222
           +YG     D L +  EY+  G + K L                Q  G+ G   + +   Q
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKG 275
           I SG+ +L S+H VHRD+   N LV  N  VK+ DFGM++ +        G    L  + 
Sbjct: 142 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 200
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPT 334
              WM PE I        + D+WS G  + E+ T  K PW Q      +  I   + L  
Sbjct: 201 ---WMPPESIMYRKFTTES-DVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 256
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            P     E  D +  C QR P  R    E+
Sbjct: 257 -PRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 23/280 (8%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESA 158
           +PG+ + P+  ES ++ G +LG G FG VY G         A+K V      D     + 
Sbjct: 41  APGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 98
Query: 159 KQLMQEIVLLSRLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPA 215
            ++  E+VLL ++      +++        D   + LE       ++  + + G   E  
Sbjct: 99  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
            R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F 
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 217
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE 331
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 271
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                  +S E +  IR CL   P +RPT  E+ +HP+++
Sbjct: 272 -----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ-----EIVLLSRLRH 173
           ++LG G  G V   F+  +G+ CA+K   L+D  K+++      Q      IV +  + +
Sbjct: 16  QVLGLGVNGKVLECFHRRTGQKCALK--LLYDSPKARQEVDHHWQASGGPHIVCILDV-Y 72
Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLH 231
            N+  ++G +     L I +E + GG ++  +Q+ G   F E       + I + + FLH
Sbjct: 73  ENM--HHGKRC----LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 232 SKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI--- 285
           S +  HRD+K  N+L    + +  +KL DFG AK    Q+   +   +PY++APEV+   
Sbjct: 127 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVLGPE 185
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA------MFKIGNSKELPTIPDDL 339
           K    C    D+WSLG  +  +    PP+    G A         ++G          ++
Sbjct: 186 KYDKSC----DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 241
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
           S++ K  IRL L+ +P  R T  + ++HP++  +  + +T
Sbjct: 242 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT 281

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 34  PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 87
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 88  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 146
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 147 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDE 342
           +  + +  +   D+++ G  + E+ T + P+S        +F +G     P +    S+ 
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 266
Query: 343 GKDFIRL---CLQRNPLNRPTAAELL 365
            K   RL   CL++    RP   ++L
Sbjct: 267 PKAMKRLMAECLKKKRDERPLFPQIL 292

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 455 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV 513
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV  N  VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSA 572
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 573 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 627
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 628 CWAYDPSRRPRFTEL 642

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 33  PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 86
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 87  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 145
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 146 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 205
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDE 342
           +  + +  +   D+++ G  + E+ T + P+S        +F +G     P +    S+ 
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 265
Query: 343 GKDFIRL---CLQRNPLNRPTAAELL 365
            K   RL   CL++    RP   ++L
Sbjct: 266 PKAMKRLMAECLKKKRDERPLFPQIL 291

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 107/200 (53%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DFG+A+H   +        + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GXVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 11  PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 64
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 65  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 123
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 124 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDE 342
           +  + +  +   D+++ G  + E+ T + P+S        +F +G     P +    S+ 
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 343 GKDFIRL---CLQRNPLNRPTAAELL 365
            K   RL   CL++    RP   ++L
Sbjct: 244 PKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 11  PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 64
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 65  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 123
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 124 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDE 342
           +  + +  +   D+++ G  + E+ T + P+S        +F +G     P +    S+ 
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 343 GKDFIRL---CLQRNPLNRPTAAELL 365
            K   RL   CL++    RP   ++L
Sbjct: 244 PKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 130/272 (47%), Gaps = 20/272 (7%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCA--MKEVTLFDDAKS 154
           S P+ P   +    P    K  K LG G FG V++   +   ++    MK  ++      
Sbjct: 172 SKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------ 225
Query: 155 KESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFG- 212
             S +  + E  ++  L+H  +V+ +   T E  +YI  E+++ GS+   L+ D G    
Sbjct: 226 --SVEAFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQP 282
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
            P + +++ QI  G+AF+  ++ +HRD++ ANILV  +   K+ADFG+A+ I       +
Sbjct: 283 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-A 341
Query: 273 FKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGN 328
            +G+ +   W APE I N     +  D+WS G  ++E+ T  + P+        +  +  
Sbjct: 342 REGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
Query: 329 SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPT 360
              +P  P++  +E  + +  C +  P  RPT
Sbjct: 401 GYRMPR-PENCPEELYNIMMRCWKNRPEERPT 431

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 8   PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 61
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 62  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 120
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 121 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDE 342
           +  + +  +   D+++ G  + E+ T + P+S        +F +G     P +    S+ 
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 240
Query: 343 GKDFIRL---CLQRNPLNRPTAAELL 365
            K   RL   CL++    RP   ++L
Sbjct: 241 PKAMKRLMAECLKKKRDERPLFPQIL 266

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 124/273 (45%), Gaps = 17/273 (6%)
Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           M  P      ++ G++LG G    V++  +       A+K V   D A+      +  +E
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRRE 62
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKL----YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
               + L HP IV  Y +   E       YI +EYV G ++  ++   G           
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSC--PLSFKGS 276
                 L F H    +HRD+K ANI++     VK+ DFG+A+ IA  G S     +  G+
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP 336
             +++PE  +  S  +   D++SLGC + E+ T +PP++    V+  ++  + +E P  P
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ--HVREDPIPP 239
Query: 337 ----DDLSDEGKDFIRLCLQRNPLNR-PTAAEL 364
               + LS +    +   L +NP NR  TAAE+
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 107/200 (53%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ DF +A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 121/263 (46%), Gaps = 12/263 (4%)
Query: 121 LGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G+FG V  G +++ SG+  ++    L  D  S+ E+    ++E+  +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG   +   + +  E    GS+   L+ + G F    +  Y  Q+  G+ +L SK  +H
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPY-WMAPEVIKNSSGCNL 293
           RD+   N+L+     VK+ DFG+ + +            +  P+ W APE +K  +  + 
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSH- 203
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A D W  G T+ EM T  + PW    G   + KI    E    P+D   +  + +  C  
Sbjct: 204 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 263
Query: 353 RNPLNRPTAAELLDHPFVKGAAP 375
             P +RPT   L D  F+  A P
Sbjct: 264 HKPEDRPTFVALRD--FLLEAQP 284

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 59
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T + +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 60  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDE 342
           +  + +  +   D+++ G  + E+ T + P+S        +F +G     P +    S+ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 343 GKDFIRL---CLQRNPLNRPTAAELL 365
            K   RL   CL++    RP   ++L
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 124/273 (45%), Gaps = 17/273 (6%)
Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           M  P      ++ G++LG G    V++  +       A+K V   D A+      +  +E
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVK-VLRADLARDPSFYLRFRRE 62
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKL----YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
               + L HP IV  Y +   E       YI +EYV G ++  ++   G           
Sbjct: 63  AQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSC--PLSFKGS 276
                 L F H    +HRD+K ANI++     VK+ DFG+A+ IA  G S     +  G+
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP 336
             +++PE  +  S  +   D++SLGC + E+ T +PP++    V+  ++  + +E P  P
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ--HVREDPIPP 239
Query: 337 ----DDLSDEGKDFIRLCLQRNPLNR-PTAAEL 364
               + LS +    +   L +NP NR  TAAE+
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ + Y S G++ + L+       +Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 211
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 212 --YYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 266
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 27/292 (9%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE +     ++  + + G   E   R++  Q+L  
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEA 126
Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 127 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 185
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDE 342
           +       +  +WSLG  + +M     P+   E +      F+             +S E
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSE 234
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGA------APLERTILAPEPSDV 388
            +  IR CL   P +RPT  E+ +HP+++        A +    L+P PS V
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKV 286

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 115/235 (48%), Gaps = 37/235 (15%)
Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQ 163
           ++N   P+++  K  ++GRG++G+VY+ ++ ++ +  A+K+V  +F+D       K++++
Sbjct: 21  IKNVKVPDNYEIKH-LIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLID---CKRILR 76
Query: 164 EIVLLSRLRHPNIVQYYGSKTVED-----KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN 218
           EI +L+RL+   I++ +     ED     +LYI LE ++   + KL +      E  ++ 
Sbjct: 77  EITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKT 135
Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK--------HIAGQSCP 270
               +L G  F+H    +HRD+K AN L++ +  VK+ DFG+A+        HI      
Sbjct: 136 ILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEE 195
Query: 271 LSFKGSP------------------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEM 307
                 P                  ++ APE+I        ++DIWS GC   E+
Sbjct: 196 KEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAEL 250

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 121/263 (46%), Gaps = 12/263 (4%)
Query: 121 LGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G+FG V  G +++ SG+  ++    L  D  S+ E+    ++E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG   +   + +  E    GS+   L+ + G F    +  Y  Q+  G+ +L SK  +H
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPY-WMAPEVIKNSSGCNL 293
           RD+   N+L+     VK+ DFG+ + +            +  P+ W APE +K  +  + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSH- 193
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A D W  G T+ EM T  + PW    G   + KI    E    P+D   +  + +  C  
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 253
Query: 353 RNPLNRPTAAELLDHPFVKGAAP 375
             P +RPT   L D  F+  A P
Sbjct: 254 HKPEDRPTFVALRD--FLLEAQP 274

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P+     G+ +G G+FG VY G ++ D      M  VT    A + +  +    E+ +L 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGDVA--VKMLNVT----APTPQQLQAFKNEVGVLR 59
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLA 228
           + RH NI+ + G  T   +L I  ++  G S+Y  L     +F    + +  +Q   G+ 
Sbjct: 60  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVI 285
           +LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S    F+   GS  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 286 K--NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDE 342
           +  + +  +   D+++ G  + E+ T + P+S        +F +G     P +    S+ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 343 GKDFIRL---CLQRNPLNRPTAAELL 365
            K   RL   CL++    RP   ++L
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 18/280 (6%)
Query: 98  VPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
           VPR    M  P      ++ G++LG G    V++  +       A+K V   D A+    
Sbjct: 15  VPRG-SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVK-VLRADLARDPSF 72
Query: 158 AKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL----YIYLEYVSGGSIYKLLQDYGQFGE 213
             +  +E    + L HP IV  Y +   E       YI +EYV G ++  ++   G    
Sbjct: 73  YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 132
Query: 214 PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSC-- 269
                        L F H    +HRD+K ANI++     VK+ DFG+A+ IA  G S   
Sbjct: 133 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 192
Query: 270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS 329
             +  G+  +++PE  +  S  +   D++SLGC + E+ T +PP++    V+  ++  + 
Sbjct: 193 TAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ--HV 249
Query: 330 KELPTIP----DDLSDEGKDFIRLCLQRNPLNR-PTAAEL 364
           +E P  P    + LS +    +   L +NP NR  TAAE+
Sbjct: 250 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 289

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 146/316 (46%), Gaps = 65/316 (20%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-FDDAKSK 155
           ++P     ++N V  E      K+LG G+ G V V   S  G   A+K + + F D    
Sbjct: 5   NIPNFEQSLKNLVVSE------KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDI--- 54
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA 215
                LM+  +L     HPN+++YY S+T +  LYI LE  +       LQD  +    +
Sbjct: 55  ----ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVS 105
Query: 216 IRNYT-----------QQILSGLAFLHSKHTVHRDIKGANILVD-------------PNG 251
             N             +QI SG+A LHS   +HRD+K  NILV               N 
Sbjct: 106 DENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165
Query: 252 RVKLADFGMAKHI-AGQSCPLSFK-------GSPYWMAPEVIKNSSGCNL------AVDI 297
           R+ ++DFG+ K + +GQS   SF+       G+  W APE+++ S+          ++DI
Sbjct: 166 RILISDFGLCKKLDSGQS---SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222
Query: 298 WSLGCTVLEMATT-KPPW-SQYEGVAAMFK-IGNSKELPTIPD-DLSDEGKDFIRLCLQR 353
           +S+GC    + +  K P+  +Y   + + + I +  E+  + D  L  E  D I   +  
Sbjct: 223 FSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282
Query: 354 NPLNRPTAAELLDHPF 369
           +PL RPTA ++L HP 
Sbjct: 283 DPLKRPTAMKVLRHPL 298

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 12/269 (4%)
Query: 121 LGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G+FG V  G +++ SG+  ++    L  D  S+ E+    ++E+  +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG   +   + +  E    GS+   L+ + G F    +  Y  Q+  G+ +L SK  +H
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPY-WMAPEVIKNSSGCNL 293
           RD+   N+L+     VK+ DFG+ + +            +  P+ W APE +K  +  + 
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 197
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A D W  G T+ EM T  + PW    G   + KI    E    P+D   +  + +  C  
Sbjct: 198 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 257
Query: 353 RNPLNRPTAAELLDHPFVKGAAPLERTIL 381
             P +RPT   L D  F+  A P +   L
Sbjct: 258 HKPEDRPTFVALRD--FLLEAQPTDMRAL 284

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 121/263 (46%), Gaps = 12/263 (4%)
Query: 121 LGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G+FG V  G +++ SG+  ++    L  D  S+ E+    ++E+  +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG   +   + +  E    GS+   L+ + G F    +  Y  Q+  G+ +L SK  +H
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPY-WMAPEVIKNSSGCNL 293
           RD+   N+L+     VK+ DFG+ + +            +  P+ W APE +K  +  + 
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 203
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A D W  G T+ EM T  + PW    G   + KI    E    P+D   +  + +  C  
Sbjct: 204 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 263
Query: 353 RNPLNRPTAAELLDHPFVKGAAP 375
             P +RPT   L D  F+  A P
Sbjct: 264 HKPEDRPTFVALRD--FLLEAQP 284

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 38/222 (17%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           ++G G++GHV   ++     + A+K++  +F+D       K++++EI +L+RL H ++V+
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID---CKRILREIAILNRLNHDHVVK 116
Query: 179 YYGS---KTVE--DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
                  K VE  D+LY+ LE ++     KL +      E  I+     +L G+ ++HS 
Sbjct: 117 VLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA 175
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHI-----AGQSCPLSFKG------------- 275
             +HRD+K AN LV+ +  VK+ DFG+A+ +          P+S +              
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKN 235
Query: 276 ----------SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEM 307
                     + ++ APE+I        A+D+WS+GC   E+
Sbjct: 236 LKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 124/273 (45%), Gaps = 17/273 (6%)
Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           M  P      ++ G++LG G    V++  +       A+K V   D A+      +  +E
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVK-VLRADLARDPSFYLRFRRE 62
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKL----YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
               + L HP IV  Y +   E       YI +EYV G ++  ++   G           
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSC--PLSFKGS 276
                 L F H    +HRD+K ANI++     VK+ DFG+A+ IA  G S     +  G+
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP 336
             +++PE  +  S  +   D++SLGC + E+ T +PP++    V+  ++  + +E P  P
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ--HVREDPIPP 239
Query: 337 ----DDLSDEGKDFIRLCLQRNPLNR-PTAAEL 364
               + LS +    +   L +NP NR  TAAE+
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 92/312 (29%), Positives = 145/312 (46%), Gaps = 61/312 (19%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-FDDAKSK 155
           ++P     ++N V  E      K+LG G+ G V V   S  G   A+K + + F D    
Sbjct: 23  NIPNFEQSLKNLVVSE------KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDI--- 72
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA 215
                LM+  +L     HPN+++YY S+T +  LYI LE  +       LQD  +    +
Sbjct: 73  ----ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVS 123
Query: 216 IRNYT-----------QQILSGLAFLHSKHTVHRDIKGANILVD-------------PNG 251
             N             +QI SG+A LHS   +HRD+K  NILV               N 
Sbjct: 124 DENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 183
Query: 252 RVKLADFGMAKHI-AGQSCPLSFK-------GSPYWMAPEVIKNSSGCNL--AVDIWSLG 301
           R+ ++DFG+ K + +GQ     F+       G+  W APE+++ S+   L  ++DI+S+G
Sbjct: 184 RILISDFGLCKKLDSGQX---XFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMG 240
Query: 302 CTVLEMATT-KPPW-SQYEGVAAMFK-IGNSKELPTIPD-DLSDEGKDFIRLCLQRNPLN 357
           C    + +  K P+  +Y   + + + I +  E+  + D  L  E  D I   +  +PL 
Sbjct: 241 CVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 300
Query: 358 RPTAAELLDHPF 369
           RPTA ++L HP 
Sbjct: 301 RPTAMKVLRHPL 312

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 92/312 (29%), Positives = 145/312 (46%), Gaps = 61/312 (19%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-FDDAKSK 155
           ++P     ++N V  E      K+LG G+ G V V   S  G   A+K + + F D    
Sbjct: 23  NIPNFEQSLKNLVVSE------KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDI--- 72
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA 215
                LM+  +L     HPN+++YY S+T +  LYI LE  +       LQD  +    +
Sbjct: 73  ----ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVS 123
Query: 216 IRNYT-----------QQILSGLAFLHSKHTVHRDIKGANILVD-------------PNG 251
             N             +QI SG+A LHS   +HRD+K  NILV               N 
Sbjct: 124 DENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 183
Query: 252 RVKLADFGMAKHI-AGQSCPLSFK-------GSPYWMAPEVIKNSSGCNL--AVDIWSLG 301
           R+ ++DFG+ K + +GQ     F+       G+  W APE+++ S+   L  ++DI+S+G
Sbjct: 184 RILISDFGLCKKLDSGQX---XFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMG 240
Query: 302 CTVLEMATT-KPPW-SQYEGVAAMFK-IGNSKELPTIPD-DLSDEGKDFIRLCLQRNPLN 357
           C    + +  K P+  +Y   + + + I +  E+  + D  L  E  D I   +  +PL 
Sbjct: 241 CVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 300
Query: 358 RPTAAELLDHPF 369
           RPTA ++L HP 
Sbjct: 301 RPTAMKVLRHPL 312

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 121/263 (46%), Gaps = 12/263 (4%)
Query: 121 LGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G+FG V  G +++ SG+  ++    L  D  S+ E+    ++E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG   +   + +  E    GS+   L+ + G F    +  Y  Q+  G+ +L SK  +H
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPY-WMAPEVIKNSSGCNL 293
           RD+   N+L+     VK+ DFG+ + +            +  P+ W APE +K  +  + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 193
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A D W  G T+ EM T  + PW    G   + KI    E    P+D   +  + +  C  
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 253
Query: 353 RNPLNRPTAAELLDHPFVKGAAP 375
             P +RPT   L D  F+  A P
Sbjct: 254 HKPEDRPTFVALRD--FLLEAQP 274

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 35/285 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY----VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V     VG + D  +      V +  D  +++    L+ E+ 
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG--------- 209
           ++  + +H NI+   G+ T +  LY+ + Y S G++ + L+       +Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + + T Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 211
Query: 270 PLSFKGSP------YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VA 321
              +K +        WMAPE + +    + + D+WS G  + E+ T     S Y G  V 
Sbjct: 212 --YYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVE 266
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +FK+         P + ++E    +R C    P  RPT  +L++
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 116/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 75  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV     VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSA 192
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 193 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 247
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 125/253 (49%), Gaps = 26/253 (10%)
Query: 119 KMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           K LG G FG V++G +N ++    A+K  TL     S ES    ++E  ++ +L+H  +V
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTK--VAIK--TLKPGTMSPES---FLEEAQIMKKLKHDKLV 67
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE------PAIRNYTQQILSGLAFLH 231
           Q Y   + E+ +YI  EY++ GS+   L+D    GE      P + +   Q+ +G+A++ 
Sbjct: 68  QLYAVVS-EEPIYIVTEYMNKGSLLDFLKD----GEGRALKLPNLVDMAAQVAAGMAYIE 122
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNS 288
             + +HRD++ ANILV      K+ADFG+A+ I       + +G+ +   W APE     
Sbjct: 123 RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAALYG 181
Query: 289 SGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
               +  D+WS G  + E+ T  + P+        + ++     +P  P D      + +
Sbjct: 182 R-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC-PQDCPISLHELM 239
Query: 348 RLCLQRNPLNRPT 360
             C +++P  RPT
Sbjct: 240 IHCWKKDPEERPT 252

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 107/200 (53%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+  FG+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 114/244 (46%), Gaps = 26/244 (10%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W+  + LG G FG+V    + D+GE  A+K+       K++E   +   EI ++ +L HP
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRE---RWCLEIQIMKKLNHP 72
Query: 175 NIVQYYGSKTVEDKL---------YIYLEYVSGGSIYKLLQDYGQ---FGEPAIRNYTQQ 222
           N+V    ++ V D L          + +EY  GG + K L  +       E  IR     
Sbjct: 73  NVV---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRV---KLADFGMAKHI-AGQSCPLSFKGSPY 278
           I S L +LH    +HRD+K  NI++ P  +    K+ D G AK +  G+ C   F G+  
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT-EFVGTLQ 188
Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKI-GNSKELPTIP 336
           ++APE+++      + VD WS G    E  T  +P    ++ V    K+   S E   + 
Sbjct: 189 YLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 337 DDLS 340
           DDL+
Sbjct: 248 DDLT 251

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 114/244 (46%), Gaps = 26/244 (10%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W+  + LG G FG+V    + D+GE  A+K+       K++E   +   EI ++ +L HP
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRE---RWCLEIQIMKKLNHP 73
Query: 175 NIVQYYGSKTVEDKL---------YIYLEYVSGGSIYKLLQDYGQ---FGEPAIRNYTQQ 222
           N+V    ++ V D L          + +EY  GG + K L  +       E  IR     
Sbjct: 74  NVV---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 130
Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRV---KLADFGMAKHI-AGQSCPLSFKGSPY 278
           I S L +LH    +HRD+K  NI++ P  +    K+ D G AK +  G+ C   F G+  
Sbjct: 131 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT-EFVGTLQ 189
Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKI-GNSKELPTIP 336
           ++APE+++      + VD WS G    E  T  +P    ++ V    K+   S E   + 
Sbjct: 190 YLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 248
Query: 337 DDLS 340
           DDL+
Sbjct: 249 DDLT 252

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 130/268 (48%), Gaps = 15/268 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G +LG G++G V    +S++    A+K +      +       + +EI LL RLRH N++
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 178 QYYGSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQFGEPAIR--NYTQQILSGLAFLHSK 233
           Q       E+K  +Y+ +EY   G + ++L    +   P  +   Y  Q++ GL +LHS+
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHI----AGQSCPLSFKGSPYWMAPEVIKN-S 288
             VH+DIK  N+L+   G +K++  G+A+ +    A  +C  S +GSP +  PE+     
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEIANGLD 187
Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK-IGNSKELPTIPDDLSDEGKDFI 347
           +     VDIWS G T+  + T   P+ + + +  +F+ IG       IP D      D +
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSY--AIPGDCGPPLSDLL 244
Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAP 375
           +  L+  P  R +  ++  H + +   P
Sbjct: 245 KGMLEYEPAKRFSIRQIRQHSWFRKKHP 272

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 133/294 (45%), Gaps = 32/294 (10%)
Query: 100 RSPGRMENPVSPESHW-KKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKS 154
           + P    +P   E  + K+ + LG G FG V    Y     ++GE  A+K  +L  ++  
Sbjct: 7   KKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGG 64
Query: 155 KESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE--DKLYIYLEYVSGGSIYKLL-QDYGQF 211
              A  L +EI +L  L H NIV+Y G  T +  + + + +E++  GS+ + L ++  + 
Sbjct: 65  NHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI 123
Query: 212 GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
                  Y  QI  G+ +L S+  VHRD+   N+LV+   +VK+ DFG+ K I       
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX 183
Query: 272 SFK---GSP-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT---------------TKP 312
           + K    SP +W APE +  S    +A D+WS G T+ E+ T                 P
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
Query: 313 PWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
              Q      +  +   K LP  P +  DE    +R C +  P NR +   L++
Sbjct: 243 THGQMTVTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 124/257 (48%), Gaps = 18/257 (7%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           P    K  K LG G FG V++  +N  +       +V +        S +  + E  ++ 
Sbjct: 13  PRESLKLEKKLGAGQFGEVWMATYNKHT-------KVAVKTMKPGSMSVEAFLAEANVMK 65
Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFG-EPAIRNYTQQILSGL 227
            L+H  +V+ +   T E  +YI  E+++ GS+   L+ D G     P + +++ QI  G+
Sbjct: 66  TLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 124
Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEV 284
           AF+  ++ +HRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE 
Sbjct: 125 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEA 183
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
           I N     +  D+WS G  ++E+ T  + P+        +  +     +P  P++  +E 
Sbjct: 184 I-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-PENCPEEL 241
Query: 344 KDFIRLCLQRNPLNRPT 360
            + +  C +  P  RPT
Sbjct: 242 YNIMMRCWKNRPEERPT 258

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 107/200 (53%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ D G+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 109 VSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           V  + + KK + LG G FG V    Y   N  +GEM A+K +    +    +      +E
Sbjct: 5   VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---EGCGPQLRSGWQRE 61
Query: 165 IVLLSRLRHPNIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQDY---GQFGEPAIRNY 219
           I +L  L H +IV+Y G      E  + + +EYV  GS    L+DY      G   +  +
Sbjct: 62  IEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGS----LRDYLPRHCVGLAQLLLF 117
Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--AGQSCPLSFKG-S 276
            QQI  G+A+LH++H +HR +   N+L+D +  VK+ DFG+AK +    +   +   G S
Sbjct: 118 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 277 P-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT 309
           P +W APE +K       A D+WS G T+ E+ T
Sbjct: 178 PVFWYAPECLKECKF-YYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 109 VSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           V  + + KK + LG G FG V    Y   N  +GEM A+K +    +    +      +E
Sbjct: 4   VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---EGCGPQLRSGWQRE 60
Query: 165 IVLLSRLRHPNIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQDY---GQFGEPAIRNY 219
           I +L  L H +IV+Y G      E  + + +EYV  GS    L+DY      G   +  +
Sbjct: 61  IEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGS----LRDYLPRHCVGLAQLLLF 116
Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--AGQSCPLSFKG-S 276
            QQI  G+A+LH++H +HR +   N+L+D +  VK+ DFG+AK +    +   +   G S
Sbjct: 117 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 277 P-YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT 309
           P +W APE +K       A D+WS G T+ E+ T
Sbjct: 177 PVFWYAPECLKECKF-YYASDVWSFGVTLYELLT 209

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 107/200 (53%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ D G+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 7/214 (3%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAM-KEVTLFDDAKSKESAK 159
           +P + +  +  E+  K+ K+LG G FG VY G     GE   +   + + ++    ++  
Sbjct: 26  APNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 85
Query: 160 QLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRN 218
           + M E ++++ + HP++V+  G   +   + +  + +  G + + + ++    G   + N
Sbjct: 86  EFMDEALIMASMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN 144
Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
           +  QI  G+ +L  +  VHRD+   N+LV     VK+ DFG+A+ + G     +  G   
Sbjct: 145 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 204
Query: 279 ---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT 309
              WMA E I      + + D+WS G T+ E+ T
Sbjct: 205 PIKWMALECIHYRKFTHQS-DVWSYGVTIWELMT 237

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 132/297 (44%), Gaps = 38/297 (12%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQ 178
           +LG G    V    N  + +  A+K +    + +      ++ +E+ +L + + H N+++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKII----EKQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
                  ED+ Y+  E + GGSI   +     F E       Q + S L FLH+K   HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 239 DIKGANILVD-PNGR--VKLADFGMAKHIA--GQSCPLSF------KGSPYWMAPEVI-- 285
           D+K  NIL + PN    VK+ DF +   I   G   P+S        GS  +MAPEV+  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 286 --KNSSGCNLAVDIWSLGCTVLEMATTKPP----------WSQYEGVAA---MFKIGNSK 330
             + +S  +   D+WSLG  +  + +  PP          W + E   A   M      +
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255
Query: 331 ELPTIPDD----LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAP 383
                PD     +S   KD I   L R+   R +AA++L HP+V+G AP E T+  P
Sbjct: 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP-ENTLPTP 311

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 10/254 (3%)
Query: 121 LGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G+FG V  G +++ SG+  ++    L  D  S+ E+    ++E+  +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG   +   + +  E    GS+   L+ + G F    +  Y  Q+  G+ +L SK  +H
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPY-WMAPEVIKNSSGCNL 293
           RD+   N+L+     VK+ DFG+ + +            +  P+ W APE +K  +  + 
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 197
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A D W  G T+ EM T  + PW    G   + KI    E    P+D   +  + +  C  
Sbjct: 198 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 257
Query: 353 RNPLNRPTAAELLD 366
             P +RPT   L D
Sbjct: 258 HKPEDRPTFVALRD 271

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 27/292 (9%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE       ++  + + G   E   R++  Q+L  
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 126
Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 127 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 185
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDE 342
           +       +  +WSLG  + +M     P+   E +      F+             +S E
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSE 234
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGA------APLERTILAPEPSDV 388
            +  IR CL   P +RPT  E+ +HP+++        A +    L+P PS V
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKV 286

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 27/292 (9%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE       ++  + + G   E   R++  Q+L  
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 127
Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 186
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDE 342
           +       +  +WSLG  + +M     P+   E +      F+             +S E
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSE 235
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGA------APLERTILAPEPSDV 388
            +  IR CL   P +RPT  E+ +HP+++        A +    L+P PS V
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKV 287

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 116/255 (45%), Gaps = 15/255 (5%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G+ +G G FG V+ G             +    +  S    ++ +QE + + +  HP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           +  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+L SK  V
Sbjct: 455 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV 513
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PYWMAPEVIKNSSGCNLA 294
           HRDI   N+LV     VKL DFG+++++   +   + KG     WMAPE I N      A
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSA 572
Query: 295 VDIWSLGCTVLE--MATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            D+W  G  + E  M   KP    ++GV     + +I N + LP +P +        +  
Sbjct: 573 SDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLMTK 627
Query: 350 CLQRNPLNRPTAAEL 364
           C   +P  RP   EL
Sbjct: 628 CWAYDPSRRPRFTEL 642

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 10/254 (3%)
Query: 121 LGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G+FG V  G +++ SG+  ++    L  D  S+ E+    ++E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG   +   + +  E    GS+   L+ + G F    +  Y  Q+  G+ +L SK  +H
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI---AGQSCPLSFKGSPY-WMAPEVIKNSSGCNL 293
           RD+   N+L+     VK+ DFG+ + +            +  P+ W APE +K  +  + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 193
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A D W  G T+ EM T  + PW    G   + KI    E    P+D   +  + +  C  
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 253
Query: 353 RNPLNRPTAAELLD 366
             P +RPT   L D
Sbjct: 254 HKPEDRPTFVALRD 267

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 105 MENPVSPE-SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ 163
           +E P   E S ++K   +G+GTFG V+   +  +G+  A+K+V L ++ K       L +
Sbjct: 9   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL-R 66
Query: 164 EIVLLSRLRHPNIVQ-----------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG 212
           EI +L  L+H N+V            Y   K     ++ + E+   G +  +L    +F 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFT 123
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK--HIAGQSCP 270
              I+   Q +L+GL ++H    +HRD+K AN+L+  +G +KLADFG+A+   +A  S P
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 271 LSFKG---SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
             +     + ++  PE++         +D+W  GC + EM T  P
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 7/214 (3%)
Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAM-KEVTLFDDAKSKESAK 159
           +P + +  +  E+  K+ K+LG G FG VY G     GE   +   + + ++    ++  
Sbjct: 3   APNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 62
Query: 160 QLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRN 218
           + M E ++++ + HP++V+  G   +   + +  + +  G + + + ++    G   + N
Sbjct: 63  EFMDEALIMASMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN 121
Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
           +  QI  G+ +L  +  VHRD+   N+LV     VK+ DFG+A+ + G     +  G   
Sbjct: 122 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 181
Query: 279 ---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT 309
              WMA E I      + + D+WS G T+ E+ T
Sbjct: 182 PIKWMALECIHYRKFTHQS-DVWSYGVTIWELMT 214

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 107/200 (53%), Gaps = 22/200 (11%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 178 -QYYGSKTVEDKLYIYL-EYVSGGSI------YKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             +  ++++E+   +YL  ++ G  +       KL  D+ QF          QIL GL +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 140
Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           +HS   +HRD+K +N+ V+ +  +K+ D G+A+H   +     +  + ++ APE++ N  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT--GYVATRWYRAPEIMLNWM 198
Query: 290 GCNLAVDIWSLGCTVLEMAT 309
             N  VDIWS+GC + E+ T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 27/294 (9%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE       ++  + + G   E   R++  Q+L  
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 127
Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 186
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDE 342
           +       +  +WSLG  + +M     P+   E +      F+             +S E
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSE 235
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGA------APLERTILAPEPSDVPP 390
            +  IR CL   P +RPT  E+ +HP+++        A +    L+P PS   P
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGP 289

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 105 MENPVSPE-SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ 163
           +E P   E S ++K   +G+GTFG V+   +  +G+  A+K+V L ++ K       L +
Sbjct: 9   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL-R 66
Query: 164 EIVLLSRLRHPNIVQ-----------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG 212
           EI +L  L+H N+V            Y   K     ++ + E+   G +  +L    +F 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFT 123
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK--HIAGQSCP 270
              I+   Q +L+GL ++H    +HRD+K AN+L+  +G +KLADFG+A+   +A  S P
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 271 LSFKG---SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
             +     + ++  PE++         +D+W  GC + EM T  P
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 44/287 (15%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNI 176
            ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+I
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALK--XLQDCPKAR-------REVELHWRASQCPHI 117
Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSG 226
           V+        Y G K     L I  E + GG ++  +QD G   F E       + I   
Sbjct: 118 VRIVDVYENLYAGRKC----LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEA 173
Query: 227 LAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + +LHS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 284 VI---KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPT 334
           V+   K    C    D WSLG     +    PP+    G+A         + G   E P 
Sbjct: 234 VLGPEKYDKSC----DXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQY-EFPN 288
Query: 335 IPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            P+  ++S+E K  IR  L+  P  R T  E  +HP++  +  + +T
Sbjct: 289 -PEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQT 334

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 127/277 (45%), Gaps = 31/277 (11%)
Query: 116 KKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           K+ + LG G FG V    Y     ++GE  A+K  +L  ++     A  L +EI +L  L
Sbjct: 12  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIA-DLKKEIEILRNL 68
Query: 172 RHPNIVQYYGSKTVE--DKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLA 228
            H NIV+Y G  T +  + + + +E++  GS+ + L ++  +        Y  QI  G+ 
Sbjct: 69  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 128
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSP-YWMAPEV 284
           +L S+  VHRD+   N+LV+   +VK+ DFG+ K I       + K    SP +W APE 
Sbjct: 129 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMAT---------------TKPPWSQYEGVAAMFKIGNS 329
           +  S    +A D+WS G T+ E+ T                 P   Q      +  +   
Sbjct: 189 LMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 247
Query: 330 KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           K LP  P +  DE    +R C +  P NR +   L++
Sbjct: 248 KRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 123/273 (45%), Gaps = 17/273 (6%)
Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           M  P      ++ G++LG G    V++  +       A+K V   D A+      +  +E
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRRE 62
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKL----YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
               + L HP IV  Y +   E       YI +EYV G ++  ++   G           
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA--GQSC--PLSFKGS 276
                 L F H    +HRD+K ANI++     VK+ DFG+A+ IA  G S     +  G+
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP 336
             +++PE  +  S  +   D++SLGC + E+ T +PP++     +  ++  + +E P  P
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQ--HVREDPIPP 239
Query: 337 ----DDLSDEGKDFIRLCLQRNPLNR-PTAAEL 364
               + LS +    +   L +NP NR  TAAE+
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 123/290 (42%), Gaps = 27/290 (9%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 30  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 89
Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE       ++  + + G   E   R++  Q+L  
Sbjct: 90  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 149
Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 150 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 208
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDE 342
           +       +  +WSLG  + +M     P+   E +      F+             +S E
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSXE 257
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGA------APLERTILAPEPS 386
            +  IR CL   P +RPT  E+ +HP+++        A +    L+P PS
Sbjct: 258 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 307

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 126/258 (48%), Gaps = 15/258 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ-EIVLLSRLRHPNIVQY 179
           LGRG FG V+    + S +    K V      K K + + L++ EI +L+  RH NI+  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFV------KVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
           + S    ++L +  E++SG  I++ +     +  E  I +Y  Q+   L FLHS +  H 
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 239 DIKGANILVDP--NGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           DI+  NI+     +  +K+ +FG A+ +  G +  L F    Y+ APEV ++    + A 
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY-APEVHQHDV-VSTAT 184
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--PTIPDDLSDEGKDFIRLCLQR 353
           D+WSLG  V  + +   P+        +  I N++         ++S E  DF+   L +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244
Query: 354 NPLNRPTAAELLDHPFVK 371
              +R TA+E L HP++K
Sbjct: 245 ERKSRMTASEALQHPWLK 262

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 26/210 (12%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEV-TLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           + +G G +G V       +G+  A+K++   FD   +   AK+ ++E+ +L   +H NI+
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN---AKRTLRELKILKHFKHDNII 117
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQ----DYGQFGEPA-------IRNYTQQILSG 226
                  ++D L   + Y    S+Y +L     D  Q    +       +R +  Q+L G
Sbjct: 118 ------AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 171
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-----QSCPLSFKGSPYWMA 281
           L ++HS   +HRD+K +N+LV+ N  +K+ DFGMA+ +       Q     +  + ++ A
Sbjct: 172 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 282 PEVIKNSSGCNLAVDIWSLGCTVLEMATTK 311
           PE++ +      A+D+WS+GC   EM   +
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 111 PESHWKKGKMLGRGTFGHV-----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           P +    GK LG G FG V     Y    SD+    A+K +        +E+   LM E+
Sbjct: 44  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA---LMSEL 100
Query: 166 VLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-----YGQFGEPAI--- 216
            +LS L  H NIV   G+ T+     +  EY   G +   L+            PAI   
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 160
Query: 217 ----------RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG 266
                      +++ Q+  G+AFL SK+ +HRD+   NIL+      K+ DFG+A+HI  
Sbjct: 161 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKN 220
Query: 267 QSCPLSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-- 320
            S     KG+      WMAPE I N        D+WS G  + E+ +     S Y G+  
Sbjct: 221 DS-NYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGS--SPYPGMPV 276
Query: 321 -AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
            +  +K+         P+    E  D ++ C   +PL RPT  +++
Sbjct: 277 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 116/269 (43%), Gaps = 21/269 (7%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE       ++  + + G   E   R++  Q+L  
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 127
Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 186
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDE 342
           +       +  +WSLG  + +M     P+   E +      F+             +S E
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSE 235
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            +  IR CL   P +RPT  E+ +HP+++
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 116/269 (43%), Gaps = 21/269 (7%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE       ++  + + G   E   R++  Q+L  
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 123 VRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 181
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDE 342
           +       +  +WSLG  + +M     P+   E +      F+             +S E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSXE 230
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            +  IR CL   P +RPT  E+ +HP+++
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 105 MENPVSPE-SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ 163
           +E P   E S ++K   +G+GTFG V+   +  +G+  A+K+V L ++ K       L +
Sbjct: 8   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL-R 65
Query: 164 EIVLLSRLRHPNIVQ-----------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG 212
           EI +L  L+H N+V            Y   K     ++ + E+   G +  +L    +F 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFT 122
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK--HIAGQSCP 270
              I+   Q +L+GL ++H    +HRD+K AN+L+  +G +KLADFG+A+   +A  S P
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 271 LSFKG---SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
             +     + ++  PE++         +D+W  GC + EM T  P
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 105 MENPVSPE-SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ 163
           +E P   E S ++K   +G+GTFG V+   +  +G+  A+K+V L ++ K       L +
Sbjct: 9   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL-R 66
Query: 164 EIVLLSRLRHPNIVQ-----------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG 212
           EI +L  L+H N+V            Y   K     ++ + E+   G +  +L    +F 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFT 123
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK--HIAGQSCP 270
              I+   Q +L+GL ++H    +HRD+K AN+L+  +G +KLADFG+A+   +A  S P
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 271 LSFKG---SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
             +     + ++  PE++         +D+W  GC + EM T  P
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 116/266 (43%), Gaps = 15/266 (5%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE       ++  + + G   E   R++  Q+L  
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 181
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
           +       +  +WSLG  + +M     P+   E +     IG           +S E + 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---FFRQRVSSECQH 233
Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVK 371
            IR CL   P +RPT  E+ +HP+++
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 26/210 (12%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEV-TLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           + +G G +G V       +G+  A+K++   FD   +   AK+ ++E+ +L   +H NI+
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN---AKRTLRELKILKHFKHDNII 116
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQ----DYGQFGEPA-------IRNYTQQILSG 226
                  ++D L   + Y    S+Y +L     D  Q    +       +R +  Q+L G
Sbjct: 117 ------AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 170
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-----QSCPLSFKGSPYWMA 281
           L ++HS   +HRD+K +N+LV+ N  +K+ DFGMA+ +       Q     +  + ++ A
Sbjct: 171 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 282 PEVIKNSSGCNLAVDIWSLGCTVLEMATTK 311
           PE++ +      A+D+WS+GC   EM   +
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 116/269 (43%), Gaps = 21/269 (7%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE       ++  + + G   E   R++  Q+L  
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 181
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDE 342
           +       +  +WSLG  + +M     P+   E +      F+             +S E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSE 230
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            +  IR CL   P +RPT  E+ +HP+++
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 116/269 (43%), Gaps = 21/269 (7%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 6   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 65
Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVS-GGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE       ++  + + G   E   R++  Q+L  
Sbjct: 66  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 125
Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 126 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 184
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDE 342
           +       +  +WSLG  + +M     P+   E +      F+             +S E
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSE 233
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            +  IR CL   P +RPT  E+ +HP+++
Sbjct: 234 CQHLIRWCLALRPSDRPTFEEIQNHPWMQ 262

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 91/316 (28%), Positives = 144/316 (45%), Gaps = 65/316 (20%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-FDDAKSK 155
           ++P     ++N V  E      K+LG G+ G V V   S  G   A+K + + F D    
Sbjct: 5   NIPNFEQSLKNLVVSE------KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDI--- 54
Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA 215
                LM+  +L     HPN+++YY S+T +  LYI LE  +       LQD  +    +
Sbjct: 55  ----ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVS 105
Query: 216 IRNYT-----------QQILSGLAFLHSKHTVHRDIKGANILVD-------------PNG 251
             N             +QI SG+A LHS   +HRD+K  NILV               N 
Sbjct: 106 DENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165
Query: 252 RVKLADFGMAKHI-AGQSCPLSFK-------GSPYWMAPEVIKNSSGCNL------AVDI 297
           R+ ++DFG+ K + +GQ     F+       G+  W APE+++ S+          ++DI
Sbjct: 166 RILISDFGLCKKLDSGQX---XFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222
Query: 298 WSLGCTVLEMATT-KPPW-SQYEGVAAMFK-IGNSKELPTIPD-DLSDEGKDFIRLCLQR 353
           +S+GC    + +  K P+  +Y   + + + I +  E+  + D  L  E  D I   +  
Sbjct: 223 FSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282
Query: 354 NPLNRPTAAELLDHPF 369
           +PL RPTA ++L HP 
Sbjct: 283 DPLKRPTAMKVLRHPL 298

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 119/236 (50%), Gaps = 19/236 (8%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDA 152
           S+  +P +    +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A
Sbjct: 2   SMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EA 58
Query: 153 KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQF 211
            S ++ K+++ E  +++ + +P++ +  G   +   + + ++ +  G +   ++++    
Sbjct: 59  TSPKANKEILDEAYVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNI 117
Query: 212 GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
           G   + N+  QI  G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +    
Sbjct: 118 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 272 SFKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
             +G      WMA E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 228

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 59/291 (20%)
Query: 137 SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYV 196
           +GE   ++ + L  +A S E    L  E+ +     HPNIV Y  +   +++L++   ++
Sbjct: 35  TGEYVTVRRINL--EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 92
Query: 197 SGGSIYKLLQDYGQFG--EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVK 254
           + GS   L+  +   G  E AI    Q +L  L ++H    VHR +K ++IL+  +G+V 
Sbjct: 93  AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 152
Query: 255 L----ADFGMAKHIAGQSCPLSF-----KGSPYWMAPEVI-KNSSGCNLAVDIWSLGCTV 304
           L    ++  M  H   Q     F     K  P W++PEV+ +N  G +   DI+S+G T 
Sbjct: 153 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITA 211
Query: 305 LEMATTKPPWSQYEGVAAMFKIGNSK-----ELPTIPDD--------------LSD---- 341
            E+A    P+        + +  N       +  TIP +              LSD    
Sbjct: 212 CELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT 271
Query: 342 ---------------------EGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                                    F+  CLQRNP  RP+A+ LL+H F K
Sbjct: 272 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 322

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 59/291 (20%)
Query: 137 SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYV 196
           +GE   ++ + L  +A S E    L  E+ +     HPNIV Y  +   +++L++   ++
Sbjct: 51  TGEYVTVRRINL--EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108
Query: 197 SGGSIYKLLQDYGQFG--EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVK 254
           + GS   L+  +   G  E AI    Q +L  L ++H    VHR +K ++IL+  +G+V 
Sbjct: 109 AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 168
Query: 255 L----ADFGMAKHIAGQSCPLSF-----KGSPYWMAPEVI-KNSSGCNLAVDIWSLGCTV 304
           L    ++  M  H   Q     F     K  P W++PEV+ +N  G +   DI+S+G T 
Sbjct: 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITA 227
Query: 305 LEMATTKPPWSQYEGVAAMFKIGNSK-----ELPTIPDD--------------LSD---- 341
            E+A    P+        + +  N       +  TIP +              LSD    
Sbjct: 228 CELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT 287
Query: 342 ---------------------EGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                                    F+  CLQRNP  RP+A+ LL+H F K
Sbjct: 288 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           G+ +GRG FG V+ G       + A+K    TL  D K+K      +QE  +L +  HPN
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPN 173
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI---LSGLAFLHS 232
           IV+  G  T +  +YI +E V GG     L+  G      ++   Q +    +G+ +L S
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLES 231
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPY-WMAPEVIKNSS 289
           K  +HRD+   N LV     +K++DFGM++  A      S   +  P  W APE + N  
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEAL-NYG 290
Query: 290 GCNLAVDIWSLGCTVLE 306
             +   D+WS G  + E
Sbjct: 291 RYSSESDVWSFGILLWE 307

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           G+ +GRG FG V+ G       + A+K    TL  D K+K      +QE  +L +  HPN
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPN 173
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI---LSGLAFLHS 232
           IV+  G  T +  +YI +E V GG     L+  G      ++   Q +    +G+ +L S
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLES 231
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPY-WMAPEVIKNSS 289
           K  +HRD+   N LV     +K++DFGM++  A      S   +  P  W APE + N  
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL-NYG 290
Query: 290 GCNLAVDIWSLGCTVLE 306
             +   D+WS G  + E
Sbjct: 291 RYSSESDVWSFGILLWE 307

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 71
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + + ++ +  G +   ++++    G   + N+  QI
Sbjct: 72  AYVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 131 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 191 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 229

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 69
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + + ++ +  G +   ++++    G   + N+  QI
Sbjct: 70  AYVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 189 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 227

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           G   G G FG VY G+ +++    A+K++    D  ++E  +Q  QEI + ++ +H N+V
Sbjct: 27  GNKXGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLV 84
Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR-----NYTQQILSGLAFLHS 232
           +  G  +  D L +   Y   GS+   L      G P +         Q   +G+ FLH 
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD--GTPPLSWHXRCKIAQGAANGINFLHE 142
Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSFKGSPYWMAPEVIKNSS 289
            H +HRDIK ANIL+D     K++DFG+A+     A         G+  + APE ++   
Sbjct: 143 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE- 201
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQY 317
                 DI+S G  +LE+ T  P   ++
Sbjct: 202 -ITPKSDIYSFGVVLLEIITGLPAVDEH 228

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 68
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + + ++ +  G +   ++++    G   + N+  QI
Sbjct: 69  AYVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 128 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 188 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 226

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 68
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + + ++ +  G +   ++++    G   + N+  QI
Sbjct: 69  AYVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 128 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 188 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 226

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 67
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + + ++ +  G +   ++++    G   + N+  QI
Sbjct: 68  AYVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 187 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNI 176
           K +G G    V+   N +  ++ A+K V L  +    ++      EI  L++L+     I
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y  +  +  +Y+ +E      +   L+          ++Y + +L  +  +H    V
Sbjct: 119 IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCN- 292
           H D+K AN L+  +G +KL DFG+A  +   +  +   S  G+  +M PE IK+ S    
Sbjct: 178 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 236
Query: 293 ---------LAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKELPTIPD-D 338
                       D+WSLGC +  M   K P+    +Q   + A+    +  E P IP+ D
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           L    +D ++ CL+R+P  R +  ELL HP+V+
Sbjct: 297 L----QDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 27/272 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNI 176
           K +G G    V+   N +  ++ A+K V L  +    ++      EI  L++L+     I
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y  +  +  +Y+ +E      +   L+          ++Y + +L  +  +H    V
Sbjct: 119 IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCN- 292
           H D+K AN L+  +G +KL DFG+A  +   +  +   S  G+  +M PE IK+ S    
Sbjct: 178 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 236
Query: 293 ---------LAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKELPTIPDDL 339
                       D+WSLGC +  M   K P+    +Q   + A+    +  E P IP+  
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK- 295
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             + +D ++ CL+R+P  R +  ELL HP+V+
Sbjct: 296 --DLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNI 176
           K +G G    V+   N +  ++ A+K V L  +    ++      EI  L++L+     I
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y  +  +  +Y+ +E      +   L+          ++Y + +L  +  +H    V
Sbjct: 119 IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCN- 292
           H D+K AN L+  +G +KL DFG+A  +   +  +   S  G+  +M PE IK+ S    
Sbjct: 178 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 293 ---------LAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKELPTIPD-D 338
                       D+WSLGC +  M   K P+    +Q   + A+    +  E P IP+ D
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           L    +D ++ CL+R+P  R +  ELL HP+V+
Sbjct: 297 L----QDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 40/273 (14%)
Query: 121 LGRGTFGHVYVG-----FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ-EIVLLSRLRHP 174
           LG G FG V++             + A+K +      ++ ESA+Q  Q E  LL+ L+H 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQ 103
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ---------------FGEPAIRNY 219
           +IV+++G  T    L +  EY+  G + + L+ +G                 G   +   
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLS 272
             Q+ +G+ +L   H VHRD+   N LV     VK+ DFGM++ I        G    L 
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKE 331
            +    WM PE I        + D+WS G  + E+ T  K PW Q     A+  I   +E
Sbjct: 224 IR----WMPPESILYRKFTTES-DVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 278
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
           L   P     E    +R C QR P  R +  ++
Sbjct: 279 LER-PRACPPEVYAIMRGCWQREPQQRHSIKDV 310

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 127/281 (45%), Gaps = 29/281 (10%)
Query: 117 KGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           + K++G G FG VY G   + SG+      +       +++     + E  ++ +  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKH 234
           I++  G  +    + I  EY+  G++ K L++  G+F    +    + I +G+ +L + +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI----------AGQSCPLSFKGSPYWMAPEV 284
            VHRD+   NILV+ N   K++DFG+++ +          +G   P+       W APE 
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR------WTAPEA 221
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
           I      + A D+WS G  + E+ T  + P+ +      M  I +   LPT P D     
Sbjct: 222 ISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDCPSAI 279
Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPE 384
              +  C Q+    RP  A+++        + L++ I AP+
Sbjct: 280 YQLMMQCWQQERARRPKFADIV--------SILDKLIRAPD 312

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 109 VSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           +  E H K    LG+G FG V    Y     ++G + A+K++         +  +   +E
Sbjct: 6   IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQRE 61
Query: 165 IVLLSRLRHPNIVQYYGSKTV--EDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQ 221
           I +L  L    IV+Y G         L + +EY+  G +   LQ +  +     +  Y+ 
Sbjct: 62  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 121
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCP 270
           QI  G+ +L S+  VHRD+   NILV+    VK+ADFG+AK +            GQS P
Sbjct: 122 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-P 180
Query: 271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
           +      +W APE + ++     + D+WS G  + E+ T     S       +  +G+ +
Sbjct: 181 I------FWYAPESLSDNIFSRQS-DVWSFGVVLYELFTYCDK-SCSPSAEFLRMMGSER 232
Query: 331 ELPTI---------------PDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
           ++P +               P     E  + ++LC   +P +RP+ + L
Sbjct: 233 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 118/236 (50%), Gaps = 19/236 (8%)
Query: 97  SVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDA 152
           S+  +P +    +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A
Sbjct: 2   SMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EA 58
Query: 153 KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQF 211
            S ++ K+++ E  +++ + +P++ +  G   +   + +  + +  G +   ++++    
Sbjct: 59  TSPKANKEILDEAYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNI 117
Query: 212 GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
           G   + N+  QI  G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +    
Sbjct: 118 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 272 SFKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
             +G      WMA E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 228

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 27/272 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNI 176
           K +G G    V+   N +  ++ A+K V L  +    ++      EI  L++L+     I
Sbjct: 18  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKI 74
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y  +  +  +Y+ +E      +   L+          ++Y + +L  +  +H    V
Sbjct: 75  IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 133
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCN- 292
           H D+K AN L+  +G +KL DFG+A  +   +  +   S  G+  +M PE IK+ S    
Sbjct: 134 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 192
Query: 293 ---------LAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKELPTIPDDL 339
                       D+WSLGC +  M   K P+    +Q   + A+    +  E P IP+  
Sbjct: 193 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK- 251
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             + +D ++ CL+R+P  R +  ELL HP+V+
Sbjct: 252 --DLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 28/217 (12%)
Query: 117 KGKMLGRGTFGHVYVGFNSDSGEM--CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +G  +GRGT+GHVY     D  +    A+K++      +    +    +EI LL  L+HP
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI------EGTGISMSACREIALLRELKHP 78
Query: 175 NIV--QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG---------QFGEPAIRNYTQQI 223
           N++  Q       + K+++  +Y     ++ +++ +          Q     +++   QI
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 224 LSGLAFLHSKHTVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLS----FKG 275
           L G+ +LH+   +HRD+K ANILV       GRVK+AD G A+       PL+       
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
           + ++ APE++  +     A+DIW++GC   E+ T++P
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 27/272 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNI 176
           K +G G    V+   N +  ++ A+K V L  +    ++      EI  L++L+     I
Sbjct: 34  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y  +  +  +Y+ +E      +   L+          ++Y + +L  +  +H    V
Sbjct: 91  IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCN- 292
           H D+K AN L+  +G +KL DFG+A  +   +  +   S  G+  +M PE IK+ S    
Sbjct: 150 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 293 ---------LAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKELPTIPDDL 339
                       D+WSLGC +  M   K P+    +Q   + A+    +  E P IP+  
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK- 267
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             + +D ++ CL+R+P  R +  ELL HP+V+
Sbjct: 268 --DLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 109 VSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           +  E H K    LG+G FG V    Y     ++G + A+K++         +  +   +E
Sbjct: 7   IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQRE 62
Query: 165 IVLLSRLRHPNIVQYYGSKTV--EDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQ 221
           I +L  L    IV+Y G         L + +EY+  G +   LQ +  +     +  Y+ 
Sbjct: 63  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 122
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCP 270
           QI  G+ +L S+  VHRD+   NILV+    VK+ADFG+AK +            GQS P
Sbjct: 123 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-P 181
Query: 271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
           +      +W APE + ++     + D+WS G  + E+ T     S       +  +G  +
Sbjct: 182 I------FWYAPESLSDNIFSRQS-DVWSFGVVLYELFTYCDK-SCSPSAEFLRMMGCER 233
Query: 331 ELPTI---------------PDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
           ++P +               P     E  + ++LC   +P +RP+ + L
Sbjct: 234 DVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 122/286 (42%), Gaps = 38/286 (13%)
Query: 111 PESHWKKGKMLGRGTFGHV-----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           P +    GK LG G FG V     Y    SD+    A+K +        +E+   LM E+
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA---LMSEL 77
Query: 166 VLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-----YGQFGEPAI--- 216
            +LS L  H NIV   G+ T+     +  EY   G +   L+            PAI   
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 217 ----------RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG 266
                      +++ Q+  G+AFL SK+ +HRD+   NIL+      K+ DFG+A+ I  
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 267 QSCPLSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-- 320
            S     KG+      WMAPE I N        D+WS G  + E+ +     S Y G+  
Sbjct: 198 DS-NYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGS--SPYPGMPV 253
Query: 321 -AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
            +  +K+         P+    E  D ++ C   +PL RPT  +++
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 70
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 71  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 190 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 228

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 122/286 (42%), Gaps = 38/286 (13%)
Query: 111 PESHWKKGKMLGRGTFGHV-----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           P +    GK LG G FG V     Y    SD+    A+K +        +E+   LM E+
Sbjct: 37  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA---LMSEL 93
Query: 166 VLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-----YGQFGEPAI--- 216
            +LS L  H NIV   G+ T+     +  EY   G +   L+            PAI   
Sbjct: 94  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 153
Query: 217 ----------RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG 266
                      +++ Q+  G+AFL SK+ +HRD+   NIL+      K+ DFG+A+ I  
Sbjct: 154 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 213
Query: 267 QSCPLSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-- 320
            S     KG+      WMAPE I N        D+WS G  + E+ +     S Y G+  
Sbjct: 214 DS-NYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGS--SPYPGMPV 269
Query: 321 -AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
            +  +K+         P+    E  D ++ C   +PL RPT  +++
Sbjct: 270 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 315

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 69
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 70  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 189 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 227

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 27/272 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNI 176
           K +G G    V+   N +  ++ A+K V L  +    ++      EI  L++L+     I
Sbjct: 15  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y  +  +  +Y+ +E      +   L+          ++Y + +L  +  +H    V
Sbjct: 72  IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCN- 292
           H D+K AN L+  +G +KL DFG+A  +   +  +   S  G+  +M PE IK+ S    
Sbjct: 131 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 293 ---------LAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKELPTIPDDL 339
                       D+WSLGC +  M   K P+    +Q   + A+    +  E P IP+  
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK- 248
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             + +D ++ CL+R+P  R +  ELL HP+V+
Sbjct: 249 --DLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 40/273 (14%)
Query: 121 LGRGTFGHVYVG-----FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ-EIVLLSRLRHP 174
           LG G FG V++             + A+K +      ++ ESA+Q  Q E  LL+ L+H 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQ 80
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ---------------FGEPAIRNY 219
           +IV+++G  T    L +  EY+  G + + L+ +G                 G   +   
Sbjct: 81  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLS 272
             Q+ +G+ +L   H VHRD+   N LV     VK+ DFGM++ I        G    L 
Sbjct: 141 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 200
Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKE 331
            +    WM PE I        + D+WS G  + E+ T  K PW Q     A+  I   +E
Sbjct: 201 IR----WMPPESILYRKFTTES-DVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 255
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
           L   P     E    +R C QR P  R +  ++
Sbjct: 256 LER-PRACPPEVYAIMRGCWQREPQQRHSIKDV 287

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 40/273 (14%)
Query: 121 LGRGTFGHVYVG-----FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ-EIVLLSRLRHP 174
           LG G FG V++             + A+K +      ++ ESA+Q  Q E  LL+ L+H 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQ 74
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ---------------FGEPAIRNY 219
           +IV+++G  T    L +  EY+  G + + L+ +G                 G   +   
Sbjct: 75  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLS 272
             Q+ +G+ +L   H VHRD+   N LV     VK+ DFGM++ I        G    L 
Sbjct: 135 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 194
Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKE 331
            +    WM PE I        + D+WS G  + E+ T  K PW Q     A+  I   +E
Sbjct: 195 IR----WMPPESILYRKFTTES-DVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 249
Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
           L   P     E    +R C QR P  R +  ++
Sbjct: 250 LER-PRACPPEVYAIMRGCWQREPQQRHSIKDV 281

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 69
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + + ++ +  G +   ++++    G   + N+  QI
Sbjct: 70  AYVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WM
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 189 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 227

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 32/282 (11%)
Query: 109 VSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           +  E H K    LG+G FG V    Y     ++G + A+K++         +  +   +E
Sbjct: 3   IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQRE 58
Query: 165 IVLLSRLRHPNIVQYYGSKTV--EDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQ 221
           I +L  L    IV+Y G        +L + +EY+  G +   LQ +  +     +  Y+ 
Sbjct: 59  IQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 118
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSP- 277
           QI  G+ +L S+  VHRD+   NILV+    VK+ADFG+AK +         +    SP 
Sbjct: 119 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI-- 335
           +W APE + ++     + D+WS G  + E+ T     S       +  +G  +++P +  
Sbjct: 179 FWYAPESLSDNIFSRQS-DVWSFGVVLYELFTYCDK-SCSPSAEFLRMMGCERDVPALCR 236
Query: 336 -------------PDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
                        P     E  + ++LC   +P +RP+ + L
Sbjct: 237 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 70
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 71  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 190 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 228

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 36  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 92
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 93  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 151
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 152 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 212 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 250

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 17  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 73
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 74  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 132
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 133 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 193 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 231

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 21  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 77
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 78  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 136
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 137 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 197 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 235

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 69
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + + ++ +  G +   ++++    G   + N+  QI
Sbjct: 70  AYVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WM
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 189 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 227

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 27/272 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNI 176
           K +G G    V+   N +  ++ A+K V L  +    ++      EI  L++L+     I
Sbjct: 14  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKI 70
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y  +  +  +Y+ +E      +   L+          ++Y + +L  +  +H    V
Sbjct: 71  IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 129
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCN- 292
           H D+K AN L+  +G +KL DFG+A  +   +  +   S  G+  +M PE IK+ S    
Sbjct: 130 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 188
Query: 293 ---------LAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKELPTIPDDL 339
                       D+WSLGC +  M   K P+    +Q   + A+    +  E P IP+  
Sbjct: 189 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK- 247
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             + +D ++ CL+R+P  R +  ELL HP+V+
Sbjct: 248 --DLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 67
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 68  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 187 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 71
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + + ++ +  G +   ++++    G   + N+  QI
Sbjct: 72  AYVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WM
Sbjct: 131 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 191 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 229

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 122/286 (42%), Gaps = 38/286 (13%)
Query: 111 PESHWKKGKMLGRGTFGHV-----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           P +    GK LG G FG V     Y    SD+    A+K +        +E+   LM E+
Sbjct: 44  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA---LMSEL 100
Query: 166 VLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-----YGQFGEPAI--- 216
            +LS L  H NIV   G+ T+     +  EY   G +   L+            PAI   
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 160
Query: 217 ----------RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG 266
                      +++ Q+  G+AFL SK+ +HRD+   NIL+      K+ DFG+A+ I  
Sbjct: 161 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 220
Query: 267 QSCPLSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-- 320
            S     KG+      WMAPE I N        D+WS G  + E+ +     S Y G+  
Sbjct: 221 DS-NYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGS--SPYPGMPV 276
Query: 321 -AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
            +  +K+         P+    E  D ++ C   +PL RPT  +++
Sbjct: 277 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 74
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 75  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 194 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 232

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 67
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 68  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 187 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 13/221 (5%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-FDDAKSKESAKQLMQEIVL 167
           +  E+ +KK K+LG G FG VY G     GE   +    +   +A S ++ K+++ E  +
Sbjct: 45  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYV 104
Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSG 226
           ++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI  G
Sbjct: 105 MASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 163
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPE 283
           + +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E
Sbjct: 164 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
            I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 224 SILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 259

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 109 VSPESHWKKGKMLGRGTFGHV----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           +  E H K    LG+G FG V    Y     ++G + A+K++         +  +   +E
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQRDFQRE 74
Query: 165 IVLLSRLRHPNIVQYYGSKTV--EDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQ 221
           I +L  L    IV+Y G         L + +EY+  G +   LQ +  +     +  Y+ 
Sbjct: 75  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 134
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCP 270
           QI  G+ +L S+  VHRD+   NILV+    VK+ADFG+AK +            GQS P
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-P 193
Query: 271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
           +      +W APE + ++     + D+WS G  + E+ T     S       +  +G  +
Sbjct: 194 I------FWYAPESLSDNIFSRQS-DVWSFGVVLYELFTYCDK-SCSPSAEFLRMMGCER 245
Query: 331 ELPTI---------------PDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
           ++P +               P     E  + ++LC   +P +RP+ + L
Sbjct: 246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 116/256 (45%), Gaps = 15/256 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMK----EVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           LG G FG V+   + +  +   +K    E  L D         ++  EI +LSR+ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 177 VQYYGSKTVEDKLYIYLE-YVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           ++       +    + +E + SG  ++  +  + +  EP      +Q++S + +L  K  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           +HRDIK  NI++  +  +KL DFG A ++       +F G+  + APEV+  +      +
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPEL 211
Query: 296 DIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL-SDEGKDFIRLCLQRN 354
           ++WSLG T+  +   + P+ + E          + E    P  L S E    +   LQ  
Sbjct: 212 EMWSLGVTLYTLVFEENPFCELE---------ETVEAAIHPPYLVSKELMSLVSGLLQPV 262
Query: 355 PLNRPTAAELLDHPFV 370
           P  R T  +L+  P+V
Sbjct: 263 PERRTTLEKLVTDPWV 278

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 122/286 (42%), Gaps = 38/286 (13%)
Query: 111 PESHWKKGKMLGRGTFGHV-----YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           P +    GK LG G FG V     Y    SD+    A+K +        +E+   LM E+
Sbjct: 39  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA---LMSEL 95
Query: 166 VLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-----YGQFGEPAI--- 216
            +LS L  H NIV   G+ T+     +  EY   G +   L+            PAI   
Sbjct: 96  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 155
Query: 217 ----------RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG 266
                      +++ Q+  G+AFL SK+ +HRD+   NIL+      K+ DFG+A+ I  
Sbjct: 156 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 215
Query: 267 QSCPLSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-- 320
            S     KG+      WMAPE I N        D+WS G  + E+ +     S Y G+  
Sbjct: 216 DS-NYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGS--SPYPGMPV 271
Query: 321 -AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
            +  +K+         P+    E  D ++ C   +PL RPT  +++
Sbjct: 272 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 317

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 8   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 64
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 65  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 123
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 124 AEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 184 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 129/265 (48%), Gaps = 13/265 (4%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++   +  A+K+++     +S   A++  +E+ LL  L+H N++   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 178 -QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
             +  + ++ED   +YL     G+    +       +  ++    Q+L GL ++HS   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRD+K +N+ V+ +  +++ DFG+A+    +     +  + ++ APE++ N    N  VD
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLARQADEEMT--GYVATRWYRAPEIMLNWMHYNQTVD 211
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           IWS+GC + E+   K  +   + +  + +I      P+ P+ L+    +  R  +Q  P 
Sbjct: 212 IWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISSEHARTYIQSLP- 269
Query: 357 NRPTAAELLDHPFVKGAAPLERTIL 381
             P   + L   F +GA PL   +L
Sbjct: 270 --PMPQKDLSSIF-RGANPLAIDLL 291

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 18/266 (6%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD---DAKSKESAKQLMQE 164
           P   ++  +  K +G+G FG V+ G       + A+K + L D   + +  E  ++  +E
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR-NYTQQI 223
           + ++S L HPNIV+ YG   + +   + +E+V  G +Y  L D     + +++      I
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 224 LSGLAFLHSKH--TVHRDIKGANIL---VDPNGRV--KLADFGMAKHIAGQSCPLSFKGS 276
             G+ ++ +++   VHRD++  NI    +D N  V  K+ADFG+++        L   G+
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL--GN 189
Query: 277 PYWMAPEVI-KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE--GVAAMFKIGNSKELP 333
             WMAPE I           D +S    +  + T + P+ +Y    +  +  I      P
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 334 TIPDDLSDEGKDFIRLCLQRNPLNRP 359
           TIP+D     ++ I LC   +P  RP
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRP 275

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 129/265 (48%), Gaps = 13/265 (4%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++   +  A+K+++     +S   A++  +E+ LL  L+H N++   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 178 -QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
             +  + ++ED   +YL     G+    +       +  ++    Q+L GL ++HS   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRD+K +N+ V+ +  +++ DFG+A+    +     +  + ++ APE++ N    N  VD
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLARQADEEMT--GYVATRWYRAPEIMLNWMHYNQTVD 211
Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           IWS+GC + E+   K  +   + +  + +I      P+ P+ L+    +  R  +Q  P 
Sbjct: 212 IWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISSEHARTYIQSLP- 269
Query: 357 NRPTAAELLDHPFVKGAAPLERTIL 381
             P   + L   F +GA PL   +L
Sbjct: 270 --PMPQKDLSSIF-RGANPLAIDLL 291

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 39/268 (14%)
Query: 118 GKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
            ++LG G FG VY G + +  GE   +   T   D  + ++ ++ M E V++  L HP+I
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHI 87
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN-----------YTQQILS 225
           V+  G    E+  +I +E          L  YG+ G    RN           Y+ QI  
Sbjct: 88  VKLIGI-IEEEPTWIIME----------LYPYGELGHYLERNKNSLKVLTLVLYSLQICK 136
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-----WM 280
            +A+L S + VHRDI   NILV     VKL DFG++++I  +     +K S       WM
Sbjct: 137 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWM 193
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPP--WSQYEGVAAMFKIGNSKELPTIPD 337
           +PE I N      A D+W     + E+ +  K P  W + + V  + + G+   LP  PD
Sbjct: 194 SPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD--RLPK-PD 249
Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELL 365
                    +  C   +P +RP   EL+
Sbjct: 250 LCPPVLYTLMTRCWDYDPSDRPRFTELV 277

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 61
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 62  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 181 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 219

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 67
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 68  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 187 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+L  G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 74
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + + ++ +  G +   ++++    G   + N+  QI
Sbjct: 75  AYVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 194 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 232

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 39/268 (14%)
Query: 118 GKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
            ++LG G FG VY G + +  GE   +   T   D  + ++ ++ M E V++  L HP+I
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHI 75
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN-----------YTQQILS 225
           V+  G    E+  +I +E          L  YG+ G    RN           Y+ QI  
Sbjct: 76  VKLIGI-IEEEPTWIIME----------LYPYGELGHYLERNKNSLKVLTLVLYSLQICK 124
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-----WM 280
            +A+L S + VHRDI   NILV     VKL DFG++++I  +     +K S       WM
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWM 181
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPP--WSQYEGVAAMFKIGNSKELPTIPD 337
           +PE I N      A D+W     + E+ +  K P  W + + V  + + G+   LP  PD
Sbjct: 182 SPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD--RLPK-PD 237
Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELL 365
                    +  C   +P +RP   EL+
Sbjct: 238 LCPPVLYTLMTRCWDYDPSDRPRFTELV 265

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 118/285 (41%), Gaps = 33/285 (11%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K GK LGRG FG V     F  D    C    V +  +  +    + LM E+ +L
Sbjct: 27  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 86
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD-------YGQFGEPAIRN- 218
             +  H N+V   G+ T     L + +E+   G++   L+        Y +  E   ++ 
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF 146
Query: 219 --------YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                   Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 271 LSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAA 322
           +  KG       WMAPE I +     +  D+WS G  + E+    A+  P     E    
Sbjct: 207 VR-KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 264
Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 265 RLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 39/268 (14%)
Query: 118 GKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
            ++LG G FG VY G + +  GE   +   T   D  + ++ ++ M E V++  L HP+I
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHI 71
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN-----------YTQQILS 225
           V+  G    E+  +I +E          L  YG+ G    RN           Y+ QI  
Sbjct: 72  VKLIGI-IEEEPTWIIME----------LYPYGELGHYLERNKNSLKVLTLVLYSLQICK 120
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-----WM 280
            +A+L S + VHRDI   NILV     VKL DFG++++I  +     +K S       WM
Sbjct: 121 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWM 177
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPP--WSQYEGVAAMFKIGNSKELPTIPD 337
           +PE I N      A D+W     + E+ +  K P  W + + V  + + G+   LP  PD
Sbjct: 178 SPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD--RLPK-PD 233
Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELL 365
                    +  C   +P +RP   EL+
Sbjct: 234 LCPPVLYTLMTRCWDYDPSDRPRFTELV 261

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV--- 177
           +G G +G V   +++   +  A+K+++     +S   A++  +E+ LL  L+H N++   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 178 -QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
             +  + ++ED   +YL     G+    +       +  ++    Q+L GL ++HS   +
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGII 145
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRD+K +N+ V+ +  +++ DFG+A+    +     +  + ++ APE++ N    N  VD
Sbjct: 146 HRDLKPSNVAVNEDCELRILDFGLARQADEEMT--GYVATRWYRAPEIMLNWMHYNQTVD 203
Query: 297 IWSLGCTVLEMATTK 311
           IWS+GC + E+   K
Sbjct: 204 IWSVGCIMAELLQGK 218

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 16/191 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G+G FG V +G     G   A+K +      K+  +A+  + E  ++++LRH N+VQ  
Sbjct: 20  IGKGEFGDVMLG--DYRGNKVAVKCI------KNDATAQAFLAEASVMTQLRHSNLVQLL 71
Query: 181 GSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTV 236
           G   VE+K  LYI  EY++ GS+   L+  G+   G   +  ++  +   + +L   + V
Sbjct: 72  GV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 130
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRD+   N+LV  +   K++DFG+ K     S   + K    W APE ++ ++    + D
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREAAFSTKS-D 187
Query: 297 IWSLGCTVLEM 307
           +WS G  + E+
Sbjct: 188 VWSFGILLWEI 198

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNI 176
           K +G G    V+   N +  ++ A+K V L  +    ++      EI  L++L+     I
Sbjct: 34  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y  +  +  +Y+ +E      +   L+          ++Y + +L  +  +H    V
Sbjct: 91  IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCN- 292
           H D+K AN L+  +G +KL DFG+A  +      +   S  G+  +M PE IK+ S    
Sbjct: 150 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 293 ---------LAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKELPTIPDDL 339
                       D+WSLGC +  M   K P+    +Q   + A+    +  E P IP+  
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK- 267
Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             + +D ++ CL+R+P  R +  ELL HP+V+
Sbjct: 268 --DLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 69
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 70  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WM
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 189 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 227

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 67
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 68  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WM
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 187 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 123/266 (46%), Gaps = 18/266 (6%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD---DAKSKESAKQLMQE 164
           P   ++  +  K +G+G FG V+ G       + A+K + L D   + +  E  ++  +E
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR-NYTQQI 223
           + ++S L HPNIV+ YG   + +   + +E+V  G +Y  L D     + +++      I
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 224 LSGLAFLHSKH--TVHRDIKGANIL---VDPNGRV--KLADFGMAKHIAGQSCPLSFKGS 276
             G+ ++ +++   VHRD++  NI    +D N  V  K+ADFG ++        L   G+
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLL--GN 189
Query: 277 PYWMAPEVI-KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE--GVAAMFKIGNSKELP 333
             WMAPE I           D +S    +  + T + P+ +Y    +  +  I      P
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 334 TIPDDLSDEGKDFIRLCLQRNPLNRP 359
           TIP+D     ++ I LC   +P  RP
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRP 275

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+LG G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 74
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 75  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WM
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 194 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 232

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 116/285 (40%), Gaps = 33/285 (11%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K GK LGRG FG V     F  D    C    V +  +  +    + LM E+ +L
Sbjct: 16  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD---------------YGQF 211
             +  H N+V   G+ T     L + +E+   G++   L+                Y  F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 212 -GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 271 LSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAA 322
           +  KG       WMAPE I +     +  D+WS G  + E+    A+  P     E    
Sbjct: 196 VR-KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 253
Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 254 RLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 116/285 (40%), Gaps = 33/285 (11%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K GK LGRG FG V     F  D    C    V +  +  +    + LM E+ +L
Sbjct: 25  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD---------------YGQF 211
             +  H N+V   G+ T     L + +E+   G++   L+                Y  F
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 212 -GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 271 LSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAA 322
           +  KG       WMAPE I +     +  D+WS G  + E+    A+  P     E    
Sbjct: 205 VR-KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 263 RLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 116/285 (40%), Gaps = 33/285 (11%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K GK LGRG FG V     F  D    C    V +  +  +    + LM E+ +L
Sbjct: 25  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD---------------YGQF 211
             +  H N+V   G+ T     L + +E+   G++   L+                Y  F
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 212 -GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX 204
Query: 271 LSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAA 322
           +  KG       WMAPE I +     +  D+WS G  + E+    A+  P     E    
Sbjct: 205 VR-KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 263 RLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 117/284 (41%), Gaps = 32/284 (11%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P      GK LGRG FG V     F  D    C    V +  +  +    + LM E+ +L
Sbjct: 26  PRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 85
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSI-------------YKLLQD-YGQF- 211
             +  H N+V   G+ T     L + +E+   G++             YK  +D Y  F 
Sbjct: 86  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFL 145
Query: 212 GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
               +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 272 SFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAAM 323
             KG       WMAPE I +     +  D+WS G  + E+    A+  P     E     
Sbjct: 206 R-KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 324 FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
            K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 264 LKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 112/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+L  G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 11  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 67
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 68  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 187 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 107/266 (40%), Gaps = 24/266 (9%)
Query: 121 LGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG   FG VY G  F    GE      +    D       ++   E +L +RL+HPN+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL------QDYGQFGE----------PAIRNYTQQ 222
             G  T +  L +   Y S G +++ L       D G   +          P   +   Q
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---W 279
           I +G+ +L S H VH+D+   N+LV     VK++D G+ + +           S     W
Sbjct: 154 IAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRW 213
Query: 280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           MAPE I      ++  DIWS G  + E+ +    P+  Y     +  I N + LP  PDD
Sbjct: 214 MAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC-PDD 271
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAEL 364
                   +  C    P  RP   ++
Sbjct: 272 CPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 112/224 (50%), Gaps = 19/224 (8%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----AMKEVTLFDDAKSKESAKQLMQE 164
           +  E+ +KK K+L  G FG VY G     GE      A+KE+    +A S ++ K+++ E
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDE 74
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
             +++ + +P++ +  G   +   + +  + +  G +   ++++    G   + N+  QI
Sbjct: 75  AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WM 280
             G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WM
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+ A
Sbjct: 194 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 232

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 107/266 (40%), Gaps = 24/266 (9%)
Query: 121 LGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG   FG VY G  F    GE      +    D       ++   E +L +RL+HPN+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLL------QDYGQFGE----------PAIRNYTQQ 222
             G  T +  L +   Y S G +++ L       D G   +          P   +   Q
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---W 279
           I +G+ +L S H VH+D+   N+LV     VK++D G+ + +           S     W
Sbjct: 137 IAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRW 196
Query: 280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           MAPE I      ++  DIWS G  + E+ +    P+  Y     +  I N + LP  PDD
Sbjct: 197 MAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC-PDD 254
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAEL 364
                   +  C    P  RP   ++
Sbjct: 255 CPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 116/285 (40%), Gaps = 33/285 (11%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K GK LGRG FG V     F  D    C    V +  +  +    + LM E+ +L
Sbjct: 62  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 121
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD---------------YGQF 211
             +  H N+V   G+ T     L + +E+   G++   L+                Y  F
Sbjct: 122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 181
Query: 212 -GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 241
Query: 271 LSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAA 322
           +  KG       WMAPE I +     +  D+WS G  + E+    A+  P     E    
Sbjct: 242 VR-KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299
Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 300 RLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 121/272 (44%), Gaps = 19/272 (6%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV---TLFDDAKSKESAKQLMQEIVLL 168
           E+ ++ G +LG+G FG V+ G         A+K +    +   +   +S    + E+ LL
Sbjct: 30  EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALL 88
Query: 169 SRLR----HPNIVQYYGSKTVEDKLYIYLEY-VSGGSIYKLLQDYGQFGEPAIRNYTQQI 223
            ++     HP +++       ++   + LE  +    ++  + + G  GE   R +  Q+
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQV 148
Query: 224 LSGLAFLHSKHTVHRDIKGANILVD-PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAP 282
           ++ +   HS+  VHRDIK  NIL+D   G  KL DFG    +  +     F G+  +  P
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-TDFDGTRVYSPP 207
Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
           E I       L   +WSLG  + +M     P+ + + +          EL   P  +S +
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL-------EAEL-HFPAHVSPD 259
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
               IR CL   P +RP+  E+L  P+++  A
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K GK LGRG FG V     F  D    C    V +  +  +    + LM E+ +L
Sbjct: 16  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD---------------YGQF 211
             +  H N+V   G+ T     L +  E+   G++   L+                Y  F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 212 -GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 271 LSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAA 322
           +  KG       WMAPE I +     +  D+WS G  + E+    A+  P     E    
Sbjct: 196 VR-KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 253
Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 254 RLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G+G FG V +G     G   A+K +      K+  +A+  + E  ++++LRH N+VQ  
Sbjct: 29  IGKGEFGDVMLG--DYRGNKVAVKCI------KNDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 181 GSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTV 236
           G   VE+K  LYI  EY++ GS+   L+  G+   G   +  ++  +   + +L   + V
Sbjct: 81  GV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRD+   N+LV  +   K++DFG+ K     S   + K    W APE ++       + D
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFSTKS-D 196
Query: 297 IWSLGCTVLEM 307
           +WS G  + E+
Sbjct: 197 VWSFGILLWEI 207

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 116/285 (40%), Gaps = 33/285 (11%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K GK LGRG FG V     F  D    C    V +  +  +    + LM E+ +L
Sbjct: 25  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD---------------YGQF 211
             +  H N+V   G+ T     L + +E+   G++   L+                Y  F
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 212 -GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 271 LSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAA 322
           +  KG       WMAPE I +     +  D+WS G  + E+    A+  P     E    
Sbjct: 205 VR-KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 263 RLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 123/266 (46%), Gaps = 18/266 (6%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD---DAKSKESAKQLMQE 164
           P   ++  +  K +G+G FG V+ G       + A+K + L D   + +  E  ++  +E
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR-NYTQQI 223
           + ++S L HPNIV+ YG   + +   + +E+V  G +Y  L D     + +++      I
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 224 LSGLAFLHSKH--TVHRDIKGANIL---VDPNGRV--KLADFGMAKHIAGQSCPLSFKGS 276
             G+ ++ +++   VHRD++  NI    +D N  V  K+ADF +++        L   G+
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLL--GN 189
Query: 277 PYWMAPEVI-KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE--GVAAMFKIGNSKELP 333
             WMAPE I           D +S    +  + T + P+ +Y    +  +  I      P
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 334 TIPDDLSDEGKDFIRLCLQRNPLNRP 359
           TIP+D     ++ I LC   +P  RP
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRP 275

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G+G FG V +G     G   A+K +      K+  +A+  + E  ++++LRH N+VQ  
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCI------KNDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 181 GSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTV 236
           G   VE+K  LYI  EY++ GS+   L+  G+   G   +  ++  +   + +L   + V
Sbjct: 66  GV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 124
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRD+   N+LV  +   K++DFG+ K     S   + K    W APE ++       + D
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFSTKS-D 181
Query: 297 IWSLGCTVLEM 307
           +WS G  + E+
Sbjct: 182 VWSFGILLWEI 192

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 16/221 (7%)
Query: 163 QEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNY 219
           +EI +L R  +HPNI+        +D  Y+Y+  E + GG +   +     F E      
Sbjct: 64  EEIEILLRYGQHPNIITL--KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV 121
Query: 220 TQQILSGLAFLHSKHTVHRDIKGANIL-VDPNGR---VKLADFGMAKHIAGQSCPLSFKG 275
              I   + +LH++  VHRD+K +NIL VD +G    +++ DFG AK +  ++  L    
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 276 -SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY-----EGVAAMFKIGNS 329
            +  ++APEV++   G + A DIWSLG  +  M T   P++       E + A    G  
Sbjct: 182 YTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF 240
Query: 330 KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
                  + +SD  KD +   L  +P  R TAA +L HP++
Sbjct: 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G+G FG V +G     G   A+K +      K+  +A+  + E  ++++LRH N+VQ  
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCI------KNDATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 181 GSKTVEDK--LYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTV 236
           G   VE+K  LYI  EY++ GS+   L+  G+   G   +  ++  +   + +L   + V
Sbjct: 253 GV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           HRD+   N+LV  +   K++DFG+ K     S   + K    W APE ++       + D
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFSTKS-D 368
Query: 297 IWSLGCTVLEM 307
           +WS G  + E+
Sbjct: 369 VWSFGILLWEI 379

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 24/265 (9%)
Query: 121 LGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG+G+FG VY G   D   GE      V   +++ S     + + E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILSGLA 228
             G  +      + +E ++ G +   L+      E       P ++   Q   +I  G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
           +L++K  VHRD+   N +V  +  VK+ DFGM + I         KG        WMAPE
Sbjct: 145 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPVRWMAPE 202
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDDLSD 341
            +K+      + D+WS G  + E+ +       Y+G++   + K          PD+  +
Sbjct: 203 SLKDGVFTT-SSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMDGGYLDQPDNCPE 259
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLD 366
              D +R+C Q NP  RPT  E+++
Sbjct: 260 RVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 24/265 (9%)
Query: 121 LGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG+G+FG VY G   D   GE      V   +++ S     + + E  ++      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILSGLA 228
             G  +      + +E ++ G +   L+      E       P ++   Q   +I  G+A
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
           +L++K  VHRD+   N +V  +  VK+ DFGM + I         KG        WMAPE
Sbjct: 142 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPVRWMAPE 199
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDDLSD 341
            +K+      + D+WS G  + E+ +       Y+G++   + K          PD+  +
Sbjct: 200 SLKDGVFTT-SSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMDGGYLDQPDNCPE 256
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLD 366
              D +R+C Q NP  RPT  E+++
Sbjct: 257 RVTDLMRMCWQFNPKMRPTFLEIVN 281

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 115/259 (44%), Gaps = 10/259 (3%)
Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           K  +++G G FG V  G     G+      +       +++  +  + E  ++ +  HPN
Sbjct: 36  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 95
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           ++   G  T    + I  E++  GS+   L Q+ GQF    +    + I +G+ +L   +
Sbjct: 96  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 155
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS------PYWMAPEVIKNS 288
            VHRD+   NILV+ N   K++DFG+++ +   +   ++  +        W APE I+  
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 289 SGCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
              + A D+WS G  + E M+  + P+        +  I     LP  P D        +
Sbjct: 216 KFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-PMDCPSALHQLM 273
Query: 348 RLCLQRNPLNRPTAAELLD 366
             C Q++  +RP   ++++
Sbjct: 274 LDCWQKDRNHRPKFGQIVN 292

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 24/265 (9%)
Query: 121 LGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG+G+FG VY G   D   GE      V   +++ S     + + E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILSGLA 228
             G  +      + +E ++ G +   L+      E       P ++   Q   +I  G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
           +L++K  VHRD+   N +V  +  VK+ DFGM + I         KG        WMAPE
Sbjct: 145 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPVRWMAPE 202
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDDLSD 341
            +K+      + D+WS G  + E+ +       Y+G++   + K          PD+  +
Sbjct: 203 SLKDGVFTT-SSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMDGGYLDQPDNCPE 259
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLD 366
              D +R+C Q NP  RPT  E+++
Sbjct: 260 RVTDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 24/265 (9%)
Query: 121 LGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG+G+FG VY G   D   GE      V   +++ S     + + E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILSGLA 228
             G  +      + +E ++ G +   L+      E       P ++   Q   +I  G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
           +L++K  VHRD+   N +V  +  VK+ DFGM + I         KG        WMAPE
Sbjct: 145 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETAYYRKGGKGLLPVRWMAPE 202
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDDLSD 341
            +K+      + D+WS G  + E+ +       Y+G++   + K          PD+  +
Sbjct: 203 SLKDGVFTT-SSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMDGGYLDQPDNCPE 259
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLD 366
              D +R+C Q NP  RPT  E+++
Sbjct: 260 RVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K GK LGRG FG V     F  D    C    V +  +  +    + LM E+ +L
Sbjct: 16  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD---------------YGQF 211
             +  H N+V   G+ T     L +  E+   G++   L+                Y  F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 212 -GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 271 LSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAA 322
           +  KG       WMAPE I +     +  D+WS G  + E+    A+  P     E    
Sbjct: 196 VR-KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 253
Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 254 RLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 118/263 (44%), Gaps = 52/263 (19%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +  GK LG G+FG V   F+ +SG+  A+K+V    D + K       +E+ ++  L H 
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKV--LQDPRYKN------RELDIMKVLDHV 60
Query: 175 NIVQ----YYGSKTVEDK----------------------------------LYIYLEYV 196
           NI++    +Y +   E K                                  L + +EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 197 SGGSIYKLLQDYGQFGEPA----IRNYTQQILSGLAFLHSKHTVHRDIKGANILVD-PNG 251
              +++K+L+ + + G       I  Y  Q+   + F+HS    HRDIK  N+LV+  + 
Sbjct: 121 PD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 252 RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTK 311
            +KL DFG AK +      ++   S ++ APE++  ++    ++D+WS+GC   E+   K
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 312 PPWSQYEGVAAMFKIGNSKELPT 334
           P +S    +  + +I      PT
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPT 262

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K GK LGRG FG V     F  D    C    V +  +  +    + LM E+ +L
Sbjct: 16  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD---------------YGQF 211
             +  H N+V   G+ T     L +  E+   G++   L+                Y  F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 212 -GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 271 LSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAA 322
           +  KG       WMAPE I +     +  D+WS G  + E+    A+  P     E    
Sbjct: 196 VR-KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 253
Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 254 RLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 24/265 (9%)
Query: 121 LGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG+G+FG VY G   D   GE      V   +++ S     + + E  ++      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILSGLA 228
             G  +      + +E ++ G +   L+      E       P ++   Q   +I  G+A
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
           +L++K  VHRD+   N +V  +  VK+ DFGM + I         KG        WMAPE
Sbjct: 144 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWMAPE 201
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDDLSD 341
            +K+      + D+WS G  + E+ +       Y+G++   + K          PD+  +
Sbjct: 202 SLKDGVFTT-SSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMDGGYLDQPDNCPE 258
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLD 366
              D +R+C Q NP  RPT  E+++
Sbjct: 259 RVTDLMRMCWQFNPKMRPTFLEIVN 283

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 24/265 (9%)
Query: 121 LGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG+G+FG VY G   D   GE      V   +++ S     + + E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILSGLA 228
             G  +      + +E ++ G +   L+      E       P ++   Q   +I  G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
           +L++K  VHRD+   N +V  +  VK+ DFGM + I         KG        WMAPE
Sbjct: 145 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWMAPE 202
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDDLSD 341
            +K+      + D+WS G  + E+ +       Y+G++   + K          PD+  +
Sbjct: 203 SLKDGVFTT-SSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMDGGYLDQPDNCPE 259
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLD 366
              D +R+C Q NP  RPT  E+++
Sbjct: 260 RVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 110/259 (42%), Gaps = 16/259 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES------AKQLMQEIVLLSRLR 172
           + +  G++G V  G +S+   +   +      D ++          K++++EI LL+   
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 173 HPNI-----VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA-IRNYTQQILSG 226
           HPNI     +  +  +    KLY+  E +    + +++ D      P  I+ +   IL G
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK 286
           L  LH    VHRD+   NIL+  N  + + DF +A+     +    +    ++ APE++ 
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SDEG 343
              G    VD+WS GC + EM   K  +        + KI      P I D +   S   
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266
Query: 344 KDFIRLCLQRNPLNRPTAA 362
           +D++R  L   P    TA 
Sbjct: 267 RDYLRNSLSNVPARAWTAV 285

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 121/270 (44%), Gaps = 31/270 (11%)
Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           H  +G ++ RG F       N D      + E   F D +      QL++E        H
Sbjct: 34  HGAEGTIVYRGMFD------NRDVAVKRILPECFSFADREV-----QLLRE-----SDEH 77
Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGG-SIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           PN+++Y+ ++      YI +E  +     Y   +D+   G   I    QQ  SGLA LHS
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHS 136
Query: 233 KHTVHRDIKGANILV---DPNGRVK--LADFGMAKHIAGQSCPLSFK----GSPYWMAPE 283
            + VHRD+K  NIL+   + +G++K  ++DFG+ K +A      S +    G+  W+APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 284 VIKNSSGCN--LAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLS 340
           ++      N    VDI+S GC    + +    P+ +     A   +G        P+   
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 341 DE-GKDFIRLCLQRNPLNRPTAAELLDHPF 369
           D   ++ I   +  +P  RP+A  +L HPF
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 110/259 (42%), Gaps = 16/259 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES------AKQLMQEIVLLSRLR 172
           + +  G++G V  G +S+   +   +      D ++          K++++EI LL+   
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 173 HPNI-----VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA-IRNYTQQILSG 226
           HPNI     +  +  +    KLY+  E +    + +++ D      P  I+ +   IL G
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK 286
           L  LH    VHRD+   NIL+  N  + + DF +A+     +    +    ++ APE++ 
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206
Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL---SDEG 343
              G    VD+WS GC + EM   K  +        + KI      P I D +   S   
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266
Query: 344 KDFIRLCLQRNPLNRPTAA 362
           +D++R  L   P    TA 
Sbjct: 267 RDYLRNSLSNVPARAWTAV 285

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 44/283 (15%)
Query: 118 GKMLGRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           GK LG G FG V     F+           V +  +  S    + L+ E  +L ++ HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG-------------------EPAI 216
           +++ YG+ + +  L + +EY   GS+   L++  + G                   E A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 217 R-----NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
                 ++  QI  G+ +L     VHRD+   NILV    ++K++DFG+++ +  +   +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 272 SFKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTK-------PPWSQYEGVA 321
                     WMA E + +      + D+WS G  + E+ T         PP    E + 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQS-DVWSFGVLLWEIVTLGGNPYPGIPP----ERLF 262
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            + K G+  E    PD+ S+E    +  C ++ P  RP  A++
Sbjct: 263 NLLKTGHRMER---PDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 44/283 (15%)
Query: 118 GKMLGRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           GK LG G FG V     F+           V +  +  S    + L+ E  +L ++ HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG-------------------EPAI 216
           +++ YG+ + +  L + +EY   GS+   L++  + G                   E A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 217 R-----NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
                 ++  QI  G+ +L     VHRD+   NILV    ++K++DFG+++ +  +   +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 272 SFKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTK-------PPWSQYEGVA 321
                     WMA E + +      + D+WS G  + E+ T         PP    E + 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQS-DVWSFGVLLWEIVTLGGNPYPGIPP----ERLF 262
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            + K G+  E    PD+ S+E    +  C ++ P  RP  A++
Sbjct: 263 NLLKTGHRMER---PDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 18/252 (7%)
Query: 121 LGRGTFGHVYVGF--NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +G G FG V++G+  N D   +  +KE ++ +D          ++E  ++ +L HP +VQ
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED--------DFIEEAEVMMKLSHPKLVQ 86
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG    +  + +  E++  G +   L+   G F    +      +  G+A+L     +H
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 146
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLA 294
           RD+   N LV  N  +K++DFGM + +       S  G+ +   W +PEV   S   + +
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRYSSKS 205
Query: 295 VDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            D+WS G  + E+ +  K P+        +  I     L   P   S      +  C + 
Sbjct: 206 -DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWKE 263
Query: 354 NPLNRPTAAELL 365
            P +RP  + LL
Sbjct: 264 RPEDRPAFSRLL 275

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 44/283 (15%)
Query: 118 GKMLGRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           GK LG G FG V     F+           V +  +  S    + L+ E  +L ++ HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG-------------------EPAI 216
           +++ YG+ + +  L + +EY   GS+   L++  + G                   E A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 217 R-----NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
                 ++  QI  G+ +L     VHRD+   NILV    ++K++DFG+++ +  +   +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 272 SFKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTK-------PPWSQYEGVA 321
                     WMA E + +      + D+WS G  + E+ T         PP    E + 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQS-DVWSFGVLLWEIVTLGGNPYPGIPP----ERLF 262
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            + K G+  E    PD+ S+E    +  C ++ P  RP  A++
Sbjct: 263 NLLKTGHRMER---PDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 115/283 (40%), Gaps = 31/283 (10%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P    K GK LGRG FG V     F  D         V +  +  +    + LM E+ +L
Sbjct: 27  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL 86
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD-------------YGQF-G 212
             +  H N+V   G+ T     L + +E+   G++   L+              Y  F  
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLT 146
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS 272
              +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      + 
Sbjct: 147 LEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 273 FKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAAMF 324
            KG       WMAPE I +     +  D+WS G  + E+    A+  P     E      
Sbjct: 207 -KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 325 KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           K G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 265 KEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP---- 174
           K++G+G+FG V   ++    +  A+K V        K   +Q  +EI +L  LR      
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR-----NEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 175 --NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFL 230
             N++    + T  + + +  E +S  ++Y+L++   +  F  P +R +   IL  L  L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 231 HSKHTVHRDIKGANILVDPNGR--VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
           H    +H D+K  NIL+   GR  +K+ DFG + +   +    +   S ++ APEVI  +
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--YTXIQSRFYRAPEVILGA 274
Query: 289 SGCNLAVDIWSLGCTVLEMATTKP 312
               + +D+WSLGC + E+ T  P
Sbjct: 275 R-YGMPIDMWSLGCILAELLTGYP 297

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P ++ + GK LG G FG V     F     +      V +       +  + LM E+ ++
Sbjct: 44  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 103
Query: 169 SRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP----AIRN----- 218
           S L +H NIV   G+ T    + +  EY   G +   L+   +  E     AI N     
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 219 -----YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF 273
                ++ Q+  G+AFL SK+ +HRD+   N+L+      K+ DFG+A+ I   S  +  
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-V 222
Query: 274 KGSPY----WMAPEVIKNSSGCNLAV--DIWSLGCTVLEM 307
           KG+      WMAPE I +   C   V  D+WS G  + E+
Sbjct: 223 KGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEI 259

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 111 PESHWKKGKMLGRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P ++ + GK LG G FG V     F     +      V +       +  + LM E+ ++
Sbjct: 36  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 95
Query: 169 SRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQF------GEPA----IR 217
           S L +H NIV   G+ T    + +  EY   G +   L+   +       G P     + 
Sbjct: 96  SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLL 155
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           +++ Q+  G+AFL SK+ +HRD+   N+L+      K+ DFG+A+ I   S  +  KG+ 
Sbjct: 156 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNA 214
Query: 278 Y----WMAPEVIKNSSGCNLAV--DIWSLGCTVLEM 307
                WMAPE I +   C   V  D+WS G  + E+
Sbjct: 215 RLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEI 247

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 62/297 (20%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNIV 177
           + LGRG +  V+   N  + E   +K +      K K       +EI +L  LR  PNI+
Sbjct: 43  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK-------REIKILENLRGGPNII 95
Query: 178 QYYGSKTVEDKL----YIYLEYVSGGS---IYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
               +  V+D +     +  E+V+      +Y+ L DY       IR Y  +IL  L + 
Sbjct: 96  TL--ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD------IRFYMYEILKALDYC 147
Query: 231 HSKHTVHRDIKGANILVDPNGR-VKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNS 288
           HS   +HRD+K  N+++D   R ++L D+G+A+    GQ   +    S Y+  PE++ + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKEL------------ 332
              + ++D+WSLGC +  M   K P+      Y+ +  + K+  +++L            
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 333 PTIPDDL--------------------SDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
           P   D L                    S E  DF+   L+ +  +R TA E ++HP+
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 111 PESHWKKGKMLGRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P ++ + GK LG G FG V     F     +      V +       +  + LM E+ ++
Sbjct: 44  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 103
Query: 169 SRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP----AIRN----- 218
           S L +H NIV   G+ T    + +  EY   G +   L+   +  E     AI N     
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLST 163
Query: 219 -----YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF 273
                ++ Q+  G+AFL SK+ +HRD+   N+L+      K+ DFG+A+ I   S  +  
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-V 222
Query: 274 KGSPY----WMAPEVIKNSSGCNLAV--DIWSLGCTVLEM 307
           KG+      WMAPE I +   C   V  D+WS G  + E+
Sbjct: 223 KGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEI 259

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 122/283 (43%), Gaps = 59/283 (20%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNIV 177
           ++LG G  G V   FN  + E  A+K   L D  K++       +E+ L  R    P+IV
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR-------REVELHWRASQCPHIV 74
Query: 178 Q--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGL 227
           +        Y G K     L I +E + GG ++  +QD G   F E       + I   +
Sbjct: 75  RIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 228 AFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEV 284
            +LHS +  HRD+K  N+L     PN  +KL DFG AK   G+                 
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE----------------- 173
Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA------AMFKIGNSKELPTIPD- 337
            K    C    D+WSLG  +  +    PP+    G+A         ++G   E P  P+ 
Sbjct: 174 -KYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN-PEW 226
Query: 338 -DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 111 PESHWKKGKMLGRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P ++ + GK LG G FG V     F     +      V +       +  + LM E+ ++
Sbjct: 44  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 103
Query: 169 SRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQF------GEPA----IR 217
           S L +H NIV   G+ T    + +  EY   G +   L+   +       G P     + 
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLL 163
Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           +++ Q+  G+AFL SK+ +HRD+   N+L+      K+ DFG+A+ I   S  +  KG+ 
Sbjct: 164 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNA 222
Query: 278 Y----WMAPEVIKNSSGCNLAV--DIWSLGCTVLEM 307
                WMAPE I +   C   V  D+WS G  + E+
Sbjct: 223 RLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEI 255

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP---- 174
           K++G+G+FG V   ++    +  A+K V        K   +Q  +EI +L  LR      
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR-----NEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 175 --NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFL 230
             N++    + T  + + +  E +S  ++Y+L++   +  F  P +R +   IL  L  L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 231 HSKHTVHRDIKGANILVDPNGR--VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
           H    +H D+K  NIL+   GR  +K+ DFG + +   +    +   S ++ APEVI  +
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--YTXIQSRFYRAPEVILGA 274
Query: 289 SGCNLAVDIWSLGCTVLEMATTKP 312
               + +D+WSLGC + E+ T  P
Sbjct: 275 R-YGMPIDMWSLGCILAELLTGYP 297

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 114/250 (45%), Gaps = 14/250 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G FG V++G+  +  ++ A+K  T+ + A S+E     ++E  ++ +L HP +VQ Y
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIK--TIREGAMSEE---DFIEEAEVMMKLSHPKLVQLY 68
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           G    +  + +  E++  G +   L+   G F    +      +  G+A+L     +HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRD 128
Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAVD 296
           +   N LV  N  +K++DFGM + +       S  G+ +   W +PEV   S   + + D
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRYSSKS-D 186
Query: 297 IWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           +WS G  + E+ +  K P+        +  I     L   P   S      +  C +  P
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERP 245
Query: 356 LNRPTAAELL 365
            +RP  + LL
Sbjct: 246 EDRPAFSRLL 255

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 16/228 (7%)
Query: 156 ESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFG 212
           +S +   +EI +L R  +HPNI+        +D  Y+Y+  E   GG +   +     F 
Sbjct: 57  KSKRDPTEEIEILLRYGQHPNIITL--KDVYDDGKYVYVVTELXKGGELLDKILRQKFFS 114
Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANIL-VDPNGR---VKLADFGMAKHIAGQS 268
           E         I   + +LH++  VHRD+K +NIL VD +G    +++ DFG AK +  ++
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 269 CPLSFKG-SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY-----EGVAA 322
             L     +  ++APEV++   G + A DIWSLG  +    T   P++       E + A
Sbjct: 175 GLLXTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILA 233
Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
               G         + +SD  KD +   L  +P  R TAA +L HP++
Sbjct: 234 RIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 10/211 (4%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S+ K  +++G G FG V  G     G+  +   +       ++   ++ + E  ++ +  
Sbjct: 14  SYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE 73
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLH 231
           HPNI++  G  T    + I  E++  G++   L+ + GQF    +    + I SG+ +L 
Sbjct: 74  HPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA 133
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS------PYWMAPEVI 285
               VHRD+   NILV+ N   K++DFG+++ +   S   ++  S        W APE I
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 286 KNSSGCNLAVDIWSLGCTVLEMAT--TKPPW 314
                 + A D WS G  + E+ +   +P W
Sbjct: 194 AFRKFTS-ASDAWSYGIVMWEVMSFGERPYW 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 117/265 (44%), Gaps = 24/265 (9%)
Query: 121 LGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG+G+FG VY G   D   GE      V   +++ S     + + E  ++      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILSGLA 228
             G  +      + +E ++ G +   L+      E       P ++   Q   +I  G+A
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
           +L++K  VHR++   N +V  +  VK+ DFGM + I         KG        WMAPE
Sbjct: 146 YLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWMAPE 203
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDDLSD 341
            +K+      + D+WS G  + E+ +       Y+G++   + K          PD+  +
Sbjct: 204 SLKDGVFTT-SSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMDGGYLDQPDNCPE 260
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLD 366
              D +R+C Q NP  RPT  E+++
Sbjct: 261 RVTDLMRMCWQFNPNMRPTFLEIVN 285

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 114/250 (45%), Gaps = 14/250 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G FG V++G+  +  ++ A+K  T+ + A S+E     ++E  ++ +L HP +VQ Y
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIK--TIREGAMSEED---FIEEAEVMMKLSHPKLVQLY 68
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           G    +  + +  E++  G +   L+   G F    +      +  G+A+L     +HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 128
Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAVD 296
           +   N LV  N  +K++DFGM + +       S  G+ +   W +PEV   S   + + D
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRYSSKS-D 186
Query: 297 IWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           +WS G  + E+ +  K P+        +  I     L   P   S      +  C +  P
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERP 245
Query: 356 LNRPTAAELL 365
            +RP  + LL
Sbjct: 246 EDRPAFSRLL 255

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP---- 174
           K++G+G FG V   ++    +  A+K V        K   +Q  +EI +L  LR      
Sbjct: 103 KVIGKGXFGQVVKAYDHKVHQHVALKMVR-----NEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 175 --NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFL 230
             N++    + T  + + +  E +S  ++Y+L++   +  F  P +R +   IL  L  L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 231 HSKHTVHRDIKGANILVDPNGR--VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
           H    +H D+K  NIL+   GR  +K+ DFG + +   Q      + S ++ APEVI  +
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-EHQRVYXXIQ-SRFYRAPEVILGA 274
Query: 289 SGCNLAVDIWSLGCTVLEMATTKP 312
               + +D+WSLGC + E+ T  P
Sbjct: 275 R-YGMPIDMWSLGCILAELLTGYP 297

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ--MELDHERMSYLLYQMLXGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 117/265 (44%), Gaps = 24/265 (9%)
Query: 121 LGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG+G+FG VY G   D   GE      V   +++ S     + + E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILSGLA 228
             G  +      + +E ++ G +   L+      E       P ++   Q   +I  G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
           +L++K  VHR++   N +V  +  VK+ DFGM + I         KG        WMAPE
Sbjct: 145 YLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWMAPE 202
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDDLSD 341
            +K+      + D+WS G  + E+ +       Y+G++   + K          PD+  +
Sbjct: 203 SLKDGVFTT-SSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMDGGYLDQPDNCPE 259
Query: 342 EGKDFIRLCLQRNPLNRPTAAELLD 366
              D +R+C Q NP  RPT  E+++
Sbjct: 260 RVTDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 27/238 (11%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W    +LG+G   +V+ G +  +G++ A+K   +F++          M+E  +L +L H 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 175 NIVQYYG---SKTVEDKLYIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGL 227
           NIV+ +      T   K+ I +E+   GS+Y +L++    YG   E       + ++ G+
Sbjct: 68  NIVKLFAIEEETTTRHKVLI-MEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGM 125
Query: 228 AFLHSKHTVHRDIKGANIL----VDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
             L     VHR+IK  NI+     D     KL DFG A+ +      +S  G+  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 284 VIKNS-------SGCNLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMFKIGNSK 330
           + + +             VD+WS+G T    AT   P+  +EG       M+KI   K
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 10/211 (4%)
Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S+ K  +++G G FG V  G     G+  +   +       ++   ++ + E  ++ +  
Sbjct: 16  SYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE 75
Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLH 231
           HPNI++  G  T    + I  E++  G++   L+ + GQF    +    + I SG+ +L 
Sbjct: 76  HPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA 135
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA------GQSCPLSFKGSPYWMAPEVI 285
               VHRD+   NILV+ N   K++DFG+++ +        ++  L  K    W APE I
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 286 KNSSGCNLAVDIWSLGCTVLEMAT--TKPPW 314
                 + A D WS G  + E+ +   +P W
Sbjct: 196 AFRKFTS-ASDAWSYGIVMWEVMSFGERPYW 225

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 114/250 (45%), Gaps = 14/250 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G FG V++G+  +  ++ A+K  T+ + A S+E     ++E  ++ +L HP +VQ Y
Sbjct: 13  IGSGQFGLVHLGYWLNKDKV-AIK--TIREGAMSEED---FIEEAEVMMKLSHPKLVQLY 66
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           G    +  + +  E++  G +   L+   G F    +      +  G+A+L     +HRD
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAVD 296
           +   N LV  N  +K++DFGM + +       S  G+ +   W +PEV   S   + + D
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRYSSKS-D 184
Query: 297 IWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           +WS G  + E+ +  K P+        +  I     L   P   S      +  C +  P
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERP 243
Query: 356 LNRPTAAELL 365
            +RP  + LL
Sbjct: 244 EDRPAFSRLL 253

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 111 PESHWKKGKMLGRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P ++ + GK LG G FG V     F     +      V +       +  + LM E+ ++
Sbjct: 44  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 103
Query: 169 SRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYG---------QF 211
           S L +H NIV   G+ T    + +  EY   G +   L+       +Y          Q 
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQL 163
Query: 212 GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL 271
               + +++ Q+  G+AFL SK+ +HRD+   N+L+      K+ DFG+A+ I   S  +
Sbjct: 164 SSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 223
Query: 272 SFKGSPY----WMAPEVIKNSSGCNLAV--DIWSLGCTVLEM 307
             KG+      WMAPE I +   C   V  D+WS G  + E+
Sbjct: 224 -VKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEI 261

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAM-KEVTLFDDAKSKESAKQLMQEIVL 167
           +  E+  +K K+LG G FG VY G     GE   +   + +  +  S ++ K+++ E  +
Sbjct: 13  ILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV 72
Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
           ++ +  P + +  G         +      G  +  + ++ G+ G   + N+  QI  G+
Sbjct: 73  MAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGM 132
Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK---------HIAGQSCPLSFKGSPY 278
           ++L     VHRD+   N+LV     VK+ DFG+A+         H  G   P+       
Sbjct: 133 SYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------ 186
Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA 322
           WMA E I      + + D+WS G TV E+ T   KP    Y+G+ A
Sbjct: 187 WMALESILRRRFTHQS-DVWSYGVTVWELMTFGAKP----YDGIPA 227

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 114/250 (45%), Gaps = 14/250 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G FG V++G+  +  ++ A+K  T+ + A S+E     ++E  ++ +L HP +VQ Y
Sbjct: 18  IGSGQFGLVHLGYWLNKDKV-AIK--TIREGAMSEED---FIEEAEVMMKLSHPKLVQLY 71
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           G    +  + +  E++  G +   L+   G F    +      +  G+A+L     +HRD
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131
Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAVD 296
           +   N LV  N  +K++DFGM + +       S  G+ +   W +PEV   S   + + D
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRYSSKS-D 189
Query: 297 IWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           +WS G  + E+ +  K P+        +  I     L   P   S      +  C +  P
Sbjct: 190 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWRERP 248
Query: 356 LNRPTAAELL 365
            +RP  + LL
Sbjct: 249 EDRPAFSRLL 258

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 121/266 (45%), Gaps = 25/266 (9%)
Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESA-KQLMQEIVLLSRLRHPNI 176
           G+++G+G FG VY G     GE+     + L D  +  E   K   +E++   + RH N+
Sbjct: 38  GELIGKGRFGQVYHG--RWHGEVA----IRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP-AIRNYTQQILSGLAFLHSKHT 235
           V + G+      L I      G ++Y +++D     +    R   Q+I+ G+ +LH+K  
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAG------QSCPLSFK-GSPYWMAPEVIKNS 288
           +H+D+K  N+  D NG+V + DFG+   I+G      +   L  + G    +APE+I+  
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFS-ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 289 S--------GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLS 340
           S          +   D+++LG    E+   + P+      A ++++G   +       + 
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269
Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLD 366
            E  D +  C       RPT  +L+D
Sbjct: 270 KEISDILLFCWAFEQEERPTFTKLMD 295

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 114/259 (44%), Gaps = 10/259 (3%)
Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           K  +++G G FG V  G     G+      +       +++  +  + E  ++ +  HPN
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           ++   G  T    + I  E++  GS+   L Q+ GQF    +    + I +G+ +L   +
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 129
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS------PYWMAPEVIKNS 288
            VHR +   NILV+ N   K++DFG+++ +   +   ++  +        W APE I+  
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 289 SGCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
              + A D+WS G  + E M+  + P+        +  I     LP  P D        +
Sbjct: 190 KFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-PMDCPSALHQLM 247
Query: 348 RLCLQRNPLNRPTAAELLD 366
             C Q++  +RP   ++++
Sbjct: 248 LDCWQKDRNHRPKFGQIVN 266

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +++ K +G G  G V   F++  G   A+K+++     +++  AK+  +E+VLL  + H 
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS--RPFQNQTHAKRAYRELVLLKCVNHK 81
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +       +   + +     +     Q+L G+ 
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGIK 138
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  +       +  + Y+ APEVI   
Sbjct: 139 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVIL-G 197
Query: 289 SGCNLAVDIWSLGCTVLEMA 308
            G    VDIWS+GC + E+ 
Sbjct: 198 MGYKENVDIWSVGCIMGELV 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 123/261 (47%), Gaps = 22/261 (8%)
Query: 119 KMLGRGTFGHVYVGFNSDSGE---MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++G+G FG VY G   D  +    CA+K ++   + +  E+    ++E +L+  L HPN
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA---FLREGLLMRGLNHPN 83
Query: 176 IVQYYGSKTVEDKL-YIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     + L ++ L Y+  G + + ++   +   P +++   +  Q+  G+ +L 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLA 141
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY------WMAPEVI 285
            +  VHRD+   N ++D +  VK+ADFG+A+ I  +    S +   +      W A E +
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY-YSVQQHRHARLPVKWTALESL 200
Query: 286 KNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGK 344
           +       + D+WS G  + E+ T   PP+   +       +   + LP  P+   D   
Sbjct: 201 QTYRFTTKS-DVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-PEYCPDSLY 258
Query: 345 DFIRLCLQRNPLNRPTAAELL 365
             ++ C + +P  RPT   L+
Sbjct: 259 QVMQQCWEADPAVRPTFRVLV 279

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ--MELDHERMSYLLYQMLXGIK 133
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 191
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 74
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L+      E       P++    Q   +I  
Sbjct: 75  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 134
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG        WM
Sbjct: 135 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPVRWM 192
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 193 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLDKPDN 249
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELL 365
             D   + +R+C Q NP  RP+  E++
Sbjct: 250 CPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 123/271 (45%), Gaps = 37/271 (13%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K+ +++G G FG V+   +   G+   +K V        K + ++  +E+  L++L H 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV--------KYNNEKAEREVKALAKLDHV 64
Query: 175 NIVQYYG----------------SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR- 217
           NIV Y G                S++    L+I +E+   G++ + ++   + GE   + 
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKV 122
Query: 218 ---NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
                 +QI  G+ ++HSK  ++RD+K +NI +    +VK+ DFG+   +         K
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK 182
Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
           G+  +M+PE I +S      VD+++LG  + E+        +        + G       
Sbjct: 183 GTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG------I 235
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
           I D    + K  ++  L + P +RP  +E+L
Sbjct: 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ--MELDHERMSYLLYQMLXGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 114/250 (45%), Gaps = 14/250 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G FG V++G+  +  ++ A+K  T+ + A S+E     ++E  ++ +L HP +VQ Y
Sbjct: 16  IGSGQFGLVHLGYWLNKDKV-AIK--TIREGAMSEED---FIEEAEVMMKLSHPKLVQLY 69
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRD 239
           G    +  + +  E++  G +   L+   G F    +      +  G+A+L     +HRD
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 240 IKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLAVD 296
           +   N LV  N  +K++DFGM + +       S  G+ +   W +PEV   S   + + D
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRYSSKS-D 187
Query: 297 IWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
           +WS G  + E+ +  K P+        +  I     L   P   S      +  C +  P
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWRERP 246
Query: 356 LNRPTAAELL 365
            +RP  + LL
Sbjct: 247 EDRPAFSRLL 256

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 14/252 (5%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V        G+     +V +    +   S  + ++E  ++  L H  +VQ
Sbjct: 15  KELGTGQFGVV------KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG  T +  ++I  EY++ G +   L++   +F    +    + +   + +L SK  +H
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLA 294
           RD+   N LV+  G VK++DFG+++++       S +GS +   W  PEV+  S   + +
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-RGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 295 VDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            DIW+ G  + E+ +  K P+ ++        I     L   P   S++    +  C   
Sbjct: 188 -DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHE 245
Query: 354 NPLNRPTAAELL 365
               RPT   LL
Sbjct: 246 KADERPTFKILL 257

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 14/252 (5%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V        G+     +V +    +   S  + ++E  ++  L H  +VQ
Sbjct: 30  KELGTGQFGVV------KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG  T +  ++I  EY++ G +   L++   +F    +    + +   + +L SK  +H
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLA 294
           RD+   N LV+  G VK++DFG+++++       S  GS +   W  PEV+  S   + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKS 202
Query: 295 VDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            DIW+ G  + E+ +  K P+ ++        I     L   P   S++    +  C   
Sbjct: 203 -DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHE 260
Query: 354 NPLNRPTAAELL 365
               RPT   LL
Sbjct: 261 KADERPTFKILL 272

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 178
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 236
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 106/198 (53%), Gaps = 14/198 (7%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H NI+   
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 181 G----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
                 KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+  LHS  
Sbjct: 90  NVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSSGCNL 293
            +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI    G   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL-GMGYKE 204
Query: 294 AVDIWSLGCTVLEMATTK 311
            VDIWS+GC + EM   K
Sbjct: 205 NVDIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 139
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 140 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 197
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 198 GMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 14/252 (5%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V        G+     +V +    +   S  + ++E  ++  L H  +VQ
Sbjct: 30  KELGTGQFGVV------KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG  T +  ++I  EY++ G +   L++   +F    +    + +   + +L SK  +H
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLA 294
           RD+   N LV+  G VK++DFG+++++       S  GS +   W  PEV+  S   + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-ETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 295 VDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            DIW+ G  + E+ +  K P+ ++        I     L   P   S++    +  C   
Sbjct: 203 -DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHE 260
Query: 354 NPLNRPTAAELL 365
               RPT   LL
Sbjct: 261 KADERPTFKILL 272

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 141
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 199
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 141
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 199
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 178
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 236
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 134
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 135 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 192
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 83
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L+      E       P++    Q   +I  
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG        WM
Sbjct: 144 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPVRWM 201
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 202 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLDKPDN 258
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELL 365
             D   + +R+C Q NP  RP+  E++
Sbjct: 259 CPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 134
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 135 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 192
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 133
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 191
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VDIWS+GC + EM   K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 105/199 (52%), Gaps = 12/199 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIK 142
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+        + F  + Y+ APEVI   
Sbjct: 143 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVIL-G 201
Query: 289 SGCNLAVDIWSLGCTVLEM 307
            G    VDIWS+GC + EM
Sbjct: 202 MGYKENVDIWSVGCIMGEM 220

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 114/281 (40%), Gaps = 29/281 (10%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P      GK LGRG FG V     F  D         V +  +  +    + LM E+ +L
Sbjct: 25  PRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD-----------YGQF-GEP 214
             +  H N+V   G+ T     L + +E+   G++   L+            Y  F    
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLE 144
Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      +  K
Sbjct: 145 HLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-K 203
Query: 275 GSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM----ATTKPPWSQYEGVAAMFKI 326
           G       WMAPE I +     +  D+WS G  + E+    A+  P     E      K 
Sbjct: 204 GDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 262
Query: 327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           G        PD  + E    +  C    P  RPT +EL++H
Sbjct: 263 GTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +++ K +G G  G V   F++  G   A+K+++     +++  AK+  +E+VLL  + H 
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS--RPFQNQTHAKRAYRELVLLKCVNHK 83
Query: 175 NIVQYYG----SKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+         KT+E+   +Y+ +E +       +   + +     +     Q+L G+ 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+          +  + Y+ APEVI   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL-G 199
Query: 289 SGCNLAVDIWSLGCTVLEMA 308
            G    VDIWS+GC + E+ 
Sbjct: 200 MGYAANVDIWSVGCIMGELV 219

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 130/303 (42%), Gaps = 49/303 (16%)
Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQ 160
           G M++  + E H  + + +G G FG V+       G + A+K     L      + + ++
Sbjct: 1   GAMKSRYTTEFH--ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 58
Query: 161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD----YGQFGEPAI 216
           +    VL    +H ++V+Y+ +   +D + I  EY +GGS+   + +       F E  +
Sbjct: 59  VYAHAVLG---QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVD----PNG---------------RVKLAD 257
           ++   Q+  GL ++HS   VH DIK +NI +     PN                  K+ D
Sbjct: 116 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 175
Query: 258 FGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP----- 312
            G   H+   S P   +G   ++A EV++ +       DI++L  TV+  A  +P     
Sbjct: 176 LG---HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 232
Query: 313 -PWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             W +               LP IP  LS E  + +++ +  +P  RP+A  L+ H  + 
Sbjct: 233 DQWHEI----------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282
Query: 372 GAA 374
            A+
Sbjct: 283 SAS 285

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 10/272 (3%)
Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           K  K++G G FG V  G     G+      +       + +  +  + E  ++ +  HPN
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 91
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           I+   G  T    + I  EY+  GS+   L ++ G+F    +    + I SG+ +L    
Sbjct: 92  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 151
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSSG 290
            VHRD+   NILV+ N   K++DFGM++ +        + +G      W APE I     
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 291 CNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            + A D+WS G  + E M+  + P+        +  I     LP  P D        +  
Sbjct: 212 TS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPP-PMDCPIALHQLMLD 269
Query: 350 CLQRNPLNRPTAAELLD--HPFVKGAAPLERT 379
           C Q+   +RP   ++++     ++    L+RT
Sbjct: 270 CWQKERSDRPKFGQIVNMLDKLIRNPNSLKRT 301

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 38/271 (14%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 89
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN--------------YTQ 221
           +V+  G  +      + +E ++ G     L+ Y +   PA+ N                 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGD----LKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP---- 277
           +I  G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG      
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLP 203
Query: 278 -YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPT 334
             WM+PE +K+      + D+WS G  + E+AT       Y+G++   + +      L  
Sbjct: 204 VRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLD 260
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
            PD+  D   + +R+C Q NP  RP+  E++
Sbjct: 261 KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 116/280 (41%), Gaps = 27/280 (9%)
Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P      GK LGRG FG V     F  D         V +  +  +    + LM E+ +L
Sbjct: 25  PRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 169 SRL-RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQD-----------YGQF-GEP 214
             +  H N+V   G+ T     L + +E+   G++   L+            Y  F    
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLE 144
Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK 274
            +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      +  K
Sbjct: 145 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR-K 203
Query: 275 GSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
           G       WMAPE I +     +  D+WS G  + E+ +     S Y GV    +     
Sbjct: 204 GDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFXRRL 260
Query: 331 ELPT---IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           +  T    PD  + E    +  C    P  RPT +EL++H
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 107/238 (44%), Gaps = 27/238 (11%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           W    +LG+G   +V+ G +  +G++ A+K   +F++          M+E  +L +L H 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 175 NIVQYYG---SKTVEDKLYIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGL 227
           NIV+ +      T   K+ I +E+   GS+Y +L++    YG   E       + ++ G+
Sbjct: 68  NIVKLFAIEEETTTRHKVLI-MEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGM 125
Query: 228 AFLHSKHTVHRDIKGANIL----VDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
             L     VHR+IK  NI+     D     KL DFG A+ +      +   G+  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 284 VIKNS-------SGCNLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMFKIGNSK 330
           + + +             VD+WS+G T    AT   P+  +EG       M+KI   K
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 89
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L+      E       P++    Q   +I  
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG        WM
Sbjct: 150 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWM 207
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 208 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLDKPDN 264
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELL 365
             D   + +R+C Q NP  RP+  E++
Sbjct: 265 CPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 38/271 (14%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 79
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN--------------YTQ 221
           +V+  G  +      + +E ++ G     L+ Y +   PA+ N                 
Sbjct: 80  VVRLLGVVSQGQPTLVIMELMTRGD----LKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 135
Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP---- 277
           +I  G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG      
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLP 193
Query: 278 -YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPT 334
             WM+PE +K+      + D+WS G  + E+AT       Y+G++   + +      L  
Sbjct: 194 VRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLD 250
Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
            PD+  D   + +R+C Q NP  RP+  E++
Sbjct: 251 KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 76
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L+      E       P++    Q   +I  
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG        WM
Sbjct: 137 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWM 194
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 195 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLDKPDN 251
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELL 365
             D   + +R+C Q NP  RP+  E++
Sbjct: 252 CPDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEM 307
             G    VDIWS+GC + EM
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 14/252 (5%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V        G+     +V +    +   S  + ++E  ++  L H  +VQ
Sbjct: 21  KELGTGQFGVV------KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG  T +  ++I  EY++ G +   L++   +F    +    + +   + +L SK  +H
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 134
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLA 294
           RD+   N LV+  G VK++DFG+++++       S  GS +   W  PEV+  S   + +
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKS 193
Query: 295 VDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            DIW+ G  + E+ +  K P+ ++        I     L   P   S++    +  C   
Sbjct: 194 -DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHE 251
Query: 354 NPLNRPTAAELL 365
               RPT   LL
Sbjct: 252 KADERPTFKILL 263

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 47/285 (16%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +G G FG V+       G + A+K     L      + + +++    VL    +H ++V+
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG---QHSHVVR 71
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKH 234
           Y+ +   +D + I  EY +GGS+   + +       F E  +++   Q+  GL ++HS  
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 131
Query: 235 TVHRDIKGANILVD----PNG---------------RVKLADFGMAKHIAGQSCPLSFKG 275
            VH DIK +NI +     PN                  K+ D G   H+   S P   +G
Sbjct: 132 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSPQVEEG 188
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP------PWSQYEGVAAMFKIGNS 329
              ++A EV++ +       DI++L  TV+  A  +P       W +             
Sbjct: 189 DSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRNGDQWHEI----------RQ 238
Query: 330 KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
             LP IP  LS E  + +++ +  +P  RP+A  L+ H  +  A+
Sbjct: 239 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 283

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 114/242 (47%), Gaps = 16/242 (6%)
Query: 163 QEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
           +EI +L R  +HPNI+           +Y+  E + GG +   +     F E        
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH 128
Query: 222 QILSGLAFLHSKHTVHRDIKGANIL-VDPNGR---VKLADFGMAKHIAGQSCPLSFKG-S 276
            I   + +LHS+  VHRD+K +NIL VD +G    +++ DFG AK +  ++  L     +
Sbjct: 129 TIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYT 188
Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELP 333
             ++APEV+K   G +   DIWSLG  +  M     P++          + +IG+ K   
Sbjct: 189 ANFVAPEVLKR-QGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK--F 245
Query: 334 TIP----DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVP 389
           T+     + +S+  KD +   L  +P  R TA ++L HP+V     L ++ L+ +   + 
Sbjct: 246 TLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLV 305
Query: 390 PG 391
            G
Sbjct: 306 KG 307

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 80
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L+      E       P++    Q   +I  
Sbjct: 81  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG        WM
Sbjct: 141 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWM 198
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 199 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLDKPDN 255
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELL 365
             D   + +R+C Q NP  RP+  E++
Sbjct: 256 CPDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 83
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L+      E       P++    Q   +I  
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG        WM
Sbjct: 144 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWM 201
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 202 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLDKPDN 258
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELL 365
             D   + +R+C Q NP  RP+  E++
Sbjct: 259 CPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 16/178 (8%)
Query: 200 SIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADF 258
            ++  + + G   E   R++  Q+L  +   H+   +HRDIK  NIL+D N G +KL DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 259 GMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE 318
           G    +   +    F G+  +  PE I+       +  +WSLG  + +M     P+   E
Sbjct: 203 GSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 261
Query: 319 GVA---AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA 373
            +      F+             +S E +  IR CL   P +RPT  E+ +HP+++  
Sbjct: 262 EIIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 82
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L+      E       P++    Q   +I  
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG        WM
Sbjct: 143 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWM 200
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 201 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLDKPDN 257
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELL 365
             D   + +R+C Q NP  RP+  E++
Sbjct: 258 CPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQ--MELDHERMSYLLYQMLVGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEM 307
             G    VDIWS+GC + EM
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 115/280 (41%), Gaps = 29/280 (10%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           PV   +  K   ++G G FG V       D   M A   +    +  SK+  +    E+ 
Sbjct: 10  PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAA--IKRMKEYASKDDHRDFAGELE 67
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP---AIRNYTQQ 222
           +L +L  HPNI+   G+      LY+ +EY   G++   L+           AI N T  
Sbjct: 68  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 127
Query: 223 ILS-------------GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
            LS             G+ +L  K  +HRD+   NILV  N   K+ADFG+++   GQ  
Sbjct: 128 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV 184
Query: 270 PLSFKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFK 325
            +          WMA E + N S      D+WS G  + E+ +    P+          K
Sbjct: 185 YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 243
Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
           +     L   P +  DE  D +R C +  P  RP+ A++L
Sbjct: 244 LPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 122/258 (47%), Gaps = 26/258 (10%)
Query: 117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPN 175
           K K LG G+F       +  S +  A+K +       SK       +EI  L     HPN
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKII-------SKRMEANTQKEITALKLCEGHPN 67
Query: 176 IVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           IV+ +  +   D+L+ +L  E ++GG +++ ++    F E       ++++S ++ +H  
Sbjct: 68  IVKLH--EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 234 HTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKG-SPYWMAPEVIKNSS 289
             VHRD+K  N+L    + N  +K+ DFG A+     + PL     + ++ APE++ N +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQN 184
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYE-------GVAAMFKI--GNSKELPTIPDDLS 340
           G + + D+WSLG  +  M + + P+  ++        V  M KI  G+         ++S
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 341 DEGKDFIRLCLQRNPLNR 358
            E KD I+  L  +P  R
Sbjct: 245 QEAKDLIQGLLTVDPNKR 262

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 115/280 (41%), Gaps = 29/280 (10%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           PV   +  K   ++G G FG V       D   M A   +    +  SK+  +    E+ 
Sbjct: 20  PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDA--AIKRMKEYASKDDHRDFAGELE 77
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP---AIRNYTQQ 222
           +L +L  HPNI+   G+      LY+ +EY   G++   L+           AI N T  
Sbjct: 78  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 223 ILS-------------GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
            LS             G+ +L  K  +HRD+   NILV  N   K+ADFG+++   GQ  
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV 194
Query: 270 PLSFKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFK 325
            +          WMA E + N S      D+WS G  + E+ +    P+          K
Sbjct: 195 YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
           +     L   P +  DE  D +R C +  P  RP+ A++L
Sbjct: 254 LPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 82
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L+      E       P++    Q   +I  
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG        WM
Sbjct: 143 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWM 200
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 201 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLDKPDN 257
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELL 365
             D   + +R+C Q NP  RP+  E++
Sbjct: 258 CPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 14/252 (5%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V        G+     +V +    +   S  + ++E  ++  L H  +VQ
Sbjct: 14  KELGTGQFGVV------KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG  T +  ++I  EY++ G +   L++   +F    +    + +   + +L SK  +H
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 127
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLA 294
           RD+   N LV+  G VK++DFG+++++       S  GS +   W  PEV+  S   + +
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKS 186
Query: 295 VDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            DIW+ G  + E+ +  K P+ ++        I     L   P   S++    +  C   
Sbjct: 187 -DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHE 244
Query: 354 NPLNRPTAAELL 365
               RPT   LL
Sbjct: 245 KADERPTFKILL 256

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEM 307
             G    VDIWS+GC + EM
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 14/252 (5%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V        G+     +V +    +   S  + ++E  ++  L H  +VQ
Sbjct: 15  KELGTGQFGVV------KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG  T +  ++I  EY++ G +   L++   +F    +    + +   + +L SK  +H
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLA 294
           RD+   N LV+  G VK++DFG+++++       S  GS +   W  PEV+  S   + +
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKS 187
Query: 295 VDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            DIW+ G  + E+ +  K P+ ++        I     L   P   S++    +  C   
Sbjct: 188 -DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHE 245
Query: 354 NPLNRPTAAELL 365
               RPT   LL
Sbjct: 246 KADERPTFKILL 257

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 114/242 (47%), Gaps = 16/242 (6%)
Query: 163 QEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
           +EI +L R  +HPNI+           +Y+  E + GG +   +     F E        
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH 128
Query: 222 QILSGLAFLHSKHTVHRDIKGANIL-VDPNGR---VKLADFGMAKHIAGQSCPLSFKG-S 276
            I   + +LHS+  VHRD+K +NIL VD +G    +++ DFG AK +  ++  L     +
Sbjct: 129 TIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYT 188
Query: 277 PYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKELP 333
             ++APEV+K   G +   DIWSLG  +  M     P++          + +IG+ K   
Sbjct: 189 ANFVAPEVLKR-QGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK--F 245
Query: 334 TIP----DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVP 389
           T+     + +S+  KD +   L  +P  R TA ++L HP+V     L ++ L+ +   + 
Sbjct: 246 TLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLV 305
Query: 390 PG 391
            G
Sbjct: 306 KG 307

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 10/272 (3%)
Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           K  K++G G FG V  G     G+      +       + +  +  + E  ++ +  HPN
Sbjct: 17  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 76
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           I+   G  T    + I  EY+  GS+   L ++ G+F    +    + I SG+ +L    
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 136
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSSG 290
            VHRD+   NILV+ N   K++DFGM++ +        + +G      W APE I     
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 291 CNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            + A D+WS G  + E M+  + P+        +  I     LP  P D        +  
Sbjct: 197 TS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPP-PMDCPIALHQLMLD 254
Query: 350 CLQRNPLNRPTAAELLD--HPFVKGAAPLERT 379
           C Q+   +RP   ++++     ++    L+RT
Sbjct: 255 CWQKERSDRPKFGQIVNMLDKLIRNPNSLKRT 286

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 111
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L+      E       P++    Q   +I  
Sbjct: 112 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N +V  +  VK+ DFGM + I         KG        WM
Sbjct: 172 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWM 229
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 230 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLDKPDN 286
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELL 365
             D   + +R+C Q NP  RP+  E++
Sbjct: 287 CPDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 10/272 (3%)
Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           K  K++G G FG V  G     G+      +       + +  +  + E  ++ +  HPN
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 70
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           I+   G  T    + I  EY+  GS+   L ++ G+F    +    + I SG+ +L    
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 130
Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSSG 290
            VHRD+   NILV+ N   K++DFGM++ +        + +G      W APE I     
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 291 CNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
            + A D+WS G  + E M+  + P+        +  I     LP  P D        +  
Sbjct: 191 TS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPP-PMDCPIALHQLMLD 248
Query: 350 CLQRNPLNRPTAAELLD--HPFVKGAAPLERT 379
           C Q+   +RP   ++++     ++    L+RT
Sbjct: 249 CWQKERSDRPKFGQIVNMLDKLIRNPNSLKRT 280

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 14/252 (5%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V        G+     +V +    +   S  + ++E  ++  L H  +VQ
Sbjct: 10  KELGTGQFGVV------KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            YG  T +  ++I  EY++ G +   L++   +F    +    + +   + +L SK  +H
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY---WMAPEVIKNSSGCNLA 294
           RD+   N LV+  G VK++DFG+++++       S  GS +   W  PEV+  S   + +
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKS 182
Query: 295 VDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            DIW+ G  + E+ +  K P+ ++        I     L   P   S++    +  C   
Sbjct: 183 -DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHE 240
Query: 354 NPLNRPTAAELL 365
               RPT   LL
Sbjct: 241 KADERPTFKILL 252

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 47/285 (16%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +G G FG V+       G + A+K     L      + + +++    VL    +H ++V+
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG---QHSHVVR 75
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKH 234
           Y+ +   +D + I  EY +GGS+   + +       F E  +++   Q+  GL ++HS  
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 235 TVHRDIKGANILVD----PNG---------------RVKLADFGMAKHIAGQSCPLSFKG 275
            VH DIK +NI +     PN                  K+ D G   H+   S P   +G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSPQVEEG 192
Query: 276 SPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP------PWSQYEGVAAMFKIGNS 329
              ++A EV++ +       DI++L  TV+  A  +P       W +             
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI----------RQ 242
Query: 330 KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
             LP IP  LS E  + +++ +  +P  RP+A  L+ H  +  A+
Sbjct: 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 129/311 (41%), Gaps = 71/311 (22%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE----SAKQLMQEIVLLSRLRHPNI 176
           +G+G++G V V   + +    A++ + + +  K ++      +++  E+ L+ +L HPNI
Sbjct: 34  IGQGSYGVVRVAIENQTR---AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 177 VQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQ---------------------------- 206
            + Y  +  ED+ YI L  E   GG +   L                             
Sbjct: 91  ARLY--EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 207 -------------DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-- 251
                        D+ Q  E  I N  +QI S L +LH++   HRDIK  N L   N   
Sbjct: 149 AINGSIHGFRESLDFVQ-REKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 252 RVKLADFGMAKHIA----GQSCPLSFK-GSPYWMAPEVIKNSS-----GCNLAVDIWSLG 301
            +KL DFG++K       G+   ++ K G+PY++APEV+  ++      C    D WS G
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC----DAWSAG 263
Query: 302 CTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDD--LSDEGKDFIRLCLQRNPLNRP 359
             +  +     P+        + ++ N K     P+   LS   +D +   L RN   R 
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323
Query: 360 TAAELLDHPFV 370
            A   L HP++
Sbjct: 324 DAMRALQHPWI 334

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 111 PESHWKKGKMLGRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P ++ + GK LG G FG V     F     +      V +       +  + LM E+ ++
Sbjct: 29  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 88
Query: 169 SRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQF---------------- 211
           S L +H NIV   G+ T    + +  EY   G +   L+   +                 
Sbjct: 89  SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLD 148
Query: 212 ---GEPA----IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI 264
              G P     + +++ Q+  G+AFL SK+ +HRD+   N+L+      K+ DFG+A+ I
Sbjct: 149 KEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 265 AGQSCPLSFKGSPY----WMAPEVIKNSSGCNLAV--DIWSLGCTVLEM 307
              S  +  KG+      WMAPE I +   C   V  D+WS G  + E+
Sbjct: 209 MNDSNYI-VKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEI 253

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 110/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 145
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 146 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 203
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VD+WS+GC + EM   K
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 129/303 (42%), Gaps = 49/303 (16%)
Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT--LFDDAKSKESAKQ 160
             M++  + E H  + + +G G FG V+       G + A+K     L      + + ++
Sbjct: 1   AEMKSRYTTEFH--ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 58
Query: 161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD----YGQFGEPAI 216
           +    VL    +H ++V+Y+ +   +D + I  EY +GGS+   + +       F E  +
Sbjct: 59  VYAHAVLG---QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVD----PNG---------------RVKLAD 257
           ++   Q+  GL ++HS   VH DIK +NI +     PN                  K+ D
Sbjct: 116 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 175
Query: 258 FGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP----- 312
            G   H+   S P   +G   ++A EV++ +       DI++L  TV+  A  +P     
Sbjct: 176 LG---HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 232
Query: 313 -PWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             W +               LP IP  LS E  + +++ +  +P  RP+A  L+ H  + 
Sbjct: 233 DQWHEI----------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282
Query: 372 GAA 374
            A+
Sbjct: 283 SAS 285

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 109/257 (42%), Gaps = 18/257 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V  G+      +  +    L ++A       +L+ E  ++ +L +P IV+
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
             G    E  + + +E    G + K LQ      +  I     Q+  G+ +L   + VHR
Sbjct: 435 MIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 493
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY------WMAPEVIKNSSGCN 292
           D+   N+L+      K++DFG++K +        +K   +      W APE I N    +
Sbjct: 494 DLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECI-NYYKFS 550
Query: 293 LAVDIWSLGCTVLE-MATTKPPWSQYEG--VAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
              D+WS G  + E  +  + P+   +G  V AM + G   E    P     E  D + L
Sbjct: 551 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGCPREMYDLMNL 607
Query: 350 CLQRNPLNRP--TAAEL 364
           C   +  NRP   A EL
Sbjct: 608 CWTYDVENRPGFAAVEL 624

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 51  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+A+ +        + +G      W +PE I    
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 227 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 284
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 285 DCWQKDRNNRPKFEQIV 301

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEM 307
             G    VDIWS+GC + EM
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEM 307
             G    VDIWS+GC + EM
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 30/267 (11%)
Query: 121 LGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           LG+G+FG VY G        +     A+K V   ++A S     + + E  ++      +
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 76
Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGE-------PAIRNYTQ---QILS 225
           +V+  G  +      + +E ++ G +   L+      E       P++    Q   +I  
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWM 280
           G+A+L++   VHRD+   N  V  +  VK+ DFGM + I         KG        WM
Sbjct: 137 GMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRWM 194
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA--AMFKIGNSKELPTIPDD 338
           +PE +K+      + D+WS G  + E+AT       Y+G++   + +      L   PD+
Sbjct: 195 SPESLKDGVFTTYS-DVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGLLDKPDN 251
Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELL 365
             D   + +R+C Q NP  RP+  E++
Sbjct: 252 CPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 109/257 (42%), Gaps = 18/257 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V  G+      +  +    L ++A       +L+ E  ++ +L +P IV+
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
             G    E  + + +E    G + K LQ      +  I     Q+  G+ +L   + VHR
Sbjct: 436 MIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 494
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY------WMAPEVIKNSSGCN 292
           D+   N+L+      K++DFG++K +        +K   +      W APE I N    +
Sbjct: 495 DLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECI-NYYKFS 551
Query: 293 LAVDIWSLGCTVLE-MATTKPPWSQYEG--VAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
              D+WS G  + E  +  + P+   +G  V AM + G   E    P     E  D + L
Sbjct: 552 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGCPREMYDLMNL 608
Query: 350 CLQRNPLNRP--TAAEL 364
           C   +  NRP   A EL
Sbjct: 609 CWTYDVENRPGFAAVEL 625

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIK 141
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 199
Query: 288 SSGCNLAVDIWSLGCTVLEM 307
             G    VDIWS+GC + EM
Sbjct: 200 GMGYKENVDIWSVGCIMGEM 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 110/204 (53%), Gaps = 14/204 (6%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 134
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 135 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 192
Query: 288 SSGCNLAVDIWSLGCTVLEMATTK 311
             G    VD+WS+GC + EM   K
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 118/285 (41%), Gaps = 23/285 (8%)
Query: 96  PSVPRSPGRMENPVSPE---SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA 152
           P     P R  +  + E   S  K  +++G G FG V  G     G+      +      
Sbjct: 23  PETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVG 82
Query: 153 KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQF 211
            +++  +  + E  ++ +  HPN+V   G  T    + I +E++  G++   L+ + GQF
Sbjct: 83  YTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQF 142
Query: 212 GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI------- 264
               +    + I +G+ +L     VHRD+   NILV+ N   K++DFG+++ I       
Sbjct: 143 TVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAV 202
Query: 265 ---AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLE-MATTKPPWSQYEGV 320
               G   P+       W APE I+     + A D+WS G  + E M+  + P+      
Sbjct: 203 YTTTGGKIPVR------WTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQ 255
Query: 321 AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
             +  I     LP  P D        +  C Q+    RP   +++
Sbjct: 256 DVIKAIEEGYRLPA-PMDCPAGLHQLMLDCWQKERAERPKFEQIV 299

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEM 307
             G    VDIWS+GC + EM
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 124/284 (43%), Gaps = 50/284 (17%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +K+ +++G G FG V+   +   G+   ++ V        K + ++  +E+  L++L H 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV--------KYNNEKAEREVKALAKLDHV 65
Query: 175 NIVQY--------YGSKTVEDKL---------------------YIYLEYVSGGSIYKLL 205
           NIV Y        Y  +T +D L                     +I +E+   G++ + +
Sbjct: 66  NIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI 125
Query: 206 QDYGQFGEPAIR----NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA 261
           +   + GE   +       +QI  G+ ++HSK  +HRD+K +NI +    +VK+ DFG+ 
Sbjct: 126 E--KRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 262 KHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA 321
             +         KG+  +M+PE I +S      VD+++LG  + E+        +     
Sbjct: 184 TSLKNDGKRTRSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 242
Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
              + G       I D    + K  ++  L + P +RP  +E+L
Sbjct: 243 TDLRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 151
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ FL 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------WM 263
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 264 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 295

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 115/280 (41%), Gaps = 29/280 (10%)
Query: 108 PVSPESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
           PV   +  K   ++G G FG V       D   M A   +    +  SK+  +    E+ 
Sbjct: 17  PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAA--IKRMKEYASKDDHRDFAGELE 74
Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP---AIRNYTQQ 222
           +L +L  HPNI+   G+      LY+ +EY   G++   L+           AI N T  
Sbjct: 75  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 134
Query: 223 ILS-------------GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
            LS             G+ +L  K  +HR++   NILV  N   K+ADFG+++   GQ  
Sbjct: 135 TLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEV 191
Query: 270 PLSFKGSPY---WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFK 325
            +          WMA E + N S      D+WS G  + E+ +    P+          K
Sbjct: 192 YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 250
Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
           +     L   P +  DE  D +R C +  P  RP+ A++L
Sbjct: 251 LPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 7/206 (3%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKE-VTLFDDAKSKESAKQLMQEIVL 167
           +  E+  +K K+LG G FG V+ G     GE   +   + + +D   ++S + +   ++ 
Sbjct: 27  IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 86
Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYK-LLQDYGQFGEPAIRNYTQQILSG 226
           +  L H +IV+  G       L +  +Y+  GS+   + Q  G  G   + N+  QI  G
Sbjct: 87  IGSLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 145
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF---KGSPYWMAPE 283
           + +L     VHR++   N+L+    +V++ADFG+A  +      L +   K    WMA E
Sbjct: 146 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMAT 309
            I      + + D+WS G TV E+ T
Sbjct: 206 SIHFGKYTHQS-DVWSYGVTVWELMT 230

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 51  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+++ +        + +G      W +PE I    
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 227 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 284
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 285 DCWQKDRNNRPKFEQIV 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 51  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+++ +        + +G      W +PE I    
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 227 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 284
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 285 DCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 51  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+++ +        + +G      W +PE I    
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 227 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 284
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 285 DCWQKDRNNRPKFEQIV 301

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 51  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+++ +        + +G      W +PE I    
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 227 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 284
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 285 DCWQKDRNNRPKFEQIV 301

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 51  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+++ +        + +G      W +PE I    
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 227 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 284
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 285 DCWQKDRNNRPKFEQIV 301

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 92
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ FL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------WM 204
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 205 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 97
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ FL 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA 155
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------WM 209
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 210 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 241

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 93
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ FL 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVK------WM 205
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 206 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 237

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 49  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 164
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+++ +        + +G      W +PE I    
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 225 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 282
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 283 DCWQKDRNNRPKFEQIV 299

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 93
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ FL 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------WM 205
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 206 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 237

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 108/204 (52%), Gaps = 22/204 (10%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG     SF  +P     Y+ APE
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGT----SFMMTPEVVTRYYRAPE 195
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEM 307
           VI    G    VDIWS+GC + EM
Sbjct: 196 VIL-GMGYKENVDIWSVGCIMGEM 218

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 22/208 (10%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG     SF   P     Y+ APE
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGT----SFMMEPEVVTRYYRAPE 195
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTK 311
           VI    G    VDIWS+GC + EM   K
Sbjct: 196 VIL-GMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 39  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+++ +        + +G      W +PE I    
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 215 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 272
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 273 DCWQKDRNNRPKFEQIV 289

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 115/257 (44%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 51  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+ + +        + +G      W +PE I    
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 227 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 284
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 285 DCWQKDRNNRPKFEQIV 301

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           E   +  ++L  G F  VY   +  SG   A+K +     +  +E  + ++QE+  + +L
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL----SNEEEKNRAIIQEVCFMKKL 82
Query: 172 R-HPNIVQYYGSKTV--------EDKLYIYLEYVSGGSI--YKLLQDYGQFGEPAIRNYT 220
             HPNIVQ+  + ++        + +  +  E   G  +   K ++  G      +    
Sbjct: 83  SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 221 QQILSGLAFLHSKH--TVHRDIKGANILVDPNGRVKLADFGMAKHI-------------A 265
            Q    +  +H +    +HRD+K  N+L+   G +KL DFG A  I             A
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAV--DIWSLGCTVLEMATTKPPWSQYEGVAAM 323
                ++   +P +  PE+I   S   +    DIW+LGC +  +   + P+       A 
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAK 258
Query: 324 FKIGNSKELPTIP--DDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
            +I N K   +IP  D         IR  LQ NP  R + AE++
Sbjct: 259 LRIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 90
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ FL 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA 148
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------WM 202
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 203 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 234

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 92
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ FL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------WM 204
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 205 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 236

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 7/206 (3%)
Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKE-VTLFDDAKSKESAKQLMQEIVL 167
           +  E+  +K K+LG G FG V+ G     GE   +   + + +D   ++S + +   ++ 
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYK-LLQDYGQFGEPAIRNYTQQILSG 226
           +  L H +IV+  G       L +  +Y+  GS+   + Q  G  G   + N+  QI  G
Sbjct: 69  IGSLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF---KGSPYWMAPE 283
           + +L     VHR++   N+L+    +V++ADFG+A  +      L +   K    WMA E
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMAT 309
            I      + + D+WS G TV E+ T
Sbjct: 188 SIHFGKYTHQS-DVWSYGVTVWELMT 212

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 108/200 (54%), Gaps = 14/200 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQ--MELDHERMSYLLYQMLVGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEM 307
             G    VDIWS+G  + EM
Sbjct: 199 GMGYKENVDIWSVGVIMGEM 218

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 49/282 (17%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LGRG FG V+   N       A+K + L +   ++E   ++M+E+  L++L HP IV+Y+
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE---KVMREVKALAKLEHPGIVRYF 69
Query: 181 GS---KTVEDKL---------YIYLEYVSGGSIYKLLQDYGQFGE---PAIRNYTQQILS 225
            +   K   +KL         YI ++     ++   +       E       +   QI  
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM--------------------AKHIA 265
            + FLHSK  +HRD+K +NI    +  VK+ DFG+                    A+H  
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH-T 188
Query: 266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK 325
           GQ       G+  +M+PE I  +S  +  VDI+SLG  + E+    P  +Q E V  +  
Sbjct: 189 GQV------GTKLYMSPEQIHGNSYSH-KVDIFSLGLILFELLY--PFSTQMERVRTLTD 239
Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           + N K  P        E    ++  L  +P+ RP A  ++++
Sbjct: 240 VRNLKFPPLFTQKYPCEYV-MVQDMLSPSPMERPEAINIIEN 280

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 22  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+++ +        + +G      W +PE I    
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 198 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 255
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 256 DCWQKDRNNRPKFEQIV 272

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 112/254 (44%), Gaps = 8/254 (3%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           +++G G FG V  G     G+      +       +++  +  + E  ++ +  HPNI+ 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             G  T    + I  EY+  GS+   L+ + GQF    +    + I +G+ +L     VH
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVH 147
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSSGCNL 293
           RD+   NIL++ N   K++DFG+++ +        + +G      W APE I      + 
Sbjct: 148 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTS- 206
Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           A D+WS G  + E+ +  + P+ +      +  +     LP+ P D        +  C Q
Sbjct: 207 ASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPS-PMDCPAALYQLMLDCWQ 265
Query: 353 RNPLNRPTAAELLD 366
           +   +RP   E+++
Sbjct: 266 KERNSRPKFDEIVN 279

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+L+D   R ++L D+G
Sbjct: 124 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWG 177
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 178 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 315 SQYEGVAAMFKIGNSKELPTIPDD--------------------------------LSDE 342
             Y+ +  + K+  +++L    D                                 +S E
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 296
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 23/236 (9%)
Query: 96  PSVPRSPGRMENPVSPE---SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA 152
           P     PGR     + E   S     K++G G  G V  G     G+      +      
Sbjct: 29  PHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG 88
Query: 153 KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQF 211
            ++   +  + E  ++ +  HPNI++  G  T      I  EY+  GS+   L+ + GQF
Sbjct: 89  YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF 148
Query: 212 GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI------- 264
               +    + + +G+ +L     VHRD+   N+LVD N   K++DFG+++ +       
Sbjct: 149 TIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 265 ---AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWS 315
               G   P+       W APE I   +  + A D+WS G  + E+     +P W+
Sbjct: 209 XTTTGGKIPIR------WTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWN 257

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 91
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ +L 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK------WM 203
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 204 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 235

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 22/208 (10%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----YWMAPE 283
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG     SF   P     Y+ APE
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGT----SFMMEPEVVTRYYRAPE 195
Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTK 311
           VI    G    VD+WS+GC + EM   K
Sbjct: 196 VIL-GMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 125/276 (45%), Gaps = 39/276 (14%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +LGRG FG VY G  +D G + A+K +    + + +    Q   E+ ++S   H N+++ 
Sbjct: 45  ILGRGGFGKVYKGRLAD-GTLVAVKRLK---EERXQGGELQFQTEVEMISMAVHRNLLRL 100
Query: 180 YG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQIL----SGLAFLHSK- 233
            G   T  ++L +Y  Y++ GS+   L++  +   P      Q+I      GLA+LH   
Sbjct: 101 RGFCMTPTERLLVY-PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 159
Query: 234 --HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--CPLSFKGSPYWMAPEVIKNSS 289
               +HRD+K ANIL+D      + DFG+AK +  +      + +G+   +APE +    
Sbjct: 160 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGK 219
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWS-----------QYEGVAAMFKIGNSKELPTIPD- 337
                 D++  G  +LE+ T +  +              + V  + K    K+L  + D 
Sbjct: 220 SSE-KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---EKKLEALVDV 275
Query: 338 DLSDEGKD--------FIRLCLQRNPLNRPTAAELL 365
           DL    KD           LC Q +P+ RP  +E++
Sbjct: 276 DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 311

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 23/236 (9%)
Query: 96  PSVPRSPGRMENPVSPE---SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA 152
           P     PGR     + E   S     K++G G  G V  G     G+      +      
Sbjct: 29  PHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG 88
Query: 153 KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQF 211
            ++   +  + E  ++ +  HPNI++  G  T      I  EY+  GS+   L+ + GQF
Sbjct: 89  YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF 148
Query: 212 GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI------- 264
               +    + + +G+ +L     VHRD+   N+LVD N   K++DFG+++ +       
Sbjct: 149 TIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 265 ---AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT--TKPPWS 315
               G   P+       W APE I   +  + A D+WS G  + E+     +P W+
Sbjct: 209 YTTTGGKIPIR------WTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWN 257

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 110
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ +L 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 168
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WM 222
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 223 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 254

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 108/200 (54%), Gaps = 14/200 (7%)
Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 175 NIV----QYYGSKTVED--KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           NI+     +   K++E+   +YI +E +   ++ +++Q   +     +     Q+L G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQ--MELDHERMSYLLYQMLVGIK 140
Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKN 287
            LHS   +HRD+K +NI+V  +  +K+ DFG+A+  AG S  ++ +  + Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 288 SSGCNLAVDIWSLGCTVLEM 307
             G    VDIWS+G  + EM
Sbjct: 199 GMGYKENVDIWSVGVIMGEM 218

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 84
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ +L 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 142
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WM 196
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 197 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 228

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 125/276 (45%), Gaps = 39/276 (14%)
Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +LGRG FG VY G  +D G + A+K +    + +++    Q   E+ ++S   H N+++ 
Sbjct: 37  ILGRGGFGKVYKGRLAD-GXLVAVKRLK---EERTQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 180 YG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQIL----SGLAFLHSK- 233
            G   T  ++L +Y  Y++ GS+   L++  +   P      Q+I      GLA+LH   
Sbjct: 93  RGFCMTPTERLLVY-PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 234 --HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--CPLSFKGSPYWMAPEVIKNSS 289
               +HRD+K ANIL+D      + DFG+AK +  +      + +G    +APE +    
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGK 211
Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWS-----------QYEGVAAMFKIGNSKELPTIPD- 337
                 D++  G  +LE+ T +  +              + V  + K    K+L  + D 
Sbjct: 212 SSE-KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---EKKLEALVDV 267
Query: 338 DLSDEGKD--------FIRLCLQRNPLNRPTAAELL 365
           DL    KD           LC Q +P+ RP  +E++
Sbjct: 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 92
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ +L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WM 204
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 205 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 90
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ +L 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 148
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WM 202
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 203 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 234

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 124 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 178 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 315 SQYEGVAAMFKIGNSKELPTIPDD--------------------------------LSDE 342
             Y+ +  + K+  +++L    D                                 +S E
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 296
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 124 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 178 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 315 SQYEGVAAMFKIGNSKELPTIPDD--------------------------------LSDE 342
             Y+ +  + K+  +++L    D                                 +S E
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 296
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 124 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 178 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 315 SQYEGVAAMFKIGNSKEL------------PTIPDDL--------------------SDE 342
             Y+ +  + K+  +++L            P   D L                    S E
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 296
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 124 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 178 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 315 SQYEGVAAMFKIGNSKEL------------PTIPDDL--------------------SDE 342
             Y+ +  + K+  +++L            P   D L                    S E
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 296
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 91
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ +L 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WM 203
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 204 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 235

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 111
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ +L 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 169
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WM 223
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 224 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 255

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 129 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 182
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 183 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 241
Query: 315 SQYEGVAAMFKIGNSKELPTIPDD--------------------------------LSDE 342
             Y+ +  + K+  +++L    D                                 +S E
Sbjct: 242 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 301
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 302 ALDFLDKLLRYDHQSRLTAREAMEHPY 328

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 124 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 178 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 315 SQYEGVAAMFKIGNSKEL------------PTIPDDL--------------------SDE 342
             Y+ +  + K+  +++L            P   D L                    S E
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 296
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 124 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 178 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 315 SQYEGVAAMFKIGNSKELPTIPDD--------------------------------LSDE 342
             Y+ +  + K+  +++L    D                                 +S E
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 296
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 124 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 178 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 315 SQYEGVAAMFKIGNSKELPTIPDD--------------------------------LSDE 342
             Y+ +  + K+  +++L    D                                 +S E
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 296
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 123 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 176
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 177 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
Query: 315 SQYEGVAAMFKIGNSKEL------------PTIPDDL--------------------SDE 342
             Y+ +  + K+  +++L            P   D L                    S E
Sbjct: 236 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 295
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 296 ALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 13/225 (5%)
Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           LG G FG V  G      +   +  + +      K   +++M+E  ++ +L +P IV+  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVA-IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ---QILSGLAFLHSKHTVH 237
           G    E  L + +E   GG ++K L   G+  E  + N  +   Q+  G+ +L  K+ VH
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS----PYWMAPEVIKNSSGCNL 293
           R++   N+L+      K++DFG++K +       + + +      W APE I N    + 
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSS 518
Query: 294 AVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
             D+WS G T+ E ++  + P+ + +G   M  I   K +   P+
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 563

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 124 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 178 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 315 SQYEGVAAMFKIGNSKEL------------PTIPDDL--------------------SDE 342
             Y+ +  + K+  +++L            P   D L                    S E
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 296
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 89
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ +L 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 147
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WM 201
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 202 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 233

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 123 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 176
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 177 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
Query: 315 SQYEGVAAMFKIGNSKELPTIPDD--------------------------------LSDE 342
             Y+ +  + K+  +++L    D                                 +S E
Sbjct: 236 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 295
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 296 ALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 45/207 (21%)
Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-VKLADFG 259
           +Y+ L DY       IR Y  +IL  L + HS   +HRD+K  N+++D   R ++L D+G
Sbjct: 122 LYQTLTDYD------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 175
Query: 260 MAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW---- 314
           +A+    GQ   +    S Y+  PE++ +    + ++D+WSLGC +  M   K P+    
Sbjct: 176 LAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
Query: 315 SQYEGVAAMFKIGNSKEL------------PTIPDDL--------------------SDE 342
             Y+ +  + K+  +++L            P   D L                    S E
Sbjct: 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 294
Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
             DF+   L+ +  +R TA E ++HP+
Sbjct: 295 ALDFLDKLLRYDHQSRLTAREAMEHPY 321

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 87
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ +L 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WM 199
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 200 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 119 KMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +++GRG FG VY G   ++D  ++ CA+K +    D        Q + E +++    HPN
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFLTEGIIMKDFSHPN 92
Query: 176 IVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN---YTQQILSGLAFLH 231
           ++   G     E    + L Y+  G +   +++  +   P +++   +  Q+  G+ +L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----------AGQSCPLSFKGSPYWM 280
           SK  VHRD+   N ++D    VK+ADFG+A+ +            G   P+       WM
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WM 204
Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           A E ++       + D+WS G  + E+ T   P
Sbjct: 205 ALESLQTQKFTTKS-DVWSFGVLLWELMTRGAP 236

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 109/257 (42%), Gaps = 18/257 (7%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G FG V  G+      +  +    L ++A       +L+ E  ++ +L +P IV+
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
             G    E  + + +E    G + K LQ      +  I     Q+  G+ +L   + VHR
Sbjct: 91  MIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 149
Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY------WMAPEVIKNSSGCN 292
           D+   N+L+      K++DFG++K +        +K   +      W APE I N    +
Sbjct: 150 DLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECI-NYYKFS 206
Query: 293 LAVDIWSLGCTVLE-MATTKPPWSQYEG--VAAMFKIGNSKELPTIPDDLSDEGKDFIRL 349
              D+WS G  + E  +  + P+   +G  V AM + G   E    P     E  D + L
Sbjct: 207 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGCPREMYDLMNL 263
Query: 350 CLQRNPLNRP--TAAEL 364
           C   +  NRP   A EL
Sbjct: 264 CWTYDVENRPGFAAVEL 280

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 32/227 (14%)
Query: 111 PESHWKKGKMLGRGTFGHVY--VGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           P  + + GK+LG G FG V     +      +     V +  +       + LM E+ ++
Sbjct: 43  PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 102
Query: 169 SRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQ----- 221
           ++L  H NIV   G+ T+   +Y+  EY   G +   L+   + F E  I    Q     
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 222 -----------------QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI 264
                            Q+  G+ FL  K  VHRD+   N+LV     VK+ DFG+A+ I
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 265 AGQSCPLSFKGSPY----WMAPEVIKNSSGCNLAVDIWSLGCTVLEM 307
              S     +G+      WMAPE +       +  D+WS G  + E+
Sbjct: 223 MSDS-NYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEI 267

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 16/257 (6%)
Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL----FDDAKSKESAKQLMQEIVLLSRLRHP 174
           K++G G FG V  G      ++ + KE+++         +++  +  + E  ++ +  HP
Sbjct: 51  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSK 233
           NI++  G  T    + I  E +  GS+   L+ +  QF    +    + I SG+ +L   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-SCPLSFKGSPY---WMAPEVIKNSS 289
             VHRD+   NIL++ N   K++DFG+++ +        + +G      W +PE I    
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 GCNLAVDIWSLGCTVLE-MATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             + A D+WS G  + E M+  + P+ +      +  +     LP  P D        + 
Sbjct: 227 FTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLML 284
Query: 349 LCLQRNPLNRPTAAELL 365
            C Q++  NRP   +++
Sbjct: 285 DCWQKDRNNRPKFEQIV 301
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	602
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-154
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-142
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-133
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-117
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-117
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-116
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-112
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-110
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-110
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-98
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-93
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-93
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-92
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-92
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-92
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-91
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-90
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-88
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-87
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-84
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-81
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-81
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-79
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-79
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-79
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-79
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-75
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-75
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-74
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-73
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-73
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-73
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-72
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-72
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-70
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-70
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-67
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-66
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-66
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-65
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-65
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-64
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-64
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-64
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-63
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-63
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-61
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-61
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-61
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-61
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-61
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-61
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-61
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-61
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-61
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-61
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-60
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-60
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-60
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-60
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-60
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-60
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-59
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-59
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-59
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-59
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-59
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-58
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-58
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-58
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-57
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-57
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-57
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-57
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-57
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-57
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-57
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-57
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-56
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-56
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-56
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-56
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-56
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-56
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-56
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-56
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-56
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-56
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-55
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-55
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-55
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-55
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-55
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-55
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-55
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-55
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-55
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-55
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-55
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-54
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-54
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-54
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-54
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-54
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-53
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-53
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-53
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-52
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-52
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-52
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-52
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-52
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-51
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-50
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-50
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-49
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-49
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-49
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-48
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-48
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-48
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-47
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-46
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-46
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-45
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-45
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-44
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-44
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-44
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-43
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-43
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-43
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-42
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-42
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-41
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-41
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-41
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-40
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-39
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-39
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-39
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-39
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-38
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-38
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-38
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-37
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-37
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-36
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-36
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-36
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-35
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-35
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-34
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-34
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-33
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-31
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-30
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-29
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-28
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-28
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-06
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-26
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-25
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-20
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-19
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-19
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-18
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-16

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  444 bits (1145), Expect = e-154
 Identities = 113/296 (38%), Positives = 165/296 (55%), Gaps = 12/296 (4%)

Query: 91  SAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD 150
           S  ++         +E             +LG+GT+G VY G +  +    A+KE+    
Sbjct: 1   SMRSTEEGDCESDLLEYDYE-YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE-- 57

Query: 151 DAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YG 209
             +    ++ L +EI L   L+H NIVQY GS +    + I++E V GGS+  LL+  +G
Sbjct: 58  --RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115

Query: 210 QF--GEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLADFGMAKHIAG 266
                E  I  YT+QIL GL +LH    VHRDIKG N+L++  +G +K++DFG +K +AG
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

Query: 267 -QSCPLSFKGSPYWMAPEVIKNSS-GCNLAVDIWSLGCTVLEMATTKPPWSQY-EGVAAM 323
              C  +F G+  +MAPE+I     G   A DIWSLGCT++EMAT KPP+ +  E  AAM
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235

Query: 324 FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
           FK+G  K  P IP+ +S E K FI  C + +P  R  A +LL   F+K ++  ++T
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT 291

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  414 bits (1065), Expect = e-142
 Identities = 81/325 (24%), Positives = 128/325 (39%), Gaps = 22/325 (6%)

Query: 66  GKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVS----PESHWKKGKML 121
             Q      L     S S+                   +++                  +
Sbjct: 7   SGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRV 66

Query: 122 GRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYG 181
           GRG+FG V+   +  +G  CA+K+V L             ++E+V  + L  P IV  YG
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRL---------EVFRVEELVACAGLSSPRIVPLYG 117

Query: 182 SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIK 241
           +      + I++E + GGS+ +L++  G   E     Y  Q L GL +LH++  +H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177

Query: 242 GANILVDPNG-RVKLADFGMAKHIAGQSCPL------SFKGSPYWMAPEVIKNSSGCNLA 294
             N+L+  +G R  L DFG A  +                G+   MAPEV+     C+  
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAK 236

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-KELPTIPDDLSDEGKDFIRLCLQR 353
           VDIWS  C +L M     PW+QY       KI +    +  IP   +      I+  L++
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK 296

Query: 354 NPLNRPTAAELLDHPFVKGAAPLER 378
            P++R +A EL              
Sbjct: 297 EPVHRASAMELRRKVGKALQEVGGL 321

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  389 bits (1002), Expect = e-133
 Identities = 76/272 (27%), Positives = 142/272 (52%), Gaps = 14/272 (5%)

Query: 109 VSPESHW-KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           +S +  + K    +GRG+F  VY G ++++    A  E+       +K   ++  +E  +
Sbjct: 21  MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD--RKLTKSERQRFKEEAEM 78

Query: 168 LSRLRHPNIVQYYGS----KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI 223
           L  L+HPNIV++Y S       +  + +  E ++ G++   L+ +       +R++ +QI
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138

Query: 224 LSGLAFLHSKHT--VHRDIKGANILVD-PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM 280
           L GL FLH++    +HRD+K  NI +  P G VK+ D G+A          +  G+P +M
Sbjct: 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFM 197

Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-TIPDDL 339
           APE+ +     + +VD+++ G  +LEMAT++ P+S+ +  A +++   S   P +     
Sbjct: 198 APEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255

Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             E K+ I  C+++N   R +  +LL+H F +
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  349 bits (898), Expect = e-117
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 15/298 (5%)

Query: 79  TISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESH----WKKGKMLGRGTFGHVYVGFN 134
           ++    P   S     S ++  SPG   +P  PES     +++   LG G++G V+   +
Sbjct: 22  SMHQLQPRRVSFRGEASETLQ-SPGY--DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRS 78

Query: 135 SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE 194
            + G + A+K          K+ A++L +        +HP  V+   +      LY+  E
Sbjct: 79  KEDGRLYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137

Query: 195 YVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRV 253
              G S+ +  + +G    E  +  Y +  L  LA LHS+  VH D+K ANI + P GR 
Sbjct: 138 L-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC 196

Query: 254 KLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           KL DFG+   +         +G P +MAPE+++       A D++SLG T+LE+A     
Sbjct: 197 KLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMEL 254

Query: 314 WSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               EG     ++      P     LS E +  + + L+ +P  R TA  LL  P ++
Sbjct: 255 PHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  348 bits (895), Expect = e-117
 Identities = 69/295 (23%), Positives = 124/295 (42%), Gaps = 31/295 (10%)

Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G M       + + + + +G G FG V+       G + A+K       A S +    L 
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK-PLAGSVDEQNALR 59

Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ----FGEPAIRN 218
           +        +H ++V+Y+ +   +D + I  EY +GGS+   + +  +    F E  +++
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119

Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR-------------------VKLADFG 259
              Q+  GL ++HS   VH DIK +NI +                         K+ D G
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 260 MAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG 319
               I   S P   +G   ++A EV++ +       DI++L  TV+  A  +P     + 
Sbjct: 180 HVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD- 235

Query: 320 VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
                +I   + LP IP  LS E  + +++ +  +P  RP+A  L+ H  +  A+
Sbjct: 236 --QWHEIRQGR-LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  346 bits (889), Expect = e-116
 Identities = 85/307 (27%), Positives = 146/307 (47%), Gaps = 10/307 (3%)

Query: 87  SHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV 146
                       P+   R +   +  ++++  K +GRG F  VY       G   A+K+V
Sbjct: 6   QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65

Query: 147 TLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ 206
            +FD   +K      ++EI LL +L HPN+++YY S   +++L I LE    G + ++++
Sbjct: 66  QIFDLMDAKA-RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124

Query: 207 DYGQ----FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK 262
            + +      E  +  Y  Q+ S L  +HS+  +HRDIK AN+ +   G VKL D G+ +
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184

Query: 263 HIAGQSCPL-SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW-SQYEGV 320
             + ++    S  G+PY+M+PE I   +G N   DIWSLGC + EMA  + P+      +
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 243

Query: 321 AAMFKIGNSKELPTIPDD-LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            ++ K     + P +P D  S+E +  + +C+  +P  RP    + D       A    +
Sbjct: 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM-HACTASS 302

Query: 380 ILAPEPS 386
           +      
Sbjct: 303 LEHHHHH 309

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  339 bits (871), Expect = e-112
 Identities = 77/382 (20%), Positives = 149/382 (39%), Gaps = 27/382 (7%)

Query: 67  KQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPES------HWKKGKM 120
              S  L      +  ++          SP +        +  + E        +   K 
Sbjct: 4   HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQ 63

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN--IVQ 178
           +G G    V+   N +  ++ A+K V L  +    ++      EI  L++L+  +  I++
Sbjct: 64  IGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            Y  +  +  +Y+ +E      +   L+          ++Y + +L  +  +H    VH 
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 179

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSG----- 290
           D+K AN L+  +G +KL DFG+A  +   +  +   S  G+  +M PE IK+ S      
Sbjct: 180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG 238

Query: 291 -----CNLAVDIWSLGCTVLEMATTKPPWSQYEG-VAAMFKIGNSKELPTIPDDLSDEGK 344
                 +   D+WSLGC +  M   K P+ Q    ++ +  I +       PD    + +
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 298

Query: 345 DFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQL 404
           D ++ CL+R+P  R +  ELL HP+V+        +      ++   +   +       +
Sbjct: 299 DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSI 358

Query: 405 RNVSTFDTERLAVHSSRVSQTS 426
              +    E  +   S  S +S
Sbjct: 359 LKAAKTLYEHYSGGESHNSSSS 380

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  333 bits (855), Expect = e-110
 Identities = 69/300 (23%), Positives = 132/300 (44%), Gaps = 21/300 (7%)

Query: 88  HSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT 147
           H +  ++   +       ++       +   K +G G    V+   N +  ++ A+K V 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN 61

Query: 148 LFDDAKSKESAKQLMQEIVLLSRLRHPN--IVQYYGSKTVEDKLYIYLEYVSGGSIYKLL 205
           L  +    ++      EI  L++L+  +  I++ Y  +  +  +Y+ +E      +   L
Sbjct: 62  L--EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL 118

Query: 206 QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA 265
           +          ++Y + +L  +  +H    VH D+K AN L+  +G +KL DFG+A  + 
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177

Query: 266 GQSCPL---SFKGSPYWMAPEVIKNSS----------GCNLAVDIWSLGCTVLEMATTKP 312
             +  +   S  G+  +M PE IK+ S            +   D+WSLGC +  M   K 
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

Query: 313 PWSQYEG-VAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           P+ Q    ++ +  I +       PD    + +D ++ CL+R+P  R +  ELL HP+V+
Sbjct: 238 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  332 bits (853), Expect = e-110
 Identities = 75/334 (22%), Positives = 146/334 (43%), Gaps = 30/334 (8%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            +   K +G G    V+   N +  ++ A+K V L  +    ++      EI  L++L+ 
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQ 66

Query: 174 PN--IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
            +  I++ Y  +  +  +Y+ +E      +   L+          ++Y + +L  +  +H
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNS 288
               VH D+K AN L+  +G +KL DFG+A  +   +  +   S  G+  +M PE IK+ 
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 289 SG----------CNLAVDIWSLGCTVLEMATTKPPWSQYEG-VAAMFKIGNSKELPTIPD 337
           S            +   D+WSLGC +  M   K P+ Q    ++ +  I +       PD
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244

Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIK 397
               + +D ++ CL+R+P  R +  ELL HP+V+              + +  G T  +K
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ--------THPVNQMAKGTTEEMK 296

Query: 398 ALGIGQLRNVSTFDTERLAVHSSRVSQTSLNASD 431
            + +GQL  +++ ++   A  +     +   + +
Sbjct: 297 YV-LGQLVGLNSPNSILKAAKTLYEHYSGGESHN 329

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  300 bits (769), Expect = 7e-98
 Identities = 109/292 (37%), Positives = 166/292 (56%), Gaps = 8/292 (2%)

Query: 93  ATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA 152
           A SP     PG       PE  + K + +G+G+FG V+ G ++ + ++ A+K + L    
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL---E 58

Query: 153 KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG 212
           ++++  + + QEI +LS+   P + +YYGS   + KL+I +EY+ GGS   LL+  G   
Sbjct: 59  EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLD 117

Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP-L 271
           E  I    ++IL GL +LHS+  +HRDIK AN+L+  +G VKLADFG+A  +        
Sbjct: 118 ETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177

Query: 272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE 331
           +F G+P+WMAPEVIK  S  +   DIWSLG T +E+A  +PP S+   +  +F I  +  
Sbjct: 178 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP 236

Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAP 383
            PT+  + S   K+F+  CL + P  RPTA ELL H F+   A  + + L  
Sbjct: 237 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK-KTSYLTE 286

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  290 bits (744), Expect = 3e-94
 Identities = 100/287 (34%), Positives = 154/287 (53%), Gaps = 13/287 (4%)

Query: 99  PRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESA 158
            R    +   + P   W+    LG G FG VY   N ++G + A K +      KS+E  
Sbjct: 5   SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET----KSEEEL 60

Query: 159 KQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIR 217
           +  + EI +L+   HP IV+  G+   + KL+I +E+  GG++  ++ +      EP I+
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120

Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP-LSFKGS 276
              +Q+L  L FLHSK  +HRD+K  N+L+   G ++LADFG++           SF G+
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180

Query: 277 PYWMAPEVI----KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL 332
           PYWMAPEV+       +  +   DIWSLG T++EMA  +PP  +   +  + KI  S   
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP- 239

Query: 333 PTI--PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLE 377
           PT+  P   S E +DF+++ L +NP  RP+AA+LL+HPFV      +
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  290 bits (744), Expect = 1e-93
 Identities = 100/319 (31%), Positives = 153/319 (47%), Gaps = 11/319 (3%)

Query: 65  DGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVS---PESHWKKGKML 121
                 H     P T +     +     A   +       +        PE  +   + +
Sbjct: 3   YYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREI 62

Query: 122 GRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYG 181
           G G+FG VY   +  + E+ A+K+++     +S E  + +++E+  L +LRHPN +QY G
Sbjct: 63  GHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 182 SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIK 241
               E   ++ +EY  G +   L        E  I   T   L GLA+LHS + +HRD+K
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181

Query: 242 GANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS--SGCNLAVDIWS 299
             NIL+   G VKL DFG A  +A  +   SF G+PYWMAPEVI        +  VD+WS
Sbjct: 182 AGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWS 238

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI-PDDLSDEGKDFIRLCLQRNPLNR 358
           LG T +E+A  KPP      ++A++ I  ++  P +     S+  ++F+  CLQ+ P +R
Sbjct: 239 LGITCIELAERKPPLFNMNAMSALYHIAQNES-PALQSGHWSEYFRNFVDSCLQKIPQDR 297

Query: 359 PTAAELLDHPFVKGAAPLE 377
           PT+  LL H FV    P  
Sbjct: 298 PTSEVLLKHRFVLRERPPT 316

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  288 bits (738), Expect = 3e-93
 Identities = 98/271 (36%), Positives = 150/271 (55%), Gaps = 12/271 (4%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           PE  +   + LG G++G VY   + ++G++ A+K+V +  D +       +++EI ++ +
Sbjct: 27  PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIMQQ 80

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAF 229
              P++V+YYGS      L+I +EY   GS+  +++       E  I    Q  L GL +
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP-LSFKGSPYWMAPEVIKNS 288
           LH    +HRDIK  NIL++  G  KLADFG+A  +        +  G+P+WMAPEVI+  
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE- 199

Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLSDEGKDF 346
            G N   DIWSLG T +EMA  KPP++    + A+F I  +   PT   P+  SD   DF
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRKPELWSDNFTDF 258

Query: 347 IRLCLQRNPLNRPTAAELLDHPFVKGAAPLE 377
           ++ CL ++P  R TA +LL HPFV+ A  + 
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  286 bits (735), Expect = 1e-92
 Identities = 96/312 (30%), Positives = 151/312 (48%), Gaps = 24/312 (7%)

Query: 87  SHSNSAATSPSVPRSPGRME------------NPVSPESHWKKGKMLGRGTFGHVYVGFN 134
             S     + ++    G +             +   P         +G G+ G V +   
Sbjct: 7   HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLARE 66

Query: 135 SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE 194
             SG   A+K + L    + ++  + L  E+V++   +H N+V+ Y S  V ++L++ +E
Sbjct: 67  KHSGRQVAVKMMDL----RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122

Query: 195 YVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVK 254
           ++ GG++  ++    +  E  I    + +L  LA+LH++  +HRDIK  +IL+  +GRVK
Sbjct: 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVK 181

Query: 255 LADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP 313
           L+DFG    I        S  G+PYWMAPEVI   S     VDIWSLG  V+EM   +PP
Sbjct: 182 LSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPP 240

Query: 314 WSQYEGVAAMFKIGNSKELPTI--PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           +     V AM ++ +S   P +     +S   +DF+   L R+P  R TA ELLDHPF+ 
Sbjct: 241 YFSDSPVQAMKRLRDSPP-PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299

Query: 372 GAAPLERTILAP 383
                E   L P
Sbjct: 300 QTGLPE--CLVP 309

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  285 bits (732), Expect = 2e-92
 Identities = 94/276 (34%), Positives = 150/276 (54%), Gaps = 12/276 (4%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+  + + + +G+G  G VY   +  +G+  A++++ L    + +   + ++ EI+++  
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRE 73

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            ++PNIV Y  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L FL
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFL 132

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIKNSS 289
           HS   +HRDIK  NIL+  +G VKL DFG    I   QS   +  G+PYWMAPEV+    
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-K 191

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI--PDDLSDEGKDFI 347
                VDIWSLG   +EM   +PP+     + A++ I  +   P +  P+ LS   +DF+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFL 250

Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAP 383
             CL+ +   R +A ELL H F+K A PL    L P
Sbjct: 251 NRCLEMDVEKRGSAKELLQHQFLKIAKPLS--SLTP 284

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  285 bits (731), Expect = 3e-92
 Identities = 89/299 (29%), Positives = 150/299 (50%), Gaps = 26/299 (8%)

Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ 160
               +   ++ +  ++  +++G G    V   + +   E  A+K + L    K + S  +
Sbjct: 4   DSSALPWSINRD-DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL---EKCQTSMDE 59

Query: 161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ--------DYGQFG 212
           L++EI  +S+  HPNIV YY S  V+D+L++ ++ +SGGS+  +++          G   
Sbjct: 60  LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119

Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL- 271
           E  I    +++L GL +LH    +HRD+K  NIL+  +G V++ADFG++  +A       
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179

Query: 272 -----SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI 326
                +F G+P WMAPEV++   G +   DIWS G T +E+AT   P+ +Y  +  +   
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239

Query: 327 GNSK--------ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLE 377
             +         +   +        +  I LCLQ++P  RPTAAELL H F + A   E
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  284 bits (728), Expect = 4e-91
 Identities = 77/290 (26%), Positives = 140/290 (48%), Gaps = 14/290 (4%)

Query: 85  PFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMK 144
              H +S     +       ME        + + + +G G+FG   +  +++ G    +K
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMEK-------YVRLQKIGEGSFGKAILVKSTEDGRQYVIK 55

Query: 145 EVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKL 204
           E+ +     S +  ++  +E+ +L+ ++HPNIVQY  S      LYI ++Y  GG ++K 
Sbjct: 56  EINI--SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKR 113

Query: 205 LQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK 262
           +       F E  I ++  QI   L  +H +  +HRDIK  NI +  +G V+L DFG+A+
Sbjct: 114 INAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173

Query: 263 HI-AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA 321
            + +      +  G+PY+++PE+ +N    N   DIW+LGC + E+ T K  +       
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232

Query: 322 AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            + KI +    P +    S + +  +    +RNP +RP+   +L+  F+ 
Sbjct: 233 LVLKIISGS-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  280 bits (718), Expect = 6e-90
 Identities = 89/280 (31%), Positives = 145/280 (51%), Gaps = 21/280 (7%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P   ++  +++G GT+G VY G +  +G++ A+K + +  D +     +++ QEI +L +
Sbjct: 22  PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-----EEIKQEINMLKK 76

Query: 171 L-RHPNIVQYYGS------KTVEDKLYIYLEYVSGGSIYKLLQ--DYGQFGEPAIRNYTQ 221
              H NI  YYG+        ++D+L++ +E+   GS+  L++        E  I    +
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136

Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP-LSFKGSPYWM 280
           +IL GL+ LH    +HRDIKG N+L+  N  VKL DFG++  +        +F G+PYWM
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196

Query: 281 APEVIK----NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTI- 335
           APEVI       +  +   D+WSLG T +EMA   PP      + A+F I  +   P + 
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-PRLK 255

Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
               S + + FI  CL +N   RP   +L+ HPF++    
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  274 bits (702), Expect = 6e-88
 Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 38/290 (13%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S +++  +LG+G FG V    N+      A+K++       ++E    ++ E++LL+ L 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-----RHTEEKLSTILSEVMLLASLN 60

Query: 173 HPNIVQYYGS-------------KTVEDKLYIYLEYVSGGSIYKLLQDYGQFG-EPAIRN 218
           H  +V+YY +                +  L+I +EY   G++Y L+              
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL------- 271
             +QIL  L+++HS+  +HRD+K  NI +D +  VK+ DFG+AK++      L       
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 272 --------SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM 323
                   S  G+  ++A EV+  +   N  +D++SLG    EM    P  +  E V  +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238

Query: 324 FKI--GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            K+   + +  P   D+     K  IRL +  +P  RP A  LL+  ++ 
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  275 bits (704), Expect = 3e-87
 Identities = 76/377 (20%), Positives = 131/377 (34%), Gaps = 64/377 (16%)

Query: 105 MENPVSPESHWKKGKMLGRG--TFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           M + +     ++   ++G+G      V +     +GE   ++ + L  +A S E    L 
Sbjct: 17  MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL--EACSNEMVTFLQ 74

Query: 163 QEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYT 220
            E+ +     HPNIV Y  +   +++L++   +++ GS   L+  +      E AI    
Sbjct: 75  GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL 134

Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFG--------MAKHIAGQSCPLS 272
           Q +L  L ++H    VHR +K ++IL+  +G+V L+             +       P  
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 273 FKGSPYWMAPEVIK-NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI----- 326
                 W++PEV++ N  G +   DI+S+G T  E+A    P+        + +      
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254

Query: 327 ---------------------------------------GNSKELPTIPDDLSDEGKDFI 347
                                                               S     F+
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314

Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNV 407
             CLQRNP  RP+A+ LL+H F K         L      V P     I      Q ++ 
Sbjct: 315 EQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTP-----ITNFEGSQSQDH 369

Query: 408 STFDTERLAVHSSRVSQ 424
           S        +    V  
Sbjct: 370 SGIFGLVTNLEELEVDD 386

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  264 bits (677), Expect = 2e-84
 Identities = 63/278 (22%), Positives = 121/278 (43%), Gaps = 33/278 (11%)

Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           K+ +++G G FG V+   +   G+   +K V       + E A    +E+  L++L H N
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKA---EREVKALAKLDHVN 65

Query: 176 IVQYYGS----------------KTVEDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIR 217
           IV Y G                 ++    L+I +E+   G++ + ++     +  +    
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 218 NYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
              +QI  G+ ++HSK  ++RD+K +NI +    +VK+ DFG+   +         KG+ 
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL 185

Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD 337
            +M+PE I +       VD+++LG  + E+         +E       + +      I D
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDLRD----GIISD 238

Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
               + K  ++  L + P +RP  +E+L    V   +P
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  256 bits (656), Expect = 2e-81
 Identities = 81/282 (28%), Positives = 130/282 (46%), Gaps = 23/282 (8%)

Query: 102 PGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL 161
           P R E+       ++    +G G++G          G++   KE+     + ++   + L
Sbjct: 2   PSRAED-------YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY--GSMTEAEKQML 52

Query: 162 MQEIVLLSRLRHPNIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQDYGQ----FGEPA 215
           + E+ LL  L+HPNIV+YY          LYI +EY  GG +  ++    +      E  
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112

Query: 216 IRNYTQQILSGLAFLHSKHT-----VHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSC 269
           +     Q+   L   H +       +HRD+K AN+ +D    VKL DFG+A+ +    S 
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172

Query: 270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS 329
             +F G+PY+M+PE +   S  N   DIWSLGC + E+    PP++ +       KI   
Sbjct: 173 AKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 231

Query: 330 KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           K    IP   SDE  + I   L     +RP+  E+L++P + 
Sbjct: 232 K-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  255 bits (654), Expect = 8e-81
 Identities = 69/294 (23%), Positives = 124/294 (42%), Gaps = 35/294 (11%)

Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +  + LGRG FG V+   N       A+K + L +   ++E     M+E+  L++L HP 
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV---MREVKALAKLEHPG 64

Query: 176 IVQYYGS------------KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP---AIRNYT 220
           IV+Y+ +             + +  LYI ++     ++   +       E       +  
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------------AGQ 267
            QI   + FLHSK  +HRD+K +NI    +  VK+ DFG+   +                
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG 327
           +      G+  +M+PE I   +  +  VDI+SLG  + E+    P  +Q E V  +  + 
Sbjct: 185 ARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVR 241

Query: 328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTIL 381
           N K  P +           ++  L  +P+ RP A  ++++   +      +T+L
Sbjct: 242 NLK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVL 294

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  252 bits (646), Expect = 2e-79
 Identities = 75/267 (28%), Positives = 132/267 (49%), Gaps = 13/267 (4%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI-VLLSRLRHPNIVQY 179
           +G GT G V+      +G + A+K++    +   KE  K+++ ++ V+L     P IVQ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSHDCPYIVQC 89

Query: 180 YGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV-HR 238
           +G+      ++I +E +   +     +  G   E  +   T  I+  L +L  KH V HR
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC----NLA 294
           D+K +NIL+D  G++KL DFG++  +          G   +MAPE I          ++ 
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIR 209

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDL--SDEGKDFIRLCL 351
            D+WSLG +++E+AT + P+   +     + K+    E P +P  +  S + + F++ CL
Sbjct: 210 ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCL 268

Query: 352 QRNPLNRPTAAELLDHPFVKGAAPLER 378
            ++   RP   +LL+H F+K    LE 
Sbjct: 269 TKDHRKRPKYNKLLEHSFIKRYETLEV 295

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  251 bits (642), Expect = 3e-79
 Identities = 79/264 (29%), Positives = 131/264 (49%), Gaps = 14/264 (5%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI-VLLSRLRHPNIVQY 179
           LGRG +G V    +  SG++ A+K +    +    +  K+L+ ++ + +  +  P  V +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVTF 71

Query: 180 YGSKTVEDKLYIYLEYVSGG--SIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKH-T 235
           YG+   E  ++I +E +       YK + D GQ   E  +      I+  L  LHSK   
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK---NSSGCN 292
           +HRD+K +N+L++  G+VK+ DFG++ ++          G   +MAPE I    N  G +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDL-SDEGKDFIRLC 350
           +  DIWSLG T++E+A  + P+  +      + ++      P +P D  S E  DF   C
Sbjct: 192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSPQLPADKFSAEFVDFTSQC 250

Query: 351 LQRNPLNRPTAAELLDHPFVKGAA 374
           L++N   RPT  EL+ HPF     
Sbjct: 251 LKKNSKERPTYPELMQHPFFTLHE 274

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  252 bits (645), Expect = 4e-79
 Identities = 77/267 (28%), Positives = 129/267 (48%), Gaps = 18/267 (6%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI-VLLSRLRHPNIVQY 179
           +GRG +G V    +  SG++ A+K +    D   ++  KQL+ ++ V++     P IVQ+
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSSDCPYIVQF 86

Query: 180 YGSKTVEDKLYIYLEYVSGGS--IYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHT 235
           YG+   E   +I +E +S      YK +         E  +   T   +  L  L     
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146

Query: 236 V-HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC--- 291
           + HRDIK +NIL+D +G +KL DFG++  +          G   +MAPE I  S+     
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY 206

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDL----SDEGKDF 346
           ++  D+WSLG T+ E+AT + P+ ++  V   + ++    + P + +      S    +F
Sbjct: 207 DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINF 265

Query: 347 IRLCLQRNPLNRPTAAELLDHPFVKGA 373
           + LCL ++   RP   ELL HPF+   
Sbjct: 266 VNLCLTKDESKRPKYKELLKHPFILMY 292

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  245 bits (628), Expect = 2e-75
 Identities = 73/297 (24%), Positives = 118/297 (39%), Gaps = 24/297 (8%)

Query: 94  TSPSVPRSPGRMENPVS--PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD 151
           +SPS+ +  G  E  V    +  +    +LG G  G +      D     A+K +     
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRI----- 56

Query: 152 AKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ 210
               E      +E+ LL     HPN+++Y+ ++      YI +E  +      + Q    
Sbjct: 57  --LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFA 114

Query: 211 FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-----RVKLADFGMAKHIA 265
                     QQ  SGLA LHS + VHRD+K  NIL+         +  ++DFG+ K +A
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 266 GQSCPLS----FKGSPYWMAPEVIKNSSGCNL--AVDIWSLGCTVLEMATT-KPPWSQYE 318
                 S      G+  W+APE++      N    VDI+S GC    + +    P+ +  
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 319 GVAAMFKIGN-SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
              A   +G  S +            ++ I   +  +P  RP+A  +L HPF     
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  242 bits (619), Expect = 6e-75
 Identities = 81/309 (26%), Positives = 141/309 (45%), Gaps = 54/309 (17%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
            +  ++K   LG G  G V+   +  SG + A K + L           Q+++E+ +L  
Sbjct: 31  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHE 87

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
              P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 147

Query: 231 HSKHTV-HRDIKGANILVDPNGRVKLADFGMAKHIAGQ---SCPLSFKGSPYWMAPEVIK 286
             KH + HRD+K +NILV+  G +KL DFG    ++GQ   S   SF G+  +M+PE ++
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQ 203

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL-------------- 332
             +  ++  DIWS+G +++EMA  + P    +        G   E               
Sbjct: 204 G-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262

Query: 333 ---------------------------PTIPDDL-SDEGKDFIRLCLQRNPLNRPTAAEL 364
                                      P +P  + S E +DF+  CL +NP  R    +L
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322

Query: 365 LDHPFVKGA 373
           + H F+K +
Sbjct: 323 MVHAFIKRS 331

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  237 bits (608), Expect = 3e-74
 Identities = 85/281 (30%), Positives = 137/281 (48%), Gaps = 21/281 (7%)

Query: 110 SPESHWKK-----GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           S +  W       G+ LG+G FG+VY+     S  + A+K V      +      QL +E
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGVEHQLRRE 59

Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQIL 224
           + + S LRHPNI++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ 
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119

Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ----SCPLSFKGSPYWM 280
           + L++ HSK  +HRDIK  N+L+   G +K+ADFG + H         C     G+  ++
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYL 174

Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDL 339
            PE+I+     +  VD+WSLG    E    KPP+ +       + +I   +   T PD +
Sbjct: 175 PPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVE--FTFPDFV 230

Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHP-FVKGAAPLERT 379
           ++  +D I   L+ NP  RP   E+L+HP     ++     
Sbjct: 231 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  236 bits (605), Expect = 1e-73
 Identities = 83/311 (26%), Positives = 141/311 (45%), Gaps = 36/311 (11%)

Query: 92  AATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD 151
           A   P V   P            + +G+ LG+G F   +   ++D+ E+ A K V     
Sbjct: 1   AKEIPEVLVDPRSRRR-------YVRGRFLGKGGFAKCFEISDADTKEVFAGKIV----- 48

Query: 152 AKSK----ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD 207
            KS        +++  EI +   L H ++V ++G     D +++ LE     S+ +L + 
Sbjct: 49  PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR 108

Query: 208 YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ 267
                EP  R Y +QI+ G  +LH    +HRD+K  N+ ++ +  VK+ DFG+A  +   
Sbjct: 109 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168

Query: 268 ------SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA 321
                  C     G+P ++APEV+    G +  VD+WS+GC +  +   KPP+ +   + 
Sbjct: 169 GERKKVLC-----GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLK 221

Query: 322 AMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHP-FVKGAAPLERT 379
             + +I  ++   +IP  ++      I+  LQ +P  RPT  ELL+   F  G  P    
Sbjct: 222 ETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR-- 277

Query: 380 ILAPEPSDVPP 390
            L      +PP
Sbjct: 278 -LPITCLTIPP 287

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  235 bits (603), Expect = 1e-73
 Identities = 77/275 (28%), Positives = 138/275 (50%), Gaps = 27/275 (9%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK----ESAKQLMQEIVLLS 169
            +K G +LG+G+F  VY   +  +G   A+K +      K         +++  E+ +  
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI-----DKKAMYKAGMVQRVQNEVKIHC 66

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLA 228
           +L+HP+I++ Y      + +Y+ LE    G + + L++    F E   R++  QI++G+ 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ------SCPLSFKGSPYWMAP 282
           +LHS   +HRD+  +N+L+  N  +K+ADFG+A  +          C     G+P +++P
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-----GTPNYISP 181

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSD 341
           E+    S   L  D+WSLGC    +   +PP+   + V     K+  +     +P  LS 
Sbjct: 182 EIA-TRSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADY--EMPSFLSI 237

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHP-FVKGAAP 375
           E KD I   L+RNP +R + + +LDHP   + ++ 
Sbjct: 238 EAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  240 bits (613), Expect = 4e-73
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 45/303 (14%)

Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
             S ++     K+LG G+ G V     S  G   A+K +         +     + EI L
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRM-------LIDFCDIALMEIKL 61

Query: 168 LSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA-------IRNY 219
           L+    HPN+++YY S+T +  LYI LE     ++  L++      E           + 
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVD-------------PNGRVKLADFGMAKHIAG 266
            +QI SG+A LHS   +HRD+K  NILV               N R+ ++DFG+ K +  
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 267 QSCPLSFK-----GSPYWMAPEVIKNSS------GCNLAVDIWSLGCTVLEMATT-KPP- 313
                        G+  W APE+++ S+          ++DI+S+GC    + +  K P 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 314 WSQYEGVAAMFK-IGNSKELPTIPDD-LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             +Y   + + + I +  E+  + D  L  E  D I   +  +PL RPTA ++L HP   
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300

Query: 372 GAA 374
             +
Sbjct: 301 PKS 303

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  235 bits (601), Expect = 2e-72
 Identities = 88/330 (26%), Positives = 150/330 (45%), Gaps = 31/330 (9%)

Query: 74  PLPPITISNSSPFSHSNSA-ATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVG 132
           P P        P   +  A A +P     P  + +P S    + +G+ LG+G F   +  
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR-RYVRGRFLGKGGFAKCFEI 60

Query: 133 FNSDSGEMCAMKEVTLFDDAKSK----ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK 188
            ++D+ E+ A K V      KS        +++  EI +   L H ++V ++G     D 
Sbjct: 61  SDADTKEVFAGKIV-----PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115

Query: 189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVD 248
           +++ LE     S+ +L +      EP  R Y +QI+ G  +LH    +HRD+K  N+ ++
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175

Query: 249 PNGRVKLADFGMAKHIAGQ------SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGC 302
            +  VK+ DFG+A  +          C     G+P ++APEV+    G +  VD+WS+GC
Sbjct: 176 EDLEVKIGDFGLATKVEYDGERKKVLC-----GTPNYIAPEVLSK-KGHSFEVDVWSIGC 229

Query: 303 TVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTA 361
            +  +   KPP+ +   +   + +I  ++   +IP  ++      I+  LQ +P  RPT 
Sbjct: 230 IMYTLLVGKPPF-ETSCLKETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTI 286

Query: 362 AELLDHP-FVKGAAPLERTILAPEPSDVPP 390
            ELL+   F  G  P     L      +PP
Sbjct: 287 NELLNDEFFTSGYIPAR---LPITCLTIPP 313

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  233 bits (596), Expect = 2e-72
 Identities = 81/277 (29%), Positives = 130/277 (46%), Gaps = 20/277 (7%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLF-DDAKSKESAKQLMQEIVLLSRLRHPNI 176
           G+ LG+G FG+VY+     +  + A+K   LF    + +    QL +EI + S LRHPNI
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALK--VLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           ++ Y       ++Y+ LE+   G +YK LQ +G+F E     + +++   L + H +  +
Sbjct: 77  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVI 136

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQ----SCPLSFKGSPYWMAPEVIKNSSGCN 292
           HRDIK  N+L+   G +K+ADFG + H         C     G+  ++ PE+I+     +
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-----GTLDYLPPEMIEG-KTHD 190

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCL 351
             VD+W  G    E     PP+           +I N       P  LSD  KD I   L
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISKLL 247

Query: 352 QRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDV 388
           + +P  R     +++HP+VK  +     +L P     
Sbjct: 248 RYHPPQRLPLKGVMEHPWVKANSR---RVLPPVYQST 281

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  229 bits (587), Expect = 1e-70
 Identities = 62/317 (19%), Positives = 119/317 (37%), Gaps = 32/317 (10%)

Query: 87  SHSNSAATSPSVPRSPGRMENPVSPESH-WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKE 145
            H +  ++        G M   V  ++  +   + LG G F +V +      G   A+K 
Sbjct: 5   HHHHHHSSGRENLYFQGHM---VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61

Query: 146 VTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGS----KTVEDKLYIYLEYVSGGSI 201
           +   +    ++  ++  +E  +     HPNI++        +  + + ++ L +   G++
Sbjct: 62  ILCHE----QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117

Query: 202 YKLLQDYGQ----FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLAD 257
           +  ++          E  I      I  GL  +H+K   HRD+K  NIL+   G+  L D
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD 177

Query: 258 FG----------MAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC--NLAVDIWSLGCTVL 305
            G           ++         + + +  + APE+    S C  +   D+WSLGC + 
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237

Query: 306 EMATTKPP--WSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAE 363
            M   + P      +G +    + N   +P      S      +   +  +P  RP    
Sbjct: 238 AMMFGEGPYDMVFQKGDSVALAVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPL 296

Query: 364 LLDHP-FVKGAAPLERT 379
           LL     ++  AP + T
Sbjct: 297 LLSQLEALQPPAPGQHT 313

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  228 bits (583), Expect = 4e-70
 Identities = 63/307 (20%), Positives = 116/307 (37%), Gaps = 46/307 (14%)

Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           M +  +    W    +LG+G   +V+ G +  +G++ A+K    F++          M+E
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKV---FNNISFLRPVDVQMRE 57

Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQ---FGEPAIRNY 219
             +L +L H NIV+ +  +      +  L  E+   GS+Y +L++        E      
Sbjct: 58  FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117

Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLSFKG 275
            + ++ G+  L     VHR+IK  NI+     D     KL DFG A+ +      +S  G
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG 177

Query: 276 SPYWMAPEVIKNSSGC-------NLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMF 324
           +  ++ P++ + +             VD+WS+G T    AT   P+  +EG       M+
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 325 KIGNSK--------------------ELPT---IPDDLSDEGKDFIRLCLQRNPLNRPTA 361
           KI   K                    ++P    +   L       +   L+ +       
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 362 AELLDHP 368
            +     
Sbjct: 298 DQFFAET 304

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  220 bits (563), Expect = 7e-67
 Identities = 74/330 (22%), Positives = 136/330 (41%), Gaps = 59/330 (17%)

Query: 87  SHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMK-- 144
           ++SN    +  V      + +       ++  + L +G F  + +       +  A+K  
Sbjct: 12  NYSNLIYLNKYVKEKDKYIND-------YRIIRTLNQGKFNKIILC--EKDNKFYALKKY 62

Query: 145 -----------EVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL 193
                        +  D    K        E+ +++ +++   +   G  T  D++YI  
Sbjct: 63  EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122

Query: 194 EYVSGGSIYKLLQDYGQ--------FGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGAN 244
           EY+   SI K  + +               I+   + +L+  +++H+ K+  HRD+K +N
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182

Query: 245 ILVDPNGRVKLADFGMAKHIAGQ----SCPLSFKGSPYWMAPEVIKNSSGC-NLAVDIWS 299
           IL+D NGRVKL+DFG ++++  +    S      G+  +M PE   N S      VDIWS
Sbjct: 183 ILMDKNGRVKLSDFGESEYMVDKKIKGSR-----GTYEFMPPEFFSNESSYNGAKVDIWS 237

Query: 300 LGCTVLEMATTKPPWSQYEGVAAMF-KIGNSK-----------------ELPTIPDDLSD 341
           LG  +  M     P+S    +  +F  I                     +     + LS+
Sbjct: 238 LGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN 297

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           E  DF++L L++NP  R T+ + L H ++ 
Sbjct: 298 EDIDFLKLFLRKNPAERITSEDALKHEWLA 327

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  220 bits (563), Expect = 2e-66
 Identities = 63/306 (20%), Positives = 116/306 (37%), Gaps = 46/306 (15%)

Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
           M +  +    W    +LG+G   +V+ G +  +G++ A+K    F++          M+E
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKV---FNNISFLRPVDVQMRE 57

Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQ---FGEPAIRNY 219
             +L +L H NIV+ +  +      +  L  E+   GS+Y +L++        E      
Sbjct: 58  FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117

Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLSFKG 275
            + ++ G+  L     VHR+IK  NI+     D     KL DFG A+ +      +S  G
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG 177

Query: 276 SPYWMAPEVIKNSSGC-------NLAVDIWSLGCTVLEMATTKPPWSQYEG----VAAMF 324
           +  ++ P++ + +             VD+WS+G T    AT   P+  +EG       M+
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 325 KIGNSK--------------------ELPT---IPDDLSDEGKDFIRLCLQRNPLNRPTA 361
           KI   K                    ++P    +   L       +   L+ +       
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 362 AELLDH 367
            +    
Sbjct: 298 DQFFAE 303

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  216 bits (552), Expect = 6e-66
 Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 21/274 (7%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           +  +   + LG G FG V++     SG    +K +   +  +S+   +Q+  EI +L  L
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI---NKDRSQVPMEQIEAEIEVLKSL 77

Query: 172 RHPNIVQYYGSKTVEDKLYIYL--EYVSGG----SIYKLLQDYGQFGEPAIRNYTQQILS 225
            HPNI++ +     ED   +Y+  E   GG     I           E  +    +Q+++
Sbjct: 78  DHPNIIKIFE--VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135

Query: 226 GLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAP 282
            LA+ HS+H VH+D+K  NIL     P+  +K+ DFG+A+         +  G+  +MAP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELPTIPDDL 339
           EV K         DIWS G  +  + T   P          +  K    +         L
Sbjct: 196 EVFKRDVT--FKCDIWSAGVVMYFLLTGCLPFTGTSL--EEVQQKATYKEPNYAVECRPL 251

Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA 373
           + +  D ++  L ++P  RP+AA++L H + K A
Sbjct: 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  220 bits (563), Expect = 2e-65
 Identities = 78/286 (27%), Positives = 138/286 (48%), Gaps = 16/286 (5%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
              +K  ++LG+G+FG V +  +  +G+ CA+K ++     K K   + L++E+ LL +L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK-RQVKQKTDKESLLREVQLLKQL 83

Query: 172 RHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            HPNI++ Y     EDK Y YL  E  +GG ++  +    +F E       +Q+LSG+ +
Sbjct: 84  DHPNIMKLYE--FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 230 LHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK 286
           +H    VHRD+K  N+L+     +  +++ DFG++ H           G+ Y++APEV+ 
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELPTIP-DDLSDE 342
            +       D+WS G  +  + +  PP     E    +  K+   K          +S+ 
Sbjct: 202 GTYD--EKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTFELPQWKKVSES 257

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDV 388
            KD IR  L   P  R +A + LDH +++     + ++  P   + 
Sbjct: 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  218 bits (557), Expect = 3e-65
 Identities = 76/314 (24%), Positives = 140/314 (44%), Gaps = 21/314 (6%)

Query: 78  ITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDS 137
           I +S S          T       P       +    +   K LG G  G V + F   +
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPK------ALRDEYIMSKTLGSGACGEVKLAFERKT 159

Query: 138 GEMCAMKEVT----LFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK-LYIY 192
            +  A++ ++        A+  + A  +  EI +L +L HP I++       + +  YI 
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN--FFDAEDYYIV 217

Query: 193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV---DP 249
           LE + GG ++  +    +  E   + Y  Q+L  + +LH    +HRD+K  N+L+   + 
Sbjct: 218 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 277

Query: 250 NGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS--GCNLAVDIWSLGCTVLEM 307
           +  +K+ DFG +K +   S   +  G+P ++APEV+ +    G N AVD WSLG  +   
Sbjct: 278 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337

Query: 308 ATTKPPWSQYEGVAAMF-KIGNSK-ELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            +  PP+S++    ++  +I + K         ++S++  D ++  L  +P  R T  E 
Sbjct: 338 LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397

Query: 365 LDHPFVKGAAPLER 378
           L HP+++      +
Sbjct: 398 LRHPWLQDEDMKRK 411

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  212 bits (543), Expect = 2e-64
 Identities = 83/295 (28%), Positives = 138/295 (46%), Gaps = 22/295 (7%)

Query: 88  HSNSAATSPSVPRSPGRMENPVSPESHW-------KKGKMLGRGTFGHVYVG-FNSDSGE 139
           H +   +   +P +                        + +G G+FG V+   ++   G 
Sbjct: 5   HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH---GS 61

Query: 140 MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGG 199
             A+K   L +     E   + ++E+ ++ RLRHPNIV + G+ T    L I  EY+S G
Sbjct: 62  DVAVK--ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119

Query: 200 SIYKLLQDYG---QFGEPAIRNYTQQILSGLAFLHSKHT--VHRDIKGANILVDPNGRVK 254
           S+Y+LL   G   Q  E    +    +  G+ +LH+++   VHR++K  N+LVD    VK
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179

Query: 255 LADFGMAKHIAGQSCPL-SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVL-EMATTKP 312
           + DFG+++  A       S  G+P WMAPEV+++    N   D++S G  +L E+AT + 
Sbjct: 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFG-VILWELATLQQ 237

Query: 313 PWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           PW        +  +G   +   IP +L+ +    I  C    P  RP+ A ++D 
Sbjct: 238 PWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  218 bits (557), Expect = 3e-64
 Identities = 82/329 (24%), Positives = 137/329 (41%), Gaps = 26/329 (7%)

Query: 80  ISNSSPFSHSNSAATSPSVPRSPGRMENPVSP--ESHWKKGKMLGRGTFGHVYVGFNSDS 137
           + +    S          +  +PG             + K + LG G +G V +    + 
Sbjct: 1   MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60

Query: 138 GEMCAMK---------EVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK 188
               A+K              D+   ++  +++  EI LL  L HPNI++ +     EDK
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD--VFEDK 118

Query: 189 LYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANIL 246
            Y YL  E+  GG +++ + +  +F E    N  +QILSG+ +LH  + VHRDIK  NIL
Sbjct: 119 KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL 178

Query: 247 V---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCT 303
           +   +    +K+ DFG++   +         G+ Y++APEV+K         D+WS G  
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNE--KCDVWSCGVI 236

Query: 304 VLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELPTIP-DDLSDEGKDFIRLCLQRNPLNRP 359
           +  +    PP     +    +  K+   K         ++SDE K+ I+L L  +   R 
Sbjct: 237 MYILLCGYPPFGG--QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294

Query: 360 TAAELLDHPFVKGAAPLERTILAPEPSDV 388
           TA E L+  ++K  A              
Sbjct: 295 TAEEALNSRWIKKYANNINKSDQKTLCGA 323

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  210 bits (537), Expect = 7e-64
 Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 21/274 (7%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK-ESAKQLMQEIVLLSR 170
             ++     +GRG++G V +     +    A K++      K   E   +  QEI ++  
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI-----PKYFVEDVDRFKQEIEIMKS 62

Query: 171 LRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           L HPNI++ Y   T ED   IYL  E  +GG +++ +     F E       + +LS +A
Sbjct: 63  LDHPNIIRLYE--TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120

Query: 229 FLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           + H  +  HRD+K  N L     P+  +KL DFG+A          +  G+PY+++P+V+
Sbjct: 121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180

Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELPTIP-DDLSD 341
           +   G     D WS G  +  +    PP  +  +  + +  KI       P     ++S 
Sbjct: 181 EGLYG--PECDEWSAGVMMYVLLCGYPPFSAPTD--SEVMLKIREGTFTFPEKDWLNVSP 236

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
           + +  IR  L ++P  R T+ + L+H + +    
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  215 bits (550), Expect = 2e-63
 Identities = 71/278 (25%), Positives = 134/278 (48%), Gaps = 27/278 (9%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK---ESAKQLMQEIVLL 168
              +    MLG+G+FG V    +  + +  A+K +      K+    +    +++E+ LL
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI-----NKASAKNKDTSTILREVELL 75

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
            +L HPNI++ +    +ED    Y+  E  +GG ++  +    +F E       +Q+ SG
Sbjct: 76  KKLDHPNIMKLFE--ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133

Query: 227 LAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + ++H  + VHRD+K  NIL+   + +  +K+ DFG++      +      G+ Y++APE
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPP-WSQ-YEGVAAMFKIGN----SKELPTIPD 337
           V++ +       D+WS G  +  + +  PP + +    +    + G       +  TI  
Sbjct: 194 VLRGTYD--EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI-- 249

Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             SD+ KD IR  L  +P  R TA + L+HP+++  + 
Sbjct: 250 --SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  215 bits (549), Expect = 4e-63
 Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 23/269 (8%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAK---QLMQEIVLLSRLRHP 174
            K LG G +G V +  +  +    A+K +      K+  S     +L++E+ +L  L HP
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKII-----RKTSVSTSSNSKLLEEVAVLKLLDHP 96

Query: 175 NIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           NI++ Y     EDK   YL  E   GG ++  +    +F E       +Q+LSG+ +LH 
Sbjct: 97  NIMKLYD--FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154

Query: 233 KHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
            + VHRD+K  N+L+   + +  +K+ DFG++     Q       G+ Y++APEV++   
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY 214

Query: 290 GCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELPTIP-DDLSDEGKD 345
                 D+WS+G  +  +    PP   Q +    +  K+   K    +    ++S+  KD
Sbjct: 215 D--EKCDVWSIGVILFILLAGYPPFGGQTD--QEILRKVEKGKYTFDSPEWKNVSEGAKD 270

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
            I+  LQ +   R +A + L+HP++K   
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKEMC 299

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  207 bits (528), Expect = 2e-62
 Identities = 74/280 (26%), Positives = 137/280 (48%), Gaps = 27/280 (9%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ---LMQEIVLL 168
              +    MLG+G+FG V    +  + +  A+K +      K+    K    +++E+ LL
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI-----NKASAKNKDTSTILREVELL 75

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
            +L HPNI++ +    +ED    Y+  E  +GG ++  +    +F E       +Q+ SG
Sbjct: 76  KKLDHPNIMKLFE--ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133

Query: 227 LAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           + ++H  + VHRD+K  NIL+   + +  +K+ DFG++      +      G+ Y++APE
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPP-WSQYE-GVAAMFKIG----NSKELPTIPD 337
           V++ +       D+WS G  +  + +  PP + + E  +    + G    +  +  TI  
Sbjct: 194 VLRGTYD--EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI-- 249

Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLE 377
             SD+ KD IR  L  +P  R TA + L+HP+++  +  E
Sbjct: 250 --SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  204 bits (520), Expect = 1e-61
 Identities = 72/262 (27%), Positives = 127/262 (48%), Gaps = 18/262 (6%)

Query: 118 GKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
            +++G G FG VY   +    G+  A+K      D    ++ + + QE  L + L+HPNI
Sbjct: 12  EEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT- 235
           +   G    E  L + +E+  GG + ++L    +     + N+  QI  G+ +LH +   
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 236 --VHRDIKGANILVD--------PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
             +HRD+K +NIL+          N  +K+ DFG+A+    ++  +S  G+  WMAPEVI
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAAGAYAWMAPEVI 186

Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
           + S   +   D+WS G  + E+ T + P+   +G+A  + +  +K    IP    +    
Sbjct: 187 RASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAK 245

Query: 346 FIRLCLQRNPLNRPTAAELLDH 367
            +  C   +P +RP+   +LD 
Sbjct: 246 LMEDCWNPDPHSRPSFTNILDQ 267

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  205 bits (524), Expect = 2e-61
 Identities = 73/281 (25%), Positives = 134/281 (47%), Gaps = 15/281 (5%)

Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT----LFDDAKSKESAKQLMQ 163
           P +    +   K LG G  G V + F   + +  A+K ++        A+  + A  +  
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64

Query: 164 EIVLLSRLRHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQ 222
           EI +L +L HP I++       + +  YI LE + GG ++  +    +  E   + Y  Q
Sbjct: 65  EIEILKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122

Query: 223 ILSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYW 279
           +L  + +LH    +HRD+K  N+L+   + +  +K+ DFG +K +   S   +  G+P +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182

Query: 280 MAPEVIKNSS--GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSK-ELPTI 335
           +APEV+ +    G N AVD WSLG  +    +  PP+S++    ++  +I + K      
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242

Query: 336 P-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
              ++S++  D ++  L  +P  R T  E L HP+++    
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  206 bits (526), Expect = 2e-61
 Identities = 84/326 (25%), Positives = 137/326 (42%), Gaps = 31/326 (9%)

Query: 67  KQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKK----GKMLG 122
               H   +   T +       S +A+ +P             S              LG
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELG 62

Query: 123 RGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGS 182
           RG    VY      + +  A+K +      K     K +  EI +L RL HPNI++    
Sbjct: 63  RGATSIVYRCKQKGTQKPYALKVL------KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 183 KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKG 242
                ++ + LE V+GG ++  + + G + E    +  +QIL  +A+LH    VHRD+K 
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKP 176

Query: 243 ANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWS 299
            N+L     P+  +K+ADFG++K +  Q    +  G+P + APE+++        VD+WS
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR-GCAYGPEVDMWS 235

Query: 300 LG-------CTVLEMATTKPPWSQYEGVAAMF-KIGNSK-ELPTIP-DDLSDEGKDFIRL 349
           +G       C          P+    G   MF +I N +    +   D++S   KD +R 
Sbjct: 236 VGIITYILLCGF-------EPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288

Query: 350 CLQRNPLNRPTAAELLDHPFVKGAAP 375
            +  +P  R T  + L HP+V G A 
Sbjct: 289 LIVLDPKKRLTTFQALQHPWVTGKAA 314

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  204 bits (521), Expect = 3e-61
 Identities = 80/290 (27%), Positives = 137/290 (47%), Gaps = 38/290 (13%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV----------------------TLFDD 151
            +     +G+G++G V + +N +     AMK +                           
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 152 AKSKESAKQLMQEIVLLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYG 209
            + +   +Q+ QEI +L +L HPN+V+         ED LY+  E V+ G + ++     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-K 132

Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
              E   R Y Q ++ G+ +LH +  +HRDIK +N+LV  +G +K+ADFG++    G   
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 270 PLS-FKGSPYWMAPEVIKNS----SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF 324
            LS   G+P +MAPE +  +    SG   A+D+W++G T+      + P+   E +  + 
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSG--KALDVWAMGVTLYCFVFGQCPFMD-ERIMCLH 249

Query: 325 -KIGNSKELPTIPD--DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            KI    +    PD  D++++ KD I   L +NP +R    E+  HP+V 
Sbjct: 250 SKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  203 bits (519), Expect = 3e-61
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 11/275 (4%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNH 64

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
            N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVIKNSSG 290
              HRDIK  N+L+D    +K++DFG+A      +         G+  ++APE++K    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRL 349
               VD+WS G  +  M   + PW Q       +     K+    P   +       +  
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244

Query: 350 CLQRNPLNRPTAAELLDHP-FVKGAAPLERTILAP 383
            L  NP  R T  ++     + K    L++    P
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKP---LKKGAKRP 276

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  205 bits (524), Expect = 3e-61
 Identities = 73/293 (24%), Positives = 142/293 (48%), Gaps = 8/293 (2%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           +++  K +G+G F  V +  +  +G   A+K   +     +  S ++L +E+ ++  L H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNH 73

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           PNIV+ +     E  LY+ +EY SGG ++  L  +G+  E   R+  +QI+S + + H K
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
             VHRD+K  N+L+D +  +K+ADFG +          +F G+P + APE+ +       
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            VD+WSLG  +  + +   P+   + +  +  ++   K    IP  +S + ++ ++  L 
Sbjct: 194 EVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGK--YRIPFYMSTDCENLLKRFLV 250

Query: 353 RNPLNRPTAAELLDHPFVKG--AAPLERTILAPEPSDVPPGVTNGIKALGIGQ 403
            NP+ R T  +++   ++         +  + PE         + +  +G  Q
Sbjct: 251 LNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQ 303

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  204 bits (522), Expect = 3e-61
 Identities = 81/282 (28%), Positives = 133/282 (47%), Gaps = 25/282 (8%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSR 170
              +   ++LG G F  V++     +G++ A+K +      KS       L  EI +L +
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-----KKSPAFRDSSLENEIAVLKK 62

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           ++H NIV            Y+ ++ VSGG ++  + + G + E       QQ+LS + +L
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 231 HSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQS----CPLSFKGSPYWMAPE 283
           H    VHRD+K  N+L    + N ++ + DFG++K          C     G+P ++APE
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC-----GTPGYVAPE 177

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELPTIP-DDL 339
           V+      + AVD WS+G     +    PP +   E  + +F KI     E  +   DD+
Sbjct: 178 VLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYE--ETESKLFEKIKEGYYEFESPFWDDI 234

Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTIL 381
           S+  KDFI   L+++P  R T  + L HP++ G   L R I 
Sbjct: 235 SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIY 276

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  206 bits (526), Expect = 3e-61
 Identities = 55/379 (14%), Positives = 119/379 (31%), Gaps = 55/379 (14%)

Query: 48  HPRAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPR-SPGRME 106
           H  +G   +  Q       ++  +R+P   +  ++    S ++S  ++       P R+E
Sbjct: 6   HHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVE 65

Query: 107 NPVSPES-HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           + +        +G +LG+          + ++GE   +  V  F +     + KQ+ +E+
Sbjct: 66  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVH-VPYFTERPPSNAIKQMKEEV 124

Query: 166 VLLSRLR-------------------------HPNIVQYYGSKTVEDKLYIYLEY----- 195
           + L  LR                            +++    +     L  +  Y     
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184

Query: 196 ---VSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGR 252
                G  +      +      A    T Q++  LA LH    VH  ++  +I++D  G 
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244

Query: 253 VKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC----------NLAVDIWSLGC 302
           V L  F            +    S  +  PE+    +              + D W+LG 
Sbjct: 245 VFLTGFEHLVR---DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301

Query: 303 TVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAA 362
            +  +     P ++   +     I  S        ++    +  +   L+    +R    
Sbjct: 302 VIYWIWCADLPITKDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPL 355

Query: 363 ELLDHPFVKGAAPLERTIL 381
           + ++ P  +         L
Sbjct: 356 QAMETPEYEQLRTELSAAL 374

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  204 bits (521), Expect = 3e-61
 Identities = 76/298 (25%), Positives = 132/298 (44%), Gaps = 20/298 (6%)

Query: 90  NSAATSPSVPRSPGRMENPVSPESHWK-----KGKMLGRGTFGHVYVGFNSDSGEMCAMK 144
           +  A  P       +   P       +      GK+LG G+F  V +     +    A+K
Sbjct: 2   DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK 61

Query: 145 EVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKL 204
            +      K  +    + +E  ++SRL HP  V+ Y +   ++KLY  L Y   G + K 
Sbjct: 62  ILEKRHIIKENK-VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120

Query: 205 LQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI 264
           ++  G F E   R YT +I+S L +LH K  +HRD+K  NIL++ +  +++ DFG AK +
Sbjct: 121 IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

Query: 265 AGQSCPL---SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA 321
           + +S      SF G+  +++PE++        + D+W+LGC + ++    PP+       
Sbjct: 181 SPESKQARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEY 238

Query: 322 AMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPT------AAELLDHPFVKG 372
            +F KI   +     P+    + +D +   L  +   R           L  HPF + 
Sbjct: 239 LIFQKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  206 bits (526), Expect = 5e-61
 Identities = 64/274 (23%), Positives = 132/274 (48%), Gaps = 12/274 (4%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           + +G+G+FG V +   +D+ +M AMK          +   + + +E+ ++  L HP +V 
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMK-YMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + S   E+ +++ ++ + GG +   LQ    F E  ++ +  +++  L +L ++  +HR
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHR 139

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI--KNSSGCNLAVD 296
           D+K  NIL+D +G V + DF +A  +  ++   +  G+  +MAPE+   +  +G + AVD
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199

Query: 297 IWSLGCTVLEMATTKPPW--SQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            WSLG T  E+   + P+          +      +    T P   S E    ++  L+ 
Sbjct: 200 WWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQEMVSLLKKLLEP 257

Query: 354 NPLNR-PTAAELLDHPFVKG---AAPLERTILAP 383
           NP  R    +++ + P++      A  ++ ++  
Sbjct: 258 NPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPG 291

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  204 bits (521), Expect = 1e-60
 Identities = 77/322 (23%), Positives = 130/322 (40%), Gaps = 47/322 (14%)

Query: 91  SAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFD 150
           S   S          ++ V  E  ++  +++G+G F  V    N ++G+  A+K V    
Sbjct: 2   SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIV---- 57

Query: 151 DAKSKESAKQ------LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL--EYVSGG--- 199
              +K ++        L +E  +   L+HP+IV+     T      +Y+  E++ G    
Sbjct: 58  -DVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE--TYSSDGMLYMVFEFMDGADLC 114

Query: 200 -SIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV---DPNGRVKL 255
             I K       + E    +Y +QIL  L + H  + +HRD+K   +L+   + +  VKL
Sbjct: 115 FEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 174

Query: 256 ADFGMAKHIAGQSCPLSFK-GSPYWMAPEVIKNSSGCNLAVDIWSLG-------CTVLEM 307
             FG+A  +         + G+P++MAPEV+K        VD+W  G             
Sbjct: 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGC--- 230

Query: 308 ATTKPP-WSQYEGVAAMFKIGN----SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAA 362
                P +   E +      G      ++   I    S+  KD +R  L  +P  R T  
Sbjct: 231 ----LPFYGTKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERITVY 282

Query: 363 ELLDHPFVKGAAPLERTILAPE 384
           E L+HP++K        I  PE
Sbjct: 283 EALNHPWLKERDRYAYKIHLPE 304

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  202 bits (515), Expect = 1e-60
 Identities = 63/271 (23%), Positives = 116/271 (42%), Gaps = 18/271 (6%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV---TLFDDAKSKESAKQLMQEIVL 167
            ++  +  K +G+G FG V+ G       + A+K +       + +  E  ++  +E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76

Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSG 226
           +S L HPNIV+ YG   + +   + +E+V  G +Y  L D                I  G
Sbjct: 77  MSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134

Query: 227 LAFLHSKHT--VHRDIKGANILVDPNGR-----VKLADFGMAKHIAGQSCPLSFKGSPYW 279
           + ++ +++   VHRD++  NI +           K+ADFG+++            G+  W
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQW 192

Query: 280 MAPEVIKNSSG-CNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKELPTIP 336
           MAPE I           D +S    +  + T + P+ +Y    +  +  I      PTIP
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252

Query: 337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           +D     ++ I LC   +P  RP  + ++  
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  203 bits (519), Expect = 1e-60
 Identities = 73/337 (21%), Positives = 129/337 (38%), Gaps = 43/337 (12%)

Query: 93  ATSPSVPRSPGRMENPVSPES------HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV 146
           A   S+  + GR ++    ++        +  ++L  G F  VY   +  SG   A+K +
Sbjct: 2   AGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL 61

Query: 147 TLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTV-------EDKLYIYLEYVSG 198
                +  +E  + ++QE+  + +L  HPNIVQ+  + ++           ++ L  +  
Sbjct: 62  ----LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117

Query: 199 GSIYKLL---QDYGQFGEPAIRNYTQQILSGLAFLHSKHT--VHRDIKGANILVDPNGRV 253
           G + + L   +  G      +     Q    +  +H +    +HRD+K  N+L+   G +
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177

Query: 254 KLADFGMAKHIAGQSCPLSFK-------------GSPYWMAPEVIKNSSGC--NLAVDIW 298
           KL DFG A  I+                       +P +  PE+I   S        DIW
Sbjct: 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237

Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR 358
           +LGC +  +   + P   +E   A  +I N K      D         IR  LQ NP  R
Sbjct: 238 ALGCILYLLCFRQHP---FED-GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEER 293

Query: 359 PTAAELLDHPF-VKGAAPLERTILAPEPSDVPPGVTN 394
            + AE++     +  A  +       E  +   G  +
Sbjct: 294 LSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGS 330

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  201 bits (513), Expect = 2e-60
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 40/290 (13%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ---LMQEIVLL 168
             ++   + LG+G F  V    +  +G   A K +        K SA+    L +E  + 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-----NTKKLSARDFQKLEREARIC 59

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSG 226
            +L+HPNIV+ +   +++++ + YL  + V+GG +++ +     + E    +  QQIL  
Sbjct: 60  RKLQHPNIVRLHD--SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117

Query: 227 LAFLHSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           +A+ HS   VHR++K  N+L+        VKLADFG+A  +        F G+P +++PE
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177

Query: 284 VIKNSSGCNLAVDIWSLG-------CTVLEMATTKPP-WSQYE-GVAAMFKIGN----SK 330
           V+K     +  VDIW+ G                 PP W + +  + A  K G     S 
Sbjct: 178 VLKK-DPYSKPVDIWACGVILYILLVGY-------PPFWDEDQHRLYAQIKAGAYDYPSP 229

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTI 380
           E  T+    + E K  I   L  NP  R TA + L  P++     +   I
Sbjct: 230 EWDTV----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  211 bits (539), Expect = 3e-60
 Identities = 72/389 (18%), Positives = 133/389 (34%), Gaps = 51/389 (13%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            W+  + LG G FG+V    + D+GE  A+K+        S ++ ++   EI ++ +L H
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQ---CRQELSPKNRERWCLEIQIMKKLNH 71

Query: 174 PNIVQYY------GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG---EPAIRNYTQQIL 224
           PN+V               D   + +EY  GG + K L  +       E  IR     I 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131

Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNG---RVKLADFGMAKHIAGQSCPLSFKGSPYWMA 281
           S L +LH    +HRD+K  NI++ P       K+ D G AK +        F G+  ++A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191

Query: 282 PEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD---- 337
           PE+++      + VD WS G    E  T   P+               K    I      
Sbjct: 192 PELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250

Query: 338 ------------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
                              L+ + + +++  L  +   R T  +  +    +        
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ-------- 302

Query: 380 ILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHSSRVS-QTSLNASDINISMNR 438
                   +       +  +  G++      + E L    S +   T +   +  +    
Sbjct: 303 ----ALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQAS 358

Query: 439 SCPVSPIGSPLLHPRSPQHLNGKMSPSPI 467
              ++       +      ++G+     +
Sbjct: 359 GLALNSAQPLTQYVIDCTVIDGRQGEGDL 387

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  204 bits (519), Expect = 3e-60
 Identities = 51/329 (15%), Positives = 98/329 (29%), Gaps = 44/329 (13%)

Query: 84  SPFSHSNSAATSPSVPRSPGRMENPVSPES-HWKKGKMLGRGTFGHVYVGFNSDSGEMCA 142
            P +   +   +     +   +++ +S      K  + L  G    V++  + +  E  A
Sbjct: 32  EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91

Query: 143 MKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSK------------------- 183
           +K V       S+   ++L +     +RL   +  +    +                   
Sbjct: 92  LK-VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150

Query: 184 -------TVEDKLYIYLEYVSG--GSIYKLLQDYGQFGEP----AIRNYTQQILSGLAFL 230
                         + +   S     ++  L     F       A+   T Q++   A L
Sbjct: 151 LSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSG 290
            SK  VH      N+ + P+GR+ L D        G   P +      +   E +  S+ 
Sbjct: 211 QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK-VGTRGP-ASSVPVTYAPREFLNASTA 268

Query: 291 C-NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD-------DLSDE 342
               A++ W LG ++  +     P+              S  +P            L D 
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF 328

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
            K  I   L  +   R    E ++ P   
Sbjct: 329 VKTLIGRFLNFDRRRRLLPLEAMETPEFL 357

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  202 bits (516), Expect = 4e-60
 Identities = 70/337 (20%), Positives = 128/337 (37%), Gaps = 58/337 (17%)

Query: 88  HSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT 147
           H + ++   ++    G +      +  +     +G+G++G V V   + +  + A+K + 
Sbjct: 4   HHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 148 LFD-DAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ 206
                  + +  +++  E+ L+ +L HPNI + Y     E  + + +E   GG +   L 
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120

Query: 207 DYGQ----------------------------------------FGEPAIRNYTQQILSG 226
            +                                            E  I N  +QI S 
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 227 LAFLHSKHTVHRDIKGANILV--DPNGRVKLADFGMAKHIAGQSCPLSFK-----GSPYW 279
           L +LH++   HRDIK  N L   + +  +KL DFG++K     +    +      G+PY+
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240

Query: 280 MAPEVIKNSSGC-NLAVDIWSLGCTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELPTI 335
           +APEV+  ++       D WS G  +  +     P     +  A    ++ N K      
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND--ADTISQVLNKKLCFENP 298

Query: 336 P-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             + LS   +D +   L RN   R  A   L HP++ 
Sbjct: 299 NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  201 bits (513), Expect = 6e-60
 Identities = 72/312 (23%), Positives = 133/312 (42%), Gaps = 9/312 (2%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            W   + LG G +G V +  N  + E  A+K   + D  ++ +  + + +EI +   L H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNH 64

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
            N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVIKNSSG 290
              HRDIK  N+L+D    +K++DFG+A      +         G+  ++APE++K    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP-DDLSDEGKDFIRL 349
               VD+WS G  +  M   + PW Q       +     K+    P   +       +  
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244

Query: 350 CLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVST 409
            L  NP  R T  ++    +     PL++    P  +      +    +  I    + S 
Sbjct: 245 ILVENPSARITIPDIKKDRWYN--KPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSP 302

Query: 410 FDTERLAVHSSR 421
            ++      S  
Sbjct: 303 VNSASRTPGSGW 314

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  200 bits (510), Expect = 1e-59
 Identities = 71/278 (25%), Positives = 126/278 (45%), Gaps = 29/278 (10%)

Query: 113 SHW-------KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
            H          G++LG+G FG      + ++GE+  MKE+  FD+    E+ +  ++E+
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE----ETQRTFLKEV 58

Query: 166 VLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQIL 224
            ++  L HPN++++ G    + +L    EY+ GG++  +++    Q+      ++ + I 
Sbjct: 59  KVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIA 118

Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS---------------C 269
           SG+A+LHS + +HRD+   N LV  N  V +ADFG+A+ +  +                 
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178

Query: 270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS 329
             +  G+PYWMAPE+I   S  +  VD++S G  + E+         Y      F +   
Sbjct: 179 RYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237

Query: 330 KEL-PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
             L    P +           C   +P  RP+  +L  
Sbjct: 238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  199 bits (507), Expect = 3e-59
 Identities = 75/284 (26%), Positives = 121/284 (42%), Gaps = 35/284 (12%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMK-----EVTLFDDAKSKESAKQLMQEIVLLSRL- 171
            ++LGRG    V    +  + +  A+K         F   + +E  +  ++E+ +L ++ 
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 172 RHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
            HPNI+Q     T E   + +L  + +  G ++  L +     E   R   + +L  +  
Sbjct: 82  GHPNIIQLKD--TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 139

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           LH  + VHRD+K  NIL+D +  +KL DFG +  +          G+P ++APE+I+ S 
Sbjct: 140 LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM 199

Query: 290 GCN-----LAVDIWSLG-------CTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELPT 334
             N       VD+WS G                 PP W + +    M   I +   +  +
Sbjct: 200 NDNHPGYGKEVDMWSTGVIMYTLLAGS-------PPFWHRKQ--MLMLRMIMSGNYQFGS 250

Query: 335 IP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLE 377
              DD SD  KD +   L   P  R TA E L HPF +     E
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  199 bits (509), Expect = 4e-59
 Identities = 69/281 (24%), Positives = 127/281 (45%), Gaps = 26/281 (9%)

Query: 117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPN 175
           K K LG G+F       +  S +  A+K +     +K  E+     +EI  L     HPN
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKII-----SKRMEA--NTQKEITALKLCEGHPN 67

Query: 176 IVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           IV+ +      D+L+ +L  E ++GG +++ ++    F E       ++++S ++ +H  
Sbjct: 68  IVKLHE--VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 234 HTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFK-GSPYWMAPEVIKNSS 289
             VHRD+K  N+L    + N  +K+ DFG A+     + PL     + ++ APE++   +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ-N 184

Query: 290 GCNLAVDIWSLGCTVLEMATTKPP-WSQYEGVAA-----MF-KIGNSK-ELPTIP-DDLS 340
           G + + D+WSLG  +  M + + P  S    +       +  KI             ++S
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244

Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTIL 381
            E KD I+  L  +P  R   + L  + +++  + L    L
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL 285

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  198 bits (505), Expect = 4e-59
 Identities = 71/262 (27%), Positives = 121/262 (46%), Gaps = 20/262 (7%)

Query: 118 GKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           G+ +G G+FG VY G ++ D     A+K   L   A + +  +    E+ +L + RH NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD----VAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHT 235
           + + G  T   +L I  ++  G S+Y  L     +F    + +  +Q   G+ +LH+K  
Sbjct: 83  LLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAK---HIAGQSCPLSFKGSPYWMAPEVIKNSSG-- 290
           +HRD+K  NI +  +  VK+ DFG+A      +G        GS  WMAPEVI+      
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 291 CNLAVDIWSLGCTVL-EMATTKPPWSQYEGV-AAMFKIGNSK---ELPTIPDDLSDEGKD 345
            +   D+++ G  VL E+ T + P+S        +  +G      +L  +  +     K 
Sbjct: 202 YSFQSDVYAFG-IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260

Query: 346 FIRLCLQRNPLNRPTAAELLDH 367
            +  CL++    RP+   +L  
Sbjct: 261 LMAECLKKKRDERPSFPRILAE 282

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  200 bits (510), Expect = 6e-59
 Identities = 78/346 (22%), Positives = 138/346 (39%), Gaps = 34/346 (9%)

Query: 49  PRAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENP 108
           P        +      D   QS  L      ++++ P    N    S             
Sbjct: 30  PNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAA 89

Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT----LFDDAKSKESAKQLMQE 164
                 +    ++GRG    V    +  +G   A+K +          + +E  +   +E
Sbjct: 90  KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149

Query: 165 IVLLSRLR-HPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQ 221
             +L ++  HP+I+      + E   +++L  + +  G ++  L +     E   R+  +
Sbjct: 150 THILRQVAGHPHIITLID--SYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR 207

Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMA 281
            +L  ++FLH+ + VHRD+K  NIL+D N +++L+DFG + H+          G+P ++A
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267

Query: 282 PEVIKNSSGC-----NLAVDIWSLG-------CTVLEMATTKPP-WSQYEGVAAMF-KIG 327
           PE++K S           VD+W+ G                 PP W + +    M   I 
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS-------PPFWHRRQ--ILMLRMIM 318

Query: 328 NSK-ELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
             + +  +   DD S   KD I   LQ +P  R TA + L HPF +
Sbjct: 319 EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  199 bits (509), Expect = 9e-59
 Identities = 84/320 (26%), Positives = 139/320 (43%), Gaps = 41/320 (12%)

Query: 87  SHSNSAATSPSVPRSPGRMENPVSP-ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKE 145
            H  S      + R    M N  +    ++   + LG+G F  V    +  +G   A K 
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 146 VTLFDDAKSKESAKQ---LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGS 200
           +        K SA+    L +E  +  +L+HPNIV+ +   +++++ + YL  + V+GG 
Sbjct: 62  I-----NTKKLSARDFQKLEREARICRKLQHPNIVRLHD--SIQEESFHYLVFDLVTGGE 114

Query: 201 IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV---DPNGRVKLAD 257
           +++ +     + E    +  QQIL  +A+ HS   VHR++K  N+L+        VKLAD
Sbjct: 115 LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174

Query: 258 FGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLG-------CTVLEMATT 310
           FG+A  +        F G+P +++PEV+K     +  VDIW+ G                
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGY------ 227

Query: 311 KPP-WSQYE-GVAAMFKIGN----SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
            PP W + +  + A  K G     S E  T+    + E K  I   L  NP  R TA + 
Sbjct: 228 -PPFWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRITADQA 282

Query: 365 LDHPFVKGAAPLERTILAPE 384
           L  P++     +   I   +
Sbjct: 283 LKVPWICNRERVASAIHRQD 302

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  197 bits (504), Expect = 9e-59
 Identities = 76/291 (26%), Positives = 129/291 (44%), Gaps = 28/291 (9%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            +  G +LG G++G V    +S++    A+K +      +       + +EI LL RLRH
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 174 PNIVQYY---GSKTVEDKLYIYLEYVSGGSIYKLLQDY---GQFGEPAIRNYTQQILSGL 227
            N++Q      ++  + K+Y+ +EY   G   + + D     +F       Y  Q++ GL
Sbjct: 66  KNVIQLVDVLYNEE-KQKMYMVMEYCVCGM--QEMLDSVPEKRFPVCQAHGYFCQLIDGL 122

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ--------SCPLSFKGSPYW 279
            +LHS+  VH+DIK  N+L+   G +K++  G+A+ +           S      GSP +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-----GSPAF 177

Query: 280 MAPEVIKNSSGCN-LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPD 337
             PE+       +   VDIWS G T+  + T   P+ + + +  +F  IG       IP 
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGS--YAIPG 234

Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHP-FVKGAAPLERTILAPEPSD 387
           D      D ++  L+  P  R +  ++  H  F K   P E  +  P   D
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPD 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  197 bits (504), Expect = 1e-58
 Identities = 65/297 (21%), Positives = 126/297 (42%), Gaps = 27/297 (9%)

Query: 91  SAATSPSVPRSPGRMENPVS----PESHWKKGKMLGRGTFGHVYVGF-NSDSGEMCAMKE 145
           S  ++ S PR   +    +     P    + G+++G+G FG VY G  + +     A++ 
Sbjct: 7   SLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE----VAIR- 61

Query: 146 VTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLL 205
             +  +  +++  K   +E++   + RH N+V + G+      L I      G ++Y ++
Sbjct: 62  -LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120

Query: 206 QDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI 264
           +D          R   Q+I+ G+ +LH+K  +H+D+K  N+  D NG+V + DFG+    
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179

Query: 265 AGQSCPL------SFKGSPYWMAPEVIKNSSG--------CNLAVDIWSLGCTVLEMATT 310
                           G    +APE+I+  S          +   D+++LG    E+   
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239

Query: 311 KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           + P+      A ++++G   +       +  E  D +  C       RPT  +L+D 
Sbjct: 240 EWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  194 bits (496), Expect = 8e-58
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 31/282 (10%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLS 169
           E H++ G+ LG G F  V       +G+  A K +       ++   S +++ +E+ +L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
            +RHPNI+  +     E+K  + L  E VSGG ++  L +     E     + +QIL G+
Sbjct: 64  EIRHPNIITLHD--IFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 228 AFLHSKHTVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
            +LHSK   H D+K  NI++     PN R+KL DFG+A  I   +   +  G+P ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

Query: 284 VIKNSSGCNLAVDIWSLG-------CTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELP 333
           ++ N     L  D+WS+G                  P   + +        I     +  
Sbjct: 182 IV-NYEPLGLEADMWSIGVITYILLSGA-------SPFLGETK--QETLTNISAVNYDFD 231

Query: 334 TIP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
                + S+  KDFIR  L ++P  R T A+ L+H ++K   
Sbjct: 232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  197 bits (502), Expect = 8e-58
 Identities = 85/301 (28%), Positives = 141/301 (46%), Gaps = 20/301 (6%)

Query: 99  PRSPGRMENPVSPES-HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES 157
           P + G ++ P+  +S  +   K +G G FG   +  +  + E+ A+K +      +    
Sbjct: 5   PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI-----ERGAAI 59

Query: 158 AKQLMQEIVLLSRLRHPNIVQYY---GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP 214
            + + +EI+    LRHPNIV++     + T    L I +EY SGG +Y+ + + G+F E 
Sbjct: 60  DENVQREIINHRSLRHPNIVRFKEVILTPT---HLAIIMEYASGGELYERICNAGRFSED 116

Query: 215 AIRNYTQQILSGLAFLHSKHTVHRDIKGANILVD--PNGRVKLADFGMAKHIAGQSCPLS 272
             R + QQ+LSG+++ HS    HRD+K  N L+D  P  R+K+ DFG +K     S P S
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176

Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL 332
             G+P ++APEV+          D+WS G T+  M     P+ +       ++    + L
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRIL 235

Query: 333 P---TIPDD--LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSD 387
               +IPDD  +S E    I      +P  R +  E+  H +     P +    +   S 
Sbjct: 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQ 295

Query: 388 V 388
            
Sbjct: 296 F 296

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  199 bits (508), Expect = 9e-58
 Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 35/286 (12%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
            + LG+G F  V       +G+  A   +       S    ++L +E  +   L+HPNIV
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINT--KKLSARDHQKLEREARICRLLKHPNIV 73

Query: 178 QYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           + +   ++ ++ + YL  + V+GG +++ +     + E    +  QQIL  +   H    
Sbjct: 74  RLHD--SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131

Query: 236 VHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSSGC 291
           VHR++K  N+L+        VKLADFG+A  + G+      F G+P +++PEV++     
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPY 190

Query: 292 NLAVDIWSLG-------CTVLEMATTKPP-WSQYE-GVAAMFKIGN----SKELPTIPDD 338
              VD+W+ G                 PP W + +  +    K G     S E  T+   
Sbjct: 191 GKPVDLWACGVILYILLVGY-------PPFWDEDQHRLYQQIKAGAYDFPSPEWDTV--- 240

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPE 384
            + E KD I   L  NP  R TAAE L HP++   + +   +   E
Sbjct: 241 -TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQE 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  195 bits (497), Expect = 1e-57
 Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 23/266 (8%)

Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
                +  +++GRG FG V    +     +  A+K++      +S+   K  + E+  LS
Sbjct: 6   DYKEIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQI------ESESERKAFIVELRQLS 56

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ---QILSG 226
           R+ HPNIV+ YG+    + + + +EY  GGS+Y +L            +      Q   G
Sbjct: 57  RVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114

Query: 227 LAFLHSKHT---VHRDIKGANILVDPNGRV-KLADFGMAKHIAGQSCPLSFKGSPYWMAP 282
           +A+LHS      +HRD+K  N+L+   G V K+ DFG A  I       + KGS  WMAP
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAP 172

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA-AMFKIGNSKELPTIPDDLSD 341
           EV + S+  +   D++S G  + E+ T + P+ +  G A  +    ++   P +  +L  
Sbjct: 173 EVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDH 367
             +  +  C  ++P  RP+  E++  
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKI 257

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  195 bits (497), Expect = 1e-57
 Identities = 77/323 (23%), Positives = 126/323 (39%), Gaps = 26/323 (8%)

Query: 79  TISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSG 138
           +       SH        +   +PG+ + P+  ES ++ G +LG G FG VY G      
Sbjct: 11  SSGLVPRGSHMAPCNDLHATKLAPGKEKEPL--ESQYQVGPLLGSGGFGSVYSGIRVSDN 68

Query: 139 EMCAMKEV--TLFDDAKSKESAKQLMQEIVLLSRLRH--PNIVQYYGSKTVEDKLYIYLE 194
              A+K V      D     +  ++  E+VLL ++      +++        D   + LE
Sbjct: 69  LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128

Query: 195 YVSG-GSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GR 252
                  ++  + + G   E   R++  Q+L  +   H+   +HRDIK  NIL+D N G 
Sbjct: 129 RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE 188

Query: 253 VKLADFGMAKHIAGQ----SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMA 308
           +KL DFG    +              G+  +  PE I+       +  +WSLG  + +M 
Sbjct: 189 LKLIDFGSGALLKDTVYTDFD-----GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

Query: 309 TTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHP 368
               P+   E      +I   +        +S E +  IR CL   P +RPT  E+ +HP
Sbjct: 244 CGDIPFEHDE------EIIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

Query: 369 -FVKGAAPLERTILAPEPSDVPP 390
                  P E   +        P
Sbjct: 296 WMQDVLLPQETAEIHLHSLSPGP 318

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  194 bits (495), Expect = 2e-57
 Identities = 74/315 (23%), Positives = 130/315 (41%), Gaps = 22/315 (6%)

Query: 87  SHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV 146
                    P  P  P   ++  + E+ ++ G +LG+G FG V+ G         A+K +
Sbjct: 5   KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64

Query: 147 --TLFDDAKSKESAKQLMQEIVLLSRLR----HPNIVQYYGSKTVEDKLYIYLEY-VSGG 199
                        +     E+ LL ++     HP +++       ++   + LE  +   
Sbjct: 65  PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124

Query: 200 SIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-NGRVKLADF 258
            ++  + + G  GE   R +  Q+++ +   HS+  VHRDIK  NIL+D   G  KL DF
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184

Query: 259 GMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY 317
           G    +  +  P + F G+  +  PE I       L   +WSLG  + +M     P+ + 
Sbjct: 185 GSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242

Query: 318 EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK---GAA 374
           +      +I  ++     P  +S +    IR CL   P +RP+  E+L  P+++      
Sbjct: 243 Q------EILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294

Query: 375 PLERTILAPEPSDVP 389
           PL  +   P P    
Sbjct: 295 PLNPSKGGPAPLAWS 309

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  195 bits (497), Expect = 3e-57
 Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 24/280 (8%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNI 176
            + +G G++       +  +    A+K +      KSK    +   EI +L R  +HPNI
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKRDPTE---EIEILLRYGQHPNI 78

Query: 177 VQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           +        +D  Y+Y+  E + GG +   +     F E         I   + +LH++ 
Sbjct: 79  ITLKD--VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136

Query: 235 TVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSS 289
            VHRD+K +NIL          +++ DFG AK +  ++  L     +  ++APEV++   
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER-Q 195

Query: 290 GCNLAVDIWSLGCTVLEMATTKPP-WSQY-EGVAAMF-KIGNSK-ELPTIP-DDLSDEGK 344
           G + A DIWSLG  +  M T   P  +   +    +  +IG+ K  L     + +SD  K
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255

Query: 345 DFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPE 384
           D +   L  +P  R TAA +L HP++     L +  L  +
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQ 295

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  194 bits (495), Expect = 3e-57
 Identities = 70/281 (24%), Positives = 120/281 (42%), Gaps = 35/281 (12%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
              +   + LGRG FG V+    + S +    K V              + +EI +L+  
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-----KVKGTDQVLVKKEISILNIA 58

Query: 172 RHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIY-KLLQDYGQFGEPAIRNYTQQILSGLA 228
           RH NI+  +   + E    + +  E++SG  I+ ++     +  E  I +Y  Q+   L 
Sbjct: 59  RHRNILHLHE--SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 229 FLHSKHTVHRDIKGANILV--DPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVI 285
           FLHS +  H DI+  NI+     +  +K+ +FG A+ +  G +  L F  +P + APEV 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPEVH 175

Query: 286 KNSSGCNLAVDIWSLG-------CTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELPTI 335
                 + A D+WSLG         +        P  ++      +   I N++      
Sbjct: 176 -QHDVVSTATDMWSLGTLVYVLLSGI-------NPFLAETN--QQIIENIMNAEYTFDEE 225

Query: 336 P-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
              ++S E  DF+   L +   +R TA+E L HP++K    
Sbjct: 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  194 bits (495), Expect = 3e-57
 Identities = 71/278 (25%), Positives = 124/278 (44%), Gaps = 21/278 (7%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLS 169
           + ++  G+ LG G F  V       +G   A K +       ++   S + + +E+ +L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
            ++HPN++  +     E+K  + L  E V+GG ++  L +     E     + +QIL+G+
Sbjct: 70  EIQHPNVITLHE--VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 228 AFLHSKHTVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
            +LHS    H D+K  NI++     P  R+K+ DFG+A  I   +   +  G+P ++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPP-WSQYE-GVAAMFKIGN----SKELPTIPD 337
           ++       L  D+WS+G     + +   P     +    A     N     +       
Sbjct: 188 IVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-- 244

Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
             S   KDFIR  L ++P  R T  + L HP++K    
Sbjct: 245 --SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  194 bits (495), Expect = 4e-57
 Identities = 69/305 (22%), Positives = 123/305 (40%), Gaps = 14/305 (4%)

Query: 92  AATSPSVPRSPGRMENPVSPESH-WKKGKMLGRGTFGHVYVGFNSDSGEMCAMK----EV 146
           A   P        +       S  +     LG G FG V+   + +  +   +K    E 
Sbjct: 2   ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61

Query: 147 TLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE-YVSGGSIYKLL 205
            L D         ++  EI +LSR+ H NI++       +    + +E + SG  ++  +
Sbjct: 62  VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121

Query: 206 QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA 265
             + +  EP      +Q++S + +L  K  +HRDIK  NI++  +  +KL DFG A ++ 
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181

Query: 266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK 325
                 +F G+  + APEV+  +      +++WSLG T+  +   + P+ + E      +
Sbjct: 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------E 235

Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEP 385
              +      P  +S E    +   LQ  P  R T  +L+  P+V     L         
Sbjct: 236 TVEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVF 293

Query: 386 SDVPP 390
               P
Sbjct: 294 RVNKP 298

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  193 bits (493), Expect = 5e-57
 Identities = 70/294 (23%), Positives = 120/294 (40%), Gaps = 31/294 (10%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMK--EVTLFDDAKSKESAKQLMQEIVLLS 169
           E  +  G+ LG G F  V       +G   A K  +      ++   S +++ +E+ +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
           ++ H N++  +     E++  + L  E VSGG ++  L       E    ++ +QIL G+
Sbjct: 71  QVLHHNVITLHD--VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 228 AFLHSKHTVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
            +LH+K   H D+K  NI++     P   +KL DFG+A  I       +  G+P ++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 284 VIKNSSGCNLAVDIWSLG-------CTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELP 333
           ++ N     L  D+WS+G                  P     +        I +   +  
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGA-------SPFLGDTK--QETLANITSVSYDFD 238

Query: 334 TIP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPS 386
                  S+  KDFIR  L +    R T  E L HP++      +  +      
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVV 292

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  199 bits (508), Expect = 6e-57
 Identities = 76/268 (28%), Positives = 131/268 (48%), Gaps = 18/268 (6%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           ++LGRG FG V+      +G++ A K        K ++  +  M E  +L+++    IV 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 179 YYGSKTVEDKLYIYLEYVSGGS----IYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
              +   +  L + +  ++GG     IY + +D   F EP    YT QI+SGL  LH ++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
            ++RD+K  N+L+D +G V+++D G+A    AGQ+    + G+P +MAPE++      + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDF 368

Query: 294 AVDIWSLGCTVLEMATTKPPW---SQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRL 349
           +VD ++LG T+ EM   + P+    +      +  ++       T PD  S   KDF   
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPDKFSPASKDFCEA 426

Query: 350 CLQRNPLNR-----PTAAELLDHPFVKG 372
            LQ++P  R      +   L  HP  + 
Sbjct: 427 LLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  191 bits (487), Expect = 1e-56
 Identities = 45/259 (17%), Positives = 95/259 (36%), Gaps = 18/259 (6%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
              L     G ++ G     G    +K   L     S   ++   +E   L    HPN++
Sbjct: 15  LTKLNENHSGELWKG--RWQGNDIVVK--VLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 178 QYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSK 233
              G           +   ++  GS+Y +L +       +     +   +  G+AFLH+ 
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 234 HT--VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN--SS 289
                   +   ++++D +   +++   +               +P W+APE ++     
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAWVAPEALQKKPED 186

Query: 290 GCNLAVDIWSLGCTVL-EMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
               + D+WS    +L E+ T + P++    +    K+      PTIP  +S      ++
Sbjct: 187 TNRRSADMWSFA-VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMK 245

Query: 349 LCLQRNPLNRPTAAELLDH 367
           +C+  +P  RP    ++  
Sbjct: 246 ICMNEDPAKRPKFDMIVPI 264

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  191 bits (487), Expect = 1e-56
 Identities = 84/266 (31%), Positives = 129/266 (48%), Gaps = 19/266 (7%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES--AKQLMQEIVLLSRL 171
           H+  G  LG GTFG V +G +  +G   A+K   + +  K +      ++ +EI  L   
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIKREIQNLKLF 68

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
           RHP+I++ Y   +     ++ +EYVSGG ++  +  +G+  E   R   QQILS + + H
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGM-AKHIAGQ----SCPLSFKGSPYWMAPEVIK 286
               VHRD+K  N+L+D +   K+ADFG+      G+    SC     GSP + APEVI 
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYAAPEVIS 183

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKD 345
                   VDIWS G  +  +     P+   E V  +F KI        IP+ L+     
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKIRGGV--FYIPEYLNRSVAT 240

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVK 371
            +   LQ +PL R T  ++ +H + K
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFK 266

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  194 bits (495), Expect = 2e-56
 Identities = 69/319 (21%), Positives = 123/319 (38%), Gaps = 20/319 (6%)

Query: 68  QQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMEN--PVSPESHWKKGKMLGRGT 125
              H      +      P  +           +   +       S   ++   + LG G 
Sbjct: 4   SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63

Query: 126 FGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV 185
           FG V+      +G +   K +    +         +  EI ++++L HP ++  +     
Sbjct: 64  FGVVHRCVEKATGRVFVAKFI----NTPYPLDKYTVKNEISIMNQLHHPKLINLHD--AF 117

Query: 186 EDKLYIYL--EYVSGGSIY-KLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKG 242
           EDK  + L  E++SGG ++ ++  +  +  E  + NY +Q   GL  +H    VH DIK 
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 177

Query: 243 ANILV--DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSL 300
            NI+        VK+ DFG+A  +           +  + APE++ +        D+W++
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMWAI 236

Query: 301 GCTVLEMATTKPP-WSQYEGVAAMF-KIGNSK-ELPTIP-DDLSDEGKDFIRLCLQRNPL 356
           G     + +   P     E        +     E        +S E KDFI+  LQ+ P 
Sbjct: 237 GVLGYVLLSGLSPFAG--EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 294

Query: 357 NRPTAAELLDHPFVKGAAP 375
            R T  + L+HP++KG   
Sbjct: 295 KRLTVHDALEHPWLKGDHS 313

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  192 bits (490), Expect = 2e-56
 Identities = 88/267 (32%), Positives = 137/267 (51%), Gaps = 20/267 (7%)

Query: 119 KMLGRGTFGHVYV---GFNSDSGEMCAMKEV---TLFDDAKSKESAKQLMQEIVLLSRLR 172
           ++LG+G +G V+       +++G++ AMK +    +  +AK          E  +L  ++
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH---TKAERNILEEVK 79

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HP IV    +     KLY+ LEY+SGG ++  L+  G F E     Y  +I   L  LH 
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           K  ++RD+K  NI+++  G VKL DFG+ K  I   +   +F G+  +MAPE++   SG 
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGH 198

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLC 350
           N AVD WSLG  + +M T  PP++  E       KI   K    +P  L+ E +D ++  
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCK--LNLPPYLTQEARDLLKKL 255

Query: 351 LQRNPLNR----PT-AAELLDHPFVKG 372
           L+RN  +R    P  A E+  HPF + 
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFRH 282

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  191 bits (488), Expect = 5e-56
 Identities = 80/261 (30%), Positives = 133/261 (50%), Gaps = 12/261 (4%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K+LG+GTFG V +     +G   AMK +   +   +K+     + E  +L   RHP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
              +    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+  V+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129

Query: 239 DIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDI 297
           DIK  N+++D +G +K+ DFG+ K  I+  +   +F G+P ++APEV+++ +    AVD 
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDW 188

Query: 298 WSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
           W LG  + EM   + P+   +    +F  I   +     P  LS E K  +   L+++P 
Sbjct: 189 WGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPK 245

Query: 357 NR----PT-AAELLDHPFVKG 372
            R    P+ A E+++H F   
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLS 266

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  190 bits (486), Expect = 6e-56
 Identities = 76/295 (25%), Positives = 116/295 (39%), Gaps = 43/295 (14%)

Query: 117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQ-LMQEIVLLSRLR-HP 174
           +  +LG G    V    N  + +  A+K +      K     +  + +E+ +L + + H 
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKII-----EKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 175 NIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           N+++       E++   YL  E + GGSI   +     F E       Q + S L FLH+
Sbjct: 72  NVLELIE--FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 233 KHTVHRDIKGANILV---DPNGRVKLADFGMAKHI-AGQSCPLSFK-------GSPYWMA 281
           K   HRD+K  NIL    +    VK+ DF +   I     C            GS  +MA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 282 PEVIKNSSGC----NLAVDIWSLG-------C-------TVLEMATTKPPWSQYEGVAAM 323
           PEV++  S      +   D+WSLG                           +       +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249

Query: 324 F-KIGNSK-ELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
           F  I   K E P      +S   KD I   L R+   R +AA++L HP+V+G AP
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  192 bits (490), Expect = 7e-56
 Identities = 90/300 (30%), Positives = 142/300 (47%), Gaps = 20/300 (6%)

Query: 84  SPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKG-------KMLGRGTFGHVYVGFNSD 136
           S          +P+ P +P +  N + P S+           K++G+G+FG V +  +  
Sbjct: 3   SQPQEPELMNANPAPPPAPSQQIN-LGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61

Query: 137 SGEMCAMKEVTLFDDAKSKESAKQLMQE-IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEY 195
                A+K V        K+  K +M E  VLL  ++HP +V  + S    DKLY  L+Y
Sbjct: 62  EEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 120

Query: 196 VSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKL 255
           ++GG ++  LQ    F EP  R Y  +I S L +LHS + V+RD+K  NIL+D  G + L
Sbjct: 121 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180

Query: 256 ADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW 314
            DFG+ K +I   S   +F G+P ++APEV+      +  VD W LG  + EM    PP+
Sbjct: 181 TDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPF 239

Query: 315 SQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR----PTAAELLDHPF 369
                 A M+  I N      +  ++++  +  +   LQ++   R        E+  H F
Sbjct: 240 YS-RNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  190 bits (486), Expect = 8e-56
 Identities = 72/311 (23%), Positives = 126/311 (40%), Gaps = 40/311 (12%)

Query: 88  HSNSAATSPSVPRSPGRMENPVSPESHWK-KGKMLGRGTFGHVYVGFNSDSGEMCAMKEV 146
           H +  ++   +       ++  +  + +    K LGRG F  V    +  +G+  A K +
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62

Query: 147 TLFDDAKSKESAK---QLMQEIVLLSRLRH-PNIVQYYGSKTVEDKLYIYL--EYVSGGS 200
                 K +       +++ EI +L   +  P ++  +     E+   I L  EY +GG 
Sbjct: 63  -----KKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE--VYENTSEIILILEYAAGGE 115

Query: 201 IYKLL--QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV---DPNGRVKL 255
           I+ L   +      E  +    +QIL G+ +LH  + VH D+K  NIL+    P G +K+
Sbjct: 116 IFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKI 175

Query: 256 ADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLG-------CTVLEMA 308
            DFGM++ I          G+P ++APE++ N      A D+W++G              
Sbjct: 176 VDFGMSRKIGHACELREIMGTPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHT---- 230

Query: 309 TTKPP-WSQYEGVAAMF-KIGNSK-ELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
               P   +       +  I     +        +S    DFI+  L +NP  RPTA   
Sbjct: 231 ---SPFVGEDN--QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285

Query: 365 LDHPFVKGAAP 375
           L H +++    
Sbjct: 286 LSHSWLQQWDF 296

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  191 bits (488), Expect = 9e-56
 Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 21/283 (7%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMK--EVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           G+ LG G F  V       +G   A K  +      ++     +++ +E+ +L ++ HPN
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 176 IVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           I+  +     E++  + L  E VSGG ++  L       E    ++ +QIL G+ +LH+K
Sbjct: 77  IITLHD--VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 234 HTVHRDIKGANILV----DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
              H D+K  NI++     P   +KL DFG+A  I       +  G+P ++APE++ N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-NYE 193

Query: 290 GCNLAVDIWSLGCTVLEMATTKPP-WSQYE-GVAAMFKIGN----SKELPTIPDDLSDEG 343
              L  D+WS+G     + +   P     +    A     +     +         S+  
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT----SELA 249

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPS 386
           KDFIR  L +    R T  E L HP++      +  +      
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVV 292

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  192 bits (489), Expect = 9e-56
 Identities = 79/345 (22%), Positives = 144/345 (41%), Gaps = 32/345 (9%)

Query: 50  RAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPV 109
            +G     S  +   +    +      P+    +S  +    A  +P   R     +  V
Sbjct: 26  NSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAV 85

Query: 110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
           +      K ++LG G FG V+    + +G   A K +      +  +  +++  EI +++
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII----KTRGMKDKEEVKNEISVMN 141

Query: 170 RLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIY-KLLQDYGQFGEPAIRNYTQQILSG 226
           +L H N++Q Y     E K  I L  EYV GG ++ +++ +     E     + +QI  G
Sbjct: 142 QLDHANLIQLYD--AFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199

Query: 227 LAFLHSKHTVHRDIKGANILV--DPNGRVKLADFGMAKHIAGQSCPLSFK-GSPYWMAPE 283
           +  +H  + +H D+K  NIL       ++K+ DFG+A+        L    G+P ++APE
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKVNFGTPEFLAPE 258

Query: 284 VIKNSSGCNLAVDIWSLG-------CTVLEMATTKPP-WSQYEGVAAMFKIGNSK-ELPT 334
           V+ N    +   D+WS+G         +        P     +    +  I   + +L  
Sbjct: 259 VV-NYDFVSFPTDMWSVGVIAYMLLSGL-------SPFLGDND-AETLNNILACRWDLED 309

Query: 335 IP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLER 378
               D+S+E K+FI   L +    R +A+E L HP++       R
Sbjct: 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSR 354

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  190 bits (484), Expect = 1e-55
 Identities = 79/280 (28%), Positives = 141/280 (50%), Gaps = 28/280 (10%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ------EIVLLSRLR 172
           + LG G+FG V++  +  +G   AMK   L      KE   +L Q      E ++LS + 
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMK--VL-----KKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HP I++ +G+     ++++ ++Y+ GG ++ LL+   +F  P  + Y  ++   L +LHS
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  ++RD+K  NIL+D NG +K+ DFG AK++   +   +  G+P ++APEV+ ++   N
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVV-STKPYN 181

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCL 351
            ++D WS G  + EM     P+         + KI N++     P   +++ KD +   +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLI 238

Query: 352 QRNPLNR-----PTAAELLDHPFVKG---AAPLERTILAP 383
            R+   R         ++ +HP+ K       L R I  P
Sbjct: 239 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 278

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  190 bits (484), Expect = 1e-55
 Identities = 82/264 (31%), Positives = 128/264 (48%), Gaps = 16/264 (6%)

Query: 119 KMLGRGTFGHVYV---GFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           K+LG+G+FG V++      SD+ ++ AMK   L           +   E  +L  + HP 
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMK--VLKKATLKVRDRVRTKMERDILVEVNHPF 87

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           IV+ + +   E KLY+ L+++ GG ++  L     F E  ++ Y  ++   L  LHS   
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 147

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           ++RD+K  NIL+D  G +KL DFG++K  I  +    SF G+  +MAPEV+    G   +
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQS 206

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
            D WS G  + EM T   P+   +        I  +K    +P  LS E +  +R+  +R
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAK--LGMPQFLSPEAQSLLRMLFKR 263

Query: 354 NPLNR----PT-AAELLDHPFVKG 372
           NP NR    P    E+  H F   
Sbjct: 264 NPANRLGAGPDGVEEIKRHSFFST 287

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  190 bits (486), Expect = 1e-55
 Identities = 86/274 (31%), Positives = 138/274 (50%), Gaps = 16/274 (5%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K LG G+FG V +  + +SG   AMK +      K K+     + E  +L  +  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE-HTLNEKRILQAVNFPFLVK 105

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
              S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS   ++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
           D+K  N+L+D  G +++ DFG AK + G++   +  G+P  +APE+I +  G N AVD W
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILS-KGYNKAVDWW 222

Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           +LG  + EMA   PP+   +    ++ KI + K     P   S + KD +R  LQ +   
Sbjct: 223 ALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTK 279

Query: 358 R-----PTAAELLDHPFVKG---AAPLERTILAP 383
           R         ++ +H +       A  +R + AP
Sbjct: 280 RFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  190 bits (484), Expect = 1e-55
 Identities = 56/330 (16%), Positives = 107/330 (32%), Gaps = 74/330 (22%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMC----------------AMKEVTL------- 148
            + ++  + +GRG FG V+   N                        M+EV         
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 149 -------------------------------FDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
                                               S         +I  +      N V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP---AIRNYTQQILSGLAFLHSKH 234
                 + +  LYI ++     ++   +       +       +   QI   + FLHSK 
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK-------------GSPYWMA 281
            +HRD+K +NI    +  VK+ DFG+   +       +               G+  +M+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 282 PEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSD 341
           PE I   +  +  VDI+SLG  + E+       +Q E V  +  +  + + P +      
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV-RNLKFPLLFTQKYP 300

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           +    ++  L  +P  RP A +++++   +
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  196 bits (500), Expect = 2e-55
 Identities = 68/263 (25%), Positives = 119/263 (45%), Gaps = 11/263 (4%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           ++LG+G FG V       +G+M A K        K ++     + E  +L ++    +V 
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTV 236
              +   +D L + L  ++GG +   +   GQ  F E     Y  +I  GL  LH +  V
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           +RD+K  NIL+D +G ++++D G+A H+          G+  +MAPEV+KN      + D
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPD 367

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--KELPTIPDDLSDEGKDFIRLCLQRN 354
            W+LGC + EM   + P+ Q +      ++     +      +  S + +      L ++
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427

Query: 355 PLNR-----PTAAELLDHPFVKG 372
           P  R      +A E+ +HP  K 
Sbjct: 428 PAERLGCRGGSAREVKEHPLFKK 450

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  190 bits (484), Expect = 2e-55
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 20/270 (7%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES--AKQLMQEIVLLSRL 171
            +   + LG G+FG V +  +  + +  A+K          K+S    ++ +EI  L  L
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLL 66

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
           RHP+I++ Y   T    + + +EY  GG ++  + +  +  E   R + QQI+  + + H
Sbjct: 67  RHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH 125

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-----SCPLSFKGSPYWMAPEVIK 286
               VHRD+K  N+L+D N  VK+ADFG++  +        SC     GSP + APEVI 
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPEVIN 180

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKD 345
                   VD+WS G  +  M   + P+   E +  +F K+ +      +PD LS   + 
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKKVNSCV--YVMPDFLSPGAQS 237

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
            IR  +  +P+ R T  E+   P+     P
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNVNLP 267

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  193 bits (491), Expect = 2e-55
 Identities = 85/321 (26%), Positives = 150/321 (46%), Gaps = 15/321 (4%)

Query: 57  ESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWK 116
           E +  W    +  +  L        +    S S+++  +  +  S  + ++ V+    ++
Sbjct: 94  EEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNS-GAEEMEVSLAKPKHRVTMN-EFE 151

Query: 117 KGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
             K+LG+GTFG V +     +G   AMK +   +   +K+     + E  +L   RHP +
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT- 235
                S    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+   
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 270

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           V+RD+K  N+++D +G +K+ DFG+ K  I   +   +F G+P ++APEV+++ +    A
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRA 329

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           VD W LG  + EM   + P+   +    +F  I   +     P  L  E K  +   L++
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLGPEAKSLLSGLLKK 386

Query: 354 NPLNR----PT-AAELLDHPF 369
           +P  R       A E++ H F
Sbjct: 387 DPKQRLGGGSEDAKEIMQHRF 407

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  190 bits (484), Expect = 2e-55
 Identities = 89/322 (27%), Positives = 143/322 (44%), Gaps = 27/322 (8%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE-IVLLSRLRHPNIV 177
           KMLG+G+FG V++     + +  A+K     D     +  +  M E  VL     HP + 
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             + +   ++ L+  +EY++GG +   +Q   +F       Y  +I+ GL FLHSK  V+
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVY 141

Query: 238 RDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           RD+K  NIL+D +G +K+ADFGM K ++ G +   +F G+P ++APE++      N +VD
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVD 200

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
            WS G  + EM   + P+   +    +F  I      P  P  L  E KD +     R P
Sbjct: 201 WWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREP 257

Query: 356 LNRPTAA-ELLDHPFVKG---AAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFD 411
             R     ++  HP  +         + I  P      P V +           + S FD
Sbjct: 258 EKRLGVRGDIRQHPLFREINWEELERKEIDPP----FRPKVKSP---------FDCSNFD 304

Query: 412 TE--RLAVHSSRVSQTSLNASD 431
            E        S   +  +N+ D
Sbjct: 305 KEFLNEKPRLSFADRALINSMD 326

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  197 bits (503), Expect = 3e-55
 Identities = 84/316 (26%), Positives = 147/316 (46%), Gaps = 23/316 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE---IVLLSRLRHPN 175
           +++GRG FG VY    +D+G+M AMK        K K+     + E   + L+S    P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           IV    +    DKL   L+ ++GG ++  L  +G F E  +R Y  +I+ GL  +H++  
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAV 295
           V+RD+K ANIL+D +G V+++D G+A   + +  P +  G+  +MAPEV++     + + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSA 372

Query: 296 DIWSLGCTVLEMATTKPPWSQYEG--VAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
           D +SLGC + ++     P+ Q++      +            +PD  S E +  +   LQ
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSPELRSLLEGLLQ 430

Query: 353 RNPLNR-----PTAAELLDHPFVKG---AAPLERTILAPEPSDVPPGVTNGIKALGIGQL 404
           R+   R       A E+ + PF +         +      P  +PP     + A     +
Sbjct: 431 RDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY---PPPLIPP--RGEVNAADAFDI 485

Query: 405 RNVSTFDTERLAVHSS 420
            +    DT+ + +  S
Sbjct: 486 GSFDEEDTKGIKLLDS 501

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  193 bits (491), Expect = 4e-55
 Identities = 97/418 (23%), Positives = 164/418 (39%), Gaps = 51/418 (12%)

Query: 99  PRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESA 158
           P +  +  +      H+  G  LG GTFG V VG +  +G   A+K   + +  K +   
Sbjct: 2   PMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLD 58

Query: 159 --KQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAI 216
              ++ +EI  L   RHP+I++ Y   +    +++ +EYVSGG ++  +   G+  E   
Sbjct: 59  VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES 118

Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ-----SCPL 271
           R   QQILSG+ + H    VHRD+K  N+L+D +   K+ADFG++  ++       SC  
Sbjct: 119 RRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 176

Query: 272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSK 330
              GSP + APEVI         VDIWS G  +  +     P+   + V  +F KI +  
Sbjct: 177 ---GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKICDGI 232

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPP 390
                P  L+      ++  LQ +P+ R T  ++ +H + K   P     L PE      
Sbjct: 233 --FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP---KYLFPEDPSYSS 287

Query: 391 G------VTNGIKALGIGQ------LRNVSTFDTERLAVH-----------------SSR 421
                  +    +     +      L N +  D   +A H                 ++ 
Sbjct: 288 TMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATS 347

Query: 422 VSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTP 479
              + L+   +        P     +P       +    K     +   +   G  + 
Sbjct: 348 PPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQ 405

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  193 bits (493), Expect = 2e-54
 Identities = 80/356 (22%), Positives = 136/356 (38%), Gaps = 28/356 (7%)

Query: 36  SSRIQSGAVTPIHPRAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATS 95
           +   QS    P  P         +      G     +  +     + SS + +       
Sbjct: 86  NKHGQSKPCEPTAPVLIPGDERKR----RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWK 141

Query: 96  PSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK 155
              P+      + V    H+   + LG G FG V+      +G   A K V        +
Sbjct: 142 QYYPQPVEIKHDHV--LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV----MTPHE 195

Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYL--EYVSGGSIY-KLLQDYGQFG 212
              + + +EI  +S LRHP +V  +     ED   + +  E++SGG ++ K+  ++ +  
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHD--AFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 253

Query: 213 EPAIRNYTQQILSGLAFLHSKHTVHRDIKGANIL-VDPNG-RVKLADFGMAKHIAGQSCP 270
           E     Y +Q+  GL  +H  + VH D+K  NI+        +KL DFG+  H+  +   
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313

Query: 271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP-WSQYE-GVAAMFKIGN 328
               G+  + APEV           D+WS+G     + +   P   + +       K  +
Sbjct: 314 KVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 372

Query: 329 ----SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTI 380
                     I    S++GKDFIR  L  +P  R T  + L+HP++       R  
Sbjct: 373 WNMDDSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 424

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  187 bits (477), Expect = 3e-54
 Identities = 85/272 (31%), Positives = 143/272 (52%), Gaps = 22/272 (8%)

Query: 119 KMLGRGTFGHVYV---GFNSDSGEMCAMKEV---TLFDDAKSKESAKQLMQEIVLLSRLR 172
           K+LG G +G V++       D+G++ AMK +   T+   AK+ E  +   +  VL    +
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR--TERQVLEHIRQ 117

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
            P +V  + +   E KL++ L+Y++GG ++  L    +F E  ++ Y  +I+  L  LH 
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 177

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSCP-LSFKGSPYWMAPEVIK-NSS 289
              ++RDIK  NIL+D NG V L DFG++K  +A ++     F G+  +MAP++++   S
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 237

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW---SQYEGVAAMF-KIGNSKELPTIPDDLSDEGKD 345
           G + AVD WSLG  + E+ T   P+    +    A +  +I  S+  P  P ++S   KD
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMSALAKD 295

Query: 346 FIRLCLQRNPLNR----PT-AAELLDHPFVKG 372
            I+  L ++P  R    P  A E+ +H F + 
Sbjct: 296 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  187 bits (476), Expect = 4e-54
 Identities = 86/326 (26%), Positives = 138/326 (42%), Gaps = 32/326 (9%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE-IVLLSRLRHPNIV 177
            +LG+G+FG V +     + E+ A+K +   D     +  +  M E  VL    + P + 
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVK-ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
           Q +      D+LY  +EYV+GG +   +Q  G+F EP    Y  +I  GL FL SK  ++
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 144

Query: 238 RDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           RD+K  N+++D  G +K+ADFGM K +I       +F G+P ++APE+I        +VD
Sbjct: 145 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVD 203

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKDFIRLCLQRNP 355
            W+ G  + EM   + P+   E    +F  I         P  +S E     +  + ++P
Sbjct: 204 WWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHP 260

Query: 356 LNR----PT-AAELLDHPFVKG---AAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNV 407
             R    P    ++ +H F +         + I  P      P              RN 
Sbjct: 261 GKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP----YKPKACG----------RNA 306

Query: 408 STFDTE--RLAVHSSRVSQTSLNASD 431
             FD    R     +   Q  +   D
Sbjct: 307 ENFDRFFTRHPPVLTPPDQEVIRNID 332

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  186 bits (474), Expect = 8e-54
 Identities = 82/287 (28%), Positives = 136/287 (47%), Gaps = 21/287 (7%)

Query: 99  PRSPGRMENPVSPESHWKKG-------KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD 151
           P+   +  N +   S  + G       ++LG+G+FG V +    ++G++ A+K V   D 
Sbjct: 2   PKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVK-VLKKDV 60

Query: 152 AKSKESAKQLMQE-IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ 210
               +  +  M E  +L     HP + Q +      D+L+  +E+V+GG +   +Q   +
Sbjct: 61  ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR 120

Query: 211 FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQSC 269
           F E   R Y  +I+S L FLH K  ++RD+K  N+L+D  G  KLADFGM K  I     
Sbjct: 121 FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180

Query: 270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGN 328
             +F G+P ++APE+++       AVD W++G  + EM     P+   E    +F  I N
Sbjct: 181 TATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILN 238

Query: 329 SKELPTIPDDLSDEGKDFIRLCLQRNPLNR----PTAA--ELLDHPF 369
            +     P  L ++    ++  + +NP  R           +L HPF
Sbjct: 239 DE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  185 bits (473), Expect = 9e-54
 Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 21/268 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE-IVLLSRLRHPNIV 177
           +++GRG++  V +     +  + AMK V   +     E    +  E  V      HP +V
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMK-VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             +     E +L+  +EYV+GG +   +Q   +  E   R Y+ +I   L +LH +  ++
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 133

Query: 238 RDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           RD+K  N+L+D  G +KL D+GM K  +       +F G+P ++APE+++       +VD
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVD 192

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAA--------MF-KIGNSKELPTIPDDLSDEGKDFI 347
            W+LG  + EM   + P+                +F  I   +    IP  LS +    +
Sbjct: 193 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASVL 250

Query: 348 RLCLQRNPLNR------PTAAELLDHPF 369
           +  L ++P  R         A++  HPF
Sbjct: 251 KSFLNKDPKERLGCHPQTGFADIQGHPF 278

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  192 bits (488), Expect = 3e-53
 Identities = 82/348 (23%), Positives = 143/348 (41%), Gaps = 25/348 (7%)

Query: 42  GAVTPIHPRAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRS 101
           G+++        A ++         + +   +P+PP     +         A      ++
Sbjct: 258 GSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKA 317

Query: 102 PGRMENPVSPESHWKKG------------KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLF 149
           P         +                   +LG+G+FG V +     + E+ A+K +   
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVK-ILKK 376

Query: 150 DDAKSKESAKQLMQE-IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY 208
           D     +  +  M E  VL    + P + Q +      D+LY  +EYV+GG +   +Q  
Sbjct: 377 DVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV 436

Query: 209 GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK-HIAGQ 267
           G+F EP    Y  +I  GL FL SK  ++RD+K  N+++D  G +K+ADFGM K +I   
Sbjct: 437 GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496

Query: 268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KI 326
               +F G+P ++APE+I        +VD W+ G  + EM   + P+   E    +F  I
Sbjct: 497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSI 554

Query: 327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR-----PTAAELLDHPF 369
                    P  +S E     +  + ++P  R         ++ +H F
Sbjct: 555 MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  184 bits (470), Expect = 7e-53
 Identities = 83/335 (24%), Positives = 140/335 (41%), Gaps = 27/335 (8%)

Query: 63  PDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLG 122
           P        + P P +    + P            V       +N +  + +    ++LG
Sbjct: 13  PFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII-DDYKVTSQVLG 71

Query: 123 RGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYG 181
            G  G V   FN  + E  A+K +         +   +  +E+ L  R  + P+IV+   
Sbjct: 72  LGINGKVLQIFNKRTQEKFALKML---------QDCPKARREVELHWRASQCPHIVRIVD 122

Query: 182 ----SKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHT 235
                      L I +E + GG ++  +QD G   F E       + I   + +LHS + 
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182

Query: 236 VHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
            HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APEV+      +
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE-KYD 241

Query: 293 LAVDIWSLGCTVLEMATTKPP-WSQYEGV--AAMF-KIGNSK-ELPTIP-DDLSDEGKDF 346
            + D+WSLG  +  +    PP +S +       M  +I   + E P     ++S+E K  
Sbjct: 242 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 301

Query: 347 IRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTIL 381
           IR  L+  P  R T  E ++HP++  +  + +T L
Sbjct: 302 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  182 bits (465), Expect = 7e-53
 Identities = 77/318 (24%), Positives = 139/318 (43%), Gaps = 38/318 (11%)

Query: 85  PFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGK-MLGRGTFGHVYVGFNSDSGEMCAM 143
              H + ++    + + P   +  V     ++  K +LG G  G V   F+  +G+ CA+
Sbjct: 2   AHHHHHHSSGLEVLFQGPEPKKYAV--TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCAL 59

Query: 144 KEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYG----SKTVEDKLYIYLEYVSG 198
           K +       S +      QE+    +    P+IV            +  L I +E + G
Sbjct: 60  KLL-----YDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110

Query: 199 GSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV---DPNGRV 253
           G ++  +Q+ G   F E       + I + + FLHS +  HRD+K  N+L    + +  +
Sbjct: 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170

Query: 254 KLADFGMAKHIAGQS----CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT 309
           KL DFG AK     +    C      +PY++APEV+      + + D+WSLG  +  +  
Sbjct: 171 KLTDFGFAKETTQNALQTPC-----YTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLC 224

Query: 310 TKPPW---SQYEGVAAMF-KIGNSK-ELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAE 363
             PP+   +       M  +I   +   P     ++S++ K  IRL L+ +P  R T  +
Sbjct: 225 GFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQ 284

Query: 364 LLDHPFVKGAAPLERTIL 381
            ++HP++  +  + +T L
Sbjct: 285 FMNHPWINQSMVVPQTPL 302

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  184 bits (468), Expect = 2e-52
 Identities = 68/268 (25%), Positives = 121/268 (45%), Gaps = 21/268 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE-IVLLSRLRHPNIV 177
           +++GRG++  V +     +  + AM+ V   +     E    +  E  V      HP +V
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMR-VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             +     E +L+  +EYV+GG +   +Q   +  E   R Y+ +I   L +LH +  ++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 176

Query: 238 RDIKGANILVDPNGRVKLADFGMAK-HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           RD+K  N+L+D  G +KL D+GM K  +       +F G+P ++APE+++       +VD
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVD 235

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAA--------MF-KIGNSKELPTIPDDLSDEGKDFI 347
            W+LG  + EM   + P+                +F  I   +    IP  LS +    +
Sbjct: 236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASVL 293

Query: 348 RLCLQRNPLNR------PTAAELLDHPF 369
           +  L ++P  R         A++  HPF
Sbjct: 294 KSFLNKDPKERLGCHPQTGFADIQGHPF 321

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  181 bits (461), Expect = 2e-52
 Identities = 70/287 (24%), Positives = 129/287 (44%), Gaps = 36/287 (12%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-FDDAKSKESAKQLMQEIVLLSRLRH 173
           ++K   +G G++G V+   N D+G++ A+K+     DD   K+ A   ++EI +L +L+H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA---LREIRMLKQLKH 61

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHS 232
           PN+V        + +L++  EY    ++   L  Y +   E  +++ T Q L  + F H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM-APEVIKNSSGC 291
            + +HRD+K  NIL+  +  +KL DFG A+ + G S     + +  W  +PE++   +  
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 292 NLAVDIWSLGCTVLEMATTKPPW---------------------SQYEGVAAM------- 323
              VD+W++GC   E+ +  P W                        +  +         
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 324 -FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                + + L     ++S      ++ CL  +P  R T  +LL HP+
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  181 bits (462), Expect = 2e-52
 Identities = 79/334 (23%), Positives = 138/334 (41%), Gaps = 69/334 (20%)

Query: 88  HSNSAATSPSVPRSPGRMENPVSPESH----WKKGKMLGRGTFGHVYVGFNSDSGEMCAM 143
           H +   T  +  + PG M    +P +     +++   LG GT+G VY   ++ + E  A+
Sbjct: 5   HHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAI 64

Query: 144 KEVTLFDDAKSKE----SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGG 199
           K + L  +   +E    +A   ++E+ LL  L+H NI++         +L++  EY    
Sbjct: 65  KRIRLEHE---EEGVPGTA---IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117

Query: 200 SIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-----GRVK 254
            + K +          I+++  Q+++G+ F HS+  +HRD+K  N+L+  +       +K
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLK 177

Query: 255 LADFGMAKHIAGQSCPLSFKGSPY----------WM-APEVIKNSSGCNLAVDIWSLGCT 303
           + DFG+A+            G P           W   PE++  S   + +VDIWS+ C 
Sbjct: 178 IGDFGLAR----------AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACI 227

Query: 304 VLEMATTKP--------------------P----W---SQYEGVAAMFKIGNSKELPTI- 335
             EM    P                    P    W   +        F     K L  + 
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL 287

Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
              L DEG D +   L+ +P+ R +A   L+HP+
Sbjct: 288 GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  181 bits (461), Expect = 3e-52
 Identities = 92/325 (28%), Positives = 136/325 (41%), Gaps = 64/325 (19%)

Query: 88  HSNSAATSPSVPRSP-GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV 146
           H +S+             ME        ++   ++G G++G V    N D+G + A+K+ 
Sbjct: 6   HHHSSGVDLGTENLYFQSMEK-------YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF 58

Query: 147 TL-FDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLL 205
               DD   K+ A   M+EI LL +LRH N+V        + + Y+  E+V   +I   L
Sbjct: 59  LESDDDKMVKKIA---MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL 114

Query: 206 QDYGQ-FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI 264
           + +        ++ Y  QI++G+ F HS + +HRDIK  NILV  +G VKL DFG A+  
Sbjct: 115 ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-- 172

Query: 265 AGQSCPLSFKGSPY-------WM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW-- 314
                 L+  G  Y       W  APE++        AVD+W++GC V EM   +P +  
Sbjct: 173 -----TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227

Query: 315 -------------------SQYEGVAAM--FKIGNSKELPTIPD---------DLSDEGK 344
                                 E       F       LP I +          LS+   
Sbjct: 228 DSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA---GVRLPEIKEREPLERRYPKLSEVVI 284

Query: 345 DFIRLCLQRNPLNRPTAAELLDHPF 369
           D  + CL  +P  RP  AELL H F
Sbjct: 285 DLAKKCLHIDPDKRPFCAELLHHDF 309

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  182 bits (464), Expect = 9e-52
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 16/278 (5%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V +  +  + ++ AMK ++ F+  K  +SA    +E  +++    P +VQ
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA-FFWEERDIMAFANSPWVVQ 133

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHR 238
            + +   +  LY+ +EY+ GG +  L+ +Y    E   R YT +++  L  +HS   +HR
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHR 192

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPYWMAPEVIKNSSGC---NL 293
           D+K  N+L+D +G +KLADFG    +  +         G+P +++PEV+K+  G      
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 252

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPD--DLSDEGKDFIR-- 348
             D WS+G  + EM     P+   + +   + KI N K   T PD  D+S E K+ I   
Sbjct: 253 ECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 311

Query: 349 LCLQRNPLNRPTAAELLDHPFVKG---AAPLERTILAP 383
           L  +   L R    E+  H F K    A    R  +AP
Sbjct: 312 LTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 349

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  182 bits (463), Expect = 2e-51
 Identities = 78/267 (29%), Positives = 126/267 (47%), Gaps = 15/267 (5%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG FG V V    ++ ++ AMK +  ++  K  E+A    +E  +L       I  
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA-CFREERDVLVNGDSKWITT 138

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            + +   ++ LY+ ++Y  GG +  LL  +  +  E   R Y  +++  +  +H  H VH
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI--AGQSCPLSFKGSPYWMAPEVIK----NSSGC 291
           RDIK  NIL+D NG ++LADFG    +   G        G+P +++PE+++         
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKE---LPTIPDDLSDEGKDFI 347
               D WSLG  + EM   + P+   E +   + KI N KE    PT   D+S+  KD I
Sbjct: 259 GPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSENAKDLI 317

Query: 348 RLCLQRNP--LNRPTAAELLDHPFVKG 372
           R  +      L +    +   HPF  G
Sbjct: 318 RRLICSREHRLGQNGIEDFKKHPFFSG 344

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  178 bits (454), Expect = 2e-50
 Identities = 81/270 (30%), Positives = 126/270 (46%), Gaps = 19/270 (7%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           K++GRG F  V V     +G++ AMK +  +D  K  E +    +E  +L       I Q
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS-CFREERDVLVNGDRRWITQ 125

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVH 237
            + +   E+ LY+ +EY  GG +  LL  +G +      R Y  +I+  +  +H    VH
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185

Query: 238 RDIKGANILVDPNGRVKLADFGMAK--HIAGQSCPLSFKGSPYWMAPEVIKNSSGC---- 291
           RDIK  NIL+D  G ++LADFG        G    L   G+P +++PE+++   G     
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245

Query: 292 --NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKE---LPTIPDDLSDEGKD 345
                 D W+LG    EM   + P+   +  A  + KI + KE   LP + + + +E +D
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304

Query: 346 FIRLCLQRNPLNR---PTAAELLDHPFVKG 372
           FI+  L   P  R     A +   HPF  G
Sbjct: 305 FIQR-LLCPPETRLGRGGAGDFRTHPFFFG 333

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  176 bits (448), Expect = 1e-49
 Identities = 53/360 (14%), Positives = 119/360 (33%), Gaps = 46/360 (12%)

Query: 71  HRLPLPPITISNSSPFSHSNSAATSPSVPR-SPGRMENPVSPES-HWKKGKMLGRGTFGH 128
           +R+P   +  ++    S ++S  ++       P R+E+ +        +G +LG+     
Sbjct: 34  NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 93

Query: 129 VYVGFNSDSGEMCAMKEVT---------------------LFDDAKSKESAKQLMQEIVL 167
                + ++GE   +                         L    K+++ AK  ++ I  
Sbjct: 94  YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153

Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYV-------SGGSIYKLLQDYGQFGEP----AI 216
              ++ P   +    +  E  +++   +        +  +  ++L  +    +     A 
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 213

Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--AGQSCPLSFK 274
              T Q++  LA LH    VH  ++  +I++D  G V L  F        +  S      
Sbjct: 214 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGF 273

Query: 275 GSPYWMAPEVIK----NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
             P   A  ++     + +    A D W+LG  +  +     P +    +     I   +
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI--FR 331

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPP 390
               IP  +    +  +   L+    +R    + ++ P  +         L    +D  P
Sbjct: 332 SCKNIPQPV----RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEP 387

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  171 bits (435), Expect = 6e-49
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 61/298 (20%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE----SAKQLMQEIVLLSR 170
           +   + +G GT+G VY   N+  GE  A+K++ L  +    E    +    ++EI +L  
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE---DEGIPSTT---IREISILKE 56

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAF 229
           L+H NIV+ Y     + +L +  E++    + KLL            +++  Q+L+G+A+
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY----------W 279
            H +  +HRD+K  N+L++  G +K+ADFG+A+            G P           W
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLAR----------AFGIPVRKYTHEIVTLW 165

Query: 280 M-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--------------------P----W 314
             AP+V+  S   +  +DIWS+GC   EM    P                    P    W
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225

Query: 315 ---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
              ++       F +       +    L + G D +   L+ +P  R TA + L+H +
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  170 bits (434), Expect = 7e-49
 Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 61/299 (20%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE----SAKQLMQEIVLLSR 170
           ++K + +G GT+G V+   N ++ E+ A+K V L DD    E    SA   ++EI LL  
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSA---LREICLLKE 57

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAF 229
           L+H NIV+ +     + KL +  E+     + K             ++++  Q+L GL F
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY----------W 279
            HS++ +HRD+K  N+L++ NG +KLA+FG+A+            G P           W
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLAR----------AFGIPVRCYSAEVVTLW 166

Query: 280 M-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPP------------------------- 313
              P+V+  +   + ++D+WS GC   E+A    P                         
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 314 W---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
           W   ++            +  L  +   L+  G+D ++  L+ NP+ R +A E L HP+
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  172 bits (439), Expect = 4e-48
 Identities = 89/334 (26%), Positives = 150/334 (44%), Gaps = 48/334 (14%)

Query: 74  PLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGF 133
           P+   +   S   S     +   +V  +PG+  +     S +   K++G G+FG VY   
Sbjct: 16  PVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVS-YTDTKVIGNGSFGVVYQAK 74

Query: 134 NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ----YYGSKTVEDKL 189
             DSGE+ A+K+V    D + K       +E+ ++ +L H NIV+    +Y S   +D++
Sbjct: 75  LCDSGELVAIKKV--LQDKRFK------NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126

Query: 190 YIYL--EYVSGGSIYKLLQDYGQFGEP----AIRNYTQQILSGLAFLHSKHTVHRDIKGA 243
           Y+ L  +YV   ++Y++ + Y +  +      ++ Y  Q+   LA++HS    HRDIK  
Sbjct: 127 YLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 185

Query: 244 NILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGC 302
           N+L+DP+   +KL DFG AK +      +S+  S Y+ APE+I  ++    ++D+WS GC
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245

Query: 303 TVLEMATTKPPWSQYEGVAAMFKI----G----------NSK----ELPTIP-------- 336
            + E+   +P +    GV  + +I    G          N      + P I         
Sbjct: 246 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 305

Query: 337 -DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                 E        L+  P  R T  E   H F
Sbjct: 306 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  170 bits (434), Expect = 4e-48
 Identities = 75/310 (24%), Positives = 131/310 (42%), Gaps = 63/310 (20%)

Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE----SAKQ 160
           ++     +  ++K   LG G F  VY   + ++ ++ A+K++ L   +++K+    +A  
Sbjct: 3   LDVKSRAKR-YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA-- 59

Query: 161 LMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNY 219
            ++EI LL  L HPNI+    +   +  + +  +++    +  +++D         I+ Y
Sbjct: 60  -LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY 117

Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY- 278
               L GL +LH    +HRD+K  N+L+D NG +KLADFG+AK            GSP  
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK----------SFGSPNR 167

Query: 279 ---------WM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP---------------- 312
                    W  APE++  +    + VD+W++GC + E+    P                
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227

Query: 313 ----P----WSQYEGVAAM-----FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRP 359
               P    W     + ++     FK      L  I     D+  D I+     NP  R 
Sbjct: 228 TLGTPTEEQWP---DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284

Query: 360 TAAELLDHPF 369
           TA + L   +
Sbjct: 285 TATQALKMKY 294

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  168 bits (429), Expect = 6e-48
 Identities = 87/327 (26%), Positives = 139/327 (42%), Gaps = 70/327 (21%)

Query: 87  SHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV 146
            H + ++   ++    G ME        ++K + +G GT+G VY   +S  G + A+K +
Sbjct: 3   HHHHHSSGRENLY-FQGLMEK-------YQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI 53

Query: 147 TLFDDAKSKE----SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIY 202
            L       E    +A   ++EI LL  L HPNIV        E  L +  E++    + 
Sbjct: 54  RL---DAEDEGIPSTA---IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLK 106

Query: 203 KLLQDYGQ-FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA 261
           K+L +      +  I+ Y  Q+L G+A  H    +HRD+K  N+L++ +G +KLADFG+A
Sbjct: 107 KVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166

Query: 262 KHIAGQSCPLSFKGSPY----------WM-APEVIKNSSGCNLAVDIWSLGCTVLEMATT 310
           +            G P           W  AP+V+  S   + +VDIWS+GC   EM T 
Sbjct: 167 R----------AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

Query: 311 KP--------------------P----W---SQYEGVAAM-FKIGNSKELPTIPDDLSDE 342
           KP                    P    W    +        F++   K   +I      E
Sbjct: 217 KPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQE 276

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPF 369
           G D +   L  +P  R +A + ++HP+
Sbjct: 277 GIDLLSNMLCFDPNKRISARDAMNHPY 303

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  168 bits (429), Expect = 1e-47
 Identities = 78/299 (26%), Positives = 129/299 (43%), Gaps = 62/299 (20%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE----SAKQLMQEIVLLSR 170
           + K   LG GT+  VY G +  +  + A+KE+ L    + +E    +A   ++E+ LL  
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL----EHEEGAPCTA---IREVSLLKD 56

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAF 229
           L+H NIV  +     E  L +  EY+    + + L D G       ++ +  Q+L GLA+
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY----------W 279
            H +  +HRD+K  N+L++  G +KLADFG+A+           K  P           W
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLAR----------AKSIPTKTYDNEVVTLW 165

Query: 280 M-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--------------------P----W 314
              P+++  S+  +  +D+W +GC   EMAT +P                    P    W
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225

Query: 315 ---SQYEGVAAM-FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                 E      +    ++ L +    L  +G D +   LQ    NR +A + + HPF
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  167 bits (426), Expect = 2e-47
 Identities = 87/314 (27%), Positives = 137/314 (43%), Gaps = 71/314 (22%)

Query: 109 VSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKE----SAKQLMQE 164
           +S  S +K+ + LG GT+  VY G N  +G   A+KEV L     S+E    +A   ++E
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL----DSEEGTPSTA---IRE 53

Query: 165 IVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY------GQFGEPAIRN 218
           I L+  L+H NIV+ Y     E+KL +  E++    + K +                ++ 
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
           +  Q+L GLAF H    +HRD+K  N+L++  G++KL DFG+A+            G P 
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR----------AFGIPV 162

Query: 279 ----------WM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--------------- 312
                     W  AP+V+  S   + ++DIWS GC + EM T KP               
Sbjct: 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222

Query: 313 -----P----W---SQYEGVAAMFKIGNSKELPTI-----PDDLSDEGKDFIRLCLQRNP 355
                P    W   ++        +    ++L  +      + L     DF+   LQ NP
Sbjct: 223 DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNP 282

Query: 356 LNRPTAAELLDHPF 369
             R +A + L HP+
Sbjct: 283 DMRLSAKQALHHPW 296

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  165 bits (419), Expect = 1e-46
 Identities = 74/295 (25%), Positives = 116/295 (39%), Gaps = 54/295 (18%)

Query: 116 KKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
              + +G+G +G V+ G +    GE  A+K   +F     K   ++   E+     LRH 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ---GENVAVK---IFSSRDEKSWFRE--TELYNTVMLRHE 62

Query: 175 NIVQYYGSKTVED----KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           NI+ +  S         +L++   Y   GS+Y  LQ        +       I SGLA L
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHL 121

Query: 231 HSKHT--------VHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-----CPLSFKGSP 277
           H +           HRD+K  NILV  NG+  +AD G+A   +  +           G+ 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 278 YWMAPEVIKNS-----SGCNLAVDIWSLGCTVL-EMAT----------TKPPWSQYEGVA 321
            +MAPEV+  +           VDIW+ G  VL E+A            KPP+       
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFG-LVLWEVARRMVSNGIVEDYKPPFYDVVPND 240

Query: 322 AMFK-----IGNSKELPTIPDDLSDEG-----KDFIRLCLQRNPLNRPTAAELLD 366
             F+     +   ++ P IP+    +         ++ C  +NP  R TA  +  
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  164 bits (418), Expect = 2e-46
 Identities = 72/287 (25%), Positives = 113/287 (39%), Gaps = 61/287 (21%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNI 176
            ++LG G  G V   FN  + E  A+K +         +   +  +E+ L  R  + P+I
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKML---------QDCPKARREVELHWRASQCPHI 73

Query: 177 VQYYG----SKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFL 230
           V+              L I +E + GG ++  +QD G   F E       + I   + +L
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133

Query: 231 HSKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
           HS +  HRD+K  N+L     PN  +KL DFG A                     E    
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KETTGE 173

Query: 288 SSGCNLAVDIWSLG-------CTVLEMATTKPP-WSQYEGV--AAMF-KIGNSK-ELPTI 335
                 + D+WSLG       C         PP +S +       M  +I   + E P  
Sbjct: 174 KYD--KSCDMWSLGVIMYILLCGY-------PPFYSNHGLAISPGMKTRIRMGQYEFPNP 224

Query: 336 P-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTIL 381
              ++S+E K  IR  L+  P  R T  E ++HP++  +  + +T L
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  165 bits (419), Expect = 1e-45
 Identities = 84/302 (27%), Positives = 140/302 (46%), Gaps = 48/302 (15%)

Query: 106 ENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           +     E  +   K++G G+FG V+     +S E+ A+K+V    D + K       +E+
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQ--DKRFK------NREL 83

Query: 166 VLLSRLRHPNIVQ----YYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEP----A 215
            ++  ++HPN+V     +Y +   +D++++ L  EYV   ++Y+  + Y +  +      
Sbjct: 84  QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLL 142

Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFK 274
           I+ Y  Q+L  LA++HS    HRDIK  N+L+DP  G +KL DFG AK +      +S+ 
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202

Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI----G--- 327
            S Y+ APE+I  ++     +DIWS GC + E+   +P +    G+  + +I    G   
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262

Query: 328 -----------NSKELPTIP---------DDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                         + P I               +  D I   L+  P  R TA E L H
Sbjct: 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322

Query: 368 PF 369
           PF
Sbjct: 323 PF 324

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  163 bits (413), Expect = 4e-45
 Identities = 49/306 (16%), Positives = 100/306 (32%), Gaps = 30/306 (9%)

Query: 87  SHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV 146
           S+ N+      +P    + E  +  +       +LG G F  VY     D  +    ++ 
Sbjct: 40  SYPNTFEWQCKLPAIKPKTEFQLGSK-LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF 98

Query: 147 TL--FDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKL 204
            L     A   E      Q +  L        +++Y +   ++   +  E  S G++   
Sbjct: 99  VLKVQKPANPWE-FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNA 157

Query: 205 LQDYGQ-----FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILV-----------D 248
           +  Y         +  + ++  ++L  +  +H    +H DIK  N ++           D
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217

Query: 249 PNGRVKLADFGMAKHIAGQSCPLSFK---GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVL 305
            +  + L D G +  +        F     +  +   E++ N    N  +D + +  TV 
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVY 276

Query: 306 EMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
            M        + EG     +         +P    D   +F  + L     +   + +LL
Sbjct: 277 CMLFGTYMKVKNEGGECKPE----GLFRRLPH--LDMWNEFFHVMLNIPDCHHLPSLDLL 330

Query: 366 DHPFVK 371
                K
Sbjct: 331 RQKLKK 336

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  159 bits (405), Expect = 5e-44
 Identities = 69/300 (23%), Positives = 123/300 (41%), Gaps = 61/300 (20%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES----AKQLMQEIVLLSRLRHPNI 176
           +G+GTFG V+   +  +G+  A+K+V + ++   KE     A   ++EI +L  L+H N+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITA---LREIKILQLLKHENV 78

Query: 177 VQ--------YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGL 227
           V                +  +Y+  ++     +  LL +   +F    I+   Q +L+GL
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-------WM 280
            ++H    +HRD+K AN+L+  +G +KLADFG+A+     S   + + + Y       W 
Sbjct: 138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF---SLAKNSQPNRYTNRVVTLWY 194

Query: 281 -APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--------------------P------ 313
             PE++         +D+W  GC + EM T  P                           
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254

Query: 314 -WSQYEGVAAM-FKIGNSKEL-PTIPD-DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
               YE    +    G  +++   +          D I   L  +P  R  + + L+H F
Sbjct: 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  159 bits (404), Expect = 7e-44
 Identities = 84/324 (25%), Positives = 136/324 (41%), Gaps = 54/324 (16%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
              ++  +M G+GTFG V +G    +G   A+K+V    D        + +Q +  L+ L
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQD---PRFRNRELQIMQDLAVL 76

Query: 172 RHPNIVQ---YYGSKTVEDK----LYIYLEYVSGGSIYKLLQDYGQFGEPA----IRNYT 220
            HPNIVQ   Y+ +    D+    L + +EYV   ++++  ++Y +         I+ + 
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 221 QQILSGLAFLH--SKHTVHRDIKGANILVDP-NGRVKLADFGMAKHIAGQSCPLSFKGSP 277
            Q++  +  LH  S +  HRDIK  N+LV+  +G +KL DFG AK ++     +++  S 
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195

Query: 278 YWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--PWSQY----------------EG 319
           Y+ APE+I  +     AVDIWS+GC   EM   +P                       E 
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255

Query: 320 VAAM------FKIGN------SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           +  +        + N      S          + E  D +   LQ  P  R    E L H
Sbjct: 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315

Query: 368 PFVKGAAPL-ERTILAPEPSDVPP 390
           P+      L +     P   D+P 
Sbjct: 316 PYF---DELHDPATKLPNNKDLPE 336

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  158 bits (401), Expect = 9e-44
 Identities = 68/295 (23%), Positives = 119/295 (40%), Gaps = 54/295 (18%)

Query: 116 KKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +  K +G+G +G V++G +    GE  A+K   +F    ++E++     EI     +RH 
Sbjct: 40  QMVKQIGKGRYGEVWMGKWR---GEKVAVK---VFFT--TEEASWFRETEIYQTVLMRHE 91

Query: 175 NIVQYYGS----KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           NI+ +  +         +LY+  +Y   GS+Y  L+        ++       +SGL  L
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHL 150

Query: 231 HSKHT--------VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK-----GSP 277
           H++           HRD+K  NILV  NG   +AD G+A      +  +        G+ 
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 278 YWMAPEVIKNSSGCN-----LAVDIWSLGCTVL-EMAT----------TKPPWSQYEGVA 321
            +M PEV+  S   N     +  D++S G  +L E+A            + P+       
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGL-ILWEVARRCVSGGIVEEYQLPYHDLVPSD 269

Query: 322 AMFK-----IGNSKELPTIPDDLSDEG-----KDFIRLCLQRNPLNRPTAAELLD 366
             ++     +   K  P+ P+  S +         +  C   NP +R TA  +  
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  157 bits (399), Expect = 1e-43
 Identities = 77/311 (24%), Positives = 116/311 (37%), Gaps = 74/311 (23%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQL----MQEIVLL 168
           S ++    +G G +G VY   +  SG   A+K V +            L    ++E+ LL
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV---PNGGGGGGGLPISTVREVALL 65

Query: 169 SRLR---HPNIVQ-----YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRN 218
            RL    HPN+V+            E K+ +  E+V    +   L            I++
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY 278
             +Q L GL FLH+   VHRD+K  NILV   G VKLADFG+A+                
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR----------IYSYQM 174

Query: 279 WM----------APEVIKNSSGC--NLAVDIWSLGCTVLEMATTKP-------------- 312
            +          APEV+           VD+WS+GC   EM   KP              
Sbjct: 175 ALTPVVVTLWYRAPEVL---LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

Query: 313 ------P----WSQYEGVAAM----FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR 358
                 P    W       ++    F     + + ++  ++ + G   +   L  NP  R
Sbjct: 232 FDLIGLPPEDDWP---RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKR 288

Query: 359 PTAAELLDHPF 369
            +A   L H +
Sbjct: 289 ISAFRALQHSY 299

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  155 bits (395), Expect = 3e-43
 Identities = 78/288 (27%), Positives = 118/288 (40%), Gaps = 47/288 (16%)

Query: 111 PESHWKKGKMLGRGTFGHVYVG----FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
            E H K  + LG+G FG V +        ++GE+ A+K   L    +     +   +EI 
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEH--LRDFEREIE 63

Query: 167 LLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
           +L  L+H NIV+Y G         L + +EY+  GS+   LQ +  +     +  YT QI
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123

Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--------AGQSCPLSFKG 275
             G+ +L +K  +HRD+   NILV+   RVK+ DFG+ K +          +        
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF- 182

Query: 276 SPYWMAPEVI---KNSSGCNLAVDIWSLGCTVLEMAT----------------TKPPWSQ 316
              W APE +   K S     A D+WS G  + E+ T                      Q
Sbjct: 183 ---WYAPESLTESKFSV----ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235

Query: 317 YEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL 364
                 +  + N+  LP  PD   DE    +  C   N   RP+  +L
Sbjct: 236 MIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  156 bits (397), Expect = 3e-43
 Identities = 64/303 (21%), Positives = 114/303 (37%), Gaps = 50/303 (16%)

Query: 105 MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE 164
            EN        +  ++  RG FG V+        E  A+K   +F      + + Q   E
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVK---IFP--IQDKQSWQNEYE 68

Query: 165 IVLLSRLRHPNIVQYYGS----KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYT 220
           +  L  ++H NI+Q+ G+     +V+  L++   +   GS+   L+         + +  
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIA 127

Query: 221 QQILSGLAFLHSKHT----------VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
           + +  GLA+LH               HRDIK  N+L+  N    +ADFG+A         
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 271 LSFK---GSPYWMAPEV----IKNSSGCNLAVDIWSLGCTVLEMATTKPPWS-------- 315
                  G+  +MAPEV    I       L +D++++G  + E+A+              
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 316 -------QYEGVAAMFKIGNSKEL-PTIPDD-LSDEG----KDFIRLCLQRNPLNRPTAA 362
                  Q+  +  M ++   K+  P + D      G     + I  C   +   R +A 
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 363 ELL 365
            + 
Sbjct: 308 CVG 310

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  155 bits (393), Expect = 1e-42
 Identities = 79/288 (27%), Positives = 120/288 (41%), Gaps = 45/288 (15%)

Query: 111 PESHWKKGKMLGRGTFGHVYVG----FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
            + + KK + LG G FG V +      N  +GEM A+K   L  DA   +      QEI 
Sbjct: 29  HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKADA-GPQHRSGWKQEID 85

Query: 167 LLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQIL 224
           +L  L H +I++Y G         L + +EYV  GS+   L  +   G   +  + QQI 
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQIC 144

Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--------AGQSCPLSFKGS 276
            G+A+LH++H +HRD+   N+L+D +  VK+ DFG+AK +          +         
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-- 202

Query: 277 PYWMAPEVIKN---SSGCNLAVDIWSLGCTVLEMAT---------------TKPPWSQYE 318
             W APE +K          A D+WS G T+ E+ T                     Q  
Sbjct: 203 --WYAPECLKEYKFYY----ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256

Query: 319 GVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +     +   + LP  PD    E    ++ C +     RPT   L+ 
Sbjct: 257 VLRLTELLERGERLPR-PDKCPAEVYHLMKNCWETEASFRPTFENLIP 303

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  154 bits (390), Expect = 2e-42
 Identities = 74/290 (25%), Positives = 119/290 (41%), Gaps = 45/290 (15%)

Query: 111 PESHWKKGKMLGRGTFGHVYVG----FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
            +   K+ + LG G FG V +        ++GE  A+K  +L  ++        L +EI 
Sbjct: 19  EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPES-GGNHIADLKKEIE 75

Query: 167 LLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
           +L  L H NIV+Y G  ++   + + + +E++  GS+ + L     +        Y  QI
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135

Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--------AGQSCPLSFKG 275
             G+ +L S+  VHRD+   N+LV+   +VK+ DFG+ K I                   
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194

Query: 276 SPYWMAPEVI---KNSSGCNLAVDIWSLGCTVLEMAT---------------TKPPWSQY 317
              W APE +   K       A D+WS G T+ E+ T                 P   Q 
Sbjct: 195 ---WYAPECLMQSKFYI----ASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247

Query: 318 EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                +  +   K LP  P +  DE    +R C +  P NR +   L++ 
Sbjct: 248 TVTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  154 bits (391), Expect = 2e-42
 Identities = 81/326 (24%), Positives = 124/326 (38%), Gaps = 54/326 (16%)

Query: 80  ISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHW-------KKGKMLGRGTFGHV--- 129
           +S      H +    +       G M +               K  + LG+G FG V   
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMC 60

Query: 130 -YVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYG--SKTVE 186
            Y     ++GE+ A+K   L    +     +   +EI +L  L+H NIV+Y G       
Sbjct: 61  RYDPLQDNTGEVVAVK--KLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116

Query: 187 DKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANI 245
             L + +EY+  GS+   LQ +  +     +  YT QI  G+ +L +K  +HRD+   NI
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 176

Query: 246 LVDPNGRVKLADFGMAKHI--------AGQSCPLSFKGSPYWMAPEVI---KNSSGCNLA 294
           LV+   RVK+ DFG+ K +          +           W APE +   K S     A
Sbjct: 177 LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYAPESLTESKFSV----A 228

Query: 295 VDIWSLGCTVLEMAT----------------TKPPWSQYEGVAAMFKIGNSKELPTIPDD 338
            D+WS G  + E+ T                      Q      +  + N+  LP  PD 
Sbjct: 229 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PDG 287

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAEL 364
             DE    +  C   N   RP+  +L
Sbjct: 288 CPDEIYMIMTECWNNNVNQRPSFRDL 313

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  152 bits (387), Expect = 3e-42
 Identities = 65/260 (25%), Positives = 109/260 (41%), Gaps = 18/260 (6%)

Query: 117 KGKMLGRGTFGHVYVG-FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           + K LG G FG V  G +         A+K   L ++A       +L+ E  ++ +L +P
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVK--ILKNEANDPALKDELLAEANVMQQLDNP 78

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
            IV+  G     +   + +E    G + K LQ      +  I     Q+  G+ +L   +
Sbjct: 79  YIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 137

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGS--PY-WMAPEVI---KN 287
            VHRD+   N+L+      K++DFG++K + A ++   +      P  W APE I   K 
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 288 SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
           SS      D+WS G  + E  +  + P+   +G      +   + +   P     E  D 
Sbjct: 198 SS----KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCPREMYDL 252

Query: 347 IRLCLQRNPLNRPTAAELLD 366
           + LC   +  NRP  A +  
Sbjct: 253 MNLCWTYDVENRPGFAAVEL 272

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  153 bits (389), Expect = 5e-42
 Identities = 78/315 (24%), Positives = 121/315 (38%), Gaps = 40/315 (12%)

Query: 111 PESHWKKGKMLGRGTFGHVYVG----FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIV 166
            E H K    LG+G FG V +        ++G + A+K   L      ++      +EI 
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRD--FQREIQ 76

Query: 167 LLSRLRHPNIVQYYG--SKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQI 223
           +L  L    IV+Y G         L + +EY+  G +   LQ +  +     +  Y+ QI
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136

Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS---CPLSFKGSPY-W 279
             G+ +L S+  VHRD+   NILV+    VK+ADFG+AK +              SP  W
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196

Query: 280 MAPEVIKN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIG----NSKE 331
            APE + +   S       D+WS G  + E+ T      S       M            
Sbjct: 197 YAPESLSDNIFSR----QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252

Query: 332 LPTI---------PDDLSDEGKDFIRLCLQRNPLNRPTAAEL---LDHPFVKGAAPLERT 379
           L  +         P     E  + ++LC   +P +RP+ + L   LD     G+   E  
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM-LWSGSRGCETH 311

Query: 380 ILAPEPSDVPPGVTN 394
                P      ++ 
Sbjct: 312 AFTAHPEGKHHSLSF 326

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  152 bits (386), Expect = 1e-41
 Identities = 67/286 (23%), Positives = 123/286 (43%), Gaps = 29/286 (10%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGF---NSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIV 166
            E+ +KK K+LG G FG VY G      +  ++  A+K   L +   S ++ K+++ E  
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREAT-SPKANKEILDEAY 69

Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILS 225
           +++ + +P++ +  G       + +  + +  G +   ++++    G   + N+  QI  
Sbjct: 70  VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PY-WMAP 282
           G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G   P  WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 283 EVI---KNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           E I     +       D+WS G TV E+ T    P+           +   + LP  P  
Sbjct: 189 ESILHRIYTH----QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-PPI 243

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPE 384
            + +    +R C   +  +RP   EL+            +    P+
Sbjct: 244 CTIDVYMIMRKCWMIDADSRPKFRELIIE--------FSKMARDPQ 281

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  152 bits (385), Expect = 2e-41
 Identities = 67/294 (22%), Positives = 108/294 (36%), Gaps = 52/294 (17%)

Query: 116 KKGKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
              + +G+G FG V+ G +    GE  A+K   +F   + +   ++   EI     LRH 
Sbjct: 45  VLQESIGKGRFGEVWRGKWR---GEEVAVK---IFSSREERSWFRE--AEIYQTVMLRHE 96

Query: 175 NIVQYYGS----KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           NI+ +  +         +L++  +Y   GS++  L  Y       +        SGLA L
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHL 155

Query: 231 HSKHT--------VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK-----GSP 277
           H +           HRD+K  NILV  NG   +AD G+A      +  +        G+ 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 278 YWMAPEVIKNSSGC-----NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK------- 325
            +MAPEV+ +S            DI+++G    E+A        +E     +        
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275

Query: 326 --------IGNSKELPTIPDDLSDEG-----KDFIRLCLQRNPLNRPTAAELLD 366
                   +   K  P IP+              +R C   N   R TA  +  
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  152 bits (387), Expect = 3e-41
 Identities = 64/264 (24%), Positives = 107/264 (40%), Gaps = 16/264 (6%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
                  G+ +GRG FG V+ G       + A+K  +  +     +   + +QE  +L +
Sbjct: 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK--SCRETL-PPDLKAKFLQEARILKQ 168

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAF 229
             HPNIV+  G  T +  +YI +E V GG     L+  G +     +        +G+ +
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--CPLSFKGSPY-WMAPEVIK 286
           L SK  +HRD+   N LV     +K++DFGM++  A          +  P  W APE + 
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 287 NSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDE 342
                +   D+WS G  + E  +    P   Y  ++       +     LP  P+   D 
Sbjct: 289 YGR-YSSESDVWSFGILLWETFSLGASP---YPNLSNQQTREFVEKGGRLP-CPELCPDA 343

Query: 343 GKDFIRLCLQRNPLNRPTAAELLD 366
               +  C    P  RP+ + +  
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQ 367

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  152 bits (385), Expect = 6e-41
 Identities = 74/329 (22%), Positives = 124/329 (37%), Gaps = 79/329 (24%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
              +  GK LG G+FG V   F+ +SG+  A+K+V    D + K       +E+ ++  L
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV--LQDPRYK------NRELDIMKVL 57

Query: 172 RHPNIVQ------------------------------------YYGSKTVEDKLYIYL-- 193
            H NI++                                               Y+ +  
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 194 EYVSGGSIYKLLQDYGQFGEPA----IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP 249
           EYV   +++K+L+ + + G       I  Y  Q+   + F+HS    HRDIK  N+LV+ 
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 250 N-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMA 308
               +KL DFG AK +      +++  S ++ APE++  ++    ++D+WS+GC   E+ 
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 309 TTKP--PWSQY----------------EGVAAMFKIGNSKELPTI---------PDDLSD 341
             KP                       E +  M         PT+         P+    
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFV 370
              D +   L+  P  R    E + HPF 
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  150 bits (380), Expect = 7e-41
 Identities = 80/304 (26%), Positives = 121/304 (39%), Gaps = 78/304 (25%)

Query: 121 LGRGTFGHVYVGFNS-DSGEMCAMKEVTLFDDAKSKE----SAKQLMQEIVLLSRLR--- 172
           +G G +G V+   +  + G   A+K V +      +E    S    ++E+ +L  L    
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLST---IREVAVLRHLETFE 72

Query: 173 HPNIVQ-----YYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILS 225
           HPN+V+            E KL +  E+V    +   L    +       I++   Q+L 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM----- 280
           GL FLHS   VHRD+K  NILV  +G++KLADFG+A+                 +     
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR----------IYSFQMALTSVVV 181

Query: 281 -----APEVIKNSSGC--NLAVDIWSLGCTVLEMATTKP--------------------P 313
                APEV+           VD+WS+GC   EM   KP                    P
Sbjct: 182 TLWYRAPEVL---LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238

Query: 314 ----WSQYEGVAAM----FKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
               W       A+    F   +++ +     D+ + GKD +  CL  NP  R +A   L
Sbjct: 239 GEEDWP---RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295

Query: 366 DHPF 369
            HP+
Sbjct: 296 SHPY 299

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  148 bits (377), Expect = 2e-40
 Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 37/311 (11%)

Query: 96  PSVPRSPGRMENPVSP--ESHW-------KKGKMLGRGTFGHVYVGF--NSDSGEM-CAM 143
           P     P   E P                   K++G G  G V  G        ++  A+
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82

Query: 144 KEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYK 203
           K   L      ++  +  + E  ++ +  HPNI++  G  T      I  EY+  GS+  
Sbjct: 83  K--ALKAGYTERQ-RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139

Query: 204 LLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK 262
            L+ + GQF    +    + + +G+ +L     VHRD+   N+LVD N   K++DFG+++
Sbjct: 140 FLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199

Query: 263 HIAGQSCP-LSFKGS--PY-WMAPEVI---KNSSGCNLAVDIWSLGCTVLEMATT-KPPW 314
            +        +  G   P  W APE I     SS    A D+WS G  + E+    + P+
Sbjct: 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS----ASDVWSFGVVMWEVLAYGERPY 255

Query: 315 SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA 374
                   +  +     LP  P          +  C  ++   RP  ++++         
Sbjct: 256 WNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV------- 307

Query: 375 PLERTILAPEP 385
            L+  I +PE 
Sbjct: 308 -LDALIRSPES 317

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  147 bits (373), Expect = 1e-39
 Identities = 71/306 (23%), Positives = 133/306 (43%), Gaps = 63/306 (20%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
            +LG G +G V    +  +GE+ A+K++  FD       A + ++EI +L   +H NI+ 
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK---PLFALRTLREIKILKHFKHENIIT 73

Query: 179 YY------GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA-IRNYTQQILSGLAFLH 231
            +        +   + +YI  E +    +++++    Q      I+ +  Q L  +  LH
Sbjct: 74  IFNIQRPDSFENFNE-VYIIQELM-QTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLH 129

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSP-----------YWM 280
             + +HRD+K +N+L++ N  +K+ DFG+A+ I   +   S                ++ 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP--------------------PWSQYEGV 320
           APEV+  S+  + A+D+WS GC + E+   +P                    P S     
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD---- 245

Query: 321 AAMFKIGNSK------ELPTIPD--------DLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
             +  I + +       LP  P          ++ +G D ++  L  +P  R TA E L+
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305

Query: 367 HPFVKG 372
           HP+++ 
Sbjct: 306 HPYLQT 311

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  145 bits (368), Expect = 1e-39
 Identities = 75/274 (27%), Positives = 119/274 (43%), Gaps = 30/274 (10%)

Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGEM--CAMKEVTLFDDAKSKESAKQ-LMQEIV 166
            E   +  + LG G+FG V  G +++ SG+    A+K   L  D  S+  A    ++E+ 
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK--CLKPDVLSQPEAMDDFIREVN 73

Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILS 225
            +  L H N+++ YG       + +  E    GS+   L+ + G F    +  Y  Q+  
Sbjct: 74  AMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI--------AGQSCPLSFKGSP 277
           G+ +L SK  +HRD+   N+L+     VK+ DFG+ + +          +   + F    
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA--- 189

Query: 278 YWMAPEVI---KNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKE-L 332
            W APE +     S     A D W  G T+ EM T  + PW    G   + KI    E L
Sbjct: 190 -WCAPESLKTRTFSH----ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244

Query: 333 PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           P  P+D   +  + +  C    P +RPT   L D
Sbjct: 245 PR-PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  145 bits (367), Expect = 2e-39
 Identities = 73/270 (27%), Positives = 115/270 (42%), Gaps = 27/270 (10%)

Query: 111 PESHWKKGKMLGRGTFGHVYVG-FNSDSGE--MCAMKEVTLFDDAKSKESAKQLMQEIVL 167
                   ++LG G FG VY G + +  GE    A+K  T   D  + ++ ++ M E V+
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK--TCKKDC-TLDNKEKFMSEAVI 66

Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSG 226
           +  L HP+IV+  G    E+  +I +E    G +   L+          +  Y+ QI   
Sbjct: 67  MKNLDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI------AGQSCPLSFKGSPYWM 280
           +A+L S + VHRDI   NILV     VKL DFG++++I            L  K    WM
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WM 181

Query: 281 APEVIKN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIP 336
           +PE I     ++      D+W     + E+ +  K P+   E    +  +     LP  P
Sbjct: 182 SPESINFRRFTTAS----DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-P 236

Query: 337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           D         +  C   +P +RP   EL+ 
Sbjct: 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  146 bits (369), Expect = 2e-39
 Identities = 61/304 (20%), Positives = 112/304 (36%), Gaps = 67/304 (22%)

Query: 118 GKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQE--IVLLSRLRHP 174
            +++GRG +G VY G  +       A+K   +F    S  + +  + E  I  +  + H 
Sbjct: 18  LELIGRGRYGAVYKGSLD---ERPVAVK---VF----SFANRQNFINEKNIYRVPLMEHD 67

Query: 175 NIVQYYG-----SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
           NI ++       +     +  + +EY   GS+ K L  +      +       +  GLA+
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAY 126

Query: 230 LHSKHT---------VHRDIKGANILVDPNGRVKLADFGMAKHIAG---------QSCPL 271
           LH++            HRD+   N+LV  +G   ++DFG++  + G          +  +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186

Query: 272 SFKGSPYWMAPEVIKNS------SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM-- 323
           S  G+  +MAPEV++ +            VD+++LG    E+          E V     
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246

Query: 324 ----------------FKIGNSKELPTIPDDLSDEG------KDFIRLCLQRNPLNRPTA 361
                             +   K+ P  P+   +        K+ I  C  ++   R TA
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306

Query: 362 AELL 365
               
Sbjct: 307 QXAE 310

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  146 bits (370), Expect = 3e-39
 Identities = 80/316 (25%), Positives = 134/316 (42%), Gaps = 54/316 (17%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRL 171
             +     +G G +G V    +  SGE  A+K+++  F     +  AK+  +E++LL  +
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS---EIFAKRAYRELLLLKHM 80

Query: 172 RHPNIVQYY-----GSKTVEDK-LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILS 225
           +H N++         S        Y+ + ++    + K++    +F E  I+    Q+L 
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMG--LKFSEEKIQYLVYQMLK 137

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM----- 280
           GL ++HS   VHRD+K  N+ V+ +  +K+ DFG+A+H   +        + Y +     
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-------TGYVVTRWYR 190

Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP------PWSQYEGV---------AAMFK 325
           APEVI +    N  VDIWS+GC + EM T K          Q   +           + K
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250

Query: 326 IGNSK------ELPTIPD--------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           + +         LP  P           S +  D +   L+ +   R TAA+ L HPF +
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

Query: 372 GAAPLERTILAPEPSD 387
                E    A +P D
Sbjct: 311 PFRDPEEETEAQQPFD 326

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  148 bits (376), Expect = 3e-39
 Identities = 80/286 (27%), Positives = 127/286 (44%), Gaps = 22/286 (7%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P    +    LG+G FG V++G  + +    A+K  TL     S E     +QE  ++ +
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIK--TLKPGTMSPE---AFLQEAQVMKK 235

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPA-IRNYTQQILSGLA 228
           LRH  +VQ Y   + E+ +YI  EY+S GS+   L+   G++     + +   QI SG+A
Sbjct: 236 LRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS-PY-WMAPEVIK 286
           ++   + VHRD++ ANILV  N   K+ADFG+A+ I             P  W APE   
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354

Query: 287 NSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
                 +  D+WS G  + E+ T  + P+        + ++     +P  P +  +   D
Sbjct: 355 YGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHD 412

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPG 391
            +  C ++ P  RPT   L           LE    + EP   P  
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAF--------LEDYFTSTEPQYQPGE 450

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  146 bits (371), Expect = 3e-39
 Identities = 74/314 (23%), Positives = 132/314 (42%), Gaps = 45/314 (14%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
             +     +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R R
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRTLREIKILLRFR 83

Query: 173 HPNIVQYY-----GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
           H NI+         +      +YI  + +    +YKLL+         I  +  QIL GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQILRGL 141

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY----WM-AP 282
            ++HS + +HRD+K +N+L++    +K+ DFG+A+          F  + Y    W  AP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL-TEYVATRWYRAP 200

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKP------PWSQYEGV---------AAMFKIG 327
           E++ NS G   ++DIWS+GC + EM + +P         Q   +           +  I 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260

Query: 328 NSK------ELPTIPD--------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA 373
           N K       LP            +   +  D +   L  NP  R    + L HP+++  
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

Query: 374 APLERTILAPEPSD 387
                  +A  P  
Sbjct: 321 YDPSDEPIAEAPFK 334

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  143 bits (363), Expect = 4e-39
 Identities = 66/263 (25%), Positives = 113/263 (42%), Gaps = 18/263 (6%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
             S     + +G G FG V++G+  +  +  A+K  T+ + A S+E     ++E  ++ +
Sbjct: 6   DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIK--TIREGAMSEE---DFIEEAEVMMK 59

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAF 229
           L HP +VQ YG    +  + +  E++  G +   L+   G F    +      +  G+A+
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS-PY-WMAPEVI-- 285
           L     +HRD+   N LV  N  +K++DFGM + +       S     P  W +PEV   
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 179

Query: 286 -KNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
            + SS      D+WS G  + E+ +  K P+        +  I     L   P   S   
Sbjct: 180 SRYSS----KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHV 234

Query: 344 KDFIRLCLQRNPLNRPTAAELLD 366
              +  C +  P +RP  + LL 
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLR 257

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  148 bits (374), Expect = 5e-39
 Identities = 87/413 (21%), Positives = 145/413 (35%), Gaps = 108/413 (26%)

Query: 81  SNSSPFSHSNSAATSPSVPRSPGRMENPVSPE----------SHWKKGKMLGRGTFGHVY 130
            ++S   H+ S +      R       P +              ++   ++G G++GHV 
Sbjct: 11  QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVC 70

Query: 131 VGFNSDSGEMCAMKEVTL-FDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY-----GSKT 184
             ++     + A+K++   F+D       K++++EI +L+RL H ++V+           
Sbjct: 71  EAYDKLEKRVVAIKKILRVFED---LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127

Query: 185 VEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGAN 244
             D+LY+ LE        KL +      E  I+     +L G+ ++HS   +HRD+K AN
Sbjct: 128 KFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186

Query: 245 ILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM------------------------ 280
            LV+ +  VK+ DFG+A+ +       S                                
Sbjct: 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246

Query: 281 ----APEVIKNSSGCNLAVDIWSLGCTVLEMATT-----------KP--PWSQYEGVAAM 323
               APE+I        A+D+WS+GC   E+               P  P S    ++  
Sbjct: 247 RWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPD 306

Query: 324 FKIGNSKELPTI-----------------PDDL----SDEGKDFIRL------------- 349
            K GN  +  T                   +D+     ++ K +IR+             
Sbjct: 307 QKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366

Query: 350 -------------CLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVP 389
                         L  NP  R T  E L HPF K     E    A E   +P
Sbjct: 367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLP 419

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  148 bits (375), Expect = 8e-39
 Identities = 75/309 (24%), Positives = 128/309 (41%), Gaps = 33/309 (10%)

Query: 94  TSPSVPRSPGRMENPVSPESHW-------KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV 146
             P+  R+   +         W            LG G +G VY G         A+K  
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-- 251

Query: 147 TLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ 206
           TL +D    E     ++E  ++  ++HPN+VQ  G  T E   YI  E+++ G++   L+
Sbjct: 252 TLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 308

Query: 207 DYG--QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI 264
           +    +     +     QI S + +L  K+ +HR++   N LV  N  VK+ADFG+++ +
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368

Query: 265 AGQSCPLSFKGS-PY-WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVA 321
            G +         P  W APE +  +   ++  D+W+ G  + E+AT    P   Y G+ 
Sbjct: 369 TGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP---YPGID 424

Query: 322 ---AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLER 378
                  +     +   P+   ++  + +R C Q NP +RP+ AE+            E 
Sbjct: 425 LSQVYELLEKDYRME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA--------FET 475

Query: 379 TILAPEPSD 387
                  SD
Sbjct: 476 MFQESSISD 484

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  143 bits (363), Expect = 8e-39
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 34/289 (11%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
             +       LG G +G VY G         A+K  TL +D    E   + ++E  ++  
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE---EFLKEAAVMKE 65

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLA 228
           ++HPN+VQ  G  T E   YI  E+++ G++   L++    +     +     QI S + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS-PY-WMAPEVIK 286
           +L  K+ +HRD+   N LV  N  VK+ADFG+++ + G +         P  W APE + 
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185

Query: 287 N---SSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVA---AMFKIGNSKELPTIPDD 338
               S       D+W+ G  + E+AT    P    Y G+        +     +   P+ 
Sbjct: 186 YNKFSI----KSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMER-PEG 236

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSD 387
             ++  + +R C Q NP +RP+ AE+            E        SD
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQA--------FETMFQESSISD 277

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  142 bits (361), Expect = 1e-38
 Identities = 74/263 (28%), Positives = 115/263 (43%), Gaps = 18/263 (6%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
                   K LG G FG V +G      +  A+K   + + + S++   +  QE   + +
Sbjct: 6   KREEITLLKELGSGQFGVVKLGKWKGQYD-VAVK--MIKEGSMSED---EFFQEAQTMMK 59

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAF 229
           L HP +V++YG  + E  +YI  EY+S G +   L+ +G       +      +  G+AF
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS-PY-WMAPEVIKN 287
           L S   +HRD+   N LVD +  VK++DFGM +++       S     P  W APEV   
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY 179

Query: 288 ---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
              SS      D+W+ G  + E+ +  K P+  Y     + K+     L   P   SD  
Sbjct: 180 FKYSS----KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTI 234

Query: 344 KDFIRLCLQRNPLNRPTAAELLD 366
              +  C    P  RPT  +LL 
Sbjct: 235 YQIMYSCWHELPEKRPTFQQLLS 257

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  142 bits (361), Expect = 1e-38
 Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 28/261 (10%)

Query: 121 LGRGTFGHVYVG-FNSDSGEMC-AMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G FG V  G +     ++  A+K   L      K   +++M+E  ++ +L +P IV+
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGT-EKADTEEMMREAQIMHQLDNPYIVR 74

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             G     + L + +E   GG ++K L     +     +     Q+  G+ +L  K+ VH
Sbjct: 75  LIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI--------AGQSCPLSFKGSPYWMAPEVI---K 286
           RD+   N+L+      K++DFG++K +        A  +     K    W APE I   K
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINFRK 189

Query: 287 NSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
            SS      D+WS G T+ E  +  + P+ + +G   M  I   K +   P +   E   
Sbjct: 190 FSS----RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYA 244

Query: 346 FIRLCLQRNPLNRPTAAELLD 366
            +  C      +RP    +  
Sbjct: 245 LMSDCWIYKWEDRPDFLTVEQ 265

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  143 bits (363), Expect = 1e-38
 Identities = 77/308 (25%), Positives = 133/308 (43%), Gaps = 55/308 (17%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S +   K LG G  G V+   ++D  +  A+K++    D    +S K  ++EI ++ RL 
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV-LTD---PQSVKHALREIKIIRRLD 66

Query: 173 HPNIV--------------QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRN 218
           H NIV                 GS T  + +YI  EY+    +  +L+  G   E   R 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARL 124

Query: 219 YTQQILSGLAFLHSKHTVHRDIKGANILVD-PNGRVKLADFGMAKHIAGQSCPLSFKGSP 277
           +  Q+L GL ++HS + +HRD+K AN+ ++  +  +K+ DFG+A+ +           S 
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL-SE 183

Query: 278 Y----WM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP------PWSQYEGV------ 320
                W  +P ++ + +    A+D+W+ GC   EM T K          Q + +      
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243

Query: 321 ---AAMFKIGNS-----KELPTIPD--------DLSDEGKDFIRLCLQRNPLNRPTAAEL 364
                  ++ +      +   T P          +S E  DF+   L  +P++R TA E 
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303

Query: 365 LDHPFVKG 372
           L HP++  
Sbjct: 304 LSHPYMSI 311

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  143 bits (364), Expect = 1e-38
 Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 52/298 (17%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
             ++  + LGRG +  V+   N  + E   +K +      K K       +EI +L  LR
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-------REIKILENLR 88

Query: 173 -HPNIVQYYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
             PNI+               L  E+V+     +L Q      +  IR Y  +IL  L +
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDY 145

Query: 230 LHSKHTVHRDIKGANILVDP-NGRVKLADFGMAKHIAGQSCPLSFK-GSPYWMAPEVIKN 287
            HS   +HRD+K  N+++D  + +++L D+G+A+         + +  S Y+  PE++ +
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVD 204

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKELPTIPD------ 337
               + ++D+WSLGC +  M   K P+      Y+ +  + K+  +++L    D      
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264

Query: 338 --------------------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
                                      +S E  DF+   L+ +  +R TA E ++HP+
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  142 bits (361), Expect = 2e-38
 Identities = 74/295 (25%), Positives = 131/295 (44%), Gaps = 27/295 (9%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD-AKSKESAKQLMQEIVLLSRLRHPNI 176
              LG G    VY+  ++      A+K   +F    + +E+ K+  +E+   S+L H NI
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIK--AIFIPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           V        +D  Y+ +EY+ G ++ + ++ +G        N+T QIL G+   H    V
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIV 133

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAGQSC--PLSFKGSPYWMAPEVIKNSSGCNLA 294
           HRDIK  NIL+D N  +K+ DFG+AK ++  S        G+  + +PE  K  +  +  
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDEC 192

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEG---VAAMFKIGNSKELPTIP----DDLSDEGKDFI 347
            DI+S+G  + EM   +PP   + G   V+   K      +P +      D+     + I
Sbjct: 193 TDIYSIGIVLYEMLVGEPP---FNGETAVSIAIKHIQD-SVPNVTTDVRKDIPQSLSNVI 248

Query: 348 RLCLQRNPLNRP-TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGIKALGI 401
               +++  NR  T  E+ D         L  ++L    ++      + +K + +
Sbjct: 249 LRATEKDKANRYKTIQEMKDD--------L-SSVLHENRANEDVYELDKMKTIAV 294

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  142 bits (359), Expect = 3e-38
 Identities = 57/272 (20%), Positives = 107/272 (39%), Gaps = 25/272 (9%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV-----TLFDDAKSKESAKQLMQEI 165
                   + LG+GTF  ++ G   + G+   + E       L    ++    +   +  
Sbjct: 6   RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAA 63

Query: 166 VLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQIL 224
            ++S+L H ++V  YG     D+  +  E+V  GS+   L+               +Q+ 
Sbjct: 64  SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 225 SGLAFLHSKHTVHRDIKGANILVD--------PNGRVKLADFGMAKHIAGQSCPLSFKGS 276
           + + FL     +H ++   NIL+             +KL+D G++  +  +         
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQE 179

Query: 277 PY-WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPT 334
              W+ PE I+N    NLA D WS G T+ E+ +    P S  +    +    +  +LP 
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239

Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            P     E  + I  C+   P +RP+   ++ 
Sbjct: 240 -PKA--AELANLINNCMDYEPDHRPSFRAIIR 268

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  141 bits (358), Expect = 3e-38
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 35/289 (12%)

Query: 111 PESHWKKGKMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVL 167
                + G+ +G G FG V+ G   + ++  +  A+K  T  +        K  +QE + 
Sbjct: 13  QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREK-FLQEALT 69

Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSG 226
           + +  HP+IV+  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + 
Sbjct: 70  MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI------AGQSCPLSFKGSPYWM 280
           LA+L SK  VHRDI   N+LV  N  VKL DFG+++++            L  K    WM
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WM 184

Query: 281 APEVIKN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIP 336
           APE I     +S    A D+W  G  + E+      P+   +    + +I N + LP  P
Sbjct: 185 APESINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-P 239

Query: 337 DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEP 385
            +        +  C   +P  RP   EL           L   +   + 
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ--------LSTILEEEKA 280

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  142 bits (361), Expect = 3e-38
 Identities = 68/279 (24%), Positives = 122/279 (43%), Gaps = 21/279 (7%)

Query: 101 SPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGE----MCAMKEVTLFDDAKSKE 156
           +P +    +  E+ +KK K+LG G FG VY G     GE      A+K   L +   S +
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREAT-SPK 59

Query: 157 SAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPA 215
           + K+++ E  +++ + +P++ +  G       + +  + +  G +   ++++    G   
Sbjct: 60  ANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQY 118

Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKG 275
           + N+  QI  G+ +L  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 276 S--PY-WMAPEVI---KNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGN 328
              P  WMA E I     +       D+WS G TV E+ T    P+           +  
Sbjct: 179 GKVPIKWMALESILHRIYTH----QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

Query: 329 SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
            + LP  P   + +    +  C   +  +RP   EL+  
Sbjct: 235 GERLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  143 bits (363), Expect = 4e-38
 Identities = 71/297 (23%), Positives = 124/297 (41%), Gaps = 28/297 (9%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGF--NSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVL 167
             ++    K++G G FG V  G        E+  A+K  TL      K+  +  + E  +
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK--TLKVGYTEKQ-RRDFLGEASI 99

Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSG 226
           + +  HPNI++  G  T    + I  EY+  GS+   L+ +  QF    +    + I SG
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPLSFKGS--PY-WMAP 282
           + +L     VHRD+   NIL++ N   K++DFG+ + +        + +G   P  W +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 283 EVI---KNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           E I   K +S    A D+WS G  + E+ +  + P+ +      +  +     LP  P D
Sbjct: 220 EAIAYRKFTS----ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMD 274

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNG 395
                   +  C Q++  NRP   +++          L++ I  P    +       
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSI--------LDKLIRNPGSLKIITSAAAR 323

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  142 bits (360), Expect = 5e-38
 Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 21/269 (7%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGF---NSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIV 166
            E+  +K K+LG G FG V+ G      +S ++   +K   + D +  ++S + +   ++
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK--VIEDKS-GRQSFQAVTDHML 67

Query: 167 LLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILS 225
            +  L H +IV+  G       L +  +Y+  GS+   ++ + G  G   + N+  QI  
Sbjct: 68  AIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS--PY-WMAP 282
           G+ +L     VHR++   N+L+    +V++ADFG+A  +      L +  +  P  WMA 
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186

Query: 283 EVI---KNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           E I   K +       D+WS G TV E+ T    P++          +   + L   P  
Sbjct: 187 ESIHFGKYTH----QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ-PQI 241

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
            + +    +  C   +   RPT  EL + 
Sbjct: 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  142 bits (359), Expect = 5e-38
 Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 30/298 (10%)

Query: 87  SHSNSAATSPSVPRSPGRMENPVSPES-----HWKKGKMLGRGTFGHVYVGFNSDSGEMC 141
           SH +   +S  VPR    M+             ++  +++GRG  G VY   ++    + 
Sbjct: 4   SHHHHHHSSGLVPR-GSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIV 62

Query: 142 AMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSI 201
           A+K +     +       ++ +E     RL+ P++V  +    ++ +LY+ +  ++G  +
Sbjct: 63  ALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDL 121

Query: 202 YKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA 261
             +L+  G    P      +QI S L   H+    HRD+K  NILV  +    L DFG+A
Sbjct: 122 AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA 181

Query: 262 KHIAGQSCPL----SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY 317
              A     L    +  G+ Y+MAPE    S       DI++L C + E  T  PP   Y
Sbjct: 182 S--ATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPP---Y 235

Query: 318 EG--VAAMFKIGN------SKELPTIPDDLSDEGKDFIRLCLQRNPLNR-PTAAELLD 366
           +G  ++ M    N      S   P IP          I   + +NP +R  T  +L  
Sbjct: 236 QGDQLSVMGAHINQAIPRPSTVRPGIPVAFD----AVIARGMAKNPEDRYVTCGDLSA 289

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  142 bits (359), Expect = 7e-38
 Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 29/294 (9%)

Query: 116 KKGKMLGRGTFGHVYVG-FNSDSGEM---CAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
            + K++G G FG VY G   + SG+     A+K  TL      K+     + E  ++ + 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK--TLKAGYTEKQ-RVDFLGEAGIMGQF 103

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFL 230
            H NI++  G  +    + I  EY+  G++ K L++  G+F    +    + I +G+ +L
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGS--PY-WMAPEVIK 286
            + + VHRD+   NILV+ N   K++DFG+++ +        +  G   P  W APE I 
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 287 N---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
               +S    A D+WS G  + E+ T  + P+ +      M  I +   LPT P D    
Sbjct: 224 YRKFTS----ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDCPSA 278

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNGI 396
               +  C Q+    RP  A+++          L++ I AP+           +
Sbjct: 279 IYQLMMQCWQQERARRPKFADIVSI--------LDKLIRAPDSLKTLADFDPRV 324

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  143 bits (361), Expect = 1e-37
 Identities = 71/319 (22%), Positives = 122/319 (38%), Gaps = 71/319 (22%)

Query: 116 KKGKMLGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            +G  +GRGT+GHVY     D    +  A+K++     + S        +EI LL  L+H
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRELKH 77

Query: 174 PNIVQYYG--SKTVEDKLYIYLEYVS--------GGSIYKLLQDYGQFGEPAIRNYTQQI 223
           PN++          + K+++  +Y               K  +   Q     +++   QI
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 224 LSGLAFLHSKHTVHRDIKGANILVDP----NGRVKLADFGMAKHIAGQSCPLSFKGSP-- 277
           L G+ +LH+   +HRD+K ANILV       GRVK+AD G A+       PL+       
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 278 -YWM-APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP---------PWSQYEGVAAMFKI 326
            +W  APE++  +     A+DIW++GC   E+ T++P           S       + +I
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257

Query: 327 ------------------------------------GNSKELPTIPDDLSDEGKDFIRLC 350
                                                  K +         +    ++  
Sbjct: 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317

Query: 351 LQRNPLNRPTAAELLDHPF 369
           L  +P+ R T+ + +  P+
Sbjct: 318 LTMDPIKRITSEQAMQDPY 336

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  138 bits (350), Expect = 7e-37
 Identities = 65/251 (25%), Positives = 100/251 (39%), Gaps = 36/251 (14%)

Query: 169 SRLRHPNIVQYY--GSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQIL 224
           + L HP IV  Y  G          Y+  EYV G ++  ++   G               
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 225 SGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL----SFKGSPYWM 280
             L F H    +HRD+K ANI++     VK+ DFG+A+ IA     +    +  G+  ++
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG---VAAMFK------IGNSKE 331
           +PE  +  S  +   D++SLGC + E+ T +PP   + G   V+  ++      I  S  
Sbjct: 187 SPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSAR 242

Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRP-TAAELLD----------HPFVKGAAPLERTI 380
              +  DL       +   L +NP NR  TAAE+                K     ERT 
Sbjct: 243 HEGLSADL----DAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTS 298

Query: 381 LAPEPSDVPPG 391
           L    +    G
Sbjct: 299 LLSSAAGNLSG 309

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  139 bits (353), Expect = 1e-36
 Identities = 68/294 (23%), Positives = 127/294 (43%), Gaps = 53/294 (18%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-FDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
             +G G +G V   F++ +G   A+K+++  F        AK+  +E+ LL  ++H N++
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS---IIHAKRTYRELRLLKHMKHENVI 91

Query: 178 QYY------GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
                     S    + +Y+    + G  +  +++   +  +  ++    QIL GL ++H
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH 149

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY----W-MAPEVIK 286
           S   +HRD+K +N+ V+ +  +K+ DFG+A+H A +        + Y    W  APE++ 
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-------TGYVATRWYRAPEIML 202

Query: 287 NSSGCNLAVDIWSLGCTVLEMATTKP------PWSQYEGV---------AAMFKIGNS-- 329
           N    N  VDIWS+GC + E+ T +          Q + +           + KI +   
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262

Query: 330 ----KELPTIPD--------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               + L  +P           +    D +   L  +   R TAA+ L H +  
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  138 bits (350), Expect = 1e-36
 Identities = 59/276 (21%), Positives = 111/276 (40%), Gaps = 37/276 (13%)

Query: 118 GKMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           G+MLG+G FG V        D   +  A+K   L  D  +    ++ ++E   +    HP
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVK--MLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 175 NIVQYYG------SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA------IRNYTQQ 222
           ++ +  G      +K       + L ++  G ++  L        P       +  +   
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKG 275
           I  G+ +L S++ +HRD+   N ++  +  V +ADFG+++ I        G +  L  K 
Sbjct: 146 IACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK- 204

Query: 276 SPYWMAPEVIKN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKE 331
              W+A E + +   +       D+W+ G T+ E+ T  + P++  E       +     
Sbjct: 205 ---WLALESLADNLYTV----HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257

Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           L   P +  +E  D +  C   +P  RP+   L   
Sbjct: 258 LK-QPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (347), Expect = 1e-36
 Identities = 65/264 (24%), Positives = 114/264 (43%), Gaps = 18/264 (6%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
                   K LG G FG V  G      +  A+K   + + + S++   + ++E  ++  
Sbjct: 22  DPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIK--MIKEGSMSED---EFIEEAKVMMN 75

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAF 229
           L H  +VQ YG  T +  ++I  EY++ G +   L++   +F    +    + +   + +
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS-PY-WMAPEVIKN 287
           L SK  +HRD+   N LV+  G VK++DFG+++++       S     P  W  PEV+  
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 195

Query: 288 ---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
              SS      DIW+ G  + E+ +  K P+ ++        I     L   P   S++ 
Sbjct: 196 SKFSS----KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKV 250

Query: 344 KDFIRLCLQRNPLNRPTAAELLDH 367
              +  C       RPT   LL +
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSN 274

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  139 bits (352), Expect = 1e-36
 Identities = 70/301 (23%), Positives = 129/301 (42%), Gaps = 53/301 (17%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRL 171
           + ++  + +G G +G V    +  +G   A+K++   F     +  AK+  +E+ LL  +
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS---ELFAKRAYRELRLLKHM 81

Query: 172 RHPNIVQYY------GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILS 225
           RH N++          +       Y+ + ++ G  + KL++   + GE  I+    Q+L 
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLK 139

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY----WM- 280
           GL ++H+   +HRD+K  N+ V+ +  +K+ DFG+A+    +        + Y    W  
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-------TGYVVTRWYR 192

Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP------PWSQYEGV---------AAMFK 325
           APEVI N       VDIWS+GC + EM T K          Q + +           + +
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252

Query: 326 IGNSK------ELPTIPD--------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           + + +       LP +          + S    + +   L  +   R TA E L HP+ +
Sbjct: 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312

Query: 372 G 372
            
Sbjct: 313 S 313

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  136 bits (346), Expect = 1e-36
 Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 34/286 (11%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P    K  + LG G FG V++G+ +   +  A+K  +L   + S +     + E  L+ +
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVK--SLKQGSMSPD---AFLAEANLMKQ 64

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLA 228
           L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +     + +   QI  G+A
Sbjct: 65  LQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS-PY-WMAPEVIK 286
           F+  ++ +HRD++ ANILV      K+ADFG+A+ I             P  W APE I 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 287 N---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVA---AMFKIGNSKELPTIPDDL 339
               +       D+WS G  + E+ T  + P   Y G+     +  +     +   PD+ 
Sbjct: 184 YGTFTIKS----DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVR-PDNC 235

Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEP 385
            +E    +RLC +  P +RPT   L           LE    A E 
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSV--------LEDFFTATEG 273

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  140 bits (355), Expect = 2e-36
 Identities = 83/408 (20%), Positives = 150/408 (36%), Gaps = 98/408 (24%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
            ++GRG++G+VY+ ++ ++ +  A+K+V  +F+D       K++++EI +L+RL+   I+
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED---LIDCKRILREITILNRLKSDYII 88

Query: 178 QYY-----GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           + Y           D+LYI LE      + KL +      E  I+     +L G  F+H 
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE 147

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM------------ 280
              +HRD+K AN L++ +  VK+ DFG+A+ I  +                         
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207

Query: 281 -----------APEVIKNSSGCNLAVDIWSLGCTVLEM-ATTKPPWSQYEGVAAMF---- 324
                      APE+I        ++DIWS GC   E+    +   +       +F    
Sbjct: 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSS 267

Query: 325 --------------------------------------KIGNSK------ELPTIP---- 336
                                                  I   +        P       
Sbjct: 268 CFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINL 327

Query: 337 ----DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGV 392
                 +SD+G + +   L+ NP  R T  + LDHP++K     +    + +   +P   
Sbjct: 328 KQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILP--- 384

Query: 393 TNGIKALGIGQLRN-----VSTFDTERLAVHSSRVSQTSLNASDINIS 435
            +    L   QLR      V +F  E +      + + +   ++   S
Sbjct: 385 FDDWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIHENNFYNNEKPSS 432

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  143 bits (361), Expect = 3e-36
 Identities = 85/358 (23%), Positives = 142/358 (39%), Gaps = 31/358 (8%)

Query: 38  RIQSGAVTPIHPRAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAATSPS 97
           R+ +GA      R      E + + P   K  ++          + S             
Sbjct: 319 RLVNGATQSFIIRP---QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEED 375

Query: 98  VPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDDAKS 154
               P   +  +  E   + G+ +G G FG V+ G   + ++  M  A+K  T  +    
Sbjct: 376 TYTMPSTRDYEIQRER-IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK--TCKNCTSD 432

Query: 155 KESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGE 213
               K  +QE + + +  HP+IV+  G  T E+ ++I +E  + G +   LQ        
Sbjct: 433 SVREK-FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDL 490

Query: 214 PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSF 273
            ++  Y  Q+ + LA+L SK  VHRDI   N+LV  N  VKL DFG+++++   +   + 
Sbjct: 491 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550

Query: 274 KG-SPY-WMAPEVIKN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIG 327
           KG  P  WMAPE I     +S      D+W  G  + E+      P+   +    + +I 
Sbjct: 551 KGKLPIKWMAPESINFRRFTSAS----DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

Query: 328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEP 385
           N + LP  P +        +  C   +P  RP   EL           L   +   + 
Sbjct: 607 NGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ--------LSTILEEEKL 655

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  141 bits (357), Expect = 4e-36
 Identities = 80/286 (27%), Positives = 125/286 (43%), Gaps = 22/286 (7%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P    +    LG+G FG V++G  + +    A+K  TL     S E     +QE  ++ +
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIK--TLKPGTMSPE---AFLQEAQVMKK 318

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLA 228
           LRH  +VQ Y   + E+ +YI  EY+S GS+   L+         P + +   QI SG+A
Sbjct: 319 LRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS-PY-WMAPEVIK 286
           ++   + VHRD++ ANILV  N   K+ADFG+A+ I             P  W APE   
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437

Query: 287 NSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
                 +  D+WS G  + E+ T  + P+        + ++     +P  P +  +   D
Sbjct: 438 YGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHD 495

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPG 391
            +  C ++ P  RPT   L           LE    + EP   P  
Sbjct: 496 LMCQCWRKEPEERPTFEYLQAF--------LEDYFTSTEPQYQPGE 533

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  137 bits (348), Expect = 5e-36
 Identities = 66/312 (21%), Positives = 118/312 (37%), Gaps = 64/312 (20%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRL 171
             ++  K +G G  G V   +++      A+K+++  F +   +  AK+  +E+VL+  +
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN---QTHAKRAYRELVLMKCV 81

Query: 172 RHPNIVQYY------GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILS 225
            H NI+          S      +YI +E +   ++ +++Q   +     +     Q+L 
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ--MELDHERMSYLLYQMLC 138

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM----- 280
           G+  LHS   +HRD+K +NI+V  +  +K+ DFG+A+         SF  +PY +     
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYR 193

Query: 281 APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP---------------------------- 312
           APEVI         VDIWS+GC + EM                                 
Sbjct: 194 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

Query: 313 ------------PWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPT 360
                       P         +F               + + +D +   L  +   R +
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312

Query: 361 AAELLDHPFVKG 372
             E L HP++  
Sbjct: 313 VDEALQHPYINV 324

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  136 bits (345), Expect = 6e-36
 Identities = 71/304 (23%), Positives = 130/304 (42%), Gaps = 45/304 (14%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            + LG+G+FG VY     G   D  E   A+K  T+ + A  +E  +  + E  ++    
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK--TVNEAASMRERIE-FLNEASVMKEFN 86

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYGQFGEPAIRNYTQ---Q 222
             ++V+  G  +      + +E ++ G +   L+       +      P++    Q   +
Sbjct: 87  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 223 ILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKG 275
           I  G+A+L++   VHRD+   N +V  +  VK+ DFGM + I        G    L  + 
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 205

Query: 276 SPYWMAPEVIKN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKE 331
              WM+PE +K+   ++      D+WS G  + E+AT  + P+        +  +     
Sbjct: 206 ---WMSPESLKDGVFTTYS----DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258

Query: 332 LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL-------LDHPFVKGAAPLERTILAPE 384
           L   PD+  D   + +R+C Q NP  RP+  E+       ++  F + +         PE
Sbjct: 259 LD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPE 317

Query: 385 PSDV 388
           P ++
Sbjct: 318 PEEL 321

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  138 bits (350), Expect = 1e-35
 Identities = 73/292 (25%), Positives = 132/292 (45%), Gaps = 36/292 (12%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P    K  K LG G FG V++   +   +  A+K  T+   + S E     + E  ++  
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVK--TMKPGSMSVE---AFLAEANVMKT 239

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLA 228
           L+H  +V+ +   T ++ +YI  E+++ GS+   L+     +   P + +++ QI  G+A
Sbjct: 240 LQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS-PY-WMAPEVIK 286
           F+  ++ +HRD++ ANILV  +   K+ADFG+A+ I             P  W APE I 
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358

Query: 287 N---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVA---AMFKIGNSKELPTIPDDL 339
               +       D+WS G  ++E+ T  + P   Y G++    +  +     +P  P++ 
Sbjct: 359 FGSFTI----KSDVWSFGILLMEIVTYGRIP---YPGMSNPEVIRALERGYRMP-RPENC 410

Query: 340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPS--DVP 389
            +E  + +  C +  P  RPT   +           L+    A E    ++P
Sbjct: 411 PEELYNIMMRCWKNRPEERPTFEYIQSV--------LDDFYTATESQYEEIP 454

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  137 bits (346), Expect = 1e-35
 Identities = 74/352 (21%), Positives = 132/352 (37%), Gaps = 84/352 (23%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRL 171
             ++  K LG+G +G V+   +  +GE+ A+K++   F +      A++  +EI++L+ L
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN---STDAQRTFREIMILTEL 65

Query: 172 R-HPNIVQYYG---SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA-IRNYTQQILSG 226
             H NIV       +    D +Y+  +Y+    ++ +++      EP   +    Q++  
Sbjct: 66  SGHENIVNLLNVLRADNDRD-VYLVFDYM-ETDLHAVIR--ANILEPVHKQYVVYQLIKV 121

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWM------ 280
           + +LHS   +HRD+K +NIL++    VK+ADFG+++         +              
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181

Query: 281 ----------------APEVIKNSSGCNLAVDIWSLGCTVLEMATTKP------------ 312
                           APE++  S+     +D+WSLGC + E+   KP            
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241

Query: 313 -----------------------------------PWSQYEGVAAMFKIGNSKELPTIPD 337
                                                S    +   +K    K  P    
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK--A 299

Query: 338 DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVP 389
           D ++E  D +   LQ NP  R +A + L HPFV                 +P
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIP 351

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  133 bits (338), Expect = 2e-35
 Identities = 65/289 (22%), Positives = 123/289 (42%), Gaps = 48/289 (16%)

Query: 105 MENPVSPESHWKK------------GKMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDD 151
           M   V+ +  + +             + +G+G FG V +G +    G   A+K   + +D
Sbjct: 1   MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVK--CIKND 55

Query: 152 AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED-KLYIYLEYVSGGSIYKLLQDYG- 209
           A ++      + E  ++++LRH N+VQ  G    E   LYI  EY++ GS+   L+  G 
Sbjct: 56  ATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 111

Query: 210 -QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK--HIAG 266
              G   +  ++  +   + +L   + VHRD+   N+LV  +   K++DFG+ K      
Sbjct: 112 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171

Query: 267 QSCPLSFKGSPYWMAPEVIKN---SSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVA 321
            +  L  K    W APE ++    S+      D+WS G  + E+ +    P    Y  + 
Sbjct: 172 DTGKLPVK----WTAPEALREKKFSTKS----DVWSFGILLWEIYSFGRVP----YPRIP 219

Query: 322 ---AMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
               + ++    ++   PD       + ++ C   +   RP+  +L + 
Sbjct: 220 LKDVVPRVEKGYKMDA-PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  140 bits (354), Expect = 2e-35
 Identities = 75/368 (20%), Positives = 134/368 (36%), Gaps = 30/368 (8%)

Query: 14  LQSRGSPEYSPIPSPRMTSPGPSSRIQSGAVTPIHPRAGGAPIESQTSWPDDGKQQSHRL 73
           L+ +       +      S   ++   +    P HP     P     +   DG       
Sbjct: 239 LKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPAR 298

Query: 74  PLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVG- 132
              P         +    +  S   P      +  +  ++       LG G FG V  G 
Sbjct: 299 ITSPDKPRPMPMDTSVFESPFSD--PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGV 356

Query: 133 FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI 191
           +     ++  A+K   L      K   +++M+E  ++ +L +P IV+  G     + L +
Sbjct: 357 YRMRKKQIDVAIK--VLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 412

Query: 192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN 250
            +E   GG ++K L     +     +     Q+  G+ +L  K+ VHR++   N+L+   
Sbjct: 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR 472

Query: 251 GRVKLADFGMAKHI--------AGQSCPLSFKGSPYWMAPEVI---KNSSGCNLAVDIWS 299
              K++DFG++K +        A  +     K    W APE I   K SS      D+WS
Sbjct: 473 HYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINFRKFSS----RSDVWS 524

Query: 300 LGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNR 358
            G T+ E  +  + P+ + +G   M  I   K +   P +   E    +  C      +R
Sbjct: 525 YGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDR 583

Query: 359 PTAAELLD 366
           P    +  
Sbjct: 584 PDFLTVEQ 591

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (338), Expect = 3e-35
 Identities = 61/266 (22%), Positives = 119/266 (44%), Gaps = 22/266 (8%)

Query: 116 KKGKMLGRGTFGHVYVGFNSDSGE---MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
              +++G+G FG VY G   D  +    CA+K  +L    + ++  +  ++E +L+  L 
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--SLSRITEMQQ-VEAFLREGLLMRGLN 80

Query: 173 HPNIVQYYGSKTVED-KLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFL 230
           HPN++   G     +   ++ L Y+  G + + ++          + ++  Q+  G+ +L
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGS----PY-WMAPEVI 285
             +  VHRD+   N ++D +  VK+ADFG+A+ I  +      +      P  W A E +
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200

Query: 286 KN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSD 341
           +    ++      D+WS G  + E+ T   PP+   +       +   + LP  P+   D
Sbjct: 201 QTYRFTT----KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-PEYCPD 255

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDH 367
                ++ C + +P  RPT   L+  
Sbjct: 256 SLYQVMQQCWEADPAVRPTFRVLVGE 281

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  135 bits (342), Expect = 3e-35
 Identities = 72/347 (20%), Positives = 133/347 (38%), Gaps = 32/347 (9%)

Query: 35  PSSRIQSGAVTPIHPRAGGAPIESQTSWPDDGKQQSHRLPLPPITISNSSPFSHSNSAAT 94
            ++ I     +P           S + +   G +  +      + I  S+       A  
Sbjct: 21  VAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQ 80

Query: 95  SPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVG--FNSDSGEM-CAMKEVTLFDD 151
              +  S   +             +++GRG FG VY G   ++D  ++ CA+K  +L   
Sbjct: 81  HVVIGPSSLIV----------HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRI 128

Query: 152 AKSKESAKQLMQEIVLLSRLRHPNIVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDY-G 209
               E   Q + E +++    HPN++   G     E    + L Y+  G +   +++   
Sbjct: 129 TDIGE-VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 187

Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
                 +  +  Q+  G+ FL SK  VHRD+   N ++D    VK+ADFG+A+ +  +  
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247

Query: 270 PLSFKGS----PY-WMAPEVIKN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGV 320
                 +    P  WMA E ++    ++      D+WS G  + E+ T   PP+      
Sbjct: 248 DSVHNKTGAKLPVKWMALESLQTQKFTT----KSDVWSFGVLLWELMTRGAPPYPDVNTF 303

Query: 321 AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                +   + L   P+   D   + +  C       RP+ +EL+  
Sbjct: 304 DITVYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  133 bits (338), Expect = 4e-35
 Identities = 78/295 (26%), Positives = 112/295 (37%), Gaps = 66/295 (22%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRL- 171
           GK LG G FG V      G       M  A+K   L   A   E  + LM E+ +LS L 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHLTE-REALMSELKVLSYLG 84

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ---------- 221
            H NIV   G+ T+     +  EY   G     L ++ +    +                
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGD----LLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 222 ------------QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI----- 264
                       Q+  G+AFL SK+ +HRD+   NIL+      K+ DFG+A+ I     
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 265 --AGQSCPLSFKGSPYWMAPEVIKNS-----SGCNLAVDIWSLGCTVLEMATT-KPPWSQ 316
                +  L  K    WMAPE I N      S      D+WS G  + E+ +    P   
Sbjct: 201 YVVKGNARLPVK----WMAPESIFNCVYTFES------DVWSYGIFLWELFSLGSSP--- 247

Query: 317 YEGVAA----MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           Y G+         I     +   P+    E  D ++ C   +PL RPT  +++  
Sbjct: 248 YPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  135 bits (341), Expect = 4e-35
 Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 45/303 (14%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAK-------SKESAKQLMQEI 165
           S +   + +  G++G V  G +S  G   A+K V                   K++++EI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 166 VLLSRLRHPNIVQYY-----GSKTVEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNY 219
            LL+   HPNI+          +    KLY+  E +    + +++           I+ +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139

Query: 220 TQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYW 279
              IL GL  LH    VHRD+   NIL+  N  + + DF +A+     +    +    ++
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWY 199

Query: 280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP------PWSQYEGV---------AAMF 324
            APE++    G    VD+WS GC + EM   K        ++Q   +           + 
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259

Query: 325 KIGNSK-------ELPTIPD--------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPF 369
              +          L  +P                D I   L+ NP  R +  + L HP+
Sbjct: 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319

Query: 370 VKG 372
            + 
Sbjct: 320 FES 322

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  133 bits (336), Expect = 7e-35
 Identities = 73/327 (22%), Positives = 121/327 (37%), Gaps = 81/327 (24%)

Query: 99  PRSPGRMENPVSPESHW-------KKGKMLGRGTFGHVY----VGFNSDSGEM-CAMKEV 146
           P S       +  +  W         GK LG G FG V           +G    A+K  
Sbjct: 2   PLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK-- 59

Query: 147 TLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ 206
            L ++A   E  + L+ E  +L ++ HP++++ YG+ + +  L + +EY   GS    L+
Sbjct: 60  MLKENASPSE-LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGS----LR 114

Query: 207 DY--------------------GQFGEPAIRNYTQ--------QILSGLAFLHSKHTVHR 238
            +                         P  R  T         QI  G+ +L     VHR
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174

Query: 239 DIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKGSPYWMAPEVIK----- 286
           D+   NILV    ++K++DFG+++ +             +  K    WMA E +      
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK----WMAIESLFDHIYT 230

Query: 287 -NSSGCNLAVDIWSLGCTVLEMAT--TKPPWSQYEGVAA---MFKIGNSKELPTIPDDLS 340
             S       D+WS G  + E+ T    P    Y G+        +     +   PD+ S
Sbjct: 231 TQS-------DVWSFGVLLWEIVTLGGNP----YPGIPPERLFNLLKTGHRME-RPDNCS 278

Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDH 367
           +E    +  C ++ P  RP  A++   
Sbjct: 279 EEMYRLMLQCWKQEPDKRPVFADISKD 305

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  135 bits (343), Expect = 1e-34
 Identities = 71/320 (22%), Positives = 132/320 (41%), Gaps = 52/320 (16%)

Query: 79  TISNSSPFS--------HSNSAATSPSVPRSPGRMENPVSPESHWKK------------G 118
           +I     F         ++  A    +    P  ME  V+ +  + +             
Sbjct: 139 SIDEEVYFENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLL 198

Query: 119 KMLGRGTFGHVYVG-FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
           + +G+G FG V +G +    G   A+K   +    K+  +A+  + E  ++++LRH N+V
Sbjct: 199 QTIGKGEFGDVMLGDYR---GNKVAVK--CI----KNDATAQAFLAEASVMTQLRHSNLV 249

Query: 178 QYYGSKTVED-KLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKH 234
           Q  G    E   LYI  EY++ GS+   L+  G    G   +  ++  +   + +L   +
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-WMAPEVIKN---SSG 290
            VHRD+   N+LV  +   K++DFG+ K  +           P  W APE ++    S+ 
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFST- 365

Query: 291 CNLAVDIWSLGCTVLEMATT-KPPWSQYEGVA---AMFKIGNSKELPTIPDDLSDEGKDF 346
                D+WS G  + E+ +  + P   Y  +     + ++    ++   PD       D 
Sbjct: 366 ---KSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPRVEKGYKMD-APDGCPPAVYDV 418

Query: 347 IRLCLQRNPLNRPTAAELLD 366
           ++ C   +   RPT  +L +
Sbjct: 419 MKNCWHLDAATRPTFLQLRE 438

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  132 bits (335), Expect = 1e-34
 Identities = 66/305 (21%), Positives = 110/305 (36%), Gaps = 48/305 (15%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            + LG G FG VY     G  +D   +  A+K  TL +    ++     + E +++S+  
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSEQDELD-FLMEALIISKFN 91

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ-------DYGQFGEPAIRNYTQQILS 225
           H NIV+  G        +I +E ++GG +   L+                + +  + I  
Sbjct: 92  HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPY---- 278
           G  +L   H +HRDI   N L+   G     K+ DFGMA+ I   S         Y    
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--------YRKGG 203

Query: 279 -------WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSK 330
                  WM PE            D WS G  + E+ +    P+        +  + +  
Sbjct: 204 CAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPP 390
            +   P +        +  C Q  P +RP  A +L+         +E     P+  +   
Sbjct: 263 RMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--------IEYCTQDPDVINTAL 313

Query: 391 GVTNG 395
            +  G
Sbjct: 314 PIEYG 318

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  136 bits (343), Expect = 1e-34
 Identities = 78/411 (18%), Positives = 146/411 (35%), Gaps = 66/411 (16%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVT-LFDDAKSKESAKQLMQEIVLLSRL 171
             ++  K +G G  G V   +++      A+K+++  F +   +  AK+  +E+VL+  +
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN---QTHAKRAYRELVLMKCV 118

Query: 172 RHPNIVQYY------GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILS 225
            H NI+          +      +Y+ +E +   ++ +++Q   +     +     Q+L 
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ--MELDHERMSYLLYQMLC 175

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           G+  LHS   +HRD+K +NI+V  +  +K+ DFG+A+          +  + Y+ APEVI
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235

Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKP--------------------------------- 312
               G    VDIWS+GC + EM   K                                  
Sbjct: 236 L-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294

Query: 313 -------PWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
                  P         +F               + + +D +   L  +P  R +  + L
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354

Query: 366 DHPFVKG-AAPLERTILAPEPSDVPPGVTNGIKALGIGQLRN-----VSTFDTERLAVHS 419
            HP++     P E     P+  D         +   I + +      V   + +      
Sbjct: 355 QHPYINVWYDPAEVEAPPPQIYD----KQLDEREHTIEEWKELIYKEVMNSEEKTKNGVV 410

Query: 420 SRVSQTSLNASDINISMNRSCPVSPIGSPLLHPRSPQHLNGKMSPSPISSP 470
                 S  A + + S+  S  V+ I S           +   S    + P
Sbjct: 411 KGQPSPSGAAVNSSESLPPSSSVNDISSM--STDQTLASDTDSSLEASAGP 459

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  131 bits (331), Expect = 3e-34
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 40/310 (12%)

Query: 87  SHSNSAATSPSVPRSPGRMENPVS----PESHWKKGKMLGRGTFGHVYVG--FNSDSGEM 140
           SH +   +S  VPR    ++N +       +    GK+LG G FG V  G     D   +
Sbjct: 4   SHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSL 63

Query: 141 -CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYG-----SKTVEDKLYIYLE 194
             A+K  T+  D  S+   ++ + E   +    HPN+++  G     S     K  + L 
Sbjct: 64  KVAVK--TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121

Query: 195 YVSGGSIYKLLQDYGQFGEPA------IRNYTQQILSGLAFLHSKHTVHRDIKGANILVD 248
           ++  G ++  L        P       +  +   I  G+ +L +++ +HRD+   N ++ 
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR 181

Query: 249 PNGRVKLADFGMAKHI-------AGQSCPLSFKGSPYWMAPEVIKN---SSGCNLAVDIW 298
            +  V +ADFG++K I        G+   +  K    W+A E + +   +S      D+W
Sbjct: 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK----WIAIESLADRVYTS----KSDVW 233

Query: 299 SLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLN 357
           + G T+ E+AT    P+   +       + +   L   P+D  DE  + +  C + +PL+
Sbjct: 234 AFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK-QPEDCLDELYEIMYSCWRTDPLD 292

Query: 358 RPTAAELLDH 367
           RPT + L   
Sbjct: 293 RPTFSVLRLQ 302

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (333), Expect = 5e-34
 Identities = 73/357 (20%), Positives = 123/357 (34%), Gaps = 63/357 (17%)

Query: 69  QSHRLPLPPITISNSSPFSHSNSAATSPS---VPRSPGRMENPVSPESHWKKGKMLGRGT 125
           +  +L    I    +  +  +   ++      VPR    +             + LG G 
Sbjct: 36  KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITL------------IRGLGHGA 83

Query: 126 FGHVYVG----FNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
           FG VY G      +D   +  A+K  TL +    ++     + E +++S+  H NIV+  
Sbjct: 84  FGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSEQDELD-FLMEALIISKFNHQNIVRCI 140

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQ----DYGQFGEPAIRNYTQ---QILSGLAFLHSK 233
           G        +I LE ++GG +   L+       Q    A+ +       I  G  +L   
Sbjct: 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200

Query: 234 HTVHRDIKGANILVDPNGR---VKLADFGMAKHIAGQSCPLSFKGSPY-----------W 279
           H +HRDI   N L+   G     K+ DFGMA+ I             Y           W
Sbjct: 201 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY--------YRKGGCAMLPVKW 252

Query: 280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDD 338
           M PE            D WS G  + E+ +    P+        +  + +   +   P +
Sbjct: 253 MPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD-PPKN 310

Query: 339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPPGVTNG 395
                   +  C Q  P +RP  A +L+         +E     P+  +    +  G
Sbjct: 311 CPGPVYRIMTQCWQHQPEDRPNFAIILER--------IEYCTQDPDVINTALPIEYG 359

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  132 bits (333), Expect = 5e-34
 Identities = 63/338 (18%), Positives = 120/338 (35%), Gaps = 81/338 (23%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES-AKQLMQEIVLLSRLR----- 172
           + LG G F  V++  +  +    AMK V      +  +   +    EI LL R+      
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIV------RGDKVYTEAAEDEIKLLQRVNDADNT 78

Query: 173 ------HPNIVQYYGS----KTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYT 220
                   +I++              + +  E V G ++  L++ Y         ++  +
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQIS 137

Query: 221 QQILSGLAFLHSK-HTVHRDIKGANILVDPNGR------VKLADFGMAKHIAGQSCPLSF 273
           +Q+L GL ++H +   +H DIK  N+L++          +K+AD G A            
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--S 195

Query: 274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP---------PWSQYEGVAAMF 324
             +  + +PEV+   +      DIWS  C + E+ T                 + +A + 
Sbjct: 196 IQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254

Query: 325 KI----------------------GNSKE-----LPTIPDDLSDEGK----------DFI 347
           ++                      G  +         + D L+++ K          DF+
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEP 385
              LQ +P  R  A  L++HP++K    +E   +    
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRE 352

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  131 bits (331), Expect = 5e-34
 Identities = 72/292 (24%), Positives = 111/292 (38%), Gaps = 64/292 (21%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRL- 171
           GK LG G FG V      G   +   +  A+K   L   A + E  + LM E+ ++S L 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK--MLKSTAHADEK-EALMSELKIMSHLG 107

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY---------------GQFGEPAI 216
           +H NIV   G+ T    + +  EY   G     L ++                     + 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGD----LLNFLRRKSRVLETDPAFAIANSTAST 163

Query: 217 RNYTQ---QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AG 266
           R+      Q+  G+AFL SK+ +HRD+   N+L+      K+ DFG+A+ I         
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223

Query: 267 QSCPLSFKGSPYWMAPEVIKNS-----SGCNLAVDIWSLGCTVL--EMATT-KPPWSQY- 317
            +  L  K    WMAPE I +      S      D+WS G  +L  E+ +    P+    
Sbjct: 224 GNARLPVK----WMAPESIFDCVYTVQS------DVWSYG--ILLWEIFSLGLNPYPGIL 271

Query: 318 --EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                  + K G        P          ++ C    P +RPT  ++   
Sbjct: 272 VNSKFYKLVKDGYQMA---QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (328), Expect = 5e-34
 Identities = 62/264 (23%), Positives = 110/264 (41%), Gaps = 22/264 (8%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGE---MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
            +++GRG FG VY G   D+      CA+K  +L       E   Q + E +++    HP
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGE-VSQFLTEGIIMKDFSHP 86

Query: 175 NIVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHS 232
           N++   G     E    + L Y+  G +   +++         +  +  Q+  G+ +L S
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPY-----WMAPEVIKN 287
           K  VHRD+   N ++D    VK+ADFG+A+ +  +        +       WMA E ++ 
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206

Query: 288 ---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
              ++      D+WS G  + E+ T   PP+           +   + L   P+   D  
Sbjct: 207 QKFTT----KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPL 261

Query: 344 KDFIRLCLQRNPLNRPTAAELLDH 367
            + +  C       RP+ +EL+  
Sbjct: 262 YEVMLKCWHPKAEMRPSFSELVSR 285

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  132 bits (333), Expect = 6e-34
 Identities = 79/345 (22%), Positives = 136/345 (39%), Gaps = 58/345 (16%)

Query: 67  KQQSHRLPLPPITISNSSPFSHSNSAATSPSVPRSPGRMENPVSPESHW-------KKGK 119
           +Q +          SN+     +   +++   P   G  E  +  +  W         GK
Sbjct: 28  RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87

Query: 120 MLGRGTFGHVYVG-------FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL- 171
            LG G FG V +                 A+K   L DDA  K+ +  L+ E+ ++  + 
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSD-LVSEMEMMKMIG 144

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ---------- 221
           +H NI+   G+ T +  LY+ +EY S G++ + L+     G     +  +          
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 222 ------QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQS 268
                 Q+  G+ +L S+  +HRD+   N+LV  N  +K+ADFG+A+ I          +
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264

Query: 269 CPLSFKGSPYWMAPEVIKNS-----SGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAA 322
             L  K    WMAPE + +      S      D+WS G  + E+ T    P+        
Sbjct: 265 GRLPVK----WMAPEALFDRVYTHQS------DVWSFGVLMWEIFTLGGSPYPGIPVEEL 314

Query: 323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
              +     +   P + ++E    +R C    P  RPT  +L++ 
Sbjct: 315 FKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  129 bits (327), Expect = 1e-33
 Identities = 78/281 (27%), Positives = 115/281 (40%), Gaps = 45/281 (16%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            + LG G FG V+       +    +M  A+K   L D   +    K   +E  LL+ L+
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAAR--KDFQREAELLTNLQ 75

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ----------- 221
           H +IV++YG     D L +  EY+  G + K L+ +G      +    +           
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 222 -----QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSC 269
                QI SG+ +L S+H VHRD+   N LV  N  VK+ DFGM++ +        G   
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 270 PLSFKGSPYWMAPEVIKN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFK 325
            L  +    WM PE I     ++      D+WS G  + E+ T  K PW Q      +  
Sbjct: 196 MLPIR----WMPPESIMYRKFTT----ESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247

Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
           I   + L   P     E  D +  C QR P  R    E+  
Sbjct: 248 ITQGRVLE-RPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  129 bits (326), Expect = 1e-33
 Identities = 74/282 (26%), Positives = 112/282 (39%), Gaps = 44/282 (15%)

Query: 118 GKMLGRGTFGHVYVG--FNSDSGE---MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            + LG   FG VY G  F    GE     A+K  TL D A+     +    E +L +RL+
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK--TLKDKAEGPLREE-FRHEAMLRARLQ 70

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ----------- 221
           HPN+V   G  T +  L +   Y S G +++ L       +    +  +           
Sbjct: 71  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130

Query: 222 -----QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSC 269
                QI +G+ +L S H VH+D+   N+LV     VK++D G+ + +          + 
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 270 PLSFKGSPYWMAPEVIKN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFK 325
            L  +    WMAPE I     S       DIWS G  + E+ +    P+  Y     +  
Sbjct: 191 LLPIR----WMAPEAIMYGKFSI----DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242

Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           I N + LP  PDD        +  C    P  RP   ++   
Sbjct: 243 IRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (328), Expect = 1e-33
 Identities = 75/299 (25%), Positives = 115/299 (38%), Gaps = 69/299 (23%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRL- 171
           GK+LG G FG V      G +     +  A+K   L + A S E  + LM E+ ++++L 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSE-REALMSELKMMTQLG 106

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-----GQFGEPAIRNYTQ----- 221
            H NIV   G+ T+   +Y+  EY   G     L +Y      +F E  I    Q     
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGD----LLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 222 -----------------QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI 264
                            Q+  G+ FL  K  VHRD+   N+LV     VK+ DFG+A+ I
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222

Query: 265 -------AGQSCPLSFKGSPYWMAPEVIKNS-----SGCNLAVDIWSLGCTVLEMATT-K 311
                     +  L  K    WMAPE +        S      D+WS G  + E+ +   
Sbjct: 223 MSDSNYVVRGNARLPVK----WMAPESLFEGIYTIKS------DVWSYGILLWEIFSLGV 272

Query: 312 PPW---SQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
            P+           + + G   +    P   ++E    ++ C   +   RP+   L   
Sbjct: 273 NPYPGIPVDANFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  128 bits (324), Expect = 3e-33
 Identities = 77/295 (26%), Positives = 114/295 (38%), Gaps = 67/295 (22%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRL- 171
           GK LGRG FG V      G +  +     A+K   L + A   E  + LM E+ +L  + 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSE-HRALMSELKILIHIG 88

Query: 172 RHPNIVQYYGSKTVEDK-LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ--------- 221
            H N+V   G+ T     L + +E+   G+    L  Y +        Y           
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGN----LSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 222 -----------QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI------ 264
                      Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204

Query: 265 -AGQSCPLSFKGSPYWMAPEVIKNS-----SGCNLAVDIWSLGCTVLEMAT--TKPPWSQ 316
                  L  K    WMAPE I +      S      D+WS G  + E+ +    P    
Sbjct: 205 VRKGDARLPLK----WMAPETIFDRVYTIQS------DVWSFGVLLWEIFSLGASP---- 250

Query: 317 YEGVAA----MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           Y GV        ++     +   PD  + E    +  C    P  RPT +EL++H
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  128 bits (325), Expect = 3e-33
 Identities = 78/325 (24%), Positives = 129/325 (39%), Gaps = 60/325 (18%)

Query: 87  SHSNSAATSPSVPRSPGRMENPVSPESHW-------KKGKMLGRGTFGHVYVG------- 132
           SH +   +   +       E P  P+  W         GK LG G FG V +        
Sbjct: 4   SHHHHHHSQDPMLAGVSEYELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDK 61

Query: 133 FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYI 191
                    A+K   L DDA  K+    L+ E+ ++  + +H NI+   G+ T +  LY+
Sbjct: 62  DKPKEAVTVAVK--MLKDDATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118

Query: 192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ----------------QILSGLAFLHSKHT 235
            +EY S G++ + L+     G     +  +                Q+  G+ +L S+  
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKGSPYWMAPEVIKNS 288
           +HRD+   N+LV  N  +K+ADFG+A+ I          +  L  K    WMAPE + + 
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK----WMAPEALFDR 234

Query: 289 -----SGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
                S      D+WS G  + E+ T    P+           +     +   P + ++E
Sbjct: 235 VYTHQS------DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD-KPANCTNE 287

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDH 367
               +R C    P  RPT  +L++ 
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVED 312

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  128 bits (323), Expect = 6e-33
 Identities = 75/321 (23%), Positives = 124/321 (38%), Gaps = 47/321 (14%)

Query: 81  SNSSPFSHSNSAATSPSVPRSPGRMENPVSPE---SHWKKGKMLGRGTFGHVYVG----F 133
            +S   +    +     +  +P    +                LG G FG V++      
Sbjct: 6   GSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65

Query: 134 NSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY 192
             +  +M  A+K   L +   S+ + +   +E  LL+ L+H +IV+++G  T    L + 
Sbjct: 66  LPEQDKMLVAVK--ALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121

Query: 193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQ---------------QILSGLAFLHSKHTVH 237
            EY+  G + + L+ +G   +                       Q+ +G+ +L   H VH
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKGSPYWMAPEVIKN--- 287
           RD+   N LV     VK+ DFGM++ I        G    L  +    WM PE I     
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR----WMPPESILYRKF 237

Query: 288 SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
           ++      D+WS G  + E+ T  K PW Q     A+  I   +EL   P     E    
Sbjct: 238 TT----ESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE-RPRACPPEVYAI 292

Query: 347 IRLCLQRNPLNRPTAAELLDH 367
           +R C QR P  R +  ++   
Sbjct: 293 MRGCWQREPQQRHSIKDVHAR 313

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  129 bits (325), Expect = 9e-33
 Identities = 82/370 (22%), Positives = 138/370 (37%), Gaps = 79/370 (21%)

Query: 76  PPITISNSSPFS--------HSNSAATSPSVPRSPGRMENPVSP-----ESHW------- 115
             I  + +  F+        H +      +       M   VS      +  W       
Sbjct: 12  YDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRL 71

Query: 116 KKGKMLGRGTFGHVYVG-------FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLL 168
             GK LG G FG V +           +     A+K   L  DA  K+    L+ E+ ++
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATEKD-LSDLISEMEMM 128

Query: 169 SRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQ------ 221
             + +H NI+   G+ T +  LY+ +EY S G++ + LQ     G     N +       
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 222 ----------QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI------- 264
                     Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+ I       
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 265 AGQSCPLSFKGSPYWMAPEVIKNS-----SGCNLAVDIWSLGCTVLEMATT-KPPWSQYE 318
              +  L  K    WMAPE + +      S      D+WS G  + E+ T    P+    
Sbjct: 249 KTTNGRLPVK----WMAPEALFDRIYTHQS------DVWSFGVLLWEIFTLGGSPYPGVP 298

Query: 319 GVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLER 378
                  +     +   P + ++E    +R C    P  RPT  +L++         L+R
Sbjct: 299 VEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--------LDR 349

Query: 379 TILAPEPSDV 388
            +      ++
Sbjct: 350 IVALTSNQEM 359

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  132 bits (333), Expect = 1e-32
 Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 31/281 (11%)

Query: 120 MLGRGTFGHVYVGFNSD-SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
            +  G  G +Y+  + + +G    +K +    DA+++  A   M E   L+ + HP+IVQ
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMA---MAERQFLAEVVHPSIVQ 143

Query: 179 YY-----GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
            +       +  +   YI +EYV G S+ +      +        Y  +IL  L++LHS 
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSI 201

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
             V+ D+K  NI++     +KL D G    I          G+P + APE+++  +G  +
Sbjct: 202 GLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY---GTPGFQAPEIVR--TGPTV 255

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           A DI+++G T+  +    P      G   +  +     +    D         +R  +  
Sbjct: 256 ATDIYTVGRTLAALTLDLPT---RNGR-YVDGLPEDDPVLKTYDSYG----RLLRRAIDP 307

Query: 354 NPLNRP-TAAELLDHPFVKGAAPLERTILAPEPSDVPPGVT 393
           +P  R  TA E+     + G     R ++A +     PG++
Sbjct: 308 DPRQRFTTAEEMSAQ--LTGVL---REVVAQDTGVPRPGLS 343

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  126 bits (319), Expect = 3e-32
 Identities = 67/292 (22%), Positives = 119/292 (40%), Gaps = 56/292 (19%)

Query: 118 GKMLGRGTFGHVY----VGFNSDSGEM-CAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
            + +G G FG V+     G          A+K   L ++A +   A    +E  L++   
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQAD-FQREAALMAEFD 108

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD----------------YGQFGEPAI 216
           +PNIV+  G   V   + +  EY++ G + + L+                   +   P  
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168

Query: 217 RNYTQ--------QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI---- 264
              +         Q+ +G+A+L  +  VHRD+   N LV  N  VK+ADFG++++I    
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 265 ---AGQSCPLSFKGSPYWMAPEVIKN---SSGCNLAVDIWSLGCTVLEMATT-KPPWSQY 317
              A  +  +  +    WM PE I     ++      D+W+ G  + E+ +    P+   
Sbjct: 229 YYKADGNDAIPIR----WMPPESIFYNRYTT----ESDVWAYGVVLWEIFSYGLQPYYGM 280

Query: 318 --EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
             E V    + GN   L   P++   E  + +RLC  + P +RP+   +   
Sbjct: 281 AHEEVIYYVRDGNI--LA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  122 bits (308), Expect = 6e-31
 Identities = 73/324 (22%), Positives = 118/324 (36%), Gaps = 59/324 (18%)

Query: 95  SPSVPRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGF-NSDSGEM-CAMKEVTLFDDA 152
                 +P     PV   +  K   ++G G FG V       D   M  A+K   + + A
Sbjct: 7   HHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYA 64

Query: 153 KSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY--- 208
              +       E+ +L +L  HPNI+   G+      LY+ +EY   G+    L D+   
Sbjct: 65  SKDDHRD-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN----LLDFLRK 119

Query: 209 -----------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG 251
                                   + ++   +  G+ +L  K  +HRD+   NILV  N 
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179

Query: 252 RVKLADFGMAKHI----AGQSCPLSFKGSPYWMAPEVIKNS-----SGCNLAVDIWSLGC 302
             K+ADFG+++            L  +    WMA E +  S     S      D+WS G 
Sbjct: 180 VAKIADFGLSRGQEVYVKKTMGRLPVR----WMAIESLNYSVYTTNS------DVWSYGV 229

Query: 303 TVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTA 361
            + E+ +    P+          K+     L   P +  DE  D +R C +  P  RP+ 
Sbjct: 230 LLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSF 288

Query: 362 AELLDHPFVKGAAPLERTILAPEP 385
           A++L          L R +   + 
Sbjct: 289 AQILVS--------LNRMLEERKT 304

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  118 bits (299), Expect = 7e-30
 Identities = 70/286 (24%), Positives = 114/286 (39%), Gaps = 49/286 (17%)

Query: 110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS 169
                   G  +G G FG VY G+ +      A+K++    D  ++E  +Q  QEI +++
Sbjct: 28  DERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85

Query: 170 RLRHPNIVQYYG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILS--- 225
           + +H N+V+  G S   +D   +Y  Y+  GS+   L                  LS   
Sbjct: 86  KCQHENLVELLGFSSDGDDLCLVY-VYMPNGSLLDRL-----SCLDG-----TPPLSWHM 134

Query: 226 ----------GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLS-- 272
                     G+ FLH  H +HRDIK ANIL+D     K++DFG+A+         ++  
Sbjct: 135 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194

Query: 273 FKGSPYWMAPEVIKNSSGCNLAV--DIWSLGCTVLEMATTKPPWSQYEG----VA-AMFK 325
             G+  +MAPE +    G  +    DI+S G  +LE+ T  P   ++      +      
Sbjct: 195 IVGTTAYMAPEAL---RG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250

Query: 326 IGNSKELPTIPD-DLSD-EGKDFIR------LCLQRNPLNRPTAAE 363
               K +    D  ++D +             CL      RP   +
Sbjct: 251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  118 bits (298), Expect = 2e-29
 Identities = 75/344 (21%), Positives = 119/344 (34%), Gaps = 115/344 (33%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES-AKQLMQEIVLLSRLRH---- 173
           + +G GTFG V +  + D+ +  A+K V      ++ +   +    E  +L ++++    
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVV------RNIKKYTRSAKIEADILKKIQNDDIN 94

Query: 174 -PNIVQYYGSKT-------VEDKLYIYLEYVSGGSIYKLLQDYGQFGEP--AIRNYTQQI 223
             NIV+Y+G          + + L        G S+Y+++      G     I+ Y  +I
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPL--------GPSLYEIITRNNYNGFHIEDIKLYCIEI 146

Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNG-------------------------RVKLADF 258
           L  L +L      H D+K  NIL+D                             +KL DF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 259 GMAKHIAGQSCPLSFKGSPY-----WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTK-- 311
           G A          S           + APEVI N  G +++ D+WS GC + E+ T    
Sbjct: 207 GCA-------TFKSDYHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLL 258

Query: 312 -PPWSQYEGVAAMFKI-------------------------------------------G 327
                  E +A M  I                                            
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318

Query: 328 NSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
               L  I     +   DF+   LQ +P  RP+ AELL H F++
Sbjct: 319 KCLPLYKIIKH--ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  115 bits (290), Expect = 3e-28
 Identities = 70/343 (20%), Positives = 106/343 (30%), Gaps = 105/343 (30%)

Query: 119 KMLGRGTFGHVYVGF-NSDSGEMCAMKEVTLFDDAKSKES-AKQLMQEIVLLSRLRHP-- 174
             LG GTFG V     ++      A+K +      ++     +    EI +L +++    
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKII------RNVGKYREAARLEINVLKKIKEKDK 78

Query: 175 ----NIVQYYGSKT-------VEDKLYIYLEYVSGGSIYKLLQDYGQFGEP--AIRNYTQ 221
                 V                + L        G + ++ L++      P   +R+   
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELL--------GKNTFEFLKENNFQPYPLPHVRHMAY 130

Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNG-------------------RVKLADFGMAK 262
           Q+   L FLH     H D+K  NIL   +                     +++ADFG A 
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189

Query: 263 HIAGQSCPLSFKGSPY-----WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPW--- 314
                        +       +  PEVI    G     D+WS+GC + E       +   
Sbjct: 190 ------TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTH 242

Query: 315 SQYEGVAAMFKI------------------------------------GNSKELPTI--P 336
              E +  M KI                                     N K L +    
Sbjct: 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 302

Query: 337 DDLSDEG-KDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLER 378
           D L      D +R  L+ +P  R T AE L HPF  G  P ER
Sbjct: 303 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEER 345

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  113 bits (286), Expect = 6e-28
 Identities = 76/330 (23%), Positives = 105/330 (31%), Gaps = 91/330 (27%)

Query: 119 KMLGRGTFGHVYVGFNSDSG-EMCAMKEVTLFDDAKSKES-AKQLMQEIVLLSRLRHP-- 174
             LG G FG V    +  +G    A+K V      K+ +   +    EI +L  L     
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIV------KNVDRYCEAARSEIQVLEHLNTTDP 73

Query: 175 ----NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP--AIRNYTQQILSGLA 228
                 VQ          + I  E + G S Y  +++ G        IR    QI   + 
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132

Query: 229 FLHSKHTVHRDIKGANILVDPNG-------------------RVKLADFGMAKHIAGQSC 269
           FLHS    H D+K  NIL   +                     +K+ DFG A        
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-------T 185

Query: 270 PLSFKGSPY-----WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTK---PPWSQYEGVA 321
                 S       + APEVI    G +   D+WS+GC ++E        P     E +A
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244

Query: 322 AMFKI-G-----------------------------------NSKELPTI--PDDLSDEG 343
            M +I G                                     K L       D+  E 
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304

Query: 344 -KDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
             D I+  L+ +P  R T  E L HPF   
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFFDL 334

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  112 bits (281), Expect = 9e-28
 Identities = 34/283 (12%), Positives = 71/283 (25%), Gaps = 49/283 (17%)

Query: 121 LGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYY 180
            G       +   ++      A+  V         +  ++ +   + LSR+  P + +  
Sbjct: 39  HGGVPPLQFWQALDTALDRQVALTFV-DPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIR--NYTQQILSGLAFLHSKHTVHR 238
                     +  E++ GGS    LQ+        +      Q + +     H       
Sbjct: 98  DVVHTRAGGLVVAEWIRGGS----LQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALS 153

Query: 239 DIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIW 298
               + + V  +G V LA                       M           N   DI 
Sbjct: 154 IDHPSRVRVSIDGDVVLAYPAT-------------------MPDA--------NPQDDIR 186

Query: 299 SLGCTVLEMATTKPPWSQYEGVAAMFKIGN---------SKELPTIPDDLSDEGKDFIRL 349
            +G ++  +   + P  +    + +              +     IP  +S         
Sbjct: 187 GIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS----AVAAR 242

Query: 350 CLQRNPLNRPTAA--ELLDHPFVKGAAPLERTILAPEPSDVPP 390
            +Q +   R  +    L+               +   P    P
Sbjct: 243 SVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAP 285

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  112 bits (281), Expect = 5e-27
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 25/208 (12%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES-AKQLMQEIVLLSRLRHP--- 174
            ++G+G+FG V   ++    E  A+K +      K+K++   Q   E+ LL  +      
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKII------KNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 175 ---NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP--AIRNYTQQILSGLAF 229
               IV         + L +  E +S  ++Y LL++    G      R + QQ+ + L F
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 230 LHSKHT--VHRDIKGANILVDPNGR--VKLADFGMAKHIAGQSCP-LSFKGSPYWMAPEV 284
           L +     +H D+K  NIL+    R  +K+ DFG +  +  +    +    S ++ +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ---SRFYRSPEV 229

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKP 312
           +      +LA+D+WSLGC ++EM T +P
Sbjct: 230 LLGM-PYDLAIDMWSLGCILVEMHTGEP 256

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  112 bits (282), Expect = 7e-27
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 31/210 (14%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKES-AKQLMQEIVLLSRLRH---- 173
           K++G+G+FG V   ++    +  A+K V      ++++   +Q  +EI +L  LR     
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV------RNEKRFHRQAAEEIRILEHLRKQDKD 156

Query: 174 --PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ--DYGQFGEPAIRNYTQQILSGLAF 229
              N++    + T  + + +  E +S  ++Y+L++   +  F  P +R +   IL  L  
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 230 LHSKHTVHRDIKGANILVDPNGR--VKLADFGMAKHIAGQSCPLSFKGSPY-----WMAP 282
           LH    +H D+K  NIL+   GR  +K+ DF       G SC    +   Y     + AP
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDF-------GSSCYEHQRVYTYIQSRFYRAP 268

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKP 312
           EVI   +   + +D+WSLGC + E+ T  P
Sbjct: 269 EVILG-ARYGMPIDMWSLGCILAELLTGYP 297

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 47.4 bits (113), Expect = 9e-06
 Identities = 15/53 (28%), Positives = 24/53 (45%), Gaps = 1/53 (1%)

Query: 328 NSKELPTIPDDLSDEG-KDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERT 379
            S+E         D    DF++ CL+ +P  R T  + L HP+++   P   T
Sbjct: 369 ESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPT 421

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  107 bits (269), Expect = 8e-26
 Identities = 71/301 (23%), Positives = 126/301 (41%), Gaps = 64/301 (21%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           ++G G FG VY G   D G   A+K        +S +  ++   EI  LS  RHP++V  
Sbjct: 46  LIGHGVFGKVYKGVLRD-GAKVALKRR----TPESSQGIEEFETEIETLSFCRHPHLVSL 100

Query: 180 YG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILS------------- 225
            G      + + IY +Y+  G++ + L  YG        +     +S             
Sbjct: 101 IGFCDERNEMILIY-KYMENGNLKRHL--YG-------SDLPTMSMSWEQRLEICIGAAR 150

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK--------HIAGQSCPLSFKGSP 277
           GL +LH++  +HRD+K  NIL+D N   K+ DFG++K        H++        KG+ 
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-----VKGTL 205

Query: 278 YWMAPEVIKNSSGCNLAV--DIWSLGCTVLEMATTKPP---------WSQYEGVAAMFKI 326
            ++ PE      G  L    D++S G  + E+   +            +  E        
Sbjct: 206 GYIDPEYF--IKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262

Query: 327 GNSKEL--PTIPDDLSDEG-KDFIRL---CLQRNPLNRPTAAELLDHPFVKGAAPLERTI 380
           G  +++  P + D +  E  + F      CL  +  +RP+  ++L    ++ A  L+ ++
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK--LEYALRLQESV 320

Query: 381 L 381
           +
Sbjct: 321 I 321

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  104 bits (263), Expect = 5e-25
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 41/272 (15%)

Query: 120 MLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQY 179
           +LGRG FG VY G  +D G + A+K      + +++    Q   E+ ++S   H N+++ 
Sbjct: 37  ILGRGGFGKVYKGRLAD-GTLVAVKR---LKEERTQGGELQFQTEVEMISMAVHRNLLRL 92

Query: 180 YG-SKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEP---AIRNYTQQIL----SGLAFLH 231
            G   T  ++L +Y  Y++ GS+   L++  +   P     R   Q+I      GLA+LH
Sbjct: 93  RGFCMTPTERLLVY-PYMANGSVASCLRERPESQPPLDWPKR---QRIALGSARGLAYLH 148

Query: 232 SK---HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPYWMAPEVIK 286
                  +HRD+K ANIL+D      + DFG+AK +  +   ++   +G+   +APE + 
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL- 207

Query: 287 NSSG-CNLAVDIWSLGCTVLEMAT-------TKPPWSQYEG----VAAMFKIGNSKEL-- 332
            S+G  +   D++  G  +LE+ T        +            V  + K    + L  
Sbjct: 208 -STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 266

Query: 333 PTIPDDLSDEG-KDFIR---LCLQRNPLNRPT 360
             +  +  DE  +  I+   LC Q +P+ RP 
Sbjct: 267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 59/311 (18%), Positives = 106/311 (34%), Gaps = 52/311 (16%)

Query: 81  SNSSPFSHSNSAATSPSVPRSPGR-MENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGE 139
            +SS            S+P   G+ +++       W  GK +G G FG +Y+ F ++  E
Sbjct: 6   HHSSGVDLGTENLYFQSMPFPEGKVLDDMEGN--QWVLGKKIGSGGFGLIYLAFPTNKPE 63

Query: 140 MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ-----------------YYGS 182
             A   V +       +    L  E+    R+   + ++                   G 
Sbjct: 64  KDARHVVKV-----EYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118

Query: 183 KTVEDKLYIYL--EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDI 240
              + + Y ++  E + G  + K+    G F +  +     ++L  L ++H    VH DI
Sbjct: 119 TEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDI 177

Query: 241 KGANILVDPN--GRVKLADFGMAK-------HIAGQSCPL-SFKGSPYWMAPEVIKNSSG 290
           K AN+L+      +V LAD+G++        H   Q  P     G+  + +   +    G
Sbjct: 178 KAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS---LDAHKG 234

Query: 291 CNLA--VDIWSLGCTVLEMATTKPPWSQYEGVAAMF------KIGNSKELPTIP---DDL 339
             L+   D+  LG  +L     K PW Q               +    +           
Sbjct: 235 VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSS 294

Query: 340 SDEGKDFIRLC 350
             E   F+   
Sbjct: 295 CCEIAQFLVCA 305

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 92.7 bits (230), Expect = 2e-20
 Identities = 79/364 (21%), Positives = 121/364 (33%), Gaps = 125/364 (34%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-----H 173
           + LG G F  V++ ++    +  AMK V         E+A   + EI LL  +R      
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETA---LDEIRLLKSVRNSDPND 97

Query: 174 PN---IVQYYGSKTVEDKLYIYLEYVS---GGSIYKLLQ--DYGQFGEPAIRNYTQQILS 225
           PN   +VQ      +      ++  V    G  + K +   +Y     P ++   QQ+L 
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157

Query: 226 GLAFLHSK-HTVHRDIKGANILV------------------------------------- 247
           GL +LH+K   +H DIK  NIL+                                     
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217

Query: 248 ------------DPNGRVKLADFGMA----KHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
                           +VK+AD G A    KH         +       + EV+   SG 
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQY------RSLEVLIG-SGY 270

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEG---------VAAMFKI---------------- 326
           N   DIWS  C   E+AT    +  + G         +A + ++                
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330

Query: 327 ------GNSKELPTIPD-----------DLSDEGK----DFIRLCLQRNPLNRPTAAELL 365
                 G+ K +  +             + S E      DF+   L+  P  R TAAE L
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390

Query: 366 DHPF 369
            HP+
Sbjct: 391 RHPW 394

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 33/247 (13%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           H+K G+ +G G+FG ++ G N  + +  A+K          +  A QL  E      L  
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK------FEPRRSDAPQLRDEYRTYKLLAG 64

Query: 174 -PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLH 231
              I   Y          + ++ + G S+  LL   G +F    +    +Q+L+ +  +H
Sbjct: 65  CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 232 SKHTVHRDIKGANILVDPNG-----RVKLADFGMAK---------HIAGQSCPLSFKGSP 277
            K  V+RDIK  N L+          + + DFGM K         HI  +    +  G+ 
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK-NLSGTA 182

Query: 278 YWMAPEVIKNSSGCNLAV--DIWSLGCTVLEMATTKPPWSQYEGV---AAMFKIGNSKEL 332
            +M+   I    G   +   D+ +LG   +       PW   +         +IG  K+ 
Sbjct: 183 RYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ- 238

Query: 333 PTIPDDL 339
            T   +L
Sbjct: 239 STPLREL 245

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 59/256 (23%), Positives = 100/256 (39%), Gaps = 33/256 (12%)

Query: 103 GRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLM 162
           G ME  V     ++ G+ +G G+FG +Y+G +  +GE  A+K          K    QL 
Sbjct: 1   GSMELRVGN--RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK------LECVKTKHPQLH 52

Query: 163 QEIVLLSRLRH-PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYT 220
            E  +   ++    I          D   + +E + G S+  L      +F    +    
Sbjct: 53  IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLA 111

Query: 221 QQILSGLAFLHSKHTVHRDIKGANILVDPNG---RVKLADFGMAK---------HIAGQS 268
            Q++S + ++HSK+ +HRD+K  N L+        V + DFG+AK         HI  + 
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171

Query: 269 CPLSFKGSPYWMAPEVIKNSSGCNLAV--DIWSLGCTVLEMATTKPPWSQYEGVAAMFK- 325
              +  G+  + +   I    G   +   D+ SLG  ++       PW   +      K 
Sbjct: 172 NK-NLTGTARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227

Query: 326 --IGNSKELPTIPDDL 339
             I   K   T  + L
Sbjct: 228 ERISEKKMS-TPIEVL 242

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 87.5 bits (217), Expect = 6e-19
 Identities = 53/293 (18%), Positives = 93/293 (31%), Gaps = 49/293 (16%)

Query: 88  HSNSAATSPSVPRSPGRMENPVSPES-------------HWKKGKMLGRGTFGHVYVGFN 134
           H + ++       +        S E+              WK      R   G +Y    
Sbjct: 4   HHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAP 63

Query: 135 SDSG--------EMCAMK----EVTLFDDAKSKESAKQLMQEIVL--LSRLRHPNIVQYY 180
           + +         +  ++K    +  LF++    + A + +Q      L       I    
Sbjct: 64  TSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCM 123

Query: 181 GSKTVEDKLYIY-LEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLAFLHSKHTVH 237
           G    +DK     L  + G S+   L         E ++     ++L  L FLH    VH
Sbjct: 124 GFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVH 182

Query: 238 RDIKGANILVDPN--GRVKLADFGMAK-------HIAGQSCP-LSFKGSPYWMAPEVIKN 287
            ++   NI VDP    +V LA +G A        H+A         +G   +++   +  
Sbjct: 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFIS---MDL 239

Query: 288 SSGCNLA--VDIWSLGCTVLEMATTKPPWSQYEGVAAMF---KIGNSKELPTI 335
             GC  +   D+ SLG  +L+      PW+            K     +    
Sbjct: 240 HKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPF 292

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 33/247 (13%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           +++ GK +G G FG + +G N  + E  A+K     +  KS+    QL  E     +L  
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAP--QLHLEYRFYKQLGS 63

Query: 174 -PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLH 231
              I Q Y          + LE + G S+  L       F    +     Q++S + ++H
Sbjct: 64  GDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 232 SKHTVHRDIKGANILVDPNG-----RVKLADFGMAK---------HIAGQSCPLSFKGSP 277
           SK+ ++RD+K  N L+   G      + + DF +AK         HI  +    S  G+ 
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK-SLTGTA 181

Query: 278 YWMAPEVIKNSSGCNLA--VDIWSLGCTVLEMATTKPPWSQYEGV---AAMFKIGNSKEL 332
            +M+   I    G   +   D+ +LG   +       PW   +         KIG++K  
Sbjct: 182 RYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238

Query: 333 PTIPDDL 339
            T  + L
Sbjct: 239 -TPIEVL 244

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 51/269 (18%), Positives = 93/269 (34%), Gaps = 45/269 (16%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            WK G  +G+G FG +Y+  + +S E        +     S      L  E+    R   
Sbjct: 36  AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSD--NGPLFTELKFYQRAAK 92

Query: 174 PNIVQ-----------------YYGSKTVEDKLYIYL--EYVSGGSIYKLLQDYGQ-FGE 213
           P  +Q                   G      K Y ++  +   G  + K+ +   + F  
Sbjct: 93  PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR 151

Query: 214 PAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN--GRVKLADFGMAK--------- 262
             +   + +IL  L ++H    VH DIK +N+L++     +V L D+G+A          
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211

Query: 263 HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLA--VDIWSLGCTVLEMATTKPPWSQYEGV 320
             A         G+  + +   I   +G   +   D+  LG  +++  T   PW      
Sbjct: 212 AYAADPK-RCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267

Query: 321 ---AAMFKIGNSKELPTIPDDLSDEGKDF 346
                  KI   + + ++  D      + 
Sbjct: 268 PKYVRDSKIRYRENIASL-MDKCFPAANA 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 71/338 (21%), Positives = 111/338 (32%), Gaps = 103/338 (30%)

Query: 118 GKMLGRGTFGHVYVGF-----NSDSGEMCAMKEVTLFDDAKSKE-----SAKQLMQEI-- 165
           GK LGRG FG V          + +    A+K   L + A   E     S  +++  I  
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSELKILIHIGH 84

Query: 166 -------------------VLLSRLRHPNIVQYYGSK----------------------T 184
                              V++   +  N+  Y  SK                       
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144

Query: 185 VEDKLYIYLEYVSG----GSIYKLLQDYGQFGEPAIRNYTQ---------------QILS 225
           +   L   L+ ++      S   + +      E                       Q+  
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204

Query: 226 GLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-------AGQSCPLSFKGSPY 278
           G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I             L  K    
Sbjct: 205 GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK---- 260

Query: 279 WMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTI-- 335
           WMAPE I +      + D+WS G  + E+ +    P   Y GV       + +    +  
Sbjct: 261 WMAPETIFDRVYTIQS-DVWSFGVLLWEIFSLGASP---YPGVKI-----DEEFCRRLKE 311

Query: 336 ------PDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                 PD  + E    +  C    P  RPT +EL++H
Sbjct: 312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 82.2 bits (202), Expect = 3e-17
 Identities = 35/215 (16%), Positives = 70/215 (32%), Gaps = 47/215 (21%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD----AKSKESAKQLMQEIV 166
           P    ++ + +G G FG V+           A+K + +          +++ ++++ EI+
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 167 LLSRL---------RHPNIVQYYGSKTV------------------------------ED 187
           +   L         R    +       V                              +D
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT-VHRDIKGANIL 246
           +L+I LE+  GG   + ++          ++   Q+ + LA   +     HRD+   N+L
Sbjct: 136 QLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194

Query: 247 VDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMA 281
           +      KL      K     SC L      Y ++
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLS 229

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 81.6 bits (201), Expect = 2e-16
 Identities = 87/466 (18%), Positives = 148/466 (31%), Gaps = 61/466 (13%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR- 172
            ++ G+ +G G+FG +Y+G N  + E  A+K          K    QL+ E  +   L+ 
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKIYRILQG 61

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLH 231
              I          D   + ++ + G S+  L      +     +     Q+++ + F+H
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 232 SKHTVHRDIKGANILVDPNGR---VKLADFGMAK---------HIAGQSCPLSFKGSPYW 279
           SK  +HRDIK  N L+    R   V + DFG+AK         HI  +    +  G+  +
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK-NLTGTARY 179

Query: 280 MAPEVIKNSSGCNLAV--DIWSLGCTVLEMATTKPPWSQYEGV---AAMFKIGNSKELPT 334
            +   +    G   +   D+ SLG  ++       PW   +         KI   K   +
Sbjct: 180 AS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236

Query: 335 IPD---DLSDEGKDFIRLCLQRNPLNRPTAAEL--------------LDHPF-------- 369
           I         E   +   C      ++P  + L               D+ F        
Sbjct: 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296

Query: 370 --VKGAAPLERTILAPEPSDVPPGVTNGIKALGIGQLRNVSTFDTERLAVHSSRVSQTSL 427
                +AP         PS + P      +  G+ + R       +R        S  +L
Sbjct: 297 QSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASVGTL 356

Query: 428 NASDINISMNRSCPVSPI--GSPLLHPRSPQHLNGKMSPSPISSPRTTSGASTPLTGGSG 485
                 +  + S    P+   S  L   S       +S S    P  TS  S      + 
Sbjct: 357 AKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDAS 416

Query: 486 AIPFNHLKQPVYLQEGFGNLAKPTSNFYGNGPSYQDTNPDIFRGMQ 531
              F     P           K +S       S         +G++
Sbjct: 417 PGAFRRTSGPQKSSPVNSAEPKHSS--SARHSSNVKNYESALKGIE 460

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	602
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-88
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-86
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-86
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-84
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-82
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-80
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-79
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-79
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-79
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-78
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-78
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-77
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-77
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-75
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-74
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-73
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-73
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-72
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-72
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-71
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-71
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-70
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-70
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-69
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-68
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-68
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-67
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-67
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-67
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-66
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-66
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-66
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-66
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-65
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-65
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-65
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-64
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-64
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-63
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-63
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-63
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-63
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-62
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-62
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-62
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-61
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-60
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-59
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-57
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-57
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-57
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-56
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-55
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-54
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-54
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-27

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  272 bits (696), Expect = 8e-88
 Identities = 96/282 (34%), Positives = 148/282 (52%), Gaps = 13/282 (4%)

Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
            ++PE  W+    LG G FG VY   N ++  + A K +    D KS+E  +  M EI +
Sbjct: 7   DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDI 62

Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSG 226
           L+   HPNIV+   +   E+ L+I +E+ +GG++  ++ +  +   E  I+   +Q L  
Sbjct: 63  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL-SFKGSPYWMAPEVI 285
           L +LH    +HRD+K  NIL   +G +KLADFG++           SF G+PYWMAPEV+
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182

Query: 286 ----KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-TIPDDLS 340
                     +   D+WSLG T++EMA  +PP  +   +  + KI  S+      P   S
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242

Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA--PLERTI 380
              KDF++ CL++N   R T ++LL HPFV   +  P+   I
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELI 284

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  267 bits (685), Expect = 1e-86
 Identities = 81/260 (31%), Positives = 134/260 (51%), Gaps = 5/260 (1%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
             ++ G+ LG+G FG+VY+     S  + A+K +      +      QL +E+ + S LR
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK-AQLEKAGVEHQLRREVEIQSHLR 64

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HPNI++ YG      ++Y+ LEY   G++Y+ LQ   +F E     Y  ++ + L++ HS
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  +HRDIK  N+L+   G +K+ADFG + H        +  G+  ++ PE+I+     +
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEG-RMHD 182

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             VD+WSLG    E    KPP+          +I   +   T PD +++  +D I   L+
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISRLLK 240

Query: 353 RNPLNRPTAAELLDHPFVKG 372
            NP  RP   E+L+HP++  
Sbjct: 241 HNPSQRPMLREVLEHPWITA 260

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  269 bits (689), Expect = 2e-86
 Identities = 95/267 (35%), Positives = 144/267 (53%), Gaps = 6/267 (2%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           PE  +   + +G G+FG VY   +  + E+ A+K+++     +S E  + +++E+  L +
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNEKWQDIIKEVRFLQK 71

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           LRHPN +QY G    E   ++ +EY  G +   L        E  I   T   L GLA+L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI--KNS 288
           HS + +HRD+K  NIL+   G VKL DFG A  +A  +   SF G+PYWMAPEVI   + 
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDE 188

Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
              +  VD+WSLG T +E+A  KPP      ++A++ I  ++         S+  ++F+ 
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248

Query: 349 LCLQRNPLNRPTAAELLDHPFVKGAAP 375
            CLQ+ P +RPT+  LL H FV    P
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRERP 275

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  262 bits (671), Expect = 2e-84
 Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 7/262 (2%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            W   + LG G +G V +  N  + E  A+K V   D  ++ +  + + +EI +   L H
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKMLNH 62

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
            N+V++YG +   +  Y++LEY SGG ++  ++      EP  + +  Q+++G+ +LH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKNSSG 290
              HRDIK  N+L+D    +K++DFG+A      +         G+  ++APE++K    
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK-IGNSKELPTIPDDLSDEGKDFIRL 349
               VD+WS G  +  M   + PW Q       +      K        +       +  
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242

Query: 350 CLQRNPLNRPTAAELLDHPFVK 371
            L  NP  R T  ++    +  
Sbjct: 243 ILVENPSARITIPDIKKDRWYN 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  257 bits (657), Expect = 6e-82
 Identities = 90/268 (33%), Positives = 144/268 (53%), Gaps = 8/268 (2%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+  + + + +G+G  G VY   +  +G+  A++++ L    + +   + ++ EI+++  
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRE 73

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            ++PNIV Y  S  V D+L++ +EY++GGS+  ++ +     E  I    ++ L  L FL
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFL 132

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSS 289
           HS   +HRDIK  NIL+  +G VKL DFG    I  +    S   G+PYWMAPEV+    
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK- 191

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP-TIPDDLSDEGKDFIR 348
                VDIWSLG   +EM   +PP+     + A++ I  +       P+ LS   +DF+ 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 349 LCLQRNPLNRPTAAELLDHPFVKGAAPL 376
            CL  +   R +A ELL H F+K A PL
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKIAKPL 279

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  251 bits (641), Expect = 7e-80
 Identities = 70/271 (25%), Positives = 124/271 (45%), Gaps = 13/271 (4%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL-----FDDAKSKESAKQLMQEIVLL 168
           +++  ++LGRG    V    +  + +  A+K + +     F   + +E  +  ++E+ +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 169 SRLR-HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
            ++  HPNI+Q   +       ++  + +  G ++  L +     E   R   + +L  +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIK- 286
             LH  + VHRD+K  NIL+D +  +KL DFG +  +          G+P ++APE+I+ 
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 183

Query: 287 ----NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP--DDLS 340
               N  G    VD+WS G  +  +    PP+   + +  +  I +       P  DD S
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243

Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
           D  KD +   L   P  R TA E L HPF +
Sbjct: 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (638), Expect = 2e-79
 Identities = 78/268 (29%), Positives = 126/268 (47%), Gaps = 16/268 (5%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++    +G G++G          G++   KE+     + ++   + L+ E+ LL  L+HP
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY--GSMTEAEKQMLVSEVNLLRELKHP 63

Query: 175 NIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQDYGQ----FGEPAIRNYTQQILSGLA 228
           NIV+YY          LYI +EY  GG +  ++    +      E  +     Q+   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 229 FLHSKHT-----VHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAP 282
             H +       +HRD+K AN+ +D    VKL DFG+A+ +    S   +F G+PY+M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
           E + N    N   DIWSLGC + E+    PP++ +       KI   K    IP   SDE
Sbjct: 184 EQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDE 241

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDHPFV 370
             + I   L     +RP+  E+L++P +
Sbjct: 242 LNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  250 bits (640), Expect = 3e-79
 Identities = 74/277 (26%), Positives = 131/277 (47%), Gaps = 9/277 (3%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
              +    +LG G F  V +  +  + ++ A+K +        +     +  EI +L ++
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI---AKKALEGKEGSMENEIAVLHKI 64

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
           +HPNIV           LY+ ++ VSGG ++  + + G + E        Q+L  + +LH
Sbjct: 65  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 232 SKHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
               VHRD+K  N+L    D + ++ ++DFG++K     S   +  G+P ++APEV+   
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183

Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIP--DDLSDEGKDF 346
              + AVD WS+G     +    PP+          +I  ++     P  DD+SD  KDF
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243

Query: 347 IRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAP 383
           IR  ++++P  R T  + L HP++ G   L++ I   
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  251 bits (641), Expect = 9e-79
 Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 10/277 (3%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           H+   + LG G FG V+      +G   A K V        +   + + +EI  +S LRH
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFV----MTPHESDKETVRKEIQTMSVLRH 82

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHS 232
           P +V  + +   ++++ +  E++SGG +++ + D + +  E     Y +Q+  GL  +H 
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 233 KHTVHRDIKGANILVDP--NGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSG 290
            + VH D+K  NI+     +  +KL DFG+  H+  +       G+  + APEV +    
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI--GNSKELPTIPDDLSDEGKDFIR 348
                D+WS+G     + +   P+        +  +   +     +    +S++GKDFIR
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261

Query: 349 LCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEP 385
             L  +P  R T  + L+HP++       R    P  
Sbjct: 262 KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 298

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (633), Expect = 1e-78
 Identities = 76/264 (28%), Positives = 142/264 (53%), Gaps = 13/264 (4%)

Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           K    +GRG+F  VY G ++++    A  E  L D   +K   ++  +E  +L  L+HPN
Sbjct: 12  KFDIEIGRGSFKTVYKGLDTETTVEVAWCE--LQDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 176 IVQYYGS----KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
           IV++Y S       +  + +  E ++ G++   L+ +       +R++ +QIL GL FLH
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 232 SKHT--VHRDIKGANILV-DPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNS 288
           ++    +HRD+K  NI +  P G VK+ D G+A  +   S   +  G+P +MAPE+ +  
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 289 SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK-IGNSKELPTIPDDLSDEGKDFI 347
              + +VD+++ G  +LEMAT++ P+S+ +  A +++ + +  +  +       E K+ I
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246

Query: 348 RLCLQRNPLNRPTAAELLDHPFVK 371
             C+++N   R +  +LL+H F +
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFFQ 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (629), Expect = 7e-78
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 13/268 (4%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            +K GK+LG G+F  V +     +    A+K +        +     + +E  ++SRL H
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDH 67

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P  V+ Y +   ++KLY  L Y   G + K ++  G F E   R YT +I+S L +LH K
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS---CPLSFKGSPYWMAPEVIKNSSG 290
             +HRD+K  NIL++ +  +++ DFG AK ++ +S      SF G+  +++PE++     
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KS 186

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC 350
              + D+W+LGC + ++    PP+          KI   +     P+    + +D +   
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEKFFPKARDLVEKL 244

Query: 351 LQRNPLNRPTAAE------LLDHPFVKG 372
           L  +   R    E      L  HPF + 
Sbjct: 245 LVLDATKRLGCEEMEGYGPLKAHPFFES 272

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (630), Expect = 1e-77
 Identities = 77/305 (25%), Positives = 137/305 (44%), Gaps = 48/305 (15%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
           +  ++K   LG G  G V+   +  SG + A K + L      +    Q+++E+ +L   
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQVLHEC 61

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
             P IV +YG+   + ++ I +E++ GGS+ ++L+  G+  E  +   +  ++ GL +L 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 232 SKHT-VHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSG 290
            KH  +HRD+K +NILV+  G +KL DFG++  +   S   SF G+  +M+PE ++  + 
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQG-TH 179

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWS----------------------------------- 315
            ++  DIWS+G +++EMA  + P                                     
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 316 -------QYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHP 368
                         +  I N           S E +DF+  CL +NP  R    +L+ H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299

Query: 369 FVKGA 373
           F+K +
Sbjct: 300 FIKRS 304

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  247 bits (632), Expect = 2e-77
 Identities = 61/264 (23%), Positives = 120/264 (45%), Gaps = 10/264 (3%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           ++   + LG G FG V+      +G +   K +    +         +  EI ++++L H
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFI----NTPYPLDKYTVKNEISIMNQLHH 85

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHS 232
           P ++  + +   + ++ + LE++SGG ++  +        E  + NY +Q   GL  +H 
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 233 KHTVHRDIKGANILVD--PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSG 290
              VH DIK  NI+ +      VK+ DFG+A  +           +  + APE++ +   
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI--GNSKELPTIPDDLSDEGKDFIR 348
                D+W++G     + +   P++  + +  +  +   + +        +S E KDFI+
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264

Query: 349 LCLQRNPLNRPTAAELLDHPFVKG 372
             LQ+ P  R T  + L+HP++KG
Sbjct: 265 NLLQKEPRKRLTVHDALEHPWLKG 288

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 2e-75
 Identities = 68/267 (25%), Positives = 120/267 (44%), Gaps = 16/267 (5%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P+     G+ +G G+FG VY G         A+K   L   A + +  +    E+ +L +
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVK--MLNVTAPTPQQLQAFKNEVGVLRK 60

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAF 229
            RH NI+ + G  T   +L I  ++  G S+Y  L     +F    + +  +Q   G+ +
Sbjct: 61  TRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIK 286
           LH+K  +HRD+K  NI +  +  VK+ DFG+A   +  S         GS  WMAPEVI+
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 287 --NSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK----ELPTIPDDLS 340
             + +  +   D+++ G  + E+ T + P+S       +  +        +L  +  +  
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 341 DEGKDFIRLCLQRNPLNRPTAAELLDH 367
              K  +  CL++    RP   ++L  
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILAS 266

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (607), Expect = 3e-74
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 11/277 (3%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            +   + LGRG FG V+    + S +    K V              + +EI +L+  RH
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-----KVKGTDQVLVKKEISILNIARH 60

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHS 232
            NI+  + S    ++L +  E++SG  I++ +     +  E  I +Y  Q+   L FLHS
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 233 KHTVHRDIKGANILVDP--NGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSG 290
            +  H DI+  NI+     +  +K+ +FG A+ +           +P + APEV ++   
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DV 179

Query: 291 CNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT--IPDDLSDEGKDFIR 348
            + A D+WSLG  V  + +   P+        +  I N++         ++S E  DF+ 
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 349 LCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEP 385
             L +   +R TA+E L HP++K       T +    
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (602), Expect = 2e-73
 Identities = 74/257 (28%), Positives = 123/257 (47%), Gaps = 5/257 (1%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
            KMLG+G+FG V++     + +  A+K +         +    ++++ VL     HP + 
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             + +   ++ L+  +EY++GG +   +Q   +F       Y  +I+ GL FLHSK  V+
Sbjct: 67  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVY 126

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVD 296
           RD+K  NIL+D +G +K+ADFGM K    G +   +F G+P ++APE++      N +VD
Sbjct: 127 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVD 185

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPL 356
            WS G  + EM   + P+   +       I      P  P  L  E KD +     R P 
Sbjct: 186 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPE 243

Query: 357 NRPTAA-ELLDHPFVKG 372
            R     ++  HP  + 
Sbjct: 244 KRLGVRGDIRQHPLFRE 260

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 7e-73
 Identities = 69/267 (25%), Positives = 115/267 (43%), Gaps = 15/267 (5%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLS 169
           ES ++ G +LG G FG VY G         A+K V      D     +  ++  E+VLL 
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 170 RLR--HPNIVQYYGSKTVEDKLYIYLEYVSGGS-IYKLLQDYGQFGEPAIRNYTQQILSG 226
           ++      +++        D   + LE       ++  + + G   E   R++  Q+L  
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122

Query: 227 LAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVI 285
           +   H+   +HRDIK  NIL+D N G +KL DFG    +   +    F G+  +  PE I
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWI 181

Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
           +       +  +WSLG  + +M     P+   E +         +        +S E + 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------RGQVFFRQRVSSECQH 233

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKG 372
            IR CL   P +RPT  E+ +HP+++ 
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 2e-72
 Identities = 74/284 (26%), Positives = 126/284 (44%), Gaps = 26/284 (9%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNI 176
            ++LG G  G V   FN  + E  A+K +         +   +  +E+ L  R  + P+I
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKML---------QDCPKARREVELHWRASQCPHI 67

Query: 177 VQYYG----SKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGLAFL 230
           V+              L I +E + GG ++  +QD G   F E       + I   + +L
Sbjct: 68  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127

Query: 231 HSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
           HS +  HRD+K  N+L     PN  +KL DFG AK     +   +   +PY++APEV+  
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 186

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPW------SQYEGVAAMFKIGNSKELPTIPDDLSD 341
               + + D+WSLG  +  +    PP+      +   G+    ++G  +       ++S+
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEP 385
           E K  IR  L+  P  R T  E ++HP++  +  + +T L    
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 290

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (591), Expect = 3e-72
 Identities = 70/286 (24%), Positives = 129/286 (45%), Gaps = 12/286 (4%)

Query: 110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVL 167
           + + ++  G+ LG G F  V       +G   A K +       ++   S + + +E+ +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
           L  ++HPN++  +     +  + + LE V+GG ++  L +     E     + +QIL+G+
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 228 AFLHSKHTVHRDIKGANILVDPNG----RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
            +LHS    H D+K  NI++        R+K+ DFG+A  I   +   +  G+P ++APE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI--GNSKELPTIPDDLSD 341
           ++ N     L  D+WS+G     + +   P+        +  +   N +       + S 
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA---APLERTILAPE 384
             KDFIR  L ++P  R T  + L HP++K       L      P+
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQ 291

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  232 bits (593), Expect = 1e-71
 Identities = 81/311 (26%), Positives = 142/311 (45%), Gaps = 20/311 (6%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV--TLFDDAKSKESAKQLMQEIVLLSRL 171
            +   +++GRG FG VY    +D+G+M AMK +        + +  A      + L+S  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 172 RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
             P IV    +    DKL   L+ ++GG ++  L  +G F E  +R Y  +I+ GL  +H
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           ++  V+RD+K ANIL+D +G V+++D G+A     +  P +  G+  +MAPEV++     
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAY 183

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM-FKIGNSKELPTIPDDLSDEGKDFIRLC 350
           + + D +SLGC + ++     P+ Q++                 +PD  S E +  +   
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243

Query: 351 LQRNPLNRPT-----AAELLDHPFVKG---AAPLERTILAPEPSDVPPGVTNGIKALGIG 402
           LQR+   R       A E+ + PF +         +    P    +PP        +   
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL---IPP-----RGEVNAA 295

Query: 403 QLRNVSTFDTE 413
              ++ +FD E
Sbjct: 296 DAFDIGSFDEE 306

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (582), Expect = 3e-71
 Identities = 62/261 (23%), Positives = 118/261 (45%), Gaps = 16/261 (6%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
                K  + +G+G FG V +G     G   A+K +      K+  +A+  + E  ++++
Sbjct: 5   NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCI------KNDATAQAFLAEASVMTQ 56

Query: 171 LRHPNIVQYYGSKTVED-KLYIYLEYVSGGSIYKLLQDYGQ--FGEPAIRNYTQQILSGL 227
           LRH N+VQ  G    E   LYI  EY++ GS+   L+  G+   G   +  ++  +   +
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
            +L   + VHRD+   N+LV  +   K++DFG+ K     S   + K    W APE ++ 
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE 174

Query: 288 SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
               +   D+WS G  + E+ +  + P+ +      + ++    ++   PD       + 
Sbjct: 175 K-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-APDGCPPAVYEV 232

Query: 347 IRLCLQRNPLNRPTAAELLDH 367
           ++ C   +   RP+  +L + 
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ 253

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 2e-70
 Identities = 68/296 (22%), Positives = 125/296 (42%), Gaps = 28/296 (9%)

Query: 119 KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESA-KQLMQEIVLLSRLRHPNIV 177
             LG G F  VY   + ++ ++ A+K++ L   +++K+   +  ++EI LL  L HPNI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 178 QYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
               +   +  + +  +++       +  +        I+ Y    L GL +LH    +H
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFK-GSPYWMAPEVIKNSSGCNLAVD 296
           RD+K  N+L+D NG +KLADFG+AK     +   + +  + ++ APE++  +    + VD
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183

Query: 297 IWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT---------------------- 334
           +W++GC + E+    P       +  + +I  +   PT                      
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243

Query: 335 ----IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPS 386
               I     D+  D I+     NP  R TA + L   +             P P+
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPN 299

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  227 bits (579), Expect = 4e-70
 Identities = 74/279 (26%), Positives = 138/279 (49%), Gaps = 14/279 (5%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
             ++  + LG G+FG V++  +  +G   AMK +   +     +  +    E ++LS + 
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVT 62

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           HP I++ +G+     ++++ ++Y+ GG ++ LL+   +F  P  + Y  ++   L +LHS
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCN 292
           K  ++RD+K  NIL+D NG +K+ DFG AK++       +  G+P ++APEV+      N
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST-KPYN 179

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            ++D WS G  + EM     P+     +    KI N++     P   +++ KD +   + 
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLIT 237

Query: 353 RNPLNR-----PTAAELLDHPFVKG---AAPLERTILAP 383
           R+   R         ++ +HP+ K       L R I  P
Sbjct: 238 RDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 276

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 9e-69
 Identities = 62/261 (23%), Positives = 106/261 (40%), Gaps = 15/261 (5%)

Query: 119 KMLGRGTFGHVYVGF--NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI 176
           K LG G FG V  G+       +  A+K   L ++A       +L+ E  ++ +L +P I
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVK--ILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 177 VQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTV 236
           V+  G     +   + +E    G + K LQ      +  I     Q+  G+ +L   + V
Sbjct: 71  VRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129

Query: 237 HRDIKGANILVDPNGRVKLADFGMAKHIAG----QSCPLSFKGSPYWMAPEVIKNSSGCN 292
           HRD+   N+L+      K++DFG++K +             K    W APE I      +
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFS 188

Query: 293 LAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL 351
              D+WS G  + E  +  + P+   +G      +   + +   P     E  D + LC 
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-CPAGCPREMYDLMNLCW 247

Query: 352 QRNPLNRPTAAEL---LDHPF 369
             +  NRP  A +   L + +
Sbjct: 248 TYDVENRPGFAAVELRLRNYY 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 1e-68
 Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 13/279 (4%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            +   K+LG+GTFG V +     +G   AMK +   +   +K+     + E  +L   RH
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRH 64

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P +     +    D+L   +EY +GG ++  L     F E   R Y  +I+S L +LHS+
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS-FKGSPYWMAPEVIKNSSGCN 292
             V+RDIK  N+++D +G +K+ DFG+ K        +  F G+P ++APEV+++ +   
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYG 183

Query: 293 LAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
            AVD W LG  + EM   + P+   +       I   +     P  LS E K  +   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLK 241

Query: 353 RNPLNRP-----TAAELLDHPFVKG---AAPLERTILAP 383
           ++P  R       A E+++H F         +++ +L P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 7e-68
 Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 7/261 (2%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
                + G+ +G G FG V+ G             +    +  S    ++ +QE + + +
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAF 229
             HP+IV+  G  T E+ ++I +E  + G +   LQ         ++  Y  Q+ + LA+
Sbjct: 65  FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FKGSPYWMAPEVIKN 287
           L SK  VHRDI   N+LV  N  VKL DFG+++++   +   +   K    WMAPE I N
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-N 182

Query: 288 SSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
                 A D+W  G  + E+      P+   +    + +I N + LP +P +        
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLYSL 241

Query: 347 IRLCLQRNPLNRPTAAELLDH 367
           +  C   +P  RP   EL   
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQ 262

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 1e-67
 Identities = 70/266 (26%), Positives = 111/266 (41%), Gaps = 12/266 (4%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGF---NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
            E   +  + LG G+FG V  G     S      A+K +   D     E+    ++E+  
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-DVLSQPEAMDDFIREVNA 64

Query: 168 LSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSG 226
           +  L H N+++ YG   +   + +  E    GS+   L+ + G F    +  Y  Q+  G
Sbjct: 65  MHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 227 LAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL----SFKGSPYWMAP 282
           + +L SK  +HRD+   N+L+     VK+ DFG+ + +             K    W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 283 EVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSD 341
           E +K     + A D W  G T+ EM T  + PW    G   + KI    E    P+D   
Sbjct: 184 ESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242

Query: 342 EGKDFIRLCLQRNPLNRPTAAELLDH 367
           +  + +  C    P +RPT   L D 
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 2e-67
 Identities = 72/267 (26%), Positives = 120/267 (44%), Gaps = 17/267 (6%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P    K  + LG G FG V++G+ +      A+K +      +   S    + E  L+ +
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK-----QGSMSPDAFLAEANLMKQ 64

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG--QFGEPAIRNYTQQILSGLA 228
           L+H  +V+ Y   T ++ +YI  EY+  GS+   L+     +     + +   QI  G+A
Sbjct: 65  LQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEVIK 286
           F+  ++ +HRD++ ANILV      K+ADFG+A+ I           K    W APE I 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 287 NSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
                 +  D+WS G  + E+ T  + P+        +  +     +   PD+  +E   
Sbjct: 184 YG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEELYQ 241

Query: 346 FIRLCLQRNPLNRPTAAEL---LDHPF 369
            +RLC +  P +RPT   L   L+  F
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 9e-67
 Identities = 70/314 (22%), Positives = 134/314 (42%), Gaps = 41/314 (13%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
             +     +G G +G V   +++ +    A+K+++ F+    +   ++ ++EI +L R R
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRTLREIKILLRFR 64

Query: 173 HPNIVQYYG---SKTVEDKLYIYL-EYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLA 228
           H NI+       + T+E    +YL  ++ G  +YKLL+         I  +  QIL GL 
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLK 123

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG----QSCPLSFKGSPYWMAPEV 284
           ++HS + +HRD+K +N+L++    +K+ DFG+A+              +  + ++ APE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 285 IKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI------------------ 326
           + NS G   ++DIWS+GC + EM + +P +     +  +  I                  
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 327 -----------GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
                       N      +  +   +  D +   L  NP  R    + L HP+++    
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303

Query: 376 LERTILAPEPSDVP 389
                +A  P    
Sbjct: 304 PSDEPIAEAPFKFD 317

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 9e-67
 Identities = 60/259 (23%), Positives = 108/259 (41%), Gaps = 12/259 (4%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
           S     + +G G FG V++G+  +  +  A+K +      +   S +  ++E  ++ +L 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLS 58

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKL-LQDYGQFGEPAIRNYTQQILSGLAFLH 231
           HP +VQ YG    +  + +  E++  G +        G F    +      +  G+A+L 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ--SCPLSFKGSPYWMAPEVIKNSS 289
               +HRD+   N LV  N  +K++DFGM + +     +     K    W +PEV  + S
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-SFS 177

Query: 290 GCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             +   D+WS G  + E+ +  K P+        +  I     L   P   S      + 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVYQIMN 236

Query: 349 LCLQRNPLNRPTAAELLDH 367
            C +  P +RP  + LL  
Sbjct: 237 HCWKERPEDRPAFSRLLRQ 255

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 1e-66
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 12/259 (4%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR 172
                 K LG G FG V  G         A+K +      +   S  + ++E  ++  L 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLS 57

Query: 173 HPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLH 231
           H  +VQ YG  T +  ++I  EY++ G +   L++   +F    +    + +   + +L 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ--SCPLSFKGSPYWMAPEVIKNSS 289
           SK  +HRD+   N LV+  G VK++DFG+++++     +  +  K    W  PEV+  S 
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS- 176

Query: 290 GCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR 348
             +   DIW+ G  + E+ +  K P+ ++        I     L   P   S++    + 
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMY 235

Query: 349 LCLQRNPLNRPTAAELLDH 367
            C       RPT   LL +
Sbjct: 236 SCWHEKADERPTFKILLSN 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 3e-66
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 31/287 (10%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL--FDDAKSKESAKQLMQEIVLL 168
           P  + + GK+LG G FG V         +     +V +    +       + LM E+ ++
Sbjct: 35  PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94

Query: 169 SRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ--------------------- 206
           ++L  H NIV   G+ T+   +Y+  EY   G +   L+                     
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 207 --DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI 264
             D        +  +  Q+  G+ FL  K  VHRD+   N+LV     VK+ DFG+A+ I
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 265 AGQS---CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGV 320
              S      + +    WMAPE +       +  D+WS G  + E+ +    P+      
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 321 AAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
           A  +K+  +      P   ++E    ++ C   +   RP+   L   
Sbjct: 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 7e-66
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 31/288 (10%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           +++K + +G GT+G VY   N  +GE+ A+K++ L  D +++      ++EI LL  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELNH 60

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSI-YKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
           PNIV+       E+KLY+  E++      +           P I++Y  Q+L GLAF HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIA-GQSCPLSFKGSPYWMAPEVIKNSSGC 291
              +HRD+K  N+L++  G +KLADFG+A+              + ++ APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT----------------- 334
           + AVDIWSLGC   EM T +  +     +  +F+I  +   P                  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240

Query: 335 ----------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
                     +   L ++G+  +   L  +P  R +A   L HPF + 
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  214 bits (546), Expect = 9e-66
 Identities = 66/272 (24%), Positives = 123/272 (45%), Gaps = 11/272 (4%)

Query: 99  PRSPGRMENPVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESA 158
           P SP   +  +           LG G +G VY G         A+K +      +     
Sbjct: 4   PSSPNYDKWEMERT-DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEV 57

Query: 159 KQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD--YGQFGEPAI 216
           ++ ++E  ++  ++HPN+VQ  G  T E   YI  E+++ G++   L++    +     +
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117

Query: 217 RNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS--FK 274
                QI S + +L  K+ +HRD+   N LV  N  VK+ADFG+++ + G +       K
Sbjct: 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177

Query: 275 GSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT 334
               W APE +  +   ++  D+W+ G  + E+AT          ++ ++++        
Sbjct: 178 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236

Query: 335 IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            P+   ++  + +R C Q NP +RP+ AE+  
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  214 bits (545), Expect = 1e-65
 Identities = 65/268 (24%), Positives = 116/268 (43%), Gaps = 12/268 (4%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            ++ G++LG G    V++  +       A+K +   D A+      +  +E    + L H
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNH 66

Query: 174 PNIVQYYGSKTVEDK----LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
           P IV  Y +   E       YI +EYV G ++  ++   G                 L F
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL----SFKGSPYWMAPEVI 285
            H    +HRD+K ANI++     VK+ DFG+A+ IA     +    +  G+  +++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 286 KNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--TIPDDLSDEG 343
           +     +   D++SLGC + E+ T +PP++    V+  ++      +P     + LS + 
Sbjct: 187 RG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPFVK 371
              +   L +NP NR   A  +    V+
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  213 bits (544), Expect = 3e-65
 Identities = 62/265 (23%), Positives = 113/265 (42%), Gaps = 10/265 (3%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
             S  K  +++G G FG V  G     G+      +       +++  +  + E  ++ +
Sbjct: 24  DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKL-LQDYGQFGEPAIRNYTQQILSGLAF 229
             HPN++   G  T    + I  E++  GS+     Q+ GQF    +    + I +G+ +
Sbjct: 84  FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS------CPLSFKGSPYWMAPE 283
           L   + VHRD+   NILV+ N   K++DFG+++ +   +        L  K    W APE
Sbjct: 144 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE 342
            I+       A D+WS G  + E+ +  + P+        +  I     LP  P D    
Sbjct: 204 AIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP-PPMDCPSA 261

Query: 343 GKDFIRLCLQRNPLNRPTAAELLDH 367
               +  C Q++  +RP   ++++ 
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 4e-65
 Identities = 62/268 (23%), Positives = 110/268 (41%), Gaps = 17/268 (6%)

Query: 121 LGRGTFGHVYVGFN--SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQ 178
           LG G FG V  G           A+K +        K   +++M+E  ++ +L +P IV+
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 179 YYGSKTVEDKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVH 237
             G     + L + +E   GG ++K L     +     +     Q+  G+ +L  K+ VH
Sbjct: 74  LIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132

Query: 238 RDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL----SFKGSPYWMAPEVIKNSSGCNL 293
           RD+   N+L+      K++DFG++K +           + K    W APE I      + 
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSS 191

Query: 294 AVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQ 352
             D+WS G T+ E  +  + P+ + +G   M  I   K +   P +   E    +  C  
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-CPPECPPELYALMSDCWI 250

Query: 353 RNPLNRPTAAEL---LDHPFVKGAAPLE 377
               +RP    +   +   +   A+ +E
Sbjct: 251 YKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  212 bits (541), Expect = 5e-65
 Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 31/284 (10%)

Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
              + +G GT+G VY   N+  GE  A+K++ L  + + +      ++EI +L  L+H N
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL--EKEDEGIPSTTIREISILKELKHSN 61

Query: 176 IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHT 235
           IV+ Y     + +L +  E++       L    G       +++  Q+L+G+A+ H +  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 236 VHRDIKGANILVDPNGRVKLADFGMAKHI-AGQSCPLSFKGSPYWMAPEVIKNSSGCNLA 294
           +HRD+K  N+L++  G +K+ADFG+A+              + ++ AP+V+  S   +  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 295 VDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPD----------------- 337
           +DIWS+GC   EM    P +        + +I      P   +                 
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

Query: 338 ----------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVK 371
                      L + G D +   L+ +P  R TA + L+H + K
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 3e-64
 Identities = 81/287 (28%), Positives = 141/287 (49%), Gaps = 17/287 (5%)

Query: 114 HWKKGKMLGRGTFGHVYVG---FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           +++  K+LG G +G V++       D+G++ AMK +      +  ++ +    E  +L  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 171 LRH-PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAF 229
           +R  P +V  + +   E KL++ L+Y++GG ++  L    +F E  ++ Y  +I+  L  
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144

Query: 230 LHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ--SCPLSFKGSPYWMAPEVIKN 287
           LH    ++RDIK  NIL+D NG V L DFG++K            F G+  +MAP++++ 
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204

Query: 288 S-SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI--GNSKELPTIPDDLSDEGK 344
             SG + AVD WSLG  + E+ T   P++      +  +I     K  P  P ++S   K
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264

Query: 345 DFIRLCLQRNPLNRP-----TAAELLDHPFVKG---AAPLERTILAP 383
           D I+  L ++P  R       A E+ +H F +         + + AP
Sbjct: 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 311

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 9e-64
 Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 19/277 (6%)

Query: 108 PVSPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVL 167
           PV   +  K   ++G G FG V        G       +    +  SK+  +    E+ +
Sbjct: 5   PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAA-IKRMKEYASKDDHRDFAGELEV 63

Query: 168 LSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDY----------------GQ 210
           L +L  HPNI+   G+      LY+ +EY   G++   L+                    
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 211 FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                + ++   +  G+ +L  K  +HRD+   NILV  N   K+ADFG+++        
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183

Query: 271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
              +    WMA E + N S      D+WS G  + E+ +           A +++     
Sbjct: 184 TMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242

Query: 331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                P +  DE  D +R C +  P  RP+ A++L  
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 1e-63
 Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 37/309 (11%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL 171
            + ++  + +G G +G V    +  +G   A+K+  L+   +S+  AK+  +E+ LL  +
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHM 74

Query: 172 RHPNIVQYYGS----KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
           RH N++         +T++D    YL     G+    L  + + GE  I+    Q+L GL
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
            ++H+   +HRD+K  N+ V+ +  +K+ DFG+A+    +     +  + ++ APEVI N
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--GYVVTRWYRAPEVILN 192

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN------------------- 328
                  VDIWS+GC + EM T K  +   + +  + +I                     
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 329 ----------SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLER 378
                      K+  +I  + S    + +   L  +   R TA E L HP+ +     E 
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312

Query: 379 TILAPEPSD 387
                +  D
Sbjct: 313 EPQVQKYDD 321

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 2e-63
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 22/284 (7%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           P    +    LG+G FG V++G  + +  + A+K +          S +  +QE  ++ +
Sbjct: 15  PRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLK-----PGTMSPEAFLQEAQVMKK 68

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKL--LQDYGQFGEPAIRNYTQQILSGLA 228
           LRH  +VQ Y   + E+ +YI  EY+S GS+      +       P + +   QI SG+A
Sbjct: 69  LRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127

Query: 229 FLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL--SFKGSPYWMAPEVIK 286
           ++   + VHRD++ ANILV  N   K+ADFG+A+ I           K    W APE   
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 287 NSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD 345
                 +  D+WS G  + E+ T  + P+        + ++     +P  P +  +   D
Sbjct: 188 YG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHD 245

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVP 389
            +  C ++ P  RPT   L           LE    + EP   P
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAF--------LEDYFTSTEPQYQP 281

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 2e-63
 Identities = 70/327 (21%), Positives = 125/327 (38%), Gaps = 55/327 (16%)

Query: 105 MENPVSPE-SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQ 163
           +E P   E S ++K   +G+GTFG V+   +  +G+  A+K+V +  + + +      ++
Sbjct: 1   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM--ENEKEGFPITALR 58

Query: 164 EIVLLSRLRHPNIVQYYGS--------KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPA 215
           EI +L  L+H N+V                +  +Y+  ++        L     +F    
Sbjct: 59  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 118

Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI-----AGQSCP 270
           I+   Q +L+GL ++H    +HRD+K AN+L+  +G +KLADFG+A+       +  +  
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178

Query: 271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK 330
            +   + ++  PE++         +D+W  GC + EM T  P          +  I    
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238

Query: 331 ELPT------------------------------IPDDLSDEGKDFIRLCLQRNPLNRPT 360
              T                                        D I   L  +P  R  
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298

Query: 361 AAELLDHPFVKGAAPLERTILAPEPSD 387
           + + L+H F             P PSD
Sbjct: 299 SDDALNHDFFWS---------DPMPSD 316

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 2e-63
 Identities = 66/283 (23%), Positives = 113/283 (39%), Gaps = 5/283 (1%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMK-EVTLFDDAKSKESAKQLMQEIVLLSR 170
           E+ +KK K+LG G FG VY G     GE   +   +    +A S ++ K+++ E  +++ 
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 171 LRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
           + +P++ +  G         I      G  +  + +     G   + N+  QI  G+ +L
Sbjct: 68  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 231 HSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL---SFKGSPYWMAPEVIKN 287
             +  VHRD+   N+LV     VK+ DFG+AK +  +         K    WMA E I +
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI 347
                   D+WS G TV E+ T           + +  I    E    P   + +    +
Sbjct: 188 -RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 246

Query: 348 RLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEPSDVPP 390
             C   +  +RP   EL+         P    ++  +     P
Sbjct: 247 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 7e-63
 Identities = 82/313 (26%), Positives = 131/313 (41%), Gaps = 48/313 (15%)

Query: 97  SVPRSPGRMENPVSP-ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSK 155
           +V  +PG  + P  P E  +   K++G G+FG VY     DSGE+ A+K+V         
Sbjct: 5   TVVATPG--QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--------L 54

Query: 156 ESAKQLMQEIVLLSRLRHPNIVQYYG----SKTVEDKLYIYL--EYVSGG---SIYKLLQ 206
           +  +   +E+ ++ +L H NIV+       S   +D++Y+ L  +YV            +
Sbjct: 55  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114

Query: 207 DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRV-KLADFGMAKHIA 265
                    ++ Y  Q+   LA++HS    HRDIK  N+L+DP+  V KL DFG AK + 
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

Query: 266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK 325
                +S+  S Y+ APE+I  ++    ++D+WS GC + E+   +P +    GV  + +
Sbjct: 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

Query: 326 IGNSKELPT---------------------------IPDDLSDEGKDFIRLCLQRNPLNR 358
           I      PT                                  E        L+  P  R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

Query: 359 PTAAELLDHPFVK 371
            T  E   H F  
Sbjct: 295 LTPLEACAHSFFD 307

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (527), Expect = 4e-62
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 14/278 (5%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            + + K LG G+FG V +  + +SG   AMK +         +  +  + E  +L  +  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100

Query: 174 PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
           P +V+   S      LY+ +EYV+GG ++  L+  G+F EP  R Y  QI+    +LHS 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 234 HTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNL 293
             ++RD+K  N+L+D  G +++ DFG AK + G++   +  G+P  +APE+I +  G N 
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILS-KGYNK 217

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQR 353
           AVD W+LG  + EMA   PP+   + +    KI + K     P   S + KD +R  LQ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQV 275

Query: 354 NPLNR-----PTAAELLDHPFVKG---AAPLERTILAP 383
           +   R         ++ +H +       A  +R + AP
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 5e-62
 Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 21/281 (7%)

Query: 113 SHWKKGKMLGRGTFGHVYVGFNSDSGEM----CAMKEVTLFDDAKSKESAKQLMQEIVLL 168
           S   + K++G G FG VY G    S        A+K +       +++     + E  ++
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIM 63

Query: 169 SRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGL 227
            +  H NI++  G  +    + I  EY+  G++ K L++  G+F    +    + I +G+
Sbjct: 64  GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS----CPLSFKGSPYWMAPE 283
            +L + + VHRD+   NILV+ N   K++DFG+++ +             K    W APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 284 VIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEG 343
            I        A D+WS G  + E+ T             + K  N       P D     
Sbjct: 184 AISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242

Query: 344 KDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPE 384
              +  C Q+    RP  A+++          L++ I AP+
Sbjct: 243 YQLMMQCWQQERARRPKFADIVSI--------LDKLIRAPD 275

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  205 bits (521), Expect = 6e-62
 Identities = 59/288 (20%), Positives = 115/288 (39%), Gaps = 38/288 (13%)

Query: 111 PESHWKKGKMLGRGTFGHVYVG-----FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           P ++ +  + +G G FG V+          +   M A+K +    +  S +      +E 
Sbjct: 11  PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREA 67

Query: 166 VLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQ--------------- 210
            L++   +PNIV+  G   V   + +  EY++ G + + L+                   
Sbjct: 68  ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 211 ---------FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA 261
                              +Q+ +G+A+L  +  VHRD+   N LV  N  VK+ADFG++
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 262 KHIAGQSCPL---SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQY 317
           ++I          +      WM PE I  +       D+W+ G  + E+ +    P+   
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGM 246

Query: 318 EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
                ++ + +   +   P++   E  + +RLC  + P +RP+   + 
Sbjct: 247 AHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 6e-62
 Identities = 74/290 (25%), Positives = 131/290 (45%), Gaps = 31/290 (10%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           ++K + +G GT+G V+   N ++ E+ A+K V L  D   +      ++EI LL  L+H 
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL--DDDDEGVPSSALREICLLKELKHK 61

Query: 175 NIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH 234
           NIV+ +     + KL +  E+             G      ++++  Q+L GL F HS++
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 235 TVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKG-SPYWMAPEVIKNSSGCNL 293
            +HRD+K  N+L++ NG +KLA+FG+A+         S +  + ++  P+V+  +   + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 294 AVDIWSLGCTVLEMATTKPPWSQYEGVAAMFK---------------------------- 325
           ++D+WS GC   E+A    P      V    K                            
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 326 IGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP 375
              +  L  +   L+  G+D ++  L+ NP+ R +A E L HP+     P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 8e-62
 Identities = 82/296 (27%), Positives = 130/296 (43%), Gaps = 38/296 (12%)

Query: 112 ESHWKKGKMLGRGTFGHVYVGFN-SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR 170
           +  ++    +G G +G V+   +  + G   A+K V +      +      ++E+ +L  
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRH 63

Query: 171 L---RHPNIVQYYGSKTV-----EDKLYIYLEYVSGGSI-YKLLQDYGQFGEPAIRNYTQ 221
           L    HPN+V+ +   TV     E KL +  E+V      Y             I++   
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 222 QILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMA 281
           Q+L GL FLHS   VHRD+K  NILV  +G++KLADFG+A+  + Q    S   + ++ A
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183

Query: 282 PEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI--------------- 326
           PEV+   S     VD+WS+GC   EM   KP +     V  + KI               
Sbjct: 184 PEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 327 ----------GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
                      +++ +     D+ + GKD +  CL  NP  R +A   L HP+ + 
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  203 bits (516), Expect = 4e-61
 Identities = 50/279 (17%), Positives = 98/279 (35%), Gaps = 28/279 (10%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            ++ G+ +G G+FG +Y+G +  +GE  A+K          K    QL  E  +   ++ 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE------CVKTKHPQLHIESKIYKMMQG 61

Query: 174 PN-IVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
              I          D   + +E +             +F    +     Q++S + ++HS
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 233 KHTVHRDIKGANILV---DPNGRVKLADFGMAKHIAGQS--------CPLSFKGSPYWMA 281
           K+ +HRD+K  N L+        V + DFG+AK                 +  G+  + +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 282 PEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE------LPTI 335
                     +   D+ SLG  ++       PW   +      K     E      +  +
Sbjct: 182 INTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 336 PDDLSDEGKDFIRLCLQRNPLNRPTAA---ELLDHPFVK 371
                 E   ++  C      ++P  +   +L  + F +
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 9e-61
 Identities = 75/283 (26%), Positives = 115/283 (40%), Gaps = 32/283 (11%)

Query: 111 PESHWKKGKMLGRGTFGHVYVG-----FNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
           P +    GK LG G FG V          SD+    A+K +        +E    LM E+
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE---ALMSEL 77

Query: 166 VLLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQ------------------ 206
            +LS L  H NIV   G+ T+     +  EY   G +   L+                  
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 207 DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG 266
           D        + +++ Q+  G+AFL SK+ +HRD+   NIL+      K+ DFG+A+ I  
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 267 QSCPLS---FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAM 323
            S  +     +    WMAPE I N        D+WS G  + E+ +          V + 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 324 F-KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELL 365
           F K+         P+    E  D ++ C   +PL RPT  +++
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 1e-60
 Identities = 62/261 (23%), Positives = 106/261 (40%), Gaps = 16/261 (6%)

Query: 118 GKMLGRGTFGHVYVGF---NSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
            +++GRG FG VY G    N      CA+K +   +         Q + E +++    HP
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHP 88

Query: 175 NIVQYYGSKTV-EDKLYIYLEYVSGGSIYKLLQDYGQ-FGEPAIRNYTQQILSGLAFLHS 232
           N++   G     E    + L Y+  G +   +++         +  +  Q+  G+ FL S
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 233 KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-----CPLSFKGSPYWMAPEVIKN 287
           K  VHRD+   N ++D    VK+ADFG+A+ +  +           K    WMA E ++ 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 288 SSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF 346
                   D+WS G  + E+ T   PP+           +   + L   P+   D   + 
Sbjct: 209 Q-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPDPLYEV 266

Query: 347 IRLCLQRNPLNRPTAAELLDH 367
           +  C       RP+ +EL+  
Sbjct: 267 MLKCWHPKAEMRPSFSELVSR 287

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  200 bits (508), Expect = 1e-59
 Identities = 68/299 (22%), Positives = 125/299 (41%), Gaps = 50/299 (16%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR- 172
            ++  + LGRG +  V+   N  + E   +K +            K++ +EI +L  LR 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-------KPVKKKKIKREIKILENLRG 88

Query: 173 HPNIVQYYGS--KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFL 230
            PNI+         V     +  E+V+     +L Q      +  IR Y  +IL  L + 
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYC 145

Query: 231 HSKHTVHRDIKGANILVDP-NGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSS 289
           HS   +HRD+K  N+++D  + +++L D+G+A+             S Y+  PE++ +  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205

Query: 290 GCNLAVDIWSLGCTVLEMATTKPPW----SQYEGVAAMFKIGNSKELPTIPD-------- 337
             + ++D+WSLGC +  M   K P+      Y+ +  + K+  +++L    D        
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 338 ------------------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG 372
                                    +S E  DF+   L+ +  +R TA E ++HP+   
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-57
 Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 25/281 (8%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKE----VTLFDDAKSKESAKQLMQEIV 166
           P      GK LG G FG V +       +    +     V +     +++    L+ E+ 
Sbjct: 11  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70

Query: 167 LLSRL-RHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYG---------------- 209
           ++  + +H NI+   G+ T +  LY+ +EY S G++ + LQ                   
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 210 QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC 269
           Q     + +   Q+  G+ +L SK  +HRD+   N+LV  +  +K+ADFG+A+ I     
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 270 PLS---FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKI 326
                  +    WMAPE + +        D+WS G  + E+ T          V  +FK+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                    P + ++E    +R C    P  RPT  +L++ 
Sbjct: 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 5e-57
 Identities = 62/285 (21%), Positives = 110/285 (38%), Gaps = 28/285 (9%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFN-----SDSGEMCAMKEVTLFDDAKSKESAKQLMQEI 165
                   + LG+G+FG VY G        +     A+K V   ++A S     + + E 
Sbjct: 18  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEA 74

Query: 166 VLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFG----------EPA 215
            ++      ++V+  G  +      + +E ++ G +   L+                   
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 216 IRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS---CPLS 272
           +     +I  G+A+L++   VHRD+   N +V  +  VK+ DFGM + I           
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL 332
                 WM+PE +K+        D+WS G  + E+AT      Q      + +      L
Sbjct: 195 GLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253

Query: 333 PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD------HPFVK 371
              PD+  D   + +R+C Q NP  RP+  E++        P  +
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 9e-57
 Identities = 66/321 (20%), Positives = 123/321 (38%), Gaps = 53/321 (16%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
            ++  K +G G  G V   +++      A+K+++     +++  AK+  +E+VL+  + H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--PFQNQTHAKRAYRELVLMKCVNH 75

Query: 174 PNIVQYYGSKTVEDK------LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGL 227
            NI+      T +        +Y+ +E +       +     +     +     Q+L G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGI 132

Query: 228 AFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKN 287
             LHS   +HRD+K +NI+V  +  +K+ DFG+A+          +  + Y+ APEVI  
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192

Query: 288 SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPT------------- 334
             G    VDIWS+GC + EM   K  +   + +    K+      P              
Sbjct: 193 -MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 335 ---------------------------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                                           + + +D +   L  +P  R +  + L H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

Query: 368 PFVK-GAAPLERTILAPEPSD 387
           P++     P E     P+  D
Sbjct: 312 PYINVWYDPAEVEAPPPQIYD 332

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 4e-56
 Identities = 63/301 (20%), Positives = 126/301 (41%), Gaps = 37/301 (12%)

Query: 116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPN 175
           +    +G G +G V   F++ +G   A+K+++     +S   AK+  +E+ LL  ++H N
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 176 IVQYYGS----KTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH 231
           ++         +++E+   +YL     G+    +    +  +  ++    QIL GL ++H
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138

Query: 232 SKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGC 291
           S   +HRD+K +N+ V+ +  +K+ DFG+A+H         +  + ++ APE++ N    
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHY 196

Query: 292 NLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN----------------------- 328
           N  VDIWS+GC + E+ T +  +   + +  +  I                         
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256

Query: 329 ------SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILA 382
                       +    +    D +   L  +   R TAA+ L H +       +   +A
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 316

Query: 383 P 383
            
Sbjct: 317 D 317

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 1e-55
 Identities = 67/281 (23%), Positives = 109/281 (38%), Gaps = 25/281 (8%)

Query: 111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEV---TLFDDAKSKESAKQLMQEIVL 167
           P    K GK LGRG FG V         +    + V    L + A   E    + +  +L
Sbjct: 11  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 168 LSRLRHPNIVQYYGSKTVED-KLYIYLEYVSGGSIYKLLQDYGQ---------------- 210
           +    H N+V   G+ T     L + +E+   G++   L+                    
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 211 FGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP 270
                +  Y+ Q+  G+ FL S+  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 271 L---SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKI 326
           +     +    WMAPE I +     +  D+WS G  + E+ +    P+   +      + 
Sbjct: 191 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 327 GNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH 367
                    PD  + E    +  C    P  RPT +EL++H
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 4e-54
 Identities = 70/291 (24%), Positives = 110/291 (37%), Gaps = 50/291 (17%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIV 177
            + +G+G FG V+ G     GE  A+K  +       +E +     EI     LRH NI+
Sbjct: 8   QESIGKGRFGEVWRG--KWRGEEVAVKIFS-----SREERSWFREAEIYQTVMLRHENIL 60

Query: 178 QYYGSKTVED----KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSK 233
            +  +   ++    +L++  +Y   GS++  L  Y    E  I+       SGLA LH +
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHME 119

Query: 234 HT--------VHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-----CPLSFKGSPYWM 280
                      HRD+K  NILV  NG   +AD G+A      +      P    G+  +M
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 281 APEVIKNSSGCNL-----AVDIWSLGCTVLEMATTKPPWSQYEGVAAMF----------- 324
           APEV+ +S            DI+++G    E+A        +E     +           
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 325 ----KIGNSKELPTIPD-----DLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
                +   K  P IP+     +        +R C   N   R TA  +  
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  183 bits (466), Expect = 5e-54
 Identities = 50/273 (18%), Positives = 90/273 (32%), Gaps = 27/273 (9%)

Query: 114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH 173
           H+K G+ +G G+FG ++ G N  + +  A+K          +  A QL  E      L  
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE------PRRSDAPQLRDEYRTYKLLAG 59

Query: 174 -PNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS 232
              I   Y          + ++ +       L     +F    +    +Q+L+ +  +H 
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 233 KHTVHRDIKGANILVD-----PNGRVKLADFGMAKHIAGQS--------CPLSFKGSPYW 279
           K  V+RDIK  N L+          + + DFGM K                 +  G+  +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 280 MAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVA---AMFKIGNSKE---LP 333
           M+          +   D+ +LG   +       PW   +         +IG  K+   L 
Sbjct: 180 MSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 334 TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD 366
            +     +E   ++           P    L  
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  154 bits (389), Expect = 2e-42
 Identities = 64/350 (18%), Positives = 121/350 (34%), Gaps = 82/350 (23%)

Query: 115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP 174
           +   + LG G F  V++  +  +    AMK V        K   +    EI LL R+   
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVNDA 69

Query: 175 NIVQ-------------YYGSKTVEDKLYIYLEYVSGGSIYKLL---QDYGQFGEPAIRN 218
           +  +              + +    + +++ + +   G     L    ++       ++ 
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 219 YTQQILSGLAFLHSKHTV-HRDIKGANILVDPNG------RVKLADFGMAKHIAGQSCPL 271
            ++Q+L GL ++H +  + H DIK  N+L++         ++K+AD G A          
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN- 188

Query: 272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG---------VAA 322
               +  + +PEV+   +      DIWS  C + E+ T    +   EG         +A 
Sbjct: 189 -SIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246

Query: 323 MFKIGNS-------------------------------------KELPTIPDDLSDEGKD 345
           + ++                                         E      D + E  D
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306

Query: 346 FIRLCLQRNPLNRPTAAELLDHPFVKGAAPLERTILAPEP-----SDVPP 390
           F+   LQ +P  R  A  L++HP++K    +E   +         SD+P 
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPG 356

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  106 bits (265), Expect = 4e-27
 Identities = 32/205 (15%), Positives = 64/205 (31%), Gaps = 34/205 (16%)

Query: 118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTL--------------FDDAKSKESAKQLMQ 163
           GK++G G    V+  ++      C +K   +               D   S  + +    
Sbjct: 5   GKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 164 EIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQI 223
           E   L +L+   + + Y      +   + +E +          +  +            I
Sbjct: 64  EFRALQKLQGLAVPKVYAW----EGNAVLMELIDAK-------ELYRVRVENPDEVLDMI 112

Query: 224 LSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPE 283
           L  +A  + +  VH D+   N+LV   G + + DF  +  +  +      +         
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILE-----RDVR 166

Query: 284 VIKN--SSGCNLAVDIWSLGCTVLE 306
            I    S       DI S    +L+
Sbjct: 167 NIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	602
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.95
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.82
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.56
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.42
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.96
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.77
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.43

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=438.95  Aligned_cols=262  Identities=29%  Similarity=0.456  Sum_probs=234.0

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEE
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345599
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++++... ......+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf             44742898898317684999999989998999999815654-49799999999999998679998877876403564211


Q ss_pred             EEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC-CCC
Q ss_conf             9996403777235522038999678989899999777632038903047878708983599567811585300248-898
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG-QSC  269 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~-~~~  269 (602)
                      +|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ...
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             CCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCCCC
T ss_conf             10003579860555532567759999999999965211343159622464777847658998888205652003567862


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             86557998989820001469999433102256689998509999998036999998408899999999899889999999
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       270 ~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~Li~~  349 (602)
                      ....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+.......+....  ..+|..+++++++||++
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             CCCCEECHHHHHHHHCCCCC-CCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--CCCCCCCCHHHHHHHHH
T ss_conf             05510088996666504898-8833310223067889987899999969999999985289--98986689999999986


Q ss_pred             HCCCCCCCCCC-----HHHHHCCCCCCCCCCC
Q ss_conf             70349999999-----9999629355698721
Q 007478          350 CLQRNPLNRPT-----AAELLDHPFVKGAAPL  376 (602)
Q Consensus       350 ~L~~dP~~Rps-----~~eiL~hp~f~~~~~~  376 (602)
                      ||++||.+|++     ++++++||||++..+.
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~  270 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf             66389344225652349999729150369999

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=438.80  Aligned_cols=260  Identities=25%  Similarity=0.444  Sum_probs=225.4

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEE
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345599
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++....   ..+..+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEE
T ss_conf             8746089989721748099999999999799999984566---4127999999999998579988846965404674367


Q ss_pred             EEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC--
Q ss_conf             999640377723552203899967898989999977763203890304787870898359956781158530024889--
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS--  268 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~--  268 (602)
                      +|||||+||+|++++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....  
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC
T ss_conf             98864589808999753799999999999999999999999759835754689978878998798323142240468865


Q ss_pred             -CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHH-HHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf             -8865579989898200014699994331022566899985099999980369-99998408899999999899889999
Q 007478          269 -CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV-AAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       269 -~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~s~~l~~L  346 (602)
                       .....+||+.|||||++.+..+++.++||||+||++|||++|++||...... .....+.........+..+++++++|
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
T ss_conf             31113255747428728618999997101617379999998299788889859999999863888788644699999999


Q ss_pred             HHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             999703499999999999629355698
Q 007478          347 IRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       347 i~~~L~~dP~~Rps~~eiL~hp~f~~~  373 (602)
                      |.+||+.||++|||++|+++||||+..
T Consensus       240 i~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             999767996689099999619845859

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=430.71  Aligned_cols=264  Identities=28%  Similarity=0.437  Sum_probs=225.9

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC--HHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEE
Q ss_conf             9992473068332975999999979994799999841641--00199999999999999826999578870541234559
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD--AKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~  189 (602)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+...  ...........+|+.+++.++|||||++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf             77685101884288909999999999979999998458754266799999999999998508998588999999989988


Q ss_pred             EEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf             99996403777235522038999678989899999777632038903047878708983599567811585300248898
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       190 ~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~  269 (602)
                      |+|||||+||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-  161 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  161 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred             EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCCCC-
T ss_conf             9999914898389998732553278999999999999999997796220444221678588967982201023337886-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHH--HHHHHHHHCCCCCCCCCCCCCHHHHHHH
Q ss_conf             86557998989820001469999433102256689998509999998036--9999984088999999998998899999
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG--VAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       270 ~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~s~~l~~Li  347 (602)
                      ....+||+.|+|||++.....|+.++|||||||++|||++|+.||.....  ...+.+. .......++..+++++++||
T Consensus       162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li  240 (364)
T d1omwa3         162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFSPELRSLL  240 (364)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-SSSCCCCCCSSSCHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHH
T ss_conf             43311345542168760389998441046778999999859998888998999999986-04688878877899999999


Q ss_pred             HHHCCCCCCCCCC-----HHHHHCCCCCCCCCCCC
Q ss_conf             9970349999999-----99996293556987210
Q 007478          348 RLCLQRNPLNRPT-----AAELLDHPFVKGAAPLE  377 (602)
Q Consensus       348 ~~~L~~dP~~Rps-----~~eiL~hp~f~~~~~~~  377 (602)
                      .+||++||++|||     ++++++||||++..+..
T Consensus       241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~  275 (364)
T d1omwa3         241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  275 (364)
T ss_dssp             HHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred             HHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHH
T ss_conf             99856698880887435799997491023789879

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=433.16  Aligned_cols=260  Identities=25%  Similarity=0.432  Sum_probs=229.8

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEE
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345599
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++...    .....+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             865758988984076819999998899989999998452----4316999999999998679979992999999899999


Q ss_pred             EEEEEECCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECC--CCCEEEECCCCCCCCCCC
Q ss_conf             99964037772355220-389996789898999997776320389030478787089835--995678115853002488
Q 007478          191 IYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP--NGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~--~g~iKL~DFGla~~~~~~  267 (602)
                      +|||||+||+|.+++.. .+.+++..++.|+.||+.||+|||++||+||||||+|||++.  ++.+||+|||+|+.+...
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             EEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf             99985799889999976237899999999999999999999756976000154673641688986999545210442565


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCC--CCCCCCCCHHHHH
Q ss_conf             98865579989898200014699994331022566899985099999980369999984088999--9999989988999
Q 007478          268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--PTIPDDLSDEGKD  345 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~s~~l~~  345 (602)
                      .......||+.|||||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+......  ......+++++++
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  258 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred             CCCCEECCCCCCCCHHHHCCCC-CCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
T ss_conf             4320006862421889975899-872676554659999998598998997999999999847889894223589999999


Q ss_pred             HHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             999970349999999999962935569872
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       346 Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                      ||.+||++||++|||+.|+|+||||+....
T Consensus       259 li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         259 FIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             HHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf             999975689667908999862913288988

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=433.83  Aligned_cols=258  Identities=24%  Similarity=0.415  Sum_probs=229.6

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      .+.|++.+.||+|+||.||+|+++.+|+.||+|+++...    ......+.+|+.+|++++|||||++++++.+++.+|+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf             403599899931778299999998999799999988726----4679999999999986799798919999998999999


Q ss_pred             EEEEECCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEC--CCCCEEEECCCCCCCCCCCC
Q ss_conf             99640377723552203-8999678989899999777632038903047878708983--59956781158530024889
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVD--PNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~--~~g~iKL~DFGla~~~~~~~  268 (602)
                      |||||+||+|++++... ..+++.+++.|+.||+.||+|||++||+||||||+|||++  .++.+||+|||+|+.+....
T Consensus       104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCC
T ss_conf             99828998088889863899899999999999999999999779265131445531134678848995256303437887


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCC--CCCCCCCCCHHHHHH
Q ss_conf             886557998989820001469999433102256689998509999998036999998408899--999999899889999
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE--LPTIPDDLSDEGKDF  346 (602)
Q Consensus       269 ~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~s~~l~~L  346 (602)
                      ......||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+....+..+.....  ....+..+++++++|
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             CEEECCCCCCCCCHHHHCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
T ss_conf             201004764534899974799-8976333898999999996889989979999999998478898930024799999999


Q ss_pred             HHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             9997034999999999996293556987
Q 007478          347 IRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       347 i~~~L~~dP~~Rps~~eiL~hp~f~~~~  374 (602)
                      |.+||++||.+|||+.|+|+||||++..
T Consensus       263 i~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             9997569966891899996097348882

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=436.22  Aligned_cols=260  Identities=28%  Similarity=0.499  Sum_probs=231.7

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      .++|++++.||+|+||+||+|.++.+++.||||++.+... ......+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf             9877898898508790999999989997999999865775-577789999999999987688886179999998998899


Q ss_pred             EEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC---
Q ss_conf             99640377723552203899967898989999977763203890304787870898359956781158530024889---
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS---  268 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~---  268 (602)
                      |||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....   
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCCC
T ss_conf             99704898777765315999999999999999999976216508847677412366888538860321024225677643


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             88655799898982000146999943310225668999850999999803699999840889999999989988999999
Q 007478          269 CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIR  348 (602)
Q Consensus       269 ~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~Li~  348 (602)
                      .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+......++....  ..+|..+++++++||.
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEKFFPKARDLVE  242 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CCCCTTCCHHHHHHHH
T ss_pred             CCCCCCCCCCCCCCEEECCCC-CCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--CCCCCCCCHHHHHHHH
T ss_conf             335556775525844002689-8966623045699999803889989959999999997189--9998547999999999


Q ss_pred             HHCCCCCCCCCCHHH------HHCCCCCCCCCC
Q ss_conf             970349999999999------962935569872
Q 007478          349 LCLQRNPLNRPTAAE------LLDHPFVKGAAP  375 (602)
Q Consensus       349 ~~L~~dP~~Rps~~e------iL~hp~f~~~~~  375 (602)
                      +||++||++|||++|      +++||||++..|
T Consensus       243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w  275 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  275 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             HHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCH
T ss_conf             985579768919789737789876976478998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=435.04  Aligned_cols=257  Identities=32%  Similarity=0.574  Sum_probs=229.8

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEE
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345599
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+... ......+.+.+|+.+++.++|||||++++++.+++.+|
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf             15376998898517785899999989994999999816885-67689999999999998568888885999999899989


Q ss_pred             EEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             99964037772355220389996789898999997776320389030478787089835995678115853002488988
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~  270 (602)
                      +|||||++|+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... .
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~  161 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-R  161 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-C
T ss_pred             EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC-C
T ss_conf             998504798589887504899999999999999999999998894652202344146689987115556335448885-2


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             65579989898200014699994331022566899985099999980369999984088999999998998899999997
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       271 ~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~Li~~~  350 (602)
                      ...+||+.|||||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+....  ..+|..+++++++||.+|
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~  238 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISRL  238 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC--CCCCCCCCHHHHHHHHHH
T ss_conf             3557887634999975899-8931440467599999832999988899999999997189--999866899999999997


Q ss_pred             CCCCCCCCCCHHHHHCCCCCCC
Q ss_conf             0349999999999962935569
Q 007478          351 LQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       351 L~~dP~~Rps~~eiL~hp~f~~  372 (602)
                      |++||++|||+.|+|+||||+.
T Consensus       239 L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         239 LKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             TCSSGGGSCCHHHHHTCHHHHH
T ss_pred             CCCCHHHCCCHHHHHCCCCCCC
T ss_conf             6479768909999971907078

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=433.82  Aligned_cols=258  Identities=34%  Similarity=0.630  Sum_probs=226.9

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      ..+|++.+.||+|+||+||+|+++.+|+.||+|++++....    ..+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf             10538878981285829999999899989999998430172----79999999999986799988058577988999899


Q ss_pred             EEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC-CC
Q ss_conf             99640377723552203899967898989999977763203890304787870898359956781158530024889-88
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CP  270 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~~  270 (602)
                      |||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.... ..
T Consensus        95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  173 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (293)
T ss_dssp             EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEEECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCCC
T ss_conf             9970379808988641-599999999999999999999998797226776888688789968642515641321366644


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHHHH
Q ss_conf             655799898982000146999943310225668999850999999803699999840889-9999999899889999999
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK-ELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       271 ~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~~Li~~  349 (602)
                      ...+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+....+..+.... .....+..+++++++||.+
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHCCCC-CCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
T ss_conf             4444477736826644799-880120313729999980488998997999999999857999888855379999999999


Q ss_pred             HCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             70349999999999962935569872
Q 007478          350 CLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       350 ~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                      ||+.||++|||+.|+|+||||+...+
T Consensus       253 ~L~~dP~~R~s~~eil~Hp~~~~~~~  278 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQHQFLKIAKP  278 (293)
T ss_dssp             HTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             86699668909999964996577888

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=433.40  Aligned_cols=260  Identities=27%  Similarity=0.465  Sum_probs=230.8

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEE
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345599
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      ..+.|++.+.||+|+||+||+|.++.+++.||+|++.....   ......+.+|+.+|+.++|||||++++++.+++.+|
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHH---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             76666998899406583999999999998999999815773---128999999999998679989991989999899888


Q ss_pred             EEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEC---CCCCEEEECCCCCCCCCCC
Q ss_conf             9996403777235522038999678989899999777632038903047878708983---5995678115853002488
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVD---PNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~---~~g~iKL~DFGla~~~~~~  267 (602)
                      +|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+.   .++.+||+|||+|+.....
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC
T ss_conf             98852689848886530367887899999999999987524130556870463001104688824998315435872589


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCC--CCCCCCCCHHHHH
Q ss_conf             98865579989898200014699994331022566899985099999980369999984088999--9999989988999
Q 007478          268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--PTIPDDLSDEGKD  345 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~s~~l~~  345 (602)
                      ....+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.........+......  ...+..+++++++
T Consensus       164 ~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  242 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD  242 (307)
T ss_dssp             ---------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             CEEEEEEECCCCCCCHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf             7044003284225918873799-980787345159999998597999998999999998616877787666678999999


Q ss_pred             HHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             99997034999999999996293556987
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       346 Li~~~L~~dP~~Rps~~eiL~hp~f~~~~  374 (602)
                      ||.+||++||++|||+.|+++||||++..
T Consensus       243 li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         243 FIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             HHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             99997608975791899986298447997

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=429.54  Aligned_cols=260  Identities=30%  Similarity=0.502  Sum_probs=232.5

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.+... ......+.+.+|+.+|+.++|||||++++++.+...+|+
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCC
T ss_conf             2370898896117680899999989998999999826774-588999999999999997487727403444432222232


Q ss_pred             EEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf             99640377723552203899967898989999977763203890304787870898359956781158530024889886
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~  271 (602)
                      ||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+...  ..
T Consensus       119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~  196 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TW  196 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BC
T ss_pred             CCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC--CC
T ss_conf             2223346622666751589899999999999999899998599861767999936077897886101033322566--64


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             55799898982000146999943310225668999850999999803699999840889999999989988999999970
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~Li~~~L  351 (602)
                      ..+||+.|||||++.+.. ++.++|||||||++|||++|++||.+.+....+.++....  ..++..+++++.+||++||
T Consensus       197 ~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L  273 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHHS
T ss_pred             CCCCCCCCCCHHHHCCCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--CCCCCCCCHHHHHHHHHHH
T ss_conf             336763567889971799-8853311450078999975889989959999999986179--8897668999999999983


Q ss_pred             CCCCCCCC-----CHHHHHCCCCCCCCCCCC
Q ss_conf             34999999-----999996293556987210
Q 007478          352 QRNPLNRP-----TAAELLDHPFVKGAAPLE  377 (602)
Q Consensus       352 ~~dP~~Rp-----s~~eiL~hp~f~~~~~~~  377 (602)
                      ++||.+|+     +++++++||||++..+..
T Consensus       274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~  304 (350)
T d1rdqe_         274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIA  304 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred             HHCHHHCCCCCCCCHHHHHCCCCCCCCCHHH
T ss_conf             4099860655345499997190515899899

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=428.09  Aligned_cols=259  Identities=27%  Similarity=0.494  Sum_probs=232.3

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++... ......+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEE
T ss_conf             5470888897207680899999989997999999845775-488999999999999986369675330356852880056


Q ss_pred             EEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf             99640377723552203899967898989999977763203890304787870898359956781158530024889886
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPL  271 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~  271 (602)
                      |||||.||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....  ..
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~  159 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TY  159 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BC
T ss_pred             EEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECCC--CC
T ss_conf             7650378632234322221110079999999987655412476770556810503868998898317521671245--64


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             55799898982000146999943310225668999850999999803699999840889999999989988999999970
Q 007478          272 SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       272 ~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~Li~~~L  351 (602)
                      +.+||+.|||||++.+.. |+.++|||||||++|||++|+.||.+.+....+.++....  ..+|..+++++++||.+||
T Consensus       160 ~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L  236 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLI  236 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHT
T ss_pred             CCCCCCCCCCHHHHCCCC-CCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--CCCCCCCCHHHHHHHHHHH
T ss_conf             345763435999983899-9804304653336899975989999969999999997089--8899778999999999995


Q ss_pred             CCCCCCCC-----CHHHHHCCCCCCCCCCC
Q ss_conf             34999999-----99999629355698721
Q 007478          352 QRNPLNRP-----TAAELLDHPFVKGAAPL  376 (602)
Q Consensus       352 ~~dP~~Rp-----s~~eiL~hp~f~~~~~~  376 (602)
                      ++||.+|+     +++++++||||++..+.
T Consensus       237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HHCHHHCCCCCHHHHHHHHCCCCCCCCCHH
T ss_conf             449976664310219999819351467989

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=429.50  Aligned_cols=258  Identities=36%  Similarity=0.610  Sum_probs=229.2

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEEE
Q ss_conf             99247306833297599999997999479999984164100199999999999999826999578870541234559999
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIY  192 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV  192 (602)
                      ..|+..+.||+|+||+||+|+++.+++.||||++..... ......+.+.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf             856762797018880999999989993999999844443-5889999999999999977899982389999989988999


Q ss_pred             EEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf             96403777235522038999678989899999777632038903047878708983599567811585300248898865
Q 007478          193 LEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCPLS  272 (602)
Q Consensus       193 ~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~  272 (602)
                      ||||.+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....   ..
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~  170 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS  170 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred             EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC---CC
T ss_conf             980699945789973799999999999999999999998689766678842179879997898443653346778---73


Q ss_pred             CCCCCCCCCCCCCCCC--CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             5799898982000146--99994331022566899985099999980369999984088999999998998899999997
Q 007478          273 FKGSPYWMAPEVIKNS--SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLC  350 (602)
Q Consensus       273 ~~GT~~Y~APE~l~~~--~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~Li~~~  350 (602)
                      .+||+.|||||++.+.  ..|+.++|||||||++|||++|+.||.+......+.++.........+..+++++++||.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
T ss_conf             13476636889983467888672145455899999998788999997999999999828999888788899999999997


Q ss_pred             CCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             034999999999996293556987
Q 007478          351 LQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       351 L~~dP~~Rps~~eiL~hp~f~~~~  374 (602)
                      |+.||++|||+.++|+||||....
T Consensus       251 L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             CCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf             737965791899997199753789

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=432.22  Aligned_cols=258  Identities=29%  Similarity=0.514  Sum_probs=220.2

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|+++....   ......+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC---TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf             5688897897127780999999989996999999875409---7899999999999986799999949999998999999


Q ss_pred             EEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCC-CCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             99640377723552203899967898989999977763203-89030478787089835995678115853002488988
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~  270 (602)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+.... .
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~  160 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-A  160 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-C
T ss_pred             EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCCC-C
T ss_conf             997679986899874249999999999999999999999985999714457799468789989995487762567886-2


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHH----------------------------
Q ss_conf             6557998989820001469999433102256689998509999998036999----------------------------
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAA----------------------------  322 (602)
Q Consensus       271 ~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~----------------------------  322 (602)
                      .+.+||++|+|||++.+.. |+.++||||+||++|||++|+.||...+....                            
T Consensus       161 ~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             CCCCCCCCCCCCHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf             1113771411946875899-894888998999999999888998998878999999887517754577421233322111


Q ss_pred             --------------HHHHHCCCCCCCCC-CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             --------------99840889999999-989988999999970349999999999962935569872
Q 007478          323 --------------MFKIGNSKELPTIP-DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       323 --------------~~~i~~~~~~~~~p-~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                                    ...+. ....+.++ ..++.++++||.+||+.||++|||++|+|+||||+...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIV-NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             ------CCCCHHHHHHHHH-TSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCCC
T ss_conf             1222354134778876650-268766764448999999999986899467908999960986476982

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=425.81  Aligned_cols=264  Identities=25%  Similarity=0.426  Sum_probs=233.3

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCH--HCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCE
Q ss_conf             999924730683329759999999799947999998416410--019999999999999982699957887054123455
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA--KSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~--~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~  188 (602)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++....  ......+.+.+|+.+|++++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf             55677982798117895999999999998999999875663213406899999999999986799899938899997998


Q ss_pred             EEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCC----CEEEECCCCCCCC
Q ss_conf             999996403777235522038999678989899999777632038903047878708983599----5678115853002
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG----RVKLADFGMAKHI  264 (602)
Q Consensus       189 ~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g----~iKL~DFGla~~~  264 (602)
                      +|+|||||+||+|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++    .+||+|||+|+..
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHC
T ss_conf             99999867786431001035642155789999999999876662542211333012798258986664696433442105


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCC--CCCCCCCCHH
Q ss_conf             48898865579989898200014699994331022566899985099999980369999984088999--9999989988
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--PTIPDDLSDE  342 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~s~~  342 (602)
                      ..........||+.|+|||++.+.. ++.++||||+||++|||++|+.||.+.+....+..+......  ..++..++.+
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  246 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL  246 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred             CCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCCHH
T ss_conf             7776312247777430999981899-997665221409999997088998899999999999816888870104788999


Q ss_pred             HHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             999999970349999999999962935569872
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       343 l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                      +++||++||+.||++|||++|+++||||+...+
T Consensus       247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             HHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCH
T ss_conf             999999986389668919999961904188870

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=419.65  Aligned_cols=253  Identities=29%  Similarity=0.535  Sum_probs=219.3

Q ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC----CCEE
Q ss_conf             924730683329759999999799947999998416410019999999999999982699957887054123----4559
Q 007478          114 HWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV----EDKL  189 (602)
Q Consensus       114 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~  189 (602)
                      .|++.+.||+|+||+||+|+++.+++.||+|++....  ......+.+.+|+.+|++++|||||++++++.+    ...+
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             EEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEE
T ss_conf             7885169700828499999999999599999985122--79899999999999998579998506999984033458889


Q ss_pred             EEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCC--CEECCCCCCCEEEC-CCCCEEEECCCCCCCCCC
Q ss_conf             999964037772355220389996789898999997776320389--03047878708983-599567811585300248
Q 007478          190 YIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKH--TVHRDIKGANILVD-PNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       190 ~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~g--IvHrDLKp~NILl~-~~g~iKL~DFGla~~~~~  266 (602)
                      |+|||||++|+|.+++.+...+++..++.++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+|+....
T Consensus        88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf             99995789894899975135546999999999999999999978997996876743511667999889800576542368


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHH-HHHCCCCCCCCCCCCCHHHHH
Q ss_conf             8988655799898982000146999943310225668999850999999803699999-840889999999989988999
Q 007478          267 QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF-KIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~-~i~~~~~~~~~p~~~s~~l~~  345 (602)
                      . .....+||+.|||||++.+ . ++.++|||||||++|||++|+.||.+......+. .+........++..+++++++
T Consensus       168 ~-~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (270)
T d1t4ha_         168 S-FAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  244 (270)
T ss_dssp             T-SBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             C-CCCCCCCCCCCCCHHHHCC-C-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHH
T ss_conf             7-6677553813008988478-9-99867110079999999878899987655999999997389986567557899999


Q ss_pred             HHHHHCCCCCCCCCCHHHHHCCCCCC
Q ss_conf             99997034999999999996293556
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       346 Li~~~L~~dP~~Rps~~eiL~hp~f~  371 (602)
                      ||.+||++||++|||++|+|+||||+
T Consensus       245 li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         245 IIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf             99997637975892999996775409

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=423.83  Aligned_cols=260  Identities=29%  Similarity=0.473  Sum_probs=227.4

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHH-HCCCCCEEEEECCCCCCCEEE
Q ss_conf             9992473068332975999999979994799999841641001999999999999998-269995788705412345599
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLS-RLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~-~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      .++|++++.||+|+||+||+|+++.+++.||||++++..... .+..+.+..|+.++. .++|||||++++++.+.+.+|
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y   79 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   79 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCC-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEE
T ss_conf             997188658940878289999999999899999980555338-4899999999999998479996878988970498316


Q ss_pred             EEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC-C
Q ss_conf             999640377723552203899967898989999977763203890304787870898359956781158530024889-8
Q 007478          191 IYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~  269 (602)
                      +|||||++|+|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+++...... .
T Consensus        80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCCCC
T ss_conf             77750379808998640478999999999999999999998689340347654044448996301555302323566533


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             86557998989820001469999433102256689998509999998036999998408899999999899889999999
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRL  349 (602)
Q Consensus       270 ~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~Li~~  349 (602)
                      ....+||+.|+|||++.+.. ++.++||||+||++|||++|+.||.+.+....+.++...  .+.+|..+++++++||.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~  236 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVK  236 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred             CCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC--CCCCCCCCCHHHHHHHHH
T ss_conf             45457877768999982799-883232011227898987388999998999999999718--998975679999999999


Q ss_pred             HCCCCCCCCCCHH-HHHCCCCCCCCCC
Q ss_conf             7034999999999-9962935569872
Q 007478          350 CLQRNPLNRPTAA-ELLDHPFVKGAAP  375 (602)
Q Consensus       350 ~L~~dP~~Rps~~-eiL~hp~f~~~~~  375 (602)
                      ||++||++||++. ++++||||++..+
T Consensus       237 ~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         237 LFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             HSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             HCCCCCCCCCCHHHHHHHCCHHCCCCH
T ss_conf             654489878388999980901315899

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=428.10  Aligned_cols=258  Identities=35%  Similarity=0.611  Sum_probs=223.8

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      .+.|++.+.||+|+||+||+|+++.+++.||+|+++....    ...+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCH----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
T ss_conf             0375984799307781999999999993999999872899----999999999999986799998849889800995899


Q ss_pred             EEEEECCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC-C
Q ss_conf             9964037772355220-3899967898989999977763203890304787870898359956781158530024889-8
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~  269 (602)
                      |||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... .
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCCC
T ss_conf             99627998188999862899999999999999999999999889887140700314878999899716123035778641


Q ss_pred             CCCCCCCCCCCCCCCCCC----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCC-CCCCCCCCCHHHH
Q ss_conf             865579989898200014----69999433102256689998509999998036999998408899-9999998998899
Q 007478          270 PLSFKGSPYWMAPEVIKN----SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE-LPTIPDDLSDEGK  344 (602)
Q Consensus       270 ~~~~~GT~~Y~APE~l~~----~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~  344 (602)
                      ..+.+||+.|+|||++..    ...|+.++|||||||++|||++|++||.+.+....+.++..... ....+..++++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHH
T ss_conf             00102562647999983202578888806657878999999820889999989999999997079987776566999999


Q ss_pred             HHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             99999703499999999999629355698
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       345 ~Li~~~L~~dP~~Rps~~eiL~hp~f~~~  373 (602)
                      +||.+||+.||++|||+.|+++||||+..
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf             99999766996689199999629231889

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=422.48  Aligned_cols=255  Identities=30%  Similarity=0.546  Sum_probs=224.3

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC--CCEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123--4559
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV--EDKL  189 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~  189 (602)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++....  ......+.+.+|+.+|++++|||||++++++.+  .+.+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT--SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEE
T ss_conf             333799679830889199999999999799999987465--797999999999999997789998248999991789989


Q ss_pred             EEEEEEECCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHCCCC-----CEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             999964037772355220----389996789898999997776320389-----03047878708983599567811585
Q 007478          190 YIYLEYVSGGSIYKLLQD----YGQFGEPAIRNYTQQILSGLAFLHSKH-----TVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       190 ~lV~E~~~ggsL~~~l~~----~~~ls~~~i~~i~~qIl~gL~yLH~~g-----IvHrDLKp~NILl~~~g~iKL~DFGl  260 (602)
                      |+|||||+||+|.+++.+    ...+++..++.++.||+.||+|||+++     |+||||||+|||++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCC
T ss_conf             99995689993899998515457899999999999999999999997167788788586765425747888579800100


Q ss_pred             CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             30024889-88655799898982000146999943310225668999850999999803699999840889999999989
Q 007478          261 AKHIAGQS-CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDL  339 (602)
Q Consensus       261 a~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  339 (602)
                      |+.+.... .....+||+.|||||++.+.. ++.++|||||||++|||++|++||.+.+......++... ..+.++..+
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~  238 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYRY  238 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTS
T ss_pred             EEECCCCCCCCCCCCCCCCCCCHHHHCCCC-CCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCC-CCCCCCCCC
T ss_conf             032245777556677882327999983999-993898875278999980188998998999999999718-998897435


Q ss_pred             CHHHHHHHHHHCCCCCCCCCCHHHHHCCCCC
Q ss_conf             9889999999703499999999999629355
Q 007478          340 SDEGKDFIRLCLQRNPLNRPTAAELLDHPFV  370 (602)
Q Consensus       340 s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f  370 (602)
                      ++++++||.+||+.||++|||+.|+++|||+
T Consensus       239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         239 SDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf             9999999999767995579189999729819

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=417.65  Aligned_cols=260  Identities=25%  Similarity=0.416  Sum_probs=221.2

Q ss_pred             EEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHC-HHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEEEEE
Q ss_conf             473068332975999999979994799999841641001-9999999999999982699957887054123455999996
Q 007478          116 KKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKS-KESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLE  194 (602)
Q Consensus       116 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~-~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E  194 (602)
                      +..++||+|+||+||+|+++.+|+.||||+++....... ....+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHH
T ss_conf             95638512728299999999999699999984202124567999999999999986799998689854225874022045


Q ss_pred             EECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC-CCCCC
Q ss_conf             40377723552203899967898989999977763203890304787870898359956781158530024889-88655
Q 007478          195 YVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-CPLSF  273 (602)
Q Consensus       195 ~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~~~~~  273 (602)
                      |+.++++..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... .....
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             HHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf             53450776554126677899999999999999988631635503577625885377841146576100057875543302


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCC---------------------
Q ss_conf             79989898200014699994331022566899985099999980369999984088999---------------------
Q 007478          274 KGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL---------------------  332 (602)
Q Consensus       274 ~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~---------------------  332 (602)
                      +||+.|+|||++.....|+.++||||+||++|||++|++||......+.+.++......                     
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             ECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHHHCCC
T ss_conf             04733363999726778880564363042899998596999999999999999985189972545210002134430347


Q ss_pred             CC-----CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             99-----99989988999999970349999999999962935569872
Q 007478          333 PT-----IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       333 ~~-----~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                      +.     +...+++++++||.+||+.||++|||+.|+|+||||++...
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             CCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             898867856568999999999976389456908999967996578999

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=412.83  Aligned_cols=262  Identities=26%  Similarity=0.419  Sum_probs=231.1

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCH-----HCHHHHHHHHHHHHHHHHCC-CCCEEEEECCCCC
Q ss_conf             99924730683329759999999799947999998416410-----01999999999999998269-9957887054123
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA-----KSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTV  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~-----~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~g~~~~  185 (602)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.+....     ......+.+.+|+.+++.++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf             66388852884176849999999999989999999624464114788899999999999999985079974799762146


Q ss_pred             CCEEEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             45599999640377723552203899967898989999977763203890304787870898359956781158530024
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       186 ~~~~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~  265 (602)
                      .+.+|||||||+||+|.++++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEECC
T ss_conf             76059999768986689999865999999999999999999999987599432346254898689983871240316726


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCC--CCCCC
Q ss_conf             8898865579989898200014-----6999943310225668999850999999803699999840889999--99998
Q 007478          266 GQSCPLSFKGSPYWMAPEVIKN-----SSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--TIPDD  338 (602)
Q Consensus       266 ~~~~~~~~~GT~~Y~APE~l~~-----~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~  338 (602)
                      .........||+.|+|||++.+     ...++.++||||+||++|||++|+.||.+.+.......+.......  .....
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf             88721345246788898886053445678899233185656023103228889889999999999981898889854346


Q ss_pred             CCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             99889999999703499999999999629355698
Q 007478          339 LSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       339 ~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~  373 (602)
                      +++++++||.+||++||++||+++|+++||||+..
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHHH
T ss_conf             89999999999765896689199999739787975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=419.14  Aligned_cols=257  Identities=27%  Similarity=0.382  Sum_probs=226.8

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEE
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345599
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      .-++|++++.||+|+||+||+|+++.+++.||+|++++..     .....+.+|+.+|+.++|||||++++++++++.+|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf             7010588789831778399999998999699999975786-----65999999999998579979890989998899889


Q ss_pred             EEEEEECCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCC--CCEEEECCCCCCCCCCC
Q ss_conf             9996403777235522038-99967898989999977763203890304787870898359--95678115853002488
Q 007478          191 IYLEYVSGGSIYKLLQDYG-QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN--GRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~~~-~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~--g~iKL~DFGla~~~~~~  267 (602)
                      +|||||.||+|++++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+  ..+||+|||+++.....
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf             99953899808899875389999999999999999999999876997513554443443788518997644111003467


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCC--CCCCCCCHHHHH
Q ss_conf             988655799898982000146999943310225668999850999999803699999840889999--999989988999
Q 007478          268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--TIPDDLSDEGKD  345 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~s~~l~~  345 (602)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+.......  ..+..+++++++
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCCCCCCCCCCCCCCHHCCCCC-CCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHCCCCCHHHHH
T ss_conf             7532122332223402104877-784011302799999998289999998999999999838999880223678999999


Q ss_pred             HHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             9999703499999999999629355698
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       346 Li~~~L~~dP~~Rps~~eiL~hp~f~~~  373 (602)
                      ||.+||++||++|||+.|+++||||+..
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             9999866996689099999639965667

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=408.83  Aligned_cols=253  Identities=28%  Similarity=0.444  Sum_probs=212.7

Q ss_pred             CCCCCEEE-EEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHH-CCCCCEEEEECCCCC---
Q ss_conf             99992473-0683329759999999799947999998416410019999999999999982-699957887054123---
Q 007478          111 PESHWKKG-KMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSR-LRHPNIVQYYGSKTV---  185 (602)
Q Consensus       111 ~~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~-l~HpnIv~l~g~~~~---  185 (602)
                      ..++|++. ++||+|+||+||+|+++.+++.||||+++.         ...+.+|+.++.+ ++|||||++++++++   
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC---------CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
T ss_conf             014879810796545486999999889998999999897---------47799999999986699997829899950346


Q ss_pred             -CCEEEEEEEEECCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECC---CCCEEEECCC
Q ss_conf             -45599999640377723552203--89996789898999997776320389030478787089835---9956781158
Q 007478          186 -EDKLYIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP---NGRVKLADFG  259 (602)
Q Consensus       186 -~~~~~lV~E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~---~g~iKL~DFG  259 (602)
                       +..+|+|||||+||+|++++...  ..+++.+++.|+.||+.||+|||++||+||||||+|||++.   .+.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             89789999977899849999986278775799999999999999999997698644410022011355556631135455


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCC--CCCCCCC-
Q ss_conf             5300248898865579989898200014699994331022566899985099999980369999984088--9999999-
Q 007478          260 MAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--KELPTIP-  336 (602)
Q Consensus       260 la~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p-  336 (602)
                      +|+...........+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+.......+...  .....++ 
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TCEECCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             EEEECCCCCCCCCCCCCCCCCCCHHHCCCC-CCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf             123336888643226775637927774898-8888888764516778865889988988778899999998538888898


Q ss_pred             ---CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             ---9899889999999703499999999999629355698
Q 007478          337 ---DDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       337 ---~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~  373 (602)
                         ..+++++++||.+||++||++|||+.|+++||||...
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCC
T ss_conf             5434699999999999756996579099999709876178

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=401.75  Aligned_cols=262  Identities=31%  Similarity=0.528  Sum_probs=219.3

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++...  ........+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i   78 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   78 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEE
T ss_conf             999776517723768099999999999799999980222--575899999999999986799838874453322432037


Q ss_pred             EEEEECCCCHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC-C
Q ss_conf             996403777235522-03899967898989999977763203890304787870898359956781158530024889-8
Q 007478          192 YLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-C  269 (602)
Q Consensus       192 V~E~~~ggsL~~~l~-~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~  269 (602)
                      ||||+.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... .
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EEEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCCC
T ss_conf             88623774455544202568888999999999999999865288992135711401134676210357861343688641


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCC----------------CC
Q ss_conf             86557998989820001469999433102256689998509999998036999998408899----------------99
Q 007478          270 PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKE----------------LP  333 (602)
Q Consensus       270 ~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~----------------~~  333 (602)
                      .....||+.|+|||++....+++.++||||+||++|+|++|+.||.+.+....+.++.....                ..
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCCCC
T ss_conf             00103652154112213665777422103333134279668799898899999999998328983331444222421243


Q ss_pred             C-----------CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             9-----------99989988999999970349999999999962935569872
Q 007478          334 T-----------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       334 ~-----------~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                      .           ....++.++++||++||+.||++|||+.|+++||||++...
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             45432222044416678999999999976399557918999967870146999

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=405.58  Aligned_cols=254  Identities=27%  Similarity=0.468  Sum_probs=218.3

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCH--HCHHHHHHHHHHHHHHHHCC--CCCEEEEECCCCCCC
Q ss_conf             99924730683329759999999799947999998416410--01999999999999998269--995788705412345
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDA--KSKESAKQLMQEIVLLSRLR--HPNIVQYYGSKTVED  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~--~~~~~~~~l~~Ei~iL~~l~--HpnIv~l~g~~~~~~  187 (602)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+....  ........+.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf             88379967984087839999999999979999998568844334556799999999999974358988127999983099


Q ss_pred             EEEEEEEEECC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCC-CCEEEECCCCCCCCC
Q ss_conf             59999964037-7723552203899967898989999977763203890304787870898359-956781158530024
Q 007478          188 KLYIYLEYVSG-GSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN-GRVKLADFGMAKHIA  265 (602)
Q Consensus       188 ~~~lV~E~~~g-gsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~-g~iKL~DFGla~~~~  265 (602)
                      .+|+||||+.+ +++.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEECC
T ss_conf             68999983368622899986158999999999999999999999877975566761114774478848977546535324


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf             88988655799898982000146999943310225668999850999999803699999840889999999989988999
Q 007478          266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       266 ~~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  345 (602)
                      .. ...+.+||+.|+|||++.+..+++.++||||+||++|||++|+.||...+..   .   .  ....++..+++++++
T Consensus       163 ~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i---~---~--~~~~~~~~~s~~~~~  233 (273)
T d1xwsa_         163 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---I---R--GQVFFRQRVSSECQH  233 (273)
T ss_dssp             SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---H---H--CCCCCSSCCCHHHHH
T ss_pred             CC-CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHHH---H---H--CCCCCCCCCCHHHHH
T ss_conf             44-5566565877479999848997886533255403453675688998873677---6---1--544778779999999


Q ss_pred             HHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             99997034999999999996293556987
Q 007478          346 FIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       346 Li~~~L~~dP~~Rps~~eiL~hp~f~~~~  374 (602)
                      ||++||+.||++|||++|+++||||++..
T Consensus       234 li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         234 LIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             99997608975893999985398667887

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=404.28  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=217.9

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCC-----EEEEEEEECCCCHHCHHHHHHHHHHHHHHHHC-CCCCEEEEECCCC
Q ss_conf             99992473068332975999999979994-----79999984164100199999999999999826-9995788705412
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGE-----MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKT  184 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~g~~~  184 (602)
                      ..++|++++.||+|+||+||+|+++.+++     .||+|.+...   ........+.+|+.+|.++ +|||||++++++.
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK---ADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf             78993970198307881999999857885542049999996633---587899999999999997158996868778886


Q ss_pred             CCCEEEEEEEEECCCCHHHHHHCC-----------------------CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCC
Q ss_conf             345599999640377723552203-----------------------899967898989999977763203890304787
Q 007478          185 VEDKLYIYLEYVSGGSIYKLLQDY-----------------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIK  241 (602)
Q Consensus       185 ~~~~~~lV~E~~~ggsL~~~l~~~-----------------------~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLK  241 (602)
                      +.+.+|+|||||++|+|.++|+..                       ..+++..++.|+.||+.||+|||+++|+|||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCC
T ss_conf             29958999972799959999986257775102210000122200125778999999999999999999973990505270


Q ss_pred             CCCEEECCCCCEEEECCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCC
Q ss_conf             87089835995678115853002488988---655799898982000146999943310225668999850-99999980
Q 007478          242 GANILVDPNGRVKLADFGMAKHIAGQSCP---LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQY  317 (602)
Q Consensus       242 p~NILl~~~g~iKL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~  317 (602)
                      |+|||++.++.+||+|||+|+........   .+..||+.|||||++.+.. ++.++|||||||++|||++ |++||.+.
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCC-CCCCEECCCHHHHHHHHHHCCCCCCCCC
T ss_conf             321443459828985142222045778615623435787657838872799-9963303000399999983899999998


Q ss_pred             HHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             36999998408899999999899889999999703499999999999629
Q 007478          318 EGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       318 ~~~~~~~~i~~~~~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~h  367 (602)
                      .....+.++......+..|..+++++++||.+||+.||++|||+++|++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             98999999985699899887678999999999758896689399999999

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=396.61  Aligned_cols=255  Identities=29%  Similarity=0.420  Sum_probs=213.3

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC------C
Q ss_conf             9924730683329759999999799947999998416410019999999999999982699957887054123------4
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV------E  186 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~------~  186 (602)
                      .+|+..++||+|+||+||+|+++.+|+.||||+++.....        ..+|+.+|++++|+||+++++++..      .
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH--------HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf             7767516982176839999999999979999998816068--------99999999866898987387899744765773


Q ss_pred             CEEEEEEEEECCCCHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCC-CEEEECCCCCC
Q ss_conf             5599999640377723552---2038999678989899999777632038903047878708983599-56781158530
Q 007478          187 DKLYIYLEYVSGGSIYKLL---QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-RVKLADFGMAK  262 (602)
Q Consensus       187 ~~~~lV~E~~~ggsL~~~l---~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~  262 (602)
                      ..+|+|||||+++.+..+.   .....+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHH
T ss_conf             18999984168860788886310368999999999999999999999866876457886037873589711673366054


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCC-------------
Q ss_conf             0248898865579989898200014699994331022566899985099999980369999984088-------------
Q 007478          263 HIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-------------  329 (602)
Q Consensus       263 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~-------------  329 (602)
                      .+.......+.+||+.|+|||++.+...++.++||||+||++|||++|++||...+....+.++...             
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             HCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHC
T ss_conf             40477653200255555682776404688821000246527785502879989879999999999974898177654306


Q ss_pred             -----CCCC---------CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             -----9999---------999989988999999970349999999999962935569872
Q 007478          330 -----KELP---------TIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       330 -----~~~~---------~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                           ...+         .....+++++.+||.+||++||++|||+.|+|+||||++...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             CCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             210110355445674444315689999999999976589557929999966984524667

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=399.91  Aligned_cols=259  Identities=27%  Similarity=0.465  Sum_probs=221.0

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC---
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345---
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED---  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~---  187 (602)
                      ..++|++.+.||+|+||+||+|.++.+|+.||||+++..  .......+.+.+|+.+|+.++|||||++++++...+   
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH--HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf             477189988980177819999999999989999998522--259699999999999998668987547999863576555


Q ss_pred             ---EEEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             ---59999964037772355220389996789898999997776320389030478787089835995678115853002
Q 007478          188 ---KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       188 ---~~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~  264 (602)
                         .+|+||||+ +.+|..+++ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCEEEEEEECC-CCCHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECC
T ss_conf             541599998405-521899987-402269999999999999999987378764566851111210012211343102206


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHC----------------
Q ss_conf             4889886557998989820001469999433102256689998509999998036999998408----------------
Q 007478          265 AGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGN----------------  328 (602)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~----------------  328 (602)
                      ...  .....||+.|+|||++.+...++.++||||+||++|||++|++||.+.+....+..+..                
T Consensus       172 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         172 DSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             CSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             CCC--CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCCH
T ss_conf             876--310245533358899817878996501030038999999786998889768999999850378848888653000


Q ss_pred             -------------CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             -------------89999999989988999999970349999999999962935569872
Q 007478          329 -------------SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       329 -------------~~~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                                   ..........+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             344331157866655667755689999999999977299557929999963962375877

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=398.00  Aligned_cols=260  Identities=32%  Similarity=0.503  Sum_probs=213.6

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCC-CCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHC---CCCCEEEEECCCC---
Q ss_conf             99924730683329759999999799-9479999984164100199999999999999826---9995788705412---
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDS-GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL---RHPNIVQYYGSKT---  184 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l---~HpnIv~l~g~~~---  184 (602)
                      .++|++.+.||+|+||+||+|++..+ ++.||||+++......  .....+.+|+.+|+.+   +||||+++++++.   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCC--HHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf             5897988899215586999999988899899999980232451--67999999999999874258988023663221466


Q ss_pred             --CCCEEEEEEEEECCCCHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             --3455999996403777235522-0389996789898999997776320389030478787089835995678115853
Q 007478          185 --VEDKLYIYLEYVSGGSIYKLLQ-DYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMA  261 (602)
Q Consensus       185 --~~~~~~lV~E~~~ggsL~~~l~-~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla  261 (602)
                        ....+|++|||+.++.+..... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHHH
T ss_conf             66674699999740587144444303789998999999999999999997588983579862789858997542100010


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCC------------
Q ss_conf             00248898865579989898200014699994331022566899985099999980369999984088------------
Q 007478          262 KHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS------------  329 (602)
Q Consensus       262 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~------------  329 (602)
                      +............||+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+....+.++...            
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             HHHCCCCCCCCCCCCHHHCCCCHHCCCC-CCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCCCCC
T ss_conf             1100234577765485114831001798-881110003289999998787998998989999999984079961105321


Q ss_pred             -------------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             -------------999999998998899999997034999999999996293556987
Q 007478          330 -------------KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAA  374 (602)
Q Consensus       330 -------------~~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~  374 (602)
                                   .....++..+++++++||.+||++||++|||+.|+|+||||++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCH
T ss_conf             1110333022345645440445899999999998748966791899996696340752

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=396.50  Aligned_cols=252  Identities=24%  Similarity=0.428  Sum_probs=217.7

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCC---EEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf             99992473068332975999999979994---799999841641001999999999999998269995788705412345
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGE---MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~  187 (602)
                      ..++|++.+.||+|+||+||+|.++.+++   .||||.+..   .......+.+.+|+.+|++++|||||+++|++...+
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS---GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             CHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf             80042785698027882999999957997889999999784---459899999999999998579988861899996288


Q ss_pred             EEEEEEEEECCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             59999964037772355220-38999678989899999777632038903047878708983599567811585300248
Q 007478          188 KLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lV~E~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~  266 (602)
                      .+|+|||||++|+|.+++.. .+.+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf             77999972279853002104567999999999999999988988527983576150448988999199888443157567


Q ss_pred             CCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             89886------55799898982000146999943310225668999850-999999803699999840889999999989
Q 007478          267 QSCPL------SFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDL  339 (602)
Q Consensus       267 ~~~~~------~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  339 (602)
                      .....      ...||+.|||||++.+.. ++.++|||||||++|||++ |++||.+......+..+..... +..+..+
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~  258 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-LPPPMDC  258 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCTTC
T ss_pred             CCCCCEEEECCCCCCCCCCCCHHHHHCCC-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCC
T ss_conf             77765365025666883003878883699-786121445357899998679999999999999999973788-9997422


Q ss_pred             CHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             9889999999703499999999999629
Q 007478          340 SDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       340 s~~l~~Li~~~L~~dP~~Rps~~eiL~h  367 (602)
                      +.++.+||.+||+.||++|||+.+|+++
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             6999999999758797689299999999

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=401.15  Aligned_cols=251  Identities=25%  Similarity=0.435  Sum_probs=216.2

Q ss_pred             CCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEE
Q ss_conf             99999247306833297599999997999479999984164100199999999999999826999578870541234559
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~  189 (602)
                      ...++|++.+.||+|+||+||+|+++.+++.||||+++....     ..+++.+|+.+|+.++|||||++++++.+.+.+
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC-----HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEE
T ss_conf             457993986598208880899999999996999999777610-----399999999999867999882677527457854


Q ss_pred             EEEEEEECCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             9999640377723552203--89996789898999997776320389030478787089835995678115853002488
Q 007478          190 YIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       190 ~lV~E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~  267 (602)
                      |+|||||++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCC
T ss_conf             78763146760677753035541579999999999999788898789305760457689989992898324454653788


Q ss_pred             CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf             988--655799898982000146999943310225668999850999999803699999840889999999989988999
Q 007478          268 SCP--LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       268 ~~~--~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  345 (602)
                      ...  ....|++.|+|||++.+.. ++.++|||||||++|||++|..||........+.++......+.++..+++++++
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  247 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  247 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CCEEECCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHH
T ss_conf             722103556654666927872799-9810430217899999986799887742599999998558888887433099999


Q ss_pred             HHHHHCCCCCCCCCCHHHHHC
Q ss_conf             999970349999999999962
Q 007478          346 FIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       346 Li~~~L~~dP~~Rps~~eiL~  366 (602)
                      ||.+||+.||++|||+.++++
T Consensus       248 li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         248 LMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHCCCCHHHCCCHHHHHH
T ss_conf             999975779768939999999

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=395.16  Aligned_cols=258  Identities=26%  Similarity=0.459  Sum_probs=221.3

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||+||+|.++ +++.||||+++....  .....+.+.+|+.+|+.++|||||++++++...+..|+
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   77 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEE
T ss_conf             999634318722778189999968-999999999812326--85899999999999986799868766012046773158


Q ss_pred             EEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC-C
Q ss_conf             996403777235522038999678989899999777632038903047878708983599567811585300248898-8
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-P  270 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-~  270 (602)
                      ++|++.++.+..+....+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEEEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCCCC
T ss_conf             99740045678998604775144568999999999998605748826787750568689978732366430114676541


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCC--------------------
Q ss_conf             655799898982000146999943310225668999850999999803699999840889--------------------
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSK--------------------  330 (602)
Q Consensus       271 ~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~--------------------  330 (602)
                      ....|++.|+|||++.+...++.++||||+||++|||++|++||.+.+....+.++....                    
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             CEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf             01024311013788717888884100211175899997797998988989999999986389971104212333221433


Q ss_pred             -------CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf             -------999999989988999999970349999999999962935569
Q 007478          331 -------ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKG  372 (602)
Q Consensus       331 -------~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~  372 (602)
                             ....+...+++++.+||++||++||++|||+.|+++||||++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             3335676466651258999999999986689668909999856922074

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=391.58  Aligned_cols=263  Identities=24%  Similarity=0.474  Sum_probs=216.7

Q ss_pred             CCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC--
Q ss_conf             999992473068332975999999979994799999841641001999999999999998269995788705412345--
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED--  187 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~--  187 (602)
                      ...++|++.+.||+|+||+||+|+++.+|+.||||++.+.   ......+.+++|+.+|+.++||||+++++++....  
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHH---CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC
T ss_conf             7389859978994064809999999999949999998031---0958999999999999976898988588899505645


Q ss_pred             ---EEEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             ---59999964037772355220389996789898999997776320389030478787089835995678115853002
Q 007478          188 ---KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHI  264 (602)
Q Consensus       188 ---~~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~  264 (602)
                         .+|++ +++.+|+|++++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          82 QMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             TCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCEEEEE-EEECCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf             54149999-96259865664405-89999999999999999999999789867778764378879997787545705650


Q ss_pred             CCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCC-----------
Q ss_conf             4889----8865579989898200014699994331022566899985099999980369999984088-----------
Q 007478          265 AGQS----CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS-----------  329 (602)
Q Consensus       265 ~~~~----~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~-----------  329 (602)
                      ....    .....+||+.|+|||++.....++.++||||+||++|||++|+.||...+...........           
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf             47776410101102652000387860478887410100467013377669799788888999998765206997566423


Q ss_pred             ----------------CCC--CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCC
Q ss_conf             ----------------999--999998998899999997034999999999996293556987210
Q 007478          330 ----------------KEL--PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAPLE  377 (602)
Q Consensus       330 ----------------~~~--~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~~~  377 (602)
                                      ...  ......++.++++||.+||++||.+|||+.++|+||||+......
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~  305 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  305 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCC
T ss_conf             433222202446775577877783789999999999997648956790899986198655588976

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=393.71  Aligned_cols=259  Identities=25%  Similarity=0.407  Sum_probs=221.4

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC---
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345---
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED---  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~---  187 (602)
                      ..++|++.+.||+|+||+||+|+++.+++.||+|+++.. ...+......+.+|+.+++.++|||||++++++...+   
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST-TTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHH-HCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCC
T ss_conf             062069868996089929999999999989999998556-6469899999999999998569998873114354326887


Q ss_pred             -EEEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             -5999996403777235522038999678989899999777632038903047878708983599567811585300248
Q 007478          188 -KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 -~~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~  266 (602)
                       .+|+|||||+|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             CEEEEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCC
T ss_conf             66999997788987101120358999999999999999999999857952763467556657543201003444322123


Q ss_pred             CC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCCC--CCCCCCC
Q ss_conf             89----88655799898982000146999943310225668999850999999803699999840889999--9999899
Q 007478          267 QS----CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKELP--TIPDDLS  340 (602)
Q Consensus       267 ~~----~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~s  340 (602)
                      ..    .....+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+......++......+  .....++
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             ---------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCC
T ss_conf             544333346425762436999983999-9966320265289999976979989969999999998469999710034789


Q ss_pred             HHHHHHHHHHCCCCCCCCCCHHHHHCCCCCC
Q ss_conf             8899999997034999999999996293556
Q 007478          341 DEGKDFIRLCLQRNPLNRPTAAELLDHPFVK  371 (602)
Q Consensus       341 ~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~  371 (602)
                      +++.+||.+||++||++||+..+.+.|+|.+
T Consensus       243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf             9999999998667976777399999999999

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=387.50  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=213.9

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCC-CCCEEEEECCCCC--CC
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269-9957887054123--45
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTV--ED  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~g~~~~--~~  187 (602)
                      ..++|++.+.||+|+||+||+|+++.+++.||+|+++...       .+.+.+|+.+|+.+. ||||+++++++..  ..
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCC
T ss_conf             9867189789831748199999988999799999988899-------999999999998515799876799999816877


Q ss_pred             EEEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCC-CEEEECCCCCCCCCC
Q ss_conf             5999996403777235522038999678989899999777632038903047878708983599-567811585300248
Q 007478          188 KLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNG-RVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~  266 (602)
                      .+|+|||||.+++|..+.   +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus       106 ~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             CEEEEEEECCCCCHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf             126888631798589974---68999999999999999998876433443456441237748998366415654266468


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHH-HHH---HHHHHC------------CC
Q ss_conf             89886557998989820001469999433102256689998509999998036-999---998408------------89
Q 007478          267 QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEG-VAA---MFKIGN------------SK  330 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~-~~~---~~~i~~------------~~  330 (602)
                      .......+||+.|+|||++.+...++.++||||+||++|||++|+.||..... ...   +.++..            ..
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCC
T ss_conf             87444322486424761026888888452323354555876048899988760189999999987884155555422544


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             --------------------999999989988999999970349999999999962935569872
Q 007478          331 --------------------ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       331 --------------------~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                                          ........+++++++||++||++||++|+|++|+|+||||+.+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             CCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf             47430000033343311211552112448999999999986699568908999964935588797

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=392.65  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=212.2

Q ss_pred             EEEEECCCEEEEEEEECC--CCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEEEEEEE
Q ss_conf             068332975999999979--994799999841641001999999999999998269995788705412345599999640
Q 007478          119 KMLGRGTFGHVYVGFNSD--SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYIYLEYV  196 (602)
Q Consensus       119 ~~LG~G~fG~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~lV~E~~  196 (602)
                      +.||+|+||+||+|.++.  +++.||||+++..  ..+....+.+.+|+.+|++++|||||+++|++.. +.+|||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHH--HCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECC
T ss_conf             783458782999999816973859999998801--0898999999999999986799898527777505-9779999747


Q ss_pred             CCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC----CC
Q ss_conf             37772355220389996789898999997776320389030478787089835995678115853002488988----65
Q 007478          197 SGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP----LS  272 (602)
Q Consensus       197 ~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~----~~  272 (602)
                      ++|+|.+++.....+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+......    ..
T Consensus        90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred             CCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCCCC
T ss_conf             88968999752257899999999999999976687479556777611310235675123413453313432344322445


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             5799898982000146999943310225668999850-999999803699999840889999999989988999999970
Q 007478          273 FKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCL  351 (602)
Q Consensus       273 ~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~Li~~~L  351 (602)
                      ..||+.|+|||++.+.. ++.++|||||||++|||++ |++||.+.........+... ..+.+|..++.++++||.+||
T Consensus       170 ~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~~~~li~~cl  247 (277)
T d1xbba_         170 GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYDLMNLCW  247 (277)
T ss_dssp             -CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHT
T ss_pred             CCCCCEECCCHHHCCCC-CCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHC
T ss_conf             67784203916653799-9843443034031328965899999998999999999828-999998656799999999975


Q ss_pred             CCCCCCCCCHHHHH---CCCCCC
Q ss_conf             34999999999996---293556
Q 007478          352 QRNPLNRPTAAELL---DHPFVK  371 (602)
Q Consensus       352 ~~dP~~Rps~~eiL---~hp~f~  371 (602)
                      +.||++|||+.+|+   +|+|+.
T Consensus       248 ~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         248 TYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHCCCHHHHHHHHHCHHHH
T ss_conf             88976890989999985288750

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=391.02  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=216.5

Q ss_pred             CCCCEEEEE-EEECCCEEEEEEEECCC--CCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCE
Q ss_conf             999247306-83329759999999799--947999998416410019999999999999982699957887054123455
Q 007478          112 ESHWKKGKM-LGRGTFGHVYVGFNSDS--GEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       112 ~~~y~~~~~-LG~G~fG~Vy~a~~~~t--g~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~  188 (602)
                      .++|.+.+. ||+|+||+||+|.++.+  +..||||+++..   ......+.+.+|+.+|++++|||||+++|++.. +.
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CE
T ss_conf             44718878487306080999999960897689999998820---397899999999999986799888068656036-80


Q ss_pred             EEEEEEEECCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             9999964037772355220-389996789898999997776320389030478787089835995678115853002488
Q 007478          189 LYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lV~E~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~  267 (602)
                      +|+|||||++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf             79999807899689975212569999999999999999878998688105767646604546885420331342115543


Q ss_pred             CC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf             98----8655799898982000146999943310225668999850-999999803699999840889999999989988
Q 007478          268 SC----PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       268 ~~----~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                      ..    .....||+.|+|||++.... ++.++|||||||++|||++ |+.||.+.........+.... .+.+|..++++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~  240 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPE  240 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTCCHH
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCC-CCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHH
T ss_conf             43211356211374335868872799-99541232201789999938999999979999999998189-99999767899


Q ss_pred             HHHHHHHHCCCCCCCCCCHHHH---HCCCCCC
Q ss_conf             9999999703499999999999---6293556
Q 007478          343 GKDFIRLCLQRNPLNRPTAAEL---LDHPFVK  371 (602)
Q Consensus       343 l~~Li~~~L~~dP~~Rps~~ei---L~hp~f~  371 (602)
                      +.+||.+||+.||++|||+.+|   |+|.|+.
T Consensus       241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             99999997577976890999999999999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=392.11  Aligned_cols=253  Identities=28%  Similarity=0.490  Sum_probs=214.0

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEE
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345599
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      ..++|++.+.||+|+||+||+|.++ ++..||||+++....     ..+.+.+|+.++++++|||||+++|++.+ +.+|
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~   83 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             CHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEE
T ss_conf             8899388679810798289999999-999999999864768-----88999999999986799988578731045-9769


Q ss_pred             EEEEEECCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf             999640377723552203--899967898989999977763203890304787870898359956781158530024889
Q 007478          191 IYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~  268 (602)
                      +||||+++|+|.+++...  ..+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCC
T ss_conf             99995789828888751478988788999999999999999974895467564225156202440423410147735886


Q ss_pred             C--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf             8--86557998989820001469999433102256689998509-99999803699999840889999999989988999
Q 007478          269 C--PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       269 ~--~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  345 (602)
                      .  .....||+.|+|||++.... ++.++|||||||++|||++| .+||........+..+... ..+..|..+++++.+
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~  241 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELYQ  241 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHH
T ss_pred             CCCCCCCCCCCCCCCHHHHHCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC-CCCCCCCCCHHHHHH
T ss_conf             44203567744445828983799-9824564525799999996898888888999999999706-888896557199999


Q ss_pred             HHHHHCCCCCCCCCCHHHHHC--CCCCCC
Q ss_conf             999970349999999999962--935569
Q 007478          346 FIRLCLQRNPLNRPTAAELLD--HPFVKG  372 (602)
Q Consensus       346 Li~~~L~~dP~~Rps~~eiL~--hp~f~~  372 (602)
                      ||.+||+.||++|||+.++++  |+||..
T Consensus       242 li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         242 LMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             99997588976893999999986113213

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=393.43  Aligned_cols=251  Identities=26%  Similarity=0.468  Sum_probs=210.3

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEE
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345599
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      ..++|++++.||+|+||+||+|+.+   ..||||+++....  .....+.+.+|+.+|++++|||||++++++. ++.+|
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~   79 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA   79 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             CCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEE
T ss_conf             5451899889830788589999999---9899999973469--9899999999999998479987864567971-55899


Q ss_pred             EEEEEECCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC-
Q ss_conf             999640377723552203-899967898989999977763203890304787870898359956781158530024889-
Q 007478          191 IYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS-  268 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-  268 (602)
                      +|||||++|+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCC
T ss_conf             99965899888999852357899999999999999998887509995161478997981899788750022133355677


Q ss_pred             --CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHH-CCC---CCCCCCCCCC
Q ss_conf             --88655799898982000146--999943310225668999850999999803699999840-889---9999999899
Q 007478          269 --CPLSFKGSPYWMAPEVIKNS--SGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIG-NSK---ELPTIPDDLS  340 (602)
Q Consensus       269 --~~~~~~GT~~Y~APE~l~~~--~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~-~~~---~~~~~p~~~s  340 (602)
                        ......||+.|||||++...  ..|+.++|||||||++|||++|+.||.+......+.... ...   ....++..++
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCHHCCCCCH
T ss_conf             63125665574317999995056899995315163599999999788998998969999999965888986000365554


Q ss_pred             HHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             889999999703499999999999629
Q 007478          341 DEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       341 ~~l~~Li~~~L~~dP~~Rps~~eiL~h  367 (602)
                      +++++||.+||..||++|||+.+|+++
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             999999999758897689299999999

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=396.13  Aligned_cols=264  Identities=30%  Similarity=0.489  Sum_probs=223.0

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEE---CCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCC-CCEEEEECCCCCC
Q ss_conf             999924730683329759999999---799947999998416410019999999999999982699-9578870541234
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFN---SDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNIVQYYGSKTVE  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~---~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H-pnIv~l~g~~~~~  186 (602)
                      ..++|++++.||+|+||+||+|++   +.+|+.||+|++++..........+.+.+|+.++++++| |||+++++++.+.
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             CHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf             51025999898328783999999876588794899999836772101689999999999998646798399962000248


Q ss_pred             CEEEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             55999996403777235522038999678989899999777632038903047878708983599567811585300248
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       187 ~~~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~  266 (602)
                      ..+|++|||+.+|+|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             CCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHHCC
T ss_conf             73001231234117999987304543788888899999999885149989654773201246999888741320222034


Q ss_pred             CC--CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCHH---HHHHHHHHCCCCCCCCCCCCC
Q ss_conf             89--886557998989820001469-999433102256689998509999998036---999998408899999999899
Q 007478          267 QS--CPLSFKGSPYWMAPEVIKNSS-GCNLAVDIWSLGCTVLEMATTKPPWSQYEG---VAAMFKIGNSKELPTIPDDLS  340 (602)
Q Consensus       267 ~~--~~~~~~GT~~Y~APE~l~~~~-~~s~~sDIWSlGviLyeLltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~s  340 (602)
                      ..  ...+..|++.|++||.+.... +++.++|||||||+||||++|+.||.....   ...+.+.. ....+.++..++
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~~s  260 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-LKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-HHCCCCCCTTSC
T ss_pred             CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCC
T ss_conf             4443221222333331068760577688713251777799999976899988887777999999833-568998865479


Q ss_pred             HHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCCCC
Q ss_conf             8899999997034999999-----9999962935569872
Q 007478          341 DEGKDFIRLCLQRNPLNRP-----TAAELLDHPFVKGAAP  375 (602)
Q Consensus       341 ~~l~~Li~~~L~~dP~~Rp-----s~~eiL~hp~f~~~~~  375 (602)
                      +++.+||++||++||++|+     |++|+++||||++..+
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCH
T ss_conf             9999999997445898819997450999974972348998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=388.61  Aligned_cols=261  Identities=24%  Similarity=0.391  Sum_probs=216.0

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC-----
Q ss_conf             999924730683329759999999799947999998416410019999999999999982699957887054123-----
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV-----  185 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~-----  185 (602)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++.+....  .....++.+|+.+|+.++|+||+++++++..     
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC--HHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf             627988999972274829999999899979999998422246--378999999999999835999660676540246544


Q ss_pred             ---CCEEEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             ---45599999640377723552203899967898989999977763203890304787870898359956781158530
Q 007478          186 ---EDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       186 ---~~~~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~  262 (602)
                         ++.+|+||||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEE
T ss_conf             44576389998535787410122203443308999999999999988522998856767222036689968763135002


Q ss_pred             CCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCC--CCCCCC
Q ss_conf             02488-----98865579989898200014699994331022566899985099999980369999984088--999999
Q 007478          263 HIAGQ-----SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNS--KELPTI  335 (602)
Q Consensus       263 ~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~--~~~~~~  335 (602)
                      .....     ......+||+.|+|||++.+...++.++||||+||++|||++|++||.+.+.......+...  ...+..
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf             23554443211356602497874289970799989178700678646617448799899899999999998418998255


Q ss_pred             CC----------------------------CCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             99----------------------------899889999999703499999999999629355698
Q 007478          336 PD----------------------------DLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGA  373 (602)
Q Consensus       336 p~----------------------------~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~  373 (602)
                      ..                            ..++++++||.+||+.||++|+|+.|+|+||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             CCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             344320344433201334455503340444599899999999873896589099999749501569

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=382.92  Aligned_cols=262  Identities=27%  Similarity=0.476  Sum_probs=222.9

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++...  .......++.+|+.+|+.++|+||+++++++.+...+++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEE
T ss_conf             999786269712868199999999999699999980321--786899999999999985675788821354444431158


Q ss_pred             EEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC-C
Q ss_conf             996403777235522038999678989899999777632038903047878708983599567811585300248898-8
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC-P  270 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-~  270 (602)
                      |+|++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++....... .
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             EEEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCCCC
T ss_conf             86302332221121235654036789999999999877433998600146761211337826652046011046887510


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC-CHHHHHHHHHHC---------------------
Q ss_conf             6557998989820001469999433102256689998509999998-036999998408---------------------
Q 007478          271 LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQ-YEGVAAMFKIGN---------------------  328 (602)
Q Consensus       271 ~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~-~~~~~~~~~i~~---------------------  328 (602)
                      ....+++.|+|||++.....++.++||||+||++|||++|+.||.. .+....+.++..                     
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             EEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCCCC
T ss_conf             01034431014667506988880444026541889985189999889999999999986118997355134432221133


Q ss_pred             ------CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             ------89999999989988999999970349999999999962935569872
Q 007478          329 ------SKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       329 ------~~~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                            ..........+++++.+||++||+.||.+|||++|+|+||||++..+
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             CCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             44454431043306568999999999986499668909999964953407989

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=389.64  Aligned_cols=249  Identities=24%  Similarity=0.420  Sum_probs=214.0

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEE
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345599
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      ..++|++.+.||+|+||+||+|.++. ++.||||+++....     ..+.+.+|+.+++.++|||||+++|++...+.+|
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CHHHCEEEEEEEECCCEEEEEEEECC-CCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEE
T ss_conf             96995888898208882999999889-99999999878867-----6899999999999668997565352431599337


Q ss_pred             EEEEEECCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf             999640377723552203-8999678989899999777632038903047878708983599567811585300248898
Q 007478          191 IYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSC  269 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~  269 (602)
                      +||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus        77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC
T ss_conf             99983699918997520134788999999999999987765316431044315326666887768655321002368873


Q ss_pred             C--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf             8--655799898982000146999943310225668999850-9999998036999998408899999999899889999
Q 007478          270 P--LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       270 ~--~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  346 (602)
                      .  ....||+.|+|||++.+.. ++.++|||||||++|||++ |++||...........+... .....|..+++++.+|
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~l  234 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQI  234 (263)
T ss_dssp             --------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-CCCCCCTTSCHHHHHH
T ss_pred             EEECCEECCCCCCCHHHHCCCC-CCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC-CCCCCCCCCCHHHHHH
T ss_conf             3504300176667857860799-9840332105999999987898887789999999999806-8889954367999999


Q ss_pred             HHHHCCCCCCCCCCHHHHHCC
Q ss_conf             999703499999999999629
Q 007478          347 IRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       347 i~~~L~~dP~~Rps~~eiL~h  367 (602)
                      |.+||+.||++|||+++|++|
T Consensus       235 i~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         235 MNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHCCCCHHHCCCHHHHHHH
T ss_conf             999765797689199999999

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=392.05  Aligned_cols=259  Identities=24%  Similarity=0.384  Sum_probs=217.2

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC-----C
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123-----4
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV-----E  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~-----~  186 (602)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++..  .......+.+.+|+.+|+.++|+|||++++++..     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT--TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCH--HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
T ss_conf             98718888983178839999999999979999998820--0286899999999999986689874259999963464566


Q ss_pred             CEEEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             55999996403777235522038999678989899999777632038903047878708983599567811585300248
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       187 ~~~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~  266 (602)
                      ...+++++++.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++.....
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             CCEEEEEEEECCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCC
T ss_conf             864999996258862320022-4530999999999999999999738876516677633455432200132100012575


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCC--------------
Q ss_conf             898865579989898200014699994331022566899985099999980369999984088999--------------
Q 007478          267 QSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL--------------  332 (602)
Q Consensus       267 ~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--------------  332 (602)
                      .  ..+..|++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+......              
T Consensus       174 ~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         174 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             G--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             C--CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCCHHH
T ss_conf             4--44434543555835533775678551243205899999768899788988999999997307997577320010244


Q ss_pred             -------CC--------CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             -------99--------99989988999999970349999999999962935569872
Q 007478          333 -------PT--------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       333 -------~~--------~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                             ..        ....+++++++||++||+.||++|||+.|+|+||||+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             5444303557875556626789999999999977588345938999855995487999

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=382.20  Aligned_cols=251  Identities=25%  Similarity=0.416  Sum_probs=212.7

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCC----CEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf             9999247306833297599999997999----479999984164100199999999999999826999578870541234
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSG----EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~  186 (602)
                      .+++|++.++||+|+||+||+|.++.++    ..||||++...   ........+.+|+.++++++|||||+++|++.+.
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf             8899686159811779099999996899878799999998844---5968999999999999856898783236778338


Q ss_pred             CEEEEEEEEECCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             5599999640377723552203-899967898989999977763203890304787870898359956781158530024
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       187 ~~~~lV~E~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~  265 (602)
                      +.+++|||||.+++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf             80389997213574022210234542089999999999985412121234257656442788899849984551030035


Q ss_pred             CCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             8898----86557998989820001469999433102256689998509-999998036999998408899999999899
Q 007478          266 GQSC----PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSKELPTIPDDLS  340 (602)
Q Consensus       266 ~~~~----~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  340 (602)
                      ....    .....||+.|+|||++.+.. ++.++|||||||++|||+++ .++|........+..+.. ...+..+..++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~  239 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTPMDCP  239 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTCB
T ss_pred             CCCCCCEEECCCCCCCCCCCHHHHCCCC-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCCCCHHHH
T ss_conf             7876526742677773434888870499-997355634489899999679886556899999999863-57899850457


Q ss_pred             HHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             88999999970349999999999962
Q 007478          341 DEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       341 ~~l~~Li~~~L~~dP~~Rps~~eiL~  366 (602)
                      .++.+||.+||..||++|||+.+|++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             99999999977679768939999999

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=382.62  Aligned_cols=248  Identities=25%  Similarity=0.405  Sum_probs=219.2

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123455999
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~l  191 (602)
                      .++|++++.||+|+||+||+|+++ +++.||||+++....  .   .+.+.+|+.++++++||||++++|++.+++.+++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--C---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC--C---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
T ss_conf             699799689820788399999988-998999999874757--7---8999999999996689860158899850781699


Q ss_pred             EEEEECCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             9964037772355220-389996789898999997776320389030478787089835995678115853002488988
Q 007478          192 YLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~  270 (602)
                      ||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf             99704899388864102467768999999999999999875468434665413588769984798861442023578722


Q ss_pred             --CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH
Q ss_conf             --655799898982000146999943310225668999850-99999980369999984088999999998998899999
Q 007478          271 --LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDFI  347 (602)
Q Consensus       271 --~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~Li  347 (602)
                        ....||+.|+|||++.+.. ++.++|||||||++|||++ |+.||..........++.... ....|..+++++.+||
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li  234 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASEKVYTIM  234 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred             EECCCCCCCCCCCCHHHCCCC-CCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC-CCCCCCCCCHHHHHHH
T ss_conf             524657887757807863799-88521033643246739755999988999999999998079-7899654659999999


Q ss_pred             HHHCCCCCCCCCCHHHHHCC
Q ss_conf             99703499999999999629
Q 007478          348 RLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       348 ~~~L~~dP~~Rps~~eiL~h  367 (602)
                      .+||+.||++|||+++|++|
T Consensus       235 ~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHCCCCHHHCCCHHHHHHH
T ss_conf             99766897689399999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=382.52  Aligned_cols=258  Identities=24%  Similarity=0.373  Sum_probs=215.7

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC------
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957887054123------
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV------  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~------  185 (602)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++....  ........+.+|+.++++++|||||++++++..      
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCC
T ss_conf             377599889621758599999999999899999988233--697999999999999986489876489989702564345


Q ss_pred             CCEEEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             45599999640377723552203899967898989999977763203890304787870898359956781158530024
Q 007478          186 EDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIA  265 (602)
Q Consensus       186 ~~~~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~  265 (602)
                      ...+|+|||||.++.+ +.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus        94 ~~~~~iv~Ey~~~~l~-~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          94 FQDVYLVMELMDANLC-QVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             CCEEEEEEECCSEEHH-HHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCEEEEEEECCCHHHH-HHHH--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCCC
T ss_conf             7626999841446778-7650--389999999999999999988652211245677632113654431320102321146


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCC-------------
Q ss_conf             8898865579989898200014699994331022566899985099999980369999984088999-------------
Q 007478          266 GQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMFKIGNSKEL-------------  332 (602)
Q Consensus       266 ~~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~-------------  332 (602)
                      ........+||+.|+|||++.+.. ++.++||||+||++|||++|++||.+.+......++......             
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             ----------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             CCCCCCCCCCCCCCCCHHHHCCCC-CCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHH
T ss_conf             665533221465555813314777-7877433356625789865989988897788999999720589879998765667


Q ss_pred             ----------CC-----------------CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             ----------99-----------------99989988999999970349999999999962935569872
Q 007478          333 ----------PT-----------------IPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDHPFVKGAAP  375 (602)
Q Consensus       333 ----------~~-----------------~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~hp~f~~~~~  375 (602)
                                ..                 ....++.++.+||++||..||++|||++|+|+||||+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  319 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             HHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf             7776417543566642126433354321013337999999999987699457908999966942087888

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=381.98  Aligned_cols=253  Identities=25%  Similarity=0.424  Sum_probs=220.0

Q ss_pred             CCCCCCEEEEEEEECCCEEEEEEEECCCCCE--EEEEEEECCCCHHCHHHHHHHHHHHHHHHHC-CCCCEEEEECCCCCC
Q ss_conf             9999924730683329759999999799947--9999984164100199999999999999826-999578870541234
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSDSGEM--CAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTVE  186 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~--vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~g~~~~~  186 (602)
                      ...++|++.+.||+|+||+||+|+++.++..  ||||+++.   ....+..+.+.+|+.+|.++ +|||||++++++.++
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC---C------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             CCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC
T ss_conf             68799688779820788289999998999699999999782---338579999999999998622899883678888418


Q ss_pred             CEEEEEEEEECCCCHHHHHHCC----------------CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCC
Q ss_conf             5599999640377723552203----------------899967898989999977763203890304787870898359
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDY----------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPN  250 (602)
Q Consensus       187 ~~~~lV~E~~~ggsL~~~l~~~----------------~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~  250 (602)
                      +.+|+||||+++|+|.++|+..                ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
T ss_conf             73699998028986999986403555551231012345789999999999999999876630895455505204898688


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCHHHHHHHHHHCC
Q ss_conf             956781158530024889886557998989820001469999433102256689998509-9999980369999984088
Q 007478          251 GRVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNS  329 (602)
Q Consensus       251 g~iKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG-~~Pf~~~~~~~~~~~i~~~  329 (602)
                      +.+||+|||+++............||..|+|||.+.... ++.++|||||||++|||++| .+||...+.......+...
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             CCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCC-CCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC
T ss_conf             763874344322444223455301377555538752699-9962215313889999983689999999999999999826


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             99999999899889999999703499999999999629
Q 007478          330 KELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       330 ~~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~h  367 (602)
                       ..+.++..+++++++||.+||..||++|||+.+|++|
T Consensus       243 -~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             -8888876678999999999767896689499999999

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=380.68  Aligned_cols=251  Identities=26%  Similarity=0.403  Sum_probs=211.8

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCC----EEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf             9992473068332975999999979994----799999841641001999999999999998269995788705412345
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGE----MCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~  187 (602)
                      .++|++.++||+|+||+||+|.++.+|+    .||+|+++..   ......+.+.+|+.++++++|||||+++|++.+. 
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-
T ss_conf             899978319820899299999995899889899999996513---4979999999999999867998881589999619-


Q ss_pred             EEEEEEEEECCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             59999964037772355220-38999678989899999777632038903047878708983599567811585300248
Q 007478          188 KLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lV~E~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~  266 (602)
                      ..++++|++.+|+|.+++.. ...+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf             83699984268740101113345799999999999999999999876950476212031167998758602552223354


Q ss_pred             CCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf             8988---655799898982000146999943310225668999850-999999803699999840889999999989988
Q 007478          267 QSCP---LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDE  342 (602)
Q Consensus       267 ~~~~---~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  342 (602)
                      ....   ....||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.........+.. ...+..|..++.+
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~p~~~~~~  241 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTID  241 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-TCCCCCCTTBCHH
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCC-CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHH
T ss_conf             44532236510586446708874699-983565440799999999779999999998999999975-9989998556899


Q ss_pred             HHHHHHHHCCCCCCCCCCHHHHHCCC
Q ss_conf             99999997034999999999996293
Q 007478          343 GKDFIRLCLQRNPLNRPTAAELLDHP  368 (602)
Q Consensus       343 l~~Li~~~L~~dP~~Rps~~eiL~hp  368 (602)
                      +.+||.+||..||++|||+.+|++|-
T Consensus       242 ~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf             99999984789934691999999999

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=381.34  Aligned_cols=255  Identities=27%  Similarity=0.462  Sum_probs=214.4

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCEEE
Q ss_conf             99992473068332975999999979994799999841641001999999999999998269995788705412345599
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~  190 (602)
                      ..++|++++.||+|+||+||+|+++.+ +.||||+++....     ..+.+.+|+.++++++|+|||+++|++.+ +.+|
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEE
T ss_conf             779979846993079809999999999-9999999880448-----88999999999986666788689999823-9759


Q ss_pred             EEEEEECCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf             99964037772355220--3899967898989999977763203890304787870898359956781158530024889
Q 007478          191 IYLEYVSGGSIYKLLQD--YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQS  268 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~--~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~  268 (602)
                      +||||+++|+|..++..  ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC
T ss_conf             99994479943542000035530599999999999999998754114335312307999899929984425554256887


Q ss_pred             --CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf             --88655799898982000146999943310225668999850999-999803699999840889999999989988999
Q 007478          269 --CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKP-PWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKD  345 (602)
Q Consensus       269 --~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~-Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  345 (602)
                        ......||+.|+|||++.... ++.++|||||||++|||++|.. +|........+..+... ....++..+++++++
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~  245 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHD  245 (285)
T ss_dssp             --------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHH
T ss_pred             CEEECCCCCCCCCCCHHHHHCCC-CCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC-CCCCCCCCCCHHHHH
T ss_conf             33524545566545808983799-8917741323589999986899999888899999999826-899998323799999


Q ss_pred             HHHHHCCCCCCCCCCHHHHHC--CCCCCCCC
Q ss_conf             999970349999999999962--93556987
Q 007478          346 FIRLCLQRNPLNRPTAAELLD--HPFVKGAA  374 (602)
Q Consensus       346 Li~~~L~~dP~~Rps~~eiL~--hp~f~~~~  374 (602)
                      ||.+||+.||++||++++|++  ++||....
T Consensus       246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf             9999756697589199999998766623899

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=378.58  Aligned_cols=250  Identities=27%  Similarity=0.438  Sum_probs=215.0

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCC---CEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCE
Q ss_conf             999247306833297599999997999---47999998416410019999999999999982699957887054123455
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSG---EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVEDK  188 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~~  188 (602)
                      .++|++++.||+|+||+||+|++..++   ..||+|.++.   .......+.+.+|+.+|++++|||||++++++. ++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT---TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCE
T ss_conf             8996987799307882999999936996449999999365---668799999999999998689999856988995-374


Q ss_pred             EEEEEEEECCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             9999964037772355220-389996789898999997776320389030478787089835995678115853002488
Q 007478          189 LYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       189 ~~lV~E~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~  267 (602)
                      +|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEECCCC
T ss_conf             79999840698077654224789999999999999987752302267441410265532067896787650342133677


Q ss_pred             CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf             98--8655799898982000146999943310225668999850-99999980369999984088999999998998899
Q 007478          268 SC--PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGK  344 (602)
Q Consensus       268 ~~--~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  344 (602)
                      ..  .....||+.|+|||++.+.. ++.++|||||||++|||++ |.+||..........++.... .+.++..+++++.
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~  239 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLY  239 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHH
T ss_pred             CCEECCCEECCCCCCHHHHHCCCC-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHH
T ss_conf             623305400583103266751699-88745244424789999826999988899999999998189-9989877799999


Q ss_pred             HHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             99999703499999999999629
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       345 ~Li~~~L~~dP~~Rps~~eiL~h  367 (602)
                      +||.+||..||++|||+.+|++|
T Consensus       240 ~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         240 SLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             99999768797689299999999

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=379.46  Aligned_cols=252  Identities=27%  Similarity=0.413  Sum_probs=209.7

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHC-CCCCEEEEECCCCC
Q ss_conf             9992473068332975999999979-----99479999984164100199999999999999826-99957887054123
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKTV  185 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~g~~~~  185 (602)
                      .++|++++.||+|+||.||+|.+..     +++.||+|+++..   ......+.+.+|..++.++ +|+||+.+++++..
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECC
T ss_conf             7997984498416783999999867775557839999998600---1717899999999998861499849974115404


Q ss_pred             -CCEEEEEEEEECCCCHHHHHHCC----------------CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEC
Q ss_conf             -45599999640377723552203----------------8999678989899999777632038903047878708983
Q 007478          186 -EDKLYIYLEYVSGGSIYKLLQDY----------------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVD  248 (602)
Q Consensus       186 -~~~~~lV~E~~~ggsL~~~l~~~----------------~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~  248 (602)
                       ...+++|||||++|+|.+++...                ..+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
T ss_conf             79757999984589929999985366666532220233214689999999999999999988737971786773106577


Q ss_pred             CCCCEEEECCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCHHHHHHH
Q ss_conf             599567811585300248898---86557998989820001469999433102256689998509-99999803699999
Q 007478          249 PNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMF  324 (602)
Q Consensus       249 ~~g~iKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG-~~Pf~~~~~~~~~~  324 (602)
                      .++.+||+|||+|+.......   .....||+.|+|||++.+.. ++.++|||||||++|||+++ .+||........+.
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf             99828984575200113566522247516672102036864688-99663221367899999868899998999899999


Q ss_pred             HHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             8408899999999899889999999703499999999999629
Q 007478          325 KIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       325 ~i~~~~~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~h  367 (602)
                      ........+.++..+++++++||.+||+.||++|||+.++++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             9996389888886578999999999767796679199999999

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=375.58  Aligned_cols=250  Identities=23%  Similarity=0.424  Sum_probs=217.3

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf             9992473068332975999999979-----99479999984164100199999999999999826999578870541234
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVE  186 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~  186 (602)
                      .++|++.+.||+|+||+||+|.++.     ++..||||+++.   .......+.+.+|+.+|+.++||||+++++++...
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~---~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT---TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECH---HCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCC
T ss_conf             889388679820788399999988876577882999999882---10857999999999999966899765524666059


Q ss_pred             CEEEEEEEEECCCCHHHHHHCCC------------------------CCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCC
Q ss_conf             55999996403777235522038------------------------999678989899999777632038903047878
Q 007478          187 DKLYIYLEYVSGGSIYKLLQDYG------------------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKG  242 (602)
Q Consensus       187 ~~~~lV~E~~~ggsL~~~l~~~~------------------------~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp  242 (602)
                      +..+++|||+.+|+|.+++....                        .+++..+..|+.||+.||+|||+++|+||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEECC
T ss_conf             80389998158992999998527554210000111001210346788989999999999999985541357868548840


Q ss_pred             CCEEECCCCCEEEECCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCH
Q ss_conf             70898359956781158530024889---886557998989820001469999433102256689998509-99999803
Q 007478          243 ANILVDPNGRVKLADFGMAKHIAGQS---CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYE  318 (602)
Q Consensus       243 ~NILl~~~g~iKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG-~~Pf~~~~  318 (602)
                      +|||++.++.+||+|||+|+.+....   ...+..|++.|+|||++.+.. ++.++|||||||++|||++| .+||....
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             CCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCHHHHHCCCHHHHHHHHCCCCCCCCCCC
T ss_conf             11689899928983314421136776411157777676767989972688-98056302523629999806899999989


Q ss_pred             HHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             699999840889999999989988999999970349999999999962
Q 007478          319 GVAAMFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       319 ~~~~~~~i~~~~~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~  366 (602)
                      ..+....+.... .+.++..+++++.+||.+||+.||++|||+.||++
T Consensus       248 ~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         248 HEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHCCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             999999997399-78887325299999999974889657939999999

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=371.77  Aligned_cols=252  Identities=28%  Similarity=0.453  Sum_probs=216.1

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEEC-----CCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHC-CCCCEEEEECCCC
Q ss_conf             9999247306833297599999997-----999479999984164100199999999999999826-9995788705412
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNS-----DSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGSKT  184 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~g~~~  184 (602)
                      ..++|++++.||+|+||.||+|+++     .+++.||||+++...   .......+.+|+.+++.+ +|||||++++++.
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE
T ss_conf             789969854982068829999998066447788699999987424---87799999999999876269998878998983


Q ss_pred             CCCEEEEEEEEECCCCHHHHHHCCC------------------CCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEE
Q ss_conf             3455999996403777235522038------------------9996789898999997776320389030478787089
Q 007478          185 VEDKLYIYLEYVSGGSIYKLLQDYG------------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANIL  246 (602)
Q Consensus       185 ~~~~~~lV~E~~~ggsL~~~l~~~~------------------~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NIL  246 (602)
                      +.+.+|+|||||++|+|.+++....                  .+++..+..|+.||+.||+|||+++++||||||+|||
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCC
T ss_conf             19978999973799879999985356654444453322233458899999999999999999887579266624102100


Q ss_pred             ECCCCCEEEECCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHH
Q ss_conf             835995678115853002488988---655799898982000146999943310225668999850-9999998036999
Q 007478          247 VDPNGRVKLADFGMAKHIAGQSCP---LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAA  322 (602)
Q Consensus       247 l~~~g~iKL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~  322 (602)
                      ++.++.+||+|||+++........   ...+||+.|+|||++.... ++.++|||||||++|||++ |.++|........
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf             0025752102340102336788615862013596876778861799-997400102589999998589988778998999


Q ss_pred             HHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             99840889999999989988999999970349999999999962
Q 007478          323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       323 ~~~i~~~~~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~  366 (602)
                      +.++......+..+..++.++.+||.+||+.||++|||+.+|++
T Consensus       257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             99998668988985436599999999975779657929999999

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=370.53  Aligned_cols=251  Identities=26%  Similarity=0.445  Sum_probs=216.4

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCC-------CEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHC-CCCCEEEEECC
Q ss_conf             9999247306833297599999997999-------479999984164100199999999999999826-99957887054
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSG-------EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRL-RHPNIVQYYGS  182 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-------~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l-~HpnIv~l~g~  182 (602)
                      ..++|++++.||+|+||.||+|++..++       ..||+|+++..   ........+.+|...+.++ +|||||+++++
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHHHHCCCCEEEECCCC
T ss_conf             5899697009851678289999985787555667549999998811---2868899999999999981399969734652


Q ss_pred             CCCCCEEEEEEEEECCCCHHHHHHCCC----------------CCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEE
Q ss_conf             123455999996403777235522038----------------9996789898999997776320389030478787089
Q 007478          183 KTVEDKLYIYLEYVSGGSIYKLLQDYG----------------QFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANIL  246 (602)
Q Consensus       183 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NIL  246 (602)
                      +.+++.+|+|||||++|+|.++|....                .+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             CCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCEE
T ss_conf             20188689999736999099999860677643222334574346799999999999999998766379786302210224


Q ss_pred             ECCCCCEEEECCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHH
Q ss_conf             83599567811585300248898---8655799898982000146999943310225668999850-9999998036999
Q 007478          247 VDPNGRVKLADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAA  322 (602)
Q Consensus       247 l~~~g~iKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~  322 (602)
                      ++.++.+||+|||+++.......   .....|++.|+|||++.+.. |+.++|||||||++|||++ |.+||........
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCC-CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHH
T ss_conf             5478976762211101135555543146678884663266751798-882555477588888740179898999999999


Q ss_pred             HHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             99840889999999989988999999970349999999999962
Q 007478          323 MFKIGNSKELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       323 ~~~i~~~~~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~  366 (602)
                      ...+.. ...+.++..+++++.+||.+||+.||++|||+.+|++
T Consensus       247 ~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHC-CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             999972-8888987435299999999976679767939999999

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=372.91  Aligned_cols=253  Identities=28%  Similarity=0.438  Sum_probs=218.2

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECC-CC--CEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf             99992473068332975999999979-99--4799999841641001999999999999998269995788705412345
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSD-SG--EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED  187 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-tg--~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~  187 (602)
                      ..++|++.+.||+|+||+||+|.+.. ++  ..||||+++.... ...+..+.+.+|+.+|+.++||||++++|++.+ .
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-C
T ss_conf             64891997898038883999999988999079999999983555-798999999999999986899998789877740-1


Q ss_pred             EEEEEEEEECCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             59999964037772355220-38999678989899999777632038903047878708983599567811585300248
Q 007478          188 KLYIYLEYVSGGSIYKLLQD-YGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAG  266 (602)
Q Consensus       188 ~~~lV~E~~~ggsL~~~l~~-~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~  266 (602)
                      .+++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             CHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCC
T ss_conf             00114654238612544421268999999999999999999875217875205668881565565433256115553035


Q ss_pred             CCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf             8988----655799898982000146999943310225668999850-99999980369999984088999999998998
Q 007478          267 QSCP----LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSD  341 (602)
Q Consensus       267 ~~~~----~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  341 (602)
                      ....    ....|+..|+|||++.+.. ++.++|||||||++|||++ |++||.+.+......++......+..+..++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             CCCCCEECCCCCCCCCCCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCH
T ss_conf             887526547632573107999983799-9942156614899999996899999996999999999847999998544539


Q ss_pred             HHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             8999999970349999999999962
Q 007478          342 EGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       342 ~l~~Li~~~L~~dP~~Rps~~eiL~  366 (602)
                      ++.+||.+||..||++|||+.+|++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             9999999976889667929999999

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.54  Aligned_cols=247  Identities=24%  Similarity=0.396  Sum_probs=206.0

Q ss_pred             EEEEEEEECCCEEEEEEEECCCC---CEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC-CCEEEE
Q ss_conf             47306833297599999997999---47999998416410019999999999999982699957887054123-455999
Q 007478          116 KKGKMLGRGTFGHVYVGFNSDSG---EMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV-EDKLYI  191 (602)
Q Consensus       116 ~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~~l  191 (602)
                      ...++||+|+||+||+|.+..++   ..||||+++.   .......+.+.+|+.+|++++||||++++|++.. ++.+++
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf             266698136880999999977998799999999884---36978999999999999867899986786789806994389


Q ss_pred             EEEEECCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             99640377723552203-89996789898999997776320389030478787089835995678115853002488988
Q 007478          192 YLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQSCP  270 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~  270 (602)
                      |||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+......
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf             99874067414421013454048999999999887652003367625776687576779998899106523225566555


Q ss_pred             -----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC-HHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf             -----65579989898200014699994331022566899985099999980-369999984088999999998998899
Q 007478          271 -----LSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQY-EGVAAMFKIGNSKELPTIPDDLSDEGK  344 (602)
Q Consensus       271 -----~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~s~~l~  344 (602)
                           ....||..|+|||++.... ++.++||||||+++|||++|..||... ........+... ..+..|..+++++.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~~~p~~~~~~l~  264 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDPLY  264 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCCCCCTTCCHHHH
T ss_pred             CCEECCCCCCCCCCCCHHHHHCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHH
T ss_conf             310025655564556768874379-9974574661999999997899998889999999999808-98899644759999


Q ss_pred             HHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             99999703499999999999629
Q 007478          345 DFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       345 ~Li~~~L~~dP~~Rps~~eiL~h  367 (602)
                      +||.+||..||++||++.||++|
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             99999768897689399999999

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.25  Aligned_cols=253  Identities=24%  Similarity=0.407  Sum_probs=217.1

Q ss_pred             CCCCCCEEEEEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCC
Q ss_conf             999992473068332975999999979-----994799999841641001999999999999998269995788705412
Q 007478          110 SPESHWKKGKMLGRGTFGHVYVGFNSD-----SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKT  184 (602)
Q Consensus       110 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~  184 (602)
                      ...++|++++.||+|+||+||+|.++.     ++..||||+++..   ........+.+|+.++++++|||||++++++.
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf             268991883598207881899999878644778968999998701---28689999999999999769998841254784


Q ss_pred             CCCEEEEEEEEECCCCHHHHHHCC----------CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEE
Q ss_conf             345599999640377723552203----------8999678989899999777632038903047878708983599567
Q 007478          185 VEDKLYIYLEYVSGGSIYKLLQDY----------GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVK  254 (602)
Q Consensus       185 ~~~~~~lV~E~~~ggsL~~~l~~~----------~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iK  254 (602)
                      .++..++||||+.+|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCCEEE
T ss_conf             28810677760489988999875033211344468879999999999999999987647965432867754035996499


Q ss_pred             EECCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCHHHHHHHHHHCCC
Q ss_conf             811585300248898---86557998989820001469999433102256689998509-99999803699999840889
Q 007478          255 LADFGMAKHIAGQSC---PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATT-KPPWSQYEGVAAMFKIGNSK  330 (602)
Q Consensus       255 L~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG-~~Pf~~~~~~~~~~~i~~~~  330 (602)
                      |+|||+|+.+.....   .....||+.|+|||.+.+.. ++.++|||||||++|||++| ++||.+.+....+..+....
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  252 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
T ss_conf             94245420235776303134023163237888873699-88333444378999999968999999989999999998088


Q ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             9999999899889999999703499999999999629
Q 007478          331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       331 ~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~h  367 (602)
                       .+..+..++.++.+||.+||+.||++|||+.+|+++
T Consensus       253 -~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         253 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             -888863353999999999757796589399999999

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.89  Aligned_cols=245  Identities=24%  Similarity=0.434  Sum_probs=212.9

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC-CCEE
Q ss_conf             999924730683329759999999799947999998416410019999999999999982699957887054123-4559
Q 007478          111 PESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTV-EDKL  189 (602)
Q Consensus       111 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~  189 (602)
                      ..++|++++.||+|+||.||+|.++  |..||||+++...      ..+.+.+|+.++++++||||++++|++.+ .+.+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CHHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCHH------HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
T ss_conf             7899488579820798089999999--9099999988577------7999999999998678989854987887238928


Q ss_pred             EEEEEEECCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             9999640377723552203--89996789898999997776320389030478787089835995678115853002488
Q 007478          190 YIYLEYVSGGSIYKLLQDY--GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGMAKHIAGQ  267 (602)
Q Consensus       190 ~lV~E~~~ggsL~~~l~~~--~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~  267 (602)
                      |+||||+++|+|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEECCCC
T ss_conf             99996369998999987457888899999999999985232113376553666567601468997763245600344787


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf             988655799898982000146999943310225668999850-9999998036999998408899999999899889999
Q 007478          268 SCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMAT-TKPPWSQYEGVAAMFKIGNSKELPTIPDDLSDEGKDF  346 (602)
Q Consensus       268 ~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  346 (602)
                        .....++..|+|||++.+.. ++.++|||||||++|||++ |++||...........+.. ...+.++..+++++++|
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~l  232 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEV  232 (262)
T ss_dssp             -------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHHH
T ss_pred             --CCCCCCCCCCCCHHHHHCCC-CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHH
T ss_conf             --76556664677817872798-885887775799999999789999999999999999980-89999976579999999


Q ss_pred             HHHHCCCCCCCCCCHHHHHCC
Q ss_conf             999703499999999999629
Q 007478          347 IRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       347 i~~~L~~dP~~Rps~~eiL~h  367 (602)
                      |.+||..||++|||+.+++++
T Consensus       233 i~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         233 MKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHCCCCHHHCCCHHHHHHH
T ss_conf             999756697689399999999

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=347.63  Aligned_cols=252  Identities=20%  Similarity=0.303  Sum_probs=200.3

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCE-EEEECCCCCCCEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699957-88705412345599
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNI-VQYYGSKTVEDKLY  190 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~  190 (602)
                      .++|++++.||+|+||+||+|+++.+++.||||++.....      ...+.+|+.+++.++|+++ +.+.+++.+.+..+
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC------CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEE
T ss_conf             8889996898507880999999988998999999721005------8889999999997038996017999995198778


Q ss_pred             EEEEEECCCCHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECC---CCCEEEECCCCCCCCCC
Q ss_conf             999640377723552-20389996789898999997776320389030478787089835---99567811585300248
Q 007478          191 IYLEYVSGGSIYKLL-QDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP---NGRVKLADFGMAKHIAG  266 (602)
Q Consensus       191 lV~E~~~ggsL~~~l-~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~---~g~iKL~DFGla~~~~~  266 (602)
                      +||||+. ++|.+.+ ...+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+.+..
T Consensus        80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEECC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf             9998738-713332443068876899999999999999999979944266787660643357776156504675134255


Q ss_pred             CCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHH---HH---HCCCCC
Q ss_conf             898--------8655799898982000146999943310225668999850999999803699999---84---088999
Q 007478          267 QSC--------PLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGVAAMF---KI---GNSKEL  332 (602)
Q Consensus       267 ~~~--------~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~~~~~---~i---~~~~~~  332 (602)
                      ...        .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..........   +.   ......
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             CCCCCCEECCCCCCCCCCCCCCCHHHHHCCC-CCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCH
T ss_conf             4455410001357767873532999991899-898321886177899998498766553057799999985235678983


Q ss_pred             CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH---HCCCCCC
Q ss_conf             99999899889999999703499999999999---6293556
Q 007478          333 PTIPDDLSDEGKDFIRLCLQRNPLNRPTAAEL---LDHPFVK  371 (602)
Q Consensus       333 ~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~ei---L~hp~f~  371 (602)
                      +.+...+++++.+||..||..||++||++.++   |+|.|.+
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             575347889999999998439955791999999999999997

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.59  Aligned_cols=247  Identities=29%  Similarity=0.391  Sum_probs=194.1

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC----E
Q ss_conf             992473068332975999999979994799999841641001999999999999998269995788705412345----5
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHPNIVQYYGSKTVED----K  188 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~g~~~~~~----~  188 (602)
                      .+|.+.+.||+|+||.||+|++  +|+.||||+++...     ........|+..+..++|||||++++++.+++    .
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC-----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEE
T ss_conf             6899988982078819999999--99899999987200-----4679999999999627998683268899837986048


Q ss_pred             EEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCC--------CCCEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             99999640377723552203899967898989999977763203--------8903047878708983599567811585
Q 007478          189 LYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHS--------KHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       189 ~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~--------~gIvHrDLKp~NILl~~~g~iKL~DFGl  260 (602)
                      +|+|||||++|+|.+++++. .+++..+..++.|++.||.|||.        +||+||||||+|||++.++.+||+|||+
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCC
T ss_conf             99999646698989998658-99989999999999999999887665204689866153173135786887768876386


Q ss_pred             CCCCCCCCC-----CCCCCCCCCCCCCCCCCCCC-----CCCCCCCCHHHHHHHHHHHHCCCCCCCCH------------
Q ss_conf             300248898-----86557998989820001469-----99943310225668999850999999803------------
Q 007478          261 AKHIAGQSC-----PLSFKGSPYWMAPEVIKNSS-----GCNLAVDIWSLGCTVLEMATTKPPWSQYE------------  318 (602)
Q Consensus       261 a~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~-----~~s~~sDIWSlGviLyeLltG~~Pf~~~~------------  318 (602)
                      ++.......     .....||+.|+|||++....     .++.++|||||||+||||++|.+||....            
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCC
T ss_conf             62346777620013552503547678221056545467776750122015999999962899887663112410122556


Q ss_pred             --HHHHHHH-HHCCCCCCCCCCC-----CCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             --6999998-4088999999998-----99889999999703499999999999629
Q 007478          319 --GVAAMFK-IGNSKELPTIPDD-----LSDEGKDFIRLCLQRNPLNRPTAAELLDH  367 (602)
Q Consensus       319 --~~~~~~~-i~~~~~~~~~p~~-----~s~~l~~Li~~~L~~dP~~Rps~~eiL~h  367 (602)
                        ....+.. .......+.++..     ...++.+|+.+||+.||++|||+.||+++
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             430999999875024688877655776899999999999760698589599999999

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=340.88  Aligned_cols=247  Identities=22%  Similarity=0.279  Sum_probs=203.5

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCC-CCEEEEECCCCCCCEEE
Q ss_conf             99924730683329759999999799947999998416410019999999999999982699-95788705412345599
Q 007478          112 ESHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH-PNIVQYYGSKTVEDKLY  190 (602)
Q Consensus       112 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~  190 (602)
                      .++|++++.||+|+||+||+|++..+|+.||+|++.....      ...+.+|+..++.+.| +||+.+++++......|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCE
T ss_conf             9806997998417882999999988997999999750258------2999999999999648999877999960188117


Q ss_pred             EEEEEECCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECC-----CCCEEEECCCCCCCC
Q ss_conf             999640377723552203-89996789898999997776320389030478787089835-----995678115853002
Q 007478          191 IYLEYVSGGSIYKLLQDY-GQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDP-----NGRVKLADFGMAKHI  264 (602)
Q Consensus       191 lV~E~~~ggsL~~~l~~~-~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~-----~g~iKL~DFGla~~~  264 (602)
                      +||||+ +++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+.+
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEEC
T ss_conf             999964-8887999975203110689999999999999999977966266771315234754344795687236605771


Q ss_pred             CCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCH---HHHHHHHHHC---CC
Q ss_conf             4889--------88655799898982000146999943310225668999850999999803---6999998408---89
Q 007478          265 AGQS--------CPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYE---GVAAMFKIGN---SK  330 (602)
Q Consensus       265 ~~~~--------~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~---~~~~~~~i~~---~~  330 (602)
                      ....        .....+||+.|||||++.+.. ++.++|||||||++|||++|+.||....   ......++..   ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCEEECCCCCEEECHHHCCHHHHCCCC-CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf             467665411102467627751026798964888-8869998983199999986987678853021999999997056799


Q ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             999999989988999999970349999999999962
Q 007478          331 ELPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAELLD  366 (602)
Q Consensus       331 ~~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~eiL~  366 (602)
                      ....+...+|+++.+|+..|+..+|++||+++.+.+
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf             958965799899999999984399300859999999

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=337.61  Aligned_cols=257  Identities=24%  Similarity=0.351  Sum_probs=198.5

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCC-----------CCCEEEEEC
Q ss_conf             992473068332975999999979994799999841641001999999999999998269-----------995788705
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-----------HPNIVQYYG  181 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-----------HpnIv~l~g  181 (602)
                      .+|++++.||+|+||+||+|+++.+|+.||||++++     .....+.+.+|+.+++.++           |+||+++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~-----~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEC-----CCCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEE
T ss_conf             857998997507781899999999997999999834-----313368999999999984014555554227676478998


Q ss_pred             CCCCC--CEEEEEEEEECCCCHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHCC-CCCEECCCCCCCEEECCCC----
Q ss_conf             41234--5599999640377723552---203899967898989999977763203-8903047878708983599----
Q 007478          182 SKTVE--DKLYIYLEYVSGGSIYKLL---QDYGQFGEPAIRNYTQQILSGLAFLHS-KHTVHRDIKGANILVDPNG----  251 (602)
Q Consensus       182 ~~~~~--~~~~lV~E~~~ggsL~~~l---~~~~~ls~~~i~~i~~qIl~gL~yLH~-~gIvHrDLKp~NILl~~~g----  251 (602)
                      ++...  ...+++++++..+......   .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++    
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             EEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCC
T ss_conf             76312565202343200035420000012234678689999999999999888764058646567705705630576564


Q ss_pred             --CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHH---------
Q ss_conf             --567811585300248898865579989898200014699994331022566899985099999980369---------
Q 007478          252 --RVKLADFGMAKHIAGQSCPLSFKGSPYWMAPEVIKNSSGCNLAVDIWSLGCTVLEMATTKPPWSQYEGV---------  320 (602)
Q Consensus       252 --~iKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~~sDIWSlGviLyeLltG~~Pf~~~~~~---------  320 (602)
                        .+||+|||.+......  ....+||+.|+|||++.... ++.++||||+||++++|++|+.||...+..         
T Consensus       168 ~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CCEEEEEECCCCCCCCCC--CCCCCCCCCCCCHHHCCCCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf             430567531442123445--42236652105713214667-776432012378999998788998987554321026899


Q ss_pred             HHHHHHHCC----------------------CC---------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf             999984088----------------------99---------------99999989988999999970349999999999
Q 007478          321 AAMFKIGNS----------------------KE---------------LPTIPDDLSDEGKDFIRLCLQRNPLNRPTAAE  363 (602)
Q Consensus       321 ~~~~~i~~~----------------------~~---------------~~~~p~~~s~~l~~Li~~~L~~dP~~Rps~~e  363 (602)
                      .....+...                      ..               ...++...++++++||.+||.+||.+|||+.|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf             99999837998788624532200013201220243235776444210001567435899999999987799457908999


Q ss_pred             HHCCCCCCCCCCCC
Q ss_conf             96293556987210
Q 007478          364 LLDHPFVKGAAPLE  377 (602)
Q Consensus       364 iL~hp~f~~~~~~~  377 (602)
                      +|+||||++....+
T Consensus       325 ~L~Hp~f~~~~~~~  338 (362)
T d1q8ya_         325 LVNHPWLKDTLGME  338 (362)
T ss_dssp             HHTCGGGTTCTTCT
T ss_pred             HHCCCCCCCCCCCC
T ss_conf             96693407898744

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.95  E-value=3.7e-28  Score=182.86  Aligned_cols=168  Identities=17%  Similarity=0.187  Sum_probs=122.8

Q ss_pred             CEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC--------------HHCHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf             2473068332975999999979994799999841641--------------00199999999999999826999578870
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD--------------AKSKESAKQLMQEIVLLSRLRHPNIVQYY  180 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--------------~~~~~~~~~l~~Ei~iL~~l~HpnIv~l~  180 (602)
                      +.+++.||+|+||+||+|.+. +|+.||||+++....              ...........+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf             022778024856599999979-9999999998604434666556563000888999999778999999981699914499


Q ss_pred             CCCCCCCEEEEEEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             54123455999996403777235522038999678989899999777632038903047878708983599567811585
Q 007478          181 GSKTVEDKLYIYLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLHSKHTVHRDIKGANILVDPNGRVKLADFGM  260 (602)
Q Consensus       181 g~~~~~~~~~lV~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGl  260 (602)
                      +...    .+++|||+++..+.+       ++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EECC----CEEEEEEECCCCCCC-------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEECCC
T ss_conf             8628----889999504565420-------0157899999999999999826888983689036114289-899987788


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             300248898865579989898------20001469999433102256689
Q 007478          261 AKHIAGQSCPLSFKGSPYWMA------PEVIKNSSGCNLAVDIWSLGCTV  304 (602)
Q Consensus       261 a~~~~~~~~~~~~~GT~~Y~A------PE~l~~~~~~s~~sDIWSlGviL  304 (602)
                      |.........       .|..      .+.+ .+ .|+..+|+||+.--+
T Consensus       149 a~~~~~~~~~-------~~l~rd~~~~~~~f-~r-~y~~~~d~~s~~~~~  189 (191)
T d1zara2         149 SVEVGEEGWR-------EILERDVRNIITYF-SR-TYRTEKDINSAIDRI  189 (191)
T ss_dssp             CEETTSTTHH-------HHHHHHHHHHHHHH-HH-HHCCCCCHHHHHHHH
T ss_pred             CCCCCCCCCH-------HHHHHHHHHHHHHH-CC-CCCCCCCHHHHHHHH
T ss_conf             4308998709-------99987799999997-57-899844689999987

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.82  E-value=1.2e-08  Score=66.55  Aligned_cols=139  Identities=12%  Similarity=0.066  Sum_probs=83.5

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCC-CCCEEEEECCCCCCCEEEE
Q ss_conf             992473068332975999999979994799999841641001999999999999998269-9957887054123455999
Q 007478          113 SHWKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       113 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~l  191 (602)
                      +.|+..+..+.++.+.||+..  .+++.+.+|.......    .....+.+|...+..+. +--+.+++.+....+..|+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HCEEEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCC----CCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEE
T ss_conf             352799767899877189999--0898699998488765----3255699999999987606998728999750896499


Q ss_pred             EEEEECCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHC----------------------------------------
Q ss_conf             9964037772355220389996789898999997776320----------------------------------------
Q 007478          192 YLEYVSGGSIYKLLQDYGQFGEPAIRNYTQQILSGLAFLH----------------------------------------  231 (602)
Q Consensus       192 V~E~~~ggsL~~~l~~~~~ls~~~i~~i~~qIl~gL~yLH----------------------------------------  231 (602)
                      ||++++|.++.+......     ....++.++...+..||                                        
T Consensus        88 v~~~l~G~~~~~~~~~~~-----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDEQ-----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTTTCS-----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEECCCCCCCCCCCCCC-----CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf             998604334354334402-----699999989999999855684214357644656555778998776555543033232


Q ss_pred             -------------------CCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             -------------------3890304787870898359956781158530
Q 007478          232 -------------------SKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       232 -------------------~~gIvHrDLKp~NILl~~~g~iKL~DFGla~  262 (602)
                                         ...++|+|+.+.|||+++++.+.|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf             00579999999984498678178986004764236499659996023144

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.56  E-value=1.3e-07  Score=60.38  Aligned_cols=82  Identities=15%  Similarity=0.169  Sum_probs=49.5

Q ss_pred             EEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC--HH-CHHHHHHHHHHHHHHHHCC-C--CCEEEEECCCCCCCEEEE
Q ss_conf             3068332975999999979994799999841641--00-1999999999999998269-9--957887054123455999
Q 007478          118 GKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDD--AK-SKESAKQLMQEIVLLSRLR-H--PNIVQYYGSKTVEDKLYI  191 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~--~~-~~~~~~~l~~Ei~iL~~l~-H--pnIv~l~g~~~~~~~~~l  191 (602)
                      .+.||.|....||++.+..+++.+++|.-.....  .. ......+...|+..|+.+. +  ..+.+++.+.  .+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEE
T ss_conf             998079852768999957998489996177130346777888778999999999986505798855289985--988779


Q ss_pred             EEEEECCCCH
Q ss_conf             9964037772
Q 007478          192 YLEYVSGGSI  201 (602)
Q Consensus       192 V~E~~~ggsL  201 (602)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEECCCCCCC
T ss_conf             8713577653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.42  E-value=1.5e-06  Score=54.05  Aligned_cols=135  Identities=17%  Similarity=0.065  Sum_probs=74.7

Q ss_pred             EEEECC-CEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCC--CCEEEEECCCCCCCEEEEEEEEE
Q ss_conf             683329-759999999799947999998416410019999999999999982699--95788705412345599999640
Q 007478          120 MLGRGT-FGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRH--PNIVQYYGSKTVEDKLYIYLEYV  196 (602)
Q Consensus       120 ~LG~G~-fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~H--pnIv~l~g~~~~~~~~~lV~E~~  196 (602)
                      .+..|. -+.||+... ..+..+.+|......       ...+..|+..++.+..  -.+.+++.+..+.+..++||+++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i   88 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   88 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             ECCCCCCCCEEEEEEE-CCCCEEEEEECCCCC-------HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEE
T ss_conf             7678654775899993-898789999589667-------76899999999999865999886132224566159998744


Q ss_pred             CCCCHHHHH--------------HCC-------CCCCHHH--HHHHHHH--------------------HHHHHHHHC--
Q ss_conf             377723552--------------203-------8999678--9898999--------------------997776320--
Q 007478          197 SGGSIYKLL--------------QDY-------GQFGEPA--IRNYTQQ--------------------ILSGLAFLH--  231 (602)
Q Consensus       197 ~ggsL~~~l--------------~~~-------~~ls~~~--i~~i~~q--------------------Il~gL~yLH--  231 (602)
                      +|.++.+..              .+-       ..+....  ...-...                    ....+..+.  
T Consensus        89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  168 (255)
T d1nd4a_          89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR  168 (255)
T ss_dssp             SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred             ECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf             13554322126899999999999987368854488755412468899999987541101134011213799999999871


Q ss_pred             -----CCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             -----3890304787870898359956781158530
Q 007478          232 -----SKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       232 -----~~gIvHrDLKp~NILl~~~g~iKL~DFGla~  262 (602)
                           ...++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf             876579567867888763577379658999853326

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.96  E-value=1.4e-05  Score=48.24  Aligned_cols=132  Identities=15%  Similarity=0.125  Sum_probs=71.4

Q ss_pred             CCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCCCC-----CEEEEEC--CCCCCCEEEEEEEEE
Q ss_conf             297599999997999479999984164100199999999999999826999-----5788705--412345599999640
Q 007478          124 GTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLRHP-----NIVQYYG--SKTVEDKLYIYLEYV  196 (602)
Q Consensus       124 G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~Hp-----nIv~l~g--~~~~~~~~~lV~E~~  196 (602)
                      +---.||++.. .+|..|++|+....  ..   ..+++..|+..+..|...     ..+..-+  .+...+..+.+++++
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~--~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~  106 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPE--RW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  106 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTT--TS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             CCCCEEEEEEC-CCCCEEEEEEECCC--CC---CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEEC
T ss_conf             61202699983-89997999984787--78---89999999999999985599878752068980566534799998652


Q ss_pred             CCCCHH------------------HHHHCC------------------------CCCCHH---HHHHHHHHHHHHHHHHC
Q ss_conf             377723------------------552203------------------------899967---89898999997776320
Q 007478          197 SGGSIY------------------KLLQDY------------------------GQFGEP---AIRNYTQQILSGLAFLH  231 (602)
Q Consensus       197 ~ggsL~------------------~~l~~~------------------------~~ls~~---~i~~i~~qIl~gL~yLH  231 (602)
                      .|..+.                  ......                        ..++..   .....+.+++..+.-+-
T Consensus       107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~  186 (325)
T d1zyla1         107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  186 (325)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_conf             77688999999999989999998863035786556778978876656899987476998898999999999999999845


Q ss_pred             ----CCCCEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             ----38903047878708983599567811585300
Q 007478          232 ----SKHTVHRDIKGANILVDPNGRVKLADFGMAKH  263 (602)
Q Consensus       232 ----~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~  263 (602)
                          ..++||+|+.+.|||++++  ..++||+-+..
T Consensus       187 ~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         187 REDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CCCCCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             45687120247888042878389--35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.77  E-value=0.00019  Score=41.49  Aligned_cols=75  Identities=13%  Similarity=0.113  Sum_probs=46.0

Q ss_pred             EEEEEECCCEEEEEEEECC-------CCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCC-CCCEEEEECCCCCCCEE
Q ss_conf             3068332975999999979-------994799999841641001999999999999998269-99578870541234559
Q 007478          118 GKMLGRGTFGHVYVGFNSD-------SGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-HPNIVQYYGSKTVEDKL  189 (602)
Q Consensus       118 ~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~  189 (602)
                      .+.|+.|-.-.+|++....       ..+.+.+++.-.   ...   .....+|..+++.+. +.-..++++++..    
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~---~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC---CCH---HHHHHHHHHHHHHHHHCCCCCEEEEECCC----
T ss_conf             99917853343489996887754457898179996599---611---65899999999999757999808998189----


Q ss_pred             EEEEEEECCCCHH
Q ss_conf             9999640377723
Q 007478          190 YIYLEYVSGGSIY  202 (602)
Q Consensus       190 ~lV~E~~~ggsL~  202 (602)
                      .+|+||++|..|.
T Consensus       117 g~I~efi~g~~l~  129 (395)
T d1nw1a_         117 GRLEEYIPSRPLS  129 (395)
T ss_dssp             EEEECCCCEEECC
T ss_pred             CEEEEEECCCCCC
T ss_conf             5699973455488

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.43  E-value=0.0025  Score=34.81  Aligned_cols=140  Identities=14%  Similarity=0.093  Sum_probs=72.9

Q ss_pred             CEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCHHCHHHHHHHHHHHHHHHHCC-----CCCEEEEEC---CCCCC
Q ss_conf             2473068332975999999979994799999841641001999999999999998269-----995788705---41234
Q 007478          115 WKKGKMLGRGTFGHVYVGFNSDSGEMCAMKEVTLFDDAKSKESAKQLMQEIVLLSRLR-----HPNIVQYYG---SKTVE  186 (602)
Q Consensus       115 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~l~~Ei~iL~~l~-----HpnIv~l~g---~~~~~  186 (602)
                      ....+.|..|---+.|+..... | .|++|+.....      ..+.+..|+.++..|.     .|..+...+   .....
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~------~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~   91 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   91 (316)
T ss_dssp             EEEEEEECC---EEEEEEEESS-C-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             CEEEECCCCCCCCCEEEEEECC-C-CEEEEECCCCC------CHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEE
T ss_conf             5685237888526738999789-7-28999807899------98899999999875430255545564104897621341


Q ss_pred             CEEEEEEEEECCCCHHHH--------------HH----CC-----------------------CCCCHHHHHHHHHHHHH
Q ss_conf             559999964037772355--------------22----03-----------------------89996789898999997
Q 007478          187 DKLYIYLEYVSGGSIYKL--------------LQ----DY-----------------------GQFGEPAIRNYTQQILS  225 (602)
Q Consensus       187 ~~~~lV~E~~~ggsL~~~--------------l~----~~-----------------------~~ls~~~i~~i~~qIl~  225 (602)
                      .....++.++.|......              +.    ..                       ...........+..+..
T Consensus        92 ~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  171 (316)
T d2ppqa1          92 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  171 (316)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_conf             25502453114655333204678888899876454443202453101110120024567777653114127999999987


Q ss_pred             HHHHHC----CCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             776320----3890304787870898359956781158530
Q 007478          226 GLAFLH----SKHTVHRDIKGANILVDPNGRVKLADFGMAK  262 (602)
Q Consensus       226 gL~yLH----~~gIvHrDLKp~NILl~~~g~iKL~DFGla~  262 (602)
                      .+....    ..|+||+|+.+.||+++.+...-|+||+.+.
T Consensus       172 ~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         172 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf             64204855454503337863656402045412674222123